<SEC-DOCUMENT>0001140361-22-024669.txt : 20220701
<SEC-HEADER>0001140361-22-024669.hdr.sgml : 20220701
<ACCEPTANCE-DATETIME>20220630212933
ACCESSION NUMBER:		0001140361-22-024669
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		87
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220701
DATE AS OF CHANGE:		20220630

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brooklyn ImmunoTherapeutics, Inc.
		CENTRAL INDEX KEY:			0000748592
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				311103425
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		221059377

	BUSINESS ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220
		BUSINESS PHONE:		(212) 582-1199

	MAIL ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN BUZZTIME INC
		DATE OF NAME CHANGE:	20051230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALROY INDUSTRIES INC
		DATE OF NAME CHANGE:	19850411
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>brhc10039260_10q.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:btx="http://brooklynitx.com/20220331" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.4.0.0
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="background-color: #ffffff; color: #000000;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_aef57c70c8cc45f0b03d78368815f85e" contextRef="c20220101to20220331" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" id="Fact_cfdaaf8af54240ad9c37cd21f8005599" contextRef="c20220101to20220331" format="ixt:datemonthday">12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" id="Fact_977a642547fa49a885e5e72648a16533" contextRef="c20220101to20220331">2022</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" id="Fact_d32c95b857cc49d5b025bb9697148cec" contextRef="c20220101to20220331">Q1</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_871499ceee824fa8b1f6465ab53ceb36" contextRef="c20220101to20220331">0000748592</ix:nonNumeric><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_2134c2193a6f4a199f8e2044d8c27aaf" contextRef="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">P5Y6M</ix:nonNumeric><ix:nonNumeric name="btx:AggregateCalendarDays" id="Fact_1d1a0b74074845069916ad1b1bee6544" contextRef="c20220101to20220331_InvestmentTypeAxis_PIPEInvestorMember">P15D</ix:nonNumeric><ix:nonFraction name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" id="Fact_c7f77014cf9a4ef9a688995037fe55b0" contextRef="c20210325to20210325" unitRef="U004" decimals="INF">0.5</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:href="btx-20220331.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220101to20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220309to20220309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-09</xbrli:startDate><xbrli:endDate>2022-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:PurchasePriceAllocationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:PurchasePriceAllocationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:PurchasePriceAllocationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-26</xbrli:startDate><xbrli:endDate>2021-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210701to20210930_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716_OwnershipAxis_CitiusPharmaceuticalsIncMember_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">btx:CitiusPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220309_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:DheshGovenderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-15</xbrli:startDate><xbrli:endDate>2021-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210205to20210205_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-05</xbrli:startDate><xbrli:endDate>2021-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210205to20210205_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-05</xbrli:startDate><xbrli:endDate>2021-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211215to20211215_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:DheshGovenderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-15</xbrli:startDate><xbrli:endDate>2021-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_LegalEntityAxis_UniversityOfSouthFloridaMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">btx:UniversityOfSouthFloridaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210413to20210413_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-13</xbrli:startDate><xbrli:endDate>2021-04-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210430to20210430_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-30</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210415to20210415_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-15</xbrli:startDate><xbrli:endDate>2021-04-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210426_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember_StatementScenarioAxis_ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_RelatedPartyTransactionsByRelatedPartyAxis_NoveCiteMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NoveCiteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180622to20180622_TypeOfArrangementAxis_CollaboratorRoyaltyAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">btx:CollaboratorRoyaltyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-22</xbrli:startDate><xbrli:endDate>2018-06-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">btx:InvestorRoyaltyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-22</xbrli:startDate><xbrli:endDate>2021-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20120501to20120501_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">btx:InvestorRoyaltyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-05-01</xbrli:startDate><xbrli:endDate>2012-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210331_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_TimeBasedNonQualifiedStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:TimeBasedNonQualifiedStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_PerformanceBasedNonqualifiedStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:PerformanceBasedNonqualifiedStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_TimeBasedNonQualifiedStockOptionMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:TimeBasedNonQualifiedStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">btx:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_EmployeeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">btx:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_InvestmentTypeAxis_PIPEInvestorMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325_StatementClassOfStockAxis_CommonClassCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220524to20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-24</xbrli:startDate><xbrli:endDate>2022-05-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220524_AwardTypeAxis_MilestoneOptionsMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:MilestoneOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220524to20220524_AwardTypeAxis_MilestoneOptionsMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:MilestoneOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-24</xbrli:startDate><xbrli:endDate>2022-05-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U001"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U002"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U003"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U004"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U005"><xbrli:measure>btx:BoardMember</xbrli:measure></xbrli:unit><xbrli:unit id="U006"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U007"><xbrli:measure>btx:Patents</xbrli:measure></xbrli:unit><xbrli:unit id="U008"><xbrli:measure>btx:Grant</xbrli:measure></xbrli:unit><xbrli:unit id="U009"><xbrli:measure>btx:Installment</xbrli:measure></xbrli:unit><xbrli:unit id="U010"><xbrli:measure>btx:Goals</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div style="text-align: center; font-weight: bold;">
          <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;" />
          <div style="color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</div>

          <div style="font-size: 12pt; font-weight: bold;">Washington, D.C. 20549<br />
          </div>

          <div>&#160;</div>

          <div style="font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_65a5bd1dc56e4e9fa76fe4c159364cb1" contextRef="c20220101to20220331">10-Q</ix:nonNumeric></div>

          <div>&#160;</div>

          <div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: normal;">(Mark One)</div>

          </div>

          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:DocumentQuarterlyReport" id="Fact_f5695269fd9849b1ad3e287311e756db" contextRef="c20220101to20220331" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric><br />
                </td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
                </td>

  </tr>


</table>
          <div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold;"> <br />
            </div>

            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">For the quarterly period ended <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_1a5e02a723a44803911ce76215333228" contextRef="c20220101to20220331" format="ixt:datemonthdayyearen">March 31, 2022</ix:nonNumeric></div>

          </div>

          <div>
            <div style="color: rgb(0, 0, 0);">or</div>

          </div>

          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:DocumentTransitionReport" id="Fact_8f0bb10d72d14a57a69b5a993fd689db" contextRef="c20220101to20220331" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                </td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
                </td>

  </tr>


</table>
          <div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> <br />
            </div>

            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">For the transition period from _________ to _____________</div>

          </div>

          <div>&#160;</div>

          <div style="font-weight: bold;">Commission file number: <ix:nonNumeric name="dei:EntityFileNumber" id="Fact_90945eedff1d43ccb6b9f2cf10eb4255" contextRef="c20220101to20220331">001-11460</ix:nonNumeric></div>

          <div>&#160; <br />
          </div>

          <div><img src="image00001.jpg" alt="graphic" /></div>

          <div style="font-weight: bold;"> <br />
          </div>

          <div style="font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_667a4cb77c0e4f97a5f98867d5da68f7" contextRef="c20220101to20220331">Brooklyn ImmunoTherapeutics, Inc.</ix:nonNumeric><br />
          </div>

          <div style="font-style: italic; font-weight: normal;">(Exact name of registrant as specified in its charter)</div>

          <div>&#160;</div>

          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_365d4ddc9f38423e9711b8d4963edc92" contextRef="c20220101to20220331" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_97b5b2e4b47d404f9034ad5fbfd3ff25" contextRef="c20220101to20220331">31-1103425</ix:nonNumeric><br />
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-style: italic;">(State of incorporation)</div>
                </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-style: italic;">(I.R.S. Employer Identification No.)</div>
                </td>

  </tr>


</table>
          <div><br />
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_24198666a6e1424db0ed06e7967ad2a3" contextRef="c20220101to20220331">10355 Science Center Drive, Suite 150</ix:nonNumeric></div>
                  <div style="text-align: center; font-weight: bold;"> <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_7ddd7994e15149029c9b495d3f55e217" contextRef="c20220101to20220331">San Diego</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_d6a7dfe18d2540d191c1187b4d1f1189" contextRef="c20220101to20220331" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></div>
                </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; text-align: center;">
                  <div style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_0e555dd5288741d7b9cd4cb57dbe1c83" contextRef="c20220101to20220331">92121</ix:nonNumeric><br />
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-style: italic;">(Address of principal executive offices)</div>
                </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-style: italic;">(Zip Code)</div>
                </td>

  </tr>


</table>
          <div style="font-weight: bold;"> <br />
          </div>

          <div style="font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_aec6d7905fe745589eba585f16b05baa" contextRef="c20220101to20220331">212</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_3140b70708c34c3b9a68858bc300e443" contextRef="c20220101to20220331">582-1199</ix:nonNumeric></div>

          <div style="font-style: italic; font-weight: normal;">(Registrant&#8217;s telephone number, including area code)</div>

          <div><br />
          </div>

          <div style="color: rgb(0, 0, 0); font-weight: normal;">Securities registered pursuant to Section 12(b) of the Act:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; color: rgb(0, 0, 0);">Title of each class</div>
                  </div>
                </td>

    <td style="width: 2%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; color: rgb(0, 0, 0);">Trading symbol</div>
                  </div>
                </td>

    <td style="width: 2%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; color: rgb(0, 0, 0);">Name of each exchange on which registered</div>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 32%; vertical-align: top;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_784fd6f68af849e29a263038edce410e" contextRef="c20220101to20220331">Common Stock, $0.005 par value</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 32%; vertical-align: top;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_e013b520c9f44ff789c9f63b9dd0b8af" contextRef="c20220101to20220331">BTX</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 32%; vertical-align: top;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_62cb464167ec4dbf90e91b7d4085fc8e" contextRef="c20220101to20220331" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric><br />
                  </div>
                </td>

  </tr>


</table>
          <div style="text-align: justify; font-weight: normal;"> <br />
          </div>

          <div style="text-align: justify; font-weight: normal;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
            for such shorter period that the registrant <span style="color: rgb(0, 0, 0);">was required to file </span>such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric name="dei:EntityCurrentReportingStatus" id="Fact_76afc7460ee64ea68778bff5cb3053c1" contextRef="c20220101to20220331">Yes</ix:nonNumeric> &#9746; No &#9744;</div>

          <div style="font-weight: normal;">&#160;</div>

          <div style="text-align: justify;"><span style="color: rgb(0, 0, 0); font-weight: normal;">Indicate by check mark whether the registrant has submitted electronically every interactive data file required to be submitted pursuant to Rule 405 of
              Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric name="dei:EntityInteractiveDataCurrent" id="Fact_bd444aff6e7b4585aa924e220d53ef0e" contextRef="c20220101to20220331">Yes</ix:nonNumeric> </span><span style="font-weight: normal;">&#9746;</span><span style="color: rgb(0, 0, 0); font-weight: normal;">&#160; No &#9744;</span></div>

          <div style="font-weight: normal;">&#160;</div>

          <div style="text-align: justify; font-weight: normal;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See
            definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>

          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 20%; vertical-align: top; font-weight: normal;">
                  <div style="text-align: justify;">Large accelerated filer</div>
                </td>

    <td style="width: 45%; vertical-align: bottom; font-weight: normal;">&#9744;</td>

    <td style="width: 20%; vertical-align: bottom; font-weight: normal;">
                  <div style="text-align: justify;">Accelerated filer</div>
                </td>

    <td style="width: 5%; vertical-align: bottom; font-weight: normal;">
                  <div style="text-align: justify;">&#9744;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 20%; vertical-align: top; font-weight: normal;">
                  <div style="text-align: justify;"><ix:nonNumeric name="dei:EntityFilerCategory" id="Fact_6ad38af2f2c743f7a2915bc8443fc032" contextRef="c20220101to20220331" format="ixt-sec:entityfilercategoryen">Non-accelerated filer</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="width: 45%; vertical-align: bottom; font-weight: normal;">&#9746;</td>

    <td style="width: 20%; vertical-align: bottom; font-weight: normal;">
                  <div style="text-align: justify;">Smaller reporting company</div>
                </td>

    <td style="width: 5%; vertical-align: bottom; font-weight: normal;"><ix:nonNumeric name="dei:EntitySmallBusiness" id="Fact_ccf1d8e8266345448d6fdca3a5cd7b08" contextRef="c20220101to20220331" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric><br />
                </td>

  </tr>

  <tr>

    <td style="width: 20%; vertical-align: top; font-weight: normal;">&#160;</td>

    <td style="width: 45%; vertical-align: bottom; font-weight: normal;">&#160;</td>

    <td style="width: 20%; vertical-align: bottom; font-weight: normal;">
                  <div style="text-align: justify;">Emerging growth company</div>
                </td>

    <td style="width: 5%; vertical-align: bottom; font-weight: normal;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_b9f91141568345a09bf6e35e6d05b327" contextRef="c20220101to20220331" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                </td>

  </tr>


</table>
          <div style="text-align: justify; font-weight: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
            standards provided <span style="color: rgb(0, 0, 0);">pursuant to </span>Section 13(a) of the Exchange Act. &#9744;</div>

          <div style="font-weight: normal;">&#160;</div>

          <div style="text-align: justify; font-weight: normal;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <ix:nonNumeric name="dei:EntityShellCompany" id="Fact_95af04fbd2c948c29a2cb7458163301a" contextRef="c20220101to20220331" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric>&#160; No &#9746;</div>

          <div style="font-weight: normal; text-align: left;">&#160; <br />
          </div>

          <div style="text-align: justify; font-weight: normal;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of June 30, 2022, the registrant had outstanding <ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" id="Fact_bc957f6268e2465a826577b07f033e50" contextRef="c20220630" unitRef="U001" decimals="INF" scale="0" format="ixt:numdotdecimal">57,468,597</ix:nonFraction> shares of common stock, $0.005 par value per share.</div>

          </div>

          <div style="text-align: justify;">
            <p style="font: 10pt 'Times New Roman'; margin: 0px; text-indent: 24.5pt;">&#160;</p>
          </div>

          <div style="text-align: justify;">
            <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /> </div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="page-break-after:always;" class="DSPFPageBreak">
              <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          </div>

          <!--PROfilePageNumberReset%LCR%1%%%--> </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><a id="TABLEOFCONTENTS"><!--Anchor--></a><!--Anchor--><!--Anchor-->TABLE OF CONTENTS</div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 6%; vertical-align: top;">&#160;</td>

    <td style="width: 89%; vertical-align: top;">&#160;</td>

    <td style="width: 5%; vertical-align: top;">
                <div style="text-align: right; color: rgb(0, 0, 0); font-weight: bold;"><span style="text-decoration: underline;">Page</span></div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: top;" colspan="2">
                <div style="text-align: justify; color: rgb(0, 0, 0);">PART I &#8211; FINANCIAL INFORMATION</div>
              </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                <div style="text-align: justify; color: rgb(0, 0, 0);">Item 1.</div>
              </td>

    <td style="width: 89%; vertical-align: top;">
                <div style="text-align: justify; color: rgb(0, 0, 0);">Financial Statements (unaudited)</div>
              </td>

    <td style="width: 5%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div><a href="#BALANCESHEETS">Condensed Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021</a></div>
              </td>

    <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">
                <div style="color: rgb(0, 0, 0);">1</div>
              </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">&#160;</td>

    <td style="width: 89%; vertical-align: top;">
                <div><a href="#STATEMENTSOFOPERATIONS">Condensed Consolidated Statements of Operations for the three months ended March 31, 2022 and 2021</a></div>
              </td>

    <td style="width: 5%; vertical-align: bottom; text-align: right;">
                <div style="color: rgb(0, 0, 0);">2</div>
              </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;"><a href="#STOCKHOLDERSANDMEMBERSEQU">Condensed Consolidated Statements of Changes in Stockholders&#8217; and Members&#8217; Equity (Deficit) for the three months ended March 31, 2022 and 2021</a></div>
              </td>

    <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">
                <div style="color: rgb(0, 0, 0);">3</div>
              </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">&#160;</td>

    <td style="width: 89%; vertical-align: top;">
                <div style="text-align: justify;"><a href="#CASHFLOWS">Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2022 and 2021</a></div>
              </td>

    <td style="width: 5%; vertical-align: bottom; text-align: right;">
                <div style="color: rgb(0, 0, 0);">4<br />
                </div>
              </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;"><a href="#NOTES">Notes to Condensed Consolidated Financial Statements</a><br />
                </div>
              </td>

    <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">5</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">Item 2.</div>
              </td>

    <td style="width: 89%; vertical-align: top;">
                <div><a href="#Item2.">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></div>
              </td>

    <td style="width: 5%; vertical-align: bottom; text-align: right;">23</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; color: rgb(0, 0, 0);">Item 3.</div>
              </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;"><a href="#Item3.">Quantitative and Qualitative Disclosures About Market Risk</a></div>
              </td>

    <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">31</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                <div style="text-align: justify; color: rgb(0, 0, 0);">Item 4.</div>
              </td>

    <td style="width: 89%; vertical-align: top;">
                <div style="text-align: justify;"><a href="#Item4.">Controls and Procedures</a></div>
              </td>

    <td style="width: 5%; vertical-align: bottom; text-align: right;">31</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top;" colspan="2">
                <div style="text-align: justify; color: rgb(0, 0, 0);">PART II &#8211; OTHER INFORMATION</div>
              </td>

    <td style="width: 5%; vertical-align: bottom; text-align: right;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; color: rgb(0, 0, 0);">Item 1.</div>
              </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;"><a href="#LegalProceedings.">Legal Proceedings</a></div>
              </td>

    <td style="width: 5%; vertical-align: bottom; background-color: rgb(204, 238, 255); text-align: right;">32</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;">
                <div style="text-align: justify; color: rgb(0, 0, 0);">Item 1A.</div>
              </td>

    <td style="width: 89%; vertical-align: top;">
                <div style="text-align: justify;"><a href="#RiskFactors.">Risk Factors</a></div>
              </td>

    <td style="width: 5%; vertical-align: bottom; text-align: right;">33</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">Item 2. <br />
              </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#UnregisteredSalesofEquity">Unregistered Sales of Equity Securities and Use of Proceeds</a></div>
              </td>

    <td style="width: 5%; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255);" rowspan="1">33<br />
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 6%; vertical-align: top;">Item 3. <br />
              </td>

    <td rowspan="1" style="width: 89%; vertical-align: top;"><a href="#DefaultsUponSeniorSecurit">Defaults Upon Senior Securities </a><br />
              </td>

    <td rowspan="1" style="width: 5%; vertical-align: bottom; text-align: right;">33 <br />
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">Item 4. <br />
              </td>

    <td rowspan="1" style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);"><a href="#MineSafetyDisclosures.">Mine Safety Disclosures </a><br />
              </td>

    <td rowspan="1" style="width: 5%; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255);">33 <br />
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 6%; vertical-align: top;">Item 5. <br />
              </td>

    <td rowspan="1" style="width: 89%; vertical-align: top;"><a href="#OtherInformation.">Other Information </a><br />
              </td>

    <td rowspan="1" style="width: 5%; vertical-align: bottom; text-align: right;">33 <br />
              </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; color: rgb(0, 0, 0);">Item 6.</div>
              </td>

    <td style="width: 89%; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify;"><a href="#Exhibits.">Exhibits</a></div>
              </td>

    <td style="width: 5%; vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255);">34</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top;" rowspan="1" colspan="2">
                <div style="text-align: justify;"><a href="#SIGNATURE">Signatures</a></div>
              </td>

    <td style="width: 5%; vertical-align: bottom; text-align: right;">35</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">i</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div>
          <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

          <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

          <div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">This Quarterly Report on Form 10-Q contains &#8220;forward-looking statements&#8221; as that term is defined under the Private Securities Litigation
              Reform Act of 1995 (&#8220;PSLRA&#8221;), Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Forward-looking statements include statements
              related to future events, results, performance, prospects and opportunities, including statements related to our strategic plans and targets, revenue generation, product availability and offerings, capital needs, capital expenditures,
              industry trends and our financial position. Forward-looking statements are based on information currently available to us, on our current expectations, estimates, forecasts, and projections about the industries in which we operate and on the
              beliefs and assumptions of management. Forward looking statements often contain words such as &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;could,&#8221; &#8220;targets,&#8221; &#8220;projects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and similar
              expressions. In addition, any statements that refer to projections of our future financial performance, our anticipated growth and trends in our business, and other characterizations of future events or circumstances, are forward-looking
              statements. Forward-looking statements by their nature address matters that are, to different degrees, subject to risks and uncertainties that could cause actual results to differ materially and adversely from those expressed in any
              forward-looking statements. For us, particular factors that might cause or contribute to such differences include those risks and uncertainties described in Part I, Item 1A &#8220;Risk Factors&#8221; of our Annual Report on Form 10-K for the year ended
              December 31, 2021 and described in other documents we file from time to time with the Securities and Exchange Commission, or SEC.</div>

          </div>

          <div>
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

          </div>

          <div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Readers are urged not to place undue reliance on the forward-looking statements in this Quarterly Report on Form 10-Q, which speak only as
              of the date of this Quarterly Report on Form 10-Q. We are including this cautionary note to make applicable, and take advantage of, the safe harbor provisions of the PSLRA. Except as required by law, we do not undertake, and expressly
              disclaim any obligation, to disseminate, after the date hereof, any updates or revisions to any such forward-looking statements to reflect any change in expectations or events, conditions or circumstances on which any such statements are
              based.</div>

          </div>

          <div>
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

          </div>

          <div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We believe that the expectations reflected in forward-looking statements in this Quarterly Report on Form 10-Q are based upon reasonable
              assumptions at the time made. However, given the risks and uncertainties, you should not rely on any forward- looking statements as a prediction of actual results, developments or other outcomes. You should read these forward-looking
              statements with the understanding that we may be unable to achieve projected results, developments or other outcomes and that actual results, developments or other outcomes may be materially different from what we expect.</div>

          </div>

          <div>
            <div><br />
            </div>

          </div>

          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Unless stated otherwise or the context otherwise requires, all references in this Quarterly Report on Form 10-Q to &#8220;Brooklyn&#8221; refer to Brooklyn ImmunoTherapeutics,
            Inc., &#8220;Brooklyn LLC&#8221; refer to Brooklyn ImmunoTherapeutics LLC, a wholly owned subsidiary of Brooklyn, and to &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; refer to Brooklyn. and its subsidiaries, including Brooklyn LLC, Novellus, Inc. and Novellus
            Therapeutics Limited.</div>

          <div>
<div><br /></div>

            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
              <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">ii</span></div>

              <div style="page-break-after: always;" class="DSPFPageBreak">
                <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

              <div style="width: 100%;" class="DSPFPageHeader">
                <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
                </div>

              </div>

            </div>

            <!--PROfilePageNumberReset%Num%1%%%--> </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div style="text-align: center; font-weight: bold;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">PART I. FINANCIAL
            INFORMATION</div>

          <div><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

          <div><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
            </span> </div>

          <div><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Item 1. Financial
            Statements</div>

        </div>

        <div style="text-align: center; font-weight: bold;"> <br />
        </div>

        <div style="text-align: center; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>

        <div style="text-align: center; font-weight: bold;">&#160;<!--Anchor-->CONDENSED CONSOLIDATED
          <!--Anchor--><a id="BALANCESHEETS"><!--Anchor--></a>BALANCE SHEETS<!--Anchor--></div>

        <div style="text-align: center; font-weight: bold;"> (In thousands, except par value amount)<br />
        </div>

        <div style="text-align: center; font-weight: bold;"> <span style="font-weight: bold;">(Unaudited)</span></div>

        <div style="text-align: center; font-weight: bold;"><span style="font-weight: bold;"> <br />
          </span></div>

        <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" colspan="1" style="vertical-align: top; font-family: &#38;amp; padding-bottom: 2px;"><br />
              </td>

    <td valign="bottom" colspan="1" style="font-family: &#38;amp; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">March 31,</div>
                <div style="color: rgb(0, 0, 0); font-weight: bold;">2022<br />
                </div>
              </td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
                <div style="color: rgb(0, 0, 0); font-weight: bold;">2021<br />
                </div>
              </td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-weight: bold; text-indent: -9pt; margin-left: 9pt;">ASSETS<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; text-align: center;"><br />
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Current assets:</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Cash</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Cash" id="Fact_95dda23c92d847678e06bd2488a77e2c" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">23,500</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Cash" id="Fact_00fbac43fe3841daa4f9f17da38d8a8c" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">16,985</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Other receivable</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" id="Fact_eb3475879c984b229da0795b69991627" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">835</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" id="Fact_ee182beb80e7427a8e44921a96eb5c21" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">684</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Prepaid expenses and other current assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" id="Fact_924d072972a64dd2b93231a29a239d7a" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">800</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" id="Fact_633ad162eaa44dc4a84145c32d193f57" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,097</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 27pt;">Total current assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_b1a7b6ef9531485da0a1aaaacd639959" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">25,135</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_5ad64840ea984061bb9d10cc8681d789" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">18,766</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Property and equipment, net</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_95132a85f15144539816df2bb02a1d59" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">308</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_616e4d8489d14af6aed2f9d5c53fce4f" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">670</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Right-of-use assets - operating leases<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_2d6c8bfbafe64faeb5325d376d987e88" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,093</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_d3cbf3d126324979a3925bafe52a7e54" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,567</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Goodwill</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_8c5567a64f284563936e2406a212f5be" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,044</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_a91021e738a643ea81d1a3e80a79f3b8" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,044</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">In-process research and development<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" id="Fact_2563293303b0443184d81479b5fd26fe" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,990</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" id="Fact_305c31e3e34e447498e6f4e82b5a4c36" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,990</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;" rowspan="1">&#160;&#160;&#160; Investment in non-controlling interest<br />
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1"><ix:nonFraction name="us-gaap:EquityMethodInvestments" id="Fact_f765a194746c48209deb2d7ac37174bf" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">385</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1"><ix:nonFraction name="us-gaap:EquityMethodInvestments" id="Fact_e1f3e4ff044e4d9596113337af2cbe4a" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Security deposits and other assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DepositAssets" id="Fact_61ebf41ddf65449da4bbbaf14da5eec2" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">421</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DepositAssets" id="Fact_c031daa388624efd81b9d901e8502cfd" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">488</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 27pt;">Total assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Assets" id="Fact_c7903c4571694ce9b1482fe730890507" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">35,376</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Assets" id="Fact_ee512d5e84194a08af027857dfe049d1" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">31,525</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); font-weight: bold; text-indent: -9pt; margin-left: 9pt;">LIABILITIES AND STOCKHOLDERS' EQUITY<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Current liabilities:</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Accounts payable</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" id="Fact_ddf230f2796345b395bd34589bc38b79" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,106</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" id="Fact_33a32138c0854027ad3522b61cc19cfa" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,755</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Accrued expenses</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_b61db524492d4b58bfb731f1120e6aff" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,384</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_d831c2cccf664f6d8fc457e89d5ba8c0" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,249</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Operating lease liabilities, current<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_b94f6793cab6457eb78f7e1832ba896a" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">149</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_ef94ba6be7944a3c824a289d1e306ede" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">426</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; text-indent: 9pt; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">Other current liabilities</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" id="Fact_8dd64977a66549d6920b51ec5a568387" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">45</ix:nonFraction><br />
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" id="Fact_f9fd8dad044942f499343933f2acd4fb" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">247</ix:nonFraction><br />
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 27pt;">Total current liabilities</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_6be829a26ca64ba286ba625da0ea7b54" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,684</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_9b27efcee29f42e691e5c5ab0193ece9" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,677</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Warrant liabilities<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" id="Fact_81c39921f8f1494584e9b0e0df2f3e0d" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">13,315</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" id="Fact_3d35589e2cd049a4b429279cfc9bb764" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Operating lease liabilities, non-current<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_abf2a7f4593748bdb9998514f383eb09" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,018</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_b71b9a9e7c01476da652aa1645264aa9" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,297</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Other liabilities</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_993b24efd49d450d9d4bd629f60f4d81" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">48</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_12693b77fb904038aee287c909bdd16b" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">48</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 27pt;">Total liabilities</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_47d0c88d67d143fd882dbfd3c41ba003" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">18,065</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_c4685ad725a0456896a4daaea179f7cc" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,022</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Stockholders' equity:<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" rowspan="1">
                <div style="text-indent: -18pt; margin-left: 18pt;">&#160;&#160;&#160; Preferred stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_c0ea5613ea6d40f0b9dffe14abd1edc5" contextRef="c20220331" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_bcd8709d033f428e8173ed7775036d5c" contextRef="c20211231" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal">0.005</ix:nonFraction></ix:nonFraction></span> par value, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_4ac7253f1c734f6ea97099ac1ba020da" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_4a03470ef4d44c388f86bc6c1a210cb6" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></ix:nonFraction></span> shares authorized, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_f02586de8d224caaadf31d214af57aa9" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_cf2c9722e4d248b3800a3c6265700290" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_9249699cab6b4d61b305f727f21d5fb3" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_62790db89ed1415c8007a230ba3678a0" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span>
                  designated and outstanding of Series A convertible preferred stock at <span style="text-indent: 0pt;">March 31</span>, <span style="text-indent: 0pt;">2022</span> and <span style="text-indent: 0pt;">December 31</span>, <span style="text-indent: 0pt;">2021</span>, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockLiquidationPreferenceValue" id="Fact_ebb9e8aebf25456688cf39b98102f735" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockLiquidationPreferenceValue" id="Fact_6d87828446cb4966bfa8abfdc0b31371" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></ix:nonFraction></span> liquidation
                  preference<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" rowspan="1"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_bf15d0c11c1f4cf69948bff8bdbae6bb" contextRef="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" rowspan="1"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_45395650bc8540d6bb8258ab24654d4f" contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Common stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_bff4899c7a4c455b8db15fdbcecbf908" contextRef="c20220331" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_257c1ec62cdd4252b18550449dd232ac" contextRef="c20211231" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal">0.005</ix:nonFraction></ix:nonFraction></span> par value, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_7119e67f1a7d414fbf6f3bffc85e9a59" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_3e6a98d480254a9d85432242ebb4f684" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">100,000</ix:nonFraction></ix:nonFraction></span> shares authorized at March 31, 2022 and December 31, 2021; <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_f601d269d9c04248b625a64786b12601" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_2e2aaa0c1032417d9bb0449e4aa7a77f" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57,452</ix:nonFraction></ix:nonFraction></span> and <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_7915b2a904804cc7a5afe329e97d0616" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_697836017c014cf592042b99e699dc22" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">52,021</ix:nonFraction></ix:nonFraction></span> issued and outstanding at <span style="text-indent: 0pt;">March 31</span>, <span style="text-indent: 0pt;">2022</span> and <span style="text-indent: 0pt;">December 31</span>, <span style="text-indent: 0pt;">2021</span>,
                  respectively</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_2b231a38168d4d269f9df29f7d542e8a" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">287</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_ca85d9de920342b1b645849103698793" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">260</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Additional paid-in capital</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_67dbf3fddadd48278c72fff99da58c09" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">167,100</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_0f4c94f4fa8e4d368768b6209f607800" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">165,944</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Accumulated deficit</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_1e9c34acc7db4ab88c524eb84650e8ca" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">150,077</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_05e0332d63fc428795de517bc62f82c3" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">140,702</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 27pt;">Total stockholders' equity<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_25a6999c8d124f7399563b7bb55bef01" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">17,311</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_7598124631174cfd8973ed650ad791d0" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">25,503</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"></div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 27pt;">Total liabilities and stockholders' equity<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_cf6023ac81b54e04b6ab6b340a1e0533" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">35,376</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_9ffeeb1208514f12a9d7a2f5890fbd93" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">31,525</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="text-align: center;">The accompanying notes are an integral part of these condensed consolidated financial statements.</div>

        <div style="text-align: center;"><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">1</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div><br />
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div style="text-align: center; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>

        <div style="text-align: center; font-weight: bold;">CONDENSED CONSOLIDATED <a id="STATEMENTSOFOPERATIONS"><!--Anchor--></a>STATEMENTS OF
          <!--Anchor-->OPERATIONS</div>

        <div style="text-align: center; font-weight: bold;">(In thousands, except per share amounts) </div>

        <div style="text-align: center; font-weight: bold;">(Unaudited)<br />
        </div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: middle; padding-bottom: 2px;"></td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: middle; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three months ended </div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 31,<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: middle; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Operating expenses:</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: middle;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: middle;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Research and development</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" id="Fact_638da90062cd47d28b4719ccb2eea0ba" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,782</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" id="Fact_c06dc0ded1a747d0951bc9b3f8b2d372" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,533</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">General and administrative</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" id="Fact_ef9b1759e1f041d596bc1c44f74cf24b" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,514</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" id="Fact_4303baf2aa5d49d597002feb679c21fa" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,623</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Transaction costs</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_a14450f374904865ac1131e50ad6c5d0" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_f61c333b1d3c4f22a01f006205b5adbc" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,765</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Total operating expenses</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_e5d0ec864b02499094c367f614eec7a3" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,296</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_62d72f53a28b42299ebf56f6f5da2e51" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,921</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Loss from operations</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_9fdd6512576e4100950533de5cde4914" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">6,296</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div>)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_785ff7982f0840c0b347b4d9ff17bdff" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,921</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Other expense, net:</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Loss on sale of NTN assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" id="Fact_9a1799e4e0134f3aa87371c04a2f3cf9" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" id="Fact_44958a1413374818ba9901628d0b4651" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,598</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div>Warrant liabilities expense</div>
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="btx:WarrantLiabilitiesExpense" id="Fact_53d505377236445c86e128619cac887c" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,322</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="btx:WarrantLiabilitiesExpense" id="Fact_6670b672141443c29a6dc1dd59eeba9f" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div>Loss on non-controlling investment<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="btx:LossOnNonControllingInvestment" id="Fact_552a4ab3f8e14a388aa62735aade4317" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">615</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="btx:LossOnNonControllingInvestment" id="Fact_42ef133b96044de7b11dcaf894db4eaa" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;">Other expense, net</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_6a8708a11c274af8b4e3b81addb20b02" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,142</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_39aecb992abb4ffb8c1d329a9b367dbc" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Total other expense, net<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div>(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_3b3bf10b2349469f81ecc69d0b5a1b32" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,079</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div>)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div>(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_4471b3114cae4a41a9c17b132f5eee0b" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,601</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div>Loss before income taxes<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_e47e0542533940909d3b8c78af5c3dde" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,375</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_d58c341ef3dd4d60ac3d10cc9658e534" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">18,522</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div>Provision for income taxes<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_8fa1b6517b524c8aa4e9bb218b205013" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_59ac382acc6d40549d5617007c42af17" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-weight: normal; text-indent: -9pt; margin-left: 9pt;">Net loss<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-weight: normal;"><br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-weight: normal;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_e33161285d0f4df7834928f03ace8720" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,375</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-weight: normal;">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-weight: normal;"><br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-weight: normal;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_20f87eec178b4014a22aca84f41fd070" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">18,522</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); font-weight: normal;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">Net loss per common share - basic and diluted<br />
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_da77134d0a68447790b46fb321f69fc9" contextRef="c20220101to20220331" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_5312d54b879e4e1981195aa9b8da666b" contextRef="c20220101to20220331" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal">0.17</ix:nonFraction></ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_8ccb809c99d24fc1b160b7febc867d56" contextRef="c20210101to20210331" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_bc79c45faf4e4bcba1d6cd7b5e7f5713" contextRef="c20210101to20210331" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal">0.67</ix:nonFraction></ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt;">Weighted average shares outstanding - basic and diluted<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_1e634c49205d45dbb042797965db0987" contextRef="c20220101to20220331" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_4d9c9f0ce11e43119b1623143a4cf04f" contextRef="c20220101to20220331" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">53,626</ix:nonFraction></ix:nonFraction><br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_596f3d01fea94e519e499c0c52c2f54f" contextRef="c20210101to20210331" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_079fbcfe08714d74b2e91efadeb3e35c" contextRef="c20210101to20210331" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">27,799</ix:nonFraction></ix:nonFraction><br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="text-align: center;">
          <div>The accompanying notes are an integral part of these condensed consolidated financial statements.</div>

        </div>

        <div style="text-align: center;"><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-weight: normal; font-style: normal; font-family: 'Times New Roman'; font-size: 8pt;" class="DSPFPageNumber">2</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div><br />
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div style="text-align: center; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>

        <div style="text-align: center; font-weight: bold;">
          <div>CONDENSED <a id="STOCKHOLDERSANDMEMBERSEQU"><!--Anchor--></a><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; orphans: 2; text-align: center; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; AND <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; orphans: 2; text-align: center; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">MEMBERS&#8217; </span>EQUITY<br />
            </span></div>

          <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; orphans: 2; text-align: center; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">For the three months ended March 31, 2022 and 2021 </span>(unaudited)</div>

          <div> (In thousands)<br />
          </div>

          <div> <br />
          </div>

          <div>
            <table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="14" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Membership Equity</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common Stock</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Series A Preferred </div>
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; font-weight: bold;">
                    <div> Additional</div>
                    <div>Paid-in </div>
                  </td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center;">Accumulated </td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Class A</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Class B</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Class C</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Capital</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Deficit</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total<br />
                    </div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balances at January 1, 2022</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_021a43c16ad04c199d62831ee1108f2a" contextRef="c20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_d451a8e4ff974e0e8e38f345be3fad53" contextRef="c20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_181f9f45f9784dcba61f700b72b00097" contextRef="c20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_69494900a391493989087818caf5a814" contextRef="c20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_d85dff8702074816bae87816a9f72842" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">52,021</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_c46cb9955f384bd4b8619b95be257158" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">260</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_097bf552b705490386fc6a29eaf241bd" contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_f248a10a32d649b2a103b8664459b0b4" contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_4a1904236f30431e8e3e576a7dbed27f" contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">165,944</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_be7f2d44384648728f38ab609891f5a3" contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">140,702</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_3fa83c71273841a5ad4ce1ded0c1dbc1" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">25,503</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Issuance of common stock in connection with private offering<br />
                    </div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_5ae1259c7f3c4fc7969e7949f4bfbafa" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_e12e78d60ac94ad9b8760203b2b4f64b" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_b5611cef85cd4c748f1021a99c94f0a0" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_04dd63f7c2cd402ab8823eb56cc33a15" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesPrivateOffering" id="Fact_f6ff24b6eedd486ab489343f14ae5bdc" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,500</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_5862d7434c7f4d39ae825c856e43893d" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">27</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesPrivateOffering" id="Fact_88aa48d6c3c24ad19d6df2cca204df07" contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_894493f8307a466da576c87d1964915a" contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_851392d1a4644ae9b30517a41bbec111" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">27</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_583e8f7d1e614a1ebd6f8761d88e3398" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_9d09b37e76be471cb22dfe520213f0d7" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Forfeiture of unvested restricted stock</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_8eb46ca6588446758b19acbf7e1f3189" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_e078d807bd934554986704e2d71d465e" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_551c93c41029416f95679eeb279f2b5f" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_66ace6e70e324ec18aa15c786b26583f" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_cd96b1e09b98430cb62c557909dc3bec" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">78</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_2b9f8aff93a24ba99118db25ad946c65" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_903756cafed1419b9c1bb68469a1929b" contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_aa856bdba1994604b1940e5f4666a4e9" contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_e50b429010514e2fa572539c120445fc" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_1da12b20d73844f5a4c7755cad143cf3" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_a5855929461c4057a1e524d4db19e802" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 12%;">
                    <div style="margin: 0px 0px 0px 7.2px; text-indent: -7.2px; font-weight: normal;">Issuance of common stock from vested restricted stock units<br />
                    </div>
                  </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_fa0893034efb4c078b3e78a8fac4fa6a" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_295708c3f52c48b0932a207535627c45" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_2774dce1ed044e348cd9056ebc3e07fa" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_9e21a898e5b1481d9abcd36e9cd8bc26" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_2a99190771f146858bf76ad5eba19200" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_057eb34be87a43bab4a26f25112f0549" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_f4df2c76923245c8918beeb4e300bd90" contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_cc191e263ebc4e72af1bfdcf6bc61292" contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_65d11ddaae2041b381d6f3153b6a3b76" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_ca05db0443da4986973f072a5e44abc4" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_7433d31dc3624a498047a5b6320bdb7a" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Stock-based compensation</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_594eae94e7e24e5fbf11da5dab4959eb" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_190372b01ec44e94b8bb5106148e4a19" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_f48d41463b904e52accc6f9f1c515178" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_6d11f5efa3c94b21804ac0a32838746e" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_3dcfe89db30045068f68bcc7d0041823" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_4c80ce931c794157b70a4f02ed73a6db" contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_965453016afa4abdaae25b9080cef784" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,183</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_71109d136b3941a69ee9815270c8b2af" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_e63d8b115d374e99a0f61e18c0972791" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,183</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; padding-bottom: 2px;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Net loss</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_a2585b9380544a8da18ff1fbaf0f8b33" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_560b0911bf524ea4885cde242aced243" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_92236684475f4503825bb4282af7df53" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_fde386201baa4357a4a68505c3eafea3" contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_357d650161074b438bde62f1a9be8c91" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_67103ad61bdb47d69acef7deefc236b1" contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_1333a22e5dbb4b378b4f1c2970c9d830" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_1929f5c304a64b8ea52d76a248fa69c6" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,375</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_032ad2c60fe34a7eb1f26a27c2010194" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,375</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; padding-bottom: 4px; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balances at March 31, 2022</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_bbdf713b90f94e5e91e5bd0e7f6b9826" contextRef="c20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_12acbaab4be24a989b0427de6a74ed80" contextRef="c20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_988bcb8d8e3d430ba027f7c620a095dd" contextRef="c20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_5139f7a753de4e5d89424b5df4bc641c" contextRef="c20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_b1f6ff3c712a4b80b1ac2ce351e3a2fd" contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57,452</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_c7c271326a9b4ec6a5061d5f4b9248b1" contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">287</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_eb59026d2a93451195cc054aabee93bb" contextRef="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_a53776b33e4d473caa779d16f2954438" contextRef="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_0407fed096a44d1e9ead8eb575a9e0a0" contextRef="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">167,100</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_dfc875f26a9d462caa08191182cd9f87" contextRef="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">150,077</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_37f50b11df60416d9fd9fdb1afc2d01f" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">17,311</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balances at January 1, 2021</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_a32417b5968e4d6fa196df890dc4bde1" contextRef="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">23,202</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_67e58c32b5b14e1eb0bcc3a193d36b4b" contextRef="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,400</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_bb08e3b508da48b9946cac89ae33e592" contextRef="c20201231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_9ec89cf77d93420781857c1e2fd8b374" contextRef="c20201231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">198</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_4fdebdbd9f2d464380e5ca61867a3a93" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_7f05bfef6ef04c5f96136c088173c653" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_09f29796071c447497c9484bbf940602" contextRef="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_6b907ae71df64d72b789b940516d77d9" contextRef="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_79f2ef0f88754243af6f24f8f3070ba7" contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_5426e87ea1684f279e4495e373d3428d" contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">18,141</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_8053963e9f53402481f56b3fa9eead2a" contextRef="c20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">7,659</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Brooklyn rights offerings membership units</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_575fdb062fe14817ada5ce77de81ed3b" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,500</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_3b83362aa76d4717b9d83dcd835b24ab" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_ee23dad6d34f4ac6bdc3314f8033a179" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_542e4a035c83495b827a1eb1c2067e0d" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_48a1af8e3ed4407da36b83c0e154ecf4" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_e2d4a3458e084f9db5274f0da76065c4" contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_bed1a1c305754e7595ecc37de829d2e4" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_5c85024f3da44835ada09ad39e019434" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_264f90d7171a4b5d9efbe8a0a12f516f" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,500</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Elimination of Brooklyn&#8217;s historical members&#8217; equity</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_271af0fb2f5f432b9c93e0cd4001d3ac" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">33,702</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_740cf99c98ac4b3184841aa90094fff3" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,400</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_687c6716f3e04ecbb8921006ef179c4b" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,000</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_39ad8fa70b8d4a8e84860a06210bbcd6" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">198</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_79001618c42d448f9f67372f61db70f4" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_9a2ee046724640128114ae8d5129d84c" contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_13665c1d8e36458e9b9823304718f919" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">36,300</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_a33271c2ae3448528f01ee0c2bd50ea2" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_bee78b69548a4ebca75339eb78fb5e79" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Issuance of common stock for business combination</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_39be41d2bbaa428fbf7bd494daf54e21" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_304036e3deb247e695d122fca3775f87" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_61907bf0229c4eff83f6b94a5068a782" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_312ab649cbf44a87b24fd8e46cc4212a" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesAcquisitions1" id="Fact_65bf87876e0c4d55b7d59a857b632a36" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,514</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_99f76be295cd46ea98d0709e8e01a7b2" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesAcquisitions1" id="Fact_333872ba4e2a45d58999e54ff126c45e" contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_b091bf06fe9140e58b95d751529a92c6" contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_32c35f1c38f74a5991489f69feb63b4d" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,170</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_89f111693540462c80a5d75266bf2a43" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_26c5c1276b544d06897bf4d6cebd4166" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,178</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Series A preferred stock retained in business combination</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_4117130b52074bba89f5166c53b38ea5" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_a8a0e3e238ab4b388501dc35b2aaeb59" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_1f584cc3df5744fdaa80add2c7f4970e" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_e6401cb2319f42c0b3b367f7cc3fae03" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_6a66c709571447b9957e18d13a7ae1db" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_9e5ce0d9289a4603a7758832c7c0ab67" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_7393aad57c36457dbc1503ff3753dc09" contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_8795c72e4ccb48a4bdeb106e91ca5c79" contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_e05e95d525654497b9393c55e260ce3d" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_04df7da0a1be4f80902ddbd5613a7688" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_4342436b20da429cacf7a738b74cda2d" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Issuance of common stock to Brooklyn members</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_4fdbd96ed0034b52bd8cb9f4b41cba82" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_1c4b6dea14cf4cbab535cb24a07e0087" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_45177c2dba254457868f9b1bf0e2bf34" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_3b0b2b84f6e84d9781f5b46d8fdad3a6" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountUnitsAcquisitions" id="Fact_de71dbcdfd984f5f92a49266b6008d90" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">38,924</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_6e32504a52654b9e9137c7b7817b6277" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">195</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountUnitsAcquisitions" id="Fact_2ab77e34dcf0470c86ae5c4754ff5172" contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_087417f976254fa5869126313d6bc36f" contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_dbe2fecd6ea14bbdbe0462f2149914aa" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">195</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_50cf7120565c4ae98a48d2bc8eb6be98" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_ffa14a0e442f4e3493fc3b157769c7d3" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Issuance of common stock to Financial Advisor upon consummation of merger</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_29e57d72dcc840a1bc9bcec139afb941" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_7bf7c07ee28847cb8e83a95fd3e04720" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_9593561da12947529f7444771e4c83fe" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_190bf1cdb14546f5b108280f4b668bb8" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" id="Fact_46b8ec74f8c3433fa690979461abfe32" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,068</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_c1641b221eb14d2881356fca6e1aadb5" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" id="Fact_205baf236a6d473187b858ad50112bab" contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_4edbc42ee06f47c7b74c92771e67ef5d" contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_453dc67d350c417f8e66423867fff97c" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,760</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_e890335d29324ba49e7ad668be5c97ac" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_4d9913beccd643c6a7d06bb9aabb528f" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,765</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Stock-based compensation</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_6af7e0e8836645f8a25ee3cb11a619fd" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_f139830f044d4772b08432dc3c108e63" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_301c55a77a4643de99e00e94a2a7741f" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_edb8eb1039184bc0972ff05a06984bf7" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;">-</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_1e716831ba5d4dea85fd5a5672f982aa" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;">-</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_8f68e8ddf2094f898dcf0207d189e61f" contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_c85bb3c4ae8d4fa99e8d73a405677ea1" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">419</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_8d6a70db1cb3446f95eb50229111f65a" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_f6c123dc0ac9496c940563faaafed7cb" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">419</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; padding-bottom: 2px; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Net loss</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_f9e1efce30924d5986473002a716d366" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_fd5b44cf074c4c76958022f3071ba1a1" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_cb1ee8de895c4517b1f93ebd01ebf14f" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_71ac66325b3c4b339f63ddbfa8e0c94d" contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_72f356c03ca64496ad6c89a075665ae6" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_6c38d99d88f34965af65b02fd7ae5d56" contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_f0f04547a596444d81eb08e39cc7c273" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_17d3aa059d9c4a8b9b60158f56bfb773" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">18,522</ix:nonFraction></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_20c94d9a7ade48b78991356efa0dd24d" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">18,522</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; padding-bottom: 4px;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balances at March 31, 2021</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_3bfbd08089c74ab9a8c2eac6e50c2402" contextRef="c20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_8240d7487b184bdf8bded35e70b43b6f" contextRef="c20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_5ef55388ba4e4361b817e4276208e023" contextRef="c20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_7707383f8d7748a78f228a00cf9dd39a" contextRef="c20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_44f0bc8b793f4ecaaaf2102ce7d8b019" contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">41,506</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_9516857651a544918a1d2846ade0f546" contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">208</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_8a651ee6b57a40eab44aa19b6647ff04" contextRef="c20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_3cf1e9f1fdf3429484c5e761cc7f9323" contextRef="c20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_ce3cd3702ded43368654729ac4b9f259" contextRef="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">50,453</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_1262a3acbb1e4fea8cb497a73ffce602" contextRef="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">36,663</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 4px double rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_2c2591f71ba84d14ac2e0e96fcf89aac" contextRef="c20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">13,999</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
          </div>

        </div>

        <div><br />
        </div>

        <div style="text-align: center;">
          <div>The accompanying notes are an integral part of these condensed consolidated financial statements.</div>

        </div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-weight: normal; font-style: normal; font-family: 'Times New Roman'; font-size: 8pt;" class="DSPFPageNumber">3</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div style="text-align: center; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>

        <div><span style="font-weight: bold;"> </span></div>

        <div style="text-align: center; font-weight: bold;">CONDENSED CONSOLIDATED STATEMENTS OF
          <!--Anchor--><!--Anchor--><!--Anchor--><a id="CASHFLOWS"><!--Anchor--></a>CASH FLOWS</div>

        <div style="text-align: center; font-weight: bold;">(In thousands) </div>

        <div style="text-align: center; font-weight: bold; text-indent: -81pt; margin-left: 81pt;"> (Unaudited)<br />
        </div>

        <div><br />
        </div>

        <div style="text-align: center;">
          <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: top; border-bottom: #000000 solid 2px;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">For the three months ended</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 31,<br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;">2022<br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;">2021<br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Cash flows used in operating activities:</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Net loss</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_6f4f0938e705409e94ac1b73bb1e3782" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,375</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_6f3b8843d08e4ee9a23065b21d921a11" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">18,522</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Adjustments to reconcile net loss to net cash used in operating activities:</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Depreciation and amortization</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_52c3a375a4bc4ef3a35ebac43a7a055b" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">36</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_46233d7668a1445c909bce61aa877bfe" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">25</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Stock-based compensation</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_6fb1e37bcaff4d3ea366570481288ecb" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,183</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_e9daee9d9c134e3ba876a7acdd3e7f0d" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">419</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Amortization of right-to-use asset</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" id="Fact_e8a57958dfa64ad9af1fda481bbc817a" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">102</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" id="Fact_846320f5f364420baaedabc15565c637" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">70</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Transaction costs - shares to Financial Advisor</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_845d862a50614f16816355c3df31707e" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_ea2dfa78201241efa117efa36c4e983e" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,765</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Loss on sale of NTN assets</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" id="Fact_fd03224a48344f47b38694ef12fd9665" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" id="Fact_c92af19678294878b3796383c06fbc0d" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,598</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 76%;">
                  <div style="margin-left: 18pt;">Loss on disposal of fixed assets<br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="btx:GainLossOnDisposalOfFixedAssets" id="Fact_66db2d7e57854ec887f6e58344ea87ec" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">371</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="btx:GainLossOnDisposalOfFixedAssets" id="Fact_457e8979737d4828a06529ce29be430c" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="margin-left: 18pt;">Gain on lease termination<br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">(<ix:nonFraction name="btx:GainOnTerminationOfLease" id="Fact_d5112a306f0e42298775a537de0108f0" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">85</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="btx:GainOnTerminationOfLease" id="Fact_2aa8db5a59a44247bb110873cb5dfef2" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 76%;">
                  <div style="margin-left: 18pt;">Warrant liabilities expense<br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="btx:WarrantLiabilitiesExpense" id="Fact_3b7eea33734148619b2f90453f98759e" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,322</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="btx:WarrantLiabilitiesExpense" id="Fact_c0a2ab30569d4c15b138ec2457bdbe58" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="margin-left: 18pt;"> Loss on non-controlling investment<br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="btx:LossOnNonControllingInvestment" id="Fact_4b1f3da2cc1944009396c13fa39c4ba3" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">615</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;"><ix:nonFraction name="btx:LossOnNonControllingInvestment" id="Fact_68a861101a8c4077a800bd61258f50fa" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Changes in operating assets and liabilities:</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="margin-left: 27pt;"> Other receivable<br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherReceivables" id="Fact_321c1973cc5047a891af6441bdf24fb0" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">146</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherReceivables" id="Fact_c6ef839db990450f8b728fa2ddfbf06e" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 27pt;">Prepaid expenses and other current assets</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" id="Fact_520f5afb31b34c90ae1ef28e60bb64af" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">298</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" id="Fact_e64fdf9e0a804db3a0b4c84741503972" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">42</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); margin-left: 27pt;">Security deposits and other non-current assets</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="btx:IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" id="Fact_bf8dd294cc0b412bb83aa8debd6020d3" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">66</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="btx:IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" id="Fact_cf7683086b6848e5a5e5b5a2bf36f095" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 27pt;">Accounts payable and accrued expenses</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_3d86258584294221bc4a8f1779bf05d1" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">486</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);"></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_1017090743054a8b989bdcf7f1f92067" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">766</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); margin-left: 27pt;">Operating lease liability</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="btx:IncreaseDecreaseInOperatingLeaseLiabilities" id="Fact_ab893a212ace4afd9248c9af7adde3b7" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">103</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">(<ix:nonFraction name="btx:IncreaseDecreaseInOperatingLeaseLiabilities" id="Fact_ec6073fc08e24ab08f7ec95a1eaa1167" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">64</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); margin-left: 27pt;">Other liabilities</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" id="Fact_6388b59ba02b4c47b13572a9b8368eec" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">202</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" id="Fact_6464b7360e484717bcde3755511ad950" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; margin-left: 27pt;">Net cash used in operating activities</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_6afe89da9d5e4371852a35cd6bcf978a" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">5,432</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_0d27849903f54936966c012f234980eb" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,430</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Cash flows used in investing activities:</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Purchase of property and equipment</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" id="Fact_907da751a9484053bd82995235768cfe" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">46</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" id="Fact_345be2badee34621acc0609312969b97" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Purchase of NTN, net of cash acquired</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ProceedsFromSalesOfAssetsInvestingActivities" id="Fact_8738013835e34e668a0b8d2e26358450" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:ProceedsFromSalesOfAssetsInvestingActivities" id="Fact_5c08b6ebac864f6aa134d216b4f43f95" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">148</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Proceeds from the sale of NTN assets, net of cash disposed</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_8481d30f6c17452cbc0f049374130a54" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_4d634b1023414ddbb6c7b5e13d186617" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">119</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; margin-left: 27pt;">Net cash (used in) provided by investing activities<br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_86c765326cbf4488a9d5ef8f728cac04" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">46</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_dd20e0dd75b346f6a76968736b843588" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">267</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Cash flows provided by financing activities:</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 76%;">
                  <div style="margin-left: 9pt;"> Proceeds from issuance of common stock and&#160; warrants in connection with private offering<br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_8f7ade7b2c2d4d62b6a51617dbace42f" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,993</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_f2fe506cce404ab4bf920a520b6a4b28" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Proceeds from sale of members&#8217; equity</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" id="Fact_81e0f700f7b24b9da524e4208f788c87" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" id="Fact_9ab7998575c94e0091fea177541ae6c4" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,475</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Repayment of
                      NTN&#8217;s PPP loan</div>
                  </div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="btx:PaymentsOfPaycheckProtectionProgramLoan" id="Fact_bb728a9e854a4dfc85c9053211f0c4fe" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="btx:PaymentsOfPaycheckProtectionProgramLoan" id="Fact_58b3dad94bc641a8b91d06894aa1f4bb" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">532</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; margin-left: 27pt;">Net cash provided by financing activities</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_7ee8c29eaf5d4137bd1dade481e9fe87" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,993</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_a3c0168a36be4dc9b4e6aedd42e190c2" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">9,943</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">Net increase in cash and cash equivalents<br />
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" id="Fact_a7ca9048f87f4fd2a35d9628a1157dbf" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,515</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" id="Fact_d342d4143f6d43069d907c90637f390c" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,780</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Cash and cash equivalents at beginning of period</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_68ddc76da6d24c3ca6d775ad07700aa7" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">16,985</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_21e1369ba44b4e44af787746f2cb5a06" contextRef="c20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,630</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Cash and cash equivalents at end of period</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_4e6af96bfd13497f9ce3100a1be4038f" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">23,500</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_f3250412451646d5979ec858937827e3" contextRef="c20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,410</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div>&#160;</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Supplemental disclosures of cash flow information:</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Cash paid during the period for:</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Interest</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_bc7be38cf8dc49669a94ff5a0b1da0a8" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_ab19eca704eb470ca2f10673d71b420b" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                  <div>&#160;</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Supplemental disclosure of non-cash investing and financing activities:</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Issuance of common stock for business combination</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:StockIssued1" id="Fact_b605189355444d24a4142fd3e8fad3c5" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:StockIssued1" id="Fact_eefa35ba47fd41208551e33ee8ef2db6" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,178</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                  <div style="margin-left: 9pt;">Series A preferred stock retained in business combination<br />
                  </div>
                </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><ix:nonFraction name="btx:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" id="Fact_f4c255ac08514813bafeb28c359e9af5" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);"><ix:nonFraction name="btx:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" id="Fact_6125f9343898419088c1928f1d5288aa" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
        </div>

        <div style="text-align: center;"> <br />
        </div>

        <div style="text-align: center;">
          <div>The accompanying notes are an integral part of these condensed consolidated financial statements.</div>

        </div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">4</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span>  <span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div style="text-align: center; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>

        <div style="text-align: center; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><!--Anchor--><!--Anchor--><!--Anchor--><a id="NOTES"><!--Anchor--></a>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div>

        <div style="text-align: center; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(Unaudited) </div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
<ix:nonNumeric name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="Text_c159c89179e84bc69ae87d8760bbfc7e" contextRef="c20220101to20220331" escape="true" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd1">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
         </div>
</ix:nonNumeric>
        <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd1" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd2">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></div>
              </td>

  </tr>


</table>
</ix:continuation>
        <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd2" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd3">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd3" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd4">
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd4" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd5">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;">Description of Business</div>
</ix:continuation>
        <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd5" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd6">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </span> </div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">
          <div>
            <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd6" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd7">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Brooklyn ImmunoTherapeutics Inc., a Delaware corporation (&#8220;Brooklyn&#8221; or the &#8220;Company&#8221;), together with its subsidiaries including Brooklyn
              ImmunoTherapeutics LLC (&#8220;Brooklyn LLC&#8221;), Novellus, Inc. (&#8220;Novellus&#8221;) and Novellus Therapeutics, Ltd. (&#8220;Novellus, Ltd.&#8221;), is a biopharmaceutical company utilizing its mRNA technology platform, including mRNA-based cell reprogramming and gene
              editing technologies, to create next generation mRNA, gene editing and cell therapies, including iPSC therapies for multiple therapeutic indications. As used herein, the &#8220;Company&#8221; refers collectively to Brooklyn and its subsidiaries.</div>
</ix:continuation>
          </div>

        </div>

        <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd7" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd8">
<div><br /></div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd8" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd9">
<div><span style="font-family: 'Times New Roman';"> </span></div>
</ix:continuation>
          <div><ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd9" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd10">
<div><span style="font-family: 'Times New Roman';"> </span></div>
</ix:continuation>
            <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd10" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd11">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On August 12, 2020, Brooklyn (then known as &#8220;NTN Buzztime, Inc.&#8221;), Brooklyn LLC and BIT Merger Sub, Inc., a wholly owned subsidiary of
              Brooklyn (the &#8220;Merger Sub&#8221;), entered into an agreement and plan of merger and reorganization (the &#8220;Merger Agreement&#8221;) pursuant to which, among other matters, Merger Sub merged with and into Brooklyn LLC, with Brooklyn LLC continuing as a
              wholly owned subsidiary of Brooklyn and as the surviving company of the merger (the &#8220;Merger&#8221;). The Merger closed on March 25, 2021. After the Merger, Brooklyn changed its name from &#8220;NTN Buzztime, Inc.&#8221; to &#8220;Brooklyn ImmunoTherapeutics, Inc.&#8221;
              The Merger was accounted for as a reverse acquisition, in which Brooklyn LLC was deemed the acquiring company for accounting purposes.</div>
</ix:continuation>
            <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd11" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd12">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd12" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd13">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 26, 2021, Brooklyn sold (the &#8220;Disposition&#8221;) its rights, title and interest in and to the assets relating to the business operated
              under the name &#8220;NTN Buzztime, Inc.&#8221; prior to the Merger to eGames.com Holdings LLC (&#8220;eGames.com&#8221;) in accordance with the terms of an asset purchase agreement dated September 18, 2020, as amended, between Brooklyn and eGames.com (the &#8220;Asset
              Purchase Agreement&#8221;). </div>
</ix:continuation>
          </div>

        </div>

        <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd13" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd14">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </span> </div>
</ix:continuation>
        <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd14" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd15">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On July 16, 2021, Brooklyn and its newly formed, wholly owned subsidiary Brooklyn Acquisition Sub, Inc. entered into an
          agreement and plan of acquisition (the &#8220;Acquisition Agreement&#8221;) with (a) Novellus LLC, (b) Novellus (the sole equity holder of Novellus, Ltd. and, prior to the closing under the Acquisition Agreement, a wholly owned subsidiary of Novellus, LLC),
          and (c) a seller representative (the &#8220;Acquisition&#8221;), pursuant to which Brooklyn acquired Novellus and its subsidiary, Novellus, Ltd. As part of the Acquisition, Brooklyn also acquired <ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" id="Fact_1bef0282c92c488d9640199d4c4b1ab8" contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U004" decimals="3" scale="-2" format="ixt:numdotdecimal">25.0</ix:nonFraction>% of the total outstanding equity interests of NoveCite, Inc. (&#8220;NoveCite&#8221;), a corporation focused on developing an allogeneic mesenchymal stem cell product for patients with acute
          respiratory distress syndrome, including from COVID-19. </div>
</ix:continuation>
        <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd15" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd16">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><br />
        </div>
</ix:continuation>

        <ix:nonNumeric name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="Text_981de089ea644818a2ff1997672bf5df" contextRef="c20220101to20220331" escape="true" continuedAt="Text_83d189ce3d7e47caac5610e044c16ef81"><ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd16" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd17">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;">Basis of Presentation</div>
</ix:continuation></ix:nonNumeric>
        <ix:continuation id="Text_83d189ce3d7e47caac5610e044c16ef81" continuedAt="Text_83d189ce3d7e47caac5610e044c16ef82"><ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd17" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd18">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </span> </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_83d189ce3d7e47caac5610e044c16ef82" continuedAt="Text_83d189ce3d7e47caac5610e044c16ef83"><ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd18" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd19">
<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_83d189ce3d7e47caac5610e044c16ef83" continuedAt="Text_83d189ce3d7e47caac5610e044c16ef84"><ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd19" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd20">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The






          accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial statements and with the instructions to
          Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the unaudited financial statements include all the
          normal recurring adjustments that are necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented.<br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_83d189ce3d7e47caac5610e044c16ef84" continuedAt="Text_83d189ce3d7e47caac5610e044c16ef85"><ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd20" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd21">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_83d189ce3d7e47caac5610e044c16ef85"><ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd21" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd22">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">These












          condensed consolidated financial statements should be read together with the audited consolidated financial statements and notes thereto contained in Brooklyn&#8217;s Annual Report on Form 10-K/A for the year ended December 31, 2021 filed with the
          Securities and Exchange Commission (the &#8220;SEC&#8221;) on June 30, 2022 (the &#8220;10-K/A&#8221;). The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited financial statements contained in the 10-K/A, but does
          not include all of the information and footnotes required by GAAP for complete financial statements. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results to be anticipated for the
          entire year ending December 31, 2022, or any other period.</div>
</ix:continuation></ix:continuation>

        <ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd22" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd23">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">5</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>


        <ix:nonNumeric name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="Text_71c8f622b17c4c8e9d9a5535cd70cf24" contextRef="c20220101to20220331" escape="true" continuedAt="Text_6f02f4d8354748949fe81ef66549af411"><ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd23" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd24">
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 36pt;"><span style="font-style: italic;">Reclassifi<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">cations</span></span>
        </div>
</ix:continuation></ix:nonNumeric>
        <ix:continuation id="Text_6f02f4d8354748949fe81ef66549af411" continuedAt="Text_6f02f4d8354748949fe81ef66549af412"><ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd24" continuedAt="Text_9f6e6c54646a44f38458ab0e817aa2bd25">
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-style: italic;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
            </span></span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_6f02f4d8354748949fe81ef66549af412"><ix:continuation id="Text_9f6e6c54646a44f38458ab0e817aa2bd25">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Certain











          reclassifications have been made to Brooklyn&#8217;s prior years&#8217; financial statements to conform to the current year presentation. These reclassifications had no effect on Brooklyn&#8217;s previously reported results of operations or accumulated deficit.</div>
</ix:continuation></ix:continuation>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 57.55pt; margin-left: 24pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160; <span style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;</span> </div>

      </div>

      <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</div>

    <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> <span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> </span> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;"> <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> <span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> </span> </span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

      <div><ix:nonNumeric name="btx:LiquidityAndCapitalResourcesTextBlock" id="Text_b6fb6892a9904282bc9f5185ebebb1c1" contextRef="c20220101to20220331" escape="true" continuedAt="Text_c5d00e8988374348a97bc56462b04ffd1">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>
</ix:nonNumeric>
        <ix:continuation id="Text_c5d00e8988374348a97bc56462b04ffd1" continuedAt="Text_c5d00e8988374348a97bc56462b04ffd2">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">LIQUIDITY AND CAPITAL RESOURCES</div>
              </td>

  </tr>


</table>
</ix:continuation>
        <ix:continuation id="Text_c5d00e8988374348a97bc56462b04ffd2" continuedAt="Text_c5d00e8988374348a97bc56462b04ffd3">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_c5d00e8988374348a97bc56462b04ffd3" continuedAt="Text_c5d00e8988374348a97bc56462b04ffd4">
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_c5d00e8988374348a97bc56462b04ffd4" continuedAt="Text_c5d00e8988374348a97bc56462b04ffd5">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has incurred significant operating losses and has an accumulated deficit as a result of ongoing efforts to develop product candidates, including conducting clinical trials and providing general and
              administrative support for operations. As of March 31, 2022, the Company had a cash balance of approximately $<ix:nonFraction name="us-gaap:Cash" id="Fact_70d2ddc9c89f48b086fd111ce26aff8a" contextRef="c20220331" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">23.5</ix:nonFraction> million and an
              accumulated deficit of approximately $<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_e59b31ee354b418b90b250dd88db2b7b" contextRef="c20220331" unitRef="U002" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">150.1</ix:nonFraction> million. For the three months ended March 31, 2022, the Company incurred a net loss of
              $<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_ad426bc1851a48e08d06c64f95028ec4" contextRef="c20220101to20220331" unitRef="U002" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">9.4</ix:nonFraction> million, and the Company used cash in operating activities of $<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_e9781adcffad4fb09b560d0bc5410e90" contextRef="c20220101to20220331" unitRef="U002" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">5.4</ix:nonFraction></span><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                million.</span><br />
            </span> </div>
</ix:continuation>
          <div style="text-indent: 27pt;">
            <ix:continuation id="Text_c5d00e8988374348a97bc56462b04ffd5" continuedAt="Text_c5d00e8988374348a97bc56462b04ffd6">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span></div>
</ix:continuation>
            <ix:continuation id="Text_c5d00e8988374348a97bc56462b04ffd6" continuedAt="Text_c5d00e8988374348a97bc56462b04ffd7">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">On March 9, 2022, the Company consummated a private placement of common stock and warrants resulting in net proceeds of approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" id="Fact_a3a657b988c645519d05897a69651710" contextRef="c20220309to20220309" unitRef="U002" decimals="-6" scale="6" format="ixt:numdotdecimal">11</ix:nonFraction>
              million (See Note 10).</div>
</ix:continuation>
            <ix:continuation id="Text_c5d00e8988374348a97bc56462b04ffd7" continuedAt="Text_c5d00e8988374348a97bc56462b04ffd8">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_c5d00e8988374348a97bc56462b04ffd8" continuedAt="Text_c5d00e8988374348a97bc56462b04ffd9">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">In connection with preparing the accompanying condensed consolidated financial statements as of and for the three months ended March 31, 2022, the Company&#8217;s management concluded that there is substantial doubt regarding the Company&#8217;s
              ability to continue as a going concern because it does not expect to have sufficient cash or working capital resources to fund operations for the twelve-month period subsequent to the issuance date of these financial statements. The Company
              will need to raise additional capital, which could be through the remaining availability under our equity line purchase agreement with Lincoln Park Capital Fund, LLC (the &#8220;Second Purchase Agreement&#8221;) (to the extent the Company is permitted to
              use such agreement) (see Note 10), public or private equity offerings, debt financings, corporate collaborations or other means. The Company may also seek governmental grants to support its clinical trials and preclinical trials. The Company
              currently has no arrangements for such capital and no assurances can be given that it will be able to raise such capital when needed, on acceptable terms, or at all.</div>
</ix:continuation>
            <ix:continuation id="Text_c5d00e8988374348a97bc56462b04ffd9" continuedAt="Text_c5d00e8988374348a97bc56462b04ffd10">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_c5d00e8988374348a97bc56462b04ffd10">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> The accompanying condensed consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The
              accompanying condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may
              result from uncertainty related to the Company&#8217;s ability to continue as a going concern.</div>
</ix:continuation>

            <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br />
            </div>

          </div>

        </div>

        <!--PROfilePageNumberReset%Num%6%%%--> </div>

    </div>

    <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;"> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div>
          <ix:nonNumeric name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="Text_fbcb17304ce04aa5b619ffb95c920909" contextRef="c20220101to20220331" escape="true" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb121">
<div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 36pt;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">3)</div>
                  </td>

    <td style="align: left; vertical-align: top; width: auto;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</div>
                  </td>

  </tr>


</table>
          </div>
</ix:nonNumeric>
        </div>

        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb121" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb122">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb122" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb123">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; text-indent: 27pt; margin-left: 9pt; font-variant: normal; text-transform: none;">Merger</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb123" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb124">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb124" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb125">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On August 12, 2020, Brooklyn, Brooklyn LLC and the Merger Sub
          entered into the Merger Agreement, and the Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which Brooklyn LLC was deemed the acquiring company for accounting purposes. Brooklyn LLC, as the accounting
          acquirer, recorded the assets acquired and liabilities assumed of Brooklyn in the Merger at their fair values as of the acquisition date.</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb125" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb126">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb126" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb127">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Brooklyn LLC was determined to be the accounting acquirer
          based upon the terms of the Merger and other factors including that (i) Brooklyn LLC members, received common stock in the Merger that represented <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_54ca8871183447f597c50d21ae2ae837" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">96.35</ix:nonFraction>%
          of Brooklyn&#8217;s outstanding common stock on a fully diluted basis, (ii) all of the directors of Brooklyn immediately after the Merger were designated by Brooklyn LLC under the terms of the Merger Agreement and (iii) existing members of Brooklyn
          LLC&#8217;s management became the management of Brooklyn immediately after the Merger.</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb127" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb128">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb128" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb129">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">At the closing of the Merger, all the outstanding membership
          interests of Brooklyn LLC converted into the right to receive an aggregate of approximately <ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" id="Fact_2aa5ef7deb78438b8a86d158059c5b0c" contextRef="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">39,992,000</ix:nonFraction> shares of common stock, of
          which <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="Fact_eeee0995e77b41bc9019bf39b4a31fee" contextRef="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,068,000</ix:nonFraction> shares were issued as compensation to Maxim Group LLC, Brooklyn LLC&#8217;s financial advisor (the &#8220;Financial Advisor&#8221;) for
          its services to Brooklyn LLC in connection with the Merger.</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb129" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1210">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">6</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1210" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1211">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The purchase price of $<ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" id="Fact_5ea9ac5eedd04a8aa8854831ba4a329b" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">8.2</ix:nonFraction> million, which represents the consideration transferred in the Merger to stockholders of Brooklyn immediately before the Merger, was calculated
          based on the closing price of $<ix:nonFraction name="us-gaap:BusinessAcquisitionSharePrice" id="Fact_6c84fa96b84946cd8dd503a066e15a48" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">5.40</ix:nonFraction> per share for approximately <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_f66bc96342f1436980f1b12d50f95e8d" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,514,000</ix:nonFraction> shares common stock that those stockholders owned on March 25, 2021 immediately prior to the Merger because that represented a more reliable measure of the fair
          value of consideration transferred in the Merger.</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1211" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1212">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1212" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1213">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Under the acquisition method of accounting, the total
          purchase price has been allocated to the acquired tangible and intangible assets and assumed liabilities of Brooklyn based on their estimated fair values as of March 25, 2021, the Merger closing date. Because the consideration paid by Brooklyn
          LLC in the Merger is more than the estimated fair values of Brooklyn&#8217;s net assets deemed to be acquired, goodwill is equal to the difference of approximately $<ix:nonFraction name="us-gaap:Goodwill" id="Fact_3663caf0241243f594b57e521f761fc3" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">8.6</ix:nonFraction> million, which has been calculated using the fair values of the net assets of Brooklyn as of March 25, 2021.</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1213" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1214">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>

        <ix:nonNumeric name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="Text_c4998b5fcb854dbda6d5d8398d1e26e9" contextRef="c20220101to20220331" escape="true" continuedAt="Text_43fb61b2c53c4e04aef97b6b6da381251"><ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1214" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1215">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The allocation of the purchase price to the tangible and
          intangible assets acquired and liabilities deemed to be assumed from Brooklyn, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):</div>
</ix:continuation></ix:nonNumeric>
        <ix:continuation id="Text_43fb61b2c53c4e04aef97b6b6da381251" continuedAt="Text_43fb61b2c53c4e04aef97b6b6da381252"><ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1215" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1216">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_43fb61b2c53c4e04aef97b6b6da381252"><ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1216" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1217">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: left;">&#160;</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: center; font-weight: bold;">Historical</div>
                <div style="text-align: center; font-weight: bold;">Balance</div>
                <div style="text-align: center; font-weight: bold;">Sheet of</div>
                <div style="text-align: center; font-weight: bold;">Brooklyn at</div>
                <div style="text-align: center; font-weight: bold;">March 25, 2021</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: center; font-weight: bold;">Fair Value</div>
                <div style="text-align: center; font-weight: bold;">Adjustment</div>
                <div style="text-align: center; font-weight: bold;">to Brooklyn</div>
                <div style="text-align: center; font-weight: bold;">Pre-Merger</div>
                <div style="text-align: center; font-weight: bold;">Assets</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">
                <div style="font-weight: bold;">Price</div>
                <div><span style="font-weight: bold;">Purchase</span></div>
                <div><span style="font-weight: bold;">Allocation</span></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;">
                <div style="text-align: left;">Cash and cash equivalents</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" id="Fact_3d78e289e5a1491c8ce7adaac53f58cf" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">148</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" id="Fact_1ffcd446d43745e8941446222d85e9ed" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" id="Fact_e1a468aeb6ce4e1a85943c659d289e7a" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">148</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;">
                <div style="text-align: left;">Accounts receivable</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_27292e40a79d4a078f3a00b2d6571307" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">103</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_98f83fff95d646e5bcb87ebed3a3cc52" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_c661f74f3c154543b323c270c04c2528" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">103</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;">
                <div style="text-align: left;">Prepaid expense and other current assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" id="Fact_bffeea1274d8447f8eaaa3528a580eaa" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">329</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" id="Fact_f88436cf458f4fbabd8f7c34fbf23761" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" id="Fact_a4989f92157f433f92ab902648f7a7a8" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">329</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;">
                <div style="text-align: left;">Property and equipment, net</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" id="Fact_2be476c51b574a5e87e6eb6e511fdc29" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,015</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" id="Fact_aacc907840bd4ce9971677d14d1c7c64" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" id="Fact_603cac1821444b43abb2cca551ab24d4" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,015</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;">
                <div style="text-align: left;">Software development costs</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" id="Fact_915f975684a94590a96fd47a47daa1e2" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,296</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div>(<ix:nonFraction name="btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" id="Fact_58e4c02ebe17455bba07f592863cce51" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">368</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div>)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" id="Fact_3e9691bbcb444f8dba2ca1942d06eb7e" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">928</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;">
                <div style="text-align: left;">Customers</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_c7a3e261acce44fb9c886c95b35b603d" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_b2c7ab411846419caaa0d4d82d2f6eb0" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">548</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_d25f2bedeb864b5b9ea40c0b1c608ce6" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">548</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;">
                <div style="text-align: left;">Trade name</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_a6e1cfaedb3e4577a06a946874406210" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_711a5c6ab7304a608ba7abdc2f5b4a61" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">299</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_2ee5f709d09c48f8b2d094ae6e244ef8" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">299</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;">
                <div style="text-align: left;">Accounts payable, accrued liabilities and other current</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
                <div style="text-align: left;">liabilities</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                <div>(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_5c9016df5e0f41df85520906ee85b7f3" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,781</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div>)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_2faa5d1c201142e8a956da64e6c9db96" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                <div>(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_77f2375cefcb4b4e8e170688768f4fee" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,781</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;">
                <div style="text-align: left;">Net assets acquired, excluding goodwill</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
                <div>(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_e0306b8f76f6407f83d033b81f7a646c" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">890</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
                <div>)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_fc89c14d1da64843bbbee084793c4f92" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">479</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
                <div>(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_85489aa712144724b3740f7c70a78146" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">411</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;">
                <div style="text-align: left;">Total consideration</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" id="Fact_8d7bcafa874a4eadb581f0fbb16b2911" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,178</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                <div style="text-align: left;">Net assets acquired, excluding goodwill</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
                <div>(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_a1191c3a12b44f17b3380877328b3570" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">411</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                <div>)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;">
                <div style="text-align: left;">Goodwill</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
                <div><ix:nonFraction name="us-gaap:Goodwill" id="Fact_78431c0eaf454962bb2bf8dfe9c8cff6" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,589</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1217" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1218">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1218" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1219">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Brooklyn LLC was obligated under the Merger Agreement to have
          $<ix:nonFraction name="btx:ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" id="Fact_bdba85beab904914ba3a94b96f090964" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">10.0</ix:nonFraction> million in cash and cash equivalents on its balance sheet at the effective time of the Merger. To ensure Brooklyn LLC had the
          required funds, certain beneficial holders of Brooklyn LLC&#8217;s Class A membership interests entered into contractual commitments to invest $<ix:nonFraction name="btx:BeneficialHoldersContractualCommitmentsToInvest" id="Fact_c263b227cdbd4fbe8a687dfed4f268de" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">10.0</ix:nonFraction>
          million into Brooklyn LLC immediately prior to the closing of the Merger. During March 2021, Brooklyn offered its Class A unit holders an additional <ix:nonFraction name="btx:PercentageOfAdditionalRightsOffering" id="Fact_a7f844c3cd4b4dd9857731875335ad32" contextRef="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">5</ix:nonFraction>%
          rights offering for an additional $<ix:nonFraction name="btx:ProceedsFromSaleOfRights" id="Fact_3d08ab31a0a74565a871a4b911784612" contextRef="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million to be raised by a rights offering. Brooklyn received funds from the rights offering
          between February 17, 2021 and April 5, 2021.</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1219" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1220">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">7</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1220" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1221">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-indent: 36pt;">Disposition</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1221" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1222">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>

        <ix:nonNumeric name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="Text_a08043633ac149379ad703bbb3529414" contextRef="c20220101to20220331" escape="true" continuedAt="Text_c2a58fa176c5481aa04fc2248429cd621"><ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1222" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1223">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On March 26, 2021, Brooklyn sold its rights, title and
          interest in and to the assets relating to the business it operated (under the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $<ix:nonFraction name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" id="Fact_2386d89efd694f3da2a680d5bc2a0a31" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction> million and assumption of specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of
          the Disposition are as follows (in thousands):</div>
</ix:continuation></ix:nonNumeric>
        <ix:continuation id="Text_c2a58fa176c5481aa04fc2248429cd621" continuedAt="Text_c2a58fa176c5481aa04fc2248429cd622"><ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1223" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1224">
<div><br /></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_c2a58fa176c5481aa04fc2248429cd622"><ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1224" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1225">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: left; font-weight: bold;">Proceeds from sale:</div>
              </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;">Cash</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" id="Fact_860bd116554740448d79977bdf7d67f5" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">132</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Escrow</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" id="Fact_1f892f0e05c2445cb735c07b7d9b3ad0" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">100</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;">
                <div style="text-align: left;">Assume advance/loans</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" id="Fact_75bbb331e3ba4a509d723d421ca5d106" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,700</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Interest on advance/loans</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" id="Fact_2a492fe34f084dbeb0a4ed9702722412" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">68</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left; font-weight: bold;">Carrying value of assets sold:</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Cash and cash equivalents</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" id="Fact_533becd8e9bf43b8a466af90fd0014a4" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Accounts receivable</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" id="Fact_08f356a73a214739a76b9004e98fb858" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">75</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Prepaids and other current assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" id="Fact_34035390e0a545979469c9c3ce48bc3f" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">124</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Property and equipment, net</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" id="Fact_bcf1e46f40644237b9a39f46ed825e78" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,014</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Software development costs</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div>(<ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" id="Fact_b56ae35b284a40e883d81c3403a6b3ff" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">927</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Customers</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" id="Fact_f510fcb805a0448286283fdb0992df7f" contextRef="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">548</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Trade name</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" id="Fact_2bd6c31d58514dc1b69c62698714cfcd" contextRef="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">299</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Goodwill</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" id="Fact_8f5c5b9cbde94be1a428f83bd6912ef1" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,589</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Other assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" id="Fact_73f486ef86ae49808b2323054b0c78d6" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">103</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; font-weight: bold;">Liabilities transferred upon sale:</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Accounts payable and accrued expenses</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" id="Fact_4997f29920a2463ebe892d6f56ed4a2c" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">113</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Obligations under finance leases</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div><ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" id="Fact_18b2deb5d2294cf5806adfa4f883a293" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">17</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Lease liability</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationLeaseLiability" id="Fact_3d13ad4b39874859be563d360a0dd54a" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">26</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Deferred revenue</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                <div><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" id="Fact_46077e98d1ab4d3685882775380c7d6c" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">55</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Other current liabilities</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" id="Fact_a384928133c04e8c8af5d8152c7e6d06" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">149</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Transaction costs</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div>(<ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationTransactionCosts" id="Fact_1aa21ee03b804496b3dc5cec6eaf3b57" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">265</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px;">
                <div style="text-align: left; font-weight: bold;">Total loss on sale of assets</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
                <div style="font-weight: bold;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
                <div style="font-weight: bold;">(<ix:nonFraction name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" id="Fact_50a454dbd5b047e2a727d7588594dd0c" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,598</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">
                <div style="font-weight: bold;">)</div>
              </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1225" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1226">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1226" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1227">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; text-indent: 36pt; font-variant: normal; text-transform: none;">Acquisition</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1227" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1228">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1228" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1229">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On July 16, 2021, Brooklyn and Brooklyn Acquisition Sub, Inc.
          entered into the Acquisition Agreement. The Acquisition closed contemporaneously with the execution and delivery of the Acquisition Agreement. At the closing:</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1229" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1230">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <div>
          <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1230" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1231">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: left;">&#8226;</div>
                </td>

    <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: justify;">Brooklyn acquired all of the outstanding equity interests of Novellus, Inc. as the result of the merger of Brooklyn Acquisition Sub, Inc. with and into Novellus, Inc., following which, Novellus, Inc., as
                    the surviving corporation, became Brooklyn&#8217;s wholly owned subsidiary and Novellus Ltd. became Brooklyn&#8217;s indirectly owned subsidiary; and</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1231" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1232">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1232" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1233">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: left;">&#8226;</div>
                </td>

    <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: justify;">Brooklyn acquired <ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" id="Fact_af2a2860e2804e85a7d94327cdad7968" contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U004" decimals="3" scale="-2" format="ixt:numdotdecimal">25.0</ix:nonFraction>% of the total outstanding equity interests of NoveCite.</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1233" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1234">
<div> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
            </span></div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1234" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1235">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As consideration for the Acquisition, Brooklyn paid $<ix:nonFraction name="us-gaap:PaymentsToAcquireOtherProductiveAssets" id="Fact_66e969db6b2644cb8788bc8d5633b1e7" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">22.9</ix:nonFraction> million in cash and delivered approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" id="Fact_63eccf3e5a2348559b2ebb57c04dbaec" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">7,022,000</ix:nonFraction>
          shares of common stock, which under the terms of the Acquisition Agreement, were valued at a total of $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_4b05f25600dd4acaa7671f83fea76ed5" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">102.0</ix:nonFraction> million based on an agreed
          upon price of $<ix:nonFraction name="btx:AssetAcquisitionSharePrice" id="Fact_b13518c6257b4ed4a15af1ab45489339" contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U003" decimals="4" scale="0" format="ixt:numdotdecimal">14.5253</ix:nonFraction> per share. At the date of issuance, the fair value of the shares were approximately $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_0a999755f83b46ac8e22ce8c197f857d" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">58.6</ix:nonFraction> million.</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1235" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1236">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1236" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1237">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Acquisition Agreement contained customary
          representations, warranties and certain indemnification provisions. Approximately <ix:nonFraction name="btx:EscrowShares" id="Fact_6484bb1e0cbd4affb5031841d72809cd" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">741,000</ix:nonFraction> of the shares issued as consideration were
          placed in escrow for a period of up to <ix:nonNumeric name="btx:EscrowPeriod" id="Fact_487a4ff1c1914871bc73abc9c40d6dd6" contextRef="c20220101to20220331_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember" format="ixt-sec:durmonth">12</ix:nonNumeric> months in order to secure indemnification obligations to Brooklyn under the Acquisition
          Agreement. The Acquisition Agreement also contains certain non-competition and non-solicitation provisions pursuant to which Novellus LLC agreed not to engage in certain competitive activities for a period of <ix:nonNumeric name="btx:AcquisitionAgreementNonCompetitivePeriod" id="Fact_87562f2ac969454dbf13b724fa88b0f8" contextRef="c20220101to20220331_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric> following the closing, including customary restrictions relating to employees. No employees of Novellus Ltd. or Novellus, Inc. prior to the
          Acquisition continued their employment, or were otherwise engaged by Brooklyn, following the Acquisition.</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1237" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1238">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">8</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1238" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1239">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">In connection with the Acquisition, the co-founders of
          Novellus, Ltd. entered into lock-up agreements with respect to approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="Fact_d08202be60be43ad8bd837f356899397" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,378,000</ix:nonFraction> of the shares of common stock received in the
          Acquisition, and Brooklyn&#8217;s Chairman of the Board of Directors (the &#8220;Board&#8221;) and its Chief Executive Officer and President entered into identical lock-up agreements with respect to their current holdings of Brooklyn stock. Each lock-up agreement
          extends for a period of <ix:nonNumeric name="btx:EachLockUpAgreementExtendsTerm" id="Fact_cc0fbbf96f174fb4a7b65a6e6d742761" contextRef="c20220101to20220331_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric>, provided that up to <ix:nonFraction name="btx:PercentageOfCommonStockSubjectToLockUpAgreement" id="Fact_4334750d17e747c29462c53c6993e610" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>% of the shares of common stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock on the Nasdaq exceeds
          specified thresholds. The lock-up agreements include customary exceptions for transfers during the applicable lock-up period.</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1239" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1240">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1240" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1241">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company expects the Acquisition will advance its
          evolution into a platform company with a pipeline of next generation engineered cellular, gene editing and cytokine programs. In addition, the acquisition of Novellus, Ltd. builds on the License Agreement. (See Note 8). The completion of the
          acquisition of Novellus, Ltd. relieved Brooklyn LLC from potential obligations to pay Novellus, Ltd. certain upfront fees, clinical development milestone fees and post-registration royalties under the License Agreement. The agreement with Factor
          Bioscience Limited (&#8220;Factor&#8221;) under the License Agreement, which grants Brooklyn LLC exclusive rights to develop certain next-generation mRNA gene editing and cell therapy products, remained unchanged.</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1241" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1242">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1242" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1243">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Although Brooklyn acquired all of the outstanding equity
          interests of Novellus, Inc., the Company accounted for the Acquisition as an asset acquisition (as the assets acquired did not constitute a business as defined in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 805,&#160;<span style="font-style: italic;">Business Combinations</span>),&#160;and was measured by the amount of cash paid and by the fair value of the shares of common stock issued. As a result, substantially all of the value acquired was attributed to IPR&amp;D, with the exception
          of the cash paid for the investment in NoveCite, which is being accounted for as an investment in equity securities, as discussed further below.</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1243" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1244">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1244" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1245">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Brooklyn paid $<ix:nonFraction name="btx:PaymentsToAcquireProductiveAssetsNet" id="Fact_aaa969455c3040e087dabadebe60d9de" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">22.9</ix:nonFraction> million in cash, net of cash acquired, as part of the consideration for the Acquisition, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" id="Fact_61b9b513c2004a4e98d922371c041212" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million was paid in cash for the investment in NoveCite. Brooklyn also issued approximately 7,022,000 shares of the Company&#8217;s common stock, of which approximately <ix:nonFraction name="btx:StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" id="Fact_804c53c4a64d49b3bd93db495b93c239" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,644,000</ix:nonFraction> shares are unrestricted and <ix:nonFraction name="btx:StockIssuedDuringPeriodRestrictedSharesAcquisitions" id="Fact_32cbaa51019d4693bad37d02fcbea093" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,378,000</ix:nonFraction>
          shares are subject to the <ix:nonNumeric name="btx:LockUpPeriodForRestrictedShares" id="Fact_6e7cd42dab4d43b9afaf996879563d46" contextRef="c20220101to20220331_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" format="ixt-sec:durwordsen">three-year</ix:nonNumeric> lockup. The unrestricted shares were valued at $<ix:nonFraction name="btx:AssetAcquisitionUnrestrictedSharesSharePrice" id="Fact_b494310fe5be4a2dbc0eb368a13acda8" contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">10.05</ix:nonFraction> per share, which was the closing price of Brooklyn&#8217;s common stock on July 16, 2021. The fair value of the restricted shares was discounted by approximately <ix:nonFraction name="btx:PercentageOfDiscountOnFairValueOfRestrictedShares" id="Fact_585f06a994b34dc2a0225605a0537e92" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">35</ix:nonFraction>% to $<ix:nonFraction name="btx:AssetAcquisitionRestrictedSharesSharePrice" id="Fact_62e2297a98c849c1b4347b9096ddff0a" contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">6.53</ix:nonFraction> per restricted share,
          which was derived from the average discount rate between the Black Scholes and Finnerty valuation models. <ix:nonNumeric name="us-gaap:AssetAcquisitionTableTextBlock" id="Text_3ac8744c64734e319bb6f2f33b766498" contextRef="c20220101to20220331" escape="true" continuedAt="Text_4cee435053b943669e552baa43f9a6701"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal;">The resulting fair value of the asset acquired is as follows (in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1245" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1246"><ix:continuation id="Text_4cee435053b943669e552baa43f9a6701" continuedAt="Text_4cee435053b943669e552baa43f9a6702">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1246" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1247"><ix:continuation id="Text_4cee435053b943669e552baa43f9a6702">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;">
                <div style="text-align: left;">&#160;</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; text-indent: -9pt; font-weight: bold;">Fair Value of</div>
                <div style="text-align: center; text-indent: -9pt; font-weight: bold;">Consideration</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;">
                <div style="text-align: left;">Cash paid</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" id="Fact_6f70d0a3d8ec46499b9156880a3455b5" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">22,882</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Cash acquired</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;">
                <div>(<ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" id="Fact_dcb3046cbe7e48b9bb25c05bcde293ef" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">28</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;">
                <div style="text-align: left;">Unrestricted shares</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="btx:StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" id="Fact_e3dde8bdb02c4d448abebe0459a5438d" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">36,628</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;">
                <div style="text-align: left;">Restricted shares</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                <div><ix:nonFraction name="btx:StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" id="Fact_0568a1c121104ae79815261a85eb68e8" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">22,056</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;">
                <div style="text-align: left;">Total fair value of consideration paid</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div><ix:nonFraction name="btx:AssetAcquisitionFairValueOfConsiderationPaid" id="Fact_e3ea6c121e994f38be759be48284e235" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">81,538</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;">
                <div style="text-align: left;">Less amount of cash paid for NoveCite investment</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>(<ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" id="Fact_ff927f0267c44d7dacf0f8b6e910bbdb" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;">
                <div style="text-align: left;">Fair value of IPR&amp;D acquired</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                <div><ix:nonFraction name="btx:ResearchAndDevelopmentInProcessAssetAcquisition" id="Fact_68692e2a1a9b4963a7affddd68b0fe7e" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">80,538</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1247" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1248">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1248" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1249">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">IPR&amp;D that is acquired through an asset purchase that has
          no alternative future uses and no separate economic values from its original intended purpose is expensed in the period the cost is incurred. Accordingly, the Company expensed the fair value of the IPR&amp;D during the third quarter of 2021 in
          the amount of $<ix:nonFraction name="btx:ResearchAndDevelopmentInProcessAssetAcquisition" id="Fact_159ca954aacf44d9978269b5c481b049" contextRef="c20210701to20210930_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="1" scale="0" format="ixt:numdotdecimal">80.5</ix:nonFraction> million.</div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1249" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1250">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1250" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1251">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Investment in NoveCite</span></div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1251" continuedAt="Text_00b56be35a80490db7afdacc9cf9cb1252">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_00b56be35a80490db7afdacc9cf9cb1252">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">As&#160; a&#160; result&#160; of&#160; the&#160; Acquisition,&#160; Brooklyn&#160; acquired&#160;
          and&#160; currently&#160; owns&#160; <ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" id="Fact_c3038e0422c74f2f8d49c7a5f2ad4a21" contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">25</ix:nonFraction>%&#160; of&#160; NoveCite&#160; and&#160; Citius Pharmaceuticals, Inc. (&#8220;Citius&#8221;) owns the remaining <ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" id="Fact_3a2d526083fe41da9af0e95f441e86e6" contextRef="c20210716_OwnershipAxis_CitiusPharmaceuticalsIncMember_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>%. A member of the Company&#8217;s management holds one of <ix:nonFraction name="btx:NumberOfBoardSeats" id="Fact_ffd3a21029bb47f98f0ad8e8c7fa1782" contextRef="c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U005" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction>
          board seats on NoveCite&#8217;s board of directors. Citius&#8217; s officers and directors hold the other two board seats. The Company is accounting for its interest in NoveCite under ASC Topic 323,&#160;<span style="font-style: italic;">Investments&#160;&#8211;&#160;Equity
            Method and Joint&#160;Ventures</span>.&#160;The investment was recorded at cost, which was $<ix:nonFraction name="us-gaap:EquityMethodInvestments" id="Fact_88551e912c5c4c86b4f2d7268884f7ca" contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million&#160;and is adjusted for the Company&#8217;s share
          of&#160;NoveCite&#8217;s earnings or losses, which are reflected in the accompanying condensed consolidated statement of operations. The investment may also reflect an equity loss in the event that circumstances indicate an other-than-temporary impairment.
          For the three months ended March 31, 2022, the Company recorded $<ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" id="Fact_c81ebe54deae41ca9e3f6ef20380b035" contextRef="c20220101to20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction> million in losses from its investment in NoveCite, of which $<ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" id="Fact_81922ac753f741fba1aeb215658cedfc" contextRef="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million relates to NoveCite&#8217;s year ended December 31, 2021.</div>
</ix:continuation>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">9</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

      </div>

    </div>

    <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div>
          <ix:nonNumeric name="us-gaap:FairValueDisclosuresTextBlock" id="Text_e7c69bb7250f40eca795c907e47ea32c" contextRef="c20220101to20220331" escape="true" continuedAt="Text_1a34a645acda4db283431699453aa1511">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FAIR VALUE OF FINANCIAL INSTRUMENTS</div>
                </td>

  </tr>


</table>
</ix:nonNumeric>
          <ix:continuation id="Text_1a34a645acda4db283431699453aa1511" continuedAt="Text_1a34a645acda4db283431699453aa1512">
<div style="text-align: left;"><br />
          </div>
</ix:continuation>
          <div>
            <ix:continuation id="Text_1a34a645acda4db283431699453aa1512" continuedAt="Text_1a34a645acda4db283431699453aa1513">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between
              market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The
              fair value hierarchy is as follows:</div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_1a34a645acda4db283431699453aa1513" continuedAt="Text_1a34a645acda4db283431699453aa1514">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_1a34a645acda4db283431699453aa1514" continuedAt="Text_1a34a645acda4db283431699453aa1515">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">Level 1 Inputs &#8211; Valued based on quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement
                    date.</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_1a34a645acda4db283431699453aa1515" continuedAt="Text_1a34a645acda4db283431699453aa1516">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_1a34a645acda4db283431699453aa1516" continuedAt="Text_1a34a645acda4db283431699453aa1517">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">Level 2 Inputs &#8211; Valued based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might
                    include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or
                    liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_1a34a645acda4db283431699453aa1517" continuedAt="Text_1a34a645acda4db283431699453aa1518">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_1a34a645acda4db283431699453aa1518" continuedAt="Text_1a34a645acda4db283431699453aa1519">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br />
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">Level 3 Inputs &#8211; Valued based on inputs for which there is little or no market value, which require the reporting entity to develop its own assumptions.</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_1a34a645acda4db283431699453aa1519" continuedAt="Text_1a34a645acda4db283431699453aa15110">
<div style="text-align: justify;"><br />
          </div>
</ix:continuation>

          <ix:nonNumeric name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="Text_4d476c48d31d495f848d9bf273e04d58" contextRef="c20220101to20220331" escape="true" continuedAt="Text_89883de871cc4b75b8f494f7e534e97c1"><ix:continuation id="Text_1a34a645acda4db283431699453aa15110" continuedAt="Text_1a34a645acda4db283431699453aa15111">
<div style="display:none;"><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following tables summarize the liabilities that are measured at fair value as of March 31, 2022 (in thousands).&#160; There were <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_c667984602f544408b5f81c18e9526a7" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> liabilities measured at fair value as of December 31, 2021:</div>
</ix:continuation></ix:nonNumeric>
        </div>

        <ix:continuation id="Text_89883de871cc4b75b8f494f7e534e97c1" continuedAt="Text_89883de871cc4b75b8f494f7e534e97c2"><ix:continuation id="Text_1a34a645acda4db283431699453aa15111" continuedAt="Text_1a34a645acda4db283431699453aa15112">
<div> <br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_1a34a645acda4db283431699453aa15112" continuedAt="Text_1a34a645acda4db283431699453aa15113"><ix:continuation id="Text_89883de871cc4b75b8f494f7e534e97c2">
<div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="10">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of March 31,
                    2022</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 1</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 2</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 3</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Liabilities:</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Pre-Funded Warrants</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_c590f96c661b499dae9cfc246b6a296e" contextRef="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_4d24f1bf1e494c1bb2f233fe27c36c74" contextRef="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,782</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_0ce6ee13d7f04d3aa72364728c0d8d7e" contextRef="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Common Warrants</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_4e46059e4d514606b161dabec557524f" contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_84da8c67fce64eccb937b5b4fc0422ea" contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_02a6bc54de6e49f09e0ceda3f13d47d8" contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,533</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_bac10a95d2364549a159476777bc5d82" contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_0cee6baa739e4427bd56ecbda3dba743" contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,782</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_dd8fde7439944542822fc3fba6b48741" contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,533</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
           </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_1a34a645acda4db283431699453aa15113" continuedAt="Text_1a34a645acda4db283431699453aa15114">
<div> <br />
        </div>
</ix:continuation>
        <div>
          <ix:continuation id="Text_1a34a645acda4db283431699453aa15114" continuedAt="Text_1a34a645acda4db283431699453aa15115">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 9, 2022, the Company issued pre-funded warrants exercisable for approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_024bade3258943298d0a6b8efa601863" contextRef="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,357,000</ix:nonFraction> shares of common stock (the &#8220;Pre-Funded Warrants&#8221;) and warrants exercisable for approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_9ed2453da04342e0be4a6626e84fc689" contextRef="c20220309_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">6,857,000</ix:nonFraction> shares of common stock (the &#8220;Common Warrants&#8221;) in connection with the PIPE Transaction (as defined below).&#160; See Note 10 for more information related to the PIPE
            Transaction.</div>
</ix:continuation>
          <ix:continuation id="Text_1a34a645acda4db283431699453aa15115" continuedAt="Text_1a34a645acda4db283431699453aa15116">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_1a34a645acda4db283431699453aa15116" continuedAt="Text_1a34a645acda4db283431699453aa15117">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Common Warrants and Pre-Funded Warrants were accounted for as liabilities
              under ASC 815-40, </span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Derivatives and Hedging, Contracts in Entity&#8217;s Own Equity</span><span style="font-size: 10pt; font-family: 'Times New Roman';"> (&#8220;ASC
              815-40&#8221;), as these warrants provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40.&#160; These warrant liabilities were measured at fair value at inception and are then
              subsequently measured on a recurring basis, with changes in fair value presented within the Company&#8217;s statement of operations.</span></div>
</ix:continuation>
          <ix:continuation id="Text_1a34a645acda4db283431699453aa15117" continuedAt="Text_1a34a645acda4db283431699453aa15118">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_1a34a645acda4db283431699453aa15118" continuedAt="Text_1a34a645acda4db283431699453aa15119">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company uses a Black-Scholes option pricing model to estimate the fair value of the Common Warrants, which is considered a Level 3 fair
            value measurement.&#160; Certain inputs used in this Black-Scholes pricing model may fluctuate in future periods based upon factors that are outside of the Company&#8217;s control.&#160; A significant change in one or more of these inputs used in the
            calculation of the fair value may cause a significant change to the fair value of the Company&#8217;s warrant liabilities, which could also result in material non-cash gains or losses being reported in the Company&#8217;s consolidated statement of
            operations.</div>
</ix:continuation>
          <div>
            <ix:continuation id="Text_1a34a645acda4db283431699453aa15119" continuedAt="Text_1a34a645acda4db283431699453aa15120">
<div><br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_1a34a645acda4db283431699453aa15120" continuedAt="Text_1a34a645acda4db283431699453aa15121">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The estimated fair value of the Pre-Funded Warrants was deemed a Level 2 measurement as of March 31, 2022, as all significant inputs to the
              valuation model used to estimate the fair value of the Pre-Funded Warrants were directly observable from the Company&#8217;s publicly-traded common stock.</div>
</ix:continuation>
            <ix:continuation id="Text_1a34a645acda4db283431699453aa15121" continuedAt="Text_1a34a645acda4db283431699453aa15122">
<div><br />
            </div>
</ix:continuation>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
              <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">10</span></div>

              <div style="page-break-after: always;" class="DSPFPageBreak">
                <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

              <div style="width: 100%;" class="DSPFPageHeader">
                <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
                </div>

              </div>

            </div>

          </div>

          <ix:continuation id="Text_1a34a645acda4db283431699453aa15122" continuedAt="Text_1a34a645acda4db283431699453aa15123">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_d9c2cd6857a34260b7d55ca777301c21" contextRef="c20220101to20220331" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">12.6</ix:nonFraction> million in the aggregate, which was $<ix:nonFraction name="btx:OverSubscriptionAmountReceived" id="Fact_f73432814a89499898cb0bcc9137fb01" contextRef="c20220331" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction> million more
            than the $<ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" id="Fact_3cab5b376eef4d0799148c719795c19a" contextRef="c20220331" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">12.0</ix:nonFraction> million proceeds received in the PIPE Transaction.&#160; The excess $<ix:nonFraction name="btx:OverSubscriptionAmountReceived" id="Fact_da2acf8c23584829b9d1ea265b76344f" contextRef="c20220331" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction> million represents an inducement to the purchaser to enter into the PIPE Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of
            operations.&#160; Given the Company&#8217;s capital requirements and market conditions, the Company consummated this financing on market terms available at the time of the transaction.</div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_1a34a645acda4db283431699453aa15123" continuedAt="Text_1a34a645acda4db283431699453aa15124">
<div><br />
        </div>
</ix:continuation>

        <ix:nonNumeric name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="Text_a999b685547c4a849f5806b959fa1fe1" contextRef="c20220101to20220331" escape="true" continuedAt="Text_72774a29f783472ab81ef7c568984ada1"><ix:continuation id="Text_1a34a645acda4db283431699453aa15124" continuedAt="Text_1a34a645acda4db283431699453aa15125">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company remeasured the fair value of the warrant liabilities as of March 31, 2022, and the following table presents the changes in the warrant
          liabilities from the issuance date (in thousands): </div>
</ix:continuation></ix:nonNumeric>
        <ix:continuation id="Text_72774a29f783472ab81ef7c568984ada1" continuedAt="Text_72774a29f783472ab81ef7c568984ada2"><ix:continuation id="Text_1a34a645acda4db283431699453aa15125" continuedAt="Text_1a34a645acda4db283431699453aa15126">
<div>&#160;</div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_1a34a645acda4db283431699453aa15126"><ix:continuation id="Text_72774a29f783472ab81ef7c568984ada2">
<div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pre-Funded <span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
                    </span></div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Warrants<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
                    </span></div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Level 2)</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Warrants<br />
                    </span>(Level 3)</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Warrant<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
                    </span>Liabilities</div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at January 1, 2022</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_e91f53e9f7c348eaafec4e90a9a976bc" contextRef="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_0d7b0b4eb10640c8b542c59f285ba7e2" contextRef="c20211231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_461b59794d13419597a58821ab77b238" contextRef="c20211231" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at March 9, 2022 (issuance date)</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_fdf9a1d1cd9347479e8f52dd1a3ab306" contextRef="c20220101to20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,646</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_5ce07e4262194ffd9da781670716e7dd" contextRef="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">9,943</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_142b19af60f14677b19de91fae0a9576" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,589</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in fair value of warrant liabilities</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" id="Fact_19c3426993cc40f99bc4b9c6ca3eac6d" contextRef="c20220101to20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">136</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" id="Fact_f457c1543836414f8a818425d81bf326" contextRef="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">590</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" id="Fact_43b553fce68f4295913dd59ebd1a349e" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">726</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at March 31, 2022</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_c5122c869dcf473cbd3634c4eb38f92c" contextRef="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,782</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_3ebcc67f462447ca978b32f0ffe757d8" contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,533</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_7a1c04c77dcb4241be871f5b084846c6" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">13,315</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
            </div>
</ix:continuation></ix:continuation>
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div><br />
      </div>

      <ix:nonNumeric name="us-gaap:LesseeOperatingLeasesTextBlock" id="Text_720ba7671df24909ae3dec6c5ae82cb9" contextRef="c20220101to20220331" escape="true" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae1">
<div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 36pt;">
                <div style="font-weight: bold;">5)</div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="font-weight: bold;">LEASES</div>
              </td>

  </tr>


</table>
      </div>
</ix:nonNumeric>
      <div>
        <div style="text-align: justify;">
          <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae1" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae2">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae2" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae3">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has operating leases for office and laboratory space in the borough of Manhattan in New York, New York and in Cambridge,
            Massachusetts, which expire in 2026 and 2028, respectively. On March 31, 2022, the Company entered into the Torrey Pines Science Center Lease in San Diego, California (the &#8220;San Diego Lease&#8221;) with<span style="font-family: 'Times New Roman'; font-size: 10pt;"> Torrey Pines Science Center Limited Partnership for approximately <ix:nonFraction name="btx:OperatingLeaseArea" id="Fact_a1daaaf3ce744851ad164ce4bc4a5d07" contextRef="c20220331" unitRef="U006" decimals="0" scale="0" format="ixt:numdotdecimal">5,200</ix:nonFraction> square feet of lab and office space.
              The term of the San Diego Lease is <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseTermOfContract" id="Fact_4a178dd9539348a8841e183032e9214a" contextRef="c20220331" format="ixt-sec:durmonth">62</ix:nonNumeric> months and the lease commencement date was April 19, 2022, which is the date the Company
              will record a right-of-use (&#8220;ROU) asset and corresponding operating lease liability. The San Diego Lease will expire in June</span> 2027.</div>
</ix:continuation>
          <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae3" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae4">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae4" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae5">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Base rent for the San Diego Lease is $<ix:nonFraction name="btx:BaseRentPerSquareFoot" id="Fact_44a6e731a8924b76b2b621af5413e1d6" contextRef="c20220101to20220331" unitRef="U006" decimals="2" scale="0" format="ixt:numdotdecimal">6.35</ix:nonFraction>
            per square foot in the first year of the San Diego Lease, with a rent abatement for the second and third full months of the first year. The base rent will increase by approximately <ix:nonFraction name="btx:PercentageBaseRentIncreaseOnEachAnniversary" id="Fact_7de0ab65c5f44e219ac58e4dd07f4e9f" contextRef="c20220331" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">3</ix:nonFraction>% on each anniversary of the lease commencement date. The Company is also required to pay its share of operating expenses and property taxes. The San Diego Lease provides
            for a one-time option to extend the lease term for an additional <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="Fact_5ed64ffe4eed4e90a1b126e56ef41e72" contextRef="c20220331" format="ixt-sec:durwordsen">five years</ix:nonNumeric> at the then fair rental value.</div>
</ix:continuation>
          <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae5" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae6">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae6" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae7">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On March 5, 2022, the Company entered into an Agreement to Assign Space Lease with Regen Lab USA LLC (&#8220;Regen&#8221;) pursuant to which the Company
            agreed to assign its Brooklyn, New York lease (the &#8220;Brooklyn Lease&#8221;) to Regen. The effective date of the assignment was contingent upon, among other things, a consent from BioBat, Inc. (the &#8220;Landlord&#8221;) to assign the Brooklyn Lease.&#160;
            Additionally, Regen agreed to purchase certain equipment from the Company for $<ix:nonFraction name="btx:LesseeCommitmentToPurchaseProperty" id="Fact_16059c6bb27841eab34b6de53e811a43" contextRef="c20220305" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">50,000</ix:nonFraction>, partly reimburse the Company $<ix:nonFraction name="btx:UnamortizedLeaseholdImprovements" id="Fact_03cc003794924dc5ae898eeb3bef2d73" contextRef="c20220305" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">50,000</ix:nonFraction> toward certain existing unamortized leasehold improvements, and to reimburse the Company for the existing security deposit the Company had
            under the Brooklyn Lease of approximately $<ix:nonFraction name="us-gaap:DepositAssets" id="Fact_3869cbc25b6e46829de50adb7a1c8664" contextRef="c20220305" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">63,000</ix:nonFraction>.</div>
</ix:continuation>
          <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae7" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae8">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae8" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae9">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 25, 2022, the Company entered into an Assignment and Assumption of Lease Agreement (the &#8220;Assignment Agreement&#8221;) with Regen, the consent
            of which was provided by the Landlord in the Assignment Agreement. The effective date of the assignment was March 28, 2022. Under the Assignment Agreement, Regen (i) accepts the assignment of the Brooklyn Lease; (ii) assumes all of the
            obligations, liabilities, covenants and conditions of the Company&#8217;s as tenant under the Brooklyn Lease; (iii) assumes and agrees to perform and observe all of the obligations, terms, requirements, covenants and conditions to be performed or
            observed by the Company under the Brooklyn Lease; and (iv) makes all of the representations and warranties binding under the Brooklyn Lease with the same force and effect as if Regens had executed the Brooklyn Lease originally as the tenant.</div>
</ix:continuation>
          <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae9" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae10">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae10" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae11">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the above assumptions by Regen, the Company shall be and remain liable and responsible for the due keeping, and full performance
            and observance, of all the provisions of the Brooklyn Lease on the part of the tenant to be kept, performed and observed. As a result of the Assignment Agreement, the Company wrote off the remaining ROU asset balance and the corresponding lease
            liability.</div>
</ix:continuation>
          <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae11" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae12">
<div><br />
          </div>
</ix:continuation>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">11</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
              </div>

            </div>

          </div>

          <div>
            <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae12" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae13">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company accounts for leases under ASC 842, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Leases</span>.
              Operating leases are included in &#8220;Right-of use assets - operating leases&#8221; within the Company&#8217;s balance sheets and represent the Company&#8217;s right to use an underlying asset for the lease term. The Company&#8217;s related obligation to make lease
              payments are included in &#8220;Operating lease liabilities, non-current&#8221; and &#8220;Operating lease liabilities, current&#8221; within the Company&#8217;s balance sheets. ROU assets and liabilities are recognized at commencement date based on the present value of
              lease payments over the lease term. Because the rate implicit in the lease is not readily determinable, the Company uses its incremental borrowing rates based on the information available at the lease commencement date in determining the
              present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet and are recognized as lease
              expense on a straight-line basis over the lease term. </div>
</ix:continuation>
            <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae13" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae14">
<div><br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae14" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae15">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Some leasing arrangements require variable payments that are dependent on usage or may vary for other reasons, such as payments for insurance,
              tax payments and other miscellaneous costs. The variable portion of lease payments is not included in the ROU assets or lease liabilities. Rather, variable payments, other than those dependent upon an index or rate, are expensed when the
              obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease contract are accounted for as lease expenses.</div>
</ix:continuation>
            <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae15" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae16">
<div><br />
            </div>
</ix:continuation>

            <ix:nonNumeric name="us-gaap:LeaseCostTableTextBlock" id="Text_b53363b260e54040ba8f2c22363a2ca7" contextRef="c20220101to20220331" escape="true" continuedAt="Text_c0ec34f93f8a4a879f797d8d84b444e61"><ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae16" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae17">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">During the three months ended March 31, 2022 and 2021, the net operating lease expenses were as follows (in thousands): </div>
</ix:continuation></ix:nonNumeric>
            <ix:continuation id="Text_c0ec34f93f8a4a879f797d8d84b444e61" continuedAt="Text_c0ec34f93f8a4a879f797d8d84b444e62"><ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae17" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae18">
<div><br />
            </div>
</ix:continuation></ix:continuation>
            <ix:continuation id="Text_c0ec34f93f8a4a879f797d8d84b444e62"><ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae18" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae19">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom;">&#160;</td>

    <td valign="bottom" colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three months ended March 31,</div>
                  </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;"><br />
                  </td>

    <td valign="bottom" colspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: #000000 solid 2px;">2022<br />
                  </td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: #000000 solid 2px;">2021<br />
                  </td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease expense</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_d3587c4322cc434b92bbcfd4091643c4" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">186</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_59b3c483300e4bb78048d832dd1c371b" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Sublease income</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SubleaseIncome" id="Fact_a66c048e3304472abcdc2cfeedafc806" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">21</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SubleaseIncome" id="Fact_747060cae7b24dcdb1fefd05e76a4a7e" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">21</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Variable lease expense</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_bf92e06af61946868fc1583dcebc7d3b" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_d62d7232cd144e898732b854f1596c9d" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">9</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Total lease expense</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_ecd11a790e124662acba04b27b7e3a05" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">168</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_a95c0ad08440459fad7725e1e5549ddf" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">139</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

            <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae19" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae20">
<div><br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae20" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae21"><ix:nonNumeric name="btx:OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" id="Text_0117423f6c5d4e8889085a4954592f89" contextRef="c20220101to20220331" escape="true" continuedAt="Text_21a3f036495840a5ab338790916147481">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2022 and the ending balances as of
              March 31, 2022, including the changes during the period (in thousands). </div>
</ix:nonNumeric></ix:continuation>
            <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae21" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae22"><ix:continuation id="Text_21a3f036495840a5ab338790916147481" continuedAt="Text_21a3f036495840a5ab338790916147482">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 8pt;"> <br />
            </div>
</ix:continuation></ix:continuation>
            <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae22" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae23"><ix:continuation id="Text_21a3f036495840a5ab338790916147482" continuedAt="Text_21a3f036495840a5ab338790916147483">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 8pt;">
              <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                      <div style="font-weight: bold;">Operating Lease</div>
                      <div><span style="font-weight: bold;">ROU Assets</span></div>
                    </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease ROU assets at January 1, 2022</div>
                    </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                    </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_1d26406e8446497bbc8641f271345017" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,567</ix:nonFraction></div>
                    </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Amortization of operating lease ROU assets</div>
                    </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" id="Fact_0fdeec55497942bd8aa7097247459b3b" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">102</ix:nonFraction></div>
                    </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                    </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Write off of ROU asset due to lease termination</div>
                    </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="btx:WriteOffOfOperatingLeaseRightOfUseAsset" id="Fact_6d314dfe334e47e7a80ad5a972fa01c2" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,372</ix:nonFraction></div>
                    </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                    </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease ROU assets at March 31, 2022</div>
                    </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                    </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_f265442e8c55443491e7a984400611fb" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,093</ix:nonFraction></div>
                    </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
            </div>
</ix:continuation></ix:continuation>
          </div>

          <div>
            <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae23" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae24"><ix:continuation id="Text_21a3f036495840a5ab338790916147483" continuedAt="Text_21a3f036495840a5ab338790916147484">
<div><br />
            </div>
</ix:continuation></ix:continuation>
            <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae24" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae25"><ix:continuation id="Text_21a3f036495840a5ab338790916147484">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;">
                    <div style="text-align: center;">Operating Lease</div>
                    <div style="text-align: center;"> Liabilities</div>
                  </td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease liabilities at January 1, 2022</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_c5605ffd4452430692858ad9ae2e48ea" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,723</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Principal payments on operating lease liabilities</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="btx:PrincipalPaymentsOnOperatingLeaseLiabilities" id="Fact_da159e13d717420382919a78c48c4973" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">103</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Write off of operating lease liability due to lease termination</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="btx:WriteOffOfOperatingLeaseLiability" id="Fact_aec2dd29f0a44a918487032b4f8cefe4" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,453</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease liabilities at March 31, 2022</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_8804d12f9aa24427bcfe91243b1602ff" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,167</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Less non-current portion</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_c68ecaba69be42b0b5d500b01a828d7e" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,018</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Current portion at March 31, 2022</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_dd876b8a35e64467b41c91c44f3ce367" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">149</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

            <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae25" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae26">
<div><br />
            </div>
</ix:continuation>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
              <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">12</span></div>

              <div style="page-break-after: always;" class="DSPFPageBreak">
                <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

              <div style="width: 100%;" class="DSPFPageHeader">
                <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
                </div>

              </div>

            </div>

            <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae26" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae27">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As of March 31, 2022, the Company&#8217;s operating leases had a weighted-average remaining life of <ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Fact_00695253f94f40e6aec229cf6141c7ba" contextRef="c20220331" format="ixt-sec:duryear">5.8</ix:nonNumeric> years with a weighted-average discount rate of <ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" id="Fact_288ea7e4d9b04a80b0620285127dae6e" contextRef="c20220331" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">10.23</ix:nonFraction>%.
              <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="Text_e2b159b4095a42d88f56aa812e76c0ed" contextRef="c20220101to20220331" escape="true" continuedAt="Text_15e8ef53077547c4a158207d9ba1b3da1"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;">The maturities of the
              operating lease liabilities are as follows (in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae27" continuedAt="Text_e82f2d000e4740f48dd05be1c586c4ae28"><ix:continuation id="Text_15e8ef53077547c4a158207d9ba1b3da1" continuedAt="Text_15e8ef53077547c4a158207d9ba1b3da2">
<div><br /></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_e82f2d000e4740f48dd05be1c586c4ae28"><ix:continuation id="Text_15e8ef53077547c4a158207d9ba1b3da2">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px; white-space: nowrap;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
                    <div>As of</div>
                    March 31,</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2022</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" id="Fact_a216e6b488cc451fa4553b95d3dfe222" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">201</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" id="Fact_4c8aecbef8094612beb259793fc0a91f" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">270</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" id="Fact_74a1ff42569b4a9b85efc9392884f403" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">272</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" id="Fact_dd7485d14e274a7191473dfa8e3b3ac4" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">274</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" id="Fact_f3fd38b85cf845d6906ea28c5873e65b" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">267</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="btx:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" id="Fact_3ef320db10524026bcd1a35f767b06cf" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">245</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total payments</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" id="Fact_d6a819a528b043c5b9d4a515272bd691" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,529</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less imputed interest</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" id="Fact_8ee9a3a6f83947e1b991443fe984c522" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">362</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: middle; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total operating lease liabilities</div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_84f0806baaa4484aa6566c4c71a74dfb" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,167</ix:nonFraction></div>
                </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
            </div>

        <div><br /></div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <ix:nonNumeric name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="Text_958859c10cee45918dfcea8c45a4d142" contextRef="c20220101to20220331" escape="true" continuedAt="Text_b59679599247470d8df0b5e21708a85d1">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">6)<br />
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT</div>
              </td>

  </tr>


</table>
</ix:nonNumeric>
        <ix:continuation id="Text_b59679599247470d8df0b5e21708a85d1" continuedAt="Text_b59679599247470d8df0b5e21708a85d2">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_b59679599247470d8df0b5e21708a85d2" continuedAt="Text_b59679599247470d8df0b5e21708a85d3">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In 2018, the Company acquired IRX, which was accounted for as a business combination. The Company recorded IPR&amp;D in the amount of $<ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" id="Fact_b985f5db9c1946bda0c3ee4a1444e500" contextRef="c20220331" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">6.0</ix:nonFraction> million, which represents the fair value assigned to technologies that were acquired in connection with the IRX Acquisition and which have not
          reached technological feasibility and have no alternative future use. IPR&amp;D assets acquired in a business combination are considered to be indefinite lived until the completion or abandonment of the associated research and development
          projects. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize products associated with the IPR&amp;D assets, these assets are then deemed definite-lived and are amortized
          based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a full or partial impairment charge related to the IPR&amp;D assets, calculated as the excess of carrying value
          of the IPR&amp;D assets over fair value</div>
</ix:continuation>
        <ix:continuation id="Text_b59679599247470d8df0b5e21708a85d3" continuedAt="Text_b59679599247470d8df0b5e21708a85d4">
<div><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_b59679599247470d8df0b5e21708a85d4" continuedAt="Text_b59679599247470d8df0b5e21708a85d5">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company also recorded goodwill in the amount of $<ix:nonFraction name="us-gaap:Goodwill" id="Fact_c773dfcfe7954c2282d334a19b615d1a" contextRef="c20220331" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction>
          million related to the IRX Acquisition. Goodwill and indefinite-lived IPR&amp;D assets are not amortized but are tested for impairment annually, or more frequently if the Company becomes aware of any events occurring or changes in circumstances
          that indicate that the fair value of the entity is less than its carrying values.</div>
</ix:continuation>
        <ix:continuation id="Text_b59679599247470d8df0b5e21708a85d5" continuedAt="Text_b59679599247470d8df0b5e21708a85d6">
<div><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_b59679599247470d8df0b5e21708a85d6" continuedAt="Text_b59679599247470d8df0b5e21708a85d7">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As of March 31, 2022, the Company performed a qualitative assessment to determine whether it is more likely than not that the fair value of the
          entity is less than its carrying value. Such qualitative factors include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and other relevant events. As a result of the qualitative
          assessment, the Company determined that due to the decline in the</div>
</ix:continuation>
        <ix:continuation id="Text_b59679599247470d8df0b5e21708a85d7" continuedAt="Text_b59679599247470d8df0b5e21708a85d8">
<div><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_b59679599247470d8df0b5e21708a85d8">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Company&#8217;s stock price of $<ix:nonFraction name="us-gaap:SharePrice" id="Fact_c8aee52868364182808a5ef735c7f224" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">4.17</ix:nonFraction> per
          share as of December 31, 2021 to $<ix:nonFraction name="us-gaap:SharePrice" id="Fact_501792ebad7f4b41a320549e93c98552" contextRef="c20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.05</ix:nonFraction> per share as of March 31, 2022, there were indications of impairment. Accordingly, the Company
          engaged a third-party valuation firm to perform a quantitative analysis to compare the entity&#8217;s carrying values to its fair value, the results of which showed that the entity&#8217;s fair value exceeded its carrying value and there was <ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_22b9b6be9b8c4a3eb9334651025126ed" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction> impairment of the recorded goodwill or IPR&amp;D.</div>
</ix:continuation>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <ix:nonNumeric name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="Text_11b1ef32b2cd47caa90778a9d86a8757" contextRef="c20220101to20220331" escape="true" continuedAt="Text_a39d3f92830f4bc9915a695a704854251">
<div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 36pt;">
                  <div style="text-align: left;"><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">7)</span>
                  </div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: bold;">ACCRUED EXPENSES</span></div>
                </td>

  </tr>


</table>
        </div>
</ix:nonNumeric>
        <ix:continuation id="Text_a39d3f92830f4bc9915a695a704854251" continuedAt="Text_a39d3f92830f4bc9915a695a704854252">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>

        <ix:nonNumeric name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="Text_0c42478fbc6b4e3fac257005d90cd5c6" contextRef="c20220101to20220331" escape="true" continuedAt="Text_57cc37eb58184d8eaadb5f9dadfd5cf61"><ix:continuation id="Text_a39d3f92830f4bc9915a695a704854252" continuedAt="Text_a39d3f92830f4bc9915a695a704854253">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued expenses consisted of the following (in thousands):</div>
</ix:continuation></ix:nonNumeric>
        <ix:continuation id="Text_57cc37eb58184d8eaadb5f9dadfd5cf61" continuedAt="Text_57cc37eb58184d8eaadb5f9dadfd5cf62"><ix:continuation id="Text_a39d3f92830f4bc9915a695a704854253" continuedAt="Text_a39d3f92830f4bc9915a695a704854254">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_57cc37eb58184d8eaadb5f9dadfd5cf62" continuedAt="Text_57cc37eb58184d8eaadb5f9dadfd5cf63"><ix:continuation id="Text_a39d3f92830f4bc9915a695a704854254" continuedAt="Text_a39d3f92830f4bc9915a695a704854255">
<table cellspacing="0" cellpadding="0" border="0" style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 31,</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</span><span style="text-decoration: underline;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
                    </span></span></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2021</span><span style="text-decoration: underline;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
                    </span></span></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued compensation<br />
                </div>
              </td>

    <td valign="bottom" style="font-family: &#38;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-family: &#38;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td valign="bottom" style="font-family: &#38;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_035e8d9810ad420299654e87e9c53183" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">637</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="font-family: &#38; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-family: &#38;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-family: &#38;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td valign="bottom" style="font-family: &#38;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_39f5fcaa73de49869a6cae48a6f9576d" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">656</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="font-family: &#38; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued research and development expenses</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="btx:AccruedResearchAndDevelopmentExpenses" id="Fact_29a951f4b24543deb46a1b129f7a069a" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">311</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="btx:AccruedResearchAndDevelopmentExpenses" id="Fact_2488abfff6dc4df1a14ce677b7518587" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">222</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued general and administrative expenses</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="btx:AccruedGeneralAndAdministrativeExpenses" id="Fact_b8f2605226fa41fcb86a434ba9df4eac" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,436</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="btx:AccruedGeneralAndAdministrativeExpenses" id="Fact_e4a16e3a8e5344b0a120fbef04f8ddec" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">371</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Total accrued expenses</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_fc5cd83fcaf24949817dced28da51ab8" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,384</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_c38061e3e8eb4de2ac1182167c422c59" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,249</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_57cc37eb58184d8eaadb5f9dadfd5cf63" continuedAt="Text_57cc37eb58184d8eaadb5f9dadfd5cf64"><ix:continuation id="Text_a39d3f92830f4bc9915a695a704854255" continuedAt="Text_a39d3f92830f4bc9915a695a704854256">
<div><br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_57cc37eb58184d8eaadb5f9dadfd5cf64"><ix:continuation id="Text_a39d3f92830f4bc9915a695a704854256">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;">Accrued general and administrative expenses include $<ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" id="Fact_94dfa07711414b0982df70e396984c7d" contextRef="c20220331" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction> million for legal-related matters.<br />
        </div>
</ix:continuation></ix:continuation>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;"> <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Text_4cf1c0a45d11426480401321d6af121c" contextRef="c20220101to20220331" escape="true" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb1">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">8)<br />
                </span> </td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">COMMITMENTS AND CONTINGENCIES</div>
              </td>

  </tr>


</table>
</ix:nonNumeric>
        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb1" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb2">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb2" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb3">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;">Legal Matters<br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb3" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb4">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>
</ix:continuation>
        <div style="text-align: justify; text-indent: 28.9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb4" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb5">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company is involved in litigation and arbitrations from time to time in the ordinary course of business. Legal fees and other costs
            associated with such actions are expensed as incurred. In addition, the Company assesses the need to record a liability for litigation and contingencies. The Company reserves for costs relating to these matters when a loss is probable, and the
            amount can be reasonably estimated.</div>
</ix:continuation>
        </div>

        <div style="text-align: justify;">
          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb5" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb6">
<div><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br />
            </span></div>
</ix:continuation>
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">13</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: justify;">
          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb6" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb7">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); text-indent: 36pt;"><span style="text-decoration: underline;"><span style="font-style: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Dhesh Govender v. Brooklyn
                Immunotherapeutics, LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021)</span></span></div>
</ix:continuation>
          <div style="text-align: justify;"> <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb7" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb8">
<div><br /></div>
</ix:continuation>
            <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb8" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb9">
<div style="display:none;"><br /></div>
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">On or about February 5, 2021, Dhesh Govender, a former short-term consultant of Brooklyn LLC, filed a complaint against Brooklyn LLC and certain individuals that plaintiff alleges were directors of Brooklyn LLC. The complaint is
              captioned, Dhesh Govender v. Brooklyn Immunotherapeutics, LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021). Plaintiff alleges that Brooklyn LLC and certain of its officers and directors (&#8220;defendants&#8221;) engaged in unlawful and
              discriminatory conduct based on race, national origin and hostile work environment. Plaintiff also asserts various breach of contract, fraud and quantum meruit claims based on an alleged oral agreement pursuant to which he alleges Brooklyn
              LLC agreed to hire him as an executive once the Merger was completed. In particular, plaintiff alleges that, in exchange for transferring an opportunity to obtain an agreement to acquire a license from Novellus for its mRNA-based gene editing
              and cell reprogramming technology to Brooklyn LLC, he was promised a $<ix:nonFraction name="btx:LossContingencyDamagesSoughtExpectedSalary" id="Fact_ea3946ce54db4930ab01bfb7556dde4f" contextRef="c20210205to20210205_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million salary and <ix:nonFraction name="btx:LossContingencyDamagesSoughtExpectedEquityPercentage" id="Fact_676b2af9293d4cff9e63b1fd03b93718" contextRef="c20210205to20210205_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">7</ix:nonFraction>% of the equity of Brooklyn LLC. Based on these and other allegations, plaintiff seeks damages of not less than $<ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" id="Fact_ebfcbb57d8714cc68d9a228fc21ec24f" contextRef="c20210205to20210205_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction> million, a permanent injunction enjoining Brooklyn LLC from exercising the option to acquire such license from Novellus or completing the
              proposed Merger. On or about February 19, 2021, an amended complaint was filed asserting the same causes of action but wi<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">thdrawing the request for injunctive relief. On June 6, 2021, defendants filed a motion to compel arbitration or, in the alternative, for partial
                dismissal of the complaint for failure to state viable fraud, quantum meruit and employment discrimination claims. After obtaining extensions of time to respond, plaintiff opposed the defendants&#8217; motion on August 9, 2021. The defendants
                filed their reply on September 3, 2021. The Court heard oral argument on the motion to compel arbitration and/or dismiss and the motion to seal on October 13,&#160;2021. By Order dated November 10,&#160;2021, the Court granted defendants&#8217; motion to
                compel Govender to arbitrate all of his claims against them, based on the arbitration clause of his consulting agreement with Brooklyn LLC.&#160; Govender thereafter filed his Statement of Claim (the &#8220;Demand&#8221;) with the American Arbitration
                Association (&#8220;AAA&#8221;), Case No. 01-21-0017-9417, on December 15,&#160;2021 against the same defendants, and served it on defendants&#8217; counsel on February 3,&#160;2022. In his Demand, Govender continues to assert statutory discrimination claims against
                all defendants, claims against Brooklyn LLC premised on the breach of an alleged oral promise to issue Govender <ix:nonFraction name="btx:LossContingencyDamagesSoughtExpectedEquityPercentage" id="Fact_5854ca9f5c67400bbf82a7d33a0c86ed" contextRef="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">7</ix:nonFraction>% of the equity
                of Brooklyn LLC and to employ Govender at a $<ix:nonFraction name="btx:LossContingencyDamagesSoughtExpectedSalary" id="Fact_2b9ea4e2770640f0894ce316caa0ef6b" contextRef="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million annual salary in exchange for allegedly arranging and negotiating the
                Novellus license, common law fraud claims against Brooklyn LLC and Cherington based on the breach of these same promises and a claim for quantum meruit against the Brooklyn LLC. In his Demand, Govender now claims that the fair and
                reasonable value of his services on the quantum meruit claim exceeded $<ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" id="Fact_6dcb5e3199d6421085bad6bb25d3b828" contextRef="c20211215to20211215_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember" unitRef="U002" decimals="-6" scale="6" format="ixt:numdotdecimal">100</ix:nonFraction> million and is seeking damages in an amount to be
                determined at the hearing. Defendants filed an answering statement to the Demand on February 28,&#160;2022 have selected a <ix:nonFraction name="btx:LossContingencyNumberOfArbitrationPanel" id="Fact_680d80a645b64fbeb376f681df20a047" contextRef="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember" unitRef="U005" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">-member arbitration panel. Defendants intend to vigorously defend themselv</span>es against these claims.</span> At this stage in the litigation, the Company is not able to predict the probability of a favorable or
              unfavorable outcome. </div>
</ix:continuation>
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: justify;">
                  <div>
                    <div style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb9" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb10">
<div><br /></div>
</ix:continuation>
                      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
                        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb10" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb11">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; text-indent: 36pt;"><span style="text-decoration: underline;">Emerald Private Equity Fund, LLC Matter</span></div>
</ix:continuation>
                        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb11" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb12">
<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
                          </span> </div>
</ix:continuation>
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb12" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb13">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">By a letter dated July 7, 2021, Emerald Private Equity Fund, LLC (&#8220;Emerald&#8221;), a stockholder of Brooklyn, made a demand pursuant
                            to 8 Del. C. 220 to inspect certain books and records of Brooklyn. The stated purpose of the demand is to investigate possible wrongdoing by persons responsible for the implementation of the Merger and the issuance of paper
                            stock certificates, including investigating whether: (i) Brooklyn&#8217;s stock certificates were issued in accordance with the Merger Agreement; (ii)&#160;certain restrictions on the sale of Brooklyn common stock following the Merger were
                            proper and applied without favor; (iii) anyone received priority in post-Merger issuances of Brooklyn&#8217;s stock certificates that allowed them to benefit from an increase in the trading price of Brooklyn&#8217;s common stock; and (iv)
                            it<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> should pursue
                              remedial measures and/or report alleged misconduct to the SEC. Brooklyn has responded to the demand letter and has produced certain information to Emerald in connection with the demand, which is subject to the terms of a
                              confidentiality agreement entered into among the parties, including certain additional stockholders who have subsequently joined as parties to such agreement (including Truell noted above). In October 2021, Emerald requested
                              that Brooklyn produce additional information related to the authority, purpose and justification for the restriction imposed on the sale of Brooklyn common stock following the Merger and the timing of share delivery to
                              Brooklyn stockholders, following which request Brooklyn agreed to produce certain additional information and emails relating to these topics.</span></div>
</ix:continuation>
                          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb13" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb14">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
                            </span></div>
</ix:continuation>
                          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb14" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb15">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
                          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
                            <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">14</span></div>

                            <div style="page-break-after: always;" class="DSPFPageBreak">
                              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

                            <div style="width: 100%;" class="DSPFPageHeader">
                              <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
                              </div>

                            </div>

                          </div>

                          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">
                            <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb15" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb16">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">On March 30,&#160;2022, counsel to Emerald advised the Company that it was prepared to file suit against the Company, certain current and former directors of the
                                Company, and the Company&#8217;s financial advisor in connection with the Merger, on behalf of Emerald and a class of similarly situated stockholders with respect to some or all of the foregoing matters, alleging claims for breach
                                of fiduciary duty, conversion and aiding and abetting breach of fiduciary duty. Emerald&#8217;s counsel expressed a willingness to engage in private pre-suit early resolution discussions with the Company and its financial advisor
                                on behalf of individual stockholders whom counsel represents in addition to Emerald; and the Company since engaged in such discussions. The Company can provide no assurance that such pre-suit early resolution discussions
                                will be successful or that suit will not ultimately be filed against the Company, nor can the Company currently predict the outcome of any such suit, if filed. The Company intends to defend itself vigorously against any and
                                all claims. Additionally, on April 7,&#160;2022,</span><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> the Company received a demand for indemnification from its financial advisor as it relates to the aforementioned
                                  potential lawsuit.</span><br />
                              </span></div>
</ix:continuation>
                          </div>

                          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb16" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb17">
<div><br /></div>
</ix:continuation>
                            <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb17" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb18">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="text-decoration: underline;">John Westman v. Novellus, Inc., Christopher Rohde, and Matthew Angel, Civil Action No. 2181CV01949
                                (Middlesex County (Massachusetts) Superior Court)</span></div>
</ix:continuation>
                            <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb18" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb19">
<div><br />
                            </div>
</ix:continuation>
                            <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb19" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb20">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> or about September 7, 2021, John Westman, a former employee of Novellus, Inc. filed a Complaint in Middlesex
                                County (Massachusetts) Superior Court against Novellus, Inc. and the company&#8217;s founders and former executives, Christopher Rohde and Matthew Angel (collectively, &#8220;Defendants&#8221;). The case includes allegations that Novellus,
                                Inc. violated the Massachusetts Wage Act.. Brooklyn acquired Novellus, Inc. on July 16,&#160;2021. Mr. Westman&#8217;s claims relate to alleged conduct that took place before Brooklyn acquired Novellus, Inc. Defense and liability in
                                association with any Wage Act claims have been assumed by Mr. Rohde and Mr. Angel. On December 24,&#160;2021, Westman dismissed the case without prejudice so the parties could mediate the matter. The parties&#8217; February 2022
                                mediation was unsuccessful and the dispute is currently in arbitration.</span></div>
</ix:continuation>
                            <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb20" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb21">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
                              </span></div>
</ix:continuation>
                            <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb21" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb22">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The company accrued $<ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" id="Fact_cc3e46ae79ee44d3a0a0e1c25f765464" contextRef="c20220331" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction> million in legal-related expenses during the quarter ended March 31, 2022 for the matters discussed above.<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
                              </span></div>
</ix:continuation>
                          </div>

                        </div>

                      </div>

                    </div>

                  </div>

                </div>

              </div>

              <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb22" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb23">
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
              </div>
</ix:continuation>
              <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb23" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb24">
<div style="display:none;"><br /></div>
<div style="font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;">Licensing Agreements</div>
</ix:continuation>
                <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb24" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb25">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>
</ix:continuation>
                <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb25" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb26">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">USF</span></div>
</ix:continuation>
                <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb26" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb27">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>
</ix:continuation>
                <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb27" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb28">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Brooklyn LLC has license agreements with University
                  of South Florida Research Association, Inc. (&#8220;USF&#8221;), granting Brooklyn LLC the right to sell, market, and distribute IRX-2, subject to a <ix:nonFraction name="btx:LossContingencyPercentageOfRoyaltyPayable" id="Fact_54bfc1b366044a4b887007b56da6dd30" contextRef="c20220101to20220331_LegalEntityAxis_UniversityOfSouthFloridaMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">7</ix:nonFraction>%
                  royalty payable to USF based on a percentage of gross product sales. Under the license agreement with USF, Brooklyn LLC is obligated to repay patent prosecution expenses incurred by USF. To date, Brooklyn LLC has not recorded any product
                  sales, or obligations related to USF patent prosecution expenses. The license agreement terminates upon the expiration of the IRX-2 patents.</div>
</ix:continuation>
                <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb28" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb29">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>
</ix:continuation>
                <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb29" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb30">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Novellus, Ltd. and Factor <br />
                  </span></div>
</ix:continuation>
                <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb30" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb31">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>
</ix:continuation>
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal;">
                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb31" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb32">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">In December 2020, Brooklyn LLC entered into option agreements (the
                    &#8220;Option Agreements&#8221;) with Novellus, Ltd. and Factor (together, the &#8220;Licensors&#8221;) to obtain the right to exclusively license the Licensors&#8217; intellectual property and mRNA cell reprogramming and gene editing technology for use in the
                    development of certain cell-based therapies to be evaluated and developed for treating human diseases, including certain types of cancer, sickle cell disease, and beta thalassemia (the &#8220;Licensed Technology&#8221;). The option was exercisable
                    before February 28, 2021 (or April 30, 2021 if the Merger had not closed by that date) and required Brooklyn LLC to pay a non-refundable option fee of $<ix:nonFraction name="btx:LossContingencyNonRefundableOptionFee" id="Fact_9eae7cdfa6864c3e8e9ae77c6bfd41aa" contextRef="c20210413to20210413_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million and then an initial license fee of $<ix:nonFraction name="btx:InitialLicenseFees" id="Fact_6c905164d7144f2db482ab8ca2e5e378" contextRef="c20210430to20210430_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction> million <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">(including the non-refundable fee of $<ix:nonFraction name="btx:LossContingencyNonRefundableOptionFee" id="Fact_86cef0a08c004be9ab3ede332ad9e279" contextRef="c20210413to20210413_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million) in order to exercise the option.</span></div>
</ix:continuation>
                </div>

                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb32" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb33">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <br />
                  </div>
</ix:continuation>
                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb33" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb34">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"> In April 2021, Brooklyn LLC and the Licensors amended the Option Agreements to extend the exercise period to May 21, 2021 and to require Brooklyn, LLC to pay a
                    total $<ix:nonFraction name="btx:AdditionalFeesObligatedToPay" id="Fact_e3dc1c0deac648a4af37b84b7b25c62d" contextRef="c20210415to20210415_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million of the $<ix:nonFraction name="btx:InitialLicenseFees" id="Fact_19bdc16d5697494babad85ca7deb7339" contextRef="c20210430to20210430_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction>
                    million initial license fees to the Licensors by April 15, 2021.</div>
</ix:continuation>
                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb34" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb35">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br />
                    </span></div>
</ix:continuation>
                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb35" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb36">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">In April 2021, Brooklyn LLC and the Licensors entered into an exclusive license agreement (the &#8220;License Agreement&#8221;) pursuant to which Brooklyn LLC acquired an exclusive worldwide license to the Licensed Technology. Under
                      the terms of the License Agreement, Brooklyn LLC is obligated to pay the Licensors a total of $<ix:nonFraction name="btx:AmountRequireToPayInitialLicenseFees" id="Fact_68aac7bcd61849ebb7e3ff7e1b78478c" contextRef="c20210426_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction> million in connection
                      with the execution of the License Agreement, all of which was paid as of June 2021.</span></div>
</ix:continuation>
                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb36" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb37">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br />
                    </span></div>
</ix:continuation>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
                    <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">15</span></div>

                    <div style="page-break-after: always;" class="DSPFPageBreak">
                      <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

                    <div style="width: 100%;" class="DSPFPageHeader">
                      <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
                      </div>

                    </div>

                  </div>

                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb37" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb38">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The completion of the acquisition of Novellus, Ltd. relieved Brooklyn LLC from potential obligations to pay Novellus, Ltd. certain upfront fees, clinical
                        development milestone fees and post-registration royalties under the License Agreement. The agreement with Factor under the License Agreement, which grants Brooklyn LLC exclusive rights to develop certain next-generation mRNA gene
                        editing and cell therapy products, remained unchanged. Accordingly, Brooklyn LLC is obligated to pay to Factor a fee</span> of $<ix:nonFraction name="btx:AmountObligatedToPayInYearTwo" id="Fact_7721019e394b42899ab80b82f9a10e35" contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember_StatementScenarioAxis_ScenarioForecastMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">3.5</ix:nonFraction>
                      million in October 2022, which will be in addition to a fee of $<ix:nonFraction name="btx:AmountObligatedToPayInYearOne" id="Fact_7496e59bed7c4a9092b5d3d9bc7e5f24" contextRef="c20211031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">2.5</ix:nonFraction> million paid to Factor in October 2021.</span> </div>
</ix:continuation>
                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb38" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb39">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;"><br />
                  </div>
</ix:continuation>
                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb39" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb40">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Brooklyn



                      LLC is also required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory milestones and specified commercialization milestones. In general, upon its
                      achievement of these milestones, Brooklyn LLC will be obligated to pay, in the case of development and regulatory milestones, milestone payments to the Licensors in specified amounts and, in the case of commercialization milestones,
                      specified royalties with respect to product sales, sublicense fees or sales of pediatric review vouchers. In the event Brooklyn LLC fails to timely achieve certain delineated milestones, the Licensors will have the right to terminate
                      Brooklyn LLC&#8217;s rights under provisions of the License Agreement relating to those milestones.</span> </div>
</ix:continuation>
                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb40" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb41">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>
</ix:continuation>
                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb41" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb42">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">Novellus, Ltd. also has a license agreement with Factor, which was entered into in February 2015, amended in June 2018 and March 2020, and then amended and restated
                    in November 2020. This license agreement provides for Novellus, Ltd. to use over <ix:nonFraction name="btx:MinimumNumberOfPatentGranted" id="Fact_fab64718ed6943d38f4d90ae045690f7" contextRef="c20220101to20220331_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">70</ix:nonFraction> granted patents owned by Factor
                    throughout the world covering synthetic mRNA, RNA-based gene editing, and RNA-based cell reprogramming, in addition to specific patents covering methods for treating specific diseases. There are also more than <ix:nonFraction name="btx:MinimumNumberOfPendingPatents" id="Fact_d7b012b70d794ee0a3081654791479e2" contextRef="c20220101to20220331_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">60</ix:nonFraction> pending patent applications throughout the world focused on these and other aspects of the technology. The patent coverage includes
                    granted patents and pending patent applications in the United States, Europe, and Japan, along with other major life sciences markets.</div>
</ix:continuation>
                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb42" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb43">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>
</ix:continuation>
                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb43" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb44">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">Novellus, Ltd. is required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory
                    milestones and specified commercialization milestones. In general, upon its achievement of these milestones, Novellus, Ltd. will be obligated, in the case of development and regulatory milestones, to make milestone payments of up to $<ix:nonFraction name="btx:MilestonePayments" id="Fact_445df466534e484aba7343c75333c9a2" contextRef="c20220101to20220331_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">51.0</ix:nonFraction> million in aggregate to Factor and, in the case of commercialization milestones, specified royalties with respect to product sales,
                    sublicense fees or sales of pediatric review vouchers. In the event Novellus, Ltd. fails to timely achieve certain delineated milestones, Factor may have the right to terminate Novellus, Ltd.&#8217;s rights under provisions of the License
                    Agreement relating to those milestones.</div>
</ix:continuation>
                  <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb44" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb45">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;">&#160;</div>
</ix:continuation>
                </div>

              </div>

            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 27pt;">
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                    <div style="text-align: justify;">
                      <div>
                        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb45" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb46">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> </span></div>
</ix:continuation>
                          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb46" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb47">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">NoveCite</span></div>
</ix:continuation>
                          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb47" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb48">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;"> <br />
                            </span></div>
</ix:continuation>
                          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb48" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb49">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;"> </span>In October 2020, Novellus, Ltd. (as
                            sublicensor) and NoveCite (as sublicensee) entered into an exclusive license agreement (the &#8220;Sublicense&#8221;) to license novel cellular therapy for acute respiratory distress syndrome, which NoveCite is licensing from Factor. Under
                            the sublicense agreement, NoveCite is required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory milestones and specified commercialization
                            milestones. In general, upon its achievement of these milestones, NoveCite will be obligated, in the case of development and regulatory milestones, to make milestone payments to the Novellus, Ltd. in specified amounts and, in
                            the case of commercialization milestones, specified royalties with respect to product sales, sublicense fees or sales of pediatric review vouchers.</div>
</ix:continuation>
                          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb49" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb50">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;"><br />
                            </span></div>
</ix:continuation>
                          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb50" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb51">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Under the terms of the Sublicense, in the
                            event that Novellus, Ltd. receives any revenue involving the original cell line included in the licensed technology, then Novellus, Ltd. shall remit to NoveCite <ix:nonFraction name="btx:PercentageOfRevenue" id="Fact_99a3fa2a00f649bf8cb90ccb544e4e2d" contextRef="c20220331_RelatedPartyTransactionsByRelatedPartyAxis_NoveCiteMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>% of such revenue.<span style="text-decoration: underline;"><br />
                            </span></div>
</ix:continuation>
                          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb51" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb52">
<div><br /></div>
</ix:continuation>
                        </div>

                      </div>

                    </div>

                  </div>

                </div>

              </div>

            </div>

          </div>

        </div>

        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb52" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb53">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;">Royalty Agreements</div>
</ix:continuation>
        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb53" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb54">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb54" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb55">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Collaborator Royalty Agreement</span></div>
</ix:continuation>
        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb55" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb56">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb56" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb57">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Effective June 22, 2018, IRX terminated its Research,
          Development and Option Facilitation Agreement and its Options Agreement (the &#8220;RDO and Options Agreements&#8221;) with a collaborative partner (the &#8220;Collaborator&#8221;), pursuant to a termination agreement (the &#8220;Termination Agreement&#8221;). <span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Termination Agreement was assigned to Brooklyn, LLC in November 2018 when Brooklyn LLC acquired the assets of IRX. </span>In
          connection with the Termination Agreement, all of the rights granted to the Collaborator under the RDO and Options Agreements were terminated, and Brooklyn LLC has no obligation to refund any payments received from the Collaborator. As
          consideration for entering into the Termination Agreement, the Collaborator will receive a royalty equal to <ix:nonFraction name="btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" id="Fact_935b0932ed9b4cb9b3df1a93161d295a" contextRef="c20180622to20180622_TypeOfArrangementAxis_CollaboratorRoyaltyAgreementMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">6</ix:nonFraction>% of revenues from the
          sale of IRX-2, for the period of time beginning with the first sale of IRX-2 through the later of (i) the twelfth anniversary of the first sale of IRX-2 or (ii) the expiration of the last IRX patent, or other exclusivity of IRX-2.</div>
</ix:continuation>
        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb57" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb58">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-indent: 36pt; text-transform: none;">&#160;</div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">16</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-indent: 36pt; text-transform: none;">
          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb58" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb59">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"> <span style="text-decoration: underline;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Royalty Agreement with certain former IRX Therapeutics Investors</span></span> </div>
</ix:continuation>
          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb59" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb60">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"> <br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb60" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb61">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">On May 1, 2012, IRX Therapeutics entered into a royalty agreement (the &#8220;IRX Investor Royalty Agreement<span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">&#8221;</span>)
              with certain investors who participated in a financing transaction. The IRX Investor Royalty Agreement was assigned to Brooklyn LLC in November 2018 when Brooklyn LLC acquired the assets of IRX. Pursuant to the IRX Investor Royalty Agreement,
              when Brooklyn LLC becomes obligated to pay royalties to USF under the agreement described above under &#8220;Licensing Agreements-USF,&#8221; it will pay an additional royalty of <ix:nonFraction name="btx:PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" id="Fact_e0c2b93b600045fd9166ec105e69f60a" contextRef="c20120501to20120501_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>% of gross sales to an entity organized by the investors who participated in such financing transaction. There are no termination provisions in the IRX Investor Royalty Agreement.
              Brooklyn LLC has not recognized any revenues to date, and no royalties are due pursuant to any of the above-mentioned royalty agreements.</span> </div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb61" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb62">
<div><span style="text-decoration: underline;"> <br />
        </span></div>
</ix:continuation>
        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb62" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb63">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Investor Royalty Agreement</span></div>
</ix:continuation>
        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb63" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb64">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb64" continuedAt="Text_852b216949fb4d84803d05fdadb7dfeb65">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <div style="text-align: justify; text-indent: 28.9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal;">
          <ix:continuation id="Text_852b216949fb4d84803d05fdadb7dfeb65">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-indent: 36pt;">On




            March 22, 2021, Brooklyn LLC restated its royalty agreement with certain beneficial holders of Brooklyn ImmunoTherapeutics Investors GP LLC and Brooklyn ImmunoTherapeutics Investors LP, whereby such beneficial holders will continue to receive,
            on an annual basis, royalties in an aggregate amount equal to <ix:nonFraction name="btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" id="Fact_71e85a04bc9b4e1f92899df6493216c6" contextRef="c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">4</ix:nonFraction>% of the net revenues of IRX-2, a cytokine-based therapy being
            developed by Brooklyn LLC to treat patients with cancer.</div>
</ix:continuation>
<div>
           <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</div>
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
         <br /></div>

      </div>

    </div>

    <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;"> <div><span style="font-family: 'Times New Roman';"> <span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </span></div>

    <ix:nonNumeric name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="Text_fe61a4ef3f6544cca1c5804b47cbc7d3" contextRef="c20220101to20220331" escape="true" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea1">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">9)<br />
              </span> </td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: normal; font-variant: normal; text-transform: none;">STOCK-BASED COMPENSATION</div>
              </div>
            </td>

  </tr>


</table>
    </div>
</ix:nonNumeric>
    <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea1" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea2">
<div><span style="font-family: 'Times New Roman';"> &#160; <span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </span></div>
</ix:continuation>
    <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea2" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea3">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Stock Options</span></div>
</ix:continuation>
    <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea3" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea4">
<div><span style="font-family: 'Times New Roman';"> <span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </span></div>
</ix:continuation>
    <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea4" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea5">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>
</ix:continuation>
    <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea5" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea6">
<div><span style="font-family: 'Times New Roman';"> <span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </span></div>
</ix:continuation>
    <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none;">
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea6" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea7">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">There were <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_b276a4713ad946b08956a2ecbfca34e0" contextRef="c20210331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_11819c0ec5d8472b91c83cc3ce6994e7" contextRef="c20210101to20210331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> stock options outstanding or granted during the </span><span style="font-family: 'Times New Roman';">three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2021.<span style="font-size: 10pt;"> <ix:nonNumeric name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="Text_6ff9800a3e994ac28e546077f88dee7f" contextRef="c20220101to20220331" escape="true" continuedAt="Text_1caca7c84fa64c9abc7ab70bbb97ee461"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">The following weighted-average assumptions were used for stock options granted during the </span></ix:nonNumeric></span><ix:continuation id="Text_1caca7c84fa64c9abc7ab70bbb97ee461" continuedAt="Text_1caca7c84fa64c9abc7ab70bbb97ee462"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">three</span></ix:continuation><span style="font-size: 10pt;"><ix:continuation id="Text_1caca7c84fa64c9abc7ab70bbb97ee462" continuedAt="Text_1caca7c84fa64c9abc7ab70bbb97ee463"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"> months ended March </span></ix:continuation></span><ix:continuation id="Text_1caca7c84fa64c9abc7ab70bbb97ee463" continuedAt="Text_1caca7c84fa64c9abc7ab70bbb97ee464"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">31,</span></ix:continuation><span style="font-size: 10pt;"><ix:continuation id="Text_1caca7c84fa64c9abc7ab70bbb97ee464" continuedAt="Text_1caca7c84fa64c9abc7ab70bbb97ee465"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">&#160;</span></ix:continuation></span><ix:continuation id="Text_1caca7c84fa64c9abc7ab70bbb97ee465" continuedAt="Text_1caca7c84fa64c9abc7ab70bbb97ee466"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">2022</span></ix:continuation><span style="font-size: 10pt;"><ix:continuation id="Text_1caca7c84fa64c9abc7ab70bbb97ee466" continuedAt="Text_1caca7c84fa64c9abc7ab70bbb97ee467"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">:</span></ix:continuation></span></span></div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea7" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea8"><ix:continuation id="Text_1caca7c84fa64c9abc7ab70bbb97ee467" continuedAt="Text_1caca7c84fa64c9abc7ab70bbb97ee468">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea8" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea9"><ix:continuation id="Text_1caca7c84fa64c9abc7ab70bbb97ee468">
<table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Three months ended </span></div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">March 31</span><span style="font-family: 'Times New Roman';">,<span style="font-size: 10pt;"> </span>2022</span></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-size: 10pt;">Weighted average risk-free rate</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255);">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact_d174144dbdaa4449ac62785d8fd0e29b" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">1.92</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="font-size: 10pt;">%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%;">
              <div style="text-align: left; font-size: 10pt;">Weighted average volatility</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact_2475f54991e048c6bec93350b01686b8" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">93</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
              <div style="font-size: 10pt;">%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-size: 10pt;">Dividend yield</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255);">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" id="Fact_f79a6190b503411aa1e767827e308802" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">0</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="font-size: 10pt;">%</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%;">
              <div style="text-align: left; font-size: 10pt;">Expected term</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%;">
              <div style="font-size: 10pt;"><span style="font-size: 10pt;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Fact_33f90305e73d41db9896f274993fcc94" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">5.78</ix:nonNumeric> years<br />
                </span></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea9" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea10">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">17</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
          </div>

        </div>

      </div>


      <ix:nonNumeric name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="Text_58ee1423da4842889e06298debdcc9cc" contextRef="c20220101to20220331" escape="true" continuedAt="Text_78932641bd174625a37f57100ba827891"><ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea10" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea11">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> The following table summarizes stock option activity for the </span><span style="font-family: 'Times New Roman';">three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2022<span style="font-size: 10pt;">:</span></span></div>
</ix:continuation></ix:nonNumeric>
      <ix:continuation id="Text_78932641bd174625a37f57100ba827891" continuedAt="Text_78932641bd174625a37f57100ba827892"><ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea11" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea12">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_78932641bd174625a37f57100ba827892"><ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea12" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea13">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Outstanding Options</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Weighted Average Exercise Price per Share</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Weighted Average Remaining Contractual Life (in years)</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Aggregate Intrinsic Value</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Outstanding January </span><span style="font-family: 'Times New Roman'; font-weight: bold;">1,<span style="font-size: 10pt;"> </span>2022</span></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_19ae4fa476dd43e1a245fbe3290f1959" contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,988,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="Fact_4b60b9b3d57e4ff682ed74f843ad1e65" contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">8.40</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="font-size: 10pt;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Fact_682fbd3758e74c458a7cf81afe31aced" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">9.38</ix:nonNumeric></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" id="Fact_322ea1273839443a8e360352507e4ee7" contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="0" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 52%;">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Granted</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_8f6ab86d166a43b69ce87c4eca299012" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,258,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" id="Fact_d40dcbe70866484cab6dd9f032528c7f" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.10</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="font-size: 10pt;">-</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" id="Fact_133e08796c154081bc5f4e36333bd95e" contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="0" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Cancelled</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="font-size: 10pt;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" id="Fact_45d89b7d87bd4cfe9f17b0a56e2032a4" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">67,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div style="font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" id="Fact_ac4df744b27a4e6bb13fe0df4723568d" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">5.94</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
              <div style="font-size: 10pt;">-</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Outstanding March 31</span><span style="font-family: 'Times New Roman'; font-weight: bold;">,<span style="font-size: 10pt;"> </span>2022</span></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_758b26653a2a4eb4afb9e1565d1db90c" contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">5,179,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="Fact_40917df3c9b9448786dda833444228e6" contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">6.90</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="font-size: 10pt;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Fact_ecdb2fd9f23048289c0462f3a72e6504" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">9.32</ix:nonNumeric></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" id="Fact_87db2e7c29b94ad58fc281714866cc95" contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">134,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Options vested and exercisable at March </span><span style="font-family: 'Times New Roman';">31,<span style="font-size: 10pt;">&#160;</span>2022</span></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" id="Fact_eccf2390ba30474cbb1daf762e7c7394" contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">10,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" id="Fact_076dbbf27e2c43bf8209f3a051ec2e29" contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">10.26</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="font-size: 10pt;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="Fact_40c691ddd8d84455a86fc9bb416bf25e" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">9.75</ix:nonNumeric></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" id="Fact_9fdcd7c4b3cc4a8b8b81aeaa058f054b" contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="0" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea13" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea14">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea14" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea15">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The per-share weighted average grant-date fair value of stock options granted during
          the </span><span style="font-family: 'Times New Roman';">three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2022<span style="font-size: 10pt;"> was </span>$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_b43edf1cbfe140ed89ddbb1971a649e1" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.58</ix:nonFraction>.</span></div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea15" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea16">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea16" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea17">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">As of March </span><span style="font-family: 'Times New Roman';">31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> the unamortized stock-based compensation expense related to outstanding unvested options was approximately </span>$<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" id="Fact_e82698ed85ed4438a8f7ede281050e3c" contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">18.5</ix:nonFraction> million<span style="font-size: 10pt;"> with a weighted average remaining requisite service period of </span><ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Fact_848429d0795845ca8ee43482bc33e26a" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">3.06</ix:nonNumeric><span style="font-size: 10pt;"> years. The Company expects to amortize this expense over the remaining requisite service period of these stock options.</span></span></div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea17" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea18">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea18" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea19">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Included in the </span><span style="font-family: 'Times New Roman';"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_0a5c088aa14547199d3875786f42de2b" contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">5,179,000</ix:nonFraction><span style="font-size: 10pt;"> stock options outstanding as of March </span>31,<span style="font-size: 10pt;">&#160;</span>2022<span style="font-size: 10pt;"> are </span><ix:nonFraction name="btx:NumberOfStockOptionGrantMade" id="Fact_725caac513f741daaa24d2046ed5b926" contextRef="c20220331" unitRef="U008" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction><span style="font-size: 10pt;"> stock option grants the Company awarded to Howard J.
            Federoff, M.D., Ph.D. upon his appointment as the Company&#8217;s Chief Executive Officer and President in April </span>2021.</span></div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea19" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea20">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea20" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea21">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Dr. Federoff was granted a nonqualified stock option covering approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_d8843da67fe244cd85f95789b659d16e" contextRef="c20220101to20220331_AwardTypeAxis_TimeBasedNonQualifiedStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">2,628,000</ix:nonFraction></span><span style="font-family: 'Times New Roman';"><span style="font-size: 10pt;"> shares of common stock (the &#8220;Time-Based Option&#8221;). The
            Time-Based Option was granted at a per share exercise price equal to the closing price of the common stock on the NYSE American stock exchange on the date of grant. Of the shares covered by the Time-Based Option, </span><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" id="Fact_4db87e11081b4745baaa4d4a18d437e1" contextRef="c20220101to20220331_AwardTypeAxis_TimeBasedNonQualifiedStockOptionMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">25</ix:nonFraction>%<span style="font-size: 10pt;"> will vest on the </span>one<span style="font-size: 10pt;">-year anniversary of the grant date, and the remaining
            shares will vest in substantially </span><ix:nonFraction name="btx:ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" id="Fact_bcadfe9bd2df4e468f2ca30a61b67629" contextRef="c20220101to20220331_AwardTypeAxis_TimeBasedNonQualifiedStockOptionMember" unitRef="U009" decimals="0" scale="0" format="ixt:numdotdecimal">36</ix:nonFraction><span style="font-size: 10pt;"> equal monthly installments thereafter, so long as Dr.
            Federoff provides continuous service to the Company throughout the relevant vesting date.</span></span></div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea21" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea22">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea22" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea23">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Dr. Federoff was also granted a performance-based nonqualified stock option covering
          approximately </span><span style="font-family: 'Times New Roman';"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_34bbc19106794447a9930aed646eda69" contextRef="c20220101to20220331_AwardTypeAxis_PerformanceBasedNonqualifiedStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">597,000</ix:nonFraction><span style="font-size: 10pt;"> shares of common stock (the
            &#8220;Milestone Option&#8221;). The Milestone Option was granted at a per share exercise price equal to the closing price of common stock on the NYSE American stock exchange on the date of grant, and its fair value is </span>$<ix:nonFraction name="btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" id="Fact_30b68b3fe4a14f79b75710c02a58c0fb" contextRef="c20220101to20220331_AwardTypeAxis_PerformanceBasedNonqualifiedStockOptionMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">4.3</ix:nonFraction> million<span style="font-size: 10pt;">. The Milestone Option will fully vest upon the </span>first<span style="font-size: 10pt;"> concurrence by
            the U.S. Food and Drug Administration that a proposed investigation may proceed following review of a Company filed investigational new drug application in connection with that the License Agreement. This milestone is subject to Dr. Federoff&#8217;s
            continuous service with the Company through such vesting date. As of March </span>31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> the Company has <ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_f3e0490a9bd44a039d1b02b026d9d146" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction>t recognized any stock-based compensation expense on the Milestone Option because the Company has determined that it is not yet probable that the performance milestone
            will be accomplished.</span></span></div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea23" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea24">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea24" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea25">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Both the Time-Based Option and the Milestone Option were granted outside the
          Company&#8217;s equity incentive plans discussed above. The unvested portion of the Time-Based Option and the Milestone Option will be cancelled upon the termination of Dr. Federoff&#8217;s employment with the Company for any reason, subject to certain
          vesting acceleration provisions upon a qualifying termination, as described in his employment agreement with the Company. Unless earlier terminated in accordance with their terms, each of the Time-Based Option and the Milestone Option will
          otherwise expire on the </span><span style="font-family: 'Times New Roman';">tenth<span style="font-size: 10pt;"> anniversary of their respective grant date and be subject to the terms and conditions of the respective option agreement approved
            by the Company. Each of the Time-Based Option and the Milestone</span></span><span style="font-size: 10pt; font-family: 'Times New Roman';"> Option was intended to constitute an &#8220;employment inducement grant&#8221; in accordance with the employment
          inducement grant rules set forth in Section </span><span style="font-family: 'Times New Roman';">711<span style="font-size: 10pt;">(a) of the NYSE American LLC Company Guide and was offered as an inducement material to Dr. Federoff in connection
            with his hiring.</span></span> </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea25" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea26">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea26" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea27">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">There were <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_fe7d43d61aa2494e98b374fa21ac0dbd" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_c5057c68e197426baeceb04be6d485ce" contextRef="c20210101to20210331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>
          options exercised during the </span><span style="font-family: 'Times New Roman';">three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2022<span style="font-size: 10pt;"> and </span>2021.</span>
      </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea27" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea28">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt;"><span style="font-family: 'Times New Roman';"> <br />
        </span></div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">18</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
          </div>

        </div>

      </div>

      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea28" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea29">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt;"><span style="font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><span style="text-decoration: underline;">RSUs</span></span> </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea29" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea30">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea30" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea31">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Outstanding RSUs are settled in an equal number of shares of common stock on the vesting date of the award. An RSU award is settled only to the
        extent vested. Vesting generally requires the continued employment or service by the award recipient through the respective vesting date. Because RSUs are settled in an equal number of shares of common stock without any offsetting payment by the
        recipient, the measurement of cost is based on the quoted market price of the stock at the measurement date, which is the grant date.</div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea31" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea32">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea32" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea33">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">There were <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_a8eef851674a4ec598e26e27482359b5" contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_05acc581f4cd4606b5fb9ee664c88d60" contextRef="c20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> RSUs outstanding or granted during the </span><span style="font-family: 'Times New Roman';">three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2021.<span style="font-size: 10pt;"> <ix:nonNumeric name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="Text_791343deab184b8cabe5fa0221e79d53" contextRef="c20220101to20220331" escape="true" continuedAt="Text_b2f035f66b164f5dbd7d49c6137578461"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">The following table summarizes RSU activity for the </span></ix:nonNumeric></span><ix:continuation id="Text_b2f035f66b164f5dbd7d49c6137578461" continuedAt="Text_b2f035f66b164f5dbd7d49c6137578462"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">three</span></ix:continuation><span style="font-size: 10pt;"><ix:continuation id="Text_b2f035f66b164f5dbd7d49c6137578462" continuedAt="Text_b2f035f66b164f5dbd7d49c6137578463"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"> months ended March </span></ix:continuation></span><ix:continuation id="Text_b2f035f66b164f5dbd7d49c6137578463" continuedAt="Text_b2f035f66b164f5dbd7d49c6137578464"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">31,</span></ix:continuation><span style="font-size: 10pt;"><ix:continuation id="Text_b2f035f66b164f5dbd7d49c6137578464" continuedAt="Text_b2f035f66b164f5dbd7d49c6137578465"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">&#160;</span></ix:continuation></span><ix:continuation id="Text_b2f035f66b164f5dbd7d49c6137578465" continuedAt="Text_b2f035f66b164f5dbd7d49c6137578466"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">2022</span></ix:continuation><span style="font-size: 10pt;"><ix:continuation id="Text_b2f035f66b164f5dbd7d49c6137578466" continuedAt="Text_b2f035f66b164f5dbd7d49c6137578467"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">:</span></ix:continuation></span></span></div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea33" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea34"><ix:continuation id="Text_b2f035f66b164f5dbd7d49c6137578467" continuedAt="Text_b2f035f66b164f5dbd7d49c6137578468">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea34" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea35"><ix:continuation id="Text_b2f035f66b164f5dbd7d49c6137578468">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Outstanding Restricted Stock Units</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Weighted Average Fair Value per Share</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">January </span><span style="font-family: 'Times New Roman'; font-weight: bold;">1,<span style="font-size: 10pt;"> 2022</span></span></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_2d64aaf0442b4669a549fddaf4229c16" contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">240,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" id="Fact_83aa811dd70a4527b9273b8e339c5f9a" contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">13.80</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%;">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Granted</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_eaadbc05ca554a7d8636ab1430e26f24" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,101,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_df1b331b13f342e69130eae4e82bd05f" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.93</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Released</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="font-size: 10pt;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" id="Fact_4d09df181be343a1bf4e1f89807e9792" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">9,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" id="Fact_a8b4babfbf2347f897d78e5a87ad2426" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">4.21</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px;">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Cancelled</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="font-size: 10pt;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_7726aa26125b44b789cafdb02c60adfd" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">9,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
              <div style="font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" id="Fact_c40cb4273667471ab0dafac7d9be0754" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">4.21</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;">March 31</span><span style="font-family: 'Times New Roman'; font-weight: bold;"><span style="font-size: 10pt;"> </span>2022</span></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_13c56424e1e649388f70af9178bb6055" contextRef="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,323,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">
              <div style="font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" id="Fact_fbefdbb9c2424e61950e4970174476dc" contextRef="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">4.05</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" rowspan="1">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Balance expected to vest at March </span><span style="font-family: 'Times New Roman';">31,<span style="font-size: 10pt;">&#160;</span>2022</span></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);">
              <div style="font-size: 10pt;"><ix:nonFraction name="btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" id="Fact_2d158f02e2164e8593047d94e61ae4de" contextRef="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">772,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea35" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea36">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea36" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea37">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">During the </span><span style="font-family: 'Times New Roman';">three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> the Company issued approximately </span><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_59557195a1c14400ae067fc818d1cf86" contextRef="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_EmployeeMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,101,000</ix:nonFraction><span style="font-size: 10pt;"> performance based RSUs (the &#8220;</span>2022<span style="font-size: 10pt;"> PSUs&#8221;) to its employees, of which approximately </span><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_31faebe2726542a98f9590a38daa4061" contextRef="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">414,000</ix:nonFraction><span style="font-size: 10pt;"> were awarded to Dr. Federoff. The </span>2022<span style="font-size: 10pt;"> PSUs are subject to the
            achievement of </span><ix:nonFraction name="btx:NumberOfPerformanceGoalsAreSubjectToAchieve" id="Fact_dcaa08dc8312405d8336d0101fd93602" contextRef="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember" unitRef="U010" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction><span style="font-size: 10pt;"> performance goals, which are weighted equally. Once a performance goal is
            achieved, the tranche of shares allocated to that performance goal will be earned and will begin to vest over a </span><ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Fact_bdadfc61876d4296a9c05511bea7b81e" contextRef="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember" format="ixt-sec:durwordsen">three-year</ix:nonNumeric><span style="font-size: 10pt;"> annual basis beginning on the date the performance goal was achieved. If a performance goal is not achieved, the tranche of shares allocated to that performance goal will be unearned and forfeited.</span></span></div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea37" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea38">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea38" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea39">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company recognizes the fair value of RSUs granted as expense on a straight-line
          basis over the requisite service period. For performance based RSUs, the Company will begin recognizing the expense once the achievement of the related performance goal is probable. As of March </span><span style="font-family: 'Times New Roman';">31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> the unamortized stock-based compensation expense related to outstanding RSUs, including performance based RSUs that have been deemed probable, was
            approximately </span>$<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" id="Fact_60f6f2e159224f55bea1de4998131acf" contextRef="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">3.6</ix:nonFraction> million<span style="font-size: 10pt;"> with a weighted average remaining requisite service period of </span><ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Fact_7ad97e6a02c742eabf8d9ebddae3f1be" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" format="ixt-sec:duryear">2.59</ix:nonNumeric><span style="font-size: 10pt;"> years. The Company expects to amortize this expense over the remaining requisite service period of the RSUs.</span></span></div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea39" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea40">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman';"><span style="font-size: 10pt;"> <br />
          </span></span></div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea40" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea41">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt;"><span style="text-decoration: underline;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Restricted Stock</span></span> </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea41" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea42">
<div style="font-family: 'Times New Roman';"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea42" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea43">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Pursuant to the Merger, Brooklyn LLC&#8217;s approximately </span><span style="font-family: 'Times New Roman';"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_e46d7d89e5db4fa8be45e78f8fc2fe3a" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,000</ix:nonFraction><span style="font-size: 10pt;"> outstanding restricted common units were exchanged for
            approximately </span><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_cbcb18df300d4193be7df425b37148ef" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">630,000</ix:nonFraction><span style="font-size: 10pt;"> shares of Brooklyn&#8217;s restricted common stock. There were no changes to
            any conditions and requirements of the restricted common stock. The shares vest quarterly beginning on March </span>31,<span style="font-size: 10pt;">&#160;</span>2021<span style="font-size: 10pt;"> and continuing through December </span>31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> contingent on continued service. Due to the modification of the restricted common units, the fair value of the restricted common stock immediately after the Merger was
            compared to the fair value of the restricted common units immediately prior to the Merger, and the change in fair value of </span>$<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_2259b75430e84d91a157122f11f89ca3" contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction>
          million<span style="font-size: 10pt;"> was recognized in the statement of operations during the </span>three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2021.<span style="font-size: 10pt;">
            The Company recognizes the fair value of restricted common stock as an expense on a straight-line basis over the requisite service period. During the quarter ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> approximately </span><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_89453cdfbce7410bbbd787e862f9c609" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">78,000</ix:nonFraction><span style="font-size: 10pt;"> shares of unvested restricted common stock were
            forfeited due to the holders of such shares no longer providing services to the Company. As of March </span>31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> there were <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_47770f018d4945deb257d3d20f3243a4" contextRef="c20220331_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> shares of unvested restricted stock outstanding.</span></span></div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea43" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea44">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman';"><span style="font-size: 10pt;"> <br />
          </span></span></div>
</ix:continuation>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">19</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
          </div>

        </div>

      </div>

      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea44" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea45">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt;"><span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Stock-Based Compensation Expense </span></div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea45" continuedAt="Text_a0a5501032fa4d71872e680feb3054ea46">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt;"><span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> <br />
        </span></div>
</ix:continuation>
      <ix:continuation id="Text_a0a5501032fa4d71872e680feb3054ea46">
<div style="display:none;"><br /></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt; text-align: justify;"><span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Stock-based compensation is recorded in general and administrative expense and research and development expense in the statement of operations. For the three months ended March 31,&#160;2022 and 2021, stock-based compensation
          expense recorded in general and administrative expense was $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_d271bb69e2d64890b5f02d5af03688c0" contextRef="c20220101to20220331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_b77ec7dff3044c77bd793b088235ea9c" contextRef="c20210101to20210331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">17,000</ix:nonFraction>, respectively. For both of the three months ended March 31,&#160;2022 and 2021, stock-based compensation expense recorded in research and development expense was $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_faedad39338b499191b44c613ac082aa" contextRef="c20220101to20220331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_6d5db873e5a247faa14e4c4f3d075269" contextRef="c20210101to20210331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction></ix:nonFraction> million.</span> </div>
</ix:continuation>
      </div>

    <div><span style="font-family: 'Times New Roman';"><br />
      </span> </div>

    <div><span style="font-family: 'Times New Roman';"> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;"> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none;">
        <ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="Text_b2be21af16d24bb093b1de68f296d004" contextRef="c20220101to20220331" escape="true" continuedAt="Text_826140b00f1447f98e79feedf69354e51">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify;">10)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">STOCKHOLDERS&#8217; EQUITY<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>
              </td>

  </tr>


</table>
</ix:nonNumeric>
        <div>
          <ix:continuation id="Text_826140b00f1447f98e79feedf69354e51" continuedAt="Text_826140b00f1447f98e79feedf69354e52">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"><span style="font-weight: normal;"> <br />
            </span></div>
</ix:continuation>
          <ix:continuation id="Text_826140b00f1447f98e79feedf69354e52" continuedAt="Text_826140b00f1447f98e79feedf69354e53">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Private Placement of
            Equity</div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e53" continuedAt="Text_826140b00f1447f98e79feedf69354e54">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br />
              </span></div>
</ix:continuation>
            <div style="text-align: justify; text-indent: 36pt;">
              <ix:continuation id="Text_826140b00f1447f98e79feedf69354e54" continuedAt="Text_826140b00f1447f98e79feedf69354e55">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 6, 2022, the Company entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with an investor (the &#8220;PIPE Investor&#8221;)
                providing for the private placement (the &#8220;PIPE Transaction&#8221;) to the PIPE Investor of approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_d02013ff700d4b69b163b0624c7dec97" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">6,857,000</ix:nonFraction> units
                (collectively, the &#8220;Units&#8221;), each Unit consisting of (i) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_644c11dc698d4335b52c3843006fac88" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of the Company&#8217;s common stock (or, in lieu thereof, one
                pre-funded warrant (the &#8220;Pre-Funded Warrants&#8221;) to purchase one share of common stock) and (ii) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_457f70bcda3b4f938ef4af4cdb8c4d92" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> warrant (the &#8220;Common
                Warrants&#8221;) to purchase one share of common stock, for an aggregate gross purchase price of approximately $<ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" id="Fact_7d22c79e1a5f4fedb9fa790c2ae175b7" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">12.0</ix:nonFraction> million (the
                &#8220;Subscription Amount&#8221;). The PIPE Transaction closed on March 9, 2022.</div>
</ix:continuation>
            </div>

            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e55" continuedAt="Text_826140b00f1447f98e79feedf69354e56">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span>
              <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>
</ix:continuation>
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e56" continuedAt="Text_826140b00f1447f98e79feedf69354e57">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each Pre-Funded Warrant has an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_26da628ae1a54ec492561419f333fb9f" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal">0.005</ix:nonFraction> per share of common stock, was immediately exercisable, may be
              exercised at any time, has no expiration date and is subject to customary adjustments. The Pre-Funded Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed <ix:nonFraction name="btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="Fact_623dd2467dca418199e6293461d5b37f" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">9.99</ix:nonFraction>% immediately after exercise thereof. Upon the closing of the transaction, the Company issued <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_b9fdfd1c3c5042e48b477f817ae2867f" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">5,500,000</ix:nonFraction> shares of common stock and issued Pre-Funded Warrants representing approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_07d309b7737243ca854960d0712d500c" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,357,000</ix:nonFraction> shares of common stock.</div>
</ix:continuation>
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e57" continuedAt="Text_826140b00f1447f98e79feedf69354e58">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span>
              <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>
</ix:continuation>
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e58" continuedAt="Text_826140b00f1447f98e79feedf69354e59">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Each Common Warrant has an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_f3f1952924344fbdab7a32530ed01383" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.91</ix:nonFraction> per share, becomes exercisable <ix:nonNumeric name="btx:ClassOfWarrantOrRightsExercisableTerm" id="Fact_4c8c38ad143e49f18ef5018ec163f74e" contextRef="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember" format="ixt-sec:durwordsen">six months</ix:nonNumeric> following the closing of the PIPE Transaction, expires <span style="-sec-ix-hidden:Fact_2134c2193a6f4a199f8e2044d8c27aaf">five-and-one-half </span> years from the date of issuance and is subject to customary adjustments. The Common Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed <ix:nonFraction name="btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="Fact_24566882c3144146ac2f36c66acf86fa" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">4.99</ix:nonFraction>% immediately after exercise thereof, subject to increase to <ix:nonFraction name="btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="Fact_3dad5e2c14e54f6484b6cdcd5d26f7ea" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">9.99</ix:nonFraction>% at the option of the holder.</div>
</ix:continuation>
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e59" continuedAt="Text_826140b00f1447f98e79feedf69354e510">
<div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">&#160;</div>
</ix:continuation>
          </div>

        </div>

      </div>

      <!--PROfilePageNumberReset%Num%21%%%-->
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 28.9pt; text-transform: none;">
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
          <div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e510" continuedAt="Text_826140b00f1447f98e79feedf69354e511">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As of March 31, 2022, the Company had <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_04dca308f3fa4d0b854848b7d07869b7" contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">6,857,000</ix:nonFraction>
              Common Warrants outstanding with a weighted average exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_0ad076b630ef4ee89dffb3cb98d56fe8" contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.91</ix:nonFraction> per share and a weighted average contractual life of <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Fact_4b9c3a444d44461982bf80597623053c" contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember" format="ixt-sec:duryear">5.45</ix:nonNumeric> years. As of March 31, 2022, the Company had <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_6a050effa79440a492be572fcf001092" contextRef="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,357,000</ix:nonFraction>
              Pre-Funded Warrants outstanding with a weighted average exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_31ad80a29dce416384f0092fae953a29" contextRef="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal">0.005</ix:nonFraction> per share. The Pre-Funded Warrants do not expire.</div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_826140b00f1447f98e79feedf69354e511" continuedAt="Text_826140b00f1447f98e79feedf69354e512">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_826140b00f1447f98e79feedf69354e512" continuedAt="Text_826140b00f1447f98e79feedf69354e513">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>
          <ix:continuation id="Text_826140b00f1447f98e79feedf69354e513" continuedAt="Text_826140b00f1447f98e79feedf69354e514">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_826140b00f1447f98e79feedf69354e514" continuedAt="Text_826140b00f1447f98e79feedf69354e515">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">The











            Common Warrants and Pre-Funded Warrants were accounted for as liabilities under ASC 815-40, as these warrants provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40. These
            warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of operations.</div>
</ix:continuation>
          <ix:continuation id="Text_826140b00f1447f98e79feedf69354e515" continuedAt="Text_826140b00f1447f98e79feedf69354e516">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_826140b00f1447f98e79feedf69354e516" continuedAt="Text_826140b00f1447f98e79feedf69354e517">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e517" continuedAt="Text_826140b00f1447f98e79feedf69354e518">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_0f0bced532194e36a8f05949e11275d8" contextRef="c20220101to20220331_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">12.6</ix:nonFraction> million in the aggregate, which was $<ix:nonFraction name="btx:OverSubscriptionAmountReceived" id="Fact_1e1b903f5db74bc6a2ec36960346eb95" contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction> million more
              than the Subscription Amount. The excess $<ix:nonFraction name="btx:OverSubscriptionAmountReceived" id="Fact_b744f3aea2c5414eab40cfa08c712c06" contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction> million represents an inducement to the PIPE Investor to enter into the transaction
              and was recorded in warrant liabilities expense in the accompanying consolidated statement of operations. Given the Company&#8217;s capital requirements and market conditions, the Company consummated this financing on market terms available at the
              time of the transaction.</div>
</ix:continuation>
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e518" continuedAt="Text_826140b00f1447f98e79feedf69354e519">
<div><br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e519" continuedAt="Text_826140b00f1447f98e79feedf69354e520">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; margin-right: 2pt;">The Company incurred fees of $<ix:nonFraction name="btx:TransactionFeesPayable" id="Fact_b9bdf9c068e9481485848f08111fbc8e" contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction>
              million through March 31, 2022 related to the PIPE Transaction, which were allocated to the fair value of the Common Warrants and the Pre-Funded Warrants and recorded in other expense, net on the accompanying condensed consolidated statement
              of operations.</div>
</ix:continuation>
            <div><ix:continuation id="Text_826140b00f1447f98e79feedf69354e520" continuedAt="Text_826140b00f1447f98e79feedf69354e521">
<div><br /></div>
</ix:continuation>
              <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
                <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">20</span></div>

                <div style="page-break-after: always;" class="DSPFPageBreak">
                  <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

                <div style="width: 100%;" class="DSPFPageHeader">
                  <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
                  </div>

                </div>

              </div>

            </div>

            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e521" continuedAt="Text_826140b00f1447f98e79feedf69354e522">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the PIPE Transaction, the Company and the PIPE Investor also entered into a registration rights agreement, dated March 6,
              2022, pursuant to which the Company agreed to prepare and file a registration statement with the SEC no later than 15 days following the filing date of the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021 (the &#8220;2021
              Annual Report&#8221;) to register the resale of the shares of common stock included in the Units and the shares of common stock issuable upon exercise of the Pre-Funded Warrants and the Common Warrants. The Company agreed to use its best efforts to
              have such registration statement declared effective as promptly as possible after the filing thereof, subject to certain specified penalties if timely effectiveness is not achieved. The Company filed the 2021 Annual Report on April 15, 2022
              and the registration statement on April 29, 2022. The registration statement became effective on May 11, 2022.</div>
</ix:continuation>
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e522" continuedAt="Text_826140b00f1447f98e79feedf69354e523">
<div><br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e523" continuedAt="Text_826140b00f1447f98e79feedf69354e524">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the registration rights agreement, the Company is obligated to pay the PIPE Investor liquidated damages equal to <ix:nonFraction name="btx:ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" id="Fact_5da6e554da4b4436a622ed13baa6d8e7" contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% of the Subscription Amount per month, with a maximum aggregate payment of <ix:nonFraction name="btx:ObligationToPayLiquidatedDamagesPercentage" id="Fact_b37bc8b30402444d912c1add9b3e56ea" contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember_RangeAxis_MaximumMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">12</ix:nonFraction>% of the Subscription Amount, in the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered for resale
              thereunder for more than <ix:nonNumeric name="btx:ConsecutiveCalendarDays" id="Fact_b7458a37edc342c2804eec9fb3b83c8e" contextRef="c20220101to20220331_InvestmentTypeAxis_PIPEInvestorMember" format="ixt-sec:durday">10</ix:nonNumeric> consecutive calendar days or more than an aggregate of <span style="-sec-ix-hidden:Fact_1d1a0b74074845069916ad1b1bee6544">fifteen</span> calendar days (which need not be consecutive calendar days) during any 12-month period.</div>
</ix:continuation>
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e524" continuedAt="Text_826140b00f1447f98e79feedf69354e525">
<div><br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e525" continuedAt="Text_826140b00f1447f98e79feedf69354e526">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On May 24, 2022, the Company provided the PIPE Investor with notice that it was not able to resell the securities registered for resale under
              the registration agreement because the Company had not timely filed this Quarterly Report on Form 10-Q (the &#8220;Q1 2022 10-Q&#8221;) with the SEC, and that the PIPE Investor could not use the registration statement to resell the related securities
              until the Company filed the Q1 2022 10-Q. Because the PIPE Investor was unable to use the registration statement for at least <ix:nonNumeric name="btx:ConsecutiveCalendarDays" id="Fact_c2fc14b003ff4312b36332789bdbf901" contextRef="c20220101to20220331_InvestmentTypeAxis_PIPEInvestorMember" format="ixt-sec:durday">10</ix:nonNumeric>
              consecutive calendar days, the Company accrued $<ix:nonFraction name="us-gaap:LossContingencyEstimateOfPossibleLoss" id="Fact_23e8abaddbe64f2592e666c38aa04f0b" contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction> million for the three months ended March 31, 2022 for the estimated contingent
              loss the Company expected to incur as a result of the late Q1 2022 10Q filing, which is recorded in other expense, net in the accompanying condensed consolidated statements of operations.</div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_826140b00f1447f98e79feedf69354e526" continuedAt="Text_826140b00f1447f98e79feedf69354e527">
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> <br />
            </span></div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; font-weight: normal; text-transform: none;">
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e527" continuedAt="Text_826140b00f1447f98e79feedf69354e528">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Reverse Stock-Split</div>
</ix:continuation>
          </div>

          <div style="color: rgb(0, 0, 0);">
            <ix:continuation id="Text_826140b00f1447f98e79feedf69354e528" continuedAt="Text_826140b00f1447f98e79feedf69354e529">
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> <br />
              </span></div>
</ix:continuation>
          </div>

        </div>

        <ix:continuation id="Text_826140b00f1447f98e79feedf69354e529" continuedAt="Text_826140b00f1447f98e79feedf69354e530">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-align: justify; text-indent: 36pt;">On
          March 25, 2021, immediately prior to the Merger, Brooklyn filed an amendment to the Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a reverse stock split. As a result of the reverse stock split, the
          number of issued and outstanding shares of common stock immediately prior to the reverse stock split was reduced into a smaller number of shares, such that every <span style="-sec-ix-hidden:Fact_c7f77014cf9a4ef9a688995037fe55b0">two</span> shares of common stock held by a stockholder of Brooklyn immediately prior to the reverse stock split were combined and reclassified into one share of common stock after the reverse
          stock split.</div>
</ix:continuation>
        <ix:continuation id="Text_826140b00f1447f98e79feedf69354e530" continuedAt="Text_826140b00f1447f98e79feedf69354e531">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-align: justify;">
          <ix:continuation id="Text_826140b00f1447f98e79feedf69354e531" continuedAt="Text_826140b00f1447f98e79feedf69354e532">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;">&#160;<br />
          </div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_826140b00f1447f98e79feedf69354e532" continuedAt="Text_826140b00f1447f98e79feedf69354e533">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_826140b00f1447f98e79feedf69354e533" continuedAt="Text_826140b00f1447f98e79feedf69354e534">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-align: justify; text-indent: 36pt;">Immediately











          following the reverse stock split there were approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits" id="Fact_36d6706333a04e26ad641be11250e235" contextRef="c20210325to20210325" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,514,000</ix:nonFraction> shares of common stock outstanding prior to the Merger. No
          fractional shares were issued in connection with the reverse stock split.</div>
</ix:continuation>
        <ix:continuation id="Text_826140b00f1447f98e79feedf69354e534" continuedAt="Text_826140b00f1447f98e79feedf69354e535">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
          <ix:continuation id="Text_826140b00f1447f98e79feedf69354e535" continuedAt="Text_826140b00f1447f98e79feedf69354e536">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify; text-indent: 36pt;"><span style="font-weight: normal;"> <span style="font-style: italic;">Merger</span></span></div>
</ix:continuation>
          <ix:continuation id="Text_826140b00f1447f98e79feedf69354e536" continuedAt="Text_826140b00f1447f98e79feedf69354e537">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-indent: 0px; text-transform: none; background-color: rgb(255, 255, 255);"><span style="font-weight: normal;"> <br />
            </span></div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_826140b00f1447f98e79feedf69354e537">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;">Under the terms of the Merger
              Agreement </span></span>(see Note 3)<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;">, on March 25, 2021, Brooklyn issued shares of common stock to the equity holders of Brooklyn LLC. The <ix:nonFraction name="us-gaap:SharesIssued" id="Fact_b6efb81785614d7eb0b8027a1055de00" contextRef="c20210325_StatementClassOfStockAxis_CommonClassAMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">87,000</ix:nonFraction>
              Class A units of Brooklyn LLC were converted into </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" id="Fact_4dfc15735aaf4dc89310df1b74287b1f" contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassAMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">22,275,000</ix:nonFraction> shares of common stock; the <ix:nonFraction name="us-gaap:SharesIssued" id="Fact_fe5edf4567da4438837a5f50ff9d14ec" contextRef="c20210325_StatementClassOfStockAxis_CommonClassBMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">15,000,000</ix:nonFraction> Class B units were converted into </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" id="Fact_70c8f730a081433298b8b30a1350ac10" contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassBMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">2,515,000</ix:nonFraction>
              shares of common stock; the <ix:nonFraction name="us-gaap:SharesIssued" id="Fact_15f49efa627b4223b4a3f2bc3dc4f282" contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">10,000,000</ix:nonFraction> Class C units were converted into </span></span>approximately <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" id="Fact_4446827b3e9d4002ae82284905b67f25" contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassCMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,676,000</ix:nonFraction><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> shares of common stock; </span></span>approximately <ix:nonFraction name="us-gaap:SharesIssued" id="Fact_2a874f27a299443f8271f36dcd079561" contextRef="c20210325_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">630,000</ix:nonFraction><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> shares of common units were
              converted into </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" id="Fact_a1ef1a8144ef42529768a3a2548a27d4" contextRef="c20210325to20210325_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">630,000</ix:nonFraction> shares of common stock, and <ix:nonFraction name="btx:ClassOfWarrantOrRightIssued" id="Fact_2903704aac6c4decaaafac56f6d47121" contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">10,500,000</ix:nonFraction> rights options were converted into </span></span>approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_9bf258b735434a179467444e5d9f796b" contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">11,828,000</ix:nonFraction><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> shares of common stock.
              Brooklyn also issued </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> <ix:nonFraction name="btx:StockIssuedDuringPeriodSharesAcquisitions1" id="Fact_8615a12f9c9e44b09fff213944ebe062" contextRef="c20210325to20210325" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,068,000</ix:nonFraction> shares of common stock to the Financial Advisor pursuant to the Merger Agreement</span></span>.</div>
</ix:continuation>
        </div>

      <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 28.9pt; text-transform: none;">
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
          <div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span></div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">21</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
              </div>

            </div>

          </div>

        </div>

      </div>

    </div>

    <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <ix:nonNumeric name="us-gaap:EarningsPerShareTextBlock" id="Text_8268f62872184c44b547e4e59daca28d" contextRef="c20220101to20220331" escape="true" continuedAt="Text_2f0d6d9e16fd42e1b89863c2f521b2a81">
<div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify;">11)</td>

    <td style="width: auto; vertical-align: top;">
                  <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"><span style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">EARNINGS PER SHARE</span> </div>
                </td>

  </tr>


</table>
        </div>
</ix:nonNumeric>
        <ix:continuation id="Text_2f0d6d9e16fd42e1b89863c2f521b2a81" continuedAt="Text_2f0d6d9e16fd42e1b89863c2f521b2a82">
<div><br /></div>
</ix:continuation>
      </div>

      <ix:continuation id="Text_2f0d6d9e16fd42e1b89863c2f521b2a82" continuedAt="Text_2f0d6d9e16fd42e1b89863c2f521b2a83">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period including
        the weighted average effect of the Pre-Funded Warrants the Company issued in connection with the PIPE Transaction, the exercise of which requires little or no consideration for the delivery of shares of common stock. The Company determined that the
        exercise of the Pre-Funded Warrants requires nominal consideration for the delivery of shares of common stock, and as such, has considered the <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_3090c48671144f8b8377e7cb02f8887a" contextRef="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,357,000</ix:nonFraction>
        shares underlying the Pre-Funded Warrants to be outstanding effective on March 9, 2022 for the purposes of calculating basic EPS. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares
        outstanding (including the weighted average effect of the Pre-Funded Warrants) plus dilutive securities. Stock options, RSUs, warrants and other convertible securities are considered potential common shares and are included in the calculation of
        diluted net loss per share using the treasury method when their effect is dilutive. Diluted net loss per share is the same as basic net loss per share in periods where the effect of potentially dilutive shares of common stock are antidilutive. <ix:nonNumeric name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="Text_e423deed33634e718bcf8ea8511a728b" contextRef="c20220101to20220331" escape="true" continuedAt="Text_5f053bd8a3584d50b9cff62772b125951"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;">The following
        table presents the amount of stock options, RSUs, warrants and convertible preferred stock that were excluded from the computation of diluted net loss per common share for three months ended March 31, 2022 and 2021, as their effect was
        anti-dilutive:</span></ix:nonNumeric></div>
</ix:continuation>
      <ix:continuation id="Text_2f0d6d9e16fd42e1b89863c2f521b2a83" continuedAt="Text_2f0d6d9e16fd42e1b89863c2f521b2a84"><ix:continuation id="Text_5f053bd8a3584d50b9cff62772b125951" continuedAt="Text_5f053bd8a3584d50b9cff62772b125952">
<div><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_2f0d6d9e16fd42e1b89863c2f521b2a84"><ix:continuation id="Text_5f053bd8a3584d50b9cff62772b125952">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">Three months ended March 31,</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; text-align: center;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">2021</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Stock options</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_e5a81f906a754888a953370cf59017f6" contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">5,179,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_8b15b0d1a4814361b2663da066126068" contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U001" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">RSUs</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_1909eb396d8a436cb8aad3986c4ad1ce" contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,323,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_c1a4c63f2ede45fd9f67c42691f7c60c" contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Warrants</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_131bfcad3017479f866a6fa017e22916" contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">6,857,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_c0a350a5978849438f89cbddec8d2b23" contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U001" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Preferred stock converted into common stock</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_500808ab65474522b7195f8b1cdc5a1e" contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">48,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_c734e221f10f44dc94a9538c6a70bd0c" contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">42,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Total potential common shares excluded from computation</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_1d0627c97bf940b2bf6705f4d9b729cb" contextRef="c20220101to20220331" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">13,407,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_c68c9aff6ab3496db5f82e47d0a6a556" contextRef="c20210101to20210331" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">42,000</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
       </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div><br />
    </div>


    <ix:nonNumeric name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="Text_71749bfdf5ce4d45be3204a3fb4fa9d8" contextRef="c20220101to20220331" escape="true" continuedAt="Text_72bf96c416e143f2a970be236a78188f1">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">12)<br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">RECENT ACCOUNTING PRONOUNCEMENTS</div>
          </td>

  </tr>


</table>
</ix:nonNumeric><ix:continuation id="Text_72bf96c416e143f2a970be236a78188f1" continuedAt="Text_72bf96c416e143f2a970be236a78188f2">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span>
     </div>
</ix:continuation>
    <ix:continuation id="Text_72bf96c416e143f2a970be236a78188f2"><ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Text_ded1775e458c4616b485ea8de8a75a66" contextRef="c20220101to20220331" escape="true">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none; text-indent: 36pt;">There were no recent accounting pronouncements issued during the
      three months ended March 31, 2022 that would have impacted the Company&#8217;s financial statements or operations.  </div>
</ix:nonNumeric></ix:continuation>

    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none;"> <br />
    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;"> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

      <div><ix:nonNumeric name="us-gaap:SubsequentEventsTextBlock" id="Text_677b4506c14f4d87b7c706a033b5aa24" contextRef="c20220101to20220331" escape="true" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c1">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>
</ix:nonNumeric>
        <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c1" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c2">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">13)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">SUBSEQUENT EVENT</div>
              </td>

  </tr>


</table>
</ix:continuation>
        <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c2" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c3">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c3" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c4">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c4" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c5">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On May 24, 2022, Dr. Federoff resigned as the Company&#8217;s Chief Executive Officer and President effective May 26, 2022, and the Board appointed
            Dr. Matthew Angel as the Company&#8217;s interim Chief Executive Officer.</div>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c5" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c6">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c6" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c7">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In connection with Dr. Federoff&#8217;s resignation, the Company entered into a Separation Agreement and General Release with Dr. Federoff (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Separation Agreement</span></span>&#8221;), pursuant to which Dr. Federoff resigned from his positions as Chief Executive Officer and as an officer, director and employee of the Company and
            all subsidiaries. Dr. Federoff&#8217;s resignation from the Board was not due to any disagreement with the Company on any matter relating to the Company&#8217;s operations, policies or practices. In consideration for Dr. Federoff&#8217;s execution of the
            Separation Agreement and non-revocation of a waiver and release of claims relating thereto, Dr. Federoff is entitled to the following benefits under the Separation Agreement:</div>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c7" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c8">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c8" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c9">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18.15pt;"><br />
                </td>

    <td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">a lump sum cash severance benefit in the amount of $<ix:nonFraction name="us-gaap:PaymentsForPostemploymentBenefits" id="Fact_3c983869ed22452d902d861caed37303" contextRef="c20220524to20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction> million,
                    representing Dr. Federoff&#8217;s target bonus for 2022;</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c9" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c10">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c10" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c11">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18.15pt;"><br />
                </td>

    <td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">payment of Dr. Federoff&#8217;s annual base salary for a period of twelve months after the expiration of the applicable revocation period (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Separation Period</span></span>&#8221;), for a total gross amount equal to $<ix:nonFraction name="btx:PaymentToOfficerBaseSalary" id="Fact_09223626aa594da891e5351e3635f9fe" contextRef="c20220524to20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million;</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c11" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c12">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c12" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c13">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18.15pt;"><br />
                </td>

    <td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">payment of Dr. Federoff&#8217;s premiums for continued health benefits provided under COBRA for the Separation Period;</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c13" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c14">
<div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c14" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c15">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18.15pt;"><br />
                </td>

    <td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">full acceleration of the vesting of all outstanding options (with the exception of the Milestone Options) that would have vested during the Separation Period, and such options,
                    together with outstanding options that vested prior to the Separation Date, representing collectively <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_95657bfbdc9b4214b59cf48b6d1216e2" contextRef="c20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,420,095</ix:nonFraction> shares of
                    common stock, may be exercised for a period of <ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="Fact_e6328d8831d64056afe859c939e12a2a" contextRef="c20220524to20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" format="ixt-sec:durwordsen">thirty-six months</ix:nonNumeric> after the Separation Date;</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c15" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c16">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c16" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c17">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18.15pt;"><br />
                </td>

    <td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">acceleration and vesting of 25/36<sup>th</sup> of the Milestone Options, representing collectively <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_a07e5a60709c42eb9d322339211604a3" contextRef="c20220524_AwardTypeAxis_MilestoneOptionsMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">414,759</ix:nonFraction> shares of common stock, may be exercised for a period of <ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="Fact_aab24a2e3d1b485dadb0456d362964a8" contextRef="c20220524to20220524_AwardTypeAxis_MilestoneOptionsMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" format="ixt-sec:durwordsen">thirty-six months</ix:nonNumeric>
                    after the Separation Date; and</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c17" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c18">
<div><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c18" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c19">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18.15pt;"><br />
                </td>

    <td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">a lump sum cash severance benefit in the amount of $<ix:nonFraction name="btx:SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" id="Fact_298322eb55d745afa7951b5bb4dca3dc" contextRef="c20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction> million,
                    representing the value Dr. Federoff would have received if he was entitled to receive a settlement of a pro rata portion of his performance restricted stock units through the expiration of the Separation Period, assuming the performance
                    metrics were waived and assuming a per share value of $<ix:nonFraction name="us-gaap:SharePrice" id="Fact_50eb1d48c62c441b97669680ee980692" contextRef="c20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.81</ix:nonFraction>.</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c19" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c20">
<div><br /></div>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c20" continuedAt="Text_40efe9bb54884b2fa648c9cc52d6595c21">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Separation Agreement also includes certain other customary representations, warranties and covenants of Dr. Federoff, and provides for
            reimbursement of certain expenses incurred by Dr Federoff. The Separation Agreement supersedes all other agreements or arrangements between Dr. Federoff and the Company regarding the subject matter of the agreement, including those with respect
            to severance payments and benefits.</div>
</ix:continuation>
          <ix:continuation id="Text_40efe9bb54884b2fa648c9cc52d6595c21">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> </span></div>
</ix:continuation></div>


        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">22</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <a id="Item2."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 44.4pt; vertical-align: top; font-weight: bold;">Item 2.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

        <div style="text-align: justify; font-style: italic;"><span style="color: rgb(0, 0, 0);">You should read this discussion together with the unaudited interim condensed consolidated financial statements, related notes, and other financial information
            included elsewhere in this Quarterly Report on Form 10-Q together with our audited consolidated financial statements, related notes, and other information contained in </span>the Form 10-K/A filed with the <span style="color: rgb(0, 0, 0);">Securities




            and Exchange Commission</span> (the &#8220;SEC&#8221;) on June 30, 2022 (the &#8220;10-K/A&#8221;),<span style="color: rgb(0, 0, 0);"> as well as the information contained in our Annual Report on Form 10-K for the year ended December 31, 2021 (the &#8220;Original 10-K&#8221;),
            filed with the SEC on April 15, 2022, to the extent the information contained in the Original 10-K was not superseded by the information contained in the 10-K/A. The following discussion contains assumptions, estimates and other forward-looking
            statements that involve a number of risks and uncertainties, including those discussed under &#8220;Risk Factors,&#8221; in Part I, Item 1A of the 10-K/A and as described from time to time in our other filings with the SEC. These risks could cause our
            actual results to differ materially from those anticipated in these forward-looking statements.</span></div>

        <div><br />
        </div>

        <div style="text-align: justify; font-weight: bold;">Overview</div>

        <div style="text-align: justify; text-indent: 36pt;"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">We are a biopharmaceutical company utilizing our mRNA technology platform, including mRNA-based cell reprogramming and gene editing technologies, to create next generation mRNA, gene-editing and
          cell therapies, including iPSC therapies for multiple therapeutic indications.&#160; Our mRNA technology platform, which includes novel lipid nanoparticles (&#8220;LNPs&#8221;) for mRNA delivery and targeted transgene insertion, was acquired through a license
          with Factor Bioscience Limited, or Factor, and through our acquisition of Novellus, Inc. and Novellus, Ltd. in July 2021, which we refer to as the Acquisition.&#160; We are also evaluating our strategy for IRX-2, a novel cytokine-based therapy, to
          treat patients with cancer.</div>

        <div><br />
        </div>

        <div style="text-indent: 36pt;"><span style="text-decoration: underline;">Acquisition of Novellus</span></div>

        <div style="text-indent: 36pt;"> <br />
        </div>

        <div>
          <div style="text-align: justify; text-indent: 36pt;">On July 16, 2021, we acquired Novellus, Inc. and Novellus, Inc.&#8217;s wholly owned subsidiary, Novellus, Ltd. Brooklyn also acquired 25.0% of the total outstanding equity interests of NoveCite,
            Inc.&#160; As consideration for the Acquisition, we paid $22.9 million in cash and delivered 7,022,000 shares of common stock, which under the terms of the Acquisition Agreement, were valued at a total of $102.0 million based on an agreed upon price
            of $14.5253 per share.&#160; At the date of issuance, the fair value of the shares were approximately $58.7 million.</div>

        </div>

        <div style="text-indent: 36pt;"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Merger with NTN Buzztime, Inc.</span></div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">On March 25, 2021, we completed the Merger with NTN Buzztime, Inc. In accordance with the Merger Agreement, on March 25, 2021, Brooklyn amended its restated certificate of incorporation in order
          to effect:</div>

        <div style="text-indent: 36pt;"> <br />
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="width: 54pt;">&#160;</td>

    <td style="vertical-align: top; width: 36pt;">
                  <div style="text-align: justify;">&#8226;</div>
                </td>

    <td style="vertical-align: top; width: auto;">
                  <div style="text-align: justify;">prior to the Merger, a reverse stock split of its common stock, par value $0.005 per share, at a ratio of one-for-two; and</div>
                </td>

  </tr>


</table>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="width: 54pt;">&#160;</td>

    <td style="vertical-align: top; width: 36pt;">
                  <div style="text-align: justify;">&#8226;</div>
                </td>

    <td style="vertical-align: top; width: auto;">
                  <div style="text-align: justify;">following the Merger, a change in its corporate name from &#8220;NTN Buzztime, Inc.&#8221; to &#8220;Brooklyn ImmunoTherapeutics, Inc.&#8221;</div>
                </td>

  </tr>


</table>
        </div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">On March 26, 2021, we sold the rights, title and interest in and to the assets relating to the business operated under the name &#8220;NTN Buzztime, Inc.&#8221; prior to the Merger to eGames.com Holdings
          LLC, or eGames.com, in exchange for eGames.com&#8217;s payment of a purchase price of $2.0 million and assumption of specified liabilities relating to such pre-Merger business. This transaction, which we refer to as the Disposition, was completed in
          accordance with the terms of an asset purchase agreement dated September 18, 2020, as amended, between us and eGames.com.</div>

        <div style="text-indent: 36pt;"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">The Merger has been accounted for as a reverse acquisition in accordance with U.S. generally accepted accounting principles, or GAAP. Under this method of accounting, Brooklyn LLC was deemed the
          &#8220;acquiring&#8221; company and Brooklyn (then known as NTN Buzztime, Inc.) was treated as the &#8220;acquired&#8221; company for financial reporting purposes. Operations prior to the Merger are those of Brooklyn LLC, and the historical financial statements of
          Brooklyn LLC became the historical financial statements of Brooklyn with respect to periods prior to the completion of the Merger.</div>

        <div style="text-align: justify; text-indent: 36pt;"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">23</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt; font-weight: bold;"><span style="text-decoration: underline;">IRX-2</span></div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">IRX-2 is a mixed, human-derived cytokine product with multiple active constituents including Interleukin-2, or IL2, and other key cytokines. Together, these cytokines are believed to signal,
          enhance and restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells, unlike many existing cancer therapies, which rely on targeting the cancer directly. IRX-2 is prepared from the supernatant of
          pooled allogeneic peripheral blood mononuclear cells, known as PBMCs, that have been stimulated using a proprietary process employing a specific population of cells and a specific mitogen.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Unlike existing recombinant IL2 therapies, IRX-2 is derived from human blood cells. We believe this may promote better tolerance, broader targeting and a natural molecular conformation leading to
          greater activity, and may permit low physiologic dosing, rather than the high doses needed in other existing IL2 therapies.&#160; Enrollment in the ongoing Phase 2b INSPIRE trial, or the INSPIRE trial, has been completed, with top-line data estimated
          to be available by the third quarter of 2022.&#160; Once INSPIRE trial data are released, we plan to use those results in addition to data from the other clinical trials in the program to evaluation our strategy with IRX-2.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Impact of COVID-19 Pandemic</span></div>

        <div> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">The development of our product candidates has been, and could continue to be, disrupted and materially adversely affected by past and continuing impacts of the COVID-19 pandemic. This is largely
          a result of measures imposed by the governments and hospitals in affected regions, businesses and schools were suspended due to quarantines intended to contain this outbreak. The spread of COVID-19 from China to other countries resulted in the
          Director General of the World Health Organization declaring COVID-19 a pandemic in March 2020. Despite progress in vaccination efforts, the longer-term impact of the COVID-19 pandemic on our development plans and on the ability to conduct our
          clinical trials remains uncertain and cannot be predicted with confidence. COVID-19 could continue to disrupt production and cause delays in the supply and delivery of products used in our operations, may affect our operations, including the
          conduct of clinical studies, or the ability of regulatory bodies to grant approvals or supervise our candidates and products, may further divert the attention and efforts of the medical community to coping with the COVID-19 and disrupt the
          marketplace in which we operate and may have a material adverse effects on our operations. COVID-19 may also affect our employees and employees and operations at suppliers that may result in delays or disruptions in supply. In addition, a
          recession or market correction resulting from the spread of COVID-19 could materially affect our business and the value of our common stock. Additionally, if the COVID-19 pandemic has a significant impact on our business and financial results for
          an extended period of time, our liquidity and cash resources could be negatively impacted. The extent to which the COVID-19 pandemic and ongoing global efforts to contain its spread will impact our operations will depend on future developments,
          which are highly uncertain, and include the duration, severity and scope of the pandemic and the actions taken to contain or treat the COVID-19 pandemic. Further, the specific clinical outcomes, or future pandemic related impacts of emerging
          COVID-19 variants cannot be reliably predicted.</div>

        <div><br />
        </div>

        <div style="text-indent: 36pt; font-weight: bold;"><span style="text-decoration: underline;">Engineered Cellular and Genetic Medicines</span></div>

        <div style="text-indent: 36pt;"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">We are advancing our gene-editing and cell therapy technology in oncology, blood disorders and monogenic disorders through a license with Factor and through the Acquisition of Novellus, Inc. and
          Novellus, Ltd. in July 2021. We expect that the first-generation product candidates resulting from the Acquisition will be derived from unedited (that is, not gene modified), induced pluripotent stem cells (&#8220;iPSC&#8221;)-derived allogeneic mesenchymal
          stem cells (&#8220;iMSC&#8221;). We expect to begin preclinical development of iMSC for clinical indications for which inhibiting inflammation and/or supporting recovery of bone marrow stromal cells is required. The prior work of Novellus and NoveCite with
          iMSC shows evidence for preclinical efficacy in inflammatory conditions (for example, acute respiratory distress syndrome, or ARDS). Interactions with the FDA provided guidance on Chemistry, Manufacturing and Controls (&#8220;CMC&#8221;), and manufacturing
          plans, which will be undertaken in a similar manner for additional iMSC applications. We expect that second generation iMSC products will involve gene editing, for which we anticipate using the stepwise addition of genes provided by the
          in-licensed Factor Bioscience gene editing machinery, NoveSlice, to efficiently place genes and regulatory sequences into safe harbor locations. Development of processes to advance CMC and manufacturing will follow the experience from first
          generation iMSC products. We expect clinical indications for gene-modified iMSC will include solid tumors and other conditions associated with episodic and/or chronic inflammation.&#160; We are also exploring opportunities to advance in vivo gene
          therapies for monogenic and other diseases by combining the NoveSlice gene editing technology in combination with ToRNAdo<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup>, the in-licensed LNP technology.</div>

        <div style="text-align: justify; text-indent: 36pt;"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">24</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: justify; font-weight: bold;">Recent Developments</div>

        <div> <br />
        </div>

        <div style="text-indent: 36pt; font-weight: bold;"><span style="text-decoration: underline;">PIPE Transaction</span></div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">On March 6, 2022, we entered into a Securities Purchase Agreement with an investor (the &#8220;PIPE Investor&#8221;) providing for the private placement (the &#8220;PIPE Transaction&#8221;) to the PIPE Investor of
          approximately 6,857,000 units (the &#8220;Units&#8221;), each of&#160; which consisted of (i) one share of our common stock (or, in lieu thereof, one pre-funded warrant (the &#8220;Pre-Funded Warrants&#8221;) to purchase one share of common stock) and (ii) one warrant (the
          &#8220;Common Warrants&#8221;) to purchase one share of common stock, for an aggregate purchase price of approximately $12.0 million (the &#8220;Subscription Amount&#8221;). The PIPE Transaction closed on March 9, 2022. We incurred fees of $1.0 million through March 31,
          2022 related to the PIPE Transaction.</div>

        <div><br />
        </div>

        <div>
          <div style="text-align: justify; text-indent: 36pt;">Each Pre-Funded Warrant has an exercise price of $0.005 per share of common stock, was immediately exercisable and may be exercised at any time and has no expiration date and is subject to
            customary adjustments. The Pre-Funded Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 9.99% immediately after exercise thereof.</div>

        </div>

        <div>
          <div><br />
          </div>

        </div>

        <div>
          <div style="text-align: justify; text-indent: 36pt;">Each Common Warrant has an exercise price of $1.91 per share, becomes exercisable six months following the closing of the PIPE Transaction, expires five-and-one-half years from the date of
            issuance, and is subject to customary adjustments. The Common Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 4.99% immediately after exercise thereof,
            subject to increase to 9.99% at the option of the holder.</div>

        </div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">The Common Warrants and Pre-Funded Warrants were accounted for as liabilities under ASC 815-40, <span style="font-style: italic;">Derivatives and Hedging, Contracts in Entity&#8217;s Own Equity,</span>
          as these warrants provide for a cashless settlement provision that fails the requirement of the indexation guidance under ASC 815-40.&#160; The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair
          value presented within the statement of operations.</div>

        <div><br />
        </div>

        <div>
          <div style="text-align: justify; text-indent: 36pt;">The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $12.6 million in the aggregate, which was $0.6 million more than the Subscription Amount.&#160; The
            excess $0.6 million represents an inducement to the PIPE Investor to enter into the PIPE Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of operations.</div>

          <div><br />
          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt;">In connection with the PIPE Transaction, we and the PIPE Investor also entered into a registration rights agreement, dated March 6, 2022, pursuant to which we agreed to prepare and file a
          registration statement with the Securities and Exchange Commission (the &#8220;SEC&#8221;) to register the resale of the shares of common stock included in the Units and the shares of common stock issuable upon exercise of the Pre-Funded Warrants and the
          Common Warrants. We agreed to use our best efforts to have such registration statement declared effective as promptly as possible after the filing thereof, subject to certain specified penalties if timely effectiveness is not achieved.&#160; We filed
          such registration statement on April 29, 2022, which became effective on May 11, 2022.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">Pursuant to the registration rights agreement, we are obligated to pay the PIPE Investor liquidated damages equal to 2% of the Subscription Amount per month, with a maximum
          aggregate payment of 12% of the Subscription Amount, in the event the PIPE Investor is not permitted to use the registration statement to resell the related securities for more than 10 consecutive calendar days or more than an aggregate of
          fifteen calendar days (which need not be consecutive calendar days) during any 12-month period.</div>

        <div style="text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">25</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">On May 24, 2022, we provided the PIPE Investor with notice that it was not able to resell the securities under the registration agreement because we did not timely file this
          Quarterly Report on Form 10-Q (the &#8220;Q1 2022 10-Q&#8221;) with the SEC, and that the PIPE Investor could not use the registration statement to resell the related securities until we filed the Q1 2022 10-Q.&#160; Because the PIPE Investor was unable to use
          the registration statement for at least 10 consecutive calendar days, we accrued $0.2 million during the three months ended March 31, 2022 for the estimated contingent loss we expect to incur as a result of the late Q1 2022 10Q filing, which is
          recorded in other expense, net in the accompanying condensed consolidated statements of operations.</div>

        <div><br />
        </div>

        <div style="text-align: justify; font-weight: bold;">Basis of Presentation</div>

        <div> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Revenues</div>

        <div style="text-indent: 36pt;"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">We are a development stage company and have had no revenues from product sales to date. We will not have revenues from product sales until such time as we receive regulatory approval of our
          product candidates, successfully commercialize our products or enter into a licensing agreement which may include up-front licensing fees, of which there can be no assurance.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Research and Development Expenses</div>

        <div style="text-indent: 36pt;"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">We expense our research and development costs as incurred. Our research and development expenses consist of costs incurred for company-sponsored research and development activities, as well as
          support for selected investigator-sponsored research. Upfront payments and milestone payments for the licensing of technology are expensed as research and development in the period in which they are incurred if the technology is not expected to
          have any alternative future uses other than the specific research and development project for which it was intended. In-Process Research and Development (&#8220;IPR&amp;D&#8221;) that is acquired through an asset acquisition and has no alternative future
          uses and, therefore, no separate economic values, is expensed to research and development costs at the time the costs are incurred.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">The major components of research and development costs include preclinical study costs, clinical manufacturing costs, clinical study and trial expenses, insurance coverage for clinical trials,
          expensed licensed technology, consulting, scientific advisors and other third-party costs, salaries and employee benefits, stock-based compensation expense, supplies and materials and allocations of various overhead costs related to our product
          development efforts.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">In the normal course of our business, we contract with third parties to perform various clinical study and trial activities in the on-going development and testing of potential products. The
          financial terms of these agreements are subject to negotiation and vary from contract to contract and may result in uneven payment flows. Payments under the contracts depend on factors such as the achievement of certain events or milestones, the
          successful enrollment of patients, the allocation of responsibilities among the parties to the agreement, and the completion of portions of the clinical study or trial or similar conditions. Preclinical and clinical study and trial associated
          activities such as production and testing of clinical material require significant up-front expenditures. We anticipate paying significant portions of a study&#8217;s or trial&#8217;s cost before such begins and incurring additional expenditures as the study
          or trial progresses and reaches certain milestones.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; font-style: italic;">General and Administrative Expenses</div>

        <div style="text-indent: 36pt;"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Our general and administrative expenses consist primarily of salaries, benefits and other costs, including equity-based compensation, for our executive and administrative personnel, legal and
          other professional fees, travel, insurance, and other corporate costs.</div>

        <div> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">26</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: justify; font-weight: bold;">Results of Operations</div>

        <div> <br />
        </div>

        <div style="text-align: justify; font-weight: bold;">Comparison of Three Months Ended March 31, 2022 and 2021</div>

        <div> <br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><br />
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="6">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three months ended March 31,</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><br />
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;"> 2022</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Change</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="10">
                <div style="text-align: center; font-weight: bold;">(in thousands)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Operating expenses:</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Research and development</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>1,782</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>1,533</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>249</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">General and administrative</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">
                <div>4,514</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">
                <div>1,623</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">
                <div>2,891</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Transaction costs</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>5,765</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(5,765</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; padding-bottom: 2px; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Total operating expenses</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>6,296</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>8,921</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(2,625</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Loss from operations</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">
                <div>(6,296</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">
                <div>(8,921</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">
                <div>2,625</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Other expense, net:</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Loss on sale of NTN assets</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>(9,598</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">9,598</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Warrant liabilities expense</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">(1,322</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">(1,322</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Loss on non-controlling investment</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">(615</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">(615</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; padding-bottom: 2px; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Other expense, net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(1,142</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(3</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(1,139</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Total other expense, net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(3,079</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(9,601</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>6,522</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Loss before income taxes</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>(9,375</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>(18,522</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>9,147</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; padding-bottom: 2px; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Provision for income taxes</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; padding-bottom: 4px; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Net loss</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(9,375</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(18,522</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>9,147</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Revenues</div>

        <div> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">We had no revenues for the three months ended March 31, 2022 or 2021.</div>

        <div> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Research and Development Expenses</div>

        <div> <br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">&#160;</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three months ended March 31,</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                <div style="font-weight: bold;">&#160;</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: center; font-weight: bold;"> 2022</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: center; font-weight: bold;">2021</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div style="text-align: center; font-weight: bold;">Change</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                <div style="font-weight: bold;">&#160;</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="10" style="vertical-align: bottom; white-space: nowrap;">
                <div style="text-align: center; font-weight: bold;">(in thousands)</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Payroll-related</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>1,383</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>863</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>520</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Clinical trials</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;">
                <div>230</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;">
                <div>435</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;">
                <div>(205</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt;">Other expenses, net</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div>169</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div>235</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                <div>(66</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; padding-bottom: 4px; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 16.2pt;">Total research and development expenses</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                <div>1,782</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                <div>1,533</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                <div>$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
                <div>249</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">For the three months ended March 31, 2022, our research and development expenses increased primarily due to increased headcount, offset by a decrease in clinical trial expense and other
          miscellaneous research and development expenses when compared to the same period in 2021.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">On January 3, 2022, we completed a reduction in our workforce (the &#8220;Reduction&#8221;), involving eight research and development employees (53% of our workforce at that time). We believe the Reduction
          will enable us to better align our workforce with the needs of our business and focus more of our capital resources on our cell therapy and gene editing platform.. In connection with the Reduction, we incurred approximately $0.5 million for
          severance and termination-related costs, which we recorded during the first quarter of 2022.</div>

        <div> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">27</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt; font-style: italic;">General and Administrative Expenses</div>

        <div>
<div><br /></div>

          <div>
            <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 58.47%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Three months ended March 31,</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1.21%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 58.47%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;"> 2022</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">2021</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Change</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1.21%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="10" style="vertical-align: bottom;">
                    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">(in thousands)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', serif; font-size: 10pt;">Stock-based compensation</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">761</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">17</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">744</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; white-space: nowrap;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', serif; font-size: 10pt;">Payroll-related</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">749</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">33</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">716</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', serif; font-size: 10pt;">Insurance</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">367</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">33</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">334</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap; width: 58.47%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', serif; font-size: 10pt;">Professional fees</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; text-align: left;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 10.16%; text-align: right;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">1,198</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; text-align: left;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; text-align: left;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 10.16%; text-align: right;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">1,256</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; text-align: left;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; text-align: left;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 10.16%; text-align: right;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">(58</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; text-align: left;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', serif; font-size: 10pt;">Loss on disposal of fixed assets</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">271</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">271</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap; width: 58.47%; padding-bottom: 2px;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman', serif; font-size: 10pt;">Other expenses, net</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; padding-bottom: 2px;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; text-align: left; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 10.16%; text-align: right; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">1,168</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; text-align: left; padding-bottom: 2px;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; padding-bottom: 2px;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; text-align: left; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 10.16%; text-align: right; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">284</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; text-align: left; padding-bottom: 2px;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; padding-bottom: 2px;">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; text-align: left; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 10.16%; text-align: right; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">884</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1.21%; text-align: left; padding-bottom: 2px;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 58.47%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="text-align: left; text-indent: 1.8pt; margin-left: 7.2pt; font-family: 'Times New Roman',serif; font-size: 10pt;">Total general and administrative expenses</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">4,514</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">1,623</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1.21%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 10.16%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="font-family: 'Times New Roman', serif; font-size: 10pt;">2,891</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1.21%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>


</table>
          </div>

          <div><br />
          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt;">
          <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
            <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif; font-size: 10pt;">The increase in general and administrative expense for the three months ended March 31, 2022 was primarily related to non-cash
              stock-based compensation expense from increased equity awards, increased headcount, increased premiums for public company insurance policies, increased other expenses, net, primarily due to legal-related matters, and losses on the disposal of
              fixed assets when compared to the same period in 2021.</div>

          </div>

        </div>

        <div> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Transaction Costs</div>

        <div> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">The $5.8 million in transaction costs during the three months ended March 31, 2021 related to the issuance of common stock to Brooklyn LLC&#8217;s financial advisor upon consummation of the Merger, and
          there were no comparable transaction costs for the three months ended March 31, 2022.</div>

        <div style="text-align: justify; text-indent: 36pt;"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Loss on Sales of NTN Assets</div>

        <div style="text-align: justify;"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">The $9.6 million loss on the sale of NTN assets for the three months ended March 31, 2021 was incurred when we completed the Disposition, and there was no comparable loss on sale for the three
          months ended March 31, 2022.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Warrant Liabilities Expense</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">The $1.3 million of warrant liabilities expense is includes (1) $0.6 million related to the excess fair value of the Common Warrants and Pre-Funded Warrant issued in connection with the PIPE
          Transaction over the $12.0 million gross proceeds received and (2) the change in the aggregate fair value of the Common Warrants and Pre-Funded Warrants of approximately $0.7 million from the March 9, 2022 issuance date to March 31, 2022.&#160; There
          was no comparable expense for the three months ended March 31, 2021.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; font-style: italic;">
          <div style="text-align: left; font-style: italic;">Loss on Non-Controlling Investment<br />
          </div>

        </div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">The $0.6 million of loss on non-controlling investment, of which $0.5 million relates to the prior year, is related to our 25% share of NoveCite&#8217;s earnings or losses.&#160; We account for our
          investment in NoveCite under the equity method.&#160; There was no comparable expense for the three months ended March 31, 2021.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Other Expense, Net</div>

        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="10">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three months ended March 31,</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;"> 2022</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Change</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="10">
                <div style="text-align: center; font-weight: bold;">(in thousands)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 59.11%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>PIPE transaction fees</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>(992</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>(992</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 59.11%; white-space: nowrap;">
                <div>Liquidated damages</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; white-space: nowrap;" colspan="1">
                <div>(240</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; white-space: nowrap;" colspan="1">-<br />
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; white-space: nowrap;" colspan="1">
                <div>(240</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 59.11%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Interest expense, net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>(1</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>(14</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>13</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 59.11%; padding-bottom: 2px; white-space: nowrap;">
                <div>Other (expense) income , net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>91</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>11</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>80</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 59.11%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="margin-left: 9pt;">Total other expense, net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>(1,142</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>(3</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 10.24%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>(1,139</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1.13%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">28</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt;">For the three months ended March 31, 2022, we recognized an increase in other expense, net of approximately $1.4 million compared to the same period in 2021, primarily as a result of $1.0 million
          of other expense related to fees allocated to the PIPE Transaction, which was allocated to the warrants issued in connection with the transaction. Additionally, we accrued for a loss for the estimated liquidated damages we expected to incur as a
          result of not timely filing the Q1 2022 10Q with the SEC.&#160; These increases in expense were offset by a decrease in interest expense of $13,000 for the three months ended March 31, 2022 when compared to the same period in 2021 due to the payoff of
          certain long-term debt at December 31, 2021.</div>

        <div><br />
        </div>

        <div style="text-align: justify; font-weight: bold;">Liquidity and Capital Resources</div>

        <div> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">At March 31, 2022, we had cash and cash equivalents of approximately $23.5 million. On March 9, 2022, we issued 5,500,000 shares of common stock and Pre-Funded Warrants representing approximately
          1,357,000 shares of common stock for net proceeds of approximately $11.0 million in connection with the PIPE Transaction.&#160; Pursuant to the purchase agreement entered into in respect of the PIPE Transaction, we are prohibited from issuing equity
          in variable rate transactions for a period of one-year following consummation of the PIPE Transaction, including issuing equity under the Second Purchase Agreement.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">We have to date incurred operating losses, and we expect these losses to increase in the future as we expand our product development programs and operate as a publicly traded company.&#160; Developing
          product candidates, conducting clinical trials and commercializing products are expensive, and we will need to raise substantial additional funds to achieve our strategic objectives. It will likely be some years before we obtain the necessary
          regulatory approvals to commercialize one or more of our product candidates. Based on our current financial condition and forecasts of available cash, including as mentioned above, we believe we do not have sufficient funds to fund our operations
          for the next twelve months from the filing of the financial statements contained in this Q1 2022 10-Q. There can be no assurance that we will ever be in a position to commercialize IRX-2 or any other product candidate we may acquire, or that we
          will obtain any additional financing that we require in the future or, even if such financing is available, that it will be obtainable on terms acceptable to us.</div>

        <div style="text-indent: 36pt;"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">In that regard, our future funding requirements will depend on many factors, including:</div>

        <div> <br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the terms and timing of any collaborative, licensing and other agreements that we may establish;</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the cost and timing of regulatory approvals;</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the cost and delays in product development as a result of any changes in regulatory oversight applicable to our products;</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the cost and timing of establishing sales, marketing and distribution capabilities;</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the effect of competition and market developments;</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the cost of filing and potentially prosecuting, defending and enforcing any patent claims and other intellectual property rights;</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>the scope, rate of progress and cost of our clinical trials and other product development activities; and</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;"><br />
              </td>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>future clinical trial results.</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">We plan to raise additional funds to support our product development activities and working capital requirements through the remaining availability under the Second Purchase Agreement (to the
          extent we are permitted to use such agreement), public or private equity offerings, debt financings, corporate collaborations or other means. We may also seek governmental grants to support our clinical trials and preclinical trials. Further, we
          may seek to raise capital to fund additional product development efforts even if we have sufficient funds for our planned operations. Any sale by us of additional equity or convertible debt securities could result in dilution to our stockholders.
          There can be no assurance that any such required additional funding will be available to us at all or available on terms acceptable to us.</div>

        <div style="text-align: justify; text-indent: 36pt;"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">29</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt;">Further, to the extent that we raise additional funds through collaborative arrangements, it may be necessary to relinquish some rights to our technologies or grant sublicenses on terms that are
          not favorable to us. If we are not able to secure additional funding when needed, we may have to delay the commercialize of our products, reduce the scope of or eliminate one or more research and development programs, which could have an adverse
          effect on our business.</div>

        <div><br />
        </div>

        <div style="text-indent: 36pt; font-style: italic;">Sources of Funds</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">PIPE Transaction</span></div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">On March 9, 2022, we issued 5,500,000 shares of common stock, Pre-Funded Warrants exercisable for approximately 1,357,000 shares of common stock and Common Warrants exercisable for approximately
          6,857,000 shares of common stock for net proceeds of approximately $11.0 million in connection with the PIPE Transaction.&#160; Pursuant to the purchase agreement entered into in respect of the PIPE Transaction, we are prohibited from issuing equity
          in variable rate transactions for a period of one-year following consummation of the PIPE Transaction, including issuing equity under the Second Purchase Agreement.</div>

        <div><br />
        </div>

        <div>
          <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);"><span style="text-decoration: underline;">Equity Securities</span></div>

        </div>

        <div>
          <div><span style="color: rgb(0, 0, 0);"> </span><br />
          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0);">As a condition to the closing of the Merger, we were required to have at least $10.0 million in cash and cash equivalents at the effective time of the Merger. In furtherance
          of, and prior to, the Merger, certain of our members entered into agreements pursuant to which those members purchased units of Brooklyn LLC for an aggregate purchase price of $10.5 million during the three months ended March 31, 2021.</div>

        <div>
          <div style="text-align: justify;"><span style="color: rgb(0, 0, 0);"> </span><br />
          </div>

        </div>

        <div style="text-indent: 36pt;"><span style="text-decoration: underline;">Disposition</span>.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">On March 26, 2021, we completed the Disposition, in which we sold to eGames.com our rights, title and interest in and to the assets relating to the business we operated prior to the Merger under
          the name &#8220;NTN Buzztime, Inc.&#8221; in exchange for eGames.com&#8217;s payment of a purchase price of $2.0 million and assumption of specified liabilities relating to such pre-Merger business.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Uses of Funds</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Net Cash Used in Operating Activities</span><span style="font-style: italic;">.</span></div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Our operations used $5.4 million during the three months ended March 31, 2022 compared to $3.4 million in the comparable period. Our results for the quarter ended March 31, 2022 include
          approximately $1.0 million of fees incurred through March 31, 2022 related to the PIPE Transaction.&#160; These fees were allocated to the fair value of the Common Warrants and the Pre-Funded Warrants and recorded in other expense, net on the
          accompanying condensed consolidated statements of operations.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Our cash use for operating activities is influenced by the level of our net loss and the amount of cash we invest in personnel and technology development to support anticipated growth in our
          business.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">License Obligations</span>.</div>

        <div><br />
        </div>

        <div style="text-indent: 36pt;">We are obligated to pay certain amounts to Factor pursuant to the license agreement we entered into in April 2021, including $3.5 million in October 2022.&#160; The license agreement also provides for milestone payments
          and royalties on the net sale of product developed under the license agreement.</div>

        <div style="text-indent: 36pt;"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">30</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Lease Obligations</span>.</div>

        <div style="text-indent: 36pt;"> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">We are obligated to pay approximately $0.7 million per year for our facilities leases, subject to annual increases and to a sharing of common area expenses with other tenants in the building. The
          leases expire at varying times between December 2026 and June 2028.</div>

        <div style="text-indent: 36pt;"> <br />
        </div>

        <div> <br />
        </div>

        <div style="text-align: justify; font-weight: bold;">Critical Accounting Policies and Estimates</div>

        <div> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">There were no significant changes in our critical accounting estimates during the three months ended March 31, 2022 from those described in &#8220;Management&#8217;s Discussion and Analysis of Financial
          Condition and Results of Operations&#8221; section of the 10-K/A.</div>

        <div><br />
        </div>

        <div style="text-align: justify; font-weight: bold;">Recent Accounting Pronouncements</div>

        <div> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">There were no recent accounting pronouncements issued during the three months ended March 31, 2022 that would have impacted our financial statements or operations.</div>

        <div> <br />
        </div>

        <a id="Item3."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 44.4pt; vertical-align: top; font-weight: bold;">Item 3.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Quantitative and Qualitative Disclosures About Market Risk.</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Under the rules and regulations of the SEC, as a smaller reporting company we are not required to provide the information otherwise required by this item.</div>

        <div> <br />
        </div>

        <a id="Item4."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 44.4pt; vertical-align: top; font-weight: bold;">Item 4.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Controls and Procedures.</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

        <div style="text-indent: 36pt; font-style: italic;">Disclosure Controls and Procedures</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">We maintain &#8220;disclosure controls and procedures,&#8221; as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act, designed to ensure that information required to be disclosed in
          our reports filed pursuant to the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including
          our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosures.</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">In designing and evaluating the disclosure controls and procedures, we recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance
          of achieving the desired control objectives, and we were required to apply our judgment in evaluating the cost-benefit relationship of possible controls and procedures. We have carried out an evaluation as of the end of the period covered by this
          Q1 2022 10-Q under the supervision, and with the participation, of our management, including our interim Chief Executive Officer and President (who serves as our principal executive officer) and our Chief Financial Officer (who serves as our
          principal financial officer), of the effectiveness of the design and operation of our disclosure controls and procedures.</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Based on that evaluation, our interim Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of the end of the period
          covered by this Q1 2022 10-Q in providing reasonable assurance of achieving the desired control objectives due primarily to the material weaknesses discussed below.</div>

        <div>&#160;</div>

        <div style="text-indent: 36pt; font-style: italic;">Management&#8217;s Plan for Material Weaknesses in Internal Control over Financial Reporting</div>

        <div>&#160;</div>

        <div style="text-align: justify; text-indent: 36pt;">Upon completion of the Merger in March 2021 and the resulting change in our business model and strategy, we experienced a complete turnover of our employees, including all of the members of our
          executive management team, which resulted in, among other things, our having insufficient accounting staff available to enable and ensure adequate segregation of duties and our lacking appropriate and complete documentation of policies and
          procedures critical to the accomplishment of financial reporting objectives. The accounting personnel and documentation deficiencies each increase the risk that a material misstatement of our financial statements will not be prevented or detected
          on a timely basis.</div>

        <div style="text-align: justify; text-indent: 36pt;"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">31</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 36pt;">Additionally, we were unable to timely file our Q1 2022 10Q with the SEC due to identifying errors in our financial statements reported in the Original 10-K for the years ended December 31, 2021
          and 2020 during our preparation of the financial statements for the quarter ended March 31, 2022.&#160; Management concluded that the errors were the result of accounting personnel&#8217;s&#8217; lack of technical proficiency in complex matters.&#160;&#160; We filed Form
          10-K/A for the years ended December 31, 2021 and 2020 on June 30, 2022 to correct the errors in our financial statements for the years ended December 31, 2021 and 2020 and for the quarters ended June 30, 2020, September 30, 2020, March 31, 2021,
          June 30, 2021 and September 30, 2021.&#160; See the Form 10-K/A for further detail on the restatement.</div>

        <div>&#160;</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Management plans to implement measures designed to ensure that the deficiencies contributing to the ineffectiveness of our internal controls over financial reporting are promptly remediated, such
          that the internal controls are designed, implemented and operating effectively. The remediation actions planned include:</div>

        <div style="text-align: justify; text-indent: 36pt;"> <br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>hiring additional accounting personnel in a number, and with experience, to allow for proper segregation of duties and the accurate application of GAAP, including a chief financial officer, whom we hired in May of 2022;</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>developing and implementing, and then monitoring the effectiveness of, written policies and procedures required to achieve our financial reporting objectives in a timely manner, including policies and procedures relating to internal
                  control over financial reporting;</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>providing additional training to accounting personnel; and.</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>consulting with an accounting advisor for technical, complex and non-recurring matters.</div>
              </td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">We are committed to developing a strong internal control environment, and we believe the remediation efforts that we have implemented and will implement will result in significant improvements in
          our control environment. We hired our Vice President of Finance in the second quarter of 2021 to oversee all accounting and financial reporting matters, including implementing a framework for internal controls over financial reporting, and we
          hired a full-time controller at the beginning of 2022. Also, during the fourth quarter of 2021, we engaged a third-party consulting firm with expertise in implementing the framework for internal controls over financial reporting, and we are
          making progress on developing this framework, including identifying key controls, creating process narratives or flowcharts, developing test plans, and beginning the testing of the key controls to ensure the framework is complete and effective.
          Our management will continue to monitor and evaluate the relevance of our risk-based approach and the effectiveness of our internal controls and procedures over financial reporting on an ongoing basis and is committed to taking further action and
          implementing additional enhancements or improvements, as necessary.</div>

        <div>&#160;</div>

        <div style="text-indent: 36pt; font-style: italic;">Changes in Internal Control over Financial Reporting</div>

        <div>&#160;</div>

        <div style="text-indent: 36pt;">Other than described above, there was no change in our internal control over financial reporting during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our
          internal control over financial reporting.</div>

        <div> <br />
        </div>

        <div style="text-align: center; font-weight: bold;">PART II &#8212; OTHER INFORMATION</div>

        <div> <br />
        </div>

        <a id="LegalProceedings."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 44.4pt; vertical-align: top; font-weight: bold;">Item 1.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Legal Proceedings.</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">This information is set forth under &#8220;Note 8&#8212;Commitments and Contingencies&#8212;Legal Matters&#8221; to the condensed consolidated financial statements included in this Q1 2022 10-Q and is incorporated in
          this Item 1 by reference.</div>

        <div> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">From time to time we may become involved in legal proceedings arising in the ordinary course of business. Except as described above, we do not believe there is any litigation pending that could
          have, individually or in the aggregate, a material adverse effect on our results of operations, financial condition or cash flows.</div>

        <div> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">32</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <a id="RiskFactors."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 44.4pt; vertical-align: top; font-weight: bold;">Item 1A.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Risk Factors.</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">An investment in our common stock involves a high degree of risk. You should consider carefully the risks and uncertainties described under Item 1A of Part I of the 10-K/A, together with all
          other information contained or incorporated by reference in this Q1 2022 10-Q. If any of the risks described in this Q1 2022 10-Q or in the 10-K/A occur, our business, financial condition, results of operations and future growth prospects could
          be materially and adversely affected. Under these circumstances, the trading price of our common stock could decline, and you may lose all or part of your investment.<span style="color: rgb(0, 0, 0);"> As of the date of this </span>Q1 2022 10-Q<span style="color: rgb(0, 0, 0);">, we do not believe that there have been any material changes to the risk factors previously disclosed in the 10-K/A except as follows:.</span></div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">We are currently operating in a period of economic uncertainty and capital markets disruption, which has been significantly impacted
          by geopolitical instability, an ongoing military conflict between Russia and Ukraine, and record inflation. Our business, financial condition and results of operations could be materially adversely affected by any negative impact on the global
          economy and capital markets resulting from the conflict in Ukraine, geopolitical tensions, or record inflation.</div>

        <div style="text-align: justify; text-indent: 24.5pt;"><span style="font-weight: bold; font-style: italic; color: rgb(0, 0, 0);"> </span><br />
        </div>

        <div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0);">U.S. and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions and the start of the military conflict between Russia
          and Ukraine. In February 2022, a full-scale military invasion of Ukraine by Russian troops began. Although the length and impact of the ongoing military conflict is highly unpredictable, the conflict in Ukraine has led to market disruptions,
          including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions, which has contributed to record inflation globally. We are continuing to monitor inflation, the situation in Ukraine and
          global capital markets and assessing its potential impact on our business.</div>

        <div style="text-align: justify; text-indent: 24.5pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>

        <div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0);">Although, to date, our business has not been materially impacted by the ongoing military conflict between Russian and Ukraine, geopolitical tensions, or record inflation,
          it is impossible to predict the extent to which our operations will be impacted in the short and long term, or the ways in which such matters may impact our business. The extent and duration of the conflict in Ukraine, geopolitical tensions,
          record inflation and resulting market disruptions are impossible to predict but could be substantial. Any such disruptions may also magnify the impact of other risks described in the 10-K/A.</div>

        <div><br />
        </div>

        <a id="UnregisteredSalesofEquity"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 44.4pt; vertical-align: top; font-weight: bold;">Item 2.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">Unregistered Sales of Equity Securities and Use of Proceeds.</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

        <div style="text-indent: 36pt;">None</div>

        <div><br />
        </div>

        <a id="DefaultsUponSeniorSecurit"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 44.4pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 3.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Defaults Upon Senior Securities.</div>
              </td>

  </tr>


</table>
        <div style="text-align: justify; text-indent: -55.45pt; margin-left: 55.45pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>

        <div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0);">None.</div>

        <div style="text-align: justify; text-indent: -55.45pt; margin-left: 55.45pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>

        <a id="MineSafetyDisclosures."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 44.4pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 4.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Mine Safety Disclosures.</div>
              </td>

  </tr>


</table>
        <div style="text-align: justify; text-indent: -55.45pt; margin-left: 55.45pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>

        <div style="text-align: justify; text-indent: 24.5pt; color: rgb(0, 0, 0);">Not Applicable.</div>

        <div style="text-align: justify; text-indent: -55.45pt; margin-left: 55.45pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>

        <a id="OtherInformation."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 44.4pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 5.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;"><span style="font-style: italic;">Other Information</span>.</div>
              </td>

  </tr>


</table>
        <div style="text-align: justify; text-indent: -55.45pt; margin-left: 55.45pt;"><span style="color: rgb(0, 0, 0);"> </span><br />
        </div>

        <div style="text-indent: 24.5pt; color: rgb(0, 0, 0);">None.</div>

        <div style="text-indent: 24.5pt; color: rgb(0, 0, 0);"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">33</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <a id="Exhibits."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 44.4pt; vertical-align: top; font-weight: bold;">Item 6.</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic; font-weight: bold;">Exhibits.</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 8%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-weight: bold;">Exhibit</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 66%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-weight: bold;">Description</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 24%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-weight: bold;">Incorporated By Reference</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/0000748592/000114036122008622/brhc10034972_ex10-1.htm">10.1</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 66%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">Securities Purchase Agreement, dated as of March 6, 2022, between Brooklyn ImmunoTherapeutics, Inc. and the purchaser party thereto.</div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 24%; vertical-align: top;">
                <div>Exhibit to Form 8-K filed on March 9, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/0000748592/000114036122008622/brhc10034972_ex10-4.htm">10.2</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 66%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div style="color: rgb(0, 0, 0);">Registration Rights Agreement, dated as of March 6, 2022, between Brooklyn ImmunoTherapeutics, Inc. and the purchaser party thereto.</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Exhibit to Form 8-K filed on March 9, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
                <div><a href="https://www.sec.gov/Archives/edgar/data/0000748592/000114036122008622/brhc10034972_ex10-2.htm">10.3</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 66%; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">Form of Pre-Funded Warrant</div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 24%; vertical-align: top;">
                <div>Exhibit to Form 8-K filed on March 9, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div><a href="https://www.sec.gov/Archives/edgar/data/0000748592/000114036122008622/brhc10034972_ex10-3.htm">10.4</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 66%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div><span style="background-color: rgb(204, 238, 255); color: rgb(0, 0, 0);">Form of Common Stock Warrant</span>.</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Exhibit to Form 8-K filed on March 9, 2022</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
                <div><a href="brhc10039260_ex10-5.htm">10.5</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 66%; vertical-align: top;">
                <div>Agreement to Assign Space Lease dated March 5, 2022 between Brooklyn ImmunoTherapeutics, LLC and Regen Lab USA LLC.</div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 24%; vertical-align: top;">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div><a href="brhc10039260_ex10-6.htm">10.6</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 66%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Assignment and Assumption of Lease dated March 25, 2022 between Brooklyn ImmunoTherapeutics, LLC and Regen Lab USA LLC</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
                <div><a href="brhc10039260_ex31-1.htm">31.1</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 66%; vertical-align: top;">
                <div>Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 24%; vertical-align: top;">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div><a href="brhc10039260_ex31-2.htm">31.2</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 66%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
                <div><a href="brhc10039260_ex32-1.htm">32.1</a></div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 66%; vertical-align: top;">
                <div>Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 24%; vertical-align: top;">
                <div>Furnished herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div><a href="brhc10039260_ex32-2.htm">32.2</a></div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 66%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Furnished herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
                <div>101.INS</div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 66%; vertical-align: top;">
                <div>Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).</div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 24%; vertical-align: top;">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>101.SCH</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 66%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Inline XBRL Taxonomy Extension Schema Document</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
                <div>101.CAL</div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 66%; vertical-align: top;">
                <div>Inline XBRL Taxonomy Extension Calculation Linkbase Document</div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 24%; vertical-align: top;">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>101.DEF</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 66%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Inline XBRL Taxonomy Extension Definition Linkbase Document</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top;">
                <div>101.LAB</div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 66%; vertical-align: top;">
                <div>Inline XBRL Taxonomy Extension Label Linkbase Document</div>
              </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 24%; vertical-align: top;">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>101.PRE</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 66%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Inline XBRL Taxonomy Extension Presentation Linkbase Document</div>
              </td>

    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 236, 255);">&#160;</td>

    <td style="width: 24%; vertical-align: top; background-color: rgb(204, 236, 255);">
                <div>Filed herewith</div>
              </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>104</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 66%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</div>
              </td>

    <td style="width: 1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 24%; vertical-align: top;">&#160;</td>

  </tr>


</table>
        <div> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">34</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div><span style="font-size: 8pt; font-style: italic;"><a href="#TABLEOFCONTENTS">Table of Contents</a></span><br />
            </div>

          </div>

        </div>

        <div style="text-align: center; font-weight: bold;"><a id="SIGNATURE"><!--Anchor--></a>SIGNATURE</div>

        <div><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

        <div> <br />
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.95%; vertical-align: top;">&#160;</td>

    <td colspan="2" style="width: 50.05%; vertical-align: bottom;">
                <div style="text-align: justify;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>
              </td>

  </tr>

  <tr>

    <td style="width: 49.95%; vertical-align: middle;">&#160;</td>

    <td style="width: 3.1%; vertical-align: middle;">&#160;</td>

    <td style="width: 46.96%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 49.95%; vertical-align: top;">
                <div style="text-align: justify;">Date: June 30, 2022</div>
              </td>

    <td style="width: 3.1%; vertical-align: bottom;">
                <div style="text-align: justify;">By:</div>
              </td>

    <td style="width: 46.96%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="font-style: italic;">/s/ <span style="font-variant: small-caps;">Andrew Jackson</span></div>
              </td>

  </tr>

  <tr>

    <td style="width: 49.95%; vertical-align: top;">&#160;</td>

    <td style="width: 3.1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 46.96%; vertical-align: bottom;">
                <div style="text-align: justify;">Andrew Jackson</div>
              </td>

  </tr>

  <tr>

    <td style="width: 49.95%; vertical-align: top;">&#160;</td>

    <td style="width: 3.1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 46.96%; vertical-align: bottom;">
                <div style="text-align: justify;">Chief Financial Officer</div>
              </td>

  </tr>


</table>
        <div> <br />
        </div>

        <div> <br />
        </div>

        <div>
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">35</span></div>

        </div>

        <div>
          <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /> </div>

      </div>

    </div>

  </div>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>2
<FILENAME>brhc10039260_ex10-5.htm
<DESCRIPTION>EXHIBIT 10.5
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.4.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">

  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.5</font><br>
    </div>
    <div style="text-align: center;"><br>
    </div>
    <div>
      <div style="color: rgb(13, 13, 13); font-weight: bold; text-align: center;">AGREEMENT TO ASSIGN SPACE LEASE</div>
      <div>&#160;</div>
      <div style="color: rgb(13, 13, 13); text-indent: 45pt;">This <font style="font-weight: bold;">AGREEMENT TO ASSIGN SPACE LEASE </font>(the &#8220;<u>Agreement</u>&#8221;) is made and entered into as of March&#160;<u>&#160; 5&#160; &#160;&#160; </u>, 2022 (the &#8220;<u>Signature Date</u>&#8221;),
        between these two Delaware limited liability companies: (a) <font style="font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS LLC </font>(&#8220;<u>BITX</u>&#8221;); and (b) <font style="font-weight: bold;">REGENLAB USA LLC </font>(&#8220;<u>Regen</u>&#8221;). Terms used
        in this Agreement may be defined after first usage. An index of defined terms appears on the last page. Certain rights and obligations under this Agreement, as stated in this Agreement, shall become effective only when certain conditions are
        satisfied and the Assignment Date has occurred.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1271f5bae9634031be71330c6f3bea06" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 21.65pt; vertical-align: top; color: rgb(13, 13, 13); font-weight: bold;">1.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(13, 13, 13); font-weight: bold;">THE LEASE</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="color: rgb(13, 13, 13); text-indent: 45pt;">Only if and when an Assignment Date occurs, BITX desires to assign to Regen, and Regen desires to assume, the Lease, as defined in (and modified by) the Second Amendment to Lease Agreement dated
        July 24, 2019 (the &#8220;<u>Lease</u>&#8221;), between BIOBAT, Inc., a Not-for-Profit 501(c)(3) corporation organized under the Laws of the State of New York (&#8220;<u>Landlord</u>&#8221;) and BITX relating to premises in Building A of the Brooklyn Army Terminal (the &#8220;<u>Premises</u>&#8221;).

        Terms used in this Agreement without definition have the same meanings as in the Lease. BITX represents and warrants that it has given Regen a true and complete unredacted copy of the Lease. Regen acknowledges it has received, reviewed, and
        approved that copy.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8f36bbe26e9646fc98167ede1f831c96" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 21.65pt; vertical-align: top; color: rgb(13, 13, 13); font-weight: bold;">2.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(13, 13, 13); font-weight: bold;">INDEMNITY BY REGEN</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="color: rgb(13, 13, 13); text-indent: 45pt;">After the Assignment Date, Regen shall indemnify and hold harmless BITX and its affiliates from and against any costs and liabilities (including those arising from the loss of life, personal
        injury, and property damage), including reasonable attorneys&#8217; fees, directly or indirectly arising from any failure by Regen to perform any obligations under the Lease arising on or after the Assignment Date.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z11890aef1db74acaa176c8d8691693dc" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 21.65pt; vertical-align: top; color: rgb(13, 13, 13); font-weight: bold;">3.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(13, 13, 13); font-weight: bold;">INDEMNITY BY BITX</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="color: rgb(13, 13, 13); text-indent: 45pt;">After the Assignment Date, BITX shall indemnify and hold harmless Regen and its affiliates from and against any costs and liabilities (including those arising from the loss of life, personal
        injury, and property damage), including reasonable attorneys&#8217; fees, directly or indirectly arising from any failure by BITX to perform any obligation arising under the Lease before the Assignment Date.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z5e2b81dd3ed245aeb56eaef26444abe5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 21.65pt; vertical-align: top; color: rgb(13, 13, 13); font-weight: bold;">4.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(13, 13, 13); font-weight: bold;">REPRESENTATIONS AND WARRANTIES BY BITX</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="color: rgb(13, 13, 13); text-indent: 45pt;">This Agreement is made without representation or warranty by BITX, and without recourse to BITX, and Regen accepts the Premises as of the Assignment Date in the condition this Agreement
        requires, except as follows. BITX represents and warrants that, as of the Signature Date and as of the Assignment Date: (i) BITX has made all payments the Lease requires; (ii) all obligations of BITX under the Lease are current (including payment
        of rent and any escalations, pass-throughs, sundry charges, parking charges, security fees, and other sums, if any, payable under the Lease to date); (iii) the Lease is in full force and effect; (iv) the Lease as defined in this Agreement has not
        been modified, amended, waived, surrendered, cancelled, or otherwise impaired, orally or in writing; (v) BITX has not assigned or encumbered its interest in the Lease (except as this Agreement contemplates) or entered into any subleases; and (vi)
        BITX has given Regen true and correct copies of BITX&#8217;s rent bills and payment records for approximately the last 90 days. As of the Signature Date, BITX represents and warrants that: (a) to BITX&#8217;s knowledge, BITX has not received notice of any
        uncured default under the Lease; and (b) BITX has not given Landlord notice of any default by Landlord. BITX shall notify Regen if any statement in the previous sentence becomes false between the Signature Date and the Assignment Date. BITX
        represents and warrants that, as of the Signature Date and as of the Assignment Date, BITX has not entered into any service, operational, refuse removal, security, monitoring, parking, utility, or other contract benefitting the Premises except
        these, for which BITX will be solely responsible: (a) broadband service contract that will expire April 30; and (b) hazardous waste removal agreement that will expire on or before the Assignment Date.</div>
      <div style="color: rgb(13, 13, 13);"> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z0eb7f440e0ac4506b0b529a62ab4006f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 21.65pt; vertical-align: top; color: rgb(13, 13, 13); font-weight: bold;">5.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(13, 13, 13); font-weight: bold;">REPRESENTATIONS AND WARRANTIES BY BOTH PARTIES</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="color: rgb(13, 13, 13); text-indent: 45pt;">BITX and Regen each (a &#8220;<font style="font-weight: bold; font-style: italic;">Warrantor</font>&#8221;) represents and warrants to the other, subject to obtaining the Consent: (i) Warrantor has duly
        authorized, executed, and delivered this Agreement; (ii) this Agreement is Warrantor&#8217;s binding and enforceable obligation; (iii) Warrantor&#8217;s entering into and performing under this Agreement does not violate any agreement, law, or regulation by
        which Warrantor is bound; (iv) Warrantor has obtained all necessary consents, and made all governmental filings (if any), necessary for Warrantor to enter into this Agreement; and (v) Warrantor is a person with whom United States citizens may
        legally do business.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z51ce6ebadb3a44b6b2cfd794d10e79b1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 21.65pt; vertical-align: top; color: rgb(13, 13, 13); font-weight: bold;">6.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(13, 13, 13); font-weight: bold;">TRANSITIONAL MATTERS</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="color: rgb(13, 13, 13); text-indent: 45pt;">On or about the Assignment Date and before transferring possession of the Premises to Regen, BITX shall at its expense professionally clean the Premises. As of the Assignment Date, Regen accepts
        the present (as of the Signature Date) condition of the Premises and of all furniture, furnishings, and equipment within the Premises (the &#8220;<u>FF&amp;E</u>&#8221;), subject only to ordinary wear and tear from the Signature Date to the Assignment Date and
        the professional cleaning required by the previous sentence. As of the Assignment Date: (i) BITX disclaims any interest in the FF&amp;E; and (ii) Regen may at its option dispose of any FF&amp;E at its cost as it sees fit. As of the Assignment Date,
        BITX shall give Regen all keys, keycards, access codes, key fobs, and similar access mechanisms for the Premises in BITX&#8217;s possession, all suitably labelled and described (the &#8220;<u>Access Mechanisms</u>&#8221;). Regen shall simultaneously acknowledge
        receipt of the Access Mechanisms. At and after the Assignment Date, BITX shall coordinate and cooperate with Landlord and Regen to give Regen possession and access to the Premises. After the Assignment Date, Regen may arrange with Landlord to reset
        any access codes or security devices for the Premises, all at Regen&#8217;s expense. BITX shall cooperate as necessary. The parties shall promptly cooperate to take all other actions, and promptly deliver all other documents, necessary or appropriate to
        effectuate their intentions as expressed in this Agreement. On the Assignment Date, Regen shall deliver to Landlord, with copies to BITX, all insurance-related documents the Lease requires, and the parties acknowledge that BITX may terminate its
        insurance at this location.</div>
      <div style="text-indent: 40pt; margin-right: 7.6pt; margin-left: 5pt; color: rgb(13, 13, 13);"> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="ze2bea44085eb483e8899865f1865986c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 21.65pt; vertical-align: top; color: rgb(13, 13, 13); font-weight: bold;">7.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">FINANCIAL MATTERS</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="color: rgb(13, 13, 13); text-indent: 45pt;">As of the Assignment Date, the parties shall cooperate to prorate monetary obligations under the Lease on a daily basis. To the extent that Landlord bills either party for any additional charges
        due under the Lease for periods before the Assignment Date, BITX shall promptly pay those bills. On the Assignment Date, Regen shall pay BITX: (a) $50,000 to partly reimburse BITX&#8217;s unamortized cost of the FF&amp;E; (b) $50,000 to partly reimburse
        BITX&#8217;s unamortized cost of its fixturization of the Premises, including clean room buildout; and (c) $63,220 to reimburse BITX for the existing security deposit under the Lease (the &#8220;<u>Security Deposit</u>&#8221;). </div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze2a17e2f6e734cea9ba0cd650dfba6ad" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 21.65pt; vertical-align: top; color: rgb(13, 13, 13); font-weight: bold;">8.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(13, 13, 13); font-weight: bold;">ASSIGNMENT DATE</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="font-size: 12pt; text-indent: 45pt;"><font style="font-size: 10pt; color: rgb(13, 13, 13);">The assignment of the Lease and all rights and obligations of BITX and Regen under this Agreement arising upon or after the Assignment Date shall
          not take effect unless and until all</font><font style="font-size: 10pt;">&#160;<font style="color: rgb(13, 13, 13);">these conditions have been met (the &#8220;<u>Assignment Date</u>&#8221;): (i) Landlord has consented to this Agreement in writing in form and
            substance satisfactory to Landlord, BITX, and Regen, which consent may include a form of Lease assignment; (ii) both BITX and Regen have countersigned that consent to confirm they agree to its terms (the &#8220;<u>Consent</u>&#8221;); (iii) BITX has cured
            any monetary and nonmonetary defaults under the Lease and made all payments then due under the Lease; (iv) BITX has delivered, and Regen has acknowledged receipt of, the Access Mechanisms; (v) the parties have made all payments this Agreement
            requires to be made on or before the Assignment Date; and (vi) BITX has professionally cleaned the Premises. On the Assignment Date, the parties shall execute and exchange an assignment of the Lease in the form the Consent or Landlord requires.</font></font></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z09d888d7e66648488bf06612bcbdde10" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 21.65pt; vertical-align: top; color: rgb(13, 13, 13); font-weight: bold;">9.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(13, 13, 13); font-weight: bold;">LANDLORD CONSENT</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(13, 13, 13); text-indent: 45pt;">The parties shall diligently and reasonably cooperate to achieve the Consent. If the Consent has not been fully signed by all parties and delivered by the date 21 days after
        the Signature Date, then either party may terminate this Agreement.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z5522e245eb7349e4b2784f62b5ff4c23" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 21.65pt; vertical-align: top; color: rgb(13, 13, 13); font-weight: bold;">10.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(13, 13, 13); font-weight: bold;">MISCELLANEOUS</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(13, 13, 13); text-indent: 45pt;">The parties waive jury trial in any dispute arising from this Agreement. BITX and Regen shall each pay any taxes on this Agreement (or the transactions it contemplates) for
        which it has primary liability by law. The parties shall promptly cooperate on all tax filings.</div>
      <div>&#160;</div>
      <div style="text-align: right; margin-right: 5.85pt; color: rgb(13, 13, 13); font-style: italic;">No Further Text on This Page.</div>
      <div style="text-align: right; margin-right: 5.85pt; color: rgb(13, 13, 13); font-style: italic;"> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: center; color: rgb(13, 13, 13); font-weight: bold;">SIGNATURE PAGE FOR AGREEMENT TO ASSIGN SPACE LEASE</div>
        <div>&#160;</div>
        <div style="color: rgb(13, 13, 13); font-size: 12pt; text-indent: 45pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF, </font><font style="font-size: 10pt;">BITX and Regen have executed this Agreement as of the Signature
            Date but effective only as of the Assignment Date.</font></div>
        <div>&#160;</div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z2badf5ea92944a219ffc5f50965b8598">

              <tr>
                <td style="width: 50%; font-weight: bold;">REGENLAB USA LLC</td>
                <td style="width: 50.00%;">
                  <div style="color: rgb(13, 13, 13); font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS LLC</div>
                </td>
              </tr>

          </table>
        </div>
        <div> <br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z297904877de74dd4ad4c191b182cd3a9">

              <tr>
                <td style="width: 3%; padding-bottom: 2px;"><font style="color: rgb(13, 13, 13);">By:</font></td>
                <td style="width: 44%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Antoine Turzi<br>
                </td>
                <td style="width: 3%; padding-bottom: 2px;" colspan="1">&#160;</td>
                <td style="width: 3%; padding-bottom: 2px;"><font style="color: rgb(13, 13, 13);">By:</font></td>
                <td style="width: 44%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Howard Federoff<br>
                </td>
                <td style="width: 3%; padding-bottom: 2px;" colspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 3%; padding-bottom: 2px;">Its:</td>
                <td style="width: 44%; border-bottom: 2px solid rgb(0, 0, 0);">Antoine Turzi, CEO<br>
                </td>
                <td style="width: 3%; padding-bottom: 2px;" colspan="1">&#160;</td>
                <td style="width: 3%; padding-bottom: 2px;">Its:</td>
                <td style="width: 44%; border-bottom: 2px solid rgb(0, 0, 0);">Howard Federoff, CEO</td>
                <td style="width: 3%; padding-bottom: 2px;" colspan="1">&#160;</td>
              </tr>

          </table>
        </div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: center; color: rgb(13, 13, 13); font-weight: bold;">INDEX OF DEFINED TERMS</div>
        <div style="text-align: center; color: rgb(13, 13, 13); font-weight: bold;"> <br>
        </div>
        <div style="color: rgb(13, 13, 13); font-weight: bold;">
          <table cellspacing="0" cellpadding="0" border="0" id="z630179f5d3f84b36a048438c74183490" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 47%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);">Access Mechanisms</div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">2<br>
                </td>
                <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 42%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);">Lease</div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">1<br>
                </td>
              </tr>
              <tr>
                <td style="width: 47%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);">Agreement</div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">1<br>
                </td>
                <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 42%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);">
                    <div style="color: rgb(13, 13, 13);">Premises</div>
                  </div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">1<br>
                </td>
              </tr>
              <tr>
                <td style="width: 47%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);">Assignment Date</div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">3<br>
                </td>
                <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 42%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);">
                    <div style="color: rgb(13, 13, 13);">Regen</div>
                  </div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">1<br>
                </td>
              </tr>
              <tr>
                <td style="width: 47%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);">BITX</div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">1<br>
                </td>
                <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 42%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);">
                    <div style="color: rgb(13, 13, 13);">Security Deposit</div>
                  </div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">3<br>
                </td>
              </tr>
              <tr>
                <td style="width: 47%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);">Consent</div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">3<br>
                </td>
                <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 42%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);">
                    <div style="color: rgb(13, 13, 13);">Signature Date</div>
                  </div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">1<br>
                </td>
              </tr>
              <tr>
                <td style="width: 47%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);">FF&amp;E</div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">2<br>
                </td>
                <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 42%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);">
                    <div style="color: rgb(13, 13, 13);">Warrantor</div>
                  </div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">2<br>
                </td>
              </tr>
              <tr>
                <td style="width: 47%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);">Landlord</div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">1<br>
                </td>
                <td style="width: 5%; vertical-align: top;" colspan="1">&#160;</td>
                <td style="width: 42%; vertical-align: top;">
                  <div style="color: rgb(13, 13, 13);"><br>
                  </div>
                </td>
                <td style="width: 3%; vertical-align: top; text-align: right;" colspan="1">&#160;</td>
              </tr>

          </table>
          <div>&#160;</div>
        </div>
        <br>
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font></div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>3
<FILENAME>brhc10039260_ex10-6.htm
<DESCRIPTION>EXHIBIT 10.6
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.4.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">

  <!--PROfilePageNumberReset%Num%1%%%-->
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.6</font><br>
  </div>
  <div>
    <div style="margin-left: 60pt;"> <br>
    </div>
    <div>Execution Copy</div>
    <div> <br>
    </div>
    <div style="font-weight: bold; text-align: center;">ASSIGNMENT AND ASSUMPTION OF LEASE</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">THIS ASSIGNMENT AND ASSUMPTION OF LEASE (the &#8220;<font style="font-weight: bold;">Assignment</font>&#8221;) made as of the 25th day of March 2022 (the &#8220;<font style="font-weight: bold;">Effective Date</font>&#8221;),




      between BROOKLYN IMMUNOTHERAPEUTICS LLC (&#8220;<font style="font-weight: bold;">Assignor</font>&#8221;), a Delaware limited liability company, and REGEN LAB USA LLC, a New York limited liability company (&#8220;<font style="font-weight: bold;">Assignee</font>&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, BioBAT, Inc. (&#8220;<font style="font-weight: bold;">Landlord</font>&#8221;), as landlord, and IRX Therapeutics, Inc. (&#8220;IRX&#8221;), as tenant, entered into an
      Agreement of Lease, dated as of September 28, 2015; as amended by a First Amendment to Lease, dated as of September 28, 2015 by and between IRX and Landlord; as assigned by IRX to Assignor by that certain Assignment and Assumption of Lease dated as
      of November 6, 2018; as such lease was further amended by that certain Second Amendment to Lease Agreement by and between Assignor and Landlord dated as of July 24, 2019, (as assigned and amended, the &#8220;<font style="font-weight: bold;">Lease</font>&#8221;),
      with respect to the Premises, located in the Brooklyn Army Terminal, Building A, at 140 58th Street, Brooklyn, New York, as further defined in the Lease (attached hereto as Exhibit A) and as shown on the drawing attached hereto as Exhibit B; and</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, Assignor now desires to assign, and Assignee desires to accept all of Assignor&#8217;s right, title and interest in and to, and assume all of its
      obligations under, the Lease;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">NOW THEREFORE</font>, in consideration of the recitals above and the mutual promises and covenants herein contained, and for other good and valuable consideration,
      the receipt and legal sufficiency of which is hereby acknowledged, the parties covenant and agree as follows:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z99417e69e7ff4a7a8c3f779896c27d0f">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Assumption of Obligations under the Lease.</u></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-weight: bold;">Assignment of Lease</font>. Assignor assigns, transfers and sets over to Assignee all of Assignor&#8217;s right, title and interest in and to, and all of its
      obligations under, the Lease.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-weight: bold;">Assumption of the Assignor&#8217;s Obligations</font>. Assignee hereby: (i) accepts the assignment of the Lease; (ii) assumes all of the obligations,
      liabilities, covenants and conditions of Assignor as tenant under the Lease; (iii) assumes and agrees to perform and observe all of the obligations, terms, requirements, covenants and conditions to be performed or observed by Assignor under the
      Lease; and (iv) makes all of the representations and warranties binding upon the Tenant under the Lease; with the same force and effect as if Assignee had executed the Lease originally as Tenant.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z00441a8b29e14e80abe7d4241d334117">

        <tr>
          <td style="width: 72pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(c)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Intentionally Deleted</font><font style="font-size: 10pt;">.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Construing Lease</font>. Nothing herein contained shall be construed to: (i) modify, waive, impair or affect any of the provisions contained in the Lease
      (except as may be expressly provided herein), (ii) operate as a consent to or approval by LANDLORD of any of the provisions, covenants and conditions of the Private Agreement, as defined below; (iii) operate as a representation or warranty by
      LANDLORD; (iv) waive any present or future breach of, or default under, the Lease, or any rights of LANDLORD against any person, firm, association or corporation liable or responsible for the performance thereof; or (v) enlarge or increase LANDLORD&#8217;s
      obligations or the Assignee&#8217;s rights under the Lease.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div>Execution Copy</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Full Force and Effect</font>. All provisions of the Lease are hereby declared by the Assignor and Assignee, respectively, to be in full force and
      effect, including the change in definition set forth in Section 5(a) below.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(f)&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <font style="font-weight: bold;">Assignor Remains Liable</font>. Notwithstanding this Assignment, Assignor shall be and remain liable and responsible for the due keeping, and full
      performance and observance, of all of the provisions of the Lease on the part of Tenant to be kept, performed and observed.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-weight: bold;">Default Applicability</font>. In the event of any default by Assignor or Assignee in the full performance and observance of any of their respective
      obligations hereunder, or in the event any representation of Assignor or Assignee contained herein should prove to be untrue, such event may, at LANDLORD&#8217;s option, be deemed a default under the Lease, and LANDLORD shall have all of the rights, powers
      and remedies provided for in the Lease or in this Assignment, or at law or in equity or by statute or otherwise with respect to defaults.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(h)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-weight: bold;">Conflict Provisions</font>. In case of any conflict between the provisions of the Lease and this Assignment, the provisions of this Assignment shall
      prevail.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(i)&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <font style="font-weight: bold;">Defined Terms</font>. All capitalized terms not defined in this Assignment shall have the meaning set forth in the Lease.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 5.75pt; margin-left: 60pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Consent</u>. LANDLORD hereby consents to the aforesaid assignment of the Lease by Assignor to Assignee, such consent being subject to and upon the conditions contained herein, to each
      of which Assignor and Assignee expressly agree. Assignee shall comply with, perform and observe all of the obligations and conditions of tenant under the Lease. Landlord does NOT consent to the document entitled Agreement to Assign Space Lease dated
      as of March 5, 2022, and signed by Assignor and Assignee (the &#8220;Private Agreement&#8221;) or any of the terms thereof. Each of Assignor and Assignee agree, represent, and covenant that the Private Agreement and the terms thereof only bind Assignor and
      Assignee, do not modify the Lease or any provision thereof, and are not binding, in any way, on Landlord, its successors or assigns, the New York City Economic Development Corporation (&#8220;NYCEDC&#8221;), or the City of New York (&#8220;City&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Further Assignments</u>. This Assignment is not, and shall not be construed as a consent by LANDLORD to, or as permitting, any other or further assignment by Assignor or Assignee.
      Any further assignment by Assignor or Assignee shall require LANDLORD&#8217;s prior written consent pursuant to and in accordance with the Lease.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zd1713511e45e4669add72369b5ddb3d4">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Representations of Assignor and Assignee</u>.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 36pt; text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Assignor&#8217;s Representations</font>. Assignor represents that:(i) to Assignor&#8217;s knowledge, there is no existing default under the
      Lease by Assignor; (ii) Assignor is the sole tenant under the Lease; (iii) the Lease is in full force and effect; (iv) the Lease has not been assigned or modified or amended in any respect whatsoever, except as stated in Section 5(a) below with
      respect to the change to the definition of Landlord&#8217;s Premises in the Lease; (v) Assignor has not encumbered the Lease with any prior transfer, assignment, mortgage, lien or any other encumbrance; (vi) Assignor has full and lawful authority to assign
      the Lease and enter into this Assignment; and (vii) except for this Assignment, the Lease embodies the entire agreement and understanding between the parties thereto with respect to the Premises demised thereunder.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div>Execution Copy</div>
    <div><br>
    </div>
    <div style="margin: 0px 0px 0px 36pt; text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Assignor&#8217;s and Assignee&#8217;s Representations</font>. Assignor and Assignee jointly and severally represent to LANDLORD (and
      Assignor and Assignee each, as to itself, represents to the other) that: The execution and delivery by Assignor and Assignee of this Assignment and the performance of their respective obligations hereunder (i) have been duly authorized by all
      requisite entity action and (ii) will not violate any provision of any applicable legal requirements, any order, writ, decree, injunction or demand of any court or other governmental authority, any organizational document or any indenture or
      agreement or other instrument to which Assignor or Assignee is a party or by which Assignor or Assignee is bound. Assignor and Assignee are not required to obtain any consent, approval or authorization from or to file any declaration or statement
      with any governmental authority or other agency in connection with or as a condition to the execution, delivery or performance of this Assignment. This Assignment has been duly authorized, executed and delivered by Assignor and Assignee. Assignor has
      not received any consideration from or on behalf of Assignee in connection with this Assignment, except as stated in the Private Agreement. Except to the extent stated in the Private Agreement, Assignee has not paid any such consideration, and there
      is no agreement to provide any such consideration at any time in the future, as described in Article 11 of the Lease. The copy of the Lease annexed hereto as Exhibit A is a true and correct copy thereof.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z2ea92967de0347de93f3e0e044c7e2c2">

        <tr>
          <td style="width: 72pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(c)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Assignee&#8217;s Representations</font><font style="font-size: 10pt;">. Assignee represents to LANDLORD that:</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>No Representations of Landlord/ Premises &#8220;As Is&#8221;</u>. No representations, statements, or warranties, express or implied, have been made by, or on behalf of, Landlord, NYCEDC, or
      the City with respect to the Premises or the transaction contemplated by the Lease, the status of title thereto, the physical condition thereof, the zoning or other laws, regulations, rules and orders applicable thereto or the use that may be made of
      the Premises, and Assignee takes the Premises &#8220;as-is&#8221; and &#8220;where-is&#8221;. Assignee has relied on no such representations, statements or warranties, and Landlord shall not be liable in any event whatsoever for any latent or patent defects in the Premises.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z5161835aafd141f78eba1ebde232303e">

        <tr>
          <td style="width: 108pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(ii)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Intentionally Deleted</u>.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z2ce875b91a3543989ec1fd222bf1694a">

        <tr>
          <td style="width: 108pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(iii)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Intentionally Deleted</u>.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160; <u>No City Interest</u>. No officer, agent, employee or representative of the City has received or will receive any payment or other consideration for the making of this Assignment and
      LANDLORD&#8217;s consent hereto and no officer, agent, employee or representative of the City has any interest or will have any direct interest in the Lease, this Assignment or any proceeds thereof.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div>Execution Copy</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Good Standing</u>. Assignee is a validly existing corporation, limited liability company or other form of entity in good standing under the laws of the State of New York, has the
      power and authority to own its assets and to transact the business in which it is now engaged or proposed to be engaged, and/or as applicable is duly qualified as a foreign corporation, limited liability company or other form of entity and in good
      standing under the laws of each other jurisdiction in which such qualification is required.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(vi)&#160;&#160;&#160;&#160; &#160;&#160; <u>Legal Actions</u>. There are no actions, suits or proceedings pending or, to the knowledge of Assignee, threatened against, or affecting Assignee or any affiliate before any court,
      federal, state or local governmental authority or arbitrator, which may, in any one case or in the aggregate, materially adversely affect the financial condition, operations, properties or business of Assignee, or the ability of Assignee to perform
      its obligations under the Lease and this Assignment.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(vii)&#160;&#160;&#160;&#160;&#160;&#160; <u>Tax Returns</u>. Assignee has filed all tax (federal, state and local) returns required to be filed and has paid all taxes, assessments and governmental charges and levies thereon to
      be due, including interest and penalties. Assignee has no knowledge of any claims for taxes due and unpaid which might become a lien upon any of its assets.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(viii)&#160;&#160;&#160;&#160;&#160; <u>Licenses/Permits</u>. Assignee has obtained all necessary licenses and permits to operate the Premises for the uses stated in the Lease and will continue to maintain such licenses
      and permits throughout the Term.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(ix)&#160;&#160;&#160; &#160;&#160; <u>Safety Procedures</u>. Assignee shall use all recognized safety procedures at the Premises and techniques to protect life and property throughout the Term.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z6204af6ca6c84409b9770c381881af0b">

        <tr>
          <td style="width: 108pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(x)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Intentionally Deleted</u>.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(d)&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-weight: bold;">Security Deposit</font>. Assignee and Assignor acknowledge and agree that: (i) prior to the Effective Date, pursuant to Section 27.1 of the Lease, the
      Assignor deposited with LANDLORD Eighty Four Thousand Ninety One and 53/00 Dollars ($84,091.53) (&#8220;Assignor&#8217;s Security Funds&#8221;); and (ii) simultaneous with the Effective Date of this Assignment, and as part of the conditions of and consideration for
      LANDLORD granting its consent to this Assignment, LANDLORD shall be entitled to withdraw the entire amount of the Assignor&#8217;s Security Funds (i.e., $84,091.53) in order to hold such amount as additional security for the faithful performance and
      observance by Assignee, as Tenant, of the terms, provisions and conditions of the Lease.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zd8574e3696024903a915c66d8c6b1883">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt;"><u>Miscellaneous</u>.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-indent: 75pt; text-align: justify;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;">Definitions. </font>The term &#8220;Landlord&#8217;s Premises&#8221; is amended and restated to read as follows, pursuant to the terms of that certain First Amendment
      to Agreement of Lease dated as of August 16, 2019 between Prime Landlord and Landlord:</div>
    <div><br>
    </div>
    <div style="text-indent: 37.55pt; text-align: justify;">(i) Dock Level: approximately 46,400 gross square feet and any loading area reflected on the site map shown in Exhibit B-1 to the Prime Lease consisting of the following components;</div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div>Execution Copy</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(ii) First Floor: approximately 48,000 gross square feet plus the common loading area reflected on the site map in Exhibit B-1 to the Prime Lease;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(iii) Floors Two Through Three: approximately 56,000 gross square feet per floor totaling approximately 112,000 gross square feet; and</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(iv) Garage as more particularly delineated on the design development diagrams attached in Exhibit B-1 to the Prime Lease as the same may be revised in accordance with the terms of the Prime Lease.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160; &#160; &#160; <font style="font-weight: bold;">Written Amendment Only</font>. This Assignment may not be altered, amended, modified or changed orally, but only by an agreement in writing signed by the
      party against whom enforcement of any such alteration, amendment, modification or change is being sought.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Captions</font>. Captions are inserted for convenience only and will not affect the construction hereof.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(d)&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Entire Agreement. </font>This Assignment, together with the Lease, constitutes the entire agreement of the parties hereto with respect to the matters
      stated herein.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Governing Law</font>. This Assignment will for all purposes be construed in accordance with and governed by the laws of the State of New York applicable to
      agreements made and to be performed wholly therein without giving effect to any principles of conflict of laws.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Signature in Counterparts/.PDF Format</font>. This Assignment may be executed in several counterparts, each of which will constitute an original
      instrument and all of which will together constitute one and the same instrument This Assignment may be delivered electronically in .PDF format, and any such delivery shall be of the same legal effect, validity and enforceability for all purposes as
      if delivered in hardcopy. Each party hereby waives any defenses to the enforcement of the terms of this Amendment based on its delivery of this Amendment in .PDF format, and hereby agrees that any such delivery by such party shall be conclusive
      proof, admissible in judicial proceedings, of such party&#8217;s delivery of this Amendment.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Remedies Cumulative</font>. Each right and remedy of LANDLORD provided for in this Assignment or in the Lease shall be cumulative and shall be in addition
      to every other right and remedy provided for herein or therein or now or hereafter existing at law or in equity or by statute or otherwise, and the exercise or beginning of the exercise by LANDLORD of any one or more of the rights or remedies so
      provided for or existing shall not preclude the simultaneous or later exercise by LANDLORD of any or all other rights or remedies so provided for or so existing.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Successors and Assigns</font>. All representations, warranties, grants, covenants, terms and provisions of this Assignment shall apply to, bind and inure
      to the benefit of the respective successors and, to the extent permitted under the Lease, the respective assigns, of Assignor, Assignee and LANDLORD.
      <div><br>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div>Execution Copy</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="color: rgb(1, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;">Definitions. </font>All capitalized terms used in this Assignment without definition shall have the meanings
      given to such terms in the Lease.</div>
    <div style="text-indent: 81pt; margin-right: 5.9pt; margin-left: 60pt;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">(j)&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;">Notices</font>. Assignee directs that for purposes of Article XXIV of the Lease, notices to Assignee shall be sent to: Building A, 140 58th Street,
      Brooklyn, New York, 11220.</div>
    <div><br>
    </div>
    <div style="font-style: italic; text-align: center;">(Remainder of page intentionally left blank; signature page follows)</div>
    <div style="margin-left: 130.3pt; font-style: italic;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div>Execution Copy</div>
    <div><br>
    </div>
    <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF</font><font style="font-size: 10pt;">, the parties hereto have signed and executed this Assignment and Assumption of Lease, effective as of the first
        date noted above.</font></div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" id="z860a32993a8944ce925414a84a9b3202" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;">

          <tr>
            <td style="width: 50%;">
              <div style="text-align: left;"><font style="font-weight: bold;">BROOKLYN IMMUNOTHERAPIES LLC, </font></div>
            </td>
            <td rowspan="1" style="width: 50%;"> <font style="font-weight: bold;">REGEN LAB USA LLC,<br>
              </font></td>
          </tr>
          <tr>
            <td style="width: 50%;"><font style="font-weight: bold;">ASSIGNOR </font></td>
            <td rowspan="1" style="width: 50%;"> <font style="font-weight: bold;">ASSIGNEE</font></td>
          </tr>

      </table>
    </div>
    <div>&#160;<font style="font-weight: bold;"><br>
      </font></div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="zc52b3275d29b414080ae881b8222c70d" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;">

            <tr>
              <td style="width: 5%; padding-bottom: 2px;">
                <div style="text-align: left;">By:</div>
              </td>
              <td colspan="1" style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Howard Federoff<br>
              </td>
              <td style="width: 5%; padding-bottom: 2px;" colspan="1">&#160;</td>
              <td style="width: 5%; padding-bottom: 2px;">
                <div style="text-align: left;">By:</div>
              </td>
              <td colspan="1" style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Antoine Turzi<br>
              </td>
              <td colspan="1" style="width: 5%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 5%;">
                <div>&#160;</div>
              </td>
              <td colspan="1" style="width: 40%;">&#160;</td>
              <td style="width: 5%;" colspan="1">&#160;</td>
              <td style="width: 5%;">
                <div>&#160;</div>
              </td>
              <td colspan="1" style="width: 40%;">&#160;</td>
              <td colspan="1" style="width: 5%;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 5%;">Name: </td>
              <td colspan="1" style="width: 40%;">Dr. Howard Federoff<br>
              </td>
              <td style="width: 5%;" colspan="1">&#160;</td>
              <td style="width: 5%;">
                <div style="text-align: left;">Name: <br>
                </div>
              </td>
              <td colspan="1" style="width: 40%;">Antoine Turzi</td>
              <td colspan="1" style="width: 5%;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 5%;">
                <div style="text-align: left;">Title:</div>
              </td>
              <td colspan="1" style="width: 40%;">President and Chief Executive Officer</td>
              <td style="width: 5%;" colspan="1">&#160;</td>
              <td style="width: 5%;">
                <div style="text-align: left;">Title:</div>
              </td>
              <td colspan="1" style="width: 40%;">
                <div style="text-align: left;">Chief Executive Officer</div>
              </td>
              <td colspan="1" style="width: 5%;">&#160;</td>
            </tr>

        </table>
      </div>
      <font style="font-weight: bold;"> </font></div>
    <div><font style="font-weight: bold;"> </font></div>
    <div><font style="font-weight: bold;"> <br>
      </font></div>
    <font style="font-weight: bold;"> </font>
    <div style="font-weight: bold;">THIS ASSIGNMENT HAS BEEN CONSENTED TO BY THE LANDLORD:</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">BIOBAT, INC.</div>
    <div style="font-weight: bold;"> <br>
    </div>
    <div style="font-weight: bold;">
      <table cellspacing="0" cellpadding="0" border="0" id="z43ad43fe9e794f73a21a405c8982a5f0" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;">

          <tr>
            <td style="width: 5%; padding-bottom: 2px;">
              <div style="text-align: left;">By:</div>
            </td>
            <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Eva Cramer<br>
            </td>
            <td style="width: 55%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%;" rowspan="1">&#160;</td>
            <td style="width: 40%;" rowspan="1">&#160;</td>
            <td style="width: 55%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 5%;"> Name: </td>
            <td style="width: 40%;">Dr. Eva Cramer</td>
            <td style="width: 55%;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%;">Title:</td>
            <td style="width: 40%;">President</td>
            <td style="width: 55%;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
    </div>
    <br>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div>Execution Copy</div>
    <div><br>
    </div>
    <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">IN WITNESS WHEREOF</font><font style="font-size: 10pt;">, the parties hereto have signed and Assumption of Lease, effective as of the first date noted above.</font></div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" id="z9f863093148c4096b6397302d56096a5" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;">

          <tr>
            <td style="width: 50%;">
              <div style="text-align: left;"><font style="font-weight: bold;">BROOKLYN IMMUNOTHERAPIES LLC,<br>
                </font></div>
            </td>
            <td rowspan="1" style="width: 50%;"> <font style="font-weight: bold;">REGEN LAB USA LLC, <br>
              </font></td>
          </tr>
          <tr>
            <td style="width: 50%;"><font style="font-weight: bold;">ASSIGNOR <br>
              </font></td>
            <td rowspan="1" style="width: 50%;"> <font style="font-weight: bold;">ASSIGNEE</font></td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" id="z41dc79fa0f124921b704dbc968e2b63d" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;">

          <tr>
            <td style="width: 5%; padding-bottom: 2px;">
              <div style="text-align: left;">By:</div>
            </td>
            <td colspan="1" style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Howard Federoff<br>
            </td>
            <td style="width: 5%; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 5%; padding-bottom: 2px;">
              <div style="text-align: left;">By:</div>
            </td>
            <td colspan="1" style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Antoine Turzi<br>
            </td>
            <td colspan="1" style="width: 5%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 5%;">
              <div>&#160;</div>
            </td>
            <td colspan="1" style="width: 40%;">&#160;</td>
            <td style="width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%;">
              <div>&#160;</div>
            </td>
            <td colspan="1" style="width: 40%;">&#160;</td>
            <td colspan="1" style="width: 5%;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 5%;">Name: </td>
            <td colspan="1" style="width: 40%;">Dr. Howard Federoff<br>
            </td>
            <td style="width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%;">
              <div style="text-align: left;">Name: <br>
              </div>
            </td>
            <td colspan="1" style="width: 40%;">Antoine Turzi</td>
            <td colspan="1" style="width: 5%;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 5%;">
              <div style="text-align: left;">Title:</div>
            </td>
            <td colspan="1" style="width: 40%;">President and Chief Executive Officer</td>
            <td style="width: 5%;" colspan="1">&#160;</td>
            <td style="width: 5%;">
              <div style="text-align: left;">Title:</div>
            </td>
            <td colspan="1" style="width: 40%;">
              <div style="text-align: left;">Chief Executive Officer</div>
            </td>
            <td colspan="1" style="width: 5%;">&#160;</td>
          </tr>

      </table>
    </div>
    <div><font style="font-weight: bold;">&#160;</font>
      <div>
        <div style="font-weight: bold;">THIS ASSIGNMENT HAS BEEN CONSENTED TO BY THE LANDLORD:</div>
        <div><br>
        </div>
        <div style="font-weight: bold;">BIOBAT, INC.</div>
        <div style="font-weight: bold;"> <br>
        </div>
        <div style="font-weight: bold;">
          <table cellspacing="0" cellpadding="0" border="0" id="z849bc8cadf294918ac830988d27a2acb" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;">

              <tr>
                <td style="width: 5%; padding-bottom: 2px;">
                  <div style="text-align: left;">By:</div>
                </td>
                <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Eva Cramer<br>
                </td>
                <td style="width: 55%; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%;" rowspan="1">&#160;</td>
                <td style="width: 40%;" rowspan="1">&#160;</td>
                <td style="width: 55%;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 5%;"> Name: </td>
                <td style="width: 40%;">Dr. Eva Cramer</td>
                <td style="width: 55%;">
                  <div>&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%;">Title:</td>
                <td style="width: 40%;">President</td>
                <td style="width: 55%;">
                  <div>&#160;</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
    <br>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div>Execution Copy</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">EXHIBIT A</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">The Lease</div>
    <div><br>
    </div>
    <div style="text-align: center;">between</div>
    <div><br>
    </div>
    <div style="text-align: center;">BIOBAT, INC.</div>
    <div><br>
    </div>
    <div style="text-align: center;">as landlord</div>
    <div><br>
    </div>
    <div style="text-align: center;">BROOKLYN IMMUNOTHERAPEUTICS LLC</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">as tenant,</div>
    <div><br>
    </div>
    <div style="text-align: center;">Consisting of the following documents:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z10b7a6eb820945b6b797e64e6e31b47f">

        <tr>
          <td style="width: 36pt; vertical-align: top;">a)</td>
          <td style="vertical-align: top;">
            <div style="text-align: justify;">Agreement of Lease dated as of September 28, 2015, between BioBAT, Inc. (&#8220;<font style="font-weight: bold;">Landlord</font>&#8221;), as landlord, and IRX Therapeutics, Inc. (&#8220;IRX&#8221;), as tenant;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z81411495ee864cb0a2aeed235144c59e">

        <tr>
          <td style="width: 36pt; vertical-align: top;">b)</td>
          <td style="vertical-align: top;">
            <div style="text-align: justify;">First Amendment to Lease, dated as of September 28, 2015, by and between IRX and Landlord;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="ze5d0197d6d924ad083cad5a01db2c140">

        <tr>
          <td style="width: 36pt; vertical-align: top;">c)</td>
          <td style="vertical-align: top;">
            <div style="text-align: justify;">Assignment and Assumption of Lease dated as of November 6, 2018, by IRX to Brooklyn Immunotherapy LLC (&#8220;BITX&#8221;); and</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="z7c72ad6446b147a282a8feeeadc283c8">

        <tr>
          <td style="width: 36pt; vertical-align: top;">d)</td>
          <td style="vertical-align: top;">
            <div style="text-align: justify;">Second Amendment to Lease Agreement by and between and Landlord and BITX dated as of July 24, 2019.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify;">For the leased premises in the Brooklyn Army Terminal, Building A, at 140 58th Street, Brooklyn, New York, Second Floor consisting of approximately 6,322 rentable square feet containing wet lab space and office space,
      plus approximately 1,910 rentable square feet of Clean Room space for a total of approximately 8,232 rentable square feet as more particularly shown on the Exhibit B hereto.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center;"><u>LEASE AGREEMENT</u></div>
    <div><u> <br>
      </u></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%LCR%1%%%-->
    <div style="text-align: center;"><u>Table of Contents</u></div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z08f454416b2d48efab9ed13a73bbb632">

          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;"><u>Page<br>
              </u></td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; text-align: right;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE I.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>LEASED PREMISES</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;">1</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 1.1</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">1</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 1.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255); text-align: right;">1</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 1.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">2</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 1.4</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">2</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE II.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>TERM</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">2</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 2.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">2</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 2.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">3</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 2.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">3</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE III.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>RENT</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">3</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 3.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">3</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 3.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">3</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 3.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">4</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 3.4</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">7</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 3.5</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">7</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE IV.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>USE</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">7</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 4.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">7</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 4.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">7</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 4.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">8</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 4.4</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">9</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">&#160;</div>
            </td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE V.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>REQUIREMENTS OF LAW</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">9</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 5.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">10</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 5.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">10</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 5.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">10</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 5.4</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">11</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE VI.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>ACCESS TO PREMISES</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">11</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 6.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">11</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">i</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center;"><u>Table of Contents</u> </div>
    <div style="text-align: center;">(continued)</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zfc99da6f86264c8a908a9fb446d908f5">

          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;"><u>Page</u></td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; text-align: right;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE VII</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>MAINTENANCE, SERVICE AND REPAIR OBLIGATIONS</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">11</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 7.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">11</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 7.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">12</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 7.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">12</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 7.4</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">13</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 7.5</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">13</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 7.6</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">14</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 7.7</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">14</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE VIII.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>ALTERATIONS</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">14</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 8.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">14</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 8.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">15</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 8.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">15</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 8.4</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">16</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">&#160;</div>
            </td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE IX.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>UTILITIES</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">17</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 9.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">17</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 9.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">17</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 9.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">17</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 9.4</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">17</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE X.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>DESTRUCTION BY FIRE OR OTHER CAUSES</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">18</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 10.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">18</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 10.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">18</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 10.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">18</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 10.4</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">19</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 10.5</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">19</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XI</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>CONDEMNATION<br>
              </div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">19</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 11.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">19</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 11.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">20</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">ii</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center;"><u>Table of Contents</u> </div>
    <div style="text-align: center;">(continued)</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z7dfc6fffef0346b2a8462f751118f608">

          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;"><u>Page</u> <br>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XII.</div>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>INSURANCE</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">20</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 12.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">20</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 12.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">22</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XIII.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>SUBROGATION AND WAIVER</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">22</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 13.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">23</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XIV.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>INDEMNIFICATION AND HOLD HARMLESS</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">23</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 14.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">23</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 14.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">23</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 14.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">24</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">&#160;</div>
            </td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XV.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>RULES AND REGULATIONS</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">24</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 15.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">24</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XVI.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>DEFAULTS BY TENANT; REMEDIES</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">24</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 16.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">24</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 16.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">24</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 16.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">25</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 16.4</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">25</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 16.5</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">25</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 16.6</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">26</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 16.7</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">26</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 16.8</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">27</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XVII.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>CONDITION OF PREMISES</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">27</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 17.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">27</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XVIII.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>ASSIGNMENT AND SUBLETTING</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">27</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 18.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">27</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 18.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">27</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 18.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">28</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 18.4</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">28</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">iii</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center;"><u>Table of Contents</u></div>
    <div style="text-align: center;"><u></u> (continued)</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zbe31e229fd1a4bb4bd004a3c1b645eba">

          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;"><u>Page</u></td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 18.5</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">28</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XIX.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>HAZARDOUS MATERIALS</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">28</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 19.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">28</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 19.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">29</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 19.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">29</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 19.4</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">30</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XX.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>NON-WAIVER OF LANDLORD&#8217;S RIGHTS</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">30</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 20.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">30</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXI.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>SUBORDINATION, NON-DISTURBANCE AND ATTORNMENT</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">30</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 21.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">30</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 21.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">31</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 21.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">31</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Scction 21.4</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">31</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXII.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>QUIET ENJOYMENT</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">32</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 22.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">32</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXIII.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>END OF TERM</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">32</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 23.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">32</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 23.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">32</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 23.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">32</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">&#160;</div>
            </td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXIV.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>NOTICES</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">33</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 24.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">33</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXV.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>SUCCESSORS AND ASSIGNS</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">34</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 25.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">34</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">iv</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center;"><u>Table of Contents</u></div>
    <div style="text-align: center;"> (continued)</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zd047e02d4a2c4b37bdfb8e654a8f6a7d">

          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;"><u>Page</u></td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; text-align: right;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXVI.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>SIGNS</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">34</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 26. l</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">34</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXVII.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>SECURITY</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">35</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 27.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">35</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXVIII.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>LIMITATION OF LIABILITY</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">35</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 28.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">35</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXIX.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>LATE PAYMENTS</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">36</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 29.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">36</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXX.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>BROKER</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">36</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 30.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">36</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXXI.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>TENANT TO PROVIDE FINANCIAL STATEMENT</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">36</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 31.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">36</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXXII.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>TENANT&#8217;S REMEDIES</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">36</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 32.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">36</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">&#160;</div>
            </td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXXIII.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>TENANT&#8217;S ESTOPPEL CERTIFICATE</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">36</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 33.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">36</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXXIV.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>WAIVERS BY TENANT</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">37</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 34.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">37</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 34.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">37</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 34.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">37</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">v</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center;"><u>Table of Content</u></div>
    <div style="text-align: center;">(continued)</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z4fa3fd43a9554311a9ce159fecb3ec3f">

          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; text-align: right;"><u>Page</u></td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 5%; vertical-align: top; text-align: right;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXXV.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>EXCULPATION</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">37</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 35.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">37</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXXVI.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>EFFECT OF CONVEYANCE BY LANDLORD</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">38</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 36.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">38</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXXVII.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>SUBSTITUTE SPACE</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">38</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 37.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">38</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXXVIII.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>VENDEX</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">38</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 38.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">38</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 38.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">38</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">&#160;</div>
            </td>
            <td rowspan="1" style="width: 5%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div>ARTICLE XXXIX.</div>
            </td>
            <td style="width: 5%; vertical-align: top; text-align: right;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>MISCELLANEOUS</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">39</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 39.1</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">41</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 39.2</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">41</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 39.3</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">42</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 39.4</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">42</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 39.5</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">42</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 39.6</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">42</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 39.7</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">42</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="margin-left: 9pt;">Section 39.8</div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right;">42</div>
            </td>
          </tr>
          <tr>
            <td style="width: 95%; vertical-align: top;">
              <div style="margin-left: 9pt;">Section 39.9</div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: right;">42</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">vi</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;"><u>LEASE AGREEMENT</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 63pt;"><font style="font-weight: bold;">THIS LEASE AGREEMENT </font>made this <u>&#160; 28&#160; </u>day of September, 2015 (the &#8220;<u>Effective Date</u>&#8221;) between <font style="font-weight: bold;">BIOBAT,
        INC., </font>a Not-for-Profit 50l(c)(3) corporation organized under the laws of the State of New York, having an address c/o SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 129, Brooklyn, New York 11203 (&#8220;<u>Landlord</u>&#8221;) and <font style="font-weight: bold;">IRX THERAPEUTICS, INC., </font>a New York corporation having an address at 140 West 57<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Street, Suite 3D, New York, New York (&#8220;<u>Tenant</u>&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">W I T N E S S E T H :</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE I. </div>
    <div style="text-align: center; font-weight: bold;">LEASED PREMISES</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 1.1&#160; &#160; &#160; </font>Landlord leases and demises to Tenant and Tenant rents and leases from Landlord the following described space (the &#8220;<u>Premises</u>&#8221;), which Premises are shown
      on <u>Exhibit A</u> attached hereto and made a part hereof and located in Building A of the Brooklyn Anny Terminal, Brooklyn, New York (the &#8220;<u>Building</u>&#8221;):</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zc7937eccee324563b2bd3188bf66368b" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 63pt;">
                <div><br>
                </div>
              </td>
              <td style="vertical-align: top; width: 180pt;">
                <div>Floor{s):</div>
              </td>
              <td style="vertical-align: top; width: auto;">
                <div>
                  <div>Second Floor</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="width: 63pt;">&#160;</td>
            <td nowrap="nowrap" style="vertical-align: top; width: 180pt;">
              <div>Rentable Square Footage (&#8220;RSF&#8221;)<br>
              </div>
            </td>
            <td style="vertical-align: top; width: auto;">
              <div>approximately 7,250 rentable square feet</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <div> <br>
      </div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 1.2&#160; &#160; &#160; </font>The Building is located upon the land more p<u>art</u>icularly described on <u>Exhibit B</u> attached hereto and made a part hereof (the &#8220;<u>Land</u>&#8221;), which
      Building and Land form a part of the Brooklyn Anny Terminal more particularly described in the Prime Lease (as hereinafter defined) (the &#8220;<u>Terminal</u>&#8221;). A portion of the Building consisting of the following components (the &#8220;<u>Landlord&#8217;s&#160;Premises</u>&#8221;)


      has been leased to Landlord by the New York City Economic Development Corporation (the &#8220;<u>Prime Landlord</u>&#8221;) pursuant to an Agreement of Lease, dated November 13, 2009 (as it has been and may hereafter be amended, the &#8220;<u>Prime Lease</u>&#8221;):</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(a)&#160;&#160;&#160;&#160;&#160;&#160; Dock Level: &#160;&#160; approximately 46,400 gross square feet and any loading area reflected on the site map shown in <u>Exhibit B-1</u>, attached hereto and made a part hereof;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(b)&#160;&#160;&#160;&#160;&#160;&#160; First Floor: &#160;&#160; approximately 48,000 gross square feet plus the common loading area reflected on the site map in <u>Exhibit B-1</u>, attached hereto and made a part hereof;</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(c)&#160;&#160;&#160;&#160;&#160;&#160; Floors&#160; Two Through Eight: &#160;&#160; approximately 56,000 gross square feet per floor totaling approximately 392,000 gross square feet; and</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(d)&#160;&#160;&#160;&#160;&#160; Roof above the southern third of Building A as more particularly delineated&#160; on the site map attached hereto as <u>Exhibit B-1</u>, attached hereto and made a part hereof.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">The Landlord&#8217;s Premises, together with the Common Areas (as hereinafter defined), is hereinafter collectively referred to as the &#8220;<u>Property</u>&#8221;.</div>
    <div style="text-align: justify;"><u> <br>
      </u></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Section 1.3&#160; &#160; &#160; </font><font style="font-size: 10pt;">For purposes of this Agreement, &#8220;<u>Tenant&#8217;s Pro Rata Share</u>&#8221; shall be a fraction, the
        numerator of which is the RSF of the Premises and the denominator of which is the RSF of the Landlord&#8217;s Premises, as the same may be re-determined any time RSF is added to the Landlord&#8217;s Premises as set forth herein. As of the date hereof, the RSF
        of the Landlord&#8217;s Premises for purposes of this calculation is 94,682 RSF. RSF shall be deemed added to the Landlord&#8217;s Premises for purposes of this calculation on the date Landlord determines that such RSF is ready to receive tenant improvements
        and is offered for rental to the public. Within thirty (30) days following written request from Tenant (but not more than once every twelve (12) months), Landlord shall certify to Tenant in writing as to the then RSF of the Landlord&#8217;s Premises. For
        purposes of determining the Tenant&#8217;s Pro Rata Share of the insurance and telephone charges for the Building, the numerator shall be the RSF of the Premises and the denominator shall be 486,000.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Section 1.4&#160; &#160; &#160; </font><font style="font-size: 10pt;">The Premises shall include the appurtenant&#160; right to use, in common with others, the public
        lobbies, lavatories, entrances, stairs, corridors, elevators, drive-up ground level loading docks, and other public portions of the Landlord&#8217;s Premises, and the Prime Lease Common Facilities (as hereinafter defined) available to Landlord
        (collectively, the &#8220;<u>Common&#160;Areas</u>&#8221;), subject in all instances and under all circumstances to (i) the terms and conditions of the Prime Lease and this Lease, (ii) any restrictions, limitations, obligations or covenants imposed on Landlord
        relating to any of the foregoing areas, and (iii) Landlord&#8217;s right to alter, improve, modify and, to the extent necessary, temporarily block off access to, portions of such Common Areas if Landlord deems it desirable or appropriate to do so. The
        Common Areas, and the use thereof and access thereto through the Premises for the purposes of operation, maintenance, inspection, display and repairs are hereby reserved to Landlord. No easement for light, air or view is granted or implied
        hereunder, and the reduction or elimination of Tenant&#8217;s light, air or view will not affect Tenant&#8217;s liability or obligations under this Lease. For purposes of this Lease, the term &#8220;<u>Prime Lease Common Facilities</u>&#8221; means all those areas and
        facilities which may now or hereafter be furnished by Prime Landlord for the non-exclusive use by, or benefit of, Landlord under the Prime Lease, including, without limitation, all entrances, exits, gates, fences and other security facilities,
        driveways, sidewalks, parking facilities (excluding parking facilities designated for the exclusive use of the tenants and occupants of particular buildings at the Terminal), loading docks, lobbies, mailbox room, hallways, stairways, utility mains,
        lines and meters serving all or portions of the Terminal (other than such branch or service lines or meters providing or measuring utility services to particular buildings (other than the Landlord&#8217;s Premises)) or the respective tenants and
        occupants of such other premises and areas exclusively controlled by a tenant of premises other than Landlord&#8217;s Premises.</font></div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE II. </div>
    <div style="text-align: center; font-weight: bold;">TERM</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Section 2.1&#160; &#160; &#160; </font><font style="font-size: 10pt;">The term of this Lease shall be for ten years and three months, commencing on the &#8220;<u>Commencement


          Date</u>&#8221; (as hereinafter defined), and terminating at midnight on the last day of the month which shall be ten years and three months following the Commencement Date, unless terminated earlier pursuant to Article XXIII (the &#8220;<u>Expiration Date</u>&#8221;).


        This Lease shall be effective and enforceable between Landlord and Tenant upon the Effective Date. The Parties acknowledge ,and agree that the Commencement Date has not been finally determined as of the Effective Date. The Commencement Date shall
        be defined as the later of(a) January 1, 2016, or (b) the first day of the month that includes the date that is three months before the Scheduled Completion Date for the Landlord&#8217;s Work. For purposes of illustration, if the Scheduled Completion
        Date for the Landlord&#8217;s Work is May 15, 2016, the Commencement Date would be February 1, 2016.</font></div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 2.2&#160; &#160; &#160; </font>&#8220;<u>Lease Year</u>&#8221; as used herein shall mean (i) each and every consecutive twelve (12) month period during the Term of this Lease, or (ii) in the event of
      Lease expiration or termination, the period between the last complete Lease Year and said expiration or termination. The first such twelve (12) month period shall commence on the Commencement Date. </div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 2.3&#160; &#160; &#160; </font>If delivery of possession of the Premises shall be delayed beyond the date specified above for the commencement of the term of this Lease for any reason
      whatsoever, Landlord shall not be liable to Tenant for any damages resulting from such delay and Tenant&#8217;s obligation to pay Rent and Additional Rent shall be abated until possession of the Premises is delivered to Tenant. In the event of such delay,
      it is understood and agreed that the Commencement Date shall also be postponed until delivery of possession of the Premises and that the Expiration Date shall be correspondingly extended. Promptly upon the determination by Landlord of the revised
      Commencement Date and the revised Expiration Date, Landlord shall send written notice to Tenant of such revised dates and the parties shall be bound by said dates.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE III. </div>
    <div style="text-align: center; font-weight: bold;">RENT</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 3.1&#160; &#160; &#160; </font>During the term of this Lease, Tenant agrees to pay to Landlord, Two Hundred Ninety Thousand &amp;00/100 ($290,000.00) Dollars per annum, payable in equal
      monthly installments of $24,166.66 on or before the first day of each month (the &#8220;Base Rent&#8221;), which Base Rent shall increase on each anniversary of the Commencement Date by an amount equal to the then-current Base Rent multiplied by three (3%)
      percent. Notwithstanding the preceding, Tenant shall not be obligated to pay Base Rent during the first ninety days following the Commencement Date.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 3.2&#160; &#160; &#160; </font>Any sums of money required to be paid under this Lease by Tenant in addition to the Base Rent herein provided, shall be deemed &#8220;Additional Rent&#8221; due and payable
      after demand therefor with the Base Rent next due or as may be otherwise provided herein. Such Additional Rent shall be deemed to be and shall constitute &#8220;Rent&#8221; hereunder and shall be collectible in the same manner and with the same remedies as if
      they had been Base Rent originally reserved herein. Tenant&#8217;s obligation to pay Additional Rent accruing during the term of the Lease shall survive the earlier termination and/or expiration of the term of this Lease. If Landlord receives from Tenant
      any payment less than the sum of the monthly Rent, including Additional Rent, and other charges then due and owing, Landlord, in its sole discretion, may allocate such payment in whole or in part to the Base Rent, any Additional Rent, and/or other
      charge then due or to any combination thereof.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div><font style="font-weight: bold;">Section 3.3&#160; &#160; &#160; </font>Payment of Operating Expenses and Taxes.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(a)&#160;&#160; &#160; &#160;&#160; Upon the Commencement Date, and then at least thirty (30) days prior to each subsequent calendar year during the Term, Landlord shall advise Tenant in writing of its reasonable estimate of
      Tenant&#8217;s Pro Rata Share of the annual Operating Expenses for each calendar year and Taxes for each calendar year. Commencing on the Commencement Date and continuing on the first day of each calendar month thereafter during the Term, Tenant shall pay
      as Additional Rent, one-twelfth (1/12th) of the estimated (as determined by Landlord) Tenant&#8217;s Pro Rata Share of such Operating Expenses and Taxes, if any, concurrently with the Monthly Base Rent payment.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(b)&#160;&#160;&#160;&#160; &#160;&#160; Within ninety (90) days after the close of each calendar year, Landlord shall deliver to Tenant an itemized statement prepared by Landlord&#8217;s property management company or chief operating
      officer, or by a certified public accountant (&#8220;<u>Landlord&#8217;s Statement</u>&#8221;) showing in reasonable detail the (A) actual Operating Expenses and Taxes for the previous year broken down by component expenses; <font style="font-weight: bold;"><font style="font-weight: normal;">(B)</font> </font>Tenant&#8217;s Pro Rata Share of such amounts; (C) the amount paid by Tenant during the year towards Operating Expenses and the amount paid by Tenant during the year towards the Taxes; and (D) the amount
      Tenant owes to Landlord, or the amount of the refund Landlord owes to Tenant on account of any underpayment or overpayment by Tenant. Any such amount due from Tenant to Landlord shall be paid within ten (10) days after receipt of the most recent
      Landlord&#8217;s Statement. Any such refund due from Landlord to Tenant shall he credited against the next due payment of the estimated Tenant&#8217;s Pro Rata Share of Operating Expenses and Taxes or, if at the end of the Term, refunded to Tenant.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(c)&#160;&#160;&#160;&#160; &#160;&#160; Landlord&#8217;s failure to submit a Landlord&#8217;s Statement to Tenant within ninety (90) days after the expiration of any calendar year shall not affect Tenant&#8217;s obligations to pay Tenant&#8217;s Pro
      Rata Share of Operating Expenses and Taxes.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(d)&#160;&#160; &#160; &#160;&#160; If the Landlord&#8217;s Premises is less than one hundred percent (100%) occupied during any calendar year or part thereof, Operating Expenses shall include all additional costs and expenses of
      operation, management, insuring, securing and maintenance of the Property which Landlord determines that it would have paid or incurred during such calendar year if the Landlord&#8217;s Premises had been one hundred percent (100%) occupied. Landlord shall
      be responsible for any portion of the Operating Expenses that exceed the Pro-Rata Shares paid by Tenant and other tenants of the Premises.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(e)&#160;&#160;&#160;&#160; &#160;&#160; Tenant shall also pay (i) before any penalties or fines are assessed lo the appropriate governmental authority any use and occupancy tax in connection with the Premises. In the event
      Landlord is required by law to collect such tax, Tenant shall pay such use and occupancy tax to Landlord as Additional Rent within ten (IO) days of demand and Landlord shall remit any amounts so paid to Landlord to the appropriate governmental
      authority in a timely fashion, and (ii) Tenant shall also pay to Landlord the applicable state sales tax on all Rent simultaneously with the payment by Tenant of the Rent as otherwise required by applicable Legal Requirements (as hereinafter
      defined).</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div>
      <div style="text-indent: 36pt;">(f)&#160;&#160;&#160; &#160; &#160; For the purposes hereof, the following definitions shall apply:</div>
      <div> <br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable" id="zeb7598c4ec9e4f52bbee0a3f4fee8204">

        <tr>
          <td style="width: 63pt;"><br>
          </td>
          <td style="width: 63pt; vertical-align: top;">(i)</td>
          <td style="width: auto; vertical-align: top;">
            <div>&#8220;Operating Expenses&#8221; shall mean:</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 99pt;">(a)&#160; &#160; &#160; &#160; All costs and expenses incurred or made by Landlord or charged to Landlord in the operation and management of the Property, exclusive of Taxes. Operating Expenses include, without
      limitation, (i) costs of cleaning, security, janitorial service for the Common Areas, rubbish removal, heating, electricity, air conditioning, utilities, risers/shafts and cable maintenance, tempered water and water for customary lavatory use, window
      cleaning, and maintenance and repairs, maintenance of the grounds, sidewalks, access roads, sanitary sewer and related connections, equipment and fixtures, drainage, stormwater management and related fixtures and equipment, and parking lots; (ii)
      service contracts or other agreements with independent contractors for any of the foregoing (including, but not limited to, fire alarm, security system, electric system, elevator and heating, ventilation and air conditioning <u>(&#8220;HVAC&#8221;)</u>
      maintenance); (iii) management fees; (iv) wages, salaries, benefits, payroll taxes and unemployment compensation insurance for employees of Landlord or any contractor of Landlord engaged in the cleaning, operating, maintenance or security of the
      Property; (v) the cost of all Landlord&#8217;s insurance including, without limitation, casualty, liability and loss of rent insurance equal to eighteen (18) month&#8217;s rent for the gross rent roll (including Additional Rent), and the amount of any insurance
      deductibles; (vi) legal fees (excluding fees incurred in connection with enforcement action against an existing tenant or in negotiating a new lease); (vii) payments, other than Taxes, to the city and/or county in which the Landlord&#8217;s Premises is
      located and other agencies or governmental agencies including, but not limited to, water and sewer charges; (viii) fees and charges of any association, or special district affecting the Property; (ix) fees and charges, under any agreements affecting
      the Common Areas such as any reciprocal easement agreements, operation and maintenance agreements and park covenant and restriction agreements and the like; (x) all rent, additional rent, (including common area charges and capital reserve fund
      contributions) and all other charges payable under the Prime Lease or any other ground lease or other lease to which this Lease is subject; (xi) supplies; and (xii) all costs of maintaining, managing, reporting, commissioning, and recommissioning the
      Landlord&#8217;s Premises or any part thereof.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 99pt;">(b)&#160; &#160; &#160; &#160; The term &#8220;Operating Expenses&#8221; shall not include: (i) repairs or other work (including rebuilding) occasioned by fire, windstorm or other casualty or condemnation to the extent covered by
      Landlord&#8217;s insurance, but excluding any deductibles; (ii) any cost (such as electricity or overtime services) to the extent such costs are separately charged to and payable by Tenant hereunder; (iii) leasing commissions and expenses associated with
      procuring tenants, including, lease concessions, lease take-over obligations; (iv) interest on and amortization of debt; (v) interest and penalties for late payment of taxes; (vi) wages or salaries of employees over the rank of property or building
      manager; (vii) expenses resulting from any violation by Landlord of the terms of any ground or underlying lease or mortgage to which this Lease is subordinate; (viii) fines and penalties (to the extent not attributable to any act or omission of
      Tenant or its agents, employees or contractors) which, under this Lease, are the responsibility of Landlord; (ix) fees and costs associated with any refinancing of mortgage debt on the Property; and (x) any item for which reimbursement is actually
      made to Landlord from another source (e.g., insurance proceeds or payment from another tenant).</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 99pt;">(c)&#160;&#160; &#160; &#160; &#160; In the event that Landlord fails to supply any services Landlord is obligated to perform under this Lease in a reasonable and timely manner, then, after thirty (30) days&#8217; notice to
      Landlord of such non-compliance and a failure to cure same, Tenant shall have the right, but not the obligation, to supply such services for its own benefit, and Tenant may deduct the costs of providing such services from the Rent payable hereunder.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 63pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; Operating Expenses shall be determined in accordance with GAAP based upon reasonable projections.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 63pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding anything to the contrary contained in this Lease, instead of using Tenant&#8217;s Pro Rata Share or sub-metering, Landlord may allocate electricity, water and sewer and gas used
      in the Common Areas to Tenant and other tenants of the Landlord&#8217;s Premises based upon Tenant&#8217;s and such other tenants&#8217; consumption of electricity, water and sewer and gas as reasonably determined by Landlord.</div>
    <div style="text-indent: 36pt; text-align: justify; margin-left: 36pt;"><br>
      (g) &#160; &#160; &#160; &#8220;<u>Taxes</u>&#8221; shall mean:<br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 63pt;">(i)&#160;&#160;&#160; &#160; &#160; All payments in lieu of taxes (including payments in connection with so-called tax investment financing transactions or similar transactions (collectively, &#8220;<u>TIFs</u>&#8221;), real estate
      taxes, personal property taxes, assessments (special or otherwise), sewer and water rents, rates and charges, and any other governmental levies, impositions and charges of a similar nature (&#8220;<u>Impositions</u>&#8221;), which may be levied, assessed or
      imposed on or in respect of all or any part of the Property and any improvements, fixtures and equipment of Landlord, real or personal, located in or around the Landlord&#8217;s Premises.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 63pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Any reasonable and appropriate expenses incurred by Landlord in contesting any of the foregoing or the assessed valuation of all or any part of the Landlord&#8217;s Premises.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 63pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; If at any time during the Term the methods of taxation prevailing at the date hereof shall be altered so that in lieu of or as a substitute for the whole or any part of the Impositions
      now levied, assessed or imposed on all or any part of the Landlord&#8217;s Premises, there shall be levied, assessed or imposed (a) an Imposition based on the income or rents received therefrom whether or not wholly or partially as a capital levy or
      otherwise, or (b) an Imposition measured by or based in whole or in part upon all or any part of the Landlord&#8217;s Premises and imposed on Landlord, then all Impositions shall be deemed to be Taxes.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 63pt;">(iv)&#160;&#160;&#160;&#160;&#160; &#160;&#160; If an appropriate governmental authority levies any use and occupancy tax, any payments for such use and occupancy tax.</div>
    <div><br>
    </div>
    <div>
      <div style="text-indent: 36pt;">(h) &#160; &#160; &#160; &#8220;Taxes&#8221; shall not include any penalties or interest paid by Landlord on account of taxes. </div>
    </div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 3.4&#160; &#160; &#160; </font>Installments of the Rent payable hereunder shall be made payable to and shall be paid at the office address of Landlord listed above or at such other place as
      Landlord and its managing agent may designate from time to time by written notice to Tenant hereunder, without demand, setoff or deduction whatsoever. Rent for any partial month during the term of the Lease shall be ratably apportioned based on the
      actual number of days.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 3.5&#160; &#160; &#160; </font>This is a &#8220;triple net&#8221; lease. Tenant&#8217;s payment of Rent shall be completely net to Landlord so that this Lease yields to Landlord the net annual Base Rent and
      Tenant shall pay any and all Base Rent, Additional Rent and costs, expenses and obligations of every kind and nature whatsoever relating to the Premises without setoff, deduction, counterclaim or abatement, except as specifically and expressly (and
      not impliedly) provided in this Lease.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE IV.</div>
    <div style="text-align: center; font-weight: bold;">USE</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 4.1&#160; &#160; &#160; </font>Tenant shall occupy and use the Premises for the following purposes only: all uses consistent with the mission of BioBAT as reflected in the third certification
      in the BioBAT Certificate of Incorporation, an excerpt of which is attached hereto as <u>Exhibit C</u> (&#8220;<u>Permitted&#160;Uses</u>&#8221;). Such Permitted Uses must be in accordance with the New York City Zoning Resolution, as amended from time to time,
      relevant certificates of occupancy and applicable Legal Requirements, and applicable Rules and Regulations (as hereinafter defined). Tenant contemplates that it shall use the Premises for administrative office space and research &amp; development
      purposes. Tenant agrees to conduct its business in the manner and according to the generally accepted business principles of the business or profession in which Tenant is engaged.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 4.2&#160; &#160; &#160; </font>Landlord and Tenant acknowledge that the Building and Building site are subject to the following:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 63pt;">(a)&#160;&#160;&#160;&#160; &#160;&#160; &#160; The terms and conditions of the Economic Development Administration (&#8220;EDA&#8221;) Special Award Conditions, wherein the use of the leased space within the Building is restricted to technology,
      biomedical and biotechnology facilities and any other activities conducive to such businesses provided that any such use is not in conflict with any restrictions place upon the Landlord or the Property. Landlord agrees that this Lease is consistent
      with the authorized general and specific purposes of the Award, that this Lease is consistent with EDA&#8217;s policies concerning, but not limited to, non-relocation (as defined in EDA&#8217;s regulations found in 12 CFR 316.3), non-discrimination and adequate
      consideration as found in 12 CFR 314.3. Moreover, the Premises must be used for no other purposes other than the general and specific purposes of the Award.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 63pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The terms and conditions of the United States Economic Development Administration (EDA), United States Department of Commerce, EDA Project Number 01-01-08862 financial assistance award,
      including, but not limited to:</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 99pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; Real Property or tangible Personal Property acquired or improved with EDA Investment Assistance must be used in a manner that is consistent with the authorized general and specific
      purposes of the Award, in this case, biotechnology research purposes and EDA policies concerning adequate consideration and environmental compliance; and may not be used in violation of the nondiscrimination requirements set forth in 13 C.F.R. 302.20
      or for inherently religious activities prohibited by applicable federal law.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 99pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; Lessee agrees to provide Lessor and/or EDA with any document, evidence or report required to assure compliance with federal and state law, including, but not limited to, applicable
      federal and state environmental laws.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 4.3&#160; &#160; &#160; </font>Notwithstanding anything to the contrary provided in this Article IV, Tenant shall not use or occupy the Premises or any portion thereof, permit or suffer the
      same to be used or occupied and/or do, or permit or suffer anything to be done, in or on the Premises or any part thereof:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160; &#160; &#160; for inpatient or outpatient clinical services (other than clinical trials relating to bioscience uses or the teaching of device/technology usage, which uses shall be permitted);</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160; &#160; for any unlawful, illegal or hazardous business, use or purpose or in any way in violation of any applicable present and future laws, rules, regulations, orders, ordinances, statutes,
      codes, executive orders, and requirements of all Governmental Authorities having jurisdiction over the Premises, the Landlord&#8217;s Premises, the Building, the Common Areas or the Terminal (including without limitation, the New York City Building Code,
      Title 25, Chapter 3 of the New York City Administrative Code and the laws, rules, regulations and orders, ordinances, statutes, codes and requirements of any applicable Fire Rating Bureau or other body exercising similar functions) (collectively, &#8220;<u>Rules


        and Regulations</u>&#8221;), or the certificates of completion and/or occupancy issued for the Premises, the Landlord&#8217;s Premises and the Building as then in force, as applicable;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; in such manner as may make void or voidable any insurance then in force with respect to the Premises, the Landlord&#8217;s Premises, the Building, the Common Areas or the Terminal;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160;&#160; &#160;&#160; that would, in any manner or respect, cause structural or other injury to the Premises, the Landlord&#8217;s Premises or the Building (or any portion thereof), or constitute a private or public
      nuisance or waste;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; that would, in any manner or respect, render the Premises incapable of being used or occupied after the expiration or sooner termination of the Term of this Lease for the purposes for
      which the same were permitted to be used and occupied on the day upon which Tenant shall first open the Premises for business to the public, except for ordinary wear and tear and damage by fire or other casualty and repairs for which Tenant is not
      responsible under this Lease; and/or</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; that would, in any manner or respect, violate the Prime Lease or any other recorded document affecting the use and occupancy of the Landlord&#8217;s Premises.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 4.4&#160;&#160; &#160; </font>Tenant shall not use the Premises for animal testing or clinical trials without the approval of the Institutional Animal Care and Use Committee (&#8220;IACUC&#8221;) or the
      Institutional Review Board (&#8220;IRB&#8221;), respectively, and the Landlord, which consent may be granted or withheld in the sole discretion of each of the above parties.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 4.5&#160;&#160; &#160; </font>Tenant understands and agrees that the enant is responsible, at its own expense, to obtain or cause to be obtained all necessary governmental licenses, permits,
      and certificate(s) of occupancy or completion required in order to use and occupy the Premises for the Permitted Uses and, except for the Landlord&#8217;s Work as defined in Section 8.l, to perform or cause to be performed construction and or any other
      work on the Premises permitted under this Lease. If any governmental license or permit shall be required for the proper and lawful conduct of Tenant&#8217;s business and uses of the Premises permitted under this Lease, including, without limitation, any
      license required to operate a laboratory and/or product development center and dispose of Hazardous Materials (as hereinafter defined), Tenant shall be responsible for and shall procure and maintain or cause to be procured and maintained such license
      or permit. Tenant agrees that Tenant is responsible that any and all use of laboratories or the like on the Premises shall comply with the requirements of licenses and permits necessary to facilitate the Permitted Uses described above, including but
      not limited to licenses and permits required from the New York State Department of Health (or successor agency). Further, Tenant represents and warrants that at all times during the Term, all activities of Tenant shall be licensed, certified, or
      registered by the appropriate governmental agencies including, without limitation, to the extent required, New York State Department of Health and New York State Department of Education. Tenant further represents and warrants that it shall maintain
      or cause to be maintained at all times, at its sole cost and expense, all other permits, licenses, certifications, or registrations that are required in connection with any laboratory operations and activities on the Premises. Landlord shall
      cooperate and execute documents where reasonably required in order to assist Tenant in obtaining licenses/permits necessary to facilitate the Permitted Uses. All related expenses and administrative costs to Landlord shall be Tenant&#8217;s responsibility.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 4.6&#160; &#160; &#160; </font>Tenant must notify Landlord of the use of radioactivity and is responsible for obtaining its own license(s) relating to the use, handling, storage or disposal
      of any radioactive material in or about the Premises. Tenant and Tenant&#8217;s employees, agents, contractors or invitees shall only use, handle or store, or permit the use, handling or storage, of the radioactive material stipulated under the applicable
      New York City Department of Health license and any related licenses for use on, in or about the Premises, in accordance with the quantity, chemical and physical form, and intended purpose specified in such license(s). A copy of such license(s) shall
      be delivered to Landlord for Landlord&#8217;s records prior to the delivery of any radioactive material to the Premises and updated copies shall be delivered to Landlord when renewed.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;">
      <div style="text-align: center; font-weight: bold;">ARTICLE V. </div>
      <div style="text-align: center; font-weight: bold;">REQUIREMENTS OF LAW</div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 5.1&#160; &#160; &#160; </font>Tenant shall give prompt notice to Landlord of any notice it receives of the violation of any law or requirements of any governmental authority with respect to
      the Premises or the use or occupation thereof. Tenant shall promptly comply with all present and future laws, orders and regulations of all state, federal, town, municipal and local governments, departments, commissions and boards or any direction of
      any public officer pursuant to law, and all orders, rules and regulations of the New York Board of Fire Underwriters or any similar body which shall impose any violation, order or duty upon Landlord or Tenant with respect to the Premises (in which
      event Tenant shall effect such compliance at its sole cost and expense) or the Building (in which event, notwithstanding anything herein to the contrary, Tenant shall promptly pay Tenant&#8217;s pro rata share of the cost to Landlord of complying
      therewith). Tenant shall pay all costs, expenses, fines, penalties or damages, which may be imposed upon Landlord by reason of Tenant&#8217;s failure to comply with the provisions of this Article.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 5.2&#160; &#160; &#160; </font>Tenant shall not place a load upon any floor of the Premises exceeding the floor load per square foot area which said floor was designed to carry and which is
      allowed by law.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 5.3&#160; &#160; &#160; </font>Tenant, at its expense, shall comply with all present or future Legal Requirements and Rules and Regulations to the extent that the same shall affect or be
      applicable to (a) Tenant&#8217;s particular manner of use of the Premises (as opposed to its mere use thereof), (b) alterations and improvements made by Tenant, or (c) a breach by Tenant of its obligations under this Lease, it being understood that
      Landlord shall be responsible for complying with Legal Requirements and Rules and Regulations imposed on the Landlord&#8217;s Premises generally and which would have to be complied with whether or not Tenant was then in occupancy of the Premises. Nothing
      herein contained, however, shall be deemed to impose any obligation upon Tenant to make any structural changes or repairs unless necessitated by Tenant&#8217;s acts or omissions or by reason of a particular use by Tenant of the Premises. For purposes of
      this Lease, the term &#8220;<u>Legal&#160;Requirement(s)</u>&#8221; means: (i) any and all present and future laws, rules, regulations, orders, ordinances, statutes, codes, executive orders, and requirements of all Governmental Authorities applicable to the Premises,
      the Landlord Premises, the Building or any street, road, avenue, or sidewalk comprising a part of, or in front of, the Property, or any vault in, or under the Premises (including, without limitation, the Building Code of New York City and the laws,
      rules, regulations, orders, ordinances, statutes, codes, and requirements of any applicable Fire Rating Bureau or other body exercising similar functions); (ii) the certificate or certificates of occupancy (or their equivalent) issued for the
      Premises or the Property as then in force; (iii) New York State Unconsolidated Laws Title 18, Chapter 5, Section 7381 q. as it may be amended from time to time; (iv) the provisions of City Planning Commission Resolution of November 21, 2001, Col. No.
      23 (C 010708 PPM) adopted pursuant to Section 197(c) of the New York City Charter; (v) with respect to improvement and use of public access and open space on the Land, if any, the provisions of City Planning Commission Resolution of November 21,
      2001, Calendar No. 25 (C 010712 ZSM) and may be amended from time to time (the &#8220;<u>Bioscience Special Permit</u>&#8221;); (vi) the rules, regulations, orders, codes, and requirements of the State Historic Preservation Office, if applicable; and (vii)
      Chapter 8-A of the New York City Administrative Code as it may be amended from time to time. For purposes of this Lease, the term &#8220;<u>Governmental Authority or Authorities</u>&#8221; means the United States of America, the State, County and
      City of New York, and any agency, department, commission, board, bureau, instrumentality or political subdivision of any of the foregoing, now existing or hereafter created, having jurisdiction over the Property or any portion thereof or any street,
      road, avenue or sidewalk comprising a part of, or in front of, the Property, or any vault in or under the Property.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 5.4&#160; &#160; &#160; </font>The patties acknowledge that Title III of the Americans With Disabilities Act of 1990 and the regulations and rules promulgated thereunder, as all of the same
      may be amended and supplemented from time to time (collectively referred to herein as the &#8220;<u>ADA</u>&#8221;) establish requirements for accessibility and barrier removal, and that such requirements may or may not apply to the Premises and the Property
      depending on, among other things: (A) whether Tenant&#8217;s business is deemed a &#8220;public accommodation&#8221; or &#8220;commercial facility&#8221;, (B) whether such requirements are &#8220;readily achievable&#8221;, and (C) whether a given alteration affects a &#8220;primary function area&#8221;
      or triggers &#8220;path of travel&#8221; requirements. The parties hereby agree that: (a) Landlord shall be responsible for ADA Title III compliance in the Common Areas, (b) Tenant shall be responsible for ADA Title Ill compliance within the Premises following
      delivery of possession, and (c) Landlord may perform, or require that Tenant perform, and Tenant shall be responsible for the cost of, ADA Title Ill &#8220;path of travel&#8221; requirements triggered by alterations within the Premises made subsequent to the
      commencement of the Term at the request of Tenant.</div>
    <div><br>
    </div>
    <div style="font-weight: bold; text-align: center;">ARTICLE VI. </div>
    <div style="font-weight: bold; text-align: center;">ACCESS TO PREMISES</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 6.1&#160; &#160; &#160; </font>Landlord shall have the right to enter and pass through the Premises at all reasonable times to examine the same, and to show them to lessees of the Building,
      and to make such repairs, improvements or additions as Landlord may deem necessary or desirable and Landlord shall be allowed to take all material into and through the Premises that may be required therefor. During the year prior to the expiration of
      the term of this Lease, or of any renewal term, Landlord may exhibit the Premises to prospective tenants or purchasers at all reasonable hours and without unreasonably interfering with Tenant&#8217;s business. If Tenant shall not be personally present to
      open and permit such entry, Landlord may enter the same by a master key.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE VII.</div>
    <div style="text-align: center; font-weight: bold;">MAINTENANCE, SERVICE AND REPAIR OBLIGATIONS</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 7.1&#160; &#160; &#160; </font>Tenant shall take good care of the Premises, the fixtures and appurtenances located therein and the machinery, equipment and systems exclusively serving the
      Premises and, at Tenant&#8217;s sole cost and expense, make all non- structural repairs thereto as and when needed to preserve the Premises and fixtures, machinery, equipment and services in good&#160; working order and condition, obsolescence and damage from
      the elements, fire or other casualty, excepted. Notwithstanding the foregoing, all damage or injury to the Premises or to any other part of the Building, or to its fixtures, equipment and appurtenances, whether requiring structural or non-structural
      repairs, caused by or resulting from carelessness, omission, neglect or improper conduct of Tenant, Tenant&#8217;s servants, employees, invitees or licensees, shall&#160; be&#160; repaired promptly by Landlord at Tenant&#8217;s sole cost and expense. Tenant shall repair
      all damage to the Property and the Premises caused by the moving of Tenant&#8217;s fixtures,&#160; furniture or equipment.&#160; All the aforesaid repairs shall be of the quality and class equal to the original work or construction. All such maintenance, repairs and
      replacements shall be done at Tenant&#8217;s sole cost and expense by Landlord&#8217;s employees or agents or, with Landlord&#8217;s express written consent, by persons requested by Tenant and consented to in writing by Landlord. All bulbs, tubes and lighting fixtures
      for the Premises installed or maintained by Tenant must comply with Landlord&#8217;s sustainability practices, including any third-party rating system concerning the environmental compliance of the Landlord&#8217;s Premises or the Premises, as the same may
      change from time to time. Tenant is responsible for reporting lighting purchases to Landlord in a format suitable to Landlord. All maintenance and repairs made by Tenant must comply with Landlord&#8217;s sustainability practices, including any third-patty
      rating system concerning the environmental compliance of the Landlord&#8217;s Premises or the Premises, as the same may change from time to time.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 7.2&#160; &#160; &#160; </font>Provided that no Event of Default, or an event which, upon the giving of notice or the passage of time, or both, could become an Event of Default, exists under
      this Lease, Landlord shall furnish, or cause to be furnished, the following services, subject to the provisions of Section 7.3 hereof: </div>
    <div><br>
    </div>
    <div>
      <div style="text-indent: 36pt; text-align: justify;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; An attractive lobby area, and elevator service for passenger and delivery needs.</div>
    </div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(b)&#160;&#160;&#160;&#160; &#160;&#160; &#160; Air conditioning during summer operations and heat during winter operations, subject to all Federal and local energy conservation regulations.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Hot and cold running water for all common area restrooms and lavatories in the Landlord&#8217;s Premises.</div>
    <div><br>
    </div>
    <div>
      <div style="text-indent: 36pt; text-align: justify;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Janitorial service for the Common Areas in the Landlord&#8217;s Premises.</div>
    </div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Electricity to operate the Common Areas during ordinary business hours, and to operate the Premises seven (7) days per week, by providing electric current in reasonable amounts necessary
      for normal office uses, lighting, and HVAC.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; General management, including supervision, inspections and management functions.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; Four (4) wall-mounted exterior lights immediately adjacent to the west-facing entrance to the Premises.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Security card reader for the west-facing entrance to the Premises, and two (2) security card readers for doors to the Premises.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 7.3&#160; &#160; &#160; </font>The services provided for in Section 7.2 herein are predicated on and are
      in anticipation of certain usage of the Premises by Tenant as follows: </div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(a)&#160;&#160;&#160;&#160; &#160;&#160; &#160; Services shall be provided for the Landlord&#8217;s Premises during ordinary business hours, unless expressly provided otherwise.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(b)&#160;&#160;&#160;&#160; &#160;&#160; Such usage of the Premises by Tenant will not require the HVAC system to function beyond design loads currently applicable to the Landlord&#8217;s Premises.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(c)&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160; Electric power usage and consumption for the Premises shall be based on (i) lighting of the Premises on a level suitable for normal office use and power for small desk-top machines and
      devices using no more than 110 volt, 20 amp circuits, and, if applicable, laboratory use at an average of 20 watts per RSF, and (ii) operating the improvements and equipment contemplated by the Tenant Improvement Construction Documents during
      ordinary business hours. Heavier use items shall not be used or installed, unless expressly permitted elsewhere herein or by separate written consent of Landlord.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt; text-align: justify;">(d)&#160;&#160;&#160;&#160; &#160;&#160; Should Tenant&#8217;s total rated electrical design load per square foot in the Premises exceed the building standard rated electrical design load, on a per rentable square foot basis, as
      determined by Landlord from time to time, for either low or high voltage electrical consumption, or if Tenant&#8217;s electrical design requires low voltage or high voltage circuits in excess of Tenant&#8217;s share of the building standard circuits, as such
      share is determined by Landlord, Landlord may (at Tenant&#8217;s expense), if reasonably possible, install within the Landlord&#8217;s Premises one (1) additional high voltage panel and/or one (1) additional low voltage panel with associated transformer (the &#8220;<u>Additional


        Electrical Equipment</u>&#8221;) as necessary to accommodate the aforesaid requirements. If the Additional Electrical Equipment is installed because Tenant&#8217;s low or high voltage rated electrical design load exceeds the applicable building standard rated
      electrical design load (on a per rentable square foot basis), then a meter may also be added by Landlord (at Tenant&#8217;s expense) to measure the electricity provided through the Additional Electrical Equipment. In addition to the foregoing, should
      Tenant desire to install or use equipment in the Premises not contemplated by the Tenant Improvement Construction Documents (as defined in the Work Letter) that will, or can be reasonably expected to, exceed the building standard rated electrical
      design load, on a per rentable square foot basis, for either low or high voltage electrical consumption, Tenant shall advise Landlord in writing in advance of the installation or use of such equipment and Landlord shall have the right, in its
      reasonable discretion, to approve or disapprove Tenant&#8217;s installation and use of such equipment in the Premises, and Landlord may condition its approval on installation of Additional Electrical Equipment and a meter therefore as set forth above.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 7.4&#160; &#160; &#160; </font>If Tenant uses any services in an amount or for a period in excess of that provided for herein, Landlord also reserves the right to charge Tenant as Additional
      Rent a reasonable sum as reimbursement for the direct cost of such added services plus five percent (5%) for Landlord&#8217;s overhead, general conditions and profit. Landlord further reserves the right to install separate metering devices for the purpose
      of determining such excessive periods and/or amounts at Tenant&#8217;s sole cost and expense. In the event of disagreement as to the reasonableness of such additional charge, the opinion of the appropriate local utility company or an independent
      professional engineering firm selected by Landlord shall prevail.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;">
      <div><font style="font-weight: bold;">Section 7.5&#160;&#160; &#160; </font>Tenant shall give Landlord prompt notice of any defective condition in any plumbing, heating system or electrical lines located in, servicing or passing through the Premises and, following
        such notice, Landlord shall remedy the condition with due diligence but at the expense of Tenant if repairs are necessitated by damage or injury attributable to Tenant, or Tenant&#8217;s servants, agents, employees, invitees or licensees as aforesaid.
        Except as specifically provided in this Lease, there shall be no allowance to Tenant for a diminution of rental value and no liability on the part of Landlord by reason of inconvenience, annoyance or injury to business arising from Landlord, Tenant
        or others making or failing to make any repairs, alterations, additions or improvements in or to any portion of the Building or the Premises or in and to the fixtures, appurtenances or equipment thereof.</div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 7.6&#160; &#160; &#160; </font>Landlord shall be responsible for complying with the provisions of Section 16.0 of the Prime Lease as they refer to the Common Areas.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 7.7&#160; &#160; &#160; </font>Except as otherwise expressly provided in this Article VII, Landlord shall have no obligation during the term of this Lease to expend any money for the
      preservation or repair of the Premises.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 7.8&#160; &#160; &#160; </font>Tenant shall be responsible to contract directly with (a) a janitorial company for daily cleaning services within the Premises and removal of trash to
      designated trash bins, and (b) a properly licensed contractor to remove biohazardous and medical waste from the Building in compliance with all applicable statutes and regulations.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE VIII. </div>
    <div style="text-align: center; font-weight: bold;">INITIAL AND SUBSEQUENT </div>
    <div style="text-align: center; font-weight: bold;">ALTERATIONS</div>
    <br>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 8.1&#160; &#160; &#160; </font>Landlord shall make the initial improvements to the Premises (collectively, the &#8220;<u>Landlord&#8217;s&#160;Work</u>&#8221;) in accordance with the terms and conditions contained
      in the work letter, plans and construction estimate set forth in <u>Exhibit </u><font style="font-weight: bold;"><font style="font-weight: normal;"><u>D</u></font>&#160;</font>(the &#8220;<u>Work Letter</u>&#8221;). The patties agree that Landlord is responsible to
      pay One Hundred Seventy Five Thousand &amp; 00/100 ($175,000.00) Dollars toward the cost of Landlord&#8217;s Work, and that Tenant shall pay the cost of Landlord&#8217;s Work in excess of this sum to the contractor prior to Landlord&#8217;s payment of the above sum.
      Other than for the Landlord&#8217;s Work, Landlord shall have no obligation whatsoever to alter, remodel, improve, repair, decorate or paint the Premises or any part thereof except as otherwise expressly provided herein or agreed upon in writing by
      Landlord, and the patties hereto affirm that Landlord has made no representations to Tenant respecting the condition of the Premises, the Landlord&#8217;s Premises or the Property except as specifically herein set forth in writing and Tenant shall accept
      the Premises in their &#8220;AS-IS, WHERE IS&#8221; condition. Landlord shall &#8220;Substantially Complete&#8221; the Landlord&#8217;s Work, as evidenced by delivery to Tenant of a certificate executed by the Landlord certifying that the Landlord&#8217;s Work has been constructed in
      substantial accordance with Exhibit D and all Legal Requirements, by no later than the Scheduled Completion Date (as hereinafter defined). Notwithstanding the foregoing, in the event that Landlord&#8217;s Work would have been Substantially Completed by the
      Scheduled Completion Date but for any act or omission of Tenant or any of its employees, agents or contractors, including, without limitation, Tenant&#8217;s changes to the Work Letter or Tenant&#8217;s failure to complete any preparatory work which Tenant is
      responsible to perform (each, a &#8220;<u>Tenant Delay</u>&#8221;), the Commencement Date shall not be delayed by the term of the Tenant Delay. By taking possession of the Premises, Tenant shall be deemed to have accepted the Premises as being in good and
      satisfactory order, condition and repair for its intended use under this Lease except for that portion of the Premises that is within the area of the Landlord&#8217;s Work. &#8220;<u>Substantial Completion</u>&#8221; shall mean the stage when Landlord&#8217;s Work is
      reasonably complete to permit Tenant to install substantially all of its FF&amp;E throughout the Premises, even though &#8220;punch list&#8221; items, or other items of construction which do not unreasonably interfere with Tenant&#8217;s ability to install its
      FF&amp;E, are not yet completed. The &#8220;<u>Scheduled Completion Date</u>&#8221; shall be the date the contractor selected by the Landlord to perform the Landlord&#8217;s Work assures both Parties with reasonable certainty that he will complete the Landlord&#8217;s Work
      after accounting for all reasonably foreseeable factors affecting the construction.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 8.2&#160; &#160; &#160; </font>Tenant may make cosmetic, non-structural alterations not requiring the approval of the New York City Department of Buildings, such as painting, carpeting,
      wallpapering, and flooring, to be undertaken in a good and workmanlike manner using new materials and in the manner permitted by this Lease. Tenant shall notify Landlord of such changes prior to the commencement of any work.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 8.3&#160; &#160; &#160; </font>Tenant shall obtain Landlord&#8217;s consent, which consent shall not be unreasonably withheld, regarding any nonstructural alterations which do not affect the Common
      Areas or roof, facade, windows or structural elements of the Building and do not diminish the value of the Building. All plans prepared by Tenant in connection with such alterations shall be delivered to Landlord for Landlord&#8217;s consent, prior to the
      commencement of any work by Tenant. Tenant shall also obtain, when appropriate, final as built plans for all such work and provide copies thereof to Landlord. Prior to commencing any alterations, Tenant shall, at its expense, obtain all permits,
      approvals and certificates required by any governmental or quasi-governmental bodies and upon completion, certificates of final approval thereof and shall promptly deliver duplicates of all such permits, approvals and certificates to Landlord. All
      alterations which shall be permit by landlords shall be accomplished at Tenant&#8217;s expense by Landlord, which expense shall include a charge of five (5%) percent of the cost of paying contractors and/or subcontractors retained by Landlord as Landlord&#8217;s
      fee for overseeing the alterations. All installations which are not in the nature of movable personal property installed in the Premises at any time, either by Tenant or Landlord on behalf of Tenant, shall, upon installation, become the property of
      Landlord and shall remain upon and be surrendered with the Premises unless Landlord, by written notice to Tenant no later than twenty (20) days prior to the Expiration Date elects to have them removed by Tenant in which event the same shall be
      removed by Tenant at Tenant&#8217;s expense prior to the Expiration Date. All property permitted or required to be removed by Tenant at the end of the term hereof remaining in the Premises after Tenant&#8217;s removal therefrom shall be deemed abandoned and may
      at the election of Landlord be either retained as Landlord&#8217;s property or removed from the Premises by Landlord at Tenant&#8217;s expense.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 8.4&#160; &#160; &#160; </font>Any and all alterations, additions and improvements will be performed in accordance with Landlord&#8217;s sustainability practices, including any third-party rating
      system concerning the environmental compliance of the Landlord&#8217;s Premises or the Premises, as the same may change from time to time. Tenant further agrees to engage a qualified third-party LEED or Green Globe Accredited Professional or similarly
      qualified professional during the design phase through implementation of any alterations, additions and improvements to review all plans, material procurement, demolition, construction and waste management procedures to ensure they are in full
      conformance to Landlord&#8217;s sustainability practices, as aforesaid.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 8.5&#160; &#160; &#160; </font>Landlord and Tenant expressly agree and acknowledge that no interest of Landlord in the Premises or the Landlord&#8217;s Premises shall be subject to any lien for
      improvements made by Tenant in or for the Premises. Landlord shall not be liable for any lien for any improvements made by Tenant, such liability being expressly prohibited by the terms of this Lease, and Tenant agrees to inform all contractors and
      material suppliers performing work in or for or supplying materials to the Premises of the existence of said prohibition. If any mechanic&#8217;s lien shall be filed against the Building or Land of which the Premises forms a part, for work claimed to have
      been done for, or materials claimed to have been furnished to, Tenant (a) the same shall be discharged by Tenant, by either payment, by bond or otherwise, at the sole cost and expense of Tenant, within fifteen (15) days of the giving of notice
      thereof by Landlord, (b) either a release or a satisfaction of lien, as the case may be, shall be filed with the County Clerk of the county in which the Building is situate within such fifteen (15) day period, and (c) a copy of such release or
      satisfaction, as the case may be, certified to by such County Clerk shall be delivered to Landlord within three (3) days after such filing. In the event such mechanic&#8217;s lien is not discharged timely, as aforesaid, Landlord may discharge same for the
      account of and at the expense of Tenant by payment, bonding or otherwise, without investigation as to the validity thereof or of any offsets or defenses thereto, and Tenant shall promptly reimburse Landlord, as Additional Rent, for all costs,
      disbursements, fees and expenses, including, without limitation, legal fees, incurred in connection with so discharging said mechanic&#8217;s lien, together with interest thereon from the time or times of payment until reimbursement by Tenant.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE IX. </div>
    <div style="text-align: center; font-weight: bold;">UTILITIES</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 9.1&#160; &#160; &#160; </font>Landlord shall supply electricity to the Premises in such quantities as Tenant shall reasonably require (provided said requirements shall not exceed the
      electrical capacity of the electrical distribution system in the Building). Tenant shall make no alterations or additions to the electrical distribution system in the Premises without the prior written consent of Landlord, which consent will not be
      unreasonably withheld or delayed. Tenant covenants and agrees that at all times its use of electric current shall not exceed the capacity of existing feeders to the Building and the risers or wiring installation therein. Tenant may not use any
      electrical equipment which, in Landlord&#8217;s reasonable judgment, will overload such installations or interfere with the use thereof by other tenants in the Building.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 9.2 &#160; &#160; &#160; </font>Subject to the provisions herein, the parties agree that Landlord shall furnish electricity to Tenant on a &#8220;submetering&#8221; basis. Landlord has installed a meter
      or meters (collectively, the &#8220;<u>Submeter</u>&#8221;), at a location designated by Landlord, and connections from the risers and/or circuits servicing the Premises to the Submeter and has performed all other work necessary for the famishing of electric
      current by Landlord to the Premises to service Tenant&#8217;s lighting and equipment. Tenant will pay Landlord, as Additional Rent for such service, the amounts determined by multiplying the usage indicated by the Submeter by the &#8220;all in&#8221; rate charged to
      Landlord by Consolidated Edison <u>plus</u> an administrative fee of five (5%) percent of such amount. The amounts computed from the Submeter readings are herein called the &#8220;Electricity Additional Rent&#8221;, and such amounts computed from the Submeter
      shall be binding and conclusive on Tenant. If the Submeter should fail to properly register or operate at any time during the term of this Lease for any reason whatsoever, Landlord may estimate the Electricity Additional Rent, and when the Submeter
      is again properly operative, an appropriate reconciliation shall be made, by Tenant paying any deficiency to Landlord within twenty (20) days after demand therefor, or by Landlord crediting Tenant with the amount of any overpayment against the next
      payment(s) of Electricity Additional Rent. The periods to be used for the aforesaid computation shall be as Landlord, in its sole discretion, may from time to time elect. Bills for the Electricity Additional Rent shall be rendered to Tenant at such
      time as Landlord may elect.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 9.3&#160; &#160; &#160; </font>If any tax is imposed upon Landlord&#8217;s receipts from the sale or resale of electric current to Tenant by Federal, State or municipal authority, Tenant agrees
      that, unless prohibited by law, Tenant&#8217;s pro rata share of such taxes shall be passed on to, and included in the bill, and paid by Tenant to Landlord as Additional Rent.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 9.4&#160; &#160; &#160; </font>Landlord shall not be liable to Tenant for any loss, damage or expense of whatever nature which Tenant may sustain or incur by reason of any failure, inadequacy
      or defect in the character, quantity or supply of utilities furnished to the Premises, whether through the primary service or back-up generation except for any loss, damage or expense due to the negligence or omission of Landlord. Tenant shall pay
      for any special fixtures, connection charges and equipment required for its usage of said utilities. Further, Tenant shall install monitoring equipment for any freezers at the Premises, and shall promptly notify Landlord in the event that any freezer
      is not receiving an adequate supply of current.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 9.5&#160; &#160; &#160; </font>Tenant, at its sole cost and expense, and subject to Landlord&#8217;s reasonable regulations and approval in its sole discretion of Tenant&#8217;s load requirements, shall
      be permitted to (a) connect to the back-up generator located within the Building to provide limited emergency power for Tenant&#8217;s selected equipment, and (b) install its own back-up generator within the Premises or other location to be designated by
      Landlord, such location to be provided for such use at no charge to Tenant.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE X.</div>
    <div style="text-align: center; font-weight: bold;">DESTRUCTION BY FIRE OR OTHER CAUSES</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 10.1&#160; &#160;&#160; </font>Tenant shall give prompt notice to Landlord in case of fire or other damage to the Premises or the Building.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 10.2&#160; &#160; </font>If the Premises or the Building shall be damaged by fire or other casualty, not the result of Tenant&#8217;s negligent or wrongful conduct, Landlord, at Landlord&#8217;s
      expense, shall repair such damage. Landlord shall have no obligation to repair any damage to, or to replace, Tenant&#8217;s personal property or any other property or effects of Tenant. If the Premises shall be rendered untenantable by reason of any such
      damage, the Rent shall abate for the period from the date of such damage to the date when such damage shall have been substantially repaired, and if only a part of the Premises shall be so rendered untenantable, the Rent shall abate for such period
      in the proportion which the rentable area of the Premises so rendered untenantable bears to the total rentable area of the Premises. However, if, prior to the date when all of such damage shall have been repaired, any part of the Premises so damaged
      shall be rendered tenantable and shall be used or occupied by Tenant or other persons claiming through or under Tenant, then the amount by which the Rent shall abate shall be equitably apportioned for the period from the date of any such use or
      occupancy to the date when all such damage shall have been repaired. Tenant hereby expressly waives the provisions of Paragraph 227 of the New York Real Property Law, and of any successor law of like import then in force, and Tenant agrees that the
      provisions of this Paragraph shall govern and control in lieu thereof.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 10.3&#160; &#160;&#160; </font>Notwithstanding the foregoing provisions of this Article 10, if the Premises or the Building shall be totally damaged or rendered wholly untenantable by fire or
      other casualty, or partially damaged or rendered untenantable to the extent of fifty (50%) percent or more of the floor space of the Premises, then, in any of such events, either party, at such party&#8217;s option, may give to the other party, within one
      hundred eighty (180) days after such fire or other casualty, a thirty (30) days&#8217; notice of termination of this Lease and, in the event such notice is given, this Lease shall come to an end and expire upon the expiration of said thirty (30) days with
      the same effect as if the date of expiration of said thirty (30) days were the expiration date, the Rent shall be apportioned as of such date and any prepaid portion for any period after such date shall be refunded by Landlord to Tenant.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 10.4&#160; &#160;&#160; </font>If this Lease shall not be terminated as provided above, Landlord shall, at its expense, to the extent of the net insurance recovery, repair or restore the
      Premises with reasonable diligence and dispatch, to the condition immediately prior to the casualty. For purposes of this Article 10, Landlord shall not be obligated to commence any repair or restoration unless and until insurance proceeds are
      actually received by Landlord and Landlord&#8217;s repair obligations shall be limited to the extent of the insurance proceeds actually received by Landlord therefor. Landlord shall not be required to repair or restore any of Tenant&#8217;s leasehold
      improvements or betterments, furniture, furnishings, decorations or any other installations made at Tenant&#8217;s expense. All insurance proceeds payable to Tenant for such items shall be held in trust by Tenant and upon the completion by Landlord of
      repair or restoration, Tenant shall prepare the Premises for occupancy by Tenant in the manner immediately prior to the damage or destruction in accordance with plans and specifications approved by Landlord.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 10.5&#160; &#160; </font>Notwithstanding any other provision of this Lease, (a) to the extent insurance proceeds in the event of a casualty are in excess of $100,000, such proceeds shall
      be paid and disbursed in accordance with the Prime Lease and (b) if the Landlord&#8217;s Premises is rendered wholly unusable or (whether or not the Landlord&#8217;s Premises is damaged in whole or in part) if the Building and/or Landlord&#8217;s Premises shall be so
      damaged that Prime Landlord, pursuant to the Prime Lease, shall decide to demolish it or to rebuild it, in whole or in part, then, in any of such events, Prime Landlord may elect, pursuant to the Prime Lease, to terminate the Prime Lease by written
      notice to Landlord, given within one hundred twenty (120) days after such fire or casualty, specifying a date for the expiration of the Prime Lease, which date shall not be more than sixty (60) days after the giving of such notice, and upon the date
      specified in such notice the term of the Prime Lease shall expire as fully and completely as if such date were the date set forth above for the termination of the Prime Lease. In such event, this Lease also shall terminate on such date and Tenant and
      its respective Representatives and, licensees, invitees, and occupants shall forthwith quit, surrender and vacate the Premises.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XI. </div>
    <div style="text-align: center; font-weight: bold;">CONDEMNATION</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 11.1&#160; &#160; &#160; </font>If all of the Premises, or a part of such Premises such that the Premises in the judgment of an licensed architect retained by Landlord are untenantable, are
      taken by exercise of the power of eminent domain or other similar proceeding (or are conveyed by Landlord in lieu of such taking), this Lease will terminate on a date which is the earlier of the date upon which the condemning authority takes
      possession of the Premises or the date on which title to the Premises is vested in the condemning authority. In the event of a partial taking where this Lease is not terminated, the Rent will be abated in the proportion of the rentable area of the
      Premises so taken to the rentable area of the Premises immediately before such taking. In the event of any such taking, the entire award relating to the Landlord&#8217;s Premises or the Property will be paid to Landlord, and Tenant will have no right or
      claim to any part of such award; however, Tenant will have the right to assert a claim against the condemning authority for loss of its business at the Premises, the value of the leasehold lost in the condemnation and any leasehold improvements
      installed by Tenant which were subject to the condemnation, so long as Landlord&#8217;s award is not reduced or otherwise impacted as a consequence of such claim, for Tenant&#8217;s moving expenses and trade fixtures owned by Tenant and interruption to Tenant&#8217;s
      business.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 11.2&#160; &#160; &#160; </font>Notwithstanding anything hereinabove contained in this Article 11, if all or any portion of the Premises shall be lawfully condemned or taken for any temporary
      public or quasi-public use, this Lease shall not terminate and Tenant shall continue to perform or observe all of Tenant&#8217;s obligations hereunder as though such condemnation or taking had not occurred, except only as Tenant may be prevented from so
      doing by reason of the lawful use and occupancy of the Premises or portion thereof affected by such condemnation or taking during such temporary period. In the event of any such condemnation or taking, Tenant shall be entitled to receive the award
      with respect to the Premises or portion thereof covered by such condemnation or taking (whether paid as damages, rent or otherwise), unless the period of occupancy extends beyond the termination of this Lease, in which case Landlord shall be entitled
      to such part of such award as shall be properly allocable to the cost of restoration of the Premises and the balance of said award shall be apportioned between Landlord and Tenant as of the scheduled Expiration Date. If such condemnation or taking
      shall end before the Expiration Date, Tenant shall, at its sole cost and expense, restore the Premises as nearly as possible to the condition in which they were prior to such condemnation or taking.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XII. </div>
    <div style="text-align: center; font-weight: bold;">INSURANCE</div>
    <div><br>
    </div>
    <div><font style="font-weight: bold;">Section 12.1&#160; &#160; &#160; </font>Tenant shall carry (at its sole expense from and after the date hereof and during the Term) the following insurance:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160; &#160;&#160; Property Insurance with &#8220;Special Form&#8221; coverage, including earthquakes and flood insurance, insuring Tenant&#8217;s improvements to the Premises and any and all furniture, equipment, supplies,
      contents and other prope1ty owned, leased, held or possessed by it and contained therein (collectively, &#8220;<u>Tenant&#8217;s Property</u>&#8221;), such insurance coverage to be equal to the full replacement cost value of Tenant&#8217;s Property, with wind and flood
      deductibles not exceeding the lesser of five percent (5%) of the total insured value (&#8220;<u>TIV</u>&#8221;) or $10,000;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160; &#160; Either as part of the above referenced property insurance or as a separate prope1ty insurance policy, business interruption insurance coverage on an &#8220;All Risk&#8221; basis in an amount not less
      than the aggregate Rent payable for the eighteen (18) month period immediately following the loss. The insurance required in this subsection shall designate Landlord as loss payee and shall be in the broadest form available covering loss of income;</div>
    <div><br>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt;">(c) &#160;&#160;&#160; &#160; Workers&#8217; compensation insurance as required by applicable law;</div>
    </div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;">
      <div style="text-indent: 36pt;">(d)&#160;&#160;&#160;&#160; &#160; Commercial general liability insurance for the Premises in a combined coverage for bodily injury and property damage in an amount not less than Five Million Dollars ($5,000,000) per occurrence. Tenant shall
        name Landlord, Landlord&#8217;s mortgagee, the Prime Landlord, the City of New York, Research Foundation for the State University of New York, State University of New York Downstate Medical Center, any manager of the Building and/or the Landlord&#8217;s
        Premises, and any other person designated by Landlord as additional insureds under such policy. Such policy shall insure against any and all liability for injury to or death of a person or persons and for damage to property occasioned by or arising
        out of any construction work being done on the Premises by Tenant, or arising out of the use or occupancy of the Premises by Tenant, its employees, agents, representatives or contractors. The liability coverage shall (i) be primary insurance as to
        all claims thereunder and provide that any insurance carried by Landlord is excess and is non-contributing with any insurance requirement of Tenant; (ii) contain cross-liability endorsements or a severability of interest clause acceptable to
        Landlord; and (iii) specifically cover the liability assumed by Tenant under this Lease including, without limitation, Tenant&#8217;s indemnification obligations under this Lease; and</div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160; &#160;&#160; Pollution/Environmental Liability Insurance covering bodily injury, including death, and property damage, including loss of use of damaged property or use of property that has not been
      physically injured or destroyed, which in any event shall not be less than two million dollars ($2,000,000) per occurrence, unless otherwise approved in writing by Landlord, which amount Landlord reserves the right, based upon in its reasonable
      evaluation of the risk and exposures from Tenant&#8217;s use of the Premises, which limit(s) may be increased from time to time as reasonably required by Landlord based on the Tenant&#8217;s activities and decreased from time to time. Tenant shall name Landlord,
      Landlord&#8217;s mortgagee, the Prime Landlord, the City of New York, any manager of the Building and/or the Landlord&#8217;s Premises, and any other person designated by Landlord as additional insureds under such policy. Such insurance shall provide coverage
      for actual, alleged or threatened emission, discharge, dispersal, seepage, release or escape of pollutants (including, without limitation, any Hazardous Materials, including any loss, cost or expense incurred as a result of any cleanup of pollutants
      (including, without limitation, any Hazardous Materials) or in the investigation, settlement or defense of any claim, suit or proceeding against any of the Additional Insureds arising from the activities and operations under this Lease. The coverage
      for bodily injury and property damage and clean up shall apply to both on and off the Premises (including throughout the Terminal) exposures and the shall include, without limitation, coverage for improper or inadequate: (i) environmental management
      practices; (ii) biological, chemical and radioactive materials handling and waste disposal; (iii) written emergency plans in the event of a chemical spill or release; (iv) training or supervision of staff who handle biological materials, chemicals
      and hazardous wastes; (v) storage of chemicals and Hazardous Materials; and (vi) loading, unloading, transportation, and/or off-site disposal of Hazardous Materials. Coverage must not exclude transportation (owned and non-owned vehicles) of the
      Hazardous Materials to and from the Premises and all related events which may occur in the Premises and/or elsewhere in the Terminal. Coverage must not exclude operations of basic lab support rooms (ESL 1), vector labs (ESL 2) and separate labs used
      for vectors and immunology (ESL 3) and ESL 4, vaccination bioscience research laboratories, and/or related product development center).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(f)&#160; &#160; &#160;&#160; All of Tenant&#8217;s insurance shall be with responsible companies qualified to do business in the State of New York, in good standing and holding a &#8220;general policy rating&#8221; of A- :VIII or
      better, as set forth in the most current issue of Best Key Rating Guide, and shall be written on an occurrence basis (and not claims made). Landlord, Landlord&#8217;s mortgagee and any other person designated by Landlord shall be named as additional
      insureds as their interests may appear with respect to commercial general liability insurance coverage.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(g)&#160;&#160; &#160;&#160;&#160; Tenant must deposit with Landlord the following for such insurance at or before Tenant or its agents, employees or contractors enters the Premises for any purpose whatsoever, and thereafter
      within fifteen (15) days before the expiration of any such policies: (i) with respect to the insurance required under <u>Section 12.l(a) and (b)</u>, an ACORD Form 28 with changes requested by Landlord or other form reasonably acceptable to
      Landlord; (ii) with respect to the insurance required under <u>Section 12(c)</u>, a certificate of insurance in form reasonably acceptable to Landlord; and (iii) with respect to the insurance required under <u>Section 12(d) and<font style="font-style: normal;"> </font></u><font style="font-style: normal;"><u>(e</u><u>)</u></font>,&#160;Tenant&#8217;s policy of insurance or an endorsement to Tenant&#8217;s policy in a form reasonable satisfactory to Landlord. All insurance shall provide that
      Landlord shall receive at least thirty (30) days prior written notice of cancellation or amendment to the same. All such policies or certificates shall be delivered with satisfactory evidence of the payment of the premium therefor.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(h) &#160; &#160;&#160; All chemicals, molecules, laboratory data, computers, merchandise, furniture, fixtures and property which may be on or about the Premises shall be at the sole risk and hazard of Tenant, and
      if the whole or any part of the Premises is destroyed or damaged by fire, water or by the leaking or bursting of water pipes, or in any other manner, no part of such loss or damage will be charged to Landlord.</div>
    <div><br>
    </div>
    <div>
      <div><font style="font-weight: bold;">Section 12.2</font> Landlord shall maintain during the Term, with solvent and responsible companies:</div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(a) &#160; &#160; &#160;&#160; Building and Personal Property Coverage, with &#8220;Special Form&#8221; coverage for the Landlord&#8217;s Premises in an amount equal to one hundred percent (100%) of the full replacement value of the
      Landlord&#8217;s Premises along with, at Landlord&#8217;s option, loss of rents insurance for up to eighteen (18) months of Rent; and</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160; commercial general liability insurance covering injuries occurring at the Property, which shall provide for a combined coverage for bodily injury and property damage in an amount not less
      than Five Million Dollars ($5,000,000) per occurrence.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160; &#160; The cost of all insurance coverage provided to Landlord shall be an Operating Expense and subject to reimbursement pursuant to Article III. All such insurance and all other insurance
      required by this Lease shall satisfy all requirements for insurance under the Prime Lease and any Mortgage (as hereinafter defined). With respect to the insurance to be carried by Tenant hereunder, to the extent that the Prime Lease or Mortgage
      requires higher limits, additional insurance, additional coverages or additional insureds or otherwise imposes requirements in addition to or more onerous than the requirements set forth herein, then Tenant, on behalf of and at the expense of Tenant,
      shall obtain insurance satisfying all such additional or more onerous requirements.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div>
      <div style="text-align: center; font-weight: bold;">ARTICLE XIII. </div>
      <div style="text-align: center; font-weight: bold;">SUBROGATION AND WAIVER</div>
      <div style="font-weight: bold;">&#160;</div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 13.1&#160; &#160;&#160; </font>Anything in this Lease to the contrary notwithstanding, to the full extent permitted by law, Landlord and Tenant each hereby waives any and all rights of
      recovery, claim, action or cause of action, against the other, its agents, servants, partners, shareholders, officers, or employees, for any loss or damage that may occur to the Premises or the Property, or any improvements thereto, or any personal
      property of such party therein, by reason of fire, the elements, or any other cause to the extent such loss or damage is covered by the terms of a valid and collectible commercial prope1ty insurance policy with special causes of loss coverage in
      effect at the time of such loss (or would have been covered by such a policy if such a policy were in effect) regardless of cause or origin, including negligence of the other party hereto, its agents, officers, partners, shareholders, servants, or
      employees, and covenants that no insurer shall hold any right of subrogation against such other patty. Landlord and Tenant will cause their respective insurers to issue appropriate waiver of subrogation rights endorsements to all policies of
      commercial property insurance policy with special causes of loss coverage carried in connection with the Property and the Premises; provided that the foregoing waiver by each party is conditioned upon the other party&#8217;s carrying insurance with the
      above described waiver of subrogation, and if such coverage is not obtained or maintained by either patty, then the other party&#8217;s waiver shall be deemed rescinded until such waiver is either obtained or reinstated.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XIV. </div>
    <div style="text-align: center; font-weight: bold;">INDEMNIFICATION AND HOLD HARMLESS</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 14.1&#160; &#160;&#160; </font>Tenant agrees to defend, indemnify and hold Landlord and its affiliates, subsidiaries, and parents (collectively, &#8220;<u>Landlord Affiliates</u>&#8221;), and each of
      their (including Landlord&#8217;s) respective officers, directors, shareholders, partners, members, representatives, agents and employees (&#8220;<u>Landlord&#8217;s Affiliated Persons</u>,&#8221; and Landlord, Landlord&#8217;s Affiliates and Landlord&#8217;s Affiliated Persons, the
      Prime Landlord, the City of New York, the State University of New York, Research Foundation for the State University of New York, State University of New York Downstate Medical Center being collectively known as the &#8220;<u>Landlord Indemnified&#160;Parties</u>&#8221;)


      harmless from and against any and all liability for any injury to or death of any person or persons or any damage to property in any way arising out of or in connection with the condition, use or occupancy of the Premises, or in any way arising out
      of any activities in or about the Premises, the Landlord&#8217;s Premises or other portions of the Prope1ty, of Tenant, its assignees or subtenants or of the respective agents, employees, licensees, contractors or invitees of Tenant or its assignees or
      subtenants (each, a &#8220;<u>Tenant Party</u>&#8221;), and from all costs, expenses and liabilities (including, but not limited to, court costs and reasonable attorneys&#8217; fees) incurred by the Indemnified Parties or any of them in connection therewith.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 14.2<font style="font-weight: bold;">&#160; &#160;&#160; </font></font>Tenant covenants and agrees that, on and after the date hereof, Landlord shall not be liable to Tenant for any injury to
      or death of any person or persons or for damage to any prope1ty of Tenant, or any person claiming through Tenant, arising out of any accident or occurrence in or about the Premises or other portions of the Landlord&#8217;s Premises or the Property,
      including, but not limited to, injury, death or damage caused by the Premises or other property of the Landlord&#8217;s Premises or the Property arising out of repair or caused by any defect in or failure of equipment, pipes or wiring, or caused by broken
      glass, or caused by the backing up of drains, or caused by gas, water, steam, electricity, or oil leaking, escaping or flowing into the Premises, or caused by fire or smoke, or caused by the acts or omissions of other tenants and occupants of the
      Landlord&#8217;s Premises.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 14.3&#160; &#160;&#160; </font>Tenant agrees to report in writing to Landlord any defective condition in or about the Premises known to Tenant, and further agrees to attempt to contact
      Landlord by telephone immediately in such instance.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XV. </div>
    <div style="text-align: center; font-weight: bold;">RULES AND REGULATIONS</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 15.1&#160; &#160; </font>Tenant shall observe strictly the rules and regulations set forth in <u>Exhibit E,</u> and all subsequent reasonable rules and regulations as Landlord or
      Landlord&#8217;s agents may from time to time adopt (such rules and regulations as have been or may hereafter be adopted or amended are hereinafter the &#8220;<u>Rules and Regulations</u>&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XVI. </div>
    <div style="text-align: center; font-weight: bold;">DEFAULTS BY TENANT; REMEDIES</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 16.1&#160; &#160;&#160; </font>Tenant shall be deemed in default of the obligations to be performed by it pursuant to the provisions of this Lease if: (a) Tenant shall fail to make payment of
      Rent or of any other payment reserved herein within the time provided in this Lease for payment of same to be made; or (b) if Tenant shall fail to fulfill any of the covenants of this Lease other than the covenants for the payments reserved herein,
      and said failure shall continue for a period of ten (10) days after written notice thereof from Landlord specifying such failure (or, in the case of a default or omission the nature of which cannot be completely cured or remedied within ten (10)
      days, Tenant shall not have diligently commenced curing such default within said ten (10) day period and not thereafter with reasonable dispatch and diligence and in good faith proceeded to remedy or cure such default, all in Landlord&#8217;s reasonable
      judgment); or (c) if the Premises shall become vacant or deserted; or (d) if there is any execution or attachment issued&#160; against Tenant; or (e) if Tenant shall become insolvent or transfer property to defraud creditors; if Tenant shall make an
      assignment for the benefit of creditors; or if a receiver is appointed for any of Tenant&#8217;s assets; or (f) if Tenant fails to bond off or otherwise remove any lien filed against the Premises or the Landlord&#8217;s Premises by reason of Tenant&#8217;s actions,
      within ten (10) days after Tenant has notice of the filing of such lien; or (g) if all or any part of this Lease shall be assigned, or if all or any part of the Premises shall he sublet, either voluntarily or by operation of law, except in strict
      accordance with the requirements of Article XXVIII hereof.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 16.2&#160; &#160; </font>In the event of such a default by Tenant under subparagraphs (a) through (g) above, Landlord may give five (5) days notice of its intention to end the term of
      this Lease and thereupon at the expiration of said five (5) days, the term of this Lease shall expire as though such date were the Expiration Date, but Tenant shall remain liable for damages as provided in this Lease and pursuant to law. Tenant shall
      then quit and surrender the Premises, but shall remain liable as hereinafter provided.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 16.3&#160; &#160;&#160; </font>If at any time during the term of this Lease, there shall be filed by or against Tenant in any court pursuant to any statute either of the United States or of
      any State a petition in bankruptcy or insolvency or for reorganization or for the appointment of a receiver or trustee of all or a portion of Tenant&#8217;s property, this Lease shall ipso facto be canceled and terminated.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 16.4&#160; &#160;&#160; </font>If the notice provided in Section 16.2 shall have been given and the term hereof shall expire as aforesaid, or if this Lease shall have been terminated in
      accordance with Section 16.3, Landlord may without additional notice re-enter the Premises, either by force or otherwise, and dispossess Tenant and the legal representative of Tenant or other occupant of the Premises by summary proceedings or
      otherwise remove their effects and hold the Premises as if this Lease had not been made, and Tenant and its legal representative or other occupant of the Premises hereby waive the service of notice of intention to re-enter or to institute legal
      proceedings to that end. If Tenant shall default hereunder prior to the date fixed as the commencement of any renewal or extension of this Lease, then Landlord may cancel and terminate such renewal or extension.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 16.5&#160; &#160;&#160; </font>In the case of any such default, re-entry, expiration and/or dispossess by summary proceedings or otherwise, as aforesaid, (a) the Rent due at the time of said
      default shall become due thereupon and be paid up to the time of such re-entry, dispossess and/or expiration, together with such expenses as Landlord may incur for legal expenses, attorneys&#8217; fees, brokerage fees and/or putting the Premises in good
      order or for preparing the same for re-rental; (b) Landlord may re-let the Premises or any part or parts thereof, either in its own name or otherwise, for a term or terms which may, at its option, be shorter or longer than the period which&#160; would
      otherwise have constituted the remainder of the term of this Lease and may grant concessions or free Rent, to such extent as Landlord in Landlord&#8217;s sole judgment considers advisable and necessary to re-let the same; and (c) Tenant or its successors
      shall also pay the Landlord as liquidated damages for the failure of Tenant to observe and perform its covenants contained herein any deficiency between the Rent hereby reserved and the net amount, if any, of the rents collected on account of the
      Lease or subleases of the Premises or parts thereof for each month of the period which would otherwise have constituted the remainder of the term of this Lease subject to Tenant&#8217;s right to terminate the Lease early as provided in Section 23.3. The
      failure of Landlord to re-let the Premises or any part of parts thereof shall not release or affect Tenant&#8217;s liability for damages. In computing such liquidated damages, there shall be added to said deficiency such expenses as Landlord shall incur in
      connection with such re-letting, such as legal expenses, attorneys&#8217; fees, brokerage, advertising and for restoring the Premises to or keeping same in good working order. Any such liquidated damages shall be paid in monthly installments on the Rent
      day specified in this Lease and any suit brought to collect the amount of the deficiency for any month shall not prejudice in any way the rights of Landlord to collect the deficiency for any subsequent month by a similar proceeding. Upon Landlord&#8217;s
      permitted entry hereunder, Landlord, at its option, may make such alterations, repairs, replacements and decorations in the Premises as Landlord in its sole judgment considers advisable or necessary for the purpose of re-letting the Premises, and the
      making of such alterations and decorations shall not operate or be construed to release Tenant from liability hereunder. Landlord shall in no event be liable in any way whatsoever for failure to re-let the Premises, or, in the event that the Premises
      are re-let, for reasonable failure to collect the Rent thereof under such re-letting, and, in no event shall Tenant be entitled to receive any excess of such net rent collected above the sums payable by Tenant to Landlord hereunder. Mention in this
      Lease of any particular remedy shall not preclude Landlord from any other remedy in law or equity. Tenant hereby expressly waives any and all rights of redemption granted by or under any present or future laws in the event of Tenant being evicted or
      dispossessed, for any cause, or in the event of Landlord obtaining possession of the Premises by reason of the violation of Tenant of any of the covenants and conditions of this Lease, or otherwise. Pursuit by Landlord of any of the foregoing
      remedies set forth in this Lease shall not preclude the pursuit of any damages incurred, or of any of the other remedies provided herein or available, at law or in equity. No act or thing done by Landlord or Landlord&#8217;s employees or agents during the
      Term shall be deemed an acceptance of a surrender of the Premises. Neither the mention in this Lease of any particular remedy, nor the exercise by Landlord of any particular remedy hereunder, or at law or in equity, shall preclude Landlord from any
      other remedy Landlord might have under this Lease, or at law or in equity.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 16.6&#160; &#160;&#160; </font>It is stipulated and agreed that in the event of the termination of this Lease pursuant to the provisions of this Paragraph, Landlord shall forthwith,
      notwithstanding any other provisions of this Paragraph or of this Lease to the contrary, be entitled to recover from Tenant as and for liquidated damages an amount equal to the Rent for the unexpired&#160; portion of the term of this Lease, subject to
      Tenant&#8217;s right to terminate the Lease early as provided in Section 23.3, discounted at the rate of four (4%) percent per annum to present worth. Nothing contained herein shall limit or prejudice the right of Landlord to prove for and obtain as
      liquidated damages by reason of such termination an amount equal to the maximum allowed by any statute or rule of law in effect at the time when, and governing the proceedings in which, such damages are to be proved.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 16.</font>7<font style="font-weight: bold;">&#160; &#160;&#160; </font>Tenant acknowledges and agrees that all disputes arising, directly or indirectly, out of or relating to this Lease
      should be dealt with by application of the laws of the State of New York and adjudicated in the state courts of the State of New York sitting in Kings County or the Federal courts sitting in the State of New York in Kings County; and hereby expressly
      and irrevocably submits Tenant to the jurisdiction of such courts in any suit, action or proceeding arising, directly or indirectly, out of or relating to this Lease. So far as is permitted under the applicable law, this consent to personal
      jurisdiction shall be self-operative and no further instrument or action, other than service of process in one of the manners permitted by law, shall be necessary in order to confer jurisdiction upon Tenant in any such court. Provided that service of
      process is effected upon Tenant in one of the manners permitted by law, Tenant irrevocably waives, to the fullest extent permitted by law, and agrees not to assert, by way of motion, as a defense or otherwise, (a) any objection which it may have, or
      may hereafter have to the laying of the venue of any such suit, action or proceeding brought in such a court as is mentioned in the previous paragraph, (b) any claim that any such suit, action or proceeding brought in such a court has been brought in
      an inconvenient forum, or (c) any claim that it is not personally subject to the jurisdiction of the above named courts. Tenant hereby further irrevocably consents to the service of process in any suit, action or proceeding by the mailing or delivery
      of the appropriate documents (e.g., process or summons) by Landlord to the Premises and delivered in one of the manners set forth in Article XXV hereof. Nothing herein shall in any way be deemed to limit the ability of Landlord to serve any such
      papers in any other manner permitted by applicable law.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">26</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 16.8&#160; &#160; </font>If Tenant shall default in the observance or performance of any obligation of Tenant under this Lease, then, unless otherwise provided elsewhere hereunder,
      Landlord may immediately or at any time thereafter without notice perform such obligation of Tenant without hereby waiving such default. If Landlord, in connection therewith incurs any costs including, but not limited to, attorneys&#8217; fees in
      instituting, prosecuting or defending any action or proceeding, such costs with interest at the rate of five (5%) percent per annum, shall be deemed to be Additional Rent hereunder and shall be paid by Tenant to Landlord within five (5) days of
      rendition of any bill or statement to Tenant therefor.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XVII. </div>
    <div style="text-align: center; font-weight: bold;">CONDITION OF PREMISES</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 17.1&#160; &#160; </font>Tenant accepts the Premises in &#8220;as is&#8221; condition, and Tenant acknowledges that Landlord makes no representation as to the conditions thereof, except as herein
      set forth.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XVIII. </div>
    <div style="text-align: center; font-weight: bold;">ASSIGNMENT AND SUBLETTING</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 18.1&#160; &#160;&#160; </font>Tenant shall not assign, mortgage, pledge, encumber, or in any manner transfer the Lease, or any part thereof, or lease all or any part of the Premises, other
      than in compliance with the provisions of this Article XVIII. Tenant is further responsible for complying with the provisions of Article XI of the Prime Lease as it pertains to Tenant&#8217;s intention to enter into a sublease or assign its interest in
      this Lease.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 18.2&#160; &#160;&#160; </font>Each of the following events shall be deemed to constitute an assignment of the Lease:</div>
    <div><br>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160; &#160;&#160; Any assignment of transfer of the Lease by operation of law;</div>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160; &#160; Any hypothecation, pledge or collateral assignment of the Lease;</div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160; Any involuntary assignment or transfer of the Lease in connection with the bankruptcy, insolvency, receivership or similar occurrence;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160; Any assignment, transfer, disposition, sale or acquiring of a controlling interest in Tenant to or by any person, entity or group related persons or affiliated entities, whether in a single
      transaction or in a series of related or unrelated transactions; and</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160;&#160;&#160; Any issuance of an interest or interests in Tenant (whether stock, partnership interest or otherwise) to any person, entity or group of related persons or affiliated entities, whether in a
      single transaction or in a series of related or unrelated transactions, such that following such issuance, such person, entity or group shall hold a controlling interest in Tenant. For purposes of the immediately preceding sentence, a &#8220;controlling
      interest&#8221; of Tenant shall mean fifty (50%) percent or more of the aggregate issued and outstanding equitable interest (whether stock, partnership interest or otherwise) thereof</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">27</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 18.3&#160; &#160; </font>Tenant shall not sublet any part of the Premises, nor assign, pledge or encumber this Lease or any interest herein, without the prior written consent of
      Landlord, which consent may be granted or withheld by Landlord in its sole discretion. Consent by Landlord to one assignment or sublease shall not destroy or waive this provision, and all later assignments and subleases shall likewise be made only
      upon prior written consent of Landlord. In the event a sublease or assignment is consented to by Landlord, any sublease or assignees shall become liable directly to Landlord for all obligations of Tenant hereunder without relieving or in any way
      modifying Tenant&#8217;s liability hereunder, but rather Tenant and its transferee shall be jointly and severally liable therefor. In the event Landlord gives its consent to any such assignment or sublease, any rent or other cost to the assignee or
      subtenant for all or any portion of the Premises over and above the Rent payable by Tenant for such space shall be due and payable, and shall be paid, to Landlord. In the event a sublease or assignment is made as herein provided, Tenant shall pay
      Landlord a charge equal to the actual costs incurred by Landlord, in Landlord&#8217;s reasonable judgment (including, but not limited to, the use and time of Landlord&#8217;s personnel), for all of the necessary legal and accounting services required to
      accomplish such assignment or subletting, as the case may be. Any transfer, assignment or sublease of all or any portion of the Premises or Tenant&#8217;s interest under this Lease made without Landlord&#8217;s consent shall be void ab initio and of no force or
      effect. For the purpose of determining whether Landlord acted reasonably in granting or withholding its consent or approval to any assignment, sublease or other transfer to the extent required hereunder, Tenant acknowledges and agrees that Landlord
      may refuse to give such consent or approval if, and to the extent that, the Prime Lessor or the Mortgagee (as defined herein) has refused to provide any required consent or approval with respect to such assignment, sublease or other transfer.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 18.4&#160; &#160;&#160; </font>Landlord may, within thirty (30) days after submission of Tenant&#8217;s written request for Landlord&#8217;s consent to subletting or an assignment of this Lease, cancel
      this Lease as to the portion of the Premises proposed to be sublet or assigned as of the date such proposed transfer is to be effective. If Landlord cancels this Lease as to any portion of the Premises, then this Lease shall cease for such portion of
      the Premises and Tenant shall pay to Landlord all Rent accrued through the cancellation date relating to the portion of the Premises covered by such proposed transfer. Thereafter, Landlord may lease such portion of the Premises to the prospective
      transferee (or to any other person) without liability to Tenant.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 18.5&#160; &#160;&#160; </font>Nothing in this Lease or any assignment, subletting, encumbrance or transfer of this lease or any part thereof shall be deemed to permit the use of the Building
      or the Lease Premises in any manner other than that authorized by Article IV of this Lease.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">28</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;">
      <div style="text-align: center; font-weight: bold;">ARTICLE XIX. </div>
      <div style="text-align: center; font-weight: bold;">HAZARDOUS MATERIALS</div>
      <div><br>
      </div>
      <div><font style="font-weight: bold;">Section 19.1&#160; &#160; </font>Tenant shall not cause or permit any Hazardous Material (as hereinafter defined) to be brought upon, kept or used in or about the Premises by Tenant, its agents, employees, contractors or
        invitees except in quantities and in a maimer authorized by applicable Governmental Laws (defined below) and in the ordinary course of Tenant&#8217;s business. Tenant further covenants and agrees that it shall not discharge any Hazardous Material in the
        ground or sewer disposal system. If Tenant breaches the obligations stated in the preceding sentences, or if the presence of Hazardous Material on the Premises caused by Tenant, its employees, contractors, invitees, agents, servants, subtenants or
        assigns, results in contamination of the Premises or any other part of the Property or if there is such a discharge, then Tenant shall (a) immediately give Landlord written notice thereof, and (b) be responsible for its indemnification obligations
        under Section 14.1 hereof which arise during or after the term as a result of such breach, contamination, or discharge. The foregoing indemnification includes, without limitation, costs incurred in connection with any investigation of site
        conditions or any cleanup, remedial, removal or restoration work required by any federal, state or local governmental agency or political subdivision. Without limiting the foregoing, if the presence of any Hazardous Material within the Premises
        caused or permitted by Tenant results in any contamination of the Premises or any other part of the Building or Land, Tenant shall promptly take all actions at its sole expense as are necessary to return the Premises or any facility or property of
        Landlord to the condition existing prior to the introduction of any such Hazardous Material.</div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 19.2&#160; &#160;&#160; </font>As used herein, the term &#8220;<u>Governmental Laws</u>&#8221; means all federal, state (including SUNY), regional, and local statutes, ordinances, rules, regulations,
      guidelines, and the like, and any notices and orders issued pursuant to any of the foregoing, concerning Hazardous Materials or public health and the environment. As used herein, the term &#8220;<u>Hazardous Materials</u>&#8221; means any pollutants, hazardous
      or toxic materials, substances or wastes, including, but not limited to: petroleum and petroleum products and derivatives; asbestos; radon; polychlorinated bi-phenyls (PCBs); urea-formaldehyde foam insulation; explosives; radioactive materials;
      laboratory wastes, medical wastes and other regulated wastes (including, without limitation, contaminated clothing, body fluids, contaminated medical instruments and equipment, catheters, used bandages, gauzes, needles and other sharps); and any
      chemicals, materials or substances designated or regulated, as hazardous or as toxic substances, materials, or wastes under any Governmental Laws.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 19.3&#160; &#160;&#160; </font>Any handling, transportation, generation, management, disposal, processing, treatment, storage and use by Tenant of Hazardous Materials in or about the Premises
      shall be subject to the rules and regulations promulgated by Landlord from time to time regarding the same or any aspect thereof (which rules and regulations may be amended, modified, deleted or added from time to time by Landlord) (collectively, the
      &#8220;<u>Hazmat Rules</u>&#8221;). All of the Hazmat Rules shall be effective upon written notice thereof to Tenant. Tenant will cause all Tenant Patties, or any others permitted by Tenant to occupy or enter the Premises to at all times abide by the Hazmat
      Rules. In the event of any breach of any Hazmat Rules, Landlord shall have all remedies in this Lease provided for in the Event of Default by Tenant and shall, in addition, have any remedies available at law or in equity, including but not limited
      to, the right to enjoin any breach of such Hazmat Rules. Within thirty (30) days after the Commencement Date and thereafter within ten (10) days of request therefore, Tenant shall provide to Landlord a written list of all Hazardous Materials and/or
      Regulated Waste handled, transported,&#160; generated, managed, disposed, processed, treated, stored and used in or about the Premises, together with such other information as Landlord may reasonably request (including, without limitation, information
      regarding the quantity of such materials in or about the Premises and Tenant&#8217;s procedures for the use, storage, transportation and/or disposal of such materials).</div>
    <div style="text-align: justify;">&#160; <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">29</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 19.4&#160; &#160;&#160; </font>In addition to the foregoing, Tenant agrees not to use or permit the use of biohazardous agents requiring a degree of containment in excess of that described as
      National Institutes of Health Biosafety Level 2, as defined in the U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention and National Institutes of Health, <u>Biosafety in Microbiological and
        Biomedical Laboratories,</u> dated May 1993 and any updates or revisions thereto (the &#8220;<u>DHH Specifications</u>&#8221;), and to conduct all scientific research and development activities in conformity with at least the minimum practices, equipment and
      facilities recommended for such activities in the DHH Specifications.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 19.5&#160; &#160; </font>Landlord and its agents shall have the right, but not the duty, to inspect the Premises at any time upon reasonable notice to determine whether Tenant is
      complying with the terms of this Article XIX. If Tenant is not in compliance with the provisions of this Article XIX, Landlord shall have the right to immediately enter upon the Premises to remedy said noncompliance upon reasonable notice at Tenant&#8217;s
      expense and any expense incurred by Landlord shall be paid by Tenant upon demand and shall be deemed Additional Rent.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XX.</div>
    <div style="text-align: center; font-weight: bold;">NON-WAIVER OF LANDLORD&#8217;S RIGHTS</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 20.1&#160; &#160; </font>The failure of Landlord to insist upon strict performance of any of the covenants or conditions of this Lease or to exercise any option herein conferred in any
      one or more instances, shall not be construed as a waiver or relinquishment for the future of any such covenant, conditions or options, but the same shall be and remain in full force and effect.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXI.</div>
    <div style="text-align: center; font-weight: bold;">SUBORDINATION, NON-DISTURBANCE AND ATTORNMENT.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 21.1&#160; &#160;&#160; </font>This Lease is and shall be subject and subordinate to all mortgages and deeds of trust and to all renewals, modifications, consolidations, replacements, and
      extensions of such documents (collectively, &#8220;<u>Mortgages</u>&#8221;) which may now or hereafter affect the Premises; provided, however, that at Landlord&#8217;s election, this Lease shall be superior to any or all Mortgages. The subordination in this Section
      21.1 is self-executing and no further instrument shall be required to establish the subordination set forth herein. Upon request of Tenant, and at Tenant&#8217;s sole cost and expense, Landlord shall endeavor to obtain and deliver to Tenant from any
      present or future mortgagee (collectively, the &#8220;<u>Mortgagee</u>&#8221;) such Mortgagee&#8217;s customary and reasonable form of written subordination, non-disturbance and attornment agreement in recordable form providing, among other things, that so long as
      Tenant performs all of the terms, covenants and conditions of this Lease and agrees to attorn to the Mortgagee, on such customary terms and conditions as such Mortgagee may reasonably require, Tenant&#8217;s rights under this Lease shall not be disturbed
      and shall remain in full force and effect for the Term, and Tenant shall not be joined by the Mortgagee in any action or proceeding to foreclose thereunder. In addition, this Lease is and shall be subject and subordinate to the existing Ground Lease
      and any other existing underlying leases affecting the Premises and to all renewals, modifications, consolidations, replacements, and extensions thereof. If any Mortgagee requests a Subordination Non-Disturbance and Attornment Agreement (a &#8220;SNDA from
      Tenant, then Tenant shall execute and deliver to Mortgagee such Mortgagee&#8217;s form of SNDA in recordable form within twenty (20) days of such request. </div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">30</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"></div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 21.2&#160; &#160;&#160; </font>After receiving notice and a notice address from any Mortgagee, no notice from Tenant to Landlord alleging any default by Landlord shall be effective unless and
      until a copy of the same is given to such Mortgagee. Any such Mortgagee shall have thirty (30) days for the cure of any such default and if such default cannot reasonably be cured within such thirty (30) days, then Mortgagee shall have thirty (30)
      days within which to commence a cure and provided such Mortgagee is proceeding diligently, such longer period as may be reasonably necessary to complete such cure. The curing of any of Landlord&#8217;s defaults by such Mortgagee shall be treated as
      performance by Landlord.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 21.3&#160; &#160;&#160; </font>With respect to any assignment by Landlord of Landlord&#8217;s interest in this Lease, or the rents payable hereunder, conditional in nature or otherwise, which
      assignment is made to any Mortgagee, Tenant agrees that the execution thereof by Landlord, and the acceptance thereof by the Mortgagee, shall never be deemed an assumption by such Mortgagee of any of the obligations of Landlord hereunder, unless such
      Mortgagee shall, by written notice sent to Tenant, specifically elect, or unless such Mortgagee shall foreclose the Mortgage and take possession of the Premises. Tenant, upon receipt of written notice from a Mortgagee that such Mortgagee is entitled
      to collect Rent hereunder may in good faith remit such Rent to Mortgagee without incurring liability to Landlord for the non-payment of such Rent.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 21.4&#160; &#160;&#160; </font>If the Mortgagee, or any party deriving its interest therefrom shall succeed to the rights of Landlord in the Premises or under this Lease, whether through
      possession or foreclosure action or delivery of a new lease or deed, then Tenant shall attorn to and recognize such party succeeding to Landlord&#8217;s rights (the party so succeeding to Landlord&#8217;s rights herein sometimes called the &#8220;<u>Successor Landlord</u>&#8221;)


      as Tenant&#8217;s landlord under this Lease, and shall promptly execute and deliver any instrument that such Successor Landlord may reasonably request to confirm such attornment. This Lease shall continue in full force and effect as, or as if it were, a
      direct lease between the Successor Landlord and Tenant, and all of the terms, conditions and covenants set forth in this Lease shall be applicable after such attornment, except that the Successor Landlord shall not:</div>
    <div><br>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160; &#160;&#160;&#160;&#160; be liable for any previous act or omission of Landlord under this Lease;</div>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; be subject to any offset that shall have theretofore accrued to Tenant against Landlord; or</div>
      </div>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt;">(c) &#160; &#160;&#160; &#160; be bound by:</div>
    </div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">31</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 63pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160; any previous modification of this Lease, not expressly provided for in this Lease unless consented to by such Successor Landlord; or</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 63pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160; any security deposit not delivered to such Successor Landlord or previous prepayment of more than one (1) month&#8217;s Rent then due, unless such prepayment shall have been expressly approved
      in writing by the Mortgagee through or by reason of which the Successor Landlord shall have succeeded to the rights of Landlord under this Lease.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXII. </div>
    <div style="text-align: center; font-weight: bold;">QUIET ENJOYMENT</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 22.1&#160; &#160; </font>Landlord covenants and agrees that upon Tenant paying the Rent and any other charges and fees payable hereunder and observing and performing all the terms,
      covenants and conditions of the Lease on Tenant&#8217;s part to be performed, Tenant may peaceably and quietly enjoy the Premises during the term of this Lease without hindrance or molestation by anyone claiming by or through Landlord subject, nevertheless,

      to the terms, covenants and conditions of this Lease.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXIII. </div>
    <div style="text-align: center; font-weight: bold;">END OF TERM</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 23.1&#160; &#160; </font>Upon the expiration or earlier termination of this Lease, Tenant shall quit and surrender to Landlord the Premises broom-clean and in good condition, ordinary
      wear and tear excepted. Tenant shall remove all of its property and shall repair all damage to the Premises or the Building occasioned by such removal. Any prope1ty not removed from the Premises shall be deemed abandoned by Tenant and may be disposed
      of in any manner deemed appropriate by Landlord, the cost of the removal and repairs occasioned by such removal to be at Tenant&#8217;s expense. Tenant&#8217;s obligations to observe or perform the terms of this Paragraph shall survive the expiration or earlier
      termination of this Lease. Tenant expressly waives, for itself and for any person claiming through or under Tenant, any rights which Tenant or such person may have under the provisions of Section 2201 of the New York Civil Practice Law and Rules and
      any similar successor law of the same import then in force, in connection with any holdover proceedings which Landlord may institute to enforce the provisions of this Article XXIII.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 23.2&#160; &#160; </font>If Tenant remains in possession of the Premises after expiration of the Term, or after any permitted termination of the Lease by Landlord, with Landlord&#8217;s
      acquiescence and without any written agreement between the parties, Tenant shall be a tenant at sufferance and such tenancy shall be subject to all the provisions hereof, except that the monthly Base Rent for said holdover period shall be one hundred
      fifty percent (150%) the amount of Base Rent due in the last full month of the Term, and Tenant shall pay I/12th of the previous year&#8217;s charges for all Additional Rent for each hold-over month. There shall be no renewal of this Lease by operation of
      law. Nothing in this Section shall be construed as a consent by Landlord to the possession of the Premises by Tenant after the expiration or earlier termination of the Term. In the event of any unauthorized holder-over, Tenant shall indemnify and
      hold harmless Landlord against all claims for damages by any other tenant to whom Landlord may have leased all or any part of the Premises effective upon the termination of this Lease. Anything in this Article to the contrary notwithstanding, the
      acceptance of any rent paid by Tenant pursuant to this Article XXIII shall not preclude Landlord from commencing and prosecuting a holdover or summary eviction proceeding, and the preceding sentence shall be deemed to be an &#8220;agreement expressly
      providing otherwise&#8221; within the meaning of Section 232-C of the Real Prope1ty Law of the State of New York and any successor law of like import.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">32</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 23.3<font style="font-weight: bold;">&#160; &#160;&#160; </font></font>On or before the first day of the thirtieth month following the Commencement Date, either patty hereto may, at any time,
      provide notice. of its intent to terminate this Lease early for any reason including for its convenience. Tenant&#8217;s ability to provide such notice is subject to it being in compliance with all of its obligations hereunder, and there being no
      then-current uncured default under Article XVI hereof. Such notice shall be in writing and may or may not specify a reason for the early termination. If notice is given, the early termination date shall be the first day of the thirty sixth month
      following the Commencement Date (the &#8220;<u>Early</u>&#160;<u>Termination Date</u>&#8221;). If Tenant chooses, in its discretion to specify a reason for its early termination, Landlord shall have thirty days in which to remedy or propose a remedy and to propose a
      schedule of implementation of the remedy which may or may not be accepted in the sole discretion of Tenant. In the event that Tenant elects to terminate this Lease early for reason unrelated to Landlord&#8217;s default hereunder, Tenant shall be
      responsible for the unamortized costs Landlord&#8217;s Work and leasing commissions.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXIV. </div>
    <div style="text-align: center; font-weight: bold;">NOTICES</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 24.1&#160; &#160;&#160; </font>Any notice permitted or required to be given by the terms of this Lease, or by any law or governmental regulation, shall be in writing. Unless otherwise
      required by such law or regulation, such notice shall be given, and shall be deemed to have been served and given when (1) deposited by registered or certified mail enclosed in a securely closed postpaid wrapper, in a United States Government general
      or branch post office, addressed to Landlord at the following addresses: </div>
    <div><br>
    </div>
    <div style="margin-left: 36pt;">BioBAT Executive Director </div>
    <div style="margin-left: 36pt;">c/o Downstate Medical Center </div>
    <div style="margin-left: 36pt;">450 Clarkson Avenue </div>
    <div style="margin-left: 36pt;">Brooklyn, New York 11203</div>
    <div><br>
    </div>
    <div style="margin-left: 36pt;">BioBAT President</div>
    <div style="margin-left: 36pt;">c/o Downstate Medical Center </div>
    <div style="margin-left: 36pt;">450 Clarkson Avenue </div>
    <div style="margin-left: 36pt;">Brooklyn, New York 11203</div>
    <div><br>
    </div>
    <div style="margin-left: 36pt;">Secretary of BioBAT Board </div>
    <div style="margin-left: 36pt;">110 William Street</div>
    <div style="margin-left: 36pt;">New York, New York 10038</div>
    <div> <br>
    </div>
    <div style="text-align: justify;"> and to Tenant at the Premises. Either party may, by notice as aforesaid designate a different address or addresses for notices, requests or demands to it. Any notice required to be given by Landlord under the
      provisions of this Article may be given by Landlord or Landlord&#8217;s managing agent or counsel. </div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">33</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXV. </div>
    <div style="text-align: center; font-weight: bold;">SUCCESSORS AND ASSIGNS</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 25.1&#160;&#160;&#160; </font>The terms, agreements, covenants and conditions contained in this Lease are binding upon and shall inure to the benefit of the patties hereto and their
      respective successors and assigns, except that Tenant shall have no right to assign this Lease or to Lease the space described herein without the express consent of the Landlord in writing except as othe1wise provided in Article XVIII.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXVI. </div>
    <div style="text-align: center; font-weight: bold;">SIGNS</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 26.1&#160; &#160; </font>Tenant shall not erect any sign in, on or about the Premises, the Building and/or the Property without the prior written consent of Landlord, which consent shall
      not be unreasonably withheld. Notwithstanding the foregoing, Tenant shall be permitted to place its name on the front entrance to the Premises and on all building directories. Tenant agrees and covenants that all such signs shall be in accordance
      with any applicable statutes, ordinances, codes, rules and/or regulations of any governmental authority and that Tenant shall maintain such signs and keep the same in a good state of repair.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">34</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXVII. </div>
    <div style="text-align: center; font-weight: bold;">SECURITY</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 27.1&#160; &#160;&#160; </font>Tenant has deposited with Landlord a sum of equal to three months Base Rent as of the date of this Lease Agreement as security for the faithful performance and
      observance by Tenant of the terms, provisions and conditions of the Lease. Landlord shall place the security in a non-interest-bearing account. It is agreed that in the event Tenant defaults in respect to any of the terms, provisions and conditions
      of the Lease, including, but not limited to, the payment of Rent, Landlord may use, apply or retain the whole or any part of the security so deposited to the extent required for the payment of any Rent or any other sum as to which Tenant is in
      default or for any sum which Landlord may expend or may be required to expend by reason of Tenant&#8217;s default, including but not limited to, any damages or deficiency in the reletting of the Premises, whether such damages or deficiency accrued before
      or after summary proceedings or other re- entry by Landlord. If any portion of the security is so used, applied, or retained, Tenant shall, within five (5) days after written demand therefor by Landlord, deposit cash with Landlord in an amount
      sufficient to restore the security to its original amount. In the event that Tenant shall fully and faithfully comply with all of the terms, provisions, covenants and conditions of the Lease, the security shall be returned to Tenant within thirty
      days following termination of the Lease as provided in Article XXIII and after delivery of possession of the Premises to Landlord. In the event of an assignment by Landlord of its estate in this Lease, Landlord shall have the obligation to transfer
      the security to the assignee and Landlord shall thereupon be released by Tenant from all liabilities for the return of such security. In the event of such assignment, Tenant agrees to look solely to the new Landlord for the return of such security.
      It is further agreed that the provisions hereof shall apply to every transfer or assignment made of the security to a new Landlord. Tenant further covenants that it will not assign or encumber or attempt to assign or encumber the monies deposited
      herein as security and that neither Landlord nor its successors or assigns shall be bound by any such assignment, encumbrance, attempted assignment or attempted encumbrance.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXVIII. </div>
    <div style="text-align: center; font-weight: bold;">LIMITATION OF LIABILITY</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 28.1&#160; &#160; </font>Landlord or its employees and agents shall not be liable for any damages or injury to property of Tenant or of any other person, including property entrusted to
      employees of Landlord, nor loss of or damage to any property of Tenant by theft or otherwise, nor for any injury or damage to persons or property resulting from any cause whatsoever, nor shall Landlord or its agents or employees be liable for any
      such damage caused by other tenants or persons in, upon or about the Building, or caused by operations in construction of any private, public or quasi-public work.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">35</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXIX. </div>
    <div style="text-align: center; font-weight: bold;">LATE PAYMENTS</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 29.1&#160; &#160;&#160; </font>Any payment of Rent or any other charges or fees not made within fifteen (15) days of the due date thereof shall have interest added at the rate of twelve (12%)
      percent per annum from the due date thereof.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXX. </div>
    <div style="text-align: center; font-weight: bold;">BROKER</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 30.1&#160; &#160;&#160; </font>Tenant represents that there was no broker responsible for bringing about or negotiating this Lease except for Colliers International NY LLC, concerning which
      Landlord will pay an applicable single commission pursuant to a separate agreement. Tenant agrees to defend, indemnify, and hold the Landlord Indemnified Parties harmless against any claims for brokerage commission or compensation with regard to the
      Premises by any broker claiming or alleging to have acted on behalf of or to have dealt with Tenant.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXXI.</div>
    <div style="text-align: center; font-weight: bold;">TENANT TO PROVIDE FINANCIAL STATEMENT</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 31.1&#160; &#160; </font>Tenant agrees that upon request by Landlord it will furnish to the Landlord such latest available financial statement as Landlord may require.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXXII. </div>
    <div style="text-align: center; font-weight: bold;">TENANT&#8217;S REMEDIES</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 32.1&#160; &#160;&#160; </font>With respect to any provision of this Lease which provides, in effect, that Landlord shall not unreasonably withhold or unreasonably delay any consent or any
      approval, Tenant in no event shall be entitled to make, nor shall Tenant make, any claim, and Tenant hereby waives any claim, for money damages; nor shall Tenant claim any money damages by way of setoff, counterclaim or defense, based upon any claim
      or assertion by Tenant that Landlord has unreasonably withheld or unreasonably delayed any consent or approval; but Tenant&#8217;s sole remedy shall be an action or proceeding to enforce any such provision, or for specific performance, injunction or
      declaratory judgment.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXXIII. </div>
    <div style="text-align: center; font-weight: bold;">TENANT&#8217;S ESTOPPEL CERTIFICATE</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 33.1&#160; &#160;&#160; </font>At any time and from time to time, and within ten (10) days after request by Landlord, Tenant agrees to execute, acknowledge and deliver to Landlord, a written
      statement certifying (a) that this Lease is unmodified and in full force and effect (or if there have been modifications that the same is in full force and effect as modified and identifying the modifications), (b) the dates to which the Rent and
      other charges have been paid, (c) that there are no offsets to the payment of Rent, (d) that Landlord is not in default under any provisions of the Lease and (e) any other certification reasonably requested by Landlord. It is intended that any such
      statement may be relied upon by any person proposing to acquire Landlord&#8217;s interest in this Lease or any prospective mortgagee of, or assignee of any mortgage upon such interest.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">36</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXXIV. </div>
    <div style="text-align: center; font-weight: bold;">WAIVERS BY TENANT</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 34.1&#160; &#160;&#160; </font>Tenant, for itself, and on behalf of any and all persons claiming through or under it, including creditors of all kinds, does hereby waive and surrender all
      right and privilege which they or any of them might have under or by reason of any present or future law, to redeem the Premises or to have a continuance of this Lease for the term hereby demised after having been dispossessed or ejected therefrom by
      process of law or after the termination of this Lease as provided herein.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 34.2&#160; &#160;&#160; </font>Tenant hereby waives the right to trial by jury in any action, summary proceeding, legal proceeding or counterclaim between or among the parties hereto or their
      successors or assigns on any matters whatsoever arising out of or in any way connected with this Lease, the relationship of Landlord and Tenant, Tenant&#8217;s use of or occupancy of the Premises and any emergency statutory or any other statutory remedy.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 34.3&#160; &#160; </font>Supplementing and in furtherance of the provisions of this Article XXXIV, hereof, Tenant hereby waives the right to interpose a counterclaim of whatever nature
      or description in any summary proceeding instituted by Landlord against Tenant for possession of the Premises or in any action or proceeding instituted by Landlord for unpaid Rent or other sums or charges payable by Tenant under this Lease. Such
      waiver is not intended to deny Tenant any right it may have to commence a separate proceeding against Landlord for any legal or equitable claims Tenant may have against Landlord.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXXV. </div>
    <div style="text-align: center; font-weight: bold;">EXCULPATION</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 35.1&#160; &#160;&#160; </font>Notwithstanding anything to the contrary contained herein, Tenant shall look solely to the interest of Landlord in the Lease and the Premises for the
      satisfaction of any of Tenant&#8217;s remedies with regard to the payment of money or othe1wise, and no other prope1ty or assets of Landlord shall be subject to levy, execution or other enforcement procedures for the satisfaction of Tenant&#8217;s remedies or
      with respect to this Lease, the relationship of Landlord and Tenant hereunder or Tenant&#8217;s use or occupancy of the Premises, such exculpation of personal liability to be absolute.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">37</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXXVI.</div>
    <div style="text-align: center; font-weight: bold;">EFFECT OF CONVEYANCE BY LANDLORD</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 36.1&#160; &#160;&#160; </font>If Landlord shall validly assign or transfer this Lease and deliver to Tenant an agreement, in recordable form or a counterpart thereof, executed by the
      assignee or transferee whereupon such assignee or transferee agrees to assume performance of all the covenants to be performed by Landlord from and after the date of such delivery to Tenant, then Landlord shall be relieved and discharged from any and
      all liabilities thereafter accruing under this Lease.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXXVII. </div>
    <div style="text-align: center; font-weight: bold;">SUBSTITUTE SPACE</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 37.1&#160; &#160;&#160; </font>At any time during the term of this Lease, Landlord shall have the right to substitute for the Premises other space in Landlord&#8217;s Premises (such other space
      hereinafter called the &#8220;<u>Substitute Premises</u>&#8221;) by written notice given to Tenant not later than sixty (60) days prior to the date set forth in said notice as the effective date (hereinafter, the &#8220;<u>Substitution Date</u>&#8221;) for such
      substitution. Landlord&#8217;s notice shall include a floor plan identifying the Substitute Premises, which premises shall have a rentable area equal to or greater than the Premises. Tenant shall vacate the Premises and surrender the same to Landlord on or
      before the Substitution Date. Tenant&#8217;s Base Rent for the Substitute Premises shall be no greater than the Rent on the prior Premises regardless of the increased size of the Substitute Premises. Landlord shall, promptly, after Tenant enters into
      occupancy of the Substitute Premises and provided Tenant is not then in default of any of the terms or conditions of this Lease, reimburse Tenant for any basic equipment transfer costs and expenses incurred by Tenant in connection with the
      substitution made hereunder which exceed those costs and expenses which would have been incurred by Tenant had the substitution not been made upon presentation of invoices therefor. From and after the Substitution Date, the term &#8220;<u>Premises</u>&#8221;
      shall mean the Substitute Premises for all purposes hereunder.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXXVIII. </div>
    <div style="text-align: center; font-weight: bold;">VENDEX</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 38.1&#160; &#160; </font>Tenant represents that it will and it will cause all subsequent assignees and transferees of this Lease to submit to the City&#8217;s Vendex background investigation
      (or any similar or successor system serving the same function) and/or Landlord&#8217;s due diligence including, but not limited to, the Internal Background Investigation Questionnaire (or any similar or successor system serving the same function) sixty
      (60) days prior to the transfer and shall require them to make the same representations contained in this Article.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 38.2&#160; &#160;&#160; </font>Tenant represents, warrants and covenants that neither Tenant nor any person or entity that directly or indirectly controls or is controlled by or is under
      common control with the Tenant or, to Tenant&#8217;s knowledge, any contractor, subcontractor, or any consultant that will be involved with Tenant&#8217;s operations at the Demised Premises:</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">38</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(a)&#160;&#160;&#160;&#160; is in default or in breach, beyond any applicable grace period, of its obligations under any written agreement with Prime Landlord or New York City, unless such default or breach has been
      waived in writing by the Prime Landlord or New York City, as the case may be;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160;&#160; has been convicted of a misdemeanor and/or found in violation of any administrative, statutory, or regulatory provision in the past five (5) years;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160; &#160; has been convicted of a felony, and/or crime related to truthfulness and/or business conduct in the past ten (10) years;</div>
    <div style="text-indent: 9pt;"><br>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 36pt;">(d) &#160; &#160;&#160; has any felony, misdemeanor and/or administrative charges currently pending;</div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160; &#160; has received written notice of default in the payment to New York City of any taxes, sewer rents or water charges, unless such default is then being contested with due diligence in
      proceedings in a court or other appropriate forum; or</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160; has owned at any time in the preceding three (3) years any property which, while in the ownership of such person, was acquired by New York City by in rem tax foreclosure, other than a
      property in which New York City has released or is in the process of releasing its interest to such person pursuant to the Administrative Code of New York City.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XXXIX. </div>
    <div style="text-align: center; font-weight: bold;">EXPANSION OPTION</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 39.1&#160; &#160;&#160; </font>Provided that no Event of Default, or an event which, upon the giving of notice or the passage of time could become and Event of Default, has occurred and is
      continuing under this Lease at such time, Tenant shall have the right to lease the Additional Space shown on <u>Exhibit A</u> at any time prior to the first anniversary of the Commencement Date. If Tenant desires to lease the Additional Space,
      Tenant shall give notice (the &#8220;<u>Tenant Election Notice</u>&#8221;) to Landlord. If Tenant shall fail to deliver such Tenant Election Notice prior to the first anniversary of the Commencement Date, then Landlord shall have the right to lease all or any
      portion of such Additional Space to any third party on any terms Landlord shall elect and Tenant shall have no further right whatsoever to lease all or any portion of the Additional Space.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 39.2&#160; &#160;&#160; </font>If Tenant shall deliver a Tenant Election Notice within the period set forth in <u>Section 39.1</u>, the following shall apply:</div>
    <div><br>
    </div>
    <div>
      <div style="text-indent: 36pt;">(a) &#160;&#160;&#160;&#160; the Additional Space shall be added to and deemed a part of the Premises thirty (30) days after delivery of Tenant&#8217;s Election Notice (the &#8220;<u>Additional Space Commencement Date</u>&#8221;) upon the same terms and
        conditions of this Lease, as the same may be modified in accordance with the following provisions of this <u>Section 39.2</u>; </div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(b)&#160;&#160;&#160;&#160; the Base Rent shall be increased on the Additional Space Commencement Date by an amount equal to the Additional Space Base Rent, which shall be calculated by multiplying the rentable square
      footage of the Additional Space by the then-current annual Base Rent per square foot;</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">39</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(c)&#160;&#160;&#160;&#160; the term of this Lease with respect to the Additional Space shall be coterminous with the Term under this Lease and shall expire on the same date as the Expiration Date (as it may have been
      extended) hereunder;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(d)&#160;&#160;&#160;&#160; the Additional Space shall be delivered in its &#8220;as is&#8221; condition (i) as a &#8220;warm lit shell&#8221; with electric service and HVAC stubbed to the Additional Space and (ii) sprinkler heads installed
      and turned up for Life Safety. Landlord shall have no obligation to perform any other work or make any installation in or to the Additional Space. Landlord shall allow Tenant a construction allowance of Ninety ($90.00) Dollars per rentable square
      foot of the Additional Space, to be paid against third-patty invoices for work completed in the Additional Space as certified by Tenant&#8217;s architect and accompanied by lien waivers and other reasonable documentation as required by Landlord for the
      completed work;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(e)&#160;&#160;&#160;&#160; Tenant&#8217;s Pro Rata Share shall be increased ratably by the rentable square footage of the Additional Space; and</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">(f)&#160;&#160;&#160;&#160;&#160; All other terms and conditions relating to the lease, use and occupancy of the Additional Space shall be as set forth in this Lease.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XL. </div>
    <div style="text-align: center; font-weight: bold;">EXTENSION OPTION</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 40.1&#160; &#160; </font>Provided that no Event of Default, or an event which, upon the giving of notice or the passage of time could become and Event of Default, has occurred and is
      continuing under this Lease at the time Tenant exercises the Renewal Option (defined below) or at the commencement of the Renewal Term (defined below), Tenant shall have the option (the &#8220;<u>Renewal Option</u>&#8221;) to renew this Lease for one additional
      term (the &#8220;<u>Renewal Term</u>&#8221;) of five (5) years by giving Landlord written notice (the &#8220;<u>Option Notice</u>&#8221;) no earlier than two years but no later than one year prior to the end of the initial Term. If Tenant fails to deliver to Landlord the
      Option Notice on or before the date that is one year prior to the end of the initial Term, time being of the essence hereunder, the option to renew this lease for the Renewal Term shall terminate and be of no further force and effect and Tenant shall
      have no further right to extend or renew this Lease. The Renewal Term shall be on the same terms and conditions as set forth in this Lease, except that Landlord may elect, in its sole discretion and at no cost to Tenant, to relocate the Premises to
      another location in the Landlord&#8217;s Premises selected by Landlord. Base Rental during the first year of the Renewal Term shall be the greater of (i) one hundred three (103%) percent of the Base Rental last in effect during the initial Term and (ii)
      Market Rent (as hereinafter defined) for renewals of tenant space in comparable quality buildings in the area in which the Premises is located.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">40</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify;">
      <div style="text-indent: 36pt;">(a)&#160;&#160;&#160;&#160; &#8220;<u>Market Rent</u>&#8221; shall be determined as follows: No later than nine (9) months prior to the Expiration Date, Landlord will advise Tenant of its determination of the Market Rent. If Landlord and Tenant
        cannot agree on the Market Rent within thirty (30) days of the date that Landlord provides Tenant with Landlord&#8217;s determination of the Market Rent, then within thirty (30) days after such failure to reach agreement, Landlord shall furnish to Tenant
        a notice in writing (&#8220;<u>Landlord&#8217;s Notice</u>&#8221;) stating what Landlord perceives to be Market Rent based on a statement from a qualified real estate appraiser retained by Landlord at Tenant&#8217;s reasonable cost and expense stating the appraiser&#8217;s
        opinion of Market Rent effective as of the commencement date of the Renewal Term and that it has been determined in accordance with this Paragraph. If the Tenant disagrees with the estimate of Market Rent submitted by Landlord with Landlord&#8217;s
        Notice, then within thirty (30) days after receipt of Landlord&#8217;s Notice, Tenant shall have the right to submit to Landlord a statement by a qualified real estate appraiser retained by Tenant at Tenant&#8217;s cost and expense stating the appraiser&#8217;s
        opinion of Market Rent effective as of the commencement date of the Renewal Term and that it has been determined in accordance with this Paragraph. If the higher estimate is not more than 105% of the lower estimate, the Market Rent shall be
        established as the average of the two appraisals. If the higher estimate is greater than 105% of the lower estimate, the two appraisers acting on behalf of Landlord and Tenant, shall, within fifteen (15) days after Tenant&#8217;s statement has been
        submitted, jointly appoint a third qualified real estate appraiser (the &#8220;<u>Referee</u>&#8221;) at Tenant&#8217;s cost. If the two appraisers are unable to agree upon the selection of a Referee, then the Referee shall be selected within fifteen (15) days
        thereafter by an arbitrator pursuant to the rules of the American Arbitration Association. The Referee shall, within thirty (30) days after appointment, render his decision which decision shall be strictly limited to choosing one of the two
        determinations made by the two appraisers chosen by Landlord and Tenant with respect to Market Rent. The decision of the Referee shall be binding upon Landlord and Tenant and shall constitute Market Rent for the purposes of determining the Base
        Rental. The cost of the Referee shall be shared equally by Landlord and Tenant. In determining Market Rent, the appraisers shall each take into account the following: (A) the amount of space and length of term taken by the Tenant; (B) the credit
        worthiness and quality of Tenant; and (C) rent in comparable buildings in the relevant competitive market. In determining Market Rent, the appraisers shall exclude from consideration: (A) tenant improvements installed by Tenant; (B) alterations
        installed by Tenant at its expense, during the Term; and (C) concessions offered to new tenants such as free rent, tenant improvement allowances, moving allowances and other concessions.</div>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ARTICLE XLI. </div>
    <div style="text-align: center; font-weight: bold;">MISCELLANEOUS</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 41.1&#160; &#160; </font>This Lease is transmitted for examination only and does not constitute an offer to Lease. This Lease shall become effective only upon execution hereof by the
      parties hereto and delivery by Landlord to Tenant of an executed Lease.</div>
    <div><br>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Section 41.2&#160; &#160;&#160; </font>This instrument contains the entire and only agreement between the parties. No oral statements or representations or prior written matter not contained herein
      shall have any force or effect.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">41</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Section 41.3&#160; &#160;&#160;</font><font style="font-size: 10pt;">This Lease shall not be modified, changed, or amended in any way or canceled, terminated or
        abridged except by a writing subscribed by both parties.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Section 41.4&#160; &#160; </font><font style="font-size: 10pt;">This Lease may be executed in one or more counterparts each one of which shall be deemed an
        original. E-mail and facsimile signatures shall also be sufficient to bind the parties hereto.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Section 41.5&#160; &#160;&#160;</font><font style="font-size: 10pt;">If any term or provision of this Lease or the application thereof to any person or circumstances
        shall, to any extent, be invalid unenforceable, the remainder of this Lease, or the application of such term or provision to persons or circumstances other than those as to which it is held invalid or unenforceable, shall not be affected thereby
        and each term and provision of this Lease shall be valid and enforced to the fullest extent permitted by law.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Section 41.6&#160; &#160; </font><font style="font-size: 10pt;">Landlord shall be excused for the period of any delay and shall not be deemed in default with
        respect to the performance of any of the term, covenants, and conditions of this Lease when prevented from so doing by causes beyond its reasonable control, which shall include, but not be limited to (a) strike, lockout or other labor troubles, (b)
        governmental restrictions or limitations, (c) failure or shortage of electrical power, gas, water, fuel oil, or other utility or service, (d) riot, war, insurrection or other national or local emergency, (e) accident, flood, fire or other casualty,
        (J) adverse weather condition, (g) other act of God, (h) delay in ability or inability to obtain a building permit or a certificate of occupancy or (i) other cause similar or dissimilar to any of the foregoing and beyond Landlord&#8217;s reasonable
        control (collectively, &#8220;<u>Force Majeure</u>&#8221;), provided, however, that none of the foregoing shall excuse delays in the payment of money.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Section 41.</font><font style="font-size: 10pt;"><font style="font-weight: bold;">7&#160; &#160;&#160; </font>Except as otherwise set forth herein, any obligations
        of Tenant and Landlord, as set forth herein (including, without limitation, Tenant&#8217;s rental and other monetary obligations, repair obligations, and obligations to indemnify Landlord), shall survive the expiration or earlier termination of this
        Lease.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Section 41.8&#160; &#160;&#160; </font><font style="font-size: 10pt;">This Lease shall be governed by and construed in accordance with the laws of the State of New
        York.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Section 41.9&#160; &#160;&#160; </font><font style="font-size: 10pt;">Neither this Lease nor any memorandum hereof shall be recorded without Landlord&#8217;s prior written
        consent.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Section 41.10&#160; &#160; </font><font style="font-size: 10pt;">Landlord shall provide approximately 250 square feet of space to Tenant to be utilized solely
        for storage purposes. Prior to placing its property in the storage space, Tenant shall provide Landlord with a written inventory of the items to be stored. Tenant shall pay an annual fee of $3,750.00, payable in monthly installments of $312.50 on
        the first day of each month during the first year of the term hereof, commencing on the Commencement Date. The annual fee increase by three (3%) percent on the first day of each subsequent lease year during the term hereof. Landlord reserves the
        right to withdraw or relocate such storage space at its sole discretion without any further responsibility to Tenant. Tenant shall provide Landlord with a written inventory of the items to be stored in such storages space, and shall secure such
        storage space at its sole cost and expense.</font></div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">42</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div><font style="font-weight: bold;">IN WITNESS WHEREOF, </font>the parties have caused these presents to be duly executed as of the day and year first above written.</div>
    <div><font style="color: rgb(73, 73, 73);"> <br>
      </font></div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" id="ze1baadf56b314534af9e5aaf0dd5d721" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;">

          <tr>
            <td style="width: 50%;">
              <div>&#160;</div>
            </td>
            <td colspan="2">
              <div style="text-align: left; font-weight: bold;">LANDLORD:</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%;">&#160;</td>
            <td colspan="2" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;">
              <div>&#160;</div>
            </td>
            <td colspan="2">
              <div style="text-align: left;"><font style="font-weight: bold;">BIOBAT, INC., </font>a New York Not-for-Profit corporation</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%;">&#160;</td>
            <td colspan="2" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; padding-bottom: 2px;">&#160;</td>
            <td rowspan="1" style="width: 3%; padding-bottom: 2px;">BY:<br>
            </td>
            <td rowspan="1" style="width: 47%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center;">/s/ Eva Cramer</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;">

          <tr>
            <td rowspan="1" style="width: 50%; padding-bottom: 2px;">&#160;</td>
            <td rowspan="1" style="text-align: center; border-bottom: 2px solid rgb(0, 0, 0); width: 3%;">&#160;<br>
            </td>
            <td rowspan="1" style="text-align: center; border-bottom: 2px solid rgb(0, 0, 0); width: 47%;">President</td>
          </tr>

      </table>
      <font style="color: rgb(73, 73, 73);"> </font></div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" id="z351c49b1b08b4c31b741f77194207be5" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;">

          <tr>
            <td style="width: 50%;">
              <div>&#160;</div>
            </td>
            <td colspan="2">TENANT:</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%;">&#160;</td>
            <td colspan="2" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;">
              <div>&#160;</div>
            </td>
            <td colspan="2">
              <div style="text-align: left;"><font style="font-weight: bold;">IRX THERAPEUTICS, INC., </font>a New <font style="color: rgb(54, 54, 54);">York corporation<br>
                </font></div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%;">&#160;</td>
            <td colspan="2" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; padding-bottom: 2px;">&#160;</td>
            <td rowspan="1" style="width: 3%; padding-bottom: 2px;">BY:<br>
            </td>
            <td rowspan="1" style="width: 47%; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">/s/ Jeffrey Hwang<br>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; padding-bottom: 2px;">&#160;</td>
            <td rowspan="1" style="border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">&#160;<br>
            </td>
            <td rowspan="1" style="border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">President &amp; COO <br>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">43</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center;"><img src="image01.jpg"></div>
    <div style="text-align: center;">
      <div><br>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">44</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center;"><img src="image02.jpg">
      <div><br>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">45</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin-top: 4px; margin-bottom: 4px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="text-align: center;"><u>EXHIBIT B</u></div>
    <div><br>
    </div>
    <div style="text-align: center;"><u>LAND</u></div>
    <div><br>
    </div>
    <div>
      <div style="text-align: center;">[ATTACHED]</div>
      <div style="text-align: center;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">46</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin-top: 4px; margin-bottom: 4px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
    </div>
  </div>
  <div style="text-align: center;">
    <div><br>
    </div>
    <img src="image03.jpg">
    <div><br>
    </div>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">47</font></div>
    <div id="DSPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div>
    <div style="text-align: center;"><u>EXHIBIT B-1</u></div>
    <div><br>
    </div>
    <div style="text-align: center;"><u>LANDLORD&#8217;S PREMISES</u></div>
  </div>
  <div>
    <div style="text-align: center; margin-right: 140.5pt; margin-left: 158.3pt;"> <br>
    </div>
    <div style="text-align: center;">[ATTACHED]</div>
    <div style="text-align: center;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">48</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
  </div>
  <div style="text-align: center;">
    <div><img src="image04.jpg"> </div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">49</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div><img src="image05.jpg">
      <div><br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">50</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div><img src="image06.jpg"></div>
    <div> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">51</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <div><img src="image08.jpg"></div>
      <div><br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">52</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: left;">
        <div style="text-align: center;"><u>EXHIBIT C</u></div>
        <div><br>
        </div>
        <div style="text-align: center;"><u>PERMITTED</u>&#160;<u>USES</u></div>
        <div><br>
        </div>
        <div style="text-indent: 63pt; text-align: justify;">The Corporation is formed and shall be operated exclusively for scientific, educational, and charitable purposes within the intent and meaning of Section 501(c)(3) of the Internal Revenue Code of
          1986, as amended (the &#8220;Code&#8221;), or corresponding provision of any subsequent federal tax laws.</div>
        <div><br>
        </div>
        <div style="text-align: justify;">Specifically, the Corporation will</div>
        <div> <br>
        </div>
        <div style="text-indent: 63pt; text-align: justify;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; attract, encourage, develop, improve and assist industry and public and private institutions in New York State by providing facilities and related support for the application of
          biotechnology, life sciences research or other appropriate technology development at the Brooklyn Army Terminal to develop and improve such research and related manufacturing; and,</div>
        <div> <br>
        </div>
        <div style="text-indent: 63pt; text-align: justify;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; attract, encourage, develop, improve and assist industry and public and private institutions in New York State by providing facilities and related support for the application of
          biotechnology, life sciences research or other appropriate technology development at the Brooklyn Army Terminal for appropriate technology transfer allowing for third party manufacture, sale and/or other distribution of products and/or services
          and (iii) facilitate research and economic development activities related to the City of New York and the research and educational mission of the State University of New York by managing, constructing, developing and operating facilities which
          support the economic development, research activities, and the mission of the State University of New York, Downstate Medical Center and the City of New York.</div>
        <div> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">53</font></div>
          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center;"><u>EXHIBIT D</u></div>
        <div><br>
        </div>
        <div style="text-align: center;"><u>WORK LETTER</u></div>
        <div><br>
        </div>
        <div style="margin-left: 36pt; text-align: justify;">BioBAT will make minor modifications to the existing model laboratory for IRX, a biotechnology company moving into this space. The model lab is located on the north-west portion of the second
          floor of Phase 2. It is composed of office space (rooms 2101, 2102, 2103, 2104, 2106, 2108, and 2111, laboratory space (room 2109), a storage room (room 2112) and a service corridor/freezer farm (room 2110). See CAD drawings. IRX Therapeutics,
          Inc. would like the following changes shown in Attachment A and described below:</div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7e91a9cd16ed476a95fbba7c744aef08">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">1.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Remove the existing wall between the laboratory (room 2109) and the storage room (room 2112).</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcf237e228da04d98bb215e9fd8806f95">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">2.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Construct a new wall 24 feet from the west wall of the storage room which will enlarge the storage room (room 2112) and decrease the size of the laboratory room (room 2109). This new wall will have a door
                  connecting the two rooms. Both rooms will be used as laboratories. Make sure lighting and HVAC are fine in both rooms.</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z58c387debd4b4854a8c1ef8a48ff21fa">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">3.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Polish floor of storage room (2112)</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z52ab7d0d3f274a22a5dc199781939928">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">4.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Install a new center island 15ft. long x 5 ft. wide in the storage room (room 2112). The center island should have a knee space in the center of each long side and a 50/50 combination of drawers and
                  cabinets.</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z36ea2a8533a840fa99c5013511fc673b">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">5.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Install a new bench (approximately 10 ft. long) against the new west wall in the storage room (2112) with a 5 ft x 2.5 ft. sink at the north end of the bench. The bench should have a knee space in the
                  center of the long side and a 50/50 combination of drawers and cabinets.</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze61979d846e140108377572e7c8c0e4b">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">6.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Install a new bench (approximately 12.5 ft. long on one side and 7.5 ft. long on the other side) in laboratory room (2109). The bench should have a sink (2.5 ft. x 5 ft.) at the north end of the bench.
                  There should be a knee space in the center of each long side and a 50/50 combination of drawers and cabinets.</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z95c865db4b69404c9e9b688898dcafc0">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">7.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Emergency power -All emergency power will need the standard 120 V NEMA 5-15 outlet except one in the service corridor/freezer farm (room 2110), which is indicated by a box on the drawing in Attachment A. It
                  will need a 120 V NEMA 5-20 outlet (see Attachment B). The emergency power locations (see Attachment A) are as follows:</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">54</font></div>
          <div style="page-break-after:always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze175de09da3f47b9b477b0c9ff1e3745">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">a.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">One instance of emergency power in storage room (room 2112) on east wall to supply one incubator.</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd8f24fed821d4aeebc8a27b915fc0283">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">b.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Two instances of emergency power on north wall of laboratory room (room 2109) to supply two incubators.</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdeaf9acfd7744bda97d9f10063a3bad0">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">c.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Ten instances of emergency power along the north wall of the service corridor/freezer farm (2110) placed about 5 feet apart. <font style="font-weight: bold;">Please note: </font>Contractor needs to check
                  existing power on the north wall of the service corridor/freezer farm (room 2110) for existing outlets and if additional instances are necessary.</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdfd3ee36ec274004947fcec3b7201b76">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">8.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Specialized outlets (See Attachment B)</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z12e3292a6f9e4b62a64c38f1724d3a7d">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">a.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">As mentioned in number 7 above, one freezer in the service corridor/freezer farm will need a 120 V NEMA 5-20 outlet.</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1855eb3d9685453bbe76530ca2e4c3e5">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">b.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Three instances of 240 V NEMA 6-20 outlets in the labs. Two will be in the southeast section of the center island in the storage room (room 2112) to supply two table centrifuges and one on a bench toward
                  the west end of the laboratory (room 2109) to supply a table centrifuge.</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">55</font></div>
          <div id="DSPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: center;">
          <div><img src="image07.jpg"></div>
          <div><br>
          </div>
          <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div id="DSPFPageNumberArea"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">56</font></div>
            <div id="DSPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <img src="image09.jpg">
          <div>
            <div>
              <div><br>
                <div><br>
                </div>
                <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div id="DSPFPageNumberArea"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">57</font></div>
                  <div id="DSPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="text-align: left;">
                  <div style="text-align: center; margin-right: 187.75pt; margin-left: 185.3pt;"><u>EXHIBIT E</u></div>
                  <div><br>
                  </div>
                  <div style="text-align: center; margin-right: 5.3pt; margin-left: 2.2pt;"><u>RULES AND REGULATIONS</u></div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">The rules and regulations set forth in this Exhibit shall be and hereby are made a part of the Lease to which they are attached. Whenever the term &#8220;Tenant&#8221; is used in these rules and
                    regulations, it shall be deemed to include Tenant, its employees or agents and any other persons permitted by Tenant to occupy or enter the Premises. The following rules and regulations may from time to time be modified by Landlord in
                    its discretion.</div>
                  <div> </div>
                  <div style="text-align: justify; text-indent: 63pt;"> </div>
                  <div style="text-align: justify; text-indent: 63pt;"> </div>
                  <div style="text-align: justify; text-indent: 63pt;"> </div>
                  <div style="text-align: justify; text-indent: 63pt;"> <br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">1.&#160; &#160; &#160; <u>Obstruction</u>: The sidewalks, any entries, passages, corridors, halls, lobbies, stairways located outside the Premises, elevators and other common facilities of the
                    Landlord&#8217;s Premises shall be controlled by Landlord and shall not be obstructed by Tenant or used for any purposes other than ingress or egress to and from the Premises. Tenant shall not place any item in any of such locations, whether
                    or not any such item constitutes an obstruction, without the prior written consent of Landlord. Landlord shall have the right to remove any obstruction or any such item without notice to Tenant and at the expense of Tenant. The floors,
                    skylights and windows that reflect or admit light into any place in said Landlord&#8217;s Premises shall not be covered or obstructed by Tenant.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">2.&#160;&#160;&#160;&#160; <u>Deliveries</u>: Tenant shall insure that all deliveries to the Premises (including, without limitation, deliveries of mail, office supplies, beverages and soft drinks,
                    catered meals and all other deliveries of bulk items) shall be made only upon the elevator designated by Landlord for deliveries and only during the ordinary business hours of the Landlord&#8217;s Premises. If any person making deliveries to
                    Tenant damages the elevator or any other part of the Landlord&#8217;s Premises or Property, Tenant shall pay to Landlord upon demand the amount required to repair such damage and restore the area to its previous condition.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">3.&#160;&#160;&#160;&#160;&#160; <u>Moving</u>: Furniture and equipment shall be moved in or out of the Landlord&#8217;s Premises only upon the elevator designated by Landlord for furniture and equipment deliveries
                    and then only during such hours and in such manner as may be prescribed by Landlord. Landlord shall have the right to approve or disapprove the movers or moving company employed by Tenant and Tenant shall cause such movers to use only
                    the loading facilities and elevator designated by Landlord. If Tenant&#8217;s movers damage the elevator or any other part of the Landlord&#8217;s Premises, Tenant shall pay to Landlord upon demand the amount required to repair such damage and
                    restore the area to its previous condition.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">4.&#160;&#160;&#160;&#160;&#160; <u>Heavy Articles</u>: No safe or article the weight of which may, in the reasonable opinion of Landlord, constitute a hazard or may cause damage to the Landlord&#8217;s Premises or
                    its equipment, shall be moved into the Premises. Safes and other heavy equipment, the weight of which will not constitute a hazard or cause damage the Landlord&#8217;s Premises or its equipment shall be moved into, from or about the
                    Landlord&#8217;s Premises only during such hours and in such manner as shall be prescribed by Landlord and Landlord shall have the right to designate the location of such articles in the Premises.&#160; The floor load for the Premises is 100
                    pounds per square foot live load and shall not be exceeded by Tenant.</div>
                  <div style="text-align: justify;"> <br>
                  </div>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">58</font></div>
                    <div style="page-break-after:always;" id="DSPFPageBreak">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">5.&#160;&#160;&#160;&#160;&#160; <u>Nuisance</u>: Tenant shall not do or permit anything to be done in the Premises, or bring or keep anything therein which would in any way constitute a nuisance or waste, or
                    obstruct or interfere with the rights of other tenants of the Landlord&#8217;s Premises, or in any way injure or annoy them, or conflict with the laws relating to fire, or with any regulations of the fire department or with any insurance
                    policy upon the Landlord&#8217;s Premises or any part thereof, or conflict with any of the rules or ordinances of any governmental authority having jurisdiction over the Landlord&#8217;s Premises (including, by way of illustration and not
                    limitation, using the Premises for sleeping, lodging or cooking).</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">6.&#160;&#160;&#160;&#160; <u>Building Security</u>: Landlord may restrict access to and from the Premises and the Landlord&#8217;s Premises outside of the ordinary business hours of the Landlord&#8217;s Premises at
                    any time for reasons of Building Security. Landlord may require identification of persons entering and leaving the Landlord&#8217;s Premises during this period and, for this purpose, may issue building passes to tenants of the Landlord&#8217;s
                    Premises. Landlord shall not be liable to any person (including, without limitation, Tenant) for excluding any person from the Landlord&#8217;s Premises or for admission of any person to the Landlord&#8217;s Premises at any time, or for damage,
                    loss or theft resulting therefrom.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">7.&#160;&#160;&#160;&#160; &#160; <u>Locks and Keys for Premises</u>: No additional lock or locks shall be placed by Tenant on any door in the Premises and no existing lock shall be changed unless the written
                    consent of Landlord shall first have been obtained, which consent shall not be unreasonably withheld. A reasonable number of keys to the Premises and to the toilet rooms, if locked by Landlord, will be furnished by Landlord, and Tenant
                    shall not have any duplicate keys made. Landlord also shall furnish to Tenant a reasonable number of card keys/fobs or building passes permitting access and egress to and from the Landlord&#8217;s Premises and elevators within the Landlord&#8217;s
                    Premises at a fee of Twenty &amp; 00/100 ($20.00) Dollars per fob or key. The distribution and use of such card keys and passes by Tenant and its employees shall be subject at all times to such additional rules as Landlord may
                    promulgate from time to time. At the termination of this Lease, Tenant shall promptly return to Landlord all keys, fobs, card keys and building passes to the Landlord&#8217;s Premises, offices, toilet rooms, and parking facilities. Tenant
                    shall promptly repot to Landlord the loss or theft of any key, card key or building pass.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">8.&#160;&#160;&#160;&#160; <u>Signs</u>: Signs on Tenant&#8217;s entrance door will be designed, furnished and installed by Tenant at Tenant&#8217;s expense, subject to Landlord&#8217;s approval.&#160; No advertisement, sign or
                    other notice shall be inscribed, painted or affixed on any part of the outside or inside of the Landlord&#8217;s Premises, except upon Tenant&#8217;s interior doors as permitted by Landlord, which advertisement, signs or other notices shall be of
                    building standard order, size and style, and at such places as shall be designated by Landlord. In addition, Landlord shall provide in the lobby of the Landlord&#8217;s Premises, at Landlord&#8217;s expense, a building directory which shall include
                    Tenant&#8217;s name.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">9. &#160;&#160; &#160; <u>Use of Water Fixtures</u>: Water closets and other water fixtures shall not be used for any purpose other than for which the same are intended and no obstructing or improper
                    substance shall be thrown, deposited or disposed of therein. Any damage resulting to the same from misuse on the part of Tenant shall be paid for by Tenant. No person shall waste water by tying back or wedging the faucets or in any
                    other manner.</div>
                  <div style="text-align: justify;"> <br>
                  </div>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">59</font></div>
                    <div style="page-break-after:always;" id="DSPFPageBreak">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">10.&#160;&#160;&#160; <u>No Animals, Excessive Noise</u>: No birds, fish, or other animals (other than seeing eye dogs) shall be allowed in the offices, halls, corridors and elevators in the
                    Landlord&#8217;s Premises. No person shall disturb Tenants of this or adjoining buildings or space by the use of any radio, musical instrument or singing, or by the making of loud or improper noises.</div>
                  <div style="text-align: justify; text-indent: 69pt; margin-right: 6.35pt; margin-left: 6.25pt;"> <br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">11.&#160; &#160;&#160; <u>Bicycles</u>: Bicycles or other vehicles shall not be permitted anywhere inside or on the sidewalks outside the Landlord&#8217;s Premises, except in those areas, if any,
                    designated by Landlord as secure bicycle parking. No motorized vehicles of any kind shall be brought into or kept in or about the Premises. Tenant and only its employees may bring bicycles into the Building only if they comply with the
                    New York City LL-52 Bicycle Access to Office Buildings Law and the Bicycle Access Rules and Regulations for the Building.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">12.&#160;&#160;&#160; <u>Trash</u>: Tenant shall not allow anything to be placed on the outside of the Landlord&#8217;s Premises, nor shall anything be thrown by Tenant out of the windows or doors, or down
                    the corridors, elevator shafts, or ventilating ducts or shafts of the Landlord&#8217;s Premises. All trash shall be placed in receptacles provided by Tenant on the Premises or in any receptacles provided by Landlord for the Landlord&#8217;s
                    Premises. Tenant will separate recyclable materials from other trash in accordance with Landlord&#8217;s instructions.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">13.&#160;&#160;&#160; <u>Hou</u><u>rsforRepairs,Maintenance&#160;and&#160;Alteration</u><u>s</u>:&#160; Any repairs, maintenance and alterations required or permitted to be done by Tenant under the Lease shall be
                    done only during the ordinary business hours of the Landlord&#8217;s Premises, unless Landlord shall have first consented in writing to such work being done outside such times. If Tenant desires to have such work done by Landlord&#8217;s employees
                    on Saturdays, Sundays, holidays or weekends outside of ordinary business hours, Tenant shall pay the extra cost of such labor.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">14.&#160; &#160;&#160; <u>No Defacing of Premises</u>: Except as permitted by Landlord and by this Lease, Tenant shall not mark up, cut, drill into, drive nails or screws into, or in any way deface&#160;
                    the doors, walls, ceilings or floors of the Premises or of the Landlord&#8217;s Premises, nor shall any connection be made to the electric wires or electric fixtures without the consent in&#160; writing on each occasion of Landlord or its agents,
                    and any defacement, damage or injury caused by Tenant shall be paid for Tenant.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">15.&#160;&#160; &#160; <u>Limit on Equipment</u>: Tenant shall not, without Landlord&#8217;s prior written consent, install or operate any computer, duplicating or other large business machines or
                    equipment, using more than 110 volts, 16 continuous load amps upon the Premises, or carry on any mechanical business thereon. If Tenant requires any interior wiring such as for a business machine, intercom, printing equipment or copying
                    equipment, such wiring shall be done only by Landlord&#8217;s electrician for the Landlord&#8217;s Premises and at Tenant&#8217;s expense. No electrical wiring shall be performed by any person unless previously approved in writing by Landlord or its
                    representative. If telegraphic or telephonic service is desired, the wiring for same shall be done as directed by the electrician of the Landlord&#8217;s Premises, or by some other employee of Landlord who may be instructed by the
                    superintendent of the Landlord&#8217;s Premises to supervise same, and no boring or cutting for wiring shall be done unless approved by Landlord or its representatives, as stated.</div>
                  <div style="text-align: justify;"> <br>
                  </div>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">60</font></div>
                    <div style="page-break-after:always;" id="DSPFPageBreak">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">16.&#160;&#160; &#160; <u>Solicitation, Food and Beverages</u>: Landlord reserves the right to restrict, control or prohibit canvassing, soliciting and peddling within the Landlord&#8217;s Premises. Tenant
                    shall not grant any concessions, licenses or permission for the sale or taking of orders for food, alcoholic beverages, services or merchandise in the Premises, nor install or permit the installation or use of any machine or equipment
                    for dispensing goods or foods or beverages in the Landlord&#8217;s Premises, nor permit machine or equipment for dispensing goods or food or beverages in the Landlord&#8217;s Premises, nor permit the preparation, serving, distribution or delivery
                    of food or beverages in the Premises without the approval of Landlord and in compliance with arrangements prescribed by Landlord, except in connection with convenience lunch rooms or beverage service or catered functions for employees,
                    clients and guests of Tenant (on a noncommercial basis). Only persons approved in writing by Landlord shall be permitted to serve, distribute, or deliver food and beverages within the Landlord&#8217;s Premises, or lo the use the elevators or
                    public areas of the Landlord&#8217;s Premises for that purpose.</div>
                  <div style="text-align: justify; text-indent: 69.4pt; margin-right: 5.9pt; margin-left: 6.6pt;"> <br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">17.&#160; &#160; <u>Smoke Free Building</u>: The Landlord&#8217;s Premises is a smoke free building and Tenant shall not permit any of its employees, agents, contractors, subcontractors, invites,
                    guests or visitors to smoke in the Landlord&#8217;s Premises or Premises.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 63pt;">18.&#160;&#160;&#160;&#160; <u>Sustainability</u>. The building is or may become in the future certified under the LEED rating system, or other standard or operated pursuant to Landlord&#8217;s sustainable
                    building practices. Landlord&#8217;s sustainability practices address whole-building operations and maintenance issues including chemical use; indoor air quality; energy efficiency; water efficiency; recycling programs; exterior maintenance
                    programs; and systems upgrades to meet green building energy, water, indoor air quality, and lighting performance standards. All construction and maintenance methods and procedures, material purchases, and disposal of waste must be in
                    compliance with minimum standards and specifications, in addition to all Legal Requirements. Furthermore, Tenant acknowledges that it is Landlord&#8217;s intention that the Property be operated in a manner which is consistent with Landlord&#8217;s
                    sustainability practices. Tenant is required to comply with these practices within its Premises.</div>
                  <div><br>
                  </div>
                  <div style="text-align: center;">BROOKLYN ARMY TERMINAL RULES AND REGULATIONS</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">l.&#160;&#160;&#160;&#160;&#160;&#160;&#160; All waste must be properly sealed and stored within Tenant&#8217;s respective unit(s) until the day of trash collection or until the waste is deposited in one of the trash containers.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">2.&#160;&#160;&#160;&#160;&#160;&#160; All Building emergencies shall be reported immediately to Brooklyn Army Terminal&#8217;s management office or the security desk in person during regular work hours or by calling 718/492-2 I 91 or
                    718/630-2429 (security desk).</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">3.&#160;&#160;&#160;&#160;&#160; All loading bays may be used only for loading and off-loading merchandise; no parking is allowed. Landlord reserves the right to tow vehicles and equipment that (a) are owned or leased by Tenant,
                    (b) are present for the benefit of Tenant, (c) are present at the Brooklyn Army Terminal by Tenant&#8217;s authorization, or (d) are otherwise contracted by Tenant or its agents, including, but not limited to, officers, employees, customers,
                    vendors, suppliers, delivery persons and/or invitees.</div>
                  <div style="text-align: justify;"> <br>
                  </div>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">61</font></div>
                    <div style="page-break-after:always;" id="DSPFPageBreak">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  </div>
                  <div>
                    <div style="text-align: justify;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Freight elevators are not to be held on any floor except while loading or off-loading merchandise; the only permitted method of holding a freight elevator is by the use of the hold button.</div>
                  </div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">5.&#160;&#160;&#160; &#160; &#160; No materials, including, but not limited to, supplies, inventory, pallets, waste, debris and/or related items, shall be stored or otherwise left in any Common Facilities or in any unoccupied
                    unit of the Brooklyn Army Terminal without prior written permission from Landlord in each occurrence. If Landlord should find said materials .in any Common Facilities or unoccupied unit of the Brooklyn Army Terminal and notify Tenant&#8217;s
                    on-site resident manager, shift supervisor, or equivalent of same, then Tenant shall have eight (8) hours within which to remove same; if said materials are not removed within said eight hours, then (i) Landlord shall have the right to
                    remove any such items at Tenant&#8217;s sole expense, including, but not limited to, moving costs, equipment rental, labor charges and administrative costs, and (ii) Tenant shall be charged at least one hundred dollars ($100) per day for
                    storage of same (based on square footage required to store said materials), which charge shall be deemed Additional Rent and shall be due&#160; and payable with the following month&#8217;s rent. Further, if Landlord gives Tenant written notice as
                    set forth in the Lease herein, then Landlord shall have the right of disposing, at Tenant&#8217;s sole expense, of any of said materials after forty-eight (48) hours of said notice. Tenant shall indemnify and hold Landlord harmless from any
                    liabilities and/or damages, direct or consequential, that may arise in connection with Landlord&#8217;s removal, storage and/or disposal of any said materials.</div>
                  <div><br>
                  </div>
                  <div>
                    <div style="text-align: justify;">6. &#160; &#160; &#160;&#160; All employees must obtain and carry with them a Brooklyn Army Terminal picture identification card, subject to a nominal charge, while on Brooklyn Army Terminal premises; employees must
                      present their identification to security personnel when requested to do so.</div>
                  </div>
                  <div><br>
                  </div>
                  <div>
                    <div style="text-align: justify;">7. &#160; &#160; &#160;&#160; Tenants shall keep access from Tenant&#8217;s Premises to all fire stairwells unobstructed, unimpeded and accessible at all times.</div>
                  </div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">8. &#160;&#160;&#160;&#160; All contractors must present to Building management a New York City Building Department Permit and a Certificate of Insurance, satisfactory to Building management, before any construction work
                    commences.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Vehicles that have been issued a parking permit must be parked in the area designated by the permit.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">10.&#160;&#160;&#160;&#160;&#160; Vehicles are prohibited from standing or parking in the fire lanes at the entrances on the north and south sides of the Building; these fire lanes must be kept unobstructed at all times for use
                    only by emergency vehicles.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">11.&#160;&#160;&#160;&#160;&#160; Landlord shall have the right to prohibit any advertising by any tenant which, in Landlord&#8217;s opinion, tends to impair the reputation of the Brooklyn Army Terminal, the Building or its
                    desirability as a Building, and upon written notice from Landlord, such tenant shall refrain from or discontinue such advertising.</div>
                  <div style="text-align: justify;"> <br>
                  </div>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">62</font></div>
                    <div style="page-break-after:always;" id="DSPFPageBreak">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  </div>
                  <div style="text-align: justify; text-indent: 0.6pt;">12.&#160;&#160;&#160;&#160; Tenant shall not bring or permit to be brought or kept in or on the Premises, any inflammable, combustible or explosive fluid, material, chemical or substance, without
                    Landlord&#8217;s prior written permission (with the exception of small quantities of cleaning supplies and office supplies and with the exception of limited amounts necessary in the ordinary course of the operation of the Tenant&#8217;s Permitted
                    Use (pursuant to Article 3) at the demised premises (provided that all such exceptions are used, handled, maintained, and stored in the demised premises, and disposed of, in accordance with this Lease including, without limitation,
                    Article 27 requiring compliance with all present and future laws, orders and regulations of all state, federal, municipal and local governments, departments, commissions and boards and any direction of any public officer pursuant to
                    law, and all orders, rules and regulations of the New York Board of Fire Underwriters, or the Insurance Services Office, or any similar body) or cause or permit any odors of cooking or other processes, or any unusual or other
                    objectionable odors to permeate in or emanate from the Premises.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 0.55pt;">13.&#160;&#160;&#160; &#160; Tenant shall not use the Premises in a manner which disturbs or interferes with other tenants in the beneficial use of their premises.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify; text-indent: 0.15pt;">14.&#160;&#160;&#160;&#160; No machinery or mechanical equipment of any kind shall be so placed or operated as to disturb other tenants; and such machinery and mechanical equipment used in a tenant&#8217;s
                    premises shall be so equipped, installed and maintained by such tenant as to prevent any disturbing noise, vibration or electrical or other interference from being transmitted from such premises to any other area of the Building.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">15.&#160;&#160;&#160;&#160;&#160; No tenant shall install any window mounted air conditioners within the Premises or any other portion of the Building.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">16.&#160;&#160;&#160;&#160; No noise or other activity, including the playing of any musical instruments, radio, television or other sound reproduction system, which would, in Landlord&#8217;s judgment, disturb other tenants in
                    the Building, shall be made or permitted by any tenant, and no cooking shall be done in any tenant&#8217;s premises, except as expressly approved in writing by Landlord.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">17.&#160;&#160;&#160;&#160; Any hazardous waste materials that may be located within any tenant&#8217;s premises shall be disposed of in accordance with all applicable laws, ordinances and regulations of any public authorities
                    governing the same.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">18.&#160;&#160;&#160;&#160;&#160; All entrance doors in each tenant&#8217;s premises shall be left locked by such tenant when such tenant&#8217;s premises are not in use.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">19.&#160;&#160;&#160; The requirements of tenants will be attended to only upon application to the Building superintendent or Landlord&#8217;s managing agent (or other person designated in writing by either of them) at his
                    office in the Building or other location in the Brooklyn Army Terminal. Building employees shall not be requested by any tenant, and will not be permitted, to perform any work or services specially for any tenant, unless expressly
                    authorized to do so by the Building superintendent or Landlord&#8217;s managing agent.</div>
                  <div style="text-align: justify; text-indent: 0.35pt; margin-right: 5.55pt; margin-left: 5.85pt;"> <br>
                  </div>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">63</font></div>
                    <div style="page-break-after:always;" id="DSPFPageBreak">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  </div>
                  <div style="text-align: justify;">20. &#160; &#160;&#160; If attendance of Landlord&#8217;s or the managing agent&#8217;s personnel and/or service contractors shall be required, as shall be reasonably determined by Landlord or its managing agent in all instances,
                    in connection with the use by any tenant of freight elevators outside of ordinary business hours or in connection with the moving into or out of the Building by or for any tenant of any machinery, equipment, safes, heavy objects,
                    freight, furniture or other bulky matter, during or outside regular business hours, the tenant so requiring such services shall pay Landlord, on demand, as Additional Rent, such amount as Landlord shall determine to be appropriate as a
                    charge for Landlord&#8217;s or its managing agent&#8217;s personnel and/or service contractors used pursuant to this Rule 20.</div>
                  <div><br>
                  </div>
                  <div style="text-align: justify;">21.&#160;&#160;&#160;&#160;&#160; Landlord may refuse admission to the Brooklyn Army Terminal, including the Building, to any person not known to the watchman in charge or not having a pass issued by Landlord or its agent or not
                    properly identified, and may require all persons admitted to or leaving the Building to register. Any person whose presence in the Brooklyn Army Terminal including the Building, at any time shall, in the judgment of Landlord or its
                    managing agent, be prejudicial to the safety, character, reputation and interests of the Brooklyn Army Terminal or of its tenants may be denied access to the Brooklyn Army Terminal, including the Building, or may be ejected therefrom.
                    In case of invasion, riot, public excitement or other commotion, Landlord may prevent all access to the Brooklyn Army Terminal during the continuance of the same, by closing the doors or otherwise, for the safety of the tenants and
                    protection of property in the Brooklyn Army Terminal. Landlord may require any person leaving the Building with any package or other object to exhibit a pass from the tenant from whose premises the package or object is being removed,
                    but the establishment and enforcement of such requirement shall not impose any responsibility on Landlord for the protection of any tenant against the removal of tenant&#8217;s property from such tenant&#8217;s premises. Landlord shall in no way be
                    responsible or liable to any tenant for damages or loss arising from the admission, exclusion or ejection of any person to or from the Tenant&#8217;s premises or the Building under the provisions of this Rule. Each tenant shall be responsible
                    for all persons for whom he requests admission or a pass and shall be liable for all acts of such persons.</div>
                  <div><br>
                  </div>
                  <div>
                    <div style="text-align: justify;">22. &#160; &#160;&#160; Tenant shall not at any time store or keep any material, supplies, furniture, furnishings or equipment of any kind in any machine room or in any mechanical or electrical equipment room in the
                      Building, whether such room be within or outside the premises demised to Tenant.</div>
                  </div>
                  <div><br>
                  </div>
                  <div>
                    <div style="text-align: justify;">23. &#160; &#160;&#160; Landlord may charge Tenant for directory board changes subsequent to initial listings. All requests for directory board listings shall be in writing on Tenant&#8217;s letterhead signed by an
                      authorized representative of Tenant.</div>
                  </div>
                  <div><br>
                  </div>
                  <div>
                    <div>24.&#160;&#160;&#160;&#160;&#160; No food shall be eaten in the main lobby of the Building and alcoholic beverages are not permitted in the Building.</div>
                  </div>
                  <div><br>
                  </div>
                  <div>
                    <div style="text-align: justify;">25.&#160;&#160;&#160;&#160;&#160; Landlord reserves the right to rescind, alter, waive, expand or add any rule or regulation at any time prescribed for the Brooklyn Army Terminal or the Building when, in Landlord&#8217;s judgment, it
                      deems it necessary, desirable or proper for its best interest and for the best interests of the other tenants in the Building, and no change or waiver of any rule or regulation in favor of one tenant shall operate as a change or
                      waiver in favor of any other tenant. Landlord shall not be responsible to any tenant for the nonobservance or violation by any other tenant of any of the rules and regulations at any time prescribed for the Building.</div>
                  </div>
                  <br>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">64</font></div>
                    <div style="page-break-after:always;" id="DSPFPageBreak">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  </div>
                  <!--PROfilePageNumberReset%Num%1%%%-->
                  <div>
                    <div style="color: rgb(0, 0, 0); font-weight: bold; text-align: center;"><u>FIRST AMENDMENT TO LEASE AGREEMENT</u></div>
                    <div style="color: rgb(0, 0, 0);"><br>
                    </div>
                    <div style="text-align: justify; text-indent: 27pt;"><font style="color: rgb(0, 0, 0);">THIS FIRST AMENDMENT TO LEASE (this <font style="color: rgb(0, 0, 0);">&#8220;</font><u>Amendment</u>&#8221;)&#160;is executed as of the 28th day of September,
                        2015, by and between </font><font style="font-weight: bold; color: rgb(0, 0, 0);">BIOBAT, INC., </font><font style="color: rgb(0, 0, 0);">a New York Not-for-Profit corporation (&#8220;<u>Landlord</u>&#8221;), and IRX </font><font style="font-weight: bold; color: rgb(0, 0, 0);">THERAPEUTICS, INC., </font><font style="color: rgb(0, 0, 0);">a New York corporation (&#8220;<u>Tenant</u>&#8221;).</font></div>
                    <div style="color: rgb(0, 0, 0);"><br>
                    </div>
                    <div style="text-align: center;"><font style="color: rgb(0, 0, 0);"><u>W</u> <u>I</u> <u>T</u> <u>N</u> <u>E</u> <u>S</u> <u>S</u> <u>E</u>
                        <u>T</u> <u>H:</u></font></div>
                    <div style="color: rgb(0, 0, 0);"><br>
                    </div>
                    <div style="text-align: justify; text-indent: 27pt;"><font style="color: rgb(0, 0, 0);">WHEREAS, Landlord and Tenant entered into that certain Lease Agreement dated as of the date hereof (the &#8220;<u>Lease</u>&#8221;), whereby Tenant leases from
                        Landlord certain space in that certain building known as Building A of the Brooklyn Army Terminal, Brooklyn, New York (the &#8220;<u>Building</u>&#8221;);&#160;and</font></div>
                    <div style="text-indent: 27pt;"><font style="color: rgb(0, 0, 0);"> <br>
                      </font></div>
                    <div style="text-indent: 27pt;"><font style="color: rgb(0, 0, 0);">WHEREAS, Landlord and Tenant desire to amend certain provisions of the Lease;</font></div>
                    <div style="color: rgb(0, 0, 0);"><br>
                    </div>
                    <div style="text-align: justify; text-indent: 27pt;"><font style="color: rgb(0, 0, 0);">NOW, THEREFORE, in consideration of the foregoing premises, the mutual covenants herein contained and each act performed hereunder by the parties,
                        and for other good and valuable consideration, Landlord and Tenant hereby enter into this Amendment.</font></div>
                    <div style="color: rgb(0, 0, 0);"><br>
                    </div>
                    <div style="color: rgb(0, 0, 0);">
                      <div style="margin-left: 26.65pt;"><font style="color: rgb(0, 0, 0);">1.&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Incorporation&#160;of&#160;Recitals</u>. The above recitals are hereby incorporated into this Amendment as if fully set forth herein.</font> </div>
                      <div style="margin-left: 62.65pt;"><font style="color: rgb(0, 0, 0);"> <br>
                        </font></div>
                    </div>
                    <div style="margin-left: 26.65pt;"><font style="color: rgb(0, 0, 0);">2.&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Section </u><u>1</u><u>.</u><u>1</u>.&#160;In Section 1.1 of the Lease, the number &#8220;7,250&#8221; is hereby deleted and replaced with the number &#8220;6,322&#8221;.</font>
                    </div>
                    <div style="color: rgb(0, 0, 0);"><br>
                    </div>
                  </div>
                  <div style="margin-left: 27.25pt; color: rgb(0, 0, 0);">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="color: rgb(0, 0, 0);"><u>Section 2.1</u>. Section 2.1 of the Lease is hereby deleted in its entirety and replaced with the following:</font> </div>
                  <div style="color: rgb(0, 0, 0);"><br>
                  </div>
                  <div style="text-align: justify; margin-left: 63pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);">&#8220;Section 2.1 </font><font style="color: rgb(0, 0, 0);">The term of this Lease shall be for ten years and three months, commencing
                      on January 1, 2016 (the &#8220;Commencement Date&#8221;), and terminating at 11:59 </font><font style="font-weight: bold; color: rgb(0, 0, 0);"><font style="font-weight: normal;">PM</font> </font><font style="color: rgb(0, 0, 0);">on March 31,
                      2026 (the &#8220;Expiration Date&#8221;), unless terminated earlier pursuant to the terms of this Lease. This Lease shall be effective and enforceable between Landlord and Tenant upon the Effective Date.&#8221;</font></div>
                  <div>
                    <div style="color: rgb(0, 0, 0);"><br>
                    </div>
                    <div style="text-align: justify; text-indent: 27pt;"><font style="color: rgb(0, 0, 0);">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Section 3.</u><u>1</u>. The first sentence of Section 3.1 of the Lease is hereby deleted in its entirety and replaced with the
                        following: &#8220;During the term of this Lease, Tenant agrees to pay to Landlord Two Hundred Fifty-Two Thousand Eight Hundred Eighty and 00/100 ($252,880.00) Dollars per annum, payable in equal monthly installments of $21,073.33 on or
                        before the first day of each month (the &#8220;Base Rent&#8221;), which Base Rent shall increase on each anniversary of the Commencement Date by an amount equal to the then-current Base Rent multiplied by three (3%) percent.&#8221;.</font></div>
                    <div style="color: rgb(0, 0, 0);"><br>
                    </div>
                    <div style="text-align: justify; text-indent: 27pt;"><font style="color: rgb(0, 0, 0);">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Section 27.1</u>. The first sentence of Section 27.1 of the Lease is hereby deleted in its entirety and replaced with the following:
                        &#8220;Tenant shall deposit with Landlord, on or before the Effective Date, a sum of Sixty-Three Thousand Two Hundred Twenty and 00/100 ($63,220) Dollars as security for the faithful performance and observance by Tenant of the terms,
                        provisions and conditions of the Lease.&#8221;.</font></div>
                    <div style="color: rgb(0, 0, 0);"><br>
                    </div>
                    <div style="text-align: justify; text-indent: 27pt;"><font style="color: rgb(0, 0, 0);">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Exhibit </u><u>A</u>.&#160;The two pages immediately following the signature page of the Lease and immediately preceding <u>Exh</u><u>ibit

                        </u><u>B</u> to the Lease are hereby deleted and replaced with <u>Exhibit </u><u>A</u> attached hereto.</font></div>
                    <div style="color: rgb(0, 0, 0);"><br>
                    </div>
                  </div>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                    <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
                    <div style="page-break-after:always;" id="DSPFPageBreak">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  </div>
                  <div style="text-align: justify; text-indent: 27pt;"><font style="color: rgb(0, 0, 0);">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Broker</u>. Tenant hereby represents and warrants to Landlord that it has dealt with no broker in connection with this Amendment other
                      than Cresa New York (the&#160;&#8220;<u>Broker</u>&#8217;&#8217;), and there are no other brokerage fees or commissions payable in connection herewith. Tenant hereby agrees to hold Landlord harmless from, and indemnified against, all loss or damage
                      (including without limitation, the cost of defending the same) arising from any claim by any broker other than the Broker claiming to have dealt with Tenant.</font></div>
                  <div style="color: rgb(0, 0, 0);"><br>
                  </div>
                  <div style="text-align: justify; text-indent: 27pt;"><font style="color: rgb(0, 0, 0);">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Examination of Amendment</u>. Submission of this instrument for examination or signature to Tenant does not constitute a reservation or
                      option, and it is not effective until execution by and delivery to both Landlord and Tenant.</font></div>
                  <div style="color: rgb(0, 0, 0);"><br>
                  </div>
                  <div style="text-align: justify; text-indent: 27pt;"><font style="color: rgb(0, 0, 0);">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Definitions</u>. Except as otherwise provided herein, the capitalized terms used in this Amendment shall have the definitions set forth
                      in the Lease.</font></div>
                  <div style="color: rgb(0, 0, 0);"><br>
                  </div>
                  <div style="text-align: justify; text-indent: 27pt;"><font style="color: rgb(0, 0, 0);">10.&#160;&#160;&#160;&#160;&#160;&#160; <u>Reservation&#160;of Rights; No Waiver</u>. By executing this Amendment, Landlord does not waive its right to assert (a) any events or
                      conditions that would constitute defaults under the Lease, or (b) any monetary or other obligations owed by Tenant to Landlord under the Lease. Landlord expressly reserves and does not waive all rights under the Lease, at law, and in
                      equity. Acceptance by Landlord of any partial performance, including without limitation partial performance of any unpaid obligations under the Lease, by Tenant is and will be without prejudice to the rights and remedies of Landlord
                      under the Lease, at law and in equity.</font></div>
                  <div style="color: rgb(0, 0, 0);"><br>
                  </div>
                  <div style="text-align: justify; text-indent: 27pt;"><font style="color: rgb(0, 0, 0);">11.&#160;&#160;&#160;&#160;&#160;&#160; <u>Incorporation</u>. This Amendment shall be incorporated into and made a part of the Lease,&#160;and all provisions of the Lease not expressly
                      modified or amended hereby shall remain in full force and&#160;effect.</font></div>
                  <div style="color: rgb(0, 0, 0);"><br>
                  </div>
                  <div style="text-align: center; color: rgb(0, 0, 0);">[SIGNATURES APPEAR ON FOLLOWING PAGE]</div>
                  <div style="color: rgb(0, 0, 0);"><br>
                  </div>
                  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                    <div id="DSPFPageBreak" style="page-break-after: always;">
                      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                  </div>
                  <font style="color: rgb(0, 0, 0);"> </font>
                  <div><font style="color: rgb(0, 0, 0);"> </font>
                    <div style="text-indent: 35.1pt; margin-right: 19.05pt; margin-left: 34.4pt;"><font style="color: rgb(0, 0, 0);">IN WITNESS WHEREOF, the parties have caused this Amendment to be executed on the day and year first above written.</font></div>
                    <div style="color: rgb(0, 0, 0);"><br>
                    </div>
                    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z455c6a2c8c8d48b6bb21025b6e022b59">

                        <tr>
                          <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                          <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0);">
                            <div style="font-weight: bold;">LANDLORD:</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                          <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0);">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 50%; vertical-align: top;">
                            <div style="color: rgb(77, 77, 77);"><font style="font-weight: bold; color: rgb(0, 0, 0);">BIOBAT, </font><font style="color: rgb(0, 0, 0);">INC., a New York Not-for-Profit corporation</font></div>
                          </td>
                        </tr>

                    </table>
                    <div style="color: rgb(0, 0, 0);"><br>
                    </div>
                    <div>
                      <table cellspacing="0" cellpadding="0" border="0" id="z6d6d477dbbbd43e5bb45425aad1d65ad" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                          <tr>
                            <td style="width: 50%; color: rgb(0, 0, 0); padding-bottom: 2px;">
                              <div>&#160;</div>
                            </td>
                            <td style="width: 5%; color: rgb(0, 0, 0); padding-bottom: 2px;">
                              <div style="text-align: left;">By:</div>
                            </td>
                            <td style="width: 40%; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">/s/ Eva Cramer<br>
                            </td>
                            <td colspan="1" style="width: 5%; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                          </tr>
                          <tr>
                            <td style="width: 50%; color: rgb(0, 0, 0); padding-bottom: 2px;">
                              <div>&#160;</div>
                            </td>
                            <td style="width: 5%; color: rgb(0, 0, 0); padding-bottom: 2px;">
                              <div style="text-align: left;">Name:</div>
                            </td>
                            <td style="width: 40%; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">Eva Cramer<br>
                            </td>
                            <td colspan="1" style="width: 5%; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                          </tr>
                          <tr>
                            <td style="width: 50%; color: rgb(0, 0, 0); padding-bottom: 2px;">
                              <div>&#160;</div>
                            </td>
                            <td style="width: 5%; color: rgb(0, 0, 0); padding-bottom: 2px;">Title:</td>
                            <td style="width: 40%; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">President<br>
                            </td>
                            <td colspan="1" style="width: 5%; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                          </tr>

                      </table>
                    </div>
                    <font style="color: rgb(0, 0, 0);"><br>
                    </font>
                    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1cabcc952a5d47b287e43f095078a9b8">

                        <tr>
                          <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                          <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0);">
                            <div style="font-weight: bold;">TENANT:</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                          <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                          <td style="width: 50%; vertical-align: top;">
                            <div><font style="color: rgb(0, 0, 0); font-weight: bold;">IRX THERAPEUTICS, INC., </font><font style="color: rgb(0, 0, 0);">a New York corporation</font></div>
                          </td>
                        </tr>

                    </table>
                    <div style="color: rgb(77, 77, 77);"><font style="color: rgb(0, 0, 0);"><u> </u><br>
                      </font>
                      <table cellspacing="0" cellpadding="0" border="0" id="zb6f3824f0b5d4ae8a6ac35184fdbccbe" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                          <tr>
                            <td style="width: 50%; color: rgb(0, 0, 0); padding-bottom: 2px;">
                              <div>&#160;</div>
                            </td>
                            <td style="width: 5%; color: rgb(0, 0, 0); padding-bottom: 2px;">
                              <div style="text-align: left;">By:</div>
                            </td>
                            <td style="width: 40%; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">/s/ Jeffrey Hwang<br>
                            </td>
                            <td colspan="1" style="width: 5%; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                          </tr>
                          <tr>
                            <td rowspan="1" style="width: 50%; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                            <td rowspan="1" style="width: 5%; color: rgb(0, 0, 0); padding-bottom: 2px;">Name:<br>
                            </td>
                            <td rowspan="1" style="width: 40%; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">Jeffrey Hwang<br>
                            </td>
                            <td colspan="1" rowspan="1" style="width: 5%; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                          </tr>
                          <tr>
                            <td style="width: 50%; color: rgb(0, 0, 0); padding-bottom: 2px;">
                              <div>&#160;</div>
                            </td>
                            <td style="width: 5%; color: rgb(0, 0, 0); padding-bottom: 2px;">Title:</td>
                            <td style="width: 40%; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">President &amp; COO<br>
                            </td>
                            <td colspan="1" style="width: 5%; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                          </tr>

                      </table>
                    </div>
                    <div style="color: rgb(0, 0, 0);"><u> <br>
                      </u></div>
                    <font style="color: rgb(0, 0, 0);"><u> </u></font>
                    <div style="font-style: italic; text-align: center;"><font style="color: rgb(0, 0, 0);">Signature Page to First Amendment to Lease Agreement</font></div>
                    <div style="font-style: italic;"><font style="color: rgb(61, 61, 61);"><font style="color: rgb(0, 0, 0);"> </font><br>
                      </font></div>
                    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                      <div id="DSPFPageBreak" style="page-break-after: always;">
                        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                    </div>
                    <div style="text-align: center;"><img src="image10.jpg"></div>
                    <div style="text-align: center;"><br>
                      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                        <div id="DSPFPageBreak" style="page-break-after: always;">
                          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                      </div>
                      <div>
                        <div style="font-weight: bold;"><u>ASSIGNMENT AND ASSUMPTION OF LEASE</u></div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 27pt;">THIS ASSIGNMENT AND ASSUMPTION OF LEASE (this &#8220;<u>Agreement</u>&#8221;) is made as of November 6, 2018, by and between IRX Therapeutics, Inc., a New York corporation (&#8220;<u>Assignor</u>&#8221;)
                          and Brooklyn Immunotherapeutics LLC, a Delaware limited liability company (&#8220;<u>Assignee</u>&#8221;).</div>
                        <div><br>
                        </div>
                        <div><u>RECITALS</u>:</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 27pt;">A.&#160;&#160;&#160;&#160;&#160;&#160; Pursuant to that certain Lease Agreement, dated September 28, 2015, between BIOBAT, INC., a Not-for-Profit 501(c)(3) corporation organized under the laws of the State of
                          New York (&#8220;<u>Landlord</u>&#8221;) and Assignor (&#8220;<u>Lease</u>&#8221;), Landlord currently leases to Assignor, that certain &#8220;Premises&#8221; (as more particularly described in the Lease). All initial capitalized terms used herein but not herein
                          defined and defined in the Lease shall have the meaning ascribed to such terms under the Lease.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 27pt;">B.&#160;&#160;&#160;&#160;&#160; &#160; Assignor desires by this Agreement to assign all of its right, title and interest in and to the Lease to Assignee, and Assignee desires to accept such assignment and to
                          agree to perform all of the obligations of the tenant under the Lease from and after the Effective Time (as hereinafter defined), all upon the terms and conditions hereinafter set forth.</div>
                        <div><br>
                        </div>
                        <div><u>TERMS</u>:</div>
                        <div><br>
                        </div>
                        <div style="text-align: left; text-indent: 27pt;">NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows:</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 27pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Assignor assigns to Assignee all of its right, title and interest in and to the Lease as of the Effective Time. Assignee hereby accepts the foregoing assignment and
                          assumes and agrees to be bound by and perform all covenants, conditions, obligations and duties of Assignor under the Lease as of the Effective Time. Assignee agrees that it has inspected the Premises and hereby agrees to take the
                          Premises in the condition existing upon the Effective Time.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 27pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Assignor shall remain obligated to Landlord for the full performance of all covenants, conditions, obligations and duties required of tenant under the Lease and shall
                          not be relieved of any such performance thereunder as a result of this Assignment. However, as of the Effective Time, Assignor shall have no continuing or future possessory rights in and to the Premises and thereafter waives any
                          right it may possess to receive notice from Landlord relative to this Agreement or the Lease.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 27pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Assignor agrees that any security deposit currently being held by Landlord in the amount of shall be retained by Landlord to satisfy the security deposit requirements of
                          &#8220;Tenant&#8221; under the Lease. Any amount of such security deposit remaining at the expiration of the term of the Lease shall be paid to Assignee after full satisfaction of any amount owed to Landlord.</div>
                        <div><br>
                        </div>
                        <div>
                          <div style="text-align: left; margin-left: 27pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Assignor represents and covenants as follows:</div>
                        </div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 63pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160; That the Lease is in full force and effect; that Assignor&#8217;s interest therein is free and clear of all encumbrances; and that Assignor has fully performed all covenants
                          and obligations under the Lease and has not done or permitted any acts in violation of the covenants contained in the Lease.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 63pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; That Assignor has not heretofore assigned, mortgaged or otherwise transferred, amended or encumbered, voluntarily or involuntarily, the Lease or its interest therein or
                          subleased or allowed use or occupancy of the Premises by any other person or entity under a sublease or occupancy agreement remaining in effect.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 63pt;">(c)&#160;&#160; &#160; &#160; That Landlord has fully performed all the covenants and obligations on its part to be performed and observed under the Lease; that Landlord has not done or permitted any
                          act or acts in violation of any of the covenants, provisions or terms thereof; and that there is not now in existence any reason or claim to offset, deduct or decrease any payments due under the Lease.</div>
                        <div><br>
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                          <div style="page-break-after:always;" id="DSPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <!--PROfilePageNumberReset%Num%2%%%-->
                        <div style="text-align: justify; text-indent: 27pt;">5.&#160;&#160;&#160;&#160; &#160;&#160;&#160; Within thirty (30) days following the Effective Time, Assignor shall pay the Landlord&#8217;s attorneys&#8217; fees and costs incurred in connection with the assignment
                          contemplated hereby. Landlord consents to the assignment of the Lease to Assignee only at such time as this Agreement has been executed by all of the parties hereto. Nothing in this Agreement shall be deemed to waive or modify any
                          of the provisions of the Lease. Consent to this Agreement shall not be deemed a consent by Landlord to any further assignment, whether or not Assignee purports to permit the same.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 27pt;">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subject to the provisions of Paragraph 5, the provisions of this Agreement shall bind and inure to the benefit of the heirs, representatives, successors and assigns of
                          the parties hereto.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 27pt;">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Assignee&#8217;s address for notices under the Lease shall be the Premises, unless changed in accordance with the Lease.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 27pt;">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each individual executing this Agreement on behalf of a partnership, corporation, limited liability company or other entity represents that he or she is duly authorized
                          to execute and deliver this Agreement on behalf of the entity which is a party to this Agreement and agrees to deliver evidence of his or her authority to the other party(ies) upon request.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 27pt;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Agreement may be executed by the parties hereto in separate counterparts, including by facsimile or PDF file, each of which when so executed and delivered shall
                          be an original, but all such counterparts shall together constitute one and the same instrument. Each counterpart may consist of a number of copies hereof each signed by less than all, but together signed by all of, the parties
                          hereto.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 27pt;">10.&#160;&#160;&#160;&#160;&#160;&#160; This Agreement is being entered into in conjunction with the purchase of the Assignor&#8217;s business by the Assignee pursuant to a certain Asset Purchase Agreement, by and
                          among Assignor and Assignee (the &#8220;<u>Transaction</u>&#8221;). The parties to this Agreement agree that this Agreement shall become effective, and shall only become effective, at such time as the closing date of the Transaction (the &#8220;<u>Effective

                            Time</u>&#8221;). If the Transaction does not close, this Agreement shall automatically become null and void.</div>
                        <div style="text-align: justify; text-indent: 35.95pt; margin-right: 20.7pt; margin-left: 22pt;"> <br>
                        </div>
                        <div style="font-style: italic;">[Signature page follows]</div>
                      </div>
                    </div>
                    <div><br>
                    </div>
                    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
                      <div id="DSPFPageBreak" style="page-break-after: always;">
                        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                    </div>
                    <div>
                      <div style="text-align: justify;">Landlord represents that the Lease is in full force and effect and that, to its knowledge, Assignor is not in default of any of its obligations thereunder.
                        Landlord consents to the subject Assignment and Assumption of Lease. Landlord makes no representation regarding Assignor&#8217;s compliance with Article XI of the Prime Lease in connection with the subject assignment and assumption.</div>
                      <div style="color: rgb(0, 0, 0);"><br>
                      </div>
                      <div style="color: rgb(0, 0, 0);">
                        <table cellspacing="0" cellpadding="0" border="0" id="zd0f1320f45104a86a98406fd7cb8f48f" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                            <tr>
                              <td style="width: 100%;">LANDLORD:</td>
                            </tr>
                            <tr>
                              <td style="width: 100%;">
                                <div>&#160;</div>
                              </td>
                            </tr>
                            <tr>
                              <td rowspan="1" style="width: 100%;">
                                <div style="font-weight: bold;"><font style="color: rgb(0, 0, 0);">BIOBAT, IN C.,</font> </div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width: 100%;">
                                <div>a New York Not-for-Profit corporation</div>
                              </td>
                            </tr>

                        </table>
                      </div>
                      <div style="color: rgb(0, 0, 0); font-weight: bold;"><br>
                      </div>
                      <div style="color: rgb(0, 0, 0);">
                        <table cellspacing="0" cellpadding="0" border="0" id="zf382793b11d04e80b469ea5a1b608575" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                            <tr>
                              <td style="width: 3%; padding-bottom: 2px;">By:<br>
                              </td>
                              <td style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ EVA Cramer<br>
                              </td>
                              <td style="width: 55%; padding-bottom: 2px;">
                                <div>&#160;</div>
                              </td>
                            </tr>
                            <tr>
                              <td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0);">EVA Cramer, President<br>
                              </td>
                              <td style="width: 55%; padding-bottom: 2px;">
                                <div>&#160;</div>
                              </td>
                            </tr>
                            <tr>
                              <td rowspan="1" colspan="2">(Print Name &amp; Title)</td>
                              <td rowspan="1" style="width: 55%;">&#160;</td>
                            </tr>
                            <tr>
                              <td colspan="2">November 02, 2018<br>
                              </td>
                              <td style="width: 55%;">
                                <div>&#160;</div>
                              </td>
                            </tr>

                        </table>
                      </div>
                      <div style="color: rgb(0, 0, 0);"><br>
                      </div>
                      <div style="color: rgb(0, 0, 0);">
                        <table cellspacing="0" cellpadding="0" border="0" id="zb12888d919fe459d8109a792c27fbb84" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                            <tr>
                              <td colspan="2">ASSIGNOR<br>
                              </td>
                              <td style="width: 5%;">
                                <div>&#160;</div>
                              </td>
                              <td colspan="2">ASSIGNER:<br>
                              </td>
                              <td colspan="1" style="width: 5%;">&#160;</td>
                            </tr>
                            <tr>
                              <td colspan="2" rowspan="1">&#160;</td>
                              <td rowspan="1" style="width: 5%;">&#160;</td>
                              <td colspan="2" rowspan="1">&#160;</td>
                              <td colspan="1" rowspan="1" style="width: 5%;">&#160;</td>
                            </tr>
                            <tr>
                              <td colspan="2" rowspan="1"><font style="font-weight: bold;">IRX THERAPEUTICS, INC.,</font><br>
                              </td>
                              <td rowspan="1" style="width: 5%;">&#160;</td>
                              <td colspan="2" rowspan="1"><font style="font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS LLC</font><br>
                              </td>
                              <td colspan="1" rowspan="1" style="width: 5%;">&#160;</td>
                            </tr>
                            <tr>
                              <td colspan="2" rowspan="1">a New York corporation<br>
                              </td>
                              <td rowspan="1" style="width: 5%;">&#160;</td>
                              <td colspan="2" rowspan="1">a Delaware limited liability company<br>
                              </td>
                              <td colspan="1" rowspan="1" style="width: 5%;">&#160;</td>
                            </tr>
                            <tr>
                              <td colspan="2">
                                <div>&#160;</div>
                              </td>
                              <td style="width: 5%;">
                                <div>&#160;</div>
                              </td>
                              <td colspan="2">
                                <div>&#160;</div>
                              </td>
                              <td colspan="1" style="width: 5%;">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width: 3%; padding-bottom: 2px;"> By:<br>
                              </td>
                              <td style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Mark Leuchtenberger</td>
                              <td style="width: 5%; padding-bottom: 2px;">
                                <div>&#160;</div>
                              </td>
                              <td style="width: 3%; padding-bottom: 2px;">
                                <div>By:<br>
                                </div>
                              </td>
                              <td style="width: 42%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Charles R. Cherington</td>
                              <td colspan="1" style="width: 5%; padding-bottom: 2px;">&#160;</td>
                            </tr>
                            <tr>
                              <td colspan="2" rowspan="1">&#160;</td>
                              <td rowspan="1" style="width: 5%;">&#160;</td>
                              <td colspan="2" rowspan="1">&#160;</td>
                              <td colspan="1" rowspan="1" style="width: 5%;">&#160;</td>
                            </tr>
                            <tr>
                              <td colspan="2" rowspan="1">Mark Leuchtenberger, Chairman, President and CEO<br>
                              </td>
                              <td rowspan="1" style="width: 5%;">&#160;</td>
                              <td colspan="2" rowspan="1">Charles R. Cherington, Manager<br>
                              </td>
                              <td colspan="1" rowspan="1" style="width: 5%;">&#160;</td>
                            </tr>
                            <tr>
                              <td colspan="2" rowspan="1">(Print Name &amp; Title)</td>
                              <td rowspan="1" style="width: 5%;">&#160;</td>
                              <td colspan="2" rowspan="1">(Print Name &amp; Title)<br>
                              </td>
                              <td colspan="1" rowspan="1" style="width: 5%;">&#160;</td>
                            </tr>

                        </table>
                      </div>
                      <div style="color: rgb(0, 0, 0);"><br>
                      </div>
                      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
                        <div id="DSPFPageBreak" style="page-break-after: always;">
                          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                      </div>
                      <!--PROfilePageNumberReset%Num%1%%%-->
                      <div>
                        <div style="text-align: right;">EXECUTION COPY</div>
                        <div><br>
                        </div>
                        <div style="font-weight: bold; text-align: center;"><u>SECOND AMENDMENT TO LEASE AGREEMENT</u></div>
                        <div><br>
                        </div>
                        <div style="text-indent: 36pt; text-align: justify;">THIS SECOND AMENDMENT TO LEASE AGREEMENT (this &#8220;<u>Second Lease</u><u> Amendment</u>&#8221;) is executed as of the <u>twenty fourth</u> day of July, 2019 (the &#8220;<u>Second Amendment</u>&#160;<u>Date</u>&#8221;),








                          by and between <font style="font-weight: bold;">BIOBAT, INC.</font>, a New York Not-for-Profit corporation, having an address c/o SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 129, Brooklyn, New York 11203 (&#8220;<u>Landlord</u>&#8221;),








                          and <font style="font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS LLC</font>, a Delaware limited liability company, having an address at the Brooklyn Army Terminal, 140 East 58th Street, Brooklyn, NY 11220 (&#8220;Tenant&#8221;). </div>
                        <div><br>
                        </div>
                        <div style="text-align: center;"><u>W</u> <u>I</u> <u>T</u>&#160;<u>N</u>&#160;<u>E</u>&#160;<u>S</u>&#160;<u>S</u>&#160;<u>E</u>&#160;<u>T</u>&#160;<u>H</u>:</div>
                        <div style="text-align: center; margin-right: 116pt; margin-left: 122.25pt;"> <br>
                        </div>
                        <div style="margin-left: 220.5pt;"><img width="4" src="image12.jpg"></div>
                        <div style="text-align: justify; text-indent: 36pt;">WHEREAS, Landlord and IRX Therapeutics, Inc., a New York corporation (&#8220;<u>IRX</u>&#8221;), entered into that certain Lease Agreement, dated as of September 28, 2015 (the &#8220;<u>Leas</u>e&#8221;),

                          as amended by that certain First Amendment to Lease Agreement, dated as of September 28, 2015 (the &#8220;<u>First Lease Amendmen</u>t&#8221;) (the Lease and First Amendment are collectively, the &#8220;Lease&#8221;), whereby IRX leased from Landlord
                          certain space of approximately 6,322 rentable square feet&#160; (the &#8220;<u>Existing Space</u>&#8221;) in that certain building known as Building A of the Brooklyn Army Terminal, Brooklyn, New York (the &#8220;Building&#8221;);</div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;"> <br>
                        </div>
                        <div style="text-align: justify; text-indent: 36pt;">WHEREAS, IRX and Tenant entered into that certain Assignment and Assumption of Lease, dated as of November 6, 2018, whereby IRX assigned to Tenant all of its right, title and
                          interest in and to the Lease, and Tenant accepted the assignment and agreed to assume and be bound by and perform all covenants, conditions, obligations and duties of IRX under the Lease; and</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 36pt;">WHEREAS, Landlord and Tenant desire to amend certain provisions of the Lease and add additional space.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; text-indent: 36pt;">NOW, THEREFORE, in consideration of the foregoing premises, the mutual covenants herein contained and each act performed hereunder by the parties, and for other good and valuable
                          consideration, Landlord and Tenant hereby enter into this Second Lease Amendment.</div>
                        <div><br>
                        </div>
                        <div style="text-indent: 36pt; text-align: justify;">1.&#160;&#160;&#160; &#160; &#160;&#160; &#160; <u>Incorporation of Recitals</u>. The above recitals are hereby incorporated into this Second Lease Amendment as if fully set forth herein.</div>
                        <div style="text-align: justify; margin-right: 20.55pt; margin-left: 58pt;"> <br>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt;">(a)&#160;&#160; &#160;&#160; &#160;&#160; Tenant hereby leases additional space of approximately 1,910 rentable square feet shown on <u>Exhibit A</u> (the &#8220;<u>Additional Space</u>&#8221;) to run coterminous with
                          the Term under this Lease and shall expire on the same date as the Expiration Date (as it may have been extended) hereunder. Accordingly, the Section 1.1 of the Lease is deleted in its entirety and replaced with the following:</div>
                        <div style="text-align: justify; margin-right: 20.85pt; margin-left: 94pt;"><font style="font-weight: bold;"> <br>
                          </font></div>
                        <div style="text-align: justify; font-size: 12pt; margin-left: 72pt;"><font style="font-size: 10pt; font-weight: bold;">Section 1.1&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">Landlord leases and demises to Tenant and Tenant rents
                            and leases from Landlord the following described space (the &#8220;<u>Premises</u>&#8221;), which Premises are shown on <u>Exhibit A</u> attached hereto and made a part hereof and located in Building A of the Brooklyn Army Terminal,
                            Brooklyn, New York (the &#8220;<u>Building</u>&#8221;):</font></div>
                        <br>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                          <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
                          <div style="page-break-after:always;" id="DSPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="margin-left: 72pt;"> </div>
                        <div style="margin-left: 72pt;"> </div>
                        <div style="text-align: justify;">
                          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">

                              <tr style="vertical-align: top;">
                                <td style="width: 72pt;">&#160;</td>
                                <td nowrap="nowrap" style="vertical-align: top; width: 180pt;">
                                  <div>Floor(s): </div>
                                </td>
                                <td style="vertical-align: top; width: auto;">
                                  <div style="text-align: justify;">Second Floor</div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div style="text-align: justify;"> <br>
                        </div>
                        <div style="text-align: justify;">
                          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">

                              <tr style="vertical-align: top;">
                                <td style="width: 72pt;">&#160;</td>
                                <td nowrap="nowrap" style="vertical-align: top; width: 180pt;">
                                  <div>Rentable Square Footage (&#8220;RSF&#8221;) </div>
                                </td>
                                <td style="vertical-align: top; width: auto;">
                                  <div style="text-align: justify;">approximately 8,232 rentable square feet consisting of the existing approximately 6,322 rentable square feet containing wet lab space and office space, plus approximately 1,910 rentable
                                    square feet of Clean Room space.</div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div style="text-align: justify; margin-left: 94pt;"> <br>
                        </div>
                        <div style="text-align: justify; margin-left: 72pt;">For purposes of this Section 1.1, the &#8220;Clean Room&#8221; shall be used to process clinical grade active pharmaceutical ingredients (api) pursuant to 21 CFR part 210 (subset b) of FDA
                          regulations, ISO classification standards and relevant cGMP guidelines.</div>
                        <div style="margin-right: 21pt; margin-left: 58pt;"> <br>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt;">(b) &#160; &#160; &#160; &#160; Exhibit A in the Lease is hereby deleted in its entirety and replaced with Exhibit A attached hereto.</div>
                        <div> <br>
                        </div>
                        <div>
                          <div style="text-align: justify; margin-left: 36pt;">(c) &#160; &#160; &#160; &#160; Section 1.3 is hereby deleted in its entirety.</div>
                        </div>
                        <div> <br>
                        </div>
                        <div>
                          <div style="text-align: justify; margin-left: 36pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; The following shall be added after Section 2.3:</div>
                        </div>
                        <div style="text-align: justify; text-indent: 4.55pt; margin-right: 20.85pt; margin-left: 94pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"> <br>
                          </font></div>
                        <div style="text-align: justify; font-size: 12pt; margin-left: 72pt;"><font style="font-size: 10pt; font-weight: bold;">Section 2.4 &#160; &#160;&#160; </font><font style="font-size: 10pt;">Preparation of Premises<font style="font-weight: bold;">.
                            </font>Tenant shall perform Tenant&#8217;s Work in&#160; the Premises in accordance with Exhibit D-1 attached hereto. Landlord shall deliver the Premises to Tenant as of the date hereof in a broom-swept condition for the purposes of
                            performing Tenant&#8217;s Work. All fixtures installed in&#160; connection with Tenant&#8217;s Work shall become a part of the Premises once they are attached to the Premises, except for the modular components of the Clean Room which Tenant
                            shall be entitled to dismantle and remove at the end of the Term provided the Premises shall be restored to the condition as of the date hereof or better.</font></div>
                        <div style="text-align: justify; text-indent: 36pt; margin-right: 20.85pt; margin-left: 94pt;"> <br>
                        </div>
                        <div style="text-align: justify; margin-left: 72pt; text-indent: 27pt;">By its execution hereof, Tenant shall accept the Premises in their condition as of the date hereof; (ii) Landlord shall have no obligation for any defects in
                          the Premises <strike>except for latent defects</strike>; and (iii) Tenant&#8217;s taking possession of the Premises shall be conclusive evidence that Tenant accepts the Premises and that the Premises were in good condition at the time
                          possession was taken.</div>
                        <div><br>
                        </div>
                        <div>
                          <div style="text-align: justify; margin-left: 36pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Exhibit B hereto is added as Exhibit D-1 to the Lease.</div>
                        </div>
                        <div> <br>
                        </div>
                        <div>
                          <div style="text-align: justify; margin-left: 36pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Section 3.1 is hereby deleted in its entirety and replaced with the following:</div>
                        </div>
                        <div style="margin-left: 94pt; font-weight: bold;"> <br>
                        </div>
                        <div style="text-align: justify; margin-left: 72pt; font-weight: bold;">Section 3.1</div>
                        <div style="text-align: justify; text-indent: 12pt; margin-right: 29.35pt; margin-left: 94pt;"><u> <br>
                          </u></div>
                        <div style="text-align: justify; font-size: 12pt; margin-left: 72pt;"><font style="font-size: 10pt;"><u>Base Rent</u>. During the Term, Tenant agrees to pay to Landlord, the following base rent payable in equal monthly installments
                            on or before the first day of each month (&#8220;Base Rent&#8221;), which Base Rent shall increase on January 1st of each Lease Year by an amount equal to the then-current Base Rent multiplied by three (3%) percent:</font></div>
                        <div style="text-align: justify; font-size: 12pt;"><font style="font-size: 10pt;"> <br>
                          </font></div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                          <div style="page-break-after:always;" id="DSPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div><br>
                        </div>
                        <table cellspacing="0" cellpadding="0" border="0" align="center" style="border-collapse: collapse; width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" id="z4ff049ed72e84ba7a97b6a000b05df9b">

                            <tr>
                              <td style="width: 30%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center; font-weight: bold;">Lease Year</div>
                                <div style="text-align: center; font-weight: bold;"> <br>
                                </div>
                                <div style="text-align: center; font-weight: bold;">For Tenant from Second Amendment Commencement Date</div>
                                <div style="text-align: center; font-weight: bold;"> <br>
                                </div>
                              </td>
                              <td style="width: 20%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center; font-weight: bold;">Annual Base Rent</div>
                              </td>
                              <td style="width: 40%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="font-weight: bold; text-align: center;">Monthly Base Rent</div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width: 30%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="margin-left: 9pt;">Lease Year 1</div>
                                <div style="margin-left: 9pt;">&#160;</div>
                                <div style="margin-left: 9pt;">July 1, 2019 &#8211; June 30, 2020</div>
                              </td>
                              <td style="width: 20%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">$365,210.36</div>
                              </td>
                              <td nowrap="nowrap" style="width: 40%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">July 1, 2019-December 31, 2019: $29,984.43</div>
                                <div>&#160;</div>
                                <div style="text-align: center;">January 1, 2020-June 30, 2020: $30,883.96</div>
                                <div style="text-align: center; margin-right: 3.7pt; margin-left: 4.1pt;"> <br>
                                </div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width: 30%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="margin-left: 9pt;">Lease Year 2</div>
                                <div style="margin-left: 9pt;">&#160;</div>
                                <div style="margin-left: 9pt;">July 1, 2020 &#8211; June 30, 2021</div>
                              </td>
                              <td style="width: 20%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">$ 376,166.66</div>
                              </td>
                              <td style="width: 40%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">July 1, 2020-December 31, 2020: $ 30,883.96</div>
                                <div>&#160;</div>
                                <div style="text-align: center;">January 1, 2021-June 30, 2021: $31,810.48<br>
                                  <br>
                                </div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width: 30%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="margin-left: 9pt;">Lease Year 3</div>
                                <div style="margin-left: 9pt;">&#160;</div>
                                <div style="margin-left: 9pt;">July 1, 2021 &#8211; June 30, 2022</div>
                              </td>
                              <td style="width: 20%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">$ 387,451.66</div>
                              </td>
                              <td style="width: 40%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">July 1, 2021-December 31, 2021: $ 31,810.48</div>
                                <div>&#160;</div>
                                <div style="text-align: center;">January 1, 2022-June 30, 2022:$32,764.80</div>
                                <div style="text-align: center; margin-right: 3.55pt; margin-left: 4.2pt;"> <br>
                                </div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width: 30%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="margin-left: 9pt;">Lease Year 4</div>
                                <div style="margin-left: 9pt;">&#160;</div>
                                <div style="margin-left: 9pt;">July 1, 2022 &#8211; June 30, 2023</div>
                              </td>
                              <td style="width: 20%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">$ 399,075.22</div>
                              </td>
                              <td style="width: 40%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">July 1, 2022-December 31, 2022: $ 32,764.8</div>
                                <div>&#160;</div>
                                <div style="text-align: center;">January 1, 2023-June 30, 2023: $33,747.74</div>
                                <div style="text-align: center; margin-right: 3.55pt; margin-left: 4.2pt;"> <br>
                                </div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width: 30%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="margin-left: 9pt;">Lease Year 5</div>
                                <div style="margin-left: 9pt;">&#160;</div>
                                <div style="margin-left: 9pt;">July 1, 2023 &#8211; June 30, 2024</div>
                              </td>
                              <td style="width: 20%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">$ 411,047.46</div>
                              </td>
                              <td style="width: 40%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">July 1, 2023-December 31, 2023: $ 33,747.74</div>
                                <div>&#160;</div>
                                <div style="text-align: center;">January 1, 2024-June 30, 2024: $ 34,760.17</div>
                                <div style="text-align: center; margin-right: 3.65pt; margin-left: 4.2pt;"> <br>
                                </div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width: 30%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="margin-left: 9pt;">Lease Year 6</div>
                                <div style="margin-left: 9pt;">&#160;</div>
                                <div style="margin-left: 9pt;">July 1, 2024 &#8211; June 30, 2025</div>
                                <div> </div>
                              </td>
                              <td style="width: 20%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">$ 423,378.88</div>
                              </td>
                              <td style="width: 40%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div>
                                  <div style="text-align: center;">July 1, 2024-December 31, 2024: $ 34,760.17</div>
                                  <div style="text-align: center;">&#160;</div>
                                  <div style="text-align: center;">January 1, 2025-June 30, 2025: $ 35,802.98</div>
                                  <div style="text-align: center;"> </div>
                                </div>
                                <div> <br>
                                </div>
                              </td>
                            </tr>
                            <tr>
                              <td rowspan="1" style="width: 30%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="margin-left: 9pt;">Lease Year 7</div>
                                <div style="margin-left: 9pt;">&#160;</div>
                                <div style="margin-left: 9pt;">July 1, 2025 &#8211; Dec. 31, 2015</div>
                                <div> <br>
                                </div>
                              </td>
                              <td rowspan="1" style="width: 20%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">$214,817.86</div>
                              </td>
                              <td rowspan="1" style="width: 40%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">July 1, 2025-December 31, 2025: $35,802.98</div>
                              </td>
                            </tr>

                        </table>
                        <div> <br>
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                          <div style="page-break-after:always;" id="DSPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="margin-left: 36pt;">Section 3.3 is hereby deleted in its entirety and replaced with the following:</div>
                        <div style="margin-left: 36pt;"> <br>
                        </div>
                        <div style="text-align: justify; margin-left: 72pt; font-weight: bold;"><font style="font-weight: bold;">Section 3.3&#160;&#160;&#160;&#160; </font>Payment of Operating Expenses and Taxes.</div>
                        <div style="margin-left: 94pt;"> <br>
                        </div>
                        <div style="text-indent: 99pt; text-align: justify;">(a)&#160;&#160;&#160;&#160;&#160;&#160; &#160; Commencing on the Commencement Date and continuing on the first day of each calendar month thereafter during the Term, Tenant shall pay, as Additional Rent, Tenant&#8217;s
                          Pro Rata Share to reimburse Landlord for its Operating Expenses and Taxes, if any, concurrently with the monthly Base Rent payment. As of the Effective Date, Tenant&#8217;s Pro Rata Share of the Operating Expenses is $10/RSF, which the
                          amount shall increase on January 1st of each Lease Year by an amount equal to the then current amount multiplied by three (3%) percent as set forth in the table below.</div>
                        <div><br>
                        </div>
                        <table cellspacing="0" cellpadding="0" border="0" align="center" style="font-family: 'Times New Roman'; font-size: 10pt; width: 90%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z60c7abb43be94904b25df249dfff4383">

                            <tr>
                              <td style="width: 28%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="font-weight: bold; text-align: center;">Lease Year</div>
                              </td>
                              <td style="width: 24%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="font-weight: bold; text-align: center;">Annual Pro Rata Share of</div>
                                <div style="font-weight: bold; text-align: center;">the Operating Expenses</div>
                                <div style="font-weight: bold; text-align: center;"> <br>
                                </div>
                              </td>
                              <td style="width: 38%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="font-weight: bold; text-align: center;">Monthly Pro Rata Share of</div>
                                <div style="font-weight: bold; text-align: center;">the Operating Expenses</div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width: 28%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">Lease Year 1</div>
                                <div>&#160;</div>
                                <div style="text-align: center;">July 1, 2019 &#8211; June 30, 2020</div>
                              </td>
                              <td style="width: 24%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">$ 83,554.80</div>
                              </td>
                              <td style="width: 38%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">July 1, 2019-December 31, 2019: $6,860.00</div>
                                <div style="text-align: center;">&#160;</div>
                                <div style="text-align: center;">January 1, 2020-June 30, 2020: $7,065.80<br>
                                  <br>
                                </div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width: 28%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">Lease Year 2</div>
                                <div>&#160;</div>
                                <div style="text-align: center;">July 1, 2020 &#8211; June 30, 2021</div>
                              </td>
                              <td style="width: 24%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">$ 86,061.44</div>
                              </td>
                              <td style="width: 38%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">July 1, 2020-December 31, 2020: $7,065.80</div>
                                <div style="text-align: center;">&#160;</div>
                                <div style="text-align: center;">January 1, 2021-June 30, 2021: $7,277.77</div>
                                <div style="text-align: center; margin-right: 4.55pt; margin-left: 4.95pt;"> <br>
                                </div>
                              </td>
                            </tr>
                            <tr>
                              <td style="width: 28%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">Lease Year 3</div>
                                <div>&#160;</div>
                                <div style="text-align: center;">July 1, 2021 &#8211; June 30, 2022</div>
                              </td>
                              <td style="width: 24%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">$ 88,643.29</div>
                              </td>
                              <td style="width: 38%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                <div style="text-align: center;">July 1, 2021-December 31, 2021: $7,277.77</div>
                                <div style="text-align: center;">&#160;</div>
                                <div style="text-align: center;">January 1, 2022-June 30, 2022: $7,496.11</div>
                                <div style="text-align: center;"> <br>
                                </div>
                              </td>
                            </tr>

                        </table>
                        <div>
                          <table cellspacing="0" cellpadding="0" border="0" align="center" style="font-family: 'Times New Roman'; font-size: 10pt; width: 90%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                              <tr>
                                <td style="width: 28%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                                  <div style="text-align: center;">Lease Year 4</div>
                                  <div style="text-align: center;">&#160;</div>
                                  <div style="text-align: center;">July 1, 2022 &#8211; June 30, 2023</div>
                                </td>
                                <td style="width: 24%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                                  <div style="text-align: center;">$ 91,302.59</div>
                                </td>
                                <td style="width: 38%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
                                  <div style="text-align: center;">July 1, 2022-December 31, 2022: $7,496.11</div>
                                  <div style="text-align: center;">&#160;</div>
                                  <div style="text-align: center;">January 1, 2023-June 30, 2023: $7,720.99</div>
                                  <div style="text-align: center; margin-right: 4.55pt; margin-left: 4.95pt;"> <br>
                                  </div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width: 28%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                  <div style="text-align: center;">Lease Year 5</div>
                                  <div style="text-align: center;">&#160;</div>
                                  <div style="text-align: center;">July 1, 2023 &#8211; June 30, 2024</div>
                                </td>
                                <td style="width: 24%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                  <div style="text-align: center;">$ 94,041.66</div>
                                </td>
                                <td style="width: 38%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                  <div style="text-align: center;">July 1, 2023-December 31, 2023: $7,720.99</div>
                                  <div style="text-align: center;">&#160;</div>
                                  <div style="text-align: center;">January 1, 2024-June 30, 2024: $7,952.62</div>
                                  <div style="text-align: center; margin-right: 4.55pt; margin-left: 4.8pt;"> <br>
                                  </div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width: 28%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                  <div style="text-align: center;">Lease Year 6</div>
                                  <div style="text-align: center;">&#160;</div>
                                  <div style="text-align: center;">July 1, 2024 &#8211; June 30, 2025</div>
                                </td>
                                <td style="width: 24%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                  <div style="text-align: center;">$ 96,862.91</div>
                                </td>
                                <td style="width: 38%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                  <div style="text-align: center;">July 1, 2024-December 31, 2024: $7,952.62</div>
                                  <div style="text-align: center;">&#160;</div>
                                  <div style="text-align: center;">January 1, 2025-June 30, 2025: $8,191.20</div>
                                  <div style="text-align: center;"> <br>
                                  </div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width: 28%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                  <div style="text-align: center;">Lease Year 7</div>
                                  <div style="text-align: center;">&#160;</div>
                                  <div style="text-align: center;">July 1, 2025 &#8211; Dec. 31, 2015</div>
                                  <div style="text-align: center;"> <br>
                                  </div>
                                </td>
                                <td style="width: 24%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                  <div style="text-align: center;">$49,147.19</div>
                                </td>
                                <td style="width: 38%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                                  <div style="text-align: center;">July 1, 2025-December 31, 2025: $8,191.20</div>
                                </td>
                              </tr>

                          </table>
                          <div> <br>
                          </div>
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                          <div style="page-break-after:always;" id="DSPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div>
                          <div>
                            <div style="margin: 0px 0px 0px 99pt;">(b)&#160;&#160;&#160; &#160; &#160;&#160; For purposes of this Lease,</div>
                          </div>
                          <div><br>
                          </div>
                          <div style="margin: 0px 0px 0px 99pt; text-align: justify;">&#8220;<u><font style="font-weight: bold;">Tenant&#8217;s Pro Rata Share</font></u>&#8221; shall be Tenant&#8217;s share of Landlord&#8217;s Operating Expenses for the Property. a fraction, the
                            numerator of which is the RSF of the Premises and the denominator of which is the RSF of the Landlord&#8217;s Premises, as the same may be re-determined any time RSF is added to or subtracted from the Landlord&#8217;s Premises as set forth
                            herein. As of the date hereof, the RSF of the Landlord&#8217;s Premises for purposes of this calculation is 184,427 RSF. RSF shall be deemed added to the Landlord&#8217;s Premises for purposes of this calculation on the date Landlord
                            determines that such RSF is ready to receive tenant improvements and is offered for rental to the public. Within thirty (30) days following written request from Tenant (but not more than once every twelve (12) months), Landlord
                            shall certify to Tenant in writing as to the then RSF of the Landlord&#8217;s Premises. For purposes of determining the Tenant&#8217;s Pro Rata Share of the insurance for the Building, the numerator shall be the RSF of the Premises and the
                            denominator shall be 184,427 RSF.</div>
                          <div style="margin-top: 0px; margin-bottom: 0px; text-align: justify;"> <br>
                          </div>
                        </div>
                        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                          <div id="DSPFPageBreak" style="page-break-after: always;">
                            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                        </div>
                        <div style="margin: 0px 0px 0px 99pt; text-align: justify;">&#8220;<font style="font-weight: bold;"><u>Operating Expenses</u></font>&#8221; shall mean all costs and expenses incurred or made by Landlord or charged to Landlord in connection with
                          the Property or the operation and management thereof, exclusive of Taxes. Operating Expenses may include, without limitation: (i) costs of cleaning, security, janitorial service for the Common Areas, rubbish removal, heating,
                          electricity, air conditioning, utilities, risers/shafts and cable maintenance, tempered water and water for customary lavatory use, window cleaning, and maintenance and repairs, maintenance of the grounds, sidewalks, access roads,
                          sanitary sewer and related connections, equipment and fixtures, drainage, storm water management and related fixtures and equipment, and parking lots; (ii) service contracts or other agreements with independent contractors for any
                          of the foregoing (including, but not limited to, fire alarm, security system, electric system, elevator, and heating, ventilation and air conditioning (&#8220;<u>HVAC</u>&#8221;) maintenance); (iii) management fees; (iv) wages, salaries,
                          benefits, payroll taxes and unemployment compensation insurance for employees of Landlord or any contractor of Landlord engaged in the cleaning, operating, maintenance or security of the Property; (v) the cost of all Landlord&#8217;s
                          insurance including, without limitation, casualty, liability and loss of rent insurance equal to eighteen (18) month&#8217;s rent for the gross rent roll (including Additional Rent), and the amount of any insurance deductibles; (vi)
                          legal fees (excluding fees incurred in connection with enforcement action against an existing tenant or in negotiating a new lease); (vii) payments, other than Taxes, to the city and/or county in which the Landlord&#8217;s Premises is
                          located and other agencies or governmental agencies including, but not limited to, water and sewer charges; (viii) fees and charges of any association, or special district affecting the Property; (ix) fees and charges, under any
                          agreements affecting the Common Areas such as any reciprocal easement agreements, operation and maintenance agreements and park covenant and restriction agreements and the like; (x) all rent, additional rent, (including, without
                          limitation, common area charges and capital reserve fund contributions) and all other charges payable under the Prime Lease or any other ground lease or other lease to which this Lease is subject; (xi) supplies; and (xii) all
                          costs of maintaining, managing, reporting, commissioning, and recommissioning the Landlord&#8217;s Premises or any part thereof.</div>
                        <div style="text-align: justify; text-indent: 36pt; margin-right: 20.55pt; margin-left: 94pt;"> <br>
                        </div>
                        <div style="text-align: justify; margin-left: 99pt; text-indent: 36pt;">The term &#8220;Operating Expenses&#8221; shall not include: (i) repairs or other work (including rebuilding) occasioned by fire, windstorm or other casualty or
                          condemnation to the extent covered by Landlord&#8217;s insurance, but excluding any deductibles; (ii) any cost (such as electricity or overtime services) to the extent such costs are separately charged to and payable by Tenant
                          hereunder; (iii) leasing commissions and expenses associated with procuring tenants, including, lease concessions, lease take-over obligations; (iv) interest on and amortization of debt; (v) interest and penalties for late payment
                          of taxes; (vi) wages or salaries of employees of property or building manager; (vii) expenses resulting from any violation by Landlord of the terms of any ground or underlying lease or mortgage to which this Lease is subordinate;
                          (viii) fines and penalties (to the extent not attributable to any act or omission of Tenant or its agents, employees or contractors) which, under this Lease, are the responsibility of Landlord; (ix) fees and costs associated with
                          any refinancing of mortgage debt on the Property; and (x) any item for which reimbursement is actually made to Landlord from another source (e.g., insurance proceeds or payment from another tenant).</div>
                        <br>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                          <div style="page-break-after:always;" id="DSPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="margin: 0px 0px 0px 99pt; text-align: justify; text-indent: 36pt;">Notwithstanding anything to the contrary contained in this Lease, Landlord may, at its sole option, instead of using Tenant&#8217;s Pro Rata Share or
                          sub-metering, allocate electricity, water and sewer, and gas used in the Common Areas to Tenant and other tenants of the Landlord&#8217;s Premises based upon Tenant&#8217;s and such other tenants&#8217; consumption of electricity, water and sewer,
                          and gas as reasonably determined by Landlord.</div>
                        <div style="text-align: justify; margin-right: 20.9pt; margin-left: 94pt;"> <br>
                        </div>
                        <div style="text-align: justify; margin-left: 99pt;">(c)&#160; &#160;&#160; &#160;&#160; Tenant shall also pay (i) before any penalties or fines are assessed to the appropriate governmental authority any use and occupancy tax in connection with the
                          Premises. In the event Landlord is required by law to collect such tax, Tenant shall pay such use and occupancy tax to Landlord as Additional Rent within ten (10) days of demand and Landlord shall remit any amounts so paid to
                          Landlord to the appropriate governmental authority in a timely fashion, and (ii) Tenant shall also pay to Landlord the applicable state sales tax on all Rent simultaneously with the payment by Tenant of the Rent as otherwise
                          required by applicable Legal Requirements (as hereinafter defined).</div>
                        <div><br>
                        </div>
                        <div>
                          <div style="margin-left: 63pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Sections 12.1 and 12.2 are hereby deleted and replaced with the following:</div>
                        </div>
                        <div style="text-align: justify; margin-right: 28.05pt; margin-left: 94pt; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;"> <br>
                          </font></div>
                        <div style="text-align: justify; font-size: 12pt; margin-left: 99pt;"><font style="font-size: 10pt; font-weight: bold;">Section 12.1 </font><font style="font-size: 10pt;">Tenant shall carry and contractually cause and require that
                            its contractors carry (at their sole expense from and after the date hereof and during the Term) the following insurance:</font></div>
                        <div><br>
                        </div>
                        <div style="margin-left: 99pt; text-indent: 27pt; text-align: justify;">(a)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; Property Insurance and Boiler &amp; Machinery insurance (the latter is applicable if Tenant has any machinery or equipment on the Premises) with
                          &#8220;Special Form&#8221; coverage, including earthquakes and flood insurance, insuring Tenant&#8217;s alterations and improvements to the Premises and any and all furniture, equipment, supplies, contents and other property owned, leased, held or
                          possessed by it and contained therein (collectively, &#8220;Tenant&#8217;s Property&#8221;), such insurance coverage to be equal to the full replacement cost value (without deduction for depreciation) of Tenant&#8217;s Property, with wind and flood
                          deductibles not exceeding the lesser of five percent (5%) of the total insured value (&#8220;TIV&#8221;) or $10,000; </div>
                        <div style="text-indent: 40.55pt; margin-right: 26.55pt; margin-left: 94pt;"> <br>
                        </div>
                        <div style="margin-left: 99pt; text-indent: 27pt; text-align: justify;">(b)&#160;&#160;&#160; &#160; &#160; &#160;&#160; Either as part of the above referenced property insurance or as a separate property insurance policy, business interruption insurance with
                          &#8220;Special Form&#8221; coverage including the same perils in (a) above in an amount not less than the aggregate Base Rent and Additional Rent payable for the eighteen (18) month period immediately following the loss. The insurance
                          required in this subsection shall designate Landlord as loss payee and shall be in the broadest form available covering loss of income;</div>
                        <div style="text-indent: 40.55pt; margin-right: 21.25pt; margin-left: 94pt;"> <br>
                        </div>
                        <div style="margin-left: 99pt; text-indent: 27pt; text-align: justify;">(c)&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; Workers&#8217; compensation, Employer&#8217;s Liability, and New York State Disability and Paid Family Leave insurance with coverage in statutory amounts
                          covering all persons employed by Tenant, and other statutory forms of insurance for all persons who under applicable law shall be required to be covered;</div>
                        <br>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                          <div style="page-break-after:always;" id="DSPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="text-indent: 27pt; text-align: justify; margin-left: 99pt;">(d)&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; &#160; Commercial general liability insurance written on the most recent edition of ISO form CG 00 01 or its equivalent for the Premises in a combined
                          coverage for bodily injury and property damage in an amount not less than Two Million Dollars ($2,000,000) per occurrence and Four Million Dollars ($4,000,000) aggregate or Five Million Dollars ($5,000,000) per occurrence and
                          aggregate during construction. Tenant shall name Landlord, Landlord&#8217;s mortgagee, the Prime Landlord, the City of New York, Research Foundation for the State University of New York, State University of New York Downstate Medical
                          Center, any manager of the Building and/or the Landlord&#8217;s Premises, and any other person designated by Landlord, and their respective employees, directors, officers, officials, members, and agents (&#8220;Additional Insureds&#8221;) as
                          additional insureds for both ongoing and products/completed operations with coverage as broad as the most recent edition of ISO CG 20 10 and CG 20 37 or their equivalents under such policy. Such policy shall insure against any and
                          all liability for injury to or death of a person or persons and for damage to property occasioned by or arising out of any construction work being done on the Premises, or arising out of the use or occupancy of the Premises by
                          Tenant, its employees, agents, representatives or contractors. The additional insured coverage that applies to the Prime Landlord (currently New York City Economic Development Corporation), the City of New York and Prime
                          Landlord&#8217;s building manager (if any) must be provided via a Designated Organization additional insured endorsement that specifically identifies each additional insured and shall not require privity of contract between the
                          aforementioned additional insureds and the Tenant. The use of blanket additional endorsements which requires privity of contract with the Additional Insureds is prohibited. Tenant acknowledges that Landlord, Prime Landlord and the
                          City are materially relying upon the content of most recent edition of ISO Form CG 00 01 or its equivalent if applicable to implement Landlord&#8217;s commercial general liability insurance requirements under this Section 12.1(b).
                          Accordingly, Tenant agrees that non-standard exclusions and other modifications to the most recent edition of ISO Form CG 00 01 01 or to its equivalent if applicable regarding coverage for contractual liability, employer&#8217;s
                          liability, and New York Labor Law are prohibited under the terms and conditions of this Section 12.1(b). The liability coverage shall (i) be primary insurance as to all claims thereunder and provide that any insurance carried by
                          Landlord is excess and is non-contributing with any insurance requirement of Tenant; (ii) contain cross liability endorsements or a severability of interest clause acceptable to Landlord; and (iii) specifically cover the liability
                          assumed by Tenant under this Lease including, without limitation, Tenant&#8217;s indemnification obligations under this Lease; and</div>
                        <div style="text-indent: 40.55pt; margin-right: 22.95pt; margin-left: 94pt;"> <br>
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                          <div style="page-break-after:always;" id="DSPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="margin-left: 99pt; text-indent: 27pt; text-align: justify;">(e)&#160;&#160;&#160; &#160; &#160; &#160;&#160; Pollution/Environmental Liability Insurance covering bodily injury, including death, and property damage, including loss of use of damaged
                          property or use of property that has not been physically injured or destroyed, which in any event shall not be less than two million dollars ($2,000,000) per occurrence, unless otherwise approved in writing by Landlord, which
                          limit(s) may be increased from time to time as reasonably required by Landlord based on the Tenant&#8217;s activities and decreased from time to time. Tenant shall name Landlord, Landlord&#8217;s mortgagee, the Prime Landlord, the City of New
                          York, any manager of the Building and/or the Landlord&#8217;s Premises, and any other person designated by Landlord as additional insureds under such policy. Such insurance shall provide coverage for actual, alleged or threatened
                          emission, discharge, dispersal, seepage, release or escape of pollutants (including, without limitation, any Hazardous Materials), including any loss, cost or expense incurred as a result of any cleanup of pollutants (including,
                          without limitation, any Hazardous Materials) or in the investigation, settlement or defense of any claim, suit or proceeding against any of the Additional Insureds arising from the activities and operations under this Lease. The
                          coverage for bodily injury and property damage and clean up shall apply to both on and off the Premises (including throughout the Terminal) exposures and shall include, without limitation, coverage for improper or inadequate: (i)
                          environmental management practices; (ii) biological, chemical and radioactive materials handling and waste disposal; (iii) written emergency plans in the event of a chemical spill or release; (iv) training or supervision of staff
                          who handle biological materials, chemicals and hazardous wastes; (v) storage of chemicals and Hazardous Materials; and (vi) loading, unloading, transportation, and/or off- site disposal of Hazardous Materials. Coverage must not
                          exclude transportation (owned and non-owned vehicles) of the Hazardous Materials to and from the Premises and all related events which may occur in the Premises and/or elsewhere in the Terminal. Coverage must not exclude
                          operations of basic lab support rooms (BSL 1), vector labs (BSL 2) and separate labs used for vectors and immunology (BSL 3) and BSL 4, vaccination bioscience research laboratories, and/or related product development center. If
                          such coverage is written on a claims-made basis, such policy shall have a retroactive date preceding the effective date of this Lease, and continuous coverage shall be maintained, or an extended discovery period exercised, for a
                          period of not less than three (3) years following the Expiration Date.</div>
                        <div><br>
                        </div>
                        <div style="margin-left: 99pt; text-align: justify;">Notwithstanding the above Section 12.1(e), Tenant shall only be required to carry such Pollution/Environmental Liability Insurance upon the earlier of occupancy of or storage of
                          chemicals and Hazardous Materials on the Premises.</div>
                        <div><br>
                        </div>
                        <div style="margin-left: 99pt; text-indent: 27pt; text-align: justify;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; Automobile Liability insurance, covering applicable owned, hired and non-owned vehicles, with limits as reasonably designated by Landlord from
                          time to time, but in any event, with limits of not less than one million dollars ($1,000,000) combined single limit with respect to bodily injury, death and property damage per occurrence and adding the Additional Insureds as
                          additional insureds on a primary and non-contributory basis.</div>
                        <div style="text-indent: 36pt; margin-right: 22.3pt; margin-left: 93.1pt;"> <br>
                        </div>
                        <div style="margin-left: 99pt; text-align: justify; text-indent: 36pt;">(g)&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; All of Tenant&#8217;s insurance shall be with responsible companies qualified to do business in the State of New York, in good standing and holding a
                          &#8220;general policy rating&#8221; of A- VIII or better, as set forth in the most current issue of Best Key Rating Guide, and shall be written on an occurrence basis (and not claims made). Landlord, Landlord&#8217;s mortgagee and any other person
                          designated by Landlord shall be named as additional insureds with respect to all liability insurance policies.</div>
                        <div style="text-indent: 36pt; margin-right: 41.55pt; margin-left: 93.1pt;"> <br>
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                          <div style="page-break-after:always;" id="DSPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="text-align: justify; text-indent: 36pt; margin-left: 99pt;"> (h)&#160;&#160;&#160;&#160; &#160; &#160; Tenant must deposit with Landlord the following for such insurance at or before Tenant or its agents, employees or contractors enters the Premises
                          for any purpose whatsoever, and thereafter within fifteen (15) days before the expiration of any such policies: (i) with respect to the insurance required under Section 12.1(a) and (b), an ACORD Form 28 with changes requested by
                          Landlord or other form reasonably acceptable to Landlord; (ii) with respect to the insurance required under Section 12(c) and 12(f), a certificate of insurance in form reasonably acceptable to Landlord; and (iii) with respect to
                          the insurance required under Section 12(d), (e), and (f), Tenant&#8217;s policy of insurance or certificates with endorsements evidencing additional insured coverage for the Additional Insureds has been added to Tenant&#8217;s policy in a
                          form reasonably satisfactory to Landlord. All insurance shall provide that Landlord shall receive at least thirty (30) days prior written notice of cancellation or amendment to the same. All such policies or certificates shall be
                          delivered with satisfactory evidence of the payment of the premium therefor. </div>
                        <div style="text-indent: 36pt; margin-right: 20.9pt; margin-left: 94pt;"> <br>
                        </div>
                        <div style="margin-left: 99pt; text-indent: 36pt; text-align: justify;">(i)&#160;&#160;&#160;&#160; &#160;&#160; All chemicals, molecules, laboratory data, computers, merchandise, furniture, fixtures and property which may be on or about the Premises shall be at
                          the sole risk and hazard of Tenant, and if the whole or any part of the Premises is destroyed or damaged by fire, water or by the leaking or bursting of water pipes, or in any other manner, no part of such loss or damage will be
                          charged to Landlord.</div>
                        <div><br>
                        </div>
                        <div style="margin-left: 99pt; text-align: justify;"><u>Section 12.2 &#160; &#160; Coverages</u>. Landlord shall maintain during the Term, with solvent and responsible companies:</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; margin-left: 99pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160; Building and Personal Property Coverage, with &#8220;Special Form&#8221; coverage for the Landlord&#8217;s Premises in an amount equal to the full replacement value of the Landlord&#8217;s
                          Premises along with, at Landlord&#8217;s option, loss of rents insurance for up to eighteen (18) months of Rent; and</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; margin-left: 99pt;">(b)&#160;&#160;&#160;&#160; &#160; commercial general liability insurance covering injuries occurring at the Property, which shall provide for a combined coverage for bodily injury and property damage in
                          an amount not less than Five Million Dollars ($5,000,000) per occurrence.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; margin-left: 99pt;">(c)&#160;&#160;&#160; &#160;&#160; The cost of all insurance coverage provided to Landlord shall be an Operating Expense and subject to reimbursement in connection with Tenant&#8217;s Pro Rata Share. All such
                          insurance and all other insurance required by this Lease shall satisfy all requirements for insurance under the Prime Lease and any Mortgage. With respect to the insurance to be carried by Tenant hereunder, to the extent that the
                          Prime Lease, Mortgage or Landlord in its commercially reasonable discretion requires higher limits, additional insurance, additional coverages or additional insureds or otherwise imposes requirements in addition to or more onerous
                          than the requirements set forth herein, then Tenant, on behalf of and at the expense of Tenant, shall obtain insurance satisfying all such additional or more onerous requirements.</div>
                        <div style="text-align: justify;"> <br>
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                          <div style="page-break-after:always;" id="DSPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="margin-left: 63pt; text-align: justify;">(i)&#160;&#160;&#160;&#160;&#160; &#160; &#160; The content of Article XIII is hereby deleted in its entirety and replaced with &#8220;INTENTIONALLY DELETED&#8221;.</div>
                        <div style="margin-right: 21.45pt; margin-left: 58pt;"> <br>
                        </div>
                        <div>
                          <div style="margin-left: 63pt; text-align: justify;">(j)&#160;&#160;&#160;&#160; &#160; &#160;&#160; Section 21.1 is hereby deleted and replaced with the following:</div>
                        </div>
                        <div style="text-align: justify; margin-right: 20.7pt; margin-left: 94pt; font-size: 12pt;"><font style="font-size: 10pt;"><u> <br>
                            </u></font></div>
                        <div style="text-align: justify; font-size: 12pt; margin-left: 99pt;"><font style="font-size: 10pt;"><u>Subordination</u>. This Lease is and shall be subject and subordinate to (i) the City Lease, (ii) the Prime Lease and (iii) all
                            Mortgages held by Landlord and Prime Landlord. The subordination in this Section 21.1 is self-executing and no further instrument shall be required to establish the subordination set forth herein. In addition, this Lease is and
                            shall be subject and subordinate to any other existing underlying leases affecting the Premises and to all renewals, modifications, consolidations, replacements, and extensions thereof. If any Mortgagee requests an SNDA from
                            Tenant, then Tenant shall execute and deliver to Mortgagee such Mortgagee&#8217;s form of SNDA in recordable form within twenty (20) days of such request.</font></div>
                        <div style="text-align: justify; margin-right: 20.7pt; margin-left: 94pt; font-size: 12pt;"><font style="font-size: 10pt;"> <br>
                          </font></div>
                        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3826305d91d244efa0d25e17bc9dc6be">

                            <tr>
                              <td style="width: 57.95pt;"><br>
                              </td>
                              <td style="width: 36.05pt; vertical-align: top;">(k)</td>
                              <td style="width: auto; vertical-align: top;">
                                <div style="text-align: justify;">&#160;Section 23.1 is modified to add the following after the last sentence:</div>
                              </td>
                            </tr>

                        </table>
                        <div style="margin-right: 31.05pt; margin-left: 94pt;"> <br>
                        </div>
                        <div style="margin-left: 99pt; text-align: justify;">Notwithstanding the foregoing, upon the expiration or earlier termination of this Lease, Landlord may, in its sole discretion, require Tenant to remove the improvements installed
                          in connection with Tenant&#8217;s Work. If Landlord elects to require some or all of Tenant&#8217;s Work to be removed, Tenant shall cause such removal and restoration to condition on the date hereof or better to occur at Tenant&#8217;s expense
                          promptly upon the early termination or expiration of this Lease or Landlord shall remove or cause to be removed Tenant&#8217;s Work at Tenant&#8217;s expense. </div>
                        <div><br>
                        </div>
                        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc81d42ff07314a33b599326ebe930a39">

                            <tr>
                              <td style="width: 58pt;"><br>
                              </td>
                              <td style="width: 36pt; vertical-align: top;">(l)</td>
                              <td style="width: auto; vertical-align: top;">
                                <div>&#160;The first sentence of Section 27.1 is hereby deleted and replaced with the following:</div>
                              </td>
                            </tr>

                        </table>
                        <div style="text-align: justify; margin-right: 20.9pt; margin-left: 94pt;"> <br>
                        </div>
                        <div style="text-align: justify; margin-left: 99pt;">&#8220;Tenant has deposited with Landlord a sum of Twenty Thousand Eight Hundred Seventy-One and 53/100 ($20,871.53) Dollars as additional security for the faithful performance and
                          observance by Tenant of the terms, provisions and conditions of the Lease.&#8221;</div>
                        <div style="margin-right: 21pt; margin-left: 58pt;"> <br>
                        </div>
                        <div style="margin-right: 21pt; margin-left: 58pt; text-align: justify;">(m)&#160;&#160;&#160; &#160; &#160;&#160;&#160; The content of Article XXXIX is hereby deleted in its entirety and replaced with &#8220;INTENTIONALLY DELETED&#8221;.</div>
                        <div style="text-align: justify; text-indent: 35.95pt; margin-right: 20.95pt; margin-left: 22pt;"> <br>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;">2.&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Landlord&#8217;s Work</u>. Tenant acknowledges that Landlord&#8217;s Work has been completed.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;">3.&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Ratification.</u> Except as expressly set forth in this Second Lease Amendment, the terms and conditions of the Lease are hereby ratified and
                          reaffirmed and shall continue in full force and effect without any change or modification and shall apply for the balance of the Lease Term.</div>
                        <div><br>
                        </div>
                        <div style="margin-left: 36pt; text-indent: 27pt; text-align: justify;">4.&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Broker</u>. Tenant hereby represents and warrants to Landlord that it has not dealt with any broker in connection with this Second Lease
                          Amendment, and there are no brokerage fees or commissions payable in connection herewith. Tenant hereby agrees to hold Landlord harmless from, and indemnified against, all loss or damage (including without limitation, the cost of
                          defending the same) arising from any claim by any broker.</div>
                        <div> <br>
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                          <div style="page-break-after:always;" id="DSPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;">5.&#160; &#160; &#160;&#160;&#160; <u>Examination of Second Lease Amendment</u>. Submission of this instrument for examination or signature to Tenant does not constitute a reservation
                          or option, and it is not effective until execution by and delivery to both Landlord and Tenant.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;">6. &#160;&#160; &#160;&#160;&#160;&#160; <u>Definitions</u>. Except as otherwise provided herein, the capitalized terms used in this Second Lease Amendment shall have the definitions set
                          forth in the Lease.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;">7.&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160; <u>Reservation of Rights; No Waiver</u>. By executing this Second Lease Amendment, Landlord does not waive its right to assert (a) any events or
                          conditions that would constitute defaults under the Lease, or (b) any monetary or other obligations owed by Tenant to Landlord under the Lease. Landlord expressly reserves and does not waive any rights under the Lease, at law, and
                          in equity. Acceptance by Landlord of any partial performance, including without limitation partial performance of any unpaid obligations under the Lease, by Tenant is and will be without prejudice to the rights and remedies of
                          Landlord under the Lease, at law and in equity.</div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;"> <br>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;">8.&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Incorporation</u>. This Second Lease Amendment shall be incorporated into and made a part of the Lease, and all provisions of the Lease not
                          expressly modified or amended hereby shall remain in full force and effect.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;">9.&#160; &#160; &#160; &#160;&#160;&#160; <u>Conflict</u>. In the event of any conflict between the provisions of the First Lease Amendment and the Second Lease Amendment, the provisions of
                          this Second Lease Amendment shall control.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;">10.&#160; &#160; &#160; &#160; <u>Effective Upon Execution</u>. This Lease is transmitted for examination only and does not constitute an offer to Lease. This Lease shall become
                          effective only upon execution hereof by the Parties and delivery by Landlord to Tenant of an executed Lease.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;">11.&#160; &#160;&#160; &#160; <u>Entire Agreement</u>. This instrument contains the entire and only agreement between the Parties. No oral statements or representations or prior
                          written matter not contained herein shall have any force or effect.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;">12.&#160;&#160; &#160; &#160;&#160;&#160; <u>Amendments</u>. This Lease shall not be modified, changed, or amended in any way or canceled, terminated or abridged except by a writing
                          subscribed by both Parties.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;">13. &#160; &#160; &#160;&#160; <u>Counterparts</u>. This Lease may be executed in one or more counterparts, each one of which shall be deemed an original. E-mail (PDF attachment)
                          and facsimile signatures shall also be sufficient to bind the Parties.</div>
                        <div><br>
                        </div>
                        <div style="text-align: justify; margin-left: 36pt; text-indent: 27pt;">14.&#160; &#160; &#160;&#160;&#160;&#160; <u>Invalidity of Certain Provisions</u>. If any term or provision of this Lease or the application thereof to any person or circumstances shall, to
                          any extent, be invalid or unenforceable, the remainder of this Lease, or the application of such term or provision to persons or circumstances other than those as to which it is held invalid or unenforceable, shall not be affected
                          thereby and each term and provision of this Lease shall be valid and enforced to the fullest extent permitted by law. </div>
                        <div><br>
                        </div>
                        <div style="text-align: center;">[SIGNATURES APPEAR ON FOLLOWING PAGE]</div>
                        <div style="text-align: center;"> <br>
                        </div>
                        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                          <div style="page-break-after:always;" id="DSPFPageBreak">
                            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                        </div>
                        <div style="margin: 0px 0px 0px 24pt; color: #050505; text-indent: 34.5pt;">IN WITNESS WHEREOF, the parties have caused this Second Lease Amendment to be executed on the day and year first above written.</div>
                        <div><br>
                        </div>
                        <div>
                          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="ze62921135cbe4bf196a52e34d599e7de">

                              <tr>
                                <td style="width: 50%; vertical-align: top;">&#160;</td>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="color: rgb(34, 34, 34); font-weight: bold;">LANDLORD:</div>
                                </td>
                              </tr>
                              <tr>
                                <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                                <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width: 50%; vertical-align: top;">&#160;</td>
                                <td style="width: 50%; vertical-align: top;">
                                  <div style="color: rgb(14, 14, 14);"><font style="font-weight: bold;">BIOBAT, INC., </font>a New York Not-for-Profit corporation</div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div><br>
                        </div>
                        <table cellspacing="0" cellpadding="0" border="0" id="za2d1a77ac0764829943c033406d2cb1a" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                            <tr>
                              <td style="width: 50%; padding-bottom: 2px;">
                                <div>&#160;</div>
                              </td>
                              <td style="width: 5%; padding-bottom: 2px;">By:</td>
                              <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Eva Cramer</td>
                              <td colspan="1" style="width: 5%; padding-bottom: 2px;">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width: 50%; padding-bottom: 2px;">
                                <div>&#160;</div>
                              </td>
                              <td style="width: 5%; padding-bottom: 2px;">
                                <div>Name:<br>
                                </div>
                              </td>
                              <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">Eva Cramer</td>
                              <td colspan="1" style="width: 5%; padding-bottom: 2px;">&#160;</td>
                            </tr>
                            <tr>
                              <td style="width: 50%; padding-bottom: 2px;">
                                <div>&#160;</div>
                              </td>
                              <td style="width: 5%; padding-bottom: 2px;">Title:<br>
                              </td>
                              <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">President</td>
                              <td colspan="1" style="width: 5%; padding-bottom: 2px;">&#160;</td>
                            </tr>

                        </table>
                        <div><br>
                        </div>
                        <div>
                          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z455762038fdb45719244708ea0d84d08">

                              <tr>
                                <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                                <td rowspan="1" style="width: 50%; vertical-align: top;">
                                  <div style="color: rgb(22, 22, 22); font-weight: bold;">TENANT:</div>
                                </td>
                              </tr>
                              <tr>
                                <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                                <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                              </tr>
                              <tr>
                                <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                                <td rowspan="1" style="width: 50%; vertical-align: top;">
                                  <div style="color: rgb(29, 29, 29);"><font style="font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS LLC,</font> a Delaware limited liability company</div>
                                </td>
                              </tr>

                          </table>
                        </div>
                        <div><br>
                        </div>
                        <div>
                          <table cellspacing="0" cellpadding="0" border="0" id="zd1882d744721432e860b7351751b50cd" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                              <tr>
                                <td style="width: 50%; padding-bottom: 2px;">
                                  <div>&#160;</div>
                                </td>
                                <td style="width: 5%; padding-bottom: 2px;">By:</td>
                                <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Mark Leuchtenberger</td>
                                <td colspan="1" style="width: 5%; padding-bottom: 2px;">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width: 50%; padding-bottom: 2px;">
                                  <div>&#160;</div>
                                </td>
                                <td style="width: 5%; padding-bottom: 2px;">Name:</td>
                                <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">Mark Leuchtenberger<br>
                                </td>
                                <td colspan="1" style="width: 5%; padding-bottom: 2px;">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width: 50%; padding-bottom: 2px;">
                                  <div>&#160;</div>
                                </td>
                                <td style="width: 5%; padding-bottom: 2px;">Title:</td>
                                <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);">Interim President and CEO<br>
                                </td>
                                <td colspan="1" style="width: 5%; padding-bottom: 2px;">&#160;</td>
                              </tr>

                          </table>
                        </div>
                        <div><br>
                        </div>
                        <div>
                          <div style="color: rgb(15, 15, 15); font-style: italic;">
                            <div style="text-align: center; color: rgb(15, 15, 15); font-style: italic;">Signature Page to Second Amendment to Lease Agreement</div>
                          </div>
                        </div>
                        <div><br>
                        </div>
                        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                          <div id="DSPFPageBreak" style="page-break-after: always;">
                            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                        </div>
                        <!--PROfilePageNumberReset%Num%1%A-%%-->
                        <div>
                          <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt;"><u>EXHIBIT A</u> </font></div>
                          <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt;">TO</font></div>
                          <div style="text-align: center;"><u>SECOND AMENDMENT TO LEASE AGREEMENT</u></div>
                          <div><br>
                          </div>
                          <div style="text-align: center;"><u>EXHIBIT A</u></div>
                          <div style="text-align: center; margin-right: 121.3pt; margin-left: 122.25pt;"><br>
                          </div>
                          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">A-1</font></div>
                            <div style="page-break-after:always;" id="DSPFPageBreak">
                              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                          </div>
                          <div style="text-align: center;">EXHIBIT B</div>
                          <div style="text-align: center; text-indent: 0.15pt; margin-right: 212.9pt; margin-left: 213.9pt;"> <br>
                          </div>
                          <div style="text-align: center;"> EXHIBIT D-1 </div>
                          <div style="text-align: center; text-indent: 0.15pt; margin-right: 212.9pt; margin-left: 213.9pt;"><u> <br>
                            </u></div>
                          <div style="text-align: center;"><u>WORK </u><u>LETTER</u></div>
                          <div style="text-align: center; text-indent: 0.15pt; margin-right: 212.9pt; margin-left: 213.9pt;"><u> <br>
                            </u></div>
                          <div style="text-align: justify; text-indent: 27pt;">[Tenant&#8217;s contractor or architect should review to make sure time periods and other requirements are workable.]</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">THIS&#160; WORK LETTER dated _____________, 2019 (this &#8220;<font style="font-weight: bold;">Work Letter</font>&#8221;) is made and entered into by and between Landlord and Tenant, and is
                            attached to and made a part of the Lease Agreement dated _____________, 2019 (the &#8220;<font style="font-weight: bold;">Lease</font>&#8221;), by and between Landlord and Tenant. Any initially capitalized terms used but not defined herein
                            shall have the meanings set forth in the Lease.</div>
                          <div><br>
                          </div>
                          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0d0100db73484b848a613bbb7da60f04">

                              <tr>
                                <td style="width: 27pt;"><br>
                                </td>
                                <td style="width: 27pt; vertical-align: top;">1.</td>
                                <td style="width: auto; vertical-align: top; text-align: justify;">
                                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">General Requirements</font><font style="font-size: 10pt;">.</font></div>
                                </td>
                              </tr>

                          </table>
                          <div><br>
                          </div>
                          <div style="text-align: justify;">
                            <div> </div>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(a) &#160; &#160;&#160; <font style="font-weight: bold;">Landlord&#8217;s Authorized Representative</font>.&#160;Landlord designates _____________ and _____________ (either such individual acting alone,
                            &#8220;<font style="font-weight: bold;">Landlord&#8217;s Representative</font>&#8221;) as the only persons authorized to act for Landlord pursuant to this Work Letter. Tenant shall not be obligated to respond to or act upon any request, approval,
                            inquiry or other communication (&#8220;<font style="font-weight: bold;">Communication</font>&#8221;) from or on behalf of Landlord in connection with this Work Letter unless such Communication is in writing from Landlord&#8217;s Representative.
                            Landlord may change either Landlord&#8217;s Representative at any time upon not less than 5 business days advance written notice to Tenant. Neither Landlord nor Landlord&#8217;s Representative shall be authorized to direct Landlord&#8217;s
                            contractors in the performance of Tenant&#8217;s Work (as hereinafter defined).</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(b)&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Tenant&#8217;s Authorized Representative</font>. Tenant designates _____________ and _____________ (either such individual acting alone, &#8220;<font style="font-weight: bold;">Tenant&#8217;s Representative</font>&#8221;) as the only persons authorized to act for Tenant pursuant to this Work Letter. Landlord shall not be obligated to respond to or act upon any request, approval,
                            inquiry or other Communication from or on behalf of Tenant in connection with this Work Letter unless such Communication is in writing from Tenant&#8217;s Representative. Tenant may change either Tenant&#8217;s Representative at any time
                            upon not less than 5 business days advance written notice to Landlord. Tenant&#8217;s Representative shall be the sole persons authorized to direct Tenant&#8217;s contractors in the performance of Tenant&#8217;s Work.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(c)&#160;&#160; &#160;&#160; &#160; <font style="font-weight: bold;">Architects, Consultants and Contractors</font>. Landlord and Tenant hereby acknowledge and agree that: (i) ________________ shall be
                            the general contractor for Tenant&#8217;s Work, (ii) ________________ shall be the architect (the &#8220;<font style="font-weight: bold;">TI Architect</font>&#8221;) for Tenant&#8217;s Work, and (iii) any subcontractors for Tenant&#8217;s Work shall be
                            selected by Tenant, but approved in writing by Landlord prior to being engaged to perform Tenant&#8217;s Work.</div>
                          <div style="text-align: justify; text-indent: 27pt;"> <br>
                          </div>
                          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">A-2</font></div>
                            <div style="page-break-after:always;" id="DSPFPageBreak">
                              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                          </div>
                          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1f46c0a5247e4203b8ed7710ea91c277">

                              <tr>
                                <td style="width: 27pt;"><br>
                                </td>
                                <td style="width: 27pt; vertical-align: top;">2.</td>
                                <td style="width: auto; vertical-align: top;">
                                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Tenant Improvements</font><font style="font-size: 10pt;">.</font></div>
                                </td>
                              </tr>

                          </table>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(a) &#160; &#160;&#160;&#160; <font style="font-weight: bold;">Tenant&#8217;s Work Defined</font>. As used herein, &#8220;<font style="font-weight: bold;">Tenant&#8217;s Work</font>&#8221; shall mean all improvements to
                            the Premises as shown on the Construction Drawings, as defined in <u>Section 2(c)</u> below. Tenant&#8217;s Work shall include the oversight of the installation of furniture, benches, equipment, clean rooms and all other improvements
                            required by Tenant to use the Premises. Other than as expressly provided herein or in the Lease, Landlord shall not have any obligation whatsoever with respect to the finishing of the Premises for Tenant&#8217;s use and occupancy.
                            Tenant shall be responsible for all costs associated with Tenant&#8217;s Work in accordance with <u>Section 8</u> hereof.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(b) &#160; &#160;&#160;&#160; <font style="font-weight: bold;">Tenant&#8217;s Space Plans</font>. Tenant shall deliver to Landlord and the TI Architect schematic drawings and outline specifications (the
                            &#8220;<font style="font-weight: bold;">Space Plans</font>&#8221;) detailing Tenant&#8217;s plans for completing Tenant&#8217;s Work within 30 days of the date hereof. Not more than 15 days thereafter, Landlord shall deliver to Tenant the reasonable
                            written objections, questions or comments of Landlord and the TI Architect with regard to the Space Plans. Tenant shall cause the Space Plans to be revised to address such reasonable written comments and shall resubmit said
                            drawings to Landlord for approval within 15 days thereafter. Such process shall continue until Landlord has approved the Space Plans in its sole discretion.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(c)&#160; &#160;&#160; &#160; <font style="font-weight: bold;">Working Drawings</font>. Not later than 14 business days following the approval of the Space Plans, Tenant shall cause the TI
                            Architect to prepare and deliver to Landlord for review and comment construction plans, specifications and drawings for Tenant&#8217;s Work (&#8220;<font style="font-weight: bold;">Construction Drawings</font>&#8221;), which Tenant&#8217;s Work shall
                            be prepared substantially in accordance with the Space Plans. Tenant shall be solely responsible for ensuring that the Construction Drawings reflect Tenant&#8217;s requirements for Tenant&#8217;s Work. Landlord shall deliver its written
                            comments on the Construction Drawings to Tenant not later than 14 business days after Landlord&#8217;s receipt of the same. Tenant shall cause the Construction Drawings to be revised to address such reasonable written comments and
                            shall resubmit said drawings to Landlord for approval within 14 business days thereafter. Such process shall continue until Landlord has approved the Construction Drawings in its sole discretion.. Any disputes in connection with
                            such comments shall be resolved in accordance with <u>Section 2(d)</u> hereof. Once approved by Landlord, subject to the provisions of <u>Section 4</u> below, Tenant shall not modify the Construction Drawings except as may be
                            reasonably required.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(d)&#160; &#160;&#160; &#160; <font style="font-weight: bold;">Approval and Completion</font>. It is hereby acknowledged by Landlord and Tenant that the Construction Drawings must be completed and
                            approved not later than [__Outside Date&#160; for Construction Start]. Upon any dispute regarding the design of Tenant&#8217;s Work, which is not settled within 10 business days after notice of such dispute is delivered by one party to the
                            other, Landlord may make the final decision regarding the design of Tenant&#8217;s Work. Any changes to the Construction Drawings following Landlord&#8217;s and Tenant&#8217;s approval of same requested by Tenant shall be processed as provided in
                            <u>Section 4</u> hereof.</div>
                          <div style="text-align: justify; text-indent: 27pt;"> <br>
                          </div>
                          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">A-3</font></div>
                            <div style="page-break-after:always;" id="DSPFPageBreak">
                              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                          </div>
                          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zac298678831445cab26d7841dfde308f">

                              <tr>
                                <td style="width: 27pt;"><br>
                                </td>
                                <td style="width: 27pt; vertical-align: top;">3.</td>
                                <td style="width: auto; vertical-align: top;">
                                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Performance of Tenant&#8217;s Work</font><font style="font-size: 10pt;">.</font></div>
                                </td>
                              </tr>

                          </table>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(a) &#160;&#160; &#160;&#160; <font style="font-weight: bold;">Mechanic&#8217;s Liens</font>. Tenant shall comply with Section 8.4 of the Lease at all times during the construction of Tenant&#8217;s Work.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(b)&#160; &#160; &#160; <font style="font-weight: bold;">Commencement and Permitting</font>. Tenant shall commence construction of Tenant&#8217;s Work upon obtaining a building permit (the &#8220;<font style="font-weight: bold;">TI Permit</font>&#8221;) authorizing the construction of Tenant&#8217;s Work consistent with the Construction Drawings approved by Landlord. The cost of obtaining the TI Permit shall be payable by Tenant.
                            Landlord shall cooperate with Tenant as may be reasonably necessary for Tenant to obtain the TI Permit. If any Governmental Authority having jurisdiction over the construction of Tenant&#8217;s Work or any portion thereof shall impose
                            terms or conditions upon the construction thereof that: (i) are inconsistent with Landlord&#8217;s or Tenant&#8217;s obligations hereunder, (ii) materially increase the cost of constructing Tenant&#8217;s Work, or (iii) will materially delay the
                            construction of Tenant&#8217;s Work, Landlord and Tenant shall reasonably and in good faith seek means by which to mitigate or eliminate any such adverse terms and conditions.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(c)&#160;&#160; &#160;&#160; <font style="font-weight: bold;">Completion of Tenant&#8217;s Work</font>. Tenant shall substantially complete or cause to be substantially completed Tenant&#8217;s Work in a good
                            and workmanlike manner, in accordance with the TI Permit subject, in each case, to Minor Variations and normal &#8220;punch list&#8221; items of a non-material nature that do not interfere with the use of the Premises and with a certificate
                            or temporary certificate of occupancy (or an equivalent approval having been issued) for the Premises permitting lawful occupancy of the Premises (but specifically excluding any permits, licenses or other governmental approvals
                            required to be obtained in connection with Tenant&#8217;s operations in the Premises) (&#8220;<font style="font-weight: bold;">Substantial Completion</font>&#8221; or &#8220;<font style="font-weight: bold;">Substantially Complete</font>&#8221;). For purposes
                            of this Work Letter, &#8220;<font style="font-weight: bold;">Minor Variations</font>&#8221; shall mean any modifications reasonably required: (i) to comply with all applicable Legal Requirements and/or to obtain or to comply&#160; with any
                            required permit (including the TI Permit); (ii) to comply with any request by Tenant for modifications to Tenant&#8217;s Work; (iii) to comport with good design, engineering, and construction practices that are not material; or (iv)
                            to make reasonable adjustments for field deviations or conditions encountered during the construction of Tenant&#8217;s Work.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(d) &#160; &#160;&#160; <font style="font-weight: bold;">Selection of Materials</font>. Where more than one type of material or structure is indicated on the Construction Drawings approved by
                            Landlord, the option will be selected at Tenant&#8217;s reasonable discretion. As to all building materials and equipment that Tenant is obligated to supply under this Work Letter, Tenant shall select the manufacturer thereof in its
                            reasonable discretion, unless a specific manufacturer has been identified during the design process.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(e)&#160; &#160; &#160; <font style="font-weight: bold;">Delivery of the Premises</font>. When Tenant&#8217;s Work is Substantially Complete, subject to the remaining terms and provisions of this <u>Section

                              3(e)</u>, Tenant shall accept the Premises. Tenant&#8217;s taking possession and acceptance of the Premises shall constitute a waiver&#160; of: (i) any warranty with respect to workmanship (including installation of equipment) or
                            material (exclusive of equipment provided directly by manufacturers), (ii) any non-compliance of Tenant&#8217;s Work with Applicable Laws, or (iii) any claim that Tenant&#8217;s Work was not completed substantially in accordance with the
                            Construction Drawings (subject to Minor Variations and such other changes as are permitted hereunder) or (iv) any latent defect (collectively, a &#8220;<font style="font-weight: bold;">Construction Defect</font>&#8221;). Tenant shall
                            immediately notify Landlord of any Construction Defect, and shall use reasonable efforts to remedy or cause the responsible contractor to remedy any such Construction Defect within 30 days after such notice. Tenant shall be
                            responsible for remedying any Construction Defect at its sole cost and expense.<br>
                            <br>
                          </div>
                          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">A-4</font></div>
                            <div style="page-break-after:always;" id="DSPFPageBreak">
                              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                          </div>
                          <div style="text-align: justify;">Tenant shall be entitled to receive the benefit of all construction warranties and manufacturer&#8217;s equipment warranties relating to equipment installed in the Premises. If requested by Landlord,
                            Tenant shall attempt to obtain extended warranties from manufacturers and suppliers of such equipment. Tenant shall promptly undertake and complete, or cause to be completed, all punch list items within ninety (90) days of
                            Substantial Completion.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">4.&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Changes</font>. Any changes requested by Tenant to Tenant&#8217;s Work after the delivery and approval by Landlord of the Space Plan shall
                            be requested and instituted in accordance with the provisions of this <u>Section 4</u> and shall be subject to the written approval of Landlord, such approval not to be unreasonably withheld, conditioned or delayed.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(a)&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Tenant&#8217;s Request For Changes</font>. If Tenant shall request changes to Tenant&#8217;s Work (&#8220;<font style="font-weight: bold;">Changes</font>&#8221;),

                            Tenant shall request such Changes by notifying Landlord in writing in substantially the same form as the AIA standard change order form (a &#8220;<font style="font-weight: bold;">Change Request</font>&#8221;), which Change Request shall
                            detail the nature and extent of any such Change. Each Change Request shall also include an estimate of: (i) the time it will take, and (ii) the architectural and engineering fees and costs that will be incurred in connection
                            with such Change Request. Such Change Request must be signed by Tenant&#8217;s Representative. Landlord shall respond to any Change Request within 10 business days following receipt thereof by either approving, denying or requesting
                            more information relating to the Change Request, each in Landlord&#8217;s sole and absolute discretion.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Landlord&#8217;s Request For Changes</font>. Once the Space Plans or Construction Drawings have been approved by Landlord, Landlord shall
                            be permitted to make any Changes that, Landlord&#8217;s reasonable discretion, are necessary or required to maintain the structural integrity of the Building, compliance with any Applicable Laws or to remain in compliance with the
                            City Lease.</div>
                          <div><br>
                          </div>
                          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdecfaa6c4b1143c69cffdc2d2854a913">

                              <tr>
                                <td style="width: 27pt;"><br>
                                </td>
                                <td style="width: 27pt; vertical-align: top;">5.</td>
                                <td style="width: auto; vertical-align: top;">
                                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Costs</font><font style="font-size: 10pt;">.</font></div>
                                </td>
                              </tr>

                          </table>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(a)&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;">Budget For Tenant Improvements</font>. Before the commencement of construction of Tenant&#8217;s Work, Tenant shall obtain a detailed
                            breakdown by trade of the costs incurred or that will be incurred in connection with the design and construction of Tenant&#8217;s Work (the &#8220;<font style="font-weight: bold;">Budget</font>&#8221;). Landlord shall have the right to review
                            and approve or make comments to the Budget. If the Landlord-approved Budget is greater than the TI Letter of Credit, Tenant shall deposit with Landlord the difference, in cash, prior to the commencement of construction of
                            Tenant&#8217;s Work or Changes, for disbursement by Landlord as described in <u>Section 5(d)</u>.</div>
                          <div><br>
                          </div>
                          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-weight: normal; font-style: normal;">A-5</font></div>
                            <div style="page-break-after:always;" id="DSPFPageBreak">
                              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(b)&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">TI Letter of Credit</font>. Tenant shall provide to Landlord a Letter of Credit (the &#8220;<font style="font-weight: bold;">TI Letter of
                              Credit</font>&#8221;) in the amount of [________________]. The TI Letter of Credit shall be held by Landlord as additional security for Tenant&#8217;s performance hereunder and may be used by Landlord upon and after any default hereunder
                            by Tenant or an Event of Default (as defined in the Lease) to either (i) cause Tenant&#8217;s Work to be completed or (ii) cause the removal of all improvements made in connection with Tenant&#8217;s Work to return the Premises to the
                            condition it was in when it was delivered by Landlord to Tenant. The TI Letter of Credit shall be returned to Tenant upon the Substantial Completion of Tenant&#8217;s Work.</div>
                          <div><br>
                          </div>
                          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z039548d2eab24b108df5a5d4b4791cc5">

                              <tr>
                                <td style="width: 27pt;"><br>
                                </td>
                                <td style="width: 27pt; vertical-align: top;">6.</td>
                                <td style="width: auto; vertical-align: top;">
                                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Tenant Access</font><font style="font-size: 10pt;">.</font></div>
                                </td>
                              </tr>

                          </table>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">No Interference</font>. Neither Tenant nor any Tenant Party (as defined in the Lease) shall interfere with the performance of
                            Tenant&#8217;s Work, nor with any inspections or issuance of final approvals by applicable governmental authorities.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Acceptance of Premises</font>. Tenant acknowledges and agrees that it has accepted the Premises as of the Commencement Date (as
                            defined in the Lease) subject to Landlord&#8217;s right to inspect the Premises at reasonable times to inspect the progress of Tenant&#8217;s Work prior to substantial completion. Tenant shall defend with counsel reasonably acceptable by
                            Landlord, indemnify and hold Landlord harmless from and against any loss of or damage to Tenant&#8217;s property, completed work, fixtures, equipment, materials or merchandise, and from liability for death of, or injury to, any
                            person, caused by the act or omission of Tenant or any Tenant Party during such inspections.</div>
                          <div><br>
                          </div>
                          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zde249e3a19e945a8bfc0827fd95a61a0">

                              <tr>
                                <td style="width: 27pt;"><br>
                                </td>
                                <td style="width: 27pt; vertical-align: top;">7.</td>
                                <td style="width: auto; vertical-align: top;">
                                  <div style="font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Miscellaneous</font><font style="font-size: 10pt;">.</font></div>
                                </td>
                              </tr>

                          </table>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(a)&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Consents</font>. Whenever consent or approval of either party is required under this Work Letter, that party shall not unreasonably
                            withhold, condition or delay such consent or approval, unless expressly set forth herein to the contrary.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify; text-indent: 27pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Modification</font>. No modification, waiver or amendment of this Work Letter or of any of its conditions or provisions shall be
                            binding upon Landlord or Tenant unless in writing signed by Landlord and Tenant.</div>
                          <div><br>
                          </div>
                          <div style="text-align: justify;">8.&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Costs.</font> Notwithstanding anything else set forth herein or in the Lease to the contrary, Tenant acknowledges and agrees to be solely responsible for
                            all costs associated with obtaining the Space Plans and Construction Drawings and for all costs and expenses associated with the completion of Tenant&#8217;s Work, including, without limitation, all costs and expenses incurred by
                            Landlord in connection with any of the foregoing. </div>
                          <div style="margin-left: 36pt; text-indent: 27pt;"> <br>
                          </div>
                          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                            <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">A-6</font></div>
                            <div style="page-break-after:always;" id="DSPFPageBreak">
                              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                          </div>
                          <!--PROfilePageNumberReset%Num%9%%%-->
                          <div>Execution Copy</div>
                          <div><br>
                          </div>
                          <div style="text-align: center; font-weight: bold;">EXHIBIT B</div>
                          <div><br>
                          </div>
                          <div style="font-weight: bold;">The Premises, outlined below, is located on the 2d floor of the southwest portion of the Building.</div>
                        </div>
                        <div> <br>
                        </div>
                        <div style="text-align: center;">
                          <div><img src="image11.jpg"></div>
                          <div><br>
                          </div>
                          <div><br>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
  <div id="DSPFPageNumberArea" style="text-align: center;">
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>brhc10039260_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.4.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="font-weight: bold; text-align: right;">
      <div>
        <div style="font-weight: bold;">Exhibit 31.1</div>
        <div style="text-align: center; font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; font-weight: bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</div>
        <div style="text-align: center; font-weight: bold;">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>
        <div style="text-align: left;"> <br>
        </div>
        <div style="text-align: justify; font-weight: normal;">I, Matthew Angel, certify that:</div>
        <div style="text-align: left;"><font style="font-weight: normal;"> <br>
          </font></div>
        <div style="text-align: left; font-weight: normal;">1. I have reviewed this Quarterly Report on Form 10-Q of Brooklyn ImmunoTherapeutics, Inc.</div>
        <div style="text-align: left;"><font style="font-weight: normal;"> <br>
          </font></div>
        <div style="text-align: left; font-weight: normal;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
          under which such statements were made, not misleading with respect to the period covered by this report.</div>
        <div style="text-align: left;"><font style="font-weight: normal;"> <br>
          </font></div>
        <div style="text-align: left; font-weight: normal;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations
          and cash flows of the registrant as of, and for, the periods presented in this report.</div>
        <div style="text-align: left;"><font style="font-weight: normal;"> <br>
          </font></div>
        <div style="text-align: left; font-weight: normal;">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
          and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
        <div style="text-align: left;"><font style="font-weight: normal;"> <br>
          </font></div>
        <div style="text-align: left; font-weight: normal;">(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the
          registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
        <div style="text-align: left;"><font style="font-weight: normal;"> <br>
          </font></div>
        <div style="text-align: left; font-weight: normal;">(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance
          regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
        <div style="text-align: left;"><font style="font-weight: normal;"> <br>
          </font></div>
        <div style="text-align: left; font-weight: normal;">(c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and
          procedures, as of the end of the period covered by this report based on such evaluation; and</div>
        <div style="text-align: left;"><font style="font-weight: normal;"> <br>
          </font></div>
        <div style="text-align: left; font-weight: normal;">(d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected,
          or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting.</div>
        <div style="text-align: left;"><font style="font-weight: normal;"> <br>
          </font></div>
        <div style="text-align: left; font-weight: normal;">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit
          committee of the registrant&#8217;s board of directors:</div>
        <div style="text-align: left;"><font style="font-weight: normal;"> <br>
          </font></div>
        <div style="text-align: left; font-weight: normal;">(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s
          ability to record, process, summarize and report financial information; and</div>
        <div style="text-align: left;"><font style="font-weight: normal;"> <br>
          </font></div>
        <div style="text-align: left; font-weight: normal;">(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls.</div>
        <div style="text-align: left;"> <br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" id="zb0beafe9b0f042ba8d08a3e9d4fd3fb9" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 49.98%; vertical-align: top;">
                <div>Date: June 30, 2022</div>
              </td>
              <td style="width: 50.02%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify;">/s/ <font style="font-style: italic; font-variant: small-caps;">Matthew Angel</font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.98%; vertical-align: top;">&#160;</td>
              <td style="width: 50.02%; vertical-align: bottom;">
                <div style="text-align: justify;">Matthew Angel</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.98%; vertical-align: top;">&#160;</td>
              <td style="width: 50.02%; vertical-align: bottom;">
                <div style="text-align: justify;">Chief Executive Officer and President</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.98%; vertical-align: top;">&#160;</td>
              <td style="width: 50.02%; vertical-align: bottom;">
                <div style="text-align: justify; font-style: italic;">(Principal Executive Officer)</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div>&#160;</div>
        <div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>brhc10039260_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.4.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-weight: bold;">Exhibit 31.2</div>
      <div> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</div>
      <div style="text-align: center; font-weight: bold;">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div> <br>
      </div>
      <div style="text-align: justify;">I, Andrew Jackson, certify that:</div>
      <div> <br>
      </div>
      <div>1. I have reviewed this Quarterly Report on Form 10-Q of Brooklyn ImmunoTherapeutics, Inc.</div>
      <div> <br>
      </div>
      <div>2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
        misleading with respect to the period covered by this report.</div>
      <div> <br>
      </div>
      <div>3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for,
        the periods presented in this report.</div>
      <div> <br>
      </div>
      <div>4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
        defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
      <div> <br>
      </div>
      <div>(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
        subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
      <div> <br>
      </div>
      <div>(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
        preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
      <div> <br>
      </div>
      <div>(c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
        report based on such evaluation; and</div>
      <div> <br>
      </div>
      <div>(d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect,
        the registrant&#8217;s internal control over financial reporting.</div>
      <div> <br>
      </div>
      <div>5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors:</div>
      <div> <br>
      </div>
      <div>(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report
        financial information; and</div>
      <div> <br>
      </div>
      <div>(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls.</div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z8b4af9214e1044418dea6a9e3f66c585" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 49.98%; vertical-align: top;">
              <div>Date: June 30, 2022</div>
            </td>
            <td style="width: 50.02%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify;">/s/ <font style="font-style: italic; font-variant: small-caps;">Andrew Jackson</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.98%; vertical-align: top;">&#160;</td>
            <td style="width: 50.02%; vertical-align: bottom;">
              <div style="text-align: justify;">Andrew Jackson</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.98%; vertical-align: top;">&#160;</td>
            <td style="width: 50.02%; vertical-align: bottom;">
              <div style="text-align: justify;">Chief Financial Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.98%; vertical-align: top;">&#160;</td>
            <td style="width: 50.02%; vertical-align: bottom;">
              <div style="text-align: justify; font-style: italic;">(Principal Financial Officer)</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>brhc10039260_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.4.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-weight: bold;">Exhibit 32.1</div>
      <div> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">CERTIFICATION PURSUANT TO 18 U.S.C. 1350,</div>
      <div style="text-align: center; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div> <br>
      </div>
      <div>In connection with the Quarterly Report on Form 10-Q of Brooklyn ImmunoTherapeutics, Inc. for the quarterly period ended March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned
        certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge on the date hereof:</div>
      <div> <br>
      </div>
      <div>1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
      <div> <br>
      </div>
      <div>2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Brooklyn ImmunoTherapeutics, Inc. for the period presented therein.</div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbd86850cf5c84552adbb6a149b20ca48">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div>Date: June 30, 2022</div>
            </td>
            <td style="width: 50%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify;">/s/ <font style="font-style: italic; font-variant: small-caps;">Matthew Angel</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-align: justify;">Matthew Angel</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-align: justify;">Chief Executive Officer and President</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-align: justify; font-style: italic;">(Principal Executive Officer)</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="text-align: justify;">The foregoing certification is being furnished solely pursuant to 18 U.S.C. &#167; 1350 and is not being filed as part of the Report or as a separate disclosure document.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
      <div> <br>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>brhc10039260_ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.4.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-weight: bold;">Exhibit 32.2</div>
      <div> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">CERTIFICATION PURSUANT TO 18 U.S.C. 1350,</div>
      <div style="text-align: center; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div> <br>
      </div>
      <div>In connection with the Quarterly Report on Form 10-Q of Brooklyn ImmunoTherapeutics, Inc. for the quarterly period ended March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned
        certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge on the date hereof:</div>
      <div> <br>
      </div>
      <div>1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
      <div> <br>
      </div>
      <div>2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Brooklyn ImmunoTherapeutics, Inc. for the period presented therein.</div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc999780c0db04180b29cd80b740ad4bd">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div>Date: June 30, 2022</div>
            </td>
            <td style="width: 50%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify;">/s/ <font style="font-style: italic; font-variant: small-caps;">Andrew Jackson</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-align: justify;">Andrew Jackson</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-align: justify;">Chief Financial Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: bottom;">
              <div style="text-align: justify; font-style: italic;">(Principal Financial Officer)</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="text-align: justify;">The foregoing certification is being furnished solely pursuant to 18 U.S.C. &#167; 1350 and is not being filed as part of the Report or as a separate disclosure document.</div>
      <div> <br>
      </div>
      <br>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>btx-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://brooklynitx.com/20220331" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:btx="http://brooklynitx.com/20220331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://brooklynitx.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
        <link:definition>010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
        <!--Parent Role: CONDENSED CONSOLIDATED BALANCE SHEETS-->
        <link:definition>010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations" id="CondensedConsolidatedStatementsOfOperations">
        <link:definition>020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity" id="CondensedConsolidatedStatementsOfStockholdersAndMembersEquity">
        <link:definition>030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows" id="CondensedConsolidatedStatementsOfCashFlows">
        <link:definition>040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation" id="DescriptionOfBusinessAndBasisOfPresentation">
        <link:definition>060100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LiquidityAndCapitalResources" id="LiquidityAndCapitalResources">
        <link:definition>060200 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions" id="MergerDispositionAndAcquisitionTransactions">
        <link:definition>060300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstruments" id="FairValueOfFinancialInstruments">
        <link:definition>060400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/Leases" id="Leases">
        <link:definition>060500 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopment" id="GoodwillAndInprocessResearchDevelopment">
        <link:definition>060600 - Disclosure - GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/AccruedExpenses" id="AccruedExpenses">
        <link:definition>060700 - Disclosure - ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>060800 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensation" id="StockbasedCompensation">
        <link:definition>060900 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockholdersEquity" id="StockholdersEquity">
        <link:definition>061000 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/EarningsPerShare" id="EarningsPerShare">
        <link:definition>061100 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/RecentAccountingPronouncements" id="RecentAccountingPronouncements">
        <link:definition>061200 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/SubsequentEvent" id="SubsequentEvent">
        <link:definition>061300 - Disclosure - SUBSEQUENT EVENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" id="DescriptionOfBusinessAndBasisOfPresentationPolicies">
        <!--Parent Role: DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION-->
        <link:definition>070100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies" id="RecentAccountingPronouncementsPolicies">
        <!--Parent Role: RECENT ACCOUNTING PRONOUNCEMENTS-->
        <link:definition>071200 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables" id="MergerDispositionAndAcquisitionTransactionsTables">
        <!--Parent Role: MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS-->
        <link:definition>080300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables" id="FairValueOfFinancialInstrumentsTables">
        <!--Parent Role: FAIR VALUE OF FINANCIAL INSTRUMENTS-->
        <link:definition>080400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LeasesTables" id="LeasesTables">
        <!--Parent Role: LEASES-->
        <link:definition>080500 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
        <!--Parent Role: ACCRUED EXPENSES-->
        <link:definition>080700 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationTables" id="StockbasedCompensationTables">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>080900 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/EarningsPerShareTables" id="EarningsPerShareTables">
        <!--Parent Role: EARNINGS PER SHARE-->
        <link:definition>081100 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails" id="DescriptionOfBusinessAndBasisOfPresentationDetails">
        <!--Parent Role: DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION-->
        <link:definition>090100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails" id="LiquidityAndCapitalResourcesDetails">
        <!--Parent Role: LIQUIDITY AND CAPITAL RESOURCES-->
        <link:definition>090200 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails" id="MergerDispositionAndAcquisitionTransactionsMergerDetails">
        <!--Parent Role: MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS-->
        <link:definition>090300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Merger (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" id="MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails">
        <!--Parent Role: MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS-->
        <link:definition>090302 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Fair Value of Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails" id="MergerDispositionAndAcquisitionTransactionsDispositionDetails">
        <!--Parent Role: MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS-->
        <link:definition>090304 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Disposition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" id="MergerDispositionAndAcquisitionTransactionsAcquisitionDetails">
        <!--Parent Role: MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS-->
        <link:definition>090308 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" id="MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails">
        <!--Parent Role: MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS-->
        <link:definition>090310 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Investment in NoveCite (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" id="FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails">
        <!--Parent Role: FAIR VALUE OF FINANCIAL INSTRUMENTS-->
        <link:definition>090400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS, Liabilities Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" id="FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails">
        <!--Parent Role: FAIR VALUE OF FINANCIAL INSTRUMENTS-->
        <link:definition>090402 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS, Changes in Warrant Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LeasesOperatingLeaseDetails" id="LeasesOperatingLeaseDetails">
        <!--Parent Role: LEASES-->
        <link:definition>090500 - Disclosure - LEASES, Operating Lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails" id="LeasesNetOperatingLeaseExpensesDetails">
        <!--Parent Role: LEASES-->
        <link:definition>090502 - Disclosure - LEASES, Net Operating Lease Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" id="LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails">
        <!--Parent Role: LEASES-->
        <link:definition>090504 - Disclosure - LEASES, Operating Lease Right-of-use Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" id="LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails">
        <!--Parent Role: LEASES-->
        <link:definition>090506 - Disclosure - LEASES, Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" id="LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2">
        <!--Parent Role: LEASES, Maturities of Operating Lease Liabilities (Details)-->
        <link:definition>090508 - Disclosure - LEASES, Maturities of Operating Lease Liabilities (Details) Calc 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopmentDetails" id="GoodwillAndInprocessResearchDevelopmentDetails">
        <!--Parent Role: GOODWILL AND IN-PROCESS RESEARCH & DEVELOPMENT-->
        <link:definition>090600 - Disclosure - GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/AccruedExpensesDetails" id="AccruedExpensesDetails">
        <!--Parent Role: ACCRUED EXPENSES-->
        <link:definition>090700 - Disclosure - ACCRUED EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails" id="CommitmentsAndContingenciesLegalMattersDetails">
        <!--Parent Role: COMMITMENTS AND CONTINGENCIES-->
        <link:definition>090800 - Disclosure - COMMITMENTS AND CONTINGENCIES, Legal Matters (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails" id="CommitmentsAndContingenciesLicensingAgreementsDetails">
        <!--Parent Role: COMMITMENTS AND CONTINGENCIES-->
        <link:definition>090802 - Disclosure - COMMITMENTS AND CONTINGENCIES, Licensing Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails" id="CommitmentsAndContingenciesRoyaltyAgreementsDetails">
        <!--Parent Role: COMMITMENTS AND CONTINGENCIES-->
        <link:definition>090804 - Disclosure - COMMITMENTS AND CONTINGENCIES, Royalty Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails" id="StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>090900 - Disclosure - STOCK-BASED COMPENSATION, Weighted-Average Assumptions Used for Grants Issued (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails" id="StockbasedCompensationStockOptionActivityDetails">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>090904 - Disclosure - STOCK-BASED COMPENSATION, Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails" id="StockbasedCompensationSummaryOfStockOptionsDetails">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>090906 - Disclosure - STOCK-BASED COMPENSATION, Summary of Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationRsusDetails" id="StockbasedCompensationRsusDetails">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>090908 - Disclosure - STOCK-BASED COMPENSATION, RSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails" id="StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>090910 - Disclosure - STOCK-BASED COMPENSATION, Restricted Stock and Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails" id="StockholdersEquityPrivatePlacementOfEquityDetails">
        <!--Parent Role: STOCKHOLDERS' EQUITY-->
        <link:definition>091000 - Disclosure - STOCKHOLDERS' EQUITY, Private Placement of Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockholdersEquityReverseStocksplitDetails" id="StockholdersEquityReverseStocksplitDetails">
        <!--Parent Role: STOCKHOLDERS' EQUITY-->
        <link:definition>091002 - Disclosure - STOCKHOLDERS' EQUITY, Reverse Stock-Split (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockholdersEquityMergerDetails" id="StockholdersEquityMergerDetails">
        <!--Parent Role: STOCKHOLDERS' EQUITY-->
        <link:definition>091004 - Disclosure - STOCKHOLDERS' EQUITY, Merger (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/EarningsPerShareDetails" id="EarningsPerShareDetails">
        <!--Parent Role: EARNINGS PER SHARE-->
        <link:definition>091100 - Disclosure - EARNINGS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/SubsequentEventDetails" id="SubsequentEventDetails">
        <!--Parent Role: SUBSEQUENT EVENT-->
        <link:definition>091300 - Disclosure - SUBSEQUENT EVENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" id="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PaymentsOfPaycheckProtectionProgramLoan" id="btx_PaymentsOfPaycheckProtectionProgramLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="CashPaidDuringThePeriodForAbstract" id="btx_CashPaidDuringThePeriodForAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="GainOnTerminationOfLease" id="btx_GainOnTerminationOfLease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="LossOnNonControllingInvestment" id="btx_LossOnNonControllingInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="WarrantLiabilitiesExpense" id="btx_WarrantLiabilitiesExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" id="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="IncreaseDecreaseInOperatingLeaseLiabilities" id="btx_IncreaseDecreaseInOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="GainLossOnDisposalOfFixedAssets" id="btx_GainLossOnDisposalOfFixedAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="LIQUIDITYANDCAPITALRESOURCESAbstract" id="btx_LIQUIDITYANDCAPITALRESOURCESAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LiquidityAndCapitalResourcesTextBlock" id="btx_LiquidityAndCapitalResourcesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NoveCiteINCMember" id="btx_NoveCiteINCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AccruedResearchAndDevelopmentExpenses" id="btx_AccruedResearchAndDevelopmentExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="AccruedGeneralAndAdministrativeExpenses" id="btx_AccruedGeneralAndAdministrativeExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="LegalMattersAbstract" id="btx_LegalMattersAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LossContingencyDamagesSoughtExpectedSalary" id="btx_LossContingencyDamagesSoughtExpectedSalary" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="LossContingencyDamagesSoughtExpectedEquityPercentage" id="btx_LossContingencyDamagesSoughtExpectedEquityPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NovellusTherapeuticsLimitedMember" id="btx_NovellusTherapeuticsLimitedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DheshGovenderMember" id="btx_DheshGovenderMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LossContingencyNumberOfArbitrationPanel" id="btx_LossContingencyNumberOfArbitrationPanel" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CollaboratorRoyaltyAgreementMember" id="btx_CollaboratorRoyaltyAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="InvestorRoyaltyAgreementMember" id="btx_InvestorRoyaltyAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RoyaltyAgreementsAbstract" id="btx_RoyaltyAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" id="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" id="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NovellusLtdAndFactorBioscienceMember" id="btx_NovellusLtdAndFactorBioscienceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NoveCiteMember" id="btx_NoveCiteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LicensingAgreementsAbstract" id="btx_LicensingAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="InitialLicenseFees" id="btx_InitialLicenseFees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="LossContingencyPercentageOfRoyaltyPayable" id="btx_LossContingencyPercentageOfRoyaltyPayable" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfRevenue" id="btx_PercentageOfRevenue" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="LossContingencyNonRefundableOptionFee" id="btx_LossContingencyNonRefundableOptionFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="MinimumNumberOfPendingPatents" id="btx_MinimumNumberOfPendingPatents" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AmountObligatedToPayInYearOne" id="btx_AmountObligatedToPayInYearOne" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="MilestonePayments" id="btx_MilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="MinimumNumberOfPatentGranted" id="btx_MinimumNumberOfPatentGranted" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AmountRequireToPayInitialLicenseFees" id="btx_AmountRequireToPayInitialLicenseFees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="AdditionalFeesObligatedToPay" id="btx_AdditionalFeesObligatedToPay" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="AmountObligatedToPayInYearTwo" id="btx_AmountObligatedToPayInYearTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="UniversityOfSouthFloridaMember" id="btx_UniversityOfSouthFloridaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AggregateIntrinsicValueAbstract" id="btx_AggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NonQualifiedStockOptionMember" id="btx_NonQualifiedStockOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PerformanceBasedNonqualifiedStockOptionMember" id="btx_PerformanceBasedNonqualifiedStockOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TimeBasedNonQualifiedStockOptionMember" id="btx_TimeBasedNonQualifiedStockOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfStockOptionGrantMade" id="btx_NumberOfStockOptionGrantMade" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="EmployeeMember" id="btx_EmployeeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="Two022PerformanceBasedRestrictedStockUnitsMember" id="btx_Two022PerformanceBasedRestrictedStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ChiefExecutiveOfficerAndPresidentMember" id="btx_ChiefExecutiveOfficerAndPresidentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NumberOfPerformanceGoalsAreSubjectToAchieve" id="btx_NumberOfPerformanceGoalsAreSubjectToAchieve" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" id="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NTNBuzztimeIncMember" id="btx_NTNBuzztimeIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfBoardSeats" id="btx_NumberOfBoardSeats" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CitiusPharmaceuticalsIncMember" id="btx_CitiusPharmaceuticalsIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PreFundedWarrantsMember" id="btx_PreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PIPEInvestorMember" id="btx_PIPEInvestorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CommonWarrantsMember" id="btx_CommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PrivatePlacementOfEquityAbstract" id="btx_PrivatePlacementOfEquityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="OverSubscriptionAmountReceived" id="btx_OverSubscriptionAmountReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ConsecutiveCalendarDays" id="btx_ConsecutiveCalendarDays" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="TransactionFeesPayable" id="btx_TransactionFeesPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" id="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="AggregateCalendarDays" id="btx_AggregateCalendarDays" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ObligationToPayLiquidatedDamagesPercentage" id="btx_ObligationToPayLiquidatedDamagesPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ClassOfWarrantOrRightsExercisableTerm" id="btx_ClassOfWarrantOrRightsExercisableTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReverseStockSplitAbstract" id="btx_ReverseStockSplitAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MergerAbstract" id="btx_MergerAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodSharesAcquisitions1" id="btx_StockIssuedDuringPeriodSharesAcquisitions1" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ClassOfWarrantOrRightIssued" id="btx_ClassOfWarrantOrRightIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" id="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="ProceedsFromSaleOfRights" id="btx_ProceedsFromSaleOfRights" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" id="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BeneficialHoldersContractualCommitmentsToInvest" id="btx_BeneficialHoldersContractualCommitmentsToInvest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="PercentageOfAdditionalRightsOffering" id="btx_PercentageOfAdditionalRightsOffering" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PurchasePriceAllocationMember" id="btx_PurchasePriceAllocationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ProFormaFairValueAdjustmentToAssetsMember" id="btx_ProFormaFairValueAdjustmentToAssetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NTNBusinessMember" id="btx_NTNBusinessMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DispositionAbstract" id="btx_DispositionAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ProceedsFromDispositionAbstract" id="btx_ProceedsFromDispositionAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" id="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" id="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" id="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" id="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="MilestoneOptionsMember" id="btx_MilestoneOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SeparationAgreementAbstract" id="btx_SeparationAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PaymentToOfficerBaseSalary" id="btx_PaymentToOfficerBaseSalary" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" id="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="UnamortizedLeaseholdImprovements" id="btx_UnamortizedLeaseholdImprovements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="PercentageBaseRentIncreaseOnEachAnniversary" id="btx_PercentageBaseRentIncreaseOnEachAnniversary" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="LesseeCommitmentToPurchaseProperty" id="btx_LesseeCommitmentToPurchaseProperty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="OperatingLeaseArea" id="btx_OperatingLeaseArea" type="dtr-types:areaItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="BaseRentPerSquareFoot" id="btx_BaseRentPerSquareFoot" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="OperatingLeaseAssestAbstract" id="btx_OperatingLeaseAssestAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="WriteOffOfOperatingLeaseRightOfUseAsset" id="btx_WriteOffOfOperatingLeaseRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="PrincipalPaymentsOnOperatingLeaseLiabilities" id="btx_PrincipalPaymentsOnOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="WriteOffOfOperatingLeaseLiability" id="btx_WriteOffOfOperatingLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" id="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" id="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" id="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EscrowPeriod" id="btx_EscrowPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AssetAcquisitionRestrictedSharesSharePrice" id="btx_AssetAcquisitionRestrictedSharesSharePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" id="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EachLockUpAgreementExtendsTerm" id="btx_EachLockUpAgreementExtendsTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AssetAcquisitionUnrestrictedSharesSharePrice" id="btx_AssetAcquisitionUnrestrictedSharesSharePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="AssetAcquisitionFairValueOfConsiderationPaid" id="btx_AssetAcquisitionFairValueOfConsiderationPaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="AcquisitionAgreementNonCompetitivePeriod" id="btx_AcquisitionAgreementNonCompetitivePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AssetAcquisitionSharePrice" id="btx_AssetAcquisitionSharePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="LockUpPeriodForRestrictedShares" id="btx_LockUpPeriodForRestrictedShares" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ResearchAndDevelopmentInProcessAssetAcquisition" id="btx_ResearchAndDevelopmentInProcessAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="EscrowShares" id="btx_EscrowShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" id="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PercentageOfDiscountOnFairValueOfRestrictedShares" id="btx_PercentageOfDiscountOnFairValueOfRestrictedShares" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PaymentsToAcquireProductiveAssetsNet" id="btx_PaymentsToAcquireProductiveAssetsNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PercentageOfCommonStockSubjectToLockUpAgreement" id="btx_PercentageOfCommonStockSubjectToLockUpAgreement" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" id="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodRestrictedSharesAcquisitions" id="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" id="btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CommonUnitsMember" id="btx_CommonUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodSharesPrivateOffering" id="btx_StockIssuedDuringPeriodSharesPrivateOffering" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="StockIssuedDuringPeriodValueAcquisitions1" id="btx_StockIssuedDuringPeriodValueAcquisitions1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="StockIssuedDuringPeriodValuePrivateOffering" id="btx_StockIssuedDuringPeriodValuePrivateOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="MembershipEquityMember" id="btx_MembershipEquityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" id="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>btx-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesNetOperatingLeaseExpensesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="btx-20220331.xsd#CondensedConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="btx-20220331.xsd#CondensedConsolidatedStatementsOfOperations" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="btx-20220331.xsd#CondensedConsolidatedBalanceSheets" />
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="calculation: Assets to OperatingLeaseRightOfUseAsset" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="calculation: Assets to IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="Cash" xlink:title="calculation: AssetsCurrent to Cash" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="calculation: AssetsCurrent to PrepaidExpenseAndOtherAssetsCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="OtherReceivablesNetCurrent" xlink:title="calculation: AssetsCurrent to OtherReceivablesNetCurrent" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="AssetsCurrent" xlink:title="calculation: Assets to AssetsCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets" xlink:label="DepositAssets" xlink:title="DepositAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="DepositAssets" xlink:title="calculation: Assets to DepositAssets" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="calculation: Assets to PropertyPlantAndEquipmentNet" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="EquityMethodInvestments" xlink:title="calculation: Assets to EquityMethodInvestments" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="Goodwill" xlink:title="calculation: Assets to Goodwill" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="AdditionalPaidInCapital" xlink:title="calculation: StockholdersEquity to AdditionalPaidInCapital" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="CommonStockValue" xlink:title="calculation: StockholdersEquity to CommonStockValue" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="PreferredStockValue" xlink:title="calculation: StockholdersEquity to PreferredStockValue" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="calculation: StockholdersEquity to RetainedEarningsAccumulatedDeficit" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="StockholdersEquity" xlink:title="calculation: LiabilitiesAndStockholdersEquity to StockholdersEquity" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="calculation: Liabilities to OperatingLeaseLiabilityNoncurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="calculation: LiabilitiesCurrent to OperatingLeaseLiabilityCurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccountsPayableCurrent" xlink:title="calculation: LiabilitiesCurrent to AccountsPayableCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccruedLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to AccruedLiabilitiesCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="OtherLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to OtherLiabilitiesCurrent" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LiabilitiesCurrent" xlink:title="calculation: Liabilities to LiabilitiesCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to OtherLiabilitiesNoncurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="DerivativeLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to DerivativeLiabilitiesNoncurrent" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="Liabilities" xlink:title="calculation: LiabilitiesAndStockholdersEquity to Liabilities" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="IncomeTaxExpenseBenefit" xlink:title="calculation: NetIncomeLoss to IncomeTaxExpenseBenefit" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="GainLossOnDispositionOfAssets1" xlink:title="GainLossOnDispositionOfAssets1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="GainLossOnDispositionOfAssets1" xlink:title="calculation: NonoperatingIncomeExpense to GainLossOnDispositionOfAssets1" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="OtherNonoperatingIncomeExpense" xlink:title="calculation: NonoperatingIncomeExpense to OtherNonoperatingIncomeExpense" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="LossOnNonControllingInvestment" xlink:title="calculation: NonoperatingIncomeExpense to LossOnNonControllingInvestment" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="WarrantLiabilitiesExpense" xlink:title="calculation: NonoperatingIncomeExpense to WarrantLiabilitiesExpense" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="NonoperatingIncomeExpense" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to NonoperatingIncomeExpense" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="NoncashMergerRelatedCosts" xlink:title="calculation: OperatingExpenses to NoncashMergerRelatedCosts" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="ResearchAndDevelopmentExpense" xlink:title="calculation: OperatingExpenses to ResearchAndDevelopmentExpense" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="GeneralAndAdministrativeExpense" xlink:title="calculation: OperatingExpenses to GeneralAndAdministrativeExpense" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="OperatingExpenses" xlink:title="calculation: OperatingIncomeLoss to OperatingExpenses" order="0.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="OperatingIncomeLoss" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to OperatingIncomeLoss" order="0.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="calculation: NetIncomeLoss to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ShareBasedCompensation" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="GainLossOnDispositionOfAssets1" xlink:title="GainLossOnDispositionOfAssets1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainLossOnDispositionOfAssets1" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainLossOnDispositionOfAssets1" order="5.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainLossOnDisposalOfFixedAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainLossOnDisposalOfFixedAssets" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="NetIncomeLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to NetIncomeLoss" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="WarrantLiabilitiesExpense" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to WarrantLiabilitiesExpense" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DepreciationDepletionAndAmortization" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DepreciationDepletionAndAmortization" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="IncreaseDecreaseInOtherReceivables" xlink:title="IncreaseDecreaseInOtherReceivables" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherReceivables" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherReceivables" order="10.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="NoncashMergerRelatedCosts" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to NoncashMergerRelatedCosts" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="11.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:label="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:title="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" order="12.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOperatingLeaseLiabilities" order="14.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherOperatingLiabilities" order="15.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="LossOnNonControllingInvestment" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to LossOnNonControllingInvestment" order="9.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to OperatingLeaseRightOfUseAssetAmortizationExpense" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="13.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_GainOnTerminationOfLease" xlink:label="GainOnTerminationOfLease" xlink:title="GainOnTerminationOfLease" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainOnTerminationOfLease" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainOnTerminationOfLease" order="7.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInOperatingActivities" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromIssuanceOfCommonStock" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PaymentsOfPaycheckProtectionProgramLoan" xlink:label="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="PaymentsOfPaycheckProtectionProgramLoan" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfPaycheckProtectionProgramLoan" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="ProceedsFromOtherEquity" xlink:title="ProceedsFromOtherEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromOtherEquity" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromOtherEquity" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInFinancingActivities" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromDivestitureOfBusinesses" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromDivestitureOfBusinesses" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:label="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="ProceedsFromSalesOfAssetsInvestingActivities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromSalesOfAssetsInvestingActivities" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInInvestingActivities" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="calculation: AssetAcquisitionFairValueOfConsiderationPaid to StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="calculation: AssetAcquisitionFairValueOfConsiderationPaid to PaymentsToAcquireProductiveAssets" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="CashAcquiredFromAcquisition" xlink:title="calculation: AssetAcquisitionFairValueOfConsiderationPaid to CashAcquiredFromAcquisition" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="calculation: AssetAcquisitionFairValueOfConsiderationPaid to StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="VariableLeaseCost" xlink:title="calculation: LeaseCost to VariableLeaseCost" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome" xlink:label="SubleaseIncome" xlink:title="SubleaseIncome" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="SubleaseIncome" xlink:title="calculation: LeaseCost to SubleaseIncome" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="OperatingLeaseCost" xlink:title="calculation: LeaseCost to OperatingLeaseCost" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="OperatingLeaseLiability" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to OperatingLeaseLiability" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to EmployeeRelatedLiabilitiesCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AccruedGeneralAndAdministrativeExpenses" xlink:label="AccruedGeneralAndAdministrativeExpenses" xlink:title="AccruedGeneralAndAdministrativeExpenses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedGeneralAndAdministrativeExpenses" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedGeneralAndAdministrativeExpenses" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AccruedResearchAndDevelopmentExpenses" xlink:label="AccruedResearchAndDevelopmentExpenses" xlink:title="AccruedResearchAndDevelopmentExpenses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedResearchAndDevelopmentExpenses" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedResearchAndDevelopmentExpenses" order="2.0" weight="1.0" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>btx-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://brooklynitx.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#SubsequentEventDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#EarningsPerShareDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquityMergerDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockholdersEquityMergerDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquityReverseStocksplitDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockholdersEquityReverseStocksplitDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockholdersEquityPrivatePlacementOfEquityDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationRsusDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensationRsusDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensationSummaryOfStockOptionsDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensationStockOptionActivityDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#CommitmentsAndContingenciesRoyaltyAgreementsDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#CommitmentsAndContingenciesLicensingAgreementsDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#CommitmentsAndContingenciesLegalMattersDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopmentDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#GoodwillAndInprocessResearchDevelopmentDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesNetOperatingLeaseExpensesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesOperatingLeaseDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesOperatingLeaseDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactionsDispositionDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactionsMergerDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#LiquidityAndCapitalResourcesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#DescriptionOfBusinessAndBasisOfPresentationDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="btx-20220331.xsd#EarningsPerShareTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensationTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="btx-20220331.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesTables" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables" xlink:type="simple" xlink:href="btx-20220331.xsd#FairValueOfFinancialInstrumentsTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactionsTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="btx-20220331.xsd#RecentAccountingPronouncementsPolicies" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:type="simple" xlink:href="btx-20220331.xsd#DescriptionOfBusinessAndBasisOfPresentationPolicies" />
  <link:roleRef roleURI="http://brooklynitx.com/role/SubsequentEvent" xlink:type="simple" xlink:href="btx-20220331.xsd#SubsequentEvent" />
  <link:roleRef roleURI="http://brooklynitx.com/role/RecentAccountingPronouncements" xlink:type="simple" xlink:href="btx-20220331.xsd#RecentAccountingPronouncements" />
  <link:roleRef roleURI="http://brooklynitx.com/role/EarningsPerShare" xlink:type="simple" xlink:href="btx-20220331.xsd#EarningsPerShare" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquity" xlink:type="simple" xlink:href="btx-20220331.xsd#StockholdersEquity" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensation" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensation" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="btx-20220331.xsd#CommitmentsAndContingencies" />
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpenses" xlink:type="simple" xlink:href="btx-20220331.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopment" xlink:type="simple" xlink:href="btx-20220331.xsd#GoodwillAndInprocessResearchDevelopment" />
  <link:roleRef roleURI="http://brooklynitx.com/role/Leases" xlink:type="simple" xlink:href="btx-20220331.xsd#Leases" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstruments" xlink:type="simple" xlink:href="btx-20220331.xsd#FairValueOfFinancialInstruments" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactions" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LiquidityAndCapitalResources" xlink:type="simple" xlink:href="btx-20220331.xsd#LiquidityAndCapitalResources" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" xlink:href="btx-20220331.xsd#DescriptionOfBusinessAndBasisOfPresentation" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="btx-20220331.xsd#CondensedConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity" xlink:type="simple" xlink:href="btx-20220331.xsd#CondensedConsolidatedStatementsOfStockholdersAndMembersEquity" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="btx-20220331.xsd#CondensedConsolidatedStatementsOfOperations" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="btx-20220331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="btx-20220331.xsd#CondensedConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="btx-20220331.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DocumentAndEntityInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AssetsAbstract" xlink:title="definition: StatementLineItems to AssetsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="definition: StatementLineItems to LiabilitiesAndStockholdersEquityAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesCurrentAbstract" xlink:title="definition: StatementLineItems to LiabilitiesCurrentAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DerivativeLiabilitiesNoncurrent" xlink:title="definition: StatementLineItems to DerivativeLiabilitiesNoncurrent" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="definition: StatementLineItems to OperatingLeaseLiabilityNoncurrent" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="definition: StatementLineItems to OtherLiabilitiesNoncurrent" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Liabilities" xlink:title="definition: StatementLineItems to Liabilities" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="EquityAbstract" xlink:title="definition: StatementLineItems to EquityAbstract" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="definition: StatementLineItems to LiabilitiesAndStockholdersEquity" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PreferredStockValue" xlink:title="definition: StatementLineItems to PreferredStockValue" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CommonStockValue" xlink:title="definition: StatementLineItems to CommonStockValue" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdditionalPaidInCapital" xlink:title="definition: StatementLineItems to AdditionalPaidInCapital" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="definition: StatementLineItems to RetainedEarningsAccumulatedDeficit" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquity" xlink:title="definition: StatementLineItems to StockholdersEquity" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AccountsPayableCurrent" xlink:title="definition: StatementLineItems to AccountsPayableCurrent" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AccruedLiabilitiesCurrent" xlink:title="definition: StatementLineItems to AccruedLiabilitiesCurrent" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="definition: StatementLineItems to OperatingLeaseLiabilityCurrent" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherLiabilitiesCurrent" xlink:title="definition: StatementLineItems to OtherLiabilitiesCurrent" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesCurrent" xlink:title="definition: StatementLineItems to LiabilitiesCurrent" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AssetsCurrentAbstract" xlink:title="definition: StatementLineItems to AssetsCurrentAbstract" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Cash" xlink:title="definition: StatementLineItems to Cash" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherReceivablesNetCurrent" xlink:title="definition: StatementLineItems to OtherReceivablesNetCurrent" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="definition: StatementLineItems to PrepaidExpenseAndOtherAssetsCurrent" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AssetsCurrent" xlink:title="definition: StatementLineItems to AssetsCurrent" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="definition: StatementLineItems to PropertyPlantAndEquipmentNet" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="definition: StatementLineItems to OperatingLeaseRightOfUseAsset" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Goodwill" xlink:title="definition: StatementLineItems to Goodwill" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="definition: StatementLineItems to IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="EquityMethodInvestments" xlink:title="definition: StatementLineItems to EquityMethodInvestments" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets" xlink:label="DepositAssets" xlink:title="DepositAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DepositAssets" xlink:title="definition: StatementLineItems to DepositAssets" order="30.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Assets" xlink:title="definition: StatementLineItems to Assets" order="31.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="32.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: StatementTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="definition: ClassOfStockDomain to SeriesAPreferredStockMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="definition: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquity" xlink:title="definition: StatementLineItems to StockholdersEquity" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesOutstanding" xlink:title="definition: StatementLineItems to SharesOutstanding" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:label="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:label="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValueAcquisitions1" xlink:label="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="StockIssuedDuringPeriodValueAcquisitions1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueAcquisitions1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesAcquisitions1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnersCapitalAccountAcquisitions" xlink:label="PartnersCapitalAccountAcquisitions" xlink:title="PartnersCapitalAccountAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PartnersCapitalAccountAcquisitions" xlink:title="definition: StatementLineItems to PartnersCapitalAccountAcquisitions" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnersCapitalAccountUnitsAcquisitions" xlink:label="PartnersCapitalAccountUnitsAcquisitions" xlink:title="PartnersCapitalAccountUnitsAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PartnersCapitalAccountUnitsAcquisitions" xlink:title="definition: StatementLineItems to PartnersCapitalAccountUnitsAcquisitions" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueAcquisitions" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueAcquisitions" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesAcquisitions" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValuePrivateOffering" xlink:label="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="StockIssuedDuringPeriodValuePrivateOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValuePrivateOffering" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodSharesPrivateOffering" xlink:label="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="StockIssuedDuringPeriodSharesPrivateOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesPrivateOffering" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:label="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:label="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="definition: StatementLineItems to SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="definition: StatementLineItems to NetIncomeLoss" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="22.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: StatementTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MembershipEquityMember" xlink:label="MembershipEquityMember" xlink:title="MembershipEquityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="MembershipEquityMember" xlink:title="definition: EquityComponentDomain to MembershipEquityMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="PreferredStockMember" xlink:title="definition: EquityComponentDomain to PreferredStockMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="AdditionalPaidInCapitalMember" xlink:title="definition: EquityComponentDomain to AdditionalPaidInCapitalMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="RetainedEarningsMember" xlink:title="definition: EquityComponentDomain to RetainedEarningsMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: StatementTable to StatementClassOfStockAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="definition: ClassOfStockDomain to CommonClassAMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassBMember" xlink:title="definition: ClassOfStockDomain to CommonClassBMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassCMember" xlink:title="definition: ClassOfStockDomain to CommonClassCMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CommonUnitsMember" xlink:label="CommonUnitsMember" xlink:title="CommonUnitsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonUnitsMember" xlink:title="definition: ClassOfStockDomain to CommonUnitsMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="definition: ClassOfStockDomain to SeriesAPreferredStockMember" order="5.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LiquidityAndCapitalResources" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstruments" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/Leases" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopment" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpenses" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingencies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquity" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/EarningsPerShare" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/RecentAccountingPronouncements" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/SubsequentEvent" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpensesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/EarningsPerShareTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestmentOwnershipPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain_2" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain_2" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="definition: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodSharesIssuedForServices" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="BusinessAcquisitionSharePrice" xlink:title="BusinessAcquisitionSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionSharePrice" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionSharePrice" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="CommonStockSharesOutstanding" xlink:title="definition: BusinessAcquisitionLineItems to CommonStockSharesOutstanding" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="Goodwill" xlink:title="definition: BusinessAcquisitionLineItems to Goodwill" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:label="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="definition: BusinessAcquisitionLineItems to ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_BeneficialHoldersContractualCommitmentsToInvest" xlink:label="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="BeneficialHoldersContractualCommitmentsToInvest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="definition: BusinessAcquisitionLineItems to BeneficialHoldersContractualCommitmentsToInvest" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfAdditionalRightsOffering" xlink:label="PercentageOfAdditionalRightsOffering" xlink:title="PercentageOfAdditionalRightsOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfAdditionalRightsOffering" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfAdditionalRightsOffering" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ProceedsFromSaleOfRights" xlink:label="ProceedsFromSaleOfRights" xlink:title="ProceedsFromSaleOfRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ProceedsFromSaleOfRights" xlink:title="definition: BusinessAcquisitionLineItems to ProceedsFromSaleOfRights" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="Goodwill" xlink:title="definition: BusinessAcquisitionLineItems to Goodwill" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="16.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:label="NonrecurringAdjustmentAxis" xlink:title="NonrecurringAdjustmentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="NonrecurringAdjustmentAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to NonrecurringAdjustmentAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="NonrecurringAdjustmentDomain" xlink:title="NonrecurringAdjustmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="NonrecurringAdjustmentAxis" xlink:to="NonrecurringAdjustmentDomain" xlink:title="definition: NonrecurringAdjustmentAxis to NonrecurringAdjustmentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="NonrecurringAdjustmentDomain_2" xlink:title="NonrecurringAdjustmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="NonrecurringAdjustmentAxis" xlink:to="NonrecurringAdjustmentDomain_2" xlink:title="definition: NonrecurringAdjustmentAxis to NonrecurringAdjustmentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ProFormaFairValueAdjustmentToAssetsMember" xlink:label="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="ProFormaFairValueAdjustmentToAssetsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NonrecurringAdjustmentDomain" xlink:to="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="definition: NonrecurringAdjustmentDomain to ProFormaFairValueAdjustmentToAssetsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PurchasePriceAllocationMember" xlink:label="PurchasePriceAllocationMember" xlink:title="PurchasePriceAllocationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NonrecurringAdjustmentDomain" xlink:to="PurchasePriceAllocationMember" xlink:title="definition: NonrecurringAdjustmentDomain to PurchasePriceAllocationMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TradeNamesMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TradeNamesMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DispositionAbstract" xlink:label="DispositionAbstract" xlink:title="DispositionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DispositionAbstract" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DispositionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:label="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ProceedsFromDispositionAbstract" xlink:label="ProceedsFromDispositionAbstract" xlink:title="ProceedsFromDispositionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="ProceedsFromDispositionAbstract" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to ProceedsFromDispositionAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationTransactionCosts" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:label="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:label="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationLeaseLiability" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:label="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:label="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:label="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="DisposalGroupIncludingDiscontinuedOperationGoodwill1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationGoodwill1" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationOtherAssets" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="25.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis to DisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2" xlink:title="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis to DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NTNBusinessMember" xlink:label="NTNBusinessMember" xlink:title="NTNBusinessMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="NTNBusinessMember" xlink:title="definition: DisposalGroupsIncludingDiscontinuedOperationsNameDomain to NTNBusinessMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TradeNamesMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TradeNamesMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestmentOwnershipPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:label="PaymentsToAcquireOtherProductiveAssets" xlink:title="PaymentsToAcquireOtherProductiveAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireOtherProductiveAssets" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireOtherProductiveAssets" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodSharesAcquisitions" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodValueAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodValueAcquisitions" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AssetAcquisitionSharePrice" xlink:label="AssetAcquisitionSharePrice" xlink:title="AssetAcquisitionSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AssetAcquisitionSharePrice" xlink:title="definition: BusinessAcquisitionLineItems to AssetAcquisitionSharePrice" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodValueNewIssues" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodValueNewIssues" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_EscrowShares" xlink:label="EscrowShares" xlink:title="EscrowShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EscrowShares" xlink:title="definition: BusinessAcquisitionLineItems to EscrowShares" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_EscrowPeriod" xlink:label="EscrowPeriod" xlink:title="EscrowPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EscrowPeriod" xlink:title="definition: BusinessAcquisitionLineItems to EscrowPeriod" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AcquisitionAgreementNonCompetitivePeriod" xlink:label="AcquisitionAgreementNonCompetitivePeriod" xlink:title="AcquisitionAgreementNonCompetitivePeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AcquisitionAgreementNonCompetitivePeriod" xlink:title="definition: BusinessAcquisitionLineItems to AcquisitionAgreementNonCompetitivePeriod" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodSharesIssuedForServices" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_EachLockUpAgreementExtendsTerm" xlink:label="EachLockUpAgreementExtendsTerm" xlink:title="EachLockUpAgreementExtendsTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EachLockUpAgreementExtendsTerm" xlink:title="definition: BusinessAcquisitionLineItems to EachLockUpAgreementExtendsTerm" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfCommonStockSubjectToLockUpAgreement" xlink:label="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="PercentageOfCommonStockSubjectToLockUpAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfCommonStockSubjectToLockUpAgreement" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PaymentsToAcquireProductiveAssetsNet" xlink:label="PaymentsToAcquireProductiveAssetsNet" xlink:title="PaymentsToAcquireProductiveAssetsNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireProductiveAssetsNet" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireProductiveAssetsNet" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodRestrictedSharesAcquisitions" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LockUpPeriodForRestrictedShares" xlink:label="LockUpPeriodForRestrictedShares" xlink:title="LockUpPeriodForRestrictedShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="LockUpPeriodForRestrictedShares" xlink:title="definition: BusinessAcquisitionLineItems to LockUpPeriodForRestrictedShares" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AssetAcquisitionUnrestrictedSharesSharePrice" xlink:label="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="AssetAcquisitionUnrestrictedSharesSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="definition: BusinessAcquisitionLineItems to AssetAcquisitionUnrestrictedSharesSharePrice" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:label="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="PercentageOfDiscountOnFairValueOfRestrictedShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfDiscountOnFairValueOfRestrictedShares" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AssetAcquisitionRestrictedSharesSharePrice" xlink:label="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="AssetAcquisitionRestrictedSharesSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="definition: BusinessAcquisitionLineItems to AssetAcquisitionRestrictedSharesSharePrice" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireProductiveAssets" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="CashAcquiredFromAcquisition" xlink:title="definition: BusinessAcquisitionLineItems to CashAcquiredFromAcquisition" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="definition: BusinessAcquisitionLineItems to AssetAcquisitionFairValueOfConsiderationPaid" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="PaymentsToAcquireInvestments" xlink:title="PaymentsToAcquireInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireInvestments" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireInvestments" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="definition: BusinessAcquisitionLineItems to ResearchAndDevelopmentInProcessAssetAcquisition" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="28.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain_2" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain_2" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="definition: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="AssetAcquisitionAxis" xlink:title="AssetAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="AssetAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to AssetAcquisitionAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="AssetAcquisitionDomain" xlink:title="AssetAcquisitionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AssetAcquisitionAxis" xlink:to="AssetAcquisitionDomain" xlink:title="definition: AssetAcquisitionAxis to AssetAcquisitionDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="AssetAcquisitionDomain_2" xlink:title="AssetAcquisitionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AssetAcquisitionAxis" xlink:to="AssetAcquisitionDomain_2" xlink:title="definition: AssetAcquisitionAxis to AssetAcquisitionDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="definition: AssetAcquisitionDomain to NovellusTherapeuticsLimitedMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RelatedPartyTransactionsByRelatedPartyAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:label="ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="definition: RelatedPartyDomain to ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="InvestmentsAbstract" xlink:title="InvestmentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="InvestmentsAbstract" xlink:title="definition: BusinessAcquisitionLineItems to InvestmentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestmentOwnershipPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="MinorityInterestOwnershipPercentageByParent" xlink:title="MinorityInterestOwnershipPercentageByParent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="MinorityInterestOwnershipPercentageByParent" xlink:title="definition: BusinessAcquisitionLineItems to MinorityInterestOwnershipPercentageByParent" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NumberOfBoardSeats" xlink:label="NumberOfBoardSeats" xlink:title="NumberOfBoardSeats" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBoardSeats" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBoardSeats" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestments" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestments" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestmentRealizedGainLossOnDisposal" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain_2" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain_2" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="definition: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="OwnershipAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to OwnershipAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="definition: OwnershipAxis to OwnershipDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain_2" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain_2" xlink:title="definition: OwnershipAxis to OwnershipDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CitiusPharmaceuticalsIncMember" xlink:label="CitiusPharmaceuticalsIncMember" xlink:title="CitiusPharmaceuticalsIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OwnershipDomain" xlink:to="CitiusPharmaceuticalsIncMember" xlink:title="definition: OwnershipDomain to CitiusPharmaceuticalsIncMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiabilityAbstract" xlink:label="FairValueNetAssetLiabilityAbstract" xlink:title="FairValueNetAssetLiabilityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueNetAssetLiabilityAbstract" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueNetAssetLiabilityAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="LiabilitiesFairValueDisclosureAbstract" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to LiabilitiesFairValueDisclosureAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="LiabilitiesFairValueDisclosure" xlink:title="LiabilitiesFairValueDisclosure" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="LiabilitiesFairValueDisclosure" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to LiabilitiesFairValueDisclosure" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel1Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel1Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByLiabilityClassAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByLiabilityClassAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="definition: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" xlink:title="definition: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to DerivativeFinancialInstrumentsLiabilitiesMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="OverSubscriptionAmountReceived" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to OverSubscriptionAmountReceived" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to StockRepurchaseProgramAuthorizedAmount1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="LiabilitiesFairValueAdjustment" xlink:title="LiabilitiesFairValueAdjustment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="LiabilitiesFairValueAdjustment" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to LiabilitiesFairValueAdjustment" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesOperatingLeaseDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopmentDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpensesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LegalMattersAbstract" xlink:label="LegalMattersAbstract" xlink:title="LegalMattersAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LegalMattersAbstract" xlink:title="definition: LossContingenciesLineItems to LegalMattersAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyDamagesSoughtExpectedSalary" xlink:label="LossContingencyDamagesSoughtExpectedSalary" xlink:title="LossContingencyDamagesSoughtExpectedSalary" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyDamagesSoughtExpectedSalary" xlink:title="definition: LossContingenciesLineItems to LossContingencyDamagesSoughtExpectedSalary" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:label="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:title="LossContingencyDamagesSoughtExpectedEquityPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:title="definition: LossContingenciesLineItems to LossContingencyDamagesSoughtExpectedEquityPercentage" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="LossContingencyDamagesSoughtValue" xlink:title="LossContingencyDamagesSoughtValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyDamagesSoughtValue" xlink:title="definition: LossContingenciesLineItems to LossContingencyDamagesSoughtValue" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyNumberOfArbitrationPanel" xlink:label="LossContingencyNumberOfArbitrationPanel" xlink:title="LossContingencyNumberOfArbitrationPanel" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyNumberOfArbitrationPanel" xlink:title="definition: LossContingenciesLineItems to LossContingencyNumberOfArbitrationPanel" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="AccruedProfessionalFeesCurrent" xlink:title="definition: LossContingenciesLineItems to AccruedProfessionalFeesCurrent" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LossContingenciesLineItems" xlink:to="LossContingenciesTable" xlink:title="definition: LossContingenciesLineItems to LossContingenciesTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: LossContingenciesTable to RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="definition: RelatedPartyDomain to NovellusTherapeuticsLimitedMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DheshGovenderMember" xlink:label="DheshGovenderMember" xlink:title="DheshGovenderMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="DheshGovenderMember" xlink:title="definition: RelatedPartyDomain to DheshGovenderMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="RangeAxis" xlink:title="definition: LossContingenciesTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LicensingAgreementsAbstract" xlink:label="LicensingAgreementsAbstract" xlink:title="LicensingAgreementsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LicensingAgreementsAbstract" xlink:title="definition: LossContingenciesLineItems to LicensingAgreementsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyPercentageOfRoyaltyPayable" xlink:label="LossContingencyPercentageOfRoyaltyPayable" xlink:title="LossContingencyPercentageOfRoyaltyPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyPercentageOfRoyaltyPayable" xlink:title="definition: LossContingenciesLineItems to LossContingencyPercentageOfRoyaltyPayable" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyNonRefundableOptionFee" xlink:label="LossContingencyNonRefundableOptionFee" xlink:title="LossContingencyNonRefundableOptionFee" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyNonRefundableOptionFee" xlink:title="definition: LossContingenciesLineItems to LossContingencyNonRefundableOptionFee" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_InitialLicenseFees" xlink:label="InitialLicenseFees" xlink:title="InitialLicenseFees" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="InitialLicenseFees" xlink:title="definition: LossContingenciesLineItems to InitialLicenseFees" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AdditionalFeesObligatedToPay" xlink:label="AdditionalFeesObligatedToPay" xlink:title="AdditionalFeesObligatedToPay" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="AdditionalFeesObligatedToPay" xlink:title="definition: LossContingenciesLineItems to AdditionalFeesObligatedToPay" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AmountRequireToPayInitialLicenseFees" xlink:label="AmountRequireToPayInitialLicenseFees" xlink:title="AmountRequireToPayInitialLicenseFees" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="AmountRequireToPayInitialLicenseFees" xlink:title="definition: LossContingenciesLineItems to AmountRequireToPayInitialLicenseFees" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AmountObligatedToPayInYearOne" xlink:label="AmountObligatedToPayInYearOne" xlink:title="AmountObligatedToPayInYearOne" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="AmountObligatedToPayInYearOne" xlink:title="definition: LossContingenciesLineItems to AmountObligatedToPayInYearOne" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AmountObligatedToPayInYearTwo" xlink:label="AmountObligatedToPayInYearTwo" xlink:title="AmountObligatedToPayInYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="AmountObligatedToPayInYearTwo" xlink:title="definition: LossContingenciesLineItems to AmountObligatedToPayInYearTwo" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MinimumNumberOfPatentGranted" xlink:label="MinimumNumberOfPatentGranted" xlink:title="MinimumNumberOfPatentGranted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="MinimumNumberOfPatentGranted" xlink:title="definition: LossContingenciesLineItems to MinimumNumberOfPatentGranted" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MinimumNumberOfPendingPatents" xlink:label="MinimumNumberOfPendingPatents" xlink:title="MinimumNumberOfPendingPatents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="MinimumNumberOfPendingPatents" xlink:title="definition: LossContingenciesLineItems to MinimumNumberOfPendingPatents" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MilestonePayments" xlink:label="MilestonePayments" xlink:title="MilestonePayments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="MilestonePayments" xlink:title="definition: LossContingenciesLineItems to MilestonePayments" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfRevenue" xlink:label="PercentageOfRevenue" xlink:title="PercentageOfRevenue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="PercentageOfRevenue" xlink:title="definition: LossContingenciesLineItems to PercentageOfRevenue" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LossContingenciesLineItems" xlink:to="LossContingenciesTable" xlink:title="definition: LossContingenciesLineItems to LossContingenciesTable" order="13.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="LegalEntityAxis" xlink:title="definition: LossContingenciesTable to LegalEntityAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="definition: LegalEntityAxis to EntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="EntityDomain_2" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LegalEntityAxis" xlink:to="EntityDomain_2" xlink:title="definition: LegalEntityAxis to EntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_UniversityOfSouthFloridaMember" xlink:label="UniversityOfSouthFloridaMember" xlink:title="UniversityOfSouthFloridaMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityDomain" xlink:to="UniversityOfSouthFloridaMember" xlink:title="definition: EntityDomain to UniversityOfSouthFloridaMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: LossContingenciesTable to RelatedPartyTransactionsByRelatedPartyAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="definition: RelatedPartyDomain to NovellusTherapeuticsLimitedMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NovellusLtdAndFactorBioscienceMember" xlink:label="NovellusLtdAndFactorBioscienceMember" xlink:title="NovellusLtdAndFactorBioscienceMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="NovellusLtdAndFactorBioscienceMember" xlink:title="definition: RelatedPartyDomain to NovellusLtdAndFactorBioscienceMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NoveCiteMember" xlink:label="NoveCiteMember" xlink:title="NoveCiteMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="NoveCiteMember" xlink:title="definition: RelatedPartyDomain to NoveCiteMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="StatementScenarioAxis" xlink:title="definition: LossContingenciesTable to StatementScenarioAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain_2" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain_2" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="ScenarioForecastMember" xlink:title="definition: ScenarioUnspecifiedDomain to ScenarioForecastMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="RangeAxis" xlink:title="definition: LossContingenciesTable to RangeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_RoyaltyAgreementsAbstract" xlink:label="RoyaltyAgreementsAbstract" xlink:title="RoyaltyAgreementsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="RoyaltyAgreementsAbstract" xlink:title="definition: LossContingenciesLineItems to RoyaltyAgreementsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:label="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:title="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:title="definition: LossContingenciesLineItems to PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:label="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="definition: LossContingenciesLineItems to PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LossContingenciesLineItems" xlink:to="LossContingenciesTable" xlink:title="definition: LossContingenciesLineItems to LossContingenciesTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: LossContingenciesTable to TypeOfArrangementAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_InvestorRoyaltyAgreementMember" xlink:label="InvestorRoyaltyAgreementMember" xlink:title="InvestorRoyaltyAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="InvestorRoyaltyAgreementMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to InvestorRoyaltyAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CollaboratorRoyaltyAgreementMember" xlink:label="CollaboratorRoyaltyAgreementMember" xlink:title="CollaboratorRoyaltyAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="CollaboratorRoyaltyAgreementMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to CollaboratorRoyaltyAgreementMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AggregateIntrinsicValueAbstract" xlink:label="AggregateIntrinsicValueAbstract" xlink:title="AggregateIntrinsicValueAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AggregateIntrinsicValueAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AggregateIntrinsicValueAbstract" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="20.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NumberOfStockOptionGrantMade" xlink:label="NumberOfStockOptionGrantMade" xlink:title="NumberOfStockOptionGrantMade" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="NumberOfStockOptionGrantMade" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to NumberOfStockOptionGrantMade" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesStockOptionsExercised" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="13.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NonQualifiedStockOptionMember" xlink:label="NonQualifiedStockOptionMember" xlink:title="NonQualifiedStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EmployeeStockOptionMember" xlink:to="NonQualifiedStockOptionMember" xlink:title="definition: EmployeeStockOptionMember to NonQualifiedStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_TimeBasedNonQualifiedStockOptionMember" xlink:label="TimeBasedNonQualifiedStockOptionMember" xlink:title="TimeBasedNonQualifiedStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NonQualifiedStockOptionMember" xlink:to="TimeBasedNonQualifiedStockOptionMember" xlink:title="definition: NonQualifiedStockOptionMember to TimeBasedNonQualifiedStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PerformanceBasedNonqualifiedStockOptionMember" xlink:label="PerformanceBasedNonqualifiedStockOptionMember" xlink:title="PerformanceBasedNonqualifiedStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NonQualifiedStockOptionMember" xlink:to="PerformanceBasedNonqualifiedStockOptionMember" xlink:title="definition: NonQualifiedStockOptionMember to PerformanceBasedNonqualifiedStockOptionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis" xlink:label="VestingAxis" xlink:title="VestingAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="VestingAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to VestingAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain" xlink:title="VestingDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="VestingAxis" xlink:to="VestingDomain" xlink:title="definition: VestingAxis to VestingDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain_2" xlink:title="VestingDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="VestingAxis" xlink:to="VestingDomain_2" xlink:title="definition: VestingAxis to VestingDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="ShareBasedCompensationAwardTrancheOneMember" xlink:title="ShareBasedCompensationAwardTrancheOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheOneMember" xlink:title="definition: VestingDomain to ShareBasedCompensationAwardTrancheOneMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationRsusDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:label="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:title="NumberOfPerformanceGoalsAreSubjectToAchieve" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to NumberOfPerformanceGoalsAreSubjectToAchieve" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="17.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_Two022PerformanceBasedRestrictedStockUnitsMember" xlink:label="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:title="Two022PerformanceBasedRestrictedStockUnitsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:title="definition: RestrictedStockUnitsRSUMember to Two022PerformanceBasedRestrictedStockUnitsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to TitleOfIndividualAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeeMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to EmployeeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ChiefExecutiveOfficerAndPresidentMember" xlink:label="ChiefExecutiveOfficerAndPresidentMember" xlink:title="ChiefExecutiveOfficerAndPresidentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ChiefExecutiveOfficerAndPresidentMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to ChiefExecutiveOfficerAndPresidentMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="6.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="IncomeStatementLocationAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to IncomeStatementLocationAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain_2" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain_2" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PrivatePlacementOfEquityAbstract" xlink:label="PrivatePlacementOfEquityAbstract" xlink:title="PrivatePlacementOfEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="PrivatePlacementOfEquityAbstract" xlink:title="definition: SubsidiarySaleOfStockLineItems to PrivatePlacementOfEquityAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="definition: SubsidiarySaleOfStockLineItems to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="definition: SubsidiarySaleOfStockLineItems to StockRepurchaseProgramAuthorizedAmount1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:label="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightsExercisableTerm" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightsExercisableTerm" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="definition: SubsidiarySaleOfStockLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="definition: SubsidiarySaleOfStockLineItems to WarrantsAndRightsOutstandingTerm" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightOutstanding" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightOutstanding" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="definition: SubsidiarySaleOfStockLineItems to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="OverSubscriptionAmountReceived" xlink:title="definition: SubsidiarySaleOfStockLineItems to OverSubscriptionAmountReceived" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:label="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="definition: SubsidiarySaleOfStockLineItems to ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ObligationToPayLiquidatedDamagesPercentage" xlink:label="ObligationToPayLiquidatedDamagesPercentage" xlink:title="ObligationToPayLiquidatedDamagesPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ObligationToPayLiquidatedDamagesPercentage" xlink:title="definition: SubsidiarySaleOfStockLineItems to ObligationToPayLiquidatedDamagesPercentage" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_TransactionFeesPayable" xlink:label="TransactionFeesPayable" xlink:title="TransactionFeesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="TransactionFeesPayable" xlink:title="definition: SubsidiarySaleOfStockLineItems to TransactionFeesPayable" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ConsecutiveCalendarDays" xlink:label="ConsecutiveCalendarDays" xlink:title="ConsecutiveCalendarDays" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ConsecutiveCalendarDays" xlink:title="definition: SubsidiarySaleOfStockLineItems to ConsecutiveCalendarDays" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AggregateCalendarDays" xlink:label="AggregateCalendarDays" xlink:title="AggregateCalendarDays" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="AggregateCalendarDays" xlink:title="definition: SubsidiarySaleOfStockLineItems to AggregateCalendarDays" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="LossContingencyEstimateOfPossibleLoss" xlink:title="LossContingencyEstimateOfPossibleLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="LossContingencyEstimateOfPossibleLoss" xlink:title="definition: SubsidiarySaleOfStockLineItems to LossContingencyEstimateOfPossibleLoss" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="definition: SubsidiarySaleOfStockLineItems to SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="19.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="InvestmentTypeAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to InvestmentTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember_2" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember_2" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="definition: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to ClassOfWarrantOrRightAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="RangeAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquityReverseStocksplitDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquityMergerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MergerAbstract" xlink:label="MergerAbstract" xlink:title="MergerAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="MergerAbstract" xlink:title="definition: ClassOfStockLineItems to MergerAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="SharesIssued" xlink:title="SharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SharesIssued" xlink:title="definition: ClassOfStockLineItems to SharesIssued" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="ConversionOfStockSharesConverted1" xlink:title="ConversionOfStockSharesConverted1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ConversionOfStockSharesConverted1" xlink:title="definition: ClassOfStockLineItems to ConversionOfStockSharesConverted1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ClassOfWarrantOrRightIssued" xlink:label="ClassOfWarrantOrRightIssued" xlink:title="ClassOfWarrantOrRightIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightIssued" xlink:title="definition: ClassOfStockLineItems to ClassOfWarrantOrRightIssued" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: ClassOfStockLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="definition: ClassOfStockLineItems to StockIssuedDuringPeriodSharesAcquisitions1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ClassOfStockLineItems" xlink:to="ScheduleOfStockByClassTable" xlink:title="definition: ClassOfStockLineItems to ScheduleOfStockByClassTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: ScheduleOfStockByClassTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: ScheduleOfStockByClassTable to StatementClassOfStockAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="definition: ClassOfStockDomain to CommonClassAMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassBMember" xlink:title="definition: ClassOfStockDomain to CommonClassBMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassCMember" xlink:title="definition: ClassOfStockDomain to CommonClassCMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfStockByClassTable to BusinessAcquisitionAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareDilutedOtherDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to EarningsPerShareDilutedOtherDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to ClassOfWarrantOrRightAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="definition: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain_2" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain_2" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to RestrictedStockUnitsRSUMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to WarrantMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="ConvertiblePreferredStockMember" xlink:title="ConvertiblePreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="ConvertiblePreferredStockMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to ConvertiblePreferredStockMember" order="4.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_SeparationAgreementAbstract" xlink:label="SeparationAgreementAbstract" xlink:title="SeparationAgreementAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="SeparationAgreementAbstract" xlink:title="definition: SubsequentEventLineItems to SeparationAgreementAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForPostemploymentBenefits" xlink:label="PaymentsForPostemploymentBenefits" xlink:title="PaymentsForPostemploymentBenefits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="PaymentsForPostemploymentBenefits" xlink:title="definition: SubsequentEventLineItems to PaymentsForPostemploymentBenefits" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PaymentToOfficerBaseSalary" xlink:label="PaymentToOfficerBaseSalary" xlink:title="PaymentToOfficerBaseSalary" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="PaymentToOfficerBaseSalary" xlink:title="definition: SubsequentEventLineItems to PaymentToOfficerBaseSalary" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="definition: SubsequentEventLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="definition: SubsequentEventLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:label="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:title="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:title="definition: SubsequentEventLineItems to SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="SharePrice" xlink:title="definition: SubsequentEventLineItems to SharePrice" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SubsequentEventLineItems" xlink:to="SubsequentEventTable" xlink:title="definition: SubsequentEventLineItems to SubsequentEventTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: SubsequentEventTable to SubsequentEventTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: SubsequentEventTable to TitleOfIndividualAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="ChiefExecutiveOfficerMember" xlink:title="ChiefExecutiveOfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ChiefExecutiveOfficerMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to ChiefExecutiveOfficerMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="AwardTypeAxis" xlink:title="definition: SubsequentEventTable to AwardTypeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MilestoneOptionsMember" xlink:label="MilestoneOptionsMember" xlink:title="MilestoneOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="MilestoneOptionsMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to MilestoneOptionsMember" order="1.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>btx-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US" id="us-gaap_AwardTypeAxis_lbl">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:title="label: AwardTypeAxis to us-gaap_AwardTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xml:lang="en-US" id="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:title="label: ArrangementsAndNonarrangementTransactionsMember to us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl">ACCRUED EXPENSES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent_lbl">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:title="label: AccountsPayableCurrent to us-gaap_AccountsPayableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent_lbl1">Accounts Payable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl1" xlink:title="label: AccountsPayableCurrent to us-gaap_AccountsPayableCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedProfessionalFeesCurrent_lbl">Legal Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:title="label: AccruedProfessionalFeesCurrent to us-gaap_AccruedProfessionalFeesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedProfessionalFeesCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedProfessionalFeesCurrent_lbl1">Accrued Professional Fees, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl1" xlink:title="label: AccruedProfessionalFeesCurrent to us-gaap_AccruedProfessionalFeesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl">Total accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl1">Accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl2" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl2">Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl1">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl">Stock based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl">Total potential common shares excluded from computation (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesNameDomain_lbl">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:title="label: AntidilutiveSecuritiesNameDomain to us-gaap_AntidilutiveSecuritiesNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="AssetAcquisitionAxis" xlink:title="AssetAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionAxis_lbl" xml:lang="en-US" id="us-gaap_AssetAcquisitionAxis_lbl">Asset Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionAxis_lbl" xlink:title="label: AssetAcquisitionAxis to us-gaap_AssetAcquisitionAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:label="AssetAcquisitionTableTextBlock" xlink:title="AssetAcquisitionTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_AssetAcquisitionTableTextBlock_lbl">Fair Value of Asset Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionTableTextBlock" xlink:to="us-gaap_AssetAcquisitionTableTextBlock_lbl" xlink:title="label: AssetAcquisitionTableTextBlock to us-gaap_AssetAcquisitionTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="AssetAcquisitionDomain" xlink:title="AssetAcquisitionDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionDomain_lbl" xml:lang="en-US" id="us-gaap_AssetAcquisitionDomain_lbl">Asset Acquisition [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionDomain" xlink:to="us-gaap_AssetAcquisitionDomain_lbl" xlink:title="label: AssetAcquisitionDomain to us-gaap_AssetAcquisitionDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:label="AssetsAndLiabilitiesLesseeAbstract" xlink:title="AssetsAndLiabilitiesLesseeAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl">Assets and Liabilities, Lessee [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAndLiabilitiesLesseeAbstract" xlink:to="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" xlink:title="label: AssetsAndLiabilitiesLesseeAbstract to us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Assets_lbl" xml:lang="en-US" id="us-gaap_Assets_lbl">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl" xlink:title="label: Assets to us-gaap_Assets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Assets_lbl1" xml:lang="en-US" id="us-gaap_Assets_lbl1">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl1" xlink:title="label: Assets to us-gaap_Assets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl1">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl1" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl1">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl1" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl">Carrying value of assets sold [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xlink:title="label: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl">Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:title="label: BasisOfAccountingPolicyPolicyTextBlock to us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xlink:title="label: BasisOfAccountingPolicyPolicyTextBlock to us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl">Accounts payable, accrued liabilities and other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl">Accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="BusinessAcquisitionSharePrice" xlink:title="BusinessAcquisitionSharePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionSharePrice_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionSharePrice_lbl">Closing price of common stock (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:title="label: BusinessAcquisitionSharePrice to us-gaap_BusinessAcquisitionSharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionSharePrice_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionSharePrice_lbl1">Business Acquisition, Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl1" xlink:title="label: BusinessAcquisitionSharePrice to us-gaap_BusinessAcquisitionSharePrice_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl">Prepaid expense and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl">Intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl">Purchase price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityTransactionCosts to us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1">Total consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityTransactionCosts to us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl">Percentage of outstanding common stock received by members and financial adviser</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationsAbstract_lbl">MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:title="label: BusinessCombinationsAbstract to us-gaap_BusinessCombinationsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAxis_lbl">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:title="label: BusinessAcquisitionAxis to us-gaap_BusinessAcquisitionAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl">Number of common stock issued in exchange of membership interests (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:title="label: BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued to us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1" xlink:title="label: BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued to us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionLineItems_lbl">Business Acquisition [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:title="label: BusinessAcquisitionLineItems to us-gaap_BusinessAcquisitionLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAcquireeDomain_lbl">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:title="label: BusinessAcquisitionAcquireeDomain to us-gaap_BusinessAcquisitionAcquireeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl">Net assets acquired, excluding goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract_lbl">Description of Business [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract_lbl1">Merger Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract_lbl1" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract_lbl2" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract_lbl2">Acquisitions [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract_lbl2" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl">Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl">Net increase in cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl">Cash and cash equivalents at beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1">Cash and cash equivalents at end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Cash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_Cash_lbl" xml:lang="en-US" id="us-gaap_Cash_lbl">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Cash" xlink:to="us-gaap_Cash_lbl" xlink:title="label: Cash to us-gaap_Cash_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Cash_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Cash_lbl1" xml:lang="en-US" id="us-gaap_Cash_lbl1">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Cash" xlink:to="us-gaap_Cash_lbl1" xlink:title="label: Cash to us-gaap_Cash_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_CashAcquiredFromAcquisition_lbl" xml:lang="en-US" id="us-gaap_CashAcquiredFromAcquisition_lbl">Cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:title="label: CashAcquiredFromAcquisition to us-gaap_CashAcquiredFromAcquisition_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAcquiredFromAcquisition_lbl1" xml:lang="en-US" id="us-gaap_CashAcquiredFromAcquisition_lbl1">Cash Acquired from Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl1" xlink:title="label: CashAcquiredFromAcquisition to us-gaap_CashAcquiredFromAcquisition_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl">Supplemental disclosure of non-cash investing and financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl">Number of rights options converted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1">Warrants to be outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2">Warrants exercisable (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightAxis_lbl">Class of Warrant or Right [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:title="label: ClassOfWarrantOrRightAxis to us-gaap_ClassOfWarrantOrRightAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockLineItems_lbl">Class of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:title="label: ClassOfStockLineItems to us-gaap_ClassOfStockLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightDomain_lbl">Class of Warrant or Right [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:title="label: ClassOfWarrantOrRightDomain to us-gaap_ClassOfWarrantOrRightDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl">Warrants exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:title="label: ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl">Number of common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightOutstanding_lbl">Warrants outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:title="label: ClassOfWarrantOrRightOutstanding to us-gaap_ClassOfWarrantOrRightOutstanding_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl">COMMITMENTS AND CONTINGENCIES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureAbstract to us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonClassBMember_lbl" xml:lang="en-US" id="us-gaap_CommonClassBMember_lbl">Common Class B [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:title="label: CommonClassBMember to us-gaap_CommonClassBMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonClassBMember_lbl1" xml:lang="en-US" id="us-gaap_CommonClassBMember_lbl1">Class B [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl1" xlink:title="label: CommonClassBMember to us-gaap_CommonClassBMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonClassBMember_lbl2" xml:lang="en-US" id="us-gaap_CommonClassBMember_lbl2">Common Class B [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl2" xlink:title="label: CommonClassBMember to us-gaap_CommonClassBMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonClassCMember_lbl" xml:lang="en-US" id="us-gaap_CommonClassCMember_lbl">Common Class C [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:title="label: CommonClassCMember to us-gaap_CommonClassCMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassCMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonClassCMember_lbl1" xml:lang="en-US" id="us-gaap_CommonClassCMember_lbl1">Class C [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl1" xlink:title="label: CommonClassCMember to us-gaap_CommonClassCMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassCMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonClassCMember_lbl2" xml:lang="en-US" id="us-gaap_CommonClassCMember_lbl2">Common Class C [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl2" xlink:title="label: CommonClassCMember to us-gaap_CommonClassCMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonClassAMember_lbl" xml:lang="en-US" id="us-gaap_CommonClassAMember_lbl">Common Class A [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:title="label: CommonClassAMember to us-gaap_CommonClassAMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonClassAMember_lbl1" xml:lang="en-US" id="us-gaap_CommonClassAMember_lbl1">Class A [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl1" xlink:title="label: CommonClassAMember to us-gaap_CommonClassAMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonClassAMember_lbl2" xml:lang="en-US" id="us-gaap_CommonClassAMember_lbl2">Common Class A [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl2" xlink:title="label: CommonClassAMember to us-gaap_CommonClassAMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember_lbl1" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl1">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl">Common stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl">Common stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl">Common stock, $0.005 par value, 100,000 shares authorized at March 31, 2022 and December 31, 2021; 57,452 and 52,021 issued and outstanding at March 31, 2022 and December 31, 2021, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl">Common stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding_lbl">Common stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:title="label: CommonStockSharesOutstanding to us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding_lbl1">Number of shares of common stock owned by Brooklyn stockholders immediately before the Merger (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl1" xlink:title="label: CommonStockSharesOutstanding to us-gaap_CommonStockSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="ConversionOfStockSharesConverted1" xlink:title="ConversionOfStockSharesConverted1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US" id="us-gaap_ConversionOfStockSharesConverted1_lbl">Number of shares converted to common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:title="label: ConversionOfStockSharesConverted1 to us-gaap_ConversionOfStockSharesConverted1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConversionOfStockSharesConverted1_lbl1" xml:lang="en-US" id="us-gaap_ConversionOfStockSharesConverted1_lbl1">Conversion of Stock, Shares Converted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl1" xlink:title="label: ConversionOfStockSharesConverted1 to us-gaap_ConversionOfStockSharesConverted1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="ConvertiblePreferredStockMember" xlink:title="ConvertiblePreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="us-gaap_ConvertiblePreferredStockMember_lbl">Preferred Stock Converted into Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:title="label: ConvertiblePreferredStockMember to us-gaap_ConvertiblePreferredStockMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US" id="us-gaap_CustomerRelationshipsMember_lbl">Customers [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:title="label: CustomerRelationshipsMember to us-gaap_CustomerRelationshipsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CustomerRelationshipsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CustomerRelationshipsMember_lbl1" xml:lang="en-US" id="us-gaap_CustomerRelationshipsMember_lbl1">Customer Relationships [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl1" xlink:title="label: CustomerRelationshipsMember to us-gaap_CustomerRelationshipsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets" xlink:label="DepositAssets" xlink:title="DepositAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepositAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DepositAssets_lbl" xml:lang="en-US" id="us-gaap_DepositAssets_lbl">Security deposits and other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepositAssets" xlink:to="us-gaap_DepositAssets_lbl" xlink:title="label: DepositAssets to us-gaap_DepositAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepositAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepositAssets_lbl1" xml:lang="en-US" id="us-gaap_DepositAssets_lbl1">Security deposit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepositAssets" xlink:to="us-gaap_DepositAssets_lbl1" xlink:title="label: DepositAssets to us-gaap_DepositAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl1" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl1">Depreciation, Depletion and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl" xml:lang="en-US" id="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl">Warrant Liabilities [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:to="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl" xlink:title="label: DerivativeFinancialInstrumentsLiabilitiesMember to us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="us-gaap_DerivativeLiabilitiesNoncurrent_lbl">Warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xlink:title="label: DerivativeLiabilitiesNoncurrent to us-gaap_DerivativeLiabilitiesNoncurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl">STOCK-BASED COMPENSATION [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl">STOCK-BASED COMPENSATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities to us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities to us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:label="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment to us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment to us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:label="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationDeferredRevenue to us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl">Intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationIntangibleAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationIntangibleAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:label="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="DisposalGroupIncludingDiscontinuedOperationGoodwill1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationGoodwill1 to us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationGoodwill1 to us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl">Prepaids and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents to us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents to us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl">Accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet to us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet to us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl">Other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities to us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationOtherAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationOtherAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl">Disposal Group Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" xlink:title="label: DisposalGroupsIncludingDiscontinuedOperationsNameDomain to us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl">Total loss on sale of assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl" xlink:title="label: DisposalGroupNotDiscontinuedOperationGainLossOnDisposal to us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl">EARNINGS PER SHARE</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl1">Earnings Per Share [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl1" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareDilutedOtherDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl">Anti-dilutive Securities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl" xlink:title="label: EarningsPerShareDilutedOtherDisclosuresAbstract to us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic_lbl">Net loss per common share - basic (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic_lbl1">Earnings Per Share, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareAbstract_lbl">EARNINGS PER SHARE [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:title="label: EarningsPerShareAbstract to us-gaap_EarningsPerShareAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareDiluted_lbl">Net loss per common share - diluted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:title="label: EarningsPerShareDiluted to us-gaap_EarningsPerShareDiluted_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl">Weighted average remaining requisite service period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" id="us-gaap_EmployeeStockOptionMember_lbl">Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:title="label: EmployeeStockOptionMember to us-gaap_EmployeeStockOptionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeStockOptionMember_lbl1" xml:lang="en-US" id="us-gaap_EmployeeStockOptionMember_lbl1">Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl1" xlink:title="label: EmployeeStockOptionMember to us-gaap_EmployeeStockOptionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl">Unamortized stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl">Accrued compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl">Unamortized stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="us-gaap_EquityComponentDomain_lbl">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xlink:title="label: EquityComponentDomain to us-gaap_EquityComponentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityAbstract_lbl" xml:lang="en-US" id="us-gaap_EquityAbstract_lbl">Stockholders' equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:title="label: EquityAbstract to us-gaap_EquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_EquityAbstract_lbl1">Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl1" xlink:title="label: EquityAbstract to us-gaap_EquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl">Losses on investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xlink:title="label: EquityMethodInvestmentRealizedGainLossOnDisposal to us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl">Percentage of total outstanding equity interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:title="label: EquityMethodInvestmentOwnershipPercentage to us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1">Ownership percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xlink:title="label: EquityMethodInvestmentOwnershipPercentage to us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestments_lbl">Investment in non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" xlink:title="label: EquityMethodInvestments to us-gaap_EquityMethodInvestments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityMethodInvestments_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestments_lbl1">Investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl1" xlink:title="label: EquityMethodInvestments to us-gaap_EquityMethodInvestments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiabilityAbstract" xlink:label="FairValueNetAssetLiabilityAbstract" xlink:title="FairValueNetAssetLiabilityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueNetAssetLiabilityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueNetAssetLiabilityAbstract_lbl" xml:lang="en-US" id="us-gaap_FairValueNetAssetLiabilityAbstract_lbl">Fair Value Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueNetAssetLiabilityAbstract" xlink:to="us-gaap_FairValueNetAssetLiabilityAbstract_lbl" xlink:title="label: FairValueNetAssetLiabilityAbstract to us-gaap_FairValueNetAssetLiabilityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueByLiabilityClassAxis_lbl" xml:lang="en-US" id="us-gaap_FairValueByLiabilityClassAxis_lbl">Liability Class [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:title="label: FairValueByLiabilityClassAxis to us-gaap_FairValueByLiabilityClassAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" id="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:title="label: FairValueByFairValueHierarchyLevelAxis to us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl">Fair value, end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1">Fair value, beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_FairValueDisclosuresAbstract_lbl">FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:title="label: FairValueDisclosuresAbstract to us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl">Liabilities Measured at Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl">Warrants fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1">Fair value at March 9, 2022 (issuance date)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" id="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:title="label: FairValueMeasurementsFairValueHierarchyDomain to us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl">Fair Value by Liability Class [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xlink:title="label: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock_lbl">FAIR VALUE OF FINANCIAL INSTRUMENTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:title="label: FairValueDisclosuresTextBlock to us-gaap_FairValueDisclosuresTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock_lbl1">Fair Value Disclosures [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl1" xlink:title="label: FairValueDisclosuresTextBlock to us-gaap_FairValueDisclosuresTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US" id="us-gaap_FairValueInputsLevel1Member_lbl">Level 1 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:title="label: FairValueInputsLevel1Member to us-gaap_FairValueInputsLevel1Member_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US" id="us-gaap_FairValueInputsLevel2Member_lbl">Level 2 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:title="label: FairValueInputsLevel2Member to us-gaap_FairValueInputsLevel2Member_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" id="us-gaap_FairValueInputsLevel3Member_lbl">Level 3 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:title="label: FairValueInputsLevel3Member to us-gaap_FairValueInputsLevel3Member_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl">Changes in Fair Value of Warrant Liabilities [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xlink:title="label: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:title="label: FiniteLivedIntangibleAssetsMajorClassNameDomain to us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:title="label: FiniteLivedIntangibleAssetsByMajorClassAxis to us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="GainLossOnDispositionOfAssets1" xlink:title="GainLossOnDispositionOfAssets1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_GainLossOnDispositionOfAssets1_lbl" xml:lang="en-US" id="us-gaap_GainLossOnDispositionOfAssets1_lbl">Loss on sale of NTN assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:title="label: GainLossOnDispositionOfAssets1 to us-gaap_GainLossOnDispositionOfAssets1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GainLossOnDispositionOfAssets1_lbl1" xml:lang="en-US" id="us-gaap_GainLossOnDispositionOfAssets1_lbl1">Loss on sale of NTN assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl1" xlink:title="label: GainLossOnDispositionOfAssets1 to us-gaap_GainLossOnDispositionOfAssets1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpense_lbl">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:title="label: GeneralAndAdministrativeExpense to us-gaap_GeneralAndAdministrativeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GeneralAndAdministrativeExpense_lbl1" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpense_lbl1">General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl1" xlink:title="label: GeneralAndAdministrativeExpense to us-gaap_GeneralAndAdministrativeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpenseMember_lbl">General and Administrative Expense [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:title="label: GeneralAndAdministrativeExpenseMember to us-gaap_GeneralAndAdministrativeExpenseMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl">GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureTextBlock to us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureTextBlock to us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Goodwill_lbl" xml:lang="en-US" id="us-gaap_Goodwill_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US" id="us-gaap_GoodwillImpairmentLoss_lbl">Impairment of goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:title="label: GoodwillImpairmentLoss to us-gaap_GoodwillImpairmentLoss_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl">GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureAbstract to us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl">Loss before income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementLocationDomain_lbl">Income Statement Location [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" xlink:title="label: IncomeStatementLocationDomain to us-gaap_IncomeStatementLocationDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementLocationAxis_lbl">Income Statement Location [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:title="label: IncomeStatementLocationAxis to us-gaap_IncomeStatementLocationAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xlink:title="label: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementAbstract_lbl">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:title="label: IncomeStatementAbstract to us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl">Disposal Group Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xlink:title="label: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis to us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xlink:title="label: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl">Provision for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl1">Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl">Other liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:title="label: IncreaseDecreaseInOtherOperatingLiabilities to us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInOtherOperatingLiabilities to us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="IncreaseDecreaseInOtherReceivables" xlink:title="IncreaseDecreaseInOtherReceivables" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherReceivables_lbl">Other receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xlink:title="label: IncreaseDecreaseInOtherReceivables to us-gaap_IncreaseDecreaseInOtherReceivables_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1">Increase (Decrease) in Other Receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" xlink:title="label: IncreaseDecreaseInOtherReceivables to us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:title="label: IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US" id="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl">In-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:title="label: IndefiniteLivedIntangibleAssetsExcludingGoodwill to us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" xml:lang="en-US" id="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" xlink:title="label: IndefiniteLivedIntangibleAssetsExcludingGoodwill to us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl">Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestPaidNet_lbl1" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl1">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl1" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentTypeCategorizationMember_lbl" xml:lang="en-US" id="us-gaap_InvestmentTypeCategorizationMember_lbl">Investments [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:title="label: InvestmentTypeCategorizationMember to us-gaap_InvestmentTypeCategorizationMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US" id="us-gaap_InvestmentTypeAxis_lbl">Investment Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" xlink:title="label: InvestmentTypeAxis to us-gaap_InvestmentTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="InvestmentsAbstract" xlink:title="InvestmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsAbstract_lbl" xml:lang="en-US" id="us-gaap_InvestmentsAbstract_lbl">Investments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsAbstract" xlink:to="us-gaap_InvestmentsAbstract_lbl" xlink:title="label: InvestmentsAbstract to us-gaap_InvestmentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeasesTextBlock_lbl">LEASES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:title="label: LesseeOperatingLeasesTextBlock to us-gaap_LesseeOperatingLeasesTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl">Total payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl">Less: Imputed interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFour to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseTermOfContract_lbl">Lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:title="label: LesseeOperatingLeaseTermOfContract to us-gaap_LesseeOperatingLeaseTermOfContract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear to us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear to us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="LesseeOperatingLeaseRenewalTerm" xlink:title="LesseeOperatingLeaseRenewalTerm" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl">Extended lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:title="label: LesseeOperatingLeaseRenewalTerm to us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearThree to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl">Maturities of Operating Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityMaturityTableTextBlock to us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearTwo to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US" id="us-gaap_LeaseCostAbstract_lbl">Net Operating Lease Expense [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl" xlink:title="label: LeaseCostAbstract to us-gaap_LeaseCostAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LeaseCost_lbl" xml:lang="en-US" id="us-gaap_LeaseCost_lbl">Total lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:title="label: LeaseCost to us-gaap_LeaseCost_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCost_lbl1" xml:lang="en-US" id="us-gaap_LeaseCost_lbl1">Lease, Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost_lbl1" xlink:title="label: LeaseCost to us-gaap_LeaseCost_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LeaseCostTableTextBlock_lbl">Net Operating Lease Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:title="label: LeaseCostTableTextBlock to us-gaap_LeaseCostTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeasesAbstract_lbl" xml:lang="en-US" id="us-gaap_LeasesAbstract_lbl">LEASES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:title="label: LeasesAbstract to us-gaap_LeasesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="LiabilitiesFairValueAdjustment" xlink:title="LiabilitiesFairValueAdjustment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesFairValueAdjustment_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueAdjustment_lbl">Change in fair value of warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueAdjustment" xlink:to="us-gaap_LiabilitiesFairValueAdjustment_lbl" xlink:title="label: LiabilitiesFairValueAdjustment to us-gaap_LiabilitiesFairValueAdjustment_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl">Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:title="label: LiabilitiesFairValueDisclosureAbstract to us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl">Liabilities transferred upon sale [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xlink:title="label: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Liabilities_lbl" xml:lang="en-US" id="us-gaap_Liabilities_lbl">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Liabilities_lbl1" xml:lang="en-US" id="us-gaap_Liabilities_lbl1">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl1" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1">Liabilities and Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="LiabilitiesFairValueDisclosure" xlink:title="LiabilitiesFairValueDisclosure" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueDisclosure_lbl">Liabilities, fair value disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:title="label: LiabilitiesFairValueDisclosure to us-gaap_LiabilitiesFairValueDisclosure_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesFairValueDisclosure_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueDisclosure_lbl1">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl1" xlink:title="label: LiabilitiesFairValueDisclosure to us-gaap_LiabilitiesFairValueDisclosure_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl">Total liabilities and stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl1">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl1">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl1" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="LossContingencyDamagesSoughtValue" xlink:title="LossContingencyDamagesSoughtValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyDamagesSoughtValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyDamagesSoughtValue_lbl" xml:lang="en-US" id="us-gaap_LossContingencyDamagesSoughtValue_lbl">Loss contingency, damages sought, value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtValue" xlink:to="us-gaap_LossContingencyDamagesSoughtValue_lbl" xlink:title="label: LossContingencyDamagesSoughtValue to us-gaap_LossContingencyDamagesSoughtValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingenciesLineItems_lbl" xml:lang="en-US" id="us-gaap_LossContingenciesLineItems_lbl">Loss Contingencies [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl" xlink:title="label: LossContingenciesLineItems to us-gaap_LossContingenciesLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingenciesTable_lbl" xml:lang="en-US" id="us-gaap_LossContingenciesTable_lbl">Loss Contingencies [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" xlink:title="label: LossContingenciesTable to us-gaap_LossContingenciesTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="LossContingencyEstimateOfPossibleLoss" xlink:title="LossContingencyEstimateOfPossibleLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" xml:lang="en-US" id="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl">Estimated contingent loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyEstimateOfPossibleLoss" xlink:to="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" xlink:title="label: LossContingencyEstimateOfPossibleLoss to us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:title="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xml:lang="en-US" id="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl">MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xlink:title="label: MergersAcquisitionsAndDispositionsDisclosuresTextBlock to us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="MinorityInterestOwnershipPercentageByParent" xlink:title="MinorityInterestOwnershipPercentageByParent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl">Ownership percentage by Citius</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:title="label: MinorityInterestOwnershipPercentageByParent to us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="NonrecurringAdjustmentDomain" xlink:title="NonrecurringAdjustmentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonrecurringAdjustmentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonrecurringAdjustmentDomain_lbl" xml:lang="en-US" id="us-gaap_NonrecurringAdjustmentDomain_lbl">Nonrecurring Adjustment [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonrecurringAdjustmentDomain" xlink:to="us-gaap_NonrecurringAdjustmentDomain_lbl" xlink:title="label: NonrecurringAdjustmentDomain to us-gaap_NonrecurringAdjustmentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:label="NonrecurringAdjustmentAxis" xlink:title="NonrecurringAdjustmentAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonrecurringAdjustmentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonrecurringAdjustmentAxis_lbl" xml:lang="en-US" id="us-gaap_NonrecurringAdjustmentAxis_lbl">Nonrecurring Adjustment [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonrecurringAdjustmentAxis" xlink:to="us-gaap_NonrecurringAdjustmentAxis_lbl" xlink:title="label: NonrecurringAdjustmentAxis to us-gaap_NonrecurringAdjustmentAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl">Net cash provided by financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl">Cash flows provided by financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl">Cash flows used in investing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Cash flows used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl">Net cash (used in) provided by investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl1">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetIncomeLoss_lbl2" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl2">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl2" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl">Recent Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl">RECENT ACCOUNTING PRONOUNCEMENTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xlink:title="label: NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock to us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl">RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xlink:title="label: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashMergerRelatedCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncashMergerRelatedCosts_lbl" xml:lang="en-US" id="us-gaap_NoncashMergerRelatedCosts_lbl">Transaction costs - shares to Financial Advisor</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashMergerRelatedCosts" xlink:to="us-gaap_NoncashMergerRelatedCosts_lbl" xlink:title="label: NoncashMergerRelatedCosts to us-gaap_NoncashMergerRelatedCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashMergerRelatedCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_NoncashMergerRelatedCosts_lbl1" xml:lang="en-US" id="us-gaap_NoncashMergerRelatedCosts_lbl1">Transaction costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashMergerRelatedCosts" xlink:to="us-gaap_NoncashMergerRelatedCosts_lbl1" xlink:title="label: NoncashMergerRelatedCosts to us-gaap_NoncashMergerRelatedCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashMergerRelatedCosts_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncashMergerRelatedCosts_lbl2" xml:lang="en-US" id="us-gaap_NoncashMergerRelatedCosts_lbl2">Noncash Merger Related Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashMergerRelatedCosts" xlink:to="us-gaap_NoncashMergerRelatedCosts_lbl2" xlink:title="label: NoncashMergerRelatedCosts to us-gaap_NoncashMergerRelatedCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl">Total other expense, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl1" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl1">Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl">Operating lease liabilities, current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl1">Current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl2">Operating Lease, Liability, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl">Weighted average discount rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:title="label: OperatingLeaseWeightedAverageDiscountRatePercent to us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl">Operating lease liabilities, non-current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1">Less non-current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl">Maturities of Operating Lease Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:title="label: OperatingLeaseLiabilitiesPaymentsDueAbstract to us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl">Right-of-use assets - operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl1">Operating lease ROU assets, Ending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl2">Operating lease ROU assets, Beginning</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl2" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseCost_lbl">Operating lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:title="label: OperatingLeaseCost to us-gaap_OperatingLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl">Weighted average remaining lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:title="label: OperatingLeaseWeightedAverageRemainingLeaseTerm1 to us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl">Operating lease liabilities, Beginning</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_OperatingLeaseLiability_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl1">Operating lease liabilities, Ending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl1" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiability_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl2">Total operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl2" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="OperatingLeaseLiabilityAbstract" xlink:title="OperatingLeaseLiabilityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityAbstract_lbl">Operating Lease, Liability [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:title="label: OperatingLeaseLiabilityAbstract to us-gaap_OperatingLeaseLiabilityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl">Amortization of right-to-use asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:title="label: OperatingLeaseRightOfUseAssetAmortizationExpense to us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1">Amortization of operating lease ROU assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1" xlink:title="label: OperatingLeaseRightOfUseAssetAmortizationExpense to us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" xlink:title="label: OperatingLeaseRightOfUseAssetAmortizationExpense to us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract_lbl">Operating expenses:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:title="label: OperatingExpensesAbstract to us-gaap_OperatingExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingExpensesAbstract_lbl1" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract_lbl1">Operating Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl1" xlink:title="label: OperatingExpensesAbstract to us-gaap_OperatingExpensesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" id="us-gaap_OperatingExpenses_lbl">Total operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:title="label: OperatingExpenses to us-gaap_OperatingExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingExpenses_lbl1" xml:lang="en-US" id="us-gaap_OperatingExpenses_lbl1">Operating Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl1" xlink:title="label: OperatingExpenses to us-gaap_OperatingExpenses_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl1">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl1" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherReceivablesNetCurrent_lbl">Other receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:title="label: OtherReceivablesNetCurrent to us-gaap_OtherReceivablesNetCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpensesAbstract" xlink:label="OtherExpensesAbstract" xlink:title="OtherExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherExpensesAbstract_lbl" xml:lang="en-US" id="us-gaap_OtherExpensesAbstract_lbl">Other expenses, net:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherExpensesAbstract" xlink:to="us-gaap_OtherExpensesAbstract_lbl" xlink:title="label: OtherExpensesAbstract to us-gaap_OtherExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherExpensesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherExpensesAbstract_lbl1" xml:lang="en-US" id="us-gaap_OtherExpensesAbstract_lbl1">Other Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherExpensesAbstract" xlink:to="us-gaap_OtherExpensesAbstract_lbl1" xlink:title="label: OtherExpensesAbstract to us-gaap_OtherExpensesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl">Other liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl1">Other Liabilities, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherLiabilitiesCurrent_lbl">Other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:title="label: OtherLiabilitiesCurrent to us-gaap_OtherLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherLiabilitiesCurrent_lbl1">Other Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl1" xlink:title="label: OtherLiabilitiesCurrent to us-gaap_OtherLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpense_lbl">Other expense, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:title="label: OtherNonoperatingIncomeExpense to us-gaap_OtherNonoperatingIncomeExpense_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnersCapitalAccountUnitsAcquisitions" xlink:label="PartnersCapitalAccountUnitsAcquisitions" xlink:title="PartnersCapitalAccountUnitsAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl" xml:lang="en-US" id="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl">Issuance of common stock to Brooklyn members (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnersCapitalAccountUnitsAcquisitions" xlink:to="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl" xlink:title="label: PartnersCapitalAccountUnitsAcquisitions to us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1" xml:lang="en-US" id="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1">Partners' Capital Account, Units, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnersCapitalAccountUnitsAcquisitions" xlink:to="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1" xlink:title="label: PartnersCapitalAccountUnitsAcquisitions to us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnersCapitalAccountAcquisitions" xlink:label="PartnersCapitalAccountAcquisitions" xlink:title="PartnersCapitalAccountAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PartnersCapitalAccountAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PartnersCapitalAccountAcquisitions_lbl" xml:lang="en-US" id="us-gaap_PartnersCapitalAccountAcquisitions_lbl">Issuance of common stock to Brooklyn members</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnersCapitalAccountAcquisitions" xlink:to="us-gaap_PartnersCapitalAccountAcquisitions_lbl" xlink:title="label: PartnersCapitalAccountAcquisitions to us-gaap_PartnersCapitalAccountAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PartnersCapitalAccountAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PartnersCapitalAccountAcquisitions_lbl1" xml:lang="en-US" id="us-gaap_PartnersCapitalAccountAcquisitions_lbl1">Partners' Capital Account, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnersCapitalAccountAcquisitions" xlink:to="us-gaap_PartnersCapitalAccountAcquisitions_lbl1" xlink:title="label: PartnersCapitalAccountAcquisitions to us-gaap_PartnersCapitalAccountAcquisitions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US" id="us-gaap_PayablesAndAccrualsAbstract_lbl">ACCRUED EXPENSES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:title="label: PayablesAndAccrualsAbstract to us-gaap_PayablesAndAccrualsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForPostemploymentBenefits" xlink:label="PaymentsForPostemploymentBenefits" xlink:title="PaymentsForPostemploymentBenefits" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsForPostemploymentBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PaymentsForPostemploymentBenefits_lbl" xml:lang="en-US" id="us-gaap_PaymentsForPostemploymentBenefits_lbl">Severance benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsForPostemploymentBenefits" xlink:to="us-gaap_PaymentsForPostemploymentBenefits_lbl" xlink:title="label: PaymentsForPostemploymentBenefits to us-gaap_PaymentsForPostemploymentBenefits_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsForPostemploymentBenefits_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsForPostemploymentBenefits_lbl1" xml:lang="en-US" id="us-gaap_PaymentsForPostemploymentBenefits_lbl1">Payments for Postemployment Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsForPostemploymentBenefits" xlink:to="us-gaap_PaymentsForPostemploymentBenefits_lbl1" xlink:title="label: PaymentsForPostemploymentBenefits to us-gaap_PaymentsForPostemploymentBenefits_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="PaymentsToAcquireInvestments" xlink:title="PaymentsToAcquireInvestments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireInvestments_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireInvestments_lbl">Less amount of cash paid for NoveCite investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:title="label: PaymentsToAcquireInvestments to us-gaap_PaymentsToAcquireInvestments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireInvestments_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireInvestments_lbl1">Payments to Acquire Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl1" xlink:title="label: PaymentsToAcquireInvestments to us-gaap_PaymentsToAcquireInvestments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:label="PaymentsToAcquireOtherProductiveAssets" xlink:title="PaymentsToAcquireOtherProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireOtherProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl" xlink:title="label: PaymentsToAcquireOtherProductiveAssets to us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl1">Payments to Acquire Other Productive Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireOtherProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl1" xlink:title="label: PaymentsToAcquireOtherProductiveAssets to us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl">Purchase of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireProductiveAssets_lbl">Cash paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:title="label: PaymentsToAcquireProductiveAssets to us-gaap_PaymentsToAcquireProductiveAssets_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockMember_lbl" xml:lang="en-US" id="us-gaap_PreferredStockMember_lbl">Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:title="label: PreferredStockMember to us-gaap_PreferredStockMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="PreferredStockLiquidationPreferenceValue" xlink:title="PreferredStockLiquidationPreferenceValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xml:lang="en-US" id="us-gaap_PreferredStockLiquidationPreferenceValue_lbl">Preferred stock, liquidation preference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xlink:title="label: PreferredStockLiquidationPreferenceValue to us-gaap_PreferredStockLiquidationPreferenceValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl">Preferred stock, $0.005 par value, 1,000 shares authorized, 156 designated and outstanding of Series A convertible preferred stock at March 31, 2022 and December 31, 2021, $156 liquidation preference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl">Preferred stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl1">Preferred Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl">Preferred stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl">Preferred stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl1">Preferred Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl">Preferred stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl1">Preferred Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl1" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:title="label: PrepaidExpenseAndOtherAssetsCurrent to us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="PriorPeriodReclassificationAdjustmentDescription" xlink:title="PriorPeriodReclassificationAdjustmentDescription" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US" id="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl">Reclassifications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:title="label: PriorPeriodReclassificationAdjustmentDescription to us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:label="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="ProceedsFromSalesOfAssetsInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl">Purchase of NTN, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfAssetsInvestingActivities" xlink:to="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl" xlink:title="label: ProceedsFromSalesOfAssetsInvestingActivities to us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1">Proceeds from Sales of Assets, Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfAssetsInvestingActivities" xlink:to="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1" xlink:title="label: ProceedsFromSalesOfAssetsInvestingActivities to us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:label="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl">Sale of rights, title and interest in and to the assets relating to the business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl" xlink:title="label: ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets to us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1">Proceeds from Sales of Business, Affiliate and Productive Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1" xlink:title="label: ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets to us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl">Proceeds from the sale of NTN assets, net of cash disposed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDivestitureOfBusinesses" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:title="label: ProceedsFromDivestitureOfBusinesses to us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="ProceedsFromIssuanceOfPrivatePlacement" xlink:title="ProceedsFromIssuanceOfPrivatePlacement" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl">Net proceeds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:title="label: ProceedsFromIssuanceOfPrivatePlacement to us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl">Proceeds from issuance of common stock and warrants in connection with private offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:title="label: ProceedsFromIssuanceOfCommonStock to us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1">Proceeds from Issuance of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xlink:title="label: ProceedsFromIssuanceOfCommonStock to us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="ProceedsFromOtherEquity" xlink:title="ProceedsFromOtherEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromOtherEquity_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromOtherEquity_lbl">Proceeds from sale of members' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromOtherEquity" xlink:to="us-gaap_ProceedsFromOtherEquity_lbl" xlink:title="label: ProceedsFromOtherEquity to us-gaap_ProceedsFromOtherEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromOtherEquity_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromOtherEquity_lbl1">Proceeds from Other Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromOtherEquity" xlink:to="us-gaap_ProceedsFromOtherEquity_lbl1" xlink:title="label: ProceedsFromOtherEquity to us-gaap_ProceedsFromOtherEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl">Related Party [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:title="label: RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyDomain_lbl">Related Party [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl" xlink:title="label: RelatedPartyDomain to us-gaap_RelatedPartyDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpense_lbl">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:title="label: ResearchAndDevelopmentExpense to us-gaap_ResearchAndDevelopmentExpense_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseMember_lbl">Research and Development Expense [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:title="label: ResearchAndDevelopmentExpenseMember to us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US" id="us-gaap_RestrictedStockMember_lbl">Restricted Common Shares [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:title="label: RestrictedStockMember to us-gaap_RestrictedStockMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember_lbl">RSU [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestrictedStockUnitsRSUMember_lbl1" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember_lbl1">Restricted Common Units [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl1" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RestrictedStockUnitsRSUMember_lbl2" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember_lbl2">RSUs [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl2" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl">Accumulated Deficit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsMember_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl1">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl1" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome" xlink:label="SubleaseIncome" xlink:title="SubleaseIncome" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubleaseIncome_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_SubleaseIncome_lbl" xml:lang="en-US" id="us-gaap_SubleaseIncome_lbl">Sublease income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl" xlink:title="label: SubleaseIncome to us-gaap_SubleaseIncome_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubleaseIncome_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubleaseIncome_lbl1" xml:lang="en-US" id="us-gaap_SubleaseIncome_lbl1">Sublease Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl1" xlink:title="label: SubleaseIncome to us-gaap_SubleaseIncome_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl">Expected term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl">Warrant expiration term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl">Weighted-average remaining contractual life, outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl">Options vested and exercisable, weighted average remaining contractual life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl">Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl">Stock-based compensation vesting percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl">Options exercisable period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl">Weighted-Average Assumptions Used for Grants Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:title="label: ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl">Summarizes of Stock Option Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:title="label: ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock to us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:title="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl">Tangible and Intangible Assets Acquired and Liabilities Assumed, Based on Estimated Fair Values</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:title="label: ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock to us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl">Summarizes of RSU Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:title="label: ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock to us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:title="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl">Changes in Warrant Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xlink:title="label: ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock to us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl">Computation of Diluted Net Loss per Common Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTable to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:title="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl">Disposition Details</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xlink:title="label: ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock to us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfStockByClassTable_lbl">Schedule of Stock by Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:title="label: ScheduleOfStockByClassTable to us-gaap_ScheduleOfStockByClassTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US" id="us-gaap_SeriesAPreferredStockMember_lbl">Series A Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:title="label: SeriesAPreferredStockMember to us-gaap_SeriesAPreferredStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SeriesAPreferredStockMember_lbl1" xml:lang="en-US" id="us-gaap_SeriesAPreferredStockMember_lbl1">Series A Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl1" xlink:title="label: SeriesAPreferredStockMember to us-gaap_SeriesAPreferredStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl">Restricted stock units vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl">Weighted Average Exercise Price per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl">Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1">Number of stock option awards granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl">Cancelled (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl">Weighted Average Fair Value Per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="ShareBasedCompensationAwardTrancheOneMember" xlink:title="ShareBasedCompensationAwardTrancheOneMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl">Vesting on one-year Anniversary [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:title="label: ShareBasedCompensationAwardTrancheOneMember to us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1" xlink:title="label: ShareBasedCompensationAwardTrancheOneMember to us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharePrice_lbl" xml:lang="en-US" id="us-gaap_SharePrice_lbl">Stock price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:title="label: SharePrice to us-gaap_SharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharePrice_lbl1" xml:lang="en-US" id="us-gaap_SharePrice_lbl1">Share price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharePrice" xlink:to="us-gaap_SharePrice_lbl1" xlink:title="label: SharePrice to us-gaap_SharePrice_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl1">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl1" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl">Cancelled (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl">Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl">Dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl">Weighted Average Fair Value Per Share, Ending balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1">Weighted Average Fair Value Per Share, Beginning balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl">Cancelled (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1">Unvested restricted common stock forfeited (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl">Outstanding Restricted Stock Units [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl">Released (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl">Stock-based Compensation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl">Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl">Number of stock units awards outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1">Outstanding, Beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2">Outstanding, Ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl3" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl3">Unvested restricted stock outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl3" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl">Assertions Used in Determining Fair Value of Stock Options Granted [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl">Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl">Released (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl">Weighted average risk-free rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl">Weighted average volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl">Cancelled (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl">Options vested and exercisable, Weighted average exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl">Outstanding, ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1">Outstanding, beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2">Number of stock option awards outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl3" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl3">Stock option outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl3" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl">Outstanding, ending balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1">Outstanding, beginning balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl">Outstanding, beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1">Outstanding, ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl">Options vested and exercisable, Outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl">Number of Option Share [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl">Options vested and exercisable, aggregate intrinsic value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl">Options Vested and Exercisable [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl">Award Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract_lbl">Weighted Average Remaining Contractual Life [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract_lbl" xlink:title="label: ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract to us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="SharesIssued" xlink:title="SharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharesIssued_lbl" xml:lang="en-US" id="us-gaap_SharesIssued_lbl">Number of shares issued in merger agreement (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xlink:title="label: SharesIssued to us-gaap_SharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesIssued_lbl1" xml:lang="en-US" id="us-gaap_SharesIssued_lbl1">Shares, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssued" xlink:to="us-gaap_SharesIssued_lbl1" xlink:title="label: SharesIssued to us-gaap_SharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl1">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesOutstanding_lbl2" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl2">Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl2" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfFinancialPositionAbstract_lbl">CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:title="label: StatementOfFinancialPositionAbstract to us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementTable_lbl" xml:lang="en-US" id="us-gaap_StatementTable_lbl">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:title="label: StatementTable to us-gaap_StatementTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="us-gaap_StatementLineItems_lbl">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:title="label: StatementLineItems to us-gaap_StatementLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfCashFlowsAbstract_lbl">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:title="label: StatementOfCashFlowsAbstract to us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="us-gaap_StatementEquityComponentsAxis_lbl">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:title="label: StatementEquityComponentsAxis to us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfStockholdersEquityAbstract_lbl">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:title="label: StatementOfStockholdersEquityAbstract to us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1" xlink:label="StockIssued1" xlink:title="StockIssued1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssued1_lbl" xml:lang="en-US" id="us-gaap_StockIssued1_lbl">Issuance of common stock for business combination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:title="label: StockIssued1 to us-gaap_StockIssued1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssued1_lbl1" xml:lang="en-US" id="us-gaap_StockIssued1_lbl1">Stock Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssued1" xlink:to="us-gaap_StockIssued1_lbl1" xlink:title="label: StockIssued1 to us-gaap_StockIssued1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl">Stock option exercised (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:title="label: StockIssuedDuringPeriodSharesStockOptionsExercised to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesStockOptionsExercised to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl">Private placement (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:title="label: StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased to us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl">Restricted stock replaced during the period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1">Issuance of common stock from vested restricted stock units (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="StockIssuedDuringPeriodSharesReverseStockSplits" xlink:title="StockIssuedDuringPeriodSharesReverseStockSplits" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl">Stock outstanding, reverse stock splits (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xlink:title="label: StockIssuedDuringPeriodSharesReverseStockSplits to us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl">Number of common stock issued as compensation for services (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:title="label: StockIssuedDuringPeriodSharesIssuedForServices to us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1">Lock-up agreements shares received in acquisition (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesIssuedForServices to us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl">Acquisition of common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions to us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1">Issuance of common stock to Financial Advisor upon consummation of merger (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions to us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl">Aggregate gross purchase price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:title="label: StockRepurchaseProgramAuthorizedAmount1 to us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1">Gross proceeds received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1" xlink:title="label: StockRepurchaseProgramAuthorizedAmount1 to us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl">Fair value of shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:title="label: StockIssuedDuringPeriodValueNewIssues to us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1">Stock Issued During Period, Value, New Issues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xlink:title="label: StockIssuedDuringPeriodValueNewIssues to us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl">Acquisition agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions to us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1">Issuance of common stock to Financial Advisor upon consummation of merger</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions to us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions to us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl">Issuance of common stock from vested restricted stock units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl">Stock conversion ratio</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:title="label: StockholdersEquityNoteStockSplitConversionRatio1 to us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl">Total stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl1">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl2">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquity_lbl3" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl3">Stockholders' Equity Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl3" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl">STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteAbstract_lbl">STOCKHOLDERS' EQUITY [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:title="label: StockholdersEquityNoteAbstract to us-gaap_StockholdersEquityNoteAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventMember_lbl">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:title="label: SubsequentEventMember to us-gaap_SubsequentEventMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeDomain_lbl">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" xlink:title="label: SubsequentEventTypeDomain to us-gaap_SubsequentEventTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventLineItems_lbl">Subsequent Event [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:title="label: SubsequentEventLineItems to us-gaap_SubsequentEventLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeAxis_lbl">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:title="label: SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventsAbstract_lbl">SUBSEQUENT EVENT [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:title="label: SubsequentEventsAbstract to us-gaap_SubsequentEventsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTable_lbl">Subsequent Event [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:title="label: SubsequentEventTable to us-gaap_SubsequentEventTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="SubsequentEventsTextBlock" xlink:title="SubsequentEventsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventsTextBlock_lbl">SUBSEQUENT EVENT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:title="label: SubsequentEventsTextBlock to us-gaap_SubsequentEventsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SubsequentEventsTextBlock_lbl1">Subsequent Events [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl1" xlink:title="label: SubsequentEventsTextBlock to us-gaap_SubsequentEventsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US" id="us-gaap_SubsidiarySaleOfStockLineItems_lbl">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:title="label: SubsidiarySaleOfStockLineItems to us-gaap_SubsidiarySaleOfStockLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US" id="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:title="label: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl">Supplemental disclosures of cash flow information:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TradeNamesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TradeNamesMember_lbl" xml:lang="en-US" id="us-gaap_TradeNamesMember_lbl">Trade Names [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradeNamesMember" xlink:to="us-gaap_TradeNamesMember_lbl" xlink:title="label: TradeNamesMember to us-gaap_TradeNamesMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US" id="us-gaap_TypeOfArrangementAxis_lbl">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:title="label: TypeOfArrangementAxis to us-gaap_TypeOfArrangementAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis" xlink:label="VestingAxis" xlink:title="VestingAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VestingAxis_lbl" xml:lang="en-US" id="us-gaap_VestingAxis_lbl">Vesting [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" xlink:title="label: VestingAxis to us-gaap_VestingAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain" xlink:title="VestingDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VestingDomain_lbl" xml:lang="en-US" id="us-gaap_VestingDomain_lbl">Vesting [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VestingDomain" xlink:to="us-gaap_VestingDomain_lbl" xlink:title="label: VestingDomain to us-gaap_VestingDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VariableLeaseCost_lbl" xml:lang="en-US" id="us-gaap_VariableLeaseCost_lbl">Variable lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" xlink:title="label: VariableLeaseCost to us-gaap_VariableLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WarrantMember_lbl" xml:lang="en-US" id="us-gaap_WarrantMember_lbl">Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:title="label: WarrantMember to us-gaap_WarrantMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantMember_lbl1" xml:lang="en-US" id="us-gaap_WarrantMember_lbl1">Warrant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantMember" xlink:to="us-gaap_WarrantMember_lbl1" xlink:title="label: WarrantMember to us-gaap_WarrantMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US" id="us-gaap_WarrantsAndRightsOutstandingTerm_lbl">Warrants outstanding weighted average contractual life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:title="label: WarrantsAndRightsOutstandingTerm to us-gaap_WarrantsAndRightsOutstandingTerm_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl">Weighted average shares outstanding - diluted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:title="label: WeightedAverageNumberOfDilutedSharesOutstanding to us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl">Weighted average shares outstanding - basic (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:title="label: WeightedAverageNumberOfSharesOutstandingBasic to us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="ChiefExecutiveOfficerMember" xlink:title="ChiefExecutiveOfficerMember" />
    <link:label xlink:type="resource" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US" id="srt_ChiefExecutiveOfficerMember_lbl">Dr. Federoffs's [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" xlink:title="label: ChiefExecutiveOfficerMember to srt_ChiefExecutiveOfficerMember_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_ChiefExecutiveOfficerMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ChiefExecutiveOfficerMember_lbl1" xml:lang="en-US" id="srt_ChiefExecutiveOfficerMember_lbl1">Chief Executive Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl1" xlink:title="label: ChiefExecutiveOfficerMember to srt_ChiefExecutiveOfficerMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:label xlink:type="resource" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_EquityMethodInvesteeNameDomain_lbl" xml:lang="en-US" id="srt_EquityMethodInvesteeNameDomain_lbl">Investment, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl" xlink:title="label: EquityMethodInvesteeNameDomain to srt_EquityMethodInvesteeNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MaximumMember_lbl" xml:lang="en-US" id="srt_MaximumMember_lbl">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:title="label: MaximumMember to srt_MaximumMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MinimumMember_lbl" xml:lang="en-US" id="srt_MinimumMember_lbl">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:title="label: MinimumMember to srt_MinimumMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipDomain_lbl" xml:lang="en-US" id="srt_OwnershipDomain_lbl">Ownership [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl" xlink:title="label: OwnershipDomain to srt_OwnershipDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipAxis_lbl" xml:lang="en-US" id="srt_OwnershipAxis_lbl">Ownership [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:title="label: OwnershipAxis to srt_OwnershipAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:label xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeMember_lbl" xml:lang="en-US" id="srt_RangeMember_lbl">Statistical Measurement [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="srt_RangeMember_lbl" xlink:title="label: RangeMember to srt_RangeMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeAxis_lbl" xml:lang="en-US" id="srt_RangeAxis_lbl">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:title="label: RangeAxis to srt_RangeAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_RangeAxis_lbl1" xml:lang="en-US" id="srt_RangeAxis_lbl1">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis_lbl1" xlink:title="label: RangeAxis to srt_RangeAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:label xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScenarioForecastMember_lbl" xml:lang="en-US" id="srt_ScenarioForecastMember_lbl">Forecast [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xlink:title="label: ScenarioForecastMember to srt_ScenarioForecastMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" id="srt_ScenarioUnspecifiedDomain_lbl">Scenario [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" xlink:title="label: ScenarioUnspecifiedDomain to srt_ScenarioUnspecifiedDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US" id="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl">Investment, Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:title="label: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:label xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_StatementScenarioAxis_lbl" xml:lang="en-US" id="srt_StatementScenarioAxis_lbl">Scenario [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:title="label: StatementScenarioAxis to srt_StatementScenarioAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US" id="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl">Title of Individual [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:title="label: TitleOfIndividualWithRelationshipToEntityDomain to srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US" id="srt_TitleOfIndividualAxis_lbl">Title of Individual [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:title="label: TitleOfIndividualAxis to srt_TitleOfIndividualAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="DocumentQuarterlyReport" xlink:title="DocumentQuarterlyReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US" id="dei_DocumentQuarterlyReport_lbl">Document Quarterly Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:title="label: DocumentQuarterlyReport to dei_DocumentQuarterlyReport_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentTransitionReport_lbl" xml:lang="en-US" id="dei_DocumentTransitionReport_lbl">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:title="label: DocumentTransitionReport to dei_DocumentTransitionReport_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:label xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" id="dei_EntityInteractiveDataCurrent_lbl">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:title="label: EntityInteractiveDataCurrent to dei_EntityInteractiveDataCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:label xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LegalEntityAxis_lbl" xml:lang="en-US" id="dei_LegalEntityAxis_lbl">Legal Entity [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:title="label: LegalEntityAxis to dei_LegalEntityAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:label xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityDomain_lbl" xml:lang="en-US" id="dei_EntityDomain_lbl">Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityDomain" xlink:to="dei_EntityDomain_lbl" xlink:title="label: EntityDomain to dei_EntityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate_lbl">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" id="dei_EntityCurrentReportingStatus_lbl">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:title="label: EntityCurrentReportingStatus to dei_EntityCurrentReportingStatus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityShellCompany_lbl" xml:lang="en-US" id="dei_EntityShellCompany_lbl">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:title="label: EntityShellCompany to dei_EntityShellCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="dei_EntityFilerCategory_lbl">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:title="label: EntityFilerCategory to dei_EntityFilerCategory_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:label xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntitySmallBusiness_lbl" xml:lang="en-US" id="dei_EntitySmallBusiness_lbl">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:title="label: EntitySmallBusiness to dei_EntitySmallBusiness_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="dei_EntityCommonStockSharesOutstanding_lbl">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:title="label: EntityCommonStockSharesOutstanding to dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl">Equity impact of the shares of new stock issued of preferred stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl" xlink:title="label: StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders to btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1">Stock Issued During Period, Shares, New Issues of Preferred Stock, Retained by Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders to btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2">Series A preferred stock retained in business combination (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders to btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:label="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" />
    <link:label xlink:type="resource" xlink:label="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" xml:lang="en-US" id="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl">Number of shares Forfeiture of unvested restricted stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:to="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" xlink:title="label: SharesIssuedSharesForfeitureOfUnvestedRestrictedStock to btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" xml:lang="en-US" id="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1">Shares Issued, Shares, Forfeiture of unvested restricted stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:to="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" xlink:title="label: SharesIssuedSharesForfeitureOfUnvestedRestrictedStock to btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2" xml:lang="en-US" id="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2">Forfeiture of unvested restricted stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:to="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2" xlink:title="label: SharesIssuedSharesForfeitureOfUnvestedRestrictedStock to btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:label="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl">Value of stock issued pursuant to rights offering membership units during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:to="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl" xlink:title="label: StockIssuedDuringPeriodValueRightsOfferingMembershipUnits to btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1">Stock Issued During Period, Value, Rights Offering Membership Units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:to="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1" xlink:title="label: StockIssuedDuringPeriodValueRightsOfferingMembershipUnits to btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2">Brooklyn rights offerings membership units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:to="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2" xlink:title="label: StockIssuedDuringPeriodValueRightsOfferingMembershipUnits to btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MembershipEquityMember" xlink:label="MembershipEquityMember" xlink:title="MembershipEquityMember" />
    <link:label xlink:type="resource" xlink:label="btx_MembershipEquityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_MembershipEquityMember_lbl" xml:lang="en-US" id="btx_MembershipEquityMember_lbl">Equity membership interest in entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MembershipEquityMember" xlink:to="btx_MembershipEquityMember_lbl" xlink:title="label: MembershipEquityMember to btx_MembershipEquityMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_MembershipEquityMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_MembershipEquityMember_lbl1" xml:lang="en-US" id="btx_MembershipEquityMember_lbl1">Membership Equity [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MembershipEquityMember" xlink:to="btx_MembershipEquityMember_lbl1" xlink:title="label: MembershipEquityMember to btx_MembershipEquityMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_MembershipEquityMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_MembershipEquityMember_lbl2" xml:lang="en-US" id="btx_MembershipEquityMember_lbl2">Membership Equity [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MembershipEquityMember" xlink:to="btx_MembershipEquityMember_lbl2" xlink:title="label: MembershipEquityMember to btx_MembershipEquityMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl">Equity impact of the value of new stock issued of preferred stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl" xlink:title="label: StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders to btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1">Stock Issued During Period, Value, New Issues of Preferred Stock, Retained by Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xlink:title="label: StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders to btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2">Series A preferred stock retained in business combination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xlink:title="label: StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders to btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValuePrivateOffering" xlink:label="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="StockIssuedDuringPeriodValuePrivateOffering" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl">Equity impact of the value of stock that has been issued in private offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValuePrivateOffering" xlink:to="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl" xlink:title="label: StockIssuedDuringPeriodValuePrivateOffering to btx_StockIssuedDuringPeriodValuePrivateOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl1">Stock Issued During Period, Value, Private Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValuePrivateOffering" xlink:to="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl1" xlink:title="label: StockIssuedDuringPeriodValuePrivateOffering to btx_StockIssuedDuringPeriodValuePrivateOffering_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl2">Issuance of common stock in connection with private offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValuePrivateOffering" xlink:to="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl2" xlink:title="label: StockIssuedDuringPeriodValuePrivateOffering to btx_StockIssuedDuringPeriodValuePrivateOffering_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:label="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl">Value of stock related to Forfeiture of unvested restricted stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:to="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" xlink:title="label: StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock to btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1">Stock Issued During Period, Value, Forfeiture of Unvested Restricted Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:to="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" xlink:title="label: StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock to btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2">Forfeiture of unvested restricted stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:to="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2" xlink:title="label: StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock to btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValueAcquisitions1" xlink:label="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="StockIssuedDuringPeriodValueAcquisitions1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl">Value of stock issued pursuant to acquisitions during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions1 to btx_StockIssuedDuringPeriodValueAcquisitions1_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl1">Stock Issued During Period, Value, Acquisitions1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl1" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions1 to btx_StockIssuedDuringPeriodValueAcquisitions1_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl2">Issuance of common stock for business combination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl2" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions1 to btx_StockIssuedDuringPeriodValueAcquisitions1_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:label="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" />
    <link:label xlink:type="resource" xlink:label="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl" xml:lang="en-US" id="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl">Amount of decrease (increase) in additional paid in capital (APIC) for the increase in redemption of temporary equity as the result of a triggering event associated with the temporary equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:to="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity to btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1" xml:lang="en-US" id="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1">Adjustments to Additional Paid in Capital, Elimination Historical Member Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:to="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity to btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2" xml:lang="en-US" id="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2">Elimination of Brooklyn's historical members' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:to="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity to btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodSharesPrivateOffering" xlink:label="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="StockIssuedDuringPeriodSharesPrivateOffering" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl">Number of shares that have been issued in private offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesPrivateOffering" xlink:to="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl" xlink:title="label: StockIssuedDuringPeriodSharesPrivateOffering to btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl1">Stock Issued During Period, Shares, Private Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesPrivateOffering" xlink:to="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesPrivateOffering to btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl2">Issuance of common stock in connection with private offering (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesPrivateOffering" xlink:to="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesPrivateOffering to btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CommonUnitsMember" xlink:label="CommonUnitsMember" xlink:title="CommonUnitsMember" />
    <link:label xlink:type="resource" xlink:label="btx_CommonUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_CommonUnitsMember_lbl" xml:lang="en-US" id="btx_CommonUnitsMember_lbl">Classification of common stock that has different rights than provided to common units, representing ownership interest in a corporation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonUnitsMember" xlink:to="btx_CommonUnitsMember_lbl" xlink:title="label: CommonUnitsMember to btx_CommonUnitsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_CommonUnitsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CommonUnitsMember_lbl1" xml:lang="en-US" id="btx_CommonUnitsMember_lbl1">Common Units [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonUnitsMember" xlink:to="btx_CommonUnitsMember_lbl1" xlink:title="label: CommonUnitsMember to btx_CommonUnitsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_CommonUnitsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="btx_CommonUnitsMember_lbl2" xml:lang="en-US" id="btx_CommonUnitsMember_lbl2">Common [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonUnitsMember" xlink:to="btx_CommonUnitsMember_lbl2" xlink:title="label: CommonUnitsMember to btx_CommonUnitsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:label="ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" />
    <link:label xlink:type="resource" xlink:label="btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl" xml:lang="en-US" id="btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl">Person with designation of chair of the board of directors, chief executive officer and president.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:to="btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl" xlink:title="label: ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember to btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl1" xml:lang="en-US" id="btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl1">Chair of the Board of Directors, Chief Executive Officer and President [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:to="btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl1" xlink:title="label: ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember to btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl2" xml:lang="en-US" id="btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl2">Chair of the Board of Directors, Chief Executive Officer and President [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:to="btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl2" xlink:title="label: ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember to btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl">Number of shares of stock issued with restrictions during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:to="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesAcquisitions to btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1">Stock Issued During Period, Restricted Shares, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:to="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesAcquisitions to btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2">Restricted shares, issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:to="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesAcquisitions to btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl">Value of stock issued without any restrictions during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:to="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions to btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1">Stock Issued During Period, Unrestricted Shares, Value, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:to="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions to btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2">Unrestricted shares, value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:to="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions to btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfCommonStockSubjectToLockUpAgreement" xlink:label="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="PercentageOfCommonStockSubjectToLockUpAgreement" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl" xml:lang="en-US" id="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl">The percentage of shares of common stock subject to the lock-up agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:to="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl" xlink:title="label: PercentageOfCommonStockSubjectToLockUpAgreement to btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1" xml:lang="en-US" id="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1">Percentage of Common Stock Subject to Lock-up Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:to="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1" xlink:title="label: PercentageOfCommonStockSubjectToLockUpAgreement to btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2" xml:lang="en-US" id="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2">Percentage of common stock subject to the lock-up agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:to="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2" xlink:title="label: PercentageOfCommonStockSubjectToLockUpAgreement to btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PaymentsToAcquireProductiveAssetsNet" xlink:label="PaymentsToAcquireProductiveAssetsNet" xlink:title="PaymentsToAcquireProductiveAssetsNet" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentsToAcquireProductiveAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PaymentsToAcquireProductiveAssetsNet_lbl" xml:lang="en-US" id="btx_PaymentsToAcquireProductiveAssetsNet_lbl">The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets excluding cash acquired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssetsNet" xlink:to="btx_PaymentsToAcquireProductiveAssetsNet_lbl" xlink:title="label: PaymentsToAcquireProductiveAssetsNet to btx_PaymentsToAcquireProductiveAssetsNet_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentsToAcquireProductiveAssetsNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PaymentsToAcquireProductiveAssetsNet_lbl1" xml:lang="en-US" id="btx_PaymentsToAcquireProductiveAssetsNet_lbl1">Cash paid, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssetsNet" xlink:to="btx_PaymentsToAcquireProductiveAssetsNet_lbl1" xlink:title="label: PaymentsToAcquireProductiveAssetsNet to btx_PaymentsToAcquireProductiveAssetsNet_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentsToAcquireProductiveAssetsNet_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PaymentsToAcquireProductiveAssetsNet_lbl2" xml:lang="en-US" id="btx_PaymentsToAcquireProductiveAssetsNet_lbl2">Cash paid, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssetsNet" xlink:to="btx_PaymentsToAcquireProductiveAssetsNet_lbl2" xlink:title="label: PaymentsToAcquireProductiveAssetsNet to btx_PaymentsToAcquireProductiveAssetsNet_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:label="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="PercentageOfDiscountOnFairValueOfRestrictedShares" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl" xml:lang="en-US" id="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl">Percentage of discount on restricted shares, which was derived from the average discount rate between the Black Scholes and Finnerty valuation models.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:to="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl" xlink:title="label: PercentageOfDiscountOnFairValueOfRestrictedShares to btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1" xml:lang="en-US" id="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1">Percentage of Discount on Fair Value of Restricted Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:to="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1" xlink:title="label: PercentageOfDiscountOnFairValueOfRestrictedShares to btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2" xml:lang="en-US" id="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2">Percentage of discount on fair value restricted shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:to="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2" xlink:title="label: PercentageOfDiscountOnFairValueOfRestrictedShares to btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl">Value of stock issued with restrictions during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:to="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesValueAcquisitions to btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1">Stock Issued During Period, Restricted Shares, Value, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:to="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesValueAcquisitions to btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2">Restricted shares, value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:to="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesValueAcquisitions to btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_EscrowShares" xlink:label="EscrowShares" xlink:title="EscrowShares" />
    <link:label xlink:type="resource" xlink:label="btx_EscrowShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_EscrowShares_lbl" xml:lang="en-US" id="btx_EscrowShares_lbl">Number of shares have been placed in escrow shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowShares" xlink:to="btx_EscrowShares_lbl" xlink:title="label: EscrowShares to btx_EscrowShares_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_EscrowShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_EscrowShares_lbl1" xml:lang="en-US" id="btx_EscrowShares_lbl1">Escrow Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowShares" xlink:to="btx_EscrowShares_lbl1" xlink:title="label: EscrowShares to btx_EscrowShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_EscrowShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_EscrowShares_lbl2" xml:lang="en-US" id="btx_EscrowShares_lbl2">Escrow shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowShares" xlink:to="btx_EscrowShares_lbl2" xlink:title="label: EscrowShares to btx_EscrowShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:label xlink:type="resource" xlink:label="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" xml:lang="en-US" id="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl">The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xml:lang="en-US" id="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1">Research and Development in Process, Asset Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" xml:lang="en-US" id="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2">Acquired in-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LockUpPeriodForRestrictedShares" xlink:label="LockUpPeriodForRestrictedShares" xlink:title="LockUpPeriodForRestrictedShares" />
    <link:label xlink:type="resource" xlink:label="btx_LockUpPeriodForRestrictedShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LockUpPeriodForRestrictedShares_lbl" xml:lang="en-US" id="btx_LockUpPeriodForRestrictedShares_lbl">The period in which shares are locked-up, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LockUpPeriodForRestrictedShares" xlink:to="btx_LockUpPeriodForRestrictedShares_lbl" xlink:title="label: LockUpPeriodForRestrictedShares to btx_LockUpPeriodForRestrictedShares_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LockUpPeriodForRestrictedShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LockUpPeriodForRestrictedShares_lbl1" xml:lang="en-US" id="btx_LockUpPeriodForRestrictedShares_lbl1">Lock-up Period for Restricted Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LockUpPeriodForRestrictedShares" xlink:to="btx_LockUpPeriodForRestrictedShares_lbl1" xlink:title="label: LockUpPeriodForRestrictedShares to btx_LockUpPeriodForRestrictedShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LockUpPeriodForRestrictedShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LockUpPeriodForRestrictedShares_lbl2" xml:lang="en-US" id="btx_LockUpPeriodForRestrictedShares_lbl2">Lock-up period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LockUpPeriodForRestrictedShares" xlink:to="btx_LockUpPeriodForRestrictedShares_lbl2" xlink:title="label: LockUpPeriodForRestrictedShares to btx_LockUpPeriodForRestrictedShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AssetAcquisitionSharePrice" xlink:label="AssetAcquisitionSharePrice" xlink:title="AssetAcquisitionSharePrice" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AssetAcquisitionSharePrice_lbl" xml:lang="en-US" id="btx_AssetAcquisitionSharePrice_lbl">Price of a single share of a number of saleable stocks paid or offered to be paid in asset acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionSharePrice" xlink:to="btx_AssetAcquisitionSharePrice_lbl" xlink:title="label: AssetAcquisitionSharePrice to btx_AssetAcquisitionSharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionSharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AssetAcquisitionSharePrice_lbl1" xml:lang="en-US" id="btx_AssetAcquisitionSharePrice_lbl1">Asset Acquisition, Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionSharePrice" xlink:to="btx_AssetAcquisitionSharePrice_lbl1" xlink:title="label: AssetAcquisitionSharePrice to btx_AssetAcquisitionSharePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionSharePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AssetAcquisitionSharePrice_lbl2" xml:lang="en-US" id="btx_AssetAcquisitionSharePrice_lbl2">Share price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionSharePrice" xlink:to="btx_AssetAcquisitionSharePrice_lbl2" xlink:title="label: AssetAcquisitionSharePrice to btx_AssetAcquisitionSharePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AcquisitionAgreementNonCompetitivePeriod" xlink:label="AcquisitionAgreementNonCompetitivePeriod" xlink:title="AcquisitionAgreementNonCompetitivePeriod" />
    <link:label xlink:type="resource" xlink:label="btx_AcquisitionAgreementNonCompetitivePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AcquisitionAgreementNonCompetitivePeriod_lbl" xml:lang="en-US" id="btx_AcquisitionAgreementNonCompetitivePeriod_lbl">The Acquisition Agreement contains non-competition and non-solicitation provisions pursuant to which the Seller has agreed not to engage in certain competitive activities for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionAgreementNonCompetitivePeriod" xlink:to="btx_AcquisitionAgreementNonCompetitivePeriod_lbl" xlink:title="label: AcquisitionAgreementNonCompetitivePeriod to btx_AcquisitionAgreementNonCompetitivePeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AcquisitionAgreementNonCompetitivePeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AcquisitionAgreementNonCompetitivePeriod_lbl1" xml:lang="en-US" id="btx_AcquisitionAgreementNonCompetitivePeriod_lbl1">Acquisition Agreement, Non Competitive Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionAgreementNonCompetitivePeriod" xlink:to="btx_AcquisitionAgreementNonCompetitivePeriod_lbl1" xlink:title="label: AcquisitionAgreementNonCompetitivePeriod to btx_AcquisitionAgreementNonCompetitivePeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AcquisitionAgreementNonCompetitivePeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AcquisitionAgreementNonCompetitivePeriod_lbl2" xml:lang="en-US" id="btx_AcquisitionAgreementNonCompetitivePeriod_lbl2">Non-compete period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionAgreementNonCompetitivePeriod" xlink:to="btx_AcquisitionAgreementNonCompetitivePeriod_lbl2" xlink:title="label: AcquisitionAgreementNonCompetitivePeriod to btx_AcquisitionAgreementNonCompetitivePeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl" xml:lang="en-US" id="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl">Amount of fair value of consideration paid in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl" xlink:title="label: AssetAcquisitionFairValueOfConsiderationPaid to btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" xml:lang="en-US" id="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl1">Asset Acquisition, Fair Value of Consideration Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" xlink:title="label: AssetAcquisitionFairValueOfConsiderationPaid to btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl2" xml:lang="en-US" id="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl2">Total fair value of consideration paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl2" xlink:title="label: AssetAcquisitionFairValueOfConsiderationPaid to btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AssetAcquisitionUnrestrictedSharesSharePrice" xlink:label="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="AssetAcquisitionUnrestrictedSharesSharePrice" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl" xml:lang="en-US" id="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl">Price of a single share of a number of saleable stocks paid or offered without any restrictions to be paid in asset acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:to="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl" xlink:title="label: AssetAcquisitionUnrestrictedSharesSharePrice to btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1" xml:lang="en-US" id="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1">Asset Acquisition, Unrestricted Shares, Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:to="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1" xlink:title="label: AssetAcquisitionUnrestrictedSharesSharePrice to btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2" xml:lang="en-US" id="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2">Unrestricted shares, fair value per share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:to="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2" xlink:title="label: AssetAcquisitionUnrestrictedSharesSharePrice to btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_EachLockUpAgreementExtendsTerm" xlink:label="EachLockUpAgreementExtendsTerm" xlink:title="EachLockUpAgreementExtendsTerm" />
    <link:label xlink:type="resource" xlink:label="btx_EachLockUpAgreementExtendsTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_EachLockUpAgreementExtendsTerm_lbl" xml:lang="en-US" id="btx_EachLockUpAgreementExtendsTerm_lbl">The period of lock-up agreement extend term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EachLockUpAgreementExtendsTerm" xlink:to="btx_EachLockUpAgreementExtendsTerm_lbl" xlink:title="label: EachLockUpAgreementExtendsTerm to btx_EachLockUpAgreementExtendsTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_EachLockUpAgreementExtendsTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_EachLockUpAgreementExtendsTerm_lbl1" xml:lang="en-US" id="btx_EachLockUpAgreementExtendsTerm_lbl1">Each Lock-up Agreement Extends Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EachLockUpAgreementExtendsTerm" xlink:to="btx_EachLockUpAgreementExtendsTerm_lbl1" xlink:title="label: EachLockUpAgreementExtendsTerm to btx_EachLockUpAgreementExtendsTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_EachLockUpAgreementExtendsTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_EachLockUpAgreementExtendsTerm_lbl2" xml:lang="en-US" id="btx_EachLockUpAgreementExtendsTerm_lbl2">Each lock-up agreement extend term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EachLockUpAgreementExtendsTerm" xlink:to="btx_EachLockUpAgreementExtendsTerm_lbl2" xlink:title="label: EachLockUpAgreementExtendsTerm to btx_EachLockUpAgreementExtendsTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl">Number of shares of stock issued without any restrictions during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:to="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesAcquisitions to btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1">Stock Issued During Period, Unrestricted Shares, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:to="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesAcquisitions to btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2">Unrestricted shares, issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:to="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesAcquisitions to btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AssetAcquisitionRestrictedSharesSharePrice" xlink:label="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="AssetAcquisitionRestrictedSharesSharePrice" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl" xml:lang="en-US" id="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl">Price of a single share of a number of saleable stocks paid or offered with restrictions to be paid in asset acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionRestrictedSharesSharePrice" xlink:to="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl" xlink:title="label: AssetAcquisitionRestrictedSharesSharePrice to btx_AssetAcquisitionRestrictedSharesSharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl1" xml:lang="en-US" id="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl1">Asset Acquisition, Restricted Shares, Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionRestrictedSharesSharePrice" xlink:to="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl1" xlink:title="label: AssetAcquisitionRestrictedSharesSharePrice to btx_AssetAcquisitionRestrictedSharesSharePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl2" xml:lang="en-US" id="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl2">Restricted shares, fair value per share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionRestrictedSharesSharePrice" xlink:to="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl2" xlink:title="label: AssetAcquisitionRestrictedSharesSharePrice to btx_AssetAcquisitionRestrictedSharesSharePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_EscrowPeriod" xlink:label="EscrowPeriod" xlink:title="EscrowPeriod" />
    <link:label xlink:type="resource" xlink:label="btx_EscrowPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_EscrowPeriod_lbl" xml:lang="en-US" id="btx_EscrowPeriod_lbl">The period of secure indemnification obligations to acquisition agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowPeriod" xlink:to="btx_EscrowPeriod_lbl" xlink:title="label: EscrowPeriod to btx_EscrowPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_EscrowPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_EscrowPeriod_lbl1" xml:lang="en-US" id="btx_EscrowPeriod_lbl1">Escrow Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowPeriod" xlink:to="btx_EscrowPeriod_lbl1" xlink:title="label: EscrowPeriod to btx_EscrowPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_EscrowPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_EscrowPeriod_lbl2" xml:lang="en-US" id="btx_EscrowPeriod_lbl2">Period of escrow</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowPeriod" xlink:to="btx_EscrowPeriod_lbl2" xlink:title="label: EscrowPeriod to btx_EscrowPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:label="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:title="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl">Tabular disclosure for lessee's operating lease right-of-use assets and liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:to="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" xlink:title="label: OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock to btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1">Operating Lease Right-of-use Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:to="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:title="label: OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock to btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2" xml:lang="en-US" id="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2">Operating Lease Right-of-use Assets and Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:to="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2" xlink:title="label: OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock to btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:label="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:title="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl" xml:lang="en-US" id="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl">No definition available.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl" xlink:title="label: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" xml:lang="en-US" id="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1">Lessee Operating Lease Weighted Average Remaining Lease Term And Discount Rate Abstract [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" xlink:title="label: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2" xml:lang="en-US" id="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2">Weighted Average Remaining Lease Term and Discount Rate [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2" xlink:title="label: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl" xml:lang="en-US" id="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl">Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fourth fiscal year following latest fiscal year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour to btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl1" xml:lang="en-US" id="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl1">Lessee, Operating Lease, Liability, Payments Due after Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour to btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl2" xml:lang="en-US" id="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl2">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl2" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour to btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_WriteOffOfOperatingLeaseLiability" xlink:label="WriteOffOfOperatingLeaseLiability" xlink:title="WriteOffOfOperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="btx_WriteOffOfOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_WriteOffOfOperatingLeaseLiability_lbl" xml:lang="en-US" id="btx_WriteOffOfOperatingLeaseLiability_lbl">Write-off of operating lease liability due to lease termination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseLiability" xlink:to="btx_WriteOffOfOperatingLeaseLiability_lbl" xlink:title="label: WriteOffOfOperatingLeaseLiability to btx_WriteOffOfOperatingLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_WriteOffOfOperatingLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_WriteOffOfOperatingLeaseLiability_lbl1" xml:lang="en-US" id="btx_WriteOffOfOperatingLeaseLiability_lbl1">Write- off of Operating Lease Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseLiability" xlink:to="btx_WriteOffOfOperatingLeaseLiability_lbl1" xlink:title="label: WriteOffOfOperatingLeaseLiability to btx_WriteOffOfOperatingLeaseLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_WriteOffOfOperatingLeaseLiability_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_WriteOffOfOperatingLeaseLiability_lbl2" xml:lang="en-US" id="btx_WriteOffOfOperatingLeaseLiability_lbl2">Write off of operating lease liability due to lease termination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseLiability" xlink:to="btx_WriteOffOfOperatingLeaseLiability_lbl2" xlink:title="label: WriteOffOfOperatingLeaseLiability to btx_WriteOffOfOperatingLeaseLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:label="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:title="PrincipalPaymentsOnOperatingLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" xml:lang="en-US" id="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl">Principal payments on operating lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:to="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" xlink:title="label: PrincipalPaymentsOnOperatingLeaseLiabilities to btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" xml:lang="en-US" id="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1">Principal payments on operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:to="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" xlink:title="label: PrincipalPaymentsOnOperatingLeaseLiabilities to btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2" xml:lang="en-US" id="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2">Principal payments on operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:to="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2" xlink:title="label: PrincipalPaymentsOnOperatingLeaseLiabilities to btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_WriteOffOfOperatingLeaseRightOfUseAsset" xlink:label="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:title="WriteOffOfOperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" id="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl">Write-off of operating lease right-of-use asset due to lease termination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:to="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl" xlink:title="label: WriteOffOfOperatingLeaseRightOfUseAsset to btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1" xml:lang="en-US" id="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1">Write-off of Operating Lease Right-of-use Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:to="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1" xlink:title="label: WriteOffOfOperatingLeaseRightOfUseAsset to btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2" xml:lang="en-US" id="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2">Write off of ROU asset due to lease termination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:to="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2" xlink:title="label: WriteOffOfOperatingLeaseRightOfUseAsset to btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_OperatingLeaseAssestAbstract" xlink:label="OperatingLeaseAssestAbstract" xlink:title="OperatingLeaseAssestAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseAssestAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_OperatingLeaseAssestAbstract_lbl1" xml:lang="en-US" id="btx_OperatingLeaseAssestAbstract_lbl1">Operating Lease, Asset [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseAssestAbstract" xlink:to="btx_OperatingLeaseAssestAbstract_lbl1" xlink:title="label: OperatingLeaseAssestAbstract to btx_OperatingLeaseAssestAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_BaseRentPerSquareFoot" xlink:label="BaseRentPerSquareFoot" xlink:title="BaseRentPerSquareFoot" />
    <link:label xlink:type="resource" xlink:label="btx_BaseRentPerSquareFoot_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_BaseRentPerSquareFoot_lbl" xml:lang="en-US" id="btx_BaseRentPerSquareFoot_lbl">Amount of base rent expense per square foot for leased asset.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BaseRentPerSquareFoot" xlink:to="btx_BaseRentPerSquareFoot_lbl" xlink:title="label: BaseRentPerSquareFoot to btx_BaseRentPerSquareFoot_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_BaseRentPerSquareFoot_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_BaseRentPerSquareFoot_lbl1" xml:lang="en-US" id="btx_BaseRentPerSquareFoot_lbl1">Base Rent per Square Foot</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BaseRentPerSquareFoot" xlink:to="btx_BaseRentPerSquareFoot_lbl1" xlink:title="label: BaseRentPerSquareFoot to btx_BaseRentPerSquareFoot_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_BaseRentPerSquareFoot_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_BaseRentPerSquareFoot_lbl2" xml:lang="en-US" id="btx_BaseRentPerSquareFoot_lbl2">Base rent (per square foot)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BaseRentPerSquareFoot" xlink:to="btx_BaseRentPerSquareFoot_lbl2" xlink:title="label: BaseRentPerSquareFoot to btx_BaseRentPerSquareFoot_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_OperatingLeaseArea" xlink:label="OperatingLeaseArea" xlink:title="OperatingLeaseArea" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseArea_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_OperatingLeaseArea_lbl" xml:lang="en-US" id="btx_OperatingLeaseArea_lbl">Area of leased property under operating lease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseArea" xlink:to="btx_OperatingLeaseArea_lbl" xlink:title="label: OperatingLeaseArea to btx_OperatingLeaseArea_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseArea_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_OperatingLeaseArea_lbl1" xml:lang="en-US" id="btx_OperatingLeaseArea_lbl1">Operating Lease Area</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseArea" xlink:to="btx_OperatingLeaseArea_lbl1" xlink:title="label: OperatingLeaseArea to btx_OperatingLeaseArea_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseArea_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_OperatingLeaseArea_lbl2" xml:lang="en-US" id="btx_OperatingLeaseArea_lbl2">Operating lease area</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseArea" xlink:to="btx_OperatingLeaseArea_lbl2" xlink:title="label: OperatingLeaseArea to btx_OperatingLeaseArea_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LesseeCommitmentToPurchaseProperty" xlink:label="LesseeCommitmentToPurchaseProperty" xlink:title="LesseeCommitmentToPurchaseProperty" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeCommitmentToPurchaseProperty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LesseeCommitmentToPurchaseProperty_lbl" xml:lang="en-US" id="btx_LesseeCommitmentToPurchaseProperty_lbl">The amount of property for which lessee committed to purchase.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeCommitmentToPurchaseProperty" xlink:to="btx_LesseeCommitmentToPurchaseProperty_lbl" xlink:title="label: LesseeCommitmentToPurchaseProperty to btx_LesseeCommitmentToPurchaseProperty_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeCommitmentToPurchaseProperty_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LesseeCommitmentToPurchaseProperty_lbl1" xml:lang="en-US" id="btx_LesseeCommitmentToPurchaseProperty_lbl1">Lessee, Commitment to Purchase Property</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeCommitmentToPurchaseProperty" xlink:to="btx_LesseeCommitmentToPurchaseProperty_lbl1" xlink:title="label: LesseeCommitmentToPurchaseProperty to btx_LesseeCommitmentToPurchaseProperty_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeCommitmentToPurchaseProperty_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LesseeCommitmentToPurchaseProperty_lbl2" xml:lang="en-US" id="btx_LesseeCommitmentToPurchaseProperty_lbl2">Commitment to purchase equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeCommitmentToPurchaseProperty" xlink:to="btx_LesseeCommitmentToPurchaseProperty_lbl2" xlink:title="label: LesseeCommitmentToPurchaseProperty to btx_LesseeCommitmentToPurchaseProperty_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageBaseRentIncreaseOnEachAnniversary" xlink:label="PercentageBaseRentIncreaseOnEachAnniversary" xlink:title="PercentageBaseRentIncreaseOnEachAnniversary" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl" xml:lang="en-US" id="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl">The percentage of base rent increase on each anniversary.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageBaseRentIncreaseOnEachAnniversary" xlink:to="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl" xlink:title="label: PercentageBaseRentIncreaseOnEachAnniversary to btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl1" xml:lang="en-US" id="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl1">Percentage, Base Rent Increase on each Anniversary</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageBaseRentIncreaseOnEachAnniversary" xlink:to="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl1" xlink:title="label: PercentageBaseRentIncreaseOnEachAnniversary to btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl2" xml:lang="en-US" id="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl2">Percentage of increase in base rent on each year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageBaseRentIncreaseOnEachAnniversary" xlink:to="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl2" xlink:title="label: PercentageBaseRentIncreaseOnEachAnniversary to btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_UnamortizedLeaseholdImprovements" xlink:label="UnamortizedLeaseholdImprovements" xlink:title="UnamortizedLeaseholdImprovements" />
    <link:label xlink:type="resource" xlink:label="btx_UnamortizedLeaseholdImprovements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_UnamortizedLeaseholdImprovements_lbl" xml:lang="en-US" id="btx_UnamortizedLeaseholdImprovements_lbl">The amount of unamortized leasehold improvements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnamortizedLeaseholdImprovements" xlink:to="btx_UnamortizedLeaseholdImprovements_lbl" xlink:title="label: UnamortizedLeaseholdImprovements to btx_UnamortizedLeaseholdImprovements_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_UnamortizedLeaseholdImprovements_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_UnamortizedLeaseholdImprovements_lbl1" xml:lang="en-US" id="btx_UnamortizedLeaseholdImprovements_lbl1">Unamortized Leasehold Improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnamortizedLeaseholdImprovements" xlink:to="btx_UnamortizedLeaseholdImprovements_lbl1" xlink:title="label: UnamortizedLeaseholdImprovements to btx_UnamortizedLeaseholdImprovements_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_UnamortizedLeaseholdImprovements_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_UnamortizedLeaseholdImprovements_lbl2" xml:lang="en-US" id="btx_UnamortizedLeaseholdImprovements_lbl2">Unamortized leasehold improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnamortizedLeaseholdImprovements" xlink:to="btx_UnamortizedLeaseholdImprovements_lbl2" xlink:title="label: UnamortizedLeaseholdImprovements to btx_UnamortizedLeaseholdImprovements_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:label="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:title="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" />
    <link:label xlink:type="resource" xlink:label="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl" xml:lang="en-US" id="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl">Amount of severance benefit, would have received if he was entitled to receive a settlement of a pro rata portion of his performance restricted stock units through the expiration of the Separation Period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:to="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl" xlink:title="label: SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits to btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl1" xml:lang="en-US" id="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl1">Severance Benefit Receivable Based on Performance Restricted Stock Units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:to="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl1" xlink:title="label: SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits to btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl2" xml:lang="en-US" id="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl2">Severance benefit receivable based on performance restricted stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:to="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl2" xlink:title="label: SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits to btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PaymentToOfficerBaseSalary" xlink:label="PaymentToOfficerBaseSalary" xlink:title="PaymentToOfficerBaseSalary" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentToOfficerBaseSalary_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PaymentToOfficerBaseSalary_lbl" xml:lang="en-US" id="btx_PaymentToOfficerBaseSalary_lbl">Amount of cash outflows for payment of annual base salary for a period of twelve months after the expiration of the applicable revocation period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentToOfficerBaseSalary" xlink:to="btx_PaymentToOfficerBaseSalary_lbl" xlink:title="label: PaymentToOfficerBaseSalary to btx_PaymentToOfficerBaseSalary_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentToOfficerBaseSalary_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PaymentToOfficerBaseSalary_lbl1" xml:lang="en-US" id="btx_PaymentToOfficerBaseSalary_lbl1">Payment to Officer Base Salary</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentToOfficerBaseSalary" xlink:to="btx_PaymentToOfficerBaseSalary_lbl1" xlink:title="label: PaymentToOfficerBaseSalary to btx_PaymentToOfficerBaseSalary_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentToOfficerBaseSalary_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PaymentToOfficerBaseSalary_lbl2" xml:lang="en-US" id="btx_PaymentToOfficerBaseSalary_lbl2">Payment of annual base salary</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentToOfficerBaseSalary" xlink:to="btx_PaymentToOfficerBaseSalary_lbl2" xlink:title="label: PaymentToOfficerBaseSalary to btx_PaymentToOfficerBaseSalary_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_SeparationAgreementAbstract" xlink:label="SeparationAgreementAbstract" xlink:title="SeparationAgreementAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_SeparationAgreementAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_SeparationAgreementAbstract_lbl1" xml:lang="en-US" id="btx_SeparationAgreementAbstract_lbl1">Separation Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeparationAgreementAbstract" xlink:to="btx_SeparationAgreementAbstract_lbl1" xlink:title="label: SeparationAgreementAbstract to btx_SeparationAgreementAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_SeparationAgreementAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_SeparationAgreementAbstract_lbl2" xml:lang="en-US" id="btx_SeparationAgreementAbstract_lbl2">Separation Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeparationAgreementAbstract" xlink:to="btx_SeparationAgreementAbstract_lbl2" xlink:title="label: SeparationAgreementAbstract to btx_SeparationAgreementAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MilestoneOptionsMember" xlink:label="MilestoneOptionsMember" xlink:title="MilestoneOptionsMember" />
    <link:label xlink:type="resource" xlink:label="btx_MilestoneOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_MilestoneOptionsMember_lbl" xml:lang="en-US" id="btx_MilestoneOptionsMember_lbl">Share-based payment arrangement granting right, subject to vesting and other restrictions based on milestones.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestoneOptionsMember" xlink:to="btx_MilestoneOptionsMember_lbl" xlink:title="label: MilestoneOptionsMember to btx_MilestoneOptionsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_MilestoneOptionsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_MilestoneOptionsMember_lbl1" xml:lang="en-US" id="btx_MilestoneOptionsMember_lbl1">Milestone Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestoneOptionsMember" xlink:to="btx_MilestoneOptionsMember_lbl1" xlink:title="label: MilestoneOptionsMember to btx_MilestoneOptionsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_MilestoneOptionsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_MilestoneOptionsMember_lbl2" xml:lang="en-US" id="btx_MilestoneOptionsMember_lbl2">Milestone Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestoneOptionsMember" xlink:to="btx_MilestoneOptionsMember_lbl2" xlink:title="label: MilestoneOptionsMember to btx_MilestoneOptionsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:label="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl">Amount classified as Lease liability attributable to disposal group held for sale or disposed of.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationLeaseLiability to btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1">Disposal Group, Including Discontinued Operation, Lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationLeaseLiability to btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2">Lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationLeaseLiability to btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl">Amount classified as software development cost attributable to disposal group held for sale or disposed of.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts to btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1">Disposal Group, Including Discontinued Operation, Software development costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts to btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2">Software development costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts to btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl">Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromCash to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1">Disposal Group, Including Discontinued Operation, Proceeds from Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromCash to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromCash to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:label="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl">Amount classified as Obligations under finance leases attributable to disposal group held for sale or disposed of.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases to btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1">Disposal Group, Including Discontinued Operation, Obligations under finance leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases to btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2">Obligations under finance leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases to btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl">Amount of costs of the business disposal including legal, accounting, and other costs incurred to consummate the business disposition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationTransactionCosts to btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1">Disposal Group, Including Discontinued Operation, Transaction Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationTransactionCosts to btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2">Transaction costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationTransactionCosts to btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl">Aggregate proceeds received from interest on advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1">Disposal Group, Including Discontinued Operation, Proceeds from Interest on Advance/Loans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2">Interest on advance/loans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl">Aggregate proceeds received from assume advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1">Disposal Group, Including Discontinued Operation, Proceeds from Assume Advance/Loans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2">Assume advance/loans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl">Aggregate proceeds received from escrow deposits in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1">Disposal Group, Including Discontinued Operation, Proceeds from Escrow</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2">Escrow</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ProceedsFromDispositionAbstract" xlink:label="ProceedsFromDispositionAbstract" xlink:title="ProceedsFromDispositionAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_ProceedsFromDispositionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ProceedsFromDispositionAbstract_lbl1" xml:lang="en-US" id="btx_ProceedsFromDispositionAbstract_lbl1">Proceeds from Disposition [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDispositionAbstract" xlink:to="btx_ProceedsFromDispositionAbstract_lbl1" xlink:title="label: ProceedsFromDispositionAbstract to btx_ProceedsFromDispositionAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ProceedsFromDispositionAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ProceedsFromDispositionAbstract_lbl2" xml:lang="en-US" id="btx_ProceedsFromDispositionAbstract_lbl2">Proceeds from sale [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDispositionAbstract" xlink:to="btx_ProceedsFromDispositionAbstract_lbl2" xlink:title="label: ProceedsFromDispositionAbstract to btx_ProceedsFromDispositionAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DispositionAbstract" xlink:label="DispositionAbstract" xlink:title="DispositionAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_DispositionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DispositionAbstract_lbl1" xml:lang="en-US" id="btx_DispositionAbstract_lbl1">Disposition [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DispositionAbstract" xlink:to="btx_DispositionAbstract_lbl1" xlink:title="label: DispositionAbstract to btx_DispositionAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NTNBusinessMember" xlink:label="NTNBusinessMember" xlink:title="NTNBusinessMember" />
    <link:label xlink:type="resource" xlink:label="btx_NTNBusinessMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NTNBusinessMember_lbl" xml:lang="en-US" id="btx_NTNBusinessMember_lbl">Name of the disposal group.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBusinessMember" xlink:to="btx_NTNBusinessMember_lbl" xlink:title="label: NTNBusinessMember to btx_NTNBusinessMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NTNBusinessMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NTNBusinessMember_lbl1" xml:lang="en-US" id="btx_NTNBusinessMember_lbl1">NTN Business [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBusinessMember" xlink:to="btx_NTNBusinessMember_lbl1" xlink:title="label: NTNBusinessMember to btx_NTNBusinessMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NTNBusinessMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NTNBusinessMember_lbl2" xml:lang="en-US" id="btx_NTNBusinessMember_lbl2">NTN Business [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBusinessMember" xlink:to="btx_NTNBusinessMember_lbl2" xlink:title="label: NTNBusinessMember to btx_NTNBusinessMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ProFormaFairValueAdjustmentToAssetsMember" xlink:label="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="ProFormaFairValueAdjustmentToAssetsMember" />
    <link:label xlink:type="resource" xlink:label="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl" xml:lang="en-US" id="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl">Fair value adjustment to acquisition-date assets reported in proforma information.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProFormaFairValueAdjustmentToAssetsMember" xlink:to="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl" xlink:title="label: ProFormaFairValueAdjustmentToAssetsMember to btx_ProFormaFairValueAdjustmentToAssetsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl1" xml:lang="en-US" id="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl1">Pro Forma Fair Value Adjustment to Assets [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProFormaFairValueAdjustmentToAssetsMember" xlink:to="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl1" xlink:title="label: ProFormaFairValueAdjustmentToAssetsMember to btx_ProFormaFairValueAdjustmentToAssetsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl2" xml:lang="en-US" id="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl2">Fair Value Adjustment to Assets [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProFormaFairValueAdjustmentToAssetsMember" xlink:to="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl2" xlink:title="label: ProFormaFairValueAdjustmentToAssetsMember to btx_ProFormaFairValueAdjustmentToAssetsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PurchasePriceAllocationMember" xlink:label="PurchasePriceAllocationMember" xlink:title="PurchasePriceAllocationMember" />
    <link:label xlink:type="resource" xlink:label="btx_PurchasePriceAllocationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PurchasePriceAllocationMember_lbl" xml:lang="en-US" id="btx_PurchasePriceAllocationMember_lbl">Purchase price allocation of acquisition-date assets and liability assumed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchasePriceAllocationMember" xlink:to="btx_PurchasePriceAllocationMember_lbl" xlink:title="label: PurchasePriceAllocationMember to btx_PurchasePriceAllocationMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PurchasePriceAllocationMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PurchasePriceAllocationMember_lbl1" xml:lang="en-US" id="btx_PurchasePriceAllocationMember_lbl1">Purchase Price Allocation [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchasePriceAllocationMember" xlink:to="btx_PurchasePriceAllocationMember_lbl1" xlink:title="label: PurchasePriceAllocationMember to btx_PurchasePriceAllocationMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfAdditionalRightsOffering" xlink:label="PercentageOfAdditionalRightsOffering" xlink:title="PercentageOfAdditionalRightsOffering" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfAdditionalRightsOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageOfAdditionalRightsOffering_lbl" xml:lang="en-US" id="btx_PercentageOfAdditionalRightsOffering_lbl">Percentage of additional right offering made by the entity for unit holders.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfAdditionalRightsOffering" xlink:to="btx_PercentageOfAdditionalRightsOffering_lbl" xlink:title="label: PercentageOfAdditionalRightsOffering to btx_PercentageOfAdditionalRightsOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfAdditionalRightsOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageOfAdditionalRightsOffering_lbl1" xml:lang="en-US" id="btx_PercentageOfAdditionalRightsOffering_lbl1">Percentage of Additional Rights Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfAdditionalRightsOffering" xlink:to="btx_PercentageOfAdditionalRightsOffering_lbl1" xlink:title="label: PercentageOfAdditionalRightsOffering to btx_PercentageOfAdditionalRightsOffering_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfAdditionalRightsOffering_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageOfAdditionalRightsOffering_lbl2" xml:lang="en-US" id="btx_PercentageOfAdditionalRightsOffering_lbl2">Percentage of additional rights offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfAdditionalRightsOffering" xlink:to="btx_PercentageOfAdditionalRightsOffering_lbl2" xlink:title="label: PercentageOfAdditionalRightsOffering to btx_PercentageOfAdditionalRightsOffering_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_BeneficialHoldersContractualCommitmentsToInvest" xlink:label="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="BeneficialHoldersContractualCommitmentsToInvest" />
    <link:label xlink:type="resource" xlink:label="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl" xml:lang="en-US" id="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl">Amount of contractual commitment made by beneficial holders to invest in the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialHoldersContractualCommitmentsToInvest" xlink:to="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl" xlink:title="label: BeneficialHoldersContractualCommitmentsToInvest to btx_BeneficialHoldersContractualCommitmentsToInvest_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl1" xml:lang="en-US" id="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl1">Beneficial Holders Contractual Commitments To Invest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialHoldersContractualCommitmentsToInvest" xlink:to="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl1" xlink:title="label: BeneficialHoldersContractualCommitmentsToInvest to btx_BeneficialHoldersContractualCommitmentsToInvest_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl2" xml:lang="en-US" id="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl2">Beneficial holders contractual commitments to invest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialHoldersContractualCommitmentsToInvest" xlink:to="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl2" xlink:title="label: BeneficialHoldersContractualCommitmentsToInvest to btx_BeneficialHoldersContractualCommitmentsToInvest_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" />
    <link:label xlink:type="resource" xlink:label="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl" xml:lang="en-US" id="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl">The amount of software development costs recognized as of the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:to="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts to btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1" xml:lang="en-US" id="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Software Development Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:to="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts to btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2" xml:lang="en-US" id="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2">Software development costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:to="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts to btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ProceedsFromSaleOfRights" xlink:label="ProceedsFromSaleOfRights" xlink:title="ProceedsFromSaleOfRights" />
    <link:label xlink:type="resource" xlink:label="btx_ProceedsFromSaleOfRights_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ProceedsFromSaleOfRights_lbl" xml:lang="en-US" id="btx_ProceedsFromSaleOfRights_lbl">The cash inflow from the sale of rights during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRights" xlink:to="btx_ProceedsFromSaleOfRights_lbl" xlink:title="label: ProceedsFromSaleOfRights to btx_ProceedsFromSaleOfRights_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ProceedsFromSaleOfRights_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ProceedsFromSaleOfRights_lbl1" xml:lang="en-US" id="btx_ProceedsFromSaleOfRights_lbl1">Proceeds From Sale Of Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRights" xlink:to="btx_ProceedsFromSaleOfRights_lbl1" xlink:title="label: ProceedsFromSaleOfRights to btx_ProceedsFromSaleOfRights_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ProceedsFromSaleOfRights_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ProceedsFromSaleOfRights_lbl2" xml:lang="en-US" id="btx_ProceedsFromSaleOfRights_lbl2">Proceeds from right offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRights" xlink:to="btx_ProceedsFromSaleOfRights_lbl2" xlink:title="label: ProceedsFromSaleOfRights to btx_ProceedsFromSaleOfRights_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:label="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" />
    <link:label xlink:type="resource" xlink:label="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl" xml:lang="en-US" id="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl">Amount of cash and cash equivalents obligated to maintain under merger agreement on balance sheet at the effective time of the merger.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:to="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl" xlink:title="label: ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement to btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1" xml:lang="en-US" id="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1">Obligated to Maintain Cash and Cash Equivalents Under Merger Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:to="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1" xlink:title="label: ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement to btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2" xml:lang="en-US" id="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2">Cash and cash equivalents obligated to have under merger agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:to="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2" xlink:title="label: ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement to btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ClassOfWarrantOrRightIssued" xlink:label="ClassOfWarrantOrRightIssued" xlink:title="ClassOfWarrantOrRightIssued" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ClassOfWarrantOrRightIssued_lbl" xml:lang="en-US" id="btx_ClassOfWarrantOrRightIssued_lbl">Number of shares issued into which the class of warrant or right may be converted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightIssued" xlink:to="btx_ClassOfWarrantOrRightIssued_lbl" xlink:title="label: ClassOfWarrantOrRightIssued to btx_ClassOfWarrantOrRightIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ClassOfWarrantOrRightIssued_lbl1" xml:lang="en-US" id="btx_ClassOfWarrantOrRightIssued_lbl1">Class of Warrant or Right, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightIssued" xlink:to="btx_ClassOfWarrantOrRightIssued_lbl1" xlink:title="label: ClassOfWarrantOrRightIssued to btx_ClassOfWarrantOrRightIssued_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightIssued_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ClassOfWarrantOrRightIssued_lbl2" xml:lang="en-US" id="btx_ClassOfWarrantOrRightIssued_lbl2">Number of rights options issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightIssued" xlink:to="btx_ClassOfWarrantOrRightIssued_lbl2" xlink:title="label: ClassOfWarrantOrRightIssued to btx_ClassOfWarrantOrRightIssued_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl">Number of shares of stock issued during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions1 to btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl1">Stock Issued During Period, Shares, Acquisitions1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions1 to btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl2">Stock issued, shares, acquisition (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions1 to btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl2" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl3" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl3">Issuance of common stock for business combination (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl3" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions1 to btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl3" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MergerAbstract" xlink:label="MergerAbstract" xlink:title="MergerAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_MergerAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_MergerAbstract_lbl1" xml:lang="en-US" id="btx_MergerAbstract_lbl1">Merger [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAbstract" xlink:to="btx_MergerAbstract_lbl1" xlink:title="label: MergerAbstract to btx_MergerAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ReverseStockSplitAbstract" xlink:label="ReverseStockSplitAbstract" xlink:title="ReverseStockSplitAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_ReverseStockSplitAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ReverseStockSplitAbstract_lbl1" xml:lang="en-US" id="btx_ReverseStockSplitAbstract_lbl1">Reverse Stock-Split [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReverseStockSplitAbstract" xlink:to="btx_ReverseStockSplitAbstract_lbl1" xlink:title="label: ReverseStockSplitAbstract to btx_ReverseStockSplitAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightsExercisableTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ClassOfWarrantOrRightsExercisableTerm_lbl" xml:lang="en-US" id="btx_ClassOfWarrantOrRightsExercisableTerm_lbl">Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightsExercisableTerm" xlink:to="btx_ClassOfWarrantOrRightsExercisableTerm_lbl" xlink:title="label: ClassOfWarrantOrRightsExercisableTerm to btx_ClassOfWarrantOrRightsExercisableTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightsExercisableTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ClassOfWarrantOrRightsExercisableTerm_lbl1" xml:lang="en-US" id="btx_ClassOfWarrantOrRightsExercisableTerm_lbl1">Class of Warrant or Rights Exercisable Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightsExercisableTerm" xlink:to="btx_ClassOfWarrantOrRightsExercisableTerm_lbl1" xlink:title="label: ClassOfWarrantOrRightsExercisableTerm to btx_ClassOfWarrantOrRightsExercisableTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightsExercisableTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ClassOfWarrantOrRightsExercisableTerm_lbl2" xml:lang="en-US" id="btx_ClassOfWarrantOrRightsExercisableTerm_lbl2">Warrant exercisable term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightsExercisableTerm" xlink:to="btx_ClassOfWarrantOrRightsExercisableTerm_lbl2" xlink:title="label: ClassOfWarrantOrRightsExercisableTerm to btx_ClassOfWarrantOrRightsExercisableTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ObligationToPayLiquidatedDamagesPercentage" xlink:label="ObligationToPayLiquidatedDamagesPercentage" xlink:title="ObligationToPayLiquidatedDamagesPercentage" />
    <link:label xlink:type="resource" xlink:label="btx_ObligationToPayLiquidatedDamagesPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ObligationToPayLiquidatedDamagesPercentage_lbl" xml:lang="en-US" id="btx_ObligationToPayLiquidatedDamagesPercentage_lbl">Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages percentage of aggregate payment on Subscription Amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentage" xlink:to="btx_ObligationToPayLiquidatedDamagesPercentage_lbl" xlink:title="label: ObligationToPayLiquidatedDamagesPercentage to btx_ObligationToPayLiquidatedDamagesPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ObligationToPayLiquidatedDamagesPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ObligationToPayLiquidatedDamagesPercentage_lbl1" xml:lang="en-US" id="btx_ObligationToPayLiquidatedDamagesPercentage_lbl1">Obligation to Pay Liquidated Damages Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentage" xlink:to="btx_ObligationToPayLiquidatedDamagesPercentage_lbl1" xlink:title="label: ObligationToPayLiquidatedDamagesPercentage to btx_ObligationToPayLiquidatedDamagesPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ObligationToPayLiquidatedDamagesPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ObligationToPayLiquidatedDamagesPercentage_lbl2" xml:lang="en-US" id="btx_ObligationToPayLiquidatedDamagesPercentage_lbl2">Obligated to pay liquidated damages percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentage" xlink:to="btx_ObligationToPayLiquidatedDamagesPercentage_lbl2" xlink:title="label: ObligationToPayLiquidatedDamagesPercentage to btx_ObligationToPayLiquidatedDamagesPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AggregateCalendarDays" xlink:label="AggregateCalendarDays" xlink:title="AggregateCalendarDays" />
    <link:label xlink:type="resource" xlink:label="btx_AggregateCalendarDays_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AggregateCalendarDays_lbl" xml:lang="en-US" id="btx_AggregateCalendarDays_lbl">In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified aggregate calendar days (which need not be consecutive calendar days) during any 12-month period for resale.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateCalendarDays" xlink:to="btx_AggregateCalendarDays_lbl" xlink:title="label: AggregateCalendarDays to btx_AggregateCalendarDays_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AggregateCalendarDays_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AggregateCalendarDays_lbl1" xml:lang="en-US" id="btx_AggregateCalendarDays_lbl1">Aggregate Calendar Days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateCalendarDays" xlink:to="btx_AggregateCalendarDays_lbl1" xlink:title="label: AggregateCalendarDays to btx_AggregateCalendarDays_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AggregateCalendarDays_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AggregateCalendarDays_lbl2" xml:lang="en-US" id="btx_AggregateCalendarDays_lbl2">Aggregate calendar days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateCalendarDays" xlink:to="btx_AggregateCalendarDays_lbl2" xlink:title="label: AggregateCalendarDays to btx_AggregateCalendarDays_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:label="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" />
    <link:label xlink:type="resource" xlink:label="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" xml:lang="en-US" id="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl">Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages equal to the Subscription Amount per month.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:to="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" xlink:title="label: ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth to btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" xml:lang="en-US" id="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1">Obligation to Pay Liquidated Damages Percentage on Subscription Amount per Month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:to="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" xlink:title="label: ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth to btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2" xml:lang="en-US" id="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2">Obligation to pay liquidated damages per month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:to="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2" xlink:title="label: ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth to btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_TransactionFeesPayable" xlink:label="TransactionFeesPayable" xlink:title="TransactionFeesPayable" />
    <link:label xlink:type="resource" xlink:label="btx_TransactionFeesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_TransactionFeesPayable_lbl" xml:lang="en-US" id="btx_TransactionFeesPayable_lbl">Fees incurred related to PIPE transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesPayable" xlink:to="btx_TransactionFeesPayable_lbl" xlink:title="label: TransactionFeesPayable to btx_TransactionFeesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_TransactionFeesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_TransactionFeesPayable_lbl1" xml:lang="en-US" id="btx_TransactionFeesPayable_lbl1">Transaction Fees Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesPayable" xlink:to="btx_TransactionFeesPayable_lbl1" xlink:title="label: TransactionFeesPayable to btx_TransactionFeesPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_TransactionFeesPayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_TransactionFeesPayable_lbl2" xml:lang="en-US" id="btx_TransactionFeesPayable_lbl2">Transaction fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesPayable" xlink:to="btx_TransactionFeesPayable_lbl2" xlink:title="label: TransactionFeesPayable to btx_TransactionFeesPayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ConsecutiveCalendarDays" xlink:label="ConsecutiveCalendarDays" xlink:title="ConsecutiveCalendarDays" />
    <link:label xlink:type="resource" xlink:label="btx_ConsecutiveCalendarDays_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ConsecutiveCalendarDays_lbl" xml:lang="en-US" id="btx_ConsecutiveCalendarDays_lbl">In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified consecutive calendar days for resale.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsecutiveCalendarDays" xlink:to="btx_ConsecutiveCalendarDays_lbl" xlink:title="label: ConsecutiveCalendarDays to btx_ConsecutiveCalendarDays_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ConsecutiveCalendarDays_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ConsecutiveCalendarDays_lbl1" xml:lang="en-US" id="btx_ConsecutiveCalendarDays_lbl1">Consecutive Calendar Days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsecutiveCalendarDays" xlink:to="btx_ConsecutiveCalendarDays_lbl1" xlink:title="label: ConsecutiveCalendarDays to btx_ConsecutiveCalendarDays_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ConsecutiveCalendarDays_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ConsecutiveCalendarDays_lbl2" xml:lang="en-US" id="btx_ConsecutiveCalendarDays_lbl2">Consecutive calendar days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsecutiveCalendarDays" xlink:to="btx_ConsecutiveCalendarDays_lbl2" xlink:title="label: ConsecutiveCalendarDays to btx_ConsecutiveCalendarDays_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:label xlink:type="resource" xlink:label="btx_OverSubscriptionAmountReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_OverSubscriptionAmountReceived_lbl" xml:lang="en-US" id="btx_OverSubscriptionAmountReceived_lbl">Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OverSubscriptionAmountReceived" xlink:to="btx_OverSubscriptionAmountReceived_lbl" xlink:title="label: OverSubscriptionAmountReceived to btx_OverSubscriptionAmountReceived_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_OverSubscriptionAmountReceived_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_OverSubscriptionAmountReceived_lbl1" xml:lang="en-US" id="btx_OverSubscriptionAmountReceived_lbl1">Over-Subscription Amount Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OverSubscriptionAmountReceived" xlink:to="btx_OverSubscriptionAmountReceived_lbl1" xlink:title="label: OverSubscriptionAmountReceived to btx_OverSubscriptionAmountReceived_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_OverSubscriptionAmountReceived_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_OverSubscriptionAmountReceived_lbl2" xml:lang="en-US" id="btx_OverSubscriptionAmountReceived_lbl2">Over-subscription amount received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OverSubscriptionAmountReceived" xlink:to="btx_OverSubscriptionAmountReceived_lbl2" xlink:title="label: OverSubscriptionAmountReceived to btx_OverSubscriptionAmountReceived_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:label="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl" xml:lang="en-US" id="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl">Percentage of securities that would be issuable upon the exercise of warrants or rights.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:to="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl" xlink:title="label: ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights to btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1" xml:lang="en-US" id="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1">Class of Warrant or Right Percent of Securities that Would be Issuable Upon Exercise of Warrants or Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:to="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1" xlink:title="label: ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights to btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2" xml:lang="en-US" id="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2">Percentage of warrants exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:to="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2" xlink:title="label: ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights to btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PrivatePlacementOfEquityAbstract" xlink:label="PrivatePlacementOfEquityAbstract" xlink:title="PrivatePlacementOfEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_PrivatePlacementOfEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PrivatePlacementOfEquityAbstract_lbl1" xml:lang="en-US" id="btx_PrivatePlacementOfEquityAbstract_lbl1">Private Placement of Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="btx_PrivatePlacementOfEquityAbstract_lbl1" xlink:title="label: PrivatePlacementOfEquityAbstract to btx_PrivatePlacementOfEquityAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PrivatePlacementOfEquityAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PrivatePlacementOfEquityAbstract_lbl2" xml:lang="en-US" id="btx_PrivatePlacementOfEquityAbstract_lbl2">Private Placement of Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="btx_PrivatePlacementOfEquityAbstract_lbl2" xlink:title="label: PrivatePlacementOfEquityAbstract to btx_PrivatePlacementOfEquityAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:label xlink:type="resource" xlink:label="btx_CommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_CommonWarrantsMember_lbl" xml:lang="en-US" id="btx_CommonWarrantsMember_lbl">A common warrant represents the right to purchase a company's stock at a specific price and at a specific date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="btx_CommonWarrantsMember_lbl" xlink:title="label: CommonWarrantsMember to btx_CommonWarrantsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_CommonWarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CommonWarrantsMember_lbl1" xml:lang="en-US" id="btx_CommonWarrantsMember_lbl1">Common Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="btx_CommonWarrantsMember_lbl1" xlink:title="label: CommonWarrantsMember to btx_CommonWarrantsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_CommonWarrantsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_CommonWarrantsMember_lbl2" xml:lang="en-US" id="btx_CommonWarrantsMember_lbl2">Common Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="btx_CommonWarrantsMember_lbl2" xlink:title="label: CommonWarrantsMember to btx_CommonWarrantsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:label xlink:type="resource" xlink:label="btx_PIPEInvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PIPEInvestorMember_lbl" xml:lang="en-US" id="btx_PIPEInvestorMember_lbl">A private investment in public equity, often called a PIPE deal, involves the selling of publicly traded common shares or some form of preferred stock or convertible security to private investors. It is an allocation of shares in a public company not through a public offering in a stock exchange. PIPE deals are part of the primary market. In the U.S., a PIPE offering may be registered with the Securities and Exchange Commission on a registration statement or may be completed as an unregistered private placement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="btx_PIPEInvestorMember_lbl" xlink:title="label: PIPEInvestorMember to btx_PIPEInvestorMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PIPEInvestorMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PIPEInvestorMember_lbl1" xml:lang="en-US" id="btx_PIPEInvestorMember_lbl1">PIPE Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="btx_PIPEInvestorMember_lbl1" xlink:title="label: PIPEInvestorMember to btx_PIPEInvestorMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PIPEInvestorMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PIPEInvestorMember_lbl2" xml:lang="en-US" id="btx_PIPEInvestorMember_lbl2">PIPE Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="btx_PIPEInvestorMember_lbl2" xlink:title="label: PIPEInvestorMember to btx_PIPEInvestorMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:label xlink:type="resource" xlink:label="btx_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PreFundedWarrantsMember_lbl" xml:lang="en-US" id="btx_PreFundedWarrantsMember_lbl">A pre-funded warrant that allows the warrant holder to purchase a specified number of a company's securities at a nominal exercise price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreFundedWarrantsMember" xlink:to="btx_PreFundedWarrantsMember_lbl" xlink:title="label: PreFundedWarrantsMember to btx_PreFundedWarrantsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PreFundedWarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PreFundedWarrantsMember_lbl1" xml:lang="en-US" id="btx_PreFundedWarrantsMember_lbl1">Pre-funded Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreFundedWarrantsMember" xlink:to="btx_PreFundedWarrantsMember_lbl1" xlink:title="label: PreFundedWarrantsMember to btx_PreFundedWarrantsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PreFundedWarrantsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PreFundedWarrantsMember_lbl2" xml:lang="en-US" id="btx_PreFundedWarrantsMember_lbl2">Pre-funded Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreFundedWarrantsMember" xlink:to="btx_PreFundedWarrantsMember_lbl2" xlink:title="label: PreFundedWarrantsMember to btx_PreFundedWarrantsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CitiusPharmaceuticalsIncMember" xlink:label="CitiusPharmaceuticalsIncMember" xlink:title="CitiusPharmaceuticalsIncMember" />
    <link:label xlink:type="resource" xlink:label="btx_CitiusPharmaceuticalsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_CitiusPharmaceuticalsIncMember_lbl" xml:lang="en-US" id="btx_CitiusPharmaceuticalsIncMember_lbl">Represents Citius Pharmaceuticals, Inc. Ownership interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CitiusPharmaceuticalsIncMember" xlink:to="btx_CitiusPharmaceuticalsIncMember_lbl" xlink:title="label: CitiusPharmaceuticalsIncMember to btx_CitiusPharmaceuticalsIncMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_CitiusPharmaceuticalsIncMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CitiusPharmaceuticalsIncMember_lbl1" xml:lang="en-US" id="btx_CitiusPharmaceuticalsIncMember_lbl1">Citius Pharmaceuticals, Inc. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CitiusPharmaceuticalsIncMember" xlink:to="btx_CitiusPharmaceuticalsIncMember_lbl1" xlink:title="label: CitiusPharmaceuticalsIncMember to btx_CitiusPharmaceuticalsIncMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NumberOfBoardSeats" xlink:label="NumberOfBoardSeats" xlink:title="NumberOfBoardSeats" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfBoardSeats_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NumberOfBoardSeats_lbl" xml:lang="en-US" id="btx_NumberOfBoardSeats_lbl">Number of members of the company's management holds board seats on board of directors.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBoardSeats" xlink:to="btx_NumberOfBoardSeats_lbl" xlink:title="label: NumberOfBoardSeats to btx_NumberOfBoardSeats_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfBoardSeats_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NumberOfBoardSeats_lbl1" xml:lang="en-US" id="btx_NumberOfBoardSeats_lbl1">Number of Board Seats</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBoardSeats" xlink:to="btx_NumberOfBoardSeats_lbl1" xlink:title="label: NumberOfBoardSeats to btx_NumberOfBoardSeats_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfBoardSeats_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NumberOfBoardSeats_lbl2" xml:lang="en-US" id="btx_NumberOfBoardSeats_lbl2">Number of board seats</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBoardSeats" xlink:to="btx_NumberOfBoardSeats_lbl2" xlink:title="label: NumberOfBoardSeats to btx_NumberOfBoardSeats_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:label xlink:type="resource" xlink:label="btx_NTNBuzztimeIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NTNBuzztimeIncMember_lbl" xml:lang="en-US" id="btx_NTNBuzztimeIncMember_lbl">Name of acquiree entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBuzztimeIncMember" xlink:to="btx_NTNBuzztimeIncMember_lbl" xlink:title="label: NTNBuzztimeIncMember to btx_NTNBuzztimeIncMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NTNBuzztimeIncMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NTNBuzztimeIncMember_lbl1" xml:lang="en-US" id="btx_NTNBuzztimeIncMember_lbl1">NTN Buzztime, Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBuzztimeIncMember" xlink:to="btx_NTNBuzztimeIncMember_lbl1" xlink:title="label: NTNBuzztimeIncMember to btx_NTNBuzztimeIncMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NTNBuzztimeIncMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NTNBuzztimeIncMember_lbl2" xml:lang="en-US" id="btx_NTNBuzztimeIncMember_lbl2">NTN Buzztime, Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBuzztimeIncMember" xlink:to="btx_NTNBuzztimeIncMember_lbl2" xlink:title="label: NTNBuzztimeIncMember to btx_NTNBuzztimeIncMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:label="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:title="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1" xml:lang="en-US" id="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1">Detailed information about Liquidity and Capital Resources [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1" xlink:title="label: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2" xml:lang="en-US" id="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2">Liquidity and Capital Resources [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2" xlink:title="label: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:label="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:title="NumberOfPerformanceGoalsAreSubjectToAchieve" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl" xml:lang="en-US" id="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl">The number of performance goals are subject to achieve under 2022 performance based restricted stock units.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:to="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl" xlink:title="label: NumberOfPerformanceGoalsAreSubjectToAchieve to btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl1" xml:lang="en-US" id="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl1">Number of Performance Goals are Subject to Achieve</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:to="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl1" xlink:title="label: NumberOfPerformanceGoalsAreSubjectToAchieve to btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl2" xml:lang="en-US" id="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl2">Number of performance goals are subject to achieve</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:to="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl2" xlink:title="label: NumberOfPerformanceGoalsAreSubjectToAchieve to btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl">The number of non-vested equity-based payment instruments, excluding stock (or unit) options expected to vest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber to btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber to btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl2" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl2">Balance expected to vest (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber to btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ChiefExecutiveOfficerAndPresidentMember" xlink:label="ChiefExecutiveOfficerAndPresidentMember" xlink:title="ChiefExecutiveOfficerAndPresidentMember" />
    <link:label xlink:type="resource" xlink:label="btx_ChiefExecutiveOfficerAndPresidentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ChiefExecutiveOfficerAndPresidentMember_lbl" xml:lang="en-US" id="btx_ChiefExecutiveOfficerAndPresidentMember_lbl">Person with designation of chief executive officer and president.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChiefExecutiveOfficerAndPresidentMember" xlink:to="btx_ChiefExecutiveOfficerAndPresidentMember_lbl" xlink:title="label: ChiefExecutiveOfficerAndPresidentMember to btx_ChiefExecutiveOfficerAndPresidentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ChiefExecutiveOfficerAndPresidentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ChiefExecutiveOfficerAndPresidentMember_lbl1" xml:lang="en-US" id="btx_ChiefExecutiveOfficerAndPresidentMember_lbl1">Chief Executive Officer and President [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChiefExecutiveOfficerAndPresidentMember" xlink:to="btx_ChiefExecutiveOfficerAndPresidentMember_lbl1" xlink:title="label: ChiefExecutiveOfficerAndPresidentMember to btx_ChiefExecutiveOfficerAndPresidentMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ChiefExecutiveOfficerAndPresidentMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ChiefExecutiveOfficerAndPresidentMember_lbl2" xml:lang="en-US" id="btx_ChiefExecutiveOfficerAndPresidentMember_lbl2">Dr. Federoff [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChiefExecutiveOfficerAndPresidentMember" xlink:to="btx_ChiefExecutiveOfficerAndPresidentMember_lbl2" xlink:title="label: ChiefExecutiveOfficerAndPresidentMember to btx_ChiefExecutiveOfficerAndPresidentMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_Two022PerformanceBasedRestrictedStockUnitsMember" xlink:label="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:title="Two022PerformanceBasedRestrictedStockUnitsMember" />
    <link:label xlink:type="resource" xlink:label="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl" xml:lang="en-US" id="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl">The name of awards.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:to="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl" xlink:title="label: Two022PerformanceBasedRestrictedStockUnitsMember to btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl1" xml:lang="en-US" id="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl1">2022 Performance-Based Restricted Stock Units [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:to="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl1" xlink:title="label: Two022PerformanceBasedRestrictedStockUnitsMember to btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl2" xml:lang="en-US" id="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl2">2022 PSUs [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:to="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl2" xlink:title="label: Two022PerformanceBasedRestrictedStockUnitsMember to btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:label xlink:type="resource" xlink:label="btx_EmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_EmployeeMember_lbl" xml:lang="en-US" id="btx_EmployeeMember_lbl">One of the employee of the entity, appointed to the position.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeMember" xlink:to="btx_EmployeeMember_lbl" xlink:title="label: EmployeeMember to btx_EmployeeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_EmployeeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_EmployeeMember_lbl1" xml:lang="en-US" id="btx_EmployeeMember_lbl1">Employee [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeMember" xlink:to="btx_EmployeeMember_lbl1" xlink:title="label: EmployeeMember to btx_EmployeeMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_EmployeeMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_EmployeeMember_lbl2" xml:lang="en-US" id="btx_EmployeeMember_lbl2">Employees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeMember" xlink:to="btx_EmployeeMember_lbl2" xlink:title="label: EmployeeMember to btx_EmployeeMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl">The amount of fair value of share-based payment arrangement, subject to vesting and other restrictions, to purchase or sell certain number of shares on performance basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue to btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl1" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue to btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl2" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl2">Stock-based compensation grant fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue to btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NumberOfStockOptionGrantMade" xlink:label="NumberOfStockOptionGrantMade" xlink:title="NumberOfStockOptionGrantMade" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfStockOptionGrantMade_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NumberOfStockOptionGrantMade_lbl" xml:lang="en-US" id="btx_NumberOfStockOptionGrantMade_lbl">Number of stock option grants made.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStockOptionGrantMade" xlink:to="btx_NumberOfStockOptionGrantMade_lbl" xlink:title="label: NumberOfStockOptionGrantMade to btx_NumberOfStockOptionGrantMade_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfStockOptionGrantMade_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NumberOfStockOptionGrantMade_lbl1" xml:lang="en-US" id="btx_NumberOfStockOptionGrantMade_lbl1">Number Of Stock Option Grant Made</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStockOptionGrantMade" xlink:to="btx_NumberOfStockOptionGrantMade_lbl1" xlink:title="label: NumberOfStockOptionGrantMade to btx_NumberOfStockOptionGrantMade_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfStockOptionGrantMade_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NumberOfStockOptionGrantMade_lbl2" xml:lang="en-US" id="btx_NumberOfStockOptionGrantMade_lbl2">Number of stock option grants made</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStockOptionGrantMade" xlink:to="btx_NumberOfStockOptionGrantMade_lbl2" xlink:title="label: NumberOfStockOptionGrantMade to btx_NumberOfStockOptionGrantMade_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl">The number of monthly installments for vesting of remaining shares in share-based compensation arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares to btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl1" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl1">Share-based Compensation Arrangement by Share-based Payment, Number of Monthly Installments for Vesting of Remaining Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares to btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl2" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl2">Number of monthly installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares to btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_TimeBasedNonQualifiedStockOptionMember" xlink:label="TimeBasedNonQualifiedStockOptionMember" xlink:title="TimeBasedNonQualifiedStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="btx_TimeBasedNonQualifiedStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_TimeBasedNonQualifiedStockOptionMember_lbl" xml:lang="en-US" id="btx_TimeBasedNonQualifiedStockOptionMember_lbl">Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on time basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TimeBasedNonQualifiedStockOptionMember" xlink:to="btx_TimeBasedNonQualifiedStockOptionMember_lbl" xlink:title="label: TimeBasedNonQualifiedStockOptionMember to btx_TimeBasedNonQualifiedStockOptionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_TimeBasedNonQualifiedStockOptionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_TimeBasedNonQualifiedStockOptionMember_lbl1" xml:lang="en-US" id="btx_TimeBasedNonQualifiedStockOptionMember_lbl1">Time-Based Non-qualified Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TimeBasedNonQualifiedStockOptionMember" xlink:to="btx_TimeBasedNonQualifiedStockOptionMember_lbl1" xlink:title="label: TimeBasedNonQualifiedStockOptionMember to btx_TimeBasedNonQualifiedStockOptionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_TimeBasedNonQualifiedStockOptionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_TimeBasedNonQualifiedStockOptionMember_lbl2" xml:lang="en-US" id="btx_TimeBasedNonQualifiedStockOptionMember_lbl2">Time-Based Non-qualified Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TimeBasedNonQualifiedStockOptionMember" xlink:to="btx_TimeBasedNonQualifiedStockOptionMember_lbl2" xlink:title="label: TimeBasedNonQualifiedStockOptionMember to btx_TimeBasedNonQualifiedStockOptionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PerformanceBasedNonqualifiedStockOptionMember" xlink:label="PerformanceBasedNonqualifiedStockOptionMember" xlink:title="PerformanceBasedNonqualifiedStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="btx_PerformanceBasedNonqualifiedStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PerformanceBasedNonqualifiedStockOptionMember_lbl" xml:lang="en-US" id="btx_PerformanceBasedNonqualifiedStockOptionMember_lbl">Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on performance basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PerformanceBasedNonqualifiedStockOptionMember" xlink:to="btx_PerformanceBasedNonqualifiedStockOptionMember_lbl" xlink:title="label: PerformanceBasedNonqualifiedStockOptionMember to btx_PerformanceBasedNonqualifiedStockOptionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PerformanceBasedNonqualifiedStockOptionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PerformanceBasedNonqualifiedStockOptionMember_lbl1" xml:lang="en-US" id="btx_PerformanceBasedNonqualifiedStockOptionMember_lbl1">Performance-Based Nonqualified Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PerformanceBasedNonqualifiedStockOptionMember" xlink:to="btx_PerformanceBasedNonqualifiedStockOptionMember_lbl1" xlink:title="label: PerformanceBasedNonqualifiedStockOptionMember to btx_PerformanceBasedNonqualifiedStockOptionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PerformanceBasedNonqualifiedStockOptionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PerformanceBasedNonqualifiedStockOptionMember_lbl2" xml:lang="en-US" id="btx_PerformanceBasedNonqualifiedStockOptionMember_lbl2">Performance-Based Nonqualified Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PerformanceBasedNonqualifiedStockOptionMember" xlink:to="btx_PerformanceBasedNonqualifiedStockOptionMember_lbl2" xlink:title="label: PerformanceBasedNonqualifiedStockOptionMember to btx_PerformanceBasedNonqualifiedStockOptionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NonQualifiedStockOptionMember" xlink:label="NonQualifiedStockOptionMember" xlink:title="NonQualifiedStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="btx_NonQualifiedStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NonQualifiedStockOptionMember_lbl" xml:lang="en-US" id="btx_NonQualifiedStockOptionMember_lbl">Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionMember" xlink:to="btx_NonQualifiedStockOptionMember_lbl" xlink:title="label: NonQualifiedStockOptionMember to btx_NonQualifiedStockOptionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NonQualifiedStockOptionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NonQualifiedStockOptionMember_lbl1" xml:lang="en-US" id="btx_NonQualifiedStockOptionMember_lbl1">Non-qualified Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionMember" xlink:to="btx_NonQualifiedStockOptionMember_lbl1" xlink:title="label: NonQualifiedStockOptionMember to btx_NonQualifiedStockOptionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NonQualifiedStockOptionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NonQualifiedStockOptionMember_lbl2" xml:lang="en-US" id="btx_NonQualifiedStockOptionMember_lbl2">Nonqualified Stock Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionMember" xlink:to="btx_NonQualifiedStockOptionMember_lbl2" xlink:title="label: NonQualifiedStockOptionMember to btx_NonQualifiedStockOptionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AggregateIntrinsicValueAbstract" xlink:label="AggregateIntrinsicValueAbstract" xlink:title="AggregateIntrinsicValueAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_AggregateIntrinsicValueAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AggregateIntrinsicValueAbstract_lbl1" xml:lang="en-US" id="btx_AggregateIntrinsicValueAbstract_lbl1">Aggregate Intrinsic Value [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueAbstract" xlink:to="btx_AggregateIntrinsicValueAbstract_lbl1" xlink:title="label: AggregateIntrinsicValueAbstract to btx_AggregateIntrinsicValueAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_UniversityOfSouthFloridaMember" xlink:label="UniversityOfSouthFloridaMember" xlink:title="UniversityOfSouthFloridaMember" />
    <link:label xlink:type="resource" xlink:label="btx_UniversityOfSouthFloridaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_UniversityOfSouthFloridaMember_lbl" xml:lang="en-US" id="btx_UniversityOfSouthFloridaMember_lbl">Legal entity involved in litigation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UniversityOfSouthFloridaMember" xlink:to="btx_UniversityOfSouthFloridaMember_lbl" xlink:title="label: UniversityOfSouthFloridaMember to btx_UniversityOfSouthFloridaMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_UniversityOfSouthFloridaMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_UniversityOfSouthFloridaMember_lbl1" xml:lang="en-US" id="btx_UniversityOfSouthFloridaMember_lbl1">University of South Florida [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UniversityOfSouthFloridaMember" xlink:to="btx_UniversityOfSouthFloridaMember_lbl1" xlink:title="label: UniversityOfSouthFloridaMember to btx_UniversityOfSouthFloridaMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_UniversityOfSouthFloridaMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_UniversityOfSouthFloridaMember_lbl2" xml:lang="en-US" id="btx_UniversityOfSouthFloridaMember_lbl2">University of South Florida [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UniversityOfSouthFloridaMember" xlink:to="btx_UniversityOfSouthFloridaMember_lbl2" xlink:title="label: UniversityOfSouthFloridaMember to btx_UniversityOfSouthFloridaMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AmountObligatedToPayInYearTwo" xlink:label="AmountObligatedToPayInYearTwo" xlink:title="AmountObligatedToPayInYearTwo" />
    <link:label xlink:type="resource" xlink:label="btx_AmountObligatedToPayInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AmountObligatedToPayInYearTwo_lbl" xml:lang="en-US" id="btx_AmountObligatedToPayInYearTwo_lbl">The entity is obligated to pay additional fees to the Licensors in second year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountObligatedToPayInYearTwo" xlink:to="btx_AmountObligatedToPayInYearTwo_lbl" xlink:title="label: AmountObligatedToPayInYearTwo to btx_AmountObligatedToPayInYearTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AmountObligatedToPayInYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AmountObligatedToPayInYearTwo_lbl1" xml:lang="en-US" id="btx_AmountObligatedToPayInYearTwo_lbl1">Amount Obligated to Pay in Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountObligatedToPayInYearTwo" xlink:to="btx_AmountObligatedToPayInYearTwo_lbl1" xlink:title="label: AmountObligatedToPayInYearTwo to btx_AmountObligatedToPayInYearTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AmountObligatedToPayInYearTwo_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AmountObligatedToPayInYearTwo_lbl2" xml:lang="en-US" id="btx_AmountObligatedToPayInYearTwo_lbl2">Additional fees obligated to pay in 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountObligatedToPayInYearTwo" xlink:to="btx_AmountObligatedToPayInYearTwo_lbl2" xlink:title="label: AmountObligatedToPayInYearTwo to btx_AmountObligatedToPayInYearTwo_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AdditionalFeesObligatedToPay" xlink:label="AdditionalFeesObligatedToPay" xlink:title="AdditionalFeesObligatedToPay" />
    <link:label xlink:type="resource" xlink:label="btx_AdditionalFeesObligatedToPay_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AdditionalFeesObligatedToPay_lbl" xml:lang="en-US" id="btx_AdditionalFeesObligatedToPay_lbl">The entity is obligated to pay additional fees to Licensors.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalFeesObligatedToPay" xlink:to="btx_AdditionalFeesObligatedToPay_lbl" xlink:title="label: AdditionalFeesObligatedToPay to btx_AdditionalFeesObligatedToPay_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AdditionalFeesObligatedToPay_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AdditionalFeesObligatedToPay_lbl1" xml:lang="en-US" id="btx_AdditionalFeesObligatedToPay_lbl1">Additional Fees Obligated to Pay</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalFeesObligatedToPay" xlink:to="btx_AdditionalFeesObligatedToPay_lbl1" xlink:title="label: AdditionalFeesObligatedToPay to btx_AdditionalFeesObligatedToPay_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AdditionalFeesObligatedToPay_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AdditionalFeesObligatedToPay_lbl2" xml:lang="en-US" id="btx_AdditionalFeesObligatedToPay_lbl2">Amount require to pay of initial license fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalFeesObligatedToPay" xlink:to="btx_AdditionalFeesObligatedToPay_lbl2" xlink:title="label: AdditionalFeesObligatedToPay to btx_AdditionalFeesObligatedToPay_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AmountRequireToPayInitialLicenseFees" xlink:label="AmountRequireToPayInitialLicenseFees" xlink:title="AmountRequireToPayInitialLicenseFees" />
    <link:label xlink:type="resource" xlink:label="btx_AmountRequireToPayInitialLicenseFees_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AmountRequireToPayInitialLicenseFees_lbl" xml:lang="en-US" id="btx_AmountRequireToPayInitialLicenseFees_lbl">Amount require to pay out of the total initial license fees.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountRequireToPayInitialLicenseFees" xlink:to="btx_AmountRequireToPayInitialLicenseFees_lbl" xlink:title="label: AmountRequireToPayInitialLicenseFees to btx_AmountRequireToPayInitialLicenseFees_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AmountRequireToPayInitialLicenseFees_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AmountRequireToPayInitialLicenseFees_lbl1" xml:lang="en-US" id="btx_AmountRequireToPayInitialLicenseFees_lbl1">Amount Require to Pay Initial License Fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountRequireToPayInitialLicenseFees" xlink:to="btx_AmountRequireToPayInitialLicenseFees_lbl1" xlink:title="label: AmountRequireToPayInitialLicenseFees to btx_AmountRequireToPayInitialLicenseFees_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AmountRequireToPayInitialLicenseFees_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AmountRequireToPayInitialLicenseFees_lbl2" xml:lang="en-US" id="btx_AmountRequireToPayInitialLicenseFees_lbl2">Amount obligated to pay in license agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountRequireToPayInitialLicenseFees" xlink:to="btx_AmountRequireToPayInitialLicenseFees_lbl2" xlink:title="label: AmountRequireToPayInitialLicenseFees to btx_AmountRequireToPayInitialLicenseFees_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MinimumNumberOfPatentGranted" xlink:label="MinimumNumberOfPatentGranted" xlink:title="MinimumNumberOfPatentGranted" />
    <link:label xlink:type="resource" xlink:label="btx_MinimumNumberOfPatentGranted_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_MinimumNumberOfPatentGranted_lbl" xml:lang="en-US" id="btx_MinimumNumberOfPatentGranted_lbl">Minimum number of granted patents.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumNumberOfPatentGranted" xlink:to="btx_MinimumNumberOfPatentGranted_lbl" xlink:title="label: MinimumNumberOfPatentGranted to btx_MinimumNumberOfPatentGranted_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_MinimumNumberOfPatentGranted_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_MinimumNumberOfPatentGranted_lbl1" xml:lang="en-US" id="btx_MinimumNumberOfPatentGranted_lbl1">Minimum Number of Patent Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumNumberOfPatentGranted" xlink:to="btx_MinimumNumberOfPatentGranted_lbl1" xlink:title="label: MinimumNumberOfPatentGranted to btx_MinimumNumberOfPatentGranted_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_MinimumNumberOfPatentGranted_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="btx_MinimumNumberOfPatentGranted_lbl2" xml:lang="en-US" id="btx_MinimumNumberOfPatentGranted_lbl2">Minimum number of patent granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumNumberOfPatentGranted" xlink:to="btx_MinimumNumberOfPatentGranted_lbl2" xlink:title="label: MinimumNumberOfPatentGranted to btx_MinimumNumberOfPatentGranted_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MilestonePayments" xlink:label="MilestonePayments" xlink:title="MilestonePayments" />
    <link:label xlink:type="resource" xlink:label="btx_MilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_MilestonePayments_lbl" xml:lang="en-US" id="btx_MilestonePayments_lbl">The amount of milestones upfront payment on licenses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestonePayments" xlink:to="btx_MilestonePayments_lbl" xlink:title="label: MilestonePayments to btx_MilestonePayments_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_MilestonePayments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_MilestonePayments_lbl1" xml:lang="en-US" id="btx_MilestonePayments_lbl1">Milestone Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestonePayments" xlink:to="btx_MilestonePayments_lbl1" xlink:title="label: MilestonePayments to btx_MilestonePayments_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_MilestonePayments_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_MilestonePayments_lbl2" xml:lang="en-US" id="btx_MilestonePayments_lbl2">Milestone payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestonePayments" xlink:to="btx_MilestonePayments_lbl2" xlink:title="label: MilestonePayments to btx_MilestonePayments_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AmountObligatedToPayInYearOne" xlink:label="AmountObligatedToPayInYearOne" xlink:title="AmountObligatedToPayInYearOne" />
    <link:label xlink:type="resource" xlink:label="btx_AmountObligatedToPayInYearOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AmountObligatedToPayInYearOne_lbl" xml:lang="en-US" id="btx_AmountObligatedToPayInYearOne_lbl">The entity is obligated to pay additional fees to the Licensors in first year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountObligatedToPayInYearOne" xlink:to="btx_AmountObligatedToPayInYearOne_lbl" xlink:title="label: AmountObligatedToPayInYearOne to btx_AmountObligatedToPayInYearOne_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AmountObligatedToPayInYearOne_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AmountObligatedToPayInYearOne_lbl1" xml:lang="en-US" id="btx_AmountObligatedToPayInYearOne_lbl1">Amount Obligated to Pay in Year One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountObligatedToPayInYearOne" xlink:to="btx_AmountObligatedToPayInYearOne_lbl1" xlink:title="label: AmountObligatedToPayInYearOne to btx_AmountObligatedToPayInYearOne_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AmountObligatedToPayInYearOne_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AmountObligatedToPayInYearOne_lbl2" xml:lang="en-US" id="btx_AmountObligatedToPayInYearOne_lbl2">Additional fees obligated to pay in 2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountObligatedToPayInYearOne" xlink:to="btx_AmountObligatedToPayInYearOne_lbl2" xlink:title="label: AmountObligatedToPayInYearOne to btx_AmountObligatedToPayInYearOne_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MinimumNumberOfPendingPatents" xlink:label="MinimumNumberOfPendingPatents" xlink:title="MinimumNumberOfPendingPatents" />
    <link:label xlink:type="resource" xlink:label="btx_MinimumNumberOfPendingPatents_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_MinimumNumberOfPendingPatents_lbl" xml:lang="en-US" id="btx_MinimumNumberOfPendingPatents_lbl">Minimum number of patents pending.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumNumberOfPendingPatents" xlink:to="btx_MinimumNumberOfPendingPatents_lbl" xlink:title="label: MinimumNumberOfPendingPatents to btx_MinimumNumberOfPendingPatents_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_MinimumNumberOfPendingPatents_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_MinimumNumberOfPendingPatents_lbl1" xml:lang="en-US" id="btx_MinimumNumberOfPendingPatents_lbl1">Minimum Number of Pending Patents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumNumberOfPendingPatents" xlink:to="btx_MinimumNumberOfPendingPatents_lbl1" xlink:title="label: MinimumNumberOfPendingPatents to btx_MinimumNumberOfPendingPatents_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_MinimumNumberOfPendingPatents_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_MinimumNumberOfPendingPatents_lbl2" xml:lang="en-US" id="btx_MinimumNumberOfPendingPatents_lbl2">Number of maximum pending patents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumNumberOfPendingPatents" xlink:to="btx_MinimumNumberOfPendingPatents_lbl2" xlink:title="label: MinimumNumberOfPendingPatents to btx_MinimumNumberOfPendingPatents_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyNonRefundableOptionFee" xlink:label="LossContingencyNonRefundableOptionFee" xlink:title="LossContingencyNonRefundableOptionFee" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyNonRefundableOptionFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LossContingencyNonRefundableOptionFee_lbl" xml:lang="en-US" id="btx_LossContingencyNonRefundableOptionFee_lbl">The amount of Non-refundable option fee in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNonRefundableOptionFee" xlink:to="btx_LossContingencyNonRefundableOptionFee_lbl" xlink:title="label: LossContingencyNonRefundableOptionFee to btx_LossContingencyNonRefundableOptionFee_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyNonRefundableOptionFee_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LossContingencyNonRefundableOptionFee_lbl1" xml:lang="en-US" id="btx_LossContingencyNonRefundableOptionFee_lbl1">Loss Contingency, Non-refundable Option Fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNonRefundableOptionFee" xlink:to="btx_LossContingencyNonRefundableOptionFee_lbl1" xlink:title="label: LossContingencyNonRefundableOptionFee to btx_LossContingencyNonRefundableOptionFee_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyNonRefundableOptionFee_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LossContingencyNonRefundableOptionFee_lbl2" xml:lang="en-US" id="btx_LossContingencyNonRefundableOptionFee_lbl2">Non-refundable option fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNonRefundableOptionFee" xlink:to="btx_LossContingencyNonRefundableOptionFee_lbl2" xlink:title="label: LossContingencyNonRefundableOptionFee to btx_LossContingencyNonRefundableOptionFee_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfRevenue" xlink:label="PercentageOfRevenue" xlink:title="PercentageOfRevenue" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageOfRevenue_lbl" xml:lang="en-US" id="btx_PercentageOfRevenue_lbl">Percentage of revenue from receives any revenue involving the original cell line included in the licensed technology, then Novellus, Ltd shall remit to NoveCite.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRevenue" xlink:to="btx_PercentageOfRevenue_lbl" xlink:title="label: PercentageOfRevenue to btx_PercentageOfRevenue_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfRevenue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageOfRevenue_lbl1" xml:lang="en-US" id="btx_PercentageOfRevenue_lbl1">Percentage of Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRevenue" xlink:to="btx_PercentageOfRevenue_lbl1" xlink:title="label: PercentageOfRevenue to btx_PercentageOfRevenue_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfRevenue_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageOfRevenue_lbl2" xml:lang="en-US" id="btx_PercentageOfRevenue_lbl2">Percentage of revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRevenue" xlink:to="btx_PercentageOfRevenue_lbl2" xlink:title="label: PercentageOfRevenue to btx_PercentageOfRevenue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyPercentageOfRoyaltyPayable" xlink:label="LossContingencyPercentageOfRoyaltyPayable" xlink:title="LossContingencyPercentageOfRoyaltyPayable" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyPercentageOfRoyaltyPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LossContingencyPercentageOfRoyaltyPayable_lbl" xml:lang="en-US" id="btx_LossContingencyPercentageOfRoyaltyPayable_lbl">Percentage of royalty payable from one party to another in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyPercentageOfRoyaltyPayable" xlink:to="btx_LossContingencyPercentageOfRoyaltyPayable_lbl" xlink:title="label: LossContingencyPercentageOfRoyaltyPayable to btx_LossContingencyPercentageOfRoyaltyPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyPercentageOfRoyaltyPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LossContingencyPercentageOfRoyaltyPayable_lbl1" xml:lang="en-US" id="btx_LossContingencyPercentageOfRoyaltyPayable_lbl1">Loss contingency, Percentage of Royalty Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyPercentageOfRoyaltyPayable" xlink:to="btx_LossContingencyPercentageOfRoyaltyPayable_lbl1" xlink:title="label: LossContingencyPercentageOfRoyaltyPayable to btx_LossContingencyPercentageOfRoyaltyPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyPercentageOfRoyaltyPayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LossContingencyPercentageOfRoyaltyPayable_lbl2" xml:lang="en-US" id="btx_LossContingencyPercentageOfRoyaltyPayable_lbl2">Percentage of royalty payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyPercentageOfRoyaltyPayable" xlink:to="btx_LossContingencyPercentageOfRoyaltyPayable_lbl2" xlink:title="label: LossContingencyPercentageOfRoyaltyPayable to btx_LossContingencyPercentageOfRoyaltyPayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_InitialLicenseFees" xlink:label="InitialLicenseFees" xlink:title="InitialLicenseFees" />
    <link:label xlink:type="resource" xlink:label="btx_InitialLicenseFees_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_InitialLicenseFees_lbl" xml:lang="en-US" id="btx_InitialLicenseFees_lbl">Initial license fees required to pay including non-refundable fee.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialLicenseFees" xlink:to="btx_InitialLicenseFees_lbl" xlink:title="label: InitialLicenseFees to btx_InitialLicenseFees_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_InitialLicenseFees_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_InitialLicenseFees_lbl1" xml:lang="en-US" id="btx_InitialLicenseFees_lbl1">Initial License Fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialLicenseFees" xlink:to="btx_InitialLicenseFees_lbl1" xlink:title="label: InitialLicenseFees to btx_InitialLicenseFees_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_InitialLicenseFees_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_InitialLicenseFees_lbl2" xml:lang="en-US" id="btx_InitialLicenseFees_lbl2">Initial license fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialLicenseFees" xlink:to="btx_InitialLicenseFees_lbl2" xlink:title="label: InitialLicenseFees to btx_InitialLicenseFees_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LicensingAgreementsAbstract" xlink:label="LicensingAgreementsAbstract" xlink:title="LicensingAgreementsAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_LicensingAgreementsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LicensingAgreementsAbstract_lbl1" xml:lang="en-US" id="btx_LicensingAgreementsAbstract_lbl1">Licensing Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicensingAgreementsAbstract" xlink:to="btx_LicensingAgreementsAbstract_lbl1" xlink:title="label: LicensingAgreementsAbstract to btx_LicensingAgreementsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LicensingAgreementsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LicensingAgreementsAbstract_lbl2" xml:lang="en-US" id="btx_LicensingAgreementsAbstract_lbl2">Licensing Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicensingAgreementsAbstract" xlink:to="btx_LicensingAgreementsAbstract_lbl2" xlink:title="label: LicensingAgreementsAbstract to btx_LicensingAgreementsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NoveCiteMember" xlink:label="NoveCiteMember" xlink:title="NoveCiteMember" />
    <link:label xlink:type="resource" xlink:label="btx_NoveCiteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NoveCiteMember_lbl" xml:lang="en-US" id="btx_NoveCiteMember_lbl">The name of company involved in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteMember" xlink:to="btx_NoveCiteMember_lbl" xlink:title="label: NoveCiteMember to btx_NoveCiteMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NoveCiteMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NoveCiteMember_lbl1" xml:lang="en-US" id="btx_NoveCiteMember_lbl1">NoveCite [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteMember" xlink:to="btx_NoveCiteMember_lbl1" xlink:title="label: NoveCiteMember to btx_NoveCiteMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NoveCiteMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NoveCiteMember_lbl2" xml:lang="en-US" id="btx_NoveCiteMember_lbl2">NoveCite [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteMember" xlink:to="btx_NoveCiteMember_lbl2" xlink:title="label: NoveCiteMember to btx_NoveCiteMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NovellusLtdAndFactorBioscienceMember" xlink:label="NovellusLtdAndFactorBioscienceMember" xlink:title="NovellusLtdAndFactorBioscienceMember" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusLtdAndFactorBioscienceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NovellusLtdAndFactorBioscienceMember_lbl" xml:lang="en-US" id="btx_NovellusLtdAndFactorBioscienceMember_lbl">The name of companies involved in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusLtdAndFactorBioscienceMember" xlink:to="btx_NovellusLtdAndFactorBioscienceMember_lbl" xlink:title="label: NovellusLtdAndFactorBioscienceMember to btx_NovellusLtdAndFactorBioscienceMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusLtdAndFactorBioscienceMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NovellusLtdAndFactorBioscienceMember_lbl1" xml:lang="en-US" id="btx_NovellusLtdAndFactorBioscienceMember_lbl1">Novellus Ltd. and Factor Bioscience [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusLtdAndFactorBioscienceMember" xlink:to="btx_NovellusLtdAndFactorBioscienceMember_lbl1" xlink:title="label: NovellusLtdAndFactorBioscienceMember to btx_NovellusLtdAndFactorBioscienceMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusLtdAndFactorBioscienceMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NovellusLtdAndFactorBioscienceMember_lbl2" xml:lang="en-US" id="btx_NovellusLtdAndFactorBioscienceMember_lbl2">Licensors [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusLtdAndFactorBioscienceMember" xlink:to="btx_NovellusLtdAndFactorBioscienceMember_lbl2" xlink:title="label: NovellusLtdAndFactorBioscienceMember to btx_NovellusLtdAndFactorBioscienceMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:label="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl" xml:lang="en-US" id="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl">Percentage of additional royalty payable on gross sales by the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:to="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl" xlink:title="label: PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales to btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1" xml:lang="en-US" id="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1">Percentage of Payment Of Additional Royalty On Gross Sales</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:to="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1" xlink:title="label: PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales to btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2" xml:lang="en-US" id="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2">Percentage of payment of additional royalty on gross sales</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:to="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2" xlink:title="label: PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales to btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:label="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:title="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl" xml:lang="en-US" id="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl">Percentage of royalty receive equal to revenues generated from disposition of business.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:to="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl" xlink:title="label: PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness to btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl1" xml:lang="en-US" id="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl1">Percentage of Royalty Receive Equal to Revenues from Sale of Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:to="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl1" xlink:title="label: PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness to btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl2" xml:lang="en-US" id="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl2">Percentage of royalty receive equal to revenues from sale of business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:to="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl2" xlink:title="label: PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness to btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_RoyaltyAgreementsAbstract" xlink:label="RoyaltyAgreementsAbstract" xlink:title="RoyaltyAgreementsAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_RoyaltyAgreementsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_RoyaltyAgreementsAbstract_lbl1" xml:lang="en-US" id="btx_RoyaltyAgreementsAbstract_lbl1">Royalty Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RoyaltyAgreementsAbstract" xlink:to="btx_RoyaltyAgreementsAbstract_lbl1" xlink:title="label: RoyaltyAgreementsAbstract to btx_RoyaltyAgreementsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_RoyaltyAgreementsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_RoyaltyAgreementsAbstract_lbl2" xml:lang="en-US" id="btx_RoyaltyAgreementsAbstract_lbl2">Royalty Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RoyaltyAgreementsAbstract" xlink:to="btx_RoyaltyAgreementsAbstract_lbl2" xlink:title="label: RoyaltyAgreementsAbstract to btx_RoyaltyAgreementsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_InvestorRoyaltyAgreementMember" xlink:label="InvestorRoyaltyAgreementMember" xlink:title="InvestorRoyaltyAgreementMember" />
    <link:label xlink:type="resource" xlink:label="btx_InvestorRoyaltyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_InvestorRoyaltyAgreementMember_lbl" xml:lang="en-US" id="btx_InvestorRoyaltyAgreementMember_lbl">Arrangement other than collaborative applicable to investor royalty.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestorRoyaltyAgreementMember" xlink:to="btx_InvestorRoyaltyAgreementMember_lbl" xlink:title="label: InvestorRoyaltyAgreementMember to btx_InvestorRoyaltyAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_InvestorRoyaltyAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_InvestorRoyaltyAgreementMember_lbl1" xml:lang="en-US" id="btx_InvestorRoyaltyAgreementMember_lbl1">Investor Royalty Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestorRoyaltyAgreementMember" xlink:to="btx_InvestorRoyaltyAgreementMember_lbl1" xlink:title="label: InvestorRoyaltyAgreementMember to btx_InvestorRoyaltyAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_InvestorRoyaltyAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_InvestorRoyaltyAgreementMember_lbl2" xml:lang="en-US" id="btx_InvestorRoyaltyAgreementMember_lbl2">Investor Royalty Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestorRoyaltyAgreementMember" xlink:to="btx_InvestorRoyaltyAgreementMember_lbl2" xlink:title="label: InvestorRoyaltyAgreementMember to btx_InvestorRoyaltyAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CollaboratorRoyaltyAgreementMember" xlink:label="CollaboratorRoyaltyAgreementMember" xlink:title="CollaboratorRoyaltyAgreementMember" />
    <link:label xlink:type="resource" xlink:label="btx_CollaboratorRoyaltyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_CollaboratorRoyaltyAgreementMember_lbl" xml:lang="en-US" id="btx_CollaboratorRoyaltyAgreementMember_lbl">Collaborative royalty arrangement in licensing deal with the company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaboratorRoyaltyAgreementMember" xlink:to="btx_CollaboratorRoyaltyAgreementMember_lbl" xlink:title="label: CollaboratorRoyaltyAgreementMember to btx_CollaboratorRoyaltyAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_CollaboratorRoyaltyAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CollaboratorRoyaltyAgreementMember_lbl1" xml:lang="en-US" id="btx_CollaboratorRoyaltyAgreementMember_lbl1">Collaborator Royalty Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaboratorRoyaltyAgreementMember" xlink:to="btx_CollaboratorRoyaltyAgreementMember_lbl1" xlink:title="label: CollaboratorRoyaltyAgreementMember to btx_CollaboratorRoyaltyAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_CollaboratorRoyaltyAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_CollaboratorRoyaltyAgreementMember_lbl2" xml:lang="en-US" id="btx_CollaboratorRoyaltyAgreementMember_lbl2">Collaborator Royalty Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaboratorRoyaltyAgreementMember" xlink:to="btx_CollaboratorRoyaltyAgreementMember_lbl2" xlink:title="label: CollaboratorRoyaltyAgreementMember to btx_CollaboratorRoyaltyAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyNumberOfArbitrationPanel" xlink:label="LossContingencyNumberOfArbitrationPanel" xlink:title="LossContingencyNumberOfArbitrationPanel" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyNumberOfArbitrationPanel_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LossContingencyNumberOfArbitrationPanel_lbl" xml:lang="en-US" id="btx_LossContingencyNumberOfArbitrationPanel_lbl">Represents the number member in arbitration panel pertaining to a loss contingency during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNumberOfArbitrationPanel" xlink:to="btx_LossContingencyNumberOfArbitrationPanel_lbl" xlink:title="label: LossContingencyNumberOfArbitrationPanel to btx_LossContingencyNumberOfArbitrationPanel_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyNumberOfArbitrationPanel_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LossContingencyNumberOfArbitrationPanel_lbl1" xml:lang="en-US" id="btx_LossContingencyNumberOfArbitrationPanel_lbl1">Loss Contingency, Number of Arbitration Panel Member</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNumberOfArbitrationPanel" xlink:to="btx_LossContingencyNumberOfArbitrationPanel_lbl1" xlink:title="label: LossContingencyNumberOfArbitrationPanel to btx_LossContingencyNumberOfArbitrationPanel_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyNumberOfArbitrationPanel_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LossContingencyNumberOfArbitrationPanel_lbl2" xml:lang="en-US" id="btx_LossContingencyNumberOfArbitrationPanel_lbl2">Number of member arbitration panel</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNumberOfArbitrationPanel" xlink:to="btx_LossContingencyNumberOfArbitrationPanel_lbl2" xlink:title="label: LossContingencyNumberOfArbitrationPanel to btx_LossContingencyNumberOfArbitrationPanel_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DheshGovenderMember" xlink:label="DheshGovenderMember" xlink:title="DheshGovenderMember" />
    <link:label xlink:type="resource" xlink:label="btx_DheshGovenderMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DheshGovenderMember_lbl" xml:lang="en-US" id="btx_DheshGovenderMember_lbl">Dhesh Govender, a former short-term consultant of the entity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DheshGovenderMember" xlink:to="btx_DheshGovenderMember_lbl" xlink:title="label: DheshGovenderMember to btx_DheshGovenderMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DheshGovenderMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DheshGovenderMember_lbl1" xml:lang="en-US" id="btx_DheshGovenderMember_lbl1">Dhesh Govender [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DheshGovenderMember" xlink:to="btx_DheshGovenderMember_lbl1" xlink:title="label: DheshGovenderMember to btx_DheshGovenderMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DheshGovenderMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DheshGovenderMember_lbl2" xml:lang="en-US" id="btx_DheshGovenderMember_lbl2">Govender [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DheshGovenderMember" xlink:to="btx_DheshGovenderMember_lbl2" xlink:title="label: DheshGovenderMember to btx_DheshGovenderMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusTherapeuticsLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NovellusTherapeuticsLimitedMember_lbl" xml:lang="en-US" id="btx_NovellusTherapeuticsLimitedMember_lbl">The name of company involved in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusTherapeuticsLimitedMember" xlink:to="btx_NovellusTherapeuticsLimitedMember_lbl" xlink:title="label: NovellusTherapeuticsLimitedMember to btx_NovellusTherapeuticsLimitedMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusTherapeuticsLimitedMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NovellusTherapeuticsLimitedMember_lbl1" xml:lang="en-US" id="btx_NovellusTherapeuticsLimitedMember_lbl1">Novellus Therapeutics Limited [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusTherapeuticsLimitedMember" xlink:to="btx_NovellusTherapeuticsLimitedMember_lbl1" xlink:title="label: NovellusTherapeuticsLimitedMember to btx_NovellusTherapeuticsLimitedMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusTherapeuticsLimitedMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NovellusTherapeuticsLimitedMember_lbl2" xml:lang="en-US" id="btx_NovellusTherapeuticsLimitedMember_lbl2">Novellus, Ltd. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusTherapeuticsLimitedMember" xlink:to="btx_NovellusTherapeuticsLimitedMember_lbl2" xlink:title="label: NovellusTherapeuticsLimitedMember to btx_NovellusTherapeuticsLimitedMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:label="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:title="LossContingencyDamagesSoughtExpectedEquityPercentage" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl" xml:lang="en-US" id="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl">The percentage of equity promised to the plaintiff seeks in the legal matter.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:to="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl" xlink:title="label: LossContingencyDamagesSoughtExpectedEquityPercentage to btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl1" xml:lang="en-US" id="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl1">Loss Contingency, Damages Sought, Expected Equity Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:to="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl1" xlink:title="label: LossContingencyDamagesSoughtExpectedEquityPercentage to btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl2" xml:lang="en-US" id="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl2">Percentage of equity promised against plaintiff</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:to="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl2" xlink:title="label: LossContingencyDamagesSoughtExpectedEquityPercentage to btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyDamagesSoughtExpectedSalary" xlink:label="LossContingencyDamagesSoughtExpectedSalary" xlink:title="LossContingencyDamagesSoughtExpectedSalary" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyDamagesSoughtExpectedSalary_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LossContingencyDamagesSoughtExpectedSalary_lbl" xml:lang="en-US" id="btx_LossContingencyDamagesSoughtExpectedSalary_lbl">The monetary amount of salary promised to the plaintiff seeks in the legal matter.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtExpectedSalary" xlink:to="btx_LossContingencyDamagesSoughtExpectedSalary_lbl" xlink:title="label: LossContingencyDamagesSoughtExpectedSalary to btx_LossContingencyDamagesSoughtExpectedSalary_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyDamagesSoughtExpectedSalary_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LossContingencyDamagesSoughtExpectedSalary_lbl1" xml:lang="en-US" id="btx_LossContingencyDamagesSoughtExpectedSalary_lbl1">Loss Contingency, Damages Sought, Expected Salary</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtExpectedSalary" xlink:to="btx_LossContingencyDamagesSoughtExpectedSalary_lbl1" xlink:title="label: LossContingencyDamagesSoughtExpectedSalary to btx_LossContingencyDamagesSoughtExpectedSalary_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyDamagesSoughtExpectedSalary_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LossContingencyDamagesSoughtExpectedSalary_lbl2" xml:lang="en-US" id="btx_LossContingencyDamagesSoughtExpectedSalary_lbl2">Defendants salary promised against plaintiff</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtExpectedSalary" xlink:to="btx_LossContingencyDamagesSoughtExpectedSalary_lbl2" xlink:title="label: LossContingencyDamagesSoughtExpectedSalary to btx_LossContingencyDamagesSoughtExpectedSalary_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LegalMattersAbstract" xlink:label="LegalMattersAbstract" xlink:title="LegalMattersAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_LegalMattersAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LegalMattersAbstract_lbl1" xml:lang="en-US" id="btx_LegalMattersAbstract_lbl1">Legal Matters [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalMattersAbstract" xlink:to="btx_LegalMattersAbstract_lbl1" xlink:title="label: LegalMattersAbstract to btx_LegalMattersAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LegalMattersAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LegalMattersAbstract_lbl2" xml:lang="en-US" id="btx_LegalMattersAbstract_lbl2">Legal Matters [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalMattersAbstract" xlink:to="btx_LegalMattersAbstract_lbl2" xlink:title="label: LegalMattersAbstract to btx_LegalMattersAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AccruedGeneralAndAdministrativeExpenses" xlink:label="AccruedGeneralAndAdministrativeExpenses" xlink:title="AccruedGeneralAndAdministrativeExpenses" />
    <link:label xlink:type="resource" xlink:label="btx_AccruedGeneralAndAdministrativeExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AccruedGeneralAndAdministrativeExpenses_lbl" xml:lang="en-US" id="btx_AccruedGeneralAndAdministrativeExpenses_lbl">Amount of accrued general and administrative expenses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedGeneralAndAdministrativeExpenses" xlink:to="btx_AccruedGeneralAndAdministrativeExpenses_lbl" xlink:title="label: AccruedGeneralAndAdministrativeExpenses to btx_AccruedGeneralAndAdministrativeExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AccruedGeneralAndAdministrativeExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AccruedGeneralAndAdministrativeExpenses_lbl1" xml:lang="en-US" id="btx_AccruedGeneralAndAdministrativeExpenses_lbl1">Accrued General and Administrative Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedGeneralAndAdministrativeExpenses" xlink:to="btx_AccruedGeneralAndAdministrativeExpenses_lbl1" xlink:title="label: AccruedGeneralAndAdministrativeExpenses to btx_AccruedGeneralAndAdministrativeExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AccruedGeneralAndAdministrativeExpenses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AccruedGeneralAndAdministrativeExpenses_lbl2" xml:lang="en-US" id="btx_AccruedGeneralAndAdministrativeExpenses_lbl2">Accrued general and administrative expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedGeneralAndAdministrativeExpenses" xlink:to="btx_AccruedGeneralAndAdministrativeExpenses_lbl2" xlink:title="label: AccruedGeneralAndAdministrativeExpenses to btx_AccruedGeneralAndAdministrativeExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AccruedResearchAndDevelopmentExpenses" xlink:label="AccruedResearchAndDevelopmentExpenses" xlink:title="AccruedResearchAndDevelopmentExpenses" />
    <link:label xlink:type="resource" xlink:label="btx_AccruedResearchAndDevelopmentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AccruedResearchAndDevelopmentExpenses_lbl" xml:lang="en-US" id="btx_AccruedResearchAndDevelopmentExpenses_lbl">Amount of accrued research and development expenses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedResearchAndDevelopmentExpenses" xlink:to="btx_AccruedResearchAndDevelopmentExpenses_lbl" xlink:title="label: AccruedResearchAndDevelopmentExpenses to btx_AccruedResearchAndDevelopmentExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AccruedResearchAndDevelopmentExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AccruedResearchAndDevelopmentExpenses_lbl1" xml:lang="en-US" id="btx_AccruedResearchAndDevelopmentExpenses_lbl1">Accrued Research and Development Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedResearchAndDevelopmentExpenses" xlink:to="btx_AccruedResearchAndDevelopmentExpenses_lbl1" xlink:title="label: AccruedResearchAndDevelopmentExpenses to btx_AccruedResearchAndDevelopmentExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AccruedResearchAndDevelopmentExpenses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AccruedResearchAndDevelopmentExpenses_lbl2" xml:lang="en-US" id="btx_AccruedResearchAndDevelopmentExpenses_lbl2">Accrued research and development expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedResearchAndDevelopmentExpenses" xlink:to="btx_AccruedResearchAndDevelopmentExpenses_lbl2" xlink:title="label: AccruedResearchAndDevelopmentExpenses to btx_AccruedResearchAndDevelopmentExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:label xlink:type="resource" xlink:label="btx_NoveCiteINCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NoveCiteINCMember_lbl" xml:lang="en-US" id="btx_NoveCiteINCMember_lbl">The name of company involved in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteINCMember" xlink:to="btx_NoveCiteINCMember_lbl" xlink:title="label: NoveCiteINCMember to btx_NoveCiteINCMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NoveCiteINCMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NoveCiteINCMember_lbl1" xml:lang="en-US" id="btx_NoveCiteINCMember_lbl1">NoveCite, INC. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteINCMember" xlink:to="btx_NoveCiteINCMember_lbl1" xlink:title="label: NoveCiteINCMember to btx_NoveCiteINCMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NoveCiteINCMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NoveCiteINCMember_lbl2" xml:lang="en-US" id="btx_NoveCiteINCMember_lbl2">NoveCite, INC. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteINCMember" xlink:to="btx_NoveCiteINCMember_lbl2" xlink:title="label: NoveCiteINCMember to btx_NoveCiteINCMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LiquidityAndCapitalResourcesTextBlock" xlink:label="LiquidityAndCapitalResourcesTextBlock" xlink:title="LiquidityAndCapitalResourcesTextBlock" />
    <link:label xlink:type="resource" xlink:label="btx_LiquidityAndCapitalResourcesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LiquidityAndCapitalResourcesTextBlock_lbl" xml:lang="en-US" id="btx_LiquidityAndCapitalResourcesTextBlock_lbl">The entire disclosure of liquidity and resource matters when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). going concern.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTextBlock" xlink:to="btx_LiquidityAndCapitalResourcesTextBlock_lbl" xlink:title="label: LiquidityAndCapitalResourcesTextBlock to btx_LiquidityAndCapitalResourcesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LiquidityAndCapitalResourcesTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LiquidityAndCapitalResourcesTextBlock_lbl1" xml:lang="en-US" id="btx_LiquidityAndCapitalResourcesTextBlock_lbl1">Liquidity And Capital Resources [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTextBlock" xlink:to="btx_LiquidityAndCapitalResourcesTextBlock_lbl1" xlink:title="label: LiquidityAndCapitalResourcesTextBlock to btx_LiquidityAndCapitalResourcesTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LiquidityAndCapitalResourcesTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LiquidityAndCapitalResourcesTextBlock_lbl2" xml:lang="en-US" id="btx_LiquidityAndCapitalResourcesTextBlock_lbl2">LIQUIDITY AND CAPITAL RESOURCES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTextBlock" xlink:to="btx_LiquidityAndCapitalResourcesTextBlock_lbl2" xlink:title="label: LiquidityAndCapitalResourcesTextBlock to btx_LiquidityAndCapitalResourcesTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:label="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:title="LIQUIDITYANDCAPITALRESOURCESAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1" xml:lang="en-US" id="btx_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1">LIQUIDITY AND CAPITAL RESOURCES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:to="btx_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1" xlink:title="label: LIQUIDITYANDCAPITALRESOURCESAbstract to btx_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:label xlink:type="resource" xlink:label="btx_GainLossOnDisposalOfFixedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_GainLossOnDisposalOfFixedAssets_lbl" xml:lang="en-US" id="btx_GainLossOnDisposalOfFixedAssets_lbl">Amount of gain (loss) on sale or disposal of fixed assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="btx_GainLossOnDisposalOfFixedAssets_lbl" xlink:title="label: GainLossOnDisposalOfFixedAssets to btx_GainLossOnDisposalOfFixedAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_GainLossOnDisposalOfFixedAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_GainLossOnDisposalOfFixedAssets_lbl1" xml:lang="en-US" id="btx_GainLossOnDisposalOfFixedAssets_lbl1">Gain (Loss) on Disposal of Fixed Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="btx_GainLossOnDisposalOfFixedAssets_lbl1" xlink:title="label: GainLossOnDisposalOfFixedAssets to btx_GainLossOnDisposalOfFixedAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_GainLossOnDisposalOfFixedAssets_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_GainLossOnDisposalOfFixedAssets_lbl2" xml:lang="en-US" id="btx_GainLossOnDisposalOfFixedAssets_lbl2">Loss on disposal of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="btx_GainLossOnDisposalOfFixedAssets_lbl2" xlink:title="label: GainLossOnDisposalOfFixedAssets to btx_GainLossOnDisposalOfFixedAssets_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xml:lang="en-US" id="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl">The increase (decrease) during the reporting period in the operating lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:title="label: IncreaseDecreaseInOperatingLeaseLiabilities to btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" xml:lang="en-US" id="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInOperatingLeaseLiabilities to btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2" xml:lang="en-US" id="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2">Operating lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2" xlink:title="label: IncreaseDecreaseInOperatingLeaseLiabilities to btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:label="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:title="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" />
    <link:label xlink:type="resource" xlink:label="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl" xml:lang="en-US" id="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl">The increase (decrease) during the reporting period in moneys or securities given as security deposits and also includes any other non-current assets which are not separately reported in during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:to="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl" xlink:title="label: IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets to btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl1" xml:lang="en-US" id="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl1">Increase (Decrease) in Deposit Assets and Other Non-current Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:to="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl1" xlink:title="label: IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets to btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl2" xml:lang="en-US" id="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl2">Security deposits and other non-current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:to="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl2" xlink:title="label: IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets to btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:label xlink:type="resource" xlink:label="btx_WarrantLiabilitiesExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_WarrantLiabilitiesExpense_lbl" xml:lang="en-US" id="btx_WarrantLiabilitiesExpense_lbl">Amount of expenses related to warrant liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="btx_WarrantLiabilitiesExpense_lbl" xlink:title="label: WarrantLiabilitiesExpense to btx_WarrantLiabilitiesExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_WarrantLiabilitiesExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_WarrantLiabilitiesExpense_lbl1" xml:lang="en-US" id="btx_WarrantLiabilitiesExpense_lbl1">Warrant Liabilities Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="btx_WarrantLiabilitiesExpense_lbl1" xlink:title="label: WarrantLiabilitiesExpense to btx_WarrantLiabilitiesExpense_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_WarrantLiabilitiesExpense_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_WarrantLiabilitiesExpense_lbl2" xml:lang="en-US" id="btx_WarrantLiabilitiesExpense_lbl2">Warrant liabilities expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="btx_WarrantLiabilitiesExpense_lbl2" xlink:title="label: WarrantLiabilitiesExpense to btx_WarrantLiabilitiesExpense_lbl2" />
    <link:label xlink:type="resource" xlink:label="btx_WarrantLiabilitiesExpense_lbl3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_WarrantLiabilitiesExpense_lbl3" xml:lang="en-US" id="btx_WarrantLiabilitiesExpense_lbl3">Warrant liabilities expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="btx_WarrantLiabilitiesExpense_lbl3" xlink:title="label: WarrantLiabilitiesExpense to btx_WarrantLiabilitiesExpense_lbl3" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:label xlink:type="resource" xlink:label="btx_LossOnNonControllingInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LossOnNonControllingInvestment_lbl" xml:lang="en-US" id="btx_LossOnNonControllingInvestment_lbl">Amount of loss on non-controlling investment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="btx_LossOnNonControllingInvestment_lbl" xlink:title="label: LossOnNonControllingInvestment to btx_LossOnNonControllingInvestment_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LossOnNonControllingInvestment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LossOnNonControllingInvestment_lbl1" xml:lang="en-US" id="btx_LossOnNonControllingInvestment_lbl1">Loss on Non-controlling Investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="btx_LossOnNonControllingInvestment_lbl1" xlink:title="label: LossOnNonControllingInvestment to btx_LossOnNonControllingInvestment_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LossOnNonControllingInvestment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LossOnNonControllingInvestment_lbl2" xml:lang="en-US" id="btx_LossOnNonControllingInvestment_lbl2">Loss on non-controlling investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="btx_LossOnNonControllingInvestment_lbl2" xlink:title="label: LossOnNonControllingInvestment to btx_LossOnNonControllingInvestment_lbl2" />
    <link:label xlink:type="resource" xlink:label="btx_LossOnNonControllingInvestment_lbl3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_LossOnNonControllingInvestment_lbl3" xml:lang="en-US" id="btx_LossOnNonControllingInvestment_lbl3">Loss on non-controlling investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="btx_LossOnNonControllingInvestment_lbl3" xlink:title="label: LossOnNonControllingInvestment to btx_LossOnNonControllingInvestment_lbl3" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_GainOnTerminationOfLease" xlink:label="GainOnTerminationOfLease" xlink:title="GainOnTerminationOfLease" />
    <link:label xlink:type="resource" xlink:label="btx_GainOnTerminationOfLease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_GainOnTerminationOfLease_lbl" xml:lang="en-US" id="btx_GainOnTerminationOfLease_lbl">Amount of gain on termination of lease before expiration of lease term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnTerminationOfLease" xlink:to="btx_GainOnTerminationOfLease_lbl" xlink:title="label: GainOnTerminationOfLease to btx_GainOnTerminationOfLease_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_GainOnTerminationOfLease_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_GainOnTerminationOfLease_lbl1" xml:lang="en-US" id="btx_GainOnTerminationOfLease_lbl1">Gain on Termination of Lease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnTerminationOfLease" xlink:to="btx_GainOnTerminationOfLease_lbl1" xlink:title="label: GainOnTerminationOfLease to btx_GainOnTerminationOfLease_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_GainOnTerminationOfLease_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_GainOnTerminationOfLease_lbl2" xml:lang="en-US" id="btx_GainOnTerminationOfLease_lbl2">Gain on lease termination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnTerminationOfLease" xlink:to="btx_GainOnTerminationOfLease_lbl2" xlink:title="label: GainOnTerminationOfLease to btx_GainOnTerminationOfLease_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CashPaidDuringThePeriodForAbstract" xlink:label="CashPaidDuringThePeriodForAbstract" xlink:title="CashPaidDuringThePeriodForAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_CashPaidDuringThePeriodForAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CashPaidDuringThePeriodForAbstract_lbl1" xml:lang="en-US" id="btx_CashPaidDuringThePeriodForAbstract_lbl1">Cash Paid During the Period for [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="btx_CashPaidDuringThePeriodForAbstract_lbl1" xlink:title="label: CashPaidDuringThePeriodForAbstract to btx_CashPaidDuringThePeriodForAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_CashPaidDuringThePeriodForAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_CashPaidDuringThePeriodForAbstract_lbl2" xml:lang="en-US" id="btx_CashPaidDuringThePeriodForAbstract_lbl2">Cash paid during the period for:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="btx_CashPaidDuringThePeriodForAbstract_lbl2" xlink:title="label: CashPaidDuringThePeriodForAbstract to btx_CashPaidDuringThePeriodForAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PaymentsOfPaycheckProtectionProgramLoan" xlink:label="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="PaymentsOfPaycheckProtectionProgramLoan" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl" xml:lang="en-US" id="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl">The amount of cash outflow for payment of paycheck protection program loans.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfPaycheckProtectionProgramLoan" xlink:to="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl" xlink:title="label: PaymentsOfPaycheckProtectionProgramLoan to btx_PaymentsOfPaycheckProtectionProgramLoan_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl1" xml:lang="en-US" id="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl1">Payments of Paycheck Protection Program Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfPaycheckProtectionProgramLoan" xlink:to="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl1" xlink:title="label: PaymentsOfPaycheckProtectionProgramLoan to btx_PaymentsOfPaycheckProtectionProgramLoan_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl2" xml:lang="en-US" id="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl2">Repayment of NTN's PPP loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfPaycheckProtectionProgramLoan" xlink:to="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl2" xlink:title="label: PaymentsOfPaycheckProtectionProgramLoan to btx_PaymentsOfPaycheckProtectionProgramLoan_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:label="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:title="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" />
    <link:label xlink:type="resource" xlink:label="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl" xml:lang="en-US" id="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl">The fair value of preferred stock issued in a reverse merger transaction in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:to="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl" xlink:title="label: NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger to btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1" xml:lang="en-US" id="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1">Noncash or Part Noncash Acquisition, Preferred Shares Issued in Connection with Reverse Merger</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:to="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1" xlink:title="label: NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger to btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2" xml:lang="en-US" id="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2">Series A preferred stock retained in business combination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:to="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2" xlink:title="label: NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger to btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>btx-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://brooklynitx.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#SubsequentEventDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#EarningsPerShareDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquityMergerDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockholdersEquityMergerDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquityReverseStocksplitDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockholdersEquityReverseStocksplitDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockholdersEquityPrivatePlacementOfEquityDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationRsusDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensationRsusDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensationSummaryOfStockOptionsDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensationStockOptionActivityDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#CommitmentsAndContingenciesRoyaltyAgreementsDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#CommitmentsAndContingenciesLicensingAgreementsDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#CommitmentsAndContingenciesLegalMattersDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopmentDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#GoodwillAndInprocessResearchDevelopmentDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesNetOperatingLeaseExpensesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesOperatingLeaseDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesOperatingLeaseDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactionsDispositionDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactionsMergerDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#LiquidityAndCapitalResourcesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails" xlink:type="simple" xlink:href="btx-20220331.xsd#DescriptionOfBusinessAndBasisOfPresentationDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="btx-20220331.xsd#EarningsPerShareTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensationTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="btx-20220331.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesTables" xlink:type="simple" xlink:href="btx-20220331.xsd#LeasesTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables" xlink:type="simple" xlink:href="btx-20220331.xsd#FairValueOfFinancialInstrumentsTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactionsTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="btx-20220331.xsd#RecentAccountingPronouncementsPolicies" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:type="simple" xlink:href="btx-20220331.xsd#DescriptionOfBusinessAndBasisOfPresentationPolicies" />
  <link:roleRef roleURI="http://brooklynitx.com/role/SubsequentEvent" xlink:type="simple" xlink:href="btx-20220331.xsd#SubsequentEvent" />
  <link:roleRef roleURI="http://brooklynitx.com/role/RecentAccountingPronouncements" xlink:type="simple" xlink:href="btx-20220331.xsd#RecentAccountingPronouncements" />
  <link:roleRef roleURI="http://brooklynitx.com/role/EarningsPerShare" xlink:type="simple" xlink:href="btx-20220331.xsd#EarningsPerShare" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquity" xlink:type="simple" xlink:href="btx-20220331.xsd#StockholdersEquity" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensation" xlink:type="simple" xlink:href="btx-20220331.xsd#StockbasedCompensation" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="btx-20220331.xsd#CommitmentsAndContingencies" />
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpenses" xlink:type="simple" xlink:href="btx-20220331.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopment" xlink:type="simple" xlink:href="btx-20220331.xsd#GoodwillAndInprocessResearchDevelopment" />
  <link:roleRef roleURI="http://brooklynitx.com/role/Leases" xlink:type="simple" xlink:href="btx-20220331.xsd#Leases" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstruments" xlink:type="simple" xlink:href="btx-20220331.xsd#FairValueOfFinancialInstruments" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions" xlink:type="simple" xlink:href="btx-20220331.xsd#MergerDispositionAndAcquisitionTransactions" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LiquidityAndCapitalResources" xlink:type="simple" xlink:href="btx-20220331.xsd#LiquidityAndCapitalResources" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" xlink:href="btx-20220331.xsd#DescriptionOfBusinessAndBasisOfPresentation" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="btx-20220331.xsd#CondensedConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity" xlink:type="simple" xlink:href="btx-20220331.xsd#CondensedConsolidatedStatementsOfStockholdersAndMembersEquity" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="btx-20220331.xsd#CondensedConsolidatedStatementsOfOperations" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="btx-20220331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="btx-20220331.xsd#CondensedConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="btx-20220331.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="DocumentQuarterlyReport" xlink:title="DocumentQuarterlyReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentQuarterlyReport" xlink:title="presentation: CoverAbstract to DocumentQuarterlyReport" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: CoverAbstract to CurrentFiscalYearEndDate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentTransitionReport" xlink:title="presentation: CoverAbstract to DocumentTransitionReport" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCurrentReportingStatus" xlink:title="presentation: CoverAbstract to EntityCurrentReportingStatus" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityInteractiveDataCurrent" xlink:title="presentation: CoverAbstract to EntityInteractiveDataCurrent" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFilerCategory" xlink:title="presentation: CoverAbstract to EntityFilerCategory" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntitySmallBusiness" xlink:title="presentation: CoverAbstract to EntitySmallBusiness" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityShellCompany" xlink:title="presentation: CoverAbstract to EntityShellCompany" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCommonStockSharesOutstanding" xlink:title="presentation: CoverAbstract to EntityCommonStockSharesOutstanding" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="presentation: ClassOfStockDomain to SeriesAPreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: StatementTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="Cash" xlink:title="presentation: AssetsCurrentAbstract to Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="OtherReceivablesNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to OtherReceivablesNetCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to PrepaidExpenseAndOtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to AssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: AssetsCurrentAbstract to PropertyPlantAndEquipmentNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: AssetsCurrentAbstract to OperatingLeaseRightOfUseAsset" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="Goodwill" xlink:title="presentation: AssetsCurrentAbstract to Goodwill" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="presentation: AssetsCurrentAbstract to IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="EquityMethodInvestments" xlink:title="presentation: AssetsCurrentAbstract to EquityMethodInvestments" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets" xlink:label="DepositAssets" xlink:title="DepositAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="DepositAssets" xlink:title="presentation: AssetsCurrentAbstract to DepositAssets" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="Assets" xlink:title="presentation: AssetsCurrentAbstract to Assets" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="AssetsAbstract" xlink:title="presentation: StatementLineItems to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccountsPayableCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OperatingLeaseLiabilityCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OtherLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OtherLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesCurrentAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="DerivativeLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to DerivativeLiabilitiesNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OperatingLeaseLiabilityNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OtherLiabilitiesNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="Liabilities" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to Liabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="PreferredStockValue" xlink:title="presentation: EquityAbstract to PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="CommonStockValue" xlink:title="presentation: EquityAbstract to CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="AdditionalPaidInCapital" xlink:title="presentation: EquityAbstract to AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: EquityAbstract to RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="StockholdersEquity" xlink:title="presentation: EquityAbstract to StockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="EquityAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to EquityAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesAndStockholdersEquity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementLineItems to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfFinancialPositionAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="PreferredStockParOrStatedValuePerShare" xlink:title="presentation: EquityAbstract to PreferredStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="PreferredStockSharesAuthorized" xlink:title="presentation: EquityAbstract to PreferredStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="PreferredStockSharesIssued" xlink:title="presentation: EquityAbstract to PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="PreferredStockSharesOutstanding" xlink:title="presentation: EquityAbstract to PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="PreferredStockLiquidationPreferenceValue" xlink:title="PreferredStockLiquidationPreferenceValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="PreferredStockLiquidationPreferenceValue" xlink:title="presentation: EquityAbstract to PreferredStockLiquidationPreferenceValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: EquityAbstract to CommonStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="CommonStockSharesAuthorized" xlink:title="presentation: EquityAbstract to CommonStockSharesAuthorized" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="CommonStockSharesIssued" xlink:title="presentation: EquityAbstract to CommonStockSharesIssued" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="CommonStockSharesOutstanding" xlink:title="presentation: EquityAbstract to CommonStockSharesOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="EquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to EquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="ResearchAndDevelopmentExpense" xlink:title="presentation: OperatingExpensesAbstract to ResearchAndDevelopmentExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="GeneralAndAdministrativeExpense" xlink:title="presentation: OperatingExpensesAbstract to GeneralAndAdministrativeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="NoncashMergerRelatedCosts" xlink:title="presentation: OperatingExpensesAbstract to NoncashMergerRelatedCosts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="OperatingExpenses" xlink:title="presentation: OperatingExpensesAbstract to OperatingExpenses" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingExpensesAbstract" xlink:title="presentation: IncomeStatementAbstract to OperatingExpensesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to OperatingIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpensesAbstract" xlink:label="OtherExpensesAbstract" xlink:title="OtherExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="GainLossOnDispositionOfAssets1" xlink:title="GainLossOnDispositionOfAssets1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="GainLossOnDispositionOfAssets1" xlink:title="presentation: OtherExpensesAbstract to GainLossOnDispositionOfAssets1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="WarrantLiabilitiesExpense" xlink:title="presentation: OtherExpensesAbstract to WarrantLiabilitiesExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="LossOnNonControllingInvestment" xlink:title="presentation: OtherExpensesAbstract to LossOnNonControllingInvestment" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="OtherNonoperatingIncomeExpense" xlink:title="presentation: OtherExpensesAbstract to OtherNonoperatingIncomeExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="NonoperatingIncomeExpense" xlink:title="presentation: OtherExpensesAbstract to NonoperatingIncomeExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OtherExpensesAbstract" xlink:title="presentation: IncomeStatementAbstract to OtherExpensesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: IncomeStatementAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeStatementAbstract to IncomeTaxExpenseBenefit" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to NetIncomeLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareBasic" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareBasic" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareDiluted" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareDiluted" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfSharesOutstandingBasic" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfDilutedSharesOutstanding" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MembershipEquityMember" xlink:label="MembershipEquityMember" xlink:title="MembershipEquityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="MembershipEquityMember" xlink:title="presentation: StatementEquityComponentsAxis to MembershipEquityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="CommonStockMember" xlink:title="presentation: StatementEquityComponentsAxis to CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="PreferredStockMember" xlink:title="presentation: StatementEquityComponentsAxis to PreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="AdditionalPaidInCapitalMember" xlink:title="presentation: StatementEquityComponentsAxis to AdditionalPaidInCapitalMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="RetainedEarningsMember" xlink:title="presentation: StatementEquityComponentsAxis to RetainedEarningsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: StatementTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="presentation: ClassOfStockDomain to CommonClassAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassBMember" xlink:title="presentation: ClassOfStockDomain to CommonClassBMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassCMember" xlink:title="presentation: ClassOfStockDomain to CommonClassCMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CommonUnitsMember" xlink:label="CommonUnitsMember" xlink:title="CommonUnitsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonUnitsMember" xlink:title="presentation: ClassOfStockDomain to CommonUnitsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="presentation: ClassOfStockDomain to SeriesAPreferredStockMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: StatementTable to StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquity" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:label="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:label="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValueAcquisitions1" xlink:label="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="StockIssuedDuringPeriodValueAcquisitions1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueAcquisitions1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesAcquisitions1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnersCapitalAccountAcquisitions" xlink:label="PartnersCapitalAccountAcquisitions" xlink:title="PartnersCapitalAccountAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="PartnersCapitalAccountAcquisitions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to PartnersCapitalAccountAcquisitions" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PartnersCapitalAccountUnitsAcquisitions" xlink:label="PartnersCapitalAccountUnitsAcquisitions" xlink:title="PartnersCapitalAccountUnitsAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="PartnersCapitalAccountUnitsAcquisitions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to PartnersCapitalAccountUnitsAcquisitions" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueAcquisitions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueAcquisitions" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesAcquisitions" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValuePrivateOffering" xlink:label="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="StockIssuedDuringPeriodValuePrivateOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValuePrivateOffering" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodSharesPrivateOffering" xlink:label="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="StockIssuedDuringPeriodSharesPrivateOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesPrivateOffering" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:label="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:label="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" order="15.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="NetIncomeLoss" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to NetIncomeLoss" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity_2" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquity_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquity" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding_2" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="presentation: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfStockholdersEquityAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DepreciationDepletionAndAmortization" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ShareBasedCompensation" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to OperatingLeaseRightOfUseAssetAmortizationExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NoncashMergerRelatedCosts" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to NoncashMergerRelatedCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="GainLossOnDispositionOfAssets1" xlink:title="GainLossOnDispositionOfAssets1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnDispositionOfAssets1" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainLossOnDispositionOfAssets1" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnDisposalOfFixedAssets" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainLossOnDisposalOfFixedAssets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_GainOnTerminationOfLease" xlink:label="GainOnTerminationOfLease" xlink:title="GainOnTerminationOfLease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainOnTerminationOfLease" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainOnTerminationOfLease" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="WarrantLiabilitiesExpense" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to WarrantLiabilitiesExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="LossOnNonControllingInvestment" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to LossOnNonControllingInvestment" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="IncreaseDecreaseInOtherReceivables" xlink:title="IncreaseDecreaseInOtherReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherReceivables" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:label="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:title="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOperatingLeaseLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherOperatingLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to IncreaseDecreaseInOperatingCapitalAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetCashProvidedByUsedInOperatingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:label="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="ProceedsFromSalesOfAssetsInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromSalesOfAssetsInvestingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromDivestitureOfBusinesses" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromDivestitureOfBusinesses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to NetCashProvidedByUsedInInvestingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromIssuanceOfCommonStock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="ProceedsFromOtherEquity" xlink:title="ProceedsFromOtherEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromOtherEquity" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromOtherEquity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PaymentsOfPaycheckProtectionProgramLoan" xlink:label="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="PaymentsOfPaycheckProtectionProgramLoan" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfPaycheckProtectionProgramLoan" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to NetCashProvidedByUsedInFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CashPaidDuringThePeriodForAbstract" xlink:label="CashPaidDuringThePeriodForAbstract" xlink:title="CashPaidDuringThePeriodForAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="InterestPaidNet" xlink:title="presentation: CashPaidDuringThePeriodForAbstract to InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="CashPaidDuringThePeriodForAbstract" xlink:title="presentation: SupplementalCashFlowInformationAbstract to CashPaidDuringThePeriodForAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="SupplementalCashFlowInformationAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to SupplementalCashFlowInformationAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1" xlink:label="StockIssued1" xlink:title="StockIssued1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="StockIssued1" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to StockIssued1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:label="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:title="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LiquidityAndCapitalResources">
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:label="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:title="LIQUIDITYANDCAPITALRESOURCESAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LiquidityAndCapitalResourcesTextBlock" xlink:label="LiquidityAndCapitalResourcesTextBlock" xlink:title="LiquidityAndCapitalResourcesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:to="LiquidityAndCapitalResourcesTextBlock" xlink:title="presentation: LIQUIDITYANDCAPITALRESOURCESAbstract to LiquidityAndCapitalResourcesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:title="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to MergersAcquisitionsAndDispositionsDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstruments">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueDisclosuresTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/Leases">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeasesTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopment">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpenses">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingencies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="StockholdersEquityNoteDisclosureTextBlock" xlink:title="presentation: StockholdersEquityNoteAbstract to StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/EarningsPerShare">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/RecentAccountingPronouncements">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:title="presentation: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/SubsequentEvent">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="SubsequentEventsTextBlock" xlink:title="SubsequentEventsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="SubsequentEventsTextBlock" xlink:title="presentation: SubsequentEventsAbstract to SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="PriorPeriodReclassificationAdjustmentDescription" xlink:title="PriorPeriodReclassificationAdjustmentDescription" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="PriorPeriodReclassificationAdjustmentDescription" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to PriorPeriodReclassificationAdjustmentDescription" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="presentation: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to NewAccountingPronouncementsPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:title="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:title="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:label="AssetAcquisitionTableTextBlock" xlink:title="AssetAcquisitionTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="AssetAcquisitionTableTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to AssetAcquisitionTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:title="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LeaseCostTableTextBlock" xlink:title="presentation: LeasesAbstract to LeaseCostTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:label="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:title="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:title="presentation: LeasesAbstract to OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpensesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to ScheduleOfAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/EarningsPerShareTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="presentation: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="presentation: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EquityMethodInvestmentOwnershipPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails">
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:label="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:title="LIQUIDITYANDCAPITALRESOURCESAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:label="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:title="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="Cash" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to RetainedEarningsAccumulatedDeficit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to NetIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to NetCashProvidedByUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="ProceedsFromIssuanceOfPrivatePlacement" xlink:title="ProceedsFromIssuanceOfPrivatePlacement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="ProceedsFromIssuanceOfPrivatePlacement" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to ProceedsFromIssuanceOfPrivatePlacement" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:to="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:title="presentation: LIQUIDITYANDCAPITALRESOURCESAbstract to DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodSharesIssuedForServices" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="BusinessAcquisitionSharePrice" xlink:title="BusinessAcquisitionSharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionSharePrice" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionSharePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="CommonStockSharesOutstanding" xlink:title="presentation: BusinessCombinationDescriptionAbstract to CommonStockSharesOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="Goodwill" xlink:title="presentation: BusinessCombinationDescriptionAbstract to Goodwill" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:label="NonrecurringAdjustmentAxis" xlink:title="NonrecurringAdjustmentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="NonrecurringAdjustmentDomain" xlink:title="NonrecurringAdjustmentDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ProFormaFairValueAdjustmentToAssetsMember" xlink:label="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="ProFormaFairValueAdjustmentToAssetsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonrecurringAdjustmentDomain" xlink:to="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="presentation: NonrecurringAdjustmentDomain to ProFormaFairValueAdjustmentToAssetsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PurchasePriceAllocationMember" xlink:label="PurchasePriceAllocationMember" xlink:title="PurchasePriceAllocationMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonrecurringAdjustmentDomain" xlink:to="PurchasePriceAllocationMember" xlink:title="presentation: NonrecurringAdjustmentDomain to PurchasePriceAllocationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonrecurringAdjustmentAxis" xlink:to="NonrecurringAdjustmentDomain" xlink:title="presentation: NonrecurringAdjustmentAxis to NonrecurringAdjustmentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="NonrecurringAdjustmentAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to NonrecurringAdjustmentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TradeNamesMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TradeNamesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="Goodwill" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to Goodwill" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:label="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="presentation: BusinessAcquisitionLineItems to ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_BeneficialHoldersContractualCommitmentsToInvest" xlink:label="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="BeneficialHoldersContractualCommitmentsToInvest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="presentation: BusinessAcquisitionLineItems to BeneficialHoldersContractualCommitmentsToInvest" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfAdditionalRightsOffering" xlink:label="PercentageOfAdditionalRightsOffering" xlink:title="PercentageOfAdditionalRightsOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfAdditionalRightsOffering" xlink:title="presentation: BusinessAcquisitionLineItems to PercentageOfAdditionalRightsOffering" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ProceedsFromSaleOfRights" xlink:label="ProceedsFromSaleOfRights" xlink:title="ProceedsFromSaleOfRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="ProceedsFromSaleOfRights" xlink:title="presentation: BusinessAcquisitionLineItems to ProceedsFromSaleOfRights" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NTNBusinessMember" xlink:label="NTNBusinessMember" xlink:title="NTNBusinessMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="NTNBusinessMember" xlink:title="presentation: DisposalGroupsIncludingDiscontinuedOperationsNameDomain to NTNBusinessMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis to DisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TradeNamesMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TradeNamesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DispositionAbstract" xlink:label="DispositionAbstract" xlink:title="DispositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:label="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="presentation: DispositionAbstract to ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ProceedsFromDispositionAbstract" xlink:label="ProceedsFromDispositionAbstract" xlink:title="ProceedsFromDispositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProceedsFromDispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="presentation: ProceedsFromDispositionAbstract to DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProceedsFromDispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="presentation: ProceedsFromDispositionAbstract to DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProceedsFromDispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="presentation: ProceedsFromDispositionAbstract to DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProceedsFromDispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="presentation: ProceedsFromDispositionAbstract to DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="ProceedsFromDispositionAbstract" xlink:title="presentation: DispositionAbstract to ProceedsFromDispositionAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:label="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:label="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="DisposalGroupIncludingDiscontinuedOperationGoodwill1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationGoodwill1" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationOtherAssets" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="presentation: DispositionAbstract to AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:label="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:label="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:label="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="presentation: DispositionAbstract to LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="presentation: DispositionAbstract to DisposalGroupIncludingDiscontinuedOperationTransactionCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="presentation: DispositionAbstract to DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DispositionAbstract" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DispositionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="presentation: BusinessCombinationsAbstract to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="presentation: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="presentation: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="AssetAcquisitionAxis" xlink:title="AssetAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="AssetAcquisitionDomain" xlink:title="AssetAcquisitionDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="presentation: AssetAcquisitionDomain to NovellusTherapeuticsLimitedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionAxis" xlink:to="AssetAcquisitionDomain" xlink:title="presentation: AssetAcquisitionAxis to AssetAcquisitionDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="AssetAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to AssetAcquisitionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:label="ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" xlink:title="presentation: RelatedPartyDomain to ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RelatedPartyTransactionsByRelatedPartyAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EquityMethodInvestmentOwnershipPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:label="PaymentsToAcquireOtherProductiveAssets" xlink:title="PaymentsToAcquireOtherProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireOtherProductiveAssets" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireOtherProductiveAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodSharesAcquisitions" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodValueAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodValueAcquisitions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AssetAcquisitionSharePrice" xlink:label="AssetAcquisitionSharePrice" xlink:title="AssetAcquisitionSharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AssetAcquisitionSharePrice" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AssetAcquisitionSharePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodValueNewIssues" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodValueNewIssues" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_EscrowShares" xlink:label="EscrowShares" xlink:title="EscrowShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EscrowShares" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EscrowShares" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_EscrowPeriod" xlink:label="EscrowPeriod" xlink:title="EscrowPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EscrowPeriod" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EscrowPeriod" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AcquisitionAgreementNonCompetitivePeriod" xlink:label="AcquisitionAgreementNonCompetitivePeriod" xlink:title="AcquisitionAgreementNonCompetitivePeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AcquisitionAgreementNonCompetitivePeriod" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AcquisitionAgreementNonCompetitivePeriod" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodSharesIssuedForServices" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_EachLockUpAgreementExtendsTerm" xlink:label="EachLockUpAgreementExtendsTerm" xlink:title="EachLockUpAgreementExtendsTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EachLockUpAgreementExtendsTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EachLockUpAgreementExtendsTerm" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfCommonStockSubjectToLockUpAgreement" xlink:label="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="PercentageOfCommonStockSubjectToLockUpAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PercentageOfCommonStockSubjectToLockUpAgreement" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PaymentsToAcquireProductiveAssetsNet" xlink:label="PaymentsToAcquireProductiveAssetsNet" xlink:title="PaymentsToAcquireProductiveAssetsNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireProductiveAssetsNet" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireProductiveAssetsNet" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodRestrictedSharesAcquisitions" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LockUpPeriodForRestrictedShares" xlink:label="LockUpPeriodForRestrictedShares" xlink:title="LockUpPeriodForRestrictedShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="LockUpPeriodForRestrictedShares" xlink:title="presentation: BusinessCombinationDescriptionAbstract to LockUpPeriodForRestrictedShares" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AssetAcquisitionUnrestrictedSharesSharePrice" xlink:label="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="AssetAcquisitionUnrestrictedSharesSharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AssetAcquisitionUnrestrictedSharesSharePrice" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:label="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="PercentageOfDiscountOnFairValueOfRestrictedShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PercentageOfDiscountOnFairValueOfRestrictedShares" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AssetAcquisitionRestrictedSharesSharePrice" xlink:label="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="AssetAcquisitionRestrictedSharesSharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AssetAcquisitionRestrictedSharesSharePrice" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireProductiveAssets" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="CashAcquiredFromAcquisition" xlink:title="presentation: BusinessCombinationDescriptionAbstract to CashAcquiredFromAcquisition" order="20.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AssetAcquisitionFairValueOfConsiderationPaid" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="PaymentsToAcquireInvestments" xlink:title="PaymentsToAcquireInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireInvestments" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireInvestments" order="24.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="presentation: BusinessCombinationDescriptionAbstract to ResearchAndDevelopmentInProcessAssetAcquisition" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="presentation: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="presentation: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CitiusPharmaceuticalsIncMember" xlink:label="CitiusPharmaceuticalsIncMember" xlink:title="CitiusPharmaceuticalsIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipDomain" xlink:to="CitiusPharmaceuticalsIncMember" xlink:title="presentation: OwnershipDomain to CitiusPharmaceuticalsIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="presentation: OwnershipAxis to OwnershipDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="OwnershipAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to OwnershipAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="InvestmentsAbstract" xlink:title="InvestmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="presentation: InvestmentsAbstract to EquityMethodInvestmentOwnershipPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="MinorityInterestOwnershipPercentageByParent" xlink:title="MinorityInterestOwnershipPercentageByParent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="MinorityInterestOwnershipPercentageByParent" xlink:title="presentation: InvestmentsAbstract to MinorityInterestOwnershipPercentageByParent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NumberOfBoardSeats" xlink:label="NumberOfBoardSeats" xlink:title="NumberOfBoardSeats" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="NumberOfBoardSeats" xlink:title="presentation: InvestmentsAbstract to NumberOfBoardSeats" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="EquityMethodInvestments" xlink:title="presentation: InvestmentsAbstract to EquityMethodInvestments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="presentation: InvestmentsAbstract to EquityMethodInvestmentRealizedGainLossOnDisposal" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="InvestmentsAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to InvestmentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel1Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel1Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="presentation: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to DerivativeFinancialInstrumentsLiabilitiesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="presentation: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByLiabilityClassAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByLiabilityClassAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiabilityAbstract" xlink:label="FairValueNetAssetLiabilityAbstract" xlink:title="FairValueNetAssetLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="LiabilitiesFairValueDisclosure" xlink:title="LiabilitiesFairValueDisclosure" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="LiabilitiesFairValueDisclosure" xlink:title="presentation: LiabilitiesFairValueDisclosureAbstract to LiabilitiesFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: LiabilitiesFairValueDisclosureAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueNetAssetLiabilityAbstract" xlink:to="LiabilitiesFairValueDisclosureAbstract" xlink:title="presentation: FairValueNetAssetLiabilityAbstract to LiabilitiesFairValueDisclosureAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueNetAssetLiabilityAbstract" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueNetAssetLiabilityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="presentation: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="OverSubscriptionAmountReceived" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to OverSubscriptionAmountReceived" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to StockRepurchaseProgramAuthorizedAmount1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="LiabilitiesFairValueAdjustment" xlink:title="LiabilitiesFairValueAdjustment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="LiabilitiesFairValueAdjustment" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to LiabilitiesFairValueAdjustment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesOperatingLeaseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_OperatingLeaseArea" xlink:label="OperatingLeaseArea" xlink:title="OperatingLeaseArea" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseArea" xlink:title="presentation: LeasesAbstract to OperatingLeaseArea" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseTermOfContract" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseTermOfContract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_BaseRentPerSquareFoot" xlink:label="BaseRentPerSquareFoot" xlink:title="BaseRentPerSquareFoot" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="BaseRentPerSquareFoot" xlink:title="presentation: LeasesAbstract to BaseRentPerSquareFoot" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageBaseRentIncreaseOnEachAnniversary" xlink:label="PercentageBaseRentIncreaseOnEachAnniversary" xlink:title="PercentageBaseRentIncreaseOnEachAnniversary" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="PercentageBaseRentIncreaseOnEachAnniversary" xlink:title="presentation: LeasesAbstract to PercentageBaseRentIncreaseOnEachAnniversary" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="LesseeOperatingLeaseRenewalTerm" xlink:title="LesseeOperatingLeaseRenewalTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseRenewalTerm" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseRenewalTerm" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LesseeCommitmentToPurchaseProperty" xlink:label="LesseeCommitmentToPurchaseProperty" xlink:title="LesseeCommitmentToPurchaseProperty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeCommitmentToPurchaseProperty" xlink:title="presentation: LeasesAbstract to LesseeCommitmentToPurchaseProperty" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_UnamortizedLeaseholdImprovements" xlink:label="UnamortizedLeaseholdImprovements" xlink:title="UnamortizedLeaseholdImprovements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="UnamortizedLeaseholdImprovements" xlink:title="presentation: LeasesAbstract to UnamortizedLeaseholdImprovements" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets" xlink:label="DepositAssets" xlink:title="DepositAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="DepositAssets" xlink:title="presentation: LeasesAbstract to DepositAssets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="OperatingLeaseCost" xlink:title="presentation: LeaseCostAbstract to OperatingLeaseCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome" xlink:label="SubleaseIncome" xlink:title="SubleaseIncome" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="SubleaseIncome" xlink:title="presentation: LeaseCostAbstract to SubleaseIncome" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="VariableLeaseCost" xlink:title="presentation: LeaseCostAbstract to VariableLeaseCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="LeaseCost" xlink:title="presentation: LeaseCostAbstract to LeaseCost" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LeaseCostAbstract" xlink:title="presentation: LeasesAbstract to LeaseCostAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:label="AssetsAndLiabilitiesLesseeAbstract" xlink:title="AssetsAndLiabilitiesLesseeAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_OperatingLeaseAssestAbstract" xlink:label="OperatingLeaseAssestAbstract" xlink:title="OperatingLeaseAssestAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseRightOfUseAssetAmortizationExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_WriteOffOfOperatingLeaseRightOfUseAsset" xlink:label="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:title="WriteOffOfOperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:title="presentation: OperatingLeaseAssestAbstract to WriteOffOfOperatingLeaseRightOfUseAsset" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset_2" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseRightOfUseAsset_2" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseRightOfUseAsset" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAndLiabilitiesLesseeAbstract" xlink:to="OperatingLeaseAssestAbstract" xlink:title="presentation: AssetsAndLiabilitiesLesseeAbstract to OperatingLeaseAssestAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="OperatingLeaseLiabilityAbstract" xlink:title="OperatingLeaseLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:label="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:title="PrincipalPaymentsOnOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:title="presentation: OperatingLeaseLiabilityAbstract to PrincipalPaymentsOnOperatingLeaseLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_WriteOffOfOperatingLeaseLiability" xlink:label="WriteOffOfOperatingLeaseLiability" xlink:title="WriteOffOfOperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="WriteOffOfOperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilityAbstract to WriteOffOfOperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability_2" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiability_2" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiability" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAndLiabilitiesLesseeAbstract" xlink:to="OperatingLeaseLiabilityAbstract" xlink:title="presentation: AssetsAndLiabilitiesLesseeAbstract to OperatingLeaseLiabilityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="AssetsAndLiabilitiesLesseeAbstract" xlink:title="presentation: LeasesAbstract to AssetsAndLiabilitiesLesseeAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:label="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:title="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="presentation: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="presentation: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to OperatingLeaseWeightedAverageDiscountRatePercent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to OperatingLeaseLiability" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="presentation: LeasesAbstract to OperatingLeaseLiabilitiesPaymentsDueAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" />
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="Goodwill" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to Goodwill" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="SharePrice" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to SharePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillImpairmentLoss" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillImpairmentLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to EmployeeRelatedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AccruedResearchAndDevelopmentExpenses" xlink:label="AccruedResearchAndDevelopmentExpenses" xlink:title="AccruedResearchAndDevelopmentExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedResearchAndDevelopmentExpenses" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedResearchAndDevelopmentExpenses" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AccruedGeneralAndAdministrativeExpenses" xlink:label="AccruedGeneralAndAdministrativeExpenses" xlink:title="AccruedGeneralAndAdministrativeExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedGeneralAndAdministrativeExpenses" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedGeneralAndAdministrativeExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccruedProfessionalFeesCurrent" xlink:title="presentation: PayablesAndAccrualsAbstract to AccruedProfessionalFeesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="presentation: RelatedPartyDomain to NovellusTherapeuticsLimitedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_DheshGovenderMember" xlink:label="DheshGovenderMember" xlink:title="DheshGovenderMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="DheshGovenderMember" xlink:title="presentation: RelatedPartyDomain to DheshGovenderMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: LossContingenciesTable to RelatedPartyTransactionsByRelatedPartyAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="RangeAxis" xlink:title="presentation: LossContingenciesTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LegalMattersAbstract" xlink:label="LegalMattersAbstract" xlink:title="LegalMattersAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyDamagesSoughtExpectedSalary" xlink:label="LossContingencyDamagesSoughtExpectedSalary" xlink:title="LossContingencyDamagesSoughtExpectedSalary" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="LossContingencyDamagesSoughtExpectedSalary" xlink:title="presentation: LegalMattersAbstract to LossContingencyDamagesSoughtExpectedSalary" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:label="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:title="LossContingencyDamagesSoughtExpectedEquityPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:title="presentation: LegalMattersAbstract to LossContingencyDamagesSoughtExpectedEquityPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="LossContingencyDamagesSoughtValue" xlink:title="LossContingencyDamagesSoughtValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="LossContingencyDamagesSoughtValue" xlink:title="presentation: LegalMattersAbstract to LossContingencyDamagesSoughtValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyNumberOfArbitrationPanel" xlink:label="LossContingencyNumberOfArbitrationPanel" xlink:title="LossContingencyNumberOfArbitrationPanel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="LossContingencyNumberOfArbitrationPanel" xlink:title="presentation: LegalMattersAbstract to LossContingencyNumberOfArbitrationPanel" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="AccruedProfessionalFeesCurrent" xlink:title="presentation: LegalMattersAbstract to AccruedProfessionalFeesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesLineItems" xlink:to="LegalMattersAbstract" xlink:title="presentation: LossContingenciesLineItems to LegalMattersAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="LossContingenciesLineItems" xlink:title="presentation: LossContingenciesTable to LossContingenciesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="LossContingenciesTable" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to LossContingenciesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_UniversityOfSouthFloridaMember" xlink:label="UniversityOfSouthFloridaMember" xlink:title="UniversityOfSouthFloridaMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityDomain" xlink:to="UniversityOfSouthFloridaMember" xlink:title="presentation: EntityDomain to UniversityOfSouthFloridaMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="presentation: LegalEntityAxis to EntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="LegalEntityAxis" xlink:title="presentation: LossContingenciesTable to LegalEntityAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="presentation: RelatedPartyDomain to NovellusTherapeuticsLimitedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NovellusLtdAndFactorBioscienceMember" xlink:label="NovellusLtdAndFactorBioscienceMember" xlink:title="NovellusLtdAndFactorBioscienceMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="NovellusLtdAndFactorBioscienceMember" xlink:title="presentation: RelatedPartyDomain to NovellusLtdAndFactorBioscienceMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NoveCiteMember" xlink:label="NoveCiteMember" xlink:title="NoveCiteMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="NoveCiteMember" xlink:title="presentation: RelatedPartyDomain to NoveCiteMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: LossContingenciesTable to RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="ScenarioForecastMember" xlink:title="presentation: ScenarioUnspecifiedDomain to ScenarioForecastMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="presentation: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="StatementScenarioAxis" xlink:title="presentation: LossContingenciesTable to StatementScenarioAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="RangeAxis" xlink:title="presentation: LossContingenciesTable to RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LicensingAgreementsAbstract" xlink:label="LicensingAgreementsAbstract" xlink:title="LicensingAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyPercentageOfRoyaltyPayable" xlink:label="LossContingencyPercentageOfRoyaltyPayable" xlink:title="LossContingencyPercentageOfRoyaltyPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="LossContingencyPercentageOfRoyaltyPayable" xlink:title="presentation: LicensingAgreementsAbstract to LossContingencyPercentageOfRoyaltyPayable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_LossContingencyNonRefundableOptionFee" xlink:label="LossContingencyNonRefundableOptionFee" xlink:title="LossContingencyNonRefundableOptionFee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="LossContingencyNonRefundableOptionFee" xlink:title="presentation: LicensingAgreementsAbstract to LossContingencyNonRefundableOptionFee" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_InitialLicenseFees" xlink:label="InitialLicenseFees" xlink:title="InitialLicenseFees" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="InitialLicenseFees" xlink:title="presentation: LicensingAgreementsAbstract to InitialLicenseFees" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AdditionalFeesObligatedToPay" xlink:label="AdditionalFeesObligatedToPay" xlink:title="AdditionalFeesObligatedToPay" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="AdditionalFeesObligatedToPay" xlink:title="presentation: LicensingAgreementsAbstract to AdditionalFeesObligatedToPay" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AmountRequireToPayInitialLicenseFees" xlink:label="AmountRequireToPayInitialLicenseFees" xlink:title="AmountRequireToPayInitialLicenseFees" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="AmountRequireToPayInitialLicenseFees" xlink:title="presentation: LicensingAgreementsAbstract to AmountRequireToPayInitialLicenseFees" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AmountObligatedToPayInYearOne" xlink:label="AmountObligatedToPayInYearOne" xlink:title="AmountObligatedToPayInYearOne" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="AmountObligatedToPayInYearOne" xlink:title="presentation: LicensingAgreementsAbstract to AmountObligatedToPayInYearOne" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AmountObligatedToPayInYearTwo" xlink:label="AmountObligatedToPayInYearTwo" xlink:title="AmountObligatedToPayInYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="AmountObligatedToPayInYearTwo" xlink:title="presentation: LicensingAgreementsAbstract to AmountObligatedToPayInYearTwo" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MinimumNumberOfPatentGranted" xlink:label="MinimumNumberOfPatentGranted" xlink:title="MinimumNumberOfPatentGranted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="MinimumNumberOfPatentGranted" xlink:title="presentation: LicensingAgreementsAbstract to MinimumNumberOfPatentGranted" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MinimumNumberOfPendingPatents" xlink:label="MinimumNumberOfPendingPatents" xlink:title="MinimumNumberOfPendingPatents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="MinimumNumberOfPendingPatents" xlink:title="presentation: LicensingAgreementsAbstract to MinimumNumberOfPendingPatents" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MilestonePayments" xlink:label="MilestonePayments" xlink:title="MilestonePayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="MilestonePayments" xlink:title="presentation: LicensingAgreementsAbstract to MilestonePayments" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfRevenue" xlink:label="PercentageOfRevenue" xlink:title="PercentageOfRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="PercentageOfRevenue" xlink:title="presentation: LicensingAgreementsAbstract to PercentageOfRevenue" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesLineItems" xlink:to="LicensingAgreementsAbstract" xlink:title="presentation: LossContingenciesLineItems to LicensingAgreementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="LossContingenciesLineItems" xlink:title="presentation: LossContingenciesTable to LossContingenciesLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="LossContingenciesTable" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to LossContingenciesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_InvestorRoyaltyAgreementMember" xlink:label="InvestorRoyaltyAgreementMember" xlink:title="InvestorRoyaltyAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="InvestorRoyaltyAgreementMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to InvestorRoyaltyAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CollaboratorRoyaltyAgreementMember" xlink:label="CollaboratorRoyaltyAgreementMember" xlink:title="CollaboratorRoyaltyAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="CollaboratorRoyaltyAgreementMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to CollaboratorRoyaltyAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: LossContingenciesTable to TypeOfArrangementAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_RoyaltyAgreementsAbstract" xlink:label="RoyaltyAgreementsAbstract" xlink:title="RoyaltyAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:label="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:title="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RoyaltyAgreementsAbstract" xlink:to="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:title="presentation: RoyaltyAgreementsAbstract to PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:label="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RoyaltyAgreementsAbstract" xlink:to="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="presentation: RoyaltyAgreementsAbstract to PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesLineItems" xlink:to="RoyaltyAgreementsAbstract" xlink:title="presentation: LossContingenciesLineItems to RoyaltyAgreementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="LossContingenciesLineItems" xlink:title="presentation: LossContingenciesTable to LossContingenciesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="LossContingenciesTable" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to LossContingenciesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:label="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="presentation: ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AggregateIntrinsicValueAbstract" xlink:label="AggregateIntrinsicValueAbstract" xlink:title="AggregateIntrinsicValueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AggregateIntrinsicValueAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="presentation: AggregateIntrinsicValueAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AggregateIntrinsicValueAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:title="presentation: AggregateIntrinsicValueAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AggregateIntrinsicValueAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:title="presentation: AggregateIntrinsicValueAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="AggregateIntrinsicValueAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to AggregateIntrinsicValueAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NonQualifiedStockOptionMember" xlink:label="NonQualifiedStockOptionMember" xlink:title="NonQualifiedStockOptionMember" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_TimeBasedNonQualifiedStockOptionMember" xlink:label="TimeBasedNonQualifiedStockOptionMember" xlink:title="TimeBasedNonQualifiedStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonQualifiedStockOptionMember" xlink:to="TimeBasedNonQualifiedStockOptionMember" xlink:title="presentation: NonQualifiedStockOptionMember to TimeBasedNonQualifiedStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PerformanceBasedNonqualifiedStockOptionMember" xlink:label="PerformanceBasedNonqualifiedStockOptionMember" xlink:title="PerformanceBasedNonqualifiedStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonQualifiedStockOptionMember" xlink:to="PerformanceBasedNonqualifiedStockOptionMember" xlink:title="presentation: NonQualifiedStockOptionMember to PerformanceBasedNonqualifiedStockOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockOptionMember" xlink:to="NonQualifiedStockOptionMember" xlink:title="presentation: EmployeeStockOptionMember to NonQualifiedStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis" xlink:label="VestingAxis" xlink:title="VestingAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain" xlink:title="VestingDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="ShareBasedCompensationAwardTrancheOneMember" xlink:title="ShareBasedCompensationAwardTrancheOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheOneMember" xlink:title="presentation: VestingDomain to ShareBasedCompensationAwardTrancheOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VestingAxis" xlink:to="VestingDomain" xlink:title="presentation: VestingAxis to VestingDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="VestingAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to VestingAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NumberOfStockOptionGrantMade" xlink:label="NumberOfStockOptionGrantMade" xlink:title="NumberOfStockOptionGrantMade" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="NumberOfStockOptionGrantMade" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to NumberOfStockOptionGrantMade" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to AllocatedShareBasedCompensationExpense" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to StockIssuedDuringPeriodSharesStockOptionsExercised" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationRsusDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_Two022PerformanceBasedRestrictedStockUnitsMember" xlink:label="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:title="Two022PerformanceBasedRestrictedStockUnitsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:title="presentation: RestrictedStockUnitsRSUMember to Two022PerformanceBasedRestrictedStockUnitsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeeMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to EmployeeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ChiefExecutiveOfficerAndPresidentMember" xlink:label="ChiefExecutiveOfficerAndPresidentMember" xlink:title="ChiefExecutiveOfficerAndPresidentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ChiefExecutiveOfficerAndPresidentMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to ChiefExecutiveOfficerAndPresidentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:label="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:title="NumberOfPerformanceGoalsAreSubjectToAchieve" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to NumberOfPerformanceGoalsAreSubjectToAchieve" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="presentation: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="IncomeStatementLocationAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to IncomeStatementLocationAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to AllocatedShareBasedCompensationExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="presentation: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="presentation: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="InvestmentTypeAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to InvestmentTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="RangeAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PrivatePlacementOfEquityAbstract" xlink:label="PrivatePlacementOfEquityAbstract" xlink:title="PrivatePlacementOfEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="presentation: PrivatePlacementOfEquityAbstract to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="presentation: PrivatePlacementOfEquityAbstract to StockRepurchaseProgramAuthorizedAmount1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:label="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightsExercisableTerm" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightsExercisableTerm" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="presentation: PrivatePlacementOfEquityAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="presentation: PrivatePlacementOfEquityAbstract to WarrantsAndRightsOutstandingTerm" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightOutstanding" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="presentation: PrivatePlacementOfEquityAbstract to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="OverSubscriptionAmountReceived" xlink:title="presentation: PrivatePlacementOfEquityAbstract to OverSubscriptionAmountReceived" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:label="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ObligationToPayLiquidatedDamagesPercentage" xlink:label="ObligationToPayLiquidatedDamagesPercentage" xlink:title="ObligationToPayLiquidatedDamagesPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ObligationToPayLiquidatedDamagesPercentage" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ObligationToPayLiquidatedDamagesPercentage" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_TransactionFeesPayable" xlink:label="TransactionFeesPayable" xlink:title="TransactionFeesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="TransactionFeesPayable" xlink:title="presentation: PrivatePlacementOfEquityAbstract to TransactionFeesPayable" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ConsecutiveCalendarDays" xlink:label="ConsecutiveCalendarDays" xlink:title="ConsecutiveCalendarDays" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ConsecutiveCalendarDays" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ConsecutiveCalendarDays" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_AggregateCalendarDays" xlink:label="AggregateCalendarDays" xlink:title="AggregateCalendarDays" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="AggregateCalendarDays" xlink:title="presentation: PrivatePlacementOfEquityAbstract to AggregateCalendarDays" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="LossContingencyEstimateOfPossibleLoss" xlink:title="LossContingencyEstimateOfPossibleLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="LossContingencyEstimateOfPossibleLoss" xlink:title="presentation: PrivatePlacementOfEquityAbstract to LossContingencyEstimateOfPossibleLoss" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="PrivatePlacementOfEquityAbstract" xlink:title="presentation: SubsidiarySaleOfStockLineItems to PrivatePlacementOfEquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="SubsidiarySaleOfStockLineItems" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to SubsidiarySaleOfStockLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="presentation: StockholdersEquityNoteAbstract to SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquityReverseStocksplitDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ReverseStockSplitAbstract" xlink:label="ReverseStockSplitAbstract" xlink:title="ReverseStockSplitAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAbstract" xlink:to="StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="presentation: ReverseStockSplitAbstract to StockholdersEquityNoteStockSplitConversionRatio1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="StockIssuedDuringPeriodSharesReverseStockSplits" xlink:title="StockIssuedDuringPeriodSharesReverseStockSplits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAbstract" xlink:to="StockIssuedDuringPeriodSharesReverseStockSplits" xlink:title="presentation: ReverseStockSplitAbstract to StockIssuedDuringPeriodSharesReverseStockSplits" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="ReverseStockSplitAbstract" xlink:title="presentation: StockholdersEquityNoteAbstract to ReverseStockSplitAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquityMergerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="presentation: EquityComponentDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: ScheduleOfStockByClassTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="presentation: ClassOfStockDomain to CommonClassAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassBMember" xlink:title="presentation: ClassOfStockDomain to CommonClassBMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassCMember" xlink:title="presentation: ClassOfStockDomain to CommonClassCMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: ScheduleOfStockByClassTable to StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfStockByClassTable to BusinessAcquisitionAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MergerAbstract" xlink:label="MergerAbstract" xlink:title="MergerAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="SharesIssued" xlink:title="SharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="SharesIssued" xlink:title="presentation: MergerAbstract to SharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="ConversionOfStockSharesConverted1" xlink:title="ConversionOfStockSharesConverted1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="ConversionOfStockSharesConverted1" xlink:title="presentation: MergerAbstract to ConversionOfStockSharesConverted1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_ClassOfWarrantOrRightIssued" xlink:label="ClassOfWarrantOrRightIssued" xlink:title="ClassOfWarrantOrRightIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="ClassOfWarrantOrRightIssued" xlink:title="presentation: MergerAbstract to ClassOfWarrantOrRightIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: MergerAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="presentation: MergerAbstract to StockIssuedDuringPeriodSharesAcquisitions1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="MergerAbstract" xlink:title="presentation: ClassOfStockLineItems to MergerAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="ClassOfStockLineItems" xlink:title="presentation: ScheduleOfStockByClassTable to ClassOfStockLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="ScheduleOfStockByClassTable" xlink:title="presentation: StockholdersEquityNoteAbstract to ScheduleOfStockByClassTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to ClassOfWarrantOrRightAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to RestrictedStockUnitsRSUMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to WarrantMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="ConvertiblePreferredStockMember" xlink:title="ConvertiblePreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="ConvertiblePreferredStockMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to ConvertiblePreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareDilutedOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: EarningsPerShareDilutedOtherDisclosuresAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="presentation: EarningsPerShareDilutedOtherDisclosuresAbstract to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to EarningsPerShareDilutedOtherDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: SubsequentEventTable to SubsequentEventTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="ChiefExecutiveOfficerMember" xlink:title="ChiefExecutiveOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ChiefExecutiveOfficerMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to ChiefExecutiveOfficerMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: SubsequentEventTable to TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_MilestoneOptionsMember" xlink:label="MilestoneOptionsMember" xlink:title="MilestoneOptionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="MilestoneOptionsMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to MilestoneOptionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="AwardTypeAxis" xlink:title="presentation: SubsequentEventTable to AwardTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_SeparationAgreementAbstract" xlink:label="SeparationAgreementAbstract" xlink:title="SeparationAgreementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForPostemploymentBenefits" xlink:label="PaymentsForPostemploymentBenefits" xlink:title="PaymentsForPostemploymentBenefits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeparationAgreementAbstract" xlink:to="PaymentsForPostemploymentBenefits" xlink:title="presentation: SeparationAgreementAbstract to PaymentsForPostemploymentBenefits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_PaymentToOfficerBaseSalary" xlink:label="PaymentToOfficerBaseSalary" xlink:title="PaymentToOfficerBaseSalary" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeparationAgreementAbstract" xlink:to="PaymentToOfficerBaseSalary" xlink:title="presentation: SeparationAgreementAbstract to PaymentToOfficerBaseSalary" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeparationAgreementAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: SeparationAgreementAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeparationAgreementAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="presentation: SeparationAgreementAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220331.xsd#btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:label="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:title="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeparationAgreementAbstract" xlink:to="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:title="presentation: SeparationAgreementAbstract to SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeparationAgreementAbstract" xlink:to="SharePrice" xlink:title="presentation: SeparationAgreementAbstract to SharePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="SeparationAgreementAbstract" xlink:title="presentation: SubsequentEventLineItems to SeparationAgreementAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventLineItems" xlink:title="presentation: SubsequentEventTable to SubsequentEventLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="SubsequentEventTable" xlink:title="presentation: SubsequentEventsAbstract to SubsequentEventTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !! -\# 2(  A$! Q$!_\0
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&444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image01.jpg
<TEXT>
begin 644 image01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" (V O$# 2(  A$! Q$!_\0
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MJ[I(XX]FP;'!9@!Q\K8R>Q]Z (O^$CT/_H,Z;_X%)_C1_P )'H?_ $&=-_\
M I/\:LS06%U#<VL\5K-%=ADGA=599@5*D.I^]E5*D'LI':AKNPNK>56N+6:
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MW45G=:+?VT$UXZI*\"^7'LFD4S2C(,0\Z(C+#[S(>_ !UG_"1Z'_ -!G3?\
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M)&U"&5L**NZ1:^(=,UV"XU-SJ*7UM:V4A27BVDC-W))*P"*N"&AC!502<9
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M.>>IXXY )**:Q?<=JJ1Q@EL=^>WI^?M34#R6X$ZA'9<.(W) ..<-@'\<#\*
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MO$G &TH^D3+:ZMIT3W,5O=S"6YM6TM9#<6?D>6\  DYDQ!Y8E/R@% JD,K$
MZ#3=3.I:D88;[5V6&]E9)'L)8T95<*\;,8%0A261?F.5^;+,N0JWVI6T4%Q<
M3WLN UBT(M)&$KA"PN#MM]R$D8)P8N>,M@''FTNSN+?Q#=7%CJ-Q% ILC;_V
M>&:2RC)Q"L+$QS8=9'1F0OY<F%!WAFR;SPO-J/\ :FFK=3O<S:FU]=;-&CVS
MQ&,031JSOY:2NCL-[$,8VX1@-U '=1ZG-8W4%A<O=W+Q,YEG-M)(TB!2<DQP
MA 3NBQC&2)%&3&V5:XU(V7FFX(N);5P8TLY D<J!\NA*%N6*@!@=P4%1U!PH
M]';4(=3T[4)(;_1)&@MH8H;.-8&M=^T1-(TK-(4VL"<J0S$A#D"K9AM++4]'
MU*7[9>MY$\\4AM8"L"OL9V:= L<8.23\W[PC.6V"@#6LI[C[9=VDM[/,LTLA
MM[A(O,\M?FRI98Q&C(^5 8L<(N[+$YJR)K!Q>0:A<R1*S73P-$(05&%6$*8&
M?:0'8\^9NV@':>*D.G,-8&H7MK?/>0)'96\GD6SRVZN-K3(^YY/+)&2'+'.X
MD, -NKX8.IQVTL>K2W=[,MU)$+B2WBMT9!DAU16)V]$R>68%@ I!H %/]GZB
M6N-1U28:E<*8(C!YB187E?EBS&I'7>?X<Y!+5HQ:C#+?3VBI="6%E1F:UE6,
MEE+#;(5VL,#DJ2 ?E."<5DVGBJ.YM;JX.CZ]#';RF,B73W#NH#$NB?>9?E/0
M;CP%!W+G<6:1KIXC;3*BC(F)38W3@?-N[GJ/X3[9 &S16^HZ>\5S L]I<Q%)
M(9XN'1A@JZ,.A!P01[&LN?PKH]PL27%J9X8Y_M"PS2O)$#M "!&)41@JC",
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M@/Q49 MIKYLK1YKNYDBM+N6$AII;V1HU(7'/VJ']X1E# &523P >JJJJ6*@
ML<D@=3T_H*CAG29G5!*"F,[XV0<C/!(&>O;H>#S7G6B^$/%;0M-XBUM;B]^T
M6$J0PW4WV55B-L9?E(#;B892"6(8R_,HKT5?^/J3Y\_(OR[LXY;G';/KWQ[4
M 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"J]G>V]YY_V6591#*T,A7D!U^\N>A(/!QT((Z@BK% %6_4RB&%'E1FE1RT;
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M\DQ<DLT?.,N#L;(SM/!&,'=JM=7]G:7%K;W5W;PSW3%+>.20*TS 9(0$Y8@
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M[:Z?;M<7]S!:P(K,TDT@15"J68DGC 56)] ">U #[6)H8%21]\G)=N<%B<G
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M$_Q;U(4@\#:".>1LUG:IK>GZ5=:;;7]R(KC49_LUK&%9FEDVEB, '  4DDX
MXR>10!HT44V5]D9/RYZ+N; )/ &?<T .HI&95*AB 6. ">IZ_P!#2T 8=IH/
MV?Q-=:OYR,TY8!=KAE5HX5*YW[3S #DKD9(&,L6W*SFUO3QK4&DK<A]0F@-T
ML4:L^(@<;V(!" G(4L1N(.,X.+\TB0Q/+,ZQQHI9G8X"@=23V% #J*;-(D,3
MRS.L<:*69V. H'4D]A2HRNH9"&5AD$'((H 6L/PSHDNB1M"US#/ (8HH\0%9
M"4!!>60LQD=AMR3C[N>];;,JE0Q +' !/4]?Z&J&EZUIFK2W4>EW]M>M:OY4
MYMY!((GYRC$<!ACE>HXR.10!H444WS$\WRMZ^9MW;,\X]<>E #JQO%NACQ!H
MXLO/$#I<V]U&[)YB[X9DE4,N1N4E ",C@]0<&MFH[B>*VMY9[F5(8(E+R22,
M%5% R22>  .] #;*UALK6.WM8Q'#&,*HY]R2>I)/))Y).34U16DZW5K#<1A@
MDJ+(H88(!&1D=C4M !138BY4^:JJVXX"MN&,\'H.<8R.QXYZTNY0P4D;B"0,
M\D#K_,?G0!C:OHLM]K6G7\5YY26V1+ T0<2C<K##9#(05/W3AL@,&  &RS*I
M4,0"QP 3U/7^AJIJ6IVFFBV^VS",W,Z6T"X+-)(W1549)X!8^BJS' 4D37L4
MTUK(EM.;>8CY)0@;:?<'J/7IQT(/- $U%9]EJUI=DI'*K3I-]EE1#O$<PCWE
M"1QD#OTSQUXJ\9$$@0NH<]%SR>O^!_(T .K%L] 6U\2W^KBZGF-[L+Q3G<(2
MB;$$1XVI@RL5(;+2%@1R#M55.H6WVZ"S656N)XFG1%(.8U*@O],LH_'ZX +5
M%%% !1110!Q.=+&GVEEHL?A4P7!+QR17 @!G$>U)(D13D[MB\.&"]&) !?J6
MIVEI?1QO)X52]MHV:T%U?!9=S QVG5=R!Q),I8;CR0H;><0:9IUM8Z=#;I8Z
MN)+C'V:<Z=:+)I_VEO,;:$C"+LDC5GW*WS!"=W6M 6&M1ZVMM%J%]#I?DP%3
M;6MJL,3*)@Z+N)< YA."K;=@ 8[FV@#[IO#PB6U\0CP^O^LC@CE\O8T+J5"@
M..IBPK 9&/8@5MZ6MA;VL5GI:VL5M!&HC@M@JI&G(7"KP!\I [<'TK.LTN!J
MBW%S;2W+*B6\4KP1I+;!D#2[GR REDBSY>1NP,':2-N*-(E*Q(J*6+$*,#).
M2?J223[F@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% #8HTB4K$BHI8L0HP,DY)^I))/N:J7\\J75C;P12MY\I\R1&4>3&JEBQW=
M06")@<_O,C&"1=K/TJ]2^A@NT\T)=1>9$,-M,8/RL<@;6964[3@]OX30!H45
MFG5T_P"$A_LE;:=W%NMP\ZM&40,SA0R[MZD[&P2NTX(!)! ET_5+6^ 6*55N
M H,EL[ 2PG:CE77.58+)&2.V]?44 6YHTFB>*9%DC=2K(PR&!Z@CN*5%5%"H
M JJ,  8 %+10 455U"Z>U2)DA:7<^&VACM4 L3A5))P#@8Y) SS6'_PD&I^9
MC^Q3LC$9E;=/SO12/+'D_-AVVG=LP 6.,$4 =-2,JN,, PR#@C/(Y%4+>ZO9
MX8Y4M8 CK&</*Z,,D;_E:,'@9(SC<0 =N<B?3?M@L8O[3-N;S'[S[."(\Y[9
MYZ8H LT5Q&MWEM8^,9[*&:V-]>:?+?K: W$4]Q(@6)?WL0(\L*Q^7:S G>H^
M6KWA6<27%T7_ +)?4E+Q2_8;MB,J5D*O&PRCAIVR.2 5)QO"@ ZFHKB=+=-T
M@E(Y_P!7&SG@$]%!/0'ZG ZD"F1O='=YD,"_O2%VS$YC[,?E&&_V>GO5:YNK
MZWMUFDMK,1I&SSEKLJ$P,\$I@CW.V@"GXEUO1=#2VU#6PR;&D6&86<DS(<'<
M!M4D$@'_ 'L<9K46]A>ZN;<";S;=5>3,+@$-G&TXPWW3]TG'>N7^)R:K=:;I
MFG:!J5OIVHWU\(XIIXO,&Y(99EP.>0T2MR"#M(/7-<]XD\4^)="UI+"ZU[PL
M-0O%8V6DPZ9=7-S(HCD(DQ')NQN0Y^7;A2-P(Y /2DNXW8@+/P_EG,#CG)'<
M=..O3ISR*:]_"JPDI<_O5#+BVD. 1GYL+\IXZ'!KQ^3QI\0+'4]'L?$MKIND
MW-QFX6"VT^>]:^BC?=*JF%Y3"P1HE(*.,DLKG[HV++Q=XDU$W'V75?"EL+*(
M75W]NM+RW_T?=(?-7S"G[O:%'F#<N4<YPP50#TK[7']G\[;/LV[L>0^[&W=]
MW&<X[8SGCKQ638Z[;W7B+5K$V5Q'-I\<1\]K=QYRN6!"94%@I7DKN7YA\V=P
M4T>YUF[L](G>;1[N"54EGN[.1A',C1.<Q*0W&[RL'><J6/& &=;VVJ+KD]Y/
M:Z2Z21PQ12(SK-$GS&5"Q4AP&VLI 3.X@@;06 -=)T>7RP)=WS<F-@.,9Y(Q
MW&/7G&<&D>Y1" 5FY)'$+GIN]!_LG]/49HV+:N\T<E]!:P#R5#PPW9E0.6;?
M@F%2< )@Y&=S94;03BZ@OCU[N5M.E\+PVK*ACCGBN)'C;R_G!<,H<>9R#M7Y
M1@C)R #K(Y!)NVAAM8J=RE>?;/4>_2LV;4+"Z62">"XD56(,<EE*0Q15DR 4
M^8#*X(R-WR@[ABL2=/'GF7)MIO#:H[NT*S+,_E*50(I(V[L$2$GC=O &W;S!
M/%\1FGW077A-(L. CV]PW51M).\=&!)]0<<$;J .DT;5[#58YI=/,K!9FADW
MV\D1WKE6R&4' *E=W3*D9R,5HHP=0PS@C(R,'\C7.>%UO-"\/VL'BF^LI-3N
M+R;=);*4B=Y9I)$1 >1A6 YR>.IZGI* "BN>\4W'V7PMK]_,\S00P2RE%D>U
M<1QKEU63<I4G:^) 1C<IY &<?2-3\27VN-]BDTQ]%BNF6YC,?F7,.=I\IV%P
M0DBEMQ&W 0K@ @*0#N:;#&D,210HL<:*%5%& H'0 =A3JC@8LA)W_>8?.,'A
MC^GI[8H DK&LY);'7KFTO+Q)(+T^?8QR.?,4@#S8QQRH.UQEB?G< !4%;-9?
MB#3!J5M T9"7EI,+FUEVEC'( 5) W+G*,ZX)QACGB@"FKW/_  GTB)]I-G_9
MBF3#1^2K^:VS(/SEB-^-N% 4[LDIC>FC2:)XID62-U*LC#(8'J".XK)TR^BO
MM;O6M;M9[=;>)0J,2$=99T?(Z!@R[2.H*$'&*V* "D=@BECG &3@9/Y"EJO>
MH98A#Y2R)*VR0.@=-G\6X$C((!7ORP)!&: '6R$--(6)65@Z@A@5&U1C!)QT
M)X Z],Y)FHHH BN)(HE228<!U53M+$,QVCI_O8SZ$YXIZ1HC2,B*K2-N<@8+
M' &3ZG  ^@%4->$IL8O(:96^U6Q)BW9V^>FX?+SC&<]L9SQFM&@ HHHH *3:
MI8,0-P! ..0#U_D/RI:* "BBB@ HHHH **: _FL2R^7M&U=O(/.23GD=.,<8
M/7/#J "BBB@ J.&993(%#CRVV'<C+D^V1R.>HXJ2L?0=1M;^_P!>BMDNTEL[
MX6UQ]H<E3)Y$+@Q@L=J;'3@!1NW'&220#8HHHH **** "BBB@ HHHH 1F *@
MY^8X&!G_ /52T44 5W@/VR.X0MNV^6X,C;=O)X3.W=G'.,XR,U8HJK9K>K<7
M@NW@> R@VI0$.(]JY#]B0V_!&/E*@C()(!:I-JE@Q W $ XY /7^0_*N3OK)
M=.N5=6GG=76.W34=3E$,[S7(E(QA_FCV_)P3CY?E7FMO1#&T.^T%LUFZ[DD@
MN3,'<NY?MCJ0=V22200-H) -*BBB@ HHHH \RL?%ECK>FV=QI/CQ8;:Y6*$(
M+2-[O>9DM@R @_*96VERCIN92&V@ANF\-ZU;ZA?P06^JSZF!;SD3K;[(9"DY
MC?YP K,K+M 7H 2<AT-,T:_O;_4)9]%U+0;KPO'BVACMK=S-#*DBHZ%E<H5
M#XPJXRO4 EEF\0K(UM/:Z]X<2RN)UMXM\OF&65_*DAB1PX!>2$R,  3^\C(#
M!3O -?3]>TO46A6SOH)))E9XD+;7D50I+*IP67$D9R.,.I[BM*L6/Q9X<EFB
MABU_2'EE?RXT6]C+.^\)M W<G>RKCU('4U>DU2QCF$3WENLACEE ,@'R1,JR
M-]%+*#Z$C- %RBJ4^K:=;WD5G/?VD5W*Q6.!YE5W(VY 4G)(\Q/^^U]14ME>
MVM_$9;&Y@N8PVTO#(' /ID=^10!8HHHH **** "BBB@ HHHH **** "BBB@
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M@XX(X;\,^O2I#\0O#LQM4MO&GA+SVN]KQK>QRF6$L0JIB0%9,%#G##((Q@Y
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MM8DN5</ FU,D-\ZDX)SU-Q8W]LDS0:U;C46MEWI/YGDFY+?NF5#(3'$SF0%
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M7^HI-;:;)I%[:I;M;"VVDA05*OR5D4JV,87:%Q\V>-B(.%/FLK-N."J[1C/
MZGG&,GN>>.E ##<P"81&:(2EMH3>-Q."V,>N 3] :+>Y@N8U>VFBF1E#!HW#
M @YP<CMP?RJ6B@ K \.2>5J6NP3RVF]M0+1)&6$A4PQ'YP0!NSNP5&-H7)+;
MB=K9Y%KY=G%$/+3;%%G8@P.%X!P.W ./2L'PQ;WJMK=S++8">\G23]Q V$F6
MWBC?<V[]YAH\<8P%VDY!P =")$*H0ZD2?<(/WN,\>O'-0B]M3TN8/O!?]8.I
MVX'U.],?[P]141U.W7R_.$\6]_+'F0N &W!<$XQR6 !S@]B:EENXXM^Y9SL8
M*=L#MDG;TP.1\PY''7T. "=F52H8@%C@ GJ>O]#3)9XHB!+*B$@D!F R!R?R
MIL5S')++&F2T4GE-@9PVP/VZ<$=?\*HZI!+J^ERP6YM1!.K12Q7]DTJ2*6 =
M6C+)D%0Z\\'<#R!A@"\MW;LL;+<0E9 I0AP0X;[N/7.#CUH>[MXPY>XA41J7
M<EP-JC@D^@&#DU4M@VC^'X5E1[A[2V566WCRTA50,*H]<<"K[R!&C4ALNVT8
M4D X)Y(Z#CJ>,X'4B@"NVI6*1R.]Y;*D3%9&,J@(1G()SP>#^1J7[3!NC7SH
MMTF-@WC+Y!(QZ\*Q^@/I4<-[%+C:MP,D@;K>1>A /4>X^HR1P#A(KY'@AD>&
MYC,FT;&A8LA8XPV 0,'J>@ZYQ@T +'?VDK(L-S#*[J)%6-PQ*G&& ';YEYZ<
MBK",KJ&0AE89!!R"*SM3M0VHZ9?+);0M;RM'))(@+O%(I7RE;(V[I/);OGRP
M,9P12U77M-\)^&+6]UN;[-;JL, V6Y!:1L*J+&N<$GC X'K@9H WZYS6M<M'
MT^01IJ:7.<0,-.N@1+L=E(Q&3CY&SP1R 0=P#5=0\8,M_<0:1IZWT-LT,<UW
M)>100>;*%,42,22SL'CXP/\ 61X)W<;?AS6(==TB.^MXY8@7DADBE&&BECD:
M.1#[JZ,,C@XR.* ,Z>\M1X4;7+_3WT\W-M#<W\+6ZO,J8!>.1<9<A2RD %NH
M4$X%;\:Q0A88@D8P2J* ..^!^/ZUQ&F$7GA_Q!HL\<P?3]7>S %T8/EDDCGA
M"2;F9 L<\2C;AEVX0*0H'9V]PEV1+:7$$UNK21/Y9W_O%;:1N!P"K*ZD8SGC
MC!! +%%4](O!?Z=#<C)#@X?R]@?!(WJ"3A6QN')X(JY0 444CDJI(4L0,A1U
M/MS0!CZ?H1LM#;34U._DP7,-Q)Y1D@SG:%&S80F?E#*P&!G.*MZ1I<&EV<<$
M.7*#'FNJAV' &=H X"JHXZ*!VKFKX:U=V]X!I^N6\EPKNOD7UL/(D, C"H23
M\N2SY(.&4-M.2HF@O=<BNI)_^$<OF+*XVMJ<;*>6*_*3@?PC([$]<#(!TYM+
M<W'GFWA,^,>84&[&0>O7JJ_D/2@6EN H%O" JL@ 0<*V"P^AP,CO@5RFGG5K
M*.=O[(UJYF$[2PBXU*%@RX*JA^;"J%(XPQ)&6+-EC/'-JT2QJFEZRP1@<O=V
MS%]H/+98_?SA@.!@%<&@#J656*E@"5.02.AZ?U-)'&D>[RT5-S%FVC&2>Y]Z
MPY=7U<*?*\-73-M) :Z@4;N,#.\\?>Y]AQSQ+_:NH^=C_A'[_P K ^;SK?=G
MG/'F?[O?N>F.0#9HJKI]S/<K(;BQGL]K842LC%ACK\C,!SFK5 !1110 4444
M %%%% !1110 4444 %%%% !5;37C>QB:!X9(B,J\+;D(S_#[>W;IVJS5&WO
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M@;<C7TOP)-9Z)M6\LH=;CLTM;.[BM#LLA]GABD\M=X/S&'.05(&T?PDFS8>
M-,TZQCLK%(+>TCNC<K$D (.1Y;*=Q./W&V$%=I"[N2&*T 4/^$8\!3PV\=MX
M;336FN81#)9Z9-ITXE,9D0K)&B.N$+9.0%^96(.14>F> ;22[FN--U[Q):Z-
M>2_;)--=FB;SB-I=9I$%Q&6VL6"N&)8G(!P="R\ VMD?*M#8VME(@BFBM[((
MQ6)G:TV,6.QHMX.[!)=%8;.0>AT[0-*TZ*".RL88T@MH;2,8SB*$DQ+SUV$D
MJ3R"3ZF@!WA_0=)\.:?]AT'3;33K3=O,5M$L89L ;FQU;"@$GDX%:5%<;XAE
MNHM>M;:T;69W5O-VVLH4 2[L @IL*KY3L/-91D[06)5: .FU72[#6+,VFK6-
MK?6K')AN85E0G_=8$=Z\^^%7A7PU??#ZQ,_AK32&:XA9;FQC)91<2#N#E21D
M=L$5UVAM+J#Q7,W]H6KQN\IC=I CABZ;"'125&Q7' (R.<'YHO!&F1^&=%30
M9-3&H75LTD[G&)%CFGD:/*98A1\R ]#Y9Z8( !H7/A[1;JQ-E<Z1ITUF008)
M+9&CP2"?E(QR0#^ ]*P-4U&VL[F7P]I'AB'5+%;9XKR.W>WC@ARA9;>1&(&Z
M3>H5",'S,G"Y-=G7$6_A)Y-8N]6O+/3YM2FOA<&22%4PB.T415D^;>ENTF&8
MDEI>JJJJH!HZ9HVE1ZY,]AI.F+9/IT<:2PQ1@%'9LHH"\HP5"><':G![9?Q1
MT+1HOA[XNO?[(T_[2NE7LWFBVCW[C$[$[BIY)YSZ\U?\':>VD7D^G1VT-G:P
MQEH[:TC2*!%:5]I$:L0I(!Y4+N.]F"Y5%=\5F*?"[Q@PQD:->$9&1_J'[&@#
M?TE0NE6:JD2*(4 6+.Q1M'"YYQZ9YJU7,Z3-KK6GAAVAMVBD7;J!CN!.%3R2
M5<,<$DN%&06^\>&SO3IJ "BBB@##\;3_ &3PM?WQP%L56];) XA82GJ0.B="
MR@]"R]1M0R+-$DD9RCJ&4XQD&F7=M!>6LUK>0Q3VTR-'+%*@=)$88*L#P00<
M$&H-&"C2+$)"]NH@CQ#(,-&-H^4CL1TH N4444 %%%% !1110 4444 %%%<E
M<?$3PQ;>.E\(3ZI!%K1B$ACE81JK,8PD6YB-TC^8"J+DX!SCC(!UM%9RZU8&
M^6T-U;K+)"L\.9X\S1LP7<@W;B-S(,XQEU )S5AK^T6*>0W,)2W4O*0X.Q06
M!)QTY1A]5/I0!9HIJ2([2*CJS1MM< Y*G .#Z'!!^A%.H **** "BBB@ HHH
MH **** "J>I6ME.(;C48X66S9IT>7I$?+=&;GC[CN#GL35RLWQ-=V5AX;U:\
MU8,VG6]I-+<A023$J$OC'.=H/2@#S+X>6URW@26:XBEBN[CQ!#*\ES:,B30)
M=Q) 84(39'Y,<848P,9QS74?#&%Y)/$VJR2+&;[5IT;3XFS':/ Q@8CIDR&/
MS2=JY\P<'J;'AW3M67X?Z!9^(?W&JVZ6*W"6Q$XWQ2(2<A1][:-V.%R<$@;C
M!\(WM)_#E]=6;"X-SJEW)+>K*DJWK>:5$RN@"L"BHOR@ %2N.* .%\++!X=\
M&_$FXU2>%-.E\6SS-+<-)"AADDMP0S.H<=60D \@E=PP2W]E=X[GPGXG:-O,
M@E\2WC+)$YP<Q18(*]B"><^F.<5TO@/0[+5X/B%IFLZ1$MC<>);@RV4ZHZR@
MQ0,)#@#[YQ*"<,-R\G&3F_L\Z#<^#O!NL1ZR;:RM[K7I9K1EN(7CECD$448!
M0E02XVA1@YP,<XH ['X3:EI^J> -+N-)MH;6!1)"\4(PHF21EE8<DD,X9@S$
MLP8%N2:ZZO+OV<8Q'\.9"<F5M4OC*3(KY;SV'8#' '! /?H17J- !2.RHI9R
M%51DDG  I:* /)?!OQ)U?Q!X:TS4IH--MWN]6@LF*K(R!&=E95W%26PH(;H"
M^PKNC<4J_$[4TT&YU>YTM(4;0;[5H;&2-A<0/;R[ DV"W#ATYP"-DF<8POD_
MPR?1W^%6G6EZ+%[5?$%O+=QSQQ20+:^?/EGWL<1[8Y.9&XVD@$\OTN@QZ=_9
M/C=K&">:SOK74[-7\N1Q())F:)(BBL88D64^9N'RNY9@AW;@#VCX?Z]-XC\.
MK?71M?.6:2WD^SD@%XSL8E6^:/+*6"-\RJ5#?-D5TE<KX"\HIJAL+FV?3/.B
M%O:QVZPO9 01?N6"_*0%V%2!]QEY88)ZJ@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "J5M:VDFEFU\B)[.17C:%QO5E)(*L&]<G(/N*NU7L,"
MU4+,LVUF4NK$C(8@CDDY!R#SU% ":>H2W8*"H\Z4X(8=9&/\7/\ 3TXQ7G/Q
MU'_)/7*1.$\8:<2KOMZ^8H(Y!)!(.!GID@@&O0=%\L6<GE$E?M-QG(4<^<^?
MN\=<^_KSFO._CP$+?#GS695_X3'3\%5W'.)<#J.,XR>PYYZ4 =3\-]H\.W>T
MDC^V=5ZC'/\ :%QFNIKDOAG(C:'J42.KM#K>J*^TY )OIGQ]<.,^]=;0!G:\
MH>QB!EFB_P!*MCNBZG$Z''W6X/0\=">5^\-&J.M1Q26<:SVANT%S;L(Q&'VL
M)D*O@D?<(#Y[;<X.,5>H \9\5>!;GQ!XR\6VOA[Q+>Z/-<6<,T\-M<R!%>6.
M6/+1&/9B0Q(69'W?NSD D$[GA#P%>Z;I%C=V_B#;JS6X0W2V09(X/*"Q6T,<
MA/E0@A'91AG9<DK]T;^D3W;_ !-\2P2W+FTCTZP>*V9W8*6>YS(H("KNV[3C
M)/E\D8 KI[>&.VMXH($"11*$11T50, 4 <AHUMXBN/[7==1%H\>HW201S6L;
M(T9*&-FVA&.W!QR"R.06+;917\$:>VF>-?$JW=_->7EQ';LIN95WB%-ZJ(XQ
M&@2,,SX"AADD[V9F"]=I>E6&DK<KIMG!:BZN)+N?RD"F69SEY&/=CZGL .@%
M0:?X?TC3M6O]4L=-M;?4;\@W5S'& \N!@9/X?GSUH Y7XW7]UH/PS\1ZGH=H
M\FL20+;Q26R,)E9V\H.&0;@4$C,#V(]ZS/#&FWM[X3\/R:'XT-I9V=M9CRX8
MX7\QVB#;9BRD[Y!-&Q/?<C!03EO4:S=*T[2_#6CVVGZ9;06&G0L(XH8EVHI=
M^@]RS?F: /'O@C)=6WPST5Y/$ A:VTZRN98(+%9)1!]JNB$X0M)YJ@1!5^8,
MA*\MANM\&7>N7\4^GP:]#>QPW*W']H&W#2)&9YB]H^'93(FQ(V.$PKG;\PW5
MQ_PN\1>%=%\#: GB'4;*T2;2;.>"VNF623$4]Q('QDD[2H.\1KM*YW$X"=?K
M>I:?X=^)=G#<:SI^AZ?-8O.\<I1!,_FR2R;=QVH&RSR.%RQ"98$+0!T%KHGB
M".W:WN/%-W-NV9NA;VZRKB-@Q4>5L&6V-A@W1NQ"ASZ9XB95":]L+0F*0F"-
MR#F3YX_D&V3YH\,P= $YC))-2V7B/1K[Q2VFV6I^=J"V\K/!&Q>/$4HC?)Y"
MNCMM(R"=W(.!ML:K#JK7]FMAJ$5O:/*6GWVIF<X"E40@@(IVON9MQ^;"D$J0
M 56TWQ US%*^M0,$NO.V+;;$V>3(FPKNRR[FC?!;.Y6.[:5C7B+72O'_ (0T
MFVMK6XM=8TFQDF<BVQ'?312%L+L:(QR.A?<,-$&V '@FN]UZXNX-:\.I!?0V
M]I<74D,\)B!DN"()'558GY0/+8D!23@8*@'.Y0!Y5X2UK2KFZ_M'Q-K>R^C^
MS6(L]4BBM;V&ZA,Y+2+&VT[EGW +\JIR?XC56XTW7?&OQ0M]:LM3EM= TO39
M)=*?^S&A9;B>)XMY:9/G/+-@ KA8\CG+>J_V;8_VK_:?V.V_M+R?LWVORE\[
MRMV[R]^,[=W.W.,\U:H YJ/3?$4-U$5USSH8DV W$49\W)',JI&A+8W$%&1>
M0I0XWF.RTCQ'#/"\OB*:9(2^8YHH'6;*HJ[]D2'"X=L*5)8\MMPB]343,HNH
MU,^URC$0Y'SC*Y;UXR!QQ\W/:@#!;2_$#7GGKKY158$0?9XVB<'KD; XQC@!
M^A())PPFAL-<CM98SK*RR=8Y);="P#/N8-M"J2%^1&"@#.65R,'=HH PY+#6
MFUJWN1K %C&SL]HD"*L@)P%8D,QPN""K+\X;.Y6"QYF@'Q+J'A+2KPZI8F^F
MM5G9O)W1R%CO XQ@%=JY'0;OO$@KTNJZ=9ZOIMSI^IVT5U97"&.6&5<JZGL:
MJ^'= TKPWIWV'0[&&RM=Q<I&.K8 R2>3@!5&>@50.   "&WL]8M7P=0^W(JK
MM,^R,L53'S;(^KDDDC ! (&"4JE8:;XF@$INM<6Z8Q,%!BC0!RL/3$>0 RS;
M<EL>9\PDX"]/10!P6N0>.;C4;F&QF6"TCAW0W%K<PQ>?([1@+MEMY2@0)(S'
MYN)1MW$83N;?S1"GV@H9<?-L!"Y]LUFZGXATC3=1CLM0U.WM+DP27>R5P@,*
M [W)/ 5>I.1TK2MYH[FWBG@</%*H=&'1E(R#0!)7S_X#^&UWXHT6[\1R^,]=
MM]0U&ZN_N^5(L.V>2/"[@Q'RJ>C+@D=,8KVB'2+B.WU9%U.>&:^N&G6X@C3?
M "JJ !('4D!1R1CVKFO@9!]F^&6FQ&7SB+B\)DWJQ8F[F))V@#//( &#D=J
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M+0 4444 %%%% !1110 5SO@*[EO=#N9;AF=UU74H06=G.U+Z=%&6). J@ =
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MHH@NL:G&HC3:"%OIQNZG))!)/&23Q720/&Z$PN)%W,"0V[#!B&&?8Y&.V,4
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M_:%\R_Z,>$9?,PH<LPYVXPQ:.\O;_P )^*+/PMJM]=7%OJ-BVE:9=6]U<1+
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MI%5B,Y88R ,D9. <>GO[&G44 %%%-FC2:)XID62-U*LC#(8'J".XH =1110
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M48&2<D_4DDGW- #J*** "J5G;P:?(MK:^5''(TUP8RY+L[R;W89/3=(Q/IN
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M#N+!R=@R6'0_7D\^]<UX!CTZ71;B&V%O,D6HW<OR0.JH9+EYU'[P [AN0G'
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MAI[3WTMR_F'3MTEU;VT\,43C$[Y PXW$)DA&*HJ9;U>HH[:"-P\<,2N-^&5
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M ))9X-_[ MG_ .B$K0TN9G\3:Y$;B"1(UMR(D7YX\JV=QVC.<<#+8]LXK/\
MA/\ \DL\&_\ 8%L__1"4 =51110 4444 %%%>;3:MJ-GJGB>[ENQ96]K?1%O
MM=U+#&T7[A8Q&)8'7$F+A3Y7WG "G<^Y0#TFBN4:WOXV@OY-1O7^T"SAEMQ!
M*=K"8N64*HV@B7:Q*#Y47>RX)%33K+Q"8;Z#4[]XKF[C)C:VDD=3,8TW9=H@
M(45HW1-@&5;>09&S0!VU%4H;)PLOGW<\C/*LF5;:!M(P!Z A1N X)W' W$5=
MH **:RDL2)&'3@8XP?IWZ?RQ0RD[L2,NY<#&/EZ\CCK]>.* '5@^"8FAT:X5
MXWC)U+4'P\:H2&O)B#@<8(.0>I!!/)-:FH6CW<#I'>7-I(5(26 KNC;!&X!E
M*L>>C!ER <9%8OP_1$T&X6.=YP-4U++OC.[[;/D<<<'(_#M0!TE%%% !1110
M!QEAH:1:(+#^T-<#7!=VD:2=VMF9W \IF7@(TBA0X(V1JQ!P6+M4\/?VSJ$4
M4MYK%M!M,JO#.^(Y8Y(^!O&!T;#$$L'<@KM0U/=:IK=O-;W,2VEUILMP6V1P
M@2O;^0T@$1$Q$DF]0.BY!) ^7+;VG74EPI$EK=0[%0[YP@+DJ"1A2>1G!X S
MTS0!5L4@NH'MKNT#F&1HLRPR,'PI3=ND7G*Y!.6'.-QSSI)!$F-D2+M.1A0,
M'&/Y<?2I** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK+UO7+31HY
M)+W>$CM9[UV  58H0I<DD@#[R]_T!(TT8.H89P1D9&#^1H 6JNE[?L2!&9D5
MF52[.S8#$#)?YL^N>]6JJZ6XDLPP=7R[Y95"C.\Y& 3@@\$'G/7G- #=*C$5
MJZB0R9GF;).<9E8X_#./PKS[XZ23)#X$6%U5)/%VF+*"5!9=[' SR3N"GCG
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MJ?P@-R?AGX6\](4A&D6(@*.69U^S1DLV0-IW%A@9X4'/S;5 .QHI-P+%><@
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M HHHH **** "BBB@ HHHH AFM+>>:&:6%&FA),4A'S)GK@]1G&#ZC@U-110
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M$YYOQA\+H;/P=KMWHVI^(;K6X;4)ILL]]<N]KY6"JQ)'R3E>"%).?<DUM?\
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M<G;@* P8TGP7KVGZ3#9'QA<S&"%(8IFMBK#;L&Y@L@4G:)%Q@##*2"ZLSQ^
M=3N+?Q+>Z PN)K"6V;5[-FM)8?L<<ES*H@D$@#+D %%(_AE PJ**[.SMX8-4
MU!DGN))K@QS/')<%UC&W8 B$_(#L). ,DD\G. #CIO ^O_9_L]KXYU2-/G!F
MDC\R8@KM7YMP7/\ $2$^\%QM&Y6E;P5K %M);^,M2@NHF:225(4(N'+2%?,0
MY#* T:=FVQ ;AU&RVLZE#Y_V_3K6Q1;R."&::\S'+&\ZQJ<A>'96^5.?F^4E
M00QW;=I'B#31B-R3\H;=@9XR?7&,^AXR>M '$-X*UTLB?\)SK MUC:'B-/-9
M3CYB_3S !PVW&23M[58G\*^()#"Z^-+]95C9'_T6/8S&8ON"C&#L;RL$D;0"
M ' 8=G10!PNI>$/$MZ9#'X[U"T,GG9\BTB 7<P*!<YP$5I5YR2&0D[HP:IW?
M@;Q7<W$\O_"QM3B#R-)'#%91+&N8U4 _QD;@20&7K\NT_-7HU% ''0>$M6AL
MH[4^,-8F5)A)YLJQ^;(H!VQNRA?E.3N*A6.%PRD$DO/#/B&6V,=GXQNK1UF=
MT=;..3",[MM;>3NV[D"G(P(P"&RV>QHH \X7POXZM)[&TMO%ZW>G*R>=>7,0
M2\C #!@H"M%(2')!=?E*)G?UK5DM-:L_A_<P6U_:+>06-S'YD=JTI\X*X5AO
M;!(;&05(8@\ ' L^(_%N@:3XFT71]3OQ%JEU(KVT"W(C+%R8EW)N!<,68 88
M97.,J"+FJ7&FZAHD&I2R6+V4>91+-&DNW*-&0A)VJY#LF>>K+@YH Q?B)X@U
M/PKHOA^UT*WT^34M3U*WTF$SH4MX2ZL2^P,#M 0X4-GH!FN#N=9\9>'?&/B2
M_P!3FL)1<V-O':3V'AZ^NDF\F:92&42XB*[FRN\@[T*Y)8-U/Q#U5;KQ/X4L
MK6&5I=-\1VOVAGB#(%EM;@ CKZ@9(&"1CG%1_#W6(K_XD?$2VTFV,,-NMC*L
M,J2P;IY(Y6=G21 8RV%SM!! #8W,Q(!@7?Q)\1VX0/*PF,+2&!?!E[)*YW$1
MA=MT4^?Y ,N,&6/.,MLSM2\4^)O[4TW4;J#4YHI+6XFA<>&;I! 1*KQ)(BW@
M5MX3 Y&"T7F<YV^_55>>Z6UNW6TW3Q;_ "HQ* )L#*X;MG@'(X.>HP2 >+3?
M$_6XM6DA^WS&W0%))_\ A![[RH]A7=(0;@.!F3:<@G,3<#*EZ7B36_&_B&X7
M2DFNK>07UD$$GA*>"%'2[@D68RFX< ##'D[2(74[2R%O<H=8TV:YCMXK^U:>
M5I4CC$J[I&B.V4*,_-L8[6Q]T\'!KB_C5?2Q_#V6\T^[G1(=2LTF%LP1YD^V
M1QO$'/W22<9]B#P30!!I7BOQ'9?$C2_"_B(Z3>)J.G/>+/96DUJ873&Y2))'
MWCD8/RGKD<8KTFO*=6>5OC]X/F%H]K%<:1>,Q:)5:1OW60S#[Q4!!@DXQQUR
M?1/#.IOK/AW3=1GM6LY[JW26:U<Y:WD*C?$V0#N5LJ<@'(.0.E &E6==:O:V
MNN6&F3RB.XO8Y7@#C D*;255B>6VEFVC)PK'@"M&B@#D?#7C72/%-Y):PH5'
MGS);"=#FX-O+MDD3@KM5MA!W9Y&0IQFQ9)&_Q&U\-AMVD:>K(47&/.O>^<G/
M/!&..,Y..BC@BCEEDCB19)2#(RJ 7(&!D]^.*PK$#_A8.M'[26/]EV'^C\XC
M_>W?S_\  NG_  "@#H:*** "BBFS2)#$\LSK'&BEF=C@*!U)/84 .HKF8/$M
MY<V;:C::'=2Z9Y@\M]VV>>$HQ\U(2,_>V@*Q4E26[ -T5O-'<V\4\#AXI5#H
MPZ,I&0: )**** "BBB@ HHHH YF\LFEU#Q.@EAMGNK")%>&#SI%&V51(R%2K
MG.0%^;(0 CG%0_"@QGX9^$?+)!_L6R^0ODA?)7']><#./:MB*T*:QJ=Q;PB&
M:>")?.8;E=E\S!*C!.,@'YLD #C )QOA+&!\,?!\F6W-HEBI&XXP(5Z#H#R>
M>IXST% '6T444 %%%% !1110 4444 %%%% !1110 5E:/JT6L37PAMI46PNY
M+1GFV_,ZA<LF"?E^8C)P>#Q@YK5KF_!!F-OK(GN'EQJUT$0PE$A7S,A48JOF
M#^(M\P#,R!CLX .DHHHH **** ,ZYT33KF&ZBFM4,=R%$H!*[L+M'3IQQQCB
MK%O86=O,);>TMXI0I0.D85@I;<1D#H6)./7FK-% $;P1/;F!XD:!EV&,J"I7
M&,8Z8QVIZ*J*%0!548  P *6B@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "LW1UVZ2PM7MG.^;8T841Y\QL<+QC/7OUSDYK2K/T&9+C3$EBF:
M='>1A(TBR$_.W=21CTP>!Q@=  6+%%2%@C2L/-D.9%VG)=B1C XST/<8.3U/
M!?&J!I;+P>Z_:<0^*=,D;R5)7'G!?WF!@+EAR<#=MYR0#V^BR-+9R,V21<W"
M\R;^!,X'/X=.W3M7%_&=RMAX2 T]KH-XHTM3,$#"T'G@^:25. <>7D%3F0#.
M"58 3P7XKTVV_MVP U.X>SU2_:4VNGW-S%$?/9R@E2,AG._<4!)4DKT45UOA
M;6X_$.D?;X8)K=/M-Q;>7,,.##.\1)';)C)QVS6-\/K^>>UOH6M9VA75=2 N
M $$:;;R4;2<@L3R<JN!]UB64D]#J&I+8:/=:A<P.D=M;-<R(\D:$!5+%2S.$
M!&.2S!?]K&30!>HKFK?QA8SKIP2/]_?/'Y< O+4N()"PCN.)B&B;;\NPLQSP
MO!Q;_MF^_M".W_X1K5_)9PANO,M?+09(W$>=OQP#PI.&'&<@ &U15>&>22>2
M-[2>)%8@2N4*N %P1AB<'<0,@'Y3G'&;% #7#EH]C*%#?."N21@\#G@YQSSP
M".^1A^)="DUK4-%?[28K:QGDN)8MK$3DPO&JDAUP 9-_0_< XK>HH YP:5KC
MSW'F:O:K!NE$2I9/&=KLQPQ6;YL*5 8!&W(6SAB#4N?":M->,2\D#%#"D<MP
MKKF25I?F^T %F$S@, N,\[P J]=7*ZUJ_B,3ZO!H>@_:'MVM8K22XG6&.5W)
M,LA;D^4BE,X!<D. .C4 <9X"MHE^(\4DUO?7%XMIJJMJ$DT9BD*Z@D1)1%VB
M5A&N=I0#:PV#MZ+XRBCG\(:Y#/:RWD,EC.CVT3!7F4QL"BD\ D<#/'->>^&;
MVX_X2^1K!+FZFCM=?:V@N9O+6XD74E!7<$(P&PH8ME58?)R2>K35K[5=6U+3
MI=-B,%MJ<$4!2ZC\S9&L4SRRIORH#%0JXW$/&2H5MU '&11:GI'@[QQX6U37
M([[^RK6W6QFU6""(?97@55:21U,3(9(YT^=68;&+%LK6FLVF7J"UB30;V>=H
MVLH8KJ(27+)#&=T*F1P +:7Y@"#L8$-B3Y;OCWPA>:O>'Q#H[7-IXBM;*>PA
M2&8*EQ#(Q 4OE6C;A6#@Y3)P'(Q6'X>U74YM#T7^S_#/B.ZU4B$:C&]_)!%#
MM8.)?M$N!<Y*(I*%\QY!)& P!H0VD(TVSTF[MO#DQ16C32"854DF1WAB ;Y1
MP(V4AE(7GC=E^JV6GOYLGB :'<EI+>TNKC4XK7>8X4>69Y.=I+1HV0 NP!B%
MPF3CZ1J_AN3PLFE>)]>U'2-?1GBN]*?6[B2_BF9E8)"-_FR_,L9C90Y*G"EE
M=MUGP^FM:5K]K>Z'H/BV\TM[=_MT6M:JTDR[E5HA;QRW'E[LJ=^_!4, &!#+
M0!G^)+W3[?QAJ2V\>GZEI<.@VH$!G!A:V26=624DD^69&@WOAEC1&,F%.'V?
M"R:I<>*=)N],L])L;2<W%UJL]B\3K?1%2L*DQJ?F5RH5B<D12\]0T_A-=7N/
MB(=1\36'DZA]AELU$4$[0VRF1)A&D^T1R@JR!F8+\\>U-WSX['PB6;1B9%=7
M-U=%EDV[@?M$G!V\9^G'I0!QUQ$NJZUK>E7)CE@O;KRYYPEBQ\LQM'' ZLC;
M]C+)*H8,V54,-K,H[[1VF;3+<74Z7%RB^7-*@ #NORL< D*<@Y4$X.1DXS5R
MHU1Q<.YE)C9558\#"D$Y.>O.1_WS[F@"2BBJ^H)#+9RPW4C10S+Y+,DS1-\_
MRC:ZD,K$D $$'.,<T 6*Q[[Q-HUC=7UM=ZA!%-8VXNKE23^YC8D*6/0$D' Z
MGL*UD<LT@,;*%; )QAQ@'(P>G..<'(/;!.7KFCQ7NEZO':06L=]?VS0F=XQ\
MS!2(RY')"D\>G:@#6HIHC E:3+;F4*1N.,#/0= >3SU/&>@IMPQ2WE8;\A21
MY8RW3L#WH Q=<\&^&M?OA>ZYH.F:E="-8EEN[9)F5%9F"C<#@99NG7/-<7\'
M=/FU7X4WFGZO;VWV>>ZU.TA1.#Y#7$JLK@KA3NWC: 1M"^X'ITTRQ&,,'/F-
ML&U&;!]\#@<=3Q7F7P!U>XOO#%Y:3:=-;06]_>/;W#,[K<*]W.3\Q4#*ME2
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MES=R+%;Q*7DE=@J1H!EG9CPJ@ DDGM5B@ HHHH **** "BBB@ HHHH ****
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M!:MXRO\ P?H%U#HGAX65Q86\L3-J\PDV,@(W+]F(SM('#$ Y//2O-O%/P_\
M#6D:3XLT[6;*.ZUZUT2?6;2>*[OTAN(XU92&C:Y?#(VT<M@B08'# 5_AW\+K
M+Q7X,T&>Q\7ZW92OI-M+=VT5Y+B4EI0/,B+#$8,81=I4$1'&#S0!ZJDGC/']
MIWOACP?;7\*QLUQ+J<F0FT^;\XMR5(Z#J ">2!S=N;OQI+%"M[H7A9;638DR
MR:U,"2W&%_T; .XKCD]/4@C@)?@18V%D]UJ7CC7O)ME\^22ZN<0H$C=2[;C\
MN$8C=D%0SX(R"O.'X67&JW<]ROB*^ELY+6RU&+_0KI_/:>68XDMS<8!7"9Z
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M3&I6O5_$OV6/X=WU[XFN]6U'2TMD>Z%FZH[1HREI5>(1L00N]B" 5W84 A:
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MGH\6H3W<ETMO%<,455CD<@[8EC:21Y @R50JHP5/I$J1W4K1/(RLB-NB5P&
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M!XHM](U'X<Z%I^I^(- TWQ8FC7=KIR:9?)Y%S]H4Q  L=K1RB,@L5.&.0RL
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MX(#("1O&[J=6N-<B\5Z)'IMM#/H\L-P+\R2;#$P,1C<':=Q_UB[,KG=G/RT
M>(^%_'^G:=I$%AXEOM+MO$443QZE%J?F1/!%;A(RJK&A+ADA,WD,0':;"D@$
M"UK'B:+2/&EF;[Q%I=M%HEQ+J-QID=H9IK995NXD4^5(WF.KSJ"J[,+(K$
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M5G,I>/58&MWLV"E0WS"7<""^,%03M;:"%)KS;X@66O0^,M9O-1L=2OO#E_\
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M[P5R2/,?@<\'..>> 1WR #K:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M%E^ZQ4U/#NH6T'B/4II)M C>YG:TM4LT;[5<+%+(K!E.W)0I,"$#<)NS@8H
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M7AE *B\L#@D@$_;(<#CGK_\ K'6@#QCX3Q6\?Q(\#2Q3Z@MK+_;HTX3Q?.\
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ML#,Y1E(.!P(XR^"NXYPNX;>[L/">G67BF37HGNWO#9+81I)<,\4,0(+;%/\
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MG!='UC9>PI,LC6VT0AB@(E!.48>8,J1GAB 0K8UKF.29?+CEFMRK(_F1A#N
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M*6\60KYL<GEE4\MPH4HJJ /NA:ZN[TE=-\.W]IX<LM,M]MF\=I:/;;;97PY
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M#+6MJUG_ &CI5Y8_:;FT^TPO#]HM9/+FBW*1O1OX6&<@]B!7F-OX?\8?V?\
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MNK("P*D_-@ S(M!M/"GQ;^&FBV=Y*L-OIFI )O9!/*VUY&*YVG<Q9]B]"HX
M5<=)\=D@M/@[K5I%$+>R:&*T+Q1_N[2)G5?,*J"=B#DA03@<"L?Q!J4E_P#'
M7X;O:V3B$V>I"=IX]LD),2$J5ZJP/E]201)QP<G.^+^K3Z_\&_"<UQ+!#8:]
M+8&]D<HK_.@EC"1MN#?O1&64;B%#<$;B  TSQCI/@*\,VLV^H2WDOA?1V$=A
M:/,9RK7"8"J-D1RP'S/@Y !R#GNM)C\3W5_X:FU)['?:_:HM41[0@3' "36S
M\E,,-H#$;T=SC@5R6J:F^F>&? MGK][/J]Q>I')'I\-GNNKLQQB1OE7*/@;4
M.XH@#EV;Y0#Z%X$TV[TKP;X=L=255O;/38;:8$[V5UC0$;P<'E>2.I&>* .6
M^'.B>)]/\1^(IM9U2RN5?5IGE,7SF>%HHC;C&?W+1C@J1R&7DA06T_AQ L=E
MI6&),?A[3HQM=MI&).VYL]!@DL1SSR<ZWAN)EUWQ5(P7#ZA'M.W!P+2WZG R
M,Y_O=^?X5P/A6_\ Q+]-B#2L(M$M(23R,QO,F&)&=W'N.#RV Q -#5-?.F7F
MIW6JW=W!807UO96T%E:&XDE8QJY^54=SN,N"  0(@1R3G+MO&=J)8")_&<\$
M<)C9V\,W/[]B(<2Y6V&,;9.  "7?C 04NJ6_G:_*2;MC_P )+:D*%W!0EG&W
MRKP-N<EFZ]>H4 >A4 >:2>(WT_3(X+S5O&<D\%L;F>\/AT@R*;>1^"+?RT92
MZ':>0T:HP/SY9?>*"MO!;-=>.&N+>^+R2Q^%Y'$T:RNP1O\ 1RNW:%4,F&^X
MW7=7IU% 'ENJ^-51[NX2Z\<V]LL22A1X7EVQ[3&7&YK?J51QEN!OD.3^["^:
M6_BK3&MEFAU+Q'9W5K;"["P>&(V2$Q/&JEF,/7RO*C9P /W P5!5&^B_$VP>
M&]6\ZZ:SC^R3;[E9?*,(V'+A]R[2.N[<N,9R.M<%;>'KF.:RT]4U*SL+;=!:
M!)+N4[)4DS,TGGYC91)+'ABY7",-ORJH!QEOXJTJ234!JOB+Q.;>[N$:2YN/
M##J0VV56@#)&<.8&2,_* # [C[YK3^'?C+13%8V=EKGB37)-/2:1S;>'Y(EV
M2;9XRRQQ8P4R@'.]FW #Y"/0(IM=CL)X]*=9+J1V$7V^RG6,399I-S&4LL19
M)%4@,%$D97>@4-K:!J%Y<[XM2A=9\EU=;1X8RF$*_>)^;Y^1G@AA_#D@'+:3
MXE2;6M&A6Y\8-;QIY$D=YX=N(Q<2LL:I))+Y"A NV0MT4M+G(50!67Q7M@6X
M2X\</]G#-+;CPS,&G5FD5<;H/OKYD;<-C$8^7&X5Z710!X;I=M.$OKZ#Q-X[
M33I+V1I(H?#TL<@CF>Y9&0M$9)"I=3O 8 !04&5V.U/Q/_9'PZO84NO&:S6,
M*,LMUHCVT,DA,2)$/,C#&)I2%\L.9-LC@-M4%?<*PO'>BIXB\&:WI$EM!<F[
MM)(XXITW(9-IV'&1R&VD'(((!!!&: /GOXO^,O!5]H>LQV6MZE/XAM[2YTZW
MCDT\21HN%BE7S$C *GRB<ARH:<M@@ +V,OC+P?;Z/K-O#K^G27-O:RPRVDEI
M-#)(1:J@0/,&^\5^4A&!!554G=OKZX?"][:1:=XBTY].U":0?:?#4.GRFZFC
MVR%Q;);2X*,XFD:9=P885_N@# U34O!VE>&O$,KZC:+=317SFZ_LR\B:2XFL
MU58$>6X;]ZJLI*YV[7 4(=QH [3PI\3?"^FZWXS;4-;AN/M6LI-;/96DLHEC
M-E;@!50.Q*",K(>S8R$WJM7O WCBVC@?1X=2G\7ZVJAHCINBM8QB$!0JEV/D
M@ [SNW@=5 W84\UX;B6'5O$Y_P"$=UDNNI)';;M(<JD(AA+!@)1NC?:GR Y)
M1'D!)VC874[B]E34(8-;?4+)6BLI;?0;I$20Y,L>QYRI&#M(;" Q *VY4P =
M?:^//MT[VFG^&_$,FHQR/!-!+:B)()%56*R3,WEX(=2"K-N!RNZCPC\0=*\5
MZW=6.E2D260:*[M98)5N+>X#$%)!MV*!M(W;B&;(&-O/):Y"-26]LM&T+7&@
MO)/,N)CIL\+W&Z0R2)'(]S"\67'); *[5!*A<=%X)M;F37ENX-.-KI<<=WB6
M6P-E)*\SV[@^6S%R?W<A9B(P-R*%RIP =]145M<P749DM9HIHU=XRT;A@'1B
MKKD=PRE2.Q!!Z5+0 4444 %5YHT:[MW);S5W8VMCY2.<CN,[?QQ5BJTL-P;^
M"6.6$0*K+)&\.YSG&-K[AM]P0V<#&,<@'/3^#XKB&V$UU+YA3R[U(Y9U@N=S
MB20B/S3M)8-@DL5#L.<YK:72;8&XRURZSJZN)+B1^&55.TDDH,(.%P,DGJ2:
MT** *MG806:Q+ 9]L2&-0\[N,$Y_B)R?0GD#@<<5P_P;CDAM?%D=[%$FJCQ!
M<O?-#('B>1TC==F.@$31*0>=RMGDUZ%7$?"G3[NWTO6-0OO*CO-5UJ[NYX4A
MV+'M?R%5< <[848L1DDL3R<T =O1110 4444 <]]BUP"4?;7D*R2&%FN8U)5
MBQ&X"WP-ORJ!\W')+$9-F72+J7<PUK4H'9F91$8F$>[.0-T9W 9XW ]!6Q10
M!ES:9<R2QN-:U&,(NW:BP88X4;CF/KPW'3YSQPNT73+E9F<:UJ.PD'RRL!4?
M,Q//EYYW => JXQSG4HH Q_['NA&JC7M4^7&UL0$C'_;+G(R.<]<]<$3R:?<
MN@5=8OT(DW[E2#)&Y3LYC(QA2/7#'G."-&B@"M8VTMLK":]N+LDY#3+&"OL-
MBK^M6:** "BBB@ HHHH **** "BBB@ HHHH S=6T^>]EC\N[GAA\J2)TBD,9
MRVW$@8#.Y0K8'0[N>@K10%5 +%B!@L>I]^*6B@ JEI#%K20DRG_2)Q^\8L>)
M7[D#CT'88&3U-VL_0U"6+*J;%6XG 7G@"5_7M^GIQB@"+P[&T<-Z&NVN%:]G
M9 PYA!<_)G:,C.2,CH0,L &/E/[0P/\ PEGPG.XX'B:W&WL?WD?/^?6O7]-6
M;%R]QD&2=RJDD[5'RCKQR%SP .>YRS>/?M#@?\)?\)CLR?\ A)8 'XX_>1\>
MO/\ 3Z4 :VN>+;!-"\1Z7+X5UG7'1[D26$-@'6ZWSW"QE@FYE4M;R+YA7C:&
M(^9,V8_',B:'IUO%X4\1PWKM SJ="F$6_<CR?=QLSN.&/ ;.0=K+6AX1U>XB
MU#Q!;6VEZG<Q0W\N522UV!FGE)= 9@X!!4D,J\AB,DFM&#6KRX\?Z?82V&H6
M4#Z9=3LD\D)1F5[7!Q&S'(\QURQ'W6P"#F@#C-*\?:]=7%VNE:'K%[8W&HSV
MZB[MY+>ZL6Q;[0<Q,NS,S,#)C ./NQECFZCK^L6GPUA\:'6->MKJ"RDN'TBU
MM$DM\Q7"J(G9HMT87=M8DB3:&;GRV%>Y5PG@>XO+KX<VNIZ:VG37=VLM]+;7
M!\N"&Z>3S)8]Z E0DAE!)#-NY)XH Y^#QA!I7B;7==;2-6U#PWJUGI]_9WVG
M:=).K_NY-Q? RNT(AP0"O?&16[X'U7_A)O%=]K]O#K$&GRZ;:I#%J%F;=1N+
MR;HVQB4$%<_,2A&/X\"/X<0KK'PE\QK6*+^UXKJ=[2T?$<9E9\I$5=<#GJK+
MDDL",YKH?AU8W.E_#[PQI]_$8;RTTNU@FC)!*.L2JR\<<$$4 <GXE\3)_P )
MWH<5IX3\03W=M?-:W-ZNDR;#;M%)@+/PIC,WD-\QVC;N."H(F^)'BB;3M'U*
M66T\2:8(]/F3[5;6?VA+=Y 2DY,3D8C\ER?0,-Q4.N[I9/$>B6NC-?I+]HTT
M731&:VA,P:8RXVHJ M(WF';\@8[@<\@UT5 '*Z3XOAOM/TJ>TT_5+F&_BC>U
MF=84-P&A$H;!=?X3D\  Y'7BN-^(WBP7UCHMFFDZ]#9>(+B'29I9[542*&>0
M+(K*WS+(VTQ8;;MWENPW>L20122Q221(TD1)C9E!*$C!P>W'%<I\6967P)?P
MPINNKIX;6VW9$:S/*JQF0@';&&(+'CC(R"10!R'A6Q.D?&G3--MOM\.GVGA)
MK.*VN@N0(KB$HVY3A\+*$SVVMR22:[3Q]:G6- U31[>ZE2:Z2WA= @*I'+-L
M).5.0P#A@<C Z#/./=^'?%S>.=&\26E[I".VE?V=J=K(TS0QMYJR>9"HQO/W
MERVPXP><[1!\0]?FN)+K1O"=O#J7C&WA\V.V>T.U$$L3XDD9T58W";3\WSG!
M'W<4 =/X)EN$M=2TR]G:XFTN^DM1*TOF,T1"S0@L26++#+$A+_,Q4L2V=QW+
MZ58;*XEDSL2-F;&[. /]D$_D,^E8_@/19O#WA#2M-O91/J$4"F\G#E_/N",R
MR;F +;G+')Y.>:U7DBO-/=X)A)#+&=LD+%LC'52AS^1SZ4 </\&X[1_AGX2D
MTVWN&LA&3!]H=&>&/][M+< ;L$*2@&2?3BL7P?:O<1>.HH[42L/&\4IC0!L!
M7LG+\CL 6/I@\]ZW/@#_ ,D;\)_]>2_S-<[X$$2V/CD10/(?^$Z!<>:),L9[
M4[AN"X R#CG&TX)XH Z+X:6FIB>\O!?*=&:]U:)K(H,B<:I<$2*V,X*E@03V
M7&,'/?UR7PO#CPO<B9E:0:QJNYE7:"?[0N,D#)P/;)KK: "L]8+Y;RZ<W,#H
M^XV^ZWY@&R,!2=X+#<KL>!D,!D;<MH44 %%%8[^)=(34KFP-ZIO+9UCFB5&9
MD9H_, .!_<&[V&,]10!L53U2R%]:2Q"0QNT;HC'YD!92N63.UQST;(JY10 V
M-2N[=(SY8D;L?+[# Z?K3J** "BN7^)EO?W7@G4(M'M+N]OV:$Q06=V;25R)
M4)VS!E\LX!.[.!CD,/E-:PT>33/$-Y=P":XNGG>0*TN%>.XEA\Q@IE/^K2%0
M/E7H< ECD Y/X[:7:6?@_P -VEII<5["/$MDXT]G7%V[S,70F3AC(7;)8\EB
M2>M>/SZ1KY\<>*XO"OPTT64QCSYM/UK2;9X[8!(U46KIMWDX9L=#D<%LEO9O
MBGI^LA_"CW=^M_"WB;3F$$-CM\K$P);=N)  5N3G[QS[6=#^WR>+]<T+2_$:
M+?V)AGOYY=-#-,TLIF,:LSY.R(A."RHDT8 !7D \6UG1_B!9P/%;_!OP6(OL
MJR7$<5C%<2DX<O\ ,D@/S-&S*J9*@QJ#NQF:STSXC7,(5?A-\/[BTL[MU94T
MZW1IR)O)<*K/\H)4G?M4;8P<D=>R^(-_JGAN71[;3?AS<^(8KK2K=)XIAYJ+
M(D=V3$_RLTS_ +QV;).?=GS7+V?BGQ#IVN7$D'P9U0[EC5H[B_EE:W9#*4EC
M=H\0J%EF 9 HRSG<3F@#%@T7XEQ75A;R?"CP-+/<)).B3:1:H&&_<$9]RJ&"
MG 0$/M4D@D,U5=5B\4IX0L;_ ,4_"KPS:Z!--9SFYTO3(ENGCWJY4*C,8VE
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M?VYXP\J-D?\ M6/S&((#M]BM>1R<C&T=N0>.YZ*@ I'574JX#*PP01D$4M%
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MEM5(95?Y& 4_>(/ 8K@@'JOA'9+IOPZT:Q1=B6R/"%\\38"R,,>8H4/T^\
M>N!TKF/!X^T6_CN.W<!V\8A)7\\Q@C-H&VLHRIV?+C/+#JN> #K/AFC1>&;A
M)-Q9=6U0%F&"_P#I]Q\Q[9/7@ <\ "NJKE?AI_R+MY_V&M6_].-Q754 %%%%
M !7GNFZU=3ZIKP2:[G2WU#=Y43G= J.D?E.&0XW?-+M7#-&R;0V[+>A44 4]
M+AN(89!=,6D:1I,F7S,;N=H^5<!22HXZ*">2:N444 %%%)N4,%)&X@D#/) Z
M_P Q^= "UXIHIN9]#@;^P=%EU* ?:1<7%\/M1U4*3*[!8M^_=&J%5 X^4*T>
M-OM=1K!$DKR)$BR.<LP4 L< <GZ*H_ >E 'G7Q4EO)'\,^;-:V5HGB6P$4T=
MT[23'S,&,H(\<Y8$;L#&2>HKP?Q9XOTZ+XC?$>W:TU">._NUM;V[A'EB2RMU
MC6[@!:5 CJ$(1@6WE]A7YUV^K^*+#5;#PQX*&NCRKM_&,,MS;6I182TM]+(K
M*=C$KED(R4+#[V&)6LOPQ\/-(UCXK_$+46O)E\06=];R65ZJ(#;J\7S-Y:@1
M2!F\R,[@Q.PYPVXD Y>^_:!N[S2=/GLO#FM74T$#KJ5P+P62;HXI%9E50X7.
M_>-W\2!1N*Y&<_[0%G#KL<TNFZ]:Z<[;YKJ*[\Z9P9"\484ML"B&1@1NSN*G
MC:V[UW6O@Y;NR7MCXD\0?VO]JBN3=WMP]WF6,?N7,6Y8SY<A#@$%0-Z@ $;<
M7Q!\-X+K4H[#Q'?:]JFHZG:B"+4)+@QVJS!V;8MNDT8"#:DPB7<<0[B1M;<
M<1I?QGT#5O&*S3>$-6O]7C46^BW=[?I"TI7RR5EW,L467BW%EW<DC')SR3>(
M/#NK/?:D^B72Z#+>?VK/I)O()[2*5%03RQH)869BLUN K#@&8 9YC]YB^"=C
M+XBDU"_UO4+V*[M9K;5UEWI+J/FR"4J9%8+%$&"X2)%_B5F8$BN,\0_"FQ^&
MGPSUC6)C::YJ=G=V-U;W$UK(!;QQSVX=0K/+A2L?S,HSMR.5 4 '07MIIL6L
M>"$TSQ<K^7J$TEK;6FJ1-;K FGSE9%38?+C7:%P-RJLI!+97&;\0M'MM2TSP
M#]CU'69+?4W:\BLFNV'V:,6CE902!LCC,B!RW\+8[D5F>//&6O\ B'XJ>&=.
MTGPS Y=9IK'-PMKJ'V>2T9&D-PKN(%(E=PF X,49(R0*S[O4/%,=S;3W5BNG
MZ5I-O):LEK>I>_8K5K5DCMF2%$!$["%E.2<B-B,;!0!V?PX\/?;]7TA=9UW6
M9=1B\.VMW82PW*O&D<T:K<;&"G;EU3&<9&-N<-CT*'PE,UU/'-K_ (@558&)
MDU/<63:O+@H-IW;P -PPH.03M&%\(H#I-Y'I<[*LC>'M)DC1<MN"1M$[[L#N
M%&,#IGN0/1;R(27%@Q>5?+F+ )YF&_=N,-M(&.<_/E<@<;MI !YW<&U2%;X:
MIXH^Q-IK:BB+>2&9X4CC)<1[.&S)]QF5B0VU2!@;%A;VOA?6)I(;A+;P[8Z*
M))6E9G)VR2/YF\MR -Y/!^\.1T-2U\,S+>RV,5_I,Z001VL/F*9'MD2+:5\G
M=MX5XF.3M8R*2B[!YFU;Z/9+XBDLS96S6,.E6]ND)@38JK(^%P!A1PN%  .W
M_9H X2;QMX7\1:W##H?B"QO;@^)K=1;I*H9O+A56=%/S.F1]\94XX/<]7:Z[
M>+%ILEYJ<2QR6\<+NWV5!-=IY<C(N)F :5#)A02%"$[L;2U37+'3].U33Y].
MLM/AG37K>'=#:HK(K0 ,I.P<D,3G)ZCD8P.^,$1*$Q(3&Q=#M'RL<@D>A.X\
M^Y]: /-->\0ZV=-:33M?M+7"3W+S-;V<GDQPHBC=NNU7;(R2LI[>8@<Q[#NO
M6.L:_?7ER;#4[*Y,T@*V"06\DFF!7C+QSLMS\[%&_AZ%@22-N>]D@BDCECDB
M1XY01(K*"'!&#D=^.*(X(HVW1Q(C;53*J =HS@?09.![F@#G+,>)&U#2[BZG
M86:0K#=VBV<2M-,<@S;_ #VV1C@[!N;W;G'3T44 %%%% !12-NRNT@#/.1G(
M_P XJ"^GDMH5>&TGNV+JACA*!@"0"WSLHP!R><X' )XH RM0\+:=?^)[;7;G
MSS=V]J;5563:A7SHI@2!SD/"O?!!((.:LZ=HEKIVH7%W:-<*UP 94:9G61PJ
MKYC9R2^U$7))X4>^=2N2B\=:?)9_:A;3B ^08W:XM@)5E6$AD_>_,%^T1@XZ
MD@+N)7< =;6+XP60^%=>Q=K:(=/F"S"V,YA;8^7*#/F <'8%R<$<YP&0^*=.
M^UP6E]+%I]Y-#Y\=O<W,/F,H#%N$=N%50Q;[N&7DG(#_ !O,EOX+U^::7R8X
M]/N':39OV 1L2VW<N['7&Y<^HZT 4?"!0^(/&^Q6##6(]Y+9!/\ 9]GR..!C
M''/()[X'45SWAB(1ZWXN83&3S=41RI!'E_Z%:C;[]-W_  *NAH **** "BBB
M@ HJ.*>*5Y4BE1WA;9(JL"4;:&P?0X93@]B#WJ2@ HHHH **** "O.O@WI\6
MDR>.;&V.8(O$MPZYB6,CS(8)",*!D N0#Z =@*]%KS[X0V[V<GC>UFS)-'XD
MN&>=V)>??%#(&?G:"%=5 4*-J+QG)(!Z#1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 1RSQ0[?-E2/<0!N8#)) 'ZD#ZD5)5
M'4=-2]D\T3W%O<+!)!')$P/E[RAWA&!0NI12I93CGL2#:MXA!;Q1!G<1J$#2
M,69L#&23U/O0!)5+2%9+20.,'[1.?]5Y?!E<CC'IW_BZ\YJ[5+2(HH;218'9
MT-Q.Y+*5.YI7+#GL"2 >X&: )+!8T27R4=%,SD[EVY8L=Q XXSGG'/7G.3X[
M^T,H/BSX3MSD>)K<=3C_ %D?;\*].\(:79Z/9WUKIL<\5M]NGF$4DB.J,[[V
M$84G:FYB0IP1D\"O+OVC(4E\3_"H,!D^)($W;02 73/7\/RH ]$\#M+)<:TS
M)<K!'>SP@S,P#.+B9B47:%V[7C&]6.2"I"LASE:U*T&I:MJENL%M'!OED0Q6
MTOGK#"=UP3O#*1(($.<D?95! !!&QX-U*\NK[7+2[BMD@M;N0VS1O*9'1I9
M=X9 H^96P49AC@A2,'H8+2VMY[B:"WABFN6#SR(@5I6"A06(^\0JJ,GL .U
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M%4L<#T Y)]AS7*>#[5-$U[6] L1 FEVZ07MM%$NS[/YS2AH0H^4*#%N& /\
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MC6HM/GU2_NH--U'4])TVT+6B^8\9@C;?(?,&T.?-("[2J[03NYK'\4Z_:/\
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M3:YM7.N3K"EJ8IXX[>(>;-QB4$J=O\65Y!^7&,'=:G6[&HV"Q3I]F59#.K,
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MCW'@KP8JE;7P)X=DGF0&U632 B,Y1V E<0GRA\A!)!QD#&6532M?"O@RYU&
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MS $7*>4?F38XQ\S@'>#S&V$&5>M"LZ]U:&TUG3=-:-WGOA*R%60!%C4%B0S
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M_3T %%%5=4O[?3+"6[NY%2),#YG5=S,0JH"Q W,Q"@9Y) [T 6J*3<"Q7G(
M/3C\_P *6@ HHHH **KW5TD+)")(/M<JMY$,DFPRE1D@=3CU(!P*G5E<94AA
MDC(.>1P: %HHHH *X+X4@17?CJWBEG>WA\2W)C264N(R\4,LBKD#:OF22-M
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M)ZOX5VUQ.WB+Q!,B6B:W?F8:<C[_ +*\2BW?<< >8S1$L .#QDXS7+Z?H?\
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MQ@9..2!T'' H K>,H8]8UV]\)Z?"UI)>Z5=22B>VFBL[QGDMPV9(W3>P7<&
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MHWWE>-L<\8(89&,'% '%:#XNU&SFTN#5?!TVD:?J5RL4-S#<Q2AIID:9F=$
M*Y?<"Q R[=.:]#KB/&GEO-HB032CR/$-OYJER^2R%MIW X'S@@*<# ]Q7;T
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MDM8S;G[4HFA,<\4VQ?*8KL</N54=F4E6&5Z"X\*W$%KJ=WKNLZ]J@&FR63I
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M*[5.[=G8"3N+LT3?#F.:Z66]\3>)[Q49GB2>]&(7+HRLNU1RNPJ"V3B1N>:
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M-&?^>AW2AL?P[/6O;:RK9(AXJU%UBB$QLK8-($(=E#S[06S@@$M@8&-QY.>
M#BFTCXB:OXLM&UZ7PI!X:M;X7<267VA[K:A;RU)8!23D!CTXR!VKTJBB@ HH
MHH HS?VG]KB\@V?V7SP9 X;>8?+((&. XDVG/(*Y& ?FJC-<:LVDV#V=SH\E
M]-,A)?>(9XLEBL>"2&*#@_,!@G!'%5VT36&U">0>)]36V>25DB$=KB-70A0,
MP9_=MAERQS_'NZ$M="U;RX?M'BG6 \89#M2S82@2EE=C]F&&*84A0 !TRWSD
M =+<:^;YF6XT&&S2X$+QL9'D4&6/;\^5&]HB_P FWAG3EP#NT8[FY.E74TTM
MA'+&9MLBN6A0*6 WGCIC#>X/3MCWOAO69I"UOXTUJ%?+D 3[/9L Y.4;/D X
M7/W<\X7/\6ZR^B:J-PB\4ZEALY,EO:LRYW#Y<1 <!\C(;F.,G(WK( 6[V755
MM[E(#IL5U*SI9&9W*@^6Q7>H +G*Y*J1\I.#\N3*[:J+4,D=B]P)GRAD=4:+
M<VSYMI(;;L)X(SN [&L:'PYK:V\23>-=8>5 X:1;6S4R9)P2/((RHQC&!D9(
M(.*N1:)?QRK,?$FJ22>48V5H[?RV/[PAMHBX(\Q>A&1$F<_-N +>GS:P\D U
M"QT^!"A,I@O7E*/\N H,2[@?FR21C X.3C2K)\.Z9?Z9#.FIZ[>ZR[R%HY+J
M&",QKV4>4B ^Y/Z=*UJ "BBB@ HHHH ***C@GBN$+P2I*@9D+(P8!E8JPX[@
M@@CL010!)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5EZ;I_D"5X9+RV6:Y:X:WD=' )SN ^]A6/SX!ZGMR*U** .!T&ZU&[TJPN
M_P"S_$=O.LGV:.VU"<)(V)F)>;:I4 (@^8DY5RJY;;N[+1YVNM,M[AXKB!IU
M\TQ7 Q(F[G:1VQG&#R.AJY10 4444 %%%% !1110 4444 %%%% !1141N81=
M+;&11<,AD6,G!900"1Z@$KG'3<,]10!+1110 4444 %%%5M3L;?5--N["]0R
M6MU"\$R!RA9&!5AE2".">00: .>\1->?\)WX16-9?L!^V&8A?D$GE#R\G/7'
MF8X/0\C&#U5<MX?\ >&O#^I0:AI6G&*\@A>"*22XEE\M'(+ !V(&=H&>H P.
M.*ZF@ HHHH **** (KNV@O+6:UO(8I[:9&CEBE0.DB,,%6!X((."#4M%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "*H!8C/S')R<__
M *J6BB@ HHHH **** .8\0:E<:?XQT"*"TU2YCO(;J-_L[H+=2H1UW[N/,.&
MVX9>-^<@<:.D&58TMV>_96MD9)9P"5P-IR2H.XX#?-SR<@=*UJ* *\D$CQ[5
MNYT;^^H3/W<=U(Z_-TZCTXJ.TL1;W+W#3S3SR0QPN\FT9"%R#A0!GYS^0JY1
M0 4444 %%%% 'FMYK&C>&_$GB*^U&[UNT"Z@]\X$)^SW30Z6A>-2 <@1 288
MH6>/Y<B-JQ[K6-&O]/M+6WG\8;;;R+V;^Q[L[(85AD50SHP_<%4>0$8\W:I4
MN2JGV*B@#S6SL[+0;B'3#JFKVA2XL+62_8Q)#=7*K;X4X.XO)' D9SQB0@=<
M52LY=)\3W#Z9;ZAXB@\RXO(D.\P03O(S7&7C#!RJ*\9&=HD25.'4G;ZO10!%
M;1/#&5DGEG)=W#R!00&8D+\H PH(4<9P!DDY)EHHH **** "BBB@ HHHH *S
M?#RR)82B9%1OM=T0%C=!M,\A!PY)R1@D]"3E<*0*TJS?#THFL)6#VSXN[I,V
M[AE^6>08)"K\PQAACA@PRV-Q -*BBB@ HHHH *IWL\GG):6KI'=2QM(CR)O0
M!60'*AE)^^.GX]@;E4;ZVNFO;:ZM)PIB5XW@D+;)%8J<\'AAMX)!P"P[T <W
MIWB.Z%_#//<07>BWLUQ:VH2V*727$3S%T9=QW )$XP%#Y0Y&:UI-8OA8K,FB
MW1GDD\M82P!3]^(LN>PVL),KN^56QG W%MH\D.K(8A;VVEV\DMS%!$-S2SRE
MVDD<D?+S(^ O4L23VK4L+.&PM$MK566%,[0SLYY.>K$D]: ,?6]=O+6Q^T:3
MH]SJ1:UN9DB(>!S)&N4C(9.-Y^4$\]" PR18DU2],L,=KI<LC>:8Y_,8Q[%'
M&]"5VN,E#U4[2Q&YE*5L44 9,-]JKQYDT<1R?:EAP;I2/*P-TV0.F=VU<9.%
MSMR0L$FN7/VUHX-&OI+=%B9YF4I][?N"J1EBN(\XX/F<'Y6QNT4 9]W=WT.I
MVT,.FM<64JGS+F.9 86R/O(V"1@YRI)X/'3-+^V[QO)V:-=J9>HDX\L;G^]@
M'^%">,G+*/X@:W:* *UG<RSS7:2VDUNL,WEH\A4B9=BMO7!/&6*\X.5/'2K-
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7):IX7TR
M^\?Z7K=YI>H7.HV<3?9=06Y$<-F,$&/8LBLQ;<V<HXYP2!@5UM% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8UQKH
MCU*:RBL;BXEB94_=SV_S%DWC"M*&' ;J!]TD<<U2N->^V0P"/1]3F$DBA?L]
MY;(=W# 9$XSE/WF 3E>V>*Z"2TMI+J*YDMX6N8@1'*R N@/7!ZBL3QQKMAX3
M\.:AK][$&>WC"QA(B\DTA)6*-0!DDL^T>FXG@9- $EG>W=N)$&BZRR;AM\V>
MW? "J.#YN2.,_-SDDU$M_?K=?;6T+6R[HL)MA<6I11O/SX,H&[!YP3P,#/&?
M.O".MWMQX5U7PWXF\9W>G:W;16^HR:K>68L)TM)'5I-J3 #"D21>9@A2R\9
M6HTOM?>.RTFZUG6(A;Z=J^K073QF.>YBC=(K0ROL"$@3-(8P,_+%O49P0#U5
M=5O"6SH&IC!P"9+;GW_UO^<4L6J7;L VA:E'EL9:2WX&>O$IX[^M>?V-SK%[
MX[T>]T[Q'=W4EWY,NI:0L0-E86;6A/)P2LK3!64[PQ#_ '652:S/$7BC6M&U
M^7Q##>7^HP?VY)H?]C1;/(B@%LS^;M"[BX>/S&<GB,L, #- 'K6GWUQ=-B?2
M[RR&W=NG:$C/'R_)(W/Z<=:O5P/PSFU6.]N[+5M:NM7\S3;'4Q)=)$KQR3F<
M2*NP+\F8@5!'&2,GMWU !1110 45F^(M4DT?2WO(=+U#5&1E'V:P5&E()QD!
MV4$#OSFN2_X6-=_]$^\;_P#@);__ !^@#OZAL[2WLH6BM(4AC:1Y2J# +NY=
MV^I9F)]R:X;_ (6-=_\ 1/O&_P#X"6__ ,?H_P"%C7?_ $3[QO\ ^ EO_P#'
MZ -\V?B?[2&&M:1Y&[)C_LJ3/?C=]HZ8QVSD'L<![6OB4NY76-( VX13I<A
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MSQNZ8ZCTP5^R>*]ISK6AYP,'^R)>N[)_Y>O[N!]>>GRU@_\ "QKO_HGWC?\
M\!+?_P"/T?\ "QKO_HGWC?\ \!+?_P"/T ;JVGBWR'#:WH)F.-K#1Y@HXYR/
MM7///4<<>]->S\7G.S7- '/&=&F.!C_KZ]>?IQ[UB?\ "QKO_HGWC?\ \!+?
M_P"/T?\ "QKO_HGWC?\ \!+?_P"/T ;<UGXO,K&'7- 2/)VJ^C3,0,<9/VH9
MYZ\<^W6I%M/%6!NUG1#\ISC2)1SNX/\ Q\]-O&.YYXZ5@?\ "QKO_HGWC?\
M\!+?_P"/T?\ "QKO_HGWC?\ \!+?_P"/T ;WV3Q7YP(UK0_*W$E?[(EW;=W
MS]JZ[<C..O..U,^Q^+_-!&N:!Y>3E?[&FSC''/VKUSV_QK$_X6-=_P#1/O&_
M_@);_P#Q^C_A8UW_ -$^\;_^ EO_ /'Z -EK+QD7RNO>'@FT#!T28G=MY.?M
M?3/./3C/>E^Q>+RF&U[003U9=%E!Z=LW1YSSWXX]ZQ?^%C7?_1/O&_\ X"6_
M_P ?H_X6-=_]$^\;_P#@);__ !^@#;2S\7B8%]<T Q9Y4:-,&(W>OVK^[QTZ
M\^U"V?B\*^_7- +;<*1HTP ;CDC[5R/O<<=1SQSB?\+&N_\ HGWC?_P$M_\
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MG'.!WXY]B/\ $?5\@Q_#CQ>T>2&+1VX8<-C \WGH,^F3UXR =*^G>(WA"_\
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MOJEHFJ(J+]H_LQ-S;4,:Y^;J(R4R,':2.YR-XZ\7*CL?ACK.%7<<7]J3C!/
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6BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image02.jpg
<TEXT>
begin 644 image02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" &B B4# 2(  A$! Q$!_\0
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MC_L[11:I;GRHP=(DM]FTD@*&C' *$@CC.W'5<@'1T5QAT[P;+%:1-X7A:-%
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ML+D\1 9&_P"4OO#=G=7'V"[\'^%9(S?.T'GP(R/;DP&23&PD3$ C;C!,2DL
M!0!WU%>4Z;X6:[:1[SX:>#++RAO6)UADF=Q-A3A8]J@H)'#;B07 P<,3U6G^
M!_"[6N+CPGX90I(Z(L%C$Z!%E8IU08/.XC& Q;!/4@'645RX\ ^"Y,L/"?AU
MOF;)&FPGD\-_#U.,&IK;P5X2BD26U\-:"CQ_*CQV$(*XRN 0O&,L/Q- '145
MS<?@/PA%#Y4?A70$BRQV+IT(7++M;C;W7@^HXJIJ'AKP+8W5A;7OA[P^EQ>.
MMO:Q?V=$SR%%+ * N<*JDYZ*!GB@#KZ*X&2P^',]M)=-H6ASBU@%RZC25>2*
M(!W5M@C+ 8#E>.<C&2PS+!HGP\2%?(T#P\D4L"S_ "Z9& 8OG<,?DX ,;'GH
M1V)&0#N:*XF2V^']S>6MM-IN@27<;3M;PR6,9D0Q2R&5D4KD!9!(2PXW-G.6
M&=33-%\)7^;_ $O3-!N<I):&XM[>%_D+,)(MRCIN+;E]2<]Z .BHKGY/!7A:
M1E,GAK1&*L6!:PB."223]WJ2S$_4^M1R> _"$CJ\GA70'=0@#-IT)("+M3^'
M^$  >@X% '245SLO@;PE-CSO"V@R87:-VGPG YX^[T^9O^^CZU-#X1\-PRF2
M'P]H\<A$@++91@D2#$G.W^(<-Z]Z -RBJ]A96NG6B6NGVT%K:QYV0P1A$7)R
M<*.!R2?QK#3P'X03R=GA70%\D@Q8TZ$;""2-OR\8+$\=R?6@#I**YU?!WA*V
MNDF7P[H,-S++N5Q8PJ[R9#Y!VY+90-Z_+GM1_P (5X26"&T_X1K01#'YC10_
M8(=J;P%D*KMXW *&QU  - '145AR>$?#<G^L\/:._##YK*,\,03_  ]R 3[@
M5?TO2=.TF+RM*T^TLH]JKLMH5B&%Z#"@<#M0!=HHHH **** "O//B]<Z%8R>
M%;[Q7J"66EVFJ+.C.H.+@(WE..">"3_"0 Q8XV@UZ'63KN@66MSZ?)?J[BSD
MDD1!(RJWF0R0MD @'Y9&YZCMC- '%V_PN\ :1IMW;3VT#Z<]Z+JXBO[GSD,_
MDM'EC(20Q64MUSD@C'%(_@3X=:38B!(;"PCO ;0O'*(Q*6CFB&X#Y-VV[D0,
M1G]XBY/RBMK_ (5QX2G6VSI4,UK'&5\EW:2*<-Y'S2@D^:?]%@Y;.=N3D\U/
MJ7@3PGJ'VJ2ZT6T>627SIY(E*RO()!,"S*0Q(;!'/0D#AB" <W=:+X!\*M:6
M23G3[B>.9(YXI69QF[AWNTQSL(G,0^9@,G !Q@7X_A[X0A2]GW9::5IKJ>2X
M#;V+QW!WYX(W)YH!&%\QRNT-702^&O#YN-,DDL(&?3DDM;5,E@BRA2ZE,X8G
M:I)8$\$^IK-TWP9X-C::?3[.U;RK!-(F*7+,H@2/"HXW$%Q&V-[?/M;&[!H
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MYW [: .BHK!33M?9$$VOPAHV)4PV"KYB[E*B7<S9X# E-F=V1MP*DDTC4?M
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M(<X& RCG:6;0K!TEHEU^]2+2=3MG"^2US.X,#I&=Z;/G. 3<28PH/[M@V J
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M, 7:*** "BBB@ HHHH **** "BBB@ HHI'8(I8YP!DX&3^0H 6BBB@ HHHH
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M?-J1AN-/AEL[E3>.(PV8R(V\N20AOFSP(\'&>67&1DBQ?W$EM:M+#:3WCAE
MA@*!R"P!/SLJX .3SG .,G ( Z^^TBRN/L(A-WY;>2)B0A?'R[B.<9QG'.*S
M?#\.M0>%;*'6;BVGU]+54N)UYBDG"\O@*GRD\X &.GO6H[/';EMAFD5<[8P
M7..@R<#/N?QK/OM0OH;GRK71KJX030H9O-A1"CDAW&7W'RP,D$ G(V[N< %O
M3([F+3;2._E$]XD*+-*  '< ;FX ')R>@^@JS45M*\T9:2"6 AW0)(5)(5B
MWRDC# !ASG!&0#D![N5:,"-F#-@D8P@P3DY/3C'&3DCMD@ =6=?PZG)J5F]C
M>6\%FBMY\<D)D,C;X\8P1CY!,.O#,AP0I4Z-1RNZO$$B+JS;78$#8-I.??D
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MSPCX:T[PJMS::+97T,-I#%#'&XC87"JAPR2'YLDG:59E ,8(50VYP#K:***
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M8*Q*0&<^@!8<G^AJ>TN8+RUANK.:*>VF19(I8G#I(C#(92.""#D$4 2T444
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MJBW>I%)%9FN 7 '*'RHQ@\=< 'OP1]!=H \B^&"75MXGU.(PSM92:]K<A\X
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M!(P0ABI.4SM)^48)!(Y (W'/(ZC>S:EKGA&0V=[9M'J]ZKJ\9&Z.*&ZB!8\
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M:'E<2 H'VD,5)/=^7'8OIEL2LD(98+?SV>2566*3+>8VXLQ48RQ!^\2Q)Q0
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M)8<S3 QJ@7:1*P(."1NR#D@D$Y(ZU%H\5_%J&L_;WEDBDNA+;,=H18S$B[%
M)(PRL3GJ6)'!P%\-Q1P:8T4*HD27-PJJBJJJ!,^  O''3^?- &I1110 4444
M %%%% %;4I!%8RN8KB;:,^7;G$C<]!R/YUYCIVJ-IOV70(Q;0VT>I&#[-!J.
MUH8$Q"(5<3$J5:6U90=FY9D3RU8Y/J]9NFZ#I6F7US>:?I]M;75TS-/+%&%:
M4LQ<[CW^9F;GNS'N<@!'9SP6^F0VC*D-LJJXER&VA<=$(4G&1C&,D,/N@&AX
M#.?#Q^=W;[=>AS)()&W?:I=P8CC(.00O (P. *MZQ>26^KZ%;II\URES<R*]
MPL.]+4+!(VYFS\F2 @.#]['<5'X0S_9,^Z/RS_:%]\N ,C[5+@\$]>OKSR >
M  ;5%%% !5?4+VWT[3[F^OI5@M+:)III6Z(B@EF/L ":L5SOQ TC4-=\,3Z?
MI%Q%;7,LL.Z1V*?NO,7S5# $J6CWKG!^]CC.0 6K7Q1H%V+<VNN:7.+F7R(/
M+NXV\V3:'V+@\MM96P.<$'H:;8>+/#U_#%+9ZWILJ2HLB;;E,E61W4XSD96.
M1N>R,?X3CG[WP1=76CW%I-J$<LCJGD'R0D=DR$A6@4#@A7=AYAD(?:26 Q6S
MH?A.RT?4S?P37$MR]M'!,\HCS.ZY_?.50$R')SSM&YR%!=RP!N^<O[WA_P!T
M<-\C<\ \<?-U[9YR.H-1Z?>V^HZ?;7UC*L]I<Q+-#*O1T8 JP]B"#5BB@ KG
M=7O()/%6A6JS9FCFE9D!/7R'X/&,@')YR-R\8?(Z*L+7E0:]X:E>1@_VN6)$
MQPQ-O*W/&<@)ZXZ^U &[1110!'<+(]O*L$@BE92$<KN"MC@X[X]*X73?".J#
MPQ;Z;J4UO*TT,BWL1NYYH=SH=P&_YI5:0@GS#]T8.XL[-WU4;*P^R>4(7*1H
M9!Y0 VE2?EZ 8V@*H]%R.>#0!G0Z1>:?>1W&G21.OE>7+%*VTS$-(P=GVGDM
M(20%'))R0-IWZCW+#Y4?SG<=BG#-T!/)[=.I[X'4BG(Y9I 8V4*V 3C#C .1
M@].<<X.0>V"0!U%%% !1110 4444 %%%% !1110!6@OK>>^NK2*0-/;!#*H/
MW=P) _(9JS2;5#%@!N( )QR0.G\S^=+0!1M[AEDU-I93*D$WRHB;FC7RD8KA
M>6.23Z_-CTJ:&[26TBN/+G19-N$>)@ZDD#E<9'7GL.O3FFV?F?:+_P Q6"^<
M-A*@ CRTY&.HSGD\Y![ 5:H \5^'MC:2>+I;ZZ&FLVG^(-=\B269EN TL\*9
MA3HRY?RW+ $,4VG:?G]2F&FP:C<Z;$L$>HZO%+>,CQ%UF$:PPL[CH0 T*XR"
M1TZ$CQCPO";_ ,46?A_52SVEYKWB&ZGCMK@HCNCJ%RR?-P)WXW#&3N!(&WT;
M3_ACX;M-1N[I+&9&DMELQ(-1NGE:$ Y5F,G3G&!Z9R<X !E>,M:U/7?$MMX3
MT2YAL%N%V7MS.5D!PL<LD$<0Q)O\IP2[810ZJ1ND7!XDN[N#4/"-O\0+729+
M?^W(Q;7UKO"27.V86X\A@S1MEHR"'895\E5 W0#P[9^!/&\VLVGAO5=2T^[_
M 'LFH13R7LUE*_R2'RF9I7#[8LE V O. M1>-K?1O&M]H4ND7,^HW^EW'GQV
MB7;1O932SQJMS/ <2 P_O'"-M V,AQD"@"GX?\'S&ZNH-:\,6I\40W,-Y%X@
MEA^UF;9< "03R,6#"-$/E#:!M;: &4#V&TMH+.UAM;.&*"VA18XHHD")&BC
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M7<KJZ, 25*\\'-7&@B:)8VB0QJ5*J5& 5(*X'L0"/3%/55084!1DG &.3R:
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M8!'#3)&SHNYF7)X08[W2M7:QTVVBM]-N'6.Z73Y6DVQM)M"J)XXUW;HR@W@
MYP!QU(H>(?#^H-:Z-=Z':VS3V4L\4^GB[)BNH[AMDHDE9=Q"EO.;@EFBV@$D
M$ '+:X&U.^AT.^EF>26:SB.GKI<B"XL[>2-;DNHX,>^1\,=J,&(42;5-&A:1
M!%XCO-8MF>.RM8Y6L[P6V]KBW8+++<&]\IP1(9)&6-."2S9W,<1:5)?7G@SP
MGJ=CHNIV&G16UE:7:0O S)$"F)XMJ.\B*4C;(904P=IVX%B6"\M;_2;'PEH6
MM:Q#8B/%[=7"6MK+(9&247"LBE3&JAP\*%MX4$';@@%ZSN+?PW\1]3MI+W&J
MW&DPW B<0M)>.\\P+LP"23^4%BBC4X.TD $L2'^/G^T_"[1KS6]/6&_:ZM)I
M(/*\N*&YD;#/(C$C"L[/L9QN8!1)N*L;&BVUUIU[JEY+I>EVFGK;B"S33)WD
M58MJO%(P(C67<^\#[IC*_*2)9''>76D6%Y8Q6=W;)<6T4D<RI+E_G1@ZL2>2
M0P!R>2>M %?PW.+VR^V-=V5[-*%/VFT151HR-\8&'?@*X.2QR6+# 8"M:H4$
M-KY,88)N BC5GZX!. ">3@$^N![5-0 4C, 5!S\QP,#/_P"JEKSS5+#2[GQ+
M?7,-PXNKI;9)KUKJ&!=D-Z=\"NH,@SM9&C*[) H4,K%VH ]#KE?B%H?B'7--
M@B\+>)/[!N8G\QG^RB838Z(3N!49')&>">*Z:&>*<,894D",48HP.UAP0?<>
ME0S:A;1V[S!VF1)1"WV>-IF5RP7!5 3P3SQ\HR3@ F@#@O"&M7/COP'X3UZQ
M$D4KS 3W".8VV1R&.3"X8LKL@.PG ')8E0K<5I7V[2YTLUOUO@OCY+>9[^./
M;/&+:/F=E"+YH8*T9Y)D$7!.,5?A]J^HR?LSZQ'HK&PU.RNKJSAN%E"X9[G?
MO!4N5QYV,9)^7()!!JYX(^WZ.=5NX]$\JZL=;>1= L+TOG=8Q%HDW;8MT*RD
M +M5@I !VJ2 >]5RGC(ZW!H<S>$X;A+];R >4L<.WR_.#SOAL;MT;/T.[.,8
M.37,VGQ$\6K]F35/AIK%N[SO;N\=W#(@*H[ @Y_B(103A,OC>2!N?H7C+QGJ
M6K6.DW/@=]%OF437UW=S+):[0&4^6T9.YB57 )X!Y_A) -7Q'?I>:)J#:OIL
MUK=1P77V);EHBKR&W<CR22&+F+S>P('F@\=>$^&=C:ZEH/PQTT0WP6/0;N6\
M@FG"LD,RHF]@K;@KMN\HCG:&Z$$5T/C?Q'XQL([ZQD\(S:E9/8R^;>6%U$D,
M:L&!.)"&9E^3CY<AG/.T5C7UIJ6D>(M,@TJ\T:?4DT&:%-5F(CEN +0!&6)
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M[.63<XQD +Q7N?B*\@TX6=S<)=OON([4>092JEY%P76/.1E5&2"/FP2JLQH
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MESY3&6( ;C&&1E#Y"G,OWDVFJ]_I<FG>+O"$ U+4;S$=VK?:KC)D86\:[F(
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MOFC7R\;\N!MSTSZ9JGJL.F3W&G_VF;<S03B>U65P#YH!0,!GDCS,#KRP[XH
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M.1*ORA0"Q//  92?3</6I4N(7E\M)%9_FR%.<;<9!]",CCWH EHHHH ****
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M%688/'-<U!X2T:QN=.6[\-:&)7U%EADL[2)56)$E> N'&<H !A"<-AAM7(4
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MR.IQQWKBO&&P>)_"$NN6MG+IAOY8(UE<,L-T4W6MQ\R??_=R1@9&'G7&XXP
M%Y9S> ?"^KS>'+6ZU+?=/J3Q74X81!Y4,^"<.?E,L@!W$D,,\J*Z'PYHR:+9
M/")%EEE?S995B6/>VU5Z+V"HH ).  HPH4#R7X5Z/#>^++J> Z;=V.W55U>.
M"VC:-+J6])6+?+&LQ4Q;E90!&?)4\YY]OH YC6[VVOH/"LS?NX+V^ADC\U6X
M/E22*#M8 $E0!DD;B!@G ,?B0E?''A,A2Q O"%'4_NAQS6OKD,TCZ8]LD+O%
M>(Y#L00NUE8KAAD[6/!R,;N"<"L;Q.Y3QMX4=8VD95O"$7&6/E#@9(&?J0*
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M%NVR5&4J4;C .1WW*1ZA@1P14.MSO%)IJ++-"L]R86EC9 $S%)M)W]?FV@
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MFE@AND$PCP2ICMEE7E0/D9V506D^?ZC\9-$OA#7&N9?)@%C.9),,=B^6V3A
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MU%%% !117'>()[JPT*:[::W^S6LW_'RES=/Y2+)L.]8\L^U0-Q+  [RV I)
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M*R.PZ':2@'IOK:KF[]T'Q&T-"$\PZ3J!4E3N $UGG!Z <C([\>AH Z2BBB@
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MC.:DTZ-I'ENKFW,,SL=BR!"T:E5!7<N<YV GD\\<@"@"]1110 4444 %%%%
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MJ]O<WBR%I4^S26SN><?+( 7*JH#$9Q@9P"!5JW\%6*6P%S<W%W>^>LTE_)%
MD\JAV8Q.8XU5HV#R*5*])&Q@G( .@T^^MM1MUN+*430.,K(H.T\D<'Z@U2\3
MZ)#KOAZ^TMUMU6YC909H!,@8YY9#C(.3G!!P3@@\BSI6G_V?"ZM<SW4TCM))
M/-M#N221D(JKP,*#C.U5!)QFKM '(^'_  I+I^I17EVVG27-N5C6YBL8DDGB
M\A5.2J Q_O-YV@L-H49Y('2S6%G.[O-:6\CR##L\8)8;2O/'/#,/HQ'>K-%
M%'4;%)K2\-M!:_;)H9$5Y8P59F4#Y^.0=J ^H4>@JU C)&/,V&4@&1D3:&;
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M&K%<KX5M)U\0Z[>W,<02Y:*6WR2TD:L@W(7).X'8K?+\@SM!.S-=50 4444
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M=J5,8#E'/&1N*J",$KO'WL-@ ?<:%;3W(N'N=2$XWG*7\R+EXUC)\M6"=%!
MVX5LL &))L-IL!=65[E,+*I5+AU#"0[FR,]<@$-U7D*0"03S-1W+_HMIC^(_
M:6XY/3]WSQM_,^G-2TEUY+6U6]M--ENMJK/)#<NB;L'<RJ4) X&%R3S@GC)
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M8/LF.CN6C^Z$&W[1AN-Y)X^;;QC(*-8>-_-RGB+P\$ P VAS-N.!D\70QSG
M],9)/- $6G7OCR3[-_:&B>'H1]L*7!CU.5R+?(&Z-?)P6P2<,5^[T!/%B[N?
M&H@#VNE>'FE559HGU&;YVW?,H;R!MPO 8@Y)Y"@<VY;'Q'):R*-<L(K@M(4D
MCTT[54QNJ#:TISM<QN3GG8PX#?+7_L[Q9]G@C_X2'3#(L,L<LHTI@68Q*(Y
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M]JY!P.06+G/& BC!WDHR'_A*2P2?^Q%'FG,Z>:<1YDP?+.,MA8LC>!^\<?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
B444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image03.jpg
<TEXT>
begin 644 image03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" /' NT# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZCOKJ"QLK
MB[NY!%;6\;2RN>BJHR3^ %4)_$&G0+<F2:4&W61G002%B$!+;5"Y<_*V H);
M8VW.TX?XFF-OX;U:99E@:.TE<2L 1&0A.X@@@@=>01[&M*@#+BU_2Y;PVT=X
MC2A@G .TD\<-C!YPO!X8A3R0"VW\1Z1/8VUZM_"EK<*&227,0&55@K;L;'PP
M.QL-UXX.-:B@#*M?$.E73%8[V-6#,H$N8]Q5W0[=P&X;HGY&00,C@@ED'B32
MIO*Q<M&)%0J9H7B +;OD8LH"N"I#(<,I*A@"R@[%% &;)KNEQ^9F^@;RT,C^
M6V_: P7MGDL< =2<@ X-*^MZ;'((Y+R%'\PQ%7.TJV6'(/0$J0">#Q@G(SHT
M4 9:Z]IKQ+)'<&16"G]W$[$!G"<@#(VEAOS]P'+;1S38/$>E31Q.+L1^:5 6
M=&B8$@D;E< KR"IR!A@4/S BM:B@#.&N:61,3J%JJPDAV:4*!C:"<G@C+*,C
MC)QUXH77-+,C(=0M4D5F0H\H5@0Y0\'G[PQ[]JT:* ,^?6M,MYDBGO[:-G5F
M&Z0 84*QYZ9PZG'7!STIPUC3"JL-1LRK'"GSUP3\O3G_ &E_[Z'J*O44 47U
MC3$*!]1LU+A2H,ZC<&Y7'/.>WK3?[:TK<H_M.QRRAE'VA.03@$<]"3BM"B@#
M/_MK2MK'^T['"L58_:$X(&2#SU &:=)K&F1R&.34;-'#;"K3J#NR1C&>N01C
MV-7J* ,^/6M*EV^7J=B^[[NVX0YZ].?]D_D?2A-:TJ1=R:G8LO'(N$(Y.!W[
MD$?6M"B@#/CUK2I=OEZG8ON^[MN$.>O3G_9/Y'TIPUC3"JL-1LRK'"GSUP3\
MO3G_ &E_[Z'J*O44 45UC3'W[-1LVV'#8G4[3D#GGU91]2/6I6O[-(VD>[MU
MC5F1F,@ #*"6!.>H"L2.V#Z59HH HKK&F.<+J-FQW%,"=3\PY(Z]?:E75M.:
M,2+?VAC.<,)EQPN\\Y[+\WTYZ5=HH SQK6E%BHU.Q+#=D"X3(VC+=^PY/H*D
MDU2PC_UE]:I\S)\TRCY@0".O4$@$>I%7** *3:MIR1[WO[14_O&90/XO?_8?
M_OEO0T'5M.$CQF_M!)']]3,N5^;9R,\?-\OUXZU=HH JIJ5C(<)>6S'CI*IZ
MML'?NP*_7CK4<6L:9-;1W$6HV;V\B[TE6=2K+L$F0<X(V$-G^Z<]*O44 46U
MC3$V;]1LUWG"YG4;CDCCGU5A]0?2E75M.:,2+?VAC.<,)EQPN\\Y[+\WTYZ5
M=HH H_VQIF^)?[1L]TR[XQYZY=>>1SR.#S[&B+6-,F1FBU&SD55+DK.I 49R
M>O3@\^Q]*O44 44UC3'!*:C9L  21.IX.T#O_M+_ -]#U%*VK:<KNC7]H'1M
MK*9E!4Y*X//7((^HQ5VB@#/CUK2I)%2/4[%G9E556X0DEON@<]3V]:(]:TJ6
M"&:/4[%X9E5HY%N$*N"%(*G/((=",=F7U%:%% %-M4L$;:U]:JVT/@S*#M+;
M0>O3=QGUXH_M2P$8<WUKL()#><N" F\]_P"X0WT.>E7** *?]J6!4D7UK@ $
MGSEX!;8._P#>!7ZC'6DCU;3I&41W]HQ;;M"S*<[CA<<]SP/6KM% %%=8TQO+
MVZC9GS"0F)U^8@ G'//# _0CUIIUK2@H)U.Q *[@?M"<C!.>O3 )_ UH44 4
M7UC3$,0?4;-3*VR,&=1O;#G YY/[N3C_ &&]#34UK2GC+IJ=BR*NXL+A" .>
M<YZ<'\C6A10!G_VUI6V1O[3L=L>=Y^T)A,$ YYXY91]2/6A-:TIXRZ:G8LBK
MN+"X0@#GG.>G!_(UH44 44UC3'QLU&S;<<#$ZG)QGU].?I5B.[MY51H[B%U<
M J5<$,#C&/KN7\QZU-10!2EU;3H<^;?VB8Z[IE&/EW>O]WGZ<TDVL:9"TRS:
MC9QM"0) \Z@H3TW<\?C5ZB@"B^L:8@!?4;-002"9U' W ]_]EO\ OD^AH_MC
M3#'YG]HV>S!.[SUQ@ $\Y[!E/XCUJ]10!2_M;3MRC[?:9;[H\Y>>2..?56'_
M  $^E)_;&F&/S/[1L]F"=WGKC  )YSV#*?Q'K5ZB@"D^K:<BQL]_:*LC;4)F
M4!CDC YY.01]0:8=:TH/(AU.Q#Q[MZ_:$RNTE6SSQ@@@^A!%:%% %%]8TQ "
M^HV:@@D$SJ.!N![_ .RW_?)]#3KC5+"V(%S?6L1)8 23*N2O+=3V[^E7** *
M/]L:893&-1L_,! *^>N02,CC/H"?PJ1=2L6E,2WEL9 _EE!*N=_S?+C/7Y6X
M_P!D^E6J* ,_^VM*V;_[3L=G][[0F.F[U].?IS3Y-6TZ*21);^T1X\[U:905
MQC.>>,9'YBKM% &=_;NDC&=4L.02/](3D 9/?T(/T-2_VI8"81&^M?-+% GG
M+DL&VD8SUW$#'J<5<HH S_[:TK9O_M.QV?WOM"8Z;O7TY^G-2?VI8"81&^M?
M-+% GG+DL&VD8SUW$#'J<5<HH HIK&F."4U&S8  DB=3P=H'?_:7_OH>HJ,Z
M_HXSG5M/&U0Q_P!)3@'&#UZ<C\Q6E10!G0Z[I,QQ#JEA(<XPEPAYY/K['\J?
M'K&F2LBQZC9NSD!0LZDL3C&.>^Y?S'K5ZB@"E_:VG?N_]/M/WBAD_?+\X.<$
M<\CY6_(^E$.K:=,P$-_:2$XP$F4YR5 []RZC_@0]15VB@#._MW23G&J6' !/
M^D)P",COZ GZ"GS:QID&[SM1LX]I(;?.HP0<'//8\'WJ]10!2_M;3MS#[?:9
M7[P\Y>.0.>?5E'_ AZT7&K:=;;_M-_:0[&"MYDRKM)S@')X)VM^1]*NT4 9_
M]M:5MC;^T[';)C8?M"8?)(&.>>58?4'TI/[=TD1"0ZI8>602&^T)@@'!YSZD
M#\:T:* ,W^W]'W;?[6T_=MW8^TIG&,YZ],<_2@Z_HX9P=6T\&/[X-RGR\XYY
MXYXK2HH SUUK2FD"+J=B7+%0HN$SD=1C/44[^V-,\V*/^T;/S)2HC7SURY8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %/60[:1?"+.\P2
M!<.4.=IQ\P92OU#+CU'6KE4=>C\[0]1B 1M]M(N)&*J<J>I ) ]P"?8U>H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** ,OQ2K/X8U=44LS6<P  R2=AK4JCKS%-#U%@@D*VTA"&/S WRGC:?O?3O
M5Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,G +DU#Q<^,>'M'3(W'S=8<8!/ ^6W/S 9)'3. &;)(Z:B@#F?MWC'+C^P-
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MGBC<1_PAYP #N_M.+!]NG^<UI:[/J\%Y9-I@L!9;93=R7;E0IP/+"X[EN#V
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M/82"-44LY&+G+  'H,GT[5W%<A\7XXIOACXECN76.W>R=99&9E"(?O,2H+8
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MMV9!)_V2<]ZG\!7JS7FHPGQA<^(6VQND=S:PPM IR>#'&F_(9 W7!7'RDD4
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M<2H5(93N(&",CD@<\U:JKJSB/2KQV56"PN2K,%!^4]22 ![Y'U%6J "BBB@
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M XX'S8SQD8(!WU%<-K7C;6--UJYLH? GB&_@C;9%=VQ@,<IPISS(,#YFY/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** .;^)1D'PY\5&"$3R_V3=[(BF\.WDMA=O?/3'>O'O'-MXG?]GWX
M=7/@RXE2^BBTA&A!BV2%O)\DD2#&X3K!@Y PS9R":^A:1E5QA@&&0<$9Y'(H
M \O\=6E[#X@^%-O=3W%\8=2*7$NW_6RK:2?O&PI7/#MT'&[&T9(C_P";IO\
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M'@+4LK.WS0\0LJM_KDY.X$;?[PZE<@8.#0!UM%%% !1110!RO_-4_P#N#?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS_B12^M^%,;OEU*1SC.,?8[@<_*1U8<97Z\8(!T%%%% !1110 4444 %%%%
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M3VUV[;HXKB% YBB4.(U_>NF(U:%CD@)BX1=P9(WBGO!$\$$5MJEG D+([02
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M2W<C.LB[V5HLM+\T@/F1RHTOF(A8"0-6;-J]KIWFV<TIF59,3+/=0N'4"$Y
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M4 %%%% &=XD1)/#NJ)*Q1&M90S  D#8<GD@?F1]16C65XL_Y%76?^O*;_P!
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M-Y:O+KQCC55"'6+DJ=K.PZOV+D\8YY[G+Q\'/#0@BB6[\1*(W$F1K5S\S@*
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MJ1?Q?,6"E0/FY)#*1Z[AZT <K'\'=#167^V?%;1LH1XSK<^UU  "G!Z84#Z
M>E0?\*2\.^68_P"U?%&PG)7^V)L$X4=,^B(/^ KZ"NP;QOX41D5_$^AJSC*@
MZA$"PYZ?-_LM^1]*?_PF?A<3>3_PDFB^;N";/MT6[<<X&-W4[6X]CZ4 <H?@
M_HNQHTUOQ8D)"KY2ZW/M"JQ91C/0$DCT)JJ/@=X:65)!J7B82)(DRL-7ERKH
M,(P.>H' /4=J[-_&OA9/+W^)=$7S/N9OXANZ]/FYZ'\C20>-_"EQL\CQ/H<O
MF %-FH1-N!)'&&YY!'U!H ^3-;N#H7CKQ'H,&KZV^GZ?J$%I!YUZY9HI V^W
M ,GSAG.?+.U9-N7>,+@Q6FIV<.G0CQ((+JX@>74+M8[>T>-Q(R2>88Y98]RL
ML:M&/+VXEV)N\Y/+GUN\MY?BE\0+NVEA>"YF80W,=QNCGP%E*F-95,HV1MM'
M*;F&_:,21L,D[QPRO;WLC-))+=037+33N8@KL&,8!ED=0P\U"<OR1;D,Y 'W
M5EJ2OJD)6Z3SH"D$41FCWQ"1;:02CE8PCMN^52!)&F]5*XJGX5O5U6*,7U]+
MND1[J-1>B1S ?*4XDE<29CC61&+;53R0RLD;32)#)I]_YUS<Q0W+7]XQ9)GL
MC+ Q$$B&6-O+R(ONC.&.4*DL,N>KTK34ME2!/[56V,NPW%M8S"62-A;*@C'D
MLNT_*Y'E%U.4\L*R.H!]'?"_S#X1C9Q"JO=731I$6*JIN). 3C(ZD8 4 @ 8
M )ZNO+OAO)/H?@#Q1>VFGO<W%O=7=S%;111B2YD6)3M"QY8EF4J-V6Z!?DV5
MT?ACQ/J>M>);VTET2]LM+@@9TNKJWDA,D@N9HPH#@9!CC23CM(,XH ZZJ^H1
MW$VGW,5C<+;7;Q,L,[1^8(G(.UBN1N .#C(SC&:L5%=Q//:S113RVTDB,BS1
M!2\9(P&7<"N1U&01Z@T <'\+_AVW@:XO62ZTR>&YCB0+;Z9]G>,QQ11<2&1V
M(81;B#G+,3D<YT_#5]YSZ5/)XOM]4BU&.26UB6"*/[2@53N3;\WRY^8]/F4'
M!Z\G\-_ UMI7B"WEN_%&EZ_<6*"X@2"V$,\;FUAM5D)69@4\J(@ IUD)SG%:
M'@G2](TWQGJ;P>*](U+5;NZFFDLXD@6:$AG\R) K%E4.[,PQNW<LQ).0#T'4
MKZWTVPGO+R01P0J79B?T'N>@'<FN+L;:\\1:U?PZI8*NENP-_;7Y\U@?+7RK
M9%4F/;M;?(P9@2Y3YE)(L:S+J>H>*#IWV79 ,QPXF5U,16*3[:ZE?E:.5/+C
M7.XMN;&T96UXLLEL_"AT71+B;3)]3G^R0S6Y8RHTSEYI5;D[POG2;CSD$Y!Y
MH YO2(+C4]2TF[@_>P:Y>MJ4\ADW)'I]K_QYI"",*"S6\A [O*0>>/3ZXWP3
M&MUKVNW\%LMOI]FT>B:>J@8,=ON\QEQT'FN\9&?^6"Y (KLJ .>\2:_/8ZEI
MNE:59O>ZI>R*Q '[NVMPZB6:4Y& %)VCJS8 & Q&Y;VT%MYGV>&*+S7,C[$"
M[W/5CCJ3ZUA^$VT_4I-1URVL$M[Z>ZN+&>4G<\@M9Y(%Y]/W98+VW'ODUT-
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MB,BV[1[AY2%R6#*BHQ0E9D2:4JY$FYH])9-6U"XDGE5FDBMKO49'\F>VC#%
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M-09(#+,L2%ID7:$,<B87()0MQFN]N[F"SM9KJ\FB@MH4:2665PB1HHR68G@
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MS38=&\/6MU!/-X<TZ%K::,J7OF8I>*OFK&N1LW@JN7) RW4G(H ].HKF#XJ
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MR.3%GS J2$;/F482$ XP32H((M0B:"VF821S22"*;8KRE)W6;),BHA5-TK
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MF2YE69N">&D5V'LW0=*V* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!&-V5^7DMFL^P\/:E?P+'KMK]N.\2>=K=PESM=0I!6VA1(2 <@-E6&-W4XH
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M** "BBB@ HHHH **** "BBB@ HHHH **** .:^&3F3X;>$W98D9M)M&*Q !
M3"G"@<8],<5TM<W\-4\OX<^%4RAVZ3:#,;!E/[E>A& 1[CBNDH **** "BBB
M@ HHHH S?$Q1?#FJ-*K,B6LCD(VUN%)X.#@\<'!P:TJR_%$2S^&]3CDF$$;6
MTFZ4AB$7:<G"\GC_ /4>E:E !1110 4444 %<]KTF/%'AB+(^::=L;1DXA;O
MG(Z] "#W(P,]#7&^-M/74?$WA.-[ZYM )KG MKKR7<FW<#@<L!U] 0,Y!Q0!
MV5%<M_PAY^UI+_PD?B/R5DWM;_;1L<;G(4G;O PX7A@<1IDD[BSU\(A;&" :
M_P"(?/B S=&]S)(0RME@1LY *G"@88\9P0 =-17*P>$)H555\4^)& =G.^YC
M8L"<A<F/@#"XQ@X&"2"VZ.#P7-'.COXM\431B$1/"]U$%D(4@.2(PP;)!^4@
M$@9!&00#KJ*Y"+P7<I%L;QAXIDRDJ.S7$(+%^C<1#:4(!7;@<88,"P-5O 5^
MTS2GQ_XQW,&! EM OS9SA?L^!U....,8P, '<T5R5YX.NKB]29/&'B>WA5HV
M^S130;"5SG),)?#$L2-V.0!@*H6%O!6I%'4^/?%F&+DX-D#\W7!^S<>V.G;%
M '9UQTWC33&U+4+-='UJZ%K.UO)/!IDDT4DH1<J&4'^^%W'"\')P,U$W@;46
M;<?'WB_.XOP]F!DY[?9^G/3H.,=!5SX:_8/^$>G_ +.74,_VA>+=27ZJ)I;E
M9W65R4^0@NIQL^4#  &,  KR^,=.DW^;X>\1-\P#YT29L@[<'[O(^YTR1CG&
MTXQO$VJ:!XI\/M8ZSX;\5?8)9XKB6V72+A3.RXD"N%7D$A <\9(R1M;;Z710
M!A>$]2L+VS-OI>EWVF6]LJ[8+C3I+-5#9("AE /') Z9P<'(&7\1=/OM:;0=
M*L]2O=+@N+[?<W-G*\<C)'&[^4&0J0'(Y((.%..N1V-<IX\U!=%FT+5IX)I;
M2WO#',T43.8A)&Z*[8.0@8J"0K'Y@> #D XR/1]*?3I8UO?'1UT P'3!K]ZT
MT<V"X)8.4"8(42M^[QMYW'GM/AZUY#8:AINI7/VBZTVZ6W<^<\VPM!#,4\QS
MO<*92 SX8J%SSR>8MM6\-->7>MS>,-,;7Y)%,4@N#%'#$N$6#RB^6C!<[RW2
M1F;Y"BA.@^&U\FKQZ]K$$(CM]1U$2QNI+++LM8(F96SAUWQ, ZX5@H(SG) .
MQHHHH **** &[ 8O+D_> KM;<!\WU[5G_P!@:/YBO_9.G[UQM;[,F1CI@X[8
MK2HH \I_:A54^ _B54 55%J  , #[5%7BNAV4=O#9V-QLLW)GG:W+^6EI''#
MO(4R8=<26TZL&.52-@Q\PW"2^W?M/-M^!_B-M[)AK4[EZK_I4/(]Z\8\-"%;
MM&>&"],# DRRHT)+!B%4(D+PE1&S %4,(%L$C9P@D /H[X7Y/@ZW=[8VTS3W
M D5H/*=BLSH&<8!+$*,E@&/4@'(KJZXGX/[%\&"(--++#>7,<DTMN(FE(F;:
M?E15;";%)48!4J<%2!VU !1110 4444 %%%% 'CW[6 ;_A2^I,(C*J7-LS_O
MI(P!YJ]0@PXS@;7(7D,#N50? ] ND^UPQ/-=7EK+#:R);SW#W+R"9O*81PN"
M9=TD<$F-L8)V_-&PA:/Z _:J9?\ A2^J1.6037%M'YF)2D?[Y3N?8I^7C^+
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M;@[AC<._KR1I+]O"?P]<7+IYOB%'N@]P$:=";@@$$@R?/L?:,GY=V,*2/6Z
M"BBB@#E_A_JVJ:S8:O/J\4"+#K%]:6C1'F2WBG>-2P[,"K+[A0>]=16'X1N-
M*N;&]?1%,<*ZC=QSQEL[;A9W64XR=NYPS8XSNSCFMR@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** .?^'H<> ?#0E+&0:9;;BQ8DGRESG< V?J
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MEM5ROF6<S,0&!,;Y[@AN2"<$@^I5Y9I;&;0O@N9=_P [1.4G??)N_LJX.6)
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MB9[FQ6U6-+$F,$PJK,48 $'=G:^[<0,D5H_"?_DEG@W_ + MG_Z(2F:!LO/
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M',;!W<&+[2HE19&$9:+,(QA%7Y58 X\Q@#SJ"1+B6V.@7TSV45M;JZ)*\91
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M^D?A!&D>F:SLB\EC?(S1-(LCH?LEMA7=?E8@8^8  C&-PP[ '>T444 %%%%
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MRA\C 7C!KJ: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G?AP5/P_\
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MEQ?QI 0R1I&4ND(PDBM-;NV_S4WN2!NE8/I2JXDO(XY9[F$11K!)8SQQM\N
MAD<"1QM,G[M D3;G14YD3=#'+!/>6EU-(+&.Z93&UL?LD,=JX+JR%P5@0$R
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MU[(2<Y7_ $9ER.1S\V.<\$\=P ;(UJ_+*/\ A&-8 (R6\VTPOW>#^_\ <_\
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M99X8#/\ Q\8Y!)^BGO@%/ >O3^(]#FOKNV^R3I?7=JUL0-T0BG>,*Q#,I;"
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MD:1E4 NP&6/J< #/T %.HH **** "BBB@ HHHH **** "BBB@ HHHH ****
M.?\ AZQ;P#X:9AACIEL2,@\^4OH /R 'L.E=!7._#@*OP_\ #2IMP--MP=H
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MD:EI/C?QT=2A>XCO+FVNH-6FACCDN5,.SR?DP"L00 9 .78XYR>^HH ****
M"BBB@#Q+X->!]=\!ZQIAU&UN]26_T>.UNKB1X3_94L+L1"F'_P!2PDS\NXED
MW$?,=OMM%% !1110 5PWA;1;ZQ^*WCK4[BT$5CJ,&F_9IU((F,:2J^< $$'
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MBX.<$8)R =V[J,$]%7.^"M&T;1H=8_L)VD-[JMU>WK.Y9C<N_P X(_A PJ@
M#Y0#R26/14 <19>,=2D\6^*=*_L*[O;?2[B"*"6R$8W!X(I"',DBC<&D)XXV
M]>F3V]<5<_$33;3Q-?:+<VMVLMI=?9FF78R$_8C=YQN#8V*XX!Y ]:Z7P]JL
M&O:!IFKV:2I;:A:Q7<2R@!U21 P# $C.#S@F@#0HHHH **** "BBB@ HHHH
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MT4212(Q+A"."H/ D7/\ =P^['EOM .IHKFI?'7AF*"65]8M@L47G,HR7VX!
M"@;BQW !0"Q(( )! A;XB^$%5F/B"PV*K2%@^5V*I;?GH5(5BK=&VG:3@T =
M717*_P#"Q_!'_0Y>&_\ P:0?_%4?\+'\$?\ 0Y>&_P#P:0?_ !5 '545RO\
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M.T9&"">20.SKD_AO?7-_I&JR7ET;EX]:U*!-T@<QHEW*J(>!MPH& 2>,<X(
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MQ^= '64444 <K\6/^26>,O\ L"WG_HAZZJN5^+'_ "2SQE_V!;S_ -$/754
M%8_C)RGA#7'6-I&6QG(1<98^6W R0,_4@5L5E>+/^15UG_KRF_\ 0#0!JT44
M4 %8WA/48M3TN>>"T2S1+^]MS&A!#-%=2QL_ '+E"Y]V/)ZG9K'\*V5KI^ES
MPV%VMW"U]>3M(K A9)+F621..Z.S(1U!7GF@#8HHHH *X_XQ0)<_"?Q@DAE
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ,&60\/X6AM[V9=--J[VJ0&.2QM+8QN9KIIGD4I&)2I,<4:MG+JL8V([*BD
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M_P"\";E+DR2)(^T$3<.$^=1#6'8FXFAW7!:^,ZNUOM6-Y798"YE#'  5EE<
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M\:;'P"PC(<EBVT?*H#*"^?.;FQ&D7;W4]O/<6UHF5N;QD+3/$ I@= ?D,4C
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M; R>>]=/7*?#5F31+^UGFMY;NWU:_%P8"H4.]S)-C:"2ORRKPV">O(()ZN@
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M_O-]3UKM:YKX=>(V\6>%8M88VQ2:ZNXXFMB3&T<=S)'&P)Y.513G R23@=
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M58?@_4[K5M-N[B]$(:/4;VVC,1ZQQ7,D2Y'8X3!Y/3/&=HW* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH Y;X8RI-X'TZ6+'EN967&,8,KXZ #
M\A74USGP[\@^$;3[("+;S)_*!.2%\Y\<_2NCH **** "BBB@ HHHH RO$O\
MR#H?^OVT_P#2B.M6LOQ$8_L, F9U#7EJ 43=\WGH1GD8!(QGM[G@ZE !1110
M 4444 %<KXB_Y'OPC_V^?^BA755ROB+_ )'OPC_V^?\ HH4 =51110!@_$!4
M?P'XD654:-M-N0PD!*D>4V<XYQ]*WJY_XA*K^ ?$JR1M*C:9<AHU&2X\IL@#
M!R3]#704 %<Q\303X'U3#0+\J<S*S+_K%X&T@[O[IZ!L$Y&173UP7QR<)\-;
MXM&L@^UV(PV< F\A /!'(ZCMD<Y'% '>T444 %<_X%FTF?P^7\/I*EA]MO%!
MDD,A>074HE?<68D-('8'/1ATZ#H*YOX>Z-=Z!X96PU%Q)<_;+R<L)3*2LMU+
M*N6(&3M<9.!SF@#I**** "O-?VD+I+/X)>*99(?.#0QQ!?,9,%YD0-E2#\I8
M-CH<8.02*]*KRK]J3_DA/B;_ +=?_2J*@#P;[+;),B/=*+>VNM3,4P4*DTP>
M4>8REEB,<:M,P2-%4<%T*RN$N7)==/MS))-:W#S12Q370@+0-&R#>JN=H#2,
M TA+@-G8J 1I/GZ+<V\%O?R:(L<%I)?WBZ;/;N4!@@+3P.1C# /')+\YA5#&
MK;@FY:[+0;[2Y-6FM=;:ZT[3K2=KV]3^TW(MYO/E"NTD@ 5UD4J9&V2NVWD,
MJ^< <[:2?;KA[F*X,$2W0N1%<$,"&*NJ.4W-\A=&Y8S#,AC<MM\W5\(WBW#R
MS230QV<I5G$2M)"7;#D *S(6!FB0+YC; /,D4JK/-I?$JWT'1GT?3/"*7]SJ
M>I-/;7)CO9"@3B9K>Y@1"^75GQ#L7YI'8J[9S0\*W.IMJC:G"Y>Z<($U&.&1
MOM+-YCNV[> %"N,?O'52V^4HC%5 /I#P;N'AVW$C,S*\JDL,$8D88/ Y'3D*
M>.0#P-JL3P2T3>%=.,&SRC'\I0*,\GDA>%)ZE><$D$DC)VZ "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** .4W _%8KSD:*#T./]?Z_A75URO\ S5/_ +@W_M>NJH *YCP(X9=?
M C52NL7()&<N<@Y.3UYQQ@8 [Y)Z>N6\!*0/$)./FUFY(P<_W?RH M^#L_8]
M1W6QA/\ :5W^\PH$_P"^;#C#$\#"?-@Y0\8VD[U97AK_ )!TW_7[=_\ I1)6
MK0 4444 %%%% &'X3;0S:Z@GAPPF./4;H7BH3N6[,K--OW<@EFR,\;2I7Y2M
M;E<[X'\/'P[8:E'+Y!GOM5O=0=H5 !$T[NF3M!+!"@).2", E0*Z*@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** .8^&;!_!.GLHVAFF('''[U_
M0 ?H*Z>N8^&9#>"=/*G(+3$':%_Y:OV' ^E=/0 4444 %%%% !1110!GZVT:
MVD(EA:8-=0 *H)P?-7#''0 \\\<=^E:%97B.:2&TM?*D:/?>VR,R@_=,JY!(
MZ _=].<'KFM6@ HHHH **** "N5\1?\ (]^$?^WS_P!%"NJKE?$7_(]^$?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% '+;6/Q0+!3M&C $XX!,_'\C^5=37*_\U3_[@W_M>NJH *YKP.K+'KA8
ML0VK7)4'H!NQQSTR#Z<Y^M=+6#X/93:ZF%E$A&I70906_=GS3\O)(Z8/&!\W
M3.20 \$X_L:XPD*?\3+4.(@0/^/R;GH.3U/N3UZUO5C>$_,_LN?SL;OM][C#
M9^7[5+M[#MCCMZGJ=F@ HHHH **** ,7PA%IT.DSKH\\L]L=0OG=Y!@B9KJ4
MS+T'"RF11QT Y/4[5<_X(TN\TC2;RWOS%ODU._NHPG:.:ZEE3)SR<.#VQG';
M)Z"@ HHHH **** "BBB@ HHHH **** /)/#7CS7DUUO#WB!M,6_NIDGTJY?Y
M%N;879BGB;D(;A$4L!&2"&4XX(/3>/=9TN#7O#&AZS)!';:A-+<R_:=HAD2!
M00A)88;S9(& P0=C ]JL?\(%I$D>@?:1+-<:'=R7=E<$*KH79BR'  VD$ @
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M\D$Y///UKHJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .96,GXEO)M)"Z0J[L\#,QXQ^'Z>]
M=-6%J&BW<FOG5M.OXK:9[3[(Z2VWG# <L&4[E*G)/?!XR#@8<]CKS1N!K5JC
ML3M9;#[H(QT,AZ<$?KF@#;K$\),39WX.<+J-T!D,/^6S>O!_X#Q^.:9'9>)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1UE$JV-LEN' 8!@HQP&9B!QP"QQTH UJ*** "BBB@#EOABQ?P/IS'&292<#
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M4 'CL3C@9/&,CKJY;XGO,G@?4?LT0E=C$C QEPJ&5 [X"L?E4LV<<8SE<;@
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M2!EB:U]1\'>(K/4=:UG2?[)NKV23?9P3(/,"FY21@LSH1$=BOP%8%RK'[@R
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MM[B2*_NKH3,@,:F6^>1XV&[^'S&0\@_*?NGI1M]3G22U+?$6TE%LHCE62PB
MN6,F-SX(Y^4CY-JA3NQ@AJ-:L=0'PKUZ"6WOFNVU"]E2-$,TIC.H2.A50"2-
MA4@ 'C J6XOK(7SRR:OXY\V/=D1Z1<^6>8R<*MMM;[BXP#U<#[SY *<6KRLL
M2+\2;=RPBDW_ -G1<@+Y15CT!+G>PX92#]U 5I=/UN2&2(R?$."Z"M]G*SZ6
MBAW$F-YV[<#]TXW#";7W#AD:G37MA+$ROK7Q!#21E2Z:-=J1SO) %K@')XX'
M]T<#;4LFI6D=Z'&M^/%:-G!1="N'1B"23_QZ$$?,P&."",9VIM (Y?$F(++_
M (KNV'FI*BLNE99B"'W.,G80$95R%#;R,,Q4BYH'B2ZF\>P:0FMV>L6ES8W5
MY)Y5OY1MC%-"BJI!.X'S7ZY.%4@X/S4HKVPMBT@UKX@N/,P5;1KM\D;,8'V4
M\ 1KTX.7)R78E?#;/=?$72IH+GQ)?6]MH]['+/JVF26JI))-:,H#-!&"S!7.
MT9"A, *!B@#L8O$VDR^)KO0([M&U.TMA=7$8/$2$C&X] <%3CJ RGHPS/;ZY
M875Z+6QG6[E&PR?9R'6)75V5G(X /ED#W(]:\VUCX;^(+O4-;U*+5;!KK5;F
M\\ZW>()&;<PHELAD"%R0UM;[QTVO( "0"TE_X!U3Q%=9UF"TL+._=I;R&RGR
MT EL[Z"1$)3#,#<1MOP S,YQQ\P!ZF)XC(L8E0R,&(4,,D*0&X]B0#Z9%8%K
MXST>?7;C27F>WNHA,5:=-D<HA*^;M?I\F]"0<'#9&0"1RND^#-=7QIX?UO5?
M[/F2WM$>ZVW#!H;PK=^<8D\LAD9KH 9=?E7D,0I&1K7PV\0_\)+>:YH<NFM<
M7;W<<L6H3NZ"*2:W93&K1R1QR;8I#NV$9*95N10!ZA%KEE+K#::#,LXC\U7>
M)DCD'R?<<@!_]:@RN1EL9R"*OM<P+OW31#8ZQMEQ\KMC"GT)W+@>X]:\B\)_
M#K7+/4K^YUN+2);:_2T6:".9I/\ 5K9JP8&-58,()2?J..3BMXK^'_B>YM/%
M$6F"P=-2CNX,,(S-<^=)/)'(7=?W?E"=HNY9'< (51B >QF]MQJ"V/FK]K:(
MS"+OL! W'T&2![\XZ&K%<!X \-ZQHVM3G4;/38;6*%T%U;R[Y;V61D9I)!L!
M&U45!DD_+Z5W] !1110 4444 <E\+2I\(G9VU+40Q\S>687L^YBW&23DG'&2
M<<8KK:Y'X5S)<>$#-$08Y-2U)D(8$;3?3XQC( QT&3CIVKKJ "BBB@ HHHH
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M[?3M.C:.T@7;&K2-(0,YY9B6)R3R235V@ HHHH **** "BBB@ HHHH ****
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M=\'_ +Z.,<82#X,^$X6# ZV6"J W]LW0((!&X8D'))!],@8 &00#T>BO,O\
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M-@E&N2!SP>3@8)R<Y(]!]T 4 >BT5YROPJB1E>/QKX\5U8N"=<D<?Q8&&!!
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M93E1"%/WR1D<$+C&U0'?\(1?>=YH\<^+!)ECGS;4KEFC8_+Y&WK&,#& &<#
M8B@#LZ*Y#_A#;[_H=O%/W/*^_:_<]/\ 4=?]O[_^U38_!NI)(7_X3OQ4S9R-
MWV(@'+'I]FQ_$PP1CI_=7 !V-%<?!X.U&".-8O'/BG]VNU2_V.0X/)SNMSDD
MCJ<D=!@$BJLGP_NY+."W?QYXRVPV[VR.MS;JY1E52680 NX"\.V7!)(()S0!
MW5%<9+X)U"2"2)O'GBP"0Y9E:S5OO%L BW^7DGICCCH !%<>!-0N%=9/'_C
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#*UG_D(Z%_U^M_Z3S5JUG:I&'OM'8R(GEW3, QY?]Q*,#WYS] :T: "BBB@
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M# _>'0@J=VWG&0>&^$/Q O?B#X<\*O!J*_VI SMKJQK%DHBLJ[EY*&1S&PP
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MQO\ ^ 3_ /Q%>M?VSIHD\N2]@BD^U?8@DS>6S3[=PC ;!+%?F '5>1D<UH4
M>(M\;/$.]0OPE\9E-V"3:2 A=O7'E]<X&/3G/:B#XV>(6C!G^$OC-),#(2TD
M8 X&>3&.^>W^%>W5GPZSIL]YJ5I#>P276F[?MD*MEX-R;U++U *\@]\''0T
M>2?\+KUW<,?"?QMMP<G[%)G/;C9]:/\ A=>N[ACX3^-MN#D_8I,Y[<;/K7K=
MKK.FW=U;VUM>P27%Q:_;88U;)D@R!Y@]5RR\^X]:T* /%%^->NY;=\)_&P&>
M,64AR/\ OCZTO_"Z]<_Z)1XW_P# )_\ XBO:J* /%?\ A=>N?]$H\;_^ 3__
M !%'_"Z]<_Z)1XW_ / )_P#XBO:J* /%?^%UZY_T2CQO_P" 3_\ Q%)_PNO7
M=PQ\)_&VW!R?L4F<]N-GUKVNB@#Q(_&_6 KD_"OQH!']\FS?Y>,\_+QQS3D^
M..IAW$_PO\;($5F.+)B00N>05&!RN3V!SST/M=% 'BK_ !VG$C!?AOXW,?*J
M38$$N%;<I';#(PZGA6..,4DOQTO(C$)/AIXV4R'&&L2,E<E\<<[<?SSC%>UT
M4 >++\<[EWA"?#;QPWF' QIY))^?[OKPF?\ OK^[DV#\:KQ+7S)/AEX_60#+
M Z6=@'&?F^F[MV'KQ[#10!XG;_'SS&"/\/?&HDW894L=Q& K'N.0N\_11_>)
M53\>)5A<R?#GQLLD;%9%^P':@559LGU ).".F#QGCVNB@#Q$_'QDWB7X>>,T
M=23M^Q?P@*V3Z?)O;V '."2$N/CZ]KG[7\._&4!5-S;[+;@_,!U[;AMS]>,C
M!]OHH \5_P"%[3[H?^+;^-\2MM4_8#\Q)? 7U)"_^A?W>6P_'IY8D9/AUXU9
MG4,FVQR& Y<@]PH*GWSSCO[910!XC:?'QKDE(OAYXSDF#;62*RWX& #^(8J,
M8[CH>*1/C]YC(L/P^\9.S(K@"RY.02V/4 !B#W /2O;Z* /$&_: 1U_T7P!X
MRE=6V2 V6-KX8A>">?E]NC>G+C\?D#1M_P (!XT\B179'^P<L%#-D#." NPG
MG@,>N!N]MHH \:C^.3^69)?ASX[6(JQ5UTS(.-H'<<9)!],#KGBI;_M K*HD
M_P"%?^,3#A0SQV>X!FW #\67 ]>>.,'W"B@#Q-OCQ/\ N0GPX\:EF52X-B1C
M[^=OJ,(2.F=K=-M*GQXE)97^'/C82!3A18$_.-^5/MF-AGK\K<?*17M=% 'A
M]Q\?VA^]\/?&*D#YA)9[<'!8?^.[6^A/8 F5OCTQNIH(OAWXV>2(-O0V&'4C
M<1N7)QP%)],MUV_-[710!XI_POB4N0/ASXV.P R?Z <H#T_,&,\X^][ D_X7
MQ*(BK_#GQLMVK!&B^P' 9CA!GKDD$8QVXS7M=% 'BD?Q]B>%7_X0'QM\Y*KM
MT\%6;K@'=_<(;\?3FNX^&OCQ?'$%ZZ^']=T8VHBS_:=MY2RF1=W[LY^;'!/
MX9#_ !<=G10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 <K\6/\ DEGC+_L"WG_HAZ^0?V88FE\>Z(T+']U<
MR-(6'*DH /*XY) 8.%8$J2Q5DC-?7GQ;94^%?C(L0H_L:\&2<<F%P*^._P!F
M6'_BX_AZ9RBQ_;)8SM+JY/DE@I*@!ER =K,>4R!@,& /L;XL?\DL\9?]@6\_
M]$/7Q7\+/A/XD\3W<TDVFMING6[+]IOM1MPD<:$;MP$GWRNU6V@8*DAF4,,_
M;GQ(O;C3OAWXIOK&5H+NVTJZFAE7JCK"Q5A[@@&OC[P9\<?&=K86UOJ.IG5[
M>-6A6RN+=)6O1SE7E8[R^3$N #N1VYW* 0#Z4\>?%/PA\./"\,%M?6ES<QV_
MDV-A9LDA&U"$W*I 6/*@9X]NE?#&K7MQXAO-:\0:H('N;J8O+Y)2,I+(V[?Y
M8P64X921T+ L<E0WVWH?A3P+\4O \]S<^&-,M+BXDDM[F>UM(X;B.6-\%ED"
M[AG:#C)X.UNXKY)^*W@,_#7XC)I,U[=_V=^ZN+>_CB'FF,XW,J[@"RL& &Y<
M[1R,T :'[/OA_P#X2/XE:3;2V37-H'$D\L4&?*5%$@8L5*KAT1"2,MYA .2#
M7K?@;QQ:ZW^U;K6HVT[RVLR'2;98$\U9(E !EWIQL,D88$YXD'I1\)#I?PX^
M&NI>)?'2W"1ZA#'I=N40">YBRY(1<#<!NX=BQV(,%0 B\MI[_ [3-EYIZ^-/
MM=FHE2XA8QRDJH.]2"H!R5Z8QG/ YH ]Y_::\*P^)OA+JTIB+7FDJ=1MW7&5
MV#]YG)''E[\C/8'!( KXI\-^(=5T."SO=-U'[*;*]B<%661XV E*NL+MMD #
MR_PX4GJID.[]&T:S\1^'0PS+I^I6N1D8+12)Z'ID-7YR>*/#[>%O%VN>&=3N
MV1+2X:)9F0A7*G]W*44G@JV>I*ASC)X( ^:]N?$OBN^U/766ZU&:Z$LQ,1C2
M3KN!( $8 &[YEP%5B>FUON;X"-')\-=,DCD1O,56*K*LA3]VF <$[ 5VLL?!
M1&1,#;BO@Y9'F^S,\OVGY=LC3-S!)&S-MCD5F8*R\[CM7<[\?(''WK\"Y7F^
M'5FQAEAB,TQA1T5,1F1BI"*-J YSL5F5,[0<+M4 ^5?VM-B_&RY,AM&3[+;E
MA B[P-O27:<E_3=@["@Z!37'MXIU^T\&:KX;1&CT.Y=9=0MH;/RE$@6(0R%B
MIVAC$C<!=WS>H([G]K*-$^."&2&:V1[6V9YEB2-I!D@NK9^?&-NY\$%-OW5!
MKR[1+9@T$:)+]H=XBL/VK[,[R$L4*#G+;65ED("CD8)8$@'WI\#88[?X:Z7%
M;B7[-&TL<)D<L61)&0'!  'R\8X(PV<L:[VO/?@.%'PYL_+27RC+(T<TV_S)
MU8[M[;LGC)4?,QVJN=K9C3T*@ HHHH **** "BBB@##U1T?Q3H5NZG<%N+A&
M$KK@JJIC;M*-Q*>K!ACY0PW[=RN=UIXO^$Q\-Q2"7>5NI(V6.,KD(H(9BP<<
M,2 H(..<8%=%0 4444 %%%% !7*^/M(EU>'3DTO7&T+7DF8V%ZMNMQM.P^8I
MC;AE*!NN,$*<Y&#U5(RJQ4L 2IR"1T/3^IH \G_X2GQ=I,OAG3-<:S>_D\0G
M2KZYBA*QW<30&='A!Q@!65&X/S(PSZP2>.M0\/Z+XUO9A-J#P>*?[+M [\6Z
M2) %/0_*K2,=O?.,C/'K<UM!/)$\T,4CQ-NC9T!*'U'H:$MH$64)#$HF8M(
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M#VP?7ZIVVEV%JMJMM8VL*VH86XCA51"&Z[,#Y<]\5<H **** "BBB@ HHHH
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MYL[FR_$VF30>,M;U?3+F"2ZGM;>VFTG5[3_1]0V!VB6"?LVYFR 'PP&5&5-
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M-J\G=Z9K.\-:KJ^G6\*ZQ %U?4M<:QO))(PD.8[8A94Q@[)1;Q[=V2&FQR
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MO&,D#G&5-<GXD.H-\2O$1N8@]Q&V@_V*$.V0P_;#]IVG!(7)(D*Y^3;GC H
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M10 4444 0PP&.XGE,TS^:5(1VRL>!C"C'&>IZ\U-110 4444 %%%% !1110
M4444 %%%% !1110!5T[3[738YH[*+RHY9I+AU#$CS)&+.0">,L2Q XR2>YJU
M110!%=V\5W:S6UPN^&9&CD7)&5(P1D<]*+2V@L[6&ULX8H+:%%CBBB0(D:*,
M!5 X  & !4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '+Z@X'Q.T!/+4L='U(A^<@"
M:QX'.,'([9X&,<YZBN:U 2_\+)T(K'F'^R=0W/Y8.UO.LMHW8R,C=QGG'MQT
MM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!SM]:N_Q$T2[$<YCBTJ_B:01YC4M-9D!G[,=AP.X#'^&NBKFM0DQ\
M2="C\V4;M)U!O* ^1L367S'GJ,X'!^\>1WZ6@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y?4)"/B=H$>%VMH^I
M,3M&<B:QZ'J!R>.AXST%=17+WSRGXG:(BR*(1H]^S1^:,EO.L]I*=2  WS<X
MR1QGGJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#FKN:3_ (63I4*7JK#_ &3>/):?:#EV\ZV"2&/IA1Y@W=?G
M(KI:YZX7'Q!T]BX(.EW("L8LC$L&2N1YG.1G:2O"[P#Y>>AH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
&HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image04.jpg
<TEXT>
begin 644 image04.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" ,* C@# 2(  A$! Q$!_\0
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M<[3]\02[>>@X+\=_P->E5Y=\76=/&_PP*$*/[:8$@@-S"P^N,9SVZ9[5ZC0
M4444 %%%% !1110 4444 >>?M!WS:?\ !_Q#.F 66&$DE5 $D\:'DJ<<,>0,
MCJ"#@CT.O+OVFXC/\$?$,09$,C6B!I&VJN;J$9)/0>]>HT %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !5+68Q+ILRO.UN@VL\JR
M&/8H())8,I P#G!'&:NUA>.KVYTWPCJM[IX@:]MX3+;K.C/&TJ\H&"D'!8 9
MSQG)X% $7Q$UNU\.^!]9U2_6[:U@MV\S['GS0&^7*D.A!&[.0ZD8R"#7G'P%
M\#1^"W\2^'[_ $Y$6ZC@G4W31R2WD#*^1(JLR_(6,9497()!8.#75^(/#OBG
MQ#H<^E:Y-X5O]/NE"W%L]A<("!R%#"<D'=C#C!&S(&6^6#PSX1\1>'YKYM.G
M\-P><JHN+2ZDR$"*OW[@[%P&^1>!E>3@D@'/> O"&A0?&#XE6?\ 8.F+IZ+I
M,UO;_9(_*C/E2$LB;<+\ZYX[C.<].A_X4K\/_P#A*/[<_P"$:L?/V;/LNP?9
M,[=N[R/N9Q[8S\V-W-:7@OPIJ.D^*_$_B#6+NPFN];%JK165N\2QB%&4$EG8
ML?GVYXX0' S@=G0 4444 %>(>#;B*U_:;^)4D[;4-KIT8."?F:.%5''J2!7M
M]>4S>!?$FG_%+Q-XIT:30[JTUV""WEMM0\P%%1(T/W5(;(5S@X[#N2 #N-7M
M;K3[R36=+\Z=B%%W8ELK/&, LG!*R*N2H'RORI&6#I8E1=:M;&\L+A[:6&;S
M$9HLGC*O&ZGG^\"."" >U<YHECX\TW3UM)KS0+P1LPBDF,[2"/<2B,Q)+E5P
MN\_,V,L2228;70O%=C/)?Z3!X4T_4;JX;^T%CBF:*\CSN2;C:4F&74YW;MP8
MM\H0 '2Z;=P>(-/EM=1MECNX?+6]LBY81R85]N<#>F> V ' /&#3I9@EP-,U
MLVT\%_NAMRZ "?Y6+0LI)#-L5FXP&&[Y1MYYK4-/\?70CE2?PI%>P/N@G\BX
M.P%OF4C=\P*84\CD;A@@8N:]8>+-1M5@5?"\L+P1L\5W!,XCN5PVX$,-RJX#
M*<*W Y!&: +6G3GPQ/::-?SW=S93,L5A>3X8KQ@02..688^5R,L#@DLI9H;N
M.;PKJE]JRO?7>BW>U[JWW;UT_8@4/#&!G8<%G49.<L.XK.M],\<3:7;:=XC'
MA/7;8JL5Z)H98_M*C.6*X9,GY3C;MR#@#( 7P]8_$+3M.^RWM[X?O?+ED$,L
MQF:7R=Q\M9&P-[!< M@$XYR<L0#H]7M9K@0:OH/V2;4HXBD)GF=89H79&924
MSC.P%7VL5/0$%@:XNH=?L_[2T*5?[4L?,A$4Q8>5(54O!,@88/W#@]/E89'7
M'T.S\<:;_:$;0^&/L8M573[6&>X18IAG(8E#B/E0%48 48"TR:V\>)?QW5CI
M_@^&5Y0;R3SY@]U&H954GRL@C.X')Z[>@+, :<MM_:NI+?Z;,MAXCLDBM[N%
MF9HPK[)"DJKCS0JM)L.<!G?!!+4PP_\ "3V]MJ%B_P#8OB*PE6.?>BRR0-M#
M/;2[6 >-@X.,X(*NI!",/(/$4VJO^T!!!XTUR^\.VEQH4CVTNCWI2WCV$N?,
ME= ,+B0DLO)6//#;!YG\:]=UCP/XKC?P5X\U_4[&^LT6XNY;SSLR*6&U75%C
MX7;]W+ [L]: /K4FW\4V/E2":QU:PD279O(DL[CR^#\I&]?F9?[CC<.5-<QX
MJU2(VNF/J"RIXJTF^L0]O:7!ADEBGO(X"0PQOADP&*$[244/@KQY=\$K_4M>
M\<:'J5OXHO=4FE\*S2RP7UUY@CNTG6-D<*JD1Y96 .YNIR>"?8?&UQIVLZ3:
MBYW1W6F:]II,3.R-'+]LB53@ [E8,=N1@@_PD94 [JBBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** /-?BP5'BWX:F559/[=(P)=K[O(DVD#D
M%0>O&>@!&ZO2J\X^+(W>)/ANBA6?_A(%8#/S8$$N<#/3U....F>?1Z "BBB@
M HHHH **** "BBB@#RK]J3_DA/B;_MU_]*HJ]5KRK]J3_DA/B;_MU_\ 2J*O
M5: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE_
MBD%_X5IXK9SMV:5=2!LX*,L3,&!P<$$ @@9! (KJ*YWXCO&GP_\ $IG;;%_9
MMP'."2 8V!P 02?0 @DX&1G- '14444 9MOKVDW.NW6BP:E:2:O:H))[)95,
MT:$ ABG7'S+S_M#U%:595KX=T>T\07NNV^G6T>L7J+'<7@3][(B@ +NZXPJ\
M#KM&>@K5H IZ7JECJL,DVF7EO>0QR-$TD$@=0Z_>7(XR.A]#Q4U]=V]A97%Y
M>S)!:V\;2RRR'"QHHRS$]@ ":H^'_#^D^';>X@T/3[>P@N)VN98X$VJTC  M
MCH.%'3TJQK&F6>LZ7=:;JENES8W49BFA<<.IZC_ZXY% %J&1)HDEA=9(W4,K
MJ<A@>A![BJ&K:YIFCS6$.J7UO:RW\XMK5)7"F:4]%7U)_J/45;L;2WL+*WL[
M*%(+6WC6***,85$4850.P  %4]8T'2]:EL)=5L8+J2PN%NK5Y%R895Z,I['_
M  % &E5+^U;#^VO[(^V0?VI]G^U_9=X\SR=VWS-O7;NXSZU=K/31=,37)-92
MPMEU:2'[,]V(P)6CR#L+=2,@?D* -"J6EZK8:LMRVFWD%T+6XDM)_*<,8ID.
M'C8=F'H>Q!Z$5=K-T30=+T/[;_9%C!:?;+AKJX\I<>9*WWF/N<4 6=2O[32[
M&6\U&YAM;2(9DFF<(B#.,LQX YZFIX9$FB26%UDC=0RNIR&!Z$'N*JZQIEGK
M.F7&GZI;I<V5PNR6&0?*Z^AJ>TMX;.UAMK6-8K>%%CCC48"*!@ >P H BNM2
ML;2>&"ZO+:":9UCBCDE56D=@Q55!.22$? '7:WH:M5CZKX9T75M7T[5-2TVV
MN=1T]MUK<.F7B.0>#]1FMB@"G]OL);Z2P^UVKWD10O;^8ID0L&9,KG(R$8C_
M '21T-1:/HFFZ-HMGI&F64,&G6:JD$ &0FTY!YR2<C.XY)/).>:C/AW2#XE'
MB V$!UH6_P!E%V1EQ%DG:.PY)YZ]NE:M 'C5UK5KJ?[1L)\/W<6HW&D>'[I-
M0M;9QO+"9<0AB53S-Y7Y7;:N#G:>:[3Q?!8I)IWB"V9$O(;^WL&D !69);N&
M)XW!5LX<*RD ,K(,,JEL^>_ K0TM)OB%>Z':V\>I6WBG4+6-IB0L\*["L#OR
MR@-SNP2I.<-EE/HNKWJ7FG:;>016I^SZE;PWUA=2( CO*@*DD[!+'(\<JD E
MB@"?ZP-0!UU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >;
M?%9V'B[X:QB=(5;7"QW=6Q;R\# )YR5Z@?,,^H])KS7XIR>1XX^&<Y&?^)Q)
M%PZ@_/;R#[I!)'N.GJ"01Z50 4444 %%%% !1110 4444 >5?M2?\D)\3?\
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M2JDDC )P*T** *6AW%W=Z+87.I6GV*^FMXY+BVW[_)D*@LFX=<'(S[5@^/\
M6_$FBQZ4WA;PX==:>Z$=T@G6(Q18))!8@9/8DX'?K75TCJ'4J<X(P<'!_,4
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M^%49(ZG)YV@X..BH P[KP\+GQ=9ZZVJ:G']E@,*V$5P4MI2=WSR(/OD;N,G
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M@ N0.3@<#/M4E%<_X9TS6K#4M>FUC5UO[2[N_.L8!%M^R1;0-F[//],$]\
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M.GP"RF1,C9NPT2F4'&-G/<"L#PO^T'X;UFWU>>XLM3MX+*YE2&6"TFN5GMT
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M[_M1MHS+Y@PV_:-V1ZYS0!>HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8YMRY4*411(=S'<"3O&X^?6&OZ9XA_:6TJ#P[>K(ND1:C'?A8"-[' ()V*
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M,;,S##9W,1R?E&!@ Z&BJ>DV]U:V*PW]Z;Z=6?\ TAHEC9E+$H"%XR%*@D
MD$X&<#A/BHZ+KWA:*[UW5[&SN+AE:STPS))<.NTH2\*EQ&21&X.1B12-I&:
M/1Z*Q_!ID;PAH9GN_MLQL8"]SDGSF\M<OR2>3SR<\UL4 %%%% !1110!Y[\8
M;BUM6\#2733K,?%%E';",#:TCB1"')Z+L9^@)W!1P"6'H5>??%X6A?P.+N*:
M67_A)[/[-LF$2K(%D.YSC) 0/A1C+;1TR#Z#0 4444 %%%% !1110 4444 <
M?\8HO.^$_C!<1'&DW3_O$WCY8F/3(YXX/8X/.,5U5C+%/96\UL ()(U>,#&-
MI&1TXZ5R_P 7W2/X5>+VDE$2C2;GDD -^Z;"<_WON\<\\$'!KK4W%1O #8Y
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MH **** "BBB@ HHHH **** /C#]LJX>U^+VB7$0B:2'28)%$L:R(2+B<C<C
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M26.'X7^)#--Y,;6C1LVPMD,0NW@@#=G;N;Y%SN<%0P/8H"J@%BQ P6/4^_%
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M ]<'FMJLOPJ=3;PQI!U]0NLFSA-ZHVX$^P>8/E^7[V>G'I6I0 4444 %%%%
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M<MYJ%S!:6D*[I)YY!&B#U+'@#ZUG/XJ\/H7$FN:8FP G?=(O!W8/)Z'8_/\
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MG_1N3\HY//7U.:T/@*_BU:345\?^,3<21^44:6T:$#.<B(V_E@\?>"YQQG%
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M110 4444 <%\=#*OPOU8V\K12B6U*LK!23]IB^7/HWW3P3@\*Q^4]XBJBA4
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MOJFFVE_9.9+6ZA2>%RA0LC ,IPP!'!'! -6:* ,K7_$.E^'_ .S?[7N?L_\
M:-['I]K^[9_,GDSL3Y0<9P>3@>IK5HHH Q7\4Z.GBZ/PP]YMUR2U^V);&)QN
MAR1N#8VGD'C.>#Q6U110!Y##J-IXG_: T^\T8W%U:Z+87NGWLZVTJQ0W0D ,
M1<IMW8#'&0"!D$Y /KU>/?L]QNFI?$W]X3%_PEEZJH7)(((R>3WXYQSCJ<<>
MPT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >:?&RY6TN
M/AW(T0E#>+;*+:3C!>.9 ?PW9_"O2Z\X^,T9DN_AXJF<$>*[1OW+!6P(IR<D
M_P /'S#J5R!S7H] !1110 4444 %%%% !1110!YK^T:VSX/:TWV?[3B:R/D;
M-_F?Z7#\NWOGICOFO2J\\^/P5_A??1M(8S)>6" JV&S]LAZ>_4_A7H= !111
M0 4444 <E\75+_"GQB%D:,_V/=G*@9($+$CD'@]#WP>,'FOGGX;^%K9=2\,3
MW'P2O(9Q/:.VK?VS.8D.5)N/*.1@'Y]AR,<$^OTMX]TRXUKP-XBTNQ"F[OM-
MN;:$,V 7>)E7)[#)%>#?# _$.-/"EG!\2?"%SI5M-':R:=!-;2NT46/]'5T1
MBS&),@@[@"23P* /I:N1U+XE>#-,U&YL-1\2Z9:WMM((IH9I@C(V"<8/TZ].
MGJ*ZZN,U#X6^"=2U/4M0U'PW87=[J#![B:=2[,PQRN3\G09VXSWSF@#@+3QO
M:^)?VCM!LO#NLP7VA0:)-,4M6!C%Q(Q+[B.K;1'P>AST):O<JYGP[X!\*>&[
MU;S0O#^G6-VL9B$\,(#[222-W7OUZXP.@ KIJ "BBB@ HHHH **** "BBB@
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M,PSC=SV'4^PKT6O/OBT2-0^'V%+?\5/ ,#_KWN.:]!H **** "BBB@ HHHH
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MM,C1RQ2H'21&&"K \$$'!!HM+:"SM8;6SAB@MH46.**) B1HHP%4#@  8 %
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M6&"4'S %BV%!ZGT6J5KI5A:ZI?:E;6<$-_?+&MU.B!7G$8(3>>Y 8@$\XXZ
M4 <_)\0=#CMOM#1:\;?9YGG+H%^R;/[VX0XQQG/ISTK!\ ?%_2O&.C-J-OI.
MM0Q">2("*QENL*B!MS&%6"DYP$SOY! ((->EUGZ+HNF:';26^CV%M90RRM/(
ML$83S)&QEVQU8X')YX'I0!QOBKXM>'_#VERW4\.K^<$#QPW&EW5H'RX09DEB
M5$&2!EB!R/6KEO\ $[PU):VDLLU_$]Q&LBQG3;EC\VW &(^?OJ1CJIW#Y>:Z
MK6-,L]9TRXT_5+=+FRN%V2PR#Y77T-6+>&.VMXH($"11*$11T50, 4 <))\5
M=$;4;2VL[35YH9%:2XN9;"6UCMHPP3<?.5"Y+D+MC#'AR<;>=S_A-=#6X\B6
M>ZAEW0Q[9[&>+YY@AC3YD'S'S$&WJ"=I /%;-]IUG?R6<E[;13O9S"YMRZY\
MN0*RAQ[X=A^-6J /.I/BYX=@\3ZQIEY(UI8:2RP7>I7/[N-+EMQ6':?F.5C<
MA\;3MP"25SL0_$OP-+$DB^,?#H5U# -J4*G!]06R#['FMF+0-*B\12Z]'8PK
MK$L'V62[ ^=HL@[?IE1^5:E 'DW[.S12Z9XXFLRDEC-XLU"2UFC(9)8CLVNK
M#[X/.&R>G7BO6:\B_9JO;^Y\+^);?4I9V_L_Q!=64$,N1]FB1(ML*K_ JY("
MC '0 5Z[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YC
M\7B__"7?#,! 8_[>Y?<<@^2^!C..>>QZ=1DY].KS'XO19\7?#.7:?EU[;NVG
M S"YQGH/N]#R<<=#7IU !1110 4444 %%%% !1110!YS^T-*L/P@\1LT9E)M
MF58PS#)8$9X90=H)?!R/EZ$X%>C5P'QX67_A5>OS6\LL$UO:R3)-&P0H0C?Q
M;T89^[\K9)8 JZED;OZ "FS.4B=UC:1E4D(N,L?09(&?J0*=6%XPU/6]+T^W
ME\.>'_[>NGN%CEM_MJ6OE1$,3)N<$'!"C:.3N]J /F6UFE\2Z;X@\6ZQ\4KO
MPQX@2[FGC\/S7H_T(03$Q020.RER"" -H&6'!.Y3]+?#S5[O7_ F@:MJ4(AN
M[ZQBN)%# @EE!W<<<@@X[9QVKPK5_",VJ>-K[5[OX%&[FF:<^9_PD$213.K,
M/-:,@ %R0>>H^8 D9KZ*T>XNKO2;.XU&R.GWLL*O/:&59?(<CYDWKPV#D9'6
M@#EOC'I=EKWP\U;1]1UZ#0(;Q%W7LN"$5'5V&"RY!52",]#^%?.O@.+PO8_$
MS2-'\(Z]XY\12VU]:E'MYHTL%B"(69_O%E7][D;5X.T'*[F]$_:#^$/B'Q[X
M@L]9TG4+>ZM[&!(XM(O'9(V?S,R8*D;0R[<G.X[<9X7')? [Q+=>"_B%J=AX
ML\'3>&_^$CDM;.R%G8S16S31,R?*)"<@B7<6!Q\N2/FS0!]4445\H?$+Q=K9
M^(FO6/Q+U/QAX<\%)+-#IC:/"(5N""JC,H3]XK)N8J2V"<<8Y /I'1M;\-MJ
MAT/1;S3C>+ ;PVMH5XCW;2_R\?>(%;U?/_[)NF^#4T?5-1\/;&U>2YGBS<SJ
MUXMF),Q"1 <)D!<E0 2.^!7T!0 4444 %%%% !1110 4444 %%%% !7)?$Z1
M$\/V"NZJTFMZ2J G!8_VA;G ]3@$_0&NMKE?B7_R+MG_ -AK2?\ TXV] '54
M444 <J/$6L?\+*;P\?#US_8O]GB[76,_NA)N*F,\8)Z<9W#!."#D=2^XJ=A
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M#!XYZ4 ?*-YX5T"Y\8?$32F\4WTUGH.CK+H]W<:KNVSF%7<[APV6WJR@='<
M X(^IOA?=2WWPU\*75S(\L\VDVKR2/G<[&)<DY]3DYKFX?@7\-HHPB>%K8@,
M&^>>9CD;>Y?./E''0\Y^\<^@Z98VVEZ;::?81"&SM(4@AC!)"(H"JO//  %
M%;Q)KNF^&M$NM7URZ6TTZU4--,RE@H)"C@ DDD@  9R:XCPY\;_A_P"(=3L=
M-TW72VH7K+'%;O:3H2YZ*6*;<]NN/>G_ +1&ES:S\'?$-A:RVL4\H@V-=7"0
M1DBXC;:7<A03C R1DD#O5#P3XE^(Q31-.U?X<P6MJJ0PW&HIKEN450 &D6)
M3C@D*">PSWH ]5JKJ%S8PQ"+49K:..?,82=U DSU7!Z_2K5?/?[53:>VJ>"(
MO%EM=KX2%W(;R\MF#,&*8";.&[9W ]-V Q % 'L6B^$/"VBZP+[0]$TO3=06
M%[<M90) 6C8QLP94 #<K&<D$CMC<<]%7P?=:3X-3Q5XCU/X?7.IW&FZ/I,-Y
MI]S'')OCU$W,,<0^< GE^X]< XK[BT%KA]#TYKW?]J-M&9?,&&W[1NR/7.:
M+U%%% !1110 4444 %%%% !1110 5Q'Q:D":/H*D09?Q#I2CS%)8'[7&?D(Z
M-QU/&W<.I%=O7&_%239H>D*79?,U[2E !4!O].A.#GDCC/R\Y [9H [*BBB@
M#R#P_P##;1)?BAXYO=3DU#4IKE[:X!N+MQY6\.WEC80"J[5"ALE5 7 '+=%=
M_"7PC<021_9-0B+\AXM5NE93C&1^\Q^&,9[4[P;K5AJOQ+\=0:?=0SO8BR@G
M$3$A7"RY!.,;@<J<$D;<$ BN[H \!UC]E[PIJ$RRQ:GJ=HRVT4 6%8@A:..-
M!(1LY+;&9N>6?/'>"7]E+P<6'DZSX@5>X:6%CT/_ $S'?;^ ([Y'L_@GQ;I/
MC704UCP_,\UB\CQ!GC*'<IP>#^?XU9\4Z_8>%] N]9U=Y4L+10TSQQ-(R@L%
MSM4$XR>?09/:@#Q#_AE+P=M7_B<^(,[AN/FP\C'(_P!7USW_ )TW_AE+PAN.
M=:U_;Y8 'F0YW]VSY?3IQU]Z^@;2XBN[6&YMVWPS(LD;8(RI&0<'GI6-XA\7
MZ)X=U;1=,U>]%O?:Q,8+&(HQ\YP5!&X#:O+KU(SGC)H \37]E3PX()8AXBUO
M8_S!1Y>W>#\K$;>< L/QX(Z'M/AK\#O#?@2]U*>WEN-42^@-L\6H1Q2*$);<
M.%&<HP4]C\W8X'JU<WI_C31K_P ;ZGX3MY9CK6G0K/<1F%@@1E0@A^A_UB\9
MSU]* /-O'/[./A/Q1KT^J03W.CF6(*;:PCB2$2#'S[=O<9R.YYSZYA_9=\-R
M16UO<^(_$<ME;AC'!YT6$9CEBN4(7.%SQSCKTQ] 5S_@[Q?H_C"WOY]"N&GC
MLKIK.?=&4*RJJEA@\X&[&>A(.,CF@#QBZ_97\.7$]NS>(]>:.-51EE:-V*
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M2=2<_,592?NK0![OX U;4M;\*VMYKEK#:ZGYDT%Q'"KK&7BF>(L@D <*VS<
MPR PS7F_Q]U/Q%+X@\)^&-&U&UT/3=7F?[7JEVD;Q#9\X3#@C.$) R-Q*J2
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MH; W '(S@9]!61XID\2(VECPM;Z7*&NU^W&_D=0MN 2WE[ ?G/ !.0#U!'(
M-VH8K2VBNI[F*WA2YG"B654 >0+G;N/4XR<9Z9J:LF1]<_X2F)(X=._X1W[*
M3)(TCBZ^T;N JXV[ HYR0<MQTP0#6J.W@BMXA';Q)%&"2%10H!)R>!ZDDU)6
M#X8D\2O>:U_PDL6F1VRWC+IILR^Y[;^%I=Q(WXQG&!D'CI0!LW5M!=P-!=PQ
M3PMC='*@93@Y&0>.M2(JHH5 %51@ #  K/\ $4NIPZ%?2:!;V]QJRPM]EBN'
M*QM)CY=Q'.,\GIGID=:DT-[]]%T]]9C@CU1K>,W:09\M9MHWA,DG;NSCD\4
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M22P)Y+9&WZ4KPOX-+-XD\<7.L:W\0['Q;?Z-#):6\%E;K D/F-B1\!5#@[
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MF7<%]!-XCBN+9Y&E!:6.':^X <@9X'4'DYX]VH **** "BBB@ HHHH ****
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M9I8[CP)%$1MG\3VB2 J3E1'*_;D<H#^'/&:]!K@/BQ_R$?A]_P!C-!_Z3W%
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M4[!LQU'RA#@\\^F*]FKQ7]E;_D5?%W_8S7G_ *!#7M5 !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'E7QB^;QO\+D;E#K98J>F1$<''J*
M]5KR;XSJ6\<?"T#?_P APGY#@\)_+U]LUZS0 4444 %%%% !1110 4444 <!
M\=_^29WO_7[I_P#Z6P5W]<!\=_\ DF=[_P!?NG_^EL%=_0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %<!\6/\ D(_#[_L9H/\
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M>'Q'HYBF57C)O(P6#$!>"<\D@?7CK3_%'@_P_P"*=*ET[7M+M[JTE"AA@QL
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M!1SY9(;!R-^26 #'!.!Z?0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!Y;\7$W^/?A</F/_$XD/RKD\0D_EZ^@KU*O*?C"P'C[X6KSDZR
MYZ''^J/?\:]6H **** "BBB@ HHHH **** .&^-*J_@"57=$5M1TT%I#A5'V
MZ#D\'C\#]#7<UPOQK_Y$%R7VA=2TTG+[ 1]N@ZMU [Y'/%=U0 4444 %%%%
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M%% !1145WY_V6;['Y7VG8WE>;G9OQQNQSC/7% $M%%% !1110 4444 %%%%
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MU&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S#XA%_\
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MT%E#/<1VL32MC?+(VU5'J>_L 2< $B];P16UO%!;1)#!$H2..-0JHH&  !P
M!VJ'4M-L=4@6#4[.VO(5=9%CN(ED4.IRK $$9!Z&@"U7!?%._>]L3X8\/^((
MM&\9W<0O-+,CM&)/+D4LN<;6R-PV'/!)VD*2.]JE/I.G7&J6VI7&GVDNHVJL
ML%T\*M+"&!#!'(RH()!P><T ?(/P[O\ XP^/+_5[+3_'5O8ZAIDQCN+6^EV/
MN;<#M"1," 48<'Y3Z9!KN_AS;_%O4_%,*3_$'0KZVT6_2+6-/4YFC5F#21L/
MLXW$J&56#;00P5A@X]?\=+;>$_"_B3Q3H>CZ9_;=O9R7)F:V :4H"WSLN&8?
M>/7UY'6LOX#ZNOBCP#;>*)]'TW3=4U:69[Q[&W$2W#)*Z!SR6)P.K'.=W8B@
M#T.:1(8GEF=8XT4LSL<!0.I)["J^EZE8ZO817VE7EM?64N?+N+:598WP2#AE
M)!P01]0:M5#9VEM8VZV]E;PV\"DE8X4"*"22< <<DD_4T 5]:U>PT2R6[U6Y
M2UMFFB@$CYQOD<(@_%F'/0=3@ FKU5=4TVQU:S>SU6SMKVTD^_!<Q+(C?56!
M!JU0!5DU*QBU*'3Y+RV2_F0R16S2J)70=65,Y('<@5:JE/I.G7&J6VI7&GVD
MNHVJLL%T\*M+"&!#!'(RH()!P><U=H ACNH9+R:U20-/"JO(@_A#9V_GM/\
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MP?\ "D,\*0O]A63:C1L"')8-E%5?F#!NA//S,[98]W0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!P'BJVBG^,G@"26**1[>RU66-GD*F
M-B+=-RC(W'#L,8/#$XXR._KSWQ=,(OC/\/4-M:3>;::J@>=U5X/EMVWQ!CDO
M\NTA<G8[GH#7H5 !1110 4444 %%%% !1110!R_C(J=8\'0MYH,NL$*\<FPH
M5M+F3\00A4CT8UU%<GXUA2?7_ HD1'5=:=\/CJ+"\((![@X/X9[5UE !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S>IPI+\0-
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M0+!:0Q00KG;'$@51DY. ..M5]<FO;?1=0FTFV6[U&.WD>VMV<()I0I*(6)
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M^]6SWSUYKMZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"I'/3&>A (Y% '245YS<?!3P!-=I<+H1MY$9G46MY/ HW,6("HX"C<<@#&,
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M_MVX*X(VXP6Z;>/IQ0!)^S^&7X-^%5DEN)'6UVDSR.[+AV&W+(A 7[H&,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMCZDI5CCG/[OH<L<=!G@ *H6-?AQ=)+&8O'GC-8A&5D5KV-V=\ !\M&<8 Y
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MCC+AW1;B$[P,87<8BP'7.T@G/)/&.OHH Y >#+U<>7XU\4J>,DR6S;B,$<-
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image05.jpg
<TEXT>
begin 644 image05.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" ,L BD# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK,L<UNI>8R6%RB1KG&YG,84*3P"3@Y&,Y% &B/ MNVP3Z]XHE12/E_M>:/(
M88)0J>=WKG(!SQ2CP)9/C[3K'B>?#%O^0W<Q<G.?]6Z\=..@V\8R<[/A[Q!H
M_B.R^UZ!J=EJ-L"%9[699 A(!VM@_*<$<'!K4H Y7_A ](_Y_/$G_A1ZC_\
M'Z/^$+A3Y;;7?$D,0^['_:<DN/\ @4FYC^+'VXP*ZJB@#RKQY:7GAFX\*OIN
MN^()[B]UVTM3%->;DDC+%I%(\L@Y1&X+)Z[N"#ZK7FWQDF6VU'X=3R2E8_\
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M,]6)))/"_KR<U=N_AMX[MK=VT/XJ:L+H LJW]I',CMG<!G^$;@ 3@\9&"."
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M@ HHHH *1F *@Y^8X&!G_P#52T4 %%%% !1110 4444 %%%% !1110 4444
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MQD%?E;(VDY9AJW.CZ/'';1)IVFPO9W:6S)#IT#I;^:RQIC"%L*'9$8*!G[X
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M 'EOQXD>)OART3LC'QCIZDJ<'!$H(^A!(/L:]2KRKX^_\TX_['/3?_:E>JT
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M%Y&!!L++U5U'WA]W)RO!*KR_QM\06'B/Q9X!MM D?5Y]*\2?Z?8VJL\R>3(
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MC@@U\]ZUX1^(/CVUN9]=\.>!/"L(MXY'N;B&*WDB1QQNP9)(R1QAP,$\8(X
M/6_V8_AU!X*\)RW\MTEQJ^JK&UT(9XYX8U4LT7EL@_BCD5B<D'(QQU]"^((\
M4-X:E'@9K!=:,B!&O<[ FX;C]<>O;/?%>??LZ?"JY^'5C?7EUKT&I?VK%"XB
MLP3;K@$[U<\OD-P<+QZY&/4?$FOZ7X:TLZCKEXEG9B1(O,<$Y9V"J  "3R?P
M&2> 30!?M//^RP_;/*^T[%\WRL[-^.=N><9Z9KP_]I>UEO\ 6OA[ISW]]!IF
MJ:F=,O;:VG:(7"3-$!OP<,%*]".<G!'6O=:\E^*EO%J/QC^$FGWB^99FZO[P
MQY(_?00K)$V1S\K<XZ'N"* /4-)M/[/TJSL]_F?9X4AWXQNVJ!G';I5JBB@
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MA4'RBI>,%53(89!SGB@#[<K-T?0=+T66_ETJQ@M9+^X:ZNGC7!FE;JS'N?\
M$U-HVI6VL:/8ZG8.9+.]@CN87*E2R.H93@\C@CBL;PKJ/B2\UGQ#!XAT6*PT
MZWN@NEW23(QNX3D$LBLQ4@KG)QD.!M!4Y /!/VF+*RB^+_A+5?&]GJ-QX#6S
M^SSM;EMGGYF;9\I&TG]T3C!*J<9V\<7XWF^ S:/J$'A'3=7N=:FB,-C]E-P5
M68A]C$2L,J6V C!.,8'WJ]S^.'Q:L_ &I66FZKX5N-8LKF#SS<,0L*OE@L8W
M*06^4D]" 0><\>>Z1\<&BC6:Y^$<PNHYV??:P;1'%O&P@F+.\ @$\ L,C;NP
MH![1X'\,W=_\(M&T#XB6UO>W/V6..[@8EE(1MT:N>[J%3<?[P/)')[F&-(8D
MBA18XT4*J*,!0.@ ["N/D\7ZFWPOC\56OA>^FU*2TCNET7S 9F+$?*"H;/!W
M#Y=V,953D#JM/FFN-/MIKNV:TN)(E>6W9U<PL0"4+*2"0>,@X..* *>M>'])
MUN?3IM7T^WO)-/G^TVIF3=Y4FTKN Z'AL\]P#U4$:E<[XRU#Q'81Z:/"VB0:
MK)-=QQW3372PBW@W#>^#]X[=P&#D$@X;!!Z*@#R;QW;A/CU\/KXV@98[#4V>
M[QA;95C'[R0A1\@W[?F?&9.BDY;HM/NY=/T>U2XM6A06LB%9W8J'8L<&:6,2
M2$XY9D&%6220ME2W%_$XW/\ PT'\-Q.D,&FBQU,QW3.H/F?9G\P-D' 5?+.2
M"/F/'!KN-'T_>MM,()HHENC-#Y-P'=B[*^XL^=P* ;F21L[I /0 &;X.M+:#
MXS_$6:*-OM,]OI<DCE@0?W<J@ 8R.$&>>>.!CGT6O+? 4\O_  NOQ_:QVK?8
MH+'2D2Y+@B0"*0J0,<@[W&1QF,^N!ZE0!XS^T?/<>#?@WJ?_  AVGPZ>EW=(
MEY+91B'R4D/SR_*!RQ"(3U^>O(=&^'7P)O\ 3X)F\?ZE'(T2NZS7,,# G (V
MM%P<GIDX&3D@$U[KJ7B_5-$\&>*-4^*?AJ!-'M[XV\,-F8[GSK-V5$:1&?!Y
M8 ]"<_<&.?'KWQI^S[=6MU??\(L5O/(+I:"T>'>_)$8V-L4Y<\], <_*HH Z
MS]EV\M;37_&'AOPQJLNL^$+)H+FSNY8RC))(N'7E1P2A[8^7(^\:]K\5^&-&
M\6Z8FG^(K%+ZR699Q$[,HWKT/RD>IXZ'/-<5\!_&OA3Q?X=F_P"$3TFUT6>W
M"/?:=;6XC6!W+A?F5%5\B,G('0C.#Q72?$K6M?T#PT-0\+:-_;5\EU"KV0!W
M/$SA7VXY!P?O8(7J00#0!U5>0?%NRL=0^,?PEM]2B::(S:BWEKO^8K"C#(4<
MKN"YR<8R&!4G'KL+,T2-(FQRH++G.T^F:^5?C-XY\0>+K?P[XO\ A[H6JPZ;
MH:7-ZNJW-M"Z,"QA+(A+@[?+D8@C<HPY"@;J /JRBJ>C7)O-(L;DN7,T$<A8
MIL+94'.T$XZ],GZU<H ^(OVN?#GB"T^(USK^I R:)>B*"PE\X,$"1+NC"9)7
MYM[=,$L3U)KT/]C'0_$%G8ZEK%[ L?A_4+=([23=&3*T<LH/ ^8;2T@^;&<C
M&0!B]^VW;AO N@7._!CU(QA,#G=$QSUSQL]._4=^[_9C18_@;X8"[R-MPWSI
MM.3<2D\9/'/![C!XSB@#U&BBB@ HHHH **** ..\0ZAXOB\5+:>&].TZZL&L
MUF>74)I((U<.X*JZ1OEB"AP0,!>,Y.-OPQ>:A>:9G61IBZA%(T4ZZ=<M/$K#
MMEE4@^JD<>M>7?M!2Q"?347Q-J&GSK;S2/I\5I/=6TRD;$>=8"'0>8R*KG(W
M8P#@UU7P+<?\*OT2W-@NGSV47V*>#84?S8CY;.ZE596<KOPPSAQGK0!Y;X,\
M0VX\4Z)I:Z_XBG\6_:HH[LW/B*WN-/=@0;E5B6=R5*>8(QY>0VT?*02OT?7S
MOX9O=9MM.T>1M7L)? \5U!!9Z1]HC345V74/E%Q]G&]@P/[D;#M8#<S=?HB@
M#A?B]ID>IZ/HJR!I3#K%K(MN;,W,5P<E=DJY"A<,2&=E4,J<Y(!I?"?P=>^'
M[W5M7NKMD35L.=/%D+9(G\R1]X7SI2,B3 7(P  1P +/Q=)_L_2DETP7]N]]
M B!6@$D=RTT:Q%/-5AR&D5L+G8S\BM/X:1FU\.MI["9383M;&.1X'\O #;5\
ME$0 ;L;0HV\C@   '5T444 %%%% 'E/Q^52WPW8@;AXRTX XY /F9_D/RKU:
MO+?CTH9?AX3(JE?&.FD @Y<Y<8&!UYSS@8![X!]2H **** "BBB@ KSCP&2O
MQ?\ B@AN58&739!  "8P;4+N)'=MN-IY 0'HPSZ/7G/PU)F\?_$RY<GS&U2W
MA(#X7;':QA?D/S X/+$X;C &#0!Z-1110 4444 %%%% !1110 4444 %%%%
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MG /?UP'CYDC^(GPUEE;8O]H7<89N%RUE, ,^I. !WH [^BBB@ HHHH ****
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M1A<>C>&4N$TMOM=K+:RO=7,GE2LC,%:=V4DHS#E2#U[\X/% &K1110 4444
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M5$"X7RF"CCL,$ =L5V5>6^'_ !%):?&SQAINKSZ;8VLL5BMH)+D"2XE97"A
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M<MMCG,:N/+)/ R&/4@9QD@<CTJO$/VL)YH_!NAQW:W?_  C,NK0#6GM/]8(
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M/7EOANWU:+XLZ>^JV>EZ5:#P_<06&FV:AGMXHYK4,&D&!C)^4*%&W'<&O4J
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M R_#:3NOC'3E' [[_P >U>KUY5\??^:<?]CGIO\ [4KU6@ HHHH **** "N
M\"?\E,^)?_7[8_\ I%%7?UP'PX_TKQE\1]17Y4DUB*T"'J##:0*3]#F@#OZ*
M** "BBB@#EOBG<Z99_#GQ'<:[9B^TV*QE:6U,C1^?A>$W+RN3@;ATSGM7S'I
MNJ:';Z3>ZQK/PL\/6EC:SZ9+*H8RLMC=AV68'<=Q&Q. ,_.00,&OHKQ=XATV
M]\:V/P[U;27O;;7=.GEFE+[$5%R-O8DG#<J=RG:<<Y'(:1\#_!MKJ\4]]K^L
MZHMNZR1V%SJ8,"+"9%A&T /B(;U'S8&&&,$B@#VJN.\<?$GPOX+DMXM<U2W2
MYEGBA-M'*C31+(<>:Z%@PC Y+8Z=,]*[&O#OVBO#_@=Y-%O?$.@W6HZ]J=_;
MV%K]CG:%Y 77(<C(V[>,;2V6PNW)8 '>7?Q0\(1W^DV5EKFGZI=:E>I8Q1:=
M=Q3LC.&(=PK9"97!//+#UKM:^6?A?K_@#_A9NE1:1X!M[&RFO[JQTG6OMAF8
MRQHCMNBRW7S%VOG #@#HQKZFH **** "BBB@ HHHH **** "BBB@ HHHH X#
MQ5_R63P!_P!>6J_RMZ\X^*(&AV>LVWB_P]#J^D:CKS+IRQ1L\_GSVQ,3IE@I
M 960C((/.#P6]'\4?-\9O 87DI8ZHS <[01;@$^@SQ5?XZ$#P]X?W3>0/^$B
MTW,N\)Y?[]?FW$$#'7.#B@#M_#UO+::!IEM<+LFAM8HW7(.&" $9''6J7A:_
MUN^?5_[>TF+3HX+Z6"R99Q(;JW4_)*5'W,CL3GKP!C.[10!XYX@U?5+;]IG3
M;"SN+J2T;PR\_P#9ZW!2*:423;25SMSP!N(XK'\%Z_K^L? SXHZAX@GN(]3C
MGU<) TCEK'$.?)5CV1BV,$@# SQ@1_%CPS#XD^.FDIIOC_\ X1CQ#_8XB@AA
MMY'FD7S)6.&#*F""WR[MWRYQ@YJA%^SIXCALM0LXOBKJR6NHR/+>1+:R!;EW
M&':0?:/F+#ALYSWS0!Z9HNLZU8_ SP_JVD:=+KVM#1[&1;5IMKW#,D>\ESGG
M!9O4X]Z[K3YIKC3[::[MFM+B2)7EMV=7,+$ E"RD@D'C(.#CBJ7A/2/^$?\
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M-4D:67@]9()9&?Q3IBHR1HPB;S@=S%E)48!7*E3E@,[2RMZ+0 4444 %%%%
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ME64#!P' ZC=R.I/; 'H'BK4KS1_#>HZCINF2ZK>6L+2QV43[7G(YVJ<$YQG
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MDXR<8!(]/H **** "BBB@ K@/ G_ "4SXE_]?MC_ .D45=_7 >!/^2F?$O\
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M^3MP ,XQS5W3OBU\9$\%OXO,&C7GA_<2T\J1 18D"E2JNK Y 4 \D2#&3@@
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M'K%M!=>1([1,R';*F2C @@A3P>U;FGV5OIVGVUC8Q+!:6T2PPQ+T1% "J/8
M 4 5]6UK2]'^S_VMJ-I9?:'\N$7$RQF1O1<GD_3M6A6+XB\*Z'XDEL9==TNV
MOI+%S);/*N3$QQDJ>V=J_D*VJ .(U[5;"R^+OA:WNKR"*>?2M0ACC9P"SO+:
M,B_5A%+CUV-CI7;UXY;Z3)>?M+W4^O6LUS#!IKW.CR3*WE0!1:H^S*;2^]Y#
MD,<;N0,BO8Z /.?#]S;I\=O%]M&\PFFTFPD==R%&9&E!_P!H$"2/C_:)/5:]
M&KR7QT)-,^,OA1]%FOK;5];7R),SI]CGMH'62X#1F-F\WRP K IV^;C:WK5
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M9_E5G8 X )!SCKBN"\*6'QFTKPUIFGV%Y\.[ZTM+=((;B5[MVD11M4EE !.
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MD$>F:\!^#NA:WHWCB_7P;XM^&\FIWL@CEBAEFD?RE)=TMP8P&4@;B%)'R#D
M4 ?8=?)GQGUGP_I_C+Q5;:OJGQ!LS<7EL2^GQJ+562'.Q3)("<A\XX&5R.,5
M]9UYK\:?#VM>)[#34\(:E:)KFAWL&KBPN),)<!2QC#@<@%D;;G"DJW(QD 'A
MGP:O]%B^+>@VJ:A\09+YFE^S6>J(@B9"DOS/^\S@+EN%(R".<9/U[7B.AZ7\
M2?%_Q"\-:MXVT?3O#VF:$)+A1:S1RS3RNK(4#@LRH01N7(!'7)QM]NH ****
M "BBB@ HHHH **** "BBB@ JGJ^IV6C:=-?ZK=0VEG" 9)I6VJN2 !]22 !U
M)( Y-7*P_&WA^#Q5X5U'1KH QW4>!D*0&4AE/S*PX90>5/TH X34?&'AOQ3\
M2O UIH6K_:]2L;Z[>XM$@(,4?V.=&:0LFY"KE%V[ER7.02!M\1M_$%E+\3?%
MT.J:]H]M:6.OKJ=HM_-<*ER\;W10AXQ_"TT9ST(CC W*,GM=$^''BS1O&47_
M  E-_I(T_P 4:S?32II3R>;;7$MC=D/&TB8P%:88(.#M//..$\?>"+;5=#G\
M.^'CH<>I>'=6FL6FN[BUM+E[*.W,R/(<)NY:;+ ?-L+-G:S  ^NO#=_)JOAW
M2]0F01RW=K%.Z!64*70,1AN1UZ'GUK&\$Z-XDTJ^UR;Q)XC75[>\NC+96ZVH
MB%G&6<[0V2S AE&#]W9P3DU=\!7*WO@;P[=1G<D^FVTJG;MR&B4CCMUZ5=TW
M6]*U2ZO;73-3L;RYL7\NZBM[A)'MWR1MD )*G*L,''0^E 'G7Q/^%E[XB\26
M_BCPAXAG\/>)8H?LTDR*62XB_NL >",^AS@<< CSK1OV=/%$>B'P]J7CUH_#
M,DRS3V-K"Q$F""<;B #E5(ZC/.#CGZ2O[VUTZU:YU"Y@M;=653+/($0%F"J,
MGC)8@#U) K'TGQIX:U;2CJ6GZ]ILUB/,W3"X557RUW29R1C:I#'/0$'H<T 5
M_&.@ZG=^!Y=%\':BNAWB)%%:W(4MY*(R\#O]U2O?K6]I,%U;:59P:A=_;KV*
M%$GNO*$7GR!0&?8.%W')P.!G%%UJ5C:::VH7=Y;06"H)&N9956((>C%R<8]\
MUQ7QF\576@_"'6/$?AG4+9)TAADM+L 31LLDB*&7@ALJWRGD9()XH TO'?A_
M7M<N] DT#Q%+HL=C>B>[6-"WVF/&-AYP1UX8$<Y_A&>MKY.^)/Q9OM!CT^[\
M,_$O_A('/F17UK!:PVY$C*3%)%F%AY:D ,I9CP!GYV(XWP]\8_$^IW#6_B3Q
M9=0RZA JV]]!<1V\=A)YI3=+&D1!&.2H&2,'<H)90#Z5U2RN)_VC=#GCOYH8
M(/#MR[VZ*-LH\]%*L>N,NC?6-?4UZ=7@/@#QIX?U#XQ:9#IWC=]=M&TFZM8!
M>QNDL=RTELS*&9%#!Q&67J<JPSC:![]0!P.F6]S#\<==EEOB\%QH=HT=OM("
MA9I1ZD-@[CDX_P!9@9Y-=]7@_P 0_$^FVGQFU"QNO&-KX;B&@V\$]RD*M<JY
MGDDV(YX0[2A^96^5S@*6W5Y//XW\2V]K!:7?C[48KF(:H)=5AN8IK"\E@A22
M&*!Q@C.1G(R3(H&<@  ^BM&^&TEQX7U_0_'>KW'B2VU*\DFA^T,Q-K$?N!"Q
M)5AR<@X'  X.?-YOV7[9=LUIXSUA+V"$Q6TKH/W0P0JC!R%YZ C@FL+P3\3=
M+U&SFO=0^)6M:+=^3!';0:@HN52X1-T[NJIAXV. H)4GG&"0%]E^"7BRPU?X
M=:2MQXBLM3U2ULPU\YNQ)*H!(WR G<.!U< ^M %WX.^ H_A]X/CTZ29+O5;B
M1KG4+U0V;B9C_M$G"C"CIG!; +&M#XCZ'KOB#P\MGX7\0/H&H"=)#=)$'W(,
MAD/IU!R.Z@=":V]%UC3==L$OM%O[6_LV) FMI5D3(ZC(/4>E,U_7-,\/:<U_
MKE];V%DK*AFG<*H9C@#- &C7RAXP^)7V'Q]?WZZW+<^+K*XO]%T[29-)\R"U
M!G(AE$AF159U"JS_ #$@C*$*,_5L,B31)+"ZR1NH974Y# ]"#W%?)'Q+\*>$
M+*T\1>/+W4[[_A*1JU\UK8"Y!@:2"[\L9_=NV &B8KN4?,%!0<@ ^N:*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /+/CZS>5\/H\G
MRYO&.FI(N>'7+G!'<9 ./85ZG7E7Q]_YIQ_V.>F_^U*]5H **** "BBB@ KS
MCX7O*OC?XEP3^?O76(I '8!=K6T>W"CH< <YY&W@8KT>O//AM"A\=?$JZM@#
M:R:M!$&"A<RI:Q>8,<=&;KCG.<GDT >AT444 %%%% '(?%_2K_7/ACXETW1U
MWW]Q9.L2<YD(Y*#'=@"H[9(SQ7SG"VE^*]-\(>'?"7PVU'2?$=C=6C76H360
MB6W2-QYC&8?.XW')W 'DGKQ7TK\3/$%SX4\ ZYKEC%#+=6-LTL23 E"W0;L$
M''/8BO M6U7Q+X1\">'/'UC\2;K7+S4FAWZ3*JRP7K.R>;#"H'R%=FT_*&&'
MQM9BI /J.OE;XO>'/"$WQ!\9ZGK'AWQ=J=Y"MNK_ &>X A<RPJ!)#\A;<GR_
M*Q*YSQ@!:^J:X7XRP1S^$4\[Q?/X01+N)O[2B8KZCRSAEX;/<XX&<T ?/7P@
ML/ MKX]T'^S?"?C>/4ENU,-WJ+*(D^64$OM4#'S1G&.J+R &W_7]?-NAW%GI
M7Q"\'C3_ (N:IXJCNKYK2XTT7OF@J(G"R-M?&T/&F<@[@VX$Y.[Z2H ****
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MP3\H4,TI'08 ' !]!?L]ZYXXU[PS=7'Q"M9X+A'5;9Y[06[S)EB790!SR%X
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M;['#;''53CH1Z5+6+X<\+Z3X=FU.;2[;R[C4KJ2[NIF8N\CN[/C)Z*"[848
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M/=Z'=1)YJNDBQLSHJC<5VYW'')YP,@'I'C3PUX<\2ZIHD^MW(2[T6Z%S %N
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MWC[P3JFFZPEU;:0+N\N7A$C*(I%6U7@#!)DF7''\+@'<0K 'M=%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ' ?&10VG>%B8)9=OB;
M2R&028B_TA1N;;QC^'Y\KEA_%MKOZXWXKH3X;T^58EE:'6]*D"; 7)^W0#"$
MD!6.<9/&"1WR.RH **** "BBB@ KS[X0W/VA_'">0(?(\3WD1_=A"_RQMN/R
M@G.[JQ8XQ@[=JCT&O/?A&FR_^((^4?\ %47!^5<#F"W/Y^OJ: /0J*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N.^+>IZCI/@>XN
M-&U!-,O7NK.W6^D5"ENLMS%&SMO!7 5CDD'&<^]=C45U;07<#07<,4\+8W1R
MH&4X.1D'CK0!\>> _B/XHU'XJW%YJMV_BFYT2UU".QM[6T1)91\@R!'&-P;
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M>?"KQ?XZ:"/Q)?>&KBWMX+B)/*BN(2TS86.[*J^/,"(GRL60?, """.2\/\
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MA\W)#?9+;=SD\9Z#MCMT !W-%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!QOB>(_\+'\$W'FSA M]!Y2J"C,T2L&;YL@@1L
M=I7YB"RDJ'YKX[7ELUWX"L4NX/MJ>*],G>V^T*LGEEW4,4)RRE@1QW!/\)K6
M\2ZQI=Q\6_!^BPRA]<M1<WDJJ!^ZMV@=,,V,Y9S&0F<$)N;E4K@OCCX.U:?Q
MUH>MPZA#:Z1>ZMI-G+]EDE@O%<231EE=3M^[<'YC\W88"_. >_45P'_"K[3_
M *&GQO\ ^%!<?_%5F_!#PI;>'9_&$\7G/<W&KS0---<&>2:.-F9&=BJDOF9\
MD[CT^8XH Y'XT>*? ND^/&L=5\"-XHUUK(3SO' ':*)?F'4'@*N21T7()QD5
MQ]]XOT18)?$NB_!;1M0\!PW!MSJ)L8EE;C+OLV'"@\;B-O&W<"<#U+QO\+]3
MU;XM:9XLTO4HEL);4Z?JMI-C<UN?E*Q94C#!CG.",9!).!5^(WPKU23X7:1X
M(^']^UGIB7I%V+B3+&W=G=LL,%@&;[N.1CGCD ]5\,75A?>&])N]%B6'2Y[2
M&6TC6,1A(60%%"CA0%(&.U:5<EK'@/3-6^&T?@FZGNTTM;2"S\V!PLNR+9M.
M2",_(,\'O71Z38Q:7I5GI]NTK0VD*01M*Y=RJJ%!9CR3@<GO0!:HKDO'_@+2
M?'/]C_VS)=Q_V7=K>0_9Y%7<P_A;*G*GCI@^XKK: /)O ]U:K\=/'%K);)8Z
M@\,;I 8N9HE$>9U=8U7#&1=P9G?('0+BO6:\X\9>']/OOC'X#U.Z>6*YMX;T
MQ[7"K.Z*FQ&RP)*B29@J@D@-GY0:]'H \:^(U_:6_P =/!"'3_[4NUB$;6L4
M+2R1++(0ETVZ)D5(C$QRKI)\Q.=H(;V6O-K'3K>']H?5KQ,^?-X;MRPW'C-Q
M(O3IR(U]^#TSSZ30 45S/@OP3I'@Z767T9;@'5;QKV?SI3)AR.BYYQG)YR<L
M><8 WM0M$O\ 3[FTF++'<1-$Q4X(# @X]^: /G.\G^-7Q'TF%CI?A_PO9[I&
M)OX<3JGS %EE61D'! 8*I)&[A2*=\'?@GI>B^-K?7K;QY::EJVGOYTEKI<4(
M6/>'5E89;"L"R\*I SC!P1Y3X!^&FL>+M!\0C2-3OX_&VD7_ /9M_:S7;0QM
M8LC(4W;22Q='4J3MVJ<CD9Z7QM\._"N@_%;P;X2\$OJ9UB2Z@_M-)E\U'@!2
M0R$.NQL"-G*X*^W&  ?8=>;>/FV_&#X6XD*LTVI H' W#[(2?EZG! YZ#OU%
M>CPQB*)(U+%44*"S%C@>I/)/N>:\[\:1M;_&'X=W<3/FY-]9RACN7:+=I!M!
M/RG*\E0-P W9VI@ ]&HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH \M^/4;NOP\9$9EC\8Z:SD#(49<9/H,D#ZD5ZE7$?%IL:/H(,$
M\N[Q%I0#QHK+%_I<?S.3RJ_PY7G<RCH37;T %%%% !1110 5R/PUF\W3];CV
M3#R=<U!/,=B5DS<.V4XQ@;MAVY&Y&S\VZNNKA?A3J/V[_A,(=D %CXCO+8-"
M5(?[DF20H^8&0@YR01C)Q0!W5%%% !112.JNI5P&5A@@C((H 6BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *K:G#<7&FW<%E<"UNI(72*<IO$3D
M$*VW(S@X.,C..HJS575FO5TJ\;2D@?41"YMEG)$;2[3L#D<A<XSCM0!XKX$C
MN-/^*6B>&+RQEM=2T^QNM2U.<R?:/[2E;RX8[LS-AB"'E &,H2R8VX(U_'.K
M/XG^)VB>#(;!572M2L]7FO&N-I 17D553:<DE"#D],>N5YWX:@I\3/#=Q<W&
MJ3^*;W3+\Z_'J((GMGS;,$"D?+;>9N\K: O)PQY%=[XO\-Z5'X\\*:O#;-#J
M6H:PB75Q%,Z/*L-C>-&IPP^7(&0.&  ;(XH ]"KQGX2>*/$TVBZA?7GA#4[J
M2^U*>YE2WD@A%J<*IA"SO&Y=75LY&.3ACC%>S44 ><^(?&WB[3="OK^'X>WY
M-O:O.1)J%JVUE7)!5')89S]W)('0$@56\/>,_&^H:-;7,/@^#51(LC"]BNO[
M/BEQ*57;#,#*N5&?FZG;CAB5]/HH \I\0_$KQ-I>A7.HOX!O[.WA81/<WEU&
MR(_F",XCC+2NN_(4JOS JW"G(W7\5^+,H$^'6IDD+N+:G9!5)Z_\M2>..W//
MX]S10!Y%XI^(7C;3]0\-6=MX)6REU6]:!OMEY'.2JH7**(GPK, <,S8&TY'I
MV$.O>*'B1V\&M&S*"4;4X<J?0XR,_0D5UM% 'DVH7GB#4?C'X*^W>'KC3[.T
MAO&>81I>1MYD1',H7$!4QJ,Y!;S0HX+5ZS110!Y;=ZQKW_"WM:?2?#<^H6VG
M:;!9L3.+?>SMYH="_P K+RRG'(,9SU6M=_$GCK[2Z1^ (3$"-LKZY$,C+9X"
M$C  /_ @.QQW=% 'EWAGQMXUUF/4IX?!]O+#%<M!&DEVUF\3*GS(_F(=^'P/
M,4!2"<#*X-_5_&?BS1K&\O\ 4/ C-8VR/,\EMJT4C)&H8LS*54_= .%W'.0!
MP,^A5#?!C97 10[>6V%/0G'3H?Y'Z'I0!Y5X0\6:[=:;)K6G?"^1KC49&9[R
MRNK2%;R)7?RY-SNLC @Y!9<$-N!PPS6\1^*]6T.9]>G^&7]GZM<,MJNI3O%=
MOC!.P_9A)+M(3:!@+O9<D9)KT;X?Q^5X#\-QX(V:;;+@@@C$2]B21^))]S6]
M0!YY<?$R>PO(K35/ ?C6&=EW2/;:<MY#'QG_ %D+L#SQQSZ@5@+XFT_QQ\5_
M"3:9#=VKZ"]Q)=?VC ]M(6GMYD6%(V&YF_=.S$@* F-Q)Q7L5>?>*[//QD\!
M7BVP;;:ZE$\P494E(BH)Z_W\?4^IH ]!HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH XSXM;(_#-C<2^2([;6M+F8R*/E OH02K$@*
M>>I[9'?([.O-?C9<?9I/A\Z[O,;Q;8QJ0ZJ!N656SD'(*EA@8.2,'->E4 %%
M%% !1110 5Y]\)5"ZA\00,_\C/.>23UM[>O0:X#X3_\ (1^(/_8S3_\ I/;T
M =_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 57U"
MY-GI]S<K;SW30Q-((( #)*0"=J D L<8&2!D]:L5#?7=O865Q>7LR06MO&TL
MLLAPL:*,LQ/8  F@#PWP3>3:Q\3?"'BB\N;"ZO-<L=3#1VSB5+*%#;M%!G:I
M$J!BKD@')8<"K/Q!U!X?C)HEIXBOM7ATD:AIDNE):VZM ;AQ=1E9'*'!+8&-
MP)4DC[H*Y_A&:75/C?H/BJ/1HM(T[7K*_-H@E8R7<:"$K=.HPJF163Y<9PN2
M3\I'4_&_5K&#5OA_8"]LO[5'B>PG6S?RI)&B8R1%_+8Y ^8X< D,!C!&0 >K
M5S/@%?%::9?#QQ)ITE_]NE^SM8*50V_&S(.2#G=QDG&W))R:Z:B@#&\:27L7
M@[7I-*F%OJ"6$[6TQZ1RB-MC=#T.#T->8^$F^(6NZ#8ZK-J6KI#J$,=W;B"Z
MT["PR*I4/NLLE\'+8 'IZ5ZEXL_Y%76?^O*;_P! -8/P6$(^$GA#[-(9$_LN
MW));.&V#</P;(_"@#S;P5JGQ/UW3YO/O-0>>TOKFQN)+<Z>J Q2E2,M%DOS@
M,%V_(20=P M>';CXI:GX@\16M]?7*6-C?>1#]D>Q2:/>B2A9&>%U8+'+'RJ@
MDY^E=G\&_P#D'>*?^QFU3_TH:M7P;_R,7CO_ +#4?_INLZ /'?[ \:>)?B)K
M-CX@O/$4]E8V5N(8(M4ALG$=P6W%W@C5)5)@<'Y<C@<D9JOH.@>-M*^*%WH>
ME:IK=IIXTFTNYHY]6@N9W".T<9622!E0 A]R 8(4\D$*/9M)7;\5O$YP1NTC
M3#D@<_O;X=OIWY_#%4U:!?CE(H:(7,GAQ25$H+LBW+8)3J "QPPZY(/04 9'
MAJ#QAIWQ(TRPUS7KJ?2;C2[B[%M)-;SL\T301D.RVL150)P1M))9<DXR#K>/
MF\0R>,O!MAHNLS:7I=[)=QZ@UO'"TS;8=\14RQNHP48$#DANAP2NCJ7_ "5/
MP]_V!=3_ /1]A5+QI&W_  L'X>2Y8(M[>1G&0"39RD G&.BDX)'3(SB@#F_B
M98^.-!T_3+OPUXQU.Z$E_!9W,=Y#8KA9G6)&4K;=I'3.0>":Q/'\GQ#T3P];
MZI%KFK6\$-_;+=I<7%@S-$TT<>$,=H,,6D7DY&%?*G(!],^)?_(NV?\ V&M)
M_P#3C;UE?'?_ ))G>_\ 7[I__I;!0!RWCJ/X@Z/X)US5K;Q!J,,ME:R3K]IN
M;%AA.6X2R&<KDJ P)/!V\9LZQIGQ3MO#Z+9ZO+?:RUNJ2 I926K2X0.<-%"Z
M(=SM_P M#\O3H&[/XMJK_"OQD& 8?V->'!&>1"Y%=90!P7P)UC^W?A3H5\/-
M\G;-!!YNWS!#%-)%$'V@ ML1<D  G)P*U_B$_BI- 7_A!8K"35C.@8WIPBQ=
M6('<\ 8)'!)SD"N0_9;_ .2$^&?^WK_TJEKU6@ KS3Q9+=Q_''P-]JMPVF/;
M7<-I,C#(N&B=Y0X)SC9%'M('=P<Y&/2Z\^\=3JGQ0^&</FA9)+J_.S=@LHLY
M,\=P"5_,4 >@T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#SDXJ6@#QY?@3I9FN;F;6)I+J:&.( Z3II@'EIA#Y)MBN02V",':0N>,T-\
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MVD>WB:>,12LH+H&W!6QR,]\>M24 %%%% !1110 4444 %%%% !1110 4444
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M3D$,HP &+;N>1U-=[X?\/>-;?0["'5O&44M_'"JSO%IR,I<#G#,<M_O$#/7
MS@4_&GA/QQJGAZ:UT;QN;6]:2)DD%HL& LBEOG3+= >!][[IX)H ]&KSKQBL
MQ^-/PY,+JJ+:ZL901DLNR#@>AW;3] :U&\/>*VV8\;S+M&#C2X/FX(R<CW!X
M[J.V0?/OC7X,U&VT'6?%\GB74+R^TRQF6SC;3XYA C[E<*B@* T;E'<@X4;R
M/D7: >Y4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM4OK"\O?#VG/<6,WGP,L(3#X R0N W0<-D<#TK4_X1S0_P#H#:;_ . J?X4
M>;>#K/PCX;^,EW:>%Y])MUU?2UE-K;;,>9&P4+'MP%RB.Y4Y+$,P^ZU>O5X;
M\%_#L>C_ !6\?6^H6\ U"VNFN[9H418T@N9)&4 >6&W;5'(=U 8)\I4@^Y4
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M$JJFH?$$*H4?\)/.< 8Y-O;DT >@T444 %%%% !1110 4444 %%%% !1110
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M2A*KU4\&N9N?$/QV\"VDEYK^G:/XGTZ&0-,\"@3-&&&1&(]IY4DY,;;0I)&
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MO++XJG[3&FO")@[>&7AN'\C*;3<,T:[R_4F.4X"YPG5@3L /4Z*** "BBB@
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M!4<CIR9<@'Z9]NU<-KWC?43\2=&\0:MX1U_2]!T>![<27-N/,E>[=(\Y5C&
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M^A44 <#9_#AQ)8/JWC#Q1JJVT\5TT%S<1"&62-U=-RK&#@.@8#=]2:[ZBB@
*HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image06.jpg
<TEXT>
begin 644 image06.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" ,8 D<# 2(  A$! Q$!_\0
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M=NSFJ>MR>+=$O/#L5[XC>6*;Q$EFKQ6D(-W9O#O"S_(0L@='7='L!!S@$C:
M>G45Q7B@>()/&%G8Z'KC645[IERY26VCECA>.:V7S4^3=OV32X#,5W!"5(#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** ,7QHE[-X8U"WTR"6>ZN(C
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MG/&<$CK:Y3X@*"?#1.?EUJV(P2/[WYT =71110 4444 %%%% !1110 4444
M%%%% !1110!Q'PU@2WUCQ^D42Q*?$3.55-@):TM6+8VKR222<<DYRV=Q[>N(
M^&K%M8\?EF9C_P )"PRTHE./LEK@9'0>B]5'RGD5V] !1110 4444 %%%% !
M1110 4444 %%%% !117&Z]'\0FUJX.@77A2+2>/)%[;7$DX^5<[BLBK][?C
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MO%O'W7T^YRIP"5)$9&1D9P30!ZM17E/_  T)\,=Q'_"2'  .[[!<X/M_J_\
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MKDLNX8RV1U'.,X/8\\]* .MHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPV=IP=I(4D1^ _&GARRUC2/#6F^"->\*'69;FXM8[K3X[2.62-"TA95<MG:
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M^ M*W@!L29 .0#YK]ZZNN5^%O_(AZ4/[JR*/H)&'/J??J:ZJ@ HHHH ****
M"BBB@##\;^(8O"?A/4]=N('N(K&$S-%&0&89' )^M<]\&4U0>&=2FUK3[O39
MKK6+Z[CM+K[\4<L[.!Z8RQZ<')/>K?QBA:Y^&NN01^5ODB5%\U=R9,B@;AW'
MJ*[*@#F?B)=^*K'PXUQX%TVPU/5UF3-M>2^6KQ$_-M.5&X<=6 QD\D!3TU-E
MD2)0TKJBE@H+' R3@#ZDD >YIU '+:C?>+(OB%I5I8Z593^$)K9S>WQE GMY
M@&*@*6&5.$'"G[Q)(QSU-)N4,%)&X@D#/) Z_P Q^=+0!PD-_P"*+S0/&D?B
MK1[73X(!<QZ=+!.)/M-OA]KL 3M.W;UP22>!TKSN."*3]CT2/Y22)H3A9'4D
M@;LE00"?F*J/3.,XQD>Y7T%IK&G7]A)+OAF1[6?R9=K)N7##<IRK8;V(R#7F
M5W\"O!GV#RKRYUO[!#:FW\J759?*CA!#E<$X"AE5\?=W*#CB@"KXB\5^&+_X
M3I;V/B+2[F]%OI\3007:3LK":( >6&.#DX)QD=3]WC2^/4FK+:>#4TFWM'B?
MQ+8>;+/(P,;"4>7\H'*EL;CG(&, Y)78TWX5_#^".*>P\,:005C>*98PY^7!
M5E;DYX!R#D]\YJM\7I#Y/A:, 2A_$^FJ,M@1D2;CGICA01DG+,!CD @'H=>"
M_'35M?BTGQ':>)K:Q@\*+?:8-.NK:18[J8-,CR'#2\%0CKG]V21D';N(]X>1
M$:-7=5:1MJ G!8X)P/4X!/T!K-US2]-\06;Z?J=K87\*R1R26]W"LR#!!Y4]
M\9P3^1'! /(/B_XJ\/:W??#VTT+7M%U"1?%^FS&&RO(YI -TFYBJD\99>?4^
M]=!X^9D^.'PL1R3YDFJ,NP[5VK: 88<[CEF(/& 2,'.:M:G\&/ U]=Q?\4Y9
M6L23"Z#V.;:02#/R[T(.P[@0J[<%/<8D\&?"'P;X9U6QUO2],:/6+5/+6X:]
MEGV_N_*91N.",9'W1CM@<4 =;XON=9L_#=_<>&+"#4=91,VUK/*(DD;(SECC
MMD]1G&,C.:OZ9)=2Z;:2:C EO>O"C3PQOO6.0@;E#8&0#D9[U.[A.7X0*69R
M0 N/7_/:G4 <[XGO?$MKJ^@Q>'M*M+[3Y[@IJ<T\_EM:Q97YT'\1QOX]=O;)
M'1444 >.2>)M2T/X]W"ZWH4PTO6EM]&TK4(9,*?*5YGWH3DY>8C=@ !<#=R3
M['7FWQ;+_P#"2?#<!B(_^$A3<O&"?(EP>N?7L>O4< ^DT %%%% !1110 444
M4 %%%% !1110 4444 %<K\2_^1=L_P#L-:3_ .G&WKJJY+XH1B7PO;1L6"OK
M&E*2K%3@ZA;]".0?<<T =;1110 4444 %%%% !1110 4444 %%%% !1110!Q
M/@\Y^(GC_P#=A,3V0R% W_Z*O/'7TYYX],5VU<AX7<-X_P#&H"R@H]FI+@@,
M?(SE<]N<<<9![YKKZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M Y7X6J%\ Z1ME\T%';?M*G)=B000,$=#QC(..*ZJN6^%]G=6'@32K6_C>.ZC
M5Q(KHR'/F-SAB2,]>2>O4UU- !1110 4444 %%%% &3XMT2R\2>&]1T?5F=;
M&\A,<S(^Q@O7(/;I7)_ UF?P9=,?$%SK\ U6]BM[RYNOM,AACG:./,G?*H'S
MTPX(X(KT*O.?@/'90>#M0MM,MX;>WM]:U&)4@??'@7+[=C8&5"[0">N* -SX
M@^!-'\>6=A;:X;M5LKI;N%K:<Q,&7MD=B.,]1G@@\UU5<;\3?B)I/PZT^PO-
M;M]0GCO;C[-&+.)9"&P3DY8<<=LGT%=E0!RU[X(TZ\^(FG^,I;F_&I6-FUE%
M DH$!0ER2RXR3\Y[XX7C(S73N@=ANY4<[2 03D$'ZC%<O?>.--L_B/IW@N2&
M[;4[VR:^25(\Q(@+##'.03L;MCH,Y(KJJ .-^'?PZT;P%+K,NC2ZA-)JUQ]H
MN'O+@S$$;L ' X&YN3ECGDGBMKQ1X>LO$GA_5-(O?-A@U&$P3RVY"2;2,<'!
MY^H(K,\!^.M-\;-K(TJVOX1I5XUC,UU$J!Y%Z[<,>/K@\CBM/Q=KMOX8\-W^
MN7L=S+:V$1GECME5G91UP"0/?J.E !X0\/67A3PSI^AZ7YIL[&(11F4@NW<E
MB !DDDG '6O.OC9X;MM7N/!DE[+=H]IXCMEC:VNI%Q'-("2^"'4Y78K(<KP0
M5&0OHG@W7X?%/A?3=;M[>XMH[V$2B&X0HZ'H000.X.#T(P1P17G7QD\1SZ,G
MA>,Q:G>JVOV@#VE@TC@1,#(&93M=G!PJJ!_&,$J0 #UFXMXKCR_-7)C<2(02
M"K#N".>F0?4$@\$BN.7X>Z7;>/=4\8P1/<:QJ5M]DN(IK@I;F,(% V!3G.R-
M3G(XW 9&#U$US+M\R)D"V\S"YB5#,Y3:<!=K#:W,;]&.W("Y8$<W9_$+3+KX
MGWW@:.TU#^T[2U6ZDG\H>1M(4_>SG^-1G&,Y&<XR =1Y<[29E2V>.3Y9%P05
M3;TSSO\ FW=EX;V^;F/A?X+LO!/A<V&G2ZMBZG-],-2FCEG21PNY69!L_AP=
MN><D$YS72W+0K;SG4"%M K"0W!3RV4DCGVQZ]FYR>G*_#_QW9_$?PE<:QX=@
MO[54GDM52Y5(V+A1@Y^<8^=3GGD$8.,$ U?'7AN#QAX;OO#]]->V]G?0E9)K
M5U4KAD8#)R><=,8(W ]16IH>FPZ-HNGZ9:M*]O96\=M&TK;G*HH4%CW.!R:R
MO&GBJT\'Z1>:MJJ7,UC;PB5DM8-\@ D5&.<@8_>(<<8"L<GMK:3J5MJVFVE]
M9.6@NH([F/<I5MCC*DJ>1QV- &%XO\$:=XJUKPYJ>H7-_%-H5U]LMDMY0B2/
ME3^\!!R/E'3!P2,\FNIKEO%OCG2?"NN^&]*U5;H3:]<FTM9(HMT:R J '.<C
M)=0, ]>< $UU- 'C/AWPWH=[^T1XKU"YO1J6I6<%I>1P[RJ6DS++$1Y8.UF6
M)8OF/0OD#/3V:O*/!^L6-]^T%XWM+"QBB>VTVSAN;AH\232JSL6SUQME5>>H
MB7' %>KT %%%% !1110 4444 %%%% !1110 4444 %<K\2_^1=L_^PUI/_IQ
MMZZJN/\ BM+Y'A**;,0\O5M*?,K[$&-0MS\S8.!ZG!Q0!V%%%% !1110 444
M4 %%%% !1110 4444 %%%% '*^'?^1[\7?\ ;G_Z*-=57*^'?^1[\7?]N?\
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M\?7NKW+BVEL['[';[RRB F95.-Q"_-%*<>LC'@DBO4: "BBB@ HHHH ****
M"BBB@ HHHH **** "N5^)?\ R+MG_P!AK2?_ $XV]=57*_$O_D7;/_L-:3_Z
M<;>@#JJ*** "BBB@ HHHH **** "BBB@ HHHH **** .5\._\CWXN_[<_P#T
M4:ZJN5\._P#(]^+O^W/_ -%&NJH **** "BBB@ HHHH **** "BBB@ HHHH
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MO+_#GP#X:U;Q]X0N?L!G\)^(FU"VM+.^F9KIDMX6W32M&0JN7Z*O &",GYJ
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M#<3B]C)=YAS'LPI'3S=QX;A<$<UZ/H^IV>LZ7:ZEI=PES8W48EAF3HZGH?\
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M6I0!X9I?P[O;W]H;7-;U?5G2VL6M=6L[&!VDC?S4E@!??PK@6_\ "#P0 1@
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MGSFAV*IR/F)QCUH [S2M.L](TVVT_3+:*ULK=!'%#$N%11V%<1\5=*LKS5?
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MI''%I1=1%:2 *6/'.2%0@<???.[<" #B_!<;/^S'&H+H9- N-K"+YL&-\$(
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ML@GC^;"JKX6)1D* ""!TS7O= !45W<P6=K-=7DT4%M"C22RRN$2-%&2S$\
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MZ=;SZEIY)M;EE^>+/7!K6H \P^'^I0:C\:?B>+8RD6J:9;.78$%U2;=M&T$
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M)^]CH!79T %%%% !1110 5ROQ+_Y%VS_ .PUI/\ Z<;>NJKE?B7_ ,B[9_\
M8:TG_P!.-O0!U5%%% !1110 4444 %%%% !1110 4444 %%%% '(^&2#X^\9
MX(.&L\X<MC]SZ=OI^/>NNKCO"LBO\0/&ZKC,<EFIQ)NY\@'I_#U''X]Z[&@
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MG2 $!5.!AAD$12-_P-\8 7;?7]H+XK"ZDE/AFQ:-D5!"=,N-B$%B6'S[LG<
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MTZSX^V  ?\)"W0H>?L=KG[O'7\?[W.:[:N(^&K%M6\>YD\W;X@*!LD\+9VH
M)))R ,?A7;T %%%% !1110 5ROQ+_P"1=L_^PUI/_IQMZZJN1^*#$:!IP&_Y
MM<TD':,C_C_@Z^@_KB@#KJ*** "BBB@ HHHH **** "BBB@ HHHH **** .-
M\)NS_$#QUE<(DUG&#NSG_1E8]S@_-TX[''.3V5<;X4#CX@^.=[,5,MGL!7
M^SC@<\C.>>.21VR>RH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#E?A/\ \DL\&_\ 8%L__1"5U5<K\)_^26>#?^P+9_\ HA*ZJ@ HHHH ****
M "BBB@ KRG]EI0/@5X;(S\QN2<G/_+S+^5>FZE?VFEV,MYJ-S#:VD0S)-,X1
M$&<99CP!SU->2_L[ZK;Z+^SOX=OKU;AH$:9"+>!YY"7O9$&$0%FY8= : /0?
M%_A.W\42Z0]WJ&J6:Z;=K>*EC<^2)F7HLG&2OT(/)P1715QFO?$C1-"FL(]1
MM]:C-[>+8PM_95P%:5L;0"4 ;(/ 7).",9! UKCQ38P0M(UMK+A<Y$>D73-@
M$ \"/)ZYXY(Z9H C@\*V\/CNX\4K?:B;B>Q%DUH]P6M@ P;>J'.UOE4?+@?>
M.,L370UQP^(NB?\ "6?\(Z8M8&IBU>],?]EW'$2G&[[F2#S@@$9&W(;"G3MO
M%>GW&WR[?6AN.!YFC7D?8'G=$,=?SR.H- #/!OA6V\*PZG%:7E_=+?7TEZ1=
MS&3R=^/W:9Z( !C.3UR?2[XHT2U\2^'=2T74&F6TOX'MY&A?:ZAAC*GU'N"/
M4$<5SWA7XD:/XFBNWTZSUL?9+V2QN%ETV8&*1.NX '';Y?O#<-RCG%OQ!X[T
MG0_#=WK=Y!J_V2VA\]E_LV>-R/3$BJ ?]XC'?% &[HFFP:-H]CIEF93;6<*0
M1&5R[;5  R3R3@5PWQ8TZ&X\0_#V^FO;J)K;74CCMDD(BF9XW.64#EE$9P20
M &<<[L5M:7X]TC4M-L+ZWMM<,-[ EQ$1HMVXVN,C+)&5Z#L2.G.",\=\2/&&
MGW&J>!8HM/UYL^(('\R32+F%4_=2#_EI$"QP_P!U><!C_"00#UVN?TWPQ!8>
M,-5\0)>ZA)+J$,4)MI;EV@BV9RR(3M!/R]N,'&-S90^*H1%([:5K@*LJJO\
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MMXZ21R[+KV"Y0H6_T*TY((')ZD@ 'J."*[:N5\ Z5K.G_P!O77B-=/COM3U
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M4YP1@X.#^8I:1R54D*6(&0HZGVYH Y;X3_\ )+/!O_8%L_\ T0E=57*_"?\
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M,X_M[2MV&(X^W0^@.><<''UR " =C1110 4444 %%%% !1110 4444 %%%%
M!1110!PO@D@_$;XBCYMPN[+DR!AC[''P!_#WX/KFNZK@? RD?$OXE$X^:\L2
M,'/_ "Y1?E7?4 %%%% !7F'[1'B;4?"?@);_ $.1;34)[N*Q&H&-7^QQNV7?
M# \'8%/U!Z@5Z?7F7[1&K7>D_#A_L%CI]]->7MO:>3J%NL\)W.""R-P>0.H.
M#SVR #RCX8^*O&<GCO0=%USQQ;3QQZM<Z7>:+!:1+<1FWB<JWR)_J3L4%@0
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MP;L=LX"Y^@KNZXGP0\1\=?$2-<>>NI6K/\@!VFPM]OS=3R&X[?C7;4 %%%%
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MQ0@"@"/PG_R*NC?]>4/_ * *U:S?#,;P^&])BF1HY$M(E9&&"I"#(([&M*@
MHHHH **** "BBB@"OJ&/[/N=VW;Y39W9QC!ZXYQ].:X#]G.T2R^"GA6*(L5:
MW>4[CSEY7<_AECCVKN]90R:1?(H)9H)% &[/*G^Z"WY GT%<)^SG=I>_!3PK
M+$&"K;O$=PYRDKH?PRIQ[4 =KJ^@Z7K%SI]QJEC!=3:?,+FU:5<^3(.CK[C
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M=N2>^:\5\ Q^#=9\9:3=?"WP#%/IL$NZ\U^X,D26C$K(T<:N<M(#L&1]T,0
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MG?<6!8X7#<+MXX-=!XWTJ?7O!>OZ19M$ESJ&GW%I$TI(17DC906(!.,GG -
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MJOIM>1> )5G^-7C1Q,K%'DA*/=!I/E2U/"_>:,;C@$8B8L 3YQ"^NT %%%%
M!1110 4444 %%%% !7"_&PX^'L_[B*X_XF&G?N99O)23_3H/E:3^ 'H6[=:[
MJO+?VGPI^!?B?><#;;]\<_:8L=CWQ_\ 6ZT >I4444 %%%% !1110 4444 %
M%%% !1110 4444 <KX=_Y'OQ=_VY_P#HHUU5<KX=_P"1[\7?]N?_ **-=50
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MLV1D1W&X2 IQAN0.N-A'0"@#TJBBB@ HHHH **** "HKMVBM9I(]N]49EW'
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MD;8Y"\@%><$=\'I7M'PA\,^*M#U+Q9J/C*?3#<ZQ>)<)!IKRF%"J;68*_ W
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MR6S(GF%QNY^0-Z\@5M+X(T:>!/M]JTUP442D74Y5B H.,N3CY1C/8#TKIZ*
M/-/$G@"4:]X;/ANRL$TB.Y=M4%Q<SB4)A=IBP2,\'/?.SMDCJ)O!'AV<L9-,
M0LP +>8X)Z<YSU^4<]3R>YST=% 'BGPV\'Z2GQ)^)-CJ^FZ=??OK*>*.817
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M)_\ (JZ-_P!>4/\ Z *U: .3_P"$"TG<3]M\38( V_\ "1ZA@>_^O_SBDC\
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M\K1ZUI3!$VY)^WP<?,1C/3J.OIFNQKE?B7_R+MG_ -AK2?\ TXV] '54444
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MX4@,5PI8$@*" -BN:^&9C_X5SX7$$[7,2Z9;(D[(4,P$2@/@\@-C(SS@UTM
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M'#*VW(!VVAR0RZ+826LWVBW>WC:.;S_/\Q2HPWF9._(YW9.>O>KM9OAGS?\
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M>#SWH \(\42Z3JWQJ\6ZII5_$_B">*PN/#C1N4E%VCQ0;&1\<$J=RN,&)O,
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M@W_D8O'?_8:C_P#3=9UU5 !1110 4444 %%%% !1110 4444 %%%% !1110
M5QWQ/N=4L])T^?P_#:S:LEY_HZ36@N6/[J7>8E,D>'$>\YW9(#+@[L5V-8?C
M6+3#X9O[O6M)AU>UL(7O1:26ZS%VC4L-BL,;^H'UH K?#ZSU>Q\.Q0:YJ%IJ
M!3:MI-;6S6X-N(T5-Z,20Y(9CSU;':NEJEH^DZ=HMF+/1M/M-/M Q806L*Q(
M">IVJ ,U=H **** "O+?VB7L6\%65GJJK+8W6H1I/  OFRHJ.Y6,GD-E5Y4,
MV,@#FO4J\E_:8TM==^'L6E)JFGZ==SWL9A:]E\M7P"& (4G.&/ &3PHR6"D
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MH_\ TW6==57&_#^SAL=<\>Q6RLJ-KWG$,[.=TEC:.W)).-S' Z <#  %=E0
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M_P#D7;/_ +#6D_\ IQMZ .JHHHH **** "BBB@ HHHH **** "BBB@ HHHH
MX#X3K:IJ/Q!%BNV+_A)IRPVE?WAM[<R'E5ZON.<8/4%A\Q[^N(^&LGFZQX_8
M1+%CQ$R[5"@'%I:C=\K,,G&3SG)Y"G*CMZ "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KG_ (A(9/ /B5%\HLVF7('FJ&3/E-]X'@CUSQ705A^.MO\
MPA/B'>P1?[.N,L5W!1Y;<X[_ $H W**** "BBB@ HHHH **** .-^,=E:WGP
MN\5-=VT$[6^E7D\)EC#&*06\@#KGHV&(R.<$^M6?A6[R_#/PI/,[RSW&EVUQ
M-)(Q9I)'C5W=B>22S$DGJ32?%C_DEGC+_L"WG_HAZ/A5L'PX\.QP2^?;0V4<
M%O<>4T7VB%!LBEV-RN]%5\'INQD]: -C5]!TO6+G3[C5+&"ZFT^87-JTJY\F
M0='7W&!5?QKXA@\*>%-4UV[AEGAL83,T46-SXZ 9XZU7\3Z]J6DZQX?M-/\
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MY,C+S@[-N "26  )(% 'IFB:?!I6D6=A:(T=O;Q+'&C$910.!QP .@ X X
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MA\V:-]I);@#Y><XZU/\ "'3M3TCX9^'M-UVQ6PU&SM1;S6ZLC!=A*@Y0E26
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M:-X_^*'@"W\.6>I,EM?3R"_N[4QVL@^PNTD:Y^8R*'7T .#\P(->]4 %%%%
M'CGPTETD?&[XA6T *ZNDYE<*Z,AA>.WQ\P7<QWJ^5+8CS@#+,:]CKR7X<6-W
M/\5?&][J36-Q;PWI^PY>WEE@)15;;MS+'P.5;:/F! .YB/6J "BBB@ HHHH
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M?R\C^E 'H5%<!_P@6M77SZI\1?%,DPX!LUM;5-ONJPD$YSS]/2C_ (5S=_\
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MTSS$8HZ_:X\JP"D@C/! 93C_ &AZBHU\6>'&E,2Z_I!D'5!>QY_B[;O]EO\
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M]O\ 9L.-F[=MQMZ;OFQZ\T\^!O"1M5MCX6T$VZJ56+^SX=@!8,0!MQ@L ?J
M:** +#>$_#C3/,V@:09718V<V4>YD5PZJ3MY =58#U /44P>#O#(B:(>'=&$
M;7 NV3[#%@S#.)2-OWQD_-UY-%% %LZ!HY*DZ3IY*W!NU_T9.)BP<RCC[Y8!
AMW7(!ZUH0QI#$D4*+'&BA511@*!T '8444 .HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image07.jpg
<TEXT>
begin 644 image07.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" -M J4# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 4M%M+FQTFUM;Z^EU"YB0*]U*BHTI_O$*  ?I5VHKBY@M4WW,T4*'/S2.%'
M+'KZ $_0$U6AU:SFU);&&8/.]L+M-HRKQ$XW!AQUQ^= %ZBBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ]GHKXUT6\\.7?Q$N]$N=,\1@K=1Z?!ID&KNUW]HC=FF#EIUCV'F+>'Z1@@
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MPKR0S#/7D'JJE:LOP]SO-OXN\86[NH5F74_,Z;<$"164$ $< 9W$G)P1V]%
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M !<3X;Z-YB237WB:>1 0K2>(;[(!*G@B4=U!_P#U##1\.-+3>MOJOB>WC97
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MV5% '*+\//"ZC TP]2>;F4]?^!4R3X;^$Y"3)HZ.2,$M-(>.1_>]S^9KKJ*
M.%;X2>!C(9$\/P13;@PFAEDBD5AT(=6# CL0<UD:K\"O U[IUS;P6-[93S1M
M&+J+4+AI$R6)^^[!LEWR&!!W'->HT4 < WP=\!R,[S>'H)97?S6D:63<7P1N
M^]P>2>,<DGJ<US'B+P=X2^'WBWX<:MI&FPZ<JZL=)_<JSO)]HMYUCW,22<.1
MDG)^8G/%>S5Y+^T5.MIIO@6ZD#;+?Q;I\K,!N" >822.X]LCDCF@#UJBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KE=-_P"2I^(?^P+IG_H^_KJJY+09!-\2/%C,&\V*
MUL+<':0OE@3.!GH3ND?/?!&>V0#K:*** "BBB@ HHHH **** "BBB@ KE/A6
MJIX"TI44*JB0  8 'FO71Z@;H:?<G3E@:^$3>0L[%8S)@[0Y )"YQD@$XKC/
M#GA[QCH6B6.FV^NZ!(EN,/)+I,I9\N68\7  ^\<<?P_[6% (_BQJ?B"V33].
MT/3-4N-/U!)X]0O=*4&[M% 7;Y.YE =\LH8GY?O<XP>F\&HD7A72X8=+N-(M
MX8%A@L;AP\D$2?+&K$,W.P*2,DC."2:S5M/'(N(RVM>&F@W*70:/.&VY^8!O
MM1&<8P<?@*8(O'L( -WX7O"0I)^RW%MM/\0QYDF?8Y'T'6@"/QFB_P#":^ )
M6^9O[2N8U4MP,V-P=V,C)&W'((PQZ'%=E7F-\_B&;XD^"K7Q%_9*1))>7L)L
M4D9BR0-%M9GQ@%;C=QW3&#G*^G4 %%%% !7F/QBN9=)U?P-?0W%T1=^);"Q>
MW$Q6,*RW W >I\P$^NQ!QC->G5R?C3X>>&/&MQ;3>)=.>\DMQB(K=S0A<$D'
M$;J"1DX)Y&30!UE%5]/LX=.T^VLK166WMHEAB#.SD*H &68DDX'4DD]ZL4 %
M%%% 'GWP996T_P 5A2"5\3ZH" >A^T,?ZBO0:\M_9])GT/Q7J._,>H^)M0NX
MXSG,2EPNT]LY4GCCGZUZE0 4444 >(?M%:GH^D:MX)O/M5C#KD&O6,\P:?;,
MMDGGEF8#+"+)<,P!'7.<8KV^DVJ6#$#< 0#CD ]?Y#\J6@ HHHH *X_XK>3_
M ,(E%]J95M_[6TKS&9MH"_VA;Y)/88[UV%<K\2OF\/6B+S,VK::8D_ONM["^
M/7&%)) .%#'!QB@#G_C+X9T]OA9XAMM)TJTANKB)8XOL\ 1C([A1RHSR6.?8
MG/!->C00QV\0CA0(@)(4=!DY/\ZDHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "O(?VFPQ\&:$5C+ :_9$D'&P9;GH<]AVZ]>Q]>KR+]IIE'@?1T+J
MC2:[9*A.-P.XGY<]\ ]CQGC&2 #UVBBB@ HHHH **** "BBB@ HHHH ****
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MH+%MQ7 ? 3//ECY/:KR_"GP$(T0>$-$PDS7 )M$)W%BQ!.,E<L<(?E P
M #*^ L,EOX9UV";;YL?B#44?:H49$Y!P!P![#BO2JY7_ (5QX(_Z$WPW_P""
MN#_XFL?_ (4YX+6-4CLM2C5< !=9O. .W^MZ=J /0J*X#_A4'@S_ )\M2_\
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MG<!N#DJ,(6+/BGJ/BO3M;\,/X=35'T>5YXM3&FV4-S,#A#$<2$;!@2_/R <
MAB5! /1:*Y'PG-?ZA<:5J4-_>W^@W6E"XAN+H1([O*X==R1JHR(RH'R\ =<D
MD]=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7':0L<?Q:\4;
M05>72-,<[FSNQ+>KD#/ X [<_7)[&N(LY8Q\;=7B(_?-X>LF4[ <*+FZS\W4
M<E>!P<<]!0!V]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.!BN^HH R_"^AV?AKP]I^C:6KK964*PQ>8VYB!W)]3UK4HHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K@;<#_A?6H'<,GPU;#;SD?Z5/S_G
MTKOJXS2;15^+_B:YD8R2'1M-$9;_ )9*9;P%1[$H&^IH [.BBB@ HHHH ***
M* "BBB@ HHHH **** ."^.7BS5/!/PUU37=#@@EO(&B0-/RD0>14W[<C<?F
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M@($3LV]"Y^\74'[BC>^)/@D>-7\-)-<B.UTO5HM1FA(R)U16POYD?@3TKLZ
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MHDSK(1_HS,S,H]"2QY]A6A<^'],N=?369K6)K];*33VD*C]Y [HY1^/F *<
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M<J!N+-@#JS'J238'P>^'PB:/_A$M*VLP8GRN<C/0YR!R>.AXST% '8OJE@A
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ML<9!Z4 =C1138F+QAB,9Y YZ=NH!!QVH =1110 4444 %%%% !1110 4444
M%%%% !1110 5Y5^U)_R0GQ-_VZ_^E45>JUP7QYTXZI\'?%MN$@?98O<XFW;?
MW6)<C:0=PV97G&X#((R" =S;R"6WBD#!PZA@P& <CK@]*DK.\-S27/AW2YYW
M+RRVL3NQZLQ0$FM&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDS'X_P#$"IMZ-::>3GUS]F''3C%.?PMK1^YX]\1#Y3UMM///8_\ 'KT]OY4
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MARPU#P#\/+G5[(O?:3IMK+;>8S*8)?LZJ25R 3C(PP./K7=T %%%% !1110
M4444 %%%% !1110 4444 %%%% !6;XFV?\(WJWG;O+^R2[]O7&PYQ[UI5E>+
M/^15UG_KRF_] - &7\*69_A=X/9R69M&LR23DD^0E=37"? AY'^#WA(S.9&^
MP1@$MNPHX49]A@8[8QVKNZ "BO-/"?Q'NO$'Q/O]#CT^W7P^+,SV-^)U+W#)
M-)$QVYY1FBEVXYVQ[CPXV^ET %%<KXRU_4]/U+2-(\/V=M/J6H>;.TUY(4M[
M6VAV>;(^WYB<R1JJCN^20 <X^C>-]0T[1K9_&]M8F_NM532[4Z$YNH;AGA$B
MN.=R#_69#8("@]""0#T*BN8NO&^DP3ZQ#$MW<RZ5-;VUPL$!8^=,0$C7.,GY
MD)/3YP 2<@4[;XD:%-J6EV+_ &JWFOKFXL_W\8C%O<0HKF*7)^5F5@R]0?4$
M@$ [.BN2A\=6,UF;B/3]4D#7US8P)# LSSF!V1Y5",V(]ZE06VGH2 "#4VN>
M+[6S^'6H>+-/C:ZMX+&2\BC<&,N54D*P(RIR,'(R.>* .GHK@O#OC#S;2^O+
MOQ'X=U^VM5CC*>'H6EE\V25DC!42R8##8 #WWDMM&:L6WQ&TNXL;Z5;'5%OK
M.^33I=.:!1<><X!4 ;MN"#NW;L8!H [6BN0NOB!I=A=/;ZO!=Z9*NE'5R+SR
MT_=!RI3.\CS =N1_MKSG(&;%XD\1>)M6\CPO!:Z;8Q:=#>27&I1&20S3)N2#
MRT<;<*02^6P5(VD<T >@T5QMW\0='TG3M<DUJ=HKG04B.HHL#J,R+E6BW ;U
M)#@$==I_&#2?B%:WFI>*UO+*_L-/\/0)+=SW5OL,9V,[C 9F?Y K JO(/?(R
M =S17+^$_&=IXD:U$-AJ5D;RR74+4W<2A9X"1\RLC,N0&C)4D,!(N1G(%;_A
M.=-L_$WB;3M8U"PLXM(A@GS(^QMCQLQ)R><;3P!G&/44 =C17C$7Q!\5ZCX'
M\*^)--FT&.'6M3CTTPR6$DWEB2[DB27<+A>B!,IC.[=R.B^O:;'=Q6$$>I7$
M-S>*H$LT,)A1V]0A9MOTW&@"S1110 4444 %%%% !1110 4444 %%%% !7)>
M(/,3XB>$71L1M#?1. Q!.5B8 ]BOR9(/<*1T.>MKE=2_Y*GX>_[ NI_^C["@
M#JJ*** "BBB@ HHHH *\BU;2_$:?'6_F\.3Z1#'>:+:O/)J5F\P&R>1<($="
M6'RMR>X]!CUVH_(B-P)S$GGA2@DVC<%)R1GKC(''M0!P4.E_$U)1))XG\,N%
MA11$=(EV.ZHV22)@1N9AD@XQ&I"C+*;%[I_Q&GAFA@\0^%[?S%=%N(]'F\R/
M*G:ZJUPRY!QP01['H>YHH X];/Q\67?KOA8#<VXC1;@X&?E(_P!+Y)&,CM[T
M/I_CQP!_PD?AN/YLEDT*8G 88'-WT(R#W&>/4=A10!PMWI/Q$NE15\6>'[',
M4BLUMH<CE6( 5AON""1RPZ#( (8&GBV^(\,R8U+PI=1ON:3=8W$/EG "J@$K
M;AG+$DY[ 8.5[>B@#B)A\242/R6\'ROM&\.MS&"0&R0<M@$[ !SM&3\W J6$
M?$(:A!Y[>%#8JR><$6X$CC(WA<G"D $@G=DL <;<MV5% 'EOCU=:U7Q;H?AR
M2]73X-;T'4K>5K660^5< 0'S  4W!#C;G!(9P<;JP_@?+!J^IZI97^BI<W^@
MQC2_^$DBADA>4KN#PR-(1()]S.[;"5^8$D'9GVZB@#B$T/Q7H/A[PWI7A34=
M&DBTW3UL;@ZC;2?OF1$1)%V-E<;6)7)SG&>X=:P?$&T@02W?AO4Y-P+EXIK7
M@  J"N_EMN=V/E+G@A0#VM% '"SR?$PP*(+7P:LWG+N9[FY*B+)W  1@[B-N
M#G YZTN_XE,JCR/!T3$KEO/N7"CG=QL7..,<C.3TQ@]S10!PRM\2C-<%HO!P
MB4'R5$MR6<C.-QV_+GY>@;&#][/!YGQ*=0/LW@Z$K(,O]HN9-Z;ES\NQ=I"[
M^[ DKT .>YHH XF3_A8XC(C/A!I%AX+"Y422X/;G8N<=V/)],F.?4/B.(F6'
MP]X8,JHOSMJ\VUV/!POD= 03R>C+W!KNJ* /.-=U7X@BQUA)O#&@K9K;N5FB
MUUU.WRCG:3;_ 'L]"0H_#YJV_A+)%+\+/!YMY!)&-(M%##'40J"#@G!!!!'8
MBNLJCH>DVFAZ7#I^FQF*TA+>7&6+;0S%L GG&2<>@H O4444 %%%% !63XO5
M7\)ZTKJ&5K&<$$9!'EM6M7._$B[>P^'?BB\A"M);Z5=2H&&02L+$9]N* *_P
MG_Y)9X-_[ MG_P"B$KJJS_#VE0:#H&F:19M*]MI]K%:1-*079(T"@L0 ,X'.
M *T* "BBL?0==BUN>]-C;SFP@94BO74K'<L02QBSRR ;?G'RL2<$[30!L444
M4 %%%% !1110 4444 %%%% !1110 5E>+/\ D5=9_P"O*;_T UJUC>-+B*T\
M':]<W.?(AL)Y),$ [1&Q/)X'% '&_LV7/VKX(^%I,N=L,L?SXS\DTB]@./EX
M[XQG)YKO]9L(]5T>^TZ9WCBNX)+=WC"EE#J5)&X$9Y[@CU!K@?V;["?3?@EX
M6@NEVR/#)< 8(^269Y$/(_NN/Z9KTEV5%+.0JJ,DDX % 'CVD_!*WTOQ58W+
M:UJNL:"NGK87-AJEUN!2)E:! J*JM$"IS&W!R<[@S ^H:#H6F:!;20:/9Q6L
M<CF1PF278]R3R3]:Q/#?Q%\+>(]9&DZ3J32:@UN+M(9K6: R0G!$B&1%#J00
M05SD<]*T?$/BO1O#MS:6^L79MYKM7>%1#))N5"@8_*IQ@R)U]?8X ,GQGX;U
M&_\ $&EZWHQT^>6UM;FQN=/O]RPWL$QC)4R -LP8\_<8-G!QUK@[SX5^(+[P
MG>0AM TW5XO$T6OZ;;6>XV<2111Q1PO^Z7HJ')"8) ..2!ZMIOB*PU*\M;>S
M\]C<V0OXV>%H_P!T6 &0P# G/0CZUL4 >4ZG\/=>UI=9DUB_TZ4ZI=6UU+:!
M6,)CB5Q]D=@JM)&"48/\I)SE0!AETSX8W3>%-6M-4GTV+6+C58M9LKBT@+QV
M-PD=O@)O^;:'A9<@@LA_A)('>>(O$=EH+64=TEU/<WLC16]O:P--)(RJ6. O
M0 #DG 'K4^BZYIVLZ%#K%C<JVGRHS^:_R; I(8,#C:5(((/(((/2@#@M<\!Z
MU'X0\(Z1HEY8SC1K5+.XMKLR16]U^[1!,PC(8E"I8)G!W'D$ UJ6O@R^M_@W
M<^#C>V\E_)IMQ8"Z*$1LTBNH8@<C[W(&<>_>QI_Q$TR_\+ZEXAM['5O[*LK&
M34!.]L%6XB0,W[LDX)(4\$@C(SBNJTR\34--M+V)'C2YA294DQN4, 0#@D9Y
M[$T >=S^"M?O/" TN1]"L[I6L \EI'(!=16[ F*5^&VD* ".@)'0U6T/X:WN
MEZ/XDM9(O#EVFL7D5RM@UFT=G;*JA=J(IR" JX88.1G Q7JU% 'A_P 1_!,L
M^C_#[PK/J%T5FN9--GGMH Q:!HV=T#/NV )$<=3\@XX..QUCPGXBMO&5YKOA
M+6+:WCOK%;2>QO8V:&.1"-DR!?X@N5P>.>XX'?T4 >3>,?#@N?BUX"FGU(-=
M20.+J)K52+I;4B57!Z(5ED4@#GYC@\<ZE[X$U"YUSQJD=QIMOH7B?33;R^3"
MZSQ7&QX_,*EBKDJ^2P*_<4;<DL?1&56*E@"5.02.AZ?U-+0!Y]\.?!=[X:U
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MYH=M$5619?MZ>6Z$[0^6Q@%@P'4<=<\##D^(EC%<HDNK>"T23(4MXC4,Q^7
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M)1@PW"5P>02.N>_X#H/1J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N>UX,?%'A@J@8":?=
MMCW,H\EN21RJ9P"3QN*#.2H/0US&O2,GCCPJJG D6[5N.H\M3_,"@#IZ***
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M!@<^_0>E %+QMXBN]&;2K'1K!+_6=5N?L]K#+*8HE"J7DDD< [555/0$DD
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MSA@5)"@_*-V<@'<Z1XNM=1>S$MAJ>G"ZM;B\4ZC;_9RB0R+&^]6.Y#\ZL,@
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MUW7V\4>)HC;PJ -'TF5<M9K\P,\O;SW#= /D4[<DDUW- 'G4GQ5MDCW+X/\
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M(OWYC 4 '=YH/1@/8=,L;;2]-M-/L(A#9VD*00Q@DA$4!57GG@ "@"S1110
MC*K%2P!*G()'0]/ZFEHHH CD@BDEBDDB1I(B3&S*"4)&#@]N.*DHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KSSXT*&L?"!(<[?%.ED;6(
M _?@<C/(YZ<\X/;(]#K@/C)_R#O"W_8S:7_Z4+0!W]%%17=S!9VLUU>3106T
M*-)++*X1(T49+,3P  ,DF@"#6-3M-&TF\U/4YA!8V<+3SRD$[$49)P,D\#H
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M-%"JBC 4#H .PIU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVR7>G75U<JCF7R98Y+=4028 .1+)GCDKP< Y .AHHHH **** "BBB@ HHHH
M**** "BBB@ KSKXU0B6R\'N=O[KQ3ICC*@G_ %P7@]C\W4=LCO7HM<!\9/\
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M_P >+CQ"?#6W24TU-$^TM=H'*&9YO/1<X*#"*RGYP67&0&KU6B@#R+4Y=?\
M$5A9S>*/A7I^ME7N8TA>:W,EL X 8&<C =0#\O/R\@<9]!\$:?=Z5X3TRRU%
MBUU#"%<&0R;.20FX]=H(7/M6Y10 4444 %%%% !1110 4444 %%%% !1110
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y[\=")/
M\%EO\N2^U;3K:-FP$#&[B;+GJ%PIY'/3WKT*O-OCO/';>&]!GGQY47B'3G?*
M[AM$X)X[_2@#TFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK+\4LR>&-79"59;.8@@
MX(.PT >9?#OPS_PEW[/OA31YM2O;"RFMD^V"T(5[F'+;H2Q&55N,XY(!'0FL
M;X,:!<W7BCQE?V6I3Q1:3X@O;.UCN$61"Q6%9&955.=L2*N&X5B,#JWIOPBV
M_P#"J?!VQ=H_L>TXVXY\E<G\^_>NL55084!1DG &.3R: ,;PEHT^@Z6]E-=Q
M7,8F=X!' 8A#&QSLY9BV"6.2<\^U;5%% !1110 455U:WGN]*O+:SNVLKJ:%
MXXKE4#F%RI"N%/!(.#@^E>4Q^ M.A\5:?HWB>?4_%]UJ=M/<SW6JSGR[>*#8
M@6-%(49,Z@@9)R2<4 >P45Y#ID-KH'QYLO#OA,)9Z:VBR7FI6%NV(E(<)$^P
M\*W('RX)&,\8KUZ@ HHHH **** "BBB@ HHHH ^>?V:=\?Q1^,,+*[8U8;I"
MP8 B>Y&">"2<GG'8YQQGZ&KY[_9.>TFU#XAR.[2ZT=6+74I79OC)?82%(CSN
M$QPJ+C/H0!]"4 >4_%>;6] _L[^P/%&OKJ6N:M#9VMG%;V<\<(8YE<*\6\HL
M:L>7P"5R0,UZ;9W]G>EQ97=O<% I812!]H/(S@\9[5S,/@>W_P"%F7WC&\NV
MNYIM/33[>VEB7;:H"2^T]PQ.>1D9;G!P.ATK1],TA772=.L[%9 @<6T"Q!@B
MA5SM SA0 /0 "@# ^(>H:O:Q:%I^@75M97>KZD+%KN=-_P!GC\F:5G13P9,1
M84,"N2,BLGQ9KMQ\,? ][?:CJUQX@U&XO!%8"_,,!>64@)%E%1 J@,Q) X#=
M. .E\:^&K?Q5HOV*:9[:YAF2[L[J,9:VN(SF.4 \':>QX(R*Y*\^%]QJVAZK
M;>)/%.HZOJ=U-'-9WTL8C&GO'@QO#"A"*X(.74 L&(/!.0##G^-36OAWQ?JD
MECIMVF@S6A1]-U%+J*Y@FF$1;<OW'X<A6 ZKU')T=0\9^)'T?QG:7<>DZ-J>
ME:=%J$%UY_G1/!-')R,'(='C89/#8'&&!K7_ .%>W>HZ)J>E>+/$U]X@M+^X
MM9VCN;>*-4$,RR,@" #:^T*1V'2M;6O!6GZQK6IZC>,9/[0TD:3+!(BO&$#N
MX;!'7,AZ\<"@#%MO%WB#SO#VCV6C6M_JE[I(U">YENG@MHL,@VEA&[98,V#C
MJ.XR1R^L>(=>UWPEK2Z3+-$+;QBNCS-<7K0RF'[;"@$,L"(R(2^P@Y8(S?.2
M &[+P?\ #\^&]1TN[;Q!JVJ-96,UE_I\@8L',&W&W "KY+8!#$^8<M\HJ*/X
M9:>OA_Q#I)OKHQ:WKAUR=\+N1S-%+L7CI^Z R<GDGVH S+CXCZ?X3T?Q/875
MD(W\(V%N'0732+*[0QF.,.P+X9G5 [ DD,3C'.=K7Q8U2VL9[BRL/#ZBTTJU
MOYEO=5:)YI)UWB*!!&2W0J"VW+.O3!%=)XB^&5CK7B\ZV=3U.TCN!#]OM+>Y
M=$NS"<PDG=F,HP# IM.<G.237D?BSX;^)(?&4\MI;:O<&UTVRL-#O[2"TDC+
MPQ*N^X,K%HU\TY(1>5R>=M '4>*/CK_8>M:_:M8Z>L>AM'#/#=7GV>ZO9"P\
MPV\;#E%7+ L1N^7;G->L>+K;[3H[F76KG1;6%O.N+FV94?RP#QO8':,[22!G
MC'>N7UCX:+>:W-JFE^(-5T*XO6CDU)=,8*EW(@P)-LF\(W Y [<Y/-;'Q'\%
MV_CO0X-*O-1U"PMX[I+EVLG56DVAAL;<""OS9P0>5'I0!3^#^J:EJW@U9M52
M_P 1W,T-I+J$+17%Q:JV(99 0,NR8)8  GFN"\'2>)[K4KS2?%DOB:UUC4["
M\2W-VT+Z9.^2#M5%\R+&5*J3DJ#[9] TGP1=:;JVE7G_  EWB.^CLYIY98+V
MX5UN?,B$:HX557:A!8#'WF)],5_"/@"YT77X=5U?Q7K6OR6MJ;.SBOF79"I.
M2YV@;Y".-YY()!SQ@ UM7DU7PWX'1]'LX]3O=-M4+6V7#7"1J-ZQ[0Q\P@':
M,<D@&G^"-?E\4Z ^L1QP165S-+_9[*S.9+=6*QRN"%(+X+[>P8 \@U#\1_!]
MOXZ\,-H=]=3V]I)<02S>4?\ 6HDBLT9Z<, 1GL<'G&#?TCP_!I-OJT%E<W20
MZA=37@4R;OL[R@&3R\YP"^^3'(#.V.,"@#C?!#W=E\0)]#MO$>H^(+2RTTG5
M)KN2.00W9E7RE&T#:2@FRHS@!<\X)R?BM)XOT[Q/<ZQ;0ZM-X1L].CDE&F:G
M#:-&RO(TSL) =V(P.F,_* ?O%=3X<_":/P3YL,/B76;W376938R,D<3&3&7;
M: S/Q][(/IBIM0^%-O?-91S>)?$1L([>W@OK+[7F'4?)"KNF!'5T7:X4@-P>
MH.0#L=&L#!J.JZ@MP98-2DBGC0[OW8$2)T)P,[<\ 'U)X UJ1%5%"H JJ,
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M#@Y&>NH **** "BBB@ HJCJ>J6^G7&G03AVFU"Y^RP*@SN?RWD.3T "1NW_
M<#)(!O4 %%%% !1110 5F^)E#^&]65CM#6DH)XX^0^I _45I4V9/,B=/E.Y2
M/F7</Q'<4 <9\%+A+GX1^$'B,I4:9!&?,ZY5 I_#(./;%=K7 ? '_DC?A/\
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ML&,R$GHY!R3D 5[?7FGB;X5^";;PSK<]OX9TXW'V"159U)(V+E "<D8*+TZ
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MN?N,$ SC;C@'H >^45YQ\+M+U_2=2NUO+C5+S0KBW1H;C5=16\F,BX4,I5B
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M]@6\_P#1#UU5 !1110 4444 %%%17:+):S)(JNC(RLK)O!!'(*]Q[=Z ."^
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MV8:2(<[&#/AO5, '/&/XU^*:VL>A6O@>T@U_4M:5YX':;RK:*WCSYDTDF,
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M;=WC\%,\@SMC_M2$%N>.>@'?Z>_% '1ZQ!=W6DWD&F7@L+Z6%D@NC")?(<C
M?82 V#S@\''-<1X<\#>(= T35;'3_%R1R7<[7<$O]F*PMYI'9Y?E:0[D);(7
M(*X'S-SG5DUSQ8&_=^#D9=K'+:K&#NXP,;3P><GM@<'/%=_%7BA"%_X5YJSL
M%.YH]1LMI?YONDS E<A>2 <$_+Q@@%GX9^$9_!'AS^QGU>74[:.5WM]]ND/D
MJS%B@"=1DD^V<# P!UM<1=>+/%"M_HGPZUF4>LNH6,?<^D[=MOYGTY8WBKQ>
M[.L/P\U!!T5YM3L_0\D+(>,^_<>^ "/X,RQV7PML3=H]BEE)>13_ &NX\QH_
M*N95=I)"J9/RDDE5[\"O"D,FLZE\08+5"WA_Q)J,/V5((&DE83Q3L;Q8$.^4
M*D+R",@;L[QED /O'PYTZUU?X;/IVKV"-!-=:A!=V<I61587DP=,@ $!@0"
MHP 0%Z#F=#^#\%E\6==\1*$T[2S#;?V5%ITK1F*55 =V7HI7:4"@%#'*RD<L
M* /5='GL;G2[672)[>?3S&!!);R!XV0<#:P)!'%7*P?"/AF#PQ#?16M[>W*7
M=RUVZW!CPDC??*!$4*&/) &,DGJ3G>H **** "BBB@ HHHH **** "BBB@ H
MHHH ***1P64@,5)& PZCWYH ^1_V,[_[=X^\6SSM$MS=6HN#&IQG,N6(!.<
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MD%]L::#+?9]@.=C8V;\Y'!P!GCN+6V@M(%@M(8H(5SMCB0*HR<G ''6I: .
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MF'_B479+@9P!"Q(/!X/0X&<'CF@#K**1"64$J5)&2IZCVXI: "BBB@ HHHH
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M DR5)W"1UW91LA<2+FO:-/LX=.T^VLK166WMHEAB#.SD*H &68DDX'4DD]Z
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M%F)]36U5?3[VVU&Q@O;">*YM+A!)%-$P974C(((ZBK% !1110 4444 %%%%
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MVRMN)SDG/4_,>?7!Z@4 ;S^(]#20(^LZ:KLNX*;I 2..<9Z<C\Q50^-?"P8
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M JC.< 1KBMBLKPG_ ,BKHW_7E#_Z *U: "BBB@ HHHH **** "BBB@ HHHH
MYN_N[A/B-H=FDSBUETG4)9(@?E9TFLPK$>H#N!_O'UKDOC6J7>L_#6P=PI;Q
M/;W0()W?N4D;&,8QD@'D'D8!YQTFH1J/BQH$@'SMHFI*3GJ!/8X_F:R_BPH.
MJ?#UN<CQ+".O'_'O<=OPH [#Q#ILNKZ1/8P:C>Z9)*5Q=63*LT8# G:6! R
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M;A)M9DWC^]G;;,/I@G/&<=! ^H^.FD98_#?A]%"@AVUN5@Q.1@ 6PX! )/\
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M>Y& "[X!AU_1&30-0T@+HMG!'#87L5TD@5$7:$<':QX4$-MS\V#G&YNVHHH
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M9929P.<=U[G';',_$ZR\967PN\2S:GX@L=0CCTRZCE@M-),+3(T;+N9C*^"
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M20!#CH[ ^@^$-%?0M/O+>1D=I]1O+W<A/(FN))0"#T(#A?\ @.>] &Y1110
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M"@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110!A>"UVZ/< /*_\
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M_ ,>J0^'(&M[6^N%G\HR.XCQ&J;06))&0S9/.7(Z 4 =;1110 4444 %%%%
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M=\,4=Q:VUIX:U&_GEN\2EGO1=S(O[M00L*F='/F')"MA0!Y@ /I:DW L5YR
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M0 4444 %%%% !1110!S'@21G77U8Y$>L7*KQT&0?YDUT]<KX!_YF/_L,W/\
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M>V^HZ?;7UC*L]I<Q+-#*O1T8 JP]B"#0!8HHHH **** "BBB@ HHHH ****
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MIQ;N7C_>W4L@VL221AA@DD^YKMK^RM=1M6MM0MH+JW9E8Q3QAT)5@RG!XR&
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M1FC#YV)HTBY3.<$FY//0 C'&[()(*]110!S,.E^*4N&E?Q+92*Q3]RVE810
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MQ&,\16%DK'+9&2T+# 7CIUY]J8WASQ>BNL'CN5@$Q&UQI-N[[\DY?;M!'08
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MQ#[?G1QA1QVK-G^%=GJ7B#7KG7)#<VU]:V$4%S"_D7:20+*KN6C557<'3[N
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M[-RL$92V0Q)(Y ()K'Q=X&\(IXDO-<N-9NK&&2[U?3IY!Y+0_?98&(W!HU!
M)/SX).,@#U2TN(KNUAN;=M\,R+)&V",J1D'!YZ5PNL>#-;\6M%;>,-:@_L:!
M][6.DQ/;K?'&/](+LQ*9Y$8..?F+X!'?T %%%% !7EWPB\$:5ILFK>(;2*_M
M+V^U2[ 0SS1*((IY(HD:$MM("*2NY<J'P,8!KU&B@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHIOF)YOE;U\S;NV9YQZX]* '4444
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MMYL5[-)"2>-I5U5^.H(*^A]B 8OQ1=SI>A6\,\$;W&O::/+D3+3!+E)65#N
M5@L9?)SE488R014^/$CP?"/Q+<0.T<\%N)X9$.&CD1U9'4CD,K $$<@@$53\
M3KXZUBXT*&+P[H\,5M?P7UR[:F)8V1 Q\L%H ZN'VG<J] !D[F ;XR\%^)_'
M7AVYTCQ)JVG6=C/<PL;?2XY$<PAU+J\SL0_R[R (U&]4).W<I (- 236-5T^
MU@@EFA:^D\0ZAJ#$(T?F,YL[=AR3)Y)B!'\"1("!O4BW\;8[V+1;&[\,Q;O&
M#W'V/2]H*M*75FEB+@C:OEQN^20 8U/:I+?X70PLT@\6>+$E>YDO)#;WXMU>
M61BSDI&@4C)X# @  =,@W/#_ ,/-/T/QA_;-K)<S(EJT48O+R>ZD\QF^]F5V
M"A8U5%V@'#."30!O>#!IZ^%-)31G=]/CMDBB,B[9,*-I#C PX((8$ A@00#Q
M5/XFR^1\-O%DV91Y>DW;YB?8XQ"Y^5L'!]#@XK4TG2+;2[G4Y;0NHO[G[7)$
M<;$D**K%0!QNV;CZL6/4FJGCC1[GQ#X0U?1K.XAMI=1MGM#-+&9!&D@VNVT$
M9(4M@9 SC/% '#>(M!L-;B^$IU"%9/*O4 RBDD"PFEVY()VEH4RH."!R#@$6
M/#MK#I^@_$ZPM#+]F@U.\=!(FTJ9K6*=QT'RAYGV\?=V\GJ>SF\/0/\ \(X%
MFE5-$F\Z('!,G^C2P8;\)2>.XK.\4_#SPSXHOC>:QIQ>Z91')-!<26[RH 0%
M=HV4L/F/!]!Z4 >?V*3W/@.^2 B;2KC7-)MI5#, +7RK"&9%QP '60-VP).0
M>G2?%'4=.?6M(T/Q#J,6B:)<127,^H3O'$LS(R;;9)7X0MDLQX;"@*>6*])I
MGA&RM?!%IX7NR;NPMH4@0E=C;48&/IW7:O/<C)ZUT,T:31/%,BR1NI5D89#
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M7+E<'(5ODS@$F/:21R2"0>JHH YK4/"MO%X5?1_#"6FC%98IX72V5TCD219
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,@$U8M[C6WG03Z=I\4)5M[+?.S!@7QA?* (($9SD'YFX^4;M6B@#%:Y\1^8
MNE:04VG).IR Y^? Q]GZ<1\Y_B;KM&Z-;SQ,Z,PT;24S&K(LFJ.&W%ERK8@(
M&%+G(+<J!T8LN]10!S\=WXJ./,T;1%^_G;JTIQ_=_P"78=><^GO4_P!H\0[D
M_P")7I.TMAC_ &E)D+N'(_<<G;DXXY &><C9HH RK:]U.25%FTCR4.W<WVE6
MVYZ\#K@8S[Y R &-A9[YK6VD-E$LSM'YT33\Q*0-V"%(8J<\< @=>U7:* *T
M[W@W^1!;O@G9OG*Y&!UPAQSD=^ #WP*S7.J^6&73K8OR2INR.-KD '9RVX("
M.  Q()VX;2HH S[B7555/LUG8R,44L)+MT ?/S 8B.0!G!XR>,#K4*7FL)$Y
MN-)MVD$>Y5MKS>"P(^7+HF.I(/3Y3G'%:U% %*.XO6\LO9*F<;P9@2N6(.,#
MG P>W7%4X]2U4K&7T*926C5Q]IB.T,I+D<\[2 .V<Y%;-% &%_:FLB"1O^$>
ME,@0%$%W%\S87()SP,EAGG[N<<@4]K[6RX$6BP8XW-)?!1R6Z80Y  4GIRV!
MG&:VJ* ,(:AKS,P70H%^X%,E^!SGY\X0X ZC&2>X6DDUC5H4/F^&KV:12V?L
MES;LK ;L;3(Z')P.H'WASP<;U% &,=4U(^9L\/WF%*XWSP N"1G&'/(&X\XS
MQSR<1S:KK$<=N4\.SRO)CS%6[A'E?*2<DD9^; &.O7CI6[10!@VNJZS)*RS^
M')H4"LRM]KB;) ) QGC.%'U/H,TJZKK!4;O#LX)0-C[7"<-@[EZ^H&#WSSMQ
M6[10!EW%_J"-%Y&D32*Q4N3/&I0';GC/)&6X''R]>14XO)S%*_\ 9MV&17*H
M6BS(5Q@#Y\9;)QD@<'..,W:* ,V'4;IY41M%U"-68 NSP84>IQ*3CZ FIK:Z
MGENI8I=/N(8U"E9G>,J^=V1@,2"-HSD8^9<$_-MN44 9JWNH-)QI3+&-I):=
M-Q!SG &1D?+U(!.[G !:5[F[_>F.P8A41D#2J"[%F#+QG& %.>^[':KM% &?
M]IU%DN/+T^)9$5O*\VXVK(=[!02JL5!4*Q.#C<!R0</-W<B*Y(TZ<R1*"BB2
M/$Q]%.[@>[!:NT4 5Q/*Q8"UE7#  NR@,-Q!(P3T W<XX('7($4-W<RF#.G3
MPAV7S/-DCS&#&6S\K-DAL(1ZG(R!DW:* (3-)A/]&F.Z0H1E/E S\Y^;H<#I
MD\CCKB0,WFLI3"!00V>IYR,>V!^=.HH B1Y6GD5H=L:_=DW [N!T'Y]?0=<\
M,,\@*_Z).<L03E. &"Y/S=""6]< YP< V** *0N[DRX_LZ<1[6RQDCSD;, #
M=T.YN21C8?458WREH\0_(V-V6&4X)Y'3K@<'O[5+10!5CFNY(F;[(L;AR LD
MO5?7*@\^WZU*[3A8MD<1)8>8#(1M&.2/EY.<<'%2T4 0SM<JR?9XH74LH<O*
M5(7G<0 IR1Q@<9R>1CE;EY8XP8(?.<NBE=P7"E@&;)] 2<=\8J6B@"NKW+0.
MWD1+)L!1&E/+8Z,0O SQD9]<=J?<-.J_Z/'%(WI)(4'4>BGMG\0!WR):* (8
M7N&$GF0HF)-J#S,[D_O'C@]>.>W//#;I[I2GV2&"4%EW^;,8\#<H)&%;)"ER
M!QDA1P"66Q10!1674_MT*M:68LS&IEE%TQD1\-E53R\, 0F"6!.3P,#<V_N-
M1B8BRT^*X^:,!GN/+&"ZAR?E)RJEFQSG:!QGC0HH K22W2PDK;(\OENP42X4
ML/NKDCOZXXQ4<$NH->,LUI;1V@9@L@N2TA QM.S9@9^;^+@ =<D"[10!GB;5
M#;HPLK02E6)1KM@%.X;1D1GJN2?0@ ;@=P1IM6#3;+*P*A7,1-XX+,&^0-^Z
M^4%>21G!X ;K6C10!G3R:L+A_(MK!H%&$#W#JSG(Y)"$+@9X^;.1R,<QR3ZX
M%7R].TUFXW!K]P!SSC]R<\?KQ[UJT4 9]U+JJ[OLEG8R_. OFW;IE.Y.(FP?
M;GZTT2:P(Y&-KI[2%UV(+EU 3:,Y;RSD[LXX'![$<Z5% &3:MKIOI/M46F+9
MF;*>7+(9!%M VG*@%MV6SP,87&?GJ#9XF.F!3-HR:CY.#)Y,K1"7$?.S<"5S
MYIQN!Y09."3NT4 4HDU%6M_-FM)5W?OBL+1G&'Y7YFYSY?![!CW $9FU;,6+
M*P(,):3-X_RR_+A1^ZY7EOFX/ ^7DXT:* *=C)?O$QOK:UADW858;AI05SU)
M*+@X[8_'O5A3+O8,B!-V 0Y)*[>N,=<Y&/3G/:I** *=VU^,&TBM6Q)R)967
M>FP]PIVG?CL1@'N<"*3^UBZ^6+!$\S<VXNQV!1\HZ<D[OFZ 8^5JT:* ,]&U
M5('WQV,\VU=F)'B4G"[@?E; SO(/I@>IIZ/J+O,KPVD*;7\J43-*<Y(4LFU>
M,8) ;@\<_>J[10!FR#6!: 1-IYNM\1)97"; 4\P8SG)'F[3GCY,AN<Y\9\6F
M,F1="#ND8 5IB(G'^L.<?O >PPFW');/'144 8T1\0F!%E325F,RLTBO(RB+
MSCN0+@980[0'W %R3M &#/"FL#3&2:;3SJ&Z3;*D+B+&\[ 4W9SLP"=WWLD9
M'%:5% %*%]1".)X;1G6(;'29E$DF.05*G8N<\Y8XJ"\?6O,A^QP:=Y>&\T2S
MOG.5V[<)W&\'/3Y3SR*U** *)?4QJ+@069L?+78WGL)-^7SD;,8QY6.<\OZ#
M-<S:[]JML66F"V(83_Z9(74_PE?W6#T (./O9S\N&UJ* ,;3I?$(M;==2M-)
M:Y!19Y+>ZD5&'\;JIC)'J$+'T+=S9:35=\96WL=GS!T,[YZKM(;9Z;\C'7'/
M6M"B@#)BDUV."R66VTRXFVQBZE6XDA7=M.]HTV.<;L8!;H3DY'-S3Y+Z1)?[
A1M[:!P^(Q!<-,&3 Y)*+@YW#'/ !SS@6J* "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image08.jpg
<TEXT>
begin 644 image08.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" (X O@# 2(  A$! Q$!_\0
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M8QM& #:HK#/ABP+,WVC6,L,'_B;W>/XN@\WC[Q_3^Z,'_",6 4C[1K&"P?\
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M[-(=^);6:2"1=_WMKHP9?08(P"0,9-:]E:1V<;I"T[!W,A\Z=Y3D]<%R2!Z
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MM\S$D2(XSM=2NT*N"=Y!'( KIJQ?&VERZUX/UG3K8[;JYM)8X&X^27:=C#)
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MQKB%7\P0[2X!WE=P7ZXYQUQS0!-4=N[R6\3RJ$=E!9020#CD<@'\P/H*DHH
M*;"7,2&9560J-RJVX ]P#@9'O@4ZB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.0IP 3D6:* "BBB@ HHHH RAH%@FL7.JQ)+'?W*QI-()6965""!L8E >,;@
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MCA?F*L<$ @=."#]#GI4E(Q(*X4G)P2.WO_GUHR=Q&TX !W=C[?Y]: %HHHH
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M.,G@#2H **** "BBLW04U..T1-8EBEG2*)&=$ WR!!YC;@<$%LX^1,8/&,4
M:5%%% !116=X@34)-+=='E$5[YD15R%.%\Q=_#<'Y-W'&?4=0 :-%5=*-T=-
MMCJ'-YL'G?($&_OA0S #/0;FP,9)/-6J "BBB@ HK&\0RZM#-I[Z3;"XB\]1
M<A2-ZH6 ) 9T!&W?GYL@E6 ?:4;7A#B)!,RM(%&YE7:">Y R<#VR: '4444
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MG^\.#Z_C5/3)=4_MG5X;^#_01*CV,ZE<&,Q(&0@'=N$@D.2 ,,/2@#5HHHH
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M%+ $CH2,]:MPW,$SND,T4CI]Y4<$KR5Y_%6'U4CM0!+112.RHI9R%51DDG
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M02"#5Z@ HIH+^:P*KY>T;6W<D\Y!&.!TYSSD],<KN4,%)&X@D#/) Z_S'YT
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MC>8K,SJH RS.K$,<<LI5CW)P,;5% $-G;BUMUB5B^"69RJJ68DDDA0!DDDG
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MY\TE@0<.,  DY!X!!H V**YW_A)D%Q-"\,"F*X,+/]KC9!\S  X)*NP4D*P
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MT8,050X^NXKN4UNT4 <Y)J]^]NTEN@R9IHT$FGW2GB)GCR-N0.,%NA/RK\Q
MK2TBZNKO[1)-&BVWG.L),<D4FU3M^9'4'J&(8<$;2,@YK1HH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%-21':14=6:-MK@')4X!P?0X(/T(H
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M3NYZ8]716B17+S))/E\[E:5F7)QT!) Z=L#DT 6**** "BBB@ HHHH ****
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M@GDD=0;>UENV#2*HV(.=W5@.>H!QCGL" ,US3CK.A7]BT^/.5EC>&66':0>
M6B=7QN&&VLN1D=S20:'%'J27C7%ZQA8M"GVVXVC,2QD.ID*2<(",K@$E@-S,
MQUJ* ,N'1+:+6+C4?.OY'GA\EH);R62W +%B1$S% 3D#.. ,# SFGIOA6TT^
M:VDBO];E^S^9M6XU6XF5MSAAN#.=VW&T9SP2#G-=!38E**0TC2'<3E@,@$Y
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MCP1Z?8PR&U>>26/S6=]YSA&!.Q41"2Q)8$=9I%X+NUB(CO%S"D@>ZA,3N#D
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M)V5?C5X'54@WO8ZB6?:#(0!#M!.,A?F;C."2>.*]!0%5 +%B!@L>I]^*\_\
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MXW0A9$<<HQ4-C(X/##D$CWJ:@ HHIL2E%(:1I#N)RP&0"<@< <#H.^!SD\T
M.KF;?Q.TL-J3'8>?<1ATCCNWE!)CB?&Y(B#S+C(SD;2,[B%Z:B@#+M]3>6?Y
MHH8K=9I('>24A@P950 ;=IW%NFX'IU)(%K3-0MM3M!<V3L\)8J&:-DY!P>&
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M\O &#)_$?NK_ 'CMCLWD;4+=M2AMH-0>&;:D$SR#RUD7G<54'(,9P0"I) W
MDUHO/$DT<+RHLL@)1"P#,!C.!WQD?G7 Z]\5? F@>,&TK5->MK;4TB*3C8Y5
M,895=PI7(RV 6XR1C+4 =[%)%-(YC?<8F,;8)P#P2/3/3Z<^]$5S!---%%-%
M)+ P65%<%HR0& 8=B00>>Q%<O_:=_KVCV.K^'#8K%=V]PUK+)$TCRJR9@(;
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MVXA7D4$Y*J[J,!B#LS:=I]SJ5M>7%I;37]GN:WFD0/);[QM;83R@8+@XQG%
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M4#*GU&01GZ@BG444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO)D>/+@D97AT!4J>K\ACD!Z ,+Q_X=\$W7PUUB.XBT2#['<721"ZOV5(YQ(
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M41?J690/<T 6**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPOKO]KW%Q%)=637$,$,TEK C[H1*79&+MC<K(%Q\JG*L3UVKT- 'F6CQ&/\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 -AC2&)(H46.-%"JBC 4#H
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M7Z,<8H KZA*[?V;/;K=LOFF0Q1Q[2X\F3"N&*[1G'WOXMH..HLK<R&1U^R7
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MH&"+_LJ*T** ,JSTRY@\2:EJ,FH3SVUW##'':2!=EN8]^=F #AM^3NW'/<
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M>(9)2<,V<8B;@;CR.P)&A0!XI]M^(;7-^9-$\5"UN(W6%DN-.WQ1NC G;Y@
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MW[OG!->PZ5I:64US=2R&YO[HJ9[AE )5<[8U'\,:[FVKDXW,22S,Q\W^#O\
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ML4DB1+'$A;RO-)3'F))N&W[N,$;>_HH PUT^'3K+2+/3++3M/2.1A'#%"3%
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M\9?A7=&ZMT:*35(Q;L6\R7=:9W* ,87;SDC[RXSG@ ]+HHHH **** "BBB@
MHHHH **** "BBB@ I'4.I4YP1@X.#^8I:* "BBB@ HHHH **** "BBB@ HHH
MH *AOI9(+*XF@A,\L<;.D0.#(P&0N>V>E34C@LI 8J2,!AU'OS0!@6OB"XN-
M0M81I,ZVL]O#<&X$\<GE"3<-K*C,<A@HR,H0Q(8A6ILNM6/]O6)ENUA86DV^
M%G4D,?(< X)!;:<C&<C.#4=CX'T*RT73M+AM2;;3X5AMO,<R-%M.X.I;.UPV
M&WK@Y5>> *\I\7^-/%6C>%-&TYK>#2KC4[B*SMUW-;O!;OM=$,LO!F6*-XY"
M"H#S(58%30!375;(?&#Q\XN-)FM+S5O#RB2X+2IA8F)*-&V5D#( AY&_:",-
MD>FZUK,OBKP/=WGPY&G:S<37B0@:@\J6ZE)420LO!*J%)*C 89(#9VM\Y>,/
M&$OA7QEXLOWTPZG!%JVARS&6](:*>..2<1;FA$C@;9$#-M9?+3=N&4K<M_VB
MM7\3V^H/:_#[[9;V$(N;EX+ULQ0*R-('81_<;8<CH1U# '(!Z%;6GQ;T]KP3
MZ%X$NXF60Q?9I+B,0CRD!5 02%;:!M&#N!)(&#6G!%\2!N:"R^'8*RX'EWEV
M O[[)7 CZY7'^^&..2M>-K\4O&MCH6E75I\,D@TVX:.UMR([AHKB&1;<11(H
M/.Y8D4'E6SC;]X-:U;XP^*=)$D-[\-+:U9=3P([KS L<TMPUQ&HW 9D9D+EU
M.UBJL N * /HB'PR;C7--UF?4]1MKFU@6*?3K:\$ELS[1G<[()'_ (.<KNV(
M67J#XM\1-3\0+IBVWB?X>Z:MFLK?8]0.L"%XQ(_EF0Q;B\DK#!(!8_. <Y(.
M!X:^/?B:Z\3W"CX?:7-X@2%X+]80UO<DQY.69@2L<>U@RMGDCD=*Z?2O%?A'
MQC8^'/$U[KGAOPWJMJMY"^FWLJS^7(\HD:XC\N2)HY&,18R#[WF%><@D [#2
M==US3Q>6'@[1-/?PK9>7_9MU%%<2)-&R.Q$>,AP&"@,IV_O!C@$BLNMW<'B;
MQ/;7&JV_A^[O9K6,:F]D^S$>G^?+(!("L9 #X\TX 1OO%2*G^'T2:5I=HNE^
M*5N]!74IRFH?VA'-_:%S+/DPLLF< Y95*RDLS;R.>=NPT.TU7QMXUCOEF<^?
M97$$A8;K:06^T/">J$<_BS=FP0#G/$7AW6/&^A+X<C\0ZK;!XGDCU![26*2"
M6W-NAC=_W1F63<[GY,;P2#A H]#F\*64NHZA>M)=++J*PB[6*ZFC1VC*X955
MQM)50IQU  .1N#&L>$M.U6XNKB9IH[BX4(\R;#(-H'E[7924\MQYB!2 )/GQ
MFMVW#+;Q"1G9PH#-)MW$XZG;QGZ<>E $E%%% !1110 4444 %%)M!8-SD CK
MQ^7X4(2R@E2I(R5/4>W% "T444 %%%% !1110 4444 %%%10M.9)Q/'$D:N!
M"R2%BZ;5Y8%1M.[<, MP <\X !+2;5#%@!N( )QR0.G\S^=+10 4444 %%%%
M !1110 4444 13(K20%E5BCEE)3<5.UAD'^$X)&?0D=Z?#M\I/+;<FT;6W;L
MCUSW^M0W5PL$ELK%OWLOE@+CD[6/(/)'';GN> 2)H8TAB2*%%CC10JHHP% Z
M #L* '4444 %%%% !1110!3U#2[#40PU"QM;H-"]N1/"LF8GVETY'W6V+D=#
MM&>@J9;2W1G9+>%6=M[$( 6;CD^_RKS[#TJ1Y$1HU=U5I&VH"<%C@G ]3@$_
M0&G4 16]M!;1JEM#%"BJ%"QH%  S@8';D_G4M%% !1110 4444 %%%% !111
M0 4444 %%4]2U*VTY8/M+D/<2>3!&JEGE?:S;5 ZG:K'V"DG@$U/;7,%U&9+
M6:*:-7>,M&X8!T8JZY'<,I4CL00>E $M%4;/5]/O=4U#3K6[AEOM/,8NX%;Y
MX=Z[DW#MD<BKU $+OB]B3R@=T;MYF1E<%>,=><]N/EYZBI555+%0 6.20.IZ
M?T%1.T8O8E+'S3&Y5?,P"N5R=N>>J\X.,]1GF:@ K@?&HC_X6C\.6:]LHI/.
MOU6VDME>:;-J<F.3:2@7'S8(#;ESG KOJ\T\9007OQQ^'7^EI'<Z?;:E<F H
MQ:17B2,8.-HP=QY.>.G- 'I=%%% !1110 4444 %%%% !1110 4444 %%%1R
MNRK)@$;5R&V[AGGL.3]/?B@"2BBB@ I/FW')&W P,<Y[\_E2T4 %%%% !111
M0 5@^.H$N?"M[%+<"VC)C+3MLQ%B13O/F I@8R=P(P#P>E;U% 'G5C9:GJ7A
MEYH;R>^.I*EM>VL4EL(XP\8C>X5VM$,C8*R,&4#@A5( 1IM2T3['K=S+(;&>
M2[<_Z5//;03PVWFI+Y'RVX+022ET<,SGYE.27)7OZ\Q\.:?XIAM;A-:BM6\J
M\N;JZ!CFEDO?,EN54#:ZQR)Y)ME5'SM ^8+Y:4 :#^*-;DMM8U33-#TFYTG3
M)[B+RGOVBNF:!Y%F;;Y112VW**6&X.&9ESBLKP7XGTGQQJP75X \][8S"*SN
M[ Q(L+&/S;9C*!YSKM1FV@J/,/8J3RFGZ7K^@>+O#OAJPU*%K)EN[VQO9X2&
M6^$,L9AE^=A*4C. 5;JK%PY -7_''AF?QA8VOB'Q-J<$#^%8;B]EM(4 ^QWB
MQ6\JQ2A@RS(-LC,WR;E:/: "20#"?P3I^H_%SQ+H]O;VUKI-GJ>B7<=OI]H#
M' %M[DLDD:+A0Y:3Y\@J9$;/&*]6L_"WAK[:]G=:-H]WK]M']H6YNK,2/(')
MQ('D+N>1M)+%LCL"N?+]<^#-S?V]F;"[M?"[^*(;2#7=-M+13#;S0Q>=FW",
M N)(<=3G<S;CT.QK?PC\1275M/'XVU&XMW5X;Z)Q*YE5X2AEVM*P9@X1P@VA
M.2@#!00#I+/X<V0=3>>$_"4BK$J1AE>;R?WQ9EBWI^Z0AY& 3 5B!\PYJW#X
M$LC:W4,OA#PE'OFEMT,*$;[)V4DO^[!\U@#D9(!P=QY%<7KWPCU_[*;^Y\>:
MU=7X+I(;.Q4&19MRS8B\S:&82GYSRBH@7 0"M&Z^$UW<++<W_B^^MK5[6-9X
M!%Y2_(@#/(5DQN."QVD(&)<#=AJ .@U7P7H]E)INDZ1X(T&]TQ_M=PZW=LAB
MAFY=%W$,4#.[ 81@J@@   'P6ST[4/)ETC5(O[$>'Q!-=P/#&(8W03NSS!VM
MV\Q$>"-$143F0%@%Q7K*?!_5)IHKNX\::B;V.\DN/.DLXMS S&4KA3M*LZQ'
M:<J%!4*N]JT/A[;>(]=\,V6HV?C:_%H&DMTAN=)ME;$,DD)W;2V22N20W)4$
M!02M %[P[I5O>_#&/1/%UK!'YSW43-)8+;QY%PXCFVA55';*.#A26;< #P-K
MPY&4\>>,&*HN\V; J<EOW1&3Z'C'T KQKQ_>>,;<:OX6U[6O#.L:=*;6V6X\
M0V)MDN)9(I"Z0^1T=2L;=RI=#N (KT_X266MSZ%=ZWXEN+)=3U>194_LPJUN
MMN@VPF/KD,GS DD[67.#F@#T&JLU_;P3^7--&IX'WLE3@GYO[HZ<G@D@=2,R
MPQ/'C?/++A%3YPHR1G+< <G//;@8 YSA7?A&PN]6U#4)Y;EI]0M$L+D94+)
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M%W':2<#DK@D<@$D L!N(!-7FNO.J?'_PH/M+!GT6]7R F1]^(Y)/ !P>F3E
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M"4<+$<]=I*R'T*IUR</\2EULXC:1B34_,*V.2,+,R,N]@6&552[,.NU3@%L
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M2,X)4;"WJ%X&?0BK5<XGC'1#>WT$.J6]VUI=):70MW5_L<KE42-P#G+2':
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M>F64=2 ;U<3XMT76+O5KRXMM3FL].N(+.+-M;)<21M#+-+(Q1ADA@8HQC?\
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M...]+10 4444 %%%% !1110 4444 %%%% !1110 C*KC# ,,@X(SR.12T44
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M/1-'X:2VN=>;7Y;2:6V-[)!Y,K;'("N,_,P  W\;QAN=V3T<L:2J%E174,&
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M<;JIS;ZHRG R&$<(X/7&"W Z\$CC(] ,B"58BZB1E+*F>2!C) ]!D?F*\_\
M&GR_%[X<-NL0674H\3,WG$&!&_= <?PC<3T'3KR >A4444 %%%% !1110 45
MSLFJZQ#XBDAGT^V70U<QI<QM/+<.PA$G^J6':JY#C=O() 4?,0*BDU;78E6*
M:RM%O_*EN?*1;B2(HIDVH9EB*JY'D\8)YD*JP R =/15?3YGN+.*25=LI7#C
M:R@,.#@, <9S@D<C!INK:A:Z1I5YJ6H2^396<+W$\FTMLC12S' !)P > ,T
M6J*\\T?QW-XPGBL/"-QIT6H10&?49)HGNX[ [MJ0L%:/,C8DX#<;&/(V[KUE
MXJUZT,?_  EGAE=-A>Z@M1=VM^ES"3*WEH<85P3(8UQM( D!)X. #J-1U*#3
MROGI<ON7</(MWF/WD7[J GJX[< $G !-(VIQQWEC:S6]ZDUVK,F+=Y$0J,LL
MDB I&?3<P#'A2QK+\8R:I#)H4VBZ;_:,R:D@EC-TUNL<312(TC$ A@H;.U@<
MXX^;;5:TL[V6XTZ(Z8(8+:^#R3"\DY5+79N4-AN9#L"G*LBER?F (!U=%%%
M!1110 45%<M.L8-K'%))O0%9)"@"%AO.0IY"Y(&.2 "5SD2T %%%% !1110
M4444 %%%% !1110 44T/F0J%;CJV, 'C\^O;C@TZ@ HHHH **** "FRJ74!9
M&C.X'*@9(!R1R#P>A[X/&#S3J* $902I.?E.1@X__72U#9/<26<+7L*07)4>
M;'')YBJW<*V 6&>A(!(Z@=*E^;<<D;<# QSGOS^5 "T444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !112?-N&"-N#D8YSVY_.@#*UO65TVYL[8?9_
M/NR5B^T2M$A8%1C<%;!)< 9ZD@#DBLNW\:V3Z;>7TZ?9H(;Y;*,W3&U\\,5
M=?/$>1RW3()1@I8UU5(RJXPP##(.",\CD4 9^BZB=3MA.ALY(6"LDEK=>>CJ
MR(ZD$ <$-D>V#T:M&BB@# L[E;;QA>Z>)U<W<7VXH874H5$46 _W7Z D##+N
M7(PP-;]<]I]J\?C;5[FXD<B:V@6UC=QM55W>844+W)3<VXDX0%5"(S]#0!S7
MCO3M,U>QT^PU2XGM9I[U/L-Q;,5N(;A5=U:([6PP57SD8V[\\9%96I>![6/1
M[F2ZO-7UF[59I7DOKLR-+N#$JD6^.W0]% VJF!AAR378:@\R?9O(W?-,JOA<
MC;WR<' _#K@9&<B2^MQ=V5Q;,Q19HVC+!58C(QG# J?H01Z@T <6[7L*3^'+
M75=5&I6T-NT5]%;VB(-T$BA40X5CNMW<H1\IE3'R#Y>YVJ6#$#< 0#CD ]?Y
M#\JXKQ?IOA+1=!O)_$<J:=I=R8X)Y%N)H!M#NT:J4<%#F1@2N,K\I^4 "]HO
MC[POK5Y9VNEZQ!<SWBEK955@)@-^2I(P1^ZE_%&'8T =11110 4444 %%%%
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M;=QYBSD8R!\J =OEX[BO3ZJR:;8RZE#J$EG;/?PH8XKEHE,J(>JJ^,@'N :
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M<)_K2O&6 (RVWY=W7A<Y"@4S2]*@T^R2V#SW065IA+=R&:0LS%LEFYXS@>@
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M(TBZ9=FV4^2A=F1I%"A2X5E3 &/W8/)8UUU% $=NKI;Q+*Y>15 9B02QQR>
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M8V,&!/S?,20,EL[AE3D$@@&1IGBBQ$EU_:?B/P[(GFL(1;3JA1#(X4/N<Y;
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MF5<R:EP0203Q&>@&?Q'OBM_PL'PQ_P!!/_R7E_\ B:/^%@^&/^@G_P"2\O\
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M.>1CO_+K0^L^(!C9X5E/R\YOX1@[1QUZ;LC/H >^!%_PL'PQ_P!!/_R7E_\
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MMUS[4^/5_$#>:6\,% I!7-_'EQG!QCC.#G!..#SG&8/^%@^&/^@G_P"2\O\
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MR<$, ,8M^01DYXQP,<\9_P#PL/0SG$'B'@@'_BG=0X).!_RP]01]10/B'H9
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M.S?NL(V&9<Q"/"G'(-6M9\-:QJ\:QW&D:O! UK+83P6^HV:K/:LVX0,3%D*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
**** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image09.jpg
<TEXT>
begin 644 image09.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" -? J # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZIHHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** .*^)GCVT\#+X?^THLCZKJ<-B%+8*1L?WDN!R0
MHQP <D@=\UV<TB0Q/+,ZQQHI9G8X"@=23V%?+WCCP[XD^(7B3QSKD.E)<Z;9
MK/HVG-_:+(]M) P+RK'CG<Z8(RO#=&QSZ#K/C/Q-XF^"\_B?1-/TC3[6XT>\
MNKA;FX>X>/9N 1 JJ"2BL<GHV 0<<@'8-XS2_P!6\%KH!@NM,U[[1,\TJM')
M]GCA+!T5MIY<Q Y!X;ISD=E7RI>ZGXD\&^*/#%O%J\.I-HGANUBL[4V,8+37
M$R1_9SR70F.$,7SD*AP/FP?19OB7K%E\/XM;$NF7UUJ.N#2;:Y\IH]/M<N4,
MID#$RP*4;$GREB>@Z  ]BN)H[:WEGG<)%$I=V/15 R35/P_K%AX@T:TU72)_
MM%A=IYD,NQDWKZX8 C\17C/QJO-=\#_##7IM7\;'5+C4K8V-O:S64$#%Y'16
M:(Q@'Y8S+D'=U7D$?,[P;\1I/#/ADQ7^C6EIHMAX7MM;L+2SF,LX@=F14D=@
MH9CM5F8*,%NYZ@'NE%>,6_Q \>W_ (DTO1K;0=&MKK6-/;4(%EE>7[!$LN \
MY5@'#*5 "[?F8<]0,2?XWZ[_ ,(9X(.C^'_[6\1^(H7&8@9$22)@LI\M#\QQ
MEMN]=H/S8H ^@JI1ZMITCLD=_:.ZJ695F4D ':2>>F>/KQ7G<?Q)E\.6_@_1
M_&IL%\6:M-Y-W!!.JK:H 3YLF"P!P8_ES@EFVD@9KFM83P'XL^"_C'Q1I'A?
M3(D\C43;WEQ91++)+AAYRLPR"7P1SG@ #( H ]QM+F"\M8;JSFBGMID62*6)
MPZ2(PR&4C@@@Y!%<%>?%*TL'0:EX:\4V2S7"VD#SV*@3RL75$3#G)8J,9Q]Y
M2<#)'5>#]"@\,^%M+T6T'[FQMTA!R3D@<GGU.3^->3?%KP_-X_\ C'X<\,+K
M-UI4&FZ3-K#R6;E)@6E6($'&,\8!SP-WKR >PZ!K.G^(-'MM4T>Y6ZL+A2T<
MJ@C."0000"""""" 000>:T*\5^']G9^%/BP/"G@_6[[5-$CT^>>_LIKOSX],
MF\U0N#_"S-ORA)8$LV #7M5 !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN:19ZII5PMS87<2S0RJ" RD9'!Y!]0<$'@\U=I%54&% 49)P!CD\F@!:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M54Y)R<+N"@C ![OI7Q*\(ZKXPN/"UAK,4FO0/)&]J8I$.^/.]0S*%8C!X!/
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M\7>(?%5EX!UI[G4KZ#Q7;>(+>/Q&+6]9([6RD1GB$!^8P0X>-=ZC<6#DEAU
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M'T5\T_$'6K6#Q1XJ7QGJWB;2DBT:W;PX(+B2WDF9XE\W 1L/,92JLI&T $G
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M-J;5ZL25QGZ] 2/*]6N]6U'P9X&-S=:E:AUUDS"_CN/),QN91'&[0E6$PVD
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MBB@"-8(D38L2*FXOM"@#<6W$_7/.?7FG31I-$\4R+)&ZE61AD,#U!'<4ZB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ]KHKP9?VI/ AN/+-IKZID#S3;1[>2.?]9GC.>G8XSQD?]J/P0LQB_L_Q#O
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MOH[3]#THZFUIK4LVHP>)+4:=J_VK4IW:6]M9(8$:)V4N5:ZPJL688#G&U2J
M'S_-J$^[3X+^UT^"T-K)I]NUYF6.TAE<SB0! 9 4^T%@QW'G&#C;6EK.L6>I
MZI%XE\1?8;G4-00N;>"T2%<F5D-Q((V(\SY78AQRQ0E70G.?<:VTVMZCXHLW
MTV*:"X*VUI,I$@5]^QU0?(PC 48)('R@JPS3]:M+BQL='T\^?;^(7EGO;WSI
M/*G6?S-J1R!F!5E6,NN1N)F.,[A@ T=:%E/XP36+FX2YN;IKF_2SMBK);P+
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MLM/"EG-$LR1O<>?(L8#,54L=OR9XQGT/7L[0?VH=8U:]^QIX:L!<R1D0 7+
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M%BI&#G:1D>X()!!(!W?AOX#_ !)L==M+V[BT:X,4L9+WET9,* 5P"/F  <G
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M@UT]<M\3U+>!=3 QTC/)QTD6NIH CN(EGMY8G5&612I61=RD$8P1W'M7Y^^
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MQB5OF'&/+^;/'(Q]=SPA+I1UJTDTOY995GN([9,%YX;B/[1NA8R*5C4/#&6
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MQT;D\^O)J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH Y;XG[1X%U/<"1B/H<<^8N*ZFN5^*/\ R(FI_P#;
M+_T:E=50!1UX1MH>HK/*(8C;2!Y2F\(NTY;;_%CKCO7PA\%KZ;1]-U'6+>-Y
M#8:M87,R18$CP10WD\B D'@B#G [9R #7W/XO8)X3UICG L9R< D_P"K;L*^
M#?A'#<W>@^,+2QB$US<6?EQQ"(2-(QBF 51@DL<X '.XC'(% 'UUXBN8])^,
M7A[7[APFE:EI+Z1%>M)F#SWGCE13SA2R(^UL?,=HR>,>@6\:QW!6&T-HL3+
MK"-,31K'E=NTDJBEB!NV\J<#!!/@?PF\>:+<^"=+\'>/;_3]3ANXH+2V)7?O
M5R^R.903M*@0?-QCS8P?F#$>J:%X9T:_AAU+1]9UB?2+J!1;QV^K3+ D7EE
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MI6GV6I7ES9BSN//62  E@5(*\\<\<^U=1X4T9?#OAG2M&CN);F/3[6.U264
M,RHH49  '0#_ .OUK5HH **** /%/&7PTU.3XJR^.=(M+>\N(I].FBM_,6-Y
M=F^*?+-TQ&4;WP.ZX/M=%% !7R5^U9JUKX@\>0Z$+G3F71-+>=5D$A=KJ65
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MO>!X!&JM'Y(!9ANRV<\9RO';;[FN>^)F_P#X5_J'G;?,VP[MO3/F)G'M76T
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M$_Q#\*>%M573?$.MVVGWK0K<+',&&Z-F900<8/*-QG(QSU%=57@GBZQUV?\
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M'X16,\JBPFU6:9XI,;&F01")N?X@9& ]V]: /4]'U_3-8O-3M=-NA-<:9/\
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MJ6B=74,5)4Y&0<$?4$$'W%.H **** "BBB@ HHHH **** $=E12SD*JC)).
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M*_,)D*-%)),$=D7Y]W";2@Z,W4LM>Z?#R"2'XP?%38NVR:;3650 %\TVN9"
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MQ%XRO;/PW<27%YXBO=/@NO*E1IXM0M[F, D*?EB.QRN,@R8.#6Y>M>:!X?\
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M#Y/Q /1X?C#X+3P')XKM[F;^QDO/LC[+<JXG8!R-G'/S9)]R:UM:^)?AG1O
M=CXOOKQUT>]$?V<K&3)(SC(4+Z@!B1VVFOFKPYX(\5001:3<>&=1DTO[!#K[
M0RV[)$MW!93Q"%5VE?.D=XBV</\ *"02!75:/X2\::]_PK33XM%AM++PSIHN
M[@ZO&\4,T\AP(2@4[F554].-SY(/! /I;3[VWU'3[:^L95GM+F)9H95Z.C %
M6'L00:Y&#XF^';CQ=-X;M6O[C48+H6<K16<C0QR;<X:3&T=".3U!^M8W[/\
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MNO)X#21W"L<#*R$<C!.[J?B+3--N8X[R\5 83<.PC9UBB'_+61U!6./AOF?
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M*HR>W7T /0Z*AL9VNK*WGDMYK9Y8U=H)MN^(D9VMM)&1T."1D<$U-0 4444
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MN<9YJ]10 4444 %0WUK!?65Q:7<8EMKB-HI4/1E88(_$&IJ* //;_P >>#_
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M ^>9 (\$X'S9QUKY]\#^#;35+KX61WOA'4;:QT[3;V+4+?4; K";HQ0JSNC
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MG\8?$*STG1WBLKSPA':61CC @+ .BQ)@84C& H&>,\9%<3XRM/$'BV.QN_\
MA']5T"SMO"4]G)<:SY=I$LFY4(+%OD!/ W[2PY"[<F@#Z(\/Z[X5O;F7_A'M
M6T6YGOIGE<65U%(T\B(@=OE)W$+Y>?0;<]JK?%C_ ))9XR_[ MY_Z(>O _A5
M%%>?%KX>7=AX?FT%K?P])#=Q2P21&X\N/890J9^4R.0'F(W;?[VS/T)\2!"?
MAWXH%VRK;G2KKS6968!?);)(4@D8[ @^E %WPG_R*NC?]>4/_H K5K*\)_\
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M_39?&'AOQYXZNM/\$7^KV.I7D,MO/_:5O%NV0(I_UC [<CC&<#C^&@#T>_\
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M ,KPSHD&@:2EG!)+<2%C)/=38,MS*?O2.0!EC^@  X %:M%% !1110 4444
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M<FMRB@##;PQ8ML'VG6 %&.-6NN1@CG]Y[YSUR!Z4A\,6A@\HWFLX"L W]J7
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY@TN_:>>!WYV3(5&PA2 1DG<"* /0:*Y?5_'_A;1]<.CZCK5M!J"*K2QG<1
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M#S2L%3<W.%R>2 3[4 <K<>#-7EUSXGW,5KI0&O)9FPFN4^T"8Q0!#'-$Q*;
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MM0%XMO=NT<=PFTJR;U5BK8Z'!&>HKD;GX>^*KNRM7U%-#O)1JE[J%W:)/+;
M^<%,;07*()8VC(*G&WS 3N/>O:** /$++X6^)+3^RK_4YM+\3ZTFDG3[R34+
MZXMP)%F>2.0.B,TH"R%#N"DA%.>2!K7?@?Q-::/+8Z.N@/\ VEX>31KXRL\<
M=O*GG$2QIL<.A-Q("K8_A/3(KUFB@#B)?"E]_P *3/A'S(&U,>'_ .RPZNPB
M,PM_+SNP#MW>W3MVK UKP#XA2[\;0:)<Z9/IOBX!;F2]DD2:R#1B*38%5A+\
MF2H)3!P#N%>K44 <SX.T&[T;4_%-S=O;^7JNJ&]@B@SM1/)BCRV0#O8QDGDC
MIC&373444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% 'CNC>&_%EY=:S<>(](6/5M:6>V_M.'5BYTFV=
M=JI;H5X(QO.W;N;DGH%JZ#\'+OP[XMMAIFN:K/H,.A7=A$+J6(^7)(XVQE50
M$QX)?CG>@.<'%>V44 >>>%='\3W&J^'+CQ#:66FV^AV,ML8K>Y\\W4S!$$@.
MT;4"JQP><MCG&:D^*WAC6M5.D:WX.E@B\1Z2\HB\Y]B30RQE)(R<'G.UAGC*
M^N"._HH \XU/PYJ_AB3PO>^$].@UB/1-*GTO^SWF6W+!EB*R1NP.&+0*IW$\
M-GUSQ^I?#;Q-?:5JXD2**\U+1-461(;O?&EU<WHN4@&['&TE-PPH.XX^;GW>
MB@#Q/4/!?C"YO?/TNRL=$U.6ULPFJ6=\T6R2%=K+=0 -'<@<E#L& 57(QD=[
MX\T&^UF[\(36202/IFM17MPSMLQ$(I58KUYRZ\?K77T4 >9>$_".M:+X0^'.
MGSPVTEWH5Z7O D_RB,V]S#N4D<G]\IQCU'O6UX\T?6YM;\.:_P"'-ES<Z1),
MLNG2S>2EU%,@5COP<.A56''3<,\\]G10!P7A/1O$-EKGB+Q-JR127^M2V4*:
M8MT7CL;:(E3MD(Y.)))2H4 MD _,6K%\6^%M?U.^\065SX=T'Q'97S&73;[5
M)U4Z>6C">64,3':C>8X*\_/CC)(]7HH R?#\&H:?96&G7SF\%M8PQR:@\N7G
MF4;7++CO@-G)R2>F.=:BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG#?++(PD;&X;@(E 89& #['E\>:?;W"0W=UI$);S8B[7Q"BX280F+)C&3O9
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MS KH64[!)$6YX#'^Z:PK#]J71+NXE@'AO4_,CC>3Y)X2"$!9^2P'"*Q&,Y(
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M\4MY) )G7=#'$7*!MOWRP(SC&,<>G55ROQ8_Y)9XR_[ MY_Z(>@#H=,NUO\
M3;2\12BW$*3!3U 8 X_6K-97A/\ Y%71O^O*'_T 5JT %%%% !1110 4444
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M-<0Q;L GY"&P>078')R3W- 'R1JWP#\2^$]/U'_A$?$5CK5BN9M0T^2%8)V
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M/I6EF%M.D(0QK: [L1F2+:P)'+D@J<Y^L/B/\1;'P-J>B6E_!+(=4\WRRFT
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M% D=P>RXC>3'3:ISQFNL\!Z%%X9\(Z;HUL\SV]G&8XC-CS-FXE0^ !N (!P
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M*NC?]>4/_H K5K*\)_\ (JZ-_P!>4/\ Z *U: "BBB@ HHHH **** "BBB@
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M&HV5NKF>Z@38I9@7&0 &)XZ]$?\ [Y;T-*;^U$[0+.CSJ%+11G>ZAF*!BHY
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M?9K6YA8 E3(B'>ZLK-$!)RNU5/+'C(!VG_"2Z()XH'U>PCN90I6"6=4E.5#
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M3\S' 5VZYKZUA<O$CM&T;,H)1L94^AP2,_0D5\X_M.V:'QEHAN!;RV^H:;)
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M!7Y;LJJJ%QP?P&WF6QL->U9?[4M=>\*7L%]#'$TL.D/)'+$ID.-XN?WB_O&
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M<6(AOHM-URSL[O<8RRSQQW" @A@"1N&X@J?7D54\2Z#X.AO+G7/$EOID$]U
M=/FO+R01B2-P5,19B!R"1BOG/PCX@U?3+.;1?#5W<V)U;QQJ*F:PBA=V6*&)
MDB0W#B,;F*X#-E@"!NY5L_Q9JFO>*-:^&<?B+59Y1/KMWIJ3B&U<2J)HE68H
MA>!CB;81@CY&'S9R0#Z!@^'_ ,,=#U:TN(]*T.RU"WNH1 S2A'2X8YB4 M]\
MD94=3CBMN/X=>$8DTU(]!LE735D2T 4_N5=BSA>>Y9C^-?,VC:8M[\-OC =1
M\5*EQ9ZK/=Q&1H07N(I$<3 JP.Z5@(P0-H+C;N)(KZ?EUZ[L/!6GZJ--OM8N
MY(;=GM[)%\URX7<P!(7@$G&0.,<4 /T/P1X:T*[M+K2-&M+6XM+=K6"1$YBB
M9VD95ST!9V/_  (T[3]'\.:5XIO+JR@L;;7]23S)RK@33H#]XKG) /?%4/#O
MBW5-6U*RMKOPAK.EPSPR3/<79CV1%7950[6)W$+G\1UZUX?\2-,U&Y_:/U+5
M= :7^U]"T*+5[>%).+DQRHKPM@9 >-Y%QU)(['% 'LNWX='Q=+XF%UX=_P"$
M@@9[>2]%W'YB,$VLK?-PP08.>0,CI5S7]1\#^)](GL=:U+0-0T\!)I8Y;N)E
M4;L*Q^;CY@0#ZY%?(LNKZ7+\-+:>&)'CN/B#+>6_V]0H^SB&,LLNUL@'?'NV
MG''7@5W_ (^6VO?#=Q8 _#BYMX[ZR B\,8\^.(SJDGG*"<1DF(9&.2H.>* /
M:$\,?#3P[H=Y:M:^'K'2M8C#3I/*BQ7*Q98-\QP=F[.1TX/'%=+IEKX>\(6=
MCI%@NG:1!/(4M;566+SI.I"@\NW<]37Q5XPA=?#>I:;<PM./ N_28Y;@[\3R
MZ@SQR $@.IAC=,,F!@<'(V^B?%R^U#QW\5-?AT+3]3U>#PO8&VLVTZ)7^RZB
MS!O,.6!&#&RDC)S$,*>I /JVLK2/$>AZS<S6^CZSIM_<0J&EBM;I)6C!Z%@I
M) ^M<WI?BEO''PAGU[0(2EW>Z;,8K<-YACN C+Y>1@MAQCL3QTS7AOP/\1FQ
MUBQCL]$TGQ#?Q^&8[F&;18Q%-:!?D:TF).&=BGF$M@[Y#C*E, 'TUK.NZ3H:
MPMK6J6&G+,VR(W=PD(D;T7<1D^PJ/5/$>AZ3%:RZKK.FV4=W_P >[W-TD0FZ
M?<+$;NHZ>HKPKXM^-?#C06$OC7PM]B\8[I[32K6^N@Z6\<@$;74VPE!'NW8.
M')V97N5\^NK?2-"8VNHZG:W^D?\ " 7=OI%VZD6[WI9]XB9A]\LLN,X)^4#^
M$4 ?5^K>+O#>CM NK^(='L&GC$T0NKV.(R(>C+N89'N.*UK*[MKZUCN;&XAN
M;:0926%PZ,/8C@U\Q?#>QUR/QSX4M;2TL&U!? 41>#5@X0)]N)'0$@CY"..,
M5[A\(O!K>!O!-OI5PUNUZ\TMU=&V+^2))&)VQJQ^5%&U0 !G;G )- '9T444
M %<E\706^%/C$ 9_XD]V?O%?^6+>G\N_2NMKD?B^&/PI\8[<Y_LBZ/'IY39[
MC_/8]" =#H;RR:+8/<;C,UO&9-S!CNVC.2."<U=JEH:0Q:+81VOF_9UMXUC\
MT8?:%&-WOCK7-^,+NXUUY_"WAZ]FMKZ52+Z_MFYTZ,J"/F!&)F#+M7K@EN@&
M0"3X>-\GB*&WB:/2X-8GBL06W H GF[>3A1<&X4#C 7&!BNMJMIEA:Z7IUM8
M:? EO9VT:Q0Q(,*B@8 %6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** .%^([L?$GP]@1F4MKID_=/B0A;.YSA>Z8
M/S'/ /0YKNJX'QTS#XD_#503M-]>DC/!(LIL?S/YUWU !5+5M6T[1[=;C5[^
MTL(&8JLEU,L2DA2Q&6(&=JL?HI/:KM>4?'BVEN+[X?F#3[34)/\ A((U6"[8
M)&Y,,A 9O+<@?+GCT'RL<%0#T7^W]'_L[^T/[6T_[!YOD?:?M*>7YF[9LW9Q
MNW?+CKGCK6E7S#XW\&ZCX<T'7M5O[/3M*@UGQ#I3P:5ITADAMA&=K,&VH,N6
MR<*.GY.\8^//$.D>#_BO(->G@O++Q!':::TK /&C2!O+BX_N!C_N@T ?3E%?
M.OQ \5>*5C^(FO6'BZ+28/#UTFGV>F")"LK>7R[%ADLWFL5 _B09!VBNO^.6
MJW4?[.6K7Y</<W%A;+(Q&,^:\2.<#'9S[?AQ0!Z=8ZMIU^T0L+^TN3+"MS&(
M9E??$3@2#!Y4D8#=*H1>%O#]I_;<D6DV$(U@$ZD1$JBZ!# ^9V.0S9SUW,3R
M37A/B+6AX$^)=_>:*MM??V'\/(XK901Y9VW*!"V&SMP0V,@D=.H)BU*\\37_
M ( \:^'M4\0W8NH]%;6O/NGM6N'CV'S8?+BE;,$B@;6PI7<=P.Y00#UZ?P?\
M/M<TJQFDTS0[[3;*-HK9P4>&) =[*I!V@ @D^P/;-7/#_@'PAI-W::EH6CVE
ML\;>?!);,0@)B\K>%!VDE"1G'.2>IS7SYX&TZZB^)WPNLVUMX83X3MKUCY$*
MJZR.Q,&-H&& 1"QRY]<FO3OV6KN:3X>ZCITLLLL.CZQ<Z?;M*VYO*4(R@_3>
M10!W-E\/O"MC'IZ6FB6L*:>9S:JF0(O.39+CG^)>#FKBZ5X=T'PLFB-;Z?8Z
M#Y36HMI"J1,K [E.>I;+$YY.23GFL.;X@30Z7=WI\%^+W$%SY"P1V*--*NUF
M\U5W_<^0CKG+)Q\U<7^UL/,^#+-<!HC]MMV95.=O)R.H#8R?:@#U.^T_08=
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MC2Y\3*L&B>(VTE/#<EO%&+F .N4W<LLA7<=WS8\M^HR*Z&#Q5KMQX_N=:O\
MQ:FF:;9^)CH":!):22+*GE_+_JQN,C_.RL<KN  +#"T >[6=[:WRRM97,%PL
M4K02&&0.$D4X9#CHP/!'4&J\6BZ9%K4VL1V%LNJS1""2\\L>:T8QA-W7;D X
MZ<"OG#X9ZMJZ?$G5=#FO9=*TF?QGJ5P]] R@:A<IL/V3:<E%*J6)SSN"@YQF
MYI'C/Q==^,K#53K1AL=4UZ;2QITUY:) +<2&', 8F1Y8_P!VY^4 DKC<'(H
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MNW<<XZ9JK;^)=#N=<ET:WUC3I=7A&9+)+E&F3'7* YX[\<<>M<-^SKJ=W/\
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MEBN9X;>>[A,,]Q;I(5BED0@%79 "00#WP,UU= !1110 4444 %%%% !1110
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MJVEW9#1])U%D:X$LJSRW%H51P(S&VU"Q.TL2=NTX#9##J?"?_(JZ-_UY0_\
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MKU>UT*TT:W\10JK:@+6W2.XQ)AP7( + Y![\D9KYFO?$&I6/@'5M,L==N_\
MA$W\2VUA)JMG?RWGV.!D8W").T<1==P4@@%2&(R<AG]+_9\;3V^)7Q0&C:Q-
MK6GHVFQPWTLOG-(JQ2KC?_&%QM#<Y"@Y.<D ]5DU;PTOCB+3VEL#XJ:U(51&
M#<"WSN*E@,A,KG!.,X/I5RZ\.:'=WEQ=W6C:;-=7"HLTTEJC/*$960,Q&2%*
MJ1GH5!'2OGKQ58ZIHGC7XRZSX12[NM<AM+$)LNV)B2XC8RR>6F,LBH"BG.W
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M=*G%M=J8V78Y4-C)&#P>HK+^+'_)+/&7_8%O/_1#T :OA/\ Y%71O^O*'_T
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MM/.@55>[*VLJO]G8';F&(NDFXDAGR3NR??+OPWHMW/<SW&E63W%S;-9RR^2
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MDT)<1>=+(ZY4,I("NH*AAG;P1P1U,._RD\[;YFT;MO3/?'M0 ZBBB@ HHHH
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M5+C4'O=SG3,& 1+".1A'/?D#G(P  ?4ZZ78+8M9K8VHLV.3 (5\LG.?NXQU
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M"OQBL+:">#3[7Q+>0^7I\*%XK:,P [5;"D+&I)R02 3G/- 'LW@OQEX/\?\
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MIETOQ LC,/$:,#)N"2:>A 7.=O# ^H)Z^F#S70T4 <S_ &1XE\H+_P )0FX
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ***;#()8DD4,%=0P#*5.#Z@\@^QYH =1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %1V\*6]O%#$ L<:A% 4   8' P!^%24B*$4*,X P,G)_,T
M+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %(@*J 6+$#!8]3[\4M5]/
MN3>:?;7+0RP&:)9#%*I5TR =K \@C."* +%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5';AQ;Q"50KA0& <N <<_,0"?J1S4E% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %5K>[,PA(M[A/,#$[UV[,?WN>_:K-% %
M'^TE&GBZ^RWFXPF7R/(;S/N;MF.F[G&,]>*<]^L>_?;W0"2&,D0LV<)OW#;G
M((X&._'7BKE% $:R$W#Q>6X"JK>81\K9)X'N,<_451N=72%586>H2[D=U$=L
MQ)"H'QSC!.< '!+ BM*B@"..0O+*GENH0@;F'#<9XJO+?&+;FTNF^8*VU-VT
M8!W<'D#('&3G/& 35RB@"C_:2^9(AM;P;&92?(;!P5&0>X^?(QUVMZ&FW.IB
MWCMFDL[YO.E\HK' 7,?7YFVYPO'7GJ*T** ,:X\010L__$OU:1%&2Z64A'^K
M\S@8W'C"\#[WR]0<6VU-!<K"MO>-E5<N+=PJ[G" $D#GJ2!T49. 1F]10!E1
M:TCBTWV&I1FY4%0UJQV$MC#XR%(ZG/&*ECU2-UR;:^3&\D-;/D*I89Z<YV9
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M3)M+;3C</53U![BK%% $:2%X4D$;C< =A&&7/K].]/=@BECG &3@9/Y"EHH
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*;'!-;M%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image10.jpg
<TEXT>
begin 644 image10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" ): PX# 2(  A$! Q$!_\0
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M$^%]>T_Q+HT&IZ1.L]K,,@CJI[JP[,.XKPSQAS^U)H6%8XCB&>N/E?\ S^-
M&C-^S=X??2F7^VM7^WLO,Q\OR]WKL"@X]MV?>M#]FK4KS^R=<\.:@_F/HMX8
MD? 7"LS97&>,,K'T&[\O9S]VO"_V>F_XK3XB@ ?\?RY]L23XX_$T )\0P/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@#E/AC:ZS8>#M/L?$D4<=_:1^03'('#HO"-D=\8'X5U=& ** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FR2)%&SRNJ(H+,S'
M'4DTZN#^*2:NRZ;_ &9-;PVI$RRO< &-)BH\EW!1OE#!L\ 9(Y'! !V.GZE8
MZBC/I][;7:*=K-!*L@!]#@U;KS;P^NMK?::NLW^FZCKJW+;Y[!< 66SY@_
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M)($9 &_=[@0@X[<9.<9)SUNF6,.GV:06X;:O)9F+,Y[LS'DD]23UH MT444
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M%MIZ-NDE9"^YW3YD0# SD<YSD"@#T $'H:*Y'P=J5Q-=1PSO<207EFE];+.
M9+=#@&)V_B.3D,<GKGD9/74 %%%% !1D>HJKJ=XNGZ?<WCI)(EO$TK)$NYV"
MC)"CN>.!7F]GX@FUC5/L5O>:W;ZQ<H9H6^R?Z';$KO5&&,NH& 7Z,>A&<  ]
M2HK.\/ZC_:NC6=YMV^=&&*^A[]SQFM&@ HHHH ,XZT9KD/B;XC?PYH2RP-(D
MTS[%>.V%PP'?:A906/ &3@9R<@8./X6\8/>M:7L,]Y=:7=77]G,EZD*SQS[0
MRLOE?*4QD,#R"..A! /1Z* <BB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#D(JY;:3][(YR!GFNP'%<YX)*-;ZKM4AO[3N@YQ]X^8<'WXP/PKHZ "BBB@
MKF?%UJ]I:76K6-W-:WL<&PM'M99%!RH96!!P2<$<C=UP3735A>. 3X5U';MS
MY)QNZ4 6])TF/3Y[BX,]Q<W5P%$LT[Y)"YP !A5 W'A0!R:TJ!T%% !1110
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MJYO1_%NG:C81W5O!J8C<LNTZ?.Q5@Q4@[5(X((Z]JMMXALPN?)U/UXTRY_\
MC= &S16*/$=G@?N=4Y_ZAES_ /&Z:WB:R&?W&J\#/_(*NC_[3H W*S]6BNY)
M-/\ L;;42Y#3_-C,>QN/?G;Q5)O$UDO6#5OPTJZ/;/\ SSK-UKQ;!#-IGDIJ
M:+)>+'*&TNY&]3&YP,QYZ@'CTH Z\=**PO\ A)K+9N\C5L?]@JZ_^-TA\46(
M&3!J_?@:3==O^V= &]16%'XGL74L(-7 !Q\VDW0/Y&/VIW_"266T'R=5YZ?\
M2NY_^-T ;=4+&\BN+[4((D9)+658Y"0 ')16!&/9@.<=*I-XELU_Y8ZJ?II5
MR?\ VG4%KXDTHW-T+>#4//5QY^W2KD'=M&-W[OKMQ^% '1T5CIXAM&_Y8ZF/
MKIER/_:=*?$%H/\ ECJ7_@MN/_B* ->BL=?$-HPXAU/CUTRX'_M.E_M^TSS%
MJ7XZ=<#_ -DH NZH\L>G7+VP)F6-C& N[+ '''?GM3-$>YET:PDOU*W;01M,
MI&"'*C<./?-9>K>);>VTNZN(H;XR11-(HDL+A5)"DC)V<#BC1O$]O>:197,T
M%^LDT"2L$T^X(!902!\G(H Z&BLK^WK/G]UJ.!U/]G7'_P 10-?LCT34/_!?
M/_\ $4 :M%97]O6?_//4/_!?<?\ Q%)_PD%AZ7O3/_'C/_\ $4 27DEXNKZ?
M';C-JYD,[;<X 7Y1GMR?TK2%<Q?>++:VU73X%CNC%</(LCM:3 IM0D8!7GI6
ME_;]@ "3= 'N;2;'Y[: -6BLK_A(-/'5YQ];:4?^RTA\0Z:!DSR?]^)/_B:
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M]U348O"MO'!H4]Q&L]PF]9X@"1-)DC)'&1C_ !ZGHSK6L $'PU=''I<0\_\
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MCITL+3+MT^-LB9R0WEJ1@9Q7.W7A_3(;&.W@TBXU62:"6)[DVMMN,HRI8@[
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M^^CM<M]A\MM0.GF(V[<YNOL^[._WW8Q[9[UV#?=-8::M;+I?VI;4B/[?]DV
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M* "BBB@ HHHH Y[Q3QJ/AO '_(2[G'_+O-7EGQ7)'QD\/D9_Y UYT/I#/_\
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M@#O0!T]%9!\,Z(3_ ,@C3O\ P'3_  I;?PYI-O+'+!IME'+&<JZ0J&!^N,T
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MZ8=!7/>+PQ&DX Q_:5OG_OJ@"VOAO0\<Z-IO_@*G^%+_ ,(WH?\ T!M-_P#
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M9XDL9=2T>XM(&5'E &6Z8R,Y_#- &F!10.E% !1110 5S\(!\=7'K_9T>?\
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M?D@/XTG_  B7AWMH6DC_ +<X_P#XFHO#<7E:UXC54")]LCVX&!@6T(_IVXH
MGU37&M-633H=-O+N=X3./):%1M!P?OR*3@E<XS]X>M<1I>@>*I]=U>[L[AO#
MD,S#:9K>&Z>X!DE?D+(0FWS,8[YSFN^UC2UOS%,EQ<6MU!GRIX",KD8(((*L
M#QP0>@]*P_!^NZC?ZUJNGZD+=ULR/+FB0H7'F21_,"2,YC/3B@"K_P (YXR\
MO \;)N]?[(C_ /BZYWQ]I>MV6DV\OB#Q##J=F;E$\@V"6XW$'#%@QZ>F,?T]
M;KB_BN\D?AZV>%VC;[6BEQ@[0P92>0?7CWQWQ0!S'A?^S8_$&I$QV[V"V,WF
MQQ(NQE%O9%\@<9.3D?6O4-,E@GTFTFLTV6TD*/$NW;M0@$#';C'%<QJGAJST
MK0M9NHY+J>4V%Q&/-D!VJR L!P ,[$Y/]T5N>%?G\*Z/E@V;.$Y'0_(* *'P
MW(_X0G2\'CRV R>?O'K72Y'J*YS3?#$NF6,5G9:]JD=O""L:;+<[1G.,F+/Y
MU:_L>]SG_A(-2_[]6_\ \:H V<UA>'S_ ,3GQ(,_\OR'I_T[05)_9-[_ -!_
M4?\ OW;_ /QJI]%TH:8UY(UU/=37<HFDDF5 <A%0#Y5 QA!0 ZYEM4U6R2XC
M4W,GF"W<KG&%RV#VXJ^WW36!J[?\55H ..3/CC_IG6^?NT <=\+/^0-J_!7_
M (G>HX!/3_29*[+-<CI'A_6=&6^BTS5M.$%S>W%Z!<:<[LK2R-(1E9E! +8Z
M#I5W[-XF &[5M&/J1I<H_P#;B@#H<UR6HZ>U_P"++I5=5\F/3[CYN<[)K@D?
M_7JY]E\3]]7T;_P52_\ R163JVGWEM=6U_J-Y;W%U->6< ,%N845$D<@;6=L
MD^8W.?3C(H Z73+$VE]JDS.&^V7*S@ <J!#''@_]^\_C6E6#X>+'5O$6[I]O
M7'M_HL'^?QK>H *\^U'<?B;IV5^43( 0V?\ EUNCT_/]*]!K@-3R?B7IJ@,/
MWL9(]?\ 1KOG_/H?6@#OZXGXSPFX^&6O0J^QI(D4-CIF1:[:N%^.)Q\*/$1&
M0?(7&/\ ?6@#L[#FR@P,?(O'IQ4]5]/&+* ?["_RJQ0 4444 %84NE3-XW@U
M</'Y"6#VK+_$6:1&!^GRFMVN5F9_^%G6J;B$.DRG;D_,?.C[>W]: .JHHHH
M**** $;[IKFDTF]&BBV+(9O[5^UDE_\ EE]L\[TZ[.,?AFNE;[IS7&122_\
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M)L-YL>%RN .-O&.<_GZ+K-[-YBZ?II4:A,N\,PRL* @%S[\_*.Y]@<<3\/\
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M'3[)'VQ_"*/%P!BTO(S_ ,3&W_\ 0Q1X!!7P5H@(QBTC'WMW11W[_6E\7_\
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MW[>_MMK0K"U5W'BK1$5W"-%<EE#X5L"/&1W_ *9K='2@ HHHH **** ,W0[
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MU:0SPV\T<CP2PR2@%)$8JPYQD9!P<<UH?VMI^/\ C]M?^_R_XT 7J*A:ZA6
M3-)&L1&0[, #GIS2I<Q/!YR21M%C.\,"OYT 8OB<9U#PYSC_ (F/<\?ZB;KZ
M^WO@]JYOQU<V2^(?L[:]=6]__9%TZZ2/]5=)M(WGCJ"/7/X9SM>);^UDOO#Q
MCNH.-0R2)!P/(FS7,>/?%TD'C'3O#%K:VT\>KV%POG[LNKD%54#I@G&<^N>
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MWD9V7CT+$8K1H **** "L3QH"?#-^!U\O'ZBMNL_7;:&\TN>VN9?)BF787R
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MS^#[_P"VLI$<<UW);94<M@LJJ<9Y^M=#H'B31$U3Q 9=:TP+)?*R9NDY7[-
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M!N_X_P"\Z_\ 7S)6Y6%X,_Y!-QU_Y"%[U_Z^I:W: "BBB@ HHHH ****  G
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MUH UZ*RKC7K&VT9-5F-RMDZ*X/V:4N V,9C"[QUY!''?%9*?$#P\\@03WP)
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M:)))=3+;JK64\0+%3U(F/&%]#5"^\,_$2RN$@EU/P_),R^<4MTO6P@89)P<
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MQVT08)O)N)#DGLJK\S$ X"G )P" =;X@N81$ME):+?RW89$M64,L@QSOSP%
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M>3\:[G1KYV\*7PU"+5+BVFDW&>SNUFBCQ@ *[SLS9P-RDD$DC')SBW7AK7M
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MJ^US@=<L,YZGJ:]#'2O!/#.C6VA^,/#\":+I>GM-=7JK)9S22%ECGV[#O1<
M%QC&<X).#7O2_='TH &) ..M1P2.Z RH$;^[NS4A&:H6&DVMC,TELI4LH3'8
M =!0!H5Y]%-;P>,_%KZA&LUJJ6A:,J'S\HQP>^>?RKT&O,=2Y\0>-5VD@16A
M)P,8VKQ0!Z<.E07W_'E/GIL;^53BHKK_ (]I?]T]\4 <O\*!M\ Z6.G^M_\
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M!&K1IM.3N(XP.<GIC-%MX3T*ZL;87VGZ?JBK$J1S7%M'+F,* H!(/&/YGUH
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M]I5C<O=B>"UB@<+ 6&Y4 .".V0>?:@#O_&04^$M:#DA?L4V2!D_ZMJF\,_\
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MD^ (BW#F]O"WU^T2?TQ7?4 %%%% "/TKS3P7>W*?$[Q#8;Q]D?S9RFT??#H
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MX+_Y!%P>QU"](_\  J6MZL+P7_R!YLG)^WWO_I3+6[0 4444 %%%% !1110
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MA9(/$=KJ^L'5K5IU2^W@$!LE(@=J@'C(7ZG/-=]\2QGP!XC!8IG3K@;@,_\
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M*Q"\Y(.'49"9Q]ZL*/X??$H1MMNYDP"J@36ZG!\S=@@<?ZV3G/\ &:C;PO\
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M:WM&^]!$?J@I/L=F5Q]F@(/./+'- "VM[;7T'F6=Q%/'G&^)PPR/<5R<+_\
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M>W->>>%[QM%U3XF7]NBRO:.UP$&2&8><P']/_P!5>JZ?*T]A;3. K21JY"]
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M8TSQ!9:/!%)J%I'RSK%+:M(T*,Q*QEA( =JD+T_AK4^SZ]_T$M/Z_P#/@_\
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MQM:2[9&/'.0(SC\Z (_%4]C;>'=0FU>W^TV$<+-/#L#[TQR,'K]*U$P!@#
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MOVKD/A0"/ MB#G=YMP2",9_?R5UV?3[O\J %P<Y_2D[>HHSTQ^!HXYP.>XH
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MK(7'EF3][''M!Q]]U3/X;LU?K/URZM[.R$UW$98O-B3:%#?,TBJIP?0D'\*
M-"B@=** "BBB@ JE#J"R:S<:>(W#0V\4YD[$.TBX^H\O]:NUGP7%LVN75LD6
M+M+>*223:/F1FD"KGJ<%7./]KWH T**** "BBB@#@->^?Q_.@!.[2(Q@<Y_T
MGT[]:ZKPS<+=:2DJ)L'F2KM]Q(P/Z@UR'B)0?B!(6S^[TJ*1!GY0PN>":Z[P
MQ)!+I$;VB%(=\@ (QT=@3^)S0!K4'H:*&^Z: ,'P3_R V_Z_+O\ ]*)*WJP?
M!'_(!/).;N[//_7Q)6]0 4444 %%%% !1110 V5ML3MSP">*X/1Y;W7KN[:Y
M35+&=H8KFUNTDD2W7>,K&(\A79. VX')SP!@#OCR*QI/#\!$D<-S=V]I*Q:6
MUA<"-R>6[;ESWVD=_4T 9>B^+_MNGI--INHF4.\3F"V=T8HQ0LI[J2N1UX(J
M_P#\))%_T#M8Z?\ /A+_ (5M001P1)%"BQQHH5448"@<  >E/(!H IW6H);6
M27#PW,@;&$B@=W&?50,C'>A;]&T_[7Y5R%VEO+,#"3Z;,;L_A5S:*-HH XO6
M]>MY-4\/R&TU13'>N=K6,H+?Z/,.!MYZY[\ UP?Q.N/#MSXGGOI'U;^WX](>
M*WM#9RI'Y9=LRG*9XR1D\<@=>GJ7B!1_;OAH]Q=R8X!_Y=Y>_:N6^)G]MM'J
M@C_LQ= 32V:;.?M/G;_E(YP$ &?P.* #X4%?#_P]T6UO%N)7>(72FVM9)-JS
M,\BA@JD\ X)/I7<MJ$*V(NREUL('RBUD,AYQ_JPN[]*XWX';C\-]-\U]^)+@
M EL_*)GP,^PQ^%=YGD8Y3^]F@#'_ .$BL\'_ $?5LYP1_9=S_P#&Z8WB2Q7
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M22LJYQDA2<<UYXOCKPU%I=E;3ZWI<-S%JS2R1O?6ZO&/M+L=RE\KP?05ZX5
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M/TK3].61=/L;6U60Y=8(E0,?? YJDWA3P\QRVA:4Q]39QG^E &SD>M<]XVF
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MJG!/V6; /_?% '4U@^-5W:*BX)S>6G0X/_'Q'55/'OAMV0)?NQ<X7%K,<_\
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MNOWL\F^"'6+;Y?\ 4PRZ>W?&?FD)[C-2^ [.WN;767N8(96.KWJ[F4,2OFG
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M!FV4NK-<!;VULHX>[Q7#,P_ H/YUI444 %%%% !1110 4444 %%%% &%K_\
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MX]/0]Q@UU=%% !1110 5S?Q%!;P?>@;N7A'R]?\ 6I7255U3C3;K_KDW3Z4
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M8JW:9+&DJA9$5UR#AAGD'(/YT /'2BBB@ HHHH *P;'_ )'?5O\ L'V8Z_\
M32YK>J-8D69Y0BB1P%9@.2!G )]LG\S0!)1110 4444 -D^[6)X)S_PC5CD
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MU16*?$$0S_H6J'Z6$O\ \30WB" ?\NFJ'G_GPF_^)H VJ*QUU^W/_+OJ8/\
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M8TT\;=?_ / "]_\ B* .F+<55T88TFS!ZB%!T_V16(=5TUDVA-=&1VLKW/\
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MT3_H,:;_ .!2?XT :M%97_"2:'G_ )#&G?\ @2G^-'_"1Z)_T&=-_P# I/\
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MBBB@ K,U/3C>:AI5R)-HLIVE*X^]NB=,?^/Y_"M.B@ '2BBB@ HHHH ****
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8VBDV"G44 (!CI2T44 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image11.jpg
<TEXT>
begin 644 image11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" )" O\# 2(  A$! Q$!_\0
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M?HZKGDB\D./_ "'5E)-?Q\UOI.?3[1)_\16Q10!BO+XAPVVVTDD=!]IDY_\
M'*KFX\5=M.T?\;V3_P"-UT5% '/QW'BLN VGZ,JYY/VR0X_\AU*7\3LYVP:*
MJ@\9GE.?_'!6Y]*7- &&&\3?\\]%_P"_DO\ \32[O$V.(]&_[^2__$UMYIU
M&)$?$9?]ZFCJN/X7E/\ 05-C7/73/RDK5^E)GUH QW&O_P #Z4/JLA_K3=OB
M/_GKI'_?N3_XJMKK2T 8A7Q%_P ]=(_[]R__ !5,*>),\2Z-^,<O_P 56Z1F
MEH P&7Q/@XET7IQF*7_XJH(%\4>:=\^B'CM!*/\ V<UTIYJI V+E@?2@#-$?
MB9G7-SHR)CG_ $>5S_Z&*D,/B ];[2?_  !D_P#CU;-(QQCW- &.L&OCI?:5
M_P" 4G_QZG&+7O\ G^TK_P  I/\ X[6Q10!C>3X@[7VE?C8R?_'J:T'B+MJ&
MD?\ @#)_\>K;HH Y^.T\3;OWFK:61GMI[CC_ +_5-]EU[_H*:?\ ^ +?_':V
MN]!H QOLNO?]!.P_\ 6_^.T[[+KO?4K#_P  F_\ CM;%+F@#%^S:]_T$[#_P
M!;_X[2?9?$';5=/_ / !O_CM;G2DS0!@367B1\>7K6GIZ_\ $N8Y_P#(M$>G
M^(_^6FNV?3MI_?\ [^5T%&: ,,6&O]];M?\ P7__ &RE^PZ]_P!!NU_\ /\
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M#I&K?]#)>?\ @-!_\16]24 8/]D:O_T,MY_X"P?_ !%(='UCMXFO/_ 6W_\
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M=@'&=R@YZY ->D? [XCZYXL\9#2M56P^QPV,DD:PVPC*;6C  YX&#T]AZ46
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MHVCUF>%$MH%A15%L[<*H ZL30,]J/5<_WJGJNYY3_>%6* "D-+2&@!:2@44
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MO4-X,VDX/_/-OY4 .M/^/6+']P?RI\OW#GIBH[/_ (]8O]Q?Y5))Q&Q'!Q0
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MI,5GZ(YDMYRV.+F9?R<BM"@ K#F_Y'6V'_4/F_\ 1D5;E8<O_([6W_8/F_\
M1L5 &Y1BBEH 3%&*444 )12T@H **6DH ,4E+10!0ULE='OB#@B"0@_\!-6;
M6%8+=(X^%48%0:RI?2;U1U:!P/\ ODU<7[HH *0X!YIV::Q ZT ,J.6,/&P?
M)5A@@^E3@C%!Z4 <O<:;-:-NLY%FF4_*LQ( !X))'>M*#^UO+7<UCT[;Z9KE
MTNG);,B*PGNHX6!XQN/6MA1\H[\4"L8VJ#5/L$FPV>=IW9W],=JKZ;'JJVR&
M,V&,9Z25M:CQ87&?^>;?RJ#267[$F#UYP.U,+$2_VL1R;'_Q^J$@N[N^>WD\
M@30JK;EW8(;/'UXKH^-O%9$&W_A(K[;G?Y$6?IEO_KTKC)[6*:V@$2",XR26
M<DDGGTJ,W4POEM1'%O:,R9W'& <'M6F5!Z]JRY&7_A(K=>[6[G\F6@3+6;CN
ML7_?1_PJI?7LEHR^<L05AD'+'NH[#/5A6J16#XB!,UJ/=3_Y'AIH&,;4YB3Q
M !CCY923_P".UDVPGM6B8&(B/[J>7(<=ASMYQ79L@/6H3"I<AA\I%%PL<ZVL
M72EMR0'&,;4ER3_WS4@U2Z>%IL6IA5MA<,XYR!C&,YR<5O?9XRN,<=ACBL7R
M5^S3;%'_ "$T/_D9": L-&I3\G9%ST_UG_Q--_M*X'6*+&#GF3/_ *#70"%3
MSBD\KY@:+A8Y74)&NXU8A$:,G:V)#UQG^'V'Y4[2'OBGEV36K*H#EG+X8GFN
MFF@$JXR1]*YSP8V6O(V.<10'IW*FBXK&EG5^<-I_Y241C6 WSC3\8[&2M95I
M1UHN.QEG^U^WV#\WHSJP4_\ '@>/]NM3%,DQY;9Z8-%PL<BM_:(Z22W5J-IW
M&!Y2&W YV]/6M:#5;V:,.-+E4$9 +]>/I5_30&L+?@;3&O&*M]![4,+&%<:[
M]ED6.]A2UW(6#2RX'!QCI7'ZOJ,=W=6_E7-I,'N(^(I"Q^\/6O3&Z<UQOB:,
M?;;==IPT\9/&>_:@+'8Q?ZL?2G,@*\@$^XI%X4?2E9T7[[*OU.*0P"@'@<4I
M W<X_*HK>YAN8]]M-'-&&*[HV##(ZCBI6^\/>@!#R>*0\>^:D  -+Q0 S SS
M_*D9<MU_2I,C%5)-2LXKEX)+J%)D RC, 1GD=: )U/S>A^E3;:1>N:?0 T*!
M2>6N\O@;L8SCG%/I* (KB%9H3&WW3Z5(J[5 ]!BG44 %(:6B@ IO0TZB@!*6
MBB@!",U7O/\ CTG_ .N;?RJS4%[_ ,>D_P#US;^5 !:\6L/^X/Y4MQDPN!Z&
MDM1_HT7^X/Y5(P[=: "/.P9XX[T^D486EH **** "BBB@ I,<TM% !36ZTZD
MH 3K2YI:3'- #2<FJVI?\@^Z_P"N3?R-6:K:E_R#[G_KDW\J //-.\(C5K'2
M;QELG\F'RB)EEW?+*YX*N%';JIZ5JVWA&XM[/R#/8@)(9(<1S!5^4*,CS?FX
M5?RKFKJ?3AINF2WL6F%Y(&(>\LXY>!)(=NYG4C/( P1DY]:S?-L'CWFS\.M&
M[;4QI4#$'/ QYO)(Z8[9],4".@B^&T1$XN4TER3NB*Q3C#9!)8&7YN 1^/X5
MV%AX<TRWFTZZ>V@%]9H5CDBRBJ6W;L+D\$NQP<]?:O.;6/1/))N+7PX\H<(8
MTTRW1FW1$@H&DYPQ4G...,<U7F&F$?N+'0%!4O'(VCPE9N^%Q)V7DYH ]IW#
M/44;U]17C&GG2I(8YY['P^OF,5C1-+MU9CC VYE^;YB#COCWJ2S;1Y;BT,K^
M';>"Z.Y99-,M54+@DC/F$[LC'0X- ST/Q1HTVM%4$NG_ &81,NRXMS(V\]P0
MPP/UXZUBMH,6@Z981Q"UW/J-F',".H)\\G/S.W'S=/KZ\0V-AX2^T22WESX1
MN;((J!5MK="&/.2V<<@'CZ^E:&J:9HUG8:9<:)9Z?#'-J-G^]M(D42+YPQRH
MY% '9J/F'UJ6HA]ZI: "@]**0T 9V@_\>UQ_U]3_ /HQJTJC@4*K8&,L3^M/
MH 6L&7_D=[;'_0/F_P#1L5;O-8EUD>,-.QT-C<D_A)!_C0!N44E% "T4@I:
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M%&:* $JMJ7-A<_\ 7-OY59JM?#-E< =3&P_2@#R&ZD@BTC1Y)X1(4M)"=P)
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MBV\*1H5CP(T [-Z55U.34TC7,2QH3\[PREV^GW1@>_TJI;V-[>^;)=VT4ZL
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M_P!,U_E5C- "!QP"><4[/%-I0* %I:2EH **** "BDIN>: 'T4E+0 44E+0
MF.:AN/\ 42?[IJ4FHY_]3)_NG^5 '-_#88\'V?\ UTF_]'/73US7P\_Y%2V'
M_36?_P!'/72T %'%%** $444ZD(H 2L/Q@N=.M/;4+,_^3"5N YZ5B^+#_Q+
M[7_K_M/_ $>E &TOWA4M1C[]24 %(:6D- #5.<_6G4Q/O/\ 6GT %8-^[+XR
MTE0>&L[K(]?FAK>K!O\ _D<]'/\ TZ77_H4- &]1110 4444 %%% H ****
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M.,FJFD_\@^'_ '?ZFKE %+2?^/4K_=D<8_X$:NU2TI2GVI6[7#X^AP?ZU>H
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M5&K*>?QI^Y?44@ US>N>&7UBZ,LFKZC FQT6*%D"J&7!ZJ<],\YP>E:MY?\
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MPO!/7'&:L*W%&:9R#(XR4^9V_,T]E^7 )_.C.!5>_NS:QQD1F1I)!&%!QUH
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M33;J]&L7=A?202^7;Q3QR11&/[S2 @Y9NFP?G6@LTLD,;I$5W=5DX(K-A/\
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M_P _<_\ Z&:Z#.* %^N* #0&S2[J &A2#G]*=@^E&:-U "8/I6+XQ_Y $O\
MUU@_]&I6WFL3Q@<Z!-_UU@_]&I0!M+]ZI:C7D\5)0 4AI::PS0 Q,;Y,#G=S
M^0J2JEF?](O!Z2C_ - 2K= !6'JR$^)]#;C 6X4\<\JO^%;E8VJ?\C#HO_;;
M_P! % &S124M !1110 4444 )BBEI* $;Z"FY!'2G4C"@".0@+P *X[X28/@
M/3F&,%IB#_VV>NRD&1^-<=\(UQ\/M( ZE').<YS(U+J=,/\ =Y_XH_E([' *
MY %+STXI O!IU,YA,_2LS72?)MMN,_:$[?6M+/M5#52-ML6XQ<)_/B@!UK&
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M1:LD92SC@C8)'Y@D?J<<XX/TZUI11ZZV?-DM4QTVMU^OR4Q&G]GA'W88@/\
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MD\UTC)P6P!GDGL!6U2+13.<6C-%)0 IHI,44 +5.\#%>6_(5;ZU5O.4P1UH
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M)='_ +S_ /H9J]B@ I:2EH **0FD- #J*0_=HH *.]+36.* %HI%;/3D49-
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M<PXH KV__'W, 1G8A/YO5O!]169:W<1OIS*5B!1-H=@,\OSUJV+RT/2X@/\
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M](0!T/\ HLW6@#?P/2C ]*,4F/6@ (%)QBG#I2=* $P.P_6DP/[OZT[%(PH
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M-&/E )Z9^M7/[/L_^?2#_OVO^%.T\[K13[M_,U8Q[4 5O[/L^UI;_P#?M?\
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M['_OJL37/^0MX>X/_'Z_?_IVFK=Q6#XD8IJOAP\G-^P_.WF%(#;_ #_[ZH_
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MX&<XSQ^IH&71M'849'I0#[ 4N[Z4K@-)4]A65(D_]M1O*(_(\_\ =;1R1Y+
M[OQK7YQVJ"XB\R:U;@>7(6^OR,/ZT 3!E]!^=+E?049]A2@^RTP$##T%&1Z"
MG?\ ?-)D^BT@$)&>@I<CT%'/H*7/^[0 @*^@I<CT%'/^S^5+GZ4 )E?0497V
MIV?I06^E(#.T<C[/-P/^/F?_ -&-5_*^U4M&_P"/:;I_Q\S_ /HQJT,X'.*
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M?&? \F.__$RA_P *BMO$/BX1GSO!4KODG(OX5'L/_KUWW%''^119]RO;T_\
MGTOOE_\ )' 1:[XI2YFG_P"$)FS(%7;_ &C#VSSG\:BO/$OBX(A_X0V2W4,
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M?Y%* * %ROM2<?Y-+MHVT )P>WZT97_)IVVDQ_G% "9'89_&CCT_6C'-&*
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M"L.&T#A:!M/:F[%/>E"+ZT#%^7TH^7^Z:-@]:0HE A?E_NBD^7L*/+%&P>M
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ME+/;  LI S^^]ZO6^H7"6\2-HVH;E0 _-#U _P"NE:N&_O/_ )_"E 8=7?\
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M3\_G2YJD3J/>6U_[\G_XN@C4?^>UM_WY/_Q=%@+N31DU1QJ7_/:V_P"_!_\
MBZ/^)E_SVM/^_#?_ !=%@+]%4/\ B9?\]K3_ +\-_P#%TY?[0_BEMC](2/\
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M0!*"/>ER/>H/]([21_\ ?'_UZ/\ 2/[\7_?'_P!>@"<L.^:3(J']_P!Y(_\
MOG_Z]'[_ /OQ_P#?'_UZ )LCWI=PQ4.9>[I_WS_]>DQ/N_UB8Y_A_P#KT 3;
MU]Z7<*C'F<9=/?Y<?UI/WG]Y?^^?_KT 2[A1N'O42;\#<ZD]^*,2YXD7K_=H
M FR!2;A4#)/VG4?]L_\ Z]1^7=?\_*_]^O\ Z] %O>!2;ZK[+CO.I_[9C_&D
MV7'_ #\)_P!^Q_C0!:WCUI-P]:J^7<_\_"?]^O\ Z](8KK_GY3'_ %R_^O0
MW3R!)>Y_Y[G'_?*U;+5Q.JZ7<ZW+J%H-2%O#%+^]F$9!7*(VT$,.> <YP!ZY
MI]OIV]5O+#5+>YL9-D9>V7A"I8;AABO5SG&#W[4 =E&5"#J*=N7UKC]/:T\.
MP'3_ .W+>-HSO99D!?+'///7D8'7&*NMK5O&4$FO62ETWJ#&N67GD#.>Q_(^
ME '1[E]Z PKEI/$EA%"DLOB33TB?[K,B@'C.>3T]ZM)K5F(Y6?7+1O*2620I
MLPJQ8\PGD_=W+GZCUH WB1ZG\Z,CU/YU@7FO:=9L5N=:MXV5@A4[2=Q7<!_W
MSS]*DAUJQEFBB35X'EEQLC^7<V691@=?O*P^JGTH W,CL:3(]?UJ!HYR,+.!
M]4!J%H+[M>QC_M@/\: ))RN\DD+S@^_ IH"9.&7)[AC40MKT[LWL9Y_YX#T^
MM!M;W_G\BQW_ -''^-,"?"C:#)G.,_.U2J<-G=U]ZI_9KWM>Q _]<!_C2K;W
MW7[="/\ M@/\: +NT==S9_WC3P?4G\ZH"VOO^?V+\+<?XT?9[T'(O4_[\#_&
MD!CZ*1_PGGBG_KC9?^@R5TK;2,$G!]ZY3PXDL?CCQ3Y\HF8Q67.S;@;9.U=9
M^ H X:/X8^'1;6MNWV^2"UP;9'NWQ"XQM=<'AAC@_7U-9_BSPOX)TO2]-LM5
MTQC:QQ211+$26&0BM(P!W,P&/GY(R?6O2<^P_*D(R1T_*@#Q^WT'P+J#6\2V
M.IQ_;8A UP)V"[6<L%D96(R3(1SD]%X( '61?#/PS#.9(+>ZB5F5Y(DO)0DI
M5RZ;UW8;:Q)&>]=J !V%'Y4 87A?PKI'AC[5_8MM]G^U>690')#%%V@\]\=?
M4\UMRD>4_7H>]2?E^5,E_P!4_3H>U '.?#$AOA[X8(/73+;_ -%K75UR'PH9
MF^''ADMR?[/A&?H@']*Z^@ II'-.II.#0!GD?\3T?]>W_LU:&*S@V=>&?^?8
M_P#H=:.X8H ,>U8/C0B/1!(T1E"W=JQ11DM_I$? ]ZW=U8/C9//T$Q[G3==6
MHW(<$?OX^0?6@!]U90ZO=Z+J5K<!H[65I@5<[)4>)TQ@'!.64Y(XP<8R:J:U
MI7]OQZM:*42*>V6U,CJ65FRQ/ () SC@CJ>>*X<:KI$VZ:*+66(OVL'!OFB#
MS 2,VY5.&&$')!SGV-;<>LP066KM%9ZXHT@;9XDEQF3=Q''V8E=K9'&'7N<
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M_P :8="TMCEK5">N2S?XT 7&1][%1U]Z4><J@*@;U);_ .M5+^PM*_Y](_\
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MB3*$@@_.<YX_YZ/_ -]'UI=+GCU6QFGT^SL+BTN92TCQ,&65TPA)YY(V ?\
M 16A#:RI$H:"])  _P"/L^G^]4MCI$5I;K#'YT:*S%4BF=5 )) P#UYY]Z ,
MY]'@+QRG0=/,D<GFJ?+3ARV[=UZ[B6SZ\]:>=.4[?^)+994LR_(G!9MS'KW;
MD^I.:FU'2+Z69#8ZC+;Q@?,'9Y"3_P!]"J_]E:Q;1NT&I/+-A53=D@8*Y)W,
M1D@$=.IS0(M:78-80&+3[*RT^,G+)' %!. ,X5L= !] *N[-0//GVO\ WY;_
M .*KG6L_%K21,;^/RPV9(]B?,N0< @ CC(S4+Z!K$OEA[R[4[B9'2\=<_=Z
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M22\A>Z*K("R_:(TWCE3C[O;&"6QC-=]I>GKI]OY8N+B=R=SRW#[W<^I[=,=
M*N8I<T &/>FMC:>:=36'RGZ4 <S\,9/.\#:*X!'[C;@^Q(KK:X_X4DGP#HA/
M/[IO_0VKL* "D-+3&;!H H8_XGX_Z]C_ .AUHUF;LZ\#_P!.Q_\ 0Q6ANYZT
M /K'\6?\@E/^ONU_]'QUK;O0BL7Q<W_$G7_K[M?_ $HCH VQTI:9GZ4;OI0
M[\:*;NHR: 'T4W/O1F@!U%,S1F@!]%,S1F@!]%1[C2YH ?13-U&30 ^DIN31
MDT /HIF:,F@!6&13J9DT9- #Z2FY/I1D^E #Z2F[CZ4FX^E #Z*9N/I1D^E
M#S13"3Z49]OTH =2TS=[49]OTH ?1FF9]J ?:@!])29]J3.>U #Z2FY]OTHW
M>WZ4 9-]QXDTSG@PW''_ '[IFH7T^F^&[B^E@@CGAC9S$7PF0>.0#P>O3O3K
MTY\2:7Q_RQN/_:=17C6,GABX^T7\OV QMYEWN&X+GDYQ^'2@#C9OB''!-$D%
MOIT<) 1Q-/Y94AB-F-N!A>?QQQ4$?Q!O%M(IX;/2!;.QCRMPV=RJI8*H7G:"
MO?TZ5:N?^$8N?+FG\37YVPD%HY-F]<L=QVIR1_2H(5\'P,4/BF\*;=ZH]W@
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MU@[1C;]N?!^9CSW/WB,>@ KI1^-&?K18#FQX/MHYO,@OM7BPP8(MZS*,,&P
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M4ERZ&R=T+'YMYK0C;7[*Y"2Q,8(X$&WG.,F-QDE5/4'Y3]WMZ$EM&&4+8PJ
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M .O0!KYHS[5D_P!M _\ ,,U+_OQ_]>@ZT/\ H&:E_P!^/_KT :N:,UE'6O\
MJ&ZE_P!^/_KTG]M?]0S4O^_'_P!>@#6S2YK'?6R%XTO4V]A /\:1]<95R-)U
M1_80K_5J -G.:,XK#_M]_P#H":M_WY3_ .+I?[>?_H"ZM_WZ3_XJ@#;S2$X[
MFL;^W7Q_R!]5_P"_*?\ Q5)_;S@?\@;5O^_2?_%4 ;6?K1FL'_A(I,_\@'6O
M^_*?_%T#Q%(>?[!UK_ORG_Q= &]FC/UK#_X2"0_\P/6!_P!L4_\ BZE769VC
MWKHFJ'VQ$I_604 :^?K0:P?[>O?^A8UK_OJU_P#CU+_;MYC/_",ZS_WU;?\
MQZ@#<SS1GZUA?V]>_P#0L:U_WU:__'J3^WKS_H5]:_[ZM?\ X]0!OYH%8/\
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M1UW-X7U-/9IK;/\ Z-H Z'\**PO[:U(_\RUJ/_?ZW_\ CE*-9U+_ *%O4/\
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MHV8GS9!GTD(H\F/&/-D_[^&@+DN\4FX'TJ-88QTED_&0FFF&,G_6R?\ ?PT
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M+]W(^C'_ !I?LT)Z[C_P(_XT 2<>@I<CTJ+[- >N?^^C_C2K;Q9XS_WT?\:
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MT_6I:* &8/I2<^E244 ,P?2CGTI]% $?S>E'S>E244 1@'<#BI*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
*HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image12.jpg
<TEXT>
begin 644 image12.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *2!2L# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958151165744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Brooklyn ImmunoTherapeutics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000748592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-1103425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10355 Science Center Drive, Suite 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">582-1199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.005 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BTX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,468,597<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958150201392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 23,500,000<span></span>
</td>
<td class="nump">$ 16,985,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivable</a></td>
<td class="nump">835,000<span></span>
</td>
<td class="nump">684,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">1,097,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">25,135,000<span></span>
</td>
<td class="nump">18,766,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">308,000<span></span>
</td>
<td class="nump">670,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets - operating leases</a></td>
<td class="nump">1,093,000<span></span>
</td>
<td class="nump">2,567,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,044,000<span></span>
</td>
<td class="nump">2,044,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">5,990,000<span></span>
</td>
<td class="nump">5,990,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment in non-controlling interest</a></td>
<td class="nump">385,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Security deposits and other assets</a></td>
<td class="nump">421,000<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">35,376,000<span></span>
</td>
<td class="nump">31,525,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,106,000<span></span>
</td>
<td class="nump">1,755,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,384,000<span></span>
</td>
<td class="nump">1,249,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">149,000<span></span>
</td>
<td class="nump">426,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">247,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,684,000<span></span>
</td>
<td class="nump">3,677,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Warrant liabilities</a></td>
<td class="nump">13,315,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">1,018,000<span></span>
</td>
<td class="nump">2,297,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">48,000<span></span>
</td>
<td class="nump">48,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">18,065,000<span></span>
</td>
<td class="nump">6,022,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.005 par value, 100,000 shares authorized at March 31, 2022 and December 31, 2021; 57,452 and 52,021 issued and outstanding at March 31, 2022 and December 31, 2021, respectively</a></td>
<td class="nump">287,000<span></span>
</td>
<td class="nump">260,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">167,100,000<span></span>
</td>
<td class="nump">165,944,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(150,077,000)<span></span>
</td>
<td class="num">(140,702,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">17,311,000<span></span>
</td>
<td class="nump">25,503,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">35,376,000<span></span>
</td>
<td class="nump">31,525,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.005 par value, 1,000 shares authorized, 156 designated and outstanding of Series A convertible preferred stock at March 31, 2022 and December 31, 2021, $156 liquidation preference</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958151059616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred stock, liquidation preference</a></td>
<td class="nump">$ 156<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">57,452<span></span>
</td>
<td class="nump">52,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">57,452<span></span>
</td>
<td class="nump">52,021<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958149910192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 1,782<span></span>
</td>
<td class="nump">$ 1,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">4,514<span></span>
</td>
<td class="nump">1,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashMergerRelatedCosts', window );">Transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,765<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">6,296<span></span>
</td>
<td class="nump">8,921<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(6,296)<span></span>
</td>
<td class="num">(8,921)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>Other expenses, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on sale of NTN assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,598)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_WarrantLiabilitiesExpense', window );">Warrant liabilities expense</a></td>
<td class="num">(1,322)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossOnNonControllingInvestment', window );">Loss on non-controlling investment</a></td>
<td class="num">(615)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(1,142)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(3,079)<span></span>
</td>
<td class="num">(9,601)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(9,375)<span></span>
</td>
<td class="num">(18,522)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (9,375)<span></span>
</td>
<td class="num">$ (18,522)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (in dollars per share)</a></td>
<td class="num">$ (0.17)<span></span>
</td>
<td class="num">$ (0.67)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (in dollars per share)</a></td>
<td class="num">$ (0.17)<span></span>
</td>
<td class="num">$ (0.67)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding - basic (in shares)</a></td>
<td class="nump">53,626<span></span>
</td>
<td class="nump">27,799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding - diluted (in shares)</a></td>
<td class="nump">53,626<span></span>
</td>
<td class="nump">27,799<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossOnNonControllingInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss on non-controlling investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossOnNonControllingInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_WarrantLiabilitiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_WarrantLiabilitiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashMergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashMergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958146067936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Membership Equity [Member] </div>
<div>Class A [Member]</div>
</th>
<th class="th">
<div>Membership Equity [Member] </div>
<div>Class B [Member]</div>
</th>
<th class="th">
<div>Membership Equity [Member] </div>
<div>Class C [Member]</div>
</th>
<th class="th">
<div>Membership Equity [Member] </div>
<div>Common [Member]</div>
</th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th">
<div>Preferred Stock [Member] </div>
<div>Series A Preferred Stock [Member]</div>
</th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 23,202<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 198<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (18,141)<span></span>
</td>
<td class="nump">$ 7,659<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits', window );">Brooklyn rights offerings membership units</a></td>
<td class="nump">10,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity', window );">Elimination of Brooklyn's historical members' equity</a></td>
<td class="num">(33,702)<span></span>
</td>
<td class="num">(1,400)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(198)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">36,300<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueAcquisitions1', window );">Issuance of common stock for business combination</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">8,170<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesAcquisitions1', window );">Issuance of common stock for business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,514<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders', window );">Series A preferred stock retained in business combination</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders', window );">Series A preferred stock retained in business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PartnersCapitalAccountAcquisitions', window );">Issuance of common stock to Brooklyn members</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 195<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(195)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PartnersCapitalAccountUnitsAcquisitions', window );">Issuance of common stock to Brooklyn members (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,924<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock to Financial Advisor upon consummation of merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">5,760<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock to Financial Advisor upon consummation of merger (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,068<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">419<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,522)<span></span>
</td>
<td class="num">(18,522)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 208<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">50,453<span></span>
</td>
<td class="num">(36,663)<span></span>
</td>
<td class="nump">13,999<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,506<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 260<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">165,944<span></span>
</td>
<td class="num">(140,702)<span></span>
</td>
<td class="nump">25,503<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,021<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValuePrivateOffering', window );">Issuance of common stock in connection with private offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesPrivateOffering', window );">Issuance of common stock in connection with private offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of common stock from vested restricted stock units</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock from vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,183<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,375)<span></span>
</td>
<td class="num">(9,375)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 287<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 167,100<span></span>
</td>
<td class="num">$ (150,077)<span></span>
</td>
<td class="nump">$ 17,311<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,452<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease (increase) in additional paid in capital (APIC) for the increase in redemption of temporary equity as the result of a triggering event associated with the temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares Forfeiture of unvested restricted stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodSharesAcquisitions1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodSharesAcquisitions1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the shares of new stock issued of preferred stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodSharesPrivateOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been issued in private offering during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodSharesPrivateOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodValueAcquisitions1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodValueAcquisitions1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Forfeiture of unvested restricted stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued of preferred stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodValuePrivateOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been issued in private offering during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodValuePrivateOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to rights offering membership units during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalAccountAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in the different classes of partners' capital accounts during the year due to acquisitions. Partners include general, limited and preferred partners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 4.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalAccountAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalAccountUnitsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in the number of units for each class of partners' capital accounts during the year due to acquisitions.  Partners include general, limited and preferred partners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=66023778&amp;loc=d3e9334-128500<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=66023778&amp;loc=d3e9337-128500<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=66023778&amp;loc=d3e9298-128500<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 05<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=66006417&amp;loc=d3e8580-128490<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalAccountUnitsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958150315968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (9,375)<span></span>
</td>
<td class="num">$ (18,522)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,183<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-to-use asset</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashMergerRelatedCosts', window );">Transaction costs - shares to Financial Advisor</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on sale of NTN assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_GainLossOnDisposalOfFixedAssets', window );">Loss on disposal of fixed assets</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_GainOnTerminationOfLease', window );">Gain on lease termination</a></td>
<td class="num">(85)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_WarrantLiabilitiesExpense', window );">Warrant liabilities expense</a></td>
<td class="nump">1,322<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossOnNonControllingInvestment', window );">Loss on non-controlling investment</a></td>
<td class="nump">615<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivable</a></td>
<td class="num">(146)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets', window );">Security deposits and other non-current assets</a></td>
<td class="nump">66<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">486<span></span>
</td>
<td class="num">(766)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liability</a></td>
<td class="num">(103)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(202)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(5,432)<span></span>
</td>
<td class="num">(3,430)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows used in investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(46)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfAssetsInvestingActivities', window );">Purchase of NTN, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from the sale of NTN assets, net of cash disposed</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(46)<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows provided by financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock and warrants in connection with private offering</a></td>
<td class="nump">11,993<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from sale of members' equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PaymentsOfPaycheckProtectionProgramLoan', window );">Repayment of NTN's PPP loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(532)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">11,993<span></span>
</td>
<td class="nump">9,943<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">6,515<span></span>
</td>
<td class="nump">6,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">16,985<span></span>
</td>
<td class="nump">1,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">23,500<span></span>
</td>
<td class="nump">8,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_CashPaidDuringThePeriodForAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common stock for business combination</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger', window );">Series A preferred stock retained in business combination</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_CashPaidDuringThePeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_CashPaidDuringThePeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_GainLossOnDisposalOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of fixed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_GainLossOnDisposalOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_GainOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_GainOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in moneys or securities given as security deposits and also includes any other non-current assets which are not separately reported in during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossOnNonControllingInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss on non-controlling investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossOnNonControllingInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of preferred stock issued in a reverse merger transaction in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PaymentsOfPaycheckProtectionProgramLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for payment of paycheck protection program loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PaymentsOfPaycheckProtectionProgramLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_WarrantLiabilitiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_WarrantLiabilitiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashMergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashMergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions that are classified as investing activities in which assets, which may include one or more investments, are sold to third-party buyers. This element can be used by entities to aggregate proceeds from all asset sales that are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958148198576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
         </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></div>
              </td>

  </tr>


</table>

<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;">Description of Business</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Brooklyn ImmunoTherapeutics Inc., a Delaware corporation (&#8220;Brooklyn&#8221; or the &#8220;Company&#8221;), together with its subsidiaries including Brooklyn
              ImmunoTherapeutics LLC (&#8220;Brooklyn LLC&#8221;), Novellus, Inc. (&#8220;Novellus&#8221;) and Novellus Therapeutics, Ltd. (&#8220;Novellus, Ltd.&#8221;), is a biopharmaceutical company utilizing its mRNA technology platform, including mRNA-based cell reprogramming and gene
              editing technologies, to create next generation mRNA, gene editing and cell therapies, including iPSC therapies for multiple therapeutic indications. As used herein, the &#8220;Company&#8221; refers collectively to Brooklyn and its subsidiaries.</div>

<div><br/></div>

<div><span style="font-family: 'Times New Roman';"> </span></div>

<div><span style="font-family: 'Times New Roman';"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On August 12, 2020, Brooklyn (then known as &#8220;NTN Buzztime, Inc.&#8221;), Brooklyn LLC and BIT Merger Sub, Inc., a wholly owned subsidiary of
              Brooklyn (the &#8220;Merger Sub&#8221;), entered into an agreement and plan of merger and reorganization (the &#8220;Merger Agreement&#8221;) pursuant to which, among other matters, Merger Sub merged with and into Brooklyn LLC, with Brooklyn LLC continuing as a
              wholly owned subsidiary of Brooklyn and as the surviving company of the merger (the &#8220;Merger&#8221;). The Merger closed on March 25, 2021. After the Merger, Brooklyn changed its name from &#8220;NTN Buzztime, Inc.&#8221; to &#8220;Brooklyn ImmunoTherapeutics, Inc.&#8221;
              The Merger was accounted for as a reverse acquisition, in which Brooklyn LLC was deemed the acquiring company for accounting purposes.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 26, 2021, Brooklyn sold (the &#8220;Disposition&#8221;) its rights, title and interest in and to the assets relating to the business operated
              under the name &#8220;NTN Buzztime, Inc.&#8221; prior to the Merger to eGames.com Holdings LLC (&#8220;eGames.com&#8221;) in accordance with the terms of an asset purchase agreement dated September 18, 2020, as amended, between Brooklyn and eGames.com (the &#8220;Asset
              Purchase Agreement&#8221;). </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </span> </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On July 16, 2021, Brooklyn and its newly formed, wholly owned subsidiary Brooklyn Acquisition Sub, Inc. entered into an
          agreement and plan of acquisition (the &#8220;Acquisition Agreement&#8221;) with (a) Novellus LLC, (b) Novellus (the sole equity holder of Novellus, Ltd. and, prior to the closing under the Acquisition Agreement, a wholly owned subsidiary of Novellus, LLC),
          and (c) a seller representative (the &#8220;Acquisition&#8221;), pursuant to which Brooklyn acquired Novellus and its subsidiary, Novellus, Ltd. As part of the Acquisition, Brooklyn also acquired 25.0% of the total outstanding equity interests of NoveCite, Inc. (&#8220;NoveCite&#8221;), a corporation focused on developing an allogeneic mesenchymal stem cell product for patients with acute
          respiratory distress syndrome, including from COVID-19. </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;">Basis of Presentation</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </span> </div>

<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The






          accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial statements and with the instructions to
          Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the unaudited financial statements include all the
          normal recurring adjustments that are necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented.<br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">These












          condensed consolidated financial statements should be read together with the audited consolidated financial statements and notes thereto contained in Brooklyn&#8217;s Annual Report on Form 10-K/A for the year ended December 31, 2021 filed with the
          Securities and Exchange Commission (the &#8220;SEC&#8221;) on June 30, 2022 (the &#8220;10-K/A&#8221;). The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited financial statements contained in the 10-K/A, but does
          not include all of the information and footnotes required by GAAP for complete financial statements. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results to be anticipated for the
          entire year ending December 31, 2022, or any other period.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 36pt;"><span style="font-style: italic;">Reclassifi<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">cations</span></span>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-style: italic;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </span></span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Certain











          reclassifications have been made to Brooklyn&#8217;s prior years&#8217; financial statements to conform to the current year presentation. These reclassifications had no effect on Brooklyn&#8217;s previously reported results of operations or accumulated deficit.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958149074160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LIQUIDITY AND CAPITAL RESOURCES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LIQUIDITYANDCAPITALRESOURCESAbstract', window );"><strong>LIQUIDITY AND CAPITAL RESOURCES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LiquidityAndCapitalResourcesTextBlock', window );">LIQUIDITY AND CAPITAL RESOURCES</a></td>
<td class="text">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">LIQUIDITY AND CAPITAL RESOURCES</div>
              </td>

  </tr>


</table>

<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has incurred significant operating losses and has an accumulated deficit as a result of ongoing efforts to develop product candidates, including conducting clinical trials and providing general and
              administrative support for operations. As of March 31, 2022, the Company had a cash balance of approximately $23.5 million and an
              accumulated deficit of approximately $150.1 million. For the three months ended March 31, 2022, the Company incurred a net loss of
              $9.4 million, and the Company used cash in operating activities of $5.4</span><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                million.</span><br/>
            </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">On March 9, 2022, the Company consummated a private placement of common stock and warrants resulting in net proceeds of approximately $11
              million (See Note 10).</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">In connection with preparing the accompanying condensed consolidated financial statements as of and for the three months ended March 31, 2022, the Company&#8217;s management concluded that there is substantial doubt regarding the Company&#8217;s
              ability to continue as a going concern because it does not expect to have sufficient cash or working capital resources to fund operations for the twelve-month period subsequent to the issuance date of these financial statements. The Company
              will need to raise additional capital, which could be through the remaining availability under our equity line purchase agreement with Lincoln Park Capital Fund, LLC (the &#8220;Second Purchase Agreement&#8221;) (to the extent the Company is permitted to
              use such agreement) (see Note 10), public or private equity offerings, debt financings, corporate collaborations or other means. The Company may also seek governmental grants to support its clinical trials and preclinical trials. The Company
              currently has no arrangements for such capital and no assurances can be given that it will be able to raise such capital when needed, on acceptable terms, or at all.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> The accompanying condensed consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The
              accompanying condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may
              result from uncertainty related to the Company&#8217;s ability to continue as a going concern.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LIQUIDITYANDCAPITALRESOURCESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LIQUIDITYANDCAPITALRESOURCESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LiquidityAndCapitalResourcesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of liquidity and resource matters when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LiquidityAndCapitalResourcesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958151157200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</a></td>
<td class="text">
<div>
            <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 36pt;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">3)</div>
                  </td>

    <td style="align: left; vertical-align: top; width: auto;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</div>
                  </td>

  </tr>


</table>
          </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; text-indent: 27pt; margin-left: 9pt; font-variant: normal; text-transform: none;">Merger</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On August 12, 2020, Brooklyn, Brooklyn LLC and the Merger Sub
          entered into the Merger Agreement, and the Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which Brooklyn LLC was deemed the acquiring company for accounting purposes. Brooklyn LLC, as the accounting
          acquirer, recorded the assets acquired and liabilities assumed of Brooklyn in the Merger at their fair values as of the acquisition date.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Brooklyn LLC was determined to be the accounting acquirer
          based upon the terms of the Merger and other factors including that (i) Brooklyn LLC members, received common stock in the Merger that represented 96.35%
          of Brooklyn&#8217;s outstanding common stock on a fully diluted basis, (ii) all of the directors of Brooklyn immediately after the Merger were designated by Brooklyn LLC under the terms of the Merger Agreement and (iii) existing members of Brooklyn
          LLC&#8217;s management became the management of Brooklyn immediately after the Merger.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">At the closing of the Merger, all the outstanding membership
          interests of Brooklyn LLC converted into the right to receive an aggregate of approximately 39,992,000 shares of common stock, of
          which 1,068,000 shares were issued as compensation to Maxim Group LLC, Brooklyn LLC&#8217;s financial advisor (the &#8220;Financial Advisor&#8221;) for
          its services to Brooklyn LLC in connection with the Merger.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The purchase price of $8.2 million, which represents the consideration transferred in the Merger to stockholders of Brooklyn immediately before the Merger, was calculated
          based on the closing price of $5.40 per share for approximately 1,514,000 shares common stock that those stockholders owned on March 25, 2021 immediately prior to the Merger because that represented a more reliable measure of the fair
          value of consideration transferred in the Merger.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Under the acquisition method of accounting, the total
          purchase price has been allocated to the acquired tangible and intangible assets and assumed liabilities of Brooklyn based on their estimated fair values as of March 25, 2021, the Merger closing date. Because the consideration paid by Brooklyn
          LLC in the Merger is more than the estimated fair values of Brooklyn&#8217;s net assets deemed to be acquired, goodwill is equal to the difference of approximately $8.6 million, which has been calculated using the fair values of the net assets of Brooklyn as of March 25, 2021.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The allocation of the purchase price to the tangible and
          intangible assets acquired and liabilities deemed to be assumed from Brooklyn, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                <div style="text-align: left;">&#160;</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                <div style="text-align: center; font-weight: bold;">Historical</div>
                <div style="text-align: center; font-weight: bold;">Balance</div>
                <div style="text-align: center; font-weight: bold;">Sheet of</div>
                <div style="text-align: center; font-weight: bold;">Brooklyn at</div>
                <div style="text-align: center; font-weight: bold;">March 25, 2021</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                <div style="text-align: center; font-weight: bold;">Fair Value</div>
                <div style="text-align: center; font-weight: bold;">Adjustment</div>
                <div style="text-align: center; font-weight: bold;">to Brooklyn</div>
                <div style="text-align: center; font-weight: bold;">Pre-Merger</div>
                <div style="text-align: center; font-weight: bold;">Assets</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;" valign="bottom">
                <div style="font-weight: bold;">Price</div>
                <div><span style="font-weight: bold;">Purchase</span></div>
                <div><span style="font-weight: bold;">Allocation</span></div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Cash and cash equivalents</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>148</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>148</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Accounts receivable</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>103</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>103</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Prepaid expense and other current assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>329</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>329</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Property and equipment, net</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>1,015</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>1,015</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Software development costs</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>1,296</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>(368</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>928</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Customers</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>548</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>548</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Trade name</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>299</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>299</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Accounts payable, accrued liabilities and other current</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                <div>(3,781</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                <div>(3,781</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom">
                <div style="text-align: left;">Net assets acquired, excluding goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>(890</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>479</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>(411</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Total consideration</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>8,178</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">Net assets acquired, excluding goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div>(411</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom">
                <div style="text-align: left;">Goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>8,589</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Brooklyn LLC was obligated under the Merger Agreement to have
          $10.0 million in cash and cash equivalents on its balance sheet at the effective time of the Merger. To ensure Brooklyn LLC had the
          required funds, certain beneficial holders of Brooklyn LLC&#8217;s Class A membership interests entered into contractual commitments to invest $10.0
          million into Brooklyn LLC immediately prior to the closing of the Merger. During March 2021, Brooklyn offered its Class A unit holders an additional 5%
          rights offering for an additional $0.5 million to be raised by a rights offering. Brooklyn received funds from the rights offering
          between February 17, 2021 and April 5, 2021.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-indent: 36pt;">Disposition</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On March 26, 2021, Brooklyn sold its rights, title and
          interest in and to the assets relating to the business it operated (under the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $2.0 million and assumption of specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of
          the Disposition are as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Proceeds from sale:</div>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">Cash</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">132</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Escrow</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>100</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Assume advance/loans</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>1,700</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Interest on advance/loans</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>68</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Carrying value of assets sold:</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Cash and cash equivalents</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(14</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Accounts receivable</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(75</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Prepaids and other current assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(124</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Property and equipment, net</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(1,014</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Software development costs</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(927</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Customers</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(548</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Trade name</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(299</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(8,589</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Other assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(103</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Liabilities transferred upon sale:</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Accounts payable and accrued expenses</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>113</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Obligations under finance leases</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>17</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Lease liability</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>26</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Deferred revenue</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>55</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Other current liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>149</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Transaction costs</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(265</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px;" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Total loss on sale of assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div style="font-weight: bold;">$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div style="font-weight: bold;">(9,598</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="font-weight: bold;">)</div>
              </td>

  </tr>


</table>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; text-indent: 36pt; font-variant: normal; text-transform: none;">Acquisition</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On July 16, 2021, Brooklyn and Brooklyn Acquisition Sub, Inc.
          entered into the Acquisition Agreement. The Acquisition closed contemporaneously with the execution and delivery of the Acquisition Agreement. At the closing:</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: left;">&#8226;</div>
                </td>

    <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: justify;">Brooklyn acquired all of the outstanding equity interests of Novellus, Inc. as the result of the merger of Brooklyn Acquisition Sub, Inc. with and into Novellus, Inc., following which, Novellus, Inc., as
                    the surviving corporation, became Brooklyn&#8217;s wholly owned subsidiary and Novellus Ltd. became Brooklyn&#8217;s indirectly owned subsidiary; and</div>
                </td>

  </tr>


</table>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: left;">&#8226;</div>
                </td>

    <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: justify;">Brooklyn acquired 25.0% of the total outstanding equity interests of NoveCite.</div>
                </td>

  </tr>


</table>

<div> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As consideration for the Acquisition, Brooklyn paid $22.9 million in cash and delivered approximately 7,022,000
          shares of common stock, which under the terms of the Acquisition Agreement, were valued at a total of $102.0 million based on an agreed
          upon price of $14.5253 per share. At the date of issuance, the fair value of the shares were approximately $58.6 million.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Acquisition Agreement contained customary
          representations, warranties and certain indemnification provisions. Approximately 741,000 of the shares issued as consideration were
          placed in escrow for a period of up to 12 months in order to secure indemnification obligations to Brooklyn under the Acquisition
          Agreement. The Acquisition Agreement also contains certain non-competition and non-solicitation provisions pursuant to which Novellus LLC agreed not to engage in certain competitive activities for a period of five years following the closing, including customary restrictions relating to employees. No employees of Novellus Ltd. or Novellus, Inc. prior to the
          Acquisition continued their employment, or were otherwise engaged by Brooklyn, following the Acquisition.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">In connection with the Acquisition, the co-founders of
          Novellus, Ltd. entered into lock-up agreements with respect to approximately 3,378,000 of the shares of common stock received in the
          Acquisition, and Brooklyn&#8217;s Chairman of the Board of Directors (the &#8220;Board&#8221;) and its Chief Executive Officer and President entered into identical lock-up agreements with respect to their current holdings of Brooklyn stock. Each lock-up agreement
          extends for a period of three years, provided that up to 75% of the shares of common stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock on the Nasdaq exceeds
          specified thresholds. The lock-up agreements include customary exceptions for transfers during the applicable lock-up period.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company expects the Acquisition will advance its
          evolution into a platform company with a pipeline of next generation engineered cellular, gene editing and cytokine programs. In addition, the acquisition of Novellus, Ltd. builds on the License Agreement. (See Note 8). The completion of the
          acquisition of Novellus, Ltd. relieved Brooklyn LLC from potential obligations to pay Novellus, Ltd. certain upfront fees, clinical development milestone fees and post-registration royalties under the License Agreement. The agreement with Factor
          Bioscience Limited (&#8220;Factor&#8221;) under the License Agreement, which grants Brooklyn LLC exclusive rights to develop certain next-generation mRNA gene editing and cell therapy products, remained unchanged.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Although Brooklyn acquired all of the outstanding equity
          interests of Novellus, Inc., the Company accounted for the Acquisition as an asset acquisition (as the assets acquired did not constitute a business as defined in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 805,&#160;<span style="font-style: italic;">Business Combinations</span>),&#160;and was measured by the amount of cash paid and by the fair value of the shares of common stock issued. As a result, substantially all of the value acquired was attributed to IPR&amp;D, with the exception
          of the cash paid for the investment in NoveCite, which is being accounted for as an investment in equity securities, as discussed further below.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Brooklyn paid $22.9 million in cash, net of cash acquired, as part of the consideration for the Acquisition, of which $1.0 million was paid in cash for the investment in NoveCite. Brooklyn also issued approximately 7,022,000 shares of the Company&#8217;s common stock, of which approximately 3,644,000 shares are unrestricted and 3,378,000
          shares are subject to the three-year lockup. The unrestricted shares were valued at $10.05 per share, which was the closing price of Brooklyn&#8217;s common stock on July 16, 2021. The fair value of the restricted shares was discounted by approximately 35% to $6.53 per restricted share,
          which was derived from the average discount rate between the Black Scholes and Finnerty valuation models. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal;">The resulting fair value of the asset acquired is as follows (in thousands):</span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">&#160;</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; text-indent: -9pt; font-weight: bold;">Fair Value of</div>
                <div style="text-align: center; text-indent: -9pt; font-weight: bold;">Consideration</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Cash paid</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>22,882</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Cash acquired</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(28</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Unrestricted shares</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>36,628</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">Restricted shares</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
                <div>22,056</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Total fair value of consideration paid</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>81,538</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">Less amount of cash paid for NoveCite investment</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div>(1,000</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Fair value of IPR&amp;D acquired</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div>80,538</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">IPR&amp;D that is acquired through an asset purchase that has
          no alternative future uses and no separate economic values from its original intended purpose is expensed in the period the cost is incurred. Accordingly, the Company expensed the fair value of the IPR&amp;D during the third quarter of 2021 in
          the amount of $80.5 million.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Investment in NoveCite</span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">As&#160; a&#160; result&#160; of&#160; the&#160; Acquisition,&#160; Brooklyn&#160; acquired&#160;
          and&#160; currently&#160; owns&#160; 25%&#160; of&#160; NoveCite&#160; and&#160; Citius Pharmaceuticals, Inc. (&#8220;Citius&#8221;) owns the remaining 75%. A member of the Company&#8217;s management holds one of three
          board seats on NoveCite&#8217;s board of directors. Citius&#8217; s officers and directors hold the other two board seats. The Company is accounting for its interest in NoveCite under ASC Topic 323,&#160;<span style="font-style: italic;">Investments&#160;&#8211;&#160;Equity
            Method and Joint&#160;Ventures</span>.&#160;The investment was recorded at cost, which was $1.0 million&#160;and is adjusted for the Company&#8217;s share
          of&#160;NoveCite&#8217;s earnings or losses, which are reflected in the accompanying condensed consolidated statement of operations. The investment may also reflect an equity loss in the event that circumstances indicate an other-than-temporary impairment.
          For the three months ended March 31, 2022, the Company recorded $0.6 million in losses from its investment in NoveCite, of which $0.5 million relates to NoveCite&#8217;s year ended December 31, 2021.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958148181072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE OF FINANCIAL INSTRUMENTS</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FAIR VALUE OF FINANCIAL INSTRUMENTS</div>
                </td>

  </tr>


</table>

<div style="text-align: left;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between
              market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The
              fair value hierarchy is as follows:</div>

<div><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">Level 1 Inputs &#8211; Valued based on quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement
                    date.</div>
                </td>

  </tr>


</table>

<div><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">Level 2 Inputs &#8211; Valued based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might
                    include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or
                    liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.</div>
                </td>

  </tr>


</table>

<div><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 18pt;"><br/>
                </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">Level 3 Inputs &#8211; Valued based on inputs for which there is little or no market value, which require the reporting entity to develop its own assumptions.</div>
                </td>

  </tr>


</table>

<div style="text-align: justify;"><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following tables summarize the liabilities that are measured at fair value as of March 31, 2022 (in thousands).&#160; There were no liabilities measured at fair value as of December 31, 2021:</div>

<div> <br/>
        </div>

<div>
          <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of March 31,
                    2022</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 1</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 2</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 3</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Liabilities:</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Pre-Funded Warrants</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,782</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Common Warrants</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,533</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,782</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,533</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
           </div>

<div> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 9, 2022, the Company issued pre-funded warrants exercisable for approximately 1,357,000 shares of common stock (the &#8220;Pre-Funded Warrants&#8221;) and warrants exercisable for approximately 6,857,000 shares of common stock (the &#8220;Common Warrants&#8221;) in connection with the PIPE Transaction (as defined below).&#160; See Note 10 for more information related to the PIPE
            Transaction.</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Common Warrants and Pre-Funded Warrants were accounted for as liabilities
              under ASC 815-40, </span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Derivatives and Hedging, Contracts in Entity&#8217;s Own Equity</span><span style="font-size: 10pt; font-family: 'Times New Roman';"> (&#8220;ASC
              815-40&#8221;), as these warrants provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40.&#160; These warrant liabilities were measured at fair value at inception and are then
              subsequently measured on a recurring basis, with changes in fair value presented within the Company&#8217;s statement of operations.</span></div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company uses a Black-Scholes option pricing model to estimate the fair value of the Common Warrants, which is considered a Level 3 fair
            value measurement.&#160; Certain inputs used in this Black-Scholes pricing model may fluctuate in future periods based upon factors that are outside of the Company&#8217;s control.&#160; A significant change in one or more of these inputs used in the
            calculation of the fair value may cause a significant change to the fair value of the Company&#8217;s warrant liabilities, which could also result in material non-cash gains or losses being reported in the Company&#8217;s consolidated statement of
            operations.</div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The estimated fair value of the Pre-Funded Warrants was deemed a Level 2 measurement as of March 31, 2022, as all significant inputs to the
              valuation model used to estimate the fair value of the Pre-Funded Warrants were directly observable from the Company&#8217;s publicly-traded common stock.</div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $12.6 million in the aggregate, which was $0.6 million more
            than the $12.0 million proceeds received in the PIPE Transaction.&#160; The excess $0.6 million represents an inducement to the purchaser to enter into the PIPE Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of
            operations.&#160; Given the Company&#8217;s capital requirements and market conditions, the Company consummated this financing on market terms available at the time of the transaction.</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company remeasured the fair value of the warrant liabilities as of March 31, 2022, and the following table presents the changes in the warrant
          liabilities from the issuance date (in thousands): </div>

<div>&#160;</div>

<div>
          <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pre-Funded <span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
                    </span></div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Warrants<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
                    </span></div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Level 2)</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Warrants<br/>
                    </span>(Level 3)</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Warrant<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
                    </span>Liabilities</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at January 1, 2022</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at March 9, 2022 (issuance date)</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,646</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9,943</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,589</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in fair value of warrant liabilities</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">136</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">590</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">726</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at March 31, 2022</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,782</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,533</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">13,315</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
            </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958148267056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>LEASES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">
<div>
        <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 36pt;">
                <div style="font-weight: bold;">5)</div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="font-weight: bold;">LEASES</div>
              </td>

  </tr>


</table>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"> <br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company has operating leases for office and laboratory space in the borough of Manhattan in New York, New York and in Cambridge,
            Massachusetts, which expire in 2026 and 2028, respectively. On March 31, 2022, the Company entered into the Torrey Pines Science Center Lease in San Diego, California (the &#8220;San Diego Lease&#8221;) with<span style="font-family: 'Times New Roman'; font-size: 10pt;"> Torrey Pines Science Center Limited Partnership for approximately 5,200 square feet of lab and office space.
              The term of the San Diego Lease is 62 months and the lease commencement date was April 19, 2022, which is the date the Company
              will record a right-of-use (&#8220;ROU) asset and corresponding operating lease liability. The San Diego Lease will expire in June</span> 2027.</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Base rent for the San Diego Lease is $6.35
            per square foot in the first year of the San Diego Lease, with a rent abatement for the second and third full months of the first year. The base rent will increase by approximately 3% on each anniversary of the lease commencement date. The Company is also required to pay its share of operating expenses and property taxes. The San Diego Lease provides
            for a one-time option to extend the lease term for an additional five years at the then fair rental value.</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On March 5, 2022, the Company entered into an Agreement to Assign Space Lease with Regen Lab USA LLC (&#8220;Regen&#8221;) pursuant to which the Company
            agreed to assign its Brooklyn, New York lease (the &#8220;Brooklyn Lease&#8221;) to Regen. The effective date of the assignment was contingent upon, among other things, a consent from BioBat, Inc. (the &#8220;Landlord&#8221;) to assign the Brooklyn Lease.&#160;
            Additionally, Regen agreed to purchase certain equipment from the Company for $50,000, partly reimburse the Company $50,000 toward certain existing unamortized leasehold improvements, and to reimburse the Company for the existing security deposit the Company had
            under the Brooklyn Lease of approximately $63,000.</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 25, 2022, the Company entered into an Assignment and Assumption of Lease Agreement (the &#8220;Assignment Agreement&#8221;) with Regen, the consent
            of which was provided by the Landlord in the Assignment Agreement. The effective date of the assignment was March 28, 2022. Under the Assignment Agreement, Regen (i) accepts the assignment of the Brooklyn Lease; (ii) assumes all of the
            obligations, liabilities, covenants and conditions of the Company&#8217;s as tenant under the Brooklyn Lease; (iii) assumes and agrees to perform and observe all of the obligations, terms, requirements, covenants and conditions to be performed or
            observed by the Company under the Brooklyn Lease; and (iv) makes all of the representations and warranties binding under the Brooklyn Lease with the same force and effect as if Regens had executed the Brooklyn Lease originally as the tenant.</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the above assumptions by Regen, the Company shall be and remain liable and responsible for the due keeping, and full performance
            and observance, of all the provisions of the Brooklyn Lease on the part of the tenant to be kept, performed and observed. As a result of the Assignment Agreement, the Company wrote off the remaining ROU asset balance and the corresponding lease
            liability.</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company accounts for leases under ASC 842, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Leases</span>.
              Operating leases are included in &#8220;Right-of use assets - operating leases&#8221; within the Company&#8217;s balance sheets and represent the Company&#8217;s right to use an underlying asset for the lease term. The Company&#8217;s related obligation to make lease
              payments are included in &#8220;Operating lease liabilities, non-current&#8221; and &#8220;Operating lease liabilities, current&#8221; within the Company&#8217;s balance sheets. ROU assets and liabilities are recognized at commencement date based on the present value of
              lease payments over the lease term. Because the rate implicit in the lease is not readily determinable, the Company uses its incremental borrowing rates based on the information available at the lease commencement date in determining the
              present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet and are recognized as lease
              expense on a straight-line basis over the lease term. </div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Some leasing arrangements require variable payments that are dependent on usage or may vary for other reasons, such as payments for insurance,
              tax payments and other miscellaneous costs. The variable portion of lease payments is not included in the ROU assets or lease liabilities. Rather, variable payments, other than those dependent upon an index or rate, are expensed when the
              obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease contract are accounted for as lease expenses.</div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">During the three months ended March 31, 2022 and 2021, the net operating lease expenses were as follows (in thousands): </div>

<div><br/>
            </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three months ended March 31,</div>
                  </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><br/>
                  </td>

    <td colspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: #000000 solid 2px;" valign="bottom">2022<br/>
                  </td>

    <td colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: #000000 solid 2px;" valign="bottom">2021<br/>
                  </td>

    <td colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease expense</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">186</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">151</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Sublease income</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(21</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(21</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Variable lease expense</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">3</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">9</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Total lease expense</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">168</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">139</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2022 and the ending balances as of
              March 31, 2022, including the changes during the period (in thousands). </div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 8pt;"> <br/>
            </div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 8pt;">
              <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                      <div style="font-weight: bold;">Operating Lease</div>
                      <div><span style="font-weight: bold;">ROU Assets</span></div>
                    </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease ROU assets at January 1, 2022</div>
                    </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                    </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,567</div>
                    </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Amortization of operating lease ROU assets</div>
                    </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(102</div>
                    </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                    </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Write off of ROU asset due to lease termination</div>
                    </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1,372</div>
                    </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                    </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease ROU assets at March 31, 2022</div>
                    </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                    </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,093</div>
                    </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
            </div>

<div><br/>
            </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: center;">Operating Lease</div>
                    <div style="text-align: center;"> Liabilities</div>
                  </td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease liabilities at January 1, 2022</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">2,723</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Principal payments on operating lease liabilities</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(103</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Write off of operating lease liability due to lease termination</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(1,453</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease liabilities at March 31, 2022</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,167</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Less non-current portion</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,018</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Current portion at March 31, 2022</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">149</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As of March 31, 2022, the Company&#8217;s operating leases had a weighted-average remaining life of 5.8 years with a weighted-average discount rate of 10.23%.
              <span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;">The maturities of the
              operating lease liabilities are as follows (in thousands):</span></div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
                    <div>As of</div>
                    March 31,</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2022</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">201</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">270</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">272</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">274</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">267</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">245</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total payments</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,529</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less imputed interest</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(362</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total operating lease liabilities</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,167</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958148181072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">6)<br/>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT</div>
              </td>

  </tr>


</table>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In 2018, the Company acquired IRX, which was accounted for as a business combination. The Company recorded IPR&amp;D in the amount of $6.0 million, which represents the fair value assigned to technologies that were acquired in connection with the IRX Acquisition and which have not
          reached technological feasibility and have no alternative future use. IPR&amp;D assets acquired in a business combination are considered to be indefinite lived until the completion or abandonment of the associated research and development
          projects. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize products associated with the IPR&amp;D assets, these assets are then deemed definite-lived and are amortized
          based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a full or partial impairment charge related to the IPR&amp;D assets, calculated as the excess of carrying value
          of the IPR&amp;D assets over fair value</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company also recorded goodwill in the amount of $2.0
          million related to the IRX Acquisition. Goodwill and indefinite-lived IPR&amp;D assets are not amortized but are tested for impairment annually, or more frequently if the Company becomes aware of any events occurring or changes in circumstances
          that indicate that the fair value of the entity is less than its carrying values.</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As of March 31, 2022, the Company performed a qualitative assessment to determine whether it is more likely than not that the fair value of the
          entity is less than its carrying value. Such qualitative factors include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and other relevant events. As a result of the qualitative
          assessment, the Company determined that due to the decline in the</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Company&#8217;s stock price of $4.17 per
          share as of December 31, 2021 to $2.05 per share as of March 31, 2022, there were indications of impairment. Accordingly, the Company
          engaged a third-party valuation firm to perform a quantitative analysis to compare the entity&#8217;s carrying values to its fair value, the results of which showed that the entity&#8217;s fair value exceeded its carrying value and there was no impairment of the recorded goodwill or IPR&amp;D.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958148255968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>ACCRUED EXPENSES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCRUED EXPENSES</a></td>
<td class="text">
<div>
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 36pt;">
                  <div style="text-align: left;"><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">7)</span>
                  </div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: bold;">ACCRUED EXPENSES</span></div>
                </td>

  </tr>


</table>
        </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued expenses consisted of the following (in thousands):</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; width: 100%;">


  <tr>

    <td style="vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 31,</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</span><span style="text-decoration: underline;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
                    </span></span></div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2021</span><span style="text-decoration: underline;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
                    </span></span></div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued compensation<br/>
                </div>
              </td>

    <td colspan="1" style="font-family: &amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="font-family: &amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">637</div>
              </td>

    <td colspan="1" style="font-family: &amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: &amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="font-family: &amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">656</div>
              </td>

    <td colspan="1" style="font-family: &amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued research and development expenses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">311</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">222</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued general and administrative expenses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1,436</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">371</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Total accrued expenses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2,384</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1,249</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;">Accrued general and administrative expenses include $0.8 million for legal-related matters.<br/>
        </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958148412000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>COMMITMENTS AND CONTINGENCIES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">8)<br/>
                </span> </td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">COMMITMENTS AND CONTINGENCIES</div>
              </td>

  </tr>


</table>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;">Legal Matters<br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company is involved in litigation and arbitrations from time to time in the ordinary course of business. Legal fees and other costs
            associated with such actions are expensed as incurred. In addition, the Company assesses the need to record a liability for litigation and contingencies. The Company reserves for costs relating to these matters when a loss is probable, and the
            amount can be reasonably estimated.</div>

<div><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-indent: 36pt;"><span style="text-decoration: underline;"><span style="font-style: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Dhesh Govender v. Brooklyn
                Immunotherapeutics, LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021)</span></span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">On or about February 5, 2021, Dhesh Govender, a former short-term consultant of Brooklyn LLC, filed a complaint against Brooklyn LLC and certain individuals that plaintiff alleges were directors of Brooklyn LLC. The complaint is
              captioned, Dhesh Govender v. Brooklyn Immunotherapeutics, LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021). Plaintiff alleges that Brooklyn LLC and certain of its officers and directors (&#8220;defendants&#8221;) engaged in unlawful and
              discriminatory conduct based on race, national origin and hostile work environment. Plaintiff also asserts various breach of contract, fraud and quantum meruit claims based on an alleged oral agreement pursuant to which he alleges Brooklyn
              LLC agreed to hire him as an executive once the Merger was completed. In particular, plaintiff alleges that, in exchange for transferring an opportunity to obtain an agreement to acquire a license from Novellus for its mRNA-based gene editing
              and cell reprogramming technology to Brooklyn LLC, he was promised a $0.5 million salary and 7% of the equity of Brooklyn LLC. Based on these and other allegations, plaintiff seeks damages of not less than $10 million, a permanent injunction enjoining Brooklyn LLC from exercising the option to acquire such license from Novellus or completing the
              proposed Merger. On or about February 19, 2021, an amended complaint was filed asserting the same causes of action but wi<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">thdrawing the request for injunctive relief. On June 6, 2021, defendants filed a motion to compel arbitration or, in the alternative, for partial
                dismissal of the complaint for failure to state viable fraud, quantum meruit and employment discrimination claims. After obtaining extensions of time to respond, plaintiff opposed the defendants&#8217; motion on August 9, 2021. The defendants
                filed their reply on September 3, 2021. The Court heard oral argument on the motion to compel arbitration and/or dismiss and the motion to seal on October 13,&#160;2021. By Order dated November 10,&#160;2021, the Court granted defendants&#8217; motion to
                compel Govender to arbitrate all of his claims against them, based on the arbitration clause of his consulting agreement with Brooklyn LLC.&#160; Govender thereafter filed his Statement of Claim (the &#8220;Demand&#8221;) with the American Arbitration
                Association (&#8220;AAA&#8221;), Case No. 01-21-0017-9417, on December 15,&#160;2021 against the same defendants, and served it on defendants&#8217; counsel on February 3,&#160;2022. In his Demand, Govender continues to assert statutory discrimination claims against
                all defendants, claims against Brooklyn LLC premised on the breach of an alleged oral promise to issue Govender 7% of the equity
                of Brooklyn LLC and to employ Govender at a $0.5 million annual salary in exchange for allegedly arranging and negotiating the
                Novellus license, common law fraud claims against Brooklyn LLC and Cherington based on the breach of these same promises and a claim for quantum meruit against the Brooklyn LLC. In his Demand, Govender now claims that the fair and
                reasonable value of his services on the quantum meruit claim exceeded $100 million and is seeking damages in an amount to be
                determined at the hearing. Defendants filed an answering statement to the Demand on February 28,&#160;2022 have selected a three</span><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">-member arbitration panel. Defendants intend to vigorously defend themselv</span>es against these claims.</span> At this stage in the litigation, the Company is not able to predict the probability of a favorable or
              unfavorable outcome. </div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; text-indent: 36pt;"><span style="text-decoration: underline;">Emerald Private Equity Fund, LLC Matter</span></div>

<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
                          </span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">By a letter dated July 7, 2021, Emerald Private Equity Fund, LLC (&#8220;Emerald&#8221;), a stockholder of Brooklyn, made a demand pursuant
                            to 8 Del. C. 220 to inspect certain books and records of Brooklyn. The stated purpose of the demand is to investigate possible wrongdoing by persons responsible for the implementation of the Merger and the issuance of paper
                            stock certificates, including investigating whether: (i) Brooklyn&#8217;s stock certificates were issued in accordance with the Merger Agreement; (ii)&#160;certain restrictions on the sale of Brooklyn common stock following the Merger were
                            proper and applied without favor; (iii) anyone received priority in post-Merger issuances of Brooklyn&#8217;s stock certificates that allowed them to benefit from an increase in the trading price of Brooklyn&#8217;s common stock; and (iv)
                            it<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> should pursue
                              remedial measures and/or report alleged misconduct to the SEC. Brooklyn has responded to the demand letter and has produced certain information to Emerald in connection with the demand, which is subject to the terms of a
                              confidentiality agreement entered into among the parties, including certain additional stockholders who have subsequently joined as parties to such agreement (including Truell noted above). In October 2021, Emerald requested
                              that Brooklyn produce additional information related to the authority, purpose and justification for the restriction imposed on the sale of Brooklyn common stock following the Merger and the timing of share delivery to
                              Brooklyn stockholders, following which request Brooklyn agreed to produce certain additional information and emails relating to these topics.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
                            </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">On March 30,&#160;2022, counsel to Emerald advised the Company that it was prepared to file suit against the Company, certain current and former directors of the
                                Company, and the Company&#8217;s financial advisor in connection with the Merger, on behalf of Emerald and a class of similarly situated stockholders with respect to some or all of the foregoing matters, alleging claims for breach
                                of fiduciary duty, conversion and aiding and abetting breach of fiduciary duty. Emerald&#8217;s counsel expressed a willingness to engage in private pre-suit early resolution discussions with the Company and its financial advisor
                                on behalf of individual stockholders whom counsel represents in addition to Emerald; and the Company since engaged in such discussions. The Company can provide no assurance that such pre-suit early resolution discussions
                                will be successful or that suit will not ultimately be filed against the Company, nor can the Company currently predict the outcome of any such suit, if filed. The Company intends to defend itself vigorously against any and
                                all claims. Additionally, on April 7,&#160;2022,</span><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> the Company received a demand for indemnification from its financial advisor as it relates to the aforementioned
                                  potential lawsuit.</span><br/>
                              </span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="text-decoration: underline;">John Westman v. Novellus, Inc., Christopher Rohde, and Matthew Angel, Civil Action No. 2181CV01949
                                (Middlesex County (Massachusetts) Superior Court)</span></div>

<div><br/>
                            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> or about September 7, 2021, John Westman, a former employee of Novellus, Inc. filed a Complaint in Middlesex
                                County (Massachusetts) Superior Court against Novellus, Inc. and the company&#8217;s founders and former executives, Christopher Rohde and Matthew Angel (collectively, &#8220;Defendants&#8221;). The case includes allegations that Novellus,
                                Inc. violated the Massachusetts Wage Act.. Brooklyn acquired Novellus, Inc. on July 16,&#160;2021. Mr. Westman&#8217;s claims relate to alleged conduct that took place before Brooklyn acquired Novellus, Inc. Defense and liability in
                                association with any Wage Act claims have been assumed by Mr. Rohde and Mr. Angel. On December 24,&#160;2021, Westman dismissed the case without prejudice so the parties could mediate the matter. The parties&#8217; February 2022
                                mediation was unsuccessful and the dispute is currently in arbitration.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
                              </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The company accrued $0.8 million in legal-related expenses during the quarter ended March 31, 2022 for the matters discussed above.<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
                              </span></div>

<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
              </div>

<div style="display:none;"><br/></div>
<div style="font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;">Licensing Agreements</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">USF</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Brooklyn LLC has license agreements with University
                  of South Florida Research Association, Inc. (&#8220;USF&#8221;), granting Brooklyn LLC the right to sell, market, and distribute IRX-2, subject to a 7%
                  royalty payable to USF based on a percentage of gross product sales. Under the license agreement with USF, Brooklyn LLC is obligated to repay patent prosecution expenses incurred by USF. To date, Brooklyn LLC has not recorded any product
                  sales, or obligations related to USF patent prosecution expenses. The license agreement terminates upon the expiration of the IRX-2 patents.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Novellus, Ltd. and Factor <br/>
                  </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">In December 2020, Brooklyn LLC entered into option agreements (the
                    &#8220;Option Agreements&#8221;) with Novellus, Ltd. and Factor (together, the &#8220;Licensors&#8221;) to obtain the right to exclusively license the Licensors&#8217; intellectual property and mRNA cell reprogramming and gene editing technology for use in the
                    development of certain cell-based therapies to be evaluated and developed for treating human diseases, including certain types of cancer, sickle cell disease, and beta thalassemia (the &#8220;Licensed Technology&#8221;). The option was exercisable
                    before February 28, 2021 (or April 30, 2021 if the Merger had not closed by that date) and required Brooklyn LLC to pay a non-refundable option fee of $0.5 million and then an initial license fee of $4.0 million <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">(including the non-refundable fee of $0.5 million) in order to exercise the option.</span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <br/>
                  </div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"> In April 2021, Brooklyn LLC and the Licensors amended the Option Agreements to extend the exercise period to May 21, 2021 and to require Brooklyn, LLC to pay a
                    total $1.0 million of the $4.0
                    million initial license fees to the Licensors by April 15, 2021.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
                    </span></div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">In April 2021, Brooklyn LLC and the Licensors entered into an exclusive license agreement (the &#8220;License Agreement&#8221;) pursuant to which Brooklyn LLC acquired an exclusive worldwide license to the Licensed Technology. Under
                      the terms of the License Agreement, Brooklyn LLC is obligated to pay the Licensors a total of $4.0 million in connection
                      with the execution of the License Agreement, all of which was paid as of June 2021.</span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
                    </span></div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The completion of the acquisition of Novellus, Ltd. relieved Brooklyn LLC from potential obligations to pay Novellus, Ltd. certain upfront fees, clinical
                        development milestone fees and post-registration royalties under the License Agreement. The agreement with Factor under the License Agreement, which grants Brooklyn LLC exclusive rights to develop certain next-generation mRNA gene
                        editing and cell therapy products, remained unchanged. Accordingly, Brooklyn LLC is obligated to pay to Factor a fee</span> of $3.5
                      million in October 2022, which will be in addition to a fee of $2.5 million paid to Factor in October 2021.</span> </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"><br/>
                  </div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Brooklyn



                      LLC is also required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory milestones and specified commercialization milestones. In general, upon its
                      achievement of these milestones, Brooklyn LLC will be obligated to pay, in the case of development and regulatory milestones, milestone payments to the Licensors in specified amounts and, in the case of commercialization milestones,
                      specified royalties with respect to product sales, sublicense fees or sales of pediatric review vouchers. In the event Brooklyn LLC fails to timely achieve certain delineated milestones, the Licensors will have the right to terminate
                      Brooklyn LLC&#8217;s rights under provisions of the License Agreement relating to those milestones.</span> </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">Novellus, Ltd. also has a license agreement with Factor, which was entered into in February 2015, amended in June 2018 and March 2020, and then amended and restated
                    in November 2020. This license agreement provides for Novellus, Ltd. to use over 70 granted patents owned by Factor
                    throughout the world covering synthetic mRNA, RNA-based gene editing, and RNA-based cell reprogramming, in addition to specific patents covering methods for treating specific diseases. There are also more than 60 pending patent applications throughout the world focused on these and other aspects of the technology. The patent coverage includes
                    granted patents and pending patent applications in the United States, Europe, and Japan, along with other major life sciences markets.</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">Novellus, Ltd. is required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory
                    milestones and specified commercialization milestones. In general, upon its achievement of these milestones, Novellus, Ltd. will be obligated, in the case of development and regulatory milestones, to make milestone payments of up to $51.0 million in aggregate to Factor and, in the case of commercialization milestones, specified royalties with respect to product sales,
                    sublicense fees or sales of pediatric review vouchers. In the event Novellus, Ltd. fails to timely achieve certain delineated milestones, Factor may have the right to terminate Novellus, Ltd.&#8217;s rights under provisions of the License
                    Agreement relating to those milestones.</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;">&#160;</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">NoveCite</span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;"> <br/>
                            </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;"> </span>In October 2020, Novellus, Ltd. (as
                            sublicensor) and NoveCite (as sublicensee) entered into an exclusive license agreement (the &#8220;Sublicense&#8221;) to license novel cellular therapy for acute respiratory distress syndrome, which NoveCite is licensing from Factor. Under
                            the sublicense agreement, NoveCite is required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory milestones and specified commercialization
                            milestones. In general, upon its achievement of these milestones, NoveCite will be obligated, in the case of development and regulatory milestones, to make milestone payments to the Novellus, Ltd. in specified amounts and, in
                            the case of commercialization milestones, specified royalties with respect to product sales, sublicense fees or sales of pediatric review vouchers.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;"><br/>
                            </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Under the terms of the Sublicense, in the
                            event that Novellus, Ltd. receives any revenue involving the original cell line included in the licensed technology, then Novellus, Ltd. shall remit to NoveCite 50% of such revenue.<span style="text-decoration: underline;"><br/>
                            </span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;">Royalty Agreements</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Collaborator Royalty Agreement</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Effective June 22, 2018, IRX terminated its Research,
          Development and Option Facilitation Agreement and its Options Agreement (the &#8220;RDO and Options Agreements&#8221;) with a collaborative partner (the &#8220;Collaborator&#8221;), pursuant to a termination agreement (the &#8220;Termination Agreement&#8221;). <span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Termination Agreement was assigned to Brooklyn, LLC in November 2018 when Brooklyn LLC acquired the assets of IRX. </span>In
          connection with the Termination Agreement, all of the rights granted to the Collaborator under the RDO and Options Agreements were terminated, and Brooklyn LLC has no obligation to refund any payments received from the Collaborator. As
          consideration for entering into the Termination Agreement, the Collaborator will receive a royalty equal to 6% of revenues from the
          sale of IRX-2, for the period of time beginning with the first sale of IRX-2 through the later of (i) the twelfth anniversary of the first sale of IRX-2 or (ii) the expiration of the last IRX patent, or other exclusivity of IRX-2.</div>

<div style="display:none;"><br/></div>
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-indent: 36pt; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"> <span style="text-decoration: underline;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Royalty Agreement with certain former IRX Therapeutics Investors</span></span> </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"> <br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">On May 1, 2012, IRX Therapeutics entered into a royalty agreement (the &#8220;IRX Investor Royalty Agreement<span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">&#8221;</span>)
              with certain investors who participated in a financing transaction. The IRX Investor Royalty Agreement was assigned to Brooklyn LLC in November 2018 when Brooklyn LLC acquired the assets of IRX. Pursuant to the IRX Investor Royalty Agreement,
              when Brooklyn LLC becomes obligated to pay royalties to USF under the agreement described above under &#8220;Licensing Agreements-USF,&#8221; it will pay an additional royalty of 1% of gross sales to an entity organized by the investors who participated in such financing transaction. There are no termination provisions in the IRX Investor Royalty Agreement.
              Brooklyn LLC has not recognized any revenues to date, and no royalties are due pursuant to any of the above-mentioned royalty agreements.</span> </div>

<div><span style="text-decoration: underline;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Investor Royalty Agreement</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-indent: 36pt;">On




            March 22, 2021, Brooklyn LLC restated its royalty agreement with certain beneficial holders of Brooklyn ImmunoTherapeutics Investors GP LLC and Brooklyn ImmunoTherapeutics Investors LP, whereby such beneficial holders will continue to receive,
            on an annual basis, royalties in an aggregate amount equal to 4% of the net revenues of IRX-2, a cytokine-based therapy being
            developed by Brooklyn LLC to treat patients with cancer.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958148412000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>STOCK-BASED COMPENSATION [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">9)<br/>
              </span> </td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: normal; font-variant: normal; text-transform: none;">STOCK-BASED COMPENSATION</div>
              </div>
            </td>

  </tr>


</table>
    </div>

<div><span style="font-family: 'Times New Roman';"> &#160; <span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Stock Options</span></div>

<div><span style="font-family: 'Times New Roman';"> <span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>

<div><span style="font-family: 'Times New Roman';"> <span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">There were no stock options outstanding or granted during the </span><span style="font-family: 'Times New Roman';">three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2021.<span style="font-size: 10pt;"> <span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">The following weighted-average assumptions were used for stock options granted during the </span></span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">three</span><span style="font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"> months ended March </span></span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">31,</span><span style="font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">&#160;</span></span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">2022</span><span style="font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">:</span></span></span></div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Three months ended </span></div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">March 31</span><span style="font-family: 'Times New Roman';">,<span style="font-size: 10pt;"> </span>2022</span></div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="text-align: left; font-size: 10pt;">Weighted average risk-free rate</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="font-size: 10pt;">1.92</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="font-size: 10pt;">%</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%;" valign="bottom">
              <div style="text-align: left; font-size: 10pt;">Weighted average volatility</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%;" valign="bottom">
              <div style="font-size: 10pt;">93</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="font-size: 10pt;">%</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="text-align: left; font-size: 10pt;">Dividend yield</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="font-size: 10pt;">0</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="font-size: 10pt;">%</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%;" valign="bottom">
              <div style="text-align: left; font-size: 10pt;">Expected term</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%;" valign="bottom">
              <div style="font-size: 10pt;"><span style="font-size: 10pt;">5.78 years<br/>
                </span></div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> The following table summarizes stock option activity for the </span><span style="font-family: 'Times New Roman';">three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2022<span style="font-size: 10pt;">:</span></span></div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Outstanding Options</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Weighted Average Exercise Price per Share</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Weighted Average Remaining Contractual Life (in years)</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Aggregate Intrinsic Value</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Outstanding January </span><span style="font-family: 'Times New Roman'; font-weight: bold;">1,<span style="font-size: 10pt;"> </span>2022</span></div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">3,988,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">8.40</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">9.38</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">-</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 52%;" valign="bottom">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-size: 10pt;">1,258,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-size: 10pt;">2.10</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-size: 10pt;">-</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-size: 10pt;">-</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Cancelled</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">(67,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="font-size: 10pt;">)</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
              <div style="font-size: 10pt;">5.94</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
              <div style="font-size: 10pt;">-</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Outstanding March 31</span><span style="font-family: 'Times New Roman'; font-weight: bold;">,<span style="font-size: 10pt;"> </span>2022</span></div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">5,179,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">6.90</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">9.32</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">134,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Options vested and exercisable at March </span><span style="font-family: 'Times New Roman';">31,<span style="font-size: 10pt;">&#160;</span>2022</span></div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">10,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">10.26</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">9.75</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">-</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The per-share weighted average grant-date fair value of stock options granted during
          the </span><span style="font-family: 'Times New Roman';">three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2022<span style="font-size: 10pt;"> was </span>$1.58.</span></div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">As of March </span><span style="font-family: 'Times New Roman';">31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> the unamortized stock-based compensation expense related to outstanding unvested options was approximately </span>$18.5 million<span style="font-size: 10pt;"> with a weighted average remaining requisite service period of </span>3.06<span style="font-size: 10pt;"> years. The Company expects to amortize this expense over the remaining requisite service period of these stock options.</span></span></div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Included in the </span><span style="font-family: 'Times New Roman';">5,179,000<span style="font-size: 10pt;"> stock options outstanding as of March </span>31,<span style="font-size: 10pt;">&#160;</span>2022<span style="font-size: 10pt;"> are </span>two<span style="font-size: 10pt;"> stock option grants the Company awarded to Howard J.
            Federoff, M.D., Ph.D. upon his appointment as the Company&#8217;s Chief Executive Officer and President in April </span>2021.</span></div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Dr. Federoff was granted a nonqualified stock option covering approximately 2,628,000</span><span style="font-family: 'Times New Roman';"><span style="font-size: 10pt;"> shares of common stock (the &#8220;Time-Based Option&#8221;). The
            Time-Based Option was granted at a per share exercise price equal to the closing price of the common stock on the NYSE American stock exchange on the date of grant. Of the shares covered by the Time-Based Option, </span>25%<span style="font-size: 10pt;"> will vest on the </span>one<span style="font-size: 10pt;">-year anniversary of the grant date, and the remaining
            shares will vest in substantially </span>36<span style="font-size: 10pt;"> equal monthly installments thereafter, so long as Dr.
            Federoff provides continuous service to the Company throughout the relevant vesting date.</span></span></div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Dr. Federoff was also granted a performance-based nonqualified stock option covering
          approximately </span><span style="font-family: 'Times New Roman';">597,000<span style="font-size: 10pt;"> shares of common stock (the
            &#8220;Milestone Option&#8221;). The Milestone Option was granted at a per share exercise price equal to the closing price of common stock on the NYSE American stock exchange on the date of grant, and its fair value is </span>$4.3 million<span style="font-size: 10pt;">. The Milestone Option will fully vest upon the </span>first<span style="font-size: 10pt;"> concurrence by
            the U.S. Food and Drug Administration that a proposed investigation may proceed following review of a Company filed investigational new drug application in connection with that the License Agreement. This milestone is subject to Dr. Federoff&#8217;s
            continuous service with the Company through such vesting date. As of March </span>31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> the Company has not recognized any stock-based compensation expense on the Milestone Option because the Company has determined that it is not yet probable that the performance milestone
            will be accomplished.</span></span></div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Both the Time-Based Option and the Milestone Option were granted outside the
          Company&#8217;s equity incentive plans discussed above. The unvested portion of the Time-Based Option and the Milestone Option will be cancelled upon the termination of Dr. Federoff&#8217;s employment with the Company for any reason, subject to certain
          vesting acceleration provisions upon a qualifying termination, as described in his employment agreement with the Company. Unless earlier terminated in accordance with their terms, each of the Time-Based Option and the Milestone Option will
          otherwise expire on the </span><span style="font-family: 'Times New Roman';">tenth<span style="font-size: 10pt;"> anniversary of their respective grant date and be subject to the terms and conditions of the respective option agreement approved
            by the Company. Each of the Time-Based Option and the Milestone</span></span><span style="font-size: 10pt; font-family: 'Times New Roman';"> Option was intended to constitute an &#8220;employment inducement grant&#8221; in accordance with the employment
          inducement grant rules set forth in Section </span><span style="font-family: 'Times New Roman';">711<span style="font-size: 10pt;">(a) of the NYSE American LLC Company Guide and was offered as an inducement material to Dr. Federoff in connection
            with his hiring.</span></span> </div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">There were no
          options exercised during the </span><span style="font-family: 'Times New Roman';">three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2022<span style="font-size: 10pt;"> and </span>2021.</span>
      </div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt;"><span style="font-family: 'Times New Roman';"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt;"><span style="font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><span style="text-decoration: underline;">RSUs</span></span> </div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Outstanding RSUs are settled in an equal number of shares of common stock on the vesting date of the award. An RSU award is settled only to the
        extent vested. Vesting generally requires the continued employment or service by the award recipient through the respective vesting date. Because RSUs are settled in an equal number of shares of common stock without any offsetting payment by the
        recipient, the measurement of cost is based on the quoted market price of the stock at the measurement date, which is the grant date.</div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">There were no RSUs outstanding or granted during the </span><span style="font-family: 'Times New Roman';">three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2021.<span style="font-size: 10pt;"> <span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">The following table summarizes RSU activity for the </span></span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">three</span><span style="font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"> months ended March </span></span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">31,</span><span style="font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">&#160;</span></span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">2022</span><span style="font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">:</span></span></span></div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Outstanding Restricted Stock Units</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Weighted Average Fair Value per Share</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">January </span><span style="font-family: 'Times New Roman'; font-weight: bold;">1,<span style="font-size: 10pt;"> 2022</span></span></div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">240,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">13.80</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%;" valign="bottom">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-size: 10pt;">1,101,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-size: 10pt;">1.93</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Released</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">(9,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="font-size: 10pt;">)</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">4.21</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Cancelled</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">(9,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="font-size: 10pt;">)</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;" valign="bottom">
              <div style="font-size: 10pt;">4.21</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;">March 31</span><span style="font-family: 'Times New Roman'; font-weight: bold;"><span style="font-size: 10pt;"> </span>2022</span></div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">1,323,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">4.05</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Balance expected to vest at March </span><span style="font-family: 'Times New Roman';">31,<span style="font-size: 10pt;">&#160;</span>2022</span></div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">772,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">During the </span><span style="font-family: 'Times New Roman';">three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> the Company issued approximately </span>1,101,000<span style="font-size: 10pt;"> performance based RSUs (the &#8220;</span>2022<span style="font-size: 10pt;"> PSUs&#8221;) to its employees, of which approximately </span>414,000<span style="font-size: 10pt;"> were awarded to Dr. Federoff. The </span>2022<span style="font-size: 10pt;"> PSUs are subject to the
            achievement of </span>four<span style="font-size: 10pt;"> performance goals, which are weighted equally. Once a performance goal is
            achieved, the tranche of shares allocated to that performance goal will be earned and will begin to vest over a </span>three-year<span style="font-size: 10pt;"> annual basis beginning on the date the performance goal was achieved. If a performance goal is not achieved, the tranche of shares allocated to that performance goal will be unearned and forfeited.</span></span></div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company recognizes the fair value of RSUs granted as expense on a straight-line
          basis over the requisite service period. For performance based RSUs, the Company will begin recognizing the expense once the achievement of the related performance goal is probable. As of March </span><span style="font-family: 'Times New Roman';">31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> the unamortized stock-based compensation expense related to outstanding RSUs, including performance based RSUs that have been deemed probable, was
            approximately </span>$3.6 million<span style="font-size: 10pt;"> with a weighted average remaining requisite service period of </span>2.59<span style="font-size: 10pt;"> years. The Company expects to amortize this expense over the remaining requisite service period of the RSUs.</span></span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman';"><span style="font-size: 10pt;"> <br/>
          </span></span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt;"><span style="text-decoration: underline;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Restricted Stock</span></span> </div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Pursuant to the Merger, Brooklyn LLC&#8217;s approximately </span><span style="font-family: 'Times New Roman';">3,000<span style="font-size: 10pt;"> outstanding restricted common units were exchanged for
            approximately </span>630,000<span style="font-size: 10pt;"> shares of Brooklyn&#8217;s restricted common stock. There were no changes to
            any conditions and requirements of the restricted common stock. The shares vest quarterly beginning on March </span>31,<span style="font-size: 10pt;">&#160;</span>2021<span style="font-size: 10pt;"> and continuing through December </span>31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> contingent on continued service. Due to the modification of the restricted common units, the fair value of the restricted common stock immediately after the Merger was
            compared to the fair value of the restricted common units immediately prior to the Merger, and the change in fair value of </span>$0.3
          million<span style="font-size: 10pt;"> was recognized in the statement of operations during the </span>three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2021.<span style="font-size: 10pt;">
            The Company recognizes the fair value of restricted common stock as an expense on a straight-line basis over the requisite service period. During the quarter ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> approximately </span>78,000<span style="font-size: 10pt;"> shares of unvested restricted common stock were
            forfeited due to the holders of such shares no longer providing services to the Company. As of March </span>31,<span style="font-size: 10pt;">&#160;</span>2022,<span style="font-size: 10pt;"> there were no shares of unvested restricted stock outstanding.</span></span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman';"><span style="font-size: 10pt;"> <br/>
          </span></span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt;"><span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Stock-Based Compensation Expense </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt;"><span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; text-indent: 36pt; text-align: justify;"><span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Stock-based compensation is recorded in general and administrative expense and research and development expense in the statement of operations. For the three months ended March 31,&#160;2022 and 2021, stock-based compensation
          expense recorded in general and administrative expense was $0.8 million and $17,000, respectively. For both of the three months ended March 31,&#160;2022 and 2021, stock-based compensation expense recorded in research and development expense was $0.4 million.</span> </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958150152016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>STOCKHOLDERS' EQUITY [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify;">10)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">STOCKHOLDERS&#8217; EQUITY<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>
              </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"><span style="font-weight: normal;"> <br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Private Placement of
            Equity</div>

<div><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/>
              </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 6, 2022, the Company entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with an investor (the &#8220;PIPE Investor&#8221;)
                providing for the private placement (the &#8220;PIPE Transaction&#8221;) to the PIPE Investor of approximately 6,857,000 units
                (collectively, the &#8220;Units&#8221;), each Unit consisting of (i) one share of the Company&#8217;s common stock (or, in lieu thereof, one
                pre-funded warrant (the &#8220;Pre-Funded Warrants&#8221;) to purchase one share of common stock) and (ii) one warrant (the &#8220;Common
                Warrants&#8221;) to purchase one share of common stock, for an aggregate gross purchase price of approximately $12.0 million (the
                &#8220;Subscription Amount&#8221;). The PIPE Transaction closed on March 9, 2022.</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span>
              <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each Pre-Funded Warrant has an exercise price of $0.005 per share of common stock, was immediately exercisable, may be
              exercised at any time, has no expiration date and is subject to customary adjustments. The Pre-Funded Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 9.99% immediately after exercise thereof. Upon the closing of the transaction, the Company issued 5,500,000 shares of common stock and issued Pre-Funded Warrants representing approximately 1,357,000 shares of common stock.</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span>
              <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Each Common Warrant has an exercise price of $1.91 per share, becomes exercisable six months following the closing of the PIPE Transaction, expires <span style="-sec-ix-hidden:Fact_2134c2193a6f4a199f8e2044d8c27aaf">five-and-one-half </span> years from the date of issuance and is subject to customary adjustments. The Common Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 4.99% immediately after exercise thereof, subject to increase to 9.99% at the option of the holder.</div>

<div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As of March 31, 2022, the Company had 6,857,000
              Common Warrants outstanding with a weighted average exercise price of $1.91 per share and a weighted average contractual life of 5.45 years. As of March 31, 2022, the Company had 1,357,000
              Pre-Funded Warrants outstanding with a weighted average exercise price of $0.005 per share. The Pre-Funded Warrants do not expire.</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">The











            Common Warrants and Pre-Funded Warrants were accounted for as liabilities under ASC 815-40, as these warrants provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40. These
            warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of operations.</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $12.6 million in the aggregate, which was $0.6 million more
              than the Subscription Amount. The excess $0.6 million represents an inducement to the PIPE Investor to enter into the transaction
              and was recorded in warrant liabilities expense in the accompanying consolidated statement of operations. Given the Company&#8217;s capital requirements and market conditions, the Company consummated this financing on market terms available at the
              time of the transaction.</div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; margin-right: 2pt;">The Company incurred fees of $1.0
              million through March 31, 2022 related to the PIPE Transaction, which were allocated to the fair value of the Common Warrants and the Pre-Funded Warrants and recorded in other expense, net on the accompanying condensed consolidated statement
              of operations.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the PIPE Transaction, the Company and the PIPE Investor also entered into a registration rights agreement, dated March 6,
              2022, pursuant to which the Company agreed to prepare and file a registration statement with the SEC no later than 15 days following the filing date of the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021 (the &#8220;2021
              Annual Report&#8221;) to register the resale of the shares of common stock included in the Units and the shares of common stock issuable upon exercise of the Pre-Funded Warrants and the Common Warrants. The Company agreed to use its best efforts to
              have such registration statement declared effective as promptly as possible after the filing thereof, subject to certain specified penalties if timely effectiveness is not achieved. The Company filed the 2021 Annual Report on April 15, 2022
              and the registration statement on April 29, 2022. The registration statement became effective on May 11, 2022.</div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the registration rights agreement, the Company is obligated to pay the PIPE Investor liquidated damages equal to 2% of the Subscription Amount per month, with a maximum aggregate payment of 12% of the Subscription Amount, in the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered for resale
              thereunder for more than 10 consecutive calendar days or more than an aggregate of <span style="-sec-ix-hidden:Fact_1d1a0b74074845069916ad1b1bee6544">fifteen</span> calendar days (which need not be consecutive calendar days) during any 12-month period.</div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On May 24, 2022, the Company provided the PIPE Investor with notice that it was not able to resell the securities registered for resale under
              the registration agreement because the Company had not timely filed this Quarterly Report on Form 10-Q (the &#8220;Q1 2022 10-Q&#8221;) with the SEC, and that the PIPE Investor could not use the registration statement to resell the related securities
              until the Company filed the Q1 2022 10-Q. Because the PIPE Investor was unable to use the registration statement for at least 10
              consecutive calendar days, the Company accrued $0.2 million for the three months ended March 31, 2022 for the estimated contingent
              loss the Company expected to incur as a result of the late Q1 2022 10Q filing, which is recorded in other expense, net in the accompanying condensed consolidated statements of operations.</div>

<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> <br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Reverse Stock-Split</div>

<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> <br/>
              </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-align: justify; text-indent: 36pt;">On
          March 25, 2021, immediately prior to the Merger, Brooklyn filed an amendment to the Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a reverse stock split. As a result of the reverse stock split, the
          number of issued and outstanding shares of common stock immediately prior to the reverse stock split was reduced into a smaller number of shares, such that every <span style="-sec-ix-hidden:Fact_c7f77014cf9a4ef9a688995037fe55b0">two</span> shares of common stock held by a stockholder of Brooklyn immediately prior to the reverse stock split were combined and reclassified into one share of common stock after the reverse
          stock split.</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;">&#160;<br/>
          </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-align: justify; text-indent: 36pt;">Immediately











          following the reverse stock split there were approximately 1,514,000 shares of common stock outstanding prior to the Merger. No
          fractional shares were issued in connection with the reverse stock split.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify; text-indent: 36pt;"><span style="font-weight: normal;"> <span style="font-style: italic;">Merger</span></span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-indent: 0px; text-transform: none; background-color: rgb(255, 255, 255);"><span style="font-weight: normal;"> <br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;">Under the terms of the Merger
              Agreement </span></span>(see Note 3)<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;">, on March 25, 2021, Brooklyn issued shares of common stock to the equity holders of Brooklyn LLC. The 87,000
              Class A units of Brooklyn LLC were converted into </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> 22,275,000 shares of common stock; the 15,000,000 Class B units were converted into </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> 2,515,000
              shares of common stock; the 10,000,000 Class C units were converted into </span></span>approximately 1,676,000<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> shares of common stock; </span></span>approximately 630,000<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> shares of common units were
              converted into </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> 630,000 shares of common stock, and 10,500,000 rights options were converted into </span></span>approximately 11,828,000<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> shares of common stock.
              Brooklyn also issued </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> 1,068,000 shares of common stock to the Financial Advisor pursuant to the Merger Agreement</span></span>.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958148210672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>EARNINGS PER SHARE [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">
<div>
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify;">11)</td>

    <td style="width: auto; vertical-align: top;">
                  <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"><span style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">EARNINGS PER SHARE</span> </div>
                </td>

  </tr>


</table>
        </div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period including
        the weighted average effect of the Pre-Funded Warrants the Company issued in connection with the PIPE Transaction, the exercise of which requires little or no consideration for the delivery of shares of common stock. The Company determined that the
        exercise of the Pre-Funded Warrants requires nominal consideration for the delivery of shares of common stock, and as such, has considered the 1,357,000
        shares underlying the Pre-Funded Warrants to be outstanding effective on March 9, 2022 for the purposes of calculating basic EPS. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares
        outstanding (including the weighted average effect of the Pre-Funded Warrants) plus dilutive securities. Stock options, RSUs, warrants and other convertible securities are considered potential common shares and are included in the calculation of
        diluted net loss per share using the treasury method when their effect is dilutive. Diluted net loss per share is the same as basic net loss per share in periods where the effect of potentially dilutive shares of common stock are antidilutive. <span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;">The following
        table presents the amount of stock options, RSUs, warrants and convertible preferred stock that were excluded from the computation of diluted net loss per common share for three months ended March 31, 2022 and 2021, as their effect was
        anti-dilutive:</span></div>

<div><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom;" valign="bottom">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">Three months ended March 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; text-align: center;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Stock options</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">5,179,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">RSUs</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">1,323,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Warrants</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">6,857,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Preferred stock converted into common stock</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">48,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">42,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Total potential common shares excluded from computation</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">13,407,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">42,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958151868528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING PRONOUNCEMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">12)<br/>
          </td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">RECENT ACCOUNTING PRONOUNCEMENTS</div>
          </td>

  </tr>


</table>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span>
     </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none; text-indent: 36pt;">There were no recent accounting pronouncements issued during the
      three months ended March 31, 2022 that would have impacted the Company&#8217;s financial statements or operations.  </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958148210672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>SUBSEQUENT EVENT [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENT</a></td>
<td class="text">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">13)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">SUBSEQUENT EVENT</div>
              </td>

  </tr>


</table>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On May 24, 2022, Dr. Federoff resigned as the Company&#8217;s Chief Executive Officer and President effective May 26, 2022, and the Board appointed
            Dr. Matthew Angel as the Company&#8217;s interim Chief Executive Officer.</div>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In connection with Dr. Federoff&#8217;s resignation, the Company entered into a Separation Agreement and General Release with Dr. Federoff (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Separation Agreement</span></span>&#8221;), pursuant to which Dr. Federoff resigned from his positions as Chief Executive Officer and as an officer, director and employee of the Company and
            all subsidiaries. Dr. Federoff&#8217;s resignation from the Board was not due to any disagreement with the Company on any matter relating to the Company&#8217;s operations, policies or practices. In consideration for Dr. Federoff&#8217;s execution of the
            Separation Agreement and non-revocation of a waiver and release of claims relating thereto, Dr. Federoff is entitled to the following benefits under the Separation Agreement:</div>

<div><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18.15pt;"><br/>
                </td>

    <td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">a lump sum cash severance benefit in the amount of $0.2 million,
                    representing Dr. Federoff&#8217;s target bonus for 2022;</div>
                </td>

  </tr>


</table>

<div><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18.15pt;"><br/>
                </td>

    <td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">payment of Dr. Federoff&#8217;s annual base salary for a period of twelve months after the expiration of the applicable revocation period (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Separation Period</span></span>&#8221;), for a total gross amount equal to $0.5 million;</div>
                </td>

  </tr>


</table>

<div><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18.15pt;"><br/>
                </td>

    <td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">payment of Dr. Federoff&#8217;s premiums for continued health benefits provided under COBRA for the Separation Period;</div>
                </td>

  </tr>


</table>

<div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18.15pt;"><br/>
                </td>

    <td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">full acceleration of the vesting of all outstanding options (with the exception of the Milestone Options) that would have vested during the Separation Period, and such options,
                    together with outstanding options that vested prior to the Separation Date, representing collectively 1,420,095 shares of
                    common stock, may be exercised for a period of thirty-six months after the Separation Date;</div>
                </td>

  </tr>


</table>

<div><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18.15pt;"><br/>
                </td>

    <td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">acceleration and vesting of 25/36<sup>th</sup> of the Milestone Options, representing collectively 414,759 shares of common stock, may be exercised for a period of thirty-six months
                    after the Separation Date; and</div>
                </td>

  </tr>


</table>

<div><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18.15pt;"><br/>
                </td>

    <td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">a lump sum cash severance benefit in the amount of $0.1 million,
                    representing the value Dr. Federoff would have received if he was entitled to receive a settlement of a pro rata portion of his performance restricted stock units through the expiration of the Separation Period, assuming the performance
                    metrics were waived and assuming a per share value of $0.81.</div>
                </td>

  </tr>


</table>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Separation Agreement also includes certain other customary representations, warranties and covenants of Dr. Federoff, and provides for
            reimbursement of certain expenses incurred by Dr Federoff. The Separation Agreement supersedes all other agreements or arrangements between Dr. Federoff and the Company regarding the subject matter of the agreement, including those with respect
            to severance payments and benefits.</div>

<div><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> </span></div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958148346992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;">Basis of Presentation</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </span> </div>

<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The






          accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial statements and with the instructions to
          Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the unaudited financial statements include all the
          normal recurring adjustments that are necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented.<br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">These












          condensed consolidated financial statements should be read together with the audited consolidated financial statements and notes thereto contained in Brooklyn&#8217;s Annual Report on Form 10-K/A for the year ended December 31, 2021 filed with the
          Securities and Exchange Commission (the &#8220;SEC&#8221;) on June 30, 2022 (the &#8220;10-K/A&#8221;). The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited financial statements contained in the 10-K/A, but does
          not include all of the information and footnotes required by GAAP for complete financial statements. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results to be anticipated for the
          entire year ending December 31, 2022, or any other period.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">
<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 36pt;"><span style="font-style: italic;">Reclassifi<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">cations</span></span>
        </div>

<div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-style: italic;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </span></span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Certain











          reclassifications have been made to Brooklyn&#8217;s prior years&#8217; financial statements to conform to the current year presentation. These reclassifications had no effect on Brooklyn&#8217;s previously reported results of operations or accumulated deficit.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958147619584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING PRONOUNCEMENTS (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none; text-indent: 36pt;">There were no recent accounting pronouncements issued during the
      three months ended March 31, 2022 that would have impacted the Company&#8217;s financial statements or operations.  </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958151035616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Tangible and Intangible Assets Acquired and Liabilities Assumed, Based on Estimated Fair Values</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The allocation of the purchase price to the tangible and
          intangible assets acquired and liabilities deemed to be assumed from Brooklyn, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                <div style="text-align: left;">&#160;</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                <div style="text-align: center; font-weight: bold;">Historical</div>
                <div style="text-align: center; font-weight: bold;">Balance</div>
                <div style="text-align: center; font-weight: bold;">Sheet of</div>
                <div style="text-align: center; font-weight: bold;">Brooklyn at</div>
                <div style="text-align: center; font-weight: bold;">March 25, 2021</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                <div style="text-align: center; font-weight: bold;">Fair Value</div>
                <div style="text-align: center; font-weight: bold;">Adjustment</div>
                <div style="text-align: center; font-weight: bold;">to Brooklyn</div>
                <div style="text-align: center; font-weight: bold;">Pre-Merger</div>
                <div style="text-align: center; font-weight: bold;">Assets</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;" valign="bottom">
                <div style="font-weight: bold;">Price</div>
                <div><span style="font-weight: bold;">Purchase</span></div>
                <div><span style="font-weight: bold;">Allocation</span></div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Cash and cash equivalents</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>148</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>148</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Accounts receivable</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>103</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>103</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Prepaid expense and other current assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>329</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>329</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Property and equipment, net</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>1,015</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>1,015</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Software development costs</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>1,296</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>(368</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>928</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Customers</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>548</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>548</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Trade name</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>299</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>299</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Accounts payable, accrued liabilities and other current</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                <div>(3,781</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                <div>(3,781</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom">
                <div style="text-align: left;">Net assets acquired, excluding goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>(890</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>479</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>(411</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Total consideration</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>8,178</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">Net assets acquired, excluding goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div>(411</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom">
                <div style="text-align: left;">Goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>8,589</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposition Details</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On March 26, 2021, Brooklyn sold its rights, title and
          interest in and to the assets relating to the business it operated (under the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $2.0 million and assumption of specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of
          the Disposition are as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Proceeds from sale:</div>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">Cash</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">132</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Escrow</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>100</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Assume advance/loans</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>1,700</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Interest on advance/loans</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>68</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Carrying value of assets sold:</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Cash and cash equivalents</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(14</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Accounts receivable</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(75</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Prepaids and other current assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(124</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Property and equipment, net</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(1,014</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Software development costs</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(927</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Customers</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(548</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Trade name</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(299</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(8,589</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Other assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(103</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Liabilities transferred upon sale:</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Accounts payable and accrued expenses</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>113</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Obligations under finance leases</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>17</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Lease liability</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>26</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Deferred revenue</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>55</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Other current liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>149</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Transaction costs</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(265</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px;" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Total loss on sale of assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div style="font-weight: bold;">$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div style="font-weight: bold;">(9,598</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="font-weight: bold;">)</div>
              </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionTableTextBlock', window );">Fair Value of Asset Acquired</a></td>
<td class="text"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal;">The resulting fair value of the asset acquired is as follows (in thousands):</span>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">&#160;</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; text-indent: -9pt; font-weight: bold;">Fair Value of</div>
                <div style="text-align: center; text-indent: -9pt; font-weight: bold;">Consideration</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Cash paid</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>22,882</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Cash acquired</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(28</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Unrestricted shares</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>36,628</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">Restricted shares</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
                <div>22,056</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Total fair value of consideration paid</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>81,538</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">Less amount of cash paid for NoveCite investment</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div>(1,000</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Fair value of IPR&amp;D acquired</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div>80,538</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6911878&amp;loc=d3e8732-128492<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958148186672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Liabilities Measured at Fair Value</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The following tables summarize the liabilities that are measured at fair value as of March 31, 2022 (in thousands).&#160; There were no liabilities measured at fair value as of December 31, 2021:</div>

<div> <br/>
        </div>

<div>
          <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of March 31,
                    2022</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 1</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 2</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 3</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Liabilities:</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Pre-Funded Warrants</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,782</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Common Warrants</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,533</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,782</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,533</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
           </div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Changes in Warrant Liabilities</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company remeasured the fair value of the warrant liabilities as of March 31, 2022, and the following table presents the changes in the warrant
          liabilities from the issuance date (in thousands): </div>

<div>&#160;</div>

<div>
          <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pre-Funded <span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
                    </span></div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Warrants<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
                    </span></div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Level 2)</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Warrants<br/>
                    </span>(Level 3)</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Warrant<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
                    </span>Liabilities</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at January 1, 2022</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at March 9, 2022 (issuance date)</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,646</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9,943</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,589</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in fair value of warrant liabilities</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">136</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">590</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">726</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at March 31, 2022</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,782</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">10,533</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">13,315</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
            </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958151978560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>LEASES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Net Operating Lease Expense</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">During the three months ended March 31, 2022 and 2021, the net operating lease expenses were as follows (in thousands): </div>

<div><br/>
            </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three months ended March 31,</div>
                  </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><br/>
                  </td>

    <td colspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: #000000 solid 2px;" valign="bottom">2022<br/>
                  </td>

    <td colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: #000000 solid 2px;" valign="bottom">2021<br/>
                  </td>

    <td colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease expense</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">186</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">151</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Sublease income</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(21</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(21</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Variable lease expense</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">3</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">9</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Total lease expense</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">168</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">139</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock', window );">Operating Lease Right-of-use Assets and Liabilities</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2022 and the ending balances as of
              March 31, 2022, including the changes during the period (in thousands). </div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 8pt;"> <br/>
            </div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 8pt;">
              <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                      <div style="font-weight: bold;">Operating Lease</div>
                      <div><span style="font-weight: bold;">ROU Assets</span></div>
                    </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease ROU assets at January 1, 2022</div>
                    </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                    </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,567</div>
                    </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Amortization of operating lease ROU assets</div>
                    </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(102</div>
                    </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                    </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Write off of ROU asset due to lease termination</div>
                    </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1,372</div>
                    </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                    </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Operating lease ROU assets at March 31, 2022</div>
                    </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                    </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,093</div>
                    </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
            </div>

<div><br/>
            </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: center;">Operating Lease</div>
                    <div style="text-align: center;"> Liabilities</div>
                  </td>

    <td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease liabilities at January 1, 2022</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">2,723</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Principal payments on operating lease liabilities</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(103</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Write off of operating lease liability due to lease termination</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(1,453</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease liabilities at March 31, 2022</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,167</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Less non-current portion</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,018</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px;" valign="bottom">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Current portion at March 31, 2022</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">149</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Operating Lease Liabilities</a></td>
<td class="text"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;">The maturities of the
              operating lease liabilities are as follows (in thousands):</span>
<div><br/></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
                    <div>As of</div>
                    March 31,</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2022</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">201</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2023</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">270</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2024</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">272</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2025</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">274</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2026</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">267</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">245</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total payments</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,529</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less imputed interest</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(362</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>

  </tr>

  <tr>

    <td style="vertical-align: middle; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total operating lease liabilities</div>
                </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,167</div>
                </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating lease right-of-use assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958148179728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>ACCRUED EXPENSES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Expenses</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued expenses consisted of the following (in thousands):</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; width: 100%;">


  <tr>

    <td style="vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">March 31,</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</span><span style="text-decoration: underline;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
                    </span></span></div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2021</span><span style="text-decoration: underline;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
                    </span></span></div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued compensation<br/>
                </div>
              </td>

    <td colspan="1" style="font-family: &amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="font-family: &amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">637</div>
              </td>

    <td colspan="1" style="font-family: &amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: &amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="font-family: &amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">656</div>
              </td>

    <td colspan="1" style="font-family: &amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued research and development expenses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">311</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">222</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued general and administrative expenses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1,436</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">371</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Total accrued expenses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2,384</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1,249</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;">Accrued general and administrative expenses include $0.8 million for legal-related matters.<br/>
        </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958152043680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>STOCK-BASED COMPENSATION [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Weighted-Average Assumptions Used for Grants Issued</a></td>
<td class="text"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">The following weighted-average assumptions were used for stock options granted during the </span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">three</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"> months ended March </span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">31,</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">&#160;</span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">2022</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">:</span>
<div style="font-family: 'Times New Roman';"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Three months ended </span></div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">March 31</span><span style="font-family: 'Times New Roman';">,<span style="font-size: 10pt;"> </span>2022</span></div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="text-align: left; font-size: 10pt;">Weighted average risk-free rate</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="font-size: 10pt;">1.92</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="font-size: 10pt;">%</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%;" valign="bottom">
              <div style="text-align: left; font-size: 10pt;">Weighted average volatility</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%;" valign="bottom">
              <div style="font-size: 10pt;">93</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="font-size: 10pt;">%</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="text-align: left; font-size: 10pt;">Dividend yield</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255);" valign="bottom">
              <div style="font-size: 10pt;">0</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="font-size: 10pt;">%</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%;" valign="bottom">
              <div style="text-align: left; font-size: 10pt;">Expected term</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%;" valign="bottom">
              <div style="font-size: 10pt;"><span style="font-size: 10pt;">5.78 years<br/>
                </span></div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summarizes of Stock Option Activity</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> The following table summarizes stock option activity for the </span><span style="font-family: 'Times New Roman';">three<span style="font-size: 10pt;"> months ended March </span>31,<span style="font-size: 10pt;">&#160;</span>2022<span style="font-size: 10pt;">:</span></span></div>

<div style="font-family: 'Times New Roman';"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Outstanding Options</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Weighted Average Exercise Price per Share</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Weighted Average Remaining Contractual Life (in years)</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Aggregate Intrinsic Value</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Outstanding January </span><span style="font-family: 'Times New Roman'; font-weight: bold;">1,<span style="font-size: 10pt;"> </span>2022</span></div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">3,988,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">8.40</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">9.38</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">-</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 52%;" valign="bottom">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-size: 10pt;">1,258,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-size: 10pt;">2.10</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-size: 10pt;">-</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-size: 10pt;">-</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Cancelled</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">(67,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="font-size: 10pt;">)</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
              <div style="font-size: 10pt;">5.94</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
              <div style="font-size: 10pt;">-</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Outstanding March 31</span><span style="font-family: 'Times New Roman'; font-weight: bold;">,<span style="font-size: 10pt;"> </span>2022</span></div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">5,179,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">6.90</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">9.32</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">134,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Options vested and exercisable at March </span><span style="font-family: 'Times New Roman';">31,<span style="font-size: 10pt;">&#160;</span>2022</span></div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">10,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">10.26</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">9.75</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">-</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summarizes of RSU Activity</a></td>
<td class="text"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">The following table summarizes RSU activity for the </span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">three</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"> months ended March </span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">31,</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">&#160;</span><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;">2022</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;">:</span>
<div style="font-family: 'Times New Roman';"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Outstanding Restricted Stock Units</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="text-align: center; font-size: 10pt; font-weight: bold;">Weighted Average Fair Value per Share</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">January </span><span style="font-family: 'Times New Roman'; font-weight: bold;">1,<span style="font-size: 10pt;"> 2022</span></span></div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">240,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">13.80</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%;" valign="bottom">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Granted</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-size: 10pt;">1,101,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-size: 10pt;">1.93</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Released</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">(9,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="font-size: 10pt;">)</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-size: 10pt;">4.21</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="text-align: left; font-size: 10pt; margin-left: 9pt;">Cancelled</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">(9,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="font-size: 10pt;">)</div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;" valign="bottom">
              <div style="font-size: 10pt;">4.21</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;">March 31</span><span style="font-family: 'Times New Roman'; font-weight: bold;"><span style="font-size: 10pt;"> </span>2022</span></div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">1,323,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">
              <div style="font-size: 10pt;">$</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">4.05</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 76%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Balance expected to vest at March </span><span style="font-family: 'Times New Roman';">31,<span style="font-size: 10pt;">&#160;</span>2022</span></div>
            </td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
              <div style="font-size: 10pt;">772,000</div>
            </td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958149071232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>EARNINGS PER SHARE [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Computation of Diluted Net Loss per Common Share</a></td>
<td class="text"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;">The following
        table presents the amount of stock options, RSUs, warrants and convertible preferred stock that were excluded from the computation of diluted net loss per common share for three months ended March 31, 2022 and 2021, as their effect was
        anti-dilutive:</span>
<div><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom;" valign="bottom">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">Three months ended March 31,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">2022</div>
            </td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; text-align: center;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">2021</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Stock options</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">5,179,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">RSUs</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">1,323,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Warrants</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">6,857,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">-</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Preferred stock converted into common stock</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">48,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">42,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Total potential common shares excluded from computation</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">13,407,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">42,000</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958144758352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)<br></strong></div></th>
<th class="th"><div>Jul. 16, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember', window );">NoveCite, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Description of Business [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of total outstanding equity interests</a></td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958243874848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LIQUIDITY AND CAPITAL RESOURCES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 09, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract', window );"><strong>Liquidity and Capital Resources [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150,077)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (140,702)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,375)<span></span>
</td>
<td class="num">$ (18,522)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,432)<span></span>
</td>
<td class="num">$ (3,430)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Net proceeds</a></td>
<td class="nump">$ 11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958146122656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Merger (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Merger Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Number of shares of common stock owned by Brooklyn stockholders immediately before the Merger (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,452,000<span></span>
</td>
<td class="nump">52,021,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Merger Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of outstanding common stock received by members and financial adviser</a></td>
<td class="nump">96.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number of common stock issued in exchange of membership interests (in shares)</a></td>
<td class="nump">39,992,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of common stock issued as compensation for services (in shares)</a></td>
<td class="nump">1,068,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Purchase price</a></td>
<td class="nump">$ 8,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Closing price of common stock (in dollars per share)</a></td>
<td class="nump">$ 5.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Number of shares of common stock owned by Brooklyn stockholders immediately before the Merger (in shares)</a></td>
<td class="nump">1,514,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 8,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958144696624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expense and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts', window );">Software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable, accrued liabilities and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired, excluding goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(890)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement', window );">Cash and cash equivalents obligated to have under merger agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_BeneficialHoldersContractualCommitmentsToInvest', window );">Beneficial holders contractual commitments to invest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfAdditionalRightsOffering', window );">Percentage of additional rights offering</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ProceedsFromSaleOfRights', window );">Proceeds from right offering</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Fair Value Adjustment to Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expense and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts', window );">Software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(368)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable, accrued liabilities and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired, excluding goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Fair Value Adjustment to Assets [Member] | Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Fair Value Adjustment to Assets [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Purchase Price Allocation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expense and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts', window );">Software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable, accrued liabilities and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired, excluding goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(411)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Purchase Price Allocation [Member] | Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Purchase Price Allocation [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_BeneficialHoldersContractualCommitmentsToInvest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual commitment made by beneficial holders to invest in the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_BeneficialHoldersContractualCommitmentsToInvest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of software development costs recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents obligated to maintain under merger agreement on balance sheet at the effective time of the merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageOfAdditionalRightsOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of additional right offering made by the entity for unit holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageOfAdditionalRightsOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ProceedsFromSaleOfRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of rights during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ProceedsFromSaleOfRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=btx_ProFormaFairValueAdjustmentToAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=btx_ProFormaFairValueAdjustmentToAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=btx_PurchasePriceAllocationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=btx_PurchasePriceAllocationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958149790320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Disposition (Details) - NTN Business [Member]<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 26, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DispositionAbstract', window );"><strong>Disposition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets', window );">Sale of rights, title and interest in and to the assets relating to the business</a></td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ProceedsFromDispositionAbstract', window );"><strong>Proceeds from sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash', window );">Cash</a></td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow', window );">Escrow</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans', window );">Assume advance/loans</a></td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans', window );">Interest on advance/loans</a></td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Carrying value of assets sold [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable</a></td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets', window );">Prepaids and other current assets</a></td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="num">(1,014)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts', window );">Software development costs</a></td>
<td class="num">(927)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="num">(8,589)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets</a></td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities transferred upon sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases', window );">Obligations under finance leases</a></td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability', window );">Lease liability</a></td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts', window );">Transaction costs</a></td>
<td class="num">(265)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Total loss on sale of assets</a></td>
<td class="num">(9,598)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=btx_NTNBusinessMember', window );">Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Carrying value of assets sold [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(548)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=btx_NTNBusinessMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Carrying value of assets sold [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">$ (299)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as Lease liability attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as Obligations under finance leases attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate proceeds received from assume advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate proceeds received from escrow deposits in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate proceeds received from interest on advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as software development cost attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of the business disposal including legal, accounting, and other costs incurred to consummate the business disposition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DispositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DispositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ProceedsFromDispositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ProceedsFromDispositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred revenue attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=btx_NTNBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=btx_NTNBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958147527008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Acquisition (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 16, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,765,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=btx_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherProductiveAssets', window );">Cash</a></td>
<td class="nump">$ 22,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Acquisition of common stock (in shares)</a></td>
<td class="nump">7,022,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition agreement</a></td>
<td class="nump">$ 102,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AssetAcquisitionSharePrice', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 14.5253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Fair value of shares issued</a></td>
<td class="nump">$ 58,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_EscrowShares', window );">Escrow shares (in shares)</a></td>
<td class="nump">741,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AcquisitionAgreementNonCompetitivePeriod', window );">Non-compete period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_EachLockUpAgreementExtendsTerm', window );">Each lock-up agreement extend term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PaymentsToAcquireProductiveAssetsNet', window );">Cash paid, net</a></td>
<td class="nump">$ 22,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions', window );">Unrestricted shares, issued (in shares)</a></td>
<td class="nump">3,644,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions', window );">Restricted shares, issued (in shares)</a></td>
<td class="nump">3,378,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LockUpPeriodForRestrictedShares', window );">Lock-up period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AssetAcquisitionUnrestrictedSharesSharePrice', window );">Unrestricted shares, fair value per share (in dollars per share)</a></td>
<td class="nump">$ 10.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfDiscountOnFairValueOfRestrictedShares', window );">Percentage of discount on fair value restricted shares</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AssetAcquisitionRestrictedSharesSharePrice', window );">Restricted shares, fair value per share (in dollars per share)</a></td>
<td class="nump">$ 6.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Cash paid</a></td>
<td class="nump">$ 22,882,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="num">(28,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions', window );">Unrestricted shares, value</a></td>
<td class="nump">36,628,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions', window );">Restricted shares, value</a></td>
<td class="nump">22,056,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AssetAcquisitionFairValueOfConsiderationPaid', window );">Total fair value of consideration paid</a></td>
<td class="nump">81,538,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Less amount of cash paid for NoveCite investment</a></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ResearchAndDevelopmentInProcessAssetAcquisition', window );">Acquired in-process research and development</a></td>
<td class="nump">$ 80,538,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=btx_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member] | Chair of the Board of Directors, Chief Executive Officer and President [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Lock-up agreements shares received in acquisition (in shares)</a></td>
<td class="nump">3,378,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=btx_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_EscrowPeriod', window );">Period of escrow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfCommonStockSubjectToLockUpAgreement', window );">Percentage of common stock subject to the lock-up agreement</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember', window );">NoveCite, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of total outstanding equity interests</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AcquisitionAgreementNonCompetitivePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Acquisition Agreement contains non-competition and non-solicitation provisions pursuant to which the Seller has agreed not to engage in certain competitive activities for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AcquisitionAgreementNonCompetitivePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AssetAcquisitionFairValueOfConsiderationPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fair value of consideration paid in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AssetAcquisitionFairValueOfConsiderationPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AssetAcquisitionRestrictedSharesSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered with restrictions to be paid in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AssetAcquisitionRestrictedSharesSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AssetAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AssetAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AssetAcquisitionUnrestrictedSharesSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered without any restrictions to be paid in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AssetAcquisitionUnrestrictedSharesSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_EachLockUpAgreementExtendsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The period of lock-up agreement extend term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_EachLockUpAgreementExtendsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_EscrowPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The period of secure indemnification obligations to acquisition agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_EscrowPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_EscrowShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares have been placed in escrow shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_EscrowShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LockUpPeriodForRestrictedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The period in which shares are locked-up, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LockUpPeriodForRestrictedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PaymentsToAcquireProductiveAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets excluding cash acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PaymentsToAcquireProductiveAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageOfCommonStockSubjectToLockUpAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of shares of common stock subject to the lock-up agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageOfCommonStockSubjectToLockUpAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageOfDiscountOnFairValueOfRestrictedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of discount on restricted shares, which was derived from the average discount rate between the Black Scholes and Finnerty valuation models.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageOfDiscountOnFairValueOfRestrictedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ResearchAndDevelopmentInProcessAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ResearchAndDevelopmentInProcessAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued with restrictions during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued with restrictions during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued without any restrictions during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued without any restrictions during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=btx_NovellusTherapeuticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=btx_NovellusTherapeuticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958144522656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Investment in NoveCite (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 16, 2021 </div>
<div>USD ($) </div>
<div>BoardMember</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 385<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember', window );">NoveCite, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_NumberOfBoardSeats', window );">Number of board seats | BoardMember</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Losses on investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember', window );">NoveCite, INC. [Member] | Citius Pharmaceuticals, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage by Citius</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_NumberOfBoardSeats">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of members of the company's management holds board seats on board of directors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_NumberOfBoardSeats</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=btx_CitiusPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=btx_CitiusPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958144474016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS, Liabilities Measured at Fair Value (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 09, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,357,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember', window );">Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,857,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | Pre-funded Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | Common Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">2,782,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Pre-funded Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">2,782,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Common Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">10,533,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Pre-funded Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Common Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">$ 10,533,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958150201232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS, Changes in Warrant Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Changes in Fair Value of Warrant Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_OverSubscriptionAmountReceived', window );">Over-subscription amount received</a></td>
<td class="nump">$ 600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Gross proceeds received</a></td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Fair value at March 9, 2022 (issuance date)</a></td>
<td class="nump">12,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, end of period</a></td>
<td class="nump">13,315<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Changes in Fair Value of Warrant Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Fair value at March 9, 2022 (issuance date)</a></td>
<td class="nump">2,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, end of period</a></td>
<td class="nump">2,782<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Changes in Fair Value of Warrant Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Fair value at March 9, 2022 (issuance date)</a></td>
<td class="nump">9,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, end of period</a></td>
<td class="nump">$ 10,533<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_OverSubscriptionAmountReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_OverSubscriptionAmountReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958151173088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES, Operating Lease (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Mar. 05, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>LEASES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_OperatingLeaseArea', window );">Operating lease area | ft&#178;</a></td>
<td class="nump">5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">62 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_BaseRentPerSquareFoot', window );">Base rent (per square foot) | ft&#178;</a></td>
<td class="nump">6.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageBaseRentIncreaseOnEachAnniversary', window );">Percentage of increase in base rent on each year</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extended lease term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LesseeCommitmentToPurchaseProperty', window );">Commitment to purchase equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_UnamortizedLeaseholdImprovements', window );">Unamortized leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Security deposit</a></td>
<td class="nump">$ 421,000<span></span>
</td>
<td class="nump">$ 63,000<span></span>
</td>
<td class="nump">$ 488,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_BaseRentPerSquareFoot">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of base rent expense per square foot for leased asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_BaseRentPerSquareFoot</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LesseeCommitmentToPurchaseProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property for which lessee committed to purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LesseeCommitmentToPurchaseProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_OperatingLeaseArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of leased property under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_OperatingLeaseArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageBaseRentIncreaseOnEachAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of base rent increase on each anniversary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageBaseRentIncreaseOnEachAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_UnamortizedLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of unamortized leasehold improvements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_UnamortizedLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958149453456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES, Net Operating Lease Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Net Operating Lease Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 186<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease expense</a></td>
<td class="nump">$ 168<span></span>
</td>
<td class="nump">$ 139<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958151180592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES, Operating Lease Right-of-use Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_OperatingLeaseAssestAbstract', window );"><strong>Operating Lease, Asset [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease ROU assets, Beginning</a></td>
<td class="nump">$ 2,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease ROU assets</a></td>
<td class="num">(102)<span></span>
</td>
<td class="num">$ (70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_WriteOffOfOperatingLeaseRightOfUseAsset', window );">Write off of ROU asset due to lease termination</a></td>
<td class="num">(1,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease ROU assets, Ending</a></td>
<td class="nump">1,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Operating Lease, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, Beginning</a></td>
<td class="nump">2,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrincipalPaymentsOnOperatingLeaseLiabilities', window );">Principal payments on operating lease liabilities</a></td>
<td class="num">(103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_WriteOffOfOperatingLeaseLiability', window );">Write off of operating lease liability due to lease termination</a></td>
<td class="num">(1,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, Ending</a></td>
<td class="nump">1,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Less non-current portion</a></td>
<td class="nump">1,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_OperatingLeaseAssestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_OperatingLeaseAssestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PrincipalPaymentsOnOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal payments on operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PrincipalPaymentsOnOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_WriteOffOfOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of operating lease liability due to lease termination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_WriteOffOfOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_WriteOffOfOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of operating lease right-of-use asset due to lease termination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_WriteOffOfOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958147518528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES, Maturities of Operating Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract', window );"><strong>Weighted Average Remaining Lease Term and Discount Rate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">10.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Maturities of Operating Lease Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total payments</a></td>
<td class="nump">1,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 1,167<span></span>
</td>
<td class="nump">$ 2,723<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958149467584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">$ 5,990<span></span>
</td>
<td class="nump">$ 5,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (in dollars per share)</a></td>
<td class="nump">$ 2.05<span></span>
</td>
<td class="nump">$ 4.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958152183328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>ACCRUED EXPENSES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 637<span></span>
</td>
<td class="nump">$ 656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AccruedResearchAndDevelopmentExpenses', window );">Accrued research and development expenses</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AccruedGeneralAndAdministrativeExpenses', window );">Accrued general and administrative expenses</a></td>
<td class="nump">1,436<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">2,384<span></span>
</td>
<td class="nump">$ 1,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal Expenses</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AccruedGeneralAndAdministrativeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued general and administrative expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AccruedGeneralAndAdministrativeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AccruedResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AccruedResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958146124736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES, Legal Matters (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 15, 2021 </div>
<div>USD ($) </div>
<div>BoardMember</div>
</th>
<th class="th">
<div>Feb. 05, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LegalMattersAbstract', window );"><strong>Legal Matters [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued Professional Fees, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LegalMattersAbstract', window );"><strong>Legal Matters [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyDamagesSoughtExpectedSalary', window );">Defendants salary promised against plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyDamagesSoughtExpectedEquityPercentage', window );">Percentage of equity promised against plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LegalMattersAbstract', window );"><strong>Legal Matters [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, damages sought, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_DheshGovenderMember', window );">Govender [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LegalMattersAbstract', window );"><strong>Legal Matters [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyDamagesSoughtExpectedSalary', window );">Defendants salary promised against plaintiff</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyDamagesSoughtExpectedEquityPercentage', window );">Percentage of equity promised against plaintiff</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyNumberOfArbitrationPanel', window );">Number of member arbitration panel | BoardMember</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_DheshGovenderMember', window );">Govender [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LegalMattersAbstract', window );"><strong>Legal Matters [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, damages sought, value</a></td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LegalMattersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LegalMattersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossContingencyDamagesSoughtExpectedEquityPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of equity promised to the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossContingencyDamagesSoughtExpectedEquityPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossContingencyDamagesSoughtExpectedSalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The monetary amount of salary promised to the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossContingencyDamagesSoughtExpectedSalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossContingencyNumberOfArbitrationPanel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number member in arbitration panel pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossContingencyNumberOfArbitrationPanel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_DheshGovenderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_DheshGovenderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958149689248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES, Licensing Agreements (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 15, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 13, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>Patents</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 26, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MilestonePayments', window );">Milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusLtdAndFactorBioscienceMember', window );">Licensors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyNonRefundableOptionFee', window );">Non-refundable option fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_InitialLicenseFees', window );">Initial license fees</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AdditionalFeesObligatedToPay', window );">Amount require to pay of initial license fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AmountRequireToPayInitialLicenseFees', window );">Amount obligated to pay in license agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AmountObligatedToPayInYearOne', window );">Additional fees obligated to pay in 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MinimumNumberOfPatentGranted', window );">Minimum number of patent granted | Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MinimumNumberOfPendingPatents', window );">Number of maximum pending patents | Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusLtdAndFactorBioscienceMember', window );">Licensors [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AmountObligatedToPayInYearTwo', window );">Additional fees obligated to pay in 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NoveCiteMember', window );">NoveCite [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfRevenue', window );">Percentage of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=btx_UniversityOfSouthFloridaMember', window );">University of South Florida [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyPercentageOfRoyaltyPayable', window );">Percentage of royalty payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AdditionalFeesObligatedToPay">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity is obligated to pay additional fees to Licensors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AdditionalFeesObligatedToPay</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AmountObligatedToPayInYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity is obligated to pay additional fees to the Licensors in first year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AmountObligatedToPayInYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AmountObligatedToPayInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity is obligated to pay additional fees to the Licensors in second year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AmountObligatedToPayInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AmountRequireToPayInitialLicenseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount require to pay out of the total initial license fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AmountRequireToPayInitialLicenseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_InitialLicenseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial license fees required to pay including non-refundable fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_InitialLicenseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LicensingAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LicensingAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossContingencyNonRefundableOptionFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of Non-refundable option fee in licensing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossContingencyNonRefundableOptionFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossContingencyPercentageOfRoyaltyPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of royalty payable from one party to another in licensing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossContingencyPercentageOfRoyaltyPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_MilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of milestones upfront payment on licenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_MilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_MinimumNumberOfPatentGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum number of granted patents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_MinimumNumberOfPatentGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_MinimumNumberOfPendingPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum number of patents pending.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_MinimumNumberOfPendingPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenue from receives any revenue involving the original cell line included in the licensed technology, then Novellus, Ltd shall remit to NoveCite.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusLtdAndFactorBioscienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusLtdAndFactorBioscienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NoveCiteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NoveCiteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=btx_UniversityOfSouthFloridaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=btx_UniversityOfSouthFloridaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958147515712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES, Royalty Agreements (Details)<br></strong></div></th>
<th class="th"><div>Mar. 22, 2021</div></th>
<th class="th"><div>Jun. 22, 2018</div></th>
<th class="th"><div>May 01, 2012</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=btx_InvestorRoyaltyAgreementMember', window );">Investor Royalty Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_RoyaltyAgreementsAbstract', window );"><strong>Royalty Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness', window );">Percentage of royalty receive equal to revenues from sale of business</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales', window );">Percentage of payment of additional royalty on gross sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=btx_CollaboratorRoyaltyAgreementMember', window );">Collaborator Royalty Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_RoyaltyAgreementsAbstract', window );"><strong>Royalty Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness', window );">Percentage of royalty receive equal to revenues from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of additional royalty payable on gross sales by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of royalty receive equal to revenues generated from disposition of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_RoyaltyAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_RoyaltyAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=btx_InvestorRoyaltyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=btx_InvestorRoyaltyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=btx_CollaboratorRoyaltyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=btx_CollaboratorRoyaltyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958149851984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION, Weighted-Average Assumptions Used for Grants Issued (Details) - Stock Options [Member] - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock option awards granted (in shares)</a></td>
<td class="nump">1,258,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of stock option awards outstanding (in shares)</a></td>
<td class="nump">5,179,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,988,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assertions Used in Determining Fair Value of Stock Options Granted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted average risk-free rate</a></td>
<td class="nump">1.92%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Weighted average volatility</a></td>
<td class="nump">93.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">5 years 9 months 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958150169104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION, Stock Option Activity (Details) - Stock Options [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Option Share [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">3,988,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">1,258,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(67,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="nump">5,179,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,988,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 8.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">2.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">5.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance (in dollars per share)</a></td>
<td class="nump">$ 6.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract', window );"><strong>Weighted Average Remaining Contractual Life [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual life, outstanding</a></td>
<td class="text">9 years 3 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 4 months 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, ending balance</a></td>
<td class="nump">$ 134,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract', window );"><strong>Options Vested and Exercisable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options vested and exercisable, Outstanding (in shares)</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Options vested and exercisable, Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 10.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options vested and exercisable, weighted average remaining contractual life</a></td>
<td class="text">9 years 9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Options vested and exercisable, aggregate intrinsic value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958144446992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION, Summary of Stock Options (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>Installment </div>
<div>Grant </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_NumberOfStockOptionGrantMade', window );">Number of stock option grants made | Grant</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 1.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unamortized stock-based compensation expense | $</a></td>
<td class="nump">$ 18,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average remaining requisite service period</a></td>
<td class="text">3 years 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of stock option awards outstanding (in shares)</a></td>
<td class="nump">5,179,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,988,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock option awards granted (in shares)</a></td>
<td class="nump">1,258,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=btx_TimeBasedNonQualifiedStockOptionMember', window );">Time-Based Non-qualified Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock option awards granted (in shares)</a></td>
<td class="nump">2,628,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares', window );">Number of monthly installments | Installment</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=btx_TimeBasedNonQualifiedStockOptionMember', window );">Time-Based Non-qualified Stock Option [Member] | Vesting on one-year Anniversary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Stock-based compensation vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=btx_PerformanceBasedNonqualifiedStockOptionMember', window );">Performance-Based Nonqualified Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock option awards granted (in shares)</a></td>
<td class="nump">597,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue', window );">Stock-based compensation grant fair value | $</a></td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_NumberOfStockOptionGrantMade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock option grants made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_NumberOfStockOptionGrantMade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fair value of share-based payment arrangement, subject to vesting and other restrictions, to purchase or sell certain number of shares on performance basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of monthly installments for vesting of remaining shares in share-based compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=btx_TimeBasedNonQualifiedStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=btx_TimeBasedNonQualifiedStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=btx_PerformanceBasedNonqualifiedStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=btx_PerformanceBasedNonqualifiedStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958147427856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION, RSUs (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>Goals </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Outstanding Restricted Stock Units [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, Beginning balance (in shares)</a></td>
<td class="nump">240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">1,101,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares)</a></td>
<td class="num">(9,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(9,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, Ending balance (in shares)</a></td>
<td class="nump">1,323,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber', window );">Balance expected to vest (in shares)</a></td>
<td class="nump">772,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Fair Value Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Fair Value Per Share, Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 13.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">1.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in dollars per share) | $ / shares</a></td>
<td class="nump">4.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancelled (in dollars per share) | $ / shares</a></td>
<td class="nump">4.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Fair Value Per Share, Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of stock units awards outstanding (in shares)</a></td>
<td class="nump">1,323,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unamortized stock-based compensation expense | $</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average remaining requisite service period</a></td>
<td class="text">2 years 7 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=btx_Two022PerformanceBasedRestrictedStockUnitsMember', window );">2022 PSUs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Fair Value Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_NumberOfPerformanceGoalsAreSubjectToAchieve', window );">Number of performance goals are subject to achieve | Goals</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Restricted stock units vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=btx_Two022PerformanceBasedRestrictedStockUnitsMember', window );">2022 PSUs [Member] | Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Outstanding Restricted Stock Units [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">1,101,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=btx_Two022PerformanceBasedRestrictedStockUnitsMember', window );">2022 PSUs [Member] | Dr. Federoff [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Outstanding Restricted Stock Units [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">414,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_NumberOfPerformanceGoalsAreSubjectToAchieve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of performance goals are subject to achieve under 2022 performance based restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_NumberOfPerformanceGoalsAreSubjectToAchieve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options expected to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=btx_Two022PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=btx_Two022PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=btx_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=btx_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=btx_ChiefExecutiveOfficerAndPresidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=btx_ChiefExecutiveOfficerAndPresidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958146044816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION, Restricted Stock and Stock-Based Compensation Expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Common Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock replaced during the period (in shares)</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Unvested restricted common stock forfeited (in shares)</a></td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock outstanding (in shares)</a></td>
<td class="nump">1,323,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Common Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock replaced during the period (in shares)</a></td>
<td class="nump">630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Unvested restricted common stock forfeited (in shares)</a></td>
<td class="nump">78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958149673776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY, Private Placement of Equity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Aggregate gross purchase price</a></td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Warrants fair value</a></td>
<td class="nump">12,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_OverSubscriptionAmountReceived', window );">Over-subscription amount received</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember', window );">Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price (in dollars per share)</a></td>
<td class="nump">$ 1.91<span></span>
</td>
<td class="nump">$ 1.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights', window );">Percentage of warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants outstanding weighted average contractual life</a></td>
<td class="text">5 years 5 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">6,857,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights', window );">Percentage of warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">1,357,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember', window );">PIPE Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,857,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Aggregate gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Warrants fair value</a></td>
<td class="nump">$ 12,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_OverSubscriptionAmountReceived', window );">Over-subscription amount received</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth', window );">Obligation to pay liquidated damages per month</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_TransactionFeesPayable', window );">Transaction fees</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ConsecutiveCalendarDays', window );">Consecutive calendar days</a></td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AggregateCalendarDays', window );">Aggregate calendar days</a></td>
<td class="text">15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimated contingent loss</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember', window );">PIPE Investor [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ObligationToPayLiquidatedDamagesPercentage', window );">Obligated to pay liquidated damages percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember', window );">PIPE Investor [Member] | Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember', window );">PIPE Investor [Member] | Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,357,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AggregateCalendarDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified aggregate calendar days (which need not be consecutive calendar days) during any 12-month period for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AggregateCalendarDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of securities that would be issuable upon the exercise of warrants or rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ClassOfWarrantOrRightsExercisableTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ClassOfWarrantOrRightsExercisableTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ConsecutiveCalendarDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified consecutive calendar days for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ConsecutiveCalendarDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ObligationToPayLiquidatedDamagesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages percentage of aggregate payment on Subscription Amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ObligationToPayLiquidatedDamagesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages equal to the Subscription Amount per month.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_OverSubscriptionAmountReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_OverSubscriptionAmountReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PrivatePlacementOfEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PrivatePlacementOfEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_TransactionFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fees incurred related to PIPE transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_TransactionFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958151047552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY, Reverse Stock-Split (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 25, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ReverseStockSplitAbstract', window );"><strong>Reverse Stock-Split [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock conversion ratio</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Stock outstanding, reverse stock splits (in shares)</a></td>
<td class="nump">1,514,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ReverseStockSplitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ReverseStockSplitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in the number of shares during the period as a result of a reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958149692384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY, Merger (Details) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesAcquisitions1', window );">Stock issued, shares, acquisition (in shares)</a></td>
<td class="nump">1,068,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued in merger agreement (in shares)</a></td>
<td class="nump">87,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted to common stock (in shares)</a></td>
<td class="nump">22,275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued in merger agreement (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted to common stock (in shares)</a></td>
<td class="nump">2,515,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued in merger agreement (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted to common stock (in shares)</a></td>
<td class="nump">1,676,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ClassOfWarrantOrRightIssued', window );">Number of rights options issued (in shares)</a></td>
<td class="nump">10,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of rights options converted (in shares)</a></td>
<td class="nump">11,828,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued in merger agreement (in shares)</a></td>
<td class="nump">630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted to common stock (in shares)</a></td>
<td class="nump">630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesAcquisitions1', window );">Stock issued, shares, acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,514,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ClassOfWarrantOrRightIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued into which the class of warrant or right may be converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ClassOfWarrantOrRightIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_MergerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_MergerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodSharesAcquisitions1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodSharesAcquisitions1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958150157616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">13,407,000<span></span>
</td>
<td class="nump">42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">5,179,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">1,323,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">6,857,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Preferred Stock Converted into Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">48,000<span></span>
</td>
<td class="nump">42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to be outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,357,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139958147499360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENT (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th"><div>May 24, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_SeparationAgreementAbstract', window );"><strong>Separation Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
<td class="nump">$ 4.17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Dr. Federoffs's [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_SeparationAgreementAbstract', window );"><strong>Separation Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForPostemploymentBenefits', window );">Severance benefit</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PaymentToOfficerBaseSalary', window );">Payment of annual base salary</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option outstanding (in shares)</a></td>
<td class="nump">1,420,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable period</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits', window );">Severance benefit receivable based on performance restricted stock</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Dr. Federoffs's [Member] | Milestone Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_SeparationAgreementAbstract', window );"><strong>Separation Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option outstanding (in shares)</a></td>
<td class="nump">414,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable period</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PaymentToOfficerBaseSalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflows for payment of annual base salary for a period of twelve months after the expiration of the applicable revocation period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PaymentToOfficerBaseSalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_SeparationAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_SeparationAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of severance benefit, would have received if he was entitled to receive a settlement of a pro rata portion of his performance restricted stock units through the expiration of the Separation Period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflows for payments of postemployment benefits (such as severance pay and health insurance benefits) recognized during the period. Postemployment benefits are benefits paid to employees after employment but before retirement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=btx_MilestoneOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=btx_MilestoneOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>brhc10039260_10q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:btx="http://brooklynitx.com/20220331"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="btx-20220331.xsd" xlink:type="simple"/>
    <context id="c20220101to20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-16</instant>
        </period>
    </context>
    <context id="c20220309to20220309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2022-03-09</startDate>
            <endDate>2022-03-09</endDate>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:PurchasePriceAllocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:PurchasePriceAllocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:PurchasePriceAllocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-26</startDate>
            <endDate>2021-03-26</endDate>
        </period>
    </context>
    <context id="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-26</instant>
        </period>
    </context>
    <context id="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-26</instant>
        </period>
    </context>
    <context id="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-26</instant>
        </period>
    </context>
    <context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-16</instant>
        </period>
    </context>
    <context id="c20220101to20220331_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20210701to20210930_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c20210716_OwnershipAxis_CitiusPharmaceuticalsIncMember_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">btx:CitiusPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-16</instant>
        </period>
    </context>
    <context id="c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220309_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-09</instant>
        </period>
    </context>
    <context id="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-09</instant>
        </period>
    </context>
    <context id="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-03-05</instant>
        </period>
    </context>
    <context id="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:DheshGovenderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-15</startDate>
            <endDate>2021-12-15</endDate>
        </period>
    </context>
    <context id="c20210205to20210205_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-05</startDate>
            <endDate>2021-02-05</endDate>
        </period>
    </context>
    <context id="c20210205to20210205_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-05</startDate>
            <endDate>2021-02-05</endDate>
        </period>
    </context>
    <context id="c20211215to20211215_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:DheshGovenderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-15</startDate>
            <endDate>2021-12-15</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_LegalEntityAxis_UniversityOfSouthFloridaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">btx:UniversityOfSouthFloridaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210413to20210413_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-13</startDate>
            <endDate>2021-04-13</endDate>
        </period>
    </context>
    <context id="c20210430to20210430_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c20210415to20210415_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-15</startDate>
            <endDate>2021-04-15</endDate>
        </period>
    </context>
    <context id="c20210426_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-26</instant>
        </period>
    </context>
    <context id="c20211031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember_StatementScenarioAxis_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_RelatedPartyTransactionsByRelatedPartyAxis_NoveCiteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NoveCiteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20180622to20180622_TypeOfArrangementAxis_CollaboratorRoyaltyAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">btx:CollaboratorRoyaltyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-22</startDate>
            <endDate>2018-06-22</endDate>
        </period>
    </context>
    <context id="c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">btx:InvestorRoyaltyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-22</startDate>
            <endDate>2021-03-22</endDate>
        </period>
    </context>
    <context id="c20120501to20120501_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">btx:InvestorRoyaltyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-05-01</startDate>
            <endDate>2012-05-01</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210331_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20211231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220331_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_TimeBasedNonQualifiedStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:TimeBasedNonQualifiedStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_PerformanceBasedNonqualifiedStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:PerformanceBasedNonqualifiedStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_TimeBasedNonQualifiedStockOptionMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:TimeBasedNonQualifiedStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">btx:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_EmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">btx:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220306_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_InvestmentTypeAxis_PIPEInvestorMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210325to20210325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325_StatementClassOfStockAxis_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_StatementClassOfStockAxis_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_StatementClassOfStockAxis_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325to20210325_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220524to20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-24</startDate>
            <endDate>2022-05-24</endDate>
        </period>
    </context>
    <context id="c20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-24</instant>
        </period>
    </context>
    <context id="c20220524_AwardTypeAxis_MilestoneOptionsMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:MilestoneOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-24</instant>
        </period>
    </context>
    <context id="c20220524to20220524_AwardTypeAxis_MilestoneOptionsMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:MilestoneOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-24</startDate>
            <endDate>2022-05-24</endDate>
        </period>
    </context>
    <unit id="U001">
        <measure>shares</measure>
    </unit>
    <unit id="U002">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U003">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U004">
        <measure>pure</measure>
    </unit>
    <unit id="U005">
        <measure>btx:BoardMember</measure>
    </unit>
    <unit id="U006">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U007">
        <measure>btx:Patents</measure>
    </unit>
    <unit id="U008">
        <measure>btx:Grant</measure>
    </unit>
    <unit id="U009">
        <measure>btx:Installment</measure>
    </unit>
    <unit id="U010">
        <measure>btx:Goals</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="c20220101to20220331"
      id="Fact_aef57c70c8cc45f0b03d78368815f85e">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="c20220101to20220331"
      id="Fact_cfdaaf8af54240ad9c37cd21f8005599">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="c20220101to20220331"
      id="Fact_977a642547fa49a885e5e72648a16533">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="c20220101to20220331"
      id="Fact_d32c95b857cc49d5b025bb9697148cec">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="c20220101to20220331"
      id="Fact_871499ceee824fa8b1f6465ab53ceb36">0000748592</dei:EntityCentralIndexKey>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_2134c2193a6f4a199f8e2044d8c27aaf">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <btx:AggregateCalendarDays
      contextRef="c20220101to20220331_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_1d1a0b74074845069916ad1b1bee6544">P15D</btx:AggregateCalendarDays>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="c20210325to20210325"
      decimals="INF"
      id="Fact_c7f77014cf9a4ef9a688995037fe55b0"
      unitRef="U004">0.5</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <dei:DocumentType
      contextRef="c20220101to20220331"
      id="Fact_65a5bd1dc56e4e9fa76fe4c159364cb1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="c20220101to20220331"
      id="Fact_f5695269fd9849b1ad3e287311e756db">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="c20220101to20220331"
      id="Fact_1a5e02a723a44803911ce76215333228">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="c20220101to20220331"
      id="Fact_8f0bb10d72d14a57a69b5a993fd689db">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="c20220101to20220331"
      id="Fact_90945eedff1d43ccb6b9f2cf10eb4255">001-11460</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="c20220101to20220331"
      id="Fact_667a4cb77c0e4f97a5f98867d5da68f7">Brooklyn ImmunoTherapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220101to20220331"
      id="Fact_365d4ddc9f38423e9711b8d4963edc92">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220101to20220331"
      id="Fact_97b5b2e4b47d404f9034ad5fbfd3ff25">31-1103425</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220101to20220331"
      id="Fact_24198666a6e1424db0ed06e7967ad2a3">10355 Science Center Drive, Suite 150</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20220101to20220331"
      id="Fact_7ddd7994e15149029c9b495d3f55e217">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20220101to20220331"
      id="Fact_d6a7dfe18d2540d191c1187b4d1f1189">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220101to20220331"
      id="Fact_0e555dd5288741d7b9cd4cb57dbe1c83">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20220101to20220331"
      id="Fact_aec6d7905fe745589eba585f16b05baa">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220101to20220331"
      id="Fact_3140b70708c34c3b9a68858bc300e443">582-1199</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="c20220101to20220331"
      id="Fact_784fd6f68af849e29a263038edce410e">Common Stock, $0.005 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220101to20220331"
      id="Fact_e013b520c9f44ff789c9f63b9dd0b8af">BTX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20220101to20220331"
      id="Fact_62cb464167ec4dbf90e91b7d4085fc8e">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="c20220101to20220331"
      id="Fact_76afc7460ee64ea68778bff5cb3053c1">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="c20220101to20220331"
      id="Fact_bd444aff6e7b4585aa924e220d53ef0e">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="c20220101to20220331"
      id="Fact_6ad38af2f2c743f7a2915bc8443fc032">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="c20220101to20220331"
      id="Fact_ccf1d8e8266345448d6fdca3a5cd7b08">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220101to20220331"
      id="Fact_b9f91141568345a09bf6e35e6d05b327">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="c20220101to20220331"
      id="Fact_95af04fbd2c948c29a2cb7458163301a">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c20220630"
      decimals="INF"
      id="Fact_bc957f6268e2465a826577b07f033e50"
      unitRef="U001">57468597</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash
      contextRef="c20220331"
      decimals="-3"
      id="Fact_95dda23c92d847678e06bd2488a77e2c"
      unitRef="U002">23500000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="c20211231"
      decimals="-3"
      id="Fact_00fbac43fe3841daa4f9f17da38d8a8c"
      unitRef="U002">16985000</us-gaap:Cash>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_eb3475879c984b229da0795b69991627"
      unitRef="U002">835000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ee182beb80e7427a8e44921a96eb5c21"
      unitRef="U002">684000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_924d072972a64dd2b93231a29a239d7a"
      unitRef="U002">800000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_633ad162eaa44dc4a84145c32d193f57"
      unitRef="U002">1097000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_b1a7b6ef9531485da0a1aaaacd639959"
      unitRef="U002">25135000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_5ad64840ea984061bb9d10cc8681d789"
      unitRef="U002">18766000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20220331"
      decimals="-3"
      id="Fact_95132a85f15144539816df2bb02a1d59"
      unitRef="U002">308000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20211231"
      decimals="-3"
      id="Fact_616e4d8489d14af6aed2f9d5c53fce4f"
      unitRef="U002">670000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20220331"
      decimals="-3"
      id="Fact_2d6c8bfbafe64faeb5325d376d987e88"
      unitRef="U002">1093000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d3cbf3d126324979a3925bafe52a7e54"
      unitRef="U002">2567000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="c20220331"
      decimals="-3"
      id="Fact_8c5567a64f284563936e2406a212f5be"
      unitRef="U002">2044000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a91021e738a643ea81d1a3e80a79f3b8"
      unitRef="U002">2044000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c20220331"
      decimals="-3"
      id="Fact_2563293303b0443184d81479b5fd26fe"
      unitRef="U002">5990000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_305c31e3e34e447498e6f4e82b5a4c36"
      unitRef="U002">5990000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f765a194746c48209deb2d7ac37174bf"
      unitRef="U002">385000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e1f3e4ff044e4d9596113337af2cbe4a"
      unitRef="U002">1000000</us-gaap:EquityMethodInvestments>
    <us-gaap:DepositAssets
      contextRef="c20220331"
      decimals="-3"
      id="Fact_61ebf41ddf65449da4bbbaf14da5eec2"
      unitRef="U002">421000</us-gaap:DepositAssets>
    <us-gaap:DepositAssets
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c031daa388624efd81b9d901e8502cfd"
      unitRef="U002">488000</us-gaap:DepositAssets>
    <us-gaap:Assets
      contextRef="c20220331"
      decimals="-3"
      id="Fact_c7903c4571694ce9b1482fe730890507"
      unitRef="U002">35376000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ee512d5e84194a08af027857dfe049d1"
      unitRef="U002">31525000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_ddf230f2796345b395bd34589bc38b79"
      unitRef="U002">1106000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_33a32138c0854027ad3522b61cc19cfa"
      unitRef="U002">1755000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_b61db524492d4b58bfb731f1120e6aff"
      unitRef="U002">2384000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d831c2cccf664f6d8fc457e89d5ba8c0"
      unitRef="U002">1249000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_b94f6793cab6457eb78f7e1832ba896a"
      unitRef="U002">149000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ef94ba6be7944a3c824a289d1e306ede"
      unitRef="U002">426000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_8dd64977a66549d6920b51ec5a568387"
      unitRef="U002">45000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f9fd8dad044942f499343933f2acd4fb"
      unitRef="U002">247000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_6be829a26ca64ba286ba625da0ea7b54"
      unitRef="U002">3684000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_9b27efcee29f42e691e5c5ab0193ece9"
      unitRef="U002">3677000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_81c39921f8f1494584e9b0e0df2f3e0d"
      unitRef="U002">13315000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3d35589e2cd049a4b429279cfc9bb764"
      unitRef="U002">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_abf2a7f4593748bdb9998514f383eb09"
      unitRef="U002">1018000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_b71b9a9e7c01476da652aa1645264aa9"
      unitRef="U002">2297000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_993b24efd49d450d9d4bd629f60f4d81"
      unitRef="U002">48000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_12693b77fb904038aee287c909bdd16b"
      unitRef="U002">48000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="c20220331"
      decimals="-3"
      id="Fact_47d0c88d67d143fd882dbfd3c41ba003"
      unitRef="U002">18065000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c4685ad725a0456896a4daaea179f7cc"
      unitRef="U002">6022000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20220331"
      decimals="3"
      id="Fact_c0ea5613ea6d40f0b9dffe14abd1edc5"
      unitRef="U003">0.005</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="3"
      id="Fact_bcd8709d033f428e8173ed7775036d5c"
      unitRef="U003">0.005</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20220331"
      decimals="-3"
      id="Fact_4ac7253f1c734f6ea97099ac1ba020da"
      unitRef="U001">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4a03470ef4d44c388f86bc6c1a210cb6"
      unitRef="U001">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f02586de8d224caaadf31d214af57aa9"
      unitRef="U001">156000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20211231"
      decimals="-3"
      id="Fact_cf2c9722e4d248b3800a3c6265700290"
      unitRef="U001">156000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20220331"
      decimals="-3"
      id="Fact_9249699cab6b4d61b305f727f21d5fb3"
      unitRef="U001">156000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20211231"
      decimals="-3"
      id="Fact_62790db89ed1415c8007a230ba3678a0"
      unitRef="U001">156000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ebb9e8aebf25456688cf39b98102f735"
      unitRef="U002">156000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_6d87828446cb4966bfa8abfdc0b31371"
      unitRef="U002">156000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockValue
      contextRef="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="-3"
      id="Fact_bf15d0c11c1f4cf69948bff8bdbae6bb"
      unitRef="U002">1000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="-3"
      id="Fact_45395650bc8540d6bb8258ab24654d4f"
      unitRef="U002">1000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20220331"
      decimals="3"
      id="Fact_bff4899c7a4c455b8db15fdbcecbf908"
      unitRef="U003">0.005</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="3"
      id="Fact_257c1ec62cdd4252b18550449dd232ac"
      unitRef="U003">0.005</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7119e67f1a7d414fbf6f3bffc85e9a59"
      unitRef="U001">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20220331"
      decimals="-3"
      id="Fact_3e6a98d480254a9d85432242ebb4f684"
      unitRef="U001">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f601d269d9c04248b625a64786b12601"
      unitRef="U001">57452000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20220331"
      decimals="-3"
      id="Fact_2e2aaa0c1032417d9bb0449e4aa7a77f"
      unitRef="U001">57452000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7915b2a904804cc7a5afe329e97d0616"
      unitRef="U001">52021000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20211231"
      decimals="-3"
      id="Fact_697836017c014cf592042b99e699dc22"
      unitRef="U001">52021000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_2b231a38168d4d269f9df29f7d542e8a"
      unitRef="U002">287000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ca85d9de920342b1b645849103698793"
      unitRef="U002">260000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20220331"
      decimals="-3"
      id="Fact_67dbf3fddadd48278c72fff99da58c09"
      unitRef="U002">167100000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0f4c94f4fa8e4d368768b6209f607800"
      unitRef="U002">165944000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20220331"
      decimals="-3"
      id="Fact_1e9c34acc7db4ab88c524eb84650e8ca"
      unitRef="U002">-150077000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20211231"
      decimals="-3"
      id="Fact_05e0332d63fc428795de517bc62f82c3"
      unitRef="U002">-140702000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="c20220331"
      decimals="-3"
      id="Fact_25a6999c8d124f7399563b7bb55bef01"
      unitRef="U002">17311000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7598124631174cfd8973ed650ad791d0"
      unitRef="U002">25503000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20220331"
      decimals="-3"
      id="Fact_cf6023ac81b54e04b6ab6b340a1e0533"
      unitRef="U002">35376000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_9ffeeb1208514f12a9d7a2f5890fbd93"
      unitRef="U002">31525000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_638da90062cd47d28b4719ccb2eea0ba"
      unitRef="U002">1782000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_c06dc0ded1a747d0951bc9b3f8b2d372"
      unitRef="U002">1533000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_ef9b1759e1f041d596bc1c44f74cf24b"
      unitRef="U002">4514000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_4303baf2aa5d49d597002feb679c21fa"
      unitRef="U002">1623000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_a14450f374904865ac1131e50ad6c5d0"
      unitRef="U002">0</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_f61c333b1d3c4f22a01f006205b5adbc"
      unitRef="U002">5765000</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:OperatingExpenses
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_e5d0ec864b02499094c367f614eec7a3"
      unitRef="U002">6296000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_62d72f53a28b42299ebf56f6f5da2e51"
      unitRef="U002">8921000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_9fdd6512576e4100950533de5cde4914"
      unitRef="U002">-6296000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_785ff7982f0840c0b347b4d9ff17bdff"
      unitRef="U002">-8921000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_9a1799e4e0134f3aa87371c04a2f3cf9"
      unitRef="U002">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_44958a1413374818ba9901628d0b4651"
      unitRef="U002">-9598000</us-gaap:GainLossOnDispositionOfAssets1>
    <btx:WarrantLiabilitiesExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_53d505377236445c86e128619cac887c"
      unitRef="U002">1322000</btx:WarrantLiabilitiesExpense>
    <btx:WarrantLiabilitiesExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_6670b672141443c29a6dc1dd59eeba9f"
      unitRef="U002">0</btx:WarrantLiabilitiesExpense>
    <btx:LossOnNonControllingInvestment
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_552a4ab3f8e14a388aa62735aade4317"
      unitRef="U002">615000</btx:LossOnNonControllingInvestment>
    <btx:LossOnNonControllingInvestment
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_42ef133b96044de7b11dcaf894db4eaa"
      unitRef="U002">0</btx:LossOnNonControllingInvestment>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_6a8708a11c274af8b4e3b81addb20b02"
      unitRef="U002">-1142000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_39aecb992abb4ffb8c1d329a9b367dbc"
      unitRef="U002">-3000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_3b3bf10b2349469f81ecc69d0b5a1b32"
      unitRef="U002">-3079000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_4471b3114cae4a41a9c17b132f5eee0b"
      unitRef="U002">-9601000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_e47e0542533940909d3b8c78af5c3dde"
      unitRef="U002">-9375000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_d58c341ef3dd4d60ac3d10cc9658e534"
      unitRef="U002">-18522000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_8fa1b6517b524c8aa4e9bb218b205013"
      unitRef="U002">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_59ac382acc6d40549d5617007c42af17"
      unitRef="U002">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_e33161285d0f4df7834928f03ace8720"
      unitRef="U002">-9375000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_20f87eec178b4014a22aca84f41fd070"
      unitRef="U002">-18522000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_da77134d0a68447790b46fb321f69fc9"
      unitRef="U003">-0.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_5312d54b879e4e1981195aa9b8da666b"
      unitRef="U003">-0.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20210101to20210331"
      decimals="2"
      id="Fact_8ccb809c99d24fc1b160b7febc867d56"
      unitRef="U003">-0.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20210101to20210331"
      decimals="2"
      id="Fact_bc79c45faf4e4bcba1d6cd7b5e7f5713"
      unitRef="U003">-0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_1e634c49205d45dbb042797965db0987"
      unitRef="U001">53626</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_4d9c9f0ce11e43119b1623143a4cf04f"
      unitRef="U001">53626</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20210101to20210331"
      decimals="0"
      id="Fact_596f3d01fea94e519e499c0c52c2f54f"
      unitRef="U001">27799</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20210101to20210331"
      decimals="0"
      id="Fact_079fbcfe08714d74b2e91efadeb3e35c"
      unitRef="U001">27799</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_021a43c16ad04c199d62831ee1108f2a"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_d451a8e4ff974e0e8e38f345be3fad53"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_181f9f45f9784dcba61f700b72b00097"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_69494900a391493989087818caf5a814"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_d85dff8702074816bae87816a9f72842"
      unitRef="U001">52021000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c46cb9955f384bd4b8619b95be257158"
      unitRef="U002">260000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_097bf552b705490386fc6a29eaf241bd"
      unitRef="U001">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_f248a10a32d649b2a103b8664459b0b4"
      unitRef="U002">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_4a1904236f30431e8e3e576a7dbed27f"
      unitRef="U002">165944000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_be7f2d44384648728f38ab609891f5a3"
      unitRef="U002">-140702000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3fa83c71273841a5ad4ce1ded0c1dbc1"
      unitRef="U002">25503000</us-gaap:StockholdersEquity>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_5ae1259c7f3c4fc7969e7949f4bfbafa"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_e12e78d60ac94ad9b8760203b2b4f64b"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_b5611cef85cd4c748f1021a99c94f0a0"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_04dd63f7c2cd402ab8823eb56cc33a15"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:StockIssuedDuringPeriodSharesPrivateOffering
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_f6ff24b6eedd486ab489343f14ae5bdc"
      unitRef="U001">5500000</btx:StockIssuedDuringPeriodSharesPrivateOffering>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_5862d7434c7f4d39ae825c856e43893d"
      unitRef="U002">27000</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:StockIssuedDuringPeriodSharesPrivateOffering
      contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_88aa48d6c3c24ad19d6df2cca204df07"
      unitRef="U001">0</btx:StockIssuedDuringPeriodSharesPrivateOffering>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_894493f8307a466da576c87d1964915a"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_851392d1a4644ae9b30517a41bbec111"
      unitRef="U002">-27000</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_583e8f7d1e614a1ebd6f8761d88e3398"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_9d09b37e76be471cb22dfe520213f0d7"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_8eb46ca6588446758b19acbf7e1f3189"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_e078d807bd934554986704e2d71d465e"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_551c93c41029416f95679eeb279f2b5f"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_66ace6e70e324ec18aa15c786b26583f"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_cd96b1e09b98430cb62c557909dc3bec"
      unitRef="U001">78000</btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_2b9f8aff93a24ba99118db25ad946c65"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_903756cafed1419b9c1bb68469a1929b"
      unitRef="U001">0</btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_aa856bdba1994604b1940e5f4666a4e9"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_e50b429010514e2fa572539c120445fc"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_1da12b20d73844f5a4c7755cad143cf3"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_a5855929461c4057a1e524d4db19e802"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_fa0893034efb4c078b3e78a8fac4fa6a"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_295708c3f52c48b0932a207535627c45"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_2774dce1ed044e348cd9056ebc3e07fa"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_9e21a898e5b1481d9abcd36e9cd8bc26"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_2a99190771f146858bf76ad5eba19200"
      unitRef="U001">9000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_057eb34be87a43bab4a26f25112f0549"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_f4df2c76923245c8918beeb4e300bd90"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_cc191e263ebc4e72af1bfdcf6bc61292"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_65d11ddaae2041b381d6f3153b6a3b76"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_ca05db0443da4986973f072a5e44abc4"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_7433d31dc3624a498047a5b6320bdb7a"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_594eae94e7e24e5fbf11da5dab4959eb"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_190372b01ec44e94b8bb5106148e4a19"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_f48d41463b904e52accc6f9f1c515178"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_6d11f5efa3c94b21804ac0a32838746e"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_3dcfe89db30045068f68bcc7d0041823"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_4c80ce931c794157b70a4f02ed73a6db"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_965453016afa4abdaae25b9080cef784"
      unitRef="U002">1183000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_71109d136b3941a69ee9815270c8b2af"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_e63d8b115d374e99a0f61e18c0972791"
      unitRef="U002">1183000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_a2585b9380544a8da18ff1fbaf0f8b33"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_560b0911bf524ea4885cde242aced243"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_92236684475f4503825bb4282af7df53"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_fde386201baa4357a4a68505c3eafea3"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_357d650161074b438bde62f1a9be8c91"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_67103ad61bdb47d69acef7deefc236b1"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_1333a22e5dbb4b378b4f1c2970c9d830"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_1929f5c304a64b8ea52d76a248fa69c6"
      unitRef="U002">-9375000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_032ad2c60fe34a7eb1f26a27c2010194"
      unitRef="U002">-9375000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="c20220331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_bbdf713b90f94e5e91e5bd0e7f6b9826"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_12acbaab4be24a989b0427de6a74ed80"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_988bcb8d8e3d430ba027f7c620a095dd"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_5139f7a753de4e5d89424b5df4bc641c"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b1f6ff3c712a4b80b1ac2ce351e3a2fd"
      unitRef="U001">57452000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c7c271326a9b4ec6a5061d5f4b9248b1"
      unitRef="U002">287000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_eb59026d2a93451195cc054aabee93bb"
      unitRef="U001">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_a53776b33e4d473caa779d16f2954438"
      unitRef="U002">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0407fed096a44d1e9ead8eb575a9e0a0"
      unitRef="U002">167100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_dfc875f26a9d462caa08191182cd9f87"
      unitRef="U002">-150077000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220331"
      decimals="-3"
      id="Fact_37f50b11df60416d9fd9fdb1afc2d01f"
      unitRef="U002">17311000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_a32417b5968e4d6fa196df890dc4bde1"
      unitRef="U002">23202000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_67e58c32b5b14e1eb0bcc3a193d36b4b"
      unitRef="U002">1400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_bb08e3b508da48b9946cac89ae33e592"
      unitRef="U002">1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_9ec89cf77d93420781857c1e2fd8b374"
      unitRef="U002">198000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4fdebdbd9f2d464380e5ca61867a3a93"
      unitRef="U001">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_7f05bfef6ef04c5f96136c088173c653"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_09f29796071c447497c9484bbf940602"
      unitRef="U001">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_6b907ae71df64d72b789b940516d77d9"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_79f2ef0f88754243af6f24f8f3070ba7"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_5426e87ea1684f279e4495e373d3428d"
      unitRef="U002">-18141000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231"
      decimals="-3"
      id="Fact_8053963e9f53402481f56b3fa9eead2a"
      unitRef="U002">7659000</us-gaap:StockholdersEquity>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_575fdb062fe14817ada5ce77de81ed3b"
      unitRef="U002">10500000</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_3b83362aa76d4717b9d83dcd835b24ab"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_ee23dad6d34f4ac6bdc3314f8033a179"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_542e4a035c83495b827a1eb1c2067e0d"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_48a1af8e3ed4407da36b83c0e154ecf4"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_e2d4a3458e084f9db5274f0da76065c4"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_bed1a1c305754e7595ecc37de829d2e4"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_5c85024f3da44835ada09ad39e019434"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_264f90d7171a4b5d9efbe8a0a12f516f"
      unitRef="U002">10500000</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_271af0fb2f5f432b9c93e0cd4001d3ac"
      unitRef="U002">-33702000</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_740cf99c98ac4b3184841aa90094fff3"
      unitRef="U002">-1400000</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_687c6716f3e04ecbb8921006ef179c4b"
      unitRef="U002">-1000000</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_39ad8fa70b8d4a8e84860a06210bbcd6"
      unitRef="U002">-198000</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_79001618c42d448f9f67372f61db70f4"
      unitRef="U002">0</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_9a2ee046724640128114ae8d5129d84c"
      unitRef="U002">0</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_13665c1d8e36458e9b9823304718f919"
      unitRef="U002">36300000</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_a33271c2ae3448528f01ee0c2bd50ea2"
      unitRef="U002">0</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_bee78b69548a4ebca75339eb78fb5e79"
      unitRef="U002">0</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_39be41d2bbaa428fbf7bd494daf54e21"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_304036e3deb247e695d122fca3775f87"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_61907bf0229c4eff83f6b94a5068a782"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_312ab649cbf44a87b24fd8e46cc4212a"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodSharesAcquisitions1
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_65bf87876e0c4d55b7d59a857b632a36"
      unitRef="U001">1514000</btx:StockIssuedDuringPeriodSharesAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_99f76be295cd46ea98d0709e8e01a7b2"
      unitRef="U002">8000</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodSharesAcquisitions1
      contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_333872ba4e2a45d58999e54ff126c45e"
      unitRef="U001">0</btx:StockIssuedDuringPeriodSharesAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_b091bf06fe9140e58b95d751529a92c6"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_32c35f1c38f74a5991489f69feb63b4d"
      unitRef="U002">8170000</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_89f111693540462c80a5d75266bf2a43"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_26c5c1276b544d06897bf4d6cebd4166"
      unitRef="U002">8178000</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_4117130b52074bba89f5166c53b38ea5"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_a8a0e3e238ab4b388501dc35b2aaeb59"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_1f584cc3df5744fdaa80add2c7f4970e"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_e6401cb2319f42c0b3b367f7cc3fae03"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_6a66c709571447b9957e18d13a7ae1db"
      unitRef="U001">0</btx:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_9e5ce0d9289a4603a7758832c7c0ab67"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_7393aad57c36457dbc1503ff3753dc09"
      unitRef="U001">156000</btx:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_8795c72e4ccb48a4bdeb106e91ca5c79"
      unitRef="U002">1000</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_e05e95d525654497b9393c55e260ce3d"
      unitRef="U002">-1000</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_04df7da0a1be4f80902ddbd5613a7688"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_4342436b20da429cacf7a738b74cda2d"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_4fdbd96ed0034b52bd8cb9f4b41cba82"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_1c4b6dea14cf4cbab535cb24a07e0087"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_45177c2dba254457868f9b1bf0e2bf34"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_3b0b2b84f6e84d9781f5b46d8fdad3a6"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountUnitsAcquisitions
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_de71dbcdfd984f5f92a49266b6008d90"
      unitRef="U001">38924000</us-gaap:PartnersCapitalAccountUnitsAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_6e32504a52654b9e9137c7b7817b6277"
      unitRef="U002">195000</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountUnitsAcquisitions
      contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_2ab77e34dcf0470c86ae5c4754ff5172"
      unitRef="U001">0</us-gaap:PartnersCapitalAccountUnitsAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_087417f976254fa5869126313d6bc36f"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_dbe2fecd6ea14bbdbe0462f2149914aa"
      unitRef="U002">-195000</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_50cf7120565c4ae98a48d2bc8eb6be98"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_ffa14a0e442f4e3493fc3b157769c7d3"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_29e57d72dcc840a1bc9bcec139afb941"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_7bf7c07ee28847cb8e83a95fd3e04720"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_9593561da12947529f7444771e4c83fe"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_190bf1cdb14546f5b108280f4b668bb8"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_46b8ec74f8c3433fa690979461abfe32"
      unitRef="U001">1068000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c1641b221eb14d2881356fca6e1aadb5"
      unitRef="U002">5000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_205baf236a6d473187b858ad50112bab"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_4edbc42ee06f47c7b74c92771e67ef5d"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_453dc67d350c417f8e66423867fff97c"
      unitRef="U002">5760000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_e890335d29324ba49e7ad668be5c97ac"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_4d9913beccd643c6a7d06bb9aabb528f"
      unitRef="U002">5765000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_6af7e0e8836645f8a25ee3cb11a619fd"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_f139830f044d4772b08432dc3c108e63"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_301c55a77a4643de99e00e94a2a7741f"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_edb8eb1039184bc0972ff05a06984bf7"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_1e716831ba5d4dea85fd5a5672f982aa"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_8f68e8ddf2094f898dcf0207d189e61f"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_c85bb3c4ae8d4fa99e8d73a405677ea1"
      unitRef="U002">419000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_8d6a70db1cb3446f95eb50229111f65a"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_f6c123dc0ac9496c940563faaafed7cb"
      unitRef="U002">419000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_f9e1efce30924d5986473002a716d366"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_fd5b44cf074c4c76958022f3071ba1a1"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_cb1ee8de895c4517b1f93ebd01ebf14f"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_71ac66325b3c4b339f63ddbfa8e0c94d"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_72f356c03ca64496ad6c89a075665ae6"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_6c38d99d88f34965af65b02fd7ae5d56"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_f0f04547a596444d81eb08e39cc7c273"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_17d3aa059d9c4a8b9b60158f56bfb773"
      unitRef="U002">-18522000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_20c94d9a7ade48b78991356efa0dd24d"
      unitRef="U002">-18522000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_3bfbd08089c74ab9a8c2eac6e50c2402"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_8240d7487b184bdf8bded35e70b43b6f"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_5ef55388ba4e4361b817e4276208e023"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_7707383f8d7748a78f228a00cf9dd39a"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_44f0bc8b793f4ecaaaf2102ce7d8b019"
      unitRef="U001">41506000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_9516857651a544918a1d2846ade0f546"
      unitRef="U002">208000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_8a651ee6b57a40eab44aa19b6647ff04"
      unitRef="U001">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_3cf1e9f1fdf3429484c5e761cc7f9323"
      unitRef="U002">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_ce3cd3702ded43368654729ac4b9f259"
      unitRef="U002">50453000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_1262a3acbb1e4fea8cb497a73ffce602"
      unitRef="U002">-36663000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210331"
      decimals="-3"
      id="Fact_2c2591f71ba84d14ac2e0e96fcf89aac"
      unitRef="U002">13999000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_6f4f0938e705409e94ac1b73bb1e3782"
      unitRef="U002">-9375000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_6f3b8843d08e4ee9a23065b21d921a11"
      unitRef="U002">-18522000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_52c3a375a4bc4ef3a35ebac43a7a055b"
      unitRef="U002">36000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_46233d7668a1445c909bce61aa877bfe"
      unitRef="U002">25000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_6fb1e37bcaff4d3ea366570481288ecb"
      unitRef="U002">1183000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_e9daee9d9c134e3ba876a7acdd3e7f0d"
      unitRef="U002">419000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_e8a57958dfa64ad9af1fda481bbc817a"
      unitRef="U002">102000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_846320f5f364420baaedabc15565c637"
      unitRef="U002">70000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_845d862a50614f16816355c3df31707e"
      unitRef="U002">0</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_ea2dfa78201241efa117efa36c4e983e"
      unitRef="U002">5765000</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_fd03224a48344f47b38694ef12fd9665"
      unitRef="U002">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_c92af19678294878b3796383c06fbc0d"
      unitRef="U002">-9598000</us-gaap:GainLossOnDispositionOfAssets1>
    <btx:GainLossOnDisposalOfFixedAssets
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_66db2d7e57854ec887f6e58344ea87ec"
      unitRef="U002">371000</btx:GainLossOnDisposalOfFixedAssets>
    <btx:GainLossOnDisposalOfFixedAssets
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_457e8979737d4828a06529ce29be430c"
      unitRef="U002">0</btx:GainLossOnDisposalOfFixedAssets>
    <btx:GainOnTerminationOfLease
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_d5112a306f0e42298775a537de0108f0"
      unitRef="U002">85000</btx:GainOnTerminationOfLease>
    <btx:GainOnTerminationOfLease
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_2aa8db5a59a44247bb110873cb5dfef2"
      unitRef="U002">0</btx:GainOnTerminationOfLease>
    <btx:WarrantLiabilitiesExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_3b7eea33734148619b2f90453f98759e"
      unitRef="U002">1322000</btx:WarrantLiabilitiesExpense>
    <btx:WarrantLiabilitiesExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_c0a2ab30569d4c15b138ec2457bdbe58"
      unitRef="U002">0</btx:WarrantLiabilitiesExpense>
    <btx:LossOnNonControllingInvestment
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_4b1f3da2cc1944009396c13fa39c4ba3"
      unitRef="U002">615000</btx:LossOnNonControllingInvestment>
    <btx:LossOnNonControllingInvestment
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_68a861101a8c4077a800bd61258f50fa"
      unitRef="U002">0</btx:LossOnNonControllingInvestment>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_321c1973cc5047a891af6441bdf24fb0"
      unitRef="U002">146000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_c6ef839db990450f8b728fa2ddfbf06e"
      unitRef="U002">-4000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_520f5afb31b34c90ae1ef28e60bb64af"
      unitRef="U002">-298000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_e64fdf9e0a804db3a0b4c84741503972"
      unitRef="U002">-42000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <btx:IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_bf8dd294cc0b412bb83aa8debd6020d3"
      unitRef="U002">-66000</btx:IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets>
    <btx:IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_cf7683086b6848e5a5e5b5a2bf36f095"
      unitRef="U002">1000</btx:IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_3d86258584294221bc4a8f1779bf05d1"
      unitRef="U002">486000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_1017090743054a8b989bdcf7f1f92067"
      unitRef="U002">-766000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <btx:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_ab893a212ace4afd9248c9af7adde3b7"
      unitRef="U002">-103000</btx:IncreaseDecreaseInOperatingLeaseLiabilities>
    <btx:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_ec6073fc08e24ab08f7ec95a1eaa1167"
      unitRef="U002">-64000</btx:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_6388b59ba02b4c47b13572a9b8368eec"
      unitRef="U002">-202000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_6464b7360e484717bcde3755511ad950"
      unitRef="U002">0</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_6afe89da9d5e4371852a35cd6bcf978a"
      unitRef="U002">-5432000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_0d27849903f54936966c012f234980eb"
      unitRef="U002">-3430000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_907da751a9484053bd82995235768cfe"
      unitRef="U002">46000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_345be2badee34621acc0609312969b97"
      unitRef="U002">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSalesOfAssetsInvestingActivities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_8738013835e34e668a0b8d2e26358450"
      unitRef="U002">0</us-gaap:ProceedsFromSalesOfAssetsInvestingActivities>
    <us-gaap:ProceedsFromSalesOfAssetsInvestingActivities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_5c08b6ebac864f6aa134d216b4f43f95"
      unitRef="U002">148000</us-gaap:ProceedsFromSalesOfAssetsInvestingActivities>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_8481d30f6c17452cbc0f049374130a54"
      unitRef="U002">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_4d634b1023414ddbb6c7b5e13d186617"
      unitRef="U002">119000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_86c765326cbf4488a9d5ef8f728cac04"
      unitRef="U002">-46000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_dd20e0dd75b346f6a76968736b843588"
      unitRef="U002">267000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_8f7ade7b2c2d4d62b6a51617dbace42f"
      unitRef="U002">11993000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_f2fe506cce404ab4bf920a520b6a4b28"
      unitRef="U002">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_81e0f700f7b24b9da524e4208f788c87"
      unitRef="U002">0</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_9ab7998575c94e0091fea177541ae6c4"
      unitRef="U002">10475000</us-gaap:ProceedsFromOtherEquity>
    <btx:PaymentsOfPaycheckProtectionProgramLoan
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_bb728a9e854a4dfc85c9053211f0c4fe"
      unitRef="U002">0</btx:PaymentsOfPaycheckProtectionProgramLoan>
    <btx:PaymentsOfPaycheckProtectionProgramLoan
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_58b3dad94bc641a8b91d06894aa1f4bb"
      unitRef="U002">532000</btx:PaymentsOfPaycheckProtectionProgramLoan>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_7ee8c29eaf5d4137bd1dade481e9fe87"
      unitRef="U002">11993000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_a3c0168a36be4dc9b4e6aedd42e190c2"
      unitRef="U002">9943000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_a7ca9048f87f4fd2a35d9628a1157dbf"
      unitRef="U002">6515000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_d342d4143f6d43069d907c90637f390c"
      unitRef="U002">6780000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20211231"
      decimals="-3"
      id="Fact_68ddc76da6d24c3ca6d775ad07700aa7"
      unitRef="U002">16985000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20201231"
      decimals="-3"
      id="Fact_21e1369ba44b4e44af787746f2cb5a06"
      unitRef="U002">1630000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20220331"
      decimals="-3"
      id="Fact_4e6af96bfd13497f9ce3100a1be4038f"
      unitRef="U002">23500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20210331"
      decimals="-3"
      id="Fact_f3250412451646d5979ec858937827e3"
      unitRef="U002">8410000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_bc7be38cf8dc49669a94ff5a0b1da0a8"
      unitRef="U002">1000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_ab19eca704eb470ca2f10673d71b420b"
      unitRef="U002">0</us-gaap:InterestPaidNet>
    <us-gaap:StockIssued1
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_b605189355444d24a4142fd3e8fad3c5"
      unitRef="U002">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_eefa35ba47fd41208551e33ee8ef2db6"
      unitRef="U002">8178000</us-gaap:StockIssued1>
    <btx:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_f4c255ac08514813bafeb28c359e9af5"
      unitRef="U002">0</btx:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger>
    <btx:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_6125f9343898419088c1928f1d5288aa"
      unitRef="U002">1000</btx:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_c159c89179e84bc69ae87d8760bbfc7e">
&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
         &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
                &lt;div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;"&gt;Description of Business&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Brooklyn ImmunoTherapeutics Inc., a Delaware corporation (&#x201c;Brooklyn&#x201d; or the &#x201c;Company&#x201d;), together with its subsidiaries including Brooklyn
              ImmunoTherapeutics LLC (&#x201c;Brooklyn LLC&#x201d;), Novellus, Inc. (&#x201c;Novellus&#x201d;) and Novellus Therapeutics, Ltd. (&#x201c;Novellus, Ltd.&#x201d;), is a biopharmaceutical company utilizing its mRNA technology platform, including mRNA-based cell reprogramming and gene
              editing technologies, to create next generation mRNA, gene editing and cell therapies, including iPSC therapies for multiple therapeutic indications. As used herein, the &#x201c;Company&#x201d; refers collectively to Brooklyn and its subsidiaries.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman';"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman';"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On August 12, 2020, Brooklyn (then known as &#x201c;NTN Buzztime, Inc.&#x201d;), Brooklyn LLC and BIT Merger Sub, Inc., a wholly owned subsidiary of
              Brooklyn (the &#x201c;Merger Sub&#x201d;), entered into an agreement and plan of merger and reorganization (the &#x201c;Merger Agreement&#x201d;) pursuant to which, among other matters, Merger Sub merged with and into Brooklyn LLC, with Brooklyn LLC continuing as a
              wholly owned subsidiary of Brooklyn and as the surviving company of the merger (the &#x201c;Merger&#x201d;). The Merger closed on March 25, 2021. After the Merger, Brooklyn changed its name from &#x201c;NTN Buzztime, Inc.&#x201d; to &#x201c;Brooklyn ImmunoTherapeutics, Inc.&#x201d;
              The Merger was accounted for as a reverse acquisition, in which Brooklyn LLC was deemed the acquiring company for accounting purposes.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On March 26, 2021, Brooklyn sold (the &#x201c;Disposition&#x201d;) its rights, title and interest in and to the assets relating to the business operated
              under the name &#x201c;NTN Buzztime, Inc.&#x201d; prior to the Merger to eGames.com Holdings LLC (&#x201c;eGames.com&#x201d;) in accordance with the terms of an asset purchase agreement dated September 18, 2020, as amended, between Brooklyn and eGames.com (the &#x201c;Asset
              Purchase Agreement&#x201d;). &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On July 16, 2021, Brooklyn and its newly formed, wholly owned subsidiary Brooklyn Acquisition Sub, Inc. entered into an
          agreement and plan of acquisition (the &#x201c;Acquisition Agreement&#x201d;) with (a) Novellus LLC, (b) Novellus (the sole equity holder of Novellus, Ltd. and, prior to the closing under the Acquisition Agreement, a wholly owned subsidiary of Novellus, LLC),
          and (c) a seller representative (the &#x201c;Acquisition&#x201d;), pursuant to which Brooklyn acquired Novellus and its subsidiary, Novellus, Ltd. As part of the Acquisition, Brooklyn also acquired 25.0% of the total outstanding equity interests of NoveCite, Inc. (&#x201c;NoveCite&#x201d;), a corporation focused on developing an allogeneic mesenchymal stem cell product for patients with acute
          respiratory distress syndrome, including from COVID-19. &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;"&gt;Basis of Presentation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The






          accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) for interim financial statements and with the instructions to
          Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the unaudited financial statements include all the
          normal recurring adjustments that are necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented.&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;These












          condensed consolidated financial statements should be read together with the audited consolidated financial statements and notes thereto contained in Brooklyn&#x2019;s Annual Report on Form 10-K/A for the year ended December 31, 2021 filed with the
          Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on June 30, 2022 (the &#x201c;10-K/A&#x201d;). The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited financial statements contained in the 10-K/A, but does
          not include all of the information and footnotes required by GAAP for complete financial statements. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results to be anticipated for the
          entire year ending December 31, 2022, or any other period.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 36pt;"&gt;&lt;span style="font-style: italic;"&gt;Reclassifi&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;cations&lt;/span&gt;&lt;/span&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-style: italic;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Certain











          reclassifications have been made to Brooklyn&#x2019;s prior years&#x2019; financial statements to conform to the current year presentation. These reclassifications had no effect on Brooklyn&#x2019;s previously reported results of operations or accumulated deficit.&lt;/div&gt;
</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="3"
      id="Fact_1bef0282c92c488d9640199d4c4b1ab8"
      unitRef="U004">0.250</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_981de089ea644818a2ff1997672bf5df">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;"&gt;Basis of Presentation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The






          accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) for interim financial statements and with the instructions to
          Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the unaudited financial statements include all the
          normal recurring adjustments that are necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented.&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;These












          condensed consolidated financial statements should be read together with the audited consolidated financial statements and notes thereto contained in Brooklyn&#x2019;s Annual Report on Form 10-K/A for the year ended December 31, 2021 filed with the
          Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on June 30, 2022 (the &#x201c;10-K/A&#x201d;). The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited financial statements contained in the 10-K/A, but does
          not include all of the information and footnotes required by GAAP for complete financial statements. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results to be anticipated for the
          entire year ending December 31, 2022, or any other period.&lt;/div&gt;
</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="c20220101to20220331"
      id="Text_71c8f622b17c4c8e9d9a5535cd70cf24">
&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; margin-left: 36pt;"&gt;&lt;span style="font-style: italic;"&gt;Reclassifi&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;cations&lt;/span&gt;&lt;/span&gt;
        &lt;/div&gt;

&lt;div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-style: italic;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Certain











          reclassifications have been made to Brooklyn&#x2019;s prior years&#x2019; financial statements to conform to the current year presentation. These reclassifications had no effect on Brooklyn&#x2019;s previously reported results of operations or accumulated deficit.&lt;/div&gt;
</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <btx:LiquidityAndCapitalResourcesTextBlock
      contextRef="c20220101to20220331"
      id="Text_b6fb6892a9904282bc9f5185ebebb1c1">
&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
                &lt;div style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;LIQUIDITY AND CAPITAL RESOURCES&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company has incurred significant operating losses and has an accumulated deficit as a result of ongoing efforts to develop product candidates, including conducting clinical trials and providing general and
              administrative support for operations. As of March 31, 2022, the Company had a cash balance of approximately $23.5 million and an
              accumulated deficit of approximately $150.1 million. For the three months ended March 31, 2022, the Company incurred a net loss of
              $9.4 million, and the Company used cash in operating activities of $5.4&lt;/span&gt;&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;
                million.&lt;/span&gt;&lt;br/&gt;
            &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;On March 9, 2022, the Company consummated a private placement of common stock and warrants resulting in net proceeds of approximately $11
              million (See Note 10).&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;In connection with preparing the accompanying condensed consolidated financial statements as of and for the three months ended March 31, 2022, the Company&#x2019;s management concluded that there is substantial doubt regarding the Company&#x2019;s
              ability to continue as a going concern because it does not expect to have sufficient cash or working capital resources to fund operations for the twelve-month period subsequent to the issuance date of these financial statements. The Company
              will need to raise additional capital, which could be through the remaining availability under our equity line purchase agreement with Lincoln Park Capital Fund, LLC (the &#x201c;Second Purchase Agreement&#x201d;) (to the extent the Company is permitted to
              use such agreement) (see Note 10), public or private equity offerings, debt financings, corporate collaborations or other means. The Company may also seek governmental grants to support its clinical trials and preclinical trials. The Company
              currently has no arrangements for such capital and no assurances can be given that it will be able to raise such capital when needed, on acceptable terms, or at all.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt; The accompanying condensed consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The
              accompanying condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may
              result from uncertainty related to the Company&#x2019;s ability to continue as a going concern.&lt;/div&gt;
</btx:LiquidityAndCapitalResourcesTextBlock>
    <us-gaap:Cash
      contextRef="c20220331"
      decimals="-5"
      id="Fact_70d2ddc9c89f48b086fd111ce26aff8a"
      unitRef="U002">23500000</us-gaap:Cash>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20220331"
      decimals="-5"
      id="Fact_e59b31ee354b418b90b250dd88db2b7b"
      unitRef="U002">-150100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331"
      decimals="-5"
      id="Fact_ad426bc1851a48e08d06c64f95028ec4"
      unitRef="U002">-9400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20220101to20220331"
      decimals="-5"
      id="Fact_e9781adcffad4fb09b560d0bc5410e90"
      unitRef="U002">-5400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="c20220309to20220309"
      decimals="-6"
      id="Fact_a3a657b988c645519d05897a69651710"
      unitRef="U002">11000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="c20220101to20220331"
      id="Text_fbcb17304ce04aa5b619ffb95c920909">
&lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="vertical-align: top; width: 36pt;"&gt;
                    &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;3)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                    &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
          &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; text-indent: 27pt; margin-left: 9pt; font-variant: normal; text-transform: none;"&gt;Merger&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On August 12, 2020, Brooklyn, Brooklyn LLC and the Merger Sub
          entered into the Merger Agreement, and the Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which Brooklyn LLC was deemed the acquiring company for accounting purposes. Brooklyn LLC, as the accounting
          acquirer, recorded the assets acquired and liabilities assumed of Brooklyn in the Merger at their fair values as of the acquisition date.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Brooklyn LLC was determined to be the accounting acquirer
          based upon the terms of the Merger and other factors including that (i) Brooklyn LLC members, received common stock in the Merger that represented 96.35%
          of Brooklyn&#x2019;s outstanding common stock on a fully diluted basis, (ii) all of the directors of Brooklyn immediately after the Merger were designated by Brooklyn LLC under the terms of the Merger Agreement and (iii) existing members of Brooklyn
          LLC&#x2019;s management became the management of Brooklyn immediately after the Merger.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;At the closing of the Merger, all the outstanding membership
          interests of Brooklyn LLC converted into the right to receive an aggregate of approximately 39,992,000 shares of common stock, of
          which 1,068,000 shares were issued as compensation to Maxim Group LLC, Brooklyn LLC&#x2019;s financial advisor (the &#x201c;Financial Advisor&#x201d;) for
          its services to Brooklyn LLC in connection with the Merger.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The purchase price of $8.2 million, which represents the consideration transferred in the Merger to stockholders of Brooklyn immediately before the Merger, was calculated
          based on the closing price of $5.40 per share for approximately 1,514,000 shares common stock that those stockholders owned on March 25, 2021 immediately prior to the Merger because that represented a more reliable measure of the fair
          value of consideration transferred in the Merger.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Under the acquisition method of accounting, the total
          purchase price has been allocated to the acquired tangible and intangible assets and assumed liabilities of Brooklyn based on their estimated fair values as of March 25, 2021, the Merger closing date. Because the consideration paid by Brooklyn
          LLC in the Merger is more than the estimated fair values of Brooklyn&#x2019;s net assets deemed to be acquired, goodwill is equal to the difference of approximately $8.6 million, which has been calculated using the fair values of the net assets of Brooklyn as of March 25, 2021.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The allocation of the purchase price to the tangible and
          intangible assets acquired and liabilities deemed to be assumed from Brooklyn, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Historical&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Balance&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Sheet of&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Brooklyn at&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;March 25, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Fair Value&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Adjustment&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;to Brooklyn&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Pre-Merger&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;Price&lt;/div&gt;
                &lt;div&gt;&lt;span style="font-weight: bold;"&gt;Purchase&lt;/span&gt;&lt;/div&gt;
                &lt;div&gt;&lt;span style="font-weight: bold;"&gt;Allocation&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash and cash equivalents&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;148&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;148&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts receivable&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;103&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;103&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Prepaid expense and other current assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;329&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;329&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Property and equipment, net&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;1,015&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;1,015&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Software development costs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;1,296&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;(368&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;928&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Customers&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;548&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;548&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Trade name&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;299&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;299&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts payable, accrued liabilities and other current&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;(3,781&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;(3,781&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Net assets acquired, excluding goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(890&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;479&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(411&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Total consideration&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;8,178&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Net assets acquired, excluding goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(411&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;8,589&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Brooklyn LLC was obligated under the Merger Agreement to have
          $10.0 million in cash and cash equivalents on its balance sheet at the effective time of the Merger. To ensure Brooklyn LLC had the
          required funds, certain beneficial holders of Brooklyn LLC&#x2019;s Class A membership interests entered into contractual commitments to invest $10.0
          million into Brooklyn LLC immediately prior to the closing of the Merger. During March 2021, Brooklyn offered its Class A unit holders an additional 5%
          rights offering for an additional $0.5 million to be raised by a rights offering. Brooklyn received funds from the rights offering
          between February 17, 2021 and April 5, 2021.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Disposition&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On March 26, 2021, Brooklyn sold its rights, title and
          interest in and to the assets relating to the business it operated (under the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $2.0 million and assumption of specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of
          the Disposition are as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Proceeds from sale:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;Cash&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;132&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Escrow&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;100&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Assume advance/loans&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;1,700&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Interest on advance/loans&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;68&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Carrying value of assets sold:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash and cash equivalents&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(14&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts receivable&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(75&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Prepaids and other current assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(124&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Property and equipment, net&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(1,014&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Software development costs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(927&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Customers&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(548&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Trade name&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(299&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(8,589&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Other assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(103&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Liabilities transferred upon sale:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts payable and accrued expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;113&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Obligations under finance leases&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;17&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Lease liability&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;26&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Deferred revenue&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;55&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Other current liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;149&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Transaction costs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(265&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Total loss on sale of assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;(9,598&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; text-indent: 36pt; font-variant: normal; text-transform: none;"&gt;Acquisition&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On July 16, 2021, Brooklyn and Brooklyn Acquisition Sub, Inc.
          entered into the Acquisition Agreement. The Acquisition closed contemporaneously with the execution and delivery of the Acquisition Agreement. At the closing:&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;
                  &lt;div style="text-align: left;"&gt;&#x2022;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;
                  &lt;div style="text-align: justify;"&gt;Brooklyn acquired all of the outstanding equity interests of Novellus, Inc. as the result of the merger of Brooklyn Acquisition Sub, Inc. with and into Novellus, Inc., following which, Novellus, Inc., as
                    the surviving corporation, became Brooklyn&#x2019;s wholly owned subsidiary and Novellus Ltd. became Brooklyn&#x2019;s indirectly owned subsidiary; and&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;
                  &lt;div style="text-align: left;"&gt;&#x2022;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;
                  &lt;div style="text-align: justify;"&gt;Brooklyn acquired 25.0% of the total outstanding equity interests of NoveCite.&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;As consideration for the Acquisition, Brooklyn paid $22.9 million in cash and delivered approximately 7,022,000
          shares of common stock, which under the terms of the Acquisition Agreement, were valued at a total of $102.0 million based on an agreed
          upon price of $14.5253 per share. At the date of issuance, the fair value of the shares were approximately $58.6 million.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Acquisition Agreement contained customary
          representations, warranties and certain indemnification provisions. Approximately 741,000 of the shares issued as consideration were
          placed in escrow for a period of up to 12 months in order to secure indemnification obligations to Brooklyn under the Acquisition
          Agreement. The Acquisition Agreement also contains certain non-competition and non-solicitation provisions pursuant to which Novellus LLC agreed not to engage in certain competitive activities for a period of five years following the closing, including customary restrictions relating to employees. No employees of Novellus Ltd. or Novellus, Inc. prior to the
          Acquisition continued their employment, or were otherwise engaged by Brooklyn, following the Acquisition.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;In connection with the Acquisition, the co-founders of
          Novellus, Ltd. entered into lock-up agreements with respect to approximately 3,378,000 of the shares of common stock received in the
          Acquisition, and Brooklyn&#x2019;s Chairman of the Board of Directors (the &#x201c;Board&#x201d;) and its Chief Executive Officer and President entered into identical lock-up agreements with respect to their current holdings of Brooklyn stock. Each lock-up agreement
          extends for a period of three years, provided that up to 75% of the shares of common stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock on the Nasdaq exceeds
          specified thresholds. The lock-up agreements include customary exceptions for transfers during the applicable lock-up period.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company expects the Acquisition will advance its
          evolution into a platform company with a pipeline of next generation engineered cellular, gene editing and cytokine programs. In addition, the acquisition of Novellus, Ltd. builds on the License Agreement. (See Note 8). The completion of the
          acquisition of Novellus, Ltd. relieved Brooklyn LLC from potential obligations to pay Novellus, Ltd. certain upfront fees, clinical development milestone fees and post-registration royalties under the License Agreement. The agreement with Factor
          Bioscience Limited (&#x201c;Factor&#x201d;) under the License Agreement, which grants Brooklyn LLC exclusive rights to develop certain next-generation mRNA gene editing and cell therapy products, remained unchanged.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Although Brooklyn acquired all of the outstanding equity
          interests of Novellus, Inc., the Company accounted for the Acquisition as an asset acquisition (as the assets acquired did not constitute a business as defined in Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 805,&#160;&lt;span style="font-style: italic;"&gt;Business Combinations&lt;/span&gt;),&#160;and was measured by the amount of cash paid and by the fair value of the shares of common stock issued. As a result, substantially all of the value acquired was attributed to IPR&amp;amp;D, with the exception
          of the cash paid for the investment in NoveCite, which is being accounted for as an investment in equity securities, as discussed further below.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Brooklyn paid $22.9 million in cash, net of cash acquired, as part of the consideration for the Acquisition, of which $1.0 million was paid in cash for the investment in NoveCite. Brooklyn also issued approximately 7,022,000 shares of the Company&#x2019;s common stock, of which approximately 3,644,000 shares are unrestricted and 3,378,000
          shares are subject to the three-year lockup. The unrestricted shares were valued at $10.05 per share, which was the closing price of Brooklyn&#x2019;s common stock on July 16, 2021. The fair value of the restricted shares was discounted by approximately 35% to $6.53 per restricted share,
          which was derived from the average discount rate between the Black Scholes and Finnerty valuation models. &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal;"&gt;The resulting fair value of the asset acquired is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; text-indent: -9pt; font-weight: bold;"&gt;Fair Value of&lt;/div&gt;
                &lt;div style="text-align: center; text-indent: -9pt; font-weight: bold;"&gt;Consideration&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash paid&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;22,882&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(28&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Unrestricted shares&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;36,628&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Restricted shares&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div&gt;22,056&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Total fair value of consideration paid&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;81,538&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Less amount of cash paid for NoveCite investment&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(1,000&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Fair value of IPR&amp;amp;D acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;80,538&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;IPR&amp;amp;D that is acquired through an asset purchase that has
          no alternative future uses and no separate economic values from its original intended purpose is expensed in the period the cost is incurred. Accordingly, the Company expensed the fair value of the IPR&amp;amp;D during the third quarter of 2021 in
          the amount of $80.5 million.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-decoration: underline;"&gt;Investment in NoveCite&lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;As&#160; a&#160; result&#160; of&#160; the&#160; Acquisition,&#160; Brooklyn&#160; acquired&#160;
          and&#160; currently&#160; owns&#160; 25%&#160; of&#160; NoveCite&#160; and&#160; Citius Pharmaceuticals, Inc. (&#x201c;Citius&#x201d;) owns the remaining 75%. A member of the Company&#x2019;s management holds one of three
          board seats on NoveCite&#x2019;s board of directors. Citius&#x2019; s officers and directors hold the other two board seats. The Company is accounting for its interest in NoveCite under ASC Topic 323,&#160;&lt;span style="font-style: italic;"&gt;Investments&#160;&#x2013;&#160;Equity
            Method and Joint&#160;Ventures&lt;/span&gt;.&#160;The investment was recorded at cost, which was $1.0 million&#160;and is adjusted for the Company&#x2019;s share
          of&#160;NoveCite&#x2019;s earnings or losses, which are reflected in the accompanying condensed consolidated statement of operations. The investment may also reflect an equity loss in the event that circumstances indicate an other-than-temporary impairment.
          For the three months ended March 31, 2022, the Company recorded $0.6 million in losses from its investment in NoveCite, of which $0.5 million relates to NoveCite&#x2019;s year ended December 31, 2021.&lt;/div&gt;
</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="4"
      id="Fact_54ca8871183447f597c50d21ae2ae837"
      unitRef="U004">0.9635</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="0"
      id="Fact_2aa5ef7deb78438b8a86d158059c5b0c"
      unitRef="U001">39992000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="0"
      id="Fact_eeee0995e77b41bc9019bf39b4a31fee"
      unitRef="U001">1068000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_5ea9ac5eedd04a8aa8854831ba4a329b"
      unitRef="U002">8200000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="2"
      id="Fact_6c84fa96b84946cd8dd503a066e15a48"
      unitRef="U003">5.40</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="0"
      id="Fact_f66bc96342f1436980f1b12d50f95e8d"
      unitRef="U001">1514000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:Goodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_3663caf0241243f594b57e521f761fc3"
      unitRef="U002">8600000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_c4998b5fcb854dbda6d5d8398d1e26e9">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The allocation of the purchase price to the tangible and
          intangible assets acquired and liabilities deemed to be assumed from Brooklyn, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Historical&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Balance&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Sheet of&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Brooklyn at&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;March 25, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Fair Value&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Adjustment&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;to Brooklyn&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Pre-Merger&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;Price&lt;/div&gt;
                &lt;div&gt;&lt;span style="font-weight: bold;"&gt;Purchase&lt;/span&gt;&lt;/div&gt;
                &lt;div&gt;&lt;span style="font-weight: bold;"&gt;Allocation&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash and cash equivalents&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;148&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;148&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts receivable&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;103&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;103&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Prepaid expense and other current assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;329&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;329&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Property and equipment, net&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;1,015&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;1,015&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Software development costs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;1,296&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;(368&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;928&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Customers&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;548&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;548&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Trade name&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;299&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;299&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts payable, accrued liabilities and other current&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;(3,781&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;(3,781&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Net assets acquired, excluding goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(890&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;479&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(411&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Total consideration&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;8,178&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Net assets acquired, excluding goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(411&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;8,589&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_3d78e289e5a1491c8ce7adaac53f58cf"
      unitRef="U002">148000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_1ffcd446d43745e8941446222d85e9ed"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_e1a468aeb6ce4e1a85943c659d289e7a"
      unitRef="U002">148000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_27292e40a79d4a078f3a00b2d6571307"
      unitRef="U002">103000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_98f83fff95d646e5bcb87ebed3a3cc52"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_c661f74f3c154543b323c270c04c2528"
      unitRef="U002">103000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_bffeea1274d8447f8eaaa3528a580eaa"
      unitRef="U002">329000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_f88436cf458f4fbabd8f7c34fbf23761"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_a4989f92157f433f92ab902648f7a7a8"
      unitRef="U002">329000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_2be476c51b574a5e87e6eb6e511fdc29"
      unitRef="U002">1015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_aacc907840bd4ce9971677d14d1c7c64"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_603cac1821444b43abb2cca551ab24d4"
      unitRef="U002">1015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_915f975684a94590a96fd47a47daa1e2"
      unitRef="U002">1296000</btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts>
    <btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_58e4c02ebe17455bba07f592863cce51"
      unitRef="U002">-368000</btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts>
    <btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_3e9691bbcb444f8dba2ca1942d06eb7e"
      unitRef="U002">928000</btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_c7a3e261acce44fb9c886c95b35b603d"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_b2c7ab411846419caaa0d4d82d2f6eb0"
      unitRef="U002">548000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_d25f2bedeb864b5b9ea40c0b1c608ce6"
      unitRef="U002">548000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember"
      decimals="-3"
      id="Fact_a6e1cfaedb3e4577a06a946874406210"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_711a5c6ab7304a608ba7abdc2f5b4a61"
      unitRef="U002">299000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_2ee5f709d09c48f8b2d094ae6e244ef8"
      unitRef="U002">299000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_5c9016df5e0f41df85520906ee85b7f3"
      unitRef="U002">3781000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_2faa5d1c201142e8a956da64e6c9db96"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_77f2375cefcb4b4e8e170688768f4fee"
      unitRef="U002">3781000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_e0306b8f76f6407f83d033b81f7a646c"
      unitRef="U002">-890000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_fc89c14d1da64843bbbee084793c4f92"
      unitRef="U002">479000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_85489aa712144724b3740f7c70a78146"
      unitRef="U002">-411000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_8d7bcafa874a4eadb581f0fbb16b2911"
      unitRef="U002">8178000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_a1191c3a12b44f17b3380877328b3570"
      unitRef="U002">-411000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_78431c0eaf454962bb2bf8dfe9c8cff6"
      unitRef="U002">8589000</us-gaap:Goodwill>
    <btx:ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_bdba85beab904914ba3a94b96f090964"
      unitRef="U002">10000000.0</btx:ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement>
    <btx:BeneficialHoldersContractualCommitmentsToInvest
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_c263b227cdbd4fbe8a687dfed4f268de"
      unitRef="U002">10000000.0</btx:BeneficialHoldersContractualCommitmentsToInvest>
    <btx:PercentageOfAdditionalRightsOffering
      contextRef="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="2"
      id="Fact_a7f844c3cd4b4dd9857731875335ad32"
      unitRef="U004">0.05</btx:PercentageOfAdditionalRightsOffering>
    <btx:ProceedsFromSaleOfRights
      contextRef="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_3d08ab31a0a74565a871a4b911784612"
      unitRef="U002">500000</btx:ProceedsFromSaleOfRights>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="c20220101to20220331"
      id="Text_a08043633ac149379ad703bbb3529414">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On March 26, 2021, Brooklyn sold its rights, title and
          interest in and to the assets relating to the business it operated (under the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $2.0 million and assumption of specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of
          the Disposition are as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Proceeds from sale:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;Cash&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;132&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Escrow&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;100&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Assume advance/loans&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;1,700&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Interest on advance/loans&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;68&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Carrying value of assets sold:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash and cash equivalents&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(14&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts receivable&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(75&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Prepaids and other current assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(124&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Property and equipment, net&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(1,014&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Software development costs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(927&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Customers&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(548&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Trade name&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(299&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(8,589&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Other assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(103&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Liabilities transferred upon sale:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts payable and accrued expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;113&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Obligations under finance leases&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;17&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Lease liability&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;26&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Deferred revenue&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;55&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Other current liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;149&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Transaction costs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(265&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Total loss on sale of assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;(9,598&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-5"
      id="Fact_2386d89efd694f3da2a680d5bc2a0a31"
      unitRef="U002">2000000.0</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromCash
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_860bd116554740448d79977bdf7d67f5"
      unitRef="U002">132000</btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromCash>
    <btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_1f892f0e05c2445cb735c07b7d9b3ad0"
      unitRef="U002">100000</btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow>
    <btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_75bbb331e3ba4a509d723d421ca5d106"
      unitRef="U002">1700000</btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans>
    <btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_2a492fe34f084dbeb0a4ed9702722412"
      unitRef="U002">68000</btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_533becd8e9bf43b8a466af90fd0014a4"
      unitRef="U002">14000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_08f356a73a214739a76b9004e98fb858"
      unitRef="U002">75000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_34035390e0a545979469c9c3ce48bc3f"
      unitRef="U002">124000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_bcf1e46f40644237b9a39f46ed825e78"
      unitRef="U002">1014000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <btx:DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_b56ae35b284a40e883d81c3403a6b3ff"
      unitRef="U002">927000</btx:DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_f510fcb805a0448286283fdb0992df7f"
      unitRef="U002">548000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_2bd6c31d58514dc1b69c62698714cfcd"
      unitRef="U002">299000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_8f5c5b9cbde94be1a428f83bd6912ef1"
      unitRef="U002">8589000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_73f486ef86ae49808b2323054b0c78d6"
      unitRef="U002">103000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_4997f29920a2463ebe892d6f56ed4a2c"
      unitRef="U002">113000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
    <btx:DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_18b2deb5d2294cf5806adfa4f883a293"
      unitRef="U002">17000</btx:DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases>
    <btx:DisposalGroupIncludingDiscontinuedOperationLeaseLiability
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_3d13ad4b39874859be563d360a0dd54a"
      unitRef="U002">26000</btx:DisposalGroupIncludingDiscontinuedOperationLeaseLiability>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_46077e98d1ab4d3685882775380c7d6c"
      unitRef="U002">55000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_a384928133c04e8c8af5d8152c7e6d06"
      unitRef="U002">149000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities>
    <btx:DisposalGroupIncludingDiscontinuedOperationTransactionCosts
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_1aa21ee03b804496b3dc5cec6eaf3b57"
      unitRef="U002">-265000</btx:DisposalGroupIncludingDiscontinuedOperationTransactionCosts>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_50a454dbd5b047e2a727d7588594dd0c"
      unitRef="U002">-9598000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="3"
      id="Fact_af2a2860e2804e85a7d94327cdad7968"
      unitRef="U004">0.250</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_66e969db6b2644cb8788bc8d5633b1e7"
      unitRef="U002">22900000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_63eccf3e5a2348559b2ebb57c04dbaec"
      unitRef="U001">7022000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_4b05f25600dd4acaa7671f83fea76ed5"
      unitRef="U002">102000000.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <btx:AssetAcquisitionSharePrice
      contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="4"
      id="Fact_b13518c6257b4ed4a15af1ab45489339"
      unitRef="U003">14.5253</btx:AssetAcquisitionSharePrice>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_0a999755f83b46ac8e22ce8c197f857d"
      unitRef="U002">58600000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <btx:EscrowShares
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_6484bb1e0cbd4affb5031841d72809cd"
      unitRef="U001">741000</btx:EscrowShares>
    <btx:EscrowPeriod
      contextRef="c20220101to20220331_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember"
      id="Fact_487a4ff1c1914871bc73abc9c40d6dd6">P12M</btx:EscrowPeriod>
    <btx:AcquisitionAgreementNonCompetitivePeriod
      contextRef="c20220101to20220331_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      id="Fact_87562f2ac969454dbf13b724fa88b0f8">P5Y</btx:AcquisitionAgreementNonCompetitivePeriod>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember"
      decimals="0"
      id="Fact_d08202be60be43ad8bd837f356899397"
      unitRef="U001">3378000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <btx:EachLockUpAgreementExtendsTerm
      contextRef="c20220101to20220331_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      id="Fact_cc0fbbf96f174fb4a7b65a6e6d742761">P3Y</btx:EachLockUpAgreementExtendsTerm>
    <btx:PercentageOfCommonStockSubjectToLockUpAgreement
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_4334750d17e747c29462c53c6993e610"
      unitRef="U004">0.75</btx:PercentageOfCommonStockSubjectToLockUpAgreement>
    <btx:PaymentsToAcquireProductiveAssetsNet
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_aaa969455c3040e087dabadebe60d9de"
      unitRef="U002">22900000</btx:PaymentsToAcquireProductiveAssetsNet>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_61b9b513c2004a4e98d922371c041212"
      unitRef="U002">1000000.0</us-gaap:PaymentsToAcquireInvestments>
    <btx:StockIssuedDuringPeriodUnrestrictedSharesAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_804c53c4a64d49b3bd93db495b93c239"
      unitRef="U001">3644000</btx:StockIssuedDuringPeriodUnrestrictedSharesAcquisitions>
    <btx:StockIssuedDuringPeriodRestrictedSharesAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_32cbaa51019d4693bad37d02fcbea093"
      unitRef="U001">3378000</btx:StockIssuedDuringPeriodRestrictedSharesAcquisitions>
    <btx:LockUpPeriodForRestrictedShares
      contextRef="c20220101to20220331_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      id="Fact_6e7cd42dab4d43b9afaf996879563d46">P3Y</btx:LockUpPeriodForRestrictedShares>
    <btx:AssetAcquisitionUnrestrictedSharesSharePrice
      contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="2"
      id="Fact_b494310fe5be4a2dbc0eb368a13acda8"
      unitRef="U003">10.05</btx:AssetAcquisitionUnrestrictedSharesSharePrice>
    <btx:PercentageOfDiscountOnFairValueOfRestrictedShares
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="2"
      id="Fact_585f06a994b34dc2a0225605a0537e92"
      unitRef="U004">0.35</btx:PercentageOfDiscountOnFairValueOfRestrictedShares>
    <btx:AssetAcquisitionRestrictedSharesSharePrice
      contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="2"
      id="Fact_62e2297a98c849c1b4347b9096ddff0a"
      unitRef="U003">6.53</btx:AssetAcquisitionRestrictedSharesSharePrice>
    <us-gaap:AssetAcquisitionTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_3ac8744c64734e319bb6f2f33b766498">&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal;"&gt;The resulting fair value of the asset acquired is as follows (in thousands):&lt;/span&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; text-indent: -9pt; font-weight: bold;"&gt;Fair Value of&lt;/div&gt;
                &lt;div style="text-align: center; text-indent: -9pt; font-weight: bold;"&gt;Consideration&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash paid&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;22,882&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(28&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Unrestricted shares&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;36,628&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Restricted shares&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div&gt;22,056&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Total fair value of consideration paid&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;81,538&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Less amount of cash paid for NoveCite investment&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(1,000&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Fair value of IPR&amp;amp;D acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;80,538&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:AssetAcquisitionTableTextBlock>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_6f70d0a3d8ec46499b9156880a3455b5"
      unitRef="U002">22882000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_dcb3046cbe7e48b9bb25c05bcde293ef"
      unitRef="U002">28000</us-gaap:CashAcquiredFromAcquisition>
    <btx:StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_e3dde8bdb02c4d448abebe0459a5438d"
      unitRef="U002">36628000</btx:StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions>
    <btx:StockIssuedDuringPeriodRestrictedSharesValueAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_0568a1c121104ae79815261a85eb68e8"
      unitRef="U002">22056000</btx:StockIssuedDuringPeriodRestrictedSharesValueAcquisitions>
    <btx:AssetAcquisitionFairValueOfConsiderationPaid
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_e3ea6c121e994f38be759be48284e235"
      unitRef="U002">81538000</btx:AssetAcquisitionFairValueOfConsiderationPaid>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_ff927f0267c44d7dacf0f8b6e910bbdb"
      unitRef="U002">1000000</us-gaap:PaymentsToAcquireInvestments>
    <btx:ResearchAndDevelopmentInProcessAssetAcquisition
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_68692e2a1a9b4963a7affddd68b0fe7e"
      unitRef="U002">80538000</btx:ResearchAndDevelopmentInProcessAssetAcquisition>
    <btx:ResearchAndDevelopmentInProcessAssetAcquisition
      contextRef="c20210701to20210930_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="1"
      id="Fact_159ca954aacf44d9978269b5c481b049"
      unitRef="U002">80.5</btx:ResearchAndDevelopmentInProcessAssetAcquisition>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="2"
      id="Fact_c3038e0422c74f2f8d49c7a5f2ad4a21"
      unitRef="U004">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c20210716_OwnershipAxis_CitiusPharmaceuticalsIncMember_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="2"
      id="Fact_3a2d526083fe41da9af0e95f441e86e6"
      unitRef="U004">0.75</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <btx:NumberOfBoardSeats
      contextRef="c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="INF"
      id="Fact_ffd3a21029bb47f98f0ad8e8c7fa1782"
      unitRef="U005">3</btx:NumberOfBoardSeats>
    <us-gaap:EquityMethodInvestments
      contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="-5"
      id="Fact_88551e912c5c4c86b4f2d7268884f7ca"
      unitRef="U002">1000000.0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="c20220101to20220331_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="-5"
      id="Fact_c81ebe54deae41ca9e3f6ef20380b035"
      unitRef="U002">600000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="-5"
      id="Fact_81922ac753f741fba1aeb215658cedfc"
      unitRef="U002">500000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="c20220101to20220331"
      id="Text_e7c69bb7250f40eca795c907e47ea32c">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;4)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;FAIR VALUE OF FINANCIAL INSTRUMENTS&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between
              market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The
              fair value hierarchy is as follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;Level 1 Inputs &#x2013; Valued based on quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement
                    date.&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;Level 2 Inputs &#x2013; Valued based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might
                    include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or
                    liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;Level 3 Inputs &#x2013; Valued based on inputs for which there is little or no market value, which require the reporting entity to develop its own assumptions.&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="text-align: justify;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The following tables summarize the liabilities that are measured at fair value as of March 31, 2022 (in thousands).&#160; There were no liabilities measured at fair value as of December 31, 2021:&lt;/div&gt;

&lt;div&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of March 31,
                    2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Description&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 1&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 2&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Liabilities:&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Warrant liabilities - Pre-Funded Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,782&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Warrant liabilities - Common Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,533&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,782&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,533&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
           &lt;/div&gt;

&lt;div&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On March 9, 2022, the Company issued pre-funded warrants exercisable for approximately 1,357,000 shares of common stock (the &#x201c;Pre-Funded Warrants&#x201d;) and warrants exercisable for approximately 6,857,000 shares of common stock (the &#x201c;Common Warrants&#x201d;) in connection with the PIPE Transaction (as defined below).&#160; See Note 10 for more information related to the PIPE
            Transaction.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Common Warrants and Pre-Funded Warrants were accounted for as liabilities
              under ASC 815-40, &lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Derivatives and Hedging, Contracts in Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; (&#x201c;ASC
              815-40&#x201d;), as these warrants provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40.&#160; These warrant liabilities were measured at fair value at inception and are then
              subsequently measured on a recurring basis, with changes in fair value presented within the Company&#x2019;s statement of operations.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company uses a Black-Scholes option pricing model to estimate the fair value of the Common Warrants, which is considered a Level 3 fair
            value measurement.&#160; Certain inputs used in this Black-Scholes pricing model may fluctuate in future periods based upon factors that are outside of the Company&#x2019;s control.&#160; A significant change in one or more of these inputs used in the
            calculation of the fair value may cause a significant change to the fair value of the Company&#x2019;s warrant liabilities, which could also result in material non-cash gains or losses being reported in the Company&#x2019;s consolidated statement of
            operations.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The estimated fair value of the Pre-Funded Warrants was deemed a Level 2 measurement as of March 31, 2022, as all significant inputs to the
              valuation model used to estimate the fair value of the Pre-Funded Warrants were directly observable from the Company&#x2019;s publicly-traded common stock.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $12.6 million in the aggregate, which was $0.6 million more
            than the $12.0 million proceeds received in the PIPE Transaction.&#160; The excess $0.6 million represents an inducement to the purchaser to enter into the PIPE Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of
            operations.&#160; Given the Company&#x2019;s capital requirements and market conditions, the Company consummated this financing on market terms available at the time of the transaction.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company remeasured the fair value of the warrant liabilities as of March 31, 2022, and the following table presents the changes in the warrant
          liabilities from the issuance date (in thousands): &lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Pre-Funded &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; Warrants&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(Level 2)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Common&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Warrants&lt;br/&gt;
                    &lt;/span&gt;(Level 3)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Total Warrant&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
                    &lt;/span&gt;Liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at January 1, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at March 9, 2022 (issuance date)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,646&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,943&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,589&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Change in fair value of warrant liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;136&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;590&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;726&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at March 31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,782&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,533&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,315&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
            &lt;/div&gt;
</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_4d476c48d31d495f848d9bf273e04d58">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The following tables summarize the liabilities that are measured at fair value as of March 31, 2022 (in thousands).&#160; There were no liabilities measured at fair value as of December 31, 2021:&lt;/div&gt;

&lt;div&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of March 31,
                    2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Description&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 1&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 2&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Liabilities:&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Warrant liabilities - Pre-Funded Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,782&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Warrant liabilities - Common Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,533&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,782&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,533&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
           &lt;/div&gt;
</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20211231"
      decimals="0"
      id="Fact_c667984602f544408b5f81c18e9526a7"
      unitRef="U002">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_c590f96c661b499dae9cfc246b6a296e"
      unitRef="U002">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_4d24f1bf1e494c1bb2f233fe27c36c74"
      unitRef="U002">2782000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_0ce6ee13d7f04d3aa72364728c0d8d7e"
      unitRef="U002">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_4e46059e4d514606b161dabec557524f"
      unitRef="U002">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_84da8c67fce64eccb937b5b4fc0422ea"
      unitRef="U002">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_02a6bc54de6e49f09e0ceda3f13d47d8"
      unitRef="U002">10533000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact_bac10a95d2364549a159476777bc5d82"
      unitRef="U002">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_0cee6baa739e4427bd56ecbda3dba743"
      unitRef="U002">2782000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_dd8fde7439944542822fc3fba6b48741"
      unitRef="U002">10533000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="0"
      id="Fact_024bade3258943298d0a6b8efa601863"
      unitRef="U001">1357000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20220309_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="0"
      id="Fact_9ed2453da04342e0be4a6626e84fc689"
      unitRef="U001">6857000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20220331"
      decimals="-5"
      id="Fact_d9c2cd6857a34260b7d55ca777301c21"
      unitRef="U002">12600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <btx:OverSubscriptionAmountReceived
      contextRef="c20220331"
      decimals="-5"
      id="Fact_f73432814a89499898cb0bcc9137fb01"
      unitRef="U002">600000</btx:OverSubscriptionAmountReceived>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="c20220331"
      decimals="-5"
      id="Fact_3cab5b376eef4d0799148c719795c19a"
      unitRef="U002">12000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <btx:OverSubscriptionAmountReceived
      contextRef="c20220331"
      decimals="-5"
      id="Fact_da2acf8c23584829b9d1ea265b76344f"
      unitRef="U002">600000</btx:OverSubscriptionAmountReceived>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_a999b685547c4a849f5806b959fa1fe1">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company remeasured the fair value of the warrant liabilities as of March 31, 2022, and the following table presents the changes in the warrant
          liabilities from the issuance date (in thousands): &lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Pre-Funded &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; Warrants&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(Level 2)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Common&lt;/div&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Warrants&lt;br/&gt;
                    &lt;/span&gt;(Level 3)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Total Warrant&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
                    &lt;/span&gt;Liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at January 1, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at March 9, 2022 (issuance date)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,646&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,943&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,589&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Change in fair value of warrant liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;136&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;590&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;726&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at March 31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,782&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,533&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,315&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
            &lt;/div&gt;
</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_e91f53e9f7c348eaafec4e90a9a976bc"
      unitRef="U002">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20211231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_0d7b0b4eb10640c8b542c59f285ba7e2"
      unitRef="U002">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_461b59794d13419597a58821ab77b238"
      unitRef="U002">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_fdf9a1d1cd9347479e8f52dd1a3ab306"
      unitRef="U002">2646000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_5ce07e4262194ffd9da781670716e7dd"
      unitRef="U002">9943000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_142b19af60f14677b19de91fae0a9576"
      unitRef="U002">12589000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="c20220101to20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_19c3426993cc40f99bc4b9c6ca3eac6d"
      unitRef="U002">136000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_f457c1543836414f8a818425d81bf326"
      unitRef="U002">590000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_43b553fce68f4295913dd59ebd1a349e"
      unitRef="U002">726000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_c5122c869dcf473cbd3634c4eb38f92c"
      unitRef="U002">2782000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_3ebcc67f462447ca978b32f0ffe757d8"
      unitRef="U002">10533000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_7a1c04c77dcb4241be871f5b084846c6"
      unitRef="U002">13315000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="c20220101to20220331"
      id="Text_720ba7671df24909ae3dec6c5ae82cb9">
&lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="vertical-align: top; width: 36pt;"&gt;
                &lt;div style="font-weight: bold;"&gt;5)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                &lt;div style="font-weight: bold;"&gt;LEASES&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company has operating leases for office and laboratory space in the borough of Manhattan in New York, New York and in Cambridge,
            Massachusetts, which expire in 2026 and 2028, respectively. On March 31, 2022, the Company entered into the Torrey Pines Science Center Lease in San Diego, California (the &#x201c;San Diego Lease&#x201d;) with&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; Torrey Pines Science Center Limited Partnership for approximately 5,200 square feet of lab and office space.
              The term of the San Diego Lease is 62 months and the lease commencement date was April 19, 2022, which is the date the Company
              will record a right-of-use (&#x201c;ROU) asset and corresponding operating lease liability. The San Diego Lease will expire in June&lt;/span&gt; 2027.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Base rent for the San Diego Lease is $6.35
            per square foot in the first year of the San Diego Lease, with a rent abatement for the second and third full months of the first year. The base rent will increase by approximately 3% on each anniversary of the lease commencement date. The Company is also required to pay its share of operating expenses and property taxes. The San Diego Lease provides
            for a one-time option to extend the lease term for an additional five years at the then fair rental value.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;On March 5, 2022, the Company entered into an Agreement to Assign Space Lease with Regen Lab USA LLC (&#x201c;Regen&#x201d;) pursuant to which the Company
            agreed to assign its Brooklyn, New York lease (the &#x201c;Brooklyn Lease&#x201d;) to Regen. The effective date of the assignment was contingent upon, among other things, a consent from BioBat, Inc. (the &#x201c;Landlord&#x201d;) to assign the Brooklyn Lease.&#160;
            Additionally, Regen agreed to purchase certain equipment from the Company for $50,000, partly reimburse the Company $50,000 toward certain existing unamortized leasehold improvements, and to reimburse the Company for the existing security deposit the Company had
            under the Brooklyn Lease of approximately $63,000.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On March 25, 2022, the Company entered into an Assignment and Assumption of Lease Agreement (the &#x201c;Assignment Agreement&#x201d;) with Regen, the consent
            of which was provided by the Landlord in the Assignment Agreement. The effective date of the assignment was March 28, 2022. Under the Assignment Agreement, Regen (i) accepts the assignment of the Brooklyn Lease; (ii) assumes all of the
            obligations, liabilities, covenants and conditions of the Company&#x2019;s as tenant under the Brooklyn Lease; (iii) assumes and agrees to perform and observe all of the obligations, terms, requirements, covenants and conditions to be performed or
            observed by the Company under the Brooklyn Lease; and (iv) makes all of the representations and warranties binding under the Brooklyn Lease with the same force and effect as if Regens had executed the Brooklyn Lease originally as the tenant.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Notwithstanding the above assumptions by Regen, the Company shall be and remain liable and responsible for the due keeping, and full performance
            and observance, of all the provisions of the Brooklyn Lease on the part of the tenant to be kept, performed and observed. As a result of the Assignment Agreement, the Company wrote off the remaining ROU asset balance and the corresponding lease
            liability.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company accounts for leases under ASC 842, &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Leases&lt;/span&gt;.
              Operating leases are included in &#x201c;Right-of use assets - operating leases&#x201d; within the Company&#x2019;s balance sheets and represent the Company&#x2019;s right to use an underlying asset for the lease term. The Company&#x2019;s related obligation to make lease
              payments are included in &#x201c;Operating lease liabilities, non-current&#x201d; and &#x201c;Operating lease liabilities, current&#x201d; within the Company&#x2019;s balance sheets. ROU assets and liabilities are recognized at commencement date based on the present value of
              lease payments over the lease term. Because the rate implicit in the lease is not readily determinable, the Company uses its incremental borrowing rates based on the information available at the lease commencement date in determining the
              present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet and are recognized as lease
              expense on a straight-line basis over the lease term. &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Some leasing arrangements require variable payments that are dependent on usage or may vary for other reasons, such as payments for insurance,
              tax payments and other miscellaneous costs. The variable portion of lease payments is not included in the ROU assets or lease liabilities. Rather, variable payments, other than those dependent upon an index or rate, are expensed when the
              obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease contract are accounted for as lease expenses.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the three months ended March 31, 2022 and 2021, the net operating lease expenses were as follows (in thousands): &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three months ended March 31,&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: #000000 solid 2px;" valign="bottom"&gt;2022&lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: #000000 solid 2px;" valign="bottom"&gt;2021&lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease expense&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;186&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;151&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Sublease income&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Variable lease expense&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;9&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease expense&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;168&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;139&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt; The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2022 and the ending balances as of
              March 31, 2022, including the changes during the period (in thousands). &lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 8pt;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 8pt;"&gt;
              &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="font-weight: bold;"&gt;Operating Lease&lt;/div&gt;
                      &lt;div&gt;&lt;span style="font-weight: bold;"&gt;ROU Assets&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease ROU assets at January 1, 2022&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,567&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Amortization of operating lease ROU assets&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(102&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                    &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Write off of ROU asset due to lease termination&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,372&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                    &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease ROU assets at March 31, 2022&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,093&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
            &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center;"&gt;Operating Lease&lt;/div&gt;
                    &lt;div style="text-align: center;"&gt; Liabilities&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease liabilities at January 1, 2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,723&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Principal payments on operating lease liabilities&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(103&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Write off of operating lease liability due to lease termination&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,453&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease liabilities at March 31, 2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,167&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less non-current portion&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,018&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Current portion at March 31, 2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;149&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of March 31, 2022, the Company&#x2019;s operating leases had a weighted-average remaining life of 5.8 years with a weighted-average discount rate of 10.23%.
              &lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;"&gt;The maturities of the
              operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;
                    &lt;div&gt;As of&lt;/div&gt;
                    March 31,&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;201&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;270&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;272&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;274&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;267&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;245&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total payments&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,529&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less imputed interest&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(362&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total operating lease liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,167&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeasesTextBlock>
    <btx:OperatingLeaseArea
      contextRef="c20220331"
      decimals="0"
      id="Fact_a1daaaf3ce744851ad164ce4bc4a5d07"
      unitRef="U006">5200</btx:OperatingLeaseArea>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="c20220331"
      id="Fact_4a178dd9539348a8841e183032e9214a">P62M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <btx:BaseRentPerSquareFoot
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_44a6e731a8924b76b2b621af5413e1d6"
      unitRef="U006">6.35</btx:BaseRentPerSquareFoot>
    <btx:PercentageBaseRentIncreaseOnEachAnniversary
      contextRef="c20220331"
      decimals="2"
      id="Fact_7de0ab65c5f44e219ac58e4dd07f4e9f"
      unitRef="U004">0.03</btx:PercentageBaseRentIncreaseOnEachAnniversary>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="c20220331"
      id="Fact_5ed64ffe4eed4e90a1b126e56ef41e72">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <btx:LesseeCommitmentToPurchaseProperty
      contextRef="c20220305"
      decimals="0"
      id="Fact_16059c6bb27841eab34b6de53e811a43"
      unitRef="U002">50000</btx:LesseeCommitmentToPurchaseProperty>
    <btx:UnamortizedLeaseholdImprovements
      contextRef="c20220305"
      decimals="0"
      id="Fact_03cc003794924dc5ae898eeb3bef2d73"
      unitRef="U002">50000</btx:UnamortizedLeaseholdImprovements>
    <us-gaap:DepositAssets
      contextRef="c20220305"
      decimals="0"
      id="Fact_3869cbc25b6e46829de50adb7a1c8664"
      unitRef="U002">63000</us-gaap:DepositAssets>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_b53363b260e54040ba8f2c22363a2ca7">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the three months ended March 31, 2022 and 2021, the net operating lease expenses were as follows (in thousands): &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; text-align: center; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Three months ended March 31,&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; text-align: center; font-weight: bold; border-bottom: #000000 solid 2px;" valign="bottom"&gt;2022&lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: #000000 solid 2px;" valign="bottom"&gt;2021&lt;br/&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease expense&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;186&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;151&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Sublease income&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Variable lease expense&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;9&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease expense&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;168&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;139&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_d3587c4322cc434b92bbcfd4091643c4"
      unitRef="U002">186000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_59b3c483300e4bb78048d832dd1c371b"
      unitRef="U002">151000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_a66c048e3304472abcdc2cfeedafc806"
      unitRef="U002">21000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_747060cae7b24dcdb1fefd05e76a4a7e"
      unitRef="U002">21000</us-gaap:SubleaseIncome>
    <us-gaap:VariableLeaseCost
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_bf92e06af61946868fc1583dcebc7d3b"
      unitRef="U002">3000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_d62d7232cd144e898732b854f1596c9d"
      unitRef="U002">9000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_ecd11a790e124662acba04b27b7e3a05"
      unitRef="U002">168000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_a95c0ad08440459fad7725e1e5549ddf"
      unitRef="U002">139000</us-gaap:LeaseCost>
    <btx:OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_0117423f6c5d4e8889085a4954592f89">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt; The tables below show the beginning balances of the operating ROU assets and lease liabilities as of January 1, 2022 and the ending balances as of
              March 31, 2022, including the changes during the period (in thousands). &lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 8pt;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 8pt;"&gt;
              &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: center; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="font-weight: bold;"&gt;Operating Lease&lt;/div&gt;
                      &lt;div&gt;&lt;span style="font-weight: bold;"&gt;ROU Assets&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease ROU assets at January 1, 2022&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,567&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Amortization of operating lease ROU assets&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(102&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                    &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Write off of ROU asset due to lease termination&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,372&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                    &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease ROU assets at March 31, 2022&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                      &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,093&lt;/div&gt;
                    &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
            &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center;"&gt;Operating Lease&lt;/div&gt;
                    &lt;div style="text-align: center;"&gt; Liabilities&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease liabilities at January 1, 2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,723&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Principal payments on operating lease liabilities&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(103&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Write off of operating lease liability due to lease termination&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,453&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease liabilities at March 31, 2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,167&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less non-current portion&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,018&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;
                    &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Current portion at March 31, 2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                    &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;149&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</btx:OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20211231"
      decimals="-3"
      id="Fact_1d26406e8446497bbc8641f271345017"
      unitRef="U002">2567000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_0fdeec55497942bd8aa7097247459b3b"
      unitRef="U002">102000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <btx:WriteOffOfOperatingLeaseRightOfUseAsset
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_6d314dfe334e47e7a80ad5a972fa01c2"
      unitRef="U002">1372000</btx:WriteOffOfOperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f265442e8c55443491e7a984400611fb"
      unitRef="U002">1093000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c5605ffd4452430692858ad9ae2e48ea"
      unitRef="U002">2723000</us-gaap:OperatingLeaseLiability>
    <btx:PrincipalPaymentsOnOperatingLeaseLiabilities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_da159e13d717420382919a78c48c4973"
      unitRef="U002">103000</btx:PrincipalPaymentsOnOperatingLeaseLiabilities>
    <btx:WriteOffOfOperatingLeaseLiability
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_aec2dd29f0a44a918487032b4f8cefe4"
      unitRef="U002">1453000</btx:WriteOffOfOperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20220331"
      decimals="-3"
      id="Fact_8804d12f9aa24427bcfe91243b1602ff"
      unitRef="U002">1167000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_c68ecaba69be42b0b5d500b01a828d7e"
      unitRef="U002">1018000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_dd876b8a35e64467b41c91c44f3ce367"
      unitRef="U002">149000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="c20220331"
      id="Fact_00695253f94f40e6aec229cf6141c7ba">P5Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="c20220331"
      decimals="4"
      id="Fact_288ea7e4d9b04a80b0620285127dae6e"
      unitRef="U004">0.1023</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_e2b159b4095a42d88f56aa812e76c0ed">&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;"&gt;The maturities of the
              operating lease liabilities are as follows (in thousands):&lt;/span&gt;
&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: middle; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: middle; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;
                    &lt;div&gt;As of&lt;/div&gt;
                    March 31,&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;201&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;270&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;272&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;274&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2026&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;267&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;245&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total payments&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,529&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less imputed interest&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(362&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: middle; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total operating lease liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                  &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,167&lt;/div&gt;
                &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="c20220331"
      decimals="-3"
      id="Fact_a216e6b488cc451fa4553b95d3dfe222"
      unitRef="U002">201000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="c20220331"
      decimals="-3"
      id="Fact_4c8aecbef8094612beb259793fc0a91f"
      unitRef="U002">270000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="c20220331"
      decimals="-3"
      id="Fact_74a1ff42569b4a9b85efc9392884f403"
      unitRef="U002">272000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="c20220331"
      decimals="-3"
      id="Fact_dd7485d14e274a7191473dfa8e3b3ac4"
      unitRef="U002">274000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f3fd38b85cf845d6906ea28c5873e65b"
      unitRef="U002">267000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <btx:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="c20220331"
      decimals="-3"
      id="Fact_3ef320db10524026bcd1a35f767b06cf"
      unitRef="U002">245000</btx:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_d6a819a528b043c5b9d4a515272bd691"
      unitRef="U002">1529000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="c20220331"
      decimals="-3"
      id="Fact_8ee9a3a6f83947e1b991443fe984c522"
      unitRef="U002">362000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20220331"
      decimals="-3"
      id="Fact_84f0806baaa4484aa6566c4c71a74dfb"
      unitRef="U002">1167000</us-gaap:OperatingLeaseLiability>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_958859c10cee45918dfcea8c45a4d142">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;6)&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
                &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;GOODWILL AND IN-PROCESS RESEARCH &amp;amp; DEVELOPMENT&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In 2018, the Company acquired IRX, which was accounted for as a business combination. The Company recorded IPR&amp;amp;D in the amount of $6.0 million, which represents the fair value assigned to technologies that were acquired in connection with the IRX Acquisition and which have not
          reached technological feasibility and have no alternative future use. IPR&amp;amp;D assets acquired in a business combination are considered to be indefinite lived until the completion or abandonment of the associated research and development
          projects. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize products associated with the IPR&amp;amp;D assets, these assets are then deemed definite-lived and are amortized
          based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a full or partial impairment charge related to the IPR&amp;amp;D assets, calculated as the excess of carrying value
          of the IPR&amp;amp;D assets over fair value&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company also recorded goodwill in the amount of $2.0
          million related to the IRX Acquisition. Goodwill and indefinite-lived IPR&amp;amp;D assets are not amortized but are tested for impairment annually, or more frequently if the Company becomes aware of any events occurring or changes in circumstances
          that indicate that the fair value of the entity is less than its carrying values.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of March 31, 2022, the Company performed a qualitative assessment to determine whether it is more likely than not that the fair value of the
          entity is less than its carrying value. Such qualitative factors include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and other relevant events. As a result of the qualitative
          assessment, the Company determined that due to the decline in the&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Company&#x2019;s stock price of $4.17 per
          share as of December 31, 2021 to $2.05 per share as of March 31, 2022, there were indications of impairment. Accordingly, the Company
          engaged a third-party valuation firm to perform a quantitative analysis to compare the entity&#x2019;s carrying values to its fair value, the results of which showed that the entity&#x2019;s fair value exceeded its carrying value and there was no impairment of the recorded goodwill or IPR&amp;amp;D.&lt;/div&gt;
</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c20220331"
      decimals="-5"
      id="Fact_b985f5db9c1946bda0c3ee4a1444e500"
      unitRef="U002">6000000.0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="c20220331"
      decimals="-5"
      id="Fact_c773dfcfe7954c2282d334a19b615d1a"
      unitRef="U002">2000000.0</us-gaap:Goodwill>
    <us-gaap:SharePrice
      contextRef="c20211231"
      decimals="2"
      id="Fact_c8aee52868364182808a5ef735c7f224"
      unitRef="U003">4.17</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="c20220331"
      decimals="2"
      id="Fact_501792ebad7f4b41a320549e93c98552"
      unitRef="U003">2.05</us-gaap:SharePrice>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_22b9b6be9b8c4a3eb9334651025126ed"
      unitRef="U002">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_11b1ef32b2cd47caa90778a9d86a8757">
&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="vertical-align: top; width: 36pt;"&gt;
                  &lt;div style="text-align: left;"&gt;&lt;span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;7)&lt;/span&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: bold;"&gt;ACCRUED EXPENSES&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued expenses consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;March 31,&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2022&lt;/span&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                    &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2021&lt;/span&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                    &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued compensation&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;637&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;656&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued research and development expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;311&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;222&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued general and administrative expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1,436&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;371&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Total accrued expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2,384&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1,249&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt;Accrued general and administrative expenses include $0.8 million for legal-related matters.&lt;br/&gt;
        &lt;/div&gt;
</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_0c42478fbc6b4e3fac257005d90cd5c6">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued expenses consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;March 31,&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2022&lt;/span&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                    &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2021&lt;/span&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                    &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued compensation&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;637&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;656&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued research and development expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;311&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;222&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued general and administrative expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1,436&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;371&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Total accrued expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2,384&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1,249&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt;Accrued general and administrative expenses include $0.8 million for legal-related matters.&lt;br/&gt;
        &lt;/div&gt;
</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_035e8d9810ad420299654e87e9c53183"
      unitRef="U002">637000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_39f5fcaa73de49869a6cae48a6f9576d"
      unitRef="U002">656000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <btx:AccruedResearchAndDevelopmentExpenses
      contextRef="c20220331"
      decimals="-3"
      id="Fact_29a951f4b24543deb46a1b129f7a069a"
      unitRef="U002">311000</btx:AccruedResearchAndDevelopmentExpenses>
    <btx:AccruedResearchAndDevelopmentExpenses
      contextRef="c20211231"
      decimals="-3"
      id="Fact_2488abfff6dc4df1a14ce677b7518587"
      unitRef="U002">222000</btx:AccruedResearchAndDevelopmentExpenses>
    <btx:AccruedGeneralAndAdministrativeExpenses
      contextRef="c20220331"
      decimals="-3"
      id="Fact_b8f2605226fa41fcb86a434ba9df4eac"
      unitRef="U002">1436000</btx:AccruedGeneralAndAdministrativeExpenses>
    <btx:AccruedGeneralAndAdministrativeExpenses
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e4a16e3a8e5344b0a120fbef04f8ddec"
      unitRef="U002">371000</btx:AccruedGeneralAndAdministrativeExpenses>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_fc5cd83fcaf24949817dced28da51ab8"
      unitRef="U002">2384000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c38061e3e8eb4de2ac1182167c422c59"
      unitRef="U002">1249000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="c20220331"
      decimals="-5"
      id="Fact_94dfa07711414b0982df70e396984c7d"
      unitRef="U002">800000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_4cf1c0a45d11426480401321d6af121c">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;8)&lt;br/&gt;
                &lt;/span&gt; &lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;COMMITMENTS AND CONTINGENCIES&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Legal Matters&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company is involved in litigation and arbitrations from time to time in the ordinary course of business. Legal fees and other costs
            associated with such actions are expensed as incurred. In addition, the Company assesses the need to record a liability for litigation and contingencies. The Company reserves for costs relating to these matters when a loss is probable, and the
            amount can be reasonably estimated.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="font-style: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;Dhesh Govender v. Brooklyn
                Immunotherapeutics, LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;On or about February 5, 2021, Dhesh Govender, a former short-term consultant of Brooklyn LLC, filed a complaint against Brooklyn LLC and certain individuals that plaintiff alleges were directors of Brooklyn LLC. The complaint is
              captioned, Dhesh Govender v. Brooklyn Immunotherapeutics, LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021). Plaintiff alleges that Brooklyn LLC and certain of its officers and directors (&#x201c;defendants&#x201d;) engaged in unlawful and
              discriminatory conduct based on race, national origin and hostile work environment. Plaintiff also asserts various breach of contract, fraud and quantum meruit claims based on an alleged oral agreement pursuant to which he alleges Brooklyn
              LLC agreed to hire him as an executive once the Merger was completed. In particular, plaintiff alleges that, in exchange for transferring an opportunity to obtain an agreement to acquire a license from Novellus for its mRNA-based gene editing
              and cell reprogramming technology to Brooklyn LLC, he was promised a $0.5 million salary and 7% of the equity of Brooklyn LLC. Based on these and other allegations, plaintiff seeks damages of not less than $10 million, a permanent injunction enjoining Brooklyn LLC from exercising the option to acquire such license from Novellus or completing the
              proposed Merger. On or about February 19, 2021, an amended complaint was filed asserting the same causes of action but wi&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;thdrawing the request for injunctive relief. On June 6, 2021, defendants filed a motion to compel arbitration or, in the alternative, for partial
                dismissal of the complaint for failure to state viable fraud, quantum meruit and employment discrimination claims. After obtaining extensions of time to respond, plaintiff opposed the defendants&#x2019; motion on August 9, 2021. The defendants
                filed their reply on September 3, 2021. The Court heard oral argument on the motion to compel arbitration and/or dismiss and the motion to seal on October 13,&#160;2021. By Order dated November 10,&#160;2021, the Court granted defendants&#x2019; motion to
                compel Govender to arbitrate all of his claims against them, based on the arbitration clause of his consulting agreement with Brooklyn LLC.&#160; Govender thereafter filed his Statement of Claim (the &#x201c;Demand&#x201d;) with the American Arbitration
                Association (&#x201c;AAA&#x201d;), Case No. 01-21-0017-9417, on December 15,&#160;2021 against the same defendants, and served it on defendants&#x2019; counsel on February 3,&#160;2022. In his Demand, Govender continues to assert statutory discrimination claims against
                all defendants, claims against Brooklyn LLC premised on the breach of an alleged oral promise to issue Govender 7% of the equity
                of Brooklyn LLC and to employ Govender at a $0.5 million annual salary in exchange for allegedly arranging and negotiating the
                Novellus license, common law fraud claims against Brooklyn LLC and Cherington based on the breach of these same promises and a claim for quantum meruit against the Brooklyn LLC. In his Demand, Govender now claims that the fair and
                reasonable value of his services on the quantum meruit claim exceeded $100 million and is seeking damages in an amount to be
                determined at the hearing. Defendants filed an answering statement to the Demand on February 28,&#160;2022 have selected a three&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;-member arbitration panel. Defendants intend to vigorously defend themselv&lt;/span&gt;es against these claims.&lt;/span&gt; At this stage in the litigation, the Company is not able to predict the probability of a favorable or
              unfavorable outcome. &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Emerald Private Equity Fund, LLC Matter&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
                          &lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;By a letter dated July 7, 2021, Emerald Private Equity Fund, LLC (&#x201c;Emerald&#x201d;), a stockholder of Brooklyn, made a demand pursuant
                            to 8 Del. C. 220 to inspect certain books and records of Brooklyn. The stated purpose of the demand is to investigate possible wrongdoing by persons responsible for the implementation of the Merger and the issuance of paper
                            stock certificates, including investigating whether: (i) Brooklyn&#x2019;s stock certificates were issued in accordance with the Merger Agreement; (ii)&#160;certain restrictions on the sale of Brooklyn common stock following the Merger were
                            proper and applied without favor; (iii) anyone received priority in post-Merger issuances of Brooklyn&#x2019;s stock certificates that allowed them to benefit from an increase in the trading price of Brooklyn&#x2019;s common stock; and (iv)
                            it&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; should pursue
                              remedial measures and/or report alleged misconduct to the SEC. Brooklyn has responded to the demand letter and has produced certain information to Emerald in connection with the demand, which is subject to the terms of a
                              confidentiality agreement entered into among the parties, including certain additional stockholders who have subsequently joined as parties to such agreement (including Truell noted above). In October 2021, Emerald requested
                              that Brooklyn produce additional information related to the authority, purpose and justification for the restriction imposed on the sale of Brooklyn common stock following the Merger and the timing of share delivery to
                              Brooklyn stockholders, following which request Brooklyn agreed to produce certain additional information and emails relating to these topics.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
                            &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;On March 30,&#160;2022, counsel to Emerald advised the Company that it was prepared to file suit against the Company, certain current and former directors of the
                                Company, and the Company&#x2019;s financial advisor in connection with the Merger, on behalf of Emerald and a class of similarly situated stockholders with respect to some or all of the foregoing matters, alleging claims for breach
                                of fiduciary duty, conversion and aiding and abetting breach of fiduciary duty. Emerald&#x2019;s counsel expressed a willingness to engage in private pre-suit early resolution discussions with the Company and its financial advisor
                                on behalf of individual stockholders whom counsel represents in addition to Emerald; and the Company since engaged in such discussions. The Company can provide no assurance that such pre-suit early resolution discussions
                                will be successful or that suit will not ultimately be filed against the Company, nor can the Company currently predict the outcome of any such suit, if filed. The Company intends to defend itself vigorously against any and
                                all claims. Additionally, on April 7,&#160;2022,&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; the Company received a demand for indemnification from its financial advisor as it relates to the aforementioned
                                  potential lawsuit.&lt;/span&gt;&lt;br/&gt;
                              &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;John Westman v. Novellus, Inc., Christopher Rohde, and Matthew Angel, Civil Action No. 2181CV01949
                                (Middlesex County (Massachusetts) Superior Court)&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
                            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;On&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; or about September 7, 2021, John Westman, a former employee of Novellus, Inc. filed a Complaint in Middlesex
                                County (Massachusetts) Superior Court against Novellus, Inc. and the company&#x2019;s founders and former executives, Christopher Rohde and Matthew Angel (collectively, &#x201c;Defendants&#x201d;). The case includes allegations that Novellus,
                                Inc. violated the Massachusetts Wage Act.. Brooklyn acquired Novellus, Inc. on July 16,&#160;2021. Mr. Westman&#x2019;s claims relate to alleged conduct that took place before Brooklyn acquired Novellus, Inc. Defense and liability in
                                association with any Wage Act claims have been assumed by Mr. Rohde and Mr. Angel. On December 24,&#160;2021, Westman dismissed the case without prejudice so the parties could mediate the matter. The parties&#x2019; February 2022
                                mediation was unsuccessful and the dispute is currently in arbitration.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
                              &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The company accrued $0.8 million in legal-related expenses during the quarter ended March 31, 2022 for the matters discussed above.&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                              &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
              &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Licensing Agreements&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;USF&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;Brooklyn LLC has license agreements with University
                  of South Florida Research Association, Inc. (&#x201c;USF&#x201d;), granting Brooklyn LLC the right to sell, market, and distribute IRX-2, subject to a 7%
                  royalty payable to USF based on a percentage of gross product sales. Under the license agreement with USF, Brooklyn LLC is obligated to repay patent prosecution expenses incurred by USF. To date, Brooklyn LLC has not recorded any product
                  sales, or obligations related to USF patent prosecution expenses. The license agreement terminates upon the expiration of the IRX-2 patents.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Novellus, Ltd. and Factor &lt;br/&gt;
                  &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;In December 2020, Brooklyn LLC entered into option agreements (the
                    &#x201c;Option Agreements&#x201d;) with Novellus, Ltd. and Factor (together, the &#x201c;Licensors&#x201d;) to obtain the right to exclusively license the Licensors&#x2019; intellectual property and mRNA cell reprogramming and gene editing technology for use in the
                    development of certain cell-based therapies to be evaluated and developed for treating human diseases, including certain types of cancer, sickle cell disease, and beta thalassemia (the &#x201c;Licensed Technology&#x201d;). The option was exercisable
                    before February 28, 2021 (or April 30, 2021 if the Merger had not closed by that date) and required Brooklyn LLC to pay a non-refundable option fee of $0.5 million and then an initial license fee of $4.0 million &lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;(including the non-refundable fee of $0.5 million) in order to exercise the option.&lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt; &lt;br/&gt;
                  &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt; In April 2021, Brooklyn LLC and the Licensors amended the Option Agreements to extend the exercise period to May 21, 2021 and to require Brooklyn, LLC to pay a
                    total $1.0 million of the $4.0
                    million initial license fees to the Licensors by April 15, 2021.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;In April 2021, Brooklyn LLC and the Licensors entered into an exclusive license agreement (the &#x201c;License Agreement&#x201d;) pursuant to which Brooklyn LLC acquired an exclusive worldwide license to the Licensed Technology. Under
                      the terms of the License Agreement, Brooklyn LLC is obligated to pay the Licensors a total of $4.0 million in connection
                      with the execution of the License Agreement, all of which was paid as of June 2021.&lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;The completion of the acquisition of Novellus, Ltd. relieved Brooklyn LLC from potential obligations to pay Novellus, Ltd. certain upfront fees, clinical
                        development milestone fees and post-registration royalties under the License Agreement. The agreement with Factor under the License Agreement, which grants Brooklyn LLC exclusive rights to develop certain next-generation mRNA gene
                        editing and cell therapy products, remained unchanged. Accordingly, Brooklyn LLC is obligated to pay to Factor a fee&lt;/span&gt; of $3.5
                      million in October 2022, which will be in addition to a fee of $2.5 million paid to Factor in October 2021.&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt;&lt;br/&gt;
                  &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Brooklyn



                      LLC is also required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory milestones and specified commercialization milestones. In general, upon its
                      achievement of these milestones, Brooklyn LLC will be obligated to pay, in the case of development and regulatory milestones, milestone payments to the Licensors in specified amounts and, in the case of commercialization milestones,
                      specified royalties with respect to product sales, sublicense fees or sales of pediatric review vouchers. In the event Brooklyn LLC fails to timely achieve certain delineated milestones, the Licensors will have the right to terminate
                      Brooklyn LLC&#x2019;s rights under provisions of the License Agreement relating to those milestones.&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;Novellus, Ltd. also has a license agreement with Factor, which was entered into in February 2015, amended in June 2018 and March 2020, and then amended and restated
                    in November 2020. This license agreement provides for Novellus, Ltd. to use over 70 granted patents owned by Factor
                    throughout the world covering synthetic mRNA, RNA-based gene editing, and RNA-based cell reprogramming, in addition to specific patents covering methods for treating specific diseases. There are also more than 60 pending patent applications throughout the world focused on these and other aspects of the technology. The patent coverage includes
                    granted patents and pending patent applications in the United States, Europe, and Japan, along with other major life sciences markets.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;Novellus, Ltd. is required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory
                    milestones and specified commercialization milestones. In general, upon its achievement of these milestones, Novellus, Ltd. will be obligated, in the case of development and regulatory milestones, to make milestone payments of up to $51.0 million in aggregate to Factor and, in the case of commercialization milestones, specified royalties with respect to product sales,
                    sublicense fees or sales of pediatric review vouchers. In the event Novellus, Ltd. fails to timely achieve certain delineated milestones, Factor may have the right to terminate Novellus, Ltd.&#x2019;s rights under provisions of the License
                    Agreement relating to those milestones.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;NoveCite&lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
                            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;/span&gt;In October 2020, Novellus, Ltd. (as
                            sublicensor) and NoveCite (as sublicensee) entered into an exclusive license agreement (the &#x201c;Sublicense&#x201d;) to license novel cellular therapy for acute respiratory distress syndrome, which NoveCite is licensing from Factor. Under
                            the sublicense agreement, NoveCite is required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory milestones and specified commercialization
                            milestones. In general, upon its achievement of these milestones, NoveCite will be obligated, in the case of development and regulatory milestones, to make milestone payments to the Novellus, Ltd. in specified amounts and, in
                            the case of commercialization milestones, specified royalties with respect to product sales, sublicense fees or sales of pediatric review vouchers.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;&lt;span style="text-decoration: underline;"&gt;&lt;br/&gt;
                            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;Under the terms of the Sublicense, in the
                            event that Novellus, Ltd. receives any revenue involving the original cell line included in the licensed technology, then Novellus, Ltd. shall remit to NoveCite 50% of such revenue.&lt;span style="text-decoration: underline;"&gt;&lt;br/&gt;
                            &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Royalty Agreements&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Collaborator Royalty Agreement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Effective June 22, 2018, IRX terminated its Research,
          Development and Option Facilitation Agreement and its Options Agreement (the &#x201c;RDO and Options Agreements&#x201d;) with a collaborative partner (the &#x201c;Collaborator&#x201d;), pursuant to a termination agreement (the &#x201c;Termination Agreement&#x201d;). &lt;span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;The Termination Agreement was assigned to Brooklyn, LLC in November 2018 when Brooklyn LLC acquired the assets of IRX. &lt;/span&gt;In
          connection with the Termination Agreement, all of the rights granted to the Collaborator under the RDO and Options Agreements were terminated, and Brooklyn LLC has no obligation to refund any payments received from the Collaborator. As
          consideration for entering into the Termination Agreement, the Collaborator will receive a royalty equal to 6% of revenues from the
          sale of IRX-2, for the period of time beginning with the first sale of IRX-2 through the later of (i) the twelfth anniversary of the first sale of IRX-2 or (ii) the expiration of the last IRX patent, or other exclusivity of IRX-2.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-indent: 36pt; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt; &lt;span style="text-decoration: underline;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Royalty Agreement with certain former IRX Therapeutics Investors&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;On May 1, 2012, IRX Therapeutics entered into a royalty agreement (the &#x201c;IRX Investor Royalty Agreement&lt;span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;&#x201d;&lt;/span&gt;)
              with certain investors who participated in a financing transaction. The IRX Investor Royalty Agreement was assigned to Brooklyn LLC in November 2018 when Brooklyn LLC acquired the assets of IRX. Pursuant to the IRX Investor Royalty Agreement,
              when Brooklyn LLC becomes obligated to pay royalties to USF under the agreement described above under &#x201c;Licensing Agreements-USF,&#x201d; it will pay an additional royalty of 1% of gross sales to an entity organized by the investors who participated in such financing transaction. There are no termination provisions in the IRX Investor Royalty Agreement.
              Brooklyn LLC has not recognized any revenues to date, and no royalties are due pursuant to any of the above-mentioned royalty agreements.&lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Investor Royalty Agreement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-indent: 36pt;"&gt;On




            March 22, 2021, Brooklyn LLC restated its royalty agreement with certain beneficial holders of Brooklyn ImmunoTherapeutics Investors GP LLC and Brooklyn ImmunoTherapeutics Investors LP, whereby such beneficial holders will continue to receive,
            on an annual basis, royalties in an aggregate amount equal to 4% of the net revenues of IRX-2, a cytokine-based therapy being
            developed by Brooklyn LLC to treat patients with cancer.&lt;/div&gt;
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <btx:LossContingencyDamagesSoughtExpectedSalary
      contextRef="c20210205to20210205_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_ea3946ce54db4930ab01bfb7556dde4f"
      unitRef="U002">500000</btx:LossContingencyDamagesSoughtExpectedSalary>
    <btx:LossContingencyDamagesSoughtExpectedEquityPercentage
      contextRef="c20210205to20210205_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"
      decimals="2"
      id="Fact_676b2af9293d4cff9e63b1fd03b93718"
      unitRef="U004">0.07</btx:LossContingencyDamagesSoughtExpectedEquityPercentage>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="c20210205to20210205_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"
      decimals="-6"
      id="Fact_ebfcbb57d8714cc68d9a228fc21ec24f"
      unitRef="U002">10000000</us-gaap:LossContingencyDamagesSoughtValue>
    <btx:LossContingencyDamagesSoughtExpectedEquityPercentage
      contextRef="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember"
      decimals="2"
      id="Fact_5854ca9f5c67400bbf82a7d33a0c86ed"
      unitRef="U004">0.07</btx:LossContingencyDamagesSoughtExpectedEquityPercentage>
    <btx:LossContingencyDamagesSoughtExpectedSalary
      contextRef="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember"
      decimals="-5"
      id="Fact_2b9ea4e2770640f0894ce316caa0ef6b"
      unitRef="U002">500000</btx:LossContingencyDamagesSoughtExpectedSalary>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="c20211215to20211215_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember"
      decimals="-6"
      id="Fact_6dcb5e3199d6421085bad6bb25d3b828"
      unitRef="U002">100000000</us-gaap:LossContingencyDamagesSoughtValue>
    <btx:LossContingencyNumberOfArbitrationPanel
      contextRef="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember"
      decimals="INF"
      id="Fact_680d80a645b64fbeb376f681df20a047"
      unitRef="U005">3</btx:LossContingencyNumberOfArbitrationPanel>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="c20220331"
      decimals="-5"
      id="Fact_cc3e46ae79ee44d3a0a0e1c25f765464"
      unitRef="U002">800000</us-gaap:AccruedProfessionalFeesCurrent>
    <btx:LossContingencyPercentageOfRoyaltyPayable
      contextRef="c20220101to20220331_LegalEntityAxis_UniversityOfSouthFloridaMember"
      decimals="2"
      id="Fact_54bfc1b366044a4b887007b56da6dd30"
      unitRef="U004">0.07</btx:LossContingencyPercentageOfRoyaltyPayable>
    <btx:LossContingencyNonRefundableOptionFee
      contextRef="c20210413to20210413_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_9eae7cdfa6864c3e8e9ae77c6bfd41aa"
      unitRef="U002">500000</btx:LossContingencyNonRefundableOptionFee>
    <btx:InitialLicenseFees
      contextRef="c20210430to20210430_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_6c905164d7144f2db482ab8ca2e5e378"
      unitRef="U002">4000000.0</btx:InitialLicenseFees>
    <btx:LossContingencyNonRefundableOptionFee
      contextRef="c20210413to20210413_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_86cef0a08c004be9ab3ede332ad9e279"
      unitRef="U002">500000</btx:LossContingencyNonRefundableOptionFee>
    <btx:AdditionalFeesObligatedToPay
      contextRef="c20210415to20210415_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_e3dc1c0deac648a4af37b84b7b25c62d"
      unitRef="U002">1000000.0</btx:AdditionalFeesObligatedToPay>
    <btx:InitialLicenseFees
      contextRef="c20210430to20210430_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_19bdc16d5697494babad85ca7deb7339"
      unitRef="U002">4000000.0</btx:InitialLicenseFees>
    <btx:AmountRequireToPayInitialLicenseFees
      contextRef="c20210426_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_68aac7bcd61849ebb7e3ff7e1b78478c"
      unitRef="U002">4000000.0</btx:AmountRequireToPayInitialLicenseFees>
    <btx:AmountObligatedToPayInYearTwo
      contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember_StatementScenarioAxis_ScenarioForecastMember"
      decimals="-5"
      id="Fact_7721019e394b42899ab80b82f9a10e35"
      unitRef="U002">3500000</btx:AmountObligatedToPayInYearTwo>
    <btx:AmountObligatedToPayInYearOne
      contextRef="c20211031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_7496e59bed7c4a9092b5d3d9bc7e5f24"
      unitRef="U002">2500000</btx:AmountObligatedToPayInYearOne>
    <btx:MinimumNumberOfPatentGranted
      contextRef="c20220101to20220331_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="0"
      id="Fact_fab64718ed6943d38f4d90ae045690f7"
      unitRef="U007">70</btx:MinimumNumberOfPatentGranted>
    <btx:MinimumNumberOfPendingPatents
      contextRef="c20220101to20220331_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="0"
      id="Fact_d7b012b70d794ee0a3081654791479e2"
      unitRef="U007">60</btx:MinimumNumberOfPendingPatents>
    <btx:MilestonePayments
      contextRef="c20220101to20220331_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_445df466534e484aba7343c75333c9a2"
      unitRef="U002">51000000.0</btx:MilestonePayments>
    <btx:PercentageOfRevenue
      contextRef="c20220331_RelatedPartyTransactionsByRelatedPartyAxis_NoveCiteMember"
      decimals="2"
      id="Fact_99a3fa2a00f649bf8cb90ccb544e4e2d"
      unitRef="U004">0.50</btx:PercentageOfRevenue>
    <btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness
      contextRef="c20180622to20180622_TypeOfArrangementAxis_CollaboratorRoyaltyAgreementMember"
      decimals="2"
      id="Fact_935b0932ed9b4cb9b3df1a93161d295a"
      unitRef="U004">0.06</btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness>
    <btx:PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales
      contextRef="c20120501to20120501_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember"
      decimals="2"
      id="Fact_e0c2b93b600045fd9166ec105e69f60a"
      unitRef="U004">0.01</btx:PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales>
    <btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness
      contextRef="c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember"
      decimals="2"
      id="Fact_71e85a04bc9b4e1f92899df6493216c6"
      unitRef="U004">0.04</btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="c20220101to20220331"
      id="Text_fe61a4ef3f6544cca1c5804b47cbc7d3">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
      &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;9)&lt;br/&gt;
              &lt;/span&gt; &lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;
                &lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: normal; font-variant: normal; text-transform: none;"&gt;STOCK-BASED COMPENSATION&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
    &lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman';"&gt; &#160; &lt;span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman';"&gt; &lt;span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman';"&gt; &lt;span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;There were no stock options outstanding or granted during the &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;three&lt;span style="font-size: 10pt;"&gt; months ended March &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2021.&lt;span style="font-size: 10pt;"&gt; &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt;The following weighted-average assumptions were used for stock options granted during the &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;"&gt;three&lt;/span&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt; months ended March &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;"&gt;31,&lt;/span&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;"&gt;2022&lt;/span&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Three months ended &lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;March 31&lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;,&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;2022&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt;"&gt;Weighted average risk-free rate&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;1.92&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;%&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt;"&gt;Weighted average volatility&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;93&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;%&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt;"&gt;Dividend yield&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;0&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;%&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt;"&gt;Expected term&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;&lt;span style="font-size: 10pt;"&gt;5.78 years&lt;br/&gt;
                &lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; The following table summarizes stock option activity for the &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;three&lt;span style="font-size: 10pt;"&gt; months ended March &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022&lt;span style="font-size: 10pt;"&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="text-align: center; font-size: 10pt; font-weight: bold;"&gt;Outstanding Options&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="text-align: center; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Exercise Price per Share&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="text-align: center; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Remaining Contractual Life (in years)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="text-align: center; font-size: 10pt; font-weight: bold;"&gt;Aggregate Intrinsic Value&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"&gt;Outstanding January &lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-weight: bold;"&gt;1,&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;2022&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;3,988,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;8.40&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;9.38&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 52%;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt; margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;1,258,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;2.10&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt; margin-left: 9pt;"&gt;Cancelled&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;(67,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;5.94&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"&gt;Outstanding March 31&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-weight: bold;"&gt;,&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;2022&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;5,179,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;6.90&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;9.32&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;134,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Options vested and exercisable at March &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;10,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;10.26&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;9.75&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The per-share weighted average grant-date fair value of stock options granted during
          the &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;three&lt;span style="font-size: 10pt;"&gt; months ended March &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022&lt;span style="font-size: 10pt;"&gt; was &lt;/span&gt;$1.58.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;As of March &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022,&lt;span style="font-size: 10pt;"&gt; the unamortized stock-based compensation expense related to outstanding unvested options was approximately &lt;/span&gt;$18.5 million&lt;span style="font-size: 10pt;"&gt; with a weighted average remaining requisite service period of &lt;/span&gt;3.06&lt;span style="font-size: 10pt;"&gt; years. The Company expects to amortize this expense over the remaining requisite service period of these stock options.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Included in the &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;5,179,000&lt;span style="font-size: 10pt;"&gt; stock options outstanding as of March &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022&lt;span style="font-size: 10pt;"&gt; are &lt;/span&gt;two&lt;span style="font-size: 10pt;"&gt; stock option grants the Company awarded to Howard J.
            Federoff, M.D., Ph.D. upon his appointment as the Company&#x2019;s Chief Executive Officer and President in April &lt;/span&gt;2021.&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Dr. Federoff was granted a nonqualified stock option covering approximately 2,628,000&lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt;"&gt; shares of common stock (the &#x201c;Time-Based Option&#x201d;). The
            Time-Based Option was granted at a per share exercise price equal to the closing price of the common stock on the NYSE American stock exchange on the date of grant. Of the shares covered by the Time-Based Option, &lt;/span&gt;25%&lt;span style="font-size: 10pt;"&gt; will vest on the &lt;/span&gt;one&lt;span style="font-size: 10pt;"&gt;-year anniversary of the grant date, and the remaining
            shares will vest in substantially &lt;/span&gt;36&lt;span style="font-size: 10pt;"&gt; equal monthly installments thereafter, so long as Dr.
            Federoff provides continuous service to the Company throughout the relevant vesting date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Dr. Federoff was also granted a performance-based nonqualified stock option covering
          approximately &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;597,000&lt;span style="font-size: 10pt;"&gt; shares of common stock (the
            &#x201c;Milestone Option&#x201d;). The Milestone Option was granted at a per share exercise price equal to the closing price of common stock on the NYSE American stock exchange on the date of grant, and its fair value is &lt;/span&gt;$4.3 million&lt;span style="font-size: 10pt;"&gt;. The Milestone Option will fully vest upon the &lt;/span&gt;first&lt;span style="font-size: 10pt;"&gt; concurrence by
            the U.S. Food and Drug Administration that a proposed investigation may proceed following review of a Company filed investigational new drug application in connection with that the License Agreement. This milestone is subject to Dr. Federoff&#x2019;s
            continuous service with the Company through such vesting date. As of March &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022,&lt;span style="font-size: 10pt;"&gt; the Company has not recognized any stock-based compensation expense on the Milestone Option because the Company has determined that it is not yet probable that the performance milestone
            will be accomplished.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Both the Time-Based Option and the Milestone Option were granted outside the
          Company&#x2019;s equity incentive plans discussed above. The unvested portion of the Time-Based Option and the Milestone Option will be cancelled upon the termination of Dr. Federoff&#x2019;s employment with the Company for any reason, subject to certain
          vesting acceleration provisions upon a qualifying termination, as described in his employment agreement with the Company. Unless earlier terminated in accordance with their terms, each of the Time-Based Option and the Milestone Option will
          otherwise expire on the &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;tenth&lt;span style="font-size: 10pt;"&gt; anniversary of their respective grant date and be subject to the terms and conditions of the respective option agreement approved
            by the Company. Each of the Time-Based Option and the Milestone&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; Option was intended to constitute an &#x201c;employment inducement grant&#x201d; in accordance with the employment
          inducement grant rules set forth in Section &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;711&lt;span style="font-size: 10pt;"&gt;(a) of the NYSE American LLC Company Guide and was offered as an inducement material to Dr. Federoff in connection
            with his hiring.&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; text-indent: 36pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;There were no
          options exercised during the &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;three&lt;span style="font-size: 10pt;"&gt; months ended March &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022&lt;span style="font-size: 10pt;"&gt; and &lt;/span&gt;2021.&lt;/span&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; text-indent: 36pt;"&gt;&lt;span style="font-family: 'Times New Roman';"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; text-indent: 36pt;"&gt;&lt;span style="font-family: 'Times New Roman';"&gt; &lt;/span&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;RSUs&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Outstanding RSUs are settled in an equal number of shares of common stock on the vesting date of the award. An RSU award is settled only to the
        extent vested. Vesting generally requires the continued employment or service by the award recipient through the respective vesting date. Because RSUs are settled in an equal number of shares of common stock without any offsetting payment by the
        recipient, the measurement of cost is based on the quoted market price of the stock at the measurement date, which is the grant date.&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;There were no RSUs outstanding or granted during the &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;three&lt;span style="font-size: 10pt;"&gt; months ended March &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2021.&lt;span style="font-size: 10pt;"&gt; &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt;The following table summarizes RSU activity for the &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;"&gt;three&lt;/span&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt; months ended March &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;"&gt;31,&lt;/span&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;"&gt;2022&lt;/span&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="text-align: center; font-size: 10pt; font-weight: bold;"&gt;Outstanding Restricted Stock Units&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="text-align: center; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Fair Value per Share&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"&gt;January &lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-weight: bold;"&gt;1,&lt;span style="font-size: 10pt;"&gt; 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;240,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;13.80&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt; margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;1,101,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;1.93&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt; margin-left: 9pt;"&gt;Released&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;(9,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;4.21&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt; margin-left: 9pt;"&gt;Cancelled&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;(9,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;4.21&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;March 31&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-weight: bold;"&gt;&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;2022&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;1,323,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;4.05&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Balance expected to vest at March &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;772,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;During the &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;three&lt;span style="font-size: 10pt;"&gt; months ended March &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022,&lt;span style="font-size: 10pt;"&gt; the Company issued approximately &lt;/span&gt;1,101,000&lt;span style="font-size: 10pt;"&gt; performance based RSUs (the &#x201c;&lt;/span&gt;2022&lt;span style="font-size: 10pt;"&gt; PSUs&#x201d;) to its employees, of which approximately &lt;/span&gt;414,000&lt;span style="font-size: 10pt;"&gt; were awarded to Dr. Federoff. The &lt;/span&gt;2022&lt;span style="font-size: 10pt;"&gt; PSUs are subject to the
            achievement of &lt;/span&gt;four&lt;span style="font-size: 10pt;"&gt; performance goals, which are weighted equally. Once a performance goal is
            achieved, the tranche of shares allocated to that performance goal will be earned and will begin to vest over a &lt;/span&gt;three-year&lt;span style="font-size: 10pt;"&gt; annual basis beginning on the date the performance goal was achieved. If a performance goal is not achieved, the tranche of shares allocated to that performance goal will be unearned and forfeited.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company recognizes the fair value of RSUs granted as expense on a straight-line
          basis over the requisite service period. For performance based RSUs, the Company will begin recognizing the expense once the achievement of the related performance goal is probable. As of March &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022,&lt;span style="font-size: 10pt;"&gt; the unamortized stock-based compensation expense related to outstanding RSUs, including performance based RSUs that have been deemed probable, was
            approximately &lt;/span&gt;$3.6 million&lt;span style="font-size: 10pt;"&gt; with a weighted average remaining requisite service period of &lt;/span&gt;2.59&lt;span style="font-size: 10pt;"&gt; years. The Company expects to amortize this expense over the remaining requisite service period of the RSUs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Restricted Stock&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Pursuant to the Merger, Brooklyn LLC&#x2019;s approximately &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;3,000&lt;span style="font-size: 10pt;"&gt; outstanding restricted common units were exchanged for
            approximately &lt;/span&gt;630,000&lt;span style="font-size: 10pt;"&gt; shares of Brooklyn&#x2019;s restricted common stock. There were no changes to
            any conditions and requirements of the restricted common stock. The shares vest quarterly beginning on March &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2021&lt;span style="font-size: 10pt;"&gt; and continuing through December &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022,&lt;span style="font-size: 10pt;"&gt; contingent on continued service. Due to the modification of the restricted common units, the fair value of the restricted common stock immediately after the Merger was
            compared to the fair value of the restricted common units immediately prior to the Merger, and the change in fair value of &lt;/span&gt;$0.3
          million&lt;span style="font-size: 10pt;"&gt; was recognized in the statement of operations during the &lt;/span&gt;three&lt;span style="font-size: 10pt;"&gt; months ended March &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2021.&lt;span style="font-size: 10pt;"&gt;
            The Company recognizes the fair value of restricted common stock as an expense on a straight-line basis over the requisite service period. During the quarter ended March &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022,&lt;span style="font-size: 10pt;"&gt; approximately &lt;/span&gt;78,000&lt;span style="font-size: 10pt;"&gt; shares of unvested restricted common stock were
            forfeited due to the holders of such shares no longer providing services to the Company. As of March &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022,&lt;span style="font-size: 10pt;"&gt; there were no shares of unvested restricted stock outstanding.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-family: 'Times New Roman';"&gt;&lt;span style="font-size: 10pt;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; text-indent: 36pt;"&gt;&lt;span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;Stock-Based Compensation Expense &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; text-indent: 36pt;"&gt;&lt;span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; text-indent: 36pt; text-align: justify;"&gt;&lt;span style="font-style: italic; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;Stock-based compensation is recorded in general and administrative expense and research and development expense in the statement of operations. For the three months ended March 31,&#160;2022 and 2021, stock-based compensation
          expense recorded in general and administrative expense was $0.8 million and $17,000, respectively. For both of the three months ended March 31,&#160;2022 and 2021, stock-based compensation expense recorded in research and development expense was $0.4 million.&lt;/span&gt; &lt;/div&gt;
</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20210331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact_b276a4713ad946b08956a2ecbfca34e0"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20210101to20210331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact_11819c0ec5d8472b91c83cc3ce6994e7"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_6ff9800a3e994ac28e546077f88dee7f">&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt;The following weighted-average assumptions were used for stock options granted during the &lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;"&gt;three&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt; months ended March &lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;"&gt;31,&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;"&gt;2022&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt;:&lt;/span&gt;
&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Three months ended &lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;March 31&lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;,&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;2022&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt;"&gt;Weighted average risk-free rate&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;1.92&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;%&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt;"&gt;Weighted average volatility&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;93&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;%&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt;"&gt;Dividend yield&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;0&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;%&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 82%;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt;"&gt;Expected term&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 15%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;&lt;span style="font-size: 10pt;"&gt;5.78 years&lt;br/&gt;
                &lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_d174144dbdaa4449ac62785d8fd0e29b"
      unitRef="U004">0.0192</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_2475f54991e048c6bec93350b01686b8"
      unitRef="U004">0.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_f79a6190b503411aa1e767827e308802"
      unitRef="U004">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_33f90305e73d41db9896f274993fcc94">P5Y9M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_58ee1423da4842889e06298debdcc9cc">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 36pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; The following table summarizes stock option activity for the &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;three&lt;span style="font-size: 10pt;"&gt; months ended March &lt;/span&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022&lt;span style="font-size: 10pt;"&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="text-align: center; font-size: 10pt; font-weight: bold;"&gt;Outstanding Options&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="text-align: center; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Exercise Price per Share&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="text-align: center; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Remaining Contractual Life (in years)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="text-align: center; font-size: 10pt; font-weight: bold;"&gt;Aggregate Intrinsic Value&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"&gt;Outstanding January &lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-weight: bold;"&gt;1,&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;2022&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;3,988,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;8.40&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;9.38&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 52%;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt; margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;1,258,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;2.10&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt; margin-left: 9pt;"&gt;Cancelled&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;(67,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;5.94&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"&gt;Outstanding March 31&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-weight: bold;"&gt;,&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;2022&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;5,179,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;6.90&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;9.32&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;134,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Options vested and exercisable at March &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;10,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;10.26&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;9.75&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_19ae4fa476dd43e1a245fbe3290f1959"
      unitRef="U001">3988000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_4b60b9b3d57e4ff682ed74f843ad1e65"
      unitRef="U003">8.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_682fbd3758e74c458a7cf81afe31aced">P9Y4M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_322ea1273839443a8e360352507e4ee7"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_8f6ab86d166a43b69ce87c4eca299012"
      unitRef="U001">1258000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_d40dcbe70866484cab6dd9f032528c7f"
      unitRef="U003">2.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_133e08796c154081bc5f4e36333bd95e"
      unitRef="U002">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_45d89b7d87bd4cfe9f17b0a56e2032a4"
      unitRef="U001">67000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_ac4df744b27a4e6bb13fe0df4723568d"
      unitRef="U003">5.94</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_758b26653a2a4eb4afb9e1565d1db90c"
      unitRef="U001">5179000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_40917df3c9b9448786dda833444228e6"
      unitRef="U003">6.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_ecdb2fd9f23048289c0462f3a72e6504">P9Y3M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_87db2e7c29b94ad58fc281714866cc95"
      unitRef="U002">134000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_eccf2390ba30474cbb1daf762e7c7394"
      unitRef="U001">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_076dbbf27e2c43bf8209f3a051ec2e29"
      unitRef="U003">10.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_40c691ddd8d84455a86fc9bb416bf25e">P9Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_9fdcd7c4b3cc4a8b8b81aeaa058f054b"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_b43edf1cbfe140ed89ddbb1971a649e1"
      unitRef="U003">1.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-5"
      id="Fact_e82698ed85ed4438a8f7ede281050e3c"
      unitRef="U002">18500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_848429d0795845ca8ee43482bc33e26a">P3Y21D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_0a5c088aa14547199d3875786f42de2b"
      unitRef="U001">5179000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <btx:NumberOfStockOptionGrantMade
      contextRef="c20220331"
      decimals="INF"
      id="Fact_725caac513f741daaa24d2046ed5b926"
      unitRef="U008">2</btx:NumberOfStockOptionGrantMade>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20220101to20220331_AwardTypeAxis_TimeBasedNonQualifiedStockOptionMember"
      decimals="0"
      id="Fact_d8843da67fe244cd85f95789b659d16e"
      unitRef="U001">2628000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c20220101to20220331_AwardTypeAxis_TimeBasedNonQualifiedStockOptionMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember"
      decimals="2"
      id="Fact_4db87e11081b4745baaa4d4a18d437e1"
      unitRef="U004">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <btx:ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares
      contextRef="c20220101to20220331_AwardTypeAxis_TimeBasedNonQualifiedStockOptionMember"
      decimals="0"
      id="Fact_bcadfe9bd2df4e468f2ca30a61b67629"
      unitRef="U009">36</btx:ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20220101to20220331_AwardTypeAxis_PerformanceBasedNonqualifiedStockOptionMember"
      decimals="0"
      id="Fact_34bbc19106794447a9930aed646eda69"
      unitRef="U001">597000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue
      contextRef="c20220101to20220331_AwardTypeAxis_PerformanceBasedNonqualifiedStockOptionMember"
      decimals="-5"
      id="Fact_30b68b3fe4a14f79b75710c02a58c0fb"
      unitRef="U002">4300000</btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_f3e0490a9bd44a039d1b02b026d9d146"
      unitRef="U002">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact_fe7d43d61aa2494e98b374fa21ac0dbd"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20210101to20210331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact_c5057c68e197426baeceb04be6d485ce"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact_a8eef851674a4ec598e26e27482359b5"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact_05acc581f4cd4606b5fb9ee664c88d60"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_791343deab184b8cabe5fa0221e79d53">&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt;The following table summarizes RSU activity for the &lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;"&gt;three&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt; months ended March &lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;"&gt;31,&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-style: normal; font-variant: normal;"&gt;2022&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: normal; font-variant: normal;"&gt;:&lt;/span&gt;
&lt;div style="font-family: 'Times New Roman';"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="text-align: center; font-size: 10pt; font-weight: bold;"&gt;Outstanding Restricted Stock Units&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="text-align: center; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Fair Value per Share&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"&gt;January &lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-weight: bold;"&gt;1,&lt;span style="font-size: 10pt;"&gt; 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;240,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;13.80&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt; margin-left: 9pt;"&gt;Granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;1,101,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;1.93&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt; margin-left: 9pt;"&gt;Released&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;(9,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;4.21&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-size: 10pt; margin-left: 9pt;"&gt;Cancelled&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;(9,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;4.21&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;March 31&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-weight: bold;"&gt;&lt;span style="font-size: 10pt;"&gt; &lt;/span&gt;2022&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;1,323,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;4.05&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Balance expected to vest at March &lt;/span&gt;&lt;span style="font-family: 'Times New Roman';"&gt;31,&lt;span style="font-size: 10pt;"&gt;&#160;&lt;/span&gt;2022&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
              &lt;div style="font-size: 10pt;"&gt;772,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; font-family: 'Times New Roman'; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_2d64aaf0442b4669a549fddaf4229c16"
      unitRef="U001">240000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fact_83aa811dd70a4527b9273b8e339c5f9a"
      unitRef="U003">13.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_eaadbc05ca554a7d8636ab1430e26f24"
      unitRef="U001">1101000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fact_df1b331b13f342e69130eae4e82bd05f"
      unitRef="U003">1.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_4d09df181be343a1bf4e1f89807e9792"
      unitRef="U001">9000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fact_a8b4babfbf2347f897d78e5a87ad2426"
      unitRef="U003">4.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_7726aa26125b44b789cafdb02c60adfd"
      unitRef="U001">9000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fact_c40cb4273667471ab0dafac7d9be0754"
      unitRef="U003">4.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_13c56424e1e649388f70af9178bb6055"
      unitRef="U001">1323000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fact_fbefdbb9c2424e61950e4970174476dc"
      unitRef="U003">4.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber
      contextRef="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_2d158f02e2164e8593047d94e61ae4de"
      unitRef="U001">772000</btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_EmployeeMember"
      decimals="0"
      id="Fact_59557195a1c14400ae067fc818d1cf86"
      unitRef="U001">1101000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember"
      decimals="0"
      id="Fact_31faebe2726542a98f9590a38daa4061"
      unitRef="U001">414000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <btx:NumberOfPerformanceGoalsAreSubjectToAchieve
      contextRef="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember"
      decimals="INF"
      id="Fact_dcaa08dc8312405d8336d0101fd93602"
      unitRef="U010">4</btx:NumberOfPerformanceGoalsAreSubjectToAchieve>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="c20220101to20220331_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember"
      id="Fact_bdadfc61876d4296a9c05511bea7b81e">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-5"
      id="Fact_60f6f2e159224f55bea1de4998131acf"
      unitRef="U002">3600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      id="Fact_7ad97e6a02c742eabf8d9ebddae3f1be">P2Y7M2D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_e46d7d89e5db4fa8be45e78f8fc2fe3a"
      unitRef="U001">3000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_cbcb18df300d4193be7df425b37148ef"
      unitRef="U001">630000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockMember"
      decimals="-5"
      id="Fact_2259b75430e84d91a157122f11f89ca3"
      unitRef="U002">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_89453cdfbce7410bbbd787e862f9c609"
      unitRef="U001">78000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20220331_AwardTypeAxis_RestrictedStockMember"
      decimals="INF"
      id="Fact_47770f018d4945deb257d3d20f3243a4"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20220331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="-5"
      id="Fact_d271bb69e2d64890b5f02d5af03688c0"
      unitRef="U002">800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20210331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact_b77ec7dff3044c77bd793b088235ea9c"
      unitRef="U002">17000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20220331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="Fact_faedad39338b499191b44c613ac082aa"
      unitRef="U002">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20210331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-5"
      id="Fact_6d5db873e5a247faa14e4c4f3d075269"
      unitRef="U002">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_b2be21af16d24bb093b1de68f296d004">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify;"&gt;10)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
                &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"&gt;STOCKHOLDERS&#x2019; EQUITY&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="font-weight: normal;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;Private Placement of
            Equity&lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
              &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On March 6, 2022, the Company entered into a Securities Purchase Agreement (the &#x201c;Purchase Agreement&#x201d;) with an investor (the &#x201c;PIPE Investor&#x201d;)
                providing for the private placement (the &#x201c;PIPE Transaction&#x201d;) to the PIPE Investor of approximately 6,857,000 units
                (collectively, the &#x201c;Units&#x201d;), each Unit consisting of (i) one share of the Company&#x2019;s common stock (or, in lieu thereof, one
                pre-funded warrant (the &#x201c;Pre-Funded Warrants&#x201d;) to purchase one share of common stock) and (ii) one warrant (the &#x201c;Common
                Warrants&#x201d;) to purchase one share of common stock, for an aggregate gross purchase price of approximately $12.0 million (the
                &#x201c;Subscription Amount&#x201d;). The PIPE Transaction closed on March 9, 2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt;
              &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Each Pre-Funded Warrant has an exercise price of $0.005 per share of common stock, was immediately exercisable, may be
              exercised at any time, has no expiration date and is subject to customary adjustments. The Pre-Funded Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 9.99% immediately after exercise thereof. Upon the closing of the transaction, the Company issued 5,500,000 shares of common stock and issued Pre-Funded Warrants representing approximately 1,357,000 shares of common stock.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt;
              &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;Each Common Warrant has an exercise price of $1.91 per share, becomes exercisable six months following the closing of the PIPE Transaction, expires &lt;span style="-sec-ix-hidden:Fact_2134c2193a6f4a199f8e2044d8c27aaf"&gt;five-and-one-half &lt;/span&gt; years from the date of issuance and is subject to customary adjustments. The Common Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 4.99% immediately after exercise thereof, subject to increase to 9.99% at the option of the holder.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of March 31, 2022, the Company had 6,857,000
              Common Warrants outstanding with a weighted average exercise price of $1.91 per share and a weighted average contractual life of 5.45 years. As of March 31, 2022, the Company had 1,357,000
              Pre-Funded Warrants outstanding with a weighted average exercise price of $0.005 per share. The Pre-Funded Warrants do not expire.&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;The











            Common Warrants and Pre-Funded Warrants were accounted for as liabilities under ASC 815-40, as these warrants provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40. These
            warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of operations.&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $12.6 million in the aggregate, which was $0.6 million more
              than the Subscription Amount. The excess $0.6 million represents an inducement to the PIPE Investor to enter into the transaction
              and was recorded in warrant liabilities expense in the accompanying consolidated statement of operations. Given the Company&#x2019;s capital requirements and market conditions, the Company consummated this financing on market terms available at the
              time of the transaction.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; margin-right: 2pt;"&gt;The Company incurred fees of $1.0
              million through March 31, 2022 related to the PIPE Transaction, which were allocated to the fair value of the Common Warrants and the Pre-Funded Warrants and recorded in other expense, net on the accompanying condensed consolidated statement
              of operations.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In connection with the PIPE Transaction, the Company and the PIPE Investor also entered into a registration rights agreement, dated March 6,
              2022, pursuant to which the Company agreed to prepare and file a registration statement with the SEC no later than 15 days following the filing date of the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2021 (the &#x201c;2021
              Annual Report&#x201d;) to register the resale of the shares of common stock included in the Units and the shares of common stock issuable upon exercise of the Pre-Funded Warrants and the Common Warrants. The Company agreed to use its best efforts to
              have such registration statement declared effective as promptly as possible after the filing thereof, subject to certain specified penalties if timely effectiveness is not achieved. The Company filed the 2021 Annual Report on April 15, 2022
              and the registration statement on April 29, 2022. The registration statement became effective on May 11, 2022.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Pursuant to the registration rights agreement, the Company is obligated to pay the PIPE Investor liquidated damages equal to 2% of the Subscription Amount per month, with a maximum aggregate payment of 12% of the Subscription Amount, in the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered for resale
              thereunder for more than 10 consecutive calendar days or more than an aggregate of &lt;span style="-sec-ix-hidden:Fact_1d1a0b74074845069916ad1b1bee6544"&gt;fifteen&lt;/span&gt; calendar days (which need not be consecutive calendar days) during any 12-month period.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On May 24, 2022, the Company provided the PIPE Investor with notice that it was not able to resell the securities registered for resale under
              the registration agreement because the Company had not timely filed this Quarterly Report on Form 10-Q (the &#x201c;Q1 2022 10-Q&#x201d;) with the SEC, and that the PIPE Investor could not use the registration statement to resell the related securities
              until the Company filed the Q1 2022 10-Q. Because the PIPE Investor was unable to use the registration statement for at least 10
              consecutive calendar days, the Company accrued $0.2 million for the three months ended March 31, 2022 for the estimated contingent
              loss the Company expected to incur as a result of the late Q1 2022 10Q filing, which is recorded in other expense, net in the accompanying condensed consolidated statements of operations.&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-style: italic; background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;Reverse Stock-Split&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; &lt;br/&gt;
              &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-align: justify; text-indent: 36pt;"&gt;On
          March 25, 2021, immediately prior to the Merger, Brooklyn filed an amendment to the Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a reverse stock split. As a result of the reverse stock split, the
          number of issued and outstanding shares of common stock immediately prior to the reverse stock split was reduced into a smaller number of shares, such that every &lt;span style="-sec-ix-hidden:Fact_c7f77014cf9a4ef9a688995037fe55b0"&gt;two&lt;/span&gt; shares of common stock held by a stockholder of Brooklyn immediately prior to the reverse stock split were combined and reclassified into one share of common stock after the reverse
          stock split.&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt;&#160;&lt;br/&gt;
          &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-align: justify; text-indent: 36pt;"&gt;Immediately











          following the reverse stock split there were approximately 1,514,000 shares of common stock outstanding prior to the Merger. No
          fractional shares were issued in connection with the reverse stock split.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify; text-indent: 36pt;"&gt;&lt;span style="font-weight: normal;"&gt; &lt;span style="font-style: italic;"&gt;Merger&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-indent: 0px; text-transform: none; background-color: rgb(255, 255, 255);"&gt;&lt;span style="font-weight: normal;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt;Under the terms of the Merger
              Agreement &lt;/span&gt;&lt;/span&gt;(see Note 3)&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt;, on March 25, 2021, Brooklyn issued shares of common stock to the equity holders of Brooklyn LLC. The 87,000
              Class A units of Brooklyn LLC were converted into &lt;/span&gt;&lt;/span&gt;approximately&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; 22,275,000 shares of common stock; the 15,000,000 Class B units were converted into &lt;/span&gt;&lt;/span&gt;approximately&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; 2,515,000
              shares of common stock; the 10,000,000 Class C units were converted into &lt;/span&gt;&lt;/span&gt;approximately 1,676,000&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; shares of common stock; &lt;/span&gt;&lt;/span&gt;approximately 630,000&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; shares of common units were
              converted into &lt;/span&gt;&lt;/span&gt;approximately&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; 630,000 shares of common stock, and 10,500,000 rights options were converted into &lt;/span&gt;&lt;/span&gt;approximately 11,828,000&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; shares of common stock.
              Brooklyn also issued &lt;/span&gt;&lt;/span&gt;approximately&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; 1,068,000 shares of common stock to the Financial Advisor pursuant to the Merger Agreement&lt;/span&gt;&lt;/span&gt;.&lt;/div&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_d02013ff700d4b69b163b0624c7dec97"
      unitRef="U001">6857000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_644c11dc698d4335b52c3843006fac88"
      unitRef="U001">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_457f70bcda3b4f938ef4af4cdb8c4d92"
      unitRef="U001">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_7d22c79e1a5f4fedb9fa790c2ae175b7"
      unitRef="U002">12000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="3"
      id="Fact_26da628ae1a54ec492561419f333fb9f"
      unitRef="U003">0.005</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="4"
      id="Fact_623dd2467dca418199e6293461d5b37f"
      unitRef="U004">0.0999</btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_b9fdfd1c3c5042e48b477f817ae2867f"
      unitRef="U001">5500000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_07d309b7737243ca854960d0712d500c"
      unitRef="U001">1357000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="2"
      id="Fact_f3f1952924344fbdab7a32530ed01383"
      unitRef="U003">1.91</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <btx:ClassOfWarrantOrRightsExercisableTerm
      contextRef="c20220101to20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      id="Fact_4c8c38ad143e49f18ef5018ec163f74e">P6M</btx:ClassOfWarrantOrRightsExercisableTerm>
    <btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="4"
      id="Fact_24566882c3144146ac2f36c66acf86fa"
      unitRef="U004">0.0499</btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights>
    <btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="4"
      id="Fact_3dad5e2c14e54f6484b6cdcd5d26f7ea"
      unitRef="U004">0.0999</btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="0"
      id="Fact_04dca308f3fa4d0b854848b7d07869b7"
      unitRef="U001">6857000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="2"
      id="Fact_0ad076b630ef4ee89dffb3cb98d56fe8"
      unitRef="U003">1.91</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      id="Fact_4b9c3a444d44461982bf80597623053c">P5Y5M12D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="0"
      id="Fact_6a050effa79440a492be572fcf001092"
      unitRef="U001">1357000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220331_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="3"
      id="Fact_31ad80a29dce416384f0092fae953a29"
      unitRef="U003">0.005</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20220331_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_0f0bced532194e36a8f05949e11275d8"
      unitRef="U002">12600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <btx:OverSubscriptionAmountReceived
      contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_1e1b903f5db74bc6a2ec36960346eb95"
      unitRef="U002">600000</btx:OverSubscriptionAmountReceived>
    <btx:OverSubscriptionAmountReceived
      contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_b744f3aea2c5414eab40cfa08c712c06"
      unitRef="U002">600000</btx:OverSubscriptionAmountReceived>
    <btx:TransactionFeesPayable
      contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_b9bdf9c068e9481485848f08111fbc8e"
      unitRef="U002">1000000.0</btx:TransactionFeesPayable>
    <btx:ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth
      contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="2"
      id="Fact_5da6e554da4b4436a622ed13baa6d8e7"
      unitRef="U004">0.02</btx:ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth>
    <btx:ObligationToPayLiquidatedDamagesPercentage
      contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_b37bc8b30402444d912c1add9b3e56ea"
      unitRef="U004">0.12</btx:ObligationToPayLiquidatedDamagesPercentage>
    <btx:ConsecutiveCalendarDays
      contextRef="c20220101to20220331_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_b7458a37edc342c2804eec9fb3b83c8e">P10D</btx:ConsecutiveCalendarDays>
    <btx:ConsecutiveCalendarDays
      contextRef="c20220101to20220331_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_c2fc14b003ff4312b36332789bdbf901">P10D</btx:ConsecutiveCalendarDays>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_23e8abaddbe64f2592e666c38aa04f0b"
      unitRef="U002">200000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits
      contextRef="c20210325to20210325"
      decimals="0"
      id="Fact_36d6706333a04e26ad641be11250e235"
      unitRef="U001">1514000</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
    <us-gaap:SharesIssued
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassAMember"
      decimals="0"
      id="Fact_b6efb81785614d7eb0b8027a1055de00"
      unitRef="U001">87000</us-gaap:SharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassAMember"
      decimals="0"
      id="Fact_4dfc15735aaf4dc89310df1b74287b1f"
      unitRef="U001">22275000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:SharesIssued
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassBMember"
      decimals="0"
      id="Fact_fe5edf4567da4438837a5f50ff9d14ec"
      unitRef="U001">15000000</us-gaap:SharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassBMember"
      decimals="0"
      id="Fact_70c8f730a081433298b8b30a1350ac10"
      unitRef="U001">2515000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:SharesIssued
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember"
      decimals="0"
      id="Fact_15f49efa627b4223b4a3f2bc3dc4f282"
      unitRef="U001">10000000</us-gaap:SharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassCMember"
      decimals="0"
      id="Fact_4446827b3e9d4002ae82284905b67f25"
      unitRef="U001">1676000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:SharesIssued
      contextRef="c20210325_StatementEquityComponentsAxis_CommonStockMember"
      decimals="0"
      id="Fact_2a874f27a299443f8271f36dcd079561"
      unitRef="U001">630000</us-gaap:SharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c20210325to20210325_StatementEquityComponentsAxis_CommonStockMember"
      decimals="0"
      id="Fact_a1ef1a8144ef42529768a3a2548a27d4"
      unitRef="U001">630000</us-gaap:ConversionOfStockSharesConverted1>
    <btx:ClassOfWarrantOrRightIssued
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember"
      decimals="0"
      id="Fact_2903704aac6c4decaaafac56f6d47121"
      unitRef="U001">10500000</btx:ClassOfWarrantOrRightIssued>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember"
      decimals="0"
      id="Fact_9bf258b735434a179467444e5d9f796b"
      unitRef="U001">11828000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <btx:StockIssuedDuringPeriodSharesAcquisitions1
      contextRef="c20210325to20210325"
      decimals="0"
      id="Fact_8615a12f9c9e44b09fff213944ebe062"
      unitRef="U001">1068000</btx:StockIssuedDuringPeriodSharesAcquisitions1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="c20220101to20220331"
      id="Text_8268f62872184c44b547e4e59daca28d">
&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify;"&gt;11)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
                  &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"&gt;&lt;span style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"&gt;EARNINGS PER SHARE&lt;/span&gt; &lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period including
        the weighted average effect of the Pre-Funded Warrants the Company issued in connection with the PIPE Transaction, the exercise of which requires little or no consideration for the delivery of shares of common stock. The Company determined that the
        exercise of the Pre-Funded Warrants requires nominal consideration for the delivery of shares of common stock, and as such, has considered the 1,357,000
        shares underlying the Pre-Funded Warrants to be outstanding effective on March 9, 2022 for the purposes of calculating basic EPS. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares
        outstanding (including the weighted average effect of the Pre-Funded Warrants) plus dilutive securities. Stock options, RSUs, warrants and other convertible securities are considered potential common shares and are included in the calculation of
        diluted net loss per share using the treasury method when their effect is dilutive. Diluted net loss per share is the same as basic net loss per share in periods where the effect of potentially dilutive shares of common stock are antidilutive. &lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;"&gt;The following
        table presents the amount of stock options, RSUs, warrants and convertible preferred stock that were excluded from the computation of diluted net loss per common share for three months ended March 31, 2022 and 2021, as their effect was
        anti-dilutive:&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;"&gt;Three months ended March 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; text-align: center;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;"&gt;2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Stock options&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;5,179,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;RSUs&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;1,323,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Warrants&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;6,857,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Preferred stock converted into common stock&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;48,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;42,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Total potential common shares excluded from computation&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;13,407,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;42,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="0"
      id="Fact_3090c48671144f8b8377e7cb02f8887a"
      unitRef="U001">1357000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="c20220101to20220331"
      id="Text_e423deed33634e718bcf8ea8511a728b">&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;"&gt;The following
        table presents the amount of stock options, RSUs, warrants and convertible preferred stock that were excluded from the computation of diluted net loss per common share for three months ended March 31, 2022 and 2021, as their effect was
        anti-dilutive:&lt;/span&gt;
&lt;div&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;"&gt;Three months ended March 31,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;"&gt;2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; text-align: center;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;"&gt;2021&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Stock options&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;5,179,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;RSUs&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;1,323,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Warrants&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;6,857,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;-&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Preferred stock converted into common stock&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;48,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;42,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Total potential common shares excluded from computation&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;13,407,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
              &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;42,000&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_e5a81f906a754888a953370cf59017f6"
      unitRef="U001">5179000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact_8b15b0d1a4814361b2663da066126068"
      unitRef="U001">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_1909eb396d8a436cb8aad3986c4ad1ce"
      unitRef="U001">1323000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact_c1a4c63f2ede45fd9f67c42691f7c60c"
      unitRef="U001">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="0"
      id="Fact_131bfcad3017479f866a6fa017e22916"
      unitRef="U001">6857000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="INF"
      id="Fact_c0a350a5978849438f89cbddec8d2b23"
      unitRef="U001">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"
      decimals="0"
      id="Fact_500808ab65474522b7195f8b1cdc5a1e"
      unitRef="U001">48000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"
      decimals="0"
      id="Fact_c734e221f10f44dc94a9538c6a70bd0c"
      unitRef="U001">42000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_1d0627c97bf940b2bf6705f4d9b729cb"
      unitRef="U001">13407000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20210331"
      decimals="0"
      id="Fact_c68c9aff6ab3496db5f82e47d0a6a556"
      unitRef="U001">42000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="c20220101to20220331"
      id="Text_71749bfdf5ce4d45be3204a3fb4fa9d8">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"&gt;12)&lt;br/&gt;
          &lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
            &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt;
     &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;There were no recent accounting pronouncements issued during the
      three months ended March 31, 2022 that would have impacted the Company&#x2019;s financial statements or operations.  &lt;/div&gt;
</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_ded1775e458c4616b485ea8de8a75a66">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;There were no recent accounting pronouncements issued during the
      three months ended March 31, 2022 that would have impacted the Company&#x2019;s financial statements or operations.  &lt;/div&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="c20220101to20220331"
      id="Text_677b4506c14f4d87b7c706a033b5aa24">
&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;13)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;SUBSEQUENT EVENT&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;On May 24, 2022, Dr. Federoff resigned as the Company&#x2019;s Chief Executive Officer and President effective May 26, 2022, and the Board appointed
            Dr. Matthew Angel as the Company&#x2019;s interim Chief Executive Officer.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;In connection with Dr. Federoff&#x2019;s resignation, the Company entered into a Separation Agreement and General Release with Dr. Federoff (the &#x201c;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="text-decoration: underline;"&gt;Separation Agreement&lt;/span&gt;&lt;/span&gt;&#x201d;), pursuant to which Dr. Federoff resigned from his positions as Chief Executive Officer and as an officer, director and employee of the Company and
            all subsidiaries. Dr. Federoff&#x2019;s resignation from the Board was not due to any disagreement with the Company on any matter relating to the Company&#x2019;s operations, policies or practices. In consideration for Dr. Federoff&#x2019;s execution of the
            Separation Agreement and non-revocation of a waiver and release of claims relating thereto, Dr. Federoff is entitled to the following benefits under the Separation Agreement:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18.15pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;a lump sum cash severance benefit in the amount of $0.2 million,
                    representing Dr. Federoff&#x2019;s target bonus for 2022;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18.15pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;payment of Dr. Federoff&#x2019;s annual base salary for a period of twelve months after the expiration of the applicable revocation period (the &#x201c;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="text-decoration: underline;"&gt;Separation Period&lt;/span&gt;&lt;/span&gt;&#x201d;), for a total gross amount equal to $0.5 million;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18.15pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;payment of Dr. Federoff&#x2019;s premiums for continued health benefits provided under COBRA for the Separation Period;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18.15pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;full acceleration of the vesting of all outstanding options (with the exception of the Milestone Options) that would have vested during the Separation Period, and such options,
                    together with outstanding options that vested prior to the Separation Date, representing collectively 1,420,095 shares of
                    common stock, may be exercised for a period of thirty-six months after the Separation Date;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18.15pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;acceleration and vesting of 25/36&lt;sup&gt;th&lt;/sup&gt; of the Milestone Options, representing collectively 414,759 shares of common stock, may be exercised for a period of thirty-six months
                    after the Separation Date; and&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18.15pt;"&gt;&lt;br/&gt;
                &lt;/td&gt;

    &lt;td style="width: 17.85pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                  &lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;a lump sum cash severance benefit in the amount of $0.1 million,
                    representing the value Dr. Federoff would have received if he was entitled to receive a settlement of a pro rata portion of his performance restricted stock units through the expiration of the Separation Period, assuming the performance
                    metrics were waived and assuming a per share value of $0.81.&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Separation Agreement also includes certain other customary representations, warranties and covenants of Dr. Federoff, and provides for
            reimbursement of certain expenses incurred by Dr Federoff. The Separation Agreement supersedes all other agreements or arrangements between Dr. Federoff and the Company regarding the subject matter of the agreement, including those with respect
            to severance payments and benefits.&lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt; &lt;/span&gt;&lt;/div&gt;
</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:PaymentsForPostemploymentBenefits
      contextRef="c20220524to20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="-5"
      id="Fact_3c983869ed22452d902d861caed37303"
      unitRef="U002">200000</us-gaap:PaymentsForPostemploymentBenefits>
    <btx:PaymentToOfficerBaseSalary
      contextRef="c20220524to20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="-5"
      id="Fact_09223626aa594da891e5351e3635f9fe"
      unitRef="U002">500000</btx:PaymentToOfficerBaseSalary>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact_95657bfbdc9b4214b59cf48b6d1216e2"
      unitRef="U001">1420095</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="c20220524to20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      id="Fact_e6328d8831d64056afe859c939e12a2a">P36M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20220524_AwardTypeAxis_MilestoneOptionsMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact_a07e5a60709c42eb9d322339211604a3"
      unitRef="U001">414759</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="c20220524to20220524_AwardTypeAxis_MilestoneOptionsMember_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      id="Fact_aab24a2e3d1b485dadb0456d362964a8">P36M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <btx:SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits
      contextRef="c20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="-5"
      id="Fact_298322eb55d745afa7951b5bb4dca3dc"
      unitRef="U002">100000</btx:SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits>
    <us-gaap:SharePrice
      contextRef="c20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="2"
      id="Fact_50eb1d48c62c441b97669680ee980692"
      unitRef="U003">0.81</us-gaap:SharePrice>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>82
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M&P  &    'AL+W=O<FMS:&5E=',O<VAE970R+GAM;*V9;6_;-A#'OPKA%7L
MG%BDGNPL,9 ZV5J@;8*Z75\,>\%(=$Q4$E62MIM]^I&T8UG3B7:!]$4C6<?3
M_ZCC_8[2Y4;(KVK)F$;?RZ)25X.EUO7%:*2R)2NI.A<UJ\R5A9 EU>94/HY4
M+1G-W:"R&)$@2$8EY=5@>NE^NY?32['2!:_8O41J5994/KUFA=A<#?#@^8>/
M_'&I[0^CZ65-']F<Z<_UO31GH[V7G)>L4EQ42++%U> :7\Q"8@<XB[\XVZB#
M8V1#>1#BJSUYFU\- JN(%2S3U@4U?]9LQHK">C(ZONV<#O;WM ,/CY^]_^&"
M-\$\4,5FHOC"<[V\&HP'*&<+NBKT1[%YPW8!Q=9?)@KE_D>;G6TP0-E*:5'N
M!AL%):^V?^GWW40<#,!1SP"R&T!.'1#N!H0NT*TR%]8-U71Z*<4&26MMO-D#
M-S=NM(F&5_8QSK4T5[D9IZ>SNP\WMQ_FMS?(',WOWKV]N?YD3EY?O[O^,+M%
M\S>WMY_FZ Q]GM^@7U_]=CG2YJ9VZ"C;W>#U]@:DYP;OJ3Q'(1XB$A "#)_Y
MA]^P;#\<MX>/3*C[>,D^7N+\A7WQKJ1DE494*:;5!13/UD$$.[#+ZD+5-&-7
M [-N%)-K-IC^_!-.@M^AZ%[(62O6<!]KZ/,^G5&UA +<CDK<*+O,UU,2QH']
M=SE:'XKO&N)D,HX/#5O"HKVPR"OL3B^9-$4@8WQ-'PH&B=QZB _N/0[CKL2N
M63*.>@7&>X&Q5^"]9#7E.6+?3;E43"%:Y4@XU5DK@2#E<5<Y-+E=,QQ,TE[I
MR5YZXI7^26A:G* RZ=R>Q!B:X:XA'J=)TBLTW0M-C\RQ89'43VYNV;<5KPT=
M]!!53$-ZTXZ,,!AWU7;-DC3HU3K>:QU[M3JZG8G%V4JQW9R:FFCU4\VK1U0P
M0Q)PFL?04PZ[NKMV)$[ZLV&R%S[Q"O]3B'S#BP*2-NG>,HBBKK3C=BUI.&C0
M$WC%O:W.:BDRIA2RQ8_*;.F2(6=KTUZX= !Y$W0$Q9,)L,).,&PK/X F/J)\
MS92V A&O4"6JLTQ46HJBL-G *\U,0+!XW,WC,;#J #L<!![M#0"QESG3.3/%
M@9MUE[-:**X/BUM_N=@Y/=03$0SH!NS&XW[9#<NP'V;;NN81&'8G-@[3!) (
M6.*8]&,--US#T4G=1<'I R^XY@QN,;"7CS_:8[R4MW;0#2NQ'Y;76296E<FC
MFC[UT1P#M,,!]'  PS3V/)N&B]@/1B-3KEC#=% F0,5P#-1$P!"3:-(OLZ$B
M]F/QK@V5PU0:/F,=E-XE'VX+VBGOVD6DG^:X023V,_*NU1X=R ;5=GD70540
MP&+43T7<8!'[N=CNDHZ)[1(P3,"L@ S3?KVD027QH_(+E9(>5TJZQ,.A*6Y=
MJ8!EG\B&BL1/16_J.DCVIR^!>(>!!@\P),33-Y.#G:$?C-L$/C;#$-\ E<?,
MVAH;"I)3*'A,8Q=P9B83* NZEHG9IO<+;4A(_"2<:Y%]78HB9U+]XMI[_03O
MME\4A2_EK1UU@T+B1^%,E*6HD++!#]&KX#P(8H-%B=:T6+$A,@W3T$PN4DLJ
M[:YRI9="\G\-E:A&[UT#_/RJQ'5E-V:+7#Z8K'Q^ _([BM-A%&^OQF1H?D)<
M*<LUU\6MM-+FP*[!$ST.;>]=,_<VK7@"GU 7R62< LD$V"7]'2MIR$V.D#O/
MN7WG9S+?[LK/3,N=T9J;E0#*!="<I!C:@H.F\<2SN2$-QXF?XZ;=6)6K@FIF
M-S0+GG&X[G5Q?&;K=0I-,&0;!6G@6; -OHD?W]O*HH!E"\H&]K5IB($- 6!)
M3#\7]DMN($Y.@?A!,709?G(( *SA#0-DZ=TPA W70S_7YTQ:W=?H7K(%,W3,
MD:N<Z._W;IG^ [Z_\_K\T9+Y4M[:,] T#2%^&5"$WN;CAZ-^(6_MJ)M>(_3W
M&LWC[F<%3 IS(4Y,15'\L7+%Y?]U7RS0/JLR4:V9U-SLRE#=ON7I?'AE;UAP
M\V1RZCZ];#VQ*@.W>KO(6V^-@5?+1ZRV\SHZ^+!AORH9P8^\4J:_7)AAP7EJ
MUJ3<?JC9GFA1NV\=#T)K4;K#):,FMZR!N;X00C^?V,\G^\]ET_\ 4$L#!!0
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M>0?J!^8MU+:/D6,Y3H-\O%D^@:"2VW6YJ;:GVB.GVB,G]VN_X^=+%CQ$C(;
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MK\B;PHI3K)%\[92W]R??HSI+^ZWX#6$-^.;:?45?%M5YOR")0!3F2F>U>LJ
M%_>OHB-9FE]A[IE4%Z*\&:D[*W =H.;GC,F7CKX55;=@[P]02P,$%     @
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M0$6TPD7TQO'4_S<!@TJ3NM]S:Q.JFH.JYJ*J>;6::K8B08AE<PF'.BH?52W
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M:T3[@R+=5K\[\YP61;JI'JYIN*19";#75VE:O!^4/V5S^$VHJ_\"4$L#!!0
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M!W(+RI&22'&H1S$OXC1CJ*@!ZZOZ.-:[^-W[-[SD_EU(V9&?1@<_C;S[=\M
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M^BQ?G2B^,U^VUUPIGIO#+:,)$UH [F\X5R\G^@&'?XZ8_0]02P,$%     @
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M71KO31%^9JA79/D ]AG$S0<+:!_&S_X'4$L#!!0    ( *ZKWE1*M&>2( 8
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M+O2,G[AS+;)#A>XUT9DDQ3W1 N(#G'UP[-J!'3>L.EL:=@JN^5KF69Q.>LR
M)&=P15E[A'5TH364KFROWE0[GES-#@1##YW:[L*-Q:(.DV$2;YNZ-0!B(YLY
MT5LC"[;[N^9J(QQ?\^-F9,W9B[JJM59+\=[E:;C+ER6BQU_VH"*D*(6;=E3
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MH&J6%N#YS&"DK;[0 <UK][._ 5!+ P04    " "NJ]Y4M\DUZ,H)  !"&0
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M;7N9H?:H4382-?="KG^@,N).QCN<2ONH+)YO' ZHC?;N8NMBL+*&B[C).8%
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M(0&\IZ]+S0TY:/]L<O,?4$L#!!0    ( *ZKWE0V@\94!P8  %<.   9
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MK@9WQ.3] 9D8Y@>65FBD66<)HWB2R+M* ]N>K>L2*LGS6R!S+A[0JX[U#F+
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MMWM]X>O/F/HBNC)].DQ<Q(=(^IGCRX\\&^#YU+G87G""Y;?D\;]02P,$%
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M'M#*&C1))9I*&PS)+3$%D*WDZ$XF<O*&"8S(6E.1Z?.1A\U(B[8;WB6D4&Y
M'2*1=R!/96G9J?6:=^;UDX%]7O3;!/NU'!DRHV_N<1Y4Z&[3RO*2*/)BO.2
MR$& HMP!:(8_/[-MLRY^Q$2=7M+WDD'D?9;&YOY5*XJ(.\FPA^^H$_?>D?\@
M)TRDO,Z G(7=(9J/<SM'<! 2#CGE;Q5P:C\BS@8#2G>?^@&"(VN6H'(W@&P'
M:F$:E[;1=L;-&FL_IC<#$EN1,Z'Q\BU"P^[@PB>J&3K-QLC*&7TC#8X-MRQP
M3H.R"7B^E=(<-O:"=O)/?P-02P,$%     @ KJO>5$&*>3._%0  5#T  !D
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M_N1>^B[5JUQD9HX:[B1S2=W39Q!;@;O$2].)ZKH,MHC Z#"Y6%ASKU$#5?&
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M;)U9V7+;.!9]YU>@U,LD5;(LR9;C)(ZK;,>9=G4R<>)DNJ:FY@$B(0D=DF
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MHG$%O+_1FG:).Z";S=$?4$L#!!0    ( *ZKWE1R.YX=/04  ,,,   9
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M.$$ Y[DQOEL$ YO_6V;_ 5!+ P04    " "NJ]Y4*D^[@/X$  !N#   &0
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M2A/;UR\SGI=H7 *?K[6F7> *M!,X_@=02P,$%     @ KJO>5.E\\PMC!@
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M8,(!5AT[M2_0_O>S'8B8!+SM)?;9]WWWG7-W\5[I%[,%0/)6"&D&=(M8]H/
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MHC5C:;QZ )A]3S.LHP%UVU :#]KC_;UE_<"8Z. -\^\/RH"'%O3ICEA'"NK
MH32.HC5#:JQZX+][#H3:?"@MA-(XBM:,Y=ZZ<H!)^C3#.AK8%>6P2\IM:8V5
M %L%_>'>LJ;58_'E>K+E@]K:_FQ7.-U]NENS=EJMU#HT/]\N>'LMU").<Y;(
MN6XZ^GBBMZ^V:\ANWQ39NEHD]3$K]&U@]7(I=3Y4Y0_T]_,L*U[>E!O8K>0[
M^1]02P,$%     @ KJO>5#BY! /T!   5A,  !D   !X;"]W;W)K<VAE971S
M+W-H965T,S(N>&ULM9AM;]LV$,>_"N$50PLDE40_=XX!)^FZ &V2Q>GVHN@+
M6CK;1"E1)2F[^?8[RHKD3A13!,B;1)+%NS_OX:>39GNIONDM@"$_4I'IL][6
MF/Q=$.AX"RG3;V4.&?ZREBIE!D_5)M"Y I:4BU(1T# <!2GC66\^*Z_=JOE,
M%D;P#&X5T46:,O5P#D+NSWI1[_'"'=]LC;T0S&<YV\ 2S.?\5N%94%M)> J9
MYC(C"M9GO47T[KP?V@7E'?]PV.NC8V*WLI+RFSVY2LYZH54$ F)C33#\MX,+
M$,):0AW?*Z.]VJ==>'S\:/W/<O.XF173<"'%OSPQV[/>I$<26+-"F#NY_PNJ
M#0VMO5@*7?XE^^K>L$?B0AN95HM10<JSPW_VHPK$T0)*.Q;0:@$M=1\<E2HO
MF6'SF9)[HNS=:,T>E%LM5Z,XGMFL+(W"7SFN,_-/[^\^O+\[(9=7R]N;Y=7]
MU<TU65Q?DL7%WY^OJO/[N\7U<G%ACY=X)]>YU+R,Z>M+,(P+_8:<DNO[:W)>
M:+2O-?GR"=(5J*_D%>$9N=_*0K,LT;/ H&;K.8@K?><'?;1+'U-O"1V=$!K2
MB'Q>7I+7K][\;"; +=?[IO6^:6FWWV'W>!=?%BMM%-;'5Y>^@YV!VXYMFG<Z
M9S&<]; K-*@=].:__Q:-PC\\*ONURK[/^GS)!!"Y)LK6ECXAAAN\@)'$J!I
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M@ E7]@;\?2VE>3RQWV+J3VGS_P!02P,$%     @ KJO>5%\WD-?0!P  4CL
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M+15/L1I%"9LK2#TUM) H7^ L;R1?%F\H/G(I>5I<+AB-F- _4-_/.9>;&]W
M]C7:T3]02P,$%     @ KJO>5)9Z20'# P  H1$  !D   !X;"]W;W)K<VAE
M971S+W-H965T,S0N>&ULK9A;D]HV%(#_BL;-=)*9'7P#]A)@!O"V(=-E">RV
M#YD^"/N /;$M*LF0S/3'1[*-L:E10ZL7\$7GD\YGZ^;!@= O+ 3@Z&L2IVQH
MA)SO'DR3^2$DF'7(#E)Q9T-H@KDXI5N3[2C@( ]*8M.QK+Z9X"@U1H/\VH*.
M!B3C<93"@B*6)0FFWR80D\/0L(WCA66T#;F\8(X&.[R%%?#7W8**,[.B!%$"
M*8M(BBALAL;8?O!L5P;D)7Z/X,!JQTBFLB;DBSR9!4/#DBV"&'PN$5C\[6$*
M<2Q)HAU_E5"CJE,&UH^/]%_RY$4R:\Q@2N(_HH"'0^/.0 %L<!;S)3E\@#*A
MGN3Y)&;Y+SJ492T#^1GC)"F#10N2*"W^\==21"W [5X(<,H YRS <2X$N&6
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M.LG^+E+[8+:WVUBE4P05HH,*J0DJ^SX'G'S;&V\\/$%3#Q3-%%ZG'@*U+XR
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MO.1Y>/AQYD?&OXD,0*(GFA=BX612EC>N*](,*!835D*AONP8IUBJ*M^[HN2
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M$#36EP<$0\14!_E\1ZDX-=0 Q5F4]S]02P,$%     @ KJO>5%#TQQB- P
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M5%KZW$76:+*)XDE:JV=<Z<J?#D/=FU$8 [T_YUQM)\9!WNV]OU!+ P04
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M!:X"\/N*,?DT4<V\N[OCOU!+ P04    " "NJ]Y4#4MVJD,$   9&0  &0
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ML.(Y?+$CZ"%_,KVA0M DW]P#D7FM#I"?;RD5+SOJ87?U:XCW#U!+ P04
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M%/]V,(8P5$8XC)?<TRA"*N%I^>C^2<\=Y[*D L8L_!&LY'9H] VR@C5-0_G
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MOXJ5(U6M5#87"$OV !*0;;NJ]J+2RT/5!Y,,8&T2Y]@&EF_?<1)2 B$MI[Q
M?)F_/;^,)^/^AHMGN010Y"6.$CDPEDJE-Z8I@R7$5%[Q%!(<F7,14X5-L3!E
M*H"&F5$<F8YE=<V8LL08]K.^)S'L\Y6*6 )/@LA5'%.Q'4/$-P/#-G8=G]AB
MJ72'.>RG= %34%_2)X$MLU0)60R)9#PA N8#8V3?^+:E#;(97QELY-XST:[,
M.'_6C;MP8%AZ1Q!!H+0$Q;\U3""*M!+NX[]"U"C7U(;[SSOU=YGSZ,R,2ICP
MZ!L+U7)@] P2PIRN(O6);SY X9"K]0(>R>R7;(JYED&"E50\+HQQ!S%+\G_Z
M4H#8,W#<$P9.8> <&-B=$P;MPJ#]IP:=PJ"3D<E=R3CX5-%A7_ -$7HVJNF'
M#&9FC>ZS1+_WJ1(XRM!.#:>?'R<?6^/1]-8GD\?[I]N'Z>CSW>/#6_(M0P9A
M:[0&@2% 1A*#(]5O2Y(O$D*"44?>"YHH2>YP#'M>^Z HB^0;TB)3Q8-G\E@8
M?+^'> ;B!P[()14@^Z;"[>M-F$&QU7&^5>?$5MODGB=J*<EM$D)8M3?1[=)W
M9^?[V&D4O*?BBK3MM\2Q'*=F/Y,_-[=KS/UF<Q^"4^85;]KEFVQG>NU3;U+S
M;NDS$)()CS$Q2)H=K>^CF50"#]B/.N:Y:*=>5&>=&YG2  8&IA4)8@W&\-4_
M=M?ZMP[8)<7\"XE58'9*F)TF]>'#2D<KX7,BLS#F:9ZE-E2$DBQTT.MP9TD1
MS6_JT.9+N-D2.O^NA[;C]BS+ZIOK?6K'\PYF^(V;_9\HW!*%^Q<H\%,B%4U"
MEBQ^A\,]<M.UK[UC',?S#G$<SVA[O0K8BJ?=TM-NXPG"! =B+[^A.YC/0&#:
MU>Z]HTR0KS1:@89136_OBXAH/FO=2YZU2XKY%Q*K8+\NL5\W!MCN0T-H\:$1
M3#ZWY@+PB2JH YD+8K6Q%R-7ENTY!Z'4N/"YC"XD5F'4*QGUSF.TYA%F]XBI
M;1V?7,RKX/':!W :5SP7SH7$*G"\$H[7",=G:Q9"$I(M@RBLX^$=\SB T;C"
MN3 N)%:!85N_*CJK$<?M2XI%-<:*3EVU95:SO4NV0(4D'HGS>LNV2$BW=17;
MI%GJ7&Z74LO!F7M5<0QBD=TN) GX*E%YD5CVEC>845:W'_2/[9M)?@_Y)9-?
MB[ $7#!,_Q',4=*ZNL9ODLAO&GE#\32KO6=<826?/2[Q=@9"3\#Q.>=JU] +
ME/>]X4]02P,$%     @ KJO>5$"CV_U3!0  #QX  !D   !X;"]W;W)K<VAE
M971S+W-H965T-#<N>&ULM9EK<^(V%(;_BL;M=+(S";9LKBEAAN"TS;2Y3-C-
M?MC9#\(6X(DOK"0@^?>5?,78R+BK?DELH_-*>B0?WH/&^XB\T37&#+P'?DAO
MM#5CFVM=I\X:!XAVH@T.^2?+B 2(\5NRTNF&8.3&08&OFX;1UP/DA=ID'#][
M)I-QM&6^%^)G N@V"!#YN,5^M+_1H)8]>/%6:R8>Z)/Q!JWP'+,OFV?"[_1<
MQ?4"'%(O"@'!RQMM"J]MTQ(!<8M7#^_IP3404UE$T9NXN7=O-$.,"/O884("
M\7\[/,.^+Y3X.'ZDHEK>IP@\O,[4_X@GSR>S0!3/(O^KY[+UC3;4@(N7:.NS
MEVC_%TXGU!-Z3N33^"_8IVT-#3A;RJ(@#>8C"+PP^8_>4Q ' 6;O1("9!IA'
M ;![(L!* ZQS>^BF =V83#*5F(.-&)J,2;0'1+3F:N(BAAE'\^E[H5CW.2/\
M4X_'L<G\\]/L[ZO;Z?S.!K.GA^>[Q_GT\_W3XR68L\AY T^;>'FF8GD\]@$N
M;,R0Y]-/X*K4@H)O#SA88/*=?_!E;H.+7S^-=<9'*/K1G70TM\EHS!.CL<!#
M%+(U!7>AB]V:>%L>#TV)@,[1Y'S,C,^M*55\0*0#+'@)3,,T:P8T.S\<ULU'
M'FYCYU1X:396OMI6K&>=T'O<BB4"T3);U_D:$0R^O42^#_A[M$?$_5ZW;(EL
MMUY6Y*9KND$.OM%X\J&8[+ V^>T7V#=^KT.F4LQ6)%;"V<UQ=F7JDZ<MHPR%
MKA>N+L$"K[PPY)<\#_DH=#"X\$) !6!:^RHDVKU86Z3GW<0:#8>&88SUW2$N
MZ1C:XE(D5L+5RW'UI+C^)"ADV&WBTJMP@6:OADNUW5$+6SJ<_SC9?C[9OG2R
M,[$%?+]YNOW*-*[Z@^ILI;VUW06*Q$I@!CF8P?DO#8[_G_O&#"JH>G PJK*J
MMCO>&=46Q^]>:6[#?&Y#:7[]&ML,ON;3'2;<-H&[=TP<CV+P3#P^OPU/OFG*
MG2XH(]SUU*;;H<ITJU+,5B16HCO*Z8Y^-MVZ_(L,$1J#CC=2[3Y*NAD>K/ZP
MTSW:0]*AM*6F2*Q$#1J%Q3/.SKOG 4H%H76 R.S (T3R;MLR4J56AG3@@V&+
M?'TF)EC%U.N,CK>2O.?6G!2IE3F9!2?SI]+WF>3,RBO8[XR.N4E'TII;M<O#
MM[Z,HS#44.ZH*QG_!8MJ6U"9\4I$9/@M\L$_WK(IYT.E'ENIFJU*K0RYL-E0
M[K,SR%<HA4QRR,X!9)]#O@11L4%K,<N[&H$/++:O!8*DD#1[P$4?M):Q4F=^
MYL"ZV<#@H&9@9<"%,8<]Z2Z>KE8$KQ##X)[C]$+J.> 5^=O&/:O(8:<\5:K9
MJM3*2 O[#^7^7VY6:F$F@OW3MG4F[[,UH?^C#(!%'0#EA4!J2VI1-#KXF5R\
M-0I%:F441=D I;Y9]J5:BV=8V2G0ZE;K('FOK1E5>SU1+L'"T<.1-/%D/QZ^
M8BJ^1#F"K&1""[\Q^ZCTZ#.E:K8JM?*/EH7E-^66/^.Z*[CB@NLE.-AP345W
MVE/I]QBCNM?D VJ+3Y5:&5]1#)CR8J )7^[Z,D."LSI_$]?YYQOA="##$MV.
MV3^FJ[2$4*56IEN4$&9#"=% =W],][3=JT4J[STS4J/42-7^J*^T\E"E5L9=
ME"BFU)TWXD:Y^?-R\[<3YJ\6KM5H4N3#:0U/:>FA'YR4!9BLXA-'RK?5-F3)
MH5#^-#_5G,9G>4?/;^'U+#F;+&22H]('1+C9H\#'2RYI= 8\<Y+D]#&Y8=$F
M/H];1(Q%07RYQLC%1#3@GR^CB&4WHH/\#'CR+U!+ P04    " "NJ]Y4'%#0
MWG0%  #]'P  &0   'AL+W=O<FMS:&5E=',O<VAE970T."YX;6RU65MOXC@4
M_BM6MEIUI&E##.'2!21*NKO5JA<-[<S#:!_<Q(#5)*:V@7:U/W[M),T%@MMT
M71X@"3Z?CS\?GWS''FXI>^1+C 5XCL*8CZRE$*LSV^;^$D>(G](5CN4_<\HB
M).0M6]A\Q3 *$J,HM&&KU;4C1&)K/$R>W;+QD*Y%2&)\RP!?1Q%B+^<XI-N1
MY5BO#[Z1Q5*H!_9XN$(+/,/B?G7+Y)V=HP0DPC$G- 8,ST?6Q#GS8$<9)"V^
M$[SEI6N@AO) Z:.ZN0Q&5DMYA$/L"P6!Y,\&3W$8*B3IQU,&:N5]*L/R]2OZ
M[\G@Y6 >$,=3&OX@@5B.K+X% CQ'ZU!\H]L_<38@5^'Y-.3)-]AF;5L6\-=<
MT"@SEAY$)$Y_T7-&1,G [1\P@)D!W#& S@&#=F;0?J]!)S-(J+;3H20\>$B@
M\9#1+6"JM413%PF9B;4</HG5O,\$D_\2:2?&L[N;Z5\GYY/9A0>F-U>W%]>S
MR=WES?57,$LC = YF GJ/X*;E9HI#HX]+! )^9>A+:0'"L?VL][.T][@@=[:
MX(K&8LG!11S@H&IO2\]S]^&K^^=0"WB%V"EH.U\!;$$([F<>.#[Z BYC+E 8
MRO 4X ^&Y/<1L %?(H9Y]E/C^_3]73F'43P]BH?]-U J/+3S:6PGL.U#TZAF
MZ$0M@ !,:22S D?)NOHY>>""R=7U=]ULI:"=>E"5<L[X"OEX9,F<PC';8&O\
MZR].M_5;'7TFP3Q#8!4R.SF9'1WZ^'H=/6"F I\G@4^3P <+%4E<+KX @W_3
MN*KC-,5V$VR5=3=C.+0W9:*TO3<ERA!8A2@W)\K5$E7-"S^OL.*M-M"T.$T#
MS2289PBLPE\WYZ_[&:NV:Y),DV">(; *F;V<S)XV&'\DKWC))-I@)B5+NEY!
M@ 0&<T08V*!PC<$QB4% PQ Q#E9RE2<I^(M<T,4KHH[SM.]^:54[IVY_9V%K
M'6S*I2&P"I?]G,N^ELO[&$64"?*/I).7@M0O!RE^5M<J%Q[5,9;VT"TSUG=;
MZK/#FM:5IJP9 JNP-LA9&S2+0(:5\B;Q0EX]K0DG,A15I\3'*O8(#>J(TW?2
M!B]8Q:Y4#P%ZJ=4Q6H"FA!H"JQ#JM IUVOK(JQAM$0LXD'6,%'IQH!A6ZSI=
MOO6ZM+7W6G:=WF _&FL:[C3Q:IJT!_U^&:LZW)(8=_['<).$)L/KK:$Z>^XY
MT.W7#'6_X=Y0M?Y^=/IAP0=\A\!HGGLRV.[AD4WU/3==):;0JCP5ZM_1ZN&,
MIRQ:\#-F/N'O")3V6_,_?;N)IW?MHT,OM+JC%^MW),(GYTF$7-/XY&F-0C(G
M\JXL3K7:5-]!4SUE%,TSA58EM]#WCOL9 M4Q*O>-HGFFT*J,%HK?T6I@0QF^
MNU]C=F%=AC>J[DVA5:DK]+VC%_@%=9':1 I? "GV>;A\%92V?6I9Z^V_MKN[
MA!F5\*;0JH05(M[1J_AFJ5$2^!USH;24?$IC?**$)IC$,9%REJNM0&T6-2GC
MIT;1/%-HU7DHR@)G\"E9U*2.GQI%\TRA53=]B[( ZLN"V:&:=)-%L*RN?)D&
M9!%6QVR&/BBKFE/H[N0"O0]-&3.%5F6LJ"R@OK*XQ2PY)(K]4DKX@%C2=],T
M*(VB>:;0JA07Q0J$G[',H<E"9&H4S3.%5F6T*&N@OJPQ(I;@?@GC#GK[6DGO
M2V/F/J,J@D55!/55T<$$F6Z*EO9##U30&7ZY@NZTZW;O](XTILUHO6.7SD4C
MS!;)^3*7A*QCD9XQYD_S,^Q)<G*[\_S<.9NF)]$%3'HP?H780LI0$.*YA&R=
M]F2<L?2L.;T1=)6<OCY0(6B47"XQ"C!3#>3_<TK%ZXWJ(#_Q'_\'4$L#!!0
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M%PS<M1NG; C:Z=!+B /&)?U;K:R!<3XV*3MAP8*$ IL&@MZJ0T'TLA4"B%1
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MG,2^^!)M/M/,T$#I.9'/D[]HDUUK]I 3<Q$%66,Y@L +TU?RG 5BIP$>5#3
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M2Y\$2S^(:)4\3#6+A(B"Y.V2$I<R=8'\_SR*Q/:#ZB!_'F_R'U!+ P04
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M+'=)U4&VKRD5KS?JB*LZ YW]"U!+ P04    " "NJ]Y4S V2X50#  #.%0
M#0   'AL+W-T>6QE<RYX;6S=6&UOVC 0_BM1NDZM-#6$C)"L@+0A59JT397:
M#_M6&>* )<?)'--!?_U\=@@O]2'6#VL9J(U]C^^YY\Z7Q.V@5BM.[^:4*F]9
M<%$/_;E2U:<@J*=S6I#ZJJRHT$A>RH(H/96SH*XD)5D-3@4/NIU.'!2$"7\T
M$(OBIE"U-RT70@W]I#5Y]O(U&_IA_-'W+-VXS.C0?[AX_VM1JNMWGKV>?3@[
MZSQ<7N_;+PQPZ0=.TMX1I%>=#DX,($8>'T=^B!NC[N]2F^7GFL@ZGF-NB<--
M1]EXP@1S3H^LU>%B82GU.T?1'^#&B$-GTELI&\>@Z<+1("_%IADCWQHT,RFH
M]TCXT!\3SB:2@5=."L97UMP%P[3DI?24O@MTJ! L]9.%0SN#&Z3A*9@HI8EM
M(]C?DV;Y'K">@4#&>2NPZUO#:% 1I:@4-WIB%AOC,\AKQO>K2BN<2;(*NSU_
MXV N.LBDE!F5;9C07YM& TYSD"/9; Y7558!@$J5A1YDC,Q*08R&M4<ST+13
MROD=/#U^YCO<RWQKSTPKB':H!35#2V,GP+_-9KFW:7LOXO4J]EBJ+PN=CC!S
M:#)Z*VG.EF:^S%L!&'N(LY.JXJO/G,U$06WR1P<<#<C:SYN7DCWI:- J4VV@
MTO<>J51LNFWY+4EU3Y=JW4[+'-?</4'-_[;.,RJH)'Q;M.[]MUSE%RN.^J\E
MV3Q5]@4[-39'@K<NLG<*(N-3$'D2/9F<@LCT!$3V7^VI>;S(Z"0*&;Y)D4%S
M7-LZ$^Z<"%NK!R?OH?\#SO!\$]2;+!A73#2S.<LR*IX=##6](A/]Q^H.OUZ?
MT9PLN+IOP:&_&7^G&5L4:;OJ%@K1K-J,OT%Z8=P>^W4L)C*ZI-FXF<K9Q P]
M/=!1FP\X[",WYN-&,!^+N1' L#B8 LS'>F%Q_J=\$C0?BV':$B>2H#X)ZF.]
M7,C8?+$X;I]4?]R9IFD4Q3%6T?'8J6",U2V.X<?-AFD##RP.1/J[6N.[C7?(
MX3[ ]O10AV"9XIV(98K7&A!WW< C3=V[C<4!#VP7L-Z!^.XXT%-NGRB"7<6T
M87<PCJ0IAD ONGLTCI'JQ/!U[P]VET11FKH1P-P*H@A#X&[$$4P!:,"0*#+O
MP;WW4;!^3P6;_^"._@!02P,$%     @ KJO>5)>*NQS     $P(   L   !?
M<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^O
MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M.=V#+.0A6^CGP?"^[_3&<!XD( ]]2P98FSJS]XT\2$#>*9?0^NT-[LJ@;\M
MF+: /$A WHFF0&?DLS#IR,:$!.0A"^AM3*[KY9.-"0G(0Q80@+DKR]S&A 3D
M8:^QO8F9\D73Z^F0@#QD 0&8HM'*WMF$!.0C"^C8<O09F2OY;(#(W,:$!.0C
M"^@X9BJ>A3)C#WOSP8<LY"-;Z#CF3*A'H8PS;4S(0CZRA8ZMR1P1N@\IR,?>
MQWFUE'Z<$/PJH+//\/!AS4JL9256L:F],>7+O%C.%6E_]AM^GM\NT:]W11&:
MLJ2:UOGJ\)W.X1NC3_\!4$L#!!0    ( *ZKWE2\ =;!X $  .P@   :
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M46\GT-M'+[L)]';4VPGT=M3;"?1VU-L)]';4VPGT=M3;"?2.J'<DT#NBWI%
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M;%!+ 0(4 Q0    ( *ZKWE3DD[Y-[@   "L"   1              "  :\
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M2P$"% ,4    " "NJ]Y4\Q+P(QT#   1"P  &               @(&+%
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ KJO>5%2>_O2E
M!   E1$  !@              ("!WA<  'AL+W=O<FMS:&5E=',O<VAE970T
M+GAM;%!+ 0(4 Q0    ( *ZKWE1@+6'F70D  !]*   8              "
M@;D<  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " "NJ]Y4
M,(UBO8('   H(0  &               @(%,)@  >&PO=V]R:W-H965T<R]S
M:&5E=#8N>&UL4$L! A0#%     @ KJO>5)8J]<GC"   )!<  !@
M     ("!!"X  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (
M *ZKWE1*M&>2( 8  $P.   8              " @1TW  !X;"]W;W)K<VAE
M971S+W-H965T."YX;6Q02P$"% ,4    " "NJ]Y4^+AE^ND0  "S+@  &
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M970Q,RYX;6Q02P$"% ,4    " "NJ]Y408IY,[\5  !4/0  &0
M    @('$:@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (
M *ZKWE10J5J,  P  !0D   9              " @;J   !X;"]W;W)K<VAE
M971S+W-H965T,34N>&UL4$L! A0#%     @ KJO>5(EV5MZ_"@  )Q\  !D
M             ("!\8P  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"
M% ,4    " "NJ]Y45^8<\X($  "O"P  &0              @('GEP  >&PO
M=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( *ZKWE1TFV@#>@(
M *<%   9              " @:"<  !X;"]W;W)K<VAE971S+W-H965T,3@N
M>&UL4$L! A0#%     @ KJO>5'([GAT]!0  PPP  !D              ("!
M49\  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " "NJ]Y4
M*D^[@/X$  !N#   &0              @('%I   >&PO=V]R:W-H965T<R]S
M:&5E=#(P+GAM;%!+ 0(4 Q0    ( *ZKWE1X(X!OA (  (T%   9
M      " @?JI  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%
M  @ KJO>5.E\\PMC!@  .P\  !D              ("!M:P  'AL+W=O<FMS
M:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " "NJ]Y4RYYCSXP#  #K"
M&0              @(%/LP  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+
M 0(4 Q0    ( *ZKWE1N<?/V'@0  #4+   9              " @1*W  !X
M;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ KJO>5#D;J$6T
M @  ^@4  !D              ("!9[L  'AL+W=O<FMS:&5E=',O<VAE970R
M-2YX;6Q02P$"% ,4    " "NJ]Y4NS[)<R@$  !3"@  &0
M@(%2O@  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( *ZK
MWE0[XOXT"@,  +\&   9              " @;'"  !X;"]W;W)K<VAE971S
M+W-H965T,C<N>&UL4$L! A0#%     @ KJO>5*65 #M& @  Z00  !D
M         ("!\L4  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4
M    " "NJ]Y4V6,QB%T#  #=#   &0              @(%OR   >&PO=V]R
M:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( *ZKWE3EB?9+2@0  ,T2
M   9              " @0/,  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL
M4$L! A0#%     @ KJO>5+YB%R42"0  U5<  !D              ("!A-
M 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " "NJ]Y4.+D$
M _0$  !6$P  &0              @('-V0  >&PO=V]R:W-H965T<R]S:&5E
M=#,R+GAM;%!+ 0(4 Q0    ( *ZKWE1?-Y#7T <  %([   9
M  " @?C>  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @
MKJO>5)9Z20'# P  H1$  !D              ("!_^8  'AL+W=O<FMS:&5E
M=',O<VAE970S-"YX;6Q02P$"% ,4    " "NJ]Y4J0\K04D%   H,   &0
M            @('YZ@  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4
M Q0    ( *ZKWE2^]?%UZ0,  #8/   9              " @7GP  !X;"]W
M;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ KJO>5%VFSVV> P
MAPX  !D              ("!F?0  'AL+W=O<FMS:&5E=',O<VAE970S-RYX
M;6Q02P$"% ,4    " "NJ]Y4[WX$W:X"  "2!P  &0              @(%N
M^   >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( *ZKWE3T
M>4.0]@,  )<2   9              " @5/[  !X;"]W;W)K<VAE971S+W-H
M965T,SDN>&UL4$L! A0#%     @ KJO>5%#TQQB- P  +0X  !D
M     ("!@/\  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *ZKWE2]%7@# 0,  ,T,   9              "
M@304 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ KJO>
M5&,4?0^^ P  ^PT  !D              ("!;!<! 'AL+W=O<FMS:&5E=',O
M<VAE970T-BYX;6Q02P$"% ,4    " "NJ]Y40*/;_5,%   /'@  &0
M        @(%A&P$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0
M   ( *ZKWE0<4-#>= 4  /T?   9              " @>L@ 0!X;"]W;W)K
M<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ KJO>5!Z-'4&3!0  1AT
M !D              ("!EB8! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q0
M2P$"% ,4    " "NJ]Y4C)Y@U&8$  !A&0  &0              @(%@+ $
M>&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( *ZKWE2'D7D"
M;08  )LG   9              " @?TP 0!X;"]W;W)K<VAE971S+W-H965T
M-3$N>&UL4$L! A0#%     @ KJO>5)Z@@^8T @  P00  !D
M ("!H3<! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " "N
MJ]Y46](Y,!0$  "=%P  &0              @($,.@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( *ZKWE3L/,; (P0  ( 9   9
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M 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "NJ]Y4O '6P> !  #L(
M&@              @ %44 $ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " "NJ]Y4%-1QY- !  "M(   $P              @ %L4@$
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     /P _ # 1  !M5 $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>177</ContextCount>
  <ElementCount>334</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>55</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>060100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>060200 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LiquidityAndCapitalResources</Role>
      <ShortName>LIQUIDITY AND CAPITAL RESOURCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>060300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>060400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/FairValueOfFinancialInstruments</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>060500 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/Leases</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>060600 - Disclosure - GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopment</Role>
      <ShortName>GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>060700 - Disclosure - ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/AccruedExpenses</Role>
      <ShortName>ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>060800 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>060900 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensation</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>061000 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockholdersEquity</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>061100 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/EarningsPerShare</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>061200 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/RecentAccountingPronouncements</Role>
      <ShortName>RECENT ACCOUNTING PRONOUNCEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>061300 - Disclosure - SUBSEQUENT EVENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/SubsequentEvent</Role>
      <ShortName>SUBSEQUENT EVENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>070100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>071200 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies</Role>
      <ShortName>RECENT ACCOUNTING PRONOUNCEMENTS (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>080300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>080400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/FairValueOfFinancialInstruments</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>080500 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LeasesTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/Leases</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>080700 - Disclosure - ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/AccruedExpensesTables</Role>
      <ShortName>ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/AccruedExpenses</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>080900 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/StockbasedCompensation</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>081100 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/EarningsPerShareTables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/EarningsPerShare</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>090100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>090200 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails</Role>
      <ShortName>LIQUIDITY AND CAPITAL RESOURCES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/LiquidityAndCapitalResources</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>090300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Merger (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Merger (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>090302 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Fair Value of Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Fair Value of Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>090304 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Disposition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Disposition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>090308 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>090310 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Investment in NoveCite (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Investment in NoveCite (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>090400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS, Liabilities Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS, Liabilities Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>090402 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS, Changes in Warrant Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS, Changes in Warrant Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>090500 - Disclosure - LEASES, Operating Lease (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LeasesOperatingLeaseDetails</Role>
      <ShortName>LEASES, Operating Lease (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>090502 - Disclosure - LEASES, Net Operating Lease Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails</Role>
      <ShortName>LEASES, Net Operating Lease Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>090504 - Disclosure - LEASES, Operating Lease Right-of-use Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails</Role>
      <ShortName>LEASES, Operating Lease Right-of-use Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>090506 - Disclosure - LEASES, Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>LEASES, Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>090600 - Disclosure - GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopmentDetails</Role>
      <ShortName>GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopment</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>090700 - Disclosure - ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/AccruedExpensesDetails</Role>
      <ShortName>ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/AccruedExpensesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>090800 - Disclosure - COMMITMENTS AND CONTINGENCIES, Legal Matters (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES, Legal Matters (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>090802 - Disclosure - COMMITMENTS AND CONTINGENCIES, Licensing Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES, Licensing Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>090804 - Disclosure - COMMITMENTS AND CONTINGENCIES, Royalty Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES, Royalty Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>090900 - Disclosure - STOCK-BASED COMPENSATION, Weighted-Average Assumptions Used for Grants Issued (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION, Weighted-Average Assumptions Used for Grants Issued (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>090904 - Disclosure - STOCK-BASED COMPENSATION, Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION, Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>090906 - Disclosure - STOCK-BASED COMPENSATION, Summary of Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION, Summary of Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>090908 - Disclosure - STOCK-BASED COMPENSATION, RSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationRsusDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION, RSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/StockbasedCompensationTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>090910 - Disclosure - STOCK-BASED COMPENSATION, Restricted Stock and Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION, Restricted Stock and Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>091000 - Disclosure - STOCKHOLDERS' EQUITY, Private Placement of Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY, Private Placement of Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>091002 - Disclosure - STOCKHOLDERS' EQUITY, Reverse Stock-Split (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockholdersEquityReverseStocksplitDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY, Reverse Stock-Split (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>091004 - Disclosure - STOCKHOLDERS' EQUITY, Merger (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockholdersEquityMergerDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY, Merger (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>091100 - Disclosure - EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/EarningsPerShareDetails</Role>
      <ShortName>EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/EarningsPerShareTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="brhc10039260_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>091300 - Disclosure - SUBSEQUENT EVENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/SubsequentEventDetails</Role>
      <ShortName>SUBSEQUENT EVENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/SubsequentEvent</ParentRole>
      <Position>55</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="brhc10039260_10q.htm">brhc10039260_10q.htm</File>
    <File>brhc10039260_ex10-5.htm</File>
    <File>brhc10039260_ex10-6.htm</File>
    <File>brhc10039260_ex31-1.htm</File>
    <File>brhc10039260_ex31-2.htm</File>
    <File>brhc10039260_ex32-1.htm</File>
    <File>brhc10039260_ex32-2.htm</File>
    <File>btx-20220331.xsd</File>
    <File>btx-20220331_cal.xml</File>
    <File>btx-20220331_def.xml</File>
    <File>btx-20220331_lab.xml</File>
    <File>btx-20220331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image00001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="524">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>88
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10039260_10q.htm": {
   "axisCustom": 0,
   "axisStandard": 24,
   "contextCount": 177,
   "dts": {
    "calculationLink": {
     "local": [
      "btx-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "btx-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "brhc10039260_10q.htm"
     ]
    },
    "labelLink": {
     "local": [
      "btx-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "btx-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "btx-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 523,
   "entityCount": 1,
   "hidden": {
    "http://brooklynitx.com/20220331": 1,
    "http://fasb.org/us-gaap/2021-01-31": 2,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 8
   },
   "keyCustom": 94,
   "keyStandard": 240,
   "memberCustom": 25,
   "memberStandard": 27,
   "nsprefix": "btx",
   "nsuri": "http://brooklynitx.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://brooklynitx.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS",
     "role": "http://brooklynitx.com/role/FairValueOfFinancialInstruments",
     "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060500 - Disclosure - LEASES",
     "role": "http://brooklynitx.com/role/Leases",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060600 - Disclosure - GOODWILL AND IN-PROCESS RESEARCH & DEVELOPMENT",
     "role": "http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopment",
     "shortName": "GOODWILL AND IN-PROCESS RESEARCH & DEVELOPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060700 - Disclosure - ACCRUED EXPENSES",
     "role": "http://brooklynitx.com/role/AccruedExpenses",
     "shortName": "ACCRUED EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060800 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://brooklynitx.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060900 - Disclosure - STOCK-BASED COMPENSATION",
     "role": "http://brooklynitx.com/role/StockbasedCompensation",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061000 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://brooklynitx.com/role/StockholdersEquity",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061100 - Disclosure - EARNINGS PER SHARE",
     "role": "http://brooklynitx.com/role/EarningsPerShare",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061200 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS",
     "role": "http://brooklynitx.com/role/RecentAccountingPronouncements",
     "shortName": "RECENT ACCOUNTING PRONOUNCEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061300 - Disclosure - SUBSEQUENT EVENT",
     "role": "http://brooklynitx.com/role/SubsequentEvent",
     "shortName": "SUBSEQUENT EVENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "070100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)",
     "role": "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "071200 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS (Policies)",
     "role": "http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies",
     "shortName": "RECENT ACCOUNTING PRONOUNCEMENTS (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS (Tables)",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables",
     "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080500 - Disclosure - LEASES (Tables)",
     "role": "http://brooklynitx.com/role/LeasesTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080700 - Disclosure - ACCRUED EXPENSES (Tables)",
     "role": "http://brooklynitx.com/role/AccruedExpensesTables",
     "shortName": "ACCRUED EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080900 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081100 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://brooklynitx.com/role/EarningsPerShareTables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "U004",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)",
     "role": "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090200 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES (Details)",
     "role": "http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails",
     "shortName": "LIQUIDITY AND CAPITAL RESOURCES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220309to20220309",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U003",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U003",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Merger (Details)",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Merger (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember",
      "decimals": "4",
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090302 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Fair Value of Assets Acquired and Liabilities Assumed (Details)",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Fair Value of Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090304 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Disposition (Details)",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Disposition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210101to20210331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueAcquisitions",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090308 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Acquisition (Details)",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireOtherProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090310 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Investment in NoveCite (Details)",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Investment in NoveCite (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember",
      "decimals": "INF",
      "lang": null,
      "name": "btx:NumberOfBoardSeats",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS, Liabilities Measured at Fair Value (Details)",
     "role": "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
     "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS, Liabilities Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "btx:OverSubscriptionAmountReceived",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090402 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS, Changes in Warrant Liabilities (Details)",
     "role": "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
     "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS, Changes in Warrant Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "btx:OperatingLeaseArea",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U006",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090500 - Disclosure - LEASES, Operating Lease (Details)",
     "role": "http://brooklynitx.com/role/LeasesOperatingLeaseDetails",
     "shortName": "LEASES, Operating Lease (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "btx:OperatingLeaseArea",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U006",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090502 - Disclosure - LEASES, Net Operating Lease Expenses (Details)",
     "role": "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails",
     "shortName": "LEASES, Net Operating Lease Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090504 - Disclosure - LEASES, Operating Lease Right-of-use Assets and Liabilities (Details)",
     "role": "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails",
     "shortName": "LEASES, Operating Lease Right-of-use Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "lang": null,
      "name": "btx:WriteOffOfOperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090506 - Disclosure - LEASES, Maturities of Operating Lease Liabilities (Details)",
     "role": "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails",
     "shortName": "LEASES, Maturities of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090600 - Disclosure - GOODWILL AND IN-PROCESS RESEARCH & DEVELOPMENT (Details)",
     "role": "http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopmentDetails",
     "shortName": "GOODWILL AND IN-PROCESS RESEARCH & DEVELOPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090700 - Disclosure - ACCRUED EXPENSES (Details)",
     "role": "http://brooklynitx.com/role/AccruedExpensesDetails",
     "shortName": "ACCRUED EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090800 - Disclosure - COMMITMENTS AND CONTINGENCIES, Legal Matters (Details)",
     "role": "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES, Legal Matters (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210205to20210205_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember",
      "decimals": "-5",
      "lang": null,
      "name": "btx:LossContingencyDamagesSoughtExpectedSalary",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "btx:MilestonePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090802 - Disclosure - COMMITMENTS AND CONTINGENCIES, Licensing Agreements (Details)",
     "role": "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES, Licensing Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "btx:MilestonePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090804 - Disclosure - COMMITMENTS AND CONTINGENCIES, Royalty Agreements (Details)",
     "role": "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES, Royalty Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090900 - Disclosure - STOCK-BASED COMPENSATION, Weighted-Average Assumptions Used for Grants Issued (Details)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails",
     "shortName": "STOCK-BASED COMPENSATION, Weighted-Average Assumptions Used for Grants Issued (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "4",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20211231_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090904 - Disclosure - STOCK-BASED COMPENSATION, Stock Option Activity (Details)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION, Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "btx:NumberOfStockOptionGrantMade",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U008",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090906 - Disclosure - STOCK-BASED COMPENSATION, Summary of Stock Options (Details)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
     "shortName": "STOCK-BASED COMPENSATION, Summary of Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "btx:NumberOfStockOptionGrantMade",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U008",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090908 - Disclosure - STOCK-BASED COMPENSATION, RSUs (Details)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
     "shortName": "STOCK-BASED COMPENSATION, RSUs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY",
     "role": "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090910 - Disclosure - STOCK-BASED COMPENSATION, Restricted Stock and Stock-Based Compensation Expense (Details)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails",
     "shortName": "STOCK-BASED COMPENSATION, Restricted Stock and Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091000 - Disclosure - STOCKHOLDERS' EQUITY, Private Placement of Equity (Details)",
     "role": "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails",
     "shortName": "STOCKHOLDERS' EQUITY, Private Placement of Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331_ClassOfWarrantOrRightAxis_CommonWarrantsMember",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U003",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210325to20210325",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091002 - Disclosure - STOCKHOLDERS' EQUITY, Reverse Stock-Split (Details)",
     "role": "http://brooklynitx.com/role/StockholdersEquityReverseStocksplitDetails",
     "shortName": "STOCKHOLDERS' EQUITY, Reverse Stock-Split (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210325to20210325",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210325to20210325",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "btx:StockIssuedDuringPeriodSharesAcquisitions1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091004 - Disclosure - STOCKHOLDERS' EQUITY, Merger (Details)",
     "role": "http://brooklynitx.com/role/StockholdersEquityMergerDetails",
     "shortName": "STOCKHOLDERS' EQUITY, Merger (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20210325to20210325",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "btx:StockIssuedDuringPeriodSharesAcquisitions1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091100 - Disclosure - EARNINGS PER SHARE (Details)",
     "role": "http://brooklynitx.com/role/EarningsPerShareDetails",
     "shortName": "EARNINGS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220331",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "U003",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091300 - Disclosure - SUBSEQUENT EVENT (Details)",
     "role": "http://brooklynitx.com/role/SubsequentEventDetails",
     "shortName": "SUBSEQUENT EVENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220524to20220524_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:PaymentsForPostemploymentBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "role": "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "btx:LiquidityAndCapitalResourcesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060200 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES",
     "role": "http://brooklynitx.com/role/LiquidityAndCapitalResources",
     "shortName": "LIQUIDITY AND CAPITAL RESOURCES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "btx:LiquidityAndCapitalResourcesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10039260_10q.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 55,
   "tag": {
    "btx_AccruedGeneralAndAdministrativeExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/AccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued general and administrative expenses.",
        "label": "Accrued General and Administrative Expenses",
        "terseLabel": "Accrued general and administrative expenses"
       }
      }
     },
     "localname": "AccruedGeneralAndAdministrativeExpenses",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AccruedResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/AccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued research and development expenses.",
        "label": "Accrued Research and Development Expenses",
        "terseLabel": "Accrued research and development expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpenses",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AcquisitionAgreementNonCompetitivePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Acquisition Agreement contains non-competition and non-solicitation provisions pursuant to which the Seller has agreed not to engage in certain competitive activities for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquisition Agreement, Non Competitive Period",
        "terseLabel": "Non-compete period"
       }
      }
     },
     "localname": "AcquisitionAgreementNonCompetitivePeriod",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_AdditionalFeesObligatedToPay": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entity is obligated to pay additional fees to Licensors.",
        "label": "Additional Fees Obligated to Pay",
        "terseLabel": "Amount require to pay of initial license fees"
       }
      }
     },
     "localname": "AdditionalFeesObligatedToPay",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease (increase) in additional paid in capital (APIC) for the increase in redemption of temporary equity as the result of a triggering event associated with the temporary equity.",
        "label": "Adjustments to Additional Paid in Capital, Elimination Historical Member Equity",
        "terseLabel": "Elimination of Brooklyn's historical members' equity"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AggregateCalendarDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified aggregate calendar days (which need not be consecutive calendar days) during any 12-month period for resale.",
        "label": "Aggregate Calendar Days",
        "terseLabel": "Aggregate calendar days"
       }
      }
     },
     "localname": "AggregateCalendarDays",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_AggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Intrinsic Value [Abstract]"
       }
      }
     },
     "localname": "AggregateIntrinsicValueAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_AmountObligatedToPayInYearOne": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entity is obligated to pay additional fees to the Licensors in first year.",
        "label": "Amount Obligated to Pay in Year One",
        "terseLabel": "Additional fees obligated to pay in 2021"
       }
      }
     },
     "localname": "AmountObligatedToPayInYearOne",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AmountObligatedToPayInYearTwo": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entity is obligated to pay additional fees to the Licensors in second year.",
        "label": "Amount Obligated to Pay in Year Two",
        "terseLabel": "Additional fees obligated to pay in 2022"
       }
      }
     },
     "localname": "AmountObligatedToPayInYearTwo",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AmountRequireToPayInitialLicenseFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount require to pay out of the total initial license fees.",
        "label": "Amount Require to Pay Initial License Fees",
        "terseLabel": "Amount obligated to pay in license agreement"
       }
      }
     },
     "localname": "AmountRequireToPayInitialLicenseFees",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AssetAcquisitionFairValueOfConsiderationPaid": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fair value of consideration paid in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.",
        "label": "Asset Acquisition, Fair Value of Consideration Paid",
        "totalLabel": "Total fair value of consideration paid"
       }
      }
     },
     "localname": "AssetAcquisitionFairValueOfConsiderationPaid",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AssetAcquisitionRestrictedSharesSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered with restrictions to be paid in asset acquisition.",
        "label": "Asset Acquisition, Restricted Shares, Share Price",
        "terseLabel": "Restricted shares, fair value per share (in dollars per share)"
       }
      }
     },
     "localname": "AssetAcquisitionRestrictedSharesSharePrice",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "btx_AssetAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in asset acquisition.",
        "label": "Asset Acquisition, Share Price",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "AssetAcquisitionSharePrice",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "btx_AssetAcquisitionUnrestrictedSharesSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered without any restrictions to be paid in asset acquisition.",
        "label": "Asset Acquisition, Unrestricted Shares, Share Price",
        "terseLabel": "Unrestricted shares, fair value per share (in dollars per share)"
       }
      }
     },
     "localname": "AssetAcquisitionUnrestrictedSharesSharePrice",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "btx_BaseRentPerSquareFoot": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of base rent expense per square foot for leased asset.",
        "label": "Base Rent per Square Foot",
        "terseLabel": "Base rent (per square foot)"
       }
      }
     },
     "localname": "BaseRentPerSquareFoot",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "btx_BeneficialHoldersContractualCommitmentsToInvest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual commitment made by beneficial holders to invest in the entity.",
        "label": "Beneficial Holders Contractual Commitments To Invest",
        "terseLabel": "Beneficial holders contractual commitments to invest"
       }
      }
     },
     "localname": "BeneficialHoldersContractualCommitmentsToInvest",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of software development costs recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Software Development Costs",
        "terseLabel": "Software development costs"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_CashPaidDuringThePeriodForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid During the Period for [Abstract]",
        "terseLabel": "Cash paid during the period for:"
       }
      }
     },
     "localname": "CashPaidDuringThePeriodForAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of chair of the board of directors, chief executive officer and president.",
        "label": "Chair of the Board of Directors, Chief Executive Officer and President [Member]",
        "terseLabel": "Chair of the Board of Directors, Chief Executive Officer and President [Member]"
       }
      }
     },
     "localname": "ChairOfTheBoardOfDirectorsChiefExecutiveOfficerAndPresidentMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_ChiefExecutiveOfficerAndPresidentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of chief executive officer and president.",
        "label": "Chief Executive Officer and President [Member]",
        "terseLabel": "Dr. Federoff [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerAndPresidentMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_CitiusPharmaceuticalsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Citius Pharmaceuticals, Inc. Ownership interest.",
        "label": "Citius Pharmaceuticals, Inc. [Member]"
       }
      }
     },
     "localname": "CitiusPharmaceuticalsIncMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_ClassOfWarrantOrRightIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued into which the class of warrant or right may be converted.",
        "label": "Class of Warrant or Right, Issued",
        "terseLabel": "Number of rights options issued (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightIssued",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of securities that would be issuable upon the exercise of warrants or rights.",
        "label": "Class of Warrant or Right Percent of Securities that Would be Issuable Upon Exercise of Warrants or Rights",
        "terseLabel": "Percentage of warrants exercisable"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_ClassOfWarrantOrRightsExercisableTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Class of Warrant or Rights Exercisable Term",
        "terseLabel": "Warrant exercisable term"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightsExercisableTerm",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_CollaboratorRoyaltyAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative royalty arrangement in licensing deal with the company.",
        "label": "Collaborator Royalty Agreement [Member]",
        "terseLabel": "Collaborator Royalty Agreement [Member]"
       }
      }
     },
     "localname": "CollaboratorRoyaltyAgreementMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_CommonUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than provided to common units, representing ownership interest in a corporation.",
        "label": "Common Units [Member]",
        "verboseLabel": "Common [Member]"
       }
      }
     },
     "localname": "CommonUnitsMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_CommonWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A common warrant represents the right to purchase a company's stock at a specific price and at a specific date.",
        "label": "Common Warrants [Member]",
        "terseLabel": "Common Warrants [Member]"
       }
      }
     },
     "localname": "CommonWarrantsMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_ConsecutiveCalendarDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified consecutive calendar days for resale.",
        "label": "Consecutive Calendar Days",
        "terseLabel": "Consecutive calendar days"
       }
      }
     },
     "localname": "ConsecutiveCalendarDays",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Detailed information about Liquidity and Capital Resources [Abstract]",
        "verboseLabel": "Liquidity and Capital Resources [Abstract]"
       }
      }
     },
     "localname": "DetailedInformationAboutLiquidityAndCapitalResourcesAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_DheshGovenderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dhesh Govender, a former short-term consultant of the entity",
        "label": "Dhesh Govender [Member]",
        "terseLabel": "Govender [Member]"
       }
      }
     },
     "localname": "DheshGovenderMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as Lease liability attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Lease liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLeaseLiability",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as Obligations under finance leases attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Obligations under finance leases",
        "terseLabel": "Obligations under finance leases"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate proceeds received from assume advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Disposal Group, Including Discontinued Operation, Proceeds from Assume Advance/Loans",
        "terseLabel": "Assume advance/loans"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Disposal Group, Including Discontinued Operation, Proceeds from Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationProceedsFromCash",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate proceeds received from escrow deposits in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Disposal Group, Including Discontinued Operation, Proceeds from Escrow",
        "terseLabel": "Escrow"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate proceeds received from interest on advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Disposal Group, Including Discontinued Operation, Proceeds from Interest on Advance/Loans",
        "terseLabel": "Interest on advance/loans"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as software development cost attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Software development costs",
        "negatedLabel": "Software development costs"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs of the business disposal including legal, accounting, and other costs incurred to consummate the business disposition.",
        "label": "Disposal Group, Including Discontinued Operation, Transaction Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationTransactionCosts",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DispositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposition [Abstract]"
       }
      }
     },
     "localname": "DispositionAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_EachLockUpAgreementExtendsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of lock-up agreement extend term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Each Lock-up Agreement Extends Term",
        "terseLabel": "Each lock-up agreement extend term"
       }
      }
     },
     "localname": "EachLockUpAgreementExtendsTerm",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_EmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One of the employee of the entity, appointed to the position.",
        "label": "Employee [Member]",
        "terseLabel": "Employees [Member]"
       }
      }
     },
     "localname": "EmployeeMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_EscrowPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of secure indemnification obligations to acquisition agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Escrow Period",
        "terseLabel": "Period of escrow"
       }
      }
     },
     "localname": "EscrowPeriod",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_EscrowShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares have been placed in escrow shares.",
        "label": "Escrow Shares",
        "terseLabel": "Escrow shares (in shares)"
       }
      }
     },
     "localname": "EscrowShares",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_GainLossOnDisposalOfFixedAssets": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of fixed assets.",
        "label": "Gain (Loss) on Disposal of Fixed Assets",
        "terseLabel": "Loss on disposal of fixed assets"
       }
      }
     },
     "localname": "GainLossOnDisposalOfFixedAssets",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_GainOnTerminationOfLease": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain on termination of lease before expiration of lease term.",
        "label": "Gain on Termination of Lease",
        "negatedLabel": "Gain on lease termination"
       }
      }
     },
     "localname": "GainOnTerminationOfLease",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security deposits and also includes any other non-current assets which are not separately reported in during the period.",
        "label": "Increase (Decrease) in Deposit Assets and Other Non-current Assets",
        "negatedLabel": "Security deposits and other non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the operating lease liabilities.",
        "label": "Increase (Decrease) in Operating Lease Liabilities",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_InitialLicenseFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial license fees required to pay including non-refundable fee.",
        "label": "Initial License Fees",
        "terseLabel": "Initial license fees"
       }
      }
     },
     "localname": "InitialLicenseFees",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_InvestorRoyaltyAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement other than collaborative applicable to investor royalty.",
        "label": "Investor Royalty Agreement [Member]",
        "terseLabel": "Investor Royalty Agreement [Member]"
       }
      }
     },
     "localname": "InvestorRoyaltyAgreementMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_LIQUIDITYANDCAPITALRESOURCESAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIQUIDITY AND CAPITAL RESOURCES [Abstract]"
       }
      }
     },
     "localname": "LIQUIDITYANDCAPITALRESOURCESAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "xbrltype": "stringItemType"
    },
    "btx_LegalMattersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Matters [Abstract]",
        "terseLabel": "Legal Matters [Abstract]"
       }
      }
     },
     "localname": "LegalMattersAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_LesseeCommitmentToPurchaseProperty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property for which lessee committed to purchase.",
        "label": "Lessee, Commitment to Purchase Property",
        "terseLabel": "Commitment to purchase equipment"
       }
      }
     },
     "localname": "LesseeCommitmentToPurchaseProperty",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fourth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments Due after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Lessee Operating Lease Weighted Average Remaining Lease Term And Discount Rate Abstract [Abstract]",
        "terseLabel": "Weighted Average Remaining Lease Term and Discount Rate [Abstract]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_LicensingAgreementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licensing Agreements [Abstract]",
        "terseLabel": "Licensing Agreements [Abstract]"
       }
      }
     },
     "localname": "LicensingAgreementsAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_LiquidityAndCapitalResourcesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of liquidity and resource matters when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). going concern.",
        "label": "Liquidity And Capital Resources [Text Block]",
        "terseLabel": "LIQUIDITY AND CAPITAL RESOURCES"
       }
      }
     },
     "localname": "LiquidityAndCapitalResourcesTextBlock",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LiquidityAndCapitalResources"
     ],
     "xbrltype": "textBlockItemType"
    },
    "btx_LockUpPeriodForRestrictedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period in which shares are locked-up, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Lock-up Period for Restricted Shares",
        "terseLabel": "Lock-up period"
       }
      }
     },
     "localname": "LockUpPeriodForRestrictedShares",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_LossContingencyDamagesSoughtExpectedEquityPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of equity promised to the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Expected Equity Percentage",
        "terseLabel": "Percentage of equity promised against plaintiff"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtExpectedEquityPercentage",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_LossContingencyDamagesSoughtExpectedSalary": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The monetary amount of salary promised to the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Expected Salary",
        "terseLabel": "Defendants salary promised against plaintiff"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtExpectedSalary",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_LossContingencyNonRefundableOptionFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of Non-refundable option fee in licensing agreement.",
        "label": "Loss Contingency, Non-refundable Option Fee",
        "terseLabel": "Non-refundable option fee"
       }
      }
     },
     "localname": "LossContingencyNonRefundableOptionFee",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_LossContingencyNumberOfArbitrationPanel": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number member in arbitration panel pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, Number of Arbitration Panel Member",
        "terseLabel": "Number of member arbitration panel"
       }
      }
     },
     "localname": "LossContingencyNumberOfArbitrationPanel",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "btx_LossContingencyPercentageOfRoyaltyPayable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of royalty payable from one party to another in licensing agreement.",
        "label": "Loss contingency, Percentage of Royalty Payable",
        "terseLabel": "Percentage of royalty payable"
       }
      }
     },
     "localname": "LossContingencyPercentageOfRoyaltyPayable",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_LossOnNonControllingInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss on non-controlling investment.",
        "label": "Loss on Non-controlling Investment",
        "negatedLabel": "Loss on non-controlling investment",
        "terseLabel": "Loss on non-controlling investment"
       }
      }
     },
     "localname": "LossOnNonControllingInvestment",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_MembershipEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity membership interest in entity.",
        "label": "Membership Equity [Member]",
        "terseLabel": "Membership Equity [Member]"
       }
      }
     },
     "localname": "MembershipEquityMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_MergerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merger [Abstract]"
       }
      }
     },
     "localname": "MergerAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_MilestoneOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions based on milestones.",
        "label": "Milestone Options [Member]",
        "terseLabel": "Milestone Options [Member]"
       }
      }
     },
     "localname": "MilestoneOptionsMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_MilestonePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of milestones upfront payment on licenses.",
        "label": "Milestone Payments",
        "terseLabel": "Milestone payments"
       }
      }
     },
     "localname": "MilestonePayments",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_MinimumNumberOfPatentGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum number of granted patents.",
        "label": "Minimum Number of Patent Granted",
        "verboseLabel": "Minimum number of patent granted"
       }
      }
     },
     "localname": "MinimumNumberOfPatentGranted",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "btx_MinimumNumberOfPendingPatents": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum number of patents pending.",
        "label": "Minimum Number of Pending Patents",
        "terseLabel": "Number of maximum pending patents"
       }
      }
     },
     "localname": "MinimumNumberOfPendingPatents",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "btx_NTNBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the disposal group.",
        "label": "NTN Business [Member]",
        "terseLabel": "NTN Business [Member]"
       }
      }
     },
     "localname": "NTNBusinessMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NTNBuzztimeIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of acquiree entity.",
        "label": "NTN Buzztime, Inc [Member]",
        "terseLabel": "NTN Buzztime, Inc [Member]"
       }
      }
     },
     "localname": "NTNBuzztimeIncMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NonQualifiedStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Non-qualified Stock Option [Member]",
        "terseLabel": "Nonqualified Stock Option [Member]"
       }
      }
     },
     "localname": "NonQualifiedStockOptionMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of preferred stock issued in a reverse merger transaction in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Preferred Shares Issued in Connection with Reverse Merger",
        "terseLabel": "Series A preferred stock retained in business combination"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_NoveCiteINCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of company involved in licensing agreement.",
        "label": "NoveCite, INC. [Member]",
        "terseLabel": "NoveCite, INC. [Member]"
       }
      }
     },
     "localname": "NoveCiteINCMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NoveCiteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of company involved in licensing agreement.",
        "label": "NoveCite [Member]",
        "terseLabel": "NoveCite [Member]"
       }
      }
     },
     "localname": "NoveCiteMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NovellusLtdAndFactorBioscienceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of companies involved in licensing agreement.",
        "label": "Novellus Ltd. and Factor Bioscience [Member]",
        "terseLabel": "Licensors [Member]"
       }
      }
     },
     "localname": "NovellusLtdAndFactorBioscienceMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NovellusTherapeuticsLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of company involved in licensing agreement.",
        "label": "Novellus Therapeutics Limited [Member]",
        "terseLabel": "Novellus, Ltd. [Member]"
       }
      }
     },
     "localname": "NovellusTherapeuticsLimitedMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NumberOfBoardSeats": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of members of the company's management holds board seats on board of directors.",
        "label": "Number of Board Seats",
        "terseLabel": "Number of board seats"
       }
      }
     },
     "localname": "NumberOfBoardSeats",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "btx_NumberOfPerformanceGoalsAreSubjectToAchieve": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of performance goals are subject to achieve under 2022 performance based restricted stock units.",
        "label": "Number of Performance Goals are Subject to Achieve",
        "terseLabel": "Number of performance goals are subject to achieve"
       }
      }
     },
     "localname": "NumberOfPerformanceGoalsAreSubjectToAchieve",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "btx_NumberOfStockOptionGrantMade": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock option grants made.",
        "label": "Number Of Stock Option Grant Made",
        "terseLabel": "Number of stock option grants made"
       }
      }
     },
     "localname": "NumberOfStockOptionGrantMade",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents obligated to maintain under merger agreement on balance sheet at the effective time of the merger.",
        "label": "Obligated to Maintain Cash and Cash Equivalents Under Merger Agreement",
        "terseLabel": "Cash and cash equivalents obligated to have under merger agreement"
       }
      }
     },
     "localname": "ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_ObligationToPayLiquidatedDamagesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages percentage of aggregate payment on Subscription Amount.",
        "label": "Obligation to Pay Liquidated Damages Percentage",
        "terseLabel": "Obligated to pay liquidated damages percentage"
       }
      }
     },
     "localname": "ObligationToPayLiquidatedDamagesPercentage",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages equal to the Subscription Amount per month.",
        "label": "Obligation to Pay Liquidated Damages Percentage on Subscription Amount per Month",
        "terseLabel": "Obligation to pay liquidated damages per month"
       }
      }
     },
     "localname": "ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_OperatingLeaseArea": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of leased property under operating lease.",
        "label": "Operating Lease Area",
        "terseLabel": "Operating lease area"
       }
      }
     },
     "localname": "OperatingLeaseArea",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "btx_OperatingLeaseAssestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Asset [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseAssestAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for lessee's operating lease right-of-use assets and liabilities.",
        "label": "Operating Lease Right-of-use Assets and Liabilities [Table Text Block]",
        "terseLabel": "Operating Lease Right-of-use Assets and Liabilities"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "btx_OverSubscriptionAmountReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.",
        "label": "Over-Subscription Amount Received",
        "terseLabel": "Over-subscription amount received"
       }
      }
     },
     "localname": "OverSubscriptionAmountReceived",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_PIPEInvestorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private investment in public equity, often called a PIPE deal, involves the selling of publicly traded common shares or some form of preferred stock or convertible security to private investors. It is an allocation of shares in a public company not through a public offering in a stock exchange. PIPE deals are part of the primary market. In the U.S., a PIPE offering may be registered with the Securities and Exchange Commission on a registration statement or may be completed as an unregistered private placement.",
        "label": "PIPE Investor [Member]",
        "terseLabel": "PIPE Investor [Member]"
       }
      }
     },
     "localname": "PIPEInvestorMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_PaymentToOfficerBaseSalary": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflows for payment of annual base salary for a period of twelve months after the expiration of the applicable revocation period.",
        "label": "Payment to Officer Base Salary",
        "terseLabel": "Payment of annual base salary"
       }
      }
     },
     "localname": "PaymentToOfficerBaseSalary",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_PaymentsOfPaycheckProtectionProgramLoan": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash outflow for payment of paycheck protection program loans.",
        "label": "Payments of Paycheck Protection Program Loan",
        "negatedLabel": "Repayment of NTN's PPP loan"
       }
      }
     },
     "localname": "PaymentsOfPaycheckProtectionProgramLoan",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_PaymentsToAcquireProductiveAssetsNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets excluding cash acquired.",
        "label": "Cash paid, net",
        "terseLabel": "Cash paid, net"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssetsNet",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_PercentageBaseRentIncreaseOnEachAnniversary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of base rent increase on each anniversary.",
        "label": "Percentage, Base Rent Increase on each Anniversary",
        "terseLabel": "Percentage of increase in base rent on each year"
       }
      }
     },
     "localname": "PercentageBaseRentIncreaseOnEachAnniversary",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PercentageOfAdditionalRightsOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of additional right offering made by the entity for unit holders.",
        "label": "Percentage of Additional Rights Offering",
        "terseLabel": "Percentage of additional rights offering"
       }
      }
     },
     "localname": "PercentageOfAdditionalRightsOffering",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PercentageOfCommonStockSubjectToLockUpAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of shares of common stock subject to the lock-up agreement",
        "label": "Percentage of Common Stock Subject to Lock-up Agreement",
        "terseLabel": "Percentage of common stock subject to the lock-up agreement"
       }
      }
     },
     "localname": "PercentageOfCommonStockSubjectToLockUpAgreement",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PercentageOfDiscountOnFairValueOfRestrictedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of discount on restricted shares, which was derived from the average discount rate between the Black Scholes and Finnerty valuation models.",
        "label": "Percentage of Discount on Fair Value of Restricted Shares",
        "terseLabel": "Percentage of discount on fair value restricted shares"
       }
      }
     },
     "localname": "PercentageOfDiscountOnFairValueOfRestrictedShares",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of additional royalty payable on gross sales by the entity.",
        "label": "Percentage of Payment Of Additional Royalty On Gross Sales",
        "terseLabel": "Percentage of payment of additional royalty on gross sales"
       }
      }
     },
     "localname": "PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PercentageOfRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenue from receives any revenue involving the original cell line included in the licensed technology, then Novellus, Ltd shall remit to NoveCite.",
        "label": "Percentage of Revenue",
        "terseLabel": "Percentage of revenue"
       }
      }
     },
     "localname": "PercentageOfRevenue",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of royalty receive equal to revenues generated from disposition of business.",
        "label": "Percentage of Royalty Receive Equal to Revenues from Sale of Business",
        "terseLabel": "Percentage of royalty receive equal to revenues from sale of business"
       }
      }
     },
     "localname": "PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PerformanceBasedNonqualifiedStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on performance basis.",
        "label": "Performance-Based Nonqualified Stock Option [Member]",
        "terseLabel": "Performance-Based Nonqualified Stock Option [Member]"
       }
      }
     },
     "localname": "PerformanceBasedNonqualifiedStockOptionMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_PreFundedWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A pre-funded warrant that allows the warrant holder to purchase a specified number of a company's securities at a nominal exercise price.",
        "label": "Pre-funded Warrants [Member]",
        "terseLabel": "Pre-funded Warrants [Member]"
       }
      }
     },
     "localname": "PreFundedWarrantsMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_PrincipalPaymentsOnOperatingLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal payments on operating lease liabilities.",
        "label": "Principal payments on operating lease liabilities",
        "negatedLabel": "Principal payments on operating lease liabilities"
       }
      }
     },
     "localname": "PrincipalPaymentsOnOperatingLeaseLiabilities",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_PrivatePlacementOfEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement of Equity [Abstract]",
        "terseLabel": "Private Placement of Equity [Abstract]"
       }
      }
     },
     "localname": "PrivatePlacementOfEquityAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_ProFormaFairValueAdjustmentToAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value adjustment to acquisition-date assets reported in proforma information.",
        "label": "Pro Forma Fair Value Adjustment to Assets [Member]",
        "terseLabel": "Fair Value Adjustment to Assets [Member]"
       }
      }
     },
     "localname": "ProFormaFairValueAdjustmentToAssetsMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_ProceedsFromDispositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Disposition [Abstract]",
        "terseLabel": "Proceeds from sale [Abstract]"
       }
      }
     },
     "localname": "ProceedsFromDispositionAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_ProceedsFromSaleOfRights": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of rights during the period.",
        "label": "Proceeds From Sale Of Rights",
        "terseLabel": "Proceeds from right offering"
       }
      }
     },
     "localname": "ProceedsFromSaleOfRights",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_PurchasePriceAllocationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price allocation of acquisition-date assets and liability assumed.",
        "label": "Purchase Price Allocation [Member]"
       }
      }
     },
     "localname": "PurchasePriceAllocationMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_ResearchAndDevelopmentInProcessAssetAcquisition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process, Asset Acquisition",
        "terseLabel": "Acquired in-process research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcessAssetAcquisition",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_ReverseStockSplitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Stock-Split [Abstract]"
       }
      }
     },
     "localname": "ReverseStockSplitAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityReverseStocksplitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_RoyaltyAgreementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Agreements [Abstract]",
        "terseLabel": "Royalty Agreements [Abstract]"
       }
      }
     },
     "localname": "RoyaltyAgreementsAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_SeparationAgreementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Separation Agreement [Abstract]",
        "terseLabel": "Separation Agreement [Abstract]"
       }
      }
     },
     "localname": "SeparationAgreementAbstract",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of severance benefit, would have received if he was entitled to receive a settlement of a pro rata portion of his performance restricted stock units through the expiration of the Separation Period.",
        "label": "Severance Benefit Receivable Based on Performance Restricted Stock Units",
        "terseLabel": "Severance benefit receivable based on performance restricted stock"
       }
      }
     },
     "localname": "SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options expected to vest.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Expected to Vest, Number",
        "terseLabel": "Balance expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fair value of share-based payment arrangement, subject to vesting and other restrictions, to purchase or sell certain number of shares on performance basis.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Fair Value",
        "terseLabel": "Stock-based compensation grant fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of monthly installments for vesting of remaining shares in share-based compensation arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment, Number of Monthly Installments for Vesting of Remaining Shares",
        "terseLabel": "Number of monthly installments"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares Forfeiture of unvested restricted stock during the period.",
        "label": "Shares Issued, Shares, Forfeiture of unvested restricted stock",
        "negatedLabel": "Forfeiture of unvested restricted stock (in shares)"
       }
      }
     },
     "localname": "SharesIssuedSharesForfeitureOfUnvestedRestrictedStock",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued with restrictions during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Restricted Shares, Acquisitions",
        "terseLabel": "Restricted shares, issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodRestrictedSharesAcquisitions",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "btx_AssetAcquisitionFairValueOfConsiderationPaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued with restrictions during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Restricted Shares, Value, Acquisitions",
        "terseLabel": "Restricted shares, value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodRestrictedSharesValueAcquisitions",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodSharesAcquisitions1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions1",
        "terseLabel": "Issuance of common stock for business combination (in shares)",
        "verboseLabel": "Stock issued, shares, acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions1",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the shares of new stock issued of preferred stock during the period.",
        "label": "Stock Issued During Period, Shares, New Issues of Preferred Stock, Retained by Stockholders",
        "terseLabel": "Series A preferred stock retained in business combination (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodSharesPrivateOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been issued in private offering during the period.",
        "label": "Stock Issued During Period, Shares, Private Offering",
        "terseLabel": "Issuance of common stock in connection with private offering (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPrivateOffering",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued without any restrictions during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Unrestricted Shares, Acquisitions",
        "terseLabel": "Unrestricted shares, issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodUnrestrictedSharesAcquisitions",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "btx_AssetAcquisitionFairValueOfConsiderationPaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued without any restrictions during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Unrestricted Shares, Value, Acquisitions",
        "terseLabel": "Unrestricted shares, value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodValueAcquisitions1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions1",
        "terseLabel": "Issuance of common stock for business combination"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions1",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Forfeiture of unvested restricted stock during the period.",
        "label": "Stock Issued During Period, Value, Forfeiture of Unvested Restricted Stock",
        "terseLabel": "Forfeiture of unvested restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued of preferred stock during the period.",
        "label": "Stock Issued During Period, Value, New Issues of Preferred Stock, Retained by Stockholders",
        "terseLabel": "Series A preferred stock retained in business combination"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodValuePrivateOffering": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been issued in private offering during the period.",
        "label": "Stock Issued During Period, Value, Private Offering",
        "terseLabel": "Issuance of common stock in connection with private offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValuePrivateOffering",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to rights offering membership units during the period.",
        "label": "Stock Issued During Period, Value, Rights Offering Membership Units",
        "terseLabel": "Brooklyn rights offerings membership units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRightsOfferingMembershipUnits",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_TimeBasedNonQualifiedStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on time basis.",
        "label": "Time-Based Non-qualified Stock Option [Member]",
        "terseLabel": "Time-Based Non-qualified Stock Option [Member]"
       }
      }
     },
     "localname": "TimeBasedNonQualifiedStockOptionMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_TransactionFeesPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fees incurred related to PIPE transaction.",
        "label": "Transaction Fees Payable",
        "terseLabel": "Transaction fees"
       }
      }
     },
     "localname": "TransactionFeesPayable",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_Two022PerformanceBasedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of awards.",
        "label": "2022 Performance-Based Restricted Stock Units [Member]",
        "terseLabel": "2022 PSUs [Member]"
       }
      }
     },
     "localname": "Two022PerformanceBasedRestrictedStockUnitsMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_UnamortizedLeaseholdImprovements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of unamortized leasehold improvements.",
        "label": "Unamortized Leasehold Improvements",
        "terseLabel": "Unamortized leasehold improvements"
       }
      }
     },
     "localname": "UnamortizedLeaseholdImprovements",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_UniversityOfSouthFloridaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal entity involved in litigation.",
        "label": "University of South Florida [Member]",
        "terseLabel": "University of South Florida [Member]"
       }
      }
     },
     "localname": "UniversityOfSouthFloridaMember",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_WarrantLiabilitiesExpense": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to warrant liabilities.",
        "label": "Warrant Liabilities Expense",
        "negatedLabel": "Warrant liabilities expense",
        "terseLabel": "Warrant liabilities expense"
       }
      }
     },
     "localname": "WarrantLiabilitiesExpense",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_WriteOffOfOperatingLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of operating lease liability due to lease termination.",
        "label": "Write- off of Operating Lease Liability",
        "negatedLabel": "Write off of operating lease liability due to lease termination"
       }
      }
     },
     "localname": "WriteOffOfOperatingLeaseLiability",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_WriteOffOfOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of operating lease right-of-use asset due to lease termination.",
        "label": "Write-off of Operating Lease Right-of-use Asset",
        "negatedLabel": "Write off of ROU asset due to lease termination"
       }
      }
     },
     "localname": "WriteOffOfOperatingLeaseRightOfUseAsset",
     "nsuri": "http://brooklynitx.com/20220331",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Dr. Federoffs's [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r194",
      "r203",
      "r244",
      "r247",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r417",
      "r418",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r194",
      "r203",
      "r244",
      "r247",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r417",
      "r418",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r194",
      "r203",
      "r233",
      "r244",
      "r247",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r417",
      "r418",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r194",
      "r203",
      "r233",
      "r244",
      "r247",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r417",
      "r418",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r97",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r97",
      "r102",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r97",
      "r102",
      "r170",
      "r245",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r135",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "ACCRUED EXPENSES"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r37",
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://brooklynitx.com/role/AccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails",
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r21",
      "r22",
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Legal Expenses"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r28",
      "r282",
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r85",
      "r86",
      "r87",
      "r278",
      "r279",
      "r280",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r248",
      "r250",
      "r285",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r250",
      "r275",
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Stock based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Total potential common shares excluded from computation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionTableTextBlock": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of asset acquisition.",
        "label": "Fair Value of Asset Acquired"
       }
      }
     },
     "localname": "AssetAcquisitionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r83",
      "r126",
      "r129",
      "r133",
      "r141",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r317",
      "r319",
      "r335",
      "r364",
      "r366",
      "r402",
      "r409"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and Liabilities, Lessee [Abstract]"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r18",
      "r19",
      "r46",
      "r83",
      "r141",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r317",
      "r319",
      "r335",
      "r364",
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying value of assets sold [Abstract]"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r251",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r243",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r243",
      "r246",
      "r299",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Purchase price",
        "terseLabel": "Total consideration"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Number of common stock issued in exchange of membership interests (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of outstanding common stock received by members and financial adviser"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Closing price of common stock (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merger Agreement [Abstract]",
        "terseLabel": "Description of Business [Abstract]",
        "verboseLabel": "Acquisitions [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Prepaid expense and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedLabel": "Accounts payable, accrued liabilities and other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r301",
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Net assets acquired, excluding goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r301",
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r35",
      "r366",
      "r427",
      "r428"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "btx_AssetAcquisitionFairValueOfConsiderationPaid",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "negatedLabel": "Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r68",
      "r75",
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r68",
      "r339"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r81",
      "r83",
      "r107",
      "r108",
      "r109",
      "r111",
      "r113",
      "r121",
      "r122",
      "r123",
      "r141",
      "r183",
      "r187",
      "r188",
      "r189",
      "r192",
      "r193",
      "r201",
      "r202",
      "r206",
      "r210",
      "r335",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r227",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Warrants exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Number of common stock (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Number of rights options converted (in shares)",
        "terseLabel": "Warrants to be outstanding (in shares)",
        "verboseLabel": "Warrants exercisable (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Warrants outstanding (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r166",
      "r167",
      "r168",
      "r180",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common Class A [Member]",
        "verboseLabel": "Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Common Class B [Member]",
        "verboseLabel": "Class B [Member]"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation.",
        "label": "Common Class C [Member]",
        "terseLabel": "Common Class C [Member]",
        "verboseLabel": "Class C [Member]"
       }
      }
     },
     "localname": "CommonClassCMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r85",
      "r86",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r27",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding (in shares)",
        "terseLabel": "Number of shares of common stock owned by Brooklyn stockholders immediately before the Merger (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r27",
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.005 par value, 100,000 shares authorized at March 31, 2022 and December 31, 2021; 57,452 and 52,021 issued and outstanding at March 31, 2022 and December 31, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r77",
      "r78",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Number of shares converted to common stock (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r201",
      "r202",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Preferred Stock Converted into Common Stock [Member]"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customers [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DepositAssets": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.",
        "label": "Security deposit",
        "terseLabel": "Security deposits and other assets"
       }
      }
     },
     "localname": "DepositAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r73",
      "r124"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents derivative instrument obligations meeting the definition of a liability which are reported as of the balance sheet date. Derivative instrument obligations are generally measured at fair value, and adjustments to the carrying amount of hedged items reflect changes in their fair value (that is, losses) that are attributable to the risk being hedged and that arise while the hedge is in effect.",
        "label": "Warrant Liabilities [Member]"
       }
      }
     },
     "localname": "DerivativeFinancialInstrumentsLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Warrant liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCK-BASED COMPENSATION [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r162"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r162"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r162"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "negatedLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r162"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred revenue attributable to disposal group held for sale or disposed of.",
        "label": "Deferred revenue"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r162"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "negatedLabel": "Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r162"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "negatedLabel": "Intangible assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r162"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r158",
      "r162"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Other current liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r162"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets",
        "negatedLabel": "Prepaids and other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r162"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "negatedLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r73",
      "r157",
      "r160"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Total loss on sale of assets"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r243",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EARNINGS PER SHARE [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r55",
      "r94",
      "r95",
      "r96",
      "r97",
      "r98",
      "r105",
      "r107",
      "r111",
      "r112",
      "r113",
      "r117",
      "r118",
      "r324",
      "r325",
      "r406",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per common share - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r55",
      "r94",
      "r95",
      "r96",
      "r97",
      "r98",
      "r107",
      "r111",
      "r112",
      "r113",
      "r117",
      "r118",
      "r324",
      "r325",
      "r406",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Net loss per common share - diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Anti-dilutive Securities [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://brooklynitx.com/role/AccruedExpensesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average remaining requisite service period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unamortized stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unamortized stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Stock Options [Member]",
        "terseLabel": "Stock Options [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r50",
      "r51",
      "r52",
      "r85",
      "r86",
      "r87",
      "r91",
      "r99",
      "r101",
      "r120",
      "r142",
      "r217",
      "r225",
      "r278",
      "r279",
      "r280",
      "r290",
      "r291",
      "r323",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r419",
      "r420",
      "r421",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Ownership percentage",
        "terseLabel": "Percentage of total outstanding equity interests"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r57",
      "r58",
      "r73"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Losses on investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r36",
      "r127",
      "r139"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Investment in non-controlling interest",
        "terseLabel": "Investment"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r242",
      "r327",
      "r371",
      "r372",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r332",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE OF FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r195",
      "r234",
      "r235",
      "r240",
      "r242",
      "r327",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r234",
      "r235",
      "r240",
      "r242",
      "r327",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r242",
      "r327",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Changes in Fair Value of Warrant Liabilities [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair value at March 9, 2022 (issuance date)",
        "terseLabel": "Warrants fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r330"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value, end of period",
        "periodStartLabel": "Fair value, beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r242",
      "r371",
      "r372",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetAssetLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosure [Abstract]"
       }
      }
     },
     "localname": "FairValueNetAssetLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r150",
      "r151",
      "r153",
      "r155",
      "r383",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r150",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Loss on sale of NTN assets",
        "negatedLabel": "Loss on sale of NTN assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r145",
      "r147",
      "r366",
      "r401"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopmentDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND IN-PROCESS RESEARCH &amp; DEVELOPMENT"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r73",
      "r146",
      "r148",
      "r149"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Impairment of goodwill"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r53",
      "r126",
      "r128",
      "r131",
      "r132",
      "r134",
      "r400",
      "r404",
      "r407",
      "r415"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r243",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r12",
      "r13",
      "r14",
      "r15",
      "r163",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r161",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r84",
      "r100",
      "r101",
      "r125",
      "r289",
      "r295",
      "r296",
      "r416"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Other receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r67",
      "r69",
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r355",
      "r357"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease expense"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Operating Lease Expense [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Net Operating Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Maturities of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Extended lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r39",
      "r83",
      "r130",
      "r141",
      "r183",
      "r184",
      "r185",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r318",
      "r319",
      "r320",
      "r335",
      "r364",
      "r365"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r83",
      "r141",
      "r335",
      "r366",
      "r403",
      "r411"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r41",
      "r83",
      "r141",
      "r183",
      "r184",
      "r185",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r318",
      "r319",
      "r320",
      "r335",
      "r364",
      "r365",
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.",
        "label": "Change in fair value of warrant liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r326"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities, fair value disclosure"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities transferred upon sale [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r174",
      "r175",
      "r176",
      "r179",
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r169",
      "r172",
      "r177"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss contingency, damages sought, value"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r173",
      "r178",
      "r181"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Estimated contingent loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r16",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Ownership percentage by Citius"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows provided by financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows used in investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r68",
      "r71",
      "r74"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net cash used in operating activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows used in operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r15",
      "r48",
      "r49",
      "r52",
      "r54",
      "r74",
      "r83",
      "r90",
      "r94",
      "r95",
      "r96",
      "r97",
      "r100",
      "r101",
      "r110",
      "r126",
      "r128",
      "r131",
      "r132",
      "r134",
      "r141",
      "r183",
      "r184",
      "r185",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r325",
      "r335",
      "r405",
      "r413"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r1",
      "r88",
      "r89",
      "r92",
      "r93",
      "r102",
      "r103",
      "r104",
      "r137",
      "r138",
      "r143",
      "r144",
      "r229",
      "r230",
      "r231",
      "r232",
      "r281",
      "r292",
      "r293",
      "r294",
      "r322",
      "r336",
      "r337",
      "r338",
      "r359",
      "r384",
      "r385",
      "r386",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "RECENT ACCOUNTING PRONOUNCEMENTS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/RecentAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashMergerRelatedCosts": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger.",
        "label": "Noncash Merger Related Costs",
        "terseLabel": "Transaction costs - shares to Financial Advisor",
        "verboseLabel": "Transaction costs"
       }
      }
     },
     "localname": "NoncashMergerRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonrecurringAdjustmentAxis": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Axis]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonrecurringAdjustmentDomain": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Domain]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r126",
      "r128",
      "r131",
      "r132",
      "r134"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r350",
      "r357"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Operating Lease Liabilities [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r348"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Total operating lease liabilities",
        "periodEndLabel": "Operating lease liabilities, Ending",
        "periodStartLabel": "Operating lease liabilities, Beginning"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails",
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r348"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "periodEndLabel": "Current portion",
        "terseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r348"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Less non-current portion",
        "terseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r347"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Right-of-use assets - operating leases",
        "periodEndLabel": "Operating lease ROU assets, Ending",
        "periodStartLabel": "Operating lease ROU assets, Beginning"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "negatedLabel": "Amortization of operating lease ROU assets",
        "terseLabel": "Amortization of right-to-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r354",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r353",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r17",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses [Abstract]",
        "terseLabel": "Other expenses, net:"
       }
      }
     },
     "localname": "OtherExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r20",
      "r21",
      "r40",
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other receivable"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PartnersCapitalAccountAcquisitions": {
     "auth_ref": [
      "r224",
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in the different classes of partners' capital accounts during the year due to acquisitions. Partners include general, limited and preferred partners.",
        "label": "Partners' Capital Account, Acquisitions",
        "terseLabel": "Issuance of common stock to Brooklyn members"
       }
      }
     },
     "localname": "PartnersCapitalAccountAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PartnersCapitalAccountUnitsAcquisitions": {
     "auth_ref": [
      "r225",
      "r307",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in the number of units for each class of partners' capital accounts during the year due to acquisitions.  Partners include general, limited and preferred partners.",
        "label": "Partners' Capital Account, Units, Acquisitions",
        "terseLabel": "Issuance of common stock to Brooklyn members (in shares)"
       }
      }
     },
     "localname": "PartnersCapitalAccountUnitsAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCRUED EXPENSES [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForPostemploymentBenefits": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflows for payments of postemployment benefits (such as severance pay and health insurance benefits) recognized during the period. Postemployment benefits are benefits paid to employees after employment but before retirement.",
        "label": "Payments for Postemployment Benefits",
        "terseLabel": "Severance benefit"
       }
      }
     },
     "localname": "PaymentsForPostemploymentBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Less amount of cash paid for NoveCite investment"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherProductiveAssets": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.",
        "label": "Payments to Acquire Other Productive Assets",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r64",
      "r309",
      "r310",
      "r311"
     ],
     "calculation": {
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": 0.0,
       "parentTag": "btx_AssetAcquisitionFairValueOfConsiderationPaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Cash paid"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "auth_ref": [
      "r81",
      "r206"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
        "label": "Preferred stock, liquidation preference"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r26",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r26",
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, $0.005 par value, 1,000 shares authorized, 156 designated and outstanding of Series A convertible preferred stock at March 31, 2022 and December 31, 2021, $156 liquidation preference"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r18",
      "r33",
      "r34"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from the sale of NTN assets, net of cash disposed"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "verboseLabel": "Proceeds from issuance of common stock and warrants in connection with private offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Net proceeds"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the issuance of equity classified as other.",
        "label": "Proceeds from Other Equity",
        "terseLabel": "Proceeds from sale of members' equity"
       }
      }
     },
     "localname": "ProceedsFromOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfAssetsInvestingActivities": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions that are classified as investing activities in which assets, which may include one or more investments, are sold to third-party buyers. This element can be used by entities to aggregate proceeds from all asset sales that are classified as investing activities.",
        "label": "Proceeds from Sales of Assets, Investing Activities",
        "verboseLabel": "Purchase of NTN, net of cash acquired"
       }
      }
     },
     "localname": "ProceedsFromSalesOfAssetsInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Proceeds from Sales of Business, Affiliate and Productive Assets",
        "terseLabel": "Sale of rights, title and interest in and to the assets relating to the business"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r23",
      "r24",
      "r159",
      "r366",
      "r408",
      "r412"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r241",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r241",
      "r360",
      "r363",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r288",
      "r381",
      "r447"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Common Shares [Member]"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "RSU [Member]",
        "terseLabel": "Restricted Common Units [Member]",
        "verboseLabel": "RSUs [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r29",
      "r225",
      "r282",
      "r366",
      "r410",
      "r422",
      "r426"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r85",
      "r86",
      "r87",
      "r91",
      "r99",
      "r101",
      "r142",
      "r278",
      "r279",
      "r280",
      "r290",
      "r291",
      "r323",
      "r419",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Computation of Diluted Net Loss per Common Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r299",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative liabilities at fair value.",
        "label": "Changes in Warrant Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r12",
      "r13",
      "r14",
      "r15",
      "r163",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposition Details"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Tangible and Intangible Assets Acquired and Liabilities Assumed, Based on Estimated Fair Values"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r251",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r255",
      "r264",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Summarizes of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Weighted-Average Assumptions Used for Grants Issued"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Summarizes of RSU Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r43",
      "r81",
      "r121",
      "r122",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r210",
      "r215",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]",
        "terseLabel": "Stock-based Compensation [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Restricted stock units vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Unvested restricted common stock forfeited (in shares)",
        "negatedLabel": "Cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Cancelled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Unvested restricted stock outstanding (in shares)",
        "periodEndLabel": "Outstanding, Ending balance (in shares)",
        "periodStartLabel": "Outstanding, Beginning balance (in shares)",
        "terseLabel": "Number of stock units awards outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Outstanding Restricted Stock Units [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted Average Fair Value Per Share, Ending balance (in dollars per share)",
        "periodStartLabel": "Weighted Average Fair Value Per Share, Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Weighted Average Fair Value Per Share [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Released (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Released (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assertions Used in Determining Fair Value of Stock Options Granted [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Weighted average volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Weighted average risk-free rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Number of stock option awards granted (in shares)",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Outstanding, ending balance",
        "periodStartLabel": "Outstanding, beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r257",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Stock option outstanding (in shares)",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "periodStartLabel": "Outstanding, beginning balance (in shares)",
        "verboseLabel": "Number of stock option awards outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Number of Option Share [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price per Share [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Vested and Exercisable [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Options vested and exercisable, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Options vested and exercisable, Outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Options vested and exercisable, Weighted average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r249",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancelled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Vesting on one-year Anniversary [Member]"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEndOfPeriodAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share price (in dollars per share)",
        "terseLabel": "Stock price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/GoodwillAndInprocessResearchDevelopmentDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Stock-based compensation vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Warrant expiration term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r270",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForGrantsIssuedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Granted"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Options exercisable period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted-average remaining contractual life, outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Options vested and exercisable, weighted average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "terseLabel": "Number of shares issued in merger agreement (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r81",
      "r83",
      "r107",
      "r108",
      "r109",
      "r111",
      "r113",
      "r121",
      "r122",
      "r123",
      "r141",
      "r183",
      "r187",
      "r188",
      "r189",
      "r192",
      "r193",
      "r201",
      "r202",
      "r206",
      "r210",
      "r217",
      "r335",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r44",
      "r50",
      "r51",
      "r52",
      "r85",
      "r86",
      "r87",
      "r91",
      "r99",
      "r101",
      "r120",
      "r142",
      "r217",
      "r225",
      "r278",
      "r279",
      "r280",
      "r290",
      "r291",
      "r323",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r419",
      "r420",
      "r421",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r85",
      "r86",
      "r87",
      "r120",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r77",
      "r78",
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Issuance of common stock for business combination"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r26",
      "r27",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Acquisition of common stock (in shares)",
        "verboseLabel": "Issuance of common stock to Financial Advisor upon consummation of merger (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Number of common stock issued as compensation for services (in shares)",
        "terseLabel": "Lock-up agreements shares received in acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r217",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Restricted stock replaced during the period (in shares)",
        "terseLabel": "Issuance of common stock from vested restricted stock units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockAndStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split.",
        "label": "Stock outstanding, reverse stock splits (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesReverseStockSplits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityReverseStocksplitDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r26",
      "r27",
      "r217",
      "r225",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "verboseLabel": "Stock option exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r44",
      "r217",
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of common stock to Financial Advisor upon consummation of merger",
        "verboseLabel": "Acquisition agreement"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r26",
      "r27",
      "r217",
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Fair value of shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r26",
      "r27",
      "r217",
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Issuance of common stock from vested restricted stock units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Gross proceeds received",
        "terseLabel": "Aggregate gross purchase price"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Private placement (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r27",
      "r30",
      "r31",
      "r83",
      "r136",
      "r141",
      "r335",
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCKHOLDERS' EQUITY [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r82",
      "r202",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r225",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stock conversion ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityReverseStocksplitDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r352",
      "r357"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r346",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r346",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r346",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r346",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENT [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r367",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENT"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r351",
      "r357"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable lease expense"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants outstanding weighted average contractual life"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r106",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted average shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r105",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted average shares outstanding - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.F)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=66006417&loc=d3e8580-128490"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=66023778&loc=d3e9298-128500"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=66023778&loc=d3e9334-128500"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=66023778&loc=d3e9337-128500"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL7498348-110258"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r448": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r449": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r451": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r452": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r453": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r454": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>89
<FILENAME>0001140361-22-024669-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-024669-xbrl.zip
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MBNLNSRY/RX^3M+QJ[_TE^:?WN='HZ!G@\.CV-I6W6C&.64]3!DM/V&,505!
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M!XW&<]2>#0JM4#HKM)4+K54F@:,)$G:$4R8F2-A\@H1M3I#@&2R7]FSQ\?'
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M8="HJF _O4[ SHS.V9NK-]=OG$'*>>I, M0Y3]XL-E(OLX<;SJ?-)BP[2ZV
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ML\$H%V(0^L ' 7<Q=T/*O" @0<A= "3&3?B !$@[#90VC44M$<P8AVW^YX=
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M^N]0>(@J#RAS$-LJ,RHZ;F=T+XO"<H;EC YP!D2>9@W?5R$%&+@!DQ(%/J>
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M,0FEJY@@=<7@FA/0!TM EH Z,IZ6@+I)0#" BBI,-/\$6/"0>5#Y (0^"@$
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M3G+0U%9"(8"28ZS)+@S"D$#@01Q(S&!;Q[AT+//:DIPEN2UIO"6YEY.<PH'
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M4Q19SA0BPBLFS=JC:-8L,2C*W3M^>@CL$>9TCR&F&4U>C'%^3$FM"<L. LL
M1LHBPX!WF"CN-/0H0!DW)63)Q66?"9;V&99:4]= (OGV=/R([G=M6.%[U54]
M$ZY4@^P7E9N;#,.C+,K)?FB+A5O0-IT1%IS9_E!WW9S26*HV:!MR^>;='[>]
MUQM15VVDW!(SJVZ"H+F\J(SFFA+3VGH.8\]K+XFC3D)'M06.>Z:E0(T&>2K(
MV)HJ7  D>Q,*2("X ;%.@+@#0(1(&:V4)MHAHJ20&A#$K6.*$V=%8^0S%8DD
M0$R F "QO91; Q"E$-IH887#EF"@%4#<<\,04$!2:]<"Q%2XD@ Q 6("Q'T"
M1 JQ]%QQBJT++K,5DB"BJ?5$&T:@61404S%-PL-7A(>M.XC:0YB*_;.*B^&@
M&*A>Y*9Z8 ]ZYCTV/#BT1 N@H3+(.$RAPPKYQ6;;*NG_<*76690?$8KV WZ6
MZYVU+&>U%9PV^I2'!UW)E&L3Y=8PY0PWB$.,F)*:.,,4!0Q:&BPYB8AH3K5^
MJ1JI.9!$@N\'0B8#[4!0+AEH6S70G*82(&:1DIA0""4U!E"BE'9.8MTX(6-W
MQ1VK67:0LOT K636);,NF76MHMP:9IVBF'.F,7;$$HZ-4IQ+"YE'DA*"&T>Y
MM[YN;AY:]P-8DS68P#&!X\8IMP8X @*X=Q9(I@BQT$FGK C&**=*.J 6)[CL
M:$81XT<0@(1ZZS]&0KV$>GN)>@L*=9Z$/>N-X#16Z$A+& HV(1!00BB0L=(+
MOAKLO4"](:3@"/!7%?S;!N_L2=UA0M@-['5"V!W8E9A["C2$UC- ( N@&O]?
M0^4-L@ V3H_;U.PE?H1A<HCK#[&+RL2651I.J=1"X-\]D+?@@&?W1&BKY[5[
MRB3V2.R1V".Q1V*/Q!Z)/1)[)/9([)'8([%'8H_$'HD]$GLD]DCLD=@CL4?;
M#R4.J#/BOZO>4.7W6=4:$;;R7*/E9]=K\<+A'$2_,!G62>7&B$"NJ63"$<N\
M@I)9+R2PAFCK&BKT $2M[4\X7].'C\*"]^/<>@^S%Q,4)2C:(!0Q[J@P&&FJ
M(7'0::"-P0&0L,5,DX:"O6= T8MW!IQ/H3DB^Y)<G9 H(='K1B*M@7!84R"L
M(D)+29A11DCE,'94HK60Z,5;\CU (I"0*"%10J)]0"+I NP8S[F5F"# !124
M&^B0MT)CWC #93DDVDDOO'D@DB+!4(*A[2WN(-#AB0XGQ%NGK;;2(TL8P0(X
M:A2#@G&%E<0+P6&++>CVKN]E$O)D:QP^FCQE:W /J/;.,^<!,=1+!C$S0 C(
ML6%T.W!RJ&UT$YPDFZ&--@,(QH+DD@$.#2&<2&XD$41K+PE@8(701@NZHB5T
M2.B0C(W6P="3ASU: JX<C^7,Q'*DN9 Z0!"%S,9H1[MP*%DI"8<2#ATB#O%@
M#P5_QPO!*4$$*\\\(EYX##C0JJ%MS3).S^:[=25H2="2H.7ER;!.2ZP *,P)
M[A1D@GC$I2-$4H<YMI@@T3 B9!EL>8F66.((DCWI]Y*:7R5 2X#V(K:2 !1+
MAIWT%!. B(">,HV]DLXIB]0C>+:)LV)^Q*@\4$!J95E'JVLW>I%1NK%Z(^_W
M?^O>]RJY*K*^#XY\5(K9[21MH>2^HIT W?Q4.X?F[2]KQ<*LS0/B(\_:C))Z
M\'N%D&=%,73VPS#RVF7@N+[]+]4=NB\E%UZ,F'":.5-FV]0-0TZ]U8 A[V!
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M(L")UBK8>S3 O*%88^$430GHK9>=UIJ,;8&#A&6O \N44,!A%[9':1+@2U
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M9^_S?O^W[GTONZT2=MII@[84OEL*S#M'WV%Q_%6INY\N53[H!:8:.9TGQ@1
M&-1+8NO ZH.5)YFS &"B*=)6&"T]T00:K3;6:#M52*5R^80,>X4,T!#-K%.0
M&$\"%FB*J=&(*, = &D^1T*&A RO$QD(A9P;9+5"E!#*!1->ZMALSR'M,4G5
M.PD9$C*\1F3 &FBD!?',"6(E%]!339@5WBJ+U5H]-U,M3 *&7=,P <,B8"CE
M\Q%TL(Y#JXWU5@:(H%XB163LM<>"/V$E:$=UR=P!.Q9'$J79'$GLD]@_WQY@
M#B,*B**(4:*EDQ!SPW6P"[AFB+>D:F,^I4;2).Y)W).XKZ;ED=*<.TRL\8!P
M8 13CAK"XW@."OE:)PHM*(=(OD!"B802ZQ@%0' "N9><H8 )B@HF(6(88LNT
MP<RW%2!2L" !1 *(9^;PKX005CODG;$LGCYJ'5[&[OP>01(G=*CG#/C==7K^
MOO@2*0L_H<T>H<T&P88"XSE$@++@I2@GA2+"(FV$TTR'ERGS/9D62=@/1-B]
M#Q:% HX0Y(G#1&)OL(:4<R8-MXN;]26YW8<,\;V?^_%4\OBG3B]\U%'=[,1^
MZQ3]/!L&?1,9MQC>WI;3/^)EMR[_ZO)VVE5MJ<!)Y4-M*A\:(_JRDYWJ06?I
M*+<<66,$B46,1FKC#,12>2T)3&GLK1>.UMJ%;9'W!%8' E9<>VX =PX)0;C1
MP@FL)/46.T X>DX>3,JL3V#52GE/8'4@8"6IQ)1!JR"2A%,D/2>$< X=,0+[
M-*JC_<*1P*I=^Y' :EM@!270'AJK(:&$>:HA$$@ 3S1C0NOGQ/)3_4'"JC:*
M>\*J/<*JJK7T8V64+'A^AA,O#"88>\4DD%P2!I7V#C\G4?+ERB'@$6![,KP\
M@5 "H01"3QM,!C("-4+0!9/)(B%@</:\4<Q!I:Q^SH#LERO0V).4JH0_"7\2
M_BPP@A"@6GF$F6*6< P%UX(*92F $&GUG(ECJ5HD@5:;Y3Z!UAZ!UE-&$W%6
M&X*< \R3LIZ5&(EB2)QQY^ESNL>G I:$66T6^X19AX)9<189XQ938&+UG7",
MD; ;C'OO)3?M**EYRND[X@PD/$IXE/#H$/#("1E0A5HD,2):$>FXLO&0SE$C
MN5H;CUYSU4W"GX0_"7\6V$-62HBU,\8R@@U3W *FM51*:XK$XB8$F[)I4C"[
M175#^U$<5++[L5:%L[$XZ,[UBK+JIYVU/BT%Y;;"[2KX=V+_=U@,HBU47/<?
M\<3**'S),Z<UEOGB*G1T5R[_UC&N LXOSO2_]LJ[E!A:[^BF/'? "8&#_TB]
M4(@ZAXV&4#$H_5JQK_86VK2*2UMKI"5)/R1)]Q!+@8$'A%C".=) $(RLP08"
MX=CB4NF]K%)I%9<F24^2_@*2C@$TE"K.%0F^D'52.@"<) J%]PA<JR%;>TL\
M6L6E2=*3I+^ I#NKA=-!9B441!L@.?(>4 68#*_]!F8ZM; ^HE5,F@3]D 7]
MN&642MQVR-S6&K4"'8=,8*@5M<0Z):BW5%$6M(L4:/U^G9O)(D]:(LEM*^0V
M:8G$;:]02PC/A!/6>@0D\4**."$" 6ZAD(ZM%V9H?=ILJY@U"7P2^!<0>".H
MUC@V51:6>"5E^"_'BH!@&7*GGM.4;S<YIP3*),I)E),H_UU8ICBP&AJ-"6%>
M4J<I0$A""#VC:WMX+Y:NV2K&2\*;A/<E3O*9@0A; Y211++PKZ"!L5=*>6>Y
M65QCFW1IZS(5LSL5>*;W];BZ[J<,W?V^_VW/S]T@Z_:+HIV9C$N2?)\RT_NY
M=7G]@;*BW^W8\AG 41;__\?V/..*">P;?,C6I+P'23GKF?ZM^QS$I8[UTD'G
MC<- (F*I%(QP'#!;<<@L9NPP\S-;F#"_8;!HK:F80#&!8NM!T5)-B/& $T,,
M9Y**X+MZ##C4"CXK$+5'J:P)%!,H)E!,H/@(*!H-G1/6"4D-H9!KZ"5VV@+H
MM(?D0+-^$R@F4$R@F$#Q$5#D4!G&,*+QW%)C+#W#UFJOA -&D@V4-[8P03IA
M8L+$A(FO !./6RGKR['"DB3?*^G?^I,G/$AXL'D;"7E,F0'8*$:(9,HR(Z0"
MG#)&E7O.$</.LOU;"(/)Y&F!^">(.S"(2R9/NZ0_F3P)#_;/Y&$&"RNE%<+C
M8/%0Y1G5 'G+E:.6KI55T?K2E1;B9[*56H ;"1L3-L;DBM@BC!*NJ SN(+$"
M.@V$P](8;A!_3I^P%ZKR27"7X"[!73OA[I&'_&$U;(+<8J4 E58:HH26F@%(
MA:=,>\W7QZ8URY:*<C^.GQZX*HXH0FTJG7@9-/HQ 5$"HM=A=ZT(;JC,2)"*
M*^N(T%S$CO:4.:^ M6B)7(67P:G]M:?&M5./(-2+\<>/SR9B:ZK22*!LJTO/
M=+]KPPK?JZ[JF7"E&F2_J-S<9!@&( B"LA^E:!6=VZ9EPJHRVQ_JKIM%X&W(
MSIMW?]SV5FU$*;TL39:8FW(3),#E167?UKL"!Q/9 @&$-)PH+94PR"G#' 4&
MD:@N'JJ75#^V-1T5)7QO'/<$1PF.-@Q'(F".Y41P'5L76R^T=193QX$F6+/&
M<H54N97@*,%1@J,MP!%UGE(LA%;$$<R@%I [@CA#0#B &B.+J68JP5&"HP1'
M6X CS@'' GMA>;"1%!<>(:$ ,%Y:BV5C?[94K930: _1J'7'#*T"B=@QKK@8
M#HJ!ZL5MKH^\)1YH(S27V!-G8ONW@ +(.&Z%!E NQ(A5LO7ABLWBCBA@^R'\
M2W)#:_%@)X*7#)97@$5/&2R20B8H9Q0J2HB$0D&+!&'*.N I:<RH?:G2H3DP
M"A[=?B!1,D.2&=(2T7_"#!$J"+US3%.N"'!*$Z(4E)HQPKT'Y/FNRC8SZ%>S
M7R!-QDLR7I+QLL<(]N31N/'020^]]9@@200QU'$&C>%>XE6"ORTH IJ'L/T
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M])/J?E?WQ2,4F@>[GV_R\8TJLE<X"4I9&LD: %,P';T'_I+=C&A1EK*-Z]=
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M_ET>:JB*Z6SK\&O7(+5S)-H2W.1]XYPM/N7]VZL@Y,5XGNW9.,#0&#P3' L
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M_50.VJC"D-&':A^\[J<JW[GT[2?9V@GE^TG+Q((';(1O\OAJ1DM 4:J)L][
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M%-(6-B/.<@/\'D_?> X>K#W<;XQ1-<B?[.R?9[:VCB7A@Q&YRNV;[LIBDJU
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M^_N5N7%VV'47OOE7'[[KW'E8[<GOG>+OD1"G0:C/SD]_*<VAV0H@4J\ FA8
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M4Q3S1R97'R?IXG$A_S[LN0R#\E?0S!>KU<TF1LU8*X_07JMN:6T4-\X-8JI
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MR8:K/T;7J;RTYF_^DMVJ_&NG=SSHWXW7-WIG;-&7;P;Z16#ZMS<?KBX_70:
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M@$2F-!U.*'5XZ-D.-[W0$T%H,[&B-L^KT9;FT -\* #X/#[GSGI3U](RF'A
M@?JO40(O'K3H,[NOIR^\/PYY#N^K/I=:UJ)^J27]$PIZ]>2T@UD#MB7MD%'F
MF('PB"THL3ASA&6N.#G]:E3TF3<HZ<&Y[:MS^[%(XL"=[D%3_U"^WN#O]M[?
M+<3S9K)"N1)&P?^5-HU,GXI0AB:C4@2>23Q"Z(HC#J]&N;I#-YT>N[^O=OMU
MZ",Z-,?LBS=[$J0:^H@.SE/?$?\PV8%7+$V?,(<9R#%7F>=Y/CSFU!\^4?#T
ME<=K<R@&IVIH575ZIOJI@?5V19,[Q,.N5A4;&:"[8^7J0:Y_5$H=L9I\UR91
M.X3AVHLN54)OCFV'D@M?!F%$[=!GU'59%)B1,$V+LA4%EDX[X&;1(>!VJ(K^
M1VH%]</:!%U25#B'55*GE;%<#A[%&_3\JW=/!A?MT/M>A].ZA41^3F8RP]Z,
MN-_UM93.>F-&TX]LQV6>S8A%/3M@GAL&IDEEX$>A[_BO40-[RP7"!@V\I1\]
MZ-;>^=M?4CEEL<B4SYW,[F5J8!-4+)NJ Z>#/AZ\R<'O_H'\[AP10!'?(!PL
M%=JQJ6D[=F!*DSG4";R N@$/N,TE]4-N1Z]1Z5MD\+L'O[NGMD$GK8\EP&9/
M2NMCD'V*(GEF3.1LT/>OWO<<_._^^M^%9'X![8AZ\;H0SFIG 1Y9DKH1-5U*
MB>V% ;.#B+I2^,21WJMTNZTS<XA]#Y[W*_*\;Y-H]HC%#85\D*-$"3E,/QM<
M[L&1'%SNTW6Y=SQM4L# ^P4*7"$(5/6]XS)I.R'Q*:.F]'U;^!9'/YRYH1V]
M2H\[(-Z@[0>/NY\V09>\MGD&<Y'IH-Q?OV\Y^-?]]:\_3F9L<A>'H^4*\I%C
MF1$/?=-A6/:/^"[Q[4B$9A 0$7DKU>R'&+2=_(3=GII/?_?T&_M7DJHF94I7
M%C#P595:!PUZ'T]SK7G2ZMJAPTG0P3E_/<[YMY0)W1-CT->#BSDXXZ?JC!_6
M0B"A<+EM"<=W+"JX%;H!=XD;^)Y%><3%(2P$A3R?L;?.*S +2! ,9L'@Q??3
M>.A@%OPU2<1C/!H-1L&K=V ')[Z_3GPAAE:U;'_D<"<,>"AD0$-I,4K\R+=!
M8P<6D=&J_F\GK5[],\<?%.S@=[\>OUNEG Z9YX,_.7C>/Y[GW9YO[MD1]5T9
M^2Z3-/!-/R0VL4V'AB;W?+&J?/%)*W:8P:#6?Q2_^93+- ZU& _C K[:RGBO
MF1[/66;K) @RE-PZ/9]+#Z=11?%3I2N\'I-,4RF,^13LN^.T7#Y]Z/\Q78[!
M.>N%<_:Z2/7LWL"@;@Y9S6G*GK!8C#I=RCA/P6LVY!]3.<GD$-5[_=M&P];9
M\_0UV:.\TQ<MH1@(T_)9L?@JL3<:!%Y$@H"8C%#7EJ'T R+<R'&EH(SP5QE[
MLX;8V^"V]=UM>_/V)H2/6AB ZX5,C2B>H)C!!6Q0M(/?,7AHO?+0=E+M.QXB
MK6#![P@%'S02?%) 4.W6[8=$R- 1A 241XYONDQ$C$:^;S,2V*]2GP\'20?G
MN?_.LY)58Y2;X4^#]G[U+N+@)O>R_:<2Q,(=?JH6/A26S00-[<#WJ.\$H71<
M6]BNR4PA',I>H_(D[J \!U^X][[P>YEO4*;R08)L#-IS\.@&W_=$?=\.8>U"
M_K]J\:]&L%W3\V3@"XN%%)2U[_@^\3S']DWN"?=51K"=H47!X/'VW^.]J74;
M&"TVH ;M_>K]OL'W[>T6L1++*RV5[;O"S/9I0'S+MKE)I<]]%CG"MQS"/>D*
M\W6>R*##0<L>>\*G?(;BJ/[&ZSUI\9)DZP>->N?<G@35^I>&>Q)D&WRL%U<4
MW>K83;+<(AQJR_\8?L7@6SU3Y9H=-Q8KLMBL\&XQ1BPI33OT34H#-[0%=[CD
MKF21'3K>"H]JEIR.;Y4IQCG?L-LX1"Y?036;U^^,&5,F4%+.]3Q^,<CTC\%#
MZVC^/1\M^T&X(UK289(*F58I:63)*!;U*;]FXA[1NQNH>TS6;4.!P3/<5FLU
MJ4<5AN[H+NJW-TH!?$MF;&2 R9@9^=E_(XF&"FTKN;U])5Z7=]4-!NKH"70Q
M1#+'8\(-^%S/M6T\^A^OVTGHJ-..1^]=2KY]3F;M-5Q9//D$J'(S*2ZO^,..
MR:A#12B<T*2>),PCGO <WW<"*H2Y*FOGM?G#P9D3#'U5.H+N3F[R.F[?TX->
M_/W__C_P(QZ[?HM_P:KF7,7R96U^4[VS?&OC(B4SWX!F_S3-T'%#:3O,-VE@
MBM!CD6"<!SP*>&@1XFBI46Q\.=OV+A=)5B51+]CDS=N_A*GQ7Q42%8NTCHQ[
M$,_M1#RO23P!"#-B3[_4)E$.?:UQ=GBZQV#9Q3RG<#P1$LENN^5EVR[%)?_W
M/,X4H!YY%;Q.J^ /+*S)T(5XP4%8^%_S;!9'3ZV\UI/5N)D8?Y^/G@S+!9<4
MS(@SXUV:)-]'3Q-5QZ;\4.%VXW8>GAE@)UQ4 1^F)O$L0CR9)<;L7M;NN+Q+
MI;)(+HQOC9_0#H';E&4SGB8P0)G,,QC18SR[5P^2?T@^5]?BB(0<Q: ;G] ?
M6_.:RYGZ%9\.*O*7(S-9T(7);/,U26C36.A.3:!+%VI:BIK*TC"X'*&AQV'I
M_\\;?!Q\SJTE_1D;#_V?-^]OOWSX%&>S;WC3FYHUM O!"Y/,-/_<9LGEJ_HG
M4_UOR1AKLU[;XC95NS8?:?%B?SI;[VUON'?)V)PET]X@U/)<-N[__^>??+!=
M?FVW8%<X#:M)Q.:SY/60J-!);]XN@!XA%+&;C48%K";S638#O 6),23\/'M"
M9 >$SV897O,Y>0"9FF=:$1@L4W?!S_/1K'C&6*9W,L5/Z]6(AGH$=Z4\ZH\^
M U*,1LDC#@1\&WY_MG0!R]H(8*@Q@(_[$#_@S3Q)4;W@J\^,4')PWLMQ(<-8
MWJ\9O %>!KKE<0+DR.9A%HN8@;+!P16O-3[-Q,7*)X"6!UKR6<M3?L7'[,24
M:T*[B[_7N5<'0F2K$R*3$]%OVVFXO0A(.A'0'E3:H-(&E;:)1.M4VOJ8[;72
M;+_)V7TB/DX>0+FA]W #N)UBC^HO,N7PF=U5SU:RB##BNZ8D/IX#<9@G FH3
MCPLFO,#UVZ*TGN7^\Y;?2S$?R9NH_:W+WTK5$5-'7$'W7,4S^?'S55O$E58C
MKHN ZSE9GWCD7)A+<=8_%]I[IK; MK$#<& 7)ZG7[$ZP3 N]]M;X"X:3>Z_>
MD-@XT+=;>7+Y-8=PC(%470CL_"C1E\L,R0/F8;Z]@M+:C&I4(C)3%@OC/]9#
MVA?VA&B2?4LN-0:JDVU?TD3,X?*'Y?:^KBL#-Q"A&Q*74A[ZGN^'W!>.:]NA
M)5NS, '/\ETG1#;UR,J(2\1":_D;O)U-Y1PT3?8I'@-4B,U[1DX)8>YZ!",7
MRP?4#%C D6+3B<%9=E\-&Z&3,YVFR1]P_TR"C;Z>F+>SA'__F&7 O>_G*6 @
M:(0X$;?W# "P,N,:/6W)>61+AP'[^XX3A$2&H>-QDXJ0R=9=O,/3TZK2TRS)
M::XEIW=F$G(&%MT23:MHDJG9(_CS9#S&] BDTIGVSO*BG$J!R'2<K0W3P3VP
M)+A+A[6RV<Q@A=:)-K'YBI7Y!SYJQ<+0T'0BXKBF*01EG#'/]:S(MR,)?TGA
M])G1+9.TZ.J2TT.&,505(3484E=4%TSUKYBF,9=K"(MIW<WY*3[_@C=6R!A:
MMF/YW"6.%U(LB&PY+,(Z$P[U ]L.5MD_AR">724>W9*K+7KA$&>YO+$Q!495
MS%R&BP6  M(H!L;"G?,S]6W$XE0S:<'-N0@H[JWCR1YL"ZI&_5+E69,%0> Y
M#O9TI2[COB2$2Y];@1?YCM?:>[TO/.OX%\MUM J6O3AN1-[NM.UK#]N^.1FZ
M$.\PV[XG8+4UM[!*?::HQF*,^G&8!@P@?:H"<2JG !OH42K=!.J/I?!TU7 (
MC10.#CG<CC%$.9[$$3CGZ@4 , _P,K@%D&H+\P6Q_#KC:?*H+96J=4)]&H)9
M9_(0H#N*0L>T+9]:P@-W-N#/!"C=K!-JM=HF#5".%;IB1+IN6B-85Q<#6).K
M_4I#*E(IVYNA4@! QF?.IV"-%!3^/!_##WR)P!J_JU:&[S$:119 M 5_6R'W
M;!:"E%!3N**M<2<Q+=-2!":F;5L="?S/KVQRIX,%OS'@C_FX('R%I.>9Y+^(
M>0I6V^P>-",IB)E/#^ 9?\$HMJ$2Z9 "<,\<]%R3*9-*)7:XJG12%@9@90Y5
MPJ_9#%Y($G!&4HA35@H&C/0<C,ZIG,7EAC!^APGI/)XUI<68SE-4Y#,<H#9/
M%T'\3U>YJ01/4!?(R1V[D\IKR%]7ONH!U#QZ3[HW6)-15K)(=1&+F7W&<W#E
M8Y?8Q_<<ET2$<?#)5#)@9-FA1VC$P"LSHY;HTF'8IY5-'H$' *[>O(V0 D^2
MI=D2PRQV9RK[[6= Q3R-<(&$N#LT@WLTRZ1R!,N%MP'EQ]-1\B0EP-OGRJ?J
M/I/>= '"-S:>P*Q-%)?"VVM,5DTQ*'097@2FG'Z!=D#@9F7%)>@E/\:9S-E
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M<5'#NX GJ<%H:) @:,H/TH9=CE+Z56JV:!#J];[#C]@I]\Q@H ? 5(-+45G
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M&HY**=WXVYDR:^!ZU:@483>K0DR3GS7\HKU:-N;4B*,E_#N XUE%SBM((BX
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MOMNRS_0^DQ[!NR?C!@-B ,X8[$>)5D.TS,IE12P?!PJ6C6KFOI)<LV29'OG
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M;J1;!R7I.\.3]$^.X&$<0>?"@3](FPUGM5 QKC;;9ZLM=YUW8*3A$28C5$@
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MZ3?=2;OV)NW%@""&@_P[/?,*@,+*OHYUU9X>14\.\SWLQSN%^HL:2.5W #V
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MCZ\)?AYR)^&4VW;BL3!*@C@*[3B.7,8DDR;PR$$I2CC&[?6S<N>/,'_ E2U
MXU5K</$R!-B@'%N7SD*K;5&UQK"/OV_QX$.ZX<LQ*-?*W3#7JBOG# @11])S
MMNR:MV;'V0W68U"NE#L\5^HH#FM6UWZK'Y-OL :#\@'<#?,!CO(<<<. S%4V
M&O$H4W$*:VXKK:&!-EC,04=Y[HOH(7PT&VK0T9<[_.CKF6VHZR1!E,$OLJP\
MH6>J^N0,&VC.,K&$"C95_6=;Z65O.U&C$@,>[.%T!/JT#0BOKL!'Z:N*QC?-
M .6GMS>-9Q6]_;0X$K;<Y3B%1S"3QS)O/:LI!V:M<9N F[R>9]IL]]5ZRFWC
MBCGXS@MKQ3/WDP.Z%8 :XV*H.BM>%+#Q="2XW3V@70I% J  ^(-FE%4%>5,4
M4N?"PD:XF$7WFZP_@^B<87$:QU;#;]9YCD5=5U'&3%OJ:@8PT[\3K*]8<S/;
MH;JVPM"QMP&]HYLK8',@W;RWBMN6;K?0\?GN<"ZLRZ(S[2(5%4(-G@NH@PAT
MT-5)Q (RS,U41:7+U\-&K)HFRW]C?SIXUHJ>N+[MDW[.-=Y\FY7N>?$.YO09
M'.&;Y,VT .XJFKG*H>-&=NA0*<*(@;<>.2(A/'2(1P0-W?EV922P/4HQ5UG_
M]*_;IT=X]&6>8\XRSE*YZ<U)EJ.KR; ]U]TS>^ZETU[4R]E</8QQEVR-S;U5
M:==]W9$#>104D17)NW0\3JL"';PB2?-BTKZ]JDS241?@PAR_^C%]K6-$7^4H
M02D]UCVYL=ZQW .F9V$7Q+2\=;Z?\XC##:B3=,V1[BNMRH:J4Z]T\E0_;*4P
M_09&Q: D!7<XMEX7?7'7IL-RZVU9F<\*Y-\/G.@S!A'U%H"(;A$Z]%@!0S>$
M"3T\..@V\MZ?S\YOS7*X:!V4<^,>,.=FOSZSM48D_EBJ2+>34ST7P]&F297!
M@=>"-8 F0K/FRWH__H)9 GE1"]-U*E W8.1!!_?><,"RHUBF=1AY3F+N>DF\
M00?8WH:8.<\G%C34W-'VV,\W8]7-3S7S(_1L?BNV\]5J9\\<<<&[J[UKB-^>
M BY["KB40:Y2;+[N'B:V9'!:R5J8;J:B<6F</NKXX1C!2-,Q'\?J)']VRJU!
M*18O=V]P9QNQG8^-6.!DZ5#F:FOG7Q8!X7&[S*'HSG+3X(/?/[]K!'IFFT#(
M(L[3"'/E(IA5>4VKA1!2<!8).H<GG97+!':LCJFH5IDSG!<^JK<;3'NUJ$I9
MVGV3S%IGEM2X&?^29T6!495F,$7:,8U"!^2L;3.0H"'Q/!D3VY5>F'BV(9A"
M;5<7?NN?>H(IU6+L+I!"S(&4.YQEF158IMB"]D :YG=\#+)/0?K@\BWF?)5*
MT<_\)7;..&L%HAN%S65>RV+&O.@RIB$6B%7/<7:GA][(L=%8U#!<'46$D<Q8
M%8<FIK(=,A_7H1S%I.<X !AJG7_9D.KK8>-M,\' &Y3OX5%S*=UZ90Q[.6#T
M!F50>%O.H'@F!LW"]5M@:>QE(0>E7GBGU(MMKL&@U O/-4N+Y^]OKR7"UD-J
M""Y"'.)13'1%B]NT4MN*>7DO,GUG@QU@$@$W-<IUV\XI(3+IF:EW9P6/J7(.
MYOW-EO,2R;%,4BPPL>ZS$:@&Y2'4CWO_\# =9^;0DO7+Q[I5Z&HW_/H1"Z7
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MV&HGU>I,$# ;8*O"8XI6ZJS%2Z:PJBX)SR.=FRZY_J=5TZ;,E:B+].IR%A[
M]W0COA]4_DKH4252[99"@ZI9B;-&*M4I?VJG.5-#G;]#)%(M&^MJB58#<ZJ6
MY1<UZKUF5<G'['1MGMAS8K7#L%I] 'U9'D!??Y-YG!;2^@BJ5C5DLI39>F+
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MJR]Z=11_[=&UIV20P4./V8:C@Z;D? <V'.RIK&'(@096>VH<RS)$O-RT:^X
M8SSXF ('BTU#AT513$)B>W[(&/-Y&(*LD\)#IY1[:TN[CS-R5D+OW[NT$-VP
MIZ/%<%.O+=]*N^^W= 3""7:!R>RSNM]NS=#;BI&G574*0KUQJIPN.UX=JH#[
M><]TA.K8D1=$3B+!>&.)'T:^ZQ,[MBEW@]A.C*&K'?'?L(,,=N$,/<?HXQVT
MF)(I6DC*;E+!DH;YEJ1Y,5G&WT"U>)KG$N@ QGR;I?%9OU]\!KF89;HP[&T^
MO;,NQ0-81,4DU[IF<J\9-\\>LT*%1I5ZOM/?/O G_"J6\$V2C4;95QV^_Y*"
M9 /&X[6R3V!^G;N!X<=PF<"W@OP< 2-K]88B=CR6<4F'R;T>!0[X5]@1>&AP
M>9=+Q7I(/6#BAYI\\ O8E_\#=^-V:LK]*I;4)H/!3BE?.6>IP(/C^[9Y8AF.
M/G=UF%F-YAYS(A8JBTM8B1C/,LT[]UJ?O#3V7^)(FX4V!WN7,6X[H2"13>%?
M3\"/S!B2W$(*PTIY:G,AS/%\!',"/%>=K5E(HZ6'O>5FFMMVD8SYM)!S!!<2
M;&#8&1CF1&9,)\AIXVQB/<D)[H%(U5/6C-HP*&;,V>8\M<,C:?$81SA*BWLI
M]FGO#DHQH\><8D8'I9C1%YAB]B8K1=A\]*ERV.<U#KAZM;F"1RS@QUD=2Z@;
MEL>#V@GZC!B=P;@\T&T,NR4MXFF!+^416,M:Q=6)%(]X# PO+*,)ZPRQW#)Q
MU<=PIA;U]N35@TV"WY)*+*ECACD9#[M520YP=PN,<#642"SS"4_'33I42@#V
M+KBMI:Y4OF^A3JC4L+BEC8XGO+(QOC-+"90BSM-(GS:J\_#9X'BEW>:&>6']
M/@::P-4\'Z5X<%X^5C\'14DNE-"I[DSU-<49W (Z:AC-FU//,";P%4U7D*5I
M+CMAI34S#F&2]TL/W^8B4# IL-LQL0!Y;A:.4K, _F@L7L4;A?H.I(-(RT/$
MI P[U,\I_;L9]957]T6*MMPNHZ+UBERO1]>.A-]LGS<]C10V[K@\AX-Y H-.
MIHHDE??2X# 03]-83U)1KW1D>GBHP9M-4G0?8N53F".841/<37 K/.US:<8-
MX@Z?D"6\\2-_79&^[1#]^NM5O;5_F:(DPX7XJDZ+$Q7<QB# N#D'=-[S5+MA
MK7A!RR#MZG"8)N[>^Q1# AWUO5ME-RBCDAYS1B4=E%%)AV=4KE22T%+EVTC^
M5DG?F%"P..*#)NS[H@!2O%4IWMI]UI'J9LI?5:?;[$::2%\P1W@$DPM")D/P
MKGV6<$IX;(MH5UWTR,"LA!U2(G9MUX^]0)+09]2+N(QE9+-(>H(%;FPX]20U
M)<C^*6%P;N8^:&GC,B6FBB=5]0 OJ0@ );<AH6,O$FE0OA^=R_?;LT1::#*T
MY;EEK>YK-L89C\ "5159]W6G\4GVV.D]7E5EZ96TXA$O8#N\_?SQW4=^)]^
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MXI()0P.00\2A?)^>HE"G*-1S7<.7(!N_H^7:.")1_828;@K%[.?UT-VJ_V^
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MDL],F,^W-U?__=>;7]]>?_I<)J98UW_[_?WM/Y^_8+=,N"R]R"Q&,*_JIPZ
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M.L-U?IE^! DRJN*;FK/*!5%I^]4JG%F2 P?B9SC%(E70!K@,/Z:OEQ#_"KW
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M.YL3V4K-J+SV=J]Y4Z.IM4P=!=8[DV09IB95LNO,&DO5@\LDP 1>(7I$69<
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MRA\BK8(#BM=@R(##-9S5/;FE>VKF1H(+XBIQ;FZ\:'1P%C[0OPC<Q6[P6NW
ME SU3'D7BT:Q!2=UL[#>JY^Y-9H^/()8?;!B7MQ;A<0.,.-85GN[:JLRZVCQ
MGXO3*#[R)Q66?I?E'[-BHJ4[?O*F%!;-WD)Q&#B!%TI!*0,V#VTJ H_$7 K'
M=VQ#T2"U7<K*R!G\]*].?.[VZ5&J_.7.YSIK^5^W*,=NDO=CU59GRD<ZUQD5
M5ZVW2K5ERG.FS12,<[?.P? 6YF#8%W2^/30LT0A-#=.*6B"3RVXB*&2-VF'"
M\SLYL:)L/"V4#D&*_-GL_/?L#F, H+_WW*Y$83@HWFD?4'@3>]"0UTDP.(GO
MQ0\\B6\]\$<M;%$L&\4$'P-WC[#[%+:B&O'\20D+7C7Z0]/RJQQ]J8\H55_I
MLO/>8YKSA@&*3CC8M(I_&Q9F^:1#.S<?U3#Z/!L]Z8FJ([C+L3M2J<] 1\!'
M8-CV:+5H\JW2:+=9J1K> #4_*V(V5)D=4NIXU./<#9G@04BDZ[A$.I[C)F%B
M+&-\AJK,[55ESU+YD$&G1J2OJ9.>[HZUSZ"X.7%.VN>D?>;^[%;[@!'[D$X?
MM(%:\ZQU+_EH<C\+'CSF&8@P^$)'$:YNWGRZM*I^FG,B_GG*F4%G-F3NT,88
M)WT 7R =G^,FJTYWUU_+ PBR0><DQ#T)LI,@F_NSF2!+IJ,19O?)D6R;O%]D
MH7QP#*/")<T6NF5G&>O'.F@LO\7RL7GW;^D([L_&TM*H[<7KN6P_?$$K<7!>
MX.FS,.P#7;<1-4<-)MF=5(UUU8A,8U5O+U_Y",_.JY!NXZ5O^42>M2,0P.\C
M?4@W>EK2=UI7EH.!+# X+L>%>N@EHB_=J5CPFZ?9):5A??F5YZ*DT,ULU+I;
M=</$#EW/]:,D$G$8,4I8Y(9QPH+($X023](>$WN_AO5 6&=&[3,[-%C7=:]?
M\YJW>X8_\"=L65UU*A=SSM[B7#=\5;1\[:*>M;O6KT7A]X^RH?2E[B?]23[P
M%*NEKF"!<&I UEN9/Y!F2QK/H8$( H<(C]FNQQ,9P *'3B@)Y=389WS/#E1C
M!<\+&?\$N_9KE@O8)J]^GMRG^>0)Q,JWTI7NYK@U7.O.;GN>%LV@(VURR#-M
M,NA0F_@G@^-D<,S]V?#8I6EKH'IO&!K4_9/C_:68/H),^<N?\/^]]L1QZFEN
M^]+EGNW;8<RHC$+A4.HX(27$PZ*^/CVMGE]+[7JRY1M+L7W\RIP1=N:[X0)5
M_H*T-N<199Q*1Q"L+!)<1#9S/>%X-/08-Q9NMK7V<:SZ1JK=;)KUZWO<\<]2
MYP_*LR"'3+0@@S(MR"G5XJ3SNX\^GE0+/)3Z7-U=IE5\DK%,OR!/*)5],_XH
M<R74X!)3/Y"&#*=A  I:1JXK?.;RA/NA2R(WBIB(N2,,2'3/Z,"*;)1[H6)
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M1N(\0[=XWGY:IUR>L0NV1L'\JY^1=!:]V%*Y^OJ5Z:]^_HV/N5:8=2K.V[0
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ME]6E3!P_C&O@H*H^['9M']B7TP_3GB]7Y>+Y:1/ ?K21M/IS;BOF^43,JD]
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M.NEV]W^YUC^C?W=^>=."W]^%_AU@KT.)M7.@!&\+IQ+ ]/KHX,]P/X7WB 3
MA?_QQO)-V_E=.CWI>[  0=&\V;Z?>\^'&PRH5A$N" #>DTDB(X>@4EC_WDM&
MM%0@93_6[^^EL1?(.*;M#D(7EAGCU 7UM2LFGK(]X)\N;#[D=1$O<#6@RBD]
M.Y2!=&3?2Q 4$U\D\-9QN^U<($8$@63HFDV8\]!5  :G$>*,F$RB\ ?@=R(!
MOW_:;Q\!$OJ^ZNEKGST&R$0B<!EUX=!C+Q"XH$Z1A=?&2=Q"/@*W 2^)I(O<
M$VXEC7"3N(V!%\6)\R_ #00;'!JQ8T7%K:X/B$ L;V0,NR2<Z$)/]8GF>?2A
MJ2/]>'/U^4H,Y0>@V^]G\)\\\WX@TWMFF<MTW),1K_,K\N@GE*>>F$)<G4(>
MP T+/U^=JSZKV,&K]]UWO[[%#;R?A5W^6!-X:*^'Q]\3 SC4S\*_%].X D1%
MV?;K*-(+,9Q95NZ38+'J9[5 59_M_P(LE ]'KHMBZ>VL%\1\9=_V*\"2A\Z7
MJ^(MGNEOP,<16H5#$8^<N;[B]13KI'\5#@BAP5]>_>GV[,.73]\^GW^[O/UT
M>7OSZOTML0Y ^W-X$' G_O6M>*\OJ(#LY0A?2@3KJ_G^*W"9"/@1TOQ9'TC>
MBY,(R!ZXY -5WZ  9"*FZG**QUVL#/QIM=\MASYI 2>+O,&**\'Q_V:UO2K?
M6/;KE16\+CEE;_Z.EBZ.6B[I8M'-K:K@NTQQGT=5A?IN@RX/X6,5(JZF))QV
MO)*[GB6,S=Y^A>?9?-50V(8H;%5%H4\EL%42U)RR<MK*LZ"<!N7JA'+5M>L-
MQM5G<\\)X^85R#\?G-NT?E ;5: N>G4=4'V1PGK:TX91?M>Q>[75;/.P@N&X
M:#KT4Y'GU?N;)'2_[_7(@8\^:1G$Y,A<-\YLM9IS8QB^7GQY\J57Q!;7?[N;
MKA==&<3>'==(6:TGC>S6;AN*?N$4W:EH,[PZD#4$W1!T0]";$]&'AR^.HFMI
M[-?3T%FHA]GJ4&7+7HIMV.:U*P@OHMT2K*4B1W%U^+)[]]1@\@YB<E5R>8/(
M#2+O%"*_ZU34).XD)C=N[15K>Q=!G%*";CWTO)=L)->#0=74:#TX;MQ0#875
M:/_/C\)JJ_'6_<KKN=OG"NT=)K#&[UK\ZD%]_2'2*]E206FOJ^9]%84#&<=>
M& C?&<BJQB +(L=CV-4<F#$^/(*05_K>V6*:+>Q$,9%9-K/>*&NK<WI2'PRH
MQ4TTN+@M7.P>+><T>GXWT>#B=G#Q]5'-N>(:S_[X?.3&/;IB)>U+&%,SA;X7
M3\(8%+5PX R\']@#(8YELIS.UIB<-=O_LS,YN^^:;-R&PFJT_V='87L-?37T
M59_]/SOZ>HD2K 9.T]*:V[HJZ0M/.%D09U9K,Y9#LBZ.A(7+TNOC;UAA)?TR
M[MKC6CLFZH5VM=I,0P,K$LTGR\4S&PIH*&"W*>#D^5' ECW(I3VFM^I6[K1/
MGJBP5J(-#PH96DTR1;Y)YOQ1(0LBUWK[?M?%X'VR\;9@B_::FL5UKGK=;<@>
MMHXZM<W3JC4I/H,C--QD/?C^8KE)IW7<K6U>=:U)\1D<H>$FZ\'W%\M-NJV3
MT]J&0S9+BI5V:O[?90.%G/(!"66C;<I^NJ)Q-\5W/W*!!Z,E\\<6E VM6/4.
MJNW?D333D'"2S\.6,(Z566Q0DW,O8FOVDIXRDX2 5\&>*^)1$6'BBL:.V;NC
M<&Q-;Y+_2KUDZHA[$?7C5OE8)WL,E!Q[Z3BF$TR U7@NSUX*IO K57OK3$+X
MW).YY<+9J%9K=JJ4+X?"]&IQQ@('"\&/$91^&,<\"@@A9V6P%2%@)[0M,QUJ
M<6IY[)">I::1W *,8\&3C<YQVM!&]\3H_M-1^\3,2,*>L]:>: *2/>[H(23O
MV&B-#WAQG!(>A0.\.GB2L1J__Q"%X7=_&CA?OISC/*S.NU\ &;T ?H^3Q43_
MSHL!-=,)[00P<CQF](>U<.VO,AK*B##*OFE$3NG<XW^"4.$+C6&9/=G"M%LQ
MT>G1 -\D<ND$T1OA2QK7=7E[Z9SE<D,7?^NZMJYP\+1];'#05_MFZN;Q0KAU
MQ046O;,.\5LS&(R81VYH&R[RD5B/QW/$: X8(P\\F<<=O2G:4&X+-NH]'H/6
M,[*N'"%^%Q%00.)\\43/\^'0@!9JZ-%FY^G1E7?:!^;*X8;OU>9\:W-:S'ET
MCW[:Q]EWG3<XUBU#EP+#D3]<G$8W$%Z$*F4J-;<X9^ZC@,#SZJXBN?<YI=O2
MP$&&)4F4E$V=N[JX^F1?N,W 0U!&Z4<_=;KM?;,_T#%CE/NA2V/S(NE*4!_Z
M]/[7W3?TA$MM[8G[PK_$<!B![$SDDT]!Y#XS"N]=-@H/]09BH82CITI!,<RZ
MCR\'@!90F-5>YQ9IQ(;"++D\5CG:[$3'<O)81.UEJV,NN[T$90ZGH6&G.A2;
M%\&=C!.<X/AT%7ZMA&@3$Z"-YG2DE%KG\,PY6D2O-!4Q-V"1*3'6E @*(=S^
M5 H0T5YLTRG.?^P>_=F)1X(G15X"[9R#H66T '@H@)?"1B*E+&KD^QWHPR5=
MEI +EK(!FFT2B4DOZR!Q,"(J%7DLDU'8SR'T,\%BSCA3;+T%5D_R]#TM-KUN
M(=?!\N/I9J;DY2BI:%N7QX.?' LNG_.QNKG5*WN][399RU86RVUX<'/[5<.D
MRXB@,(\N_Z;5#)?;UGT]<AYU@]J;0VW%AA1Z+[*O[E.0^I&SW)XM]&NTE?H@
M0O6$M6<+_!IMI3YX,&_N6;W!ORDQMCF)M1U<7(M"]=2Y8[4!Z,:P2^6"GK8[
MJQ\X0>88>I9R'NKJODLKAKX.E78.ECO9^DE@+3NMN(^*5('5GFAN6D#W</VG
M?'UZNA$]<Z-7MQFFU9!-&>Q?!ME4E-;OPKWM#H;MSDY?-"V\<!&R)0WT4;KE
M%^]?J=>GZ$M?C,5P&XIE'>A].WMXF$*?3GO=P_TZ7F5]%+,&[99!N[W9D'5S
M8<]Y#PVO<G9% UB##^H"O8(R3G3BPYQ^-;N@V^V. ;$=4EZW8;"1R%5-S8+:
MG:@AABT30T7E]B[<2$,-SVNG6Z>&3D7A\4Y?R);TP$?D;U7<!J>,OE9*WQO,
MM0_'TMF2]E>C_(\" JTF\W%K)+VJ[5=@457Y[XO$E=INK$'B^8*I0>(=V%B#
MQ'.1^&0+?K:=31N<KTRMH<F?G9.7:]UW:G7@RU78UT016Q86VV42ZVBHLDM)
M /6 QNM.JW.XA72!M>)R?=PC#<DV)+MRDMV"KZ8AUX9<&W)]LH0].'UFN+PT
MR9::$]G?9;W8GE"X[_I21 2@D6G+G8037?"N/M$0XI9CNJS]X\W5YRLQE!\B
M*;Z?P7\6:TBA*GEFEKE,QST9\3J_(AR?4*9_8IH,Z!*A((S&PL]W'E"?5>P
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MG;&7LPS(XYF91/3/K,>2G5@*/P).H),'9U("2G;( 4N2??B+_\%RRBS(9Y)
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M\L=MI=1'$;^2/D-3:V;+^7_;_[+_1I3IA?WI>_QCE(Q]^./_ U!+ P04
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M.'$ ( "-ZNHRG"$"*9#"',HB/?V61<'+Q^OGY[_S^>+MJ%A<D'@AJC!"5Q2
MV2.<+8'_J5 ++])\=BE:TBZM8K'*VLC4K)2LDMJ4!,)JBNJ@<(OR<[DF6X:
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M;I*?O%B,X!MZ\D]>=C/<:38\_/_==V]H$#00H(J<SB?_1IQ/QT.178I<%#_
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MZ+9^<0F6B0GP+;Q>LB1>":X>[ U2,$-@(K2AIA-I5%W/H0L9COAW#D8I*L:
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M$?NPVNDX"KQ3T/IQ.J'YG5CA!(57.?_'2?_TQ$!6I&5*#T%PAGJJNAY_^";
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M?K?;.ABVP^Z1&/G#8Q&V.OYA9S@<'G3:CT.DS0<+'F/"J-Y:69A27P _G/-
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MMDIO51R[#DIO.9=TPSAV<_SLP\WBV/TUX-@7)=G63--FVN];*TV2Y/-5?RM
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M^<(*69V?:DS76@O:>6&M3Z+H>M1<-(P/<9IF_U_NLL3+O-F?%NG\%U>_EC^
M@$AA.]# Z@?U"#)57".+2QU+O\3=JZLR>!FN?XB=2][@8UAY+B,OA(,DZ7WF
M3]!<QW_?/(<SB:J7(,Z)GE?_G**D_9"F!?@*6M=?7GU0TJQN)SW>#WT")]-
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MDEH"VSD:1:B&*"&JQ'%@DT'[-A43"B_G.(Z?&]%^#THG3Y'+*C%A5JGD.'-
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M,@A>1VL4S\@05A()R8&FU )Q! ^FLDJCKG1=MB'33JFO!.:3"I:EJF""]$[
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M.O"S-LV+-!Q&(B_5&?'8FO6&"L>X]1D=+&M/Z*S?/\7W_IIA!/37. 4R]H(
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MV+TH;DXHJO@G#%?8/YKUP[*,L'=4Z&[9*QH['PG*CP+>X$3%4)V>[Y*Y2'^
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MB]DHPAXQL)\0'8!I8'90OT+[3VU#4*N:$4(>^DTP1F5E+7TGC(1%XJ'B8EA
M&RS[HAL? GTLBZ+%[O3$4I#Q_8='V(<8Z=5!&6C0HC6WRYS+?@57!&I"^7:4
MV QK6K-#HT!/-^5X,8N!_?N]C^=(RETC*7O/D91O&4EQ5\WVDJOF>-S5#1SN
M%JU#ATM]<\0SBZ')NCVZ'>U.P5Z(5+<+8C:$?!Y@3 D\&6='YL39I.HU*,4)
MJ0PD<HP]VY6[%N902^+!V@2,V7!)AIWXK(;7LA_A[B+H]_2UFDX)L"=%(1UI
MO#9XNGY*I,DX)8,-Q5@^Z5<#^X" U,20&1;#^8(]# CPQIVOAE[!!+7HO>KB
M&8]#XD3)O4F-9.GK)3_:UZA@VR.[&\QW=!Q% S%TMH=W;VQ' ^0<$%=*ZF@A
MA3''W AG,PA+@E'NM 1,_=*P4@@;)/K;%*4U.%Z5R^(FD0>B2B1#L#6 8H()
MQ?$;=VYM7ZCTDY.8*N+.($"0\*VL"4F*TA&,/1!:?F/Q==!#"/I-X',,<-%[
M.'S:9E3Z'K9$EZ.'MU1L/(ZD$IU((#9/8VWO)$,^L9T=!##(QH[;7[#U(C@^
M"0D)##*"S6-%(SU]'F+RS^ZR :A+CHCJ,SK!8S!B6,]AO76RX93VWT!&2VCW
MMC90A.^,C?]%BX+N)&!%4H)UH\&MI0\3ZQ\[+>H)@YBC#:VCL56&?TG!7*1B
M)F'<AW$^><H:-7.:O%UPXCE:$@F7.1T!H7/W 6K7;.'T:M0+287<+_+4!&[Q
M-,+!^(*&6X8%OY,;M[./ONE>YM\-QN9D[!L'13T3*739V%SBF7B?A(XQ%=&0
M62SQB=""[\R!<5HZ:'J>AK&M?H>!O S',0_ZA@+F@D!7PI,U[D.ZAF3,>CUA
M85.XCC0J]G2 [W>!V&^SD4*(P8_HN'B?0%T2FEA(,*1+TW'2@C=CXXT7D\ C
M0_P5&IF7@'H6.3/^[M"[<=XJWND5^$8>%/5*B"&4(<$3)W \ABX&K=;&*:$.
M@0!5[E$A\--7Q="+Y>.@HM\I ?,(@-F'']Z_.7KW'K&MG^#NV5A>KG\\EL!H
M&,O 'CB)@*(@>&6(M3D744V!7#I2*4T!-X^P7C3#"[?]PWD/B@IX_D$0VIBA
M!*B%P<&R&5:MQEXHS0B>/92/NI>.ZBD7L] ]RKW[<JW! 5^!J35HGE^5-]$P
M)#3G2Y  6G,U."Y8\AH<E$+BGJ!]*@I9.C<+VDQEI/@!U",^2 L.0CE%# 4M
MJ,*Y:HJE'])3PFHC'@(_M9I/NDDO-R)H4_-U4JD7=\F@"@FF"< H,:^:E>#J
M#^^HF2")X%-@^'F42!/PA%*1_8[GY?03R8 24BU++%B+<D#$;&8S$Q.5X#9]
M@";A_H8Z^IJ([2?,J'L+I7('MUEA.C#89"]+HU/Q0Y(<(\XP'^3$3( 2G=@3
MB6-[E5U(\J/S-%PJH2"#ZKD&ZMKI@;8@-"F(8\S_DY$(FMX3O\3%1/!3@$ZF
M7A0\8!Y)G6?QPPHM_:CUM'QR29D[/5<V2CK>B6W8E6!?D(/,3&J840)-AG95
MBY=&BV$9MB/#:(HAAQX*ZJ?YQT*;O!%:#Y8Q3]4X3.LK;FVG]DXLYFW V9,"
M,2AO")%ZL)K1':1F<2EYT?"I:HKS-CQ' !\< =Q_C@!^TPC@QG+<SX07/,=>
M%@9"1RM7>2XZ7#T;&T2>/IDH?4 />+2/0Q779'BSQJ##3S>,Q.>!:;9NBD9+
MARX7 V?,>* ^_GE!O%V)$*8W$3IMW3";:K8($,1!_0R0.U(LLDBMV) :+ VE
M@[&;'S/$I)6LDJ5)X5(6(QP36-T-9KBY4I8J!;3=DO  D#\13B)G@HW76Q.5
M@BF(0(6/"\K]=B,3]$E8+;([<P$HQ&P-:<-E4^"V$;JH97,XC;+D3D\_K8N(
M#O?]?"+10@PW4G8=K@J9/D> T>5)U1;%<\/X\NU3T^@&!5DD>M'F:.@$%].J
MEM6;=#T #.B28UAH!-#M-S5W3_;F[W*/1(%E5%T2,5D6-<5KG[@,#1'DIM!:
M?>FF<3_70YMN%=!%&Y6.I42Z/@?%I+"X*O2>9/IM4,ZO2P/2'KBLB@W2*LYX
M!V;O>+QLB\)BCQ*!"\><)XB?U8,>VE,D:A(. ?+^#!P(/)K"!I_(*QAOXH9,
M(HV@+IG,M_&<'X5KZO33R<'[PZ-[#/@>]]+F<M<XU-A%X[3-BMU+:29 %8GV
MK,:2T"LS *RFY>W,G<55KJA@SDP?POWAD0($&?ZR0C+='[*MEV"J_76E6$V0
MCO(/ZK <:S@9E9WPNG"'PX_NIO)D,$ZY8>V;QPYT0CN_</?C9S[%4"\Q\O/+
MZ9^^=<U3?"\CU1)GH6",1)-W,67$C.SD44^0+UX:V$UAX 84!H(!GI/[,<HS
M:8)GAYM4=C77LATR/>;<G1EU%,>4'\8KI$4-FXNE9YR769:1:Y"A=V*B])0+
M*JR$&D@,JJ#^4%^KYW54(X*XTWX3] 8';V<.^J0UG?DBG7"S4-"B2Y0M$*)8
MD(?C+T<\EA6S!,<_!V1F;E'_O($9AE=?5;@'@7"'!_J($9[:H*:/#$LDLR3:
M(0NDRYM3-^0 *F^W"I!)N]3.#G2+K@YRX,@E-AK=7V5:<CM\4K6?@R;WD(@=
MM@DVQG37<>7?^3D@F,\YY"*)00V6@]HCY*B]5>@4FE\HE[L)D7@]A!+@3@#U
M>MI$.6=2Q?:&\E/6HI+-X&+[H,\.PP=N5&54""GM>DU=0&HO(_ V8.PFD@U8
M*!B/AA]F4"YT'_E)>G5W%Z;A:M8O34#G439:)@6!>W</%-%N%Q'@M^> =,;R
MJV5NUS-)N;KJF^O/KOHCDY0'GXSE?I10HJ'P(VU5@[8 M>5,#*2CE_X83)+8
M,-Q1&>!%JJH0/@<@]T@W1"S=,Z.(N00@J0U)#2*+X[MJ,D'KFYD:5_Z,[(WP
M?UC)*6ZO&UG8S.G%858$"=Q.Q'#J/ T %>8ZP#CA"[\[9% ;J43.G59N2\A[
M.+/)[7&A]7_P:>JJ_C0#++VV\\UE?W73O(:XJ/O .R:D/<2S2&7K!.VKB8<X
MR9T*7_ME"#M$33T"EJ7W(*'@%>E;JMDT:+E>G=Q%O"/7LE/_@V]DA;YD"4=;
M,\\+%C;)*@4Y5H04[C*C) 4-K?:U\VCSU+8'R/>##)V?RQXC]8P0B[E? <!:
MXOA!R).%#!:(68KXF774AF8@+_UCY6GP2:J<7Q(;,4](LN3E >WD51G3YM&M
M[1=-#QDM]$JU2IXY]5$'-Y6'1LD(/1!BVXQ+N- DK+3[:3.PL6V<>U3%N;16
MRDPPNMTBC0^.%R&OA(<\?)#I8/06[BLW^&I5#/%LV#B[X(6?J'/':P$W9/!.
M2(C(G]& 8'1!-S$,4B'?71$2Q?KNP%=4MU+!2P.Z35Q2,I/T[< ;-@V"^1UV
MN_O1&5:4C)$RIB#N%S\:1_H5>.G39E&YS(%TNA>!S/YR%&#!O]6%.@XM80PD
M6M5O_4@\WWGJ,K"?$ON0\<>D),=V?_&?]%=$VU:T7!GBZUDN+VY:WF4<3CG2
MRC-W"A59C6MNN-8]0&?0.VE^76=3OI)&>B5M]EU)&M'SV2<M7 OX:SLP;WPC
MZHDC-GGNF<'$7P[^1.G)<*ED0RI8M9,/O+@@%.?4UV>)4]7$BX=ACDA4%VVB
M#8+&A@(.L#(<4G:[UJ"SG0!X*<R@;@*SV2,U%8+]<=&!J )@VRL&#H1@2]G[
MII@U*[CTXQ[A+[O['W@5?YL;V.M;!8%@WB2Z,@* "RS"S>%>*+F?!E!^W1!F
MV/)-@!FYQ][%?\)PX5MM65[BJ37@RF4[+"[I6*+2P"J@E5N4)*S$3\4_BV94
M+]KLG:!6Q\05A/A!06:/]Z&0M>C,^ZY8O.7=N&:+RW XL@ /'-4J5^M17;/!
M"(8%F<\G?+\I!+ ?"^:4VP65 IJJ%6L?L3@9%)MCV7"Q.[2!+SH;#&Z5NDK(
M?$A)P.T&.H;)8!V=HI&V0\3^@)@6\&ERQK\>1S:/7]\L(CL]HYS%9-6H(,D+
M!%Q/Z8T)/ P,+EY2]:B V,R=GPDF4<A<XGDQ?(L?4UBP$3*HG*=V#C>%>\F%
MFP;8WS"PIAA5=4&E<!Y4_0).J."J$?<&G(ZZ!9^7+ S!\S3H"5C0G*CBE?>U
MEQ6E._E4P:.N5J'(@ A]"'('D'*D=LCY"V-  ZII1*69AQ^MGY$>@ +!"$7
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ML)BVRM_AP\FV4,6L^#MVIOBP1W?C6#5^-5S (>+,5G"""4%0'\X5U9*QY6]
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MQB?\T; 5=37NMASD\I?@Q:)YA]B6C(8EM!029TC<2AAP%EH2X.55&Q>SO=@
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M%37HDVB]S:36\]6Y5%V!-=)+V.$I[&)E<FQJ+A0&@@6*>^0Z4FIH"0QZ+6Q
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M]S53!UDGTJ-L;S*4!/7\L'I")("F[-:ZIO&/-9'9U%KH-C5@P+F/#WMP8/D
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M[TO\[QXIL\V-#?<Y,VOS%/C8_FJ.V-[4,XJ_E;]M;*[2[:XL>6!H5Z.Z^0L
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M;2U[#1"8=-7A@P#NHZ6.;AT#@N>^@_N_!1B$"5A>XB4@F2M"B #CC;LZ!OK
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M#O8'V[N[@_7A_GB\46[M;C]"7)D9NK^2!B^>2H-_F%$UCO!8Q$H+H&?[XL/
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M=/(?;V*LXQCT>W\N+UK>USIF$PT],H$\#(F\/")I)I.66':[:PR+(<\PNY(
M+P^./WCPZ^^?OYP?G1Q[)Q\9_[*-R>MYM$$-=9]KY_1? NYL7X) >)I"+HN;
M&[ YS+WF!%Y*RSU.K@A^T]LA,)*]$LXF^70NHS181JL\GF2^=[28N&D7-0"2
M!QD6WB2I_?8FLL6W:F"]H_E\M:"T>_5B[].G]_C:#]$LN,;R,TI,CT)JGL!-
M-+ S.R:CER81.?"!#3#)]WK02'FGA^^/S@\^$8)DJY7]5 1VT"UW_(N#M5*/
M[>@+N*/&=O6&>[Y"<16R<A%8@V+JSG9_L#'9W-C:=(@K22^"!57WF Q_;-RJ
M\LO/<L2-2*9-5&9*'YM16HD<%0D[#Y?1* VR)&-2S&X4(B7LE!K#=_=,!E1=
MG14:UP9<RWF22IKK!#NC4;LZ!?EM5Q]M<L,$U4:AIOI)D/^P?0UUPJ)?FW:(
MJJ&DRES];+^V6#TUCP)J=!NH.<*BI=L,3:)0#O-<+\&[MGX \A]-$PQ3F3'6
M".8?:VQ3KEF"IZ@.0CI8I=PA+T=+TFF"Q9U*0K?J7Q-.%/D6*4:1?BV^A.I[
MI*$=_5WW),J31E:+4W4:KO(\";??KG*R6T,53U)5O@*EH')2P-I #S%1,Q,<
M/R+DM,EENAI,B0FE@&IA?T\7Y3TFZSX_//W\Y'R; ZI5]%J$",7"UU;P3>X8
M-8GB)9-)ML*&P'&TF! 0#\/W&" 74.@6R?4L"B^H0:^=?6]5:Z,JP8 9V;,5
M<=W*HYS[KB\Z7ZW,OI.WO]@&\=B]*STSMMY\O-U9 >?5O>>-ESS+5G,I,315
M]>,(].+5(E1ZGLT!-%RL;UU$W^$()!16N13BZ2TJLH8.JU13LE /X@7V>)9&
M?-X7W2I\$9;1 ?+@:]0,Z>69$41\Z45YT3=N)%0%Z$;S?*YT7 \CVN5_]7DY
M-71ROBRY2UWHJ+RN6/&Y-K&HCKRF3UV99E1'M*8CU5U89G%T%>E:5M4I34\R
M-T#&U!(&[N-JEFO @ -]BWK>;\DU]C?R:XG6]PK[1JH/-J_A)HS2T':Z8HB@
M) .2R[!GE92ONFS (6N:)LLX*O[%3VMK(O$?+HJ&^T(-)/E5W(T(F#K-*L?Z
M61+-5@.C&;>QTAB^6E5)7H)JM@[\JL6V+09#-*)@NA1PF-'6N?_C931SF\(*
MVQ (.FS(9_H""HRV_3CJO;#/V921LTOOLWI"9BU6BH-WIFR#4F$Y=HJU)L>-
MD4LOQ3LN>*'4O]* ;%K(8VZ)KEXG%74[<H]HE7@"KS5PNC2JV5R[S.31U+9&
MMUBCBE6  R:Z6Q_BLDB#!=P?@\>^CLKTW&ZEP/-N!)MK;,GYI="?!@LLE6X+
MA,K/?&75'NJF9EJMRL6DC1$,*.*OD@]3B2909U?S<4K-VG\6/FN-2+H&PY8;
MX'M'I+6YJ1I@#EA;"1C0(<0^9=A*3;?+HTLR8:%@^H+)Y3/D87#Z"W CSY04
MQFN3@G,8RC&1)X3:R#HNFAQS,/HN@@O& 3#H+SF<;3:-@'UC_SV!!T#@'SKX
MB#Z^2F; BH(TGMUP.U#K ]\Z+VEO5Z*N)J!4#SM9DHN' 0KP(J-7BH=+)I/5
M,A"3RA'Y3O\WZ6A+T\Z198NZHL=VQPJTS#8L'<$L%-+!,Z6,B4,9+M8]4X(%
M\55]+=VK4;Q_"8.,$AH%VS?6MS7F9E3"91$VX[R]]LXV,H0)J5&5M]KJ[&?I
MRS8R1BK>CYQ[WUCLBH'6!%T*S' Z;;1;(H8311290"B(L<>P.?)TFD7H@8W"
M%<\KC 1\ES%?;EC]"%?14WOF'A[LL?S.>X%.E&%?$(!BQ\-I[MDWK._95][H
MSKI]/7"Q5_'1']QH&?X'&YMO;/4W$=8A*^"UMIAOA-2-5%]LFQH J:6+Z":3
M3QC.D!6WC&XWF0QA-1)C9/EFFD@'97LT7\[(XF:_AH41A0Z[2* AW3%=%=U6
MRI,%\,Q ','4)#3(BH8>LK<Q1EXT+ 8*(^/VM1U[>=+#@,REB)C"2-HXP ZR
MK.<S<!5L,,'VW+1Q3/7*:H"@GO>>]Z#"7'5:L<K[ [5G16,,&=YTE9*P-=MH
M6G@G*8VDMW&YPE 3;SUS?PWW^/SDJUR?6V BGZW&?P+E*@)S3^%+D(*B$2PO
MO6V_\I"J2 &[L+/C4T 6<^H*O(@PE"='"RPN!='G]M7.L._[9$+N$G%4BJ^U
MV3RN(-CG>D#K(\F6'7919%A4&*:$@LK$&\/>E2P0?4%MW5,WT>#FR,3#@LD$
MK@KYRS0/>Z:&ANSF.DBB0NZ'V'  AHFOXA!["!3!"(TK; %[!ELW)<6-Z&L!
M*OIEO/3M*+3?D'B@H0)%H[?,?U+I+HE)9I>DUH4KY-JZY7PCO2>*;=M(HHT+
M(%</ST)'=7A1-Q5\U8T1J/$CA-@4ER\^C]8:\E*>LQI(M?JFL3?@2FZR5QW=
M76!0/5M:6A^=5%LMSMZA)]:&FW(;YPE_PNN61? 99BA,T$D6I?A$9D,NPC>G
MP20#\N+FYU\^?/10&_.Y:X8.T&'C=R]+K-ZZABBB#D[T,9(1O""^X+:5F!N
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M5F-4GI:7-YE2SG"*7'^*CMX4/7FJ4ROY!FXD;\:H9^/(=HQ?)]Y<#/BPW4F
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MMD&()Q):IA,6POIE_&J>3);,.>Y1F>R$(XAWA.<:%I([&:13Q CUQ5.N]EQ
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MXUF$.W6\FH.$Q*JI_ ?X^8?!#P=O?_CA[=O[NH!5-^4V^*.'?_OMZ-W1N7=
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M\M>JE<%V+&W4[#=\D>W]W[[(;AVU_K0>+T>71_2]VP^J+_?_!5!+ P04
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M:<;+T?D!__?!#>K_H_P?4$L#!!0    ( *ZKWE0,CMCSX 0  ($/   7
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MQ-)4YR3"'G79\!MNG!-*ZW%92AUY:'NYY]0D=N#_6I=F6^Q3DFO<4U/?TH:
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M/3T]?7SZ]-&G"RCDY/3X[W>W4U%W3/L0/->H5M(">[\G2GY^H&Y<]J=CGOR
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M8Q#/X/ST@9\.=6WW5!2CXPXC+A;'##9Y$IC;2TFONR-SWG)'YD/"^(J;;Z!
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M7LU>%9V&K&7.%67GR1(2S2;+K?*VYE&K^2-0W';Y'B)WYG.OJ!=B=DW]%<R
M>'O=N>)0W*40+:<,E:/(70J:Q7&$-QE6))))B[>',<Y106_4S:ME)\23X6W
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MPBPND'U&T5<?=\S+HDTOM)P<!$^PY)MC:":%07 OSAME+HJKUSFU"M*FRW8
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M2#!P<W S4'K56BBN$/+G012PF":3XFH\ *GS,;:)VE%,V&EI1H61'[#_[L5
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M6A6/_W$3Z+7VI'S=<M]7^+[OQUG>]ZVR\<B( E,R_/#N_/)@^UJGP_I^]U=
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MAJU+B$ 89#EU?N4#]=3<!W(TWXY[*A04K*->%M:VBOO8'%]B6^YZ"MSU-/N
M\'+7DQW +G<]36_TG.!=S^ [^ZXG[5N3!=3]YME=3P[CO+N>W6;^WO6L;T8M
M-STUMSH&_<BXYSD*UXQ3;#BO4Z]$Y1-/T.%@M+%'2;DV> ="$+^ B]^+('F
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M+R#?P@@F\&EOVDGE*>JZJ@S%U^VPRKKQR&UE9/#C>I914>_B[+=+'%]>I3G
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MY#0R?\?EY2TZ)_=U$68F&P'XS"SC@FF-SG&TX(OG26HS$7%PJ"UP&4FU%^X
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M,8I]6)1IVO*4Q6,&?B_(?>L7<B_7=69?CY]K1J;>&%CK^3HZF+&"0N Y0&7
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MPB4,/FFV_(2S>YRAV3T=-SZRMX*_)V2:)R<P:/93B3ML'ME@\QEGMP1*08_
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MM![M/@WCE1, ! Z3&Q44!NM-U^A P1''YI<F/H8:LC@<,F30P*)!JMD;J63
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MG9VAT_/KFZO/GQ;G-]?AK; :WG=GVD@2$FMNLM-;#X!1(R9:;YB8R*X5=N<
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MN3:U>=Y@-@)H@U1!OR'-WM8PD0AE YLDXNV!K+8]6T5%M38(*[K1!(&K";1
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M2;D[#U.-(7H>!^3>C@WU2"(EZ;N01Q,"4.BSL+C=C/+PKJI!*N[ZF0*%8+-
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M1!I%*(*PG;0S6P$Q6_=P-<]L2]9!/<:NMP&3RP:K&D%V$OO-K)]5MEZ_,)A
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MI,L71;4V=;3V V61\"A5BQHFC (Z:-7 QV3L,CZ&U=1*FVF-HJB&6QC'M-I
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M0Q'5ST5>)(_\8 CV]AKBZSB>+Q]U11:ALH(C5":S(([$F@OX'4(08/%<1.?
M.OJ-1$?8#>E=.G$E[G<"NX+MD8(&Y["OZB).BUXLO/M._Y:=N!MDM]8-4>0=
M7F> 5':%0;TJ.LD.OET(ZGV"^0W(R3-N9IQB^VZ\H3(/,]-375LS8(IJY]B-
M6@Z*P4P)!YB.Y@]L,8'?FEV_^=VH'(K2#02>4,6&@T"F4'86Q>HS)*H0E&5&
MN[:K9+UAD5_CY2;C@2^^+=>;%5ZQJT:9FFX*+J87=_71;9<XXWJKUQQH!STU
M@G, IE-0(<&?:^$J1#.! W4:-<JR'MX),TR'W.SJSS.2YVQ5OG4922AB",X(
MH4RZP*!,0*%\B:45]IL$27*X\S*<A3<]P]D)&I5AQN^F:;2SC6KCY77A'5'8
M'K%-/90J@+[P5(R8*\1]>3YV>Y^%07;*QAXJ@]]S-W9?:;G,-K@YL6@XMC.M
MV.\_:2O"2:;&E<O^CIEK0Y4S,195I>H;!(,9C!DC12P?%FTH506-#0G;C3Q/
M"E87>=O0+1Q2NWFV@FUSB2O@G.D<S/H<YPS-H>2DD6F6?2]G\P--X^!S Z7Q
M8(8,+!PWLYJ D4TS4-@Z=#A&"$?D(#GB9%#01::K\0!/0T[& KMO$(+D'F_R
M),5YN=<@3_@>K^.7QK_4HFI7O2>;IM7!A-',H1OIL_)M)FX6)EOR5==#S8H'
M[(C0Q@>AB9,EUH3R8]_^,H$QLR26$)LH0A")DR1_(GF\_IB1S5-^FC*IHYI&
M/V9'%R4I[5Y>/.'R@-&\O,KBFNI?^>I13'&\Q-</&!>S=#5;K?@WC->L]IKD
M&\I=@P7EJ2/HKT5/%P'<,O94,3M: 9\X?,/%\TFCBDIWI2"?L'NMUL',[TQ/
M2O$ZO0^42Y?XIPI&LCM@VM\BA.0D?F>A\?)K7KW]VGM-2]VU!;)K^ J3A5W'
M;S(91S+E"TVV08UYK\G.5ZM?S0MK#N+/E2?QA];IAF*!Q8M1@P!H]WZ4L0N;
MUZ0LXPY".]G&U..7^3K.<XT:RDKV]:U?$DZQNK8=:9#$C:&J"&NW=8*_!$EU
M@!<*CO/2MA:S6-4H4EYV*TF8)K;MD3LX8_LM+ZE-G&75UN[V!>8U=_0E:^ZH
M2H[ECMPV*'>T;I3<T=2.R@)HAK9%*@J%<:&]25,3ZS;I4$=>J44=G6VW>+):
MI];OJM [&P&KP^\,5[+U91!@^;]-2-4?DW7'FJ?PE3<C"4^B S;=/&(.S#3$
MV7% P8 ?"@<;E_:T-TAWT>XM,)1S:=FP]\":)X"&<:(;-,:[1[4YP);@##8@
M+[W#U4"CWT.AU-[34QTAAR\IUO$56:_O2,8J0LGIZ #&BNZ( 'Q)\^"0@Q#P
ML=$[D?EQ06U/@T/U:7!U<<3+\S>)JHU!L]N<'[CHNPOJC[ 0&02$ D!Y9G L
M(-EHY"^QOSFK/%OQM+KY]&-&\APX*2D\ &4=H0?/:440DYOKT9W$Z#([R+S6
M%[&@'Y,4Y<Q"_N?]5G<5\@'E6P,U6'T6.(,48.EW"9/.L!>LNXG/ Y</?XC.
M-WR*C-Q5XWI2'FD9L\HYNG^CNA,8O@:NASU7*EV[KK[4!Y+=X:1@NX'J;Z;J
M2=KVM1RY-^V(@;MW+>O  4_?A7/S!4;E!!<A17.VN6Z]KG+"B@ZPXJP\.X3G
MA]#3@RM>VN0.AUBWS"O D5@E'2>_PA[*U'1=4T?!AZ91;$%\] ;&@^IL]_P
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MC -1S_PMN&N;M]8T@4W Q&H.RGRM@=5(,JBQ,Y+.4(;G'H "0DT75@7 FF<
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M:A&Y))<>U S.-EWH-XCVI<$-C"K)MAVYJCM26NMB=BNZ=*IFI+'I5, 1@8Y
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M37!Z H:F.4I]T^ W:,I'HP\ N1][T!VN\#]U@#JFA/P1&B8]I% T19)(HQ8
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M)Q[Y^RUY/$S%2@/TH.ZB5&<[]C)Z"6IV/DU>DU:7Y-&XN*F?X*<H5144,T<
M;K A(WNU:V]6[)7=.>B: J<@D8*3-F^$TLB!T:(6\5D?IO*P&\IQRG#4Q!1A
M\.@78UBK@8LUG%1ZHU(<NJ1VE:>,04T,$@:#L&=XK]F8^XC912I/.#OT86N@
M:,[C/J;P.V6U+P\ZEM"K,!R9JN0X;QZ(VR/Y(\0P1_]8X^0)%RC*7NHGXAP9
M%BRP]#_)D\>$I=C6[/1&VDQ&L$X/L3AHAI'(U>\8E7B]S4A*'JFCIP\RZNV?
M*->A.$-?RYB=ETU%Y'B7\".+V,/+I)S[2G$3?(A5?Q^=I]HG;IV:JI8#CT6H
MDZIULAU1^+$/0_GLM7:]_HAHQ[[W/NY9)13T4&>= D<$K#2.Z+4B0'^:LB,"
MPLW?.PK)2Y26+[?1"QNLS7/X83[U/-[$!Q>2ZK4$GL\/*K:,30?D],U$4+#U
M+!ZM\G%;U*7D)=]U&&7B"HO7,,^W@)8ZL+7K=6-LJQ>AB6^'=$Z%Z1!S_V&-
M(&BN<@#K=@Z@%PE(@$NNMP!7NWP ,%Y!\P)F5<%R \-J05!['*MTG?!;P*A=
MO@ 8HX"QT.!6^,&-[\#;W,-O:G?>PJ[;L'ZMV(E>;5]O%=>P+ "+-;)N/HU2
MSQQT#._&=-F2KM]H&6"[><#-Y>Y;R;4;QY>W17QLEVN&8M<^]QM<0V_D=M^V
MK=VDK7(-K[/G-0.<:\]#3M^KV=M%-7DK-%<.6%!64W03I4\\J)<+-V49UJ$-
M]X98SVL*U) LYF8!F_XE;AW1"^/T7'7@-B@X''P )Q##BD9B:/5F,*2;"GAC
M"/12.+&8I+D%3O6POO:M^]#K9J*V*.CP7BE=?_G0$3$O&,JB'9_1KLENSQ;]
MNI=&+"U[J.DX,O2Z^_<+M>F:"X6.N4'['NA>,Y58^U[G-Y>)+Q=RN+YKGVIO
M(K/K5-^[QOKR("\74\FV[]K5J^]:[7U@=ET+/'RP0H6O97R1Q5_H^$3R3PDI
MU@FFOU8[J-BRM(::819/N XI"#$L6>HT8=M*A&((2W#Q"@8Q:Z"0<1UY;$!#
MW&VSLM,T 2[!ADQ;9;Z(E,,K(V4E3K^B*(N1($<-_8+<<R@@&D9I:"3ZC^@V
M6F#'>5N-OGBL)Z5LO_[IH\X00$"C+E!)JSQHXV;3;&:6RV(WV>\Y*8J[*#U:
MNAHO0%$0:RL J$S-3EW(<EJG%MA4N3D([*TKMX[<Z-?YD P],EY4,&;T\,)+
M;<7Q'0NJF'6$GZ*FSAT0^HH[.UFJ@CR75DQN">#%O&ZJ86W@J!18LJ*;3>N
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MBE>MTDIJS_'Y,D&1*!5M%E'#2W5K?OT!>*DB0=P)$D")L;%C=3&10"8>)!)
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M:%&0K\*PW)4)3HYQ!39Q&)/3FGR!1JLR!1R$C+*<(O3(,+3^VNV8"\JDVT<
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M5LKEN)IPRZ&2[%JHKP4R%I=7W_&J@5P]OAJ"ZR!+D0N(<SU4ALZ>&2!;PC
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M@E>V"0UP_^3?#H?2DA,:7;81ESTE&E*]=#FJ ?K+@P/(7J#M4":%M*L-J>V
MIO>:??6=1169..:D! \)J-B'FX9#?HR(5^=.I4< 2=-S1";HC<4!/=]?E+__
M7L0[@%8?]% @#DGK>E-)7#K+8N@;2HDG/+[J<Z\<8RI7?T-/1&.5?B;%1;E8
MJTU CP1C?Q5K^!1PDG =9CU+),X2B>-=) ZECTYQ'.O-/R#>N+A-"X#&S2DI
MNA@3"DS8:)%B8GT6D _8,:(GW>@=W<I]/V:BR%T',AUEQ=L=(%IGU;8'LO+W
M)790FJN1S5<QXD<P98\ +:9^CXCQ>C0X0K0:X_MQ5W7!MQ;FJL29?.M7SKI"
MWL#L"62'.!R<6.@5;I?UBH4]0OHHO>@B6K520Q>W'3'S^!X\SIE5SV37:8&O
MJI_V#:MK\F*[KL*%;<CEN'B$9S.:,FBJY6KW^-R-(G,UD!\R-'C%.![2LM':
MI?4;DTRI#2*O6X?^\9@;<S]2P*[)UU//$NNRR(L@Q>_GD %\$J1M8!^7U".$
M*<BL"S!^%0V^_M-7?'V",/H:)PF!)?+G1H>GGSW""$,673R<V#5]_V?_]G7?
MU7T:V\I>KM(X@G;Y!_8,W)"1?QWOW"^^*$2.=!XMDWCU<XDP62),E@@3-\1;
M(DR6"),EPF2),%DB3/S8O.P^#+F*_E76N2,HLY28\)ATBTWHFIS4:4J&E"NK
MZ<GI(8,W.-#\].[GL:IG6/O'U!E+N=SI>H=L.6OV0JJ3H+X.^M:"5UMS24.V
M%FMA&W1HE5FX#?)ZEWR55 61Q'0XR="V$.+3N@\;!5D5H<+G[._NBL0$ 96,
MJXQ>6]^(S_9]ND72,_9XSXA7E<?O1]S$:5R N_B [WH50?H:(WEK<W[Q]CGX
M%\PNDP#I9^@M:91L'UA7*>FD:DZ-9&:;U2PM5A&]M,5C6S04X YDU0L0>/QL
MXSW=69.@; ]M>93V'A'7[%*H(GK?4BE661WB\JKR/:+V.0NB*@,I'6&LSXUN
MAY]]Q)) R-$ &O+WUV/3F:3@6.,MW0-D$[#VE:M^GYZ?OO<QWA54JON\XEKO
MWM75K$<0PM<T_AWU<X0@$V_BX-C3[7%M&R-#/;:]!X7\(>D4M;'/6<W6YEVW
M447"*730!WSSXA DJ"@+YM-6-J[3I"NS?L(T-?;I45W3=9@P*L:DE(R ,J/2
M^;Y:,*J?,L-XKBD1%X#45#W1-Z&%$%0YA9U@5KE8BTDZSV^;P931XQW1R13T
MD(%]$$?7W_!3IP#1KXLMR.IO<UD1F39,;5;X;5CLS#S=>SZ&AR_T&:R_36CL
M(8-[D!5O#TF ]%;[>7M*LLQ9ZYS TG#J7"S+--WGM27A"*E_7W>*,!:30C_!
M3?$5P?4*'$ "*W%Y-]+GJ'("4\"N<K$$DW2>UX: +:/O]ZI-:HD\[ZA<K>=M
MD#(NUUJI>P);(E'W8E2F[4ZOK8N$L/K7Z\]JH=(L[;H?PA"6*5KG!6^4NW96
MZIYNBX17]V)AINU.KRV,A+ :21Q^KBU,"E[QJTIGY<J@OIC0E'2X3V L*NZ+
M.1C;)5X/^$J<9DC_Q?>UB68JMR5UWMP#<9R*K0TXY68W ^NOO@ZL<TAV-166
M75E@#M9^/_L7PSLBO=:$\8ZC\W*9;9N-R_/40X3U2Q)7GOPS_!S$*7X^M8G[
MPO_3B?WZDJ(6U]F,5J\9H#VK9X17TU\C>3F/?I.Z4L/VR)JMY1.GGX&!M'K7
M-TC^&R:H86C$IM40*X,$YZZ,JSN9^3.\30\@'RSO]$JWWJ%J:>=!.4X?BB96
MM2YKS^[2<PAT7JM815$E7Y \QJ_;(E]O4..&*6I5BK09!:2*.(\K#<G5P"17
M@5O']]TW3I\"?-^H;B^)&@$9Y77:/IG[Z)"34!$13*93'-YZ<D7.O82JIE+?
M+PE5EX2JM72=A*H=HB5;ZJS2WJ:HO\ 3ZO1JU7 1)/@%[Z<M #BB[C1#HQX*
M$YB7""(7;W5W!<FG#);['+%(2IQF'M,@US!.\6-']>OU2$I:DM69:VWZ8+9:
MS[D[*=EDYJUTMLZTG<-&J;',7#8CN33:UN9B- -N;4+9Z6]IW[NY;_O?K?DE
M8[L$BL7M^R2:%1XSY/8KFN)FZ8S:G]E:05-#L-^E\TB!$:#=>G^3F\SMGD!+
M<^C<D#JN..>2UN/,QTMROR6YWY+<;TGNYTG,RI+<;TGNMR3W6_Q?7?_75$[
M&9U8G52"/B95F5ZE@Z.MV38668=JL]9L:H^L>]1"/[#@4/0V^@@*>]@C#X?S
MSK'99A,G,>H@U"&(+"K# @W%?KX4QLF\(A?&P;TT%\L;C?3NIASGZZF%MM78
MJY)VR"]=E6/OD73$$(\V26H*O$R-0HZ9:,P4WTIUVX1C#GEG"WJ<:.<+JIRL
MC2_9#B;W@$>IJC_>!$T8;."J5NW6^-,4Y3I'/?G5#'C[O,;!M^5UQ@"FJFLN
M"+>5NQ4)K2E,?3EA%1VP)WH'@Y3T<HSS'0=N&M\S!KI0C7.!GM80MR*R-05#
MBVR =%BL4_.#@,][W$!@\3[CP2"ESKD&!*LQ4P29N[FX$R\^E!=Q5);6YEE#
MNPU-?I^- M 82S\#G)J>&<7)D> U?G/I=]KT[3J?G[HM9_&S-O)-@$O-MDNI
MM&]#1C12T=:S&J>Q='4L98Z*[IJ$0?>P #F^U8SGN%-:]V'"G$EXJP\N&=[O
M:* IJ]K6H)-IJ(8[X.\ ;#*9<Y\&,,5.9SU"9?>.1I:,0FT-)D;;-%;M/H\?
MN23W)EEJK>N=2U%O8RSI9)>?<SR93 QO:DR-W0N3S/QND*/Z^' P;_O\PT,K
MY?I\H\-HMG1_)QPR9DM_&+$XJ0^?(:=W-&P$:K0U7(;-TLCV[>\P:3.E?= ?
M'P,6Z@.CP^(=C0B6XFP-A4Y[_,]'K2"WD16]D77\>UV]N[=FIZW455(Y2XP&
M=PX3S1UG21TTCJK.XT<#.ZE(31Q"FF+7=-UX=EX8>^+IA2II49@ABH[\X\]2
M9+CKGZ;PN5NS,L8 J7>HHJ#SOID:VV[-LQ5^>[V-S&W2VJ*_ZL2U-W%:1>6
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M1;&T1T@;IQE=\"G7VN+1Z'&*A8[A)G& FDD/Z+U JPKK7K8*_7OLO-MOGF1
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MY+MX>Z@ZB,"=1LGV&1R5DJYB3U]\*?0IL;<Q;=$W?4KLRZ$)&+^3\ 2"07@
MFZ#=]J$0N H!H3!2/4WCXONK-G3;.<@JQZ?BSE,.PT).K!%ST*ADIRX#Y!$$
M2?P[B#ZA]<X=S/-U6I^'!8D4<L3%N9#B%?<+:]**& %"7AW^'X*+(C_$JPNU
M, \JO_>YX'<OF,-4IO,EF..]!'-TXH%OD";2, Z2VQ1IHJR&^%T<O,0)$A3D
MGT&0ETBH57$L8SV4X]22. \3B-O'VF61(6VPPB>UYXH<VU5? URE$:5[UNDC
M",L,WSI !/<PS=I_7@1YG--B/(SS)?4XGJ\#2K]X._[YWS'(<)CIVQT.,J6<
M9:D5(M4E*.2 +IK.JTS$L*W4<S*MLJ1FY,HZH*#;=%\BZXD[[0/U2$Z"DA2>
M1FEMVM;K3J@B>'_*5JH0S^'<BCS>!Z7)]5$:8Q^E,?;QO#!&%WP"C'TD,.;C
M$1U-KI^D,?:3-,9^.B^,T06? &,_$1CS<-VGZ"+!<1X$HP^X=?>4+U>GO_L@
MYM< 4-,-9G35V';U>E/0'H^]@\LDR//UYI<@RX*T6&>/\>NVH*Q0A'1M-!B;
MSC$AJ:L."4J>H*:C]AXR<%/B#9JFFIPZIPJHVDO)+"IK-D1&V5!6O+X9X+"N
M+AVS6%I[-)<>M%DE<>?V/8^D12J5Q/5>EQ!,J<OI_*9XDM:V+DD_2-ZF22BT
M=72X3!>W!@@[8%Y/AM.$<UAV7KRUNGFK).5OL;)IASNK-%H'!.9#H>K[+RE\
MR4%VP!"HEH+H,TQ#5*H"&"D:?Q-VZOI(Q4]7G[W.NP)9? AP6D;AR1EEHM<L
MW2A6N;1]"SPYY.!8I3+L]50-QW9<N<%G,!5S#3:<WT@Q]X:&S>QM(DS7O#/H
MY(FVD813_3R[1[1F&-Z*]2VPX(YQA6<2W@8##.Y<N"1T%.0>%)4L1X")HEF$
M!4A5<0K8D[_3;93@&X8.U JU3])(%G)5%THZ4)+=XJRAV)-04>[^G"!76?48
MCZ 2:YN+4VZCMY<\GK"5K&2_#)($1!=O[5Y;0RAUHJ#.C;<=K\+-(S";U9PN
MVD>W0G_CR9'$?@J3JM $2<7:BRL4FZ%S",*?QD>$&FZ2^>7#7??RA$Q[WG<W
MLA=_$ZP?YE@LFFFV_BTZ9T#!B[LWU,_BBQ^\UICJMO.^$7*Y#=)7D-^V1Z\=
M_2S70;S;M5FN@RS709;K($NHOE-AU-9"]7T,^%Q"]?T*U3<5E[.$ZB^A^DNH
MOL^6>PG5%XNYA.HOH?I+J/[,O;Z$ZB^A^F?BUBRA^@YO/@Z.99:0,2M7!RZ#
M)"R3ZL]'F"0W,/L:9.1[OK/59_[J *L^4[["^@"RI_+E]-;A#I8X[6 (X@,@
M]2A'W#X?(2"V;ZPG1P-45-ED0?ST=E:I^07M\SU.K'K._!'L2[3V#G+PD,'7
M+-BMRF(+,YQ8LY;W P%TQ5+=Y^EE2KT/Z.LIT<(8D&[H.?@\G1W&7^)B.U!:
MWM=:_DBX#TW,3\5+XES,6!V<\S,#=;R/$3E'!UD8OQ.)I7\I9@^R&$9/19 5
MUB= 7>4P='.;YR5@+GJFJ&/DP!?4L0Q\4QWDT< 7B&4X8-'V!9Q5]*^RSGHN
M<0%G2,RY@-,E?A\#24EE%D:$J'V&WPSP82*S[L'^^G'Q8>U/96I=Y-%D)N?%
M_J>N%WN=1K:/JZ:_8C/3OO!<-W2F$V<YHELN^+ N^/B<R'>YX./'!9\[)"7(
MUVAJ0AS3U^J?UJ_NU(UB97J@?FP75<1'8Z=Z/06M,A"0)WE,@O;TCD)@[UHZ
M78=00@[B1GF/477^16'@^YG7'4#V ?0E>P;9;KVYA"D=H[(%CK@5%W 0+<IR
MBM CP]"99V.1_0>/2)H'D#W]5B+UW4!((H%+T[Y63J=QL+]EI!%U,8.'M;=C
MZ0&_I^>*F^;>IF&&95FGUT&X7:5I?$#U!MD;&02L7K(-#%8IZ2 X]"4704:)
ML^]OS-),(!(9? T2; DE9AH*-6>:Z5$[""LU"74FF!XW&QNZ5!-4MQ2'2\?5
M7O,S?#C%4Z#V%Z3ED2_00P._@+. 4)!3#A-\AOJ[?E-,3U_28 >S L?25.)L
M81+=[O89/ #:B^6RY(V^Q.0.HD)11A$FQ.P:1/S9UWGF"NQA'M>9ATC 4+\=
MLTWWOCD(!5[K1?U.E&TZ^2]^;NO<@Z(_TUU_VX,T=R YB]4='I,R7,*\X(E!
M^]Z5I/_=GC!]G.!6<3>XN@34#:Z:P*YQH.I^L,=%$85B)+J\AMM<-0^/KQ\_
ME2\)%@2MJ^"./,2G?VQCM(F/;G8Y5P2)[B;+:^Q!_5QW=0I>@P+0CX#G[/%_
M!%F,CRY8XYWYO5$:Y;N;72\21*+W*2P\3O#.ZG&6@ISOX1$].^Q1G7TC6 2)
M[9@.WGJ9[X>(E\>#\N=TVEE=P86;,J>> B^>L@$9:(JM-UT8<LD7:&25*3#1
M63"JA+D$D"&EGP\3I*XL#*K!LMY\:08+5UP&+57> :TU.RK598-%!%_6OH7E
MU3!<6@PXZ]M>EV[1<(5<U5MOE;Z:+0L5I'&*RX"/6MQO/(HU8A"BU,HL+IBH
M1OR7+"[ >K-9;U0,G&*I1K?2I9P'F9[\:MB2KD-C">;8&MS8W#H(M_<=:&K2
M3C&_:JP#G8GO5W"?AR%_/">UKVAQ-92 0(*]QWNF?<%$C[1)4E/'KU//LS&:
M)B>NG)C.&"CNFS]R(O)L$_6%'R9;RXX_(S%FG(;Q/D@>@K?J7'R=TML?#^ZX
MZQ0]IM!4*>H#ED8H0QE@:G7YXKBS#)$TO<!9]\PXJ8JMC"*)"L[-05><ZP1.
MN6> DA72^'QGW!%W $#W,,5WR(89)*3I^9#JTGL,+J;8ID#6K<#C3 X,Z2Y5
M(':I@J_+,P 776!3R+HD8.5SNH QVPFBA>[X'05*#?Z^KL(^Q5<^$A4=Z\LP
M]/N<_W-0-.\4LYS4=W_ S[EYTM?8+P#ODX)H=4"_OH)'@#/,=V]H(B#A6_95
MLEODN[>M8LHU716<NT[CJW!EDA=*0F;@U2U.=01DBENTH1-B:S#!*6N2M,OF
M&SN<(V4:>38[\82P74TU%TE5A@:GN,S0H!9_GT-#K$D'A@:UD>?H3\XP ^O<
MQ1W?!-^3C3 ]U7:[_JIDA4WJ%.4N]%E%W;H=?UP!MFVM48-@@%\MS\,@^2<(
MR >[QC/B^)FRC!S;/A$@A6$UM+0FL\]";P[+<L@VPW?[("4[TM<]6C8_?P7)
M 7R&:;$ECU_'LE%!/Y7->6)?K+$9D$]MA,=O;<@*C0?X\U>HB72BM"+ CZ7/
M%M=T_<P#YV/=7M^[4Y 5U4S&O&N7UT%R7?Z\L4S1T8QHKFOW^6D$!6EO8*GE
M@%.*:Z"Y+G[68*9H:#XLUY4[ECE+W/35!GGT(]%)Y:$(48+'V>*4IZMYP$JT
MP%I2KYDML":V->%\Q@BV MI1J<:8J0F<P>F7-&KV<T%T_2U$I/7SD"J@%?&0
M03";QWG!65)7$V*;W0*-=&OG%#'L:;RP&)#F8M#9D!/%$?_UG$[O1ISTJ"7P
M%[$VM*OH0808?L'GX[&]4[3I$X31USA)5FETF^XSB"WC(ZH! 65[!0X@@7O<
M =8CUGKM+(+T-7Y)FN0YIX=6&$>46F4;Y"J6M3<)W*)^W\2H<Q&,#F#06#3G
M)66$D-8*1.A(MWBC)O7BU@R<'AK@:!7U;:!2*[")5*_=]T-'!E(9ZO496=,@
M9H $'X_AGK9(W0]9' X2A X^M,E!.Q_\@P)3K)%@Z/*U]NR)8<-PN]L'<8;=
MDSN8D[$&?"+":)!$_N%&2EQ#!H6LP]!YTNS^^"H,LQ)O!SB2H!PM=G#&5WP_
MIFI:D+"N:$A0MFD+>)3VAO#U;I_ -P >05)MH9Q6/O0+A-+TC=@2]-;&N$SG
M0761^X.;4PD>RA+,;<3F4X_6FF':KDIQ,.YI8=H.7@(O2F7:?)YR95S'C8[H
M2MB1K$#?Z9SB]9JFT9] "K( 3WFK:(=64UBJ JVG^#"2+=4'DKB4)U!2%%\'
M3.(J?'=:&T&%,YV0K@\R'V<V61%U@,29R8QF6;< G8<,;D">(V4$R0T0X$=
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MB@=]XE%='NF5/><3&+Y9DO;J2"[NG'4O47E+5-X2E??>H_+:!M\5$7*&;]
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M@R&7<I/6T73K1'5X,0+FT*_ZL)FH5<U8^]F-I=OZ #)\,AMF<76INMZ 1"*
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M+FAT;5!+ 0(4 Q0    ( *ZKWE1(485SA10  'AM   7              "
M 7_" 0!B<FAC,3 P,SDR-C!?97@Q,"TU+FAT;5!+ 0(4 Q0    ( *ZKWE33
M40UY@&@! &%^"  7              "  3G7 0!B<FAC,3 P,SDR-C!?97@Q
M,"TV+FAT;5!+ 0(4 Q0    ( *ZKWE11*L:DMP<  ,(?   7
M  "  >X_ P!B<FAC,3 P,SDR-C!?97@S,2TQ+FAT;5!+ 0(4 Q0    ( *ZK
MWE2HM.#_<0<  % 9   7              "  =I' P!B<FAC,3 P,SDR-C!?
M97@S,2TR+FAT;5!+ 0(4 Q0    ( *ZKWE0,CMCSX 0  ($/   7
M      "  8!/ P!B<FAC,3 P,SDR-C!?97@S,BTQ+FAT;5!+ 0(4 Q0    (
M *ZKWE3W%=B.R@0  .D.   7              "  954 P!B<FAC,3 P,SDR
M-C!?97@S,BTR+FAT;5!+ 0(4 Q0    ( *ZKWE0AL1<(6!<  +K_   0
M          "  919 P!B='@M,C R,C S,S$N>'-D4$L! A0#%     @ KJO>
M5+'SP\QZ#@  .\0  !0              ( !&G$# &)T>"TR,#(R,#,S,5]C
M86PN>&UL4$L! A0#%     @ KJO>5/9 #\.K1@  @R\% !0
M ( !QG\# &)T>"TR,#(R,#,S,5]D968N>&UL4$L! A0#%     @ KJO>5#C^
M5 ;(SP  O\(, !0              ( !H\8# &)T>"TR,#(R,#,S,5]L86(N
M>&UL4$L! A0#%     @ KJO>5)R!;;O390  J'T' !0              ( !
MG98$ &)T>"TR,#(R,#,S,5]P<F4N>&UL4$L! A0#%     @ KJO>5'_.XY"T
M$   0!$   X              ( !HOP$ &EM86=E,# P,#$N:G!G4$L%!@
0   -  T 8@,  ((-!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
